Citrus Sinensis ID: 042150

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800---
Protein Sequence
NYLINCGSPTNASLYNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTSDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEIMKMVHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRPADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTNPPALPTRTIVPQAPSSHVREKEVDGNASSDLRTSQVFSQLMTNEGR
Secondary Structure (PSIPRED)
cEEEcccccccccccccEEEcccccccccccccccEEEccccccccccccccEEEEEccccEEEEEEccccEEEEEEEEcccccccccccccEEEEEEccEEEcccccccccEEEEEEEEEEccEEEEEEEEcccccEEEEEEEEEEEcccccccccccccccccccccccccccccHHEEEEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccEEEEEEEcccccccEEEEEEEEccccccccEEEEEEEccccccccccccccccccccccccccccccccccccEEEEEcccccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHEEEccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccEEEEcccEEEEEEEEccccEEEEEEccccccccHHHHHHHHHHHHHccccccccEEEEEccccEEEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccccccccccccccccccccccEEEEEccccccccHHHHHHcccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cEEEEccccccccccccEEEEccccccccccccccccccccccccccccccEEEEEEccccEEEEEccccccEEEEEEEEEcccccccccccEEEEEEccEEEEccccccccEEEEEEEEccccEEEEEEEEcccccEEEEEEEEEEccccHccccccccccccccccccccccccccEEEEEEEEccccccccccccccEEEcccccHcccccccccccccccEEEcccccccccccHHHHHHHHHHccccccccccccEEEEEEccccccEEEEEEEEEEEEEcccccEEEEEEEcccEccccccEEEEccccccEEEEEEEEEEcccccEEEEEEcccccccccccccHEccEEEEEEcccccccccccccccHHEHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccEcHHHHHHHHcccccccEEEcccccEEEEEEEccccEEEEEEcccccHccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEHHHccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccEccccccHHHEEEcccccEEEccccHHHcccccccccEEEEEEcccccccHHHHHHHHccccccEHHHHEEEEEHHcccccccccccHHHHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHccccc
Coil and Loop (DISEMBL)
nylincgsptnaslynrffvpdassksvsfsadnsislksktppqdspspydtarvftsdgsyklnikrngthlvrfhfspfesdnfklasakfgvLANGLLLLQDFSTQVVVLKEFIVKvdgdvieiefrpvgdknfgFVNAIevfsapedfivddgarvisgsgsiEEFRNLSSEILETILRInvggseltpfndtlwrtwvpddeFLVLKSAAKRvatthppnyqkggasreigpdnvYMTAQEMNrdnamlgarfnitwdfpvgshgnrhlvrlhfcdivspslnQLYFNVFINdysaykdldlssitfhslaspvymdfvadsddagvvrvsvgpselsgslkVNAILNGVEIMKMVHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKcrkkkpkprpadsvgwtplraygcsshskmsegtvnaspgqngyhrlkipftdlqtatnnfdknliigsggfGMVYKgvlrdntkvavkrgvpgsrqglpefqTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMekgplkkhlygpdrtplswKQRLEICIGAARglhylhtgsaegiihrdikstnilldenyvskvadfglsrsgpcldethvstgvkgsfgyldpeyfrrqqltdksdvySFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKgmlehiidpqligkiNLDSLKKFGETAEKCLAdygvdrpsmgDVLWNLEYALQLqesgsglpreqredsntnppalptrtivpqapsshvrekevdgnassdlrTSQVFSQLMTNEGR
Flexible Loop (DISEMBL)
nylincgsptnasLYNRFFVPDASSKSVSFSADnsislksktppqdspspyDTARVFTSDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFIVKVDGDVIEIEfrpvgdknfGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKrvatthppnyqkggasreigpDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSvgpselsgslkvNAILNGVEIMKMVHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLfkcrkkkpkprpadsvgwtpLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVkrgvpgsrqglpefqTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQRedsntnppalptrtivpqapsshvrekevdgnassdlrtsqvfsqlmtnegr
Low Complexity Region (SEG)
NYLINCGSPTNASLYNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTSDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEIMKMVHLTVSETGEKNKKIWIvvgsvvggfvllclvalavlvlfkcrkkkpkprpADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTNPPALPTRTIVPQAPSSHVREKEVDGNASSDLRTSQVFSQLMTNEGR
Disordered region (IsUnstruct)
*****C****NASLYNRFFV***********************************VFTSDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRV**********************YM******RDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEIMKMVHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCR************GWTPLRAYG*******************GYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL****************************************************************
Disordered Region (DISOPRED)
NYLINCGSPTNASLYNRFFVPDASS************************PYDTARVFTSDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPDNVYMTAQEMNR**AMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSV*****************V***********************VGSVVGGFVLLCLVALAVLVLFK************************************************IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRG*******L**FQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA************************************************************LMTN***
Disordered Region (DISEMBL)
NYLINCGSPTNASLYNRFFVPDASSKSVSFSADNSI***************DTARVFTSDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEIMKMVHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCR**********SVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE***************NPPALPTRTIVPQ*****************DLRTSQVFSQLMTNEGR
Disordered Region (DISPRO)
NYLINCGSPTNASLYNRFFVPDASS*********************SPSPYDTARVFTSDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEIMKMVHLT*******NKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKK****************************************HRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESG************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
NYLINCGSPTNASLYNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTSDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEIMKMVHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRPADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTNPPALPTRTIVPQAPSSHVREKEVDGNASSDLRTSQVFSQLMTNEGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	803	2.2.26 [Sep-21-2011]
Q9FLW0	824	Probable receptor-like pr	yes	no	0.981	0.956	0.655	0.0
Q9FN92	829	Probable receptor-like pr	no	no	0.967	0.937	0.507	0.0
Q9LX66	830	Receptor-like protein kin	no	no	0.971	0.939	0.509	0.0
Q9LK35	855	Receptor-like protein kin	no	no	0.980	0.920	0.476	0.0
Q9T020	878	Probable receptor-like pr	no	no	0.962	0.880	0.471	0.0
Q9SJT0	871	Probable receptor-like pr	no	no	0.922	0.850	0.480	0.0
Q9FLJ8	842	Probable receptor-like pr	no	no	0.943	0.900	0.464	0.0
O22187	834	Probable receptor-like pr	no	no	0.965	0.929	0.438	1e-172
Q9SA72	849	Probable receptor-like pr	no	no	0.935	0.884	0.415	1e-168
Q9SCZ4	895	Receptor-like protein kin	no	no	0.905	0.812	0.430	1e-160

>sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1

 Score = 1045 bits (2702), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 530/809 (65%), Positives = 631/809 (77%), Gaps = 21/809 (2%)

Query: 1   NYLINCGSPTNASLYN-RFFVPDASSKSVSF-SADNSISLKSKTPPQDSPSPYDTARVFT 58
           NYLIN GS TN S +  R F+ D+S    SF S D SIS+    P  DSP  Y+TARVF 
Sbjct: 31  NYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSISISDTNPSPDSPVLYNTARVFP 90

Query: 59  SDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFI 118
             GSYK  +   GTH +R HF+PF++  F L SAKF VL NG  ++  FST  VV+KEFI
Sbjct: 91  VGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLINGFSVINSFSTSSVVVKEFI 150

Query: 119 VKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGAR-VISGSGSIEEFRNLSSE 177
           +K+D  V+EI F P     FGFVNA+EVFSAP+D+I+D G + VI  S  I  F NLSS+
Sbjct: 151 LKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIMDQGTKLVIPNSAQI--FSNLSSQ 208

Query: 178 ILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIG 237
           +LET+ RINVGGS+LTPFNDTLWRTWV DD +L+L++AA+R  TTH PNYQ GGA+REI 
Sbjct: 209 VLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAARRAWTTHSPNYQNGGATREIA 268

Query: 238 PDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFI 297
           PDNVYMTAQEM+RDN  L ARFNI+W F V      HLVRLHFCDIVS SLNQLYFNVFI
Sbjct: 269 PDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLVRLHFCDIVSSSLNQLYFNVFI 328

Query: 298 NDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVE 357
           N+Y A+KD+DLS++TFH LASP+Y+DFVA+SD +G++R+SVGPS+LS   +VNA+LNGVE
Sbjct: 329 NEYLAFKDVDLSTLTFHVLASPLYIDFVAESDRSGMLRISVGPSDLSNPARVNALLNGVE 388

Query: 358 IMKMVHLTVSE--TGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRPADS 415
           IM+++    SE  +G++N  +WIVVGSV+GGFV L L  L+VL L  CR+K  K R ++S
Sbjct: 389 IMRILSPVSSEVVSGKRNV-VWIVVGSVLGGFVFLSLFFLSVLCL--CRRKNNKTRSSES 445

Query: 416 VGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG 475
            GWTPLR +  SS+S+ +E TV++S    GYH L+I F +LQ+ TNNFD++L+IG GGFG
Sbjct: 446 TGWTPLRRFRGSSNSRTTERTVSSS----GYHTLRISFAELQSGTNNFDRSLVIGVGGFG 501

Query: 476 MVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV 535
           MV++G L+DNTKVAVKRG PGSRQGLPEF +EIT+LSKIRHRHLVSLVGYCEEQSEMILV
Sbjct: 502 MVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRHLVSLVGYCEEQSEMILV 561

Query: 536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL 595
           YEYM+KGPLK HLYG    PLSWKQRLE+CIGAARGLHYLHTGS++GIIHRDIKSTNILL
Sbjct: 562 YEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGLHYLHTGSSQGIIHRDIKSTNILL 621

Query: 596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF 655
           D NYV+KVADFGLSRSGPC+DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF
Sbjct: 622 DNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF 681

Query: 656 EVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKC 715
           EVLCAR AVDPLL REQVNLAEWA++WQ+KGML+ I+DP +  +I   SLKKF ETAEKC
Sbjct: 682 EVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNIADEIKPCSLKKFAETAEKC 741

Query: 716 LADYGVDRPSMGDVLWNLEYALQLQESGS-GLPREQREDSNTNPPALPTRTIVPQAPSSH 774
            ADYGVDRP++GDVLWNLE+ LQLQESG   +P E   D  T+P     RT      +  
Sbjct: 742 CADYGVDRPTIGDVLWNLEHVLQLQESGPLNIPEEDYGDV-TDP-----RTARQGLSNGS 795

Query: 775 VREKEVDGNASSDLRTSQVFSQLMTNEGR 803
             E++     S  + ++QVFSQLMTN GR
Sbjct: 796 NIERDYGDGTSGIISSTQVFSQLMTNAGR 824

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1

 Score =  745 bits (1923), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 419/826 (50%), Positives = 529/826 (64%), Gaps = 49/826 (5%)

Query: 1   NYLINCGSPTNASLYNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTSD 60
           NYLINCGS TN ++ +R F+ D  + +   S +  ++  ++    D    Y TAR+FT  
Sbjct: 30  NYLINCGSSTNVTVTSRVFISDNLASNFLTSPNEILAASNRNSNSD---IYQTARIFTGI 86

Query: 61  GSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFIVK 120
             Y+ ++ R G H +R HF+PF+  NF++ SAKF V +   +LL DF+    V+KE+ + 
Sbjct: 87  SKYRFSVAR-GRHWIRLHFNPFQYQNFQMVSAKFSVSSETHVLLSDFTVSSRVMKEYSLN 145

Query: 121 VDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEILE 180
           V  D +E+ F P GD +F F+NA+EV S P+     D     S +GS  +F+ LS + LE
Sbjct: 146 VATDHLELTFTPSGD-SFAFLNALEVVSVPDTLFSGDP----SFAGSPGKFQGLSWQALE 200

Query: 181 TILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPDN 240
           T+ R+N+GG  +TP NDTL R W PD EFLV K+  K V+     +Y  G A+ E  P  
Sbjct: 201 TVYRVNMGGPRVTPSNDTLSRIWEPDSEFLVEKNLVKSVSKIASVDYVPGFATEETAPRT 260

Query: 241 VYMTAQEMNR-DNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFIND 299
           VY T  EMN  DN    + FN+TWDF V   G ++ +R HFCDIVS +LNQLYFN++++ 
Sbjct: 261 VYGTCTEMNSADNP--SSNFNVTWDFDVDP-GFQYFLRFHFCDIVSKALNQLYFNLYVDS 317

Query: 300 YSAYKDLDLSSITFHSLASPVYMDFVADSDD-AGVVRVSVGPSELSGSLKVNAILNGVEI 358
               ++LDLSS   ++L+    MDFV  S      +RVS+G S +       AILNG+EI
Sbjct: 318 MDVVENLDLSSYLSNTLSGAYAMDFVTGSAKLTKRIRVSIGRSSVHTDYPT-AILNGLEI 376

Query: 359 MKM----------VHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKP 408
           MKM            L    +    K + +++G  +G   LL LV L     F   KK+ 
Sbjct: 377 MKMNNSKSQLSIGTFLPSGSSSTTKKNVGMIIGLTIGS--LLALVVLGGF--FVLYKKRG 432

Query: 409 KPRPADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLI 468
           + +  +S  W PL +   +  +  S GT  AS   N  +R  IP   ++ ATN+FD+N  
Sbjct: 433 RDQDGNSKTWIPLSS---NGTTSSSNGTTLASIASNSSYR--IPLVAVKEATNSFDENRA 487

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IG GGFG VYKG L D TKVAVKR  P S+QGL EF+TEI +LS+ RHRHLVSL+GYC+E
Sbjct: 488 IGVGGFGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 547

Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
            +EMILVYEYME G LK HLYG     LSWKQRLEICIG+ARGLHYLHTG A+ +IHRD+
Sbjct: 548 NNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHYLHTGDAKPVIHRDV 607

Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVY 648
           KS NILLDEN ++KVADFGLS++GP +D+THVST VKGSFGYLDPEYFRRQQLT+KSDVY
Sbjct: 608 KSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 667

Query: 649 SFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKF 708
           SFGVV+FEVLCAR  +DP L RE VNLAEWAM+WQKKG LEHIIDP L GKI  DSL+KF
Sbjct: 668 SFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDPSLRGKIRPDSLRKF 727

Query: 709 GETAEKCLADYGVDRPSMGDVLWNLEYALQLQES-GSGLPREQREDSNTNPPALPTR--- 764
           GET EKCLADYGVDRPSMGDVLWNLEYALQLQE+   G P    EDS      LP R   
Sbjct: 728 GETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVVDGDP----EDSTNMIGELPLRFND 783

Query: 765 -------TIVPQAPSSHVREKEVDGNASSDLRTSQVFSQLMTNEGR 803
                       A      E+E   + SS +  S+VFSQL+ +EGR
Sbjct: 784 YNHGDTSVNFSVAKEGRFDEEESSVDDSSGVSMSKVFSQLIKSEGR 829

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1

 Score =  744 bits (1921), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 420/824 (50%), Positives = 535/824 (64%), Gaps = 44/824 (5%)

Query: 1   NYLINCGSPTNASLYNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTSD 60
           NYLINCGSPTN +L  R F+ D  S  +  S+   ++        D    Y TARVFT  
Sbjct: 30  NYLINCGSPTNGTLMGRIFLSDKLSSKLLTSSKEILASVGGNSGSD---IYHTARVFTEV 86

Query: 61  GSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFS-TQVVVLKEFIV 119
            SYK ++ R G H VR +F+PF+  NFK+ SAKF V +   +LL DF+ T   V+KE+ +
Sbjct: 87  SSYKFSVTR-GRHWVRLYFNPFDYQNFKMGSAKFAVSSQSHVLLSDFTVTSSKVVKEYSL 145

Query: 120 KVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEIL 179
            V  + + + F P    +F FVNAIEV S P D ++    R +   G+  +F ++S + L
Sbjct: 146 NVTTNDLVLTFTP-SSGSFAFVNAIEVISIP-DTLITGSPRFV---GNPAQFPDMSMQGL 200

Query: 180 ETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPD 239
           ETI R+N+GG  +   NDTL RTWVPD EFL+ K+ AK ++     N+  G A+ +  P 
Sbjct: 201 ETIHRVNMGGPLVASNNDTLTRTWVPDSEFLLEKNLAKSMSKFSTVNFVPGYATEDSAPR 260

Query: 240 NVYMTAQEMNR-DNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFIN 298
            VY +  EMN  DN    + FN+TW+F V   G ++  R HFCDIVS SLNQLYFN++++
Sbjct: 261 TVYGSCTEMNSADNP--NSIFNVTWEFDV-DPGFQYYFRFHFCDIVSLSLNQLYFNLYVD 317

Query: 299 DYSAYKDLDLSSITFHSLASPVYMDFVADS-DDAGVVRVSVGPSELSGSLKVNAILNGVE 357
              A  D+DLS++  ++LA    MDFV  +   +  VRVS+GPS +      NAI+NG+E
Sbjct: 318 SMVAATDIDLSTLVDNTLAGAYSMDFVTQTPKGSNKVRVSIGPSTVHTDYP-NAIVNGLE 376

Query: 358 IMKMVH---------LTVSETGEKNKKIWIVVGSVVGGFVLLCLVAL-AVLVLFKCRKKK 407
           IMKM +              +      + ++VGS +G   LL +V L +  VL+K RK+ 
Sbjct: 377 IMKMNNSKGQLSTGTFVPGSSSSSKSNLGLIVGSAIGS--LLAVVFLGSCFVLYKKRKRG 434

Query: 408 PKPRPADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNL 467
              +   S  W P    G S  SK S GT   S   N  +R  IPF  ++ ATNNFD++ 
Sbjct: 435 ---QDGHSKTWMPFSINGTSMGSKYSNGTTLTSITTNANYR--IPFAAVKDATNNFDESR 489

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
            IG GGFG VYKG L D TKVAVKRG P S+QGL EF+TEI +LS+ RHRHLVSL+GYC+
Sbjct: 490 NIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E +EMIL+YEYME G +K HLYG     L+WKQRLEICIGAARGLHYLHTG ++ +IHRD
Sbjct: 550 ENNEMILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRD 609

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +KS NILLDEN+++KVADFGLS++GP LD+THVST VKGSFGYLDPEYFRRQQLTDKSDV
Sbjct: 610 VKSANILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDV 669

Query: 648 YSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKK 707
           YSFGVVLFEVLCAR  +DP L RE VNLAEWAM+WQKKG L+ IID  L G I  DSL+K
Sbjct: 670 YSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRK 729

Query: 708 FGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTN-----PPALP 762
           F ET EKCLADYGVDRPSMGDVLWNLEYALQLQE+   +   + ED++TN     PP + 
Sbjct: 730 FAETGEKCLADYGVDRPSMGDVLWNLEYALQLQEA---VIDGEPEDNSTNMIGELPPQIN 786

Query: 763 TRT---IVPQAPSSHVREKEVDGNASSDLRTSQVFSQLMTNEGR 803
             +        P +  R +E   +  S +  S+VFSQL+ +EGR
Sbjct: 787 NFSQGDTSVNVPGTAGRFEESSIDDLSGVSMSKVFSQLVKSEGR 830

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1

 Score =  712 bits (1837), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 401/841 (47%), Positives = 524/841 (62%), Gaps = 54/841 (6%)

Query: 1   NYLINCGSPTNASLYNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTSD 60
           NYLI+CGS  N +  NR FVPD+   S+     NS    S T    + S Y TARVF+S 
Sbjct: 31  NYLISCGSSQNITFQNRIFVPDSLHSSLVLKIGNSSVATSTTSNNSTNSIYQTARVFSSL 90

Query: 61  GSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVV----VLKE 116
            SY+  I   G H +R HFSP  +  + L SA   V+    +LL +FS        + KE
Sbjct: 91  ASYRFKITSLGRHWIRLHFSPINNSTWNLTSASITVVTEDFVLLNNFSFNNFNGSYIFKE 150

Query: 117 FIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSS 176
           + V V  + + + F P  + +  FVNAIEV S P++ I D    +   +     F  LS 
Sbjct: 151 YTVNVTSEFLTLSFIP-SNNSVVFVNAIEVVSVPDNLIPDQALALNPST----PFSGLSL 205

Query: 177 EILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKG-GASRE 235
              ET+ R+N+GG  LT  NDTL R W  D E+L + S+   V T +P + +     ++E
Sbjct: 206 LAFETVYRLNMGGPLLTSQNDTLGRQWDNDAEYLHVNSSV-LVVTANPSSIKYSPSVTQE 264

Query: 236 IGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNV 295
             P+ VY TA  M   N +    FN+TW  PV     R+ VR+HFCDIVS +LN L FN+
Sbjct: 265 TAPNMVYATADTMGDAN-VASPSFNVTWVLPVDPDF-RYFVRVHFCDIVSQALNTLVFNL 322

Query: 296 FINDYSAYKDLDLSSITFHSLASPVYMDFVADS--DDAGVVRVSVGPSELSGSLKVNAIL 353
           ++ND  A   LDLS++T + L  P + DF+++   + +GV+ VSVGP   S +   NA +
Sbjct: 323 YVNDDLALGSLDLSTLT-NGLKVPYFKDFISNGSVESSGVLTVSVGPD--SQADITNATM 379

Query: 354 NGVEIMKMVHLTVSETGEKNKK-------------IWIVVGSVVGGFVLLCLVALAVLVL 400
           NG+E++K+ +   S +G  + K               +++GS+VG   L+ L+A+     
Sbjct: 380 NGLEVLKISNEAKSLSGVSSVKSLLPGGSGSKSKKKAVIIGSLVGAVTLILLIAVCCYCC 439

Query: 401 FKCRKKKPKPRPADSVG---WTPLRAYGCS--------SHSKMSEGTVNASPGQNGYHRL 449
               +K+    P +      W PL  YG S        SH   +   ++ +    G   +
Sbjct: 440 LVASRKQRSTSPQEGGNGHPWLPLPLYGLSQTLTKSTASHKSATASCISLASTHLGRCFM 499

Query: 450 KIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEIT 509
              F ++  ATN FD++ ++G GGFG VYKG L D TKVAVKRG P S QG+ EF+TEI 
Sbjct: 500 ---FQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEIE 556

Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
           +LSK+RHRHLVSL+GYC+E+SEMILVYEYM  GPL+ HLYG D  PLSWKQRLEICIGAA
Sbjct: 557 MLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGAA 616

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
           RGLHYLHTG+++ IIHRD+K+TNILLDEN V+KVADFGLS++GP LD+THVST VKGSFG
Sbjct: 617 RGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQTHVSTAVKGSFG 676

Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE 689
           YLDPEYFRRQQLT+KSDVYSFGVVL EVLC R A++P+L REQVN+AEWAM WQKKG+L+
Sbjct: 677 YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQKKGLLD 736

Query: 690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPRE 749
            I+D  L GK+N  SLKKFGETAEKCLA+YGVDRPSMGDVLWNLEYALQL+E+ S L  E
Sbjct: 737 QIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLEETSSAL-ME 795

Query: 750 QREDSNTNPPALPTRTIVPQAPSSHVREK-------EVDGNASSDLRTSQVFSQLMTNEG 802
             ++S  + P +P   + P   S  + ++         D +A  D  TS VFSQL+   G
Sbjct: 796 PDDNSTNHIPGIPMAPMEPFDNSMSIIDRGGVNSGTGTDDDA-EDATTSAVFSQLVHPRG 854

Query: 803 R 803
           R
Sbjct: 855 R 855

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1

 Score =  684 bits (1765), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 400/848 (47%), Positives = 514/848 (60%), Gaps = 75/848 (8%)

Query: 3   LINCGSPTNASLYN-RFFVPDASS-KSVSFSADNSISLKSKTPPQDS-PSP-YDTARVFT 58
           LI+CGS +++   + R F  D  + + +    D  +S     PP D   SP Y TAR+F 
Sbjct: 59  LIDCGSKSSSKTPDGRVFKSDQETIQYIEAKEDIQVS----APPSDKVASPIYLTARIFR 114

Query: 59  SDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFS-------TQV 111
            + +YK ++ R G H VR HF  F +D F L  A F VL    +LL +F        +Q 
Sbjct: 115 EEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLHNFKISNNNNDSQA 174

Query: 112 VVLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEF 171
            V KE++V +      + FRP+   +  F+NAIEV SAP++ I D G  +    G    F
Sbjct: 175 AVQKEYLVNMTDAQFALRFRPM-KSSAAFINAIEVVSAPDELISDSGTALFPVIG----F 229

Query: 172 RNLSSEILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATT-----HPPN 226
             LS    +++ R+NVGG  + P NDTL RTW+PD EFL  ++ AK V TT     +PP 
Sbjct: 230 SGLSDYAYQSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKTTPSAIKYPPE 289

Query: 227 YQKGGASREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSP 286
                 +  I P  VY TA EM  ++  +   FN++W+FP     N +L+RLHFCDIVS 
Sbjct: 290 -----VTPLIAPQTVYATAVEM-ANSLTIDPNFNVSWNFPSNPSFN-YLIRLHFCDIVSK 342

Query: 287 SLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGV-VRVSVGPSELSG 345
           SLN LYFNV+IN  +A   LDLS++   +LA+P Y D V ++   G  ++V +GP     
Sbjct: 343 SLNDLYFNVYINGKTAISGLDLSTVA-GNLAAPYYKDIVVNATLMGPELQVQIGPMGEDT 401

Query: 346 SLKVNAILNGVEIMKMVHLTVSETGEKNKKIWIVVGSVVG----------GFVLL--CLV 393
             K NAILNGVE++KM +   S  GE     + V G   G          GFV++    +
Sbjct: 402 GTK-NAILNGVEVLKMSNSVNSLDGE-----FGVDGRTTGMGKHGMVATAGFVMMFGAFI 455

Query: 394 ALAVLVL-FKCRKKKPKPRPADSVGWTPLRA----YGCSSHSKMSEGTVNASPGQNGYHR 448
            L  +V  +K R +  + R + S    P+ A    +  S          N++ G   Y  
Sbjct: 456 GLGAMVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFS 515

Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEI 508
           L    ++LQ AT NF+ + IIG GGFG VY G L D TKVAVKRG P S QG+ EFQTEI
Sbjct: 516 L----SELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEI 571

Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +LSK+RHRHLVSL+GYC+E SEMILVYE+M  GP + HLYG +  PL+WKQRLEICIG+
Sbjct: 572 QMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGS 631

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           ARGLHYLHTG+A+GIIHRD+KSTNILLDE  V+KVADFGLS+      + HVST VKGSF
Sbjct: 632 ARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSF 690

Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML 688
           GYLDPEYFRRQQLTDKSDVYSFGVVL E LCAR A++P L REQVNLAEWAMQW++KG+L
Sbjct: 691 GYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLL 750

Query: 689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPR 748
           E IIDP L G IN +S+KKF E AEKCL DYGVDRP+MGDVLWNLEYALQLQE+ +    
Sbjct: 751 EKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKA 810

Query: 749 EQREDSNTN---PPALPTRTIVPQAPSSHVRE----------KEVDGNASSDLRTSQVFS 795
           E+ E++  +   P ++P     P  PS    E          +E  G A  +   + +F+
Sbjct: 811 EETENAKPDVVTPGSVPVSDPSPITPSVTTNEAATVPVPAKVEENSGTAVDEHSGTAMFT 870

Query: 796 QLMTNEGR 803
           Q     GR
Sbjct: 871 QFANLNGR 878

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SJT0|Y2214_ARATH Probable receptor-like protein kinase At2g21480 OS=Arabidopsis thaliana GN=At2g21480 PE=3 SV=1

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/783 (48%), Positives = 486/783 (62%), Gaps = 42/783 (5%)

Query: 3   LINCGSPTNASL-YNRFFVPDASSKSVSFSADNSISLKSKTPPQDS-PSP-YDTARVFTS 59
           LI+CGS ++      R F  D+ +     + D+   ++   PP D  PSP Y TA++F  
Sbjct: 58  LIDCGSKSSTKTPEGRVFKSDSETVQYIEAKDD---IQVSAPPSDKLPSPIYLTAKIFRE 114

Query: 60  DGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFS-------TQVV 112
           +  YK ++ R G H VR HF  F +D F L  A F VL    +LL +F        +Q  
Sbjct: 115 EAIYKFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHNFKLSNDNNDSQAT 174

Query: 113 VLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFR 172
           V KE+++ +      + F+P+   +  F+N IE+ SAP++ I D G  +   +G    F 
Sbjct: 175 VQKEYLLNMTDAQFALRFKPM-KGSAAFINGIELVSAPDELISDAGTSLFPVNG----FS 229

Query: 173 NLSSEILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGA 232
            LS    +++ R+NVGG  +TP NDTL RTW PD E+L  ++ AK V T         G 
Sbjct: 230 GLSDYAYQSVYRVNVGGPLITPQNDTLGRTWTPDKEYLKDENLAKDVKTNPTAIIYPPGV 289

Query: 233 SREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLY 292
           +  I P  VY T  EM  D+  +   FN+TW+FP  +    + +RLHFCDI+S SLN LY
Sbjct: 290 TPLIAPQTVYATGAEM-ADSQTIDPNFNVTWNFP-SNPSFHYFIRLHFCDIISKSLNDLY 347

Query: 293 FNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSD-DAGVVRVSVGP-SELSGSLKVN 350
           FNV+IN  +A   LDLS++    L++P Y D V +S      ++V +GP  E +G  K N
Sbjct: 348 FNVYINGKTAISGLDLSTVA-GDLSAPYYKDIVVNSTLMTSELQVQIGPMGEDTG--KKN 404

Query: 351 AILNGVEIMKMVHLTVSETGE-----KNKKIWIVVGSVVGGFVLL--CLVALAVLVL-FK 402
           AILNGVE++KM +   S  GE     +   +         GFV++    V L  +V  +K
Sbjct: 405 AILNGVEVLKMSNSVNSLDGEFGVDGQRASMGKQGMVATAGFVMMFGAFVGLGAMVYKWK 464

Query: 403 CRKKKPKPRPADSVGWTPLRA----YGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQT 458
            R +  + R + S    P+ A    +  S          N++ G   Y  L    ++LQ 
Sbjct: 465 KRPQDWQKRNSFSSWLLPIHAGDSTFMTSKTGSHKSNLYNSALGLGRYFSL----SELQE 520

Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH 518
            T NFD + IIG GGFG VY G + D T+VA+KRG P S QG+ EF TEI +LSK+RHRH
Sbjct: 521 VTKNFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEIQMLSKLRHRH 580

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
           LVSL+GYC+E +EMILVYEYM  GP + HLYG + +PL+WKQRLEICIGAARGLHYLHTG
Sbjct: 581 LVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAARGLHYLHTG 640

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
           +A+GIIHRD+KSTNILLDE  V+KVADFGLS+      + HVST VKGSFGYLDPEYFRR
Sbjct: 641 TAQGIIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRR 699

Query: 639 QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG 698
           QQLTDKSDVYSFGVVL E LCAR A++P L REQVNLAEWAM W++KG+LE IIDP L+G
Sbjct: 700 QQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLEKIIDPHLVG 759

Query: 699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTNP 758
            +N +S+KKF E AEKCLADYGVDRP+MGDVLWNLEYALQLQE+ S    E  E     P
Sbjct: 760 AVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQGKAEAEEVETPKP 819

Query: 759 PAL 761
            A+
Sbjct: 820 VAV 822

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1

 Score =  644 bits (1661), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 384/826 (46%), Positives = 496/826 (60%), Gaps = 68/826 (8%)

Query: 1   NYLINCGSPTNASLYN-RFFVPDASSKSVSFSADNSISLKSKTPPQDSPSP----YDTAR 55
           NYLI+CGS     L + R F  D  S +   + ++  +     P  DS +     Y TAR
Sbjct: 33  NYLIDCGSSDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSNASTLPLYLTAR 92

Query: 56  VFTSDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFS---TQVV 112
           +F    +Y   I R G H +R HF P     + L ++ F V  +  +LL DFS   T  +
Sbjct: 93  IFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTTVLLHDFSAGDTSSI 152

Query: 113 VLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFR 172
           V KE+++    + + + F+P    +  F+NA+E+ S P++ + D  + V        +F+
Sbjct: 153 VFKEYLIYA-AEKLSLYFKP-HKGSTAFINAVEIVSVPDELVPDSASSVPQA----PDFK 206

Query: 173 NLSSEILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPN--YQKG 230
            LSS  LE + RIN+GG  ++P  D L RTW+ D  +      ++ V T  P    Y  G
Sbjct: 207 GLSSFSLEILHRINIGGDLISPKIDPLSRTWLSDKPYNTFPEGSRNV-TVDPSTITYPDG 265

Query: 231 GASREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQ 290
           GA+  I P+ VY TA+EM  D       FN++W   V   G+ + +RLHFCDIVS SLN 
Sbjct: 266 GATALIAPNPVYATAEEM-ADAQTSQPNFNLSWRMSV-DFGHDYFIRLHFCDIVSKSLND 323

Query: 291 LYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFV--ADSDDAGVVRVSVGPSELSGSLK 348
           L FNVFIN  SA   LDLSS+T  +L +  Y DFV  A +   G + V VGP+    S K
Sbjct: 324 LIFNVFINKLSAISALDLSSLT-SALGTAYYADFVLNASTITNGSILVQVGPTPNLQSGK 382

Query: 349 VNAILNGVEIMKMVHLTVS-------------ETGEKNKKIWIVVGSVVGGFVLLCLVAL 395
            NAILNG+EIMK+ +   S               G  + K   + G    GFV+     L
Sbjct: 383 PNAILNGLEIMKLNNAAGSLDGLFGVDGKYKGPIGGMSSKKLAIAGI---GFVMALTAFL 439

Query: 396 AVLVLFKCRKKKPK---PRPADSVGWTPLRAY--------GCSSHSKMSEGTVNASPGQN 444
            V+VL    +++PK    + + S    PL A         G S+  +MS      S   N
Sbjct: 440 GVVVLLVRWQRRPKDWQKQNSFSSWLLPLHASHSSYISSKGGSTSRRMSIFGSKKSK-SN 498

Query: 445 GYHRL--------KIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG 496
           G+             PFT+LQTAT NFD+N + G GGFG VY G +   T+VA+KRG   
Sbjct: 499 GFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQVAIKRGSQS 558

Query: 497 SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG-----P 551
           S QG+ EFQTEI +LSK+RHRHLVSL+G+C+E  EMILVYEYM  GPL+ HLYG     P
Sbjct: 559 SEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGSKENDP 618

Query: 552 DRTP-LSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR 610
           +  P LSWKQRLEICIG+ARGLHYLHTG+A+GIIHRD+K+TNILLDEN V+KV+DFGLS+
Sbjct: 619 NPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSDFGLSK 678

Query: 611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAR 670
             P +DE HVST VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR  ++P L R
Sbjct: 679 DAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVINPQLPR 737

Query: 671 EQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
           EQVNLAE+AM   +KGMLE IIDP+++G I+  SL+KF E AEKCLA+YGVDRP MGDVL
Sbjct: 738 EQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPGMGDVL 797

Query: 731 WNLEYALQLQESGSGLP-REQREDSNTNPPALPTRTIVPQAPSSHV 775
           WNLEYALQLQE+ + +   E +   N     +P   +  Q+PS  +
Sbjct: 798 WNLEYALQLQEASAQVDLSEDKTTMNIEMDLIPGEEM--QSPSHSI 841

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O22187|Y2232_ARATH Probable receptor-like protein kinase At2g23200 OS=Arabidopsis thaliana GN=At2g23200 PE=3 SV=1

 Score =  607 bits (1564), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 362/825 (43%), Positives = 497/825 (60%), Gaps = 50/825 (6%)

Query: 1   NYLINCGSPTNASLYNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTSD 60
           N+ +NCGS +N     + FV D +S + S S  N  +         +P  Y T R+F   
Sbjct: 38  NFYVNCGSDSNVFYGGQTFVGDTNSSTNSVSFTNKGTEVINDQSSVAPEIYRTVRIFRHP 97

Query: 61  GSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANG--LLLLQDFSTQVVV----L 114
            SYK  +   G H VR HFS   S    L +A+F V A       L+ FS Q +     +
Sbjct: 98  SSYKFKLDSLGLHFVRLHFSVVFS-RADLLTARFTVSATSGSNHHLKSFSPQNLTNTPRV 156

Query: 115 KEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNL 174
           +EF++ ++    EI F P    +   +NAIEVFSAP+D                 E  + 
Sbjct: 157 EEFLLMMNSLEFEIRFVP-DHSSLALINAIEVFSAPDDL----------------EIPSA 199

Query: 175 SSEILETILRINVGGSELTPFNDTLWRTWVPDDE-FLVLKSAAKRVATTHPPNYQKG--G 231
           S + L TI R+NVGG ++TP NDTL RTW+PDD+ FL  K +A+ + +T  PNY  G   
Sbjct: 200 SDKNLHTIYRLNVGGEKITPDNDTLGRTWLPDDDDFLYRKDSARNINSTQTPNYVGGLSS 259

Query: 232 ASREIGPDNVYMTAQEMNRD-NAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQ 290
           A+    PD VY TA+ MNR  N  +G   N+TW F V S+ +RH +R+HF DI+S   N 
Sbjct: 260 ATDSTAPDFVYKTAKAMNRSSNEQVGMLMNVTWSFKVKSN-HRHFIRIHFSDILSNLSNS 318

Query: 291 LY-FNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKV 349
              F +F+N    Y  +D+       LASP + D V  SD +G++ +S+G  E +   K 
Sbjct: 319 DSDFYLFVN---GYWRVDVKPSEQPRLASPFFKDVVNVSDGSGLLNISIGTKEAN---KD 372

Query: 350 NAILNGVEIMKMVHLTVSE-TGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKP 408
              LNG+E+M+++  + S+ +   + ++ I+ G  V       LV   + ++F  R++  
Sbjct: 373 AGFLNGLEMMEVLSKSGSDYSNRSSSRVHIITGCAVAAAAASALVFSLLFMVFLKRRRSK 432

Query: 409 KPRP-ADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNL 467
           K +P  +   W+PL  +   S         + SP +N +  L IPFTD+ +ATNNFD+ L
Sbjct: 433 KTKPEVEGTVWSPLPLHRGGSSDNRPISQYHNSPLRNLHLGLTIPFTDILSATNNFDEQL 492

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +IG GGFG VYK +L D TK A+KRG  GS QG+ EFQTEI VLS+IRHRHLVSL GYCE
Sbjct: 493 LIGKGGFGYVYKAILPDGTKAAIKRGKTGSGQGILEFQTEIQVLSRIRHRHLVSLTGYCE 552

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG-IIHR 586
           E SEMILVYE+MEKG LK+HLYG +   L+WKQRLEICIGAARGL YLH+  +EG IIHR
Sbjct: 553 ENSEMILVYEFMEKGTLKEHLYGSNLPSLTWKQRLEICIGAARGLDYLHSSGSEGAIIHR 612

Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
           D+KSTNILLDE+ ++KVADFGLS+     DE+++S  +KG+FGYLDPEY +  +LT+KSD
Sbjct: 613 DVKSTNILLDEHNIAKVADFGLSKIHNQ-DESNISINIKGTFGYLDPEYLQTHKLTEKSD 671

Query: 647 VYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLK 706
           VY+FGVVL EVL AR A+DP L  E+VNL+EW M  + KG ++ I+DP LIG+I  +SLK
Sbjct: 672 VYAFGVVLLEVLFARPAIDPYLPHEEVNLSEWVMFCKSKGTIDEILDPSLIGQIETNSLK 731

Query: 707 KFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDS----NTNPPALP 762
           KF E AEKCL +YG +RPSM DV+W+LEY LQLQ   +   RE  E+     N+    + 
Sbjct: 732 KFMEIAEKCLKEYGDERPSMRDVIWDLEYVLQLQMMTN--RREAHEEDSTAINSGGSLVA 789

Query: 763 TRTIVPQAPSSHVREKEVDGNAS----SDLRTSQVFSQLMTNEGR 803
            R +V  + S++   +  D + +    +D   ++VFSQL  ++ R
Sbjct: 790 PRLMVSDSFSTNSIFQNGDESKNRFGFTDSSETRVFSQLKISDAR 834

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  591 bits (1523), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 338/813 (41%), Positives = 483/813 (59%), Gaps = 62/813 (7%)

Query: 1   NYLINCGSPTNASLYNRFFVPDAS-SKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTS 59
           ++L++CGS     +  R +V D S +KSV+    ++I+  +          Y TARVF +
Sbjct: 32  SFLVDCGSNATTEVDGRTWVGDLSPNKSVTLQGFDAITASTSKGSSVYAEIYKTARVFDA 91

Query: 60  DGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDF------------ 107
             +Y       G + VR HFSPF  +N  +  + F V A+GL L+ D             
Sbjct: 92  VLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSFSVFADGLRLMLDINIAGEIAHKNLI 151

Query: 108 -------STQVVVLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGAR 160
                  +T   ++KEF++      + + F P    +FGFVNAIE+ S  +    +   +
Sbjct: 152 LESTGHNATASSLVKEFLLPTGPGKLVLSFIP-EKGSFGFVNAIEIVSVDDKLFKESVTK 210

Query: 161 VISGSGSIEEFRNLSSEILETILRINVGGSELTPFND-TLWRTWVPDDEFLVLKSAAKRV 219
           V    G  E    L    +ET+ R+NVGG +L P  D  L+RTW  D  ++V+++A   V
Sbjct: 211 V----GGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKLYRTWETDLSYMVIENAGVEV 266

Query: 220 ATTHPPNYQKGGASREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLH 279
             +    Y     S  + P  VY TA+ M+ +  +L  RFNI+W F V  + + +LVRLH
Sbjct: 267 KNSSNITYALADDS-PVAPLLVYETARMMS-NTEVLEKRFNISWKFEVDPNFD-YLVRLH 323

Query: 280 FCDIVSPSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPV-----YMDFVADSDDAGVV 334
           FC+++    NQ  F ++IN+ +A  + D+ +   H+          Y+D V+  +D  V+
Sbjct: 324 FCELLVDKQNQRIFRIYINNQTAAGNFDIFA---HAGGKNKGIYQDYLDPVSSKND--VL 378

Query: 335 RVSVGPSELSGSLKVNAILNGVEIMKM------VHLT-VSETGE-----KNKKIWIVVGS 382
            + +GP    G+   +A+L+G+EI K+       HL     TG      K + IWI VG+
Sbjct: 379 WIQLGPDSSVGA-SGDALLSGLEIFKLSKNGNLAHLIRFDSTGHSVSDSKMRIIWISVGA 437

Query: 383 VVGGFVLLCLVALAVLVLFKCRKKKPKPRPADSVGWTPLRAY--GCSSHSKMSEGTVNAS 440
            +   +    + + V+ L K R+ K      +  GW PL  +    ++++K + G++  +
Sbjct: 438 GIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATGGSLRLN 497

Query: 441 PGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG 500
                    K    +++ AT NFD  L IG GGFG VY+G L D T +A+KR  P S+QG
Sbjct: 498 TLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQG 557

Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ 560
           L EF+TEI +LS++RHRHLVSL+G+C+E +EMILVYEYM  G L+ HL+G +  PLSWKQ
Sbjct: 558 LAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQ 617

Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV 620
           RLE CIG+ARGLHYLHTGS  GIIHRD+K+TNILLDEN+V+K++DFGLS++GP +D THV
Sbjct: 618 RLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHTHV 677

Query: 621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM 680
           ST VKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFE +CAR  ++P L ++Q+NLAEWA+
Sbjct: 678 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWAL 737

Query: 681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ 740
            WQK+  LE IID  L G  + +SL+K+GE AEKCLAD G +RP MG+VLW+LEY LQ+ 
Sbjct: 738 SWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQIH 797

Query: 741 ESGSGLPREQREDSNTNPPALPTRTIVPQAPSS 773
           E  + L ++  E+S ++  A      V +AP S
Sbjct: 798 E--AWLRKQNGENSFSSSQA------VEEAPES 822

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1

 Score =  566 bits (1458), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 342/795 (43%), Positives = 466/795 (58%), Gaps = 68/795 (8%)

Query: 3   LINCGSPTN--ASLYNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPS-PYDTARVFTS 59
           L+NCG   +      NR ++ D  SK +S S+++S +  + T     P  PY TARVF S
Sbjct: 37  LLNCGGGASNLTDTDNRIWISDVKSKFLSSSSEDSKTSPALTQDPSVPEVPYMTARVFRS 96

Query: 60  DGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFS--------TQV 111
             +Y   +  +G   VR +F P   D     ++ F V      LL++FS        T  
Sbjct: 97  PFTYTFPVA-SGRKFVRLYFYPNSYDGLNATNSLFSVSFGPYTLLKNFSASQTAEALTYA 155

Query: 112 VVLKEFIVKVDGDVIEIEFRP--VGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIE 169
            ++KEF+V V+G  + + F P       + FVN IEV S P+ +   DG   + GS    
Sbjct: 156 FIIKEFVVNVEGGTLNMTFTPESAPSNAYAFVNGIEVTSMPDMYSSTDGTLTMVGSSGSV 215

Query: 170 EFRNLSSEILETILRINVGGSELTPFNDT-LWRTWVPDDEFLVLKSAAKRVATTHPPNYQ 228
              N  S  LE + R+NVGG++++P  DT L+R+W  D  ++    A   +  T  PN  
Sbjct: 216 TIDN--STALENVYRLNVGGNDISPSADTGLYRSWYDDQPYIF--GAGLGIPETADPNMT 271

Query: 229 ---KGGASREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVS 285
                G    + P +VY TA+ M    A +   +N+TW F + S G  +LVRLHFC++ S
Sbjct: 272 IKYPTGTPTYVAPVDVYSTARSMG-PTAQINLNYNLTWIFSIDS-GFTYLVRLHFCEVSS 329

Query: 286 --PSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVR---VSVGP 340
               +NQ  F +++N+ +A  + D+ + T  S   P + D+V +  +    +   +++ P
Sbjct: 330 NITKINQRVFTIYLNNQTAEPEADVIAWT-SSNGVPFHKDYVVNPPEGNGQQDLWLALHP 388

Query: 341 SELSGSLKVNAILNGVEIMKM---------------------VHLTVSETGEKNKKIWIV 379
           + ++     +++LNGVEI KM                         +  T  K+K    +
Sbjct: 389 NPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVTADPSKVLRPTTRKSKSNTAI 448

Query: 380 VGSVVGGFVLLCLV-ALAVLVLFKCRKKKP-KPRPADSVGWTPLRAYGCSSHSKMSEGTV 437
           +     G V+L L+    V   ++ RK+   +P    + GW PL  YG +SHS  S    
Sbjct: 449 IAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLYG-NSHSAGS---- 503

Query: 438 NASPGQNGYHRLKIP--------FTDLQTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKV 488
            A     G +   +P        F +++ AT NFD++ ++G GGFG VY+G +    TKV
Sbjct: 504 -AKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKV 562

Query: 489 AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL 548
           A+KRG P S QG+ EFQTEI +LSK+RHRHLVSL+GYCEE  EMILVY+YM  G +++HL
Sbjct: 563 AIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHL 622

Query: 549 YGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL 608
           Y      L WKQRLEICIGAARGLHYLHTG+   IIHRD+K+TNILLDE +V+KV+DFGL
Sbjct: 623 YKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL 682

Query: 609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLL 668
           S++GP LD THVST VKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFE LCAR A++P L
Sbjct: 683 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNPTL 742

Query: 669 AREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGD 728
           A+EQV+LAEWA    KKGML+ I+DP L GKI  +  KKF ETA KC+ D G++RPSMGD
Sbjct: 743 AKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMGD 802

Query: 729 VLWNLEYALQLQESG 743
           VLWNLE+ALQLQES 
Sbjct: 803 VLWNLEFALQLQESA 817

Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	803
224134727	826	predicted protein [Populus trichocarpa]	0.990	0.962	0.729	0.0
255564329	831	ATP binding protein, putative [Ricinus c	0.995	0.961	0.734	0.0
225464565	822	PREDICTED: probable receptor-like protei	0.993	0.970	0.708	0.0
356575998	823	PREDICTED: probable receptor-like protei	0.983	0.959	0.674	0.0
356534111	826	PREDICTED: probable receptor-like protei	0.988	0.961	0.668	0.0
357473035	794	Kinase-like protein [Medicago truncatula	0.922	0.933	0.688	0.0
297808405	823	kinase family protein [Arabidopsis lyrat	0.980	0.956	0.660	0.0
15237872	824	putative receptor-like protein kinase [A	0.981	0.956	0.655	0.0
357443861	814	Pto disease resistance protein [Medicago	0.956	0.943	0.631	0.0
449445991	827	PREDICTED: probable receptor-like protei	0.988	0.960	0.653	0.0

>gi|224134727|ref|XP_002327474.1| predicted protein [Populus trichocarpa] gi|222836028|gb|EEE74449.1| predicted protein [Populus trichocarpa]

 Score = 1197 bits (3096), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 589/807 (72%), Positives = 678/807 (84%), Gaps = 12/807 (1%)

Query: 1   NYLINCGSPTNASLY---NRFFVPDASSKS-VSFSADNSISLKSKTPPQDSPSPYDTARV 56
           N+L+NCGS TN S     +R F+PD++ +  VS S   SISLK++ P  +SP+ Y TARV
Sbjct: 28  NFLVNCGSNTNTSFTPTDSRIFLPDSTKQGPVSLSKGQSISLKNQNPSPNSPTLYSTARV 87

Query: 57  FTSDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKE 116
           FT+  SY+ NIKRNGTHLVRFHFSPF++  F L++AKF +L NG LLL DFST+VVVLKE
Sbjct: 88  FTTASSYQFNIKRNGTHLVRFHFSPFKAQGFDLSTAKFSILVNGNLLLSDFSTKVVVLKE 147

Query: 117 FIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSS 176
           +I++VD + +EI F P G+ +FGFVNAIEVFSAP+DFI+D+GA+++S +G IE ++NLSS
Sbjct: 148 YILRVDDNALEILFSPAGESSFGFVNAIEVFSAPKDFILDEGAKLVSANG-IEVYKNLSS 206

Query: 177 EILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREI 236
            +LETI RINVGGS+L PFNDTLWRTW+PD++FLVLKSAAKR  TTH PNYQ GGASREI
Sbjct: 207 HVLETIHRINVGGSKLVPFNDTLWRTWIPDEDFLVLKSAAKRAVTTHVPNYQSGGASREI 266

Query: 237 GPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVF 296
            P+NVYMTAQ+MN+DN  L +RFNITW+FPVGS G RHLVRLHFCDIVS SL+QLYF+V+
Sbjct: 267 APENVYMTAQQMNKDNNPLQSRFNITWNFPVGSGGVRHLVRLHFCDIVSTSLSQLYFDVY 326

Query: 297 INDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGV 356
           +NDYSAY DLDLSS+TFH L+SP+Y+DF+ DS+D G V+VS+GPS +S  +KVNAILNGV
Sbjct: 327 LNDYSAYNDLDLSSLTFHVLSSPMYIDFIVDSNDLGAVQVSIGPSAVSSLMKVNAILNGV 386

Query: 357 EIMKMVHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRPADSV 416
           EIMKMV+ +   +  K   +WIVV S +GGFVL CL    V++  KC+KKKPKP   +S 
Sbjct: 387 EIMKMVNPSHLHSESKKITVWIVVASSIGGFVL-CLAVFVVILACKCKKKKPKPTRVESA 445

Query: 417 GWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGM 476
           GWTPLR YG S+HS+MSE TVN       Y  LKIPF D+Q ATNNFD +LIIGSGGFGM
Sbjct: 446 GWTPLRVYGGSTHSRMSEVTVNE------YRSLKIPFADVQLATNNFDNSLIIGSGGFGM 499

Query: 477 VYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY 536
           V+KGVL+DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY
Sbjct: 500 VFKGVLKDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY 559

Query: 537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD 596
           EYMEKGPLKKHLYGP  + LSWKQRLEICIGAARGLHYLHTGSA+GIIHRDIKSTNILLD
Sbjct: 560 EYMEKGPLKKHLYGPGCSHLSWKQRLEICIGAARGLHYLHTGSAQGIIHRDIKSTNILLD 619

Query: 597 ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFE 656
           ENY++KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVL E
Sbjct: 620 ENYLAKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLE 679

Query: 657 VLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCL 716
           VLCAR AVDPLLAREQVNLAEWAMQWQKKG+LE IIDP L+G+I  +SLKKFGETAEKCL
Sbjct: 680 VLCARPAVDPLLAREQVNLAEWAMQWQKKGILEQIIDPHLMGQIKQNSLKKFGETAEKCL 739

Query: 717 ADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTNPPALPTRTIVPQAPSSHVR 776
           ADYGVDRPSMGDVLWNLEYALQLQES S   RE R+DSN N P L T  I PQAPS +  
Sbjct: 740 ADYGVDRPSMGDVLWNLEYALQLQESDSKPSREPRDDSNANAPELTTPRIAPQAPSINTE 799

Query: 777 EKEVDGNASSDLRTSQVFSQLMTNEGR 803
            +   G+  S++R SQVFSQLMTN+GR
Sbjct: 800 TETDSGDGPSEIRNSQVFSQLMTNDGR 826

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255564329|ref|XP_002523161.1| ATP binding protein, putative [Ricinus communis] gi|223537568|gb|EEF39192.1| ATP binding protein, putative [Ricinus communis]

 Score = 1179 bits (3049), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 593/807 (73%), Positives = 673/807 (83%), Gaps = 8/807 (0%)

Query: 1   NYLINCGSPTNASLYNRFFVPDASSKSVSF--SADNSISLKSKTPPQDSPSPYDTARVFT 58
           NYL+NCGS TN SL NR FV D SSKS  F  S   SISL ++ P  + PS + TARVFT
Sbjct: 29  NYLLNCGSTTNTSLDNRVFVSD-SSKSGWFVLSTAQSISLTNQNPSPNLPSLHHTARVFT 87

Query: 59  SDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFI 118
           S  SYK NIK+NGTHL+RFHFSPF +  F L++AKF V  NG  LL DFST+VVV+KE++
Sbjct: 88  SSSSYKFNIKKNGTHLLRFHFSPFAAQTFNLSTAKFSVFVNGYKLLSDFSTKVVVIKEYV 147

Query: 119 VKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEI 178
           + +D +V+EI F PV +  F FV+AIEVFSAP+DFIVD GAR++S +  IEE++NLS  +
Sbjct: 148 LILDVEVVEILFSPVNESGFAFVSAIEVFSAPQDFIVDYGARLVS-TDRIEEYKNLSLNV 206

Query: 179 LETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGP 238
           LETI RINVGGS+LTPFNDTLWRTW+PDD+FLVLKSAAK+  TTH PNYQ GGAS EI P
Sbjct: 207 LETIHRINVGGSKLTPFNDTLWRTWIPDDDFLVLKSAAKKAVTTHSPNYQSGGASEEIAP 266

Query: 239 DNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFIN 298
           DNVYMTAQ MNRDNA +GARFNITWDFPVGS   +HL+R+HFCD VS SLNQLYF+V+IN
Sbjct: 267 DNVYMTAQVMNRDNATVGARFNITWDFPVGSSHVQHLIRMHFCDFVSTSLNQLYFDVYIN 326

Query: 299 DYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEI 358
           DYSAYKDLDLSS+TFH LASP+Y+DF+ADSDD+G +R+S+GPS+LS SLKVNAILNGVEI
Sbjct: 327 DYSAYKDLDLSSLTFHVLASPIYIDFIADSDDSGAIRISIGPSDLSTSLKVNAILNGVEI 386

Query: 359 MKMVHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRPADSVGW 418
           MKMV+   S    K   IWIV+GS++GG VLL L+ +AVL+  K +KK  KPR A+S GW
Sbjct: 387 MKMVNFHASHNSSKKTLIWIVLGSILGGLVLLSLLVIAVLLKRKRKKKTLKPRRAESAGW 446

Query: 419 TPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVY 478
           TPLR YG SS S+MSE TV ASPG NGYH L+ PF D+Q ATNNFD+NLIIGSGGFGMVY
Sbjct: 447 TPLRIYGGSSRSRMSEVTVIASPGPNGYHSLRFPFADIQLATNNFDENLIIGSGGFGMVY 506

Query: 479 KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY 538
           + VL+DNTKVAVKRGVPGSRQGLPEFQTEITVLS+IRHRHLVSL+GYCEEQSEMILVYEY
Sbjct: 507 RAVLKDNTKVAVKRGVPGSRQGLPEFQTEITVLSRIRHRHLVSLIGYCEEQSEMILVYEY 566

Query: 539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN 598
           ME+GPLK HLYG    PLSWKQRLEICI AARGLHYLHTGS +GIIHRDIKSTNILLD+N
Sbjct: 567 MERGPLKNHLYGSGCPPLSWKQRLEICIAAARGLHYLHTGSTQGIIHRDIKSTNILLDQN 626

Query: 599 YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           YV+KVADFGLSRSGPCL+ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL
Sbjct: 627 YVAKVADFGLSRSGPCLNETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 686

Query: 659 CARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLAD 718
           CAR AVDPLLAREQVNLAEWAMQWQKKGMLE IIDP LIG+I+  SLKK+GE AEKCLAD
Sbjct: 687 CARPAVDPLLAREQVNLAEWAMQWQKKGMLEKIIDPHLIGQISQSSLKKYGEIAEKCLAD 746

Query: 719 YGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTNPPALP-TRTIVPQAPSSHV-R 776
           YGVDRP+MGDVLWNLEY LQL ESG    RE  ED N N   L  + ++V Q  SS+   
Sbjct: 747 YGVDRPTMGDVLWNLEYVLQLAESGPS--RETCEDRNANAQELASSSSMVAQCSSSNADT 804

Query: 777 EKEVDGNASSDLRTSQVFSQLMTNEGR 803
           E++ DGN  SD+ TS+VFSQLMTNEGR
Sbjct: 805 ERDDDGNGGSDISTSKVFSQLMTNEGR 831

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225464565|ref|XP_002272986.1| PREDICTED: probable receptor-like protein kinase At5g24010 [Vitis vinifera]

 Score = 1137 bits (2940), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 570/804 (70%), Positives = 657/804 (81%), Gaps = 6/804 (0%)

Query: 1   NYLINCGSPTNASLYNRFFVPDASSK-SVSFSADNSISLKSKTPPQDSPSPYDTARVFTS 59
           N+LINCGS +N+++ NR FV D++   SVS SA  SISL    P   S + Y TARVFT 
Sbjct: 24  NFLINCGSSSNSTVDNRVFVGDSAKPISVSVSAGKSISLTDSNPSPGSSNLYHTARVFTG 83

Query: 60  DGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFIV 119
              Y+  I++ GTH VRFHF PF S N +L SAKFGV  NG  +L++F+T+  V+KE+I+
Sbjct: 84  ASRYEFRIQQAGTHFVRFHFWPFNSRNHRLKSAKFGVSLNGYPILRNFTTKNAVIKEYIL 143

Query: 120 KVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEIL 179
           +VD   +E+ F P G   FGFVNAIEVFSAP D I D G R++S SGS EEF NLSS+IL
Sbjct: 144 RVDDKKLEVLFSPEGGSRFGFVNAIEVFSAPGDLIPDYGPRLLSPSGS-EEFYNLSSKIL 202

Query: 180 ETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPD 239
           ET+ RINVGGS LTPFNDTLWRTW+ D++FLVLKSAAK   TTH PNYQ+GGA++EI PD
Sbjct: 203 ETVHRINVGGSILTPFNDTLWRTWINDEDFLVLKSAAKPALTTHTPNYQEGGATQEIAPD 262

Query: 240 NVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFIND 299
           NVYMTAQ+MNRDN    +RFNI+W F VGSH  RHLVRLHFCDIVS SLN LYFNV+IN 
Sbjct: 263 NVYMTAQQMNRDNVTSDSRFNISWKFEVGSHSARHLVRLHFCDIVSKSLNLLYFNVYING 322

Query: 300 YSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEIM 359
             A +DLDLS +TFH LASP YMDFV DSD++GV R+SVGPS+LS     NAILNGVEIM
Sbjct: 323 LLAVRDLDLSVLTFHELASPYYMDFVVDSDNSGVTRISVGPSDLSPVSARNAILNGVEIM 382

Query: 360 KMVHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRPADSVGWT 419
           K+V+    ++ +K K IW++VGS+V GFV++CL+ LAVLV  KC+KKKPKPRPA+SVGWT
Sbjct: 383 KLVNFVAQQSEDKKKNIWVLVGSIVVGFVVVCLIVLAVLVALKCKKKKPKPRPAESVGWT 442

Query: 420 PLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYK 479
           PLR    SS+S+MSEGT N   G N Y  LKIPF D+Q ATNNFD++L+IGSGGFGMVYK
Sbjct: 443 PLRV--ASSYSRMSEGTANPYLGPNLYLGLKIPFADIQLATNNFDRSLVIGSGGFGMVYK 500

Query: 480 GVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM 539
           GVLRDNT++AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM
Sbjct: 501 GVLRDNTRIAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM 560

Query: 540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY 599
           +KGPLK HLYG +  PL+WKQRL+ICIGAARGLHYLHTGSA+GIIHRDIKSTNILLDENY
Sbjct: 561 DKGPLKTHLYGSELPPLTWKQRLDICIGAARGLHYLHTGSAQGIIHRDIKSTNILLDENY 620

Query: 600 VSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           V+KVADFGLS+SGPCL+ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVL EVLC
Sbjct: 621 VAKVADFGLSKSGPCLNETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEVLC 680

Query: 660 ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADY 719
           AR AVDPLLAREQVNLAEWAMQWQ+KG+L  IIDP L+GKI   SLKKFGETAEKCLA+Y
Sbjct: 681 ARPAVDPLLAREQVNLAEWAMQWQQKGLLAKIIDPHLVGKIKPSSLKKFGETAEKCLAEY 740

Query: 720 GVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTNPPALPTRTIVPQAPSSHVREKE 779
           GVDRP+MGDVLWNLEY LQLQE+G+   RE  EDS+ N   LP+ + VP   SS++R + 
Sbjct: 741 GVDRPTMGDVLWNLEYVLQLQETGT--RRESHEDSDINTSELPSHSAVPLPHSSNIRTER 798

Query: 780 VDGNASSDLRTSQVFSQLMTNEGR 803
             G AS D+ T+QVFSQLMTNEGR
Sbjct: 799 SHGYASGDISTTQVFSQLMTNEGR 822

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575998|ref|XP_003556122.1| PREDICTED: probable receptor-like protein kinase At5g24010-like [Glycine max]

 Score = 1125 bits (2909), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 544/806 (67%), Positives = 653/806 (81%), Gaps = 16/806 (1%)

Query: 1   NYLINCGSPTNASLYNRFFVPDASSKSVSF-SADNSISLKSKTPPQDSPSPYDTARVFTS 59
           N+L++CGS +NASL+NR FV D++    +F S+ +SISL  + PPQ+ P+ Y TAR+F S
Sbjct: 31  NFLLSCGSHSNASLFNRVFVGDSTDSGSTFLSSGDSISLTYQKPPQNLPTLYHTARLFRS 90

Query: 60  DGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFST-QVVVLKEFI 118
            G Y+ N+K+NGTHLVRFHFSPF++ +F L SAKF V  NG+ +L +F     V+LKEFI
Sbjct: 91  TGRYRFNMKKNGTHLVRFHFSPFKAQSFDLKSAKFNVSVNGVSVLSNFQPPNDVLLKEFI 150

Query: 119 VKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEI 178
           +K+  +V+EI FRPVGD  F FVNA+EVF+AP DF++D GAR++  SG +EE+R+LSS++
Sbjct: 151 LKIVSNVLEILFRPVGDSGFAFVNALEVFTAPVDFVIDFGARLVGPSG-VEEYRSLSSQV 209

Query: 179 LETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGP 238
           LET+ RINVGG ++TPFNDTLWRTW+PD+++LV K AAK   +TH PNYQKGGA+REI P
Sbjct: 210 LETVHRINVGGLKITPFNDTLWRTWIPDEDYLVFKGAAKPAVSTHTPNYQKGGATREIAP 269

Query: 239 DNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFIN 298
           +NVYMTAQ+MNR+N+ L +RFNITW+FPV   G  HLVRLHFCDIVSP+LN LYF+V+IN
Sbjct: 270 ENVYMTAQQMNRENSSLASRFNITWNFPVSPGGVPHLVRLHFCDIVSPALNLLYFDVYIN 329

Query: 299 DYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEI 358
            Y AYKDLDLS++  H+LASPVY+DFV +SDD G V+VSVGPSELS S+++NAILNG EI
Sbjct: 330 GYIAYKDLDLSALAIHTLASPVYVDFVTNSDDTGFVQVSVGPSELSSSIRMNAILNGAEI 389

Query: 359 MKMVHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRPADSVGW 418
           MKMV+   +    + K +W++VGS+ GG V+L LV  A L+  KCR KKPK R  +SVGW
Sbjct: 390 MKMVNDVGTNVVHRRKNLWVLVGSIAGGIVVLFLVVTAFLLGTKCRNKKPKQRTVESVGW 449

Query: 419 TPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVY 478
           TPL  +G SS S+ SE      PG +G   +KIPF ++Q+ATNNFD+NLIIGSGGFGMVY
Sbjct: 450 TPLSMFGGSSLSRSSE------PGSHGLLGMKIPFAEIQSATNNFDRNLIIGSGGFGMVY 503

Query: 479 KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY 538
           KG LRDN KVAVKRG+PGSRQGLPEFQTEITVLSKIRHRHLVSLVG+CEE SEMILVYEY
Sbjct: 504 KGELRDNVKVAVKRGMPGSRQGLPEFQTEITVLSKIRHRHLVSLVGFCEENSEMILVYEY 563

Query: 539 MEKGPLKKHLYGPD-RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE 597
           +EKGPLKKHLYG   +TPLSWKQRLEICIGAARGLHYLHTG A+GIIHRDIKSTNILLDE
Sbjct: 564 VEKGPLKKHLYGSSLQTPLSWKQRLEICIGAARGLHYLHTGFAQGIIHRDIKSTNILLDE 623

Query: 598 NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
           NYV+KVADFGLSRSGPC++ETHVST VKGSFGYLDPEY+RRQQLTDKSDVYSFGVVLFEV
Sbjct: 624 NYVAKVADFGLSRSGPCINETHVSTNVKGSFGYLDPEYYRRQQLTDKSDVYSFGVVLFEV 683

Query: 658 LCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLA 717
           LC R AVDP LAREQVNLAEWA++W +KGMLE I+DP L+G+I   SLKKF ETAEKCLA
Sbjct: 684 LCGRPAVDPQLAREQVNLAEWALEWLQKGMLEQIVDPHLVGQIQQSSLKKFCETAEKCLA 743

Query: 718 DYGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTNPPALPTRTIVPQAPSSHVRE 777
           +YGVDRP+MGDVLWNLEYALQLQES      E   +S+       T  ++P  PS++ R 
Sbjct: 744 EYGVDRPAMGDVLWNLEYALQLQES------EPHANSSARESVSVTNAVIPGNPSTNRRT 797

Query: 778 KEVDGNASSDLRTSQVFSQLMTNEGR 803
           +    N SSD+ TSQVFSQLM NEGR
Sbjct: 798 ERDYYNCSSDVSTSQVFSQLMNNEGR 823

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356534111|ref|XP_003535601.1| PREDICTED: probable receptor-like protein kinase At5g24010-like [Glycine max]

 Score = 1110 bits (2872), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 541/809 (66%), Positives = 657/809 (81%), Gaps = 15/809 (1%)

Query: 1   NYLINCGSPTNASLYNRFFVPDASSKSVSF-SADNSISLKSKTPPQDSPSPYDTARVFTS 59
           N+L++CGS +NASL+NR F+ D+++   +F S+D+SISL  + PPQ+  + Y TARVF S
Sbjct: 27  NFLLSCGSYSNASLFNRVFMGDSTNPGSTFLSSDDSISLTYQKPPQNLSTLYHTARVFRS 86

Query: 60  DGSYKLNIKRNGTHLVRFHFSPFESDN-FKLASAKFGVLANGLLLLQDFST-QVVVLKEF 117
              Y+ N+K+NGTHLVRFHFSPF++ + F L SAKF V  NG+ +L +F     V+LKEF
Sbjct: 87  TARYRFNMKKNGTHLVRFHFSPFKAQSTFDLKSAKFNVFVNGVSVLSNFQPPNDVLLKEF 146

Query: 118 IVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSE 177
           I+K++ +V+EI FRPVG+  F FVNA+EVF+AP DF++D GAR++  SG +EE+RNLSS+
Sbjct: 147 ILKIESNVLEILFRPVGESGFAFVNALEVFTAPVDFVIDVGARLVGPSG-VEEYRNLSSQ 205

Query: 178 ILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIG 237
           +LET+ RINVGG ++TPFNDTLWRTW+PD+++LV K AAK   +TH PNYQKGGA+RE+ 
Sbjct: 206 VLETVHRINVGGLKITPFNDTLWRTWIPDEDYLVFKGAAKPAVSTHTPNYQKGGATREVA 265

Query: 238 PDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGN-RHLVRLHFCDIVSPSLNQLYFNVF 296
           P+NVYMTAQ+MNR+N+ L +RFNITW+FPV   G   HLVRLHFCDIVSP+LN LYF+V+
Sbjct: 266 PENVYMTAQQMNRENSSLASRFNITWNFPVSPGGGVPHLVRLHFCDIVSPALNLLYFDVY 325

Query: 297 INDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGV 356
           IN Y AYKDLDLS++T H+LASPVY+DFV +S D+G V+VSVGPSELS S+++NAILNG 
Sbjct: 326 INGYIAYKDLDLSALTIHTLASPVYVDFVTNSVDSGFVQVSVGPSELSSSIRMNAILNGA 385

Query: 357 EIMKMVHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRPADSV 416
           EIMKMV+   +    +   +W++VGS VGG  +L LV  A L+  KCRK KPK R  +SV
Sbjct: 386 EIMKMVNDVGTNVVHRRTNLWVLVGSTVGGIGVLFLVVTAFLLGTKCRKNKPKQRTIESV 445

Query: 417 GWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGM 476
           GWTPL  +G SS S+ SE      PG +G   +KIPF ++Q+ATNNFD++LIIGSGGFGM
Sbjct: 446 GWTPLSMFGGSSLSRSSE------PGSHGLLGMKIPFAEIQSATNNFDRSLIIGSGGFGM 499

Query: 477 VYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY 536
           VYKGVLRDN KVAVKRG+PGSRQGLPEFQTEITVLSKIRHRHLVSLVG+CEE SEMILVY
Sbjct: 500 VYKGVLRDNVKVAVKRGMPGSRQGLPEFQTEITVLSKIRHRHLVSLVGFCEENSEMILVY 559

Query: 537 EYMEKGPLKKHLYGPD-RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL 595
           EY+EKGPLKKHLYG   +TPLSWKQRLEICIGAARGLHYLHTG A+GIIHRDIKSTNILL
Sbjct: 560 EYVEKGPLKKHLYGSSLQTPLSWKQRLEICIGAARGLHYLHTGFAQGIIHRDIKSTNILL 619

Query: 596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF 655
           DENYV+KVADFGLSRSGPC++ETHVST VKGSFGYLDPEY+RRQQLTDKSDVYSFGVVLF
Sbjct: 620 DENYVAKVADFGLSRSGPCINETHVSTNVKGSFGYLDPEYYRRQQLTDKSDVYSFGVVLF 679

Query: 656 EVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKC 715
           EVLC R AVDP LAREQVNLAEW ++W +KGM+E I+DP L+G+I  +SLKKF ETAEKC
Sbjct: 680 EVLCGRPAVDPQLAREQVNLAEWGLEWLQKGMVEQIVDPHLVGQIQQNSLKKFCETAEKC 739

Query: 716 LADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTNPPALP-TRTIVPQAPSSH 774
           LA+YGVDRP+MGDVLWNLEYALQLQESG    RE   + + +   +  T  I+P  PS++
Sbjct: 740 LAEYGVDRPAMGDVLWNLEYALQLQESGQ--QREPHANRHASEEFVSVTNAIIPGNPSTN 797

Query: 775 VREKEVDGNASSDLRTSQVFSQLMTNEGR 803
            R +    N SSD+ TSQVFSQLM NEGR
Sbjct: 798 RRTERDHYNCSSDVSTSQVFSQLMNNEGR 826

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357473035|ref|XP_003606802.1| Kinase-like protein [Medicago truncatula] gi|355507857|gb|AES88999.1| Kinase-like protein [Medicago truncatula]

 Score = 1066 bits (2757), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 518/752 (68%), Positives = 614/752 (81%), Gaps = 11/752 (1%)

Query: 1   NYLINCGSPTNASLYNRFFVPDASSK--SVSFSADNSISLKSKTPPQDSPSPYDTARVFT 58
           NYL+NCGS  NA+++NR F+ D S+   S   SA+ SISL ++ P  +  + Y TAR+FT
Sbjct: 28  NYLLNCGSNNNATIFNRLFIGDDSTNLGSNFLSAEKSISLTNQNPSPNLATLYHTARIFT 87

Query: 59  SDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQV-----VV 113
           S GSY+  +K+NGT  VRFHFS F++  F L  AKF VL    L+L +F   +      V
Sbjct: 88  SKGSYRFTLKQNGTFFVRFHFSCFKAQGFDLKDAKFNVLVGEKLVLSNFKLNLKPSNDTV 147

Query: 114 LKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRN 173
           +KEFI+K + +++EI FRPV D  FGF+N IEVFSAPED++VD GAR + G   + E++N
Sbjct: 148 IKEFILKFESNLLEIVFRPVSDSGFGFINGIEVFSAPEDYVVDYGARFV-GPFGVREYKN 206

Query: 174 LSSEILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGAS 233
           LS+ +LETI RINVGG +LTPFNDTLWRTW+PD +FLV K AAK V +TH P+YQKGGA+
Sbjct: 207 LSN-VLETIHRINVGGEKLTPFNDTLWRTWIPDKDFLVFKDAAKAVVSTHTPDYQKGGAA 265

Query: 234 REIGPDNVYMTAQEMNRD-NAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLY 292
           REI PD+VYMTAQEMNRD N++L ++FNITW+F V S G RHLVRLHFCDIVSPSLN LY
Sbjct: 266 REIAPDSVYMTAQEMNRDHNSILASQFNITWNFSVDSIGVRHLVRLHFCDIVSPSLNLLY 325

Query: 293 FNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAI 352
           F+V+IN YSAYKD+DLSS+TFH LASPVY+DFV DSDD+GV+++SVGPS+LS S+++NAI
Sbjct: 326 FDVYINGYSAYKDVDLSSLTFHMLASPVYVDFVVDSDDSGVIQISVGPSDLSSSMRMNAI 385

Query: 353 LNGVEIMKMVHLTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRP 412
           LNG EIMK++++T S    + KK+ ++VGS+VGG V+L LV    LV  + RK KPK R 
Sbjct: 386 LNGAEIMKLLNVTDSHVAPRKKKLLVLVGSIVGGIVVLLLVIAVFLVCCRRRKMKPKIRT 445

Query: 413 ADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSG 472
             S+GWTPLR +G SS S+MSEGT   SPG  GY  LKI F+D+Q ATNNFD++L+IGSG
Sbjct: 446 VGSIGWTPLRMFGGSSLSRMSEGTAYPSPGSCGYLGLKISFSDIQLATNNFDESLVIGSG 505

Query: 473 GFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM 532
           GFG VYKGVLRDN KVAVKRG+PGSRQGLPEFQ EI++LS IRHRHLVSLVG+CEE SEM
Sbjct: 506 GFGKVYKGVLRDNVKVAVKRGMPGSRQGLPEFQREISILSNIRHRHLVSLVGFCEENSEM 565

Query: 533 ILVYEYMEKGPLKKHLYGPD-RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKST 591
           ILVYEY+EKGPLK HLYG +   PLSWKQRLEICIGAARGLHYLHTG   G+IHRDIKST
Sbjct: 566 ILVYEYVEKGPLKDHLYGSEGLQPLSWKQRLEICIGAARGLHYLHTGFTRGVIHRDIKST 625

Query: 592 NILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFG 651
           NILLDE++V+KVADFGLSRSGPC+DETHVST VKGSFGYLDPEYFR QQLTDKSDVYSFG
Sbjct: 626 NILLDEDHVAKVADFGLSRSGPCIDETHVSTNVKGSFGYLDPEYFRMQQLTDKSDVYSFG 685

Query: 652 VVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGET 711
           VVLFEVLC R AVDP L REQVNLAEWA++WQKKGMLE+IIDP L+GKI   SLKKFGET
Sbjct: 686 VVLFEVLCVRPAVDPQLDREQVNLAEWALKWQKKGMLENIIDPYLVGKIKDRSLKKFGET 745

Query: 712 AEKCLADYGVDRPSMGDVLWNLEYALQLQESG 743
           AEKCLA+YGVDRPSMGDVLWNLEY+LQLQESG
Sbjct: 746 AEKCLAEYGVDRPSMGDVLWNLEYSLQLQESG 777

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297808405|ref|XP_002872086.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297317923|gb|EFH48345.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score = 1049 bits (2713), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 535/810 (66%), Positives = 630/810 (77%), Gaps = 23/810 (2%)

Query: 1   NYLINCGSPTNASLYN-RFFVPDASSKSVSF-SADNSISLKSKTPPQDSPSPYDTARVFT 58
           NYLIN GS TN S +  R F+ D+S    SF S D SIS+    P  DSP+ Y+TARVF 
Sbjct: 30  NYLINSGSNTNTSFFTIRSFLSDSSKPGSSFLSTDRSISISDPNPSPDSPALYNTARVFP 89

Query: 59  SDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFI 118
             GSYK  +   GTH +R HF+PF++ +F L SAKF VL NG  ++  FST  VV+KEFI
Sbjct: 90  IGGSYKFQVTTKGTHFIRLHFAPFKASSFNLRSAKFRVLINGFSVMNSFSTSSVVVKEFI 149

Query: 119 VKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGAR-VISGSGSIEEFRNLSSE 177
           +K+D  V+EI F P     FGFVNA+EVFSAP D+I+D G + VI  S  I  F NLSS+
Sbjct: 150 LKIDDPVLEISFLPSKASGFGFVNAVEVFSAPNDYIMDQGTKLVIPNSAQI--FSNLSSQ 207

Query: 178 ILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIG 237
           +LET+ RINVGGS+LTPFNDTLWRTWV DD +L+L++AA+R  TTH PNYQ GGA+REI 
Sbjct: 208 VLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAARRAWTTHSPNYQNGGATREIA 267

Query: 238 PDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFI 297
           PDNVYMTAQEM+RDN  L ARFNI+W F V      HLVRLHFCDIVS SLNQLYFNVFI
Sbjct: 268 PDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLVRLHFCDIVSSSLNQLYFNVFI 327

Query: 298 NDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVE 357
           N+Y AYKD+DLS++TFH LASP+Y+DFVA+SD +G++R+SVGPS+LS   +VNA+LNGVE
Sbjct: 328 NEYLAYKDVDLSTLTFHVLASPLYIDFVAESDRSGMLRISVGPSDLSNPARVNALLNGVE 387

Query: 358 IMKMVHLTVSE--TGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRPADS 415
           IM+++    SE  +G++N  +WIVVGSV+GGFV L L  L VL L  CR+K  K R ++S
Sbjct: 388 IMRILSPVSSEVVSGKRNV-VWIVVGSVLGGFVFLSLFFLCVLCL--CRRKNNKTRSSES 444

Query: 416 VGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG 475
            GWTPLR +  SS+S+ +E TV++S    GYH L+I F +LQ+ TNNFDK+L+IG GGFG
Sbjct: 445 TGWTPLRRFRGSSNSRTTERTVSSS----GYHTLRISFAELQSGTNNFDKSLVIGVGGFG 500

Query: 476 MVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV 535
           MV+KG L+DNTKVAVKRG PGSRQGLPEF +EIT+LSKIRHRHLVSLVGYCEEQSEMILV
Sbjct: 501 MVFKGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRHLVSLVGYCEEQSEMILV 560

Query: 536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL 595
           YEYM+KGPLK HLYG    PLSWKQRLE+CIGAARGLHYLHTGS++GIIHRDIKSTNILL
Sbjct: 561 YEYMDKGPLKSHLYGSSNPPLSWKQRLEVCIGAARGLHYLHTGSSQGIIHRDIKSTNILL 620

Query: 596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF 655
           D NYV+KVADFGLSRSGPC+DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF
Sbjct: 621 DNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF 680

Query: 656 EVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKC 715
           EVLCAR AVDPLL REQVNLAEWA++WQ+KGML+ I+DP +  +I   SLKKF ETAEKC
Sbjct: 681 EVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNIADEIKPCSLKKFAETAEKC 740

Query: 716 LADYGVDRPSMGDVLWNLEYALQLQESGS-GLPREQREDSNTNPPALPTRTIVPQAPSSH 774
            ADYGVDRP++GDVLWNLE+ LQLQESG    P E   D   +  A        Q PSS 
Sbjct: 741 CADYGVDRPTIGDVLWNLEHVLQLQESGPLNNPEEVYGDVTDSGTAR-------QGPSSG 793

Query: 775 VREKEVDGNASSD-LRTSQVFSQLMTNEGR 803
                  G+ +S  + +SQVFSQLMTN GR
Sbjct: 794 SNTDRDYGDGTSGIISSSQVFSQLMTNAGR 823

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15237872|ref|NP_197789.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|75334039|sp|Q9FLW0.1|Y5241_ARATH RecName: Full=Probable receptor-like protein kinase At5g24010; Flags: Precursor gi|9758225|dbj|BAB08724.1| receptor-protein kinase-like protein [Arabidopsis thaliana] gi|332005862|gb|AED93245.1| putative receptor-like protein kinase [Arabidopsis thaliana]

 Score = 1045 bits (2702), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 530/809 (65%), Positives = 631/809 (77%), Gaps = 21/809 (2%)

Query: 1   NYLINCGSPTNASLYN-RFFVPDASSKSVSF-SADNSISLKSKTPPQDSPSPYDTARVFT 58
           NYLIN GS TN S +  R F+ D+S    SF S D SIS+    P  DSP  Y+TARVF 
Sbjct: 31  NYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSISISDTNPSPDSPVLYNTARVFP 90

Query: 59  SDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFI 118
             GSYK  +   GTH +R HF+PF++  F L SAKF VL NG  ++  FST  VV+KEFI
Sbjct: 91  VGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLINGFSVINSFSTSSVVVKEFI 150

Query: 119 VKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGAR-VISGSGSIEEFRNLSSE 177
           +K+D  V+EI F P     FGFVNA+EVFSAP+D+I+D G + VI  S  I  F NLSS+
Sbjct: 151 LKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIMDQGTKLVIPNSAQI--FSNLSSQ 208

Query: 178 ILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIG 237
           +LET+ RINVGGS+LTPFNDTLWRTWV DD +L+L++AA+R  TTH PNYQ GGA+REI 
Sbjct: 209 VLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAARRAWTTHSPNYQNGGATREIA 268

Query: 238 PDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFI 297
           PDNVYMTAQEM+RDN  L ARFNI+W F V      HLVRLHFCDIVS SLNQLYFNVFI
Sbjct: 269 PDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLVRLHFCDIVSSSLNQLYFNVFI 328

Query: 298 NDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVE 357
           N+Y A+KD+DLS++TFH LASP+Y+DFVA+SD +G++R+SVGPS+LS   +VNA+LNGVE
Sbjct: 329 NEYLAFKDVDLSTLTFHVLASPLYIDFVAESDRSGMLRISVGPSDLSNPARVNALLNGVE 388

Query: 358 IMKMVHLTVSE--TGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRPADS 415
           IM+++    SE  +G++N  +WIVVGSV+GGFV L L  L+VL L  CR+K  K R ++S
Sbjct: 389 IMRILSPVSSEVVSGKRNV-VWIVVGSVLGGFVFLSLFFLSVLCL--CRRKNNKTRSSES 445

Query: 416 VGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG 475
            GWTPLR +  SS+S+ +E TV++S    GYH L+I F +LQ+ TNNFD++L+IG GGFG
Sbjct: 446 TGWTPLRRFRGSSNSRTTERTVSSS----GYHTLRISFAELQSGTNNFDRSLVIGVGGFG 501

Query: 476 MVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV 535
           MV++G L+DNTKVAVKRG PGSRQGLPEF +EIT+LSKIRHRHLVSLVGYCEEQSEMILV
Sbjct: 502 MVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRHLVSLVGYCEEQSEMILV 561

Query: 536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL 595
           YEYM+KGPLK HLYG    PLSWKQRLE+CIGAARGLHYLHTGS++GIIHRDIKSTNILL
Sbjct: 562 YEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGLHYLHTGSSQGIIHRDIKSTNILL 621

Query: 596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF 655
           D NYV+KVADFGLSRSGPC+DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF
Sbjct: 622 DNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF 681

Query: 656 EVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKC 715
           EVLCAR AVDPLL REQVNLAEWA++WQ+KGML+ I+DP +  +I   SLKKF ETAEKC
Sbjct: 682 EVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNIADEIKPCSLKKFAETAEKC 741

Query: 716 LADYGVDRPSMGDVLWNLEYALQLQESGS-GLPREQREDSNTNPPALPTRTIVPQAPSSH 774
            ADYGVDRP++GDVLWNLE+ LQLQESG   +P E   D  T+P     RT      +  
Sbjct: 742 CADYGVDRPTIGDVLWNLEHVLQLQESGPLNIPEEDYGDV-TDP-----RTARQGLSNGS 795

Query: 775 VREKEVDGNASSDLRTSQVFSQLMTNEGR 803
             E++     S  + ++QVFSQLMTN GR
Sbjct: 796 NIERDYGDGTSGIISSTQVFSQLMTNAGR 824

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357443861|ref|XP_003592208.1| Pto disease resistance protein [Medicago truncatula] gi|355481256|gb|AES62459.1| Pto disease resistance protein [Medicago truncatula]

 Score = 1040 bits (2690), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 510/807 (63%), Positives = 631/807 (78%), Gaps = 39/807 (4%)

Query: 1   NYLINCGSPTNASLYNRFFVPDASSKSVSF-SADNSISLKSKTPPQDSPSPYDTARVFTS 59
           NYLINCGS +NASL+NR F+ D+++   +F S+D+SISL +K P  +  + Y TARVF +
Sbjct: 43  NYLINCGSHSNASLFNRLFMSDSTNPGSNFLSSDDSISLTNKNPSPNLQTLYHTARVFIT 102

Query: 60  DGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFST-QVVVLKEFI 118
            G Y+ N+K+NGTHL+RFHF PF+  +F L SAKF VL NG+ +L  F     V++KEFI
Sbjct: 103 TGRYRFNMKKNGTHLIRFHFFPFKDQSFDLKSAKFSVLVNGISILSQFKPPDDVMVKEFI 162

Query: 119 VKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEI 178
           +K++ +++++ FRP     FG+VNA+EVF+APEDF++D G R++  SG +EE+RNLSS++
Sbjct: 163 LKIESNLLQVLFRPF-KSGFGYVNAVEVFTAPEDFVIDYGTRLVGPSG-VEEYRNLSSQV 220

Query: 179 LETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGP 238
           LET+ RINVGG ++TPFNDTLWRTW+PD+++LV K AAK   +TH P+YQKGGA+ EI P
Sbjct: 221 LETVHRINVGGMKITPFNDTLWRTWIPDEDYLVFKEAAKHAVSTHTPDYQKGGATPEIAP 280

Query: 239 DNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFIN 298
           +NVYMTAQ+MNR+N+ L +RFNITW+FPV   G  HL+RLHFCDIVS SLN LYF+V+IN
Sbjct: 281 ENVYMTAQQMNRENSSLASRFNITWNFPVARDGVSHLIRLHFCDIVSTSLNLLYFDVYIN 340

Query: 299 DYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEI 358
            Y AYKDLDLS++TFH+LASPVY+DFVA+SDD+ V+++SVGPS+LS S+++NAILNG EI
Sbjct: 341 GYIAYKDLDLSALTFHTLASPVYVDFVANSDDSSVIQISVGPSDLSSSIRINAILNGAEI 400

Query: 359 MKMVH-LTVSETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRPADSVG 417
           MKMV+ +  +    + K +W ++GS+ GG V+   V    L+  +CRK+K K    +SVG
Sbjct: 401 MKMVNDVDNTNIFHRRKHLWELIGSIAGGIVIAFFVVTIFLLATRCRKRKSKESTVESVG 460

Query: 418 WTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMV 477
           WTPLR +G SS S+ SE       G  GY  +KIPF ++Q+ATNNFD+NLIIGSGGFGMV
Sbjct: 461 WTPLRMFGGSSLSRTSEH------GSYGYLGMKIPFAEIQSATNNFDRNLIIGSGGFGMV 514

Query: 478 YKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE 537
           YKGVLRDN KVAVKRG+PGSRQGLPEF TEIT+LSKIRHRHLVSLVG+CEE SEMILVYE
Sbjct: 515 YKGVLRDNVKVAVKRGMPGSRQGLPEFHTEITILSKIRHRHLVSLVGFCEENSEMILVYE 574

Query: 538 YMEKGPLKKHLYGPDR-TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD 596
           Y+EKGPLKKHLYG  R +PLSWKQRLEICIG+ARGLHYLHTG A+GIIHRDIKSTNIL+D
Sbjct: 575 YVEKGPLKKHLYGSSRQSPLSWKQRLEICIGSARGLHYLHTGFAQGIIHRDIKSTNILID 634

Query: 597 ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFE 656
           E+ V+KVADFGLSRSGP LDETHVSTG                QLTDKSDVYSFGVVLFE
Sbjct: 635 EDNVAKVADFGLSRSGPSLDETHVSTG---------------NQLTDKSDVYSFGVVLFE 679

Query: 657 VLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCL 716
           VLC R AVDP L REQVNLAEWA++W +KGML+HI+DP L+G I   SLKKFGETAEKCL
Sbjct: 680 VLCGRPAVDPQLTREQVNLAEWAIEWLQKGMLDHIVDPHLVGDIKPRSLKKFGETAEKCL 739

Query: 717 ADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTNPPALPTRTIVPQAPSSHVR 776
           A+YGVDRP+MGDVLWNLEYALQLQES          D + +     T TIVP+  +S + 
Sbjct: 740 AEYGVDRPTMGDVLWNLEYALQLQES----------DRSASEAVNETTTIVPENSTSRI- 788

Query: 777 EKEVDGNASSDLRTSQVFSQLMTNEGR 803
           E+  D N  SD+ TS+VFSQLM N+GR
Sbjct: 789 ERNYD-NDYSDISTSRVFSQLMNNDGR 814

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449445991|ref|XP_004140755.1| PREDICTED: probable receptor-like protein kinase At5g24010-like [Cucumis sativus]

 Score = 1040 bits (2688), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 527/807 (65%), Positives = 641/807 (79%), Gaps = 13/807 (1%)

Query: 2   YLINCGSPTNASLYNRFFVPDASSKSVSF-SADNSISLKSKTPPQDSPSPYDTARVFTSD 60
           YL++CGS +N+S +NR FV D+   +  F +A  S++L  + PP DSPS Y TARVFT  
Sbjct: 29  YLLSCGSSSNSSFFNRIFVADSLKPASDFLAAGKSVALSDRNPPPDSPSLYHTARVFTRV 88

Query: 61  GSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFIVK 120
            SYK NIK+NGTH +RFH SPF S  F L SA F + ANG+ L         V+KEF+V+
Sbjct: 89  SSYKFNIKKNGTHFLRFHLSPFSSPAFALHSANFTISANGVFLSTISHVNDSVIKEFMVR 148

Query: 121 VDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLSSEILE 180
           +D +V+EIEF+P    +FGF NAIEVFSAP++ I D+GA+++   G   E+  L+S+ILE
Sbjct: 149 IDTNVLEIEFQPASSSSFGFANAIEVFSAPKELITDNGAKLVDSDGG-REYYKLTSQILE 207

Query: 181 TILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPDN 240
           T  RINVGG +LTPFNDTLWRTWVPD+ +L LKSAAK  +T H PNY+ GG +RE+ PD 
Sbjct: 208 TKYRINVGGPKLTPFNDTLWRTWVPDEPYLALKSAAKLASTFHTPNYEPGGPTREVAPDI 267

Query: 241 VYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFINDY 300
           VYMTAQ+MN+D ++ GA+FN+TW+FP+ S+G  HLVRLHFCD VS +LNQLYFNV+IN Y
Sbjct: 268 VYMTAQQMNKDYSISGAKFNLTWNFPLDSNGVNHLVRLHFCDFVSSALNQLYFNVYINGY 327

Query: 301 SAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEIMK 360
            AY+DLDLSS++   L++P Y+DF+ DS  +G V++SVGPS+LS SL+ NAILNG EIM+
Sbjct: 328 PAYRDLDLSSLS-LQLSTPFYIDFIVDSGSSGDVQISVGPSDLSSSLRYNAILNGAEIME 386

Query: 361 MVHLTV--SETGEKNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRP-ADSVG 417
           MV+  V  +E  ++ + +W++VG VVGGF+ LCL+ +A +V F C+++K +    A+S G
Sbjct: 387 MVNSKVLFTEIEKRKRNLWVIVGPVVGGFIGLCLI-VAAIVAFGCKRRKKRKPKRAESAG 445

Query: 418 WTPLRAYGC-SSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGM 476
           WT ++AYG  SS SK+S G+  AS G NGYH LKIPF+++Q+ATNNFDK+LIIGSGGFGM
Sbjct: 446 WTSVQAYGGGSSDSKLSRGSTLASFGPNGYHSLKIPFSEIQSATNNFDKSLIIGSGGFGM 505

Query: 477 VYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY 536
           VYKGVLRDN KVAVKRGVPGSRQGLPEF TEI +LSKIRH HLVSLVGYCEEQSEMILVY
Sbjct: 506 VYKGVLRDNIKVAVKRGVPGSRQGLPEFHTEIAILSKIRHHHLVSLVGYCEEQSEMILVY 565

Query: 537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD 596
           EYMEKGPLKK LYG   +PLSWKQRLEICIGAARGLHYLHTG A+GIIHRDIKSTNILLD
Sbjct: 566 EYMEKGPLKKQLYGSVVSPLSWKQRLEICIGAARGLHYLHTGFAQGIIHRDIKSTNILLD 625

Query: 597 ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFE 656
           ENYV+KVADFGLSRSGP LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFE
Sbjct: 626 ENYVAKVADFGLSRSGPRLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFE 685

Query: 657 VLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCL 716
           VLCAR AVDPLLAREQVNLAEWA+ WQ+KGMLE I+DP L+G+IN +SLKK+GETAEKCL
Sbjct: 686 VLCARPAVDPLLAREQVNLAEWALHWQRKGMLEKIVDPHLVGQINPNSLKKYGETAEKCL 745

Query: 717 ADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTNPPALPTRTIVPQAPSSHVR 776
           ADYG+DRP+MGDVLWNLEY LQLQ   S  P E  +  +++    PT T +   PS+  R
Sbjct: 746 ADYGIDRPTMGDVLWNLEYVLQLQIGPSNEPSEPVDIDDSD---FPTSTAI--HPSNMRR 800

Query: 777 EKEVDGNASSDLRTSQVFSQLMTNEGR 803
             E   +  SD+ T++VFSQL+TN+GR
Sbjct: 801 HSEEGTDNFSDISTTKVFSQLLTNDGR 827

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	803
TAIR|locus:2178707	824	AT5G24010 [Arabidopsis thalian	0.981	0.956	0.630	2.7e-267
TAIR|locus:2174249	829	AT5G59700 [Arabidopsis thalian	0.474	0.459	0.645	5.3e-197
TAIR|locus:2075346	830	HERK1 "hercules receptor kinas	0.469	0.454	0.638	1.1e-194
TAIR|locus:2151349	855	THE1 "THESEUS1" [Arabidopsis t	0.476	0.447	0.629	5.9e-187
TAIR|locus:2136338	878	AT4G39110 [Arabidopsis thalian	0.417	0.381	0.658	1.5e-177
TAIR|locus:2050080	871	AT2G21480 [Arabidopsis thalian	0.449	0.414	0.616	2.4e-177
TAIR|locus:2163158	842	AT5G61350 [Arabidopsis thalian	0.399	0.381	0.664	1.4e-170
TAIR|locus:2081895	895	FER "FERONIA" [Arabidopsis tha	0.404	0.363	0.645	1.4e-156
TAIR|locus:2058636	834	AT2G23200 [Arabidopsis thalian	0.963	0.928	0.433	3.1e-154
TAIR|locus:2039717	815	AT2G39360 [Arabidopsis thalian	0.371	0.365	0.665	6.5e-151

TAIR|locus:2178707 AT5G24010 [Arabidopsis thaliana (taxid:3702)]

 Score = 2571 (910.1 bits), Expect = 2.7e-267, P = 2.7e-267
 Identities = 510/809 (63%), Positives = 608/809 (75%)

Query:     1 NYLINCGSPTNASLYN-RFFVPDASSKSVSF-SADNSISLKSKTPPQDSPSPYDTARVFT 58
             NYLIN GS TN S +  R F+ D+S    SF S D SIS+    P  DSP  Y+TARVF 
Sbjct:    31 NYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSISISDTNPSPDSPVLYNTARVFP 90

Query:    59 SDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFI 118
               GSYK  +   GTH +R HF+PF++  F L SAKF VL NG  ++  FST  VV+KEFI
Sbjct:    91 VGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLINGFSVINSFSTSSVVVKEFI 150

Query:   119 VKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGAR-VISGSGSIEEFRNLSSE 177
             +K+D  V+EI F P     FGFVNA+EVFSAP+D+I+D G + VI  S  I  F NLSS+
Sbjct:   151 LKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIMDQGTKLVIPNSAQI--FSNLSSQ 208

Query:   178 ILETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIG 237
             +LET+ RINVGGS+LTPFNDTLWRTWV DD +L+L++AA+R  TTH PNYQ GGA+REI 
Sbjct:   209 VLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAARRAWTTHSPNYQNGGATREIA 268

Query:   238 PDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFI 297
             PDNVYMTAQEM+RDN  L ARFNI+W F V      HLVRLHFCDIVS SLNQLYFNVFI
Sbjct:   269 PDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLVRLHFCDIVSSSLNQLYFNVFI 328

Query:   298 NDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVE 357
             N+Y A+KD+DLS++TFH LASP+Y+DFVA+SD +G++R+SVGPS+LS   +VNA+LNGVE
Sbjct:   329 NEYLAFKDVDLSTLTFHVLASPLYIDFVAESDRSGMLRISVGPSDLSNPARVNALLNGVE 388

Query:   358 IMKMVHLTVSE--TGEKNKKIWIXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXADS 415
             IM+++    SE  +G++N  +WI                                  ++S
Sbjct:   389 IMRILSPVSSEVVSGKRNV-VWIVVGSVLGGFVFLSLFFLSVLCLCRRKNNKTRS--SES 445

Query:   416 VGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG 475
              GWTPLR +  SS+S+ +E TV++S    GYH L+I F +LQ+ TNNFD++L+IG GGFG
Sbjct:   446 TGWTPLRRFRGSSNSRTTERTVSSS----GYHTLRISFAELQSGTNNFDRSLVIGVGGFG 501

Query:   476 MVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV 535
             MV++G L+DNTKVAVKRG PGSRQGLPEF +EIT+LSKIRHRHLVSLVGYCEEQSEMILV
Sbjct:   502 MVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRHLVSLVGYCEEQSEMILV 561

Query:   536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL 595
             YEYM+KGPLK HLYG    PLSWKQRLE+CIGAARGLHYLHTGS++GIIHRDIKSTNILL
Sbjct:   562 YEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGLHYLHTGSSQGIIHRDIKSTNILL 621

Query:   596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF 655
             D NYV+KVADFGLSRSGPC+DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF
Sbjct:   622 DNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF 681

Query:   656 EVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKC 715
             EVLCAR AVDPLL REQVNLAEWA++WQ+KGML+ I+DP +  +I   SLKKF ETAEKC
Sbjct:   682 EVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNIADEIKPCSLKKFAETAEKC 741

Query:   716 LADYGVDRPSMGDVLWNLEYALQLQESGS-GLPREQREDSNTNPPALPTRTIVPQAPSSH 774
              ADYGVDRP++GDVLWNLE+ LQLQESG   +P E   D  T+P     RT      +  
Sbjct:   742 CADYGVDRPTIGDVLWNLEHVLQLQESGPLNIPEEDYGDV-TDP-----RTARQGLSNGS 795

Query:   775 VREKEVDGNASSDLRTSQVFSQLMTNEGR 803
               E++     S  + ++QVFSQLMTN GR
Sbjct:   796 NIERDYGDGTSGIISSTQVFSQLMTNAGR 824

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2174249 AT5G59700 [Arabidopsis thaliana (taxid:3702)]

 Score = 1250 (445.1 bits), Expect = 5.3e-197, Sum P(2) = 5.3e-197
 Identities = 259/401 (64%), Positives = 298/401 (74%)

Query:   414 DSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGG 473
             +S  W PL + G +S S    GT  AS   N  +R  IP   ++ ATN+FD+N  IG GG
Sbjct:   438 NSKTWIPLSSNGTTSSSN---GTTLASIASNSSYR--IPLVAVKEATNSFDENRAIGVGG 492

Query:   474 FGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI 533
             FG VYKG L D TKVAVKR  P S+QGL EF+TEI +LS+ RHRHLVSL+GYC+E +EMI
Sbjct:   493 FGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMI 552

Query:   534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNI 593
             LVYEYME G LK HLYG     LSWKQRLEICIG+ARGLHYLHTG A+ +IHRD+KS NI
Sbjct:   553 LVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHYLHTGDAKPVIHRDVKSANI 612

Query:   594 LLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVV 653
             LLDEN ++KVADFGLS++GP +D+THVST VKGSFGYLDPEYFRRQQLT+KSDVYSFGVV
Sbjct:   613 LLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 672

Query:   654 LFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAE 713
             +FEVLCAR  +DP L RE VNLAEWAM+WQKKG LEHIIDP L GKI  DSL+KFGET E
Sbjct:   673 MFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDPSLRGKIRPDSLRKFGETGE 732

Query:   714 KCLADYGVDRPSMGDVLWNLEYALQLQESG-SGLPREQREDSNTNPPALPTR-------- 764
             KCLADYGVDRPSMGDVLWNLEYALQLQE+   G P    EDS      LP R        
Sbjct:   733 KCLADYGVDRPSMGDVLWNLEYALQLQEAVVDGDP----EDSTNMIGELPLRFNDYNHGD 788

Query:   765 TIVPQAPSSHVR--EKEVDGNASSDLRTSQVFSQLMTNEGR 803
             T V  + +   R  E+E   + SS +  S+VFSQL+ +EGR
Sbjct:   789 TSVNFSVAKEGRFDEEESSVDDSSGVSMSKVFSQLIKSEGR 829

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0007131 "reciprocal meiotic recombination" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0033044 "regulation of chromosome organization" evidence=RCA

GO:0042138 "meiotic DNA double-strand break formation" evidence=RCA

GO:0045132 "meiotic chromosome segregation" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2075346 HERK1 "hercules receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1242 (442.3 bits), Expect = 1.1e-194, Sum P(2) = 1.1e-194
 Identities = 254/398 (63%), Positives = 293/398 (73%)

Query:   418 WTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMV 477
             W P    G S  SK S GT   S   N  +R  IPF  ++ ATNNFD++  IG GGFG V
Sbjct:   442 WMPFSINGTSMGSKYSNGTTLTSITTNANYR--IPFAAVKDATNNFDESRNIGVGGFGKV 499

Query:   478 YKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE 537
             YKG L D TKVAVKRG P S+QGL EF+TEI +LS+ RHRHLVSL+GYC+E +EMIL+YE
Sbjct:   500 YKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYE 559

Query:   538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE 597
             YME G +K HLYG     L+WKQRLEICIGAARGLHYLHTG ++ +IHRD+KS NILLDE
Sbjct:   560 YMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDE 619

Query:   598 NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
             N+++KVADFGLS++GP LD+THVST VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV
Sbjct:   620 NFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 679

Query:   658 LCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLA 717
             LCAR  +DP L RE VNLAEWAM+WQKKG L+ IID  L G I  DSL+KF ET EKCLA
Sbjct:   680 LCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLA 739

Query:   718 DYGVDRPSMGDVLWNLEYALQLQESG-SGLPREQREDSNTN-----PPAL------PTRT 765
             DYGVDRPSMGDVLWNLEYALQLQE+   G P    ED++TN     PP +       T  
Sbjct:   740 DYGVDRPSMGDVLWNLEYALQLQEAVIDGEP----EDNSTNMIGELPPQINNFSQGDTSV 795

Query:   766 IVPQAPSSHVREKEVDGNASSDLRTSQVFSQLMTNEGR 803
              VP   +    E  +D    S +  S+VFSQL+ +EGR
Sbjct:   796 NVP-GTAGRFEESSIDD--LSGVSMSKVFSQLVKSEGR 830

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0009791 "post-embryonic development" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=IGI;RCA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1247 (444.0 bits), Expect = 5.9e-187, Sum P(2) = 5.9e-187
 Identities = 251/399 (62%), Positives = 299/399 (74%)

Query:   418 WTPLRAYGCS---SHSKMSEGTVNASPGQNGYHRLK--IPFTDLQTATNNFDKNLIIGSG 472
             W PL  YG S   + S  S  +  AS        L     F ++  ATN FD++ ++G G
Sbjct:   460 WLPLPLYGLSQTLTKSTASHKSATASCISLASTHLGRCFMFQEIMDATNKFDESSLLGVG 519

Query:   473 GFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM 532
             GFG VYKG L D TKVAVKRG P S QG+ EF+TEI +LSK+RHRHLVSL+GYC+E+SEM
Sbjct:   520 GFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 579

Query:   533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTN 592
             ILVYEYM  GPL+ HLYG D  PLSWKQRLEICIGAARGLHYLHTG+++ IIHRD+K+TN
Sbjct:   580 ILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTN 639

Query:   593 ILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGV 652
             ILLDEN V+KVADFGLS++GP LD+THVST VKGSFGYLDPEYFRRQQLT+KSDVYSFGV
Sbjct:   640 ILLDENLVAKVADFGLSKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 699

Query:   653 VLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETA 712
             VL EVLC R A++P+L REQVN+AEWAM WQKKG+L+ I+D  L GK+N  SLKKFGETA
Sbjct:   700 VLMEVLCCRPALNPVLPREQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETA 759

Query:   713 EKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQREDSNTNP-PALPTRTIVPQAP 771
             EKCLA+YGVDRPSMGDVLWNLEYALQL+E+ S L   + +D++TN  P +P   + P   
Sbjct:   760 EKCLAEYGVDRPSMGDVLWNLEYALQLEETSSALM--EPDDNSTNHIPGIPMAPMEPFDN 817

Query:   772 SSHVREKE-------VDGNASSDLRTSQVFSQLMTNEGR 803
             S  + ++         D +A  D  TS VFSQL+   GR
Sbjct:   818 SMSIIDRGGVNSGTGTDDDAE-DATTSAVFSQLVHPRGR 855

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0009791 "post-embryonic development" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=IGI;RCA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1149 (409.5 bits), Expect = 1.5e-177, Sum P(2) = 1.5e-177
 Identities = 226/343 (65%), Positives = 264/343 (76%)

Query:   438 NASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS 497
             N++ G   Y  L    ++LQ AT NF+ + IIG GGFG VY G L D TKVAVKRG P S
Sbjct:   505 NSTLGLGRYFSL----SELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQS 560

Query:   498 RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLS 557
              QG+ EFQTEI +LSK+RHRHLVSL+GYC+E SEMILVYE+M  GP + HLYG +  PL+
Sbjct:   561 EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLT 620

Query:   558 WKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE 617
             WKQRLEICIG+ARGLHYLHTG+A+GIIHRD+KSTNILLDE  V+KVADFGLS+      +
Sbjct:   621 WKQRLEICIGSARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQ 679

Query:   618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
              HVST VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVL E LCAR A++P L REQVNLAE
Sbjct:   680 NHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAE 739

Query:   678 WAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL 737
             WAMQW++KG+LE IIDP L G IN +S+KKF E AEKCL DYGVDRP+MGDVLWNLEYAL
Sbjct:   740 WAMQWKRKGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYAL 799

Query:   738 QLQESGSGLPREQREDSNTN---PPALPTRTIVPQAPSSHVRE 777
             QLQE+ +    E+ E++  +   P ++P     P  PS    E
Sbjct:   800 QLQEAFTQGKAEETENAKPDVVTPGSVPVSDPSPITPSVTTNE 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

GO:0030048 "actin filament-based movement" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2050080 AT2G21480 [Arabidopsis thaliana (taxid:3702)]

 Score = 1153 (410.9 bits), Expect = 2.4e-177, Sum P(2) = 2.4e-177
 Identities = 230/373 (61%), Positives = 273/373 (73%)

Query:   438 NASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS 497
             N++ G   Y  L    ++LQ  T NFD + IIG GGFG VY G + D T+VA+KRG P S
Sbjct:   504 NSALGLGRYFSL----SELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQS 559

Query:   498 RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLS 557
              QG+ EF TEI +LSK+RHRHLVSL+GYC+E +EMILVYEYM  GP + HLYG + +PL+
Sbjct:   560 EQGITEFHTEIQMLSKLRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLT 619

Query:   558 WKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE 617
             WKQRLEICIGAARGLHYLHTG+A+GIIHRD+KSTNILLDE  V+KVADFGLS+      +
Sbjct:   620 WKQRLEICIGAARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQ 678

Query:   618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
              HVST VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVL E LCAR A++P L REQVNLAE
Sbjct:   679 NHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAE 738

Query:   678 WAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL 737
             WAM W++KG+LE IIDP L+G +N +S+KKF E AEKCLADYGVDRP+MGDVLWNLEYAL
Sbjct:   739 WAMLWKQKGLLEKIIDPHLVGAVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYAL 798

Query:   738 QLQESGSGLPREQREDSNTNPPALPTRTIV-PQAPSSHVREKEVDGNASSDLRT------ 790
             QLQE+ S    E  E     P A+P      P A ++   E+ V      D  T      
Sbjct:   799 QLQEAFSQGKAEAEEVETPKPVAVPAAAPTSPAATTAAASERPVSQTEEKDDSTVDQHSG 858

Query:   791 SQVFSQLMTNEGR 803
             + +F+Q  +  GR
Sbjct:   859 TTMFTQFASLNGR 871

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2163158 AT5G61350 [Arabidopsis thaliana (taxid:3702)]

 Score = 1129 (402.5 bits), Expect = 1.4e-170, Sum P(2) = 1.4e-170
 Identities = 220/331 (66%), Positives = 261/331 (78%)

Query:   452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVL 511
             PFT+LQTAT NFD+N + G GGFG VY G +   T+VA+KRG   S QG+ EFQTEI +L
Sbjct:   514 PFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQVAIKRGSQSSEQGINEFQTEIQML 573

Query:   512 SKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG-----PDRTP-LSWKQRLEIC 565
             SK+RHRHLVSL+G+C+E  EMILVYEYM  GPL+ HLYG     P+  P LSWKQRLEIC
Sbjct:   574 SKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGSKENDPNPIPTLSWKQRLEIC 633

Query:   566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK 625
             IG+ARGLHYLHTG+A+GIIHRD+K+TNILLDEN V+KV+DFGLS+  P +DE HVST VK
Sbjct:   634 IGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSDFGLSKDAP-MDEGHVSTAVK 692

Query:   626 GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK 685
             GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR  ++P L REQVNLAE+AM   +K
Sbjct:   693 GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVINPQLPREQVNLAEYAMNLHRK 752

Query:   686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSG 745
             GMLE IIDP+++G I+  SL+KF E AEKCLA+YGVDRP MGDVLWNLEYALQLQE+ + 
Sbjct:   753 GMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPGMGDVLWNLEYALQLQEASAQ 812

Query:   746 LP-REQREDSNTNPPALPTRTIVPQAPSSHV 775
             +   E +   N     +P   +  Q+PS  +
Sbjct:   813 VDLSEDKTTMNIEMDLIPGEEM--QSPSHSI 841

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2081895 FER "FERONIA" [Arabidopsis thaliana (taxid:3702)]

 Score = 1088 (388.1 bits), Expect = 1.4e-156, Sum P(3) = 1.4e-156
 Identities = 213/330 (64%), Positives = 253/330 (76%)

Query:   417 GWTPLRAYGCSSHSKMSEGT-VNASPGQNGYHRL--KIPFTDLQTATNNFDKNLIIGSGG 473
             GW PL  YG +SHS  S  T    S   +    L     F +++ AT NFD++ ++G GG
Sbjct:   488 GWLPLSLYG-NSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGG 546

Query:   474 FGMVYKGVLRDNT-KVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM 532
             FG VY+G +   T KVA+KRG P S QG+ EFQTEI +LSK+RHRHLVSL+GYCEE  EM
Sbjct:   547 FGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM 606

Query:   533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTN 592
             ILVY+YM  G +++HLY      L WKQRLEICIGAARGLHYLHTG+   IIHRD+K+TN
Sbjct:   607 ILVYDYMAHGTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTN 666

Query:   593 ILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGV 652
             ILLDE +V+KV+DFGLS++GP LD THVST VKGSFGYLDPEYFRRQQLT+KSDVYSFGV
Sbjct:   667 ILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 726

Query:   653 VLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETA 712
             VLFE LCAR A++P LA+EQV+LAEWA    KKGML+ I+DP L GKI  +  KKF ETA
Sbjct:   727 VLFEALCARPALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETA 786

Query:   713 EKCLADYGVDRPSMGDVLWNLEYALQLQES 742
              KC+ D G++RPSMGDVLWNLE+ALQLQES
Sbjct:   787 MKCVLDQGIERPSMGDVLWNLEFALQLQES 816

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0016020 "membrane" evidence=IDA

GO:0010483 "pollen tube reception" evidence=IMP

GO:0043680 "filiform apparatus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009791 "post-embryonic development" evidence=IMP

GO:0050832 "defense response to fungus" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0000902 "cell morphogenesis" evidence=RCA

GO:0006007 "glucose catabolic process" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0010193 "response to ozone" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0030244 "cellulose biosynthetic process" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048193 "Golgi vesicle transport" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2058636 AT2G23200 [Arabidopsis thaliana (taxid:3702)]

 Score = 1504 (534.5 bits), Expect = 3.1e-154, P = 3.1e-154
 Identities = 358/826 (43%), Positives = 490/826 (59%)

Query:     1 NYLINCGSPTNASLYNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTSD 60
             N+ +NCGS +N     + FV D +S + S S  N  +         +P  Y T R+F   
Sbjct:    38 NFYVNCGSDSNVFYGGQTFVGDTNSSTNSVSFTNKGTEVINDQSSVAPEIYRTVRIFRHP 97

Query:    61 GSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLA-NGLLL-LQDFSTQVVVLKEFI 118
              SYK  +   G H VR HFS   S    L +A+F V A +G    L+ FS Q +     +
Sbjct:    98 SSYKFKLDSLGLHFVRLHFSVVFS-RADLLTARFTVSATSGSNHHLKSFSPQNLTNTPRV 156

Query:   119 VK--VDGDVIEIEFRPVGD-KNFGFVNAIEVFSAPEDFIVDDGARVISGSGSIEEFRNLS 175
              +  +  + +E E R V D  +   +NAIEVFSAP+D                 E  + S
Sbjct:   157 EEFLLMMNSLEFEIRFVPDHSSLALINAIEVFSAPDDL----------------EIPSAS 200

Query:   176 SEILETILRINVGGSELTPFNDTLWRTWVPDDE-FLVLKSAAKRVATTHPPNYQKG--GA 232
              + L TI R+NVGG ++TP NDTL RTW+PDD+ FL  K +A+ + +T  PNY  G   A
Sbjct:   201 DKNLHTIYRLNVGGEKITPDNDTLGRTWLPDDDDFLYRKDSARNINSTQTPNYVGGLSSA 260

Query:   233 SREIGPDNVYMTAQEMNRD-NAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQ- 290
             +    PD VY TA+ MNR  N  +G   N+TW F V S+ +RH +R+HF DI+S   N  
Sbjct:   261 TDSTAPDFVYKTAKAMNRSSNEQVGMLMNVTWSFKVKSN-HRHFIRIHFSDILSNLSNSD 319

Query:   291 LYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVN 350
               F +F+N Y  ++ +D+       LASP + D V  SD +G++ +S+G  E +   K  
Sbjct:   320 SDFYLFVNGY--WR-VDVKPSEQPRLASPFFKDVVNVSDGSGLLNISIGTKEAN---KDA 373

Query:   351 AILNGVEIMKMVHLTVSE-TGEKNKKIWIXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 409
               LNG+E+M+++  + S+ +   + ++ I                               
Sbjct:   374 GFLNGLEMMEVLSKSGSDYSNRSSSRVHIITGCAVAAAAASALVFSLLFMVFLKRRRSKK 433

Query:   410 XX-XADSVGWTPLRAY--GCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKN 466
                  +   W+PL  +  G S +  +S+   + SP +N +  L IPFTD+ +ATNNFD+ 
Sbjct:   434 TKPEVEGTVWSPLPLHRGGSSDNRPISQ--YHNSPLRNLHLGLTIPFTDILSATNNFDEQ 491

Query:   467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
             L+IG GGFG VYK +L D TK A+KRG  GS QG+ EFQTEI VLS+IRHRHLVSL GYC
Sbjct:   492 LLIGKGGFGYVYKAILPDGTKAAIKRGKTGSGQGILEFQTEIQVLSRIRHRHLVSLTGYC 551

Query:   527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG-IIH 585
             EE SEMILVYE+MEKG LK+HLYG +   L+WKQRLEICIGAARGL YLH+  +EG IIH
Sbjct:   552 EENSEMILVYEFMEKGTLKEHLYGSNLPSLTWKQRLEICIGAARGLDYLHSSGSEGAIIH 611

Query:   586 RDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS 645
             RD+KSTNILLDE+ ++KVADFGLS+     DE+++S  +KG+FGYLDPEY +  +LT+KS
Sbjct:   612 RDVKSTNILLDEHNIAKVADFGLSKIHN-QDESNISINIKGTFGYLDPEYLQTHKLTEKS 670

Query:   646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
             DVY+FGVVL EVL AR A+DP L  E+VNL+EW M  + KG ++ I+DP LIG+I  +SL
Sbjct:   671 DVYAFGVVLLEVLFARPAIDPYLPHEEVNLSEWVMFCKSKGTIDEILDPSLIGQIETNSL 730

Query:   706 KKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPRE-QREDS---NTNPPAL 761
             KKF E AEKCL +YG +RPSM DV+W+LEY LQLQ   +   RE   EDS   N+    +
Sbjct:   731 KKFMEIAEKCLKEYGDERPSMRDVIWDLEYVLQLQMMTNR--REAHEEDSTAINSGGSLV 788

Query:   762 PTRTIVPQAPSSHVREKEVDGNAS----SDLRTSQVFSQLMTNEGR 803
               R +V  + S++   +  D + +    +D   ++VFSQL  ++ R
Sbjct:   789 APRLMVSDSFSTNSIFQNGDESKNRFGFTDSSETRVFSQLKISDAR 834

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2039717 AT2G39360 [Arabidopsis thaliana (taxid:3702)]

 Score = 1083 (386.3 bits), Expect = 6.5e-151, Sum P(2) = 6.5e-151
 Identities = 201/302 (66%), Positives = 247/302 (81%)

Query:   440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ 499
             S  + GY   + P   ++ AT++FD++L+IG GGFG VYKGVLRD T+VAVKRG P SRQ
Sbjct:   467 SSSKIGY---RYPLALIKEATDDFDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQ 523

Query:   500 GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSW 558
             GL EF+TE+ +L++ RHRHLVSL+GYC+E SEMI+VYEYMEKG LK HLY  D  P LSW
Sbjct:   524 GLAEFKTEVEMLTQFRHRHLVSLIGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSW 583

Query:   559 KQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET 618
             +QRLEIC+GAARGLHYLHTGS   IIHRD+KS NILLD+N+++KVADFGLS++GP LD+T
Sbjct:   584 RQRLEICVGAARGLHYLHTGSTRAIIHRDVKSANILLDDNFMAKVADFGLSKTGPDLDQT 643

Query:   619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW 678
             HVST VKGSFGYLDPEY  RQQLT+KSDVYSFGVV+ EV+C R  +DP L RE+VNL EW
Sbjct:   644 HVSTAVKGSFGYLDPEYLTRQQLTEKSDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEW 703

Query:   679 AMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ 738
             AM+  KKG LE IIDP L+GK+ L+ +KK+ E  EKCL+  G++RP+MGD+LWNLE+ LQ
Sbjct:   704 AMKLVKKGKLEDIIDPFLVGKVKLEEVKKYCEVTEKCLSQNGIERPAMGDLLWNLEFMLQ 763

Query:   739 LQ 740
             +Q
Sbjct:   764 VQ 765

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FLW0	Y5241_ARATH	2, ., 7, ., 1, 1, ., -	0.6551	0.9813	0.9563	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.44.494.1 hypothetical protein (760 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	803
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-51
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-51
pfam12819	335	pfam12819, Malectin_like, Carbohydrate-binding pro	7e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-43
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-35
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-33
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-30
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-29
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-27
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-27
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-26
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-26
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-25
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-25
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-24
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-22
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-21
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-21
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-21
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-19
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-17
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-15
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-11
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-08
pfam11721	164	pfam11721, Malectin, Di-glucose binding within end	4e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	9e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-04
pfam11721	164	pfam11721, Malectin, Di-glucose binding within end	7e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	8e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.003
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.004

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  182 bits (465), Expect = 2e-52
 Identities = 72/200 (36%), Positives = 106/200 (53%), Gaps = 16/200 (8%)

Query: 468 IIGSGGFGMVYKGVLRDN-----TKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVS 521
            +G G FG VYKG L+        +VAVK      S Q + EF  E  ++ K+ H ++V 
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+G C E+  +++V EYM  G L  +L       LS    L   +  ARG+ YL    ++
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SK 122

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG---VKGSFGYLDPEYFRR 638
             IHRD+ + N L+ EN V K++DFGLSR     D   V  G   ++    ++ PE  + 
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLKE 178

Query: 639 QQLTDKSDVYSFGVVLFEVL 658
            + T KSDV+SFGV+L+E+ 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIF 198

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  182 bits (465), Expect = 3e-52
 Identities = 75/203 (36%), Positives = 110/203 (54%), Gaps = 17/203 (8%)

Query: 468 IIGSGGFGMVYKGVLRDN----TKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVS 521
            +G G FG VYKG L+      T+VAVK  +    S +   +F  E  V+ K+ H ++V 
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHL-------YGPDRTPLSWKQRLEICIGAARGLHY 574
           L+G C E+  + LV EYME G L  +L         P+++ LS K  L   I  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L    ++  +HRD+ + N L+ E+ V K++DFGLSR     D     TG K    ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 635 YFRRQQLTDKSDVYSFGVVLFEV 657
             +    T KSDV+SFGV+L+E+
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEI 200

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  180 bits (458), Expect = 2e-51
 Identities = 73/197 (37%), Positives = 106/197 (53%), Gaps = 11/197 (5%)

Query: 468 IIGSGGFGMVYKGVLRDN-----TKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVS 521
            +G G FG VYKG L+        +VAVK      S Q + EF  E  ++ K+ H ++V 
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+G C E+  + +V EYME G L  +L       LS    L   +  ARG+ YL    ++
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGMEYLE---SK 121

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
             IHRD+ + N L+ EN V K++DFGLSR     D+ +   G K    ++ PE  +  + 
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPESLKEGKF 180

Query: 642 TDKSDVYSFGVVLFEVL 658
           T KSDV+SFGV+L+E+ 
Sbjct: 181 TSKSDVWSFGVLLWEIF 197

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  178 bits (455), Expect = 6e-51
 Identities = 71/197 (36%), Positives = 106/197 (53%), Gaps = 10/197 (5%)

Query: 469 IGSGGFGMVYKGVLRD-----NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG VYKG L+       TKVAVK    G S +   EF  E +++ K+ H ++V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
           +G C +   + +V EYM  G L   L       L+ K  L++ +  A+G+ YL    ++ 
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKGMEYLE---SKN 122

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
            +HRD+ + N L+ EN V K++DFGLSR     D      G K    ++ PE  +  + T
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182

Query: 643 DKSDVYSFGVVLFEVLC 659
            KSDV+SFGV+L+E+  
Sbjct: 183 SKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER

 Score =  181 bits (460), Expect = 7e-51
 Identities = 87/377 (23%), Positives = 141/377 (37%), Gaps = 61/377 (16%)

Query: 4   INCGSPTNASLY----NRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTS 59
           I+CG P+N S         +V DA       S + S    S    +    PY T R F  
Sbjct: 1   IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSK----PYKTLRSFP- 55

Query: 60  DGS---YKLNI--KRNGTHLVRFHFSPFESDNFKLASA--KFGVLANG-----LLLLQDF 107
           DG    Y L +   +   +L+R  F     D     S+   F +         + L  D 
Sbjct: 56  DGKRNCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDS 115

Query: 108 STQVVVLKEFIVKV-DGDVIEIEFRPVGDKNFGFVNAIEVFSAPEDFIVDDGARVISGSG 166
              VV  KE+I+ V   D + +     G     F++A+E+   P+      G        
Sbjct: 116 GDSVV--KEYIIHVTKSDTLSVCLVNTG-TGTPFISALELRPLPDSLYPSSG-------- 164

Query: 167 SIEEFRNLSSEILETILRINVG--GSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHP 224
                    S+ L+ + R+N G     +   +D   R W P            +++T+  
Sbjct: 165 --------GSQALKLVARLNFGGSEGTIRYPDDVYDRIWEPFFSS----PGWSQISTSLS 212

Query: 225 PNYQKGGASREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIV 284
            +     A   I P  V  TA      +    A  N TWD    +    + V LHF +I 
Sbjct: 213 VDISSNNAP-YIPPSAVLQTAVTPTNAS----APLNFTWDLVDPNFE--YYVYLHFAEIQ 265

Query: 285 SPSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELS 344
             SL    F+++IN  + Y D+        +    +Y+DF  +    G++ +S+ P+  S
Sbjct: 266 --SLETREFDIYINGKTVYGDVS--PKYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGS 321

Query: 345 GSLKVNAILNGVEIMKM 361
               +  +LN +EI K+
Sbjct: 322 ---TLPPLLNALEIFKV 335

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  172 bits (439), Expect = 2e-49
 Identities = 73/192 (38%), Positives = 103/192 (53%), Gaps = 10/192 (5%)

Query: 469 IGSGGFGMVYKGVLR-DNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
           +G GGFG VY    +    KVA+K      S   L E   EI +L K+ H ++V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
           E+++ + LV EY E G LK  L   +   LS  + L I +    GL YLH   + GIIHR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLH---SNGIIHR 116

Query: 587 DIKSTNILLDE-NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ-LTDK 644
           D+K  NILLD  N   K+ADFGLS+      +  +   + G+  Y+ PE    +   ++K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 645 SDVYSFGVVLFE 656
           SD++S GV+L+E
Sbjct: 175 SDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  159 bits (405), Expect = 4e-44
 Identities = 85/273 (31%), Positives = 127/273 (46%), Gaps = 33/273 (12%)

Query: 468 IIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRHRHLVSLV 523
            +GSG FG VYK   +     VAVK  +    +   + QT   EI +L ++ H ++V L+
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKI-LKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
              E++  + LV EY E G L  +L      PLS  +  +I +   RGL YLH   + GI
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLH---SNGI 119

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE-YFRRQQLT 642
           IHRD+K  NILLDEN V K+ADFGL++       +   T   G+  Y+ PE         
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNGYG 177

Query: 643 DKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI-- 700
            K DV+S GV+L+E+L  +    P      ++         +  ++  I+ P L      
Sbjct: 178 PKVDVWSLGVILYELLTGKP---PFSGENILD---------QLQLIRRILGPPLEFDEPK 225

Query: 701 ---NLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
                +  K      +KCL      RP+  ++L
Sbjct: 226 WSSGSEEAKDL---IKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  156 bits (397), Expect = 5e-43
 Identities = 75/265 (28%), Positives = 110/265 (41%), Gaps = 23/265 (8%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGY 525
            +G G FG VY     +    VA+K       +   E    EI +L K++H ++V L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
            E++ ++ LV EY E G L   L    R  LS  +           L YLH   ++GI+H
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 586 RDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS 645
           RD+K  NILLDE+   K+ADFGL+R    LD     T   G+  Y+ PE    +      
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177

Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           D++S GV+L+E+L  +    P    +Q+       +   K           I        
Sbjct: 178 DIWSLGVILYELLTGKP---PFPGDDQLLE---LFKKIGKPKPPFPPPEWDIS----PEA 227

Query: 706 KKFGETAEKCLADYGVDRPSMGDVL 730
           K       K L      R +  + L
Sbjct: 228 KDL---IRKLLVKDPEKRLTAEEAL 249

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  134 bits (339), Expect = 3e-35
 Identities = 64/189 (33%), Positives = 105/189 (55%), Gaps = 5/189 (2%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +GSG FG V++G+ ++  +VA+K           +FQ E+  L ++RH+HL+SL   C  
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
              + ++ E MEKG L   L  P+   L     +++    A G+ YL     +  IHRD+
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130

Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVY 648
            + NIL+ E+ V KVADFGL+R     ++ ++S+  K  + +  PE       + KSDV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188

Query: 649 SFGVVLFEV 657
           SFG++L+E+
Sbjct: 189 SFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  133 bits (335), Expect = 7e-35
 Identities = 75/193 (38%), Positives = 110/193 (56%), Gaps = 14/193 (7%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGL---PEFQTEITVLSKIRHRHLVSLVGY 525
           IGSG FG+V+ G   +  KVA+K      R+G     +F  E  V+ K+ H  LV L G 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKT----IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
           C E+S + LV+E+ME G L  +L    R   S +  L +C+    G+ YL + +   +IH
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 586 RDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYFRRQQLTDK 644
           RD+ + N L+ EN V KV+DFG++R    LD+ +  STG K    +  PE F   + + K
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181

Query: 645 SDVYSFGVVLFEV 657
           SDV+SFGV+++EV
Sbjct: 182 SDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  132 bits (334), Expect = 2e-34
 Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 20/210 (9%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTK-VAVK--RGVPGSRQGLPEFQTEITVLSKIRHRH 518
            + +  ++G G FG VY  + +D  + +AVK       S + L   + EI +LS ++H +
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 519 LVSLVG-YCEEQSEMILVY-EYMEKGPLKKHL--YGPDRTPL--SW-KQRLEICIGAARG 571
           +V   G   +E+   + ++ EY+  G L   L  +G    P+   + +Q LE       G
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-------G 113

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH   + GI+HRDIK  NIL+D + V K+ADFG ++    ++    +  V+G+  ++
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
            PE  R ++    +D++S G  + E+   +
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  127 bits (321), Expect = 7e-33
 Identities = 63/191 (32%), Positives = 103/191 (53%), Gaps = 14/191 (7%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
           IG G FG V  G  R   KVAVK  +    + Q    F  E +V++ +RH +LV L+G  
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLLGVV 69

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
            + + + +V EYM KG L  +L    R  ++  Q+L   +    G+ YL     +  +HR
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126

Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
           D+ + N+L+ E+ V+KV+DFGL++     + +      K    +  PE  R ++ + KSD
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSD 181

Query: 647 VYSFGVVLFEV 657
           V+SFG++L+E+
Sbjct: 182 VWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (310), Expect = 2e-31
 Identities = 74/193 (38%), Positives = 101/193 (52%), Gaps = 13/193 (6%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G     TKVAVK   PG+    PE F  E  ++ K+RH  LV L   C 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L   +   L   Q +++    A G+ YL    +   IHRD
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRD 128

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCL---DETHVSTGVKGSFGYLDPEYFRRQQLTDK 644
           + + NIL+ EN V K+ADFGL+R    L   DE     G K    +  PE     + T K
Sbjct: 129 LAARNILVGENLVCKIADFGLAR----LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184

Query: 645 SDVYSFGVVLFEV 657
           SDV+SFG++L E+
Sbjct: 185 SDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  120 bits (304), Expect = 1e-30
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 15/199 (7%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE---FQTEITVLSKIRHRHLVSLVG 524
           IG G FG VY      D     +K  +  S     E      E+ +L K+ H +++    
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKE-IDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 525 YCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
             EE+ ++ +V EY + G L + +     +  P   +Q L+  +     L YLH+     
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RK 123

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET-HVSTGVKGSFGYLDPEYFRRQQL 641
           I+HRDIK  NI L  N + K+ DFG+S+    L  T  ++  V G+  YL PE  + +  
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKV---LSSTVDLAKTVVGTPYYLSPELCQNKPY 180

Query: 642 TDKSDVYSFGVVLFEVLCA 660
             KSD++S G VL+E LC 
Sbjct: 181 NYKSDIWSLGCVLYE-LCT 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 2e-30
 Identities = 71/200 (35%), Positives = 108/200 (54%), Gaps = 25/200 (12%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP-----EFQTEITVLSKIRHRHLVSLV 523
           IG G FG VYKGVL+ NT+VAVK      R  LP     +F  E  +L +  H ++V L+
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKT----CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G C ++  + +V E +  G L   L    +  L+ K+ L++ + AA G+ YL    ++  
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNC 114

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH-----VSTGVKG-SFGYLDPEYFR 637
           IHRD+ + N L+ EN V K++DFG+SR      E       VS G+K     +  PE   
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR------EEEGGIYTVSDGLKQIPIKWTAPEALN 168

Query: 638 RQQLTDKSDVYSFGVVLFEV 657
             + T +SDV+S+G++L+E 
Sbjct: 169 YGRYTSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 3e-30
 Identities = 65/190 (34%), Positives = 102/190 (53%), Gaps = 5/190 (2%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG V++G+  + T VAVK   PG+     +F  E  ++ K+RH  L+ L   C  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +  + +V E M+ G L ++L G     L   Q +++    A G+ YL    A+  IHRD+
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129

Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVY 648
            + N+L+ EN + KVADFGL+R     D      G K    +  PE     + + KSDV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVIK-EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188

Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 189 SFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 3e-30
 Identities = 67/196 (34%), Positives = 105/196 (53%), Gaps = 9/196 (4%)

Query: 468 IIGSGGFGMVYKGVLRDNTK----VAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLVSL 522
           +IG G FG V +G L+   K    VA+K    GS      +F TE +++ +  H +++ L
Sbjct: 11  VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
            G   +   ++++ EYME G L K L   D    +  Q + +  G A G+ YL   S   
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
            +HRD+ + NIL++ N V KV+DFGLSR     + T+ + G K    +  PE    ++ T
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186

Query: 643 DKSDVYSFGVVLFEVL 658
             SDV+SFG+V++EV+
Sbjct: 187 SASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 2e-29
 Identities = 69/190 (36%), Positives = 103/190 (54%), Gaps = 8/190 (4%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +GSG FG+V+ G  R    VA+K    G+     +F  E  V+ K+ H +LV L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q  + +V EYM  G L  +L    +  L  +  L++C      + YL +    G IHRD+
Sbjct: 71  QRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDL 126

Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+ E+ V KV+DFGL+R    LD+ +  S G K    +  PE F   + + KSDV
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184

Query: 648 YSFGVVLFEV 657
           +SFGV+++EV
Sbjct: 185 WSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  117 bits (295), Expect = 3e-29
 Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 22/208 (10%)

Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FG V+ G         D   VAVK      S     +F+ E  +L+  +H ++V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD----------RTPLSWKQRLEICIGAA 569
             G C E    I+V+EYME G L K L  +GPD             L+  Q L+I +  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
            G+ YL   +++  +HRD+ + N L+  + V K+ DFG+SR     D   V         
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
           ++ PE    ++ T +SDV+SFGVVL+E+
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 8e-29
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 20/199 (10%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           +IG G FG+VYKG+ L     VA+K+        + L     EI +L  ++H ++V  +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 525 YCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLS---WKQRLEICIGAARGLHYLHTGS 579
             E    + ++ EY E G L++ +  +GP    L      Q L+       GL YLH   
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ-------GLAYLHE-- 117

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
            +G+IHRDIK+ NIL  ++ V K+ADFG++      D +     V G+  ++ PE     
Sbjct: 118 -QGVIHRDIKAANILTTKDGVVKLADFGVATKLN--DVSKDDASVVGTPYWMAPEVIEMS 174

Query: 640 QLTDKSDVYSFGVVLFEVL 658
             +  SD++S G  + E+L
Sbjct: 175 GASTASDIWSLGCTVIELL 193

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  115 bits (290), Expect = 9e-29
 Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 30/206 (14%)

Query: 463 FDKNLIIGSGGFGMVYKG-VLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           F+    IG GGFG VYK    R   +VA+K     S++   +   EI +L K +H ++V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYL 575
             G   ++ E+ +V E+   G LK  L        S  Q L       +C    +GL YL
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL-------KSTNQTLTESQIAYVCKELLKGLEYL 114

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK-----GSFGY 630
           H   + GIIHRDIK+ NILL  +   K+ DFGLS          +S         G+  +
Sbjct: 115 H---SNGIIHRDIKAANILLTSDGEVKLIDFGLS--------AQLSDTKARNTMVGTPYW 163

Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFE 656
           + PE    +    K+D++S G+   E
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  116 bits (290), Expect = 6e-28
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 18/207 (8%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKR---GVPGSRQGLPEFQTEITVLSKIRH-RHLVSLVG 524
           +G G FG VY    RD   VA+K     +    + +  F  EI +L+ + H  ++V L  
Sbjct: 8   LGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 525 YCEEQSEMILVYEYMEKGPLKKHL-YGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           + +++  + LV EY++ G L+  L     + PLS  + L I       L YLH+   +GI
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122

Query: 584 IHRDIKSTNILLDENY-VSKVADFGLSR----SGPCLDETHVSTGVKGSFGYLDPEYFRR 638
           IHRDIK  NILLD +  V K+ DFGL++     G       + +   G+ GY+ PE    
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 639 QQL---TDKSDVYSFGVVLFEVLCART 662
             L   +  SD++S G+ L+E+L    
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLP 209

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  112 bits (281), Expect = 2e-27
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 15/200 (7%)

Query: 469 IGSGGFGMVYKG---VLRDNT--KVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG V       L DNT  +VAVK     G  Q   +F+ EI +L  + H ++V  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 523 VGYCEEQSEMI--LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            G CE+       L+ EY+  G L+ +L    R  ++ K+ L       +G+ YL +   
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGS--- 127

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS--FGYLDPEYFRR 638
           +  IHRD+ + NIL++   + K++DFGL++  P   + +       S  F Y  PE  R 
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186

Query: 639 QQLTDKSDVYSFGVVLFEVL 658
            + +  SDV+SFGV L+E+ 
Sbjct: 187 SKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  110 bits (277), Expect = 5e-27
 Identities = 70/190 (36%), Positives = 102/190 (53%), Gaps = 8/190 (4%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +GSG FG+V+ G  R   KVA+K    G+     +F  E  V+ K+ H  LV L G C +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q  + +V E+ME G L  +L    +  LS    L +C     G+ YL   S    IHRD+
Sbjct: 71  QKPLYIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDL 126

Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+    V KV+DFG++R    LD+ + S+ G K    +  PE F   + + KSDV
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 648 YSFGVVLFEV 657
           +SFGV+++EV
Sbjct: 185 WSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  109 bits (274), Expect = 1e-26
 Identities = 68/206 (33%), Positives = 113/206 (54%), Gaps = 14/206 (6%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVL----RDNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIR 515
           ++  K  +IG+G FG V++G+L    R    VA+K   PG + +   +F +E +++ +  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +    +++ EYME G L K+L   D    S  Q + +  G A G+ YL
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYL 123

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S    +HRD+ + NIL++ N   KV+DFGLSR     P  + T+ ++G K    +  
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP--EGTYTTSGGKIPIRWTA 178

Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+SFG+V++EV+
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  107 bits (268), Expect = 5e-26
 Identities = 70/216 (32%), Positives = 115/216 (53%), Gaps = 20/216 (9%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIRHRHLVSL 522
           ++G G FG V+KG L+D T VAVK      ++ LP+     F +E  +L +  H ++V L
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKT----CKEDLPQELKIKFLSEARILKQYDHPNIVKL 57

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
           +G C ++  + +V E +  G     L    +  L  KQ ++  + AA G+ YL +   + 
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLES---KN 113

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG-SFGYLDPEYFRRQQL 641
            IHRD+ + N L+ EN V K++DFG+SR     D  + S+G+K     +  PE     + 
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 642 TDKSDVYSFGVVLFEV----LCARTAVDPLLAREQV 673
           + +SDV+S+G++L+E     +C    +    AREQV
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  106 bits (267), Expect = 1e-25
 Identities = 69/190 (36%), Positives = 100/190 (52%), Gaps = 8/190 (4%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG+V  G  R    VA+K    GS     EF  E  V+ K+ H  LV L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q  + +V EYM  G L  +L    +      Q LE+C     G+ YL +   +  IHRD+
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRF-QPSQLLEMCKDVCEGMAYLES---KQFIHRDL 126

Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+D+    KV+DFGLSR    LD+ + S+ G K    +  PE     + + KSDV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184

Query: 648 YSFGVVLFEV 657
           ++FGV+++EV
Sbjct: 185 WAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  107 bits (268), Expect = 1e-25
 Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 469 IGSGGFGMVYKGVL------RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG V+          +D   VAVK     S     +F  E  +L+ ++H H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHL--YGPDR---------TPLSWKQRLEICIGAARG 571
            G C E   +I+V+EYM+ G L K L  +GPD            L+  Q L I    A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           + YL   +++  +HRD+ + N L+ EN + K+ DFG+SR     D   V         ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            PE    ++ T +SDV+S GVVL+E+ 
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  105 bits (263), Expect = 4e-25
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 22/209 (10%)

Query: 469 IGSGGFGMVYKGVL------RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG V+          +D   VAVK     S     +FQ E  +L+ ++H+H+V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRT-----------PLSWKQRLEICIGAA 569
            G C E   +++V+EYM  G L + L  +GPD              L+  Q L I    A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
            G+ YL   ++   +HRD+ + N L+ +  V K+ DFG+SR     D   V         
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           ++ PE    ++ T +SD++SFGVVL+E+ 
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  105 bits (263), Expect = 5e-25
 Identities = 70/216 (32%), Positives = 103/216 (47%), Gaps = 30/216 (13%)

Query: 469 IGSGGFGMVYK----GVL--RDNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVS 521
           IG G FG V++    G+L     T VAVK      S     +FQ E  ++++  H ++V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHL--------------------YGPDRTPLSWKQR 561
           L+G C     M L++EYM  G L + L                     G +  PLS  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS 621
           L I    A G+ YL   S    +HRD+ + N L+ EN V K+ADFGLSR+    D    S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
                   ++ PE     + T +SDV+++GVVL+E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  104 bits (260), Expect = 9e-25
 Identities = 62/191 (32%), Positives = 102/191 (53%), Gaps = 8/191 (4%)

Query: 469 IGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +G G +G VY+GV  + +  VAVK  +      + EF  E  V+ +I+H +LV L+G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            +    ++ E+M  G L  +L   +R  ++    L +    +  + YL     +  IHRD
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVS-TGVKGSFGYLDPEYFRRQQLTDKSD 646
           + + N L+ EN++ KVADFGLSR      +T+ +  G K    +  PE     + + KSD
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 188 VWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  104 bits (260), Expect = 9e-25
 Identities = 76/214 (35%), Positives = 109/214 (50%), Gaps = 15/214 (7%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 72  EEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 127

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVST---GVKGSFGYLDPEYFRRQQLTDK 644
           +++ NIL+ EN V KVADFGL+R    L E +  T   G K    +  PE     + T K
Sbjct: 128 LRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 645 SDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAE 677
           SDV+SFG++L E+    R     ++ RE ++  E
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 1e-24
 Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 14/197 (7%)

Query: 469 IGSGGFGMVYKGVLRDNT----KVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG V KGV    +    +VAVK         G  EF  E +V++++ H  +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G C+ +  ++LV E    GPL K+L    R  +      E+    A G+ YL +   +  
Sbjct: 63  GVCKGEP-LMLVMELAPLGPLLKYLK--KRREIPVSDLKELAHQVAMGMAYLES---KHF 116

Query: 584 IHRDIKSTNILL-DENYVSKVADFGLSRS-GPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
           +HRD+ + N+LL + +   K++DFG+SR+ G   D    +T  +    +  PE     + 
Sbjct: 117 VHRDLAARNVLLVNRHQA-KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 642 TDKSDVYSFGVVLFEVL 658
           + KSDV+S+GV L+E  
Sbjct: 176 SSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 2e-24
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 11/197 (5%)

Query: 468 IIGSGGFGMVYKGVLR---DNTKVAVKRGV---PGSRQGLPEFQTEITVLSKIRHRHLVS 521
           ++GSG FG VYKGV     +  K+ V   V     S +   E   E  V++ + H H+V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+G C   S++ L+ + M  G L  ++    +  +  +  L  C+  A+G+ YL     +
Sbjct: 74  LLGICL-SSQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYL---EEK 128

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E    +  
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188

Query: 642 TDKSDVYSFGVVLFEVL 658
           T KSDV+S+GV ++E++
Sbjct: 189 THKSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  103 bits (257), Expect = 2e-24
 Identities = 65/191 (34%), Positives = 101/191 (52%), Gaps = 12/191 (6%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY-C 526
            IG G FG V  G  R   KVAVK     +      F  E +V++++RH +LV L+G   
Sbjct: 13  TIGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
           EE+  + +V EYM KG L  +L    R+ L     L+  +     + YL    A   +HR
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHR 126

Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
           D+ + N+L+ E+ V+KV+DFGL++      +T      K    +  PE  R ++ + KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKSD 181

Query: 647 VYSFGVVLFEV 657
           V+SFG++L+E+
Sbjct: 182 VWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  101 bits (254), Expect = 6e-24
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 18/202 (8%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPG-SR----QGLPEFQTEITVLSKIRHRHLVSL 522
           +IG G FG VY G L D+    +   V   +R    + + +F  E  ++    H +++SL
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 523 VGYC--EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
           +G C   E S ++ V  YM+ G L+  +      P + K  +   +  A+G+ YL   ++
Sbjct: 62  LGICLPSEGSPLV-VLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGMEYL---AS 116

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS----TGVKGSFGYLDPEYF 636
           +  +HRD+ + N +LDE++  KVADFGL+R     D+ + S    TG K    ++  E  
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARD--IYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 637 RRQQLTDKSDVYSFGVVLFEVL 658
           + Q+ T KSDV+SFGV+L+E++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  101 bits (253), Expect = 1e-23
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 38/231 (16%)

Query: 468 IIGSGGFGMVYKGVLRDNT-KVAVKRGVPGSRQGLPEFQ---TEITVLSKIRHRHLVSLV 523
            IG G FG V K V R +  K+ V + +        E Q   +E+ +L +++H ++V   
Sbjct: 7   TIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--- 62

Query: 524 GYCE-----EQSEMILVYEYMEKGPL--------KKHLYGPDRTPLSWKQRLEICIGAAR 570
            Y +         + +V EY E G L        K+  Y  +     W+   ++ +    
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF--IWRILTQLLLA--- 117

Query: 571 GLHYLHTGSAEG--IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--STGVKG 626
            L+  H  S  G  ++HRD+K  NI LD N   K+ DFGL++    L        T V G
Sbjct: 118 -LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI---LGHDSSFAKTYV-G 172

Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           +  Y+ PE        +KSD++S G +++E LCA +   P  AR Q+ LA 
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYE-LCALSP--PFTARNQLQLAS 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (252), Expect = 1e-23
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 8/191 (4%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVA+K    GS    PE F  E  ++ +++H  LV L     
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           ++   I + EYME G L   L  P+   L+  + +++    A G+ ++     +  IHRD
Sbjct: 72  QEPIYI-ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ E    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 187 WSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  100 bits (250), Expect = 2e-23
 Identities = 71/194 (36%), Positives = 102/194 (52%), Gaps = 14/194 (7%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    NTKVAVK   PG+    PE F  E  ++ K+RH  LV L     
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L   +   L     +++    A G+ Y+   +    IHRD
Sbjct: 72  EEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVST---GVKGSFGYLDPEYFRRQQLTDK 644
           ++S NIL+ +  V K+ADFGL+R    L E +  T   G K    +  PE     + T K
Sbjct: 128 LRSANILVGDGLVCKIADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 645 SDVYSFGVVLFEVL 658
           SDV+SFG++L E++
Sbjct: 184 SDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  100 bits (249), Expect = 2e-23
 Identities = 72/208 (34%), Positives = 113/208 (54%), Gaps = 16/208 (7%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
           IIG G FG V +G      KVAVK      + Q    F  E  V++K+ H++LV L+G  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
                + +V E M KG L   L    R  +S  Q L+  +  A G+ YL +   + ++HR
Sbjct: 69  LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124

Query: 587 DIKSTNILLDENYVSKVADFGLSRSGP-CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS 645
           D+ + NIL+ E+ V+KV+DFGL+R G   +D + +   VK    +  PE  + ++ + KS
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP--VK----WTAPEALKHKKFSSKS 178

Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQV 673
           DV+S+GV+L+EV     A  P ++ ++V
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEV 206

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  100 bits (251), Expect = 2e-23
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 23/210 (10%)

Query: 469 IGSGGFGMVYKG------VLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG V+          +D   VAVK     +     +FQ E  +L+ ++H H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHL--YGPD------------RTPLSWKQRLEICIGA 568
            G C +   +I+V+EYM+ G L K L  +GPD            +  L   Q L I    
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           A G+ YL   +++  +HRD+ + N L+  N + K+ DFG+SR     D   V        
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            ++ PE    ++ T +SDV+SFGV+L+E+ 
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIF 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.0 bits (247), Expect = 5e-23
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 27/205 (13%)

Query: 465 KNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVP------GSRQGLPEFQTEITVLSKIRHR 517
           K  ++GSG FG VY+G+  D+    AVK  V         ++ + + + EI +LSK++H 
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKE-VSLADDGQTGQEAVKQLEQEIALLSKLQHP 62

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTP---LSWKQRLEICIGAARGL 572
           ++V  +G   E+  + +  E +  G L K L  YG    P   L  +Q L        GL
Sbjct: 63  NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------GL 115

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLD 632
            YLH       +HRDIK  NIL+D N V K+ADFG+++              KGS  ++ 
Sbjct: 116 EYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWMA 169

Query: 633 PEYFRRQQLTD-KSDVYSFGVVLFE 656
           PE   +Q      +D++S G  + E
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLE 194

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  104 bits (262), Expect = 5e-23
 Identities = 96/374 (25%), Positives = 159/374 (42%), Gaps = 43/374 (11%)

Query: 372 KNKKIWIVVGSVVGGFVLLCLVALAVLVLFKCRKKKPKPRPADSVGWTPLRAYGCSSHSK 431
           K    W  +   +G F++L LVA    V  + R      R  +  G   L+ +     SK
Sbjct: 624 KTPSWWFYITCTLGAFLVLALVAFG-FVFIRGRNNLELKRVENEDGTWELQFF----DSK 678

Query: 432 MSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVK 491
           +S+                I   D+ ++    ++N+I   G  G  YKG    N    V 
Sbjct: 679 VSK---------------SITINDILSSLK--EENVIS-RGKKGASYKGKSIKNGMQFVV 720

Query: 492 RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGP 551
           + +      +P   +EI  + K++H ++V L+G C  +    L++EY+E   L + L   
Sbjct: 721 KEINDV-NSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN- 776

Query: 552 DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
               LSW++R +I IG A+ L +LH   +  ++  ++    I++D      +    LS  
Sbjct: 777 ----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLP 829

Query: 612 GP-CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAR 670
           G  C D          S  Y+ PE    + +T+KSD+Y FG++L E+L  ++  D     
Sbjct: 830 GLLCTDTKCFI-----SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV 884

Query: 671 EQVNLAEWAMQWQKKGMLEHIIDPQLIGK--INLDSLKKFGETAEKCLADYGVDRPSMGD 728
              ++ EWA        L+  IDP + G   +N + + +    A  C A     RP   D
Sbjct: 885 HG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND 943

Query: 729 VLWNLEYALQLQES 742
           VL  LE A +   S
Sbjct: 944 VLKTLESASRSSSS 957

Length = 968

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.7 bits (246), Expect = 5e-23
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 11/210 (5%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV---PGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IG G FG+V+K V + + +V   + +     +R+   E   E  VL+K+   +++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
             ++ ++ +V EY E G L K L      PL   Q     I    GL +LH+   + I+H
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILH 124

Query: 586 RDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS 645
           RDIKS N+ LD     K+ D G+++     D T+ +  + G+  YL PE    +   +KS
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYNEKS 182

Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNL 675
           DV++ GVVL+E  C  T   P  A  Q  L
Sbjct: 183 DVWALGVVLYE-CC--TGKHPFDANNQGAL 209

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 99.4 bits (248), Expect = 5e-23
 Identities = 69/209 (33%), Positives = 102/209 (48%), Gaps = 28/209 (13%)

Query: 469 IGSGGFGMVYKGVLR----DNTKVAVK-RGVP--GSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FG VY+G+ R    D  ++ V  + +P   S Q   +F  E  ++SK  H+++V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLY----GPDR-TPLSWKQRLEICIGAARGLHYLH 576
           L+G   E+    ++ E M  G LK  L      P+R + L+ K  L      A+G  YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 577 TGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGS-----F 628
                  IHRDI + N LL       V+K+ADFG++R     D    S   KG       
Sbjct: 134 E---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAMLPI 185

Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
            ++ PE F     T K+DV+SFGV+L+E+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 98.8 bits (247), Expect = 9e-23
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 19/201 (9%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL 519
            N +K   IG G  G VYK   R    +VA+K+ +   +Q       EI ++   +H ++
Sbjct: 22  KNLEK---IGEGASGEVYKATDRATGKEVAIKK-MRLRKQNKELIINEILIMKDCKHPNI 77

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           V          E+ +V EYM+ G L   +   +   ++  Q   +C    +GL YLH   
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYLH--- 133

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFG----LSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           ++ +IHRDIKS NILL ++   K+ADFG    L++             V G+  ++ PE 
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS------KRNSVVGTPYWMAPEV 187

Query: 636 FRRQQLTDKSDVYSFGVVLFE 656
            +R+    K D++S G++  E
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 9e-23
 Identities = 72/228 (31%), Positives = 113/228 (49%), Gaps = 34/228 (14%)

Query: 469 IGSGGFGMVYKGVLRD------NTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FGMVY+G+ +        T+VA+K        R+ + EF  E +V+ +    H+V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYG--PD------RTPLSWKQRLEICIGAARGL 572
            L+G        ++V E M KG LK +L    P+        P + ++ +++    A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL- 631
            YL    A+  +HRD+ + N ++ E+   K+ DFG++R    + ET      KG  G L 
Sbjct: 133 AYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRD---IYETDYYR--KGGKGLLP 184

Query: 632 ----DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
                PE  +    T KSDV+SFGVVL+E+  A  A  P   L+ E+V
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEM--ATLAEQPYQGLSNEEV 230

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 62/212 (29%), Positives = 89/212 (41%), Gaps = 33/212 (15%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IG G FG VY  V L     +AVK  R      + + E   E+ VL  ++H +LV   G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-----ARGLHYLHTGSA 580
              + ++ +  EY   G L++ L              E  I         GL YLH+   
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILD-------EHVIRVYTLQLLEGLAYLHS--- 117

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFG----LSRSGPCLDETHVSTGVKGSFG---YLDP 633
            GI+HRDIK  NI LD N V K+ DFG    L  +      T +   V+   G   Y+ P
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT-----TTMGEEVQSLAGTPAYMAP 172

Query: 634 EYFRRQQLTDK---SDVYSFGVVLFEVLCART 662
           E     +       +D++S G V+ E+   + 
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 10/195 (5%)

Query: 469 IGSGGFGMVYKG----VLRDNTKVAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLVSLV 523
           +G G FG+V +G           VAVK         +  +F  E  ++  + H +L+ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G       +++V E    G L   L              +  +  A G+ YL +   +  
Sbjct: 63  GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRF 118

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQLT 642
           IHRD+ + NILL  +   K+ DFGL R+ P  ++ +V    +K  F +  PE  R +  +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178

Query: 643 DKSDVYSFGVVLFEV 657
             SDV+ FGV L+E+
Sbjct: 179 HASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 98.2 bits (244), Expect = 1e-22
 Identities = 59/190 (31%), Positives = 100/190 (52%), Gaps = 5/190 (2%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG V+ G   ++TKVAVK   PG+   +  F  E  ++  ++H  LV L     +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +  + ++ EYM KG L   L   +   +   + ++     A G+ Y+     +  IHRD+
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 129

Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVY 648
           ++ N+L+ E+ + K+ADFGL+R     +E     G K    +  PE       T KSDV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188

Query: 649 SFGVVLFEVL 658
           SFG++L+E++
Sbjct: 189 SFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 97.8 bits (243), Expect = 1e-22
 Identities = 68/191 (35%), Positives = 101/191 (52%), Gaps = 8/191 (4%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     TKVA+K   PG+   +PE F  E  ++ K+RH  LV L     
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V E+M KG L   L   D   L   Q +++    A G+ Y+   +    IHRD
Sbjct: 72  EEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +N V K+ADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 187 WSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 30/213 (14%)

Query: 469 IGSGGFGMVYKGVL------RDNTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRH 518
           +G G FG VYKG L         T VA+K       P  +Q   EF+ E  ++S ++H +
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDLQHPN 69

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLY-----------GPDRT---PLSWKQRLEI 564
           +V L+G C ++    +++EY+  G L + L              D T    L     L I
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
            I  A G+ YL   S+   +HRD+ + N L+ E    K++DFGLSR     D   V +  
Sbjct: 130 AIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
                ++ PE     + T +SD++SFGVVL+E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 66/239 (27%), Positives = 111/239 (46%), Gaps = 28/239 (11%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRH 518
           ++ ++  ++G G  G+VYK   +      A+K+  V G  +   +   E+  L      +
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPL----KKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
           +V   G   ++ E+ +V EYM+ G L    KK    P+   L+      I     +GL Y
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEP-VLA-----YIARQILKGLDY 114

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           LHT     IIHRDIK +N+L++     K+ADFG+S+      +   +T V G+  Y+ PE
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFV-GTVTYMSPE 170

Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID 693
             + +  +  +D++S G+ L E  CA     P L   Q +  E         +++ I D
Sbjct: 171 RIQGESYSYAADIWSLGLTLLE--CA-LGKFPFLPPGQPSFFE---------LMQAICD 217

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 97.9 bits (245), Expect = 2e-22
 Identities = 52/160 (32%), Positives = 81/160 (50%), Gaps = 34/160 (21%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKR--------GVPGS--RQGLPEFQTEITVLSKIRH 516
            +G G +G+VYK    +    VA+K+        G+P +  R        EI++L +++H
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR--------EISLLKELKH 57

Query: 517 RHLVSL--VGYCEEQSEMILVYEYME---KGPLKKHLYGPDRTPLSWKQRLEICIGAARG 571
            ++V L  V + E +  + LV+EY +   K  L K        PLS      I     RG
Sbjct: 58  PNIVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKR-----PGPLSPNLIKSIMYQLLRG 110

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           L Y H   +  I+HRD+K  NIL++ + V K+ADFGL+R+
Sbjct: 111 LAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARA 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 97.8 bits (243), Expect = 2e-22
 Identities = 71/224 (31%), Positives = 115/224 (51%), Gaps = 26/224 (11%)

Query: 469 IGSGGFGMVY----KGVLRDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY    KGV++D   T+VA+K      S +   EF  E +V+ +    H+V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    +++ E M +G LK +L          P + P S K+ +++    A G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG--SFGYL 631
           YL   +A   +HRD+ + N ++ E++  K+ DFG++R     +  +   G KG     ++
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 188

Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
            PE  +    T  SDV+SFGVVL+E+  A  A  P   ++ EQV
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGMSNEQV 230

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.0 bits (240), Expect = 5e-22
 Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 23/204 (11%)

Query: 469 IGSGGFGMVYKGVLRDNT------KVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG V   V + +T      KV  K+ +   R+ +    TE  +LS+I H  +V L
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKII-KRKEVEHTLTERNILSRINHPFIVKL 58

Query: 523 VGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQRL--EICIGAARGLHYLHTG 578
             +   Q+E  + LV EY   G L  HL    R      +    EI +     L YLH  
Sbjct: 59  --HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLH-- 110

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
            + GII+RD+K  NILLD +   K+ DFGL++      E   +    G+  YL PE    
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELS--SEGSRTNTFCGTPEYLAPEVLLG 167

Query: 639 QQLTDKSDVYSFGVVLFEVLCART 662
           +      D +S GV+L+E+L  + 
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 97.1 bits (242), Expect = 5e-22
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 25/213 (11%)

Query: 468 IIGSGGFGMVYKGVLRD------NTKVAVKR-GVPGSRQGLPEFQTEITVLSKI-RHRHL 519
            +G G FG V K            + VAVK      + + L +  +E+ ++  I +H+++
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEIC 565
           ++L+G C ++  + +V EY   G L+  L               R P   L+ K  +   
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK 625
              ARG+ +L   +++  IHRD+ + N+L+ E++V K+ADFGL+R    +D    +T  +
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 626 GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
               ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 96.1 bits (239), Expect = 7e-22
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 25/212 (11%)

Query: 467 LIIGSGGFGMVYKGVLRD-------NTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRH 516
             +GSG FG VY+G   D         +VAVK   +G     +   EF  E  ++S   H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGP--DRTP---LSWKQRLEICIGAARG 571
            ++V L+G C       ++ E ME G L  +L     +R     L+ K+ L+IC+  A+G
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDE-----NYVSKVADFGLSRSGPCLDETHVSTGVKG 626
             YL        IHRD+ + N L+ E     + V K+ DFGL+R     D          
Sbjct: 119 CVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
              ++ PE     + T +SDV+SFGV+++E+L
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 96.6 bits (240), Expect = 8e-22
 Identities = 65/214 (30%), Positives = 115/214 (53%), Gaps = 27/214 (12%)

Query: 469 IGSGGFGMVYK----GVLRDN----TKVAVKR-GVPGSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ ++     TKVAVK      + + L +  +E+ ++  I +H++
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y P + P   LS+K  +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ E+ V K+ADFGL+R    +D    +T  
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 27/222 (12%)

Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVK--RGVPGSRQGLP 502
            P ++LQ  T        +G G FG V+    +        T V VK  +          
Sbjct: 2   FPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQS 53

Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL-------YGPDRTP 555
           EF+ E+ +  K+ H+++V L+G C E     ++ EY + G LK+ L             P
Sbjct: 54  EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113

Query: 556 LSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL 615
           LS KQ++ +C   A G+ +L        +HRD+ + N L+      KV+   LS+     
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKD-VYN 169

Query: 616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
            E +          +L PE  +    + KSDV+SFGV+++EV
Sbjct: 170 SEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 56/170 (32%), Positives = 83/170 (48%), Gaps = 42/170 (24%)

Query: 463 FDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR-GVPGSRQGLPEFQT---EITVLSKIRHR 517
           ++K   IG G +G VYK    +    VA+K+  +   ++G P   T   EI +L K+RH 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFP--ITAIREIKLLQKLRHP 58

Query: 518 HLVSLVGYC--EEQSEMILVYEYME---KGPLK-----------KHLYGPDRTPLSWKQR 561
           ++V L      + +  + +V+EYM+    G L            K            KQ 
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM---------KQL 109

Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           LE       GL YLH+    GI+HRDIK +NIL++ + V K+ADFGL+R 
Sbjct: 110 LE-------GLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 11/196 (5%)

Query: 463 FDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           FD    +G G +G VYK + ++    VA+K  VP   + L E   EI++L +    ++V 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKV-VP-VEEDLQEIIKEISILKQCDSPYIVK 62

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
             G   + +++ +V EY   G +   +   ++T L+ ++   I     +GL YLH   + 
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT-LTEEEIAAILYQTLKGLEYLH---SN 118

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGSFGYLDPEYFRRQQ 640
             IHRDIK+ NILL+E   +K+ADFG+S     L +T      V G+  ++ PE  +   
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQ---LTDTMAKRNTVIGTPFWMAPEVIQEIG 175

Query: 641 LTDKSDVYSFGVVLFE 656
             +K+D++S G+   E
Sbjct: 176 YNNKADIWSLGITAIE 191

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 72/218 (33%), Positives = 110/218 (50%), Gaps = 30/218 (13%)

Query: 469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLP-----EFQTEITVLSKIRHRHLVSL 522
           IG G FG V+ G LR DNT VAVK      R+ LP     +F  E  +L +  H ++V L
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 58

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLY--GPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
           +G C ++  + +V E ++ G     L   GP    L  K+ +++   AA G+ YL +   
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYLES--- 112

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG------VKGSFGYLDPE 634
           +  IHRD+ + N L+ E  V K++DFG+SR     D  + STG      VK    +  PE
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEE--DGVYASTGGMKQIPVK----WTAPE 166

Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                + + +SDV+SFG++L+E           L+ +Q
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 71/225 (31%), Positives = 112/225 (49%), Gaps = 28/225 (12%)

Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY+G  RD       T+VAVK      S +   EF  E +V+      H+V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    ++V E M  G LK +L          P R P + ++ +++    A G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET-HVSTGVKG--SFGY 630
           YL   +A+  +HRD+ + N ++  ++  K+ DFG++R    + ET +   G KG     +
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD---IYETDYYRKGGKGLLPVRW 187

Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
           + PE  +    T  SD++SFGVVL+E+     A  P   L+ EQV
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEI--TSLAEQPYQGLSNEQV 230

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 4e-21
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 20/212 (9%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKR-----GVPGSRQGLPEFQTEITVLSKI 514
            N+ +  ++G G FG VY     D  + +AVK+       P +++ +   + EI +L  +
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 515 RHRHLVSLVGYCEEQSEMILVY-EYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARG 571
           +H  +V   G C    E + ++ EYM  G +K  L  YG     ++ K   +I      G
Sbjct: 62  QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EG 116

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFG 629
           + YLH+     I+HRDIK  NIL D     K+ DFG S+     C   T + + V G+  
Sbjct: 117 VEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPY 172

Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           ++ PE    +    K+DV+S G  + E+L  +
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 93.0 bits (231), Expect = 6e-21
 Identities = 65/201 (32%), Positives = 108/201 (53%), Gaps = 16/201 (7%)

Query: 468 IIGSGGFGMVYKGVLRDNTK----VAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSL 522
           +IG+G FG V +G L+   K    VA+K    G + +   +F +E +++ +  H +++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDR--TPLSWKQRLEICIGAARGLHYLHTGSA 580
            G   +   ++++ E+ME G L   L   D   T +   Q + +  G A G+ YL   S 
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL---SE 124

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVST-GVKGSFGYLDPEYFR 637
              +HRD+ + NIL++ N V KV+DFGLSR       D T+ S+ G K    +  PE   
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            ++ T  SDV+S+G+V++EV+
Sbjct: 185 YRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 92.8 bits (231), Expect = 6e-21
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTKV-AVK---RGVPGSRQGLPEFQTEITVLSKIRHR 517
           +F+   +IG G FG V     RD  K+ A+K   +     +  +     E  +L ++ H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ-RLEIC-IGAARGLHYL 575
            LV+L    +++  M LV + +  G L+ HL    +   S +Q +  IC I  A  L YL
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLA--LEYL 116

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+   +GIIHRDIK  NILLDE     + DF ++     +    ++T   G+ GY+ PE 
Sbjct: 117 HS---KGIIHRDIKPDNILLDEQGHVHITDFNIATK---VTPDTLTTSTSGTPGYMAPEV 170

Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCART 662
             RQ  +   D +S GV  +E L  + 
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 93.0 bits (231), Expect = 6e-21
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 22/203 (10%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP---------EFQTEITVLSKIRHRH 518
           +IG+G FG V  G L    K+  KR +P + + L          +F +E +++ +  H +
Sbjct: 11  VIGAGEFGEVCSGRL----KLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
           ++ L G   +   +++V EYME G L   L   D    +  Q + +  G A G+ YL   
Sbjct: 67  IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYL--- 122

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLDPEY 635
           S  G +HRD+ + NIL++ N V KV+DFGLSR     P  +  + + G K    +  PE 
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTAPEA 180

Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
              ++ T  SDV+S+G+V++EV+
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 93.9 bits (233), Expect = 6e-21
 Identities = 62/214 (28%), Positives = 112/214 (52%), Gaps = 27/214 (12%)

Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y   R P   +++K  +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 233

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 93.5 bits (232), Expect = 1e-20
 Identities = 72/215 (33%), Positives = 108/215 (50%), Gaps = 35/215 (16%)

Query: 468 IIGSGGFGMVYKGVLRDN---TKVAVKRGVP-GSRQGLPEFQTEITVLSKI-RHRHLVSL 522
           +IG G FG V K  ++ +      A+KR     S+    +F  E+ VL K+  H ++++L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 523 VGYCEEQSEMILVYEYMEKGPL-----KKHLYGPD---------RTPLSWKQRLEICIGA 568
           +G CE +  + L  EY   G L     K  +   D          + LS +Q L      
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           ARG+ YL   S +  IHRD+ + NIL+ ENYV+K+ADFGLSR      E +    VK + 
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVY----VKKTM 182

Query: 629 GYLDPEYFRRQQL-----TDKSDVYSFGVVLFEVL 658
           G L   +   + L     T  SDV+S+GV+L+E++
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 92.8 bits (230), Expect = 2e-20
 Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 37/216 (17%)

Query: 468 IIGSGGFGMVYKGVLR-DNTKV--AVKRGVP-GSRQGLPEFQTEITVLSKI-RHRHLVSL 522
           +IG G FG V + +++ D  K+  A+K      S     +F  E+ VL K+  H ++++L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 523 VGYCEEQSEMILVYEY---------------MEKGPLKKHLYGPDRTPLSWKQRLEICIG 567
           +G CE +  + +  EY               +E  P     +G   T L+ +Q L+    
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST-LTSQQLLQFASD 127

Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS 627
            A G+ YL   S +  IHRD+ + N+L+ EN  SK+ADFGLSR     +E +    VK +
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG----EEVY----VKKT 176

Query: 628 FGYLDPEYFRRQQL-----TDKSDVYSFGVVLFEVL 658
            G L   +   + L     T KSDV+SFGV+L+E++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 10/203 (4%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE---FQTEITVLSKIRHRH 518
            ++    IG G FG +Y    + +++  V + +  ++  + E    + E+ +L+K++H +
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
           +V+     +E   + +V EY + G L K +        S  Q L   +  + GL ++H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD- 119

Query: 579 SAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               I+HRDIKS NI L +N  V+K+ DFG++R     D   ++    G+  YL PE  +
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQ 175

Query: 638 RQQLTDKSDVYSFGVVLFEVLCA 660
            +   +K+D++S G VL+E LC 
Sbjct: 176 NRPYNNKTDIWSLGCVLYE-LCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 90.3 bits (224), Expect = 7e-20
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 29/212 (13%)

Query: 468 IIGSGGFGMVYKGVLR--DNT--KVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           I+G G FG V +G L   D +  KVAVK  +    +   + EF +E   +    H +++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 522 LVGYCEEQSEM------ILVYEYMEKGPLKKHLY------GPDRTPLSWKQRLEICIGAA 569
           L+G C E S +      +++  +M+ G L   L        P++ PL  +  L+  +  A
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIA 123

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKG 626
            G+ YL   S    IHRD+ + N +L E+    VADFGLS+   SG    +  ++   K 
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KM 177

Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
              ++  E    +  T KSDV++FGV ++E+ 
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 90.2 bits (224), Expect = 7e-20
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 22/202 (10%)

Query: 469 IGSGGFGMVYK---GVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL- 522
           +G G FG V       L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL----EICIGAARGLHYLHT 577
            V Y   +  + LV EY+  G L+ +L    R  L  ++ L    +IC    +G+ YL  
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQIC----KGMEYL-- 124

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST--GVKGSFGYLDPEY 635
             ++  +HRD+ + NIL++     K+ DFGL++  P   E +     G    F Y  PE 
Sbjct: 125 -GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PES 182

Query: 636 FRRQQLTDKSDVYSFGVVLFEV 657
               + +  SDV+SFGVVL+E+
Sbjct: 183 LTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 28/215 (13%)

Query: 469 IGSGGFGMV----YKGVLRDNTK--VAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVS 521
           +G G FG V    Y     D T   VAVK       Q     ++ EI +L  + H ++V 
Sbjct: 12  LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 522 LVGYCEEQSEMI--LVYEYMEKGPLKKHLYGPDRTPLSWKQRL----EICIGAARGLHYL 575
             G C EQ      L+ EY+  G L+ +L    +  L+  Q L    +IC     G+ YL
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQIC----EGMAYL 123

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH-VSTGVKGSFGYLDPE 634
           H   ++  IHRD+ + N+LLD + + K+ DFGL+++ P   E + V         +   E
Sbjct: 124 H---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLA 669
             +  + +  SDV+SFGV L+E+L   T  D   +
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELL---THCDSKQS 212

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 90.4 bits (224), Expect = 1e-19
 Identities = 59/214 (27%), Positives = 109/214 (50%), Gaps = 27/214 (12%)

Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V +    G+ +      V   V       + + L +  +E+ ++  I +H++
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLY-----GPDRT---------PLSWKQRLEI 564
           +++L+G C ++  + ++ EY  KG L++ L      GPD T          LS+K  +  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL    +   IHRD+ + N+L+ E+ V K+ADFGL+R    +D    ++  
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFG++++E+ 
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 59/191 (30%), Positives = 96/191 (50%), Gaps = 8/191 (4%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG V+      +TKVAVK   PGS   +  F  E  V+  ++H  LV L     +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +  + ++ E+M KG L   L   + +     + ++     A G+ ++        IHRD+
Sbjct: 73  EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDL 128

Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVS-TGVKGSFGYLDPEYFRRQQLTDKSDV 647
           ++ NIL+  + V K+ADFGL+R     D  + +  G K    +  PE       T KSDV
Sbjct: 129 RAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186

Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 187 WSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 21/195 (10%)

Query: 488 VAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKK 546
           VAVK   P  S     +F  E+ +LS++   ++  L+G C     + ++ EYME G L +
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 547 HLY---GPDRT------PLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE 597
            L                LS+   L +    A G+ YL    +   +HRD+ + N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165

Query: 598 NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
           NY  K+ADFG+SR+    D   V         ++  E     + T KSDV++FGV L+E+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Query: 658 LCARTAVDPLLAREQ 672
           L         L REQ
Sbjct: 226 L--------TLCREQ 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 88.5 bits (219), Expect = 3e-19
 Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 13/198 (6%)

Query: 468 IIGSGGFGMVYKGVL---RDNTKVAVKRGVPGSRQGLPEFQTEIT----VLSKIRHRHLV 520
           ++GSG FG V+KG+     D+ K+ V       R G   FQ EIT     +  + H ++V
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ-EITDHMLAMGSLDHAYIV 72

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            L+G C   S + LV +    G L  H+    R  L  ++ L  C+  A+G++YL     
Sbjct: 73  RLLGICPGAS-LQLVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEE--- 127

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
             ++HR++ + NILL  + + ++ADFG++      D+ +  +  K    ++  E     +
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Query: 641 LTDKSDVYSFGVVLFEVL 658
            T +SDV+S+GV ++E++
Sbjct: 188 YTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 15/198 (7%)

Query: 468 IIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSL 522
            IG G FG VY+GV          VAVK     +   + E F  E  ++ +  H H+V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
           +G   E   + +V E    G L+ +L   ++  L     +      +  L YL +   + 
Sbjct: 73  IGVITENP-VWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLES---KR 127

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQ 640
            +HRDI + N+L+      K+ DFGLSR    L++       KG     ++ PE    ++
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESINFRR 184

Query: 641 LTDKSDVYSFGVVLFEVL 658
            T  SDV+ FGV ++E+L
Sbjct: 185 FTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 87.4 bits (216), Expect = 6e-19
 Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 39/217 (17%)

Query: 468 IIGSGGFG-----MVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVS 521
           +IG G FG      + K  LR +  +   +    S+    +F  E+ VL K+  H ++++
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 522 LVGYCEEQSEMILVYEY---------------MEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           L+G CE +  + L  EY               +E  P          T LS +Q L    
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST-LSSQQLLHFAA 119

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
             ARG+ YL   S +  IHRD+ + NIL+ ENYV+K+ADFGLSR      E +    VK 
Sbjct: 120 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVY----VKK 168

Query: 627 SFGYLDPEYFRRQQL-----TDKSDVYSFGVVLFEVL 658
           + G L   +   + L     T  SDV+S+GV+L+E++
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 87.8 bits (218), Expect = 6e-19
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 17/197 (8%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           IG G +G+VYK         VA+K+                EI +L ++ H +++ L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
              + ++ LV+E+M+       L    +  L             +GL + H   + GI+H
Sbjct: 67  FRHKGDLYLVFEFMDTD--LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121

Query: 586 RDIKSTNILLDENYVSKVADFGLSRS--GPCLDETH-VSTGVKGSFGYLDPE-YFRRQQL 641
           RD+K  N+L++   V K+ADFGL+RS   P    TH V T       Y  PE     +  
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-----RWYRAPELLLGDKGY 176

Query: 642 TDKSDVYSFGVVLFEVL 658
           +   D++S G +  E+L
Sbjct: 177 STPVDIWSVGCIFAELL 193

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 56/144 (38%), Positives = 77/144 (53%), Gaps = 9/144 (6%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSG +G VYK   +     VA+K  +  PG        Q EI++L + RH ++V+  G 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
              + ++ +V EY   G L+  +Y   R PLS  Q   +C    +GL YLH     G IH
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIH 124

Query: 586 RDIKSTNILLDENYVSKVADFGLS 609
           RDIK  NILL E+   K+ADFG+S
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 88.2 bits (218), Expect = 1e-18
 Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 27/214 (12%)

Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D     V   V       + + L +  +E+ ++  I +H++
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL---------YGPD--RTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L         Y  D  + P   L++K  +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ E+ V K+ADFGL+R    +D    +T  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 57/196 (29%), Positives = 103/196 (52%), Gaps = 12/196 (6%)

Query: 469 IGSGGFGMVYKGVLRDNTK---VAVKRGVPGSRQGL-PEFQTEITVLSKIRHRHLVSLVG 524
           +GSG FG V KGV +   K   VA+K     + + +  E   E  ++ ++ + ++V ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGP-DRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
            CE ++ M LV E    GPL K L G  D   +S    +E+    + G+ YL     +  
Sbjct: 63  VCEAEALM-LVMEMASGGPLNKFLSGKKDEITVS--NVVELMHQVSMGMKYLE---GKNF 116

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS-TGVKGSFGYLDPEYFRRQQLT 642
           +HRD+ + N+LL   + +K++DFGLS++    D  + + +  K    +  PE    ++ +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 643 DKSDVYSFGVVLFEVL 658
            +SDV+S+G+ ++E  
Sbjct: 177 SRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 77/282 (27%), Positives = 116/282 (41%), Gaps = 44/282 (15%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT----EITVLSKIRHRHLVSLV 523
            +G G  G V K  L++   +   + +  +    P+ Q     E+ +    +  ++V   
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTI--TTDPNPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 524 G-YCEEQSEMI-LVYEYMEKGPL----KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           G + +E S  I +  EY E G L    KK      R     K   +I     +GL YLH+
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI--GEKVLGKIAESVLKGLSYLHS 123

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLS-RSGPCLDETHVSTGVKGSFGYLDPEYF 636
                IIHRDIK +NILL      K+ DFG+S      L  T   T    SF Y+ PE  
Sbjct: 124 ---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGT----SF-YMAPERI 175

Query: 637 RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID--- 693
           + +  +  SDV+S G+ L EV   R    P     +  L           +L +I++   
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRF---PFPPEGEPPLGPIE-------LLSYIVNMPN 225

Query: 694 PQLI----GKINL-DSLKKFGETAEKCLADYGVDRPSMGDVL 730
           P+L       I   +  K F    ++CL      RP+  D+L
Sbjct: 226 PELKDEPGNGIKWSEEFKDF---IKQCLEKDPTRRPTPWDML 264

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 42/225 (18%)

Query: 468 IIGSGGFGMVYKGV------LRDNTKVAVKRGVPGSRQG-LPEFQTEITVLSKIRHRHLV 520
            +G G FG V K            T VAVK     +    L +  +E  +L ++ H H++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHL----------------------YGPDRTPLSW 558
            L G C +   ++L+ EY + G L+  L                        PD   L+ 
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 559 KQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET 618
              +      +RG+ YL   +   ++HRD+ + N+L+ E    K++DFGLSR     D  
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-----DVY 178

Query: 619 HVSTGVKGSFG-----YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
              + VK S G     ++  E       T +SDV+SFGV+L+E++
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 10/208 (4%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE---FQTEITVLSKIRHRH 518
            ++K  ++G G FG+V+    + + K+ + + +P  +    E    Q E  VL  + H +
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
           ++       E   +++V EY   G L +++     + L     L   +     LH++HT 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT- 119

Query: 579 SAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
             + I+HRD+K+ NILLD++  V K+ DFG+S+    L     +  V G+  Y+ PE   
Sbjct: 120 --KLILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELCE 174

Query: 638 RQQLTDKSDVYSFGVVLFEVLCARTAVD 665
            +    KSD+++ G VL+E+   + A +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 15/219 (6%)

Query: 468 IIGSGGFG--MVYKGVLRDNTKVAVKRGVPGSRQGLPE---FQTEITVLSKIRHRHLVSL 522
           ++G G FG   +Y+    D++ V  K  V  +R    E      EI +LS ++H ++++ 
Sbjct: 7   VLGKGAFGEATLYRRT-EDDSLVVWKE-VNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
             +  + + +++  EY   G L   +          +  L         + Y+H     G
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AG 121

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           I+HRDIK+ NI L +  + K+ DFG+S+      E  ++  V G+  Y+ PE  +  +  
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKYN 179

Query: 643 DKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQ 681
            KSD+++ G VL+E+L  +   D   A   +NL    +Q
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFD---ATNPLNLVVKIVQ 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 85.7 bits (213), Expect = 6e-18
 Identities = 52/160 (32%), Positives = 77/160 (48%), Gaps = 28/160 (17%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT---------EITVLSKIRHR 517
            IGSG +G+V   V  R   KVA+K+ +         F           EI +L  +RH 
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKK-IS------NVFDDLIDAKRILREIKLLRHLRHE 59

Query: 518 HLVSLV-----GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGL 572
           +++ L+        E+ +++ +V E ME   L K +  P   PL+            RGL
Sbjct: 60  NIIGLLDILRPPSPEDFNDVYIVTELMETD-LHKVIKSPQ--PLTDDHIQYFLYQILRGL 116

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
            YLH  SA  +IHRD+K +NIL++ N   K+ DFGL+R  
Sbjct: 117 KYLH--SA-NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 25/216 (11%)

Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKR------GVPGSRQGLPEFQTEITVLS 512
             NF     IG G F +VYK +   + + VA+K+          +RQ   +   EI +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57

Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLK---KHLYGPDRT---PLSWKQRLEICI 566
           ++ H +++  +    E +E+ +V E  + G L    KH     R       WK  +++C 
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC- 116

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
                L ++H+   + I+HRDIK  N+ +    V K+ D GL R      +T  +  + G
Sbjct: 117 ---SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVG 168

Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
           +  Y+ PE         KSD++S G +L+E+   ++
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.8 bits (207), Expect = 1e-17
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 29/217 (13%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRD---NTKVAVK-----RGVPGSRQGLPE-FQTEITVLS 512
            + K   +G+G F   Y+   RD    T +AVK     R     ++ + E  + EI +++
Sbjct: 1   EWLKGQQLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMA 58

Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAAR 570
           ++ H H++ ++G   E S   L  E+M  G +   L  YG  +  +      ++     R
Sbjct: 59  RLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----R 114

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTG-----V 624
           GL YLH      IIHRD+K  N+L+D      ++ADFG   +   L       G     +
Sbjct: 115 GLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFG---AAARLAAKGTGAGEFQGQL 168

Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
            G+  ++ PE  R +Q     DV+S G V+ E+  A+
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 32/227 (14%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKI 514
           ++F    IIG G F  V     +  N + A+K  +   RQ + E      + E  VL+++
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIK--ILDKRQLIKEKKVKYVKIEKEVLTRL 58

Query: 515 -RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
             H  ++ L    +++  +  V EY   G L +++       L  K            L 
Sbjct: 59  NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR--KYGSLDEKCTRFYAAEILLALE 116

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--------------SGPCLDETH 619
           YLH   ++GIIHRD+K  NILLD++   K+ DFG ++              +     +  
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 620 VSTGVKGSF-G---YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
            +     SF G   Y+ PE    +     SD+++ G +++++L  + 
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 63/196 (32%), Positives = 95/196 (48%), Gaps = 14/196 (7%)

Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKRGVPGSR--QGLPEFQT--EITVLSKIRHRHLVSLV 523
           IG G  G+V+K   R+  + VA+K+ V   R   G+P  Q   EI  L   +H ++V L+
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKK-VALRRLEGGIPN-QALREIKALQACQHPYVVKLL 65

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
                 S  +LV EYM    L + L   +R PL   Q         +G+ Y+H   A GI
Sbjct: 66  DVFPHGSGFVLVMEYMPSD-LSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMH---ANGI 120

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           +HRD+K  N+L+  + V K+ADFGL+R     +    S  V  +  Y  PE     +  D
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYD 179

Query: 644 KS-DVYSFGVVLFEVL 658
              D+++ G +  E+L
Sbjct: 180 PGVDLWAVGCIFAELL 195

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 24/211 (11%)

Query: 469 IGSGGFGMVYKGVL----RDNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G   FG +YKG L     D+ ++   + +    + Q   EFQ E ++++++ H ++V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLY---------------GPDRTPLSWKQRLEICIG 567
           +G   ++  + +++EY+ +G L + L                G  ++ L     L I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS 627
            A G+ YL   S+   +H+D+ + NIL+ E    K++D GLSR     D   V       
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE     + +  SD++SFGVVL+E+ 
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 31/166 (18%)

Query: 462 NFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE---FQT--EITVLSKIR 515
            ++K   +G G + +VYK         VA+K+   G R+   +   F    EI +L +++
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA------ 569
           H +++ L+     +S + LV+E+ME   L+K            K +  I +  A      
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME-TDLEK----------VIKDK-SIVLTPADIKSYM 108

Query: 570 ----RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
               RGL YLH   +  I+HRD+K  N+L+  + V K+ADFGL+RS
Sbjct: 109 LMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARS 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)

Query: 469 IGSGGFGMVYKGVL---RDNTK------VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL 519
           IG G FG   K +L   +++ K      + + +  P  R+   E + E+ VLS ++H ++
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNI 61

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           V      EE   + +V +Y E G L K +           Q L+  +     L ++H   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD-- 119

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET-HVSTGVKGSFGYLDPEYFRR 638
              I+HRDIKS NI L ++   K+ DFG++R    L+ T  ++    G+  YL PE    
Sbjct: 120 -RKILHRDIKSQNIFLTKDGTIKLGDFGIAR---VLNSTVELARTCIGTPYYLSPEICEN 175

Query: 639 QQLTDKSDVYSFGVVLFEVLCARTA 663
           +   +KSD+++ G VL+E+   + A
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 35/216 (16%)

Query: 465 KNLIIGSGGFGMVYKGV-LRDNTKVAVKR---------GVPGSRQGLPEFQTEITVLSKI 514
           K  +IGSG FG VY G+       +AVK+              R  L     EI +L ++
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSW---KQRLEICIGAA 569
           +H ++V  +G   +   + +  EY+  G +   L  YG     L     +Q L       
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL------- 116

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG------ 623
           +GL+YLH     GIIHRDIK  NIL+D     K++DFG+S+    L+   +ST       
Sbjct: 117 KGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK---LEANSLSTKTNGARP 170

Query: 624 -VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            ++GS  ++ PE  ++   T K+D++S G ++ E+L
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 22/220 (10%)

Query: 465 KNLIIGSGGFGMVYKGVLRDNTKVAVKR------GVPGSRQGLPEFQTEITVLSKIRHRH 518
           K  ++G G +G VY G+      +AVK+       V  + +   + Q E+ +L  ++H +
Sbjct: 4   KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLH 576
           +V  +G C + + + +  E++  G +   L  +GP   P+  K   +I  G A    YLH
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLH 119

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR----SGPCLDETHVSTGVKGSFGYLD 632
                 ++HRDIK  N++L  N + K+ DFG +R     G     +++   + G+  ++ 
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVLCAR---TAVDPLLA 669
           PE         KSD++S G  +FE+   +    ++D L A
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 76/285 (26%), Positives = 118/285 (41%), Gaps = 49/285 (17%)

Query: 469 IGSGGFGMVYKGVLRDNTK---------VAVKRGVPGSRQGLPE-FQTEITVLSKIRHRH 518
           +G G F  +YKGVLR  +          V+V   V GS       F    +++S++ H+H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLY-GPDRTPLSWKQRLEICIGAARGLHYLHT 577
           LV L G C    E I+V EY++ GPL   L+   +   L WK  L++    A  LHYL  
Sbjct: 63  LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119

Query: 578 GSAEGIIHRDIKSTNILL-----DENYV--SKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
              + ++H ++   NIL+     +E YV   K++D G+  +    +E            +
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI------PW 170

Query: 631 LDPEYFRRQQ--LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML 688
           + PE  R  Q  LT  +D +SFG  L E+        PL      + +E    +Q +  L
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE--PLSTL---SSSEKERFYQDQHRL 225

Query: 689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL 733
                P            +      +C       RPS   +L +L
Sbjct: 226 -----PMP-------DCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.9 bits (203), Expect = 4e-17
 Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 31/209 (14%)

Query: 469 IGSGGFGMVY---KGVLRD--NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           I  G +G V+   K    D    KV  K  +    Q + +  TE  +LS+ +  ++V L 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQ-VDQVLTERDILSQAQSPYVVKL- 58

Query: 524 GYCEEQSE--MILVYEYMEKGPLKK--HLYG--PDRTPLSWKQRL-EICIGAARGLHYLH 576
            Y   Q +  + LV EY+  G L       G   +      +  + EI +     L YLH
Sbjct: 59  -YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA---RIYIAEIVLA----LEYLH 110

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG------PCLDETHVSTGVKGSFGY 630
              + GIIHRD+K  NIL+D N   K+ DFGLS+ G         D+      + G+  Y
Sbjct: 111 ---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167

Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           + PE    Q  +   D +S G +L+E L 
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 82.4 bits (204), Expect = 5e-17
 Identities = 81/232 (34%), Positives = 111/232 (47%), Gaps = 37/232 (15%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTK---VAVKR-GVPGSRQGLP-EFQTEITVLSKIRH 516
            F+K   IG G +G+VY+   RD T    VA+K+  +   R G+P     EIT+L  +RH
Sbjct: 8   EFEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65

Query: 517 RHLVSL----VGYCEEQSEMI-LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARG 571
            ++V L    VG   +  + I LV EY E+  L   L     TP S  Q   + +   RG
Sbjct: 66  PNIVELKEVVVG---KHLDSIFLVMEYCEQD-LASLLDN-MPTPFSESQVKCLMLQLLRG 120

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDET-HVSTGVKGSF 628
           L YLH      IIHRD+K +N+LL +    K+ADFGL+R    P    T  V T      
Sbjct: 121 LQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVT-----L 172

Query: 629 GYLDPE-YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLA----REQVNL 675
            Y  PE        T   D+++ G +L E+L    A  PLL      EQ++L
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELL----AHKPLLPGKSEIEQLDL 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 81.8 bits (202), Expect = 8e-17
 Identities = 85/275 (30%), Positives = 116/275 (42%), Gaps = 45/275 (16%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQ---TEITVLSKIRHRHLVSLVG 524
           IG G FG VY    +R N  VA+K+     +Q   ++Q    E+  L ++RH + +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 525 YCEEQSEMILVYEYM---EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
               +    LV EY        L+ H     + PL   +   IC GA +GL YLH+    
Sbjct: 83  CYLREHTAWLVMEYCLGSASDILEVH-----KKPLQEVEIAAICHGALQGLAYLHS---H 134

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY---FRR 638
             IHRDIK+ NILL E    K+ADFG S S      + V T       ++ PE       
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFVGTPY-----WMAPEVILAMDE 188

Query: 639 QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII--DPQL 696
            Q   K DV+S G+   E L  R    PL     +N    AM       L HI   D   
Sbjct: 189 GQYDGKVDVWSLGITCIE-LAERKP--PLF---NMN----AMS-----ALYHIAQNDSPT 233

Query: 697 IGKINL-DSLKKFGETAEKCLADYGVDRPSMGDVL 730
           +   +  D  + F    + CL     DRPS  ++L
Sbjct: 234 LSSNDWSDYFRNF---VDSCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 18/202 (8%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSR----QGLPEFQTEITVLSKIRHRHLVSLVG 524
           +G GGFG V    ++   K+   + +   R    +G      E  +L K+  R +VSL  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL----EICIGAARGLHYLHTGSA 580
             E + ++ LV   M  G LK H+Y          + +    +I  G    L +LH    
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ--- 113

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
             I++RD+K  N+LLD++   +++D GL+       +     G  G+ GY+ PE  + + 
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGYMAPEVLQGEV 170

Query: 641 LTDKSDVYSFGVVLFEVLCART 662
                D ++ G  L+E++  R+
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRS 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.0 bits (201), Expect = 9e-17
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 33/204 (16%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQT-----EITVLSKI-RHRHLVS 521
           +G G FG VY    ++    VA+K+     ++    ++      E+  L K+  H ++V 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKK----MKKKFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG----PDRTPLSWKQRLEICIGAARGLHYLHT 577
           L     E  E+  V+EYME      +LY         P S      I     +GL ++H 
Sbjct: 63  LKEVFRENDELYFVFEYMEG-----NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLDPE 634
               G  HRD+K  N+L+    V K+ADFGL+R   S P   + +VST       Y  PE
Sbjct: 118 ---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD-YVSTR-----WYRAPE 168

Query: 635 YFRRQQLTDKS-DVYSFGVVLFEV 657
              R        D+++ G ++ E+
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAEL 192

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 14/195 (7%)

Query: 469 IGSGGFGMVYKGVL---RDNTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V KG+    +    VAVK  +          E   E  V+ ++ + ++V ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G CE +S M LV E  E GPL K L       ++ K   E+    + G+ YL   +    
Sbjct: 63  GICEAESWM-LVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEETN---F 116

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL   + +K++DFGLS++    DE +      G +   +  PE     + 
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGA-DENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 642 TDKSDVYSFGVVLFE 656
           + KSDV+SFGV+++E
Sbjct: 176 SSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 80.9 bits (199), Expect = 2e-16
 Identities = 55/197 (27%), Positives = 101/197 (51%), Gaps = 11/197 (5%)

Query: 468 IIGSGGFGMVYKGVL---RDNTKVAVKRGVPGSRQGLP---EFQTEITVLSKIRHRHLVS 521
           ++GSG FG VYKG+     +  K+ V   +     G     EF  E  +++ + H HLV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+G C   + + LV + M  G L  +++   +  +  +  L  C+  A+G+ YL      
Sbjct: 74  LLGVCLSPT-IQLVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEE---R 128

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            ++HRD+ + N+L+      K+ DFGL+R     ++ + + G K    ++  E    ++ 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 642 TDKSDVYSFGVVLFEVL 658
           T +SDV+S+GV ++E++
Sbjct: 189 THQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 30/216 (13%)

Query: 465 KNLIIGSGGFGMVYKGVLRDNTKV-AVKR--------GVPGSRQG--LPEFQTEITVLSK 513
           K  +IG G +G VY  +     ++ AVK+        G   SRQ   +   ++EI  L  
Sbjct: 5   KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 514 IRHRHLVSLVGYCEEQSEMILVY-EYMEKGPLKKHL--YGPDRTPLS---WKQRLEICIG 567
           + H ++V  +G  E   E + ++ EY+  G +   L  YG     L     +Q LE    
Sbjct: 65  LDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE---- 119

Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS 627
              GL YLH+   +GI+HRD+K+ N+L+D + + K++DFG+S+    + +   +  ++GS
Sbjct: 120 ---GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173

Query: 628 FGYLDPE--YFRRQQLTDKSDVYSFGVVLFEVLCAR 661
             ++ PE  +   Q  + K D++S G V+ E+   R
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 54/145 (37%), Positives = 75/145 (51%), Gaps = 12/145 (8%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
           IG G FG VYK +  R N  VA+K   +  +   + + Q EI  LS+ R  ++    G  
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68

Query: 527 EEQSEMILVYEYMEKGPLKKHL-YGP-DRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
            + S++ ++ EY   G     L  G  D T +++  R E+      GL YLH    EG I
Sbjct: 69  LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-EVL----LGLEYLH---EEGKI 120

Query: 585 HRDIKSTNILLDENYVSKVADFGLS 609
           HRDIK+ NILL E    K+ADFG+S
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)

Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHRH 518
           F +  ++G GGFG V    +R   K+     +++     R+G      E  +L K+  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL----EICIGAARGLHY 574
           +VSL    E +  + LV   M  G LK H+Y          + +    EIC G    L  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LED 117

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           LH    E I++RD+K  NILLD++   +++D GL+   P   E     G  G+ GY+ PE
Sbjct: 118 LHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMAPE 171

Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCART 662
             + ++ T   D ++ G +L+E++  ++
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 36/213 (16%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSL-- 522
            IG G +GMV          KVA+K+  P   Q   + +T  EI +L + +H +++ +  
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ-RTLREIKILRRFKHENIIGILD 70

Query: 523 ---VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL---EICI---GAARGLH 573
                  E  +++ +V E ME       LY   +T     Q L    I        RGL 
Sbjct: 71  IIRPPSFESFNDVYIVQELMET-----DLYKLIKT-----QHLSNDHIQYFLYQILRGLK 120

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF----G 629
           Y+H  SA  ++HRD+K +N+LL+ N   K+ DFGL+R     D  H  TG    +     
Sbjct: 121 YIH--SA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIA---DPEHDHTGFLTEYVATRW 174

Query: 630 YLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCAR 661
           Y  PE     +   K+ D++S G +L E+L  R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 21/203 (10%)

Query: 469 IGSGGFGMVY------KGVLRDNT--KVAVKRGVPGSRQG-LPEFQTEITVLSKIRHRHL 519
           +G G FG V       +G   DNT  +VAVK   P S    + + + EI +L  + H ++
Sbjct: 12  LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 520 VSLVGYCEEQ--SEMILVYEYMEKGPLKKHLYGP-DRTPLSWKQRLEICIGAARGLHYLH 576
           V   G C E   + + L+ E++  G LK++L  P ++  ++ KQ+L+  +   +G+ YL 
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL- 125

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH-VSTGVKGSFGYLDPEY 635
            GS +  +HRD+ + N+L++  +  K+ DFGL+++     E + V   +     +  PE 
Sbjct: 126 -GSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
             + +    SDV+SFGV L+E+L
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 26/203 (12%)

Query: 472 GGFGMVYKGVLRDNT-----KVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGY 525
           G FG ++ G+L D       +V VK     + +  +     E  +L  + H++++ ++  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 526 CEEQSEMILV-YEYMEKGPLKKHL----YGPDRTP--LSWKQRLEICIGAARGLHYLHTG 578
           C E  E   V Y YM  G LK  L     G    P  LS +Q + + I  A G+ YLH  
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRS-GP----CLDETHVSTGVKGSFGYLDP 633
              G+IH+DI + N ++DE    K+ D  LSR   P    CL +   +  VK    ++  
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE-NRPVK----WMAL 188

Query: 634 EYFRRQQLTDKSDVYSFGVVLFE 656
           E    ++ +  SDV+SFGV+L+E
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWE 211

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 38/272 (13%)

Query: 469 IGSGGFGMVYKGVLR--DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           +G G +G VYK V R  DN   A+K    G  S++   +   EI +L+ + H +++S   
Sbjct: 8   LGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 525 YCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLS----WKQRLEICIGAARGLHYLHTG 578
              + +++ +V EY   G L K +      R  +     W+  +++     RGL  LH  
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQALH-- 120

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
             + I+HRD+KS NILL  N + K+ D G+S+    L +    T + G+  Y+ PE ++ 
Sbjct: 121 -EQKILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKTQI-GTPHYMAPEVWKG 175

Query: 639 QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG 698
           +  + KSD++S G +L+E+        P  AR   +L     + +          P  I 
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAP---PFEARSMQDLRYKVQRGK--------YPP--IP 222

Query: 699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
            I    L+ F       L      RP+   +L
Sbjct: 223 PIYSQDLQNF---IRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 14/195 (7%)

Query: 469 IGSGGFGMVYKGVLRDNTKV--AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
           +G G FG VYK   +  T +  A K     S + L +F  EI +LS+ +H ++V L    
Sbjct: 13  LGDGAFGKVYKAQHK-ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
             ++++ ++ E+ + G L   +   +R  L+  Q   +C      L++LH   +  +IHR
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLH---SHKVIHR 127

Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY-----FRRQQL 641
           D+K+ NILL  +   K+ADFG+S       +    T + G+  ++ PE      F+    
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNPY 185

Query: 642 TDKSDVYSFGVVLFE 656
             K+D++S G+ L E
Sbjct: 186 DYKADIWSLGITLIE 200

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 17/202 (8%)

Query: 469 IGSGGFGMVY------KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G GGFG V        G L    K+  KR     R+G      E  +L+K+  R +VSL
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKR--LKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR---GLHYLHTGS 579
               + ++++ LV   M  G L+ H+Y  D     + +    C   A+   GL +LH   
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEP-RACFYTAQIISGLEHLHQ-- 115

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              II+RD+K  N+LLD +   +++D GL+      D    + G  G+ G++ PE  + +
Sbjct: 116 -RRIIYRDLKPENVLLDNDGNVRISDLGLAVE--LKDGQSKTKGYAGTPGFMAPELLQGE 172

Query: 640 QLTDKSDVYSFGVVLFEVLCAR 661
           +     D ++ GV L+E++ AR
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 79.5 bits (196), Expect = 5e-16
 Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 21/210 (10%)

Query: 461 NNFDKNLIIGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLPE-FQTEITVLSK 513
           NN      +G+G FG V +    G+ + +   KVAVK   P +     E   +E+ ++S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 514 I-RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGL 572
           +  H ++V+L+G C     ++++ EY   G L   L     + L+ +  L      A+G+
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV-KGS---- 627
            +L   +++  IHRD+ + N+LL    + K+ DFGL+R     D  + S  V KG+    
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLP 206

Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
             ++ PE       T +SDV+S+G++L+E+
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 17/204 (8%)

Query: 469 IGSGGFGMVYKGVLRDNTKV-AVKRGVPGSRQGLPEFQT----EITVLSKIRHRHLVSLV 523
           +G+G  G+V K + R   K+ AVK  +    +     Q     E+ +L K    ++V   
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKT-IR--LEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHL-YGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
           G      ++ +  EYM+ G L K L     R P     +  I +   +GL YLH      
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLH--EKHK 121

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           IIHRD+K +NIL++     K+ DFG+S     L  +   T V G+  Y+ PE  +    +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQ---LVNSLAKTFV-GTSSYMAPERIQGNDYS 177

Query: 643 DKSDVYSFGVVLFEVLCARTAVDP 666
            KSD++S G+ L E+   R    P
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 78.5 bits (193), Expect = 7e-16
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)

Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHRH 518
           F +  ++G GGFG V    +R   K+     +++     R+G      E  +L K+  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL----EICIGAARGLHY 574
           +V+L    E +  + LV   M  G LK H+Y         ++ L    EI  G    L  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LED 117

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           LH    E  ++RD+K  NILLD+    +++D GL+   P   E     G  G+ GY+ PE
Sbjct: 118 LHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIP---EGESIRGRVGTVGYMAPE 171

Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
               Q+ T   D +  G +++E++  ++   P   R++
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQS---PFRGRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 78.6 bits (193), Expect = 7e-16
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 10/197 (5%)

Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTKVAVKR--GVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           F K   IG G FG V+KG+     KV   +   +  +   + + Q EITVLS+    ++ 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
              G   + +++ ++ EY+  G     L   +  PL   Q   I     +GL YLH+   
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHS--- 119

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           E  IHRDIK+ N+LL E+   K+ADFG+  +G   D         G+  ++ PE  ++  
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 641 LTDKSDVYSFGVVLFEV 657
              K+D++S G+   E+
Sbjct: 178 YDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 7e-16
 Identities = 49/166 (29%), Positives = 77/166 (46%), Gaps = 37/166 (22%)

Query: 469 IGSGGFGMVYKGVL---RDNTKVAVK--RGVPGSRQGLPEFQT---EITVLSKIRHRHLV 520
           IG G +G VYK      +D  + A+K  +G      G+   Q+   EI +L +++H ++V
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS--QSACREIALLRELKHENVV 65

Query: 521 SLVGYCEEQSEMI--LVYEYMEK--GPLKKHLYGPDRTPLS--------WKQRLEICIGA 568
           SLV    E ++    L+++Y E     + K      R  +         W Q L      
Sbjct: 66  SLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-QILN----- 119

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSR 610
             G+HYLH   +  ++HRD+K  NIL+     E  V K+ D GL+R
Sbjct: 120 --GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 78.8 bits (194), Expect = 8e-16
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 29/203 (14%)

Query: 488 VAVKRGVP-GSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKK 546
           VAVK   P  ++    +F  E+ +LS+++  +++ L+G C ++  + ++ EYME G L +
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 547 HLY----------GPDRTP-------LSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIK 589
            L           G D  P       +S+   L + +  A G+ YL   S+   +HRD+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165

Query: 590 STNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYS 649
           + N L+ EN   K+ADFG+SR+    D   +         ++  E     + T  SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225

Query: 650 FGVVLFEVLCARTAVDPLLAREQ 672
           FGV L+E+L        +L +EQ
Sbjct: 226 FGVTLWEIL--------MLCKEQ 240

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 77.7 bits (191), Expect = 9e-16
 Identities = 66/206 (32%), Positives = 93/206 (45%), Gaps = 20/206 (9%)

Query: 469 IGSGGFGMVY-----KGVLRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVS 521
           +G G FG VY     K V  +  KV +K    G        Q   E  +LSK+ H  +V 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 522 LVGYCEEQSEMILVYEYMEKGPL--KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
                 E+    ++ EY E   L  K          LS  Q  E  I    G+HY+H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-- 124

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFR 637
              I+HRD+K+ NI L  N + K+ DFG+SR   G C     ++T   G+  Y+ PE  +
Sbjct: 125 -RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSC----DLATTFTGTPYYMSPEALK 178

Query: 638 RQQLTDKSDVYSFGVVLFEVLCARTA 663
            Q    KSD++S G +L+E+ C   A
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCCLAHA 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 18/162 (11%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHR 517
           N ++   ++G G +G+V K   +     VA+K  +              E+ VL ++RH 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKG---PLKKHLYG--PDRTPLSWKQRLEICIGAARGL 572
           ++V+L      +  + LV+EY+E+     L+    G  PD       Q L       + +
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLL-------QAI 113

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC 614
            Y H   +  IIHRDIK  NIL+ E+ V K+ DFG +R+   
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 28/160 (17%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKR-GVPGSRQGLP-EFQTEITVLSKIRHRHLVSLVGY 525
           +G G FG VYK   ++    VA+K+  +   + G P     EI +L K++H ++V L+  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 526 CEEQSE--------MILVYEYMEK---GPLKK---HLYGPDRTPLSWKQRLEICIGAARG 571
             E+ +        + +V  YM+    G L+     L           Q LE       G
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ-IKCYMLQLLE-------G 127

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           ++YLH      I+HRDIK+ NIL+D   + K+ADFGL+R 
Sbjct: 128 INYLH---ENHILHRDIKAANILIDNQGILKIADFGLARP 164

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 16/183 (8%)

Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL----------YGPD 552
           +F  EI ++S++++ +++ L+G C     + ++ EYME G L + L          +  +
Sbjct: 63  DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122

Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
              +S    L + +  A G+ YL   ++   +HRD+ + N L+  +Y  K+ADFG+SR+ 
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV--LCARTAVDPLLAR 670
              D   +         ++  E     + T  SDV++FGV L+E+  LC       LL+ 
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS-LLSD 238

Query: 671 EQV 673
           EQV
Sbjct: 239 EQV 241

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 63/280 (22%), Positives = 124/280 (44%), Gaps = 34/280 (12%)

Query: 464 DKNLIIGSGGFGMVYKGVLRDNTKVAV---KRGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
             +++I       +YKG+  +N +V +   K+   G +  +   + EI  L +I   +++
Sbjct: 23  YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNIL 81

Query: 521 SLVGY----CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
            + G+     ++   + L+ EY  +G L++ L       LS+K +L++ I   +GL+ L+
Sbjct: 82  KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLY 139

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
                   ++++ S + L+ ENY  K+   GL +        +V+  V     Y   +  
Sbjct: 140 K--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKML 192

Query: 637 RR--QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP 694
                + T K D+YS GVVL+E+   +   + L  +E  +L               II+ 
Sbjct: 193 NDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL---------------IINK 237

Query: 695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
               K+ LD   +     E C +   + RP++ ++L+NL 
Sbjct: 238 NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 49/157 (31%), Positives = 83/157 (52%), Gaps = 21/157 (13%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKR-GVPGSRQGLPEFQT-EITVLSKIR---HRHLVS 521
            IG G +G VYK   L     VA+K+  VP S +G+P     EI +L ++    H ++V 
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 522 LVGYC-----EEQSEMILVYEYMEKGPLKKHLYGPDRTP---LSWKQRLEICIGAARGLH 573
           L+  C     + + ++ LV+E++++  L  +L    + P   L  +   ++     RG+ 
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQD-LATYL---SKCPKPGLPPETIKDLMRQLLRGVD 121

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR 610
           +LH+     I+HRD+K  NIL+  +   K+ADFGL+R
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.4 bits (191), Expect = 3e-15
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 12/199 (6%)

Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSL 522
           ++G G FG V    L+   ++     +K+ V      +    TE  VL+   +H  L  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
               + +  +  V EY+  G L  H+    R      +     I    GL +LH     G
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQFLHE---RG 116

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           II+RD+K  N+LLD     K+ADFG+ + G     T  ++   G+  Y+ PE    Q   
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYG 174

Query: 643 DKSDVYSFGVVLFEVLCAR 661
              D ++ GV+L+E+L  +
Sbjct: 175 PAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 18/204 (8%)

Query: 469 IGSGGFGMVYKGVLRDNT---KVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG V +G L  +    KVAVK  +    +R  + +F +E   + +  H +++ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 524 GYCEEQSEM------ILVYEYMEKGPLKKHLY----GPDRTPLSWKQRLEICIGAARGLH 573
           G C +  E       +++  +M+ G L   L     G     L  +  ++     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YL   S++  IHRD+ + N +L+EN    VADFGLS+     D        K    ++  
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 634 EYFRRQQLTDKSDVYSFGVVLFEV 657
           E    +  T KSDV+SFGV ++E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 26/218 (11%)

Query: 468 IIGSGGFG--MVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           ++G G FG  ++ + V  D      +  +P S   + + + E  +L+K++H ++V+    
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 526 CEEQSEMILVYEY------MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
            E    + +V EY      M+K  L++    P+ T L W   +++C+G    + ++H   
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW--FVQMCLG----VQHIHE-- 118

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFR 637
            + ++HRDIKS NI L +N   K+ DFG +R  + P     +  T V G+  Y+ PE + 
Sbjct: 119 -KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV-GTPYYVPPEIWE 173

Query: 638 RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL 675
                +KSD++S G +L+E LC  T   P  A    NL
Sbjct: 174 NMPYNNKSDIWSLGCILYE-LC--TLKHPFQANSWKNL 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 27/203 (13%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
           IG G   +VY  + L +N KVA+KR  +   +  + E + E+  +S+  H ++V      
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 527 EEQSEMILVYEYMEKGPL---KKHLYGPDRTPLSWKQRLEICIGAA-----RGLHYLHTG 578
               E+ LV  Y+  G L    K  Y             E  I        +GL YLH+ 
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD-------EAIIATVLKEVLKGLEYLHS- 120

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF----GYLDPE 634
              G IHRDIK+ NILL E+   K+ADFG+S S    D    +  V+ +F     ++ PE
Sbjct: 121 --NGQIHRDIKAGNILLGEDGSVKIADFGVSAS--LADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 635 YFRRQQ-LTDKSDVYSFGVVLFE 656
              +      K+D++SFG+   E
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIE 199

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 20/212 (9%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV------PGSRQGLPEFQTEITVLSKIR 515
           N+ +  ++G G FG VY     D  +    + V      P + + +   + EI +L  ++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 516 HRHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARG 571
           H  +V   G   +++E  + +  EYM  G +K  L  YG     ++ K   +I      G
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EG 118

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFG 629
           + YLH+     I+HRDIK  NIL D     K+ DFG S+     C+  T + + V G+  
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPY 174

Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           ++ PE    +    K+DV+S G  + E+L  +
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 16/221 (7%)

Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSL 522
           +IG G +  V    L+ N ++     VK+ +    + +   QTE  V  +   +  LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ--RLEICIGAARGLHYLHTGSA 580
               +  S + LV EY+  G L  H+    + P    +    EICI     L++LH    
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LNFLHE--- 114

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
            GII+RD+K  N+LLD +   K+ D+G+ + G  L     ++   G+  Y+ PE  R ++
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILRGEE 172

Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQ 681
                D ++ GV++FE++  R+  D +     +N  ++  Q
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 12/220 (5%)

Query: 465 KNLIIGSGGFGMVYKGVL---RDNTKVAVKRGV---PGSRQGLPEFQTEITVLSKIRHRH 518
           K  ++GSG FG VYKG+     +N K+ V   V     S +   E   E  V++ +   +
Sbjct: 11  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 70

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
           +  L+G C   S + LV + M  G L  ++   ++  +  +  L  C+  A+G+ YL   
Sbjct: 71  VCRLLGICL-TSTVQLVTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLEEV 128

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
               ++HRD+ + N+L+      K+ DFGL+R     +  + + G K    ++  E    
Sbjct: 129 R---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185

Query: 639 QQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAE 677
           ++ T +SDV+S+GV ++E++       D + ARE  +L E
Sbjct: 186 RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 20/206 (9%)

Query: 468 IIGSGGFGMVYKGVLRDNTK-VAVKR-----GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           ++G G FG VY     D  + +AVK+       P + + +   + EI +L  + H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 522 LVGYCEEQSEMIL--VYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLHT 577
             G   +  E  L    E+M  G +K  L  YG     ++ K   +I      G+ YLH+
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEY 635
                I+HRDIK  NIL D     K+ DFG S+     CL  T + + V G+  ++ PE 
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEV 180

Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCAR 661
              +    K+D++S G  + E+L  +
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 10/191 (5%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
           IG G FG V+KG+  R    VA+K   +  +   + + Q EITVLS+    ++    G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
            + +++ ++ EY+  G     L      P    Q   +     +GL YLH+   E  IHR
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS---EKKIHR 125

Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
           DIK+ N+LL E    K+ADFG+  +G   D         G+  ++ PE  ++     K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Query: 647 VYSFGVVLFEV 657
           ++S G+   E+
Sbjct: 184 IWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 37/161 (22%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKR--------GVPGS--RQGLPEFQTEITVLSKIRHR 517
           IG G +G+VYK         VA+K+        GVP +  R        EI++L ++ H 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR--------EISLLKELNHP 58

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRL------EICIGAAR 570
           ++V L+     ++++ LV+E+++   LKK++   D +P       L      ++     +
Sbjct: 59  NIVRLLDVVHSENKLYLVFEFLDLD-LKKYM---DSSPLTGLDPPLIKSYLYQLL----Q 110

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           G+ Y H+     ++HRD+K  N+L+D     K+ADFGL+R+
Sbjct: 111 GIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 74.8 bits (184), Expect = 3e-14
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 34/222 (15%)

Query: 465 KNLIIGSGGFGMVYKGV-LRDNTKVAVKR--------GVPGSRQGLPE----FQT--EIT 509
           K   +G G +G V K         VA+K+         V   RQ +      F T  E+ 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
           ++++I+H +++ LV    E   + LV + M    LKK +    +  L+  Q   I +   
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV--DRKIRLTESQVKCILLQIL 129

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR-------SGPCLDETHVS- 621
            GL+ LH       +HRD+   NI ++   + K+ADFGL+R       S     +  +  
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 622 ----TGVKGSFGYLDPE-YFRRQQLTDKSDVYSFGVVLFEVL 658
               T    +  Y  PE     ++     D++S G +  E+L
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228

Length = 335

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 18/158 (11%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKR-GVPGSRQGLPEFQT-EITVLSKIRHRH 518
            ++K   IG G +G V+K   R+  + VA+KR  +    +G+P     EI +L +++H++
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG----PDR-TPLSWKQRLEICIGAARGLH 573
           +V L        ++ LV+EY ++  LKK+        D     S+  +L       +GL 
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQD-LKKYFDSCNGDIDPEIVKSFMFQL------LKGLA 113

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           + H   +  ++HRD+K  N+L+++N   K+ADFGL+R+
Sbjct: 114 FCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.2 bits (179), Expect = 4e-14
 Identities = 60/191 (31%), Positives = 93/191 (48%), Gaps = 10/191 (5%)

Query: 469 IGSGGFGMVYKGVL-RDNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
           IG G FG VYKG+  R    VA+K   +  +   + + Q EITVLS+    ++    G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
            + +++ ++ EY+  G     L  P   PL       I     +GL YLH+   E  IHR
Sbjct: 72  LKGTKLWIIMEYLGGGS-ALDLLKPG--PLEETYIATILREILKGLDYLHS---ERKIHR 125

Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
           DIK+ N+LL E    K+ADFG+  +G   D         G+  ++ PE  ++     K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183

Query: 647 VYSFGVVLFEV 657
           ++S G+   E+
Sbjct: 184 IWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.9 bits (181), Expect = 4e-14
 Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 13/203 (6%)

Query: 463 FDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-PEFQTEIT----VLSKIRH 516
           F K  ++GSG FG VYKG+ + +  KV +   +   R+   P+   EI     V++ + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLY-GPDRTPLSWKQRLEICIGAARGLHYL 575
            H+  L+G C   S + L+ + M  G L  ++    D     +   L  C+  A+G++YL
Sbjct: 69  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYL 125

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
                  ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E 
Sbjct: 126 EE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182

Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
              +  T +SDV+S+GV ++E++
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 72.6 bits (178), Expect = 4e-14
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 22/202 (10%)

Query: 468 IIGSGGFGMVYKGVLRDNTK----VAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           I+G+G FG + +G L+  +K    VA+   R     +Q    F  E   L +  H ++V 
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRR-GFLAEALTLGQFDHSNIVR 70

Query: 522 LVGYCEEQSEMILVYEYMEKGP----LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           L G     + M++V EYM  G     L+KH        L   Q + +  G A G+ YL  
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLRKH-----EGQLVAGQLMGMLPGLASGMKYL-- 123

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFG-LSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
            S  G +H+ + +  +L++ + V K++ F  L       +  + +   K    +  PE  
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK--SEAIYTTMSGKSPVLWAAPEAI 180

Query: 637 RRQQLTDKSDVYSFGVVLFEVL 658
           +    +  SDV+SFG+V++EV+
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 73.4 bits (180), Expect = 5e-14
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 12/165 (7%)

Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL---------YGPDR 553
           +F  EI ++S+++  +++ L+  C     + ++ EYME G L + L            D 
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 554 TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP 613
             +S+   + +    A G+ YL   S+   +HRD+ + N L+ +NY  K+ADFG+SR+  
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             D   +         ++  E     + T  SDV++FGV L+E+L
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 12/195 (6%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV-PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG VYK   ++   +A  + +   S + L ++  EI +L+   H ++V L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
              ++ ++ E+   G +   +   DR  L+  Q   IC      L YLH+     IIHRD
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHS---MKIIHRD 135

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD---- 643
           +K+ N+LL  +   K+ADFG+S     +          G+  ++ PE    + + D    
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKN--VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193

Query: 644 -KSDVYSFGVVLFEV 657
            K+D++S G+ L E+
Sbjct: 194 YKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 22/154 (14%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKR-GVPGSRQGLPEFQT-EITVLSKIRHRHLVSLVGY 525
           IG G +G+VYKG   +    VA+K+  +    +G+P     EI++L +++H ++V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 526 CEEQSEMILVYEYMEKGPLKKHL-------YGPDRTPLSW-KQRLEICIGAARGLHYLHT 577
             ++S + L++E++    LKK+L       Y       S+  Q L+       G+ + H 
Sbjct: 68  LMQESRLYLIFEFLSMD-LKKYLDSLPKGQYMDAELVKSYLYQILQ-------GILFCH- 118

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
             +  ++HRD+K  N+L+D   V K+ADFGL+R+
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARA 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 72.3 bits (178), Expect = 2e-13
 Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 42/214 (19%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQT---------EITVLSKIRHRH 518
           +GSG +G V          KVA+K+    SR   P FQ+         E+ +L  + H +
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKL---SR---P-FQSAIHAKRTYRELRLLKHMDHEN 75

Query: 519 LVSLVG-YC--EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL---EICIGA---A 569
           ++ L+  +       +   VY       L  HL G D   +   Q+L    I        
Sbjct: 76  VIGLLDVFTPASSLEDFQDVY-------LVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL 128

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
           RGL Y+H  SA GIIHRD+K +NI ++E+   K+ DFGL+R     DE    TG   +  
Sbjct: 129 RGLKYIH--SA-GIIHRDLKPSNIAVNEDCELKILDFGLARH--TDDEM---TGYVATRW 180

Query: 630 YLDPE-YFRRQQLTDKSDVYSFGVVLFEVLCART 662
           Y  PE            D++S G ++ E+L  +T
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 18/199 (9%)

Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           ++G GGFG V    +R   K+     +++     R+G      E  +L K+  R +VSL 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL----EICIGAARGLHYLHTGS 579
              E +  + LV   M  G LK H+Y         ++ +    E+C G    L  L    
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG----LEDLQR-- 120

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
            E I++RD+K  NILLD+    +++D GL+   P   E     G  G+ GY+ PE    +
Sbjct: 121 -ERIVYRDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGRVGTVGYMAPEVINNE 176

Query: 640 QLTDKSDVYSFGVVLFEVL 658
           + T   D +  G +++E++
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 19/207 (9%)

Query: 468 IIGSGGFGMVYKGVLR--DNT--KVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           ++G G FG V +  L+  D +  KVAVK  +    S   + EF  E   + +  H +++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 522 LVG---YCEEQSEM---ILVYEYMEKGPLKKHLY----GPDRTPLSWKQRLEICIGAARG 571
           L+G       +  +   +++  +M+ G L   L     G +   L  +  +   I  A G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           + YL   S++  IHRD+ + N +L+EN    VADFGLS+     D        K    +L
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             E       T  SDV++FGV ++E++
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 46/154 (29%), Positives = 84/154 (54%), Gaps = 9/154 (5%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHL 519
           NF +   +G G +  VYKG  R   + VA+K     + +G P     EI+++ +++H ++
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           V L      +++++LV+EYM+K  LKK++  +G  R  L             +G+ + H 
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
                ++HRD+K  N+L+++    K+ADFGL+R+
Sbjct: 119 ---NRVLHRDLKPQNLLINKRGELKLADFGLARA 149

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVP---GSRQGLPE---FQTEITVLSKIR 515
           N+    ++G G FG VY     D  +    + VP    S++   E    + EI +L  +R
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 516 HRHLVSLVGYC---EEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAAR 570
           H  +V   G C    E+ ++ +  EYM  G +K  L  YG     ++ +   +I     +
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----Q 117

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSF 628
           G+ YLH+     I+HRDIK  NIL D     K+ DFG S+     C+  T + + V G+ 
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTP 173

Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
            ++ PE    +    K+DV+S    + E+L  +
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 55/166 (33%), Positives = 84/166 (50%), Gaps = 28/166 (16%)

Query: 463 FDKNLIIGSGGFGMVYKGVLRD-NTKVAVKR-GVPGSRQGLPEFQT-EITVLSKIRHRHL 519
           FD    IG G +G VYK   +D    VA+K+  +   ++G P     EI +L ++ HR++
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 520 VSL----------VGYCEEQSEMILVYEYMEK---GPLKKHL--YGPDRTPLSWKQRLEI 564
           V+L          + + +++    LV+EYM+    G L+  L  +  D      KQ LE 
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE- 127

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR 610
                 GL+Y H    +  +HRDIK +NILL+     K+ADFGL+R
Sbjct: 128 ------GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLAR 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 12/205 (5%)

Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQTEITVLSK 513
           D +T  +NF K   IG G  G+V    ++ + K VAVK+     +Q       E+ ++  
Sbjct: 17  DPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 73

Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
            +H ++V +        E+ +V E++E G L   +     T ++ +Q   +C+   + L 
Sbjct: 74  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALS 130

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
            LH   A+G+IHRDIKS +ILL  +   K++DFG         E      + G+  ++ P
Sbjct: 131 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKSLVGTPYWMAP 185

Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVL 658
           E   R     + D++S G+++ E++
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 18/199 (9%)

Query: 468 IIGSGGFGMVYKGVLRDNTKV-AVKR---GVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           ++G GGFG V    +R   K+ A K+        R+G      E  +L K+  R +VSL 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL----EICIGAARGLHYLHTGS 579
              E +  + LV   M  G LK H+Y         ++ +    EI  G    L  LH   
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LEDLHR-- 120

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
            E I++RD+K  NILLD+    +++D GL+   P   E     G  G+ GY+ PE  + +
Sbjct: 121 -ERIVYRDLKPENILLDDYGHIRISDLGLAVEIP---EGETIRGRVGTVGYMAPEVVKNE 176

Query: 640 QLTDKSDVYSFGVVLFEVL 658
           + T   D +  G +++E++
Sbjct: 177 RYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 70.7 bits (174), Expect = 4e-13
 Identities = 52/171 (30%), Positives = 83/171 (48%), Gaps = 41/171 (23%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQT---EITVLSKIR-HRHLVSL- 522
           +G G +G+V+K + R     VA+K+ +  + +   + Q    EI  L ++  H ++V L 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKK-IFDAFRNATDAQRTFREIMFLQELGDHPNIVKLL 73

Query: 523 -VGYCEEQSEMILVYEYME--------KGPLKK-H----LYGPDRTPLSWKQRLEICIGA 568
            V   E   ++ LV+EYME           L+  H    +Y          Q L      
Sbjct: 74  NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY----------QLL------ 117

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH 619
            + L Y+H+G    +IHRD+K +NILL+ +   K+ADFGL+RS   L+E  
Sbjct: 118 -KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 64/226 (28%), Positives = 92/226 (40%), Gaps = 41/226 (18%)

Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK-RGVPGSRQGLPEFQTEITVLSK 513
           L   T  F+   +IG G +G VYK    +    VA+K   +    +   E + E  +L K
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE--EEIKEEYNILRK 58

Query: 514 I-RHRHLVSLVG------YCEEQSEMILVYEYMEKGP---LKKHLYGPDRTPLSWKQRLE 563
              H ++ +  G            ++ LV E    G    L K L           +RL+
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL-------RKKGKRLK 111

Query: 564 ------ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE 617
                 I     RGL YLH      +IHRDIK  NILL +N   K+ DFG+S     LD 
Sbjct: 112 EEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ---LDS 165

Query: 618 T--HVSTGVKGSFGYLDPE-----YFRRQQLTDKSDVYSFGVVLFE 656
           T    +T + G+  ++ PE              +SDV+S G+   E
Sbjct: 166 TLGRRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.4 bits (172), Expect = 6e-13
 Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 35/274 (12%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV-----PGSRQGLPEFQTEITVLSKIR 515
           ++F+K   +G+G  G+V+K   + +  +  ++ +     P  R    +   E+ VL +  
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN---QIIRELQVLHECN 61

Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-EICIGAARGLHY 574
             ++V   G      E+ +  E+M+ G L + L    R P   +Q L ++ I   +GL Y
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVIKGLTY 118

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       I+HRD+K +NIL++     K+ DFG+  SG  +D   ++    G+  Y+ PE
Sbjct: 119 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDS--MANSFVGTRSYMSPE 172

Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP 694
             +    + +SD++S G+ L E+   R  + P  A+E                LE +   
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE----------------LELMFGC 216

Query: 695 QLIGKINLDSLKKFGETAEKCLADYGVD-RPSMG 727
            + G               + L+ YG D RP M 
Sbjct: 217 PVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMA 250

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 18/160 (11%)

Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEI 564
           E+ ++ + R  ++VS  G    ++ + +  E+M+ G L +     GP    +  K    I
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK----I 108

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD---ETHVS 621
            +    GL YL+  +   I+HRDIK +NIL++     K+ DFG+  SG  ++   +T V 
Sbjct: 109 AVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGV--SGELINSIADTFVG 164

Query: 622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           T       Y+ PE  +  + T KSDV+S G+ + E+   +
Sbjct: 165 TST-----YMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 19/159 (11%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKR--------GVPGSRQGLPEFQTEITVLS 512
           NF K   IG G +G+VYK   +   + VA+K+        GVP +         EI++L 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI------REISLLK 54

Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGL 572
           ++ H ++V L+     ++++ LV+E++ +  LKK +     + +             +GL
Sbjct: 55  ELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
            + H   +  ++HRD+K  N+L++     K+ADFGL+R+
Sbjct: 114 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 16/162 (9%)

Query: 455 DLQTATNNFDKNLI--IGSGGFGMVYKGVLRDNTKVAVKRGV---PGSRQGLPEFQTEIT 509
           DL       D  LI  IGSG +G VYK    +  ++A  + +   PG  +     Q EI 
Sbjct: 1   DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEII 58

Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKK--HLYGPDRTPLSWKQRLEICIG 567
           ++   +H ++V+  G    + ++ +  E+   G L+   H+ GP    LS  Q   +   
Sbjct: 59  MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRE 114

Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS 609
             +GL+YLH+   +G +HRDIK  NILL +N   K+ADFG+S
Sbjct: 115 TLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 70.1 bits (171), Expect = 8e-13
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 12/203 (5%)

Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSL 522
           +IG G +  V    L+   ++     VK+ +    + +   QTE  V  +   H  LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
               + +S +  V EY+  G L  H+    + P    +     I  A  L+YLH     G
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHE---RG 116

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           II+RD+K  N+LLD     K+ D+G+ + G  L     ++   G+  Y+ PE  R +   
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 643 DKSDVYSFGVVLFEVLCARTAVD 665
              D ++ GV++FE++  R+  D
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 29/211 (13%)

Query: 462 NFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGV------PGSRQGLPEFQTEITVLSKI 514
           NF     IG G F  VY+   L D   VA+K+          +RQ   +   EI +L ++
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59

Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPL--------KKHLYGPDRTPLSWKQRLEICI 566
            H +++  +    E +E+ +V E  + G L        K+    P+RT   WK  +++C 
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERT--VWKYFVQLC- 116

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
                + ++H+     ++HRDIK  N+ +    V K+ D GL R      +T  +  + G
Sbjct: 117 ---SAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVG 168

Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
           +  Y+ PE         KSD++S G +L+E+
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 70.6 bits (173), Expect = 9e-13
 Identities = 56/182 (30%), Positives = 78/182 (42%), Gaps = 19/182 (10%)

Query: 484 DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGP 543
              KV VK    G   G      EI +L  I HR +++L+     +S + +V   M K  
Sbjct: 118 QRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYK 169

Query: 544 LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKV 603
                Y     PL  +Q + I       L YLH     GIIHRD+K+ NI LDE   + +
Sbjct: 170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVL 226

Query: 604 ADFGLSRSGPCLDETHVST----GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            DFG +    C  + H  T    G  G+     PE         K+D++S G+VLFE+  
Sbjct: 227 GDFGAA----CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282

Query: 660 AR 661
             
Sbjct: 283 KN 284

Length = 392

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.8 bits (171), Expect = 9e-13
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 32/206 (15%)

Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSK------IRHR 517
           ++G G FG V    L+   +     A+K+ V      L +   E T++ +        H 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVV-----LEDDDVECTMVERRVLALAWEHP 56

Query: 518 HLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQRL---EICIGAARGL 572
            L  L  +C  Q++  +  V EY+  G L  H+    R   + + R    EI  G    L
Sbjct: 57  FLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-RARFYAAEIICG----L 109

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLD 632
            +LH    +GII+RD+K  N+LLD++   K+ADFG+ +     +    ++   G+  Y+ 
Sbjct: 110 QFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIA 164

Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE  + Q+  +  D +SFGV+L+E+L
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 34/211 (16%)

Query: 469 IGSGGFGMVYKGVLRDN------------TKVAVKRGVPGSRQGLPEFQTEITVLSK-IR 515
           +GSG FG VYK   ++N               A  +      + + +  +E+T++ + +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPL---------KKHLYGPDRTPLSWKQRLEICI 566
           H ++V       E   + +V + +E  PL         KK  +  +R    W   +++ +
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---WNIFVQMVL 124

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
                L YLH    + I+HRD+   NI+L E+    + DFGL++           T V G
Sbjct: 125 A----LRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK---QPESKLTSVVG 175

Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
           +  Y  PE  + +   +K+DV++FG +L+++
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 69.1 bits (170), Expect = 1e-12
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 32/212 (15%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV-AVKR----GVPGSRQGLPEFQT--EITVLSK 513
           ++F+    +G+G FG V     + + K  A+K      +   +Q         E  +L  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ---VEHVLNEKRILQS 57

Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR--- 570
           IRH  LV+L G  ++ S + LV EY+  G L  HL    R P            AA+   
Sbjct: 58  IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-----ARFYAAQVVL 112

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK---GS 627
            L YLH+     I++RD+K  N+LLD +   K+ DFG ++         V        G+
Sbjct: 113 ALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGT 161

Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
             YL PE    +      D ++ G++++E+L 
Sbjct: 162 PEYLAPEIILSKGYGKAVDWWALGILIYEMLA 193

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 63/202 (31%), Positives = 88/202 (43%), Gaps = 28/202 (13%)

Query: 469 IGSGGFGMVYKGVLRDNTKV-AVKRGVPGSRQGLPEFQTEI-----TVLSKIRHRHLVSL 522
           IGSG  G VYK   +    V AVK+     R G  E    I      VL      ++V  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 523 VGYCEEQSEMILVYEYM----EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            GY    S++ +  E M    +K  L K + GP    +  K    + +   + LHYL   
Sbjct: 80  YGYFITDSDVFICMELMSTCLDK--LLKRIQGPIPEDILGK----MTVAIVKALHYLKE- 132

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
              G+IHRD+K +NILLD +   K+ DFG+S     L ++   T   G   Y+ PE    
Sbjct: 133 -KHGVIHRDVKPSNILLDASGNVKLCDFGISGR---LVDSKAKTRSAGCAAYMAPERIDP 188

Query: 639 QQLTDK----SDVYSFGVVLFE 656
                K    +DV+S G+ L E
Sbjct: 189 PDPNPKYDIRADVWSLGISLVE 210

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 1e-12
 Identities = 62/234 (26%), Positives = 92/234 (39%), Gaps = 46/234 (19%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNT-------KVAVKRGVPGSRQGLPEFQTEITVLSK 513
           ++F+   +IG G FG V+  ++RD         KV  K  +    Q     + E  +L+ 
Sbjct: 1   DDFEVIKVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIA-HVRAERDILAD 57

Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL--EICIGAARG 571
                +V L    +++  + LV EYM  G L   L   D  P    +    E+    A  
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV--LA-- 113

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG----------------PCL 615
           L  +H     G IHRDIK  NIL+D +   K+ADFGL +                     
Sbjct: 114 LDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 616 DETHVSTGVK-----------GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           D   V                G+  Y+ PE  R      + D +S GV+L+E+L
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 49/169 (28%), Positives = 83/169 (49%), Gaps = 8/169 (4%)

Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           E+ VL +    ++V   G      E+ +  E+M+ G L + L    R P +   ++ I +
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
              RGL YL       I+HRD+K +NIL++     K+ DFG+  SG  +D   ++    G
Sbjct: 109 --LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDS--MANSFVG 160

Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL 675
           +  Y+ PE  +    T +SD++S G+ L E+   R  + P  A+E   +
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 21/203 (10%)

Query: 468 IIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           ++G G FG V     K   +      +K+ V  ++  +    TE  VL   RH  L SL 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
              + +  +  V EY+  G L  HL     +  DRT     +           L YLH+G
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE-------IVSALDYLHSG 114

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
               I++RD+K  N++LD++   K+ DFGL + G  + +        G+  YL PE    
Sbjct: 115 K---IVYRDLKLENLMLDKDGHIKITDFGLCKEG--ITDAATMKTFCGTPEYLAPEVLED 169

Query: 639 QQLTDKSDVYSFGVVLFEVLCAR 661
                  D +  GVV++E++C R
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 37/268 (13%)

Query: 462 NFDKNLIIGSGGFGMVY--KGVLRDNT------KVAVKRGVPGSRQGLPEFQTEITVLSK 513
           NF+   ++G+G +G V+  + V   +       KV  K  +    +     +TE  VL  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 514 IRHR-HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIG----A 568
           +R    LV+L    +  +++ L+ +Y+  G L  HLY  +    S    + + I     A
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLA 117

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKG 626
              LH L      GII+RDIK  NILLD      + DFGLS+       +  +      G
Sbjct: 118 LDHLHQL------GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCG 168

Query: 627 SFGYLDPEYFRRQQL--TDKSDVYSFGVVLFEVLCARTAVDPL-LAREQVNLAEWAMQWQ 683
           +  Y+ PE  R          D +S GV+ FE+L   T   P  +  EQ + +E + +  
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL---TGASPFTVDGEQNSQSEISRRIL 225

Query: 684 KKG-MLEHIIDPQ---LIGKINLDSLKK 707
           K        +  +    I K+     KK
Sbjct: 226 KSKPPFPKTMSAEARDFIQKLLEKDPKK 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 43/147 (29%), Positives = 78/147 (53%), Gaps = 8/147 (5%)

Query: 468 IIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPE--FQTEITVLSKIRHRHLVSLVG 524
           ++G G +GMV K   ++  + VA+K+ +      + +     EI +L ++RH +LV+L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
               +  + LV+E+++   L      P+    S  ++    I   RG+ + H+     II
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI--LRGIEFCHS---HNII 122

Query: 585 HRDIKSTNILLDENYVSKVADFGLSRS 611
           HRDIK  NIL+ ++ V K+ DFG +R+
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFART 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 16/216 (7%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV-----PGSRQGLPEFQTEITVLSKIR 515
           ++F++   +G+G  G+V K   + +  +  ++ +     P  R    +   E+ VL +  
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN---QIIRELQVLHECN 61

Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
             ++V   G      E+ +  E+M+ G L + L    R P     ++ I +   RGL YL
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYL 119

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
                  I+HRD+K +NIL++     K+ DFG+  SG  +D   ++    G+  Y+ PE 
Sbjct: 120 R--EKHQIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDS--MANSFVGTRSYMSPER 173

Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE 671
            +    + +SD++S G+ L E+   R  + P  A+E
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 9/197 (4%)

Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
            D  + IG G  G+V     +   K VAVK+     +Q       E+ ++    H ++V 
Sbjct: 24  LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           +        E+ +V E++E G L   +     T ++ +Q   +C+   R L YLH    +
Sbjct: 84  MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHN---Q 137

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
           G+IHRDIKS +ILL  +   K++DFG         E      + G+  ++ PE   R   
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGF--CAQVSKEVPKRKSLVGTPYWMAPEVISRLPY 195

Query: 642 TDKSDVYSFGVVLFEVL 658
             + D++S G+++ E++
Sbjct: 196 GTEVDIWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 69.5 bits (170), Expect = 3e-12
 Identities = 45/142 (31%), Positives = 76/142 (53%), Gaps = 6/142 (4%)

Query: 527 EEQSEMI-LVYEYMEKGPLKKHLYGPDRTPLSWKQRLE--ICIGAARGLHYLHTGSAEGI 583
            E   MI LV +Y   G L++ +    +T  ++++     + I     +H++H+   + +
Sbjct: 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHM 164

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           IHRDIKS NILL  N + K+ DFG S+         V     G+  Y+ PE +RR+  + 
Sbjct: 165 IHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSK 224

Query: 644 KSDVYSFGVVLFEVLCARTAVD 665
           K+D++S GV+L+E+L  +   D
Sbjct: 225 KADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 36/216 (16%)

Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRH 516
            +   + +++G G +G+VY    L    ++A+K  +P   SR   P    EI + S ++H
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKE-IPERDSRYVQP-LHEEIALHSYLKH 64

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL---YGP-----DRTPLSWKQRLEICIGA 568
           R++V  +G   E     +  E +  G L   L   +GP            KQ LE     
Sbjct: 65  RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE----- 119

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDE-NYVSKVADFG----LSRSGPCLDETHVSTG 623
             GL YLH      I+HRDIK  N+L++  + V K++DFG    L+   PC  ET     
Sbjct: 120 --GLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-TET----- 168

Query: 624 VKGSFGYLDPEYFRRQQ--LTDKSDVYSFGVVLFEV 657
             G+  Y+ PE   +        +D++S G  + E+
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEM 204

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 12/195 (6%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV-PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG VYK   ++   +A  + +   S + L ++  EI +L+   H ++V L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            ++ + ++ E+   G +   +   +R PL+  Q   +C      L+YLH      IIHRD
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELER-PLTEPQIRVVCKQTLEALNYLHENK---IIHRD 128

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD---- 643
           +K+ NIL   +   K+ADFG+S       +   S    G+  ++ PE    +   D    
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYD 186

Query: 644 -KSDVYSFGVVLFEV 657
            K+DV+S G+ L E+
Sbjct: 187 YKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 51/158 (32%), Positives = 83/158 (52%), Gaps = 30/158 (18%)

Query: 469 IGSGGFGMVYKGVLRD---NTKVAVKR--------GVPGSRQGLPEFQTEITVLSKIRHR 517
           IG G +G+VYK   RD   N  +A+K+        GVP +         EI++L +++H 
Sbjct: 10  IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAI------REISLLKEMQHG 61

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRL--EICIGAARGLHY 574
           ++V L      +  + LV+EY++   LKKH+   D +P  +   RL         RG+ Y
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDLD-LKKHM---DSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVS-KVADFGLSRS 611
            H+     ++HRD+K  N+L+D    + K+ADFGL+R+
Sbjct: 118 CHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152

Length = 294

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 21/165 (12%)

Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQT----EITVLSKIRHRHLVSLV 523
           IG G +G+V+K   R+  + VA+K+ V       P  +     EI +L +++H +LV+L+
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDD--PVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 524 GYCEEQSEMILVYEYMEK---GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
                + ++ LV+EY +      L+K+  G            +I     + +++ H    
Sbjct: 67  EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPE-----HLIKKIIWQTLQAVNFCH---K 118

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDET-HVST 622
              IHRD+K  NIL+ +    K+ DFG +R  +GP  D T +V+T
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT 163

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 16/201 (7%)

Query: 469 IGSGGFGMVYKGVLRDNT-------KVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G GGFG V   V   NT       K+  KR    S + +   + EI  L K+    +V+
Sbjct: 1   LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVN 57

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L    E ++ + LV   M  G LK H+Y      L  ++ +        G+ +LH+    
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---M 114

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            I++RD+K  N+LLD+    +++D GL+     L +    T   G+ GY+ PE  + +  
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVE---LKDGKTITQRAGTNGYMAPEILKEEPY 171

Query: 642 TDKSDVYSFGVVLFEVLCART 662
           +   D ++ G  ++E++  RT
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRT 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 16/205 (7%)

Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSL 522
           +IG G +  V    L+   ++     +K+ +    + +   QTE  V      H  LV L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ--RLEICIGAARGLHYLHTGSA 580
               + +S +  V E++  G L  H+    + P    +    EI +     L++LH    
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHER-- 115

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
            GII+RD+K  N+LLD     K+ D+G+ + G  +     ++   G+  Y+ PE  R + 
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYIAPEILRGED 172

Query: 641 LTDKSDVYSFGVVLFEVLCARTAVD 665
                D ++ GV++FE++  R+  D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 67.9 bits (166), Expect = 5e-12
 Identities = 65/270 (24%), Positives = 108/270 (40%), Gaps = 59/270 (21%)

Query: 408 PKPRPADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNL 467
           P P P  S           SS S  S  + +A              ++L       ++  
Sbjct: 44  PLPLPPPSSS---------SSSSSSSSASGSAPSAA-------KSLSEL-------ERVN 80

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
            IGSG  G VYK + R   ++   + + G+ +     Q   EI +L  + H ++V     
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
            +   E+ ++ E+M+ G L+      ++         ++      G+ YLH      I+H
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQ------FLADVARQILSGIAYLHR---RHIVH 191

Query: 586 RDIKSTNILLDENYVSKVADFGLSR-----SGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           RDIK +N+L++     K+ADFG+SR       PC      ++ V G+  Y+ PE      
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC------NSSV-GTIAYMSPERIN--- 241

Query: 641 LTD---------KSDVYSFGVVLFEVLCAR 661
            TD           D++S GV + E    R
Sbjct: 242 -TDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 67.0 bits (164), Expect = 7e-12
 Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 17/199 (8%)

Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVL---SKIRHRHLV 520
           ++G G FG V     +   ++    A+K+G   +R  +     E  +    +  RH  LV
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
           +L    + +  +  V EY   G L  H++  D            C+    GL YLH    
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACV--VLGLQYLHE--- 119

Query: 581 EGIIHRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             I++RD+K  N+LLD E +V K+ADFGL + G    +   ST   G+  +L PE     
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFV-KIADFGLCKEGMGFGDR-TST-FCGTPEFLAPEVLTET 176

Query: 640 QLTDKSDVYSFGVVLFEVL 658
             T   D +  GV+++E+L
Sbjct: 177 SYTRAVDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 66.2 bits (161), Expect = 8e-12
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 29/211 (13%)

Query: 462 NFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGV------PGSRQGLPEFQTEITVLSKI 514
           NF     IG G F  VY+   L D   VA+K+          +R    +   EI +L ++
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59

Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPL--------KKHLYGPDRTPLSWKQRLEICI 566
            H +++       E +E+ +V E  + G L        K+    P++T   WK  +++C 
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKT--VWKYFVQLC- 116

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
                L ++H+     ++HRDIK  N+ +    V K+ D GL R      +T  +  + G
Sbjct: 117 ---SALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVG 168

Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
           +  Y+ PE         KSD++S G +L+E+
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 56/162 (34%), Positives = 82/162 (50%), Gaps = 16/162 (9%)

Query: 455 DLQTATNNFDKNLI--IGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGLPEFQTEIT 509
           D+       D  LI  +GSG +G VYK   L      AVK  +  PG    L   Q EI 
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIF 58

Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKK--HLYGPDRTPLSWKQRLEICIG 567
           ++ + +H ++V+  G    + ++ +  EY   G L+   H+ GP    LS  Q   +C  
Sbjct: 59  MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP----LSELQIAYVCRE 114

Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS 609
             +GL YLH+   +G +HRDIK  NILL +N   K+ADFG++
Sbjct: 115 TLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 25/223 (11%)

Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITV 510
           I  + L+     F+   ++G+G +G VYKG      ++A  + +  +     E + EI +
Sbjct: 6   IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65

Query: 511 LSKI-RHRHLVSLVGYCEEQS------EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE 563
           L K   HR++ +  G   ++S      ++ LV E+   G +   +       L       
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125

Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
           IC    RGL +LH   A  +IHRDIK  N+LL EN   K+ DFG+S     LD T    G
Sbjct: 126 ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ---LDRT---VG 176

Query: 624 VKGSF----GYLDPEYFRRQQLTD-----KSDVYSFGVVLFEV 657
            + +F     ++ PE     +  D     +SD++S G+   E+
Sbjct: 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 37/90 (41%), Positives = 53/90 (58%), Gaps = 5/90 (5%)

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           A  L +LH+    GII+RD+K  NILLDE    K+ DFGLS+    +D    +    G+ 
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTV 162

Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            Y+ PE   R+  T  +D +SFGV++FE+L
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 32/220 (14%)

Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKR-GVPGSRQGLP-EFQTEITVLSKIR---HRHLVSL 522
           IG G +G VYK     +   VA+K   V  +  GLP     E+ +L ++    H ++V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 523 VGYC-----EEQSEMILVYEYMEKGPLKKHLYGPDRTP---LSWKQRLEICIGAARGLHY 574
           +  C     + ++++ LV+E++++  L+ +L   D+ P   L  +   ++     RGL +
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQD-LRTYL---DKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS-TGVKGSFGYLDP 633
           LH      I+HRD+K  NIL+      K+ADFGL+R   C     ++ T V  +  Y  P
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC----QMALTPVVVTLWYRAP 176

Query: 634 EYFRRQQLTDKSDVYSFGVVLFE------VLCARTAVDPL 667
           E   +       D++S G +  E      + C  +  D L
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 47/210 (22%)

Query: 469 IGSGGFGMVYKGVLRD---NTKVAVKRGV-PGSRQGLPEFQT--EITVLSKIRHRHLVSL 522
           +G G FG+V     RD      VA+K+ + P S   L + +T  E+ +L  +RH +++SL
Sbjct: 18  VGMGAFGLVCSA--RDQLTGQNVAIKKIMKPFSTPVLAK-RTYRELKLLKHLRHENIISL 74

Query: 523 VGYCEEQSEMI-LVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYL 575
                   E I  V E          L G D   L   + LE            RGL Y+
Sbjct: 75  SDIFISPLEDIYFVTE----------LLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYV 124

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+    G++HRD+K +NIL++EN   K+ DFGL+R    + +  ++       GY+   Y
Sbjct: 125 HSA---GVVHRDLKPSNILINENCDLKICDFGLAR----IQDPQMT-------GYVSTRY 170

Query: 636 FRR-------QQLTDKSDVYSFGVVLFEVL 658
           +R        Q+   + D++S G +  E+L
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 49/168 (29%), Positives = 71/168 (42%), Gaps = 31/168 (18%)

Query: 506 TEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQ 560
           TE  VL   RH  L +L    +    +  V EY   G L  HL     +  DR       
Sbjct: 44  TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---- 99

Query: 561 RLEICIGA--ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET 618
                 GA     L YLH+     +++RD+K  N++LD++   K+ DFGL + G      
Sbjct: 100 -----YGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEG------ 145

Query: 619 HVSTGVKGSFGYLDPEYFRRQQLTDKS-----DVYSFGVVLFEVLCAR 661
            +S G         PEY   + L D       D +  GVV++E++C R
Sbjct: 146 -ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 49/179 (27%), Positives = 85/179 (47%), Gaps = 33/179 (18%)

Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSR-QGLP-EFQTE 507
            PF D     + ++K   IG G FG V+K   +   + VA+K+ +  +  +G P     E
Sbjct: 5   FPFCD---EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE 61

Query: 508 ITVLSKIRHRHLVSLVGYCEEQSEM--------ILVYEYME-------KGPLKKHLYGPD 552
           I +L  ++H ++V+L+  C  ++           LV+E+ E            K      
Sbjct: 62  IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEI 121

Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           +  +  K  L        GL+Y+H      I+HRD+K+ NIL+ ++ + K+ADFGL+R+
Sbjct: 122 KKVM--KMLLN-------GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARA 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.3 bits (167), Expect = 1e-11
 Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 16/171 (9%)

Query: 504 FQTEITVLSKIRHRHLVSLV--GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQR 561
           F+ E  + +++ H ++V+L+  G       +  V+EY+    L++ L      P     R
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGRTLREVLAADGALPAGETGR 83

Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDET 618
           L       + L  L     +GI+HRD+K  NI++        +KV DFG+    P + + 
Sbjct: 84  L-----MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138

Query: 619 HV-----STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAV 664
            V     +T V G+  Y  PE  R + +T  SD+Y++G++  E L  +  V
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 9/198 (4%)

Query: 462 NFDKNLIIGSGGFGMVYKG-VLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
             D  + IG G  G+V          +VAVK+     +Q       E+ ++   +H ++V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            +        E+ +V E++E G L   +     T ++ +Q   +C+   + L +LH   A
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLH---A 133

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           +G+IHRDIKS +ILL  +   K++DFG         E      + G+  ++ PE   R  
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGF--CAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191

Query: 641 LTDKSDVYSFGVVLFEVL 658
              + D++S G+++ E++
Sbjct: 192 YGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 9/200 (4%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGV---PGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           ++G G +G V     R + K  V + +     SR+     + E  +LS+++H ++V+   
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 525 YCE-EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
             E E   + +V  + E G L   L       L   Q +E  +  A  L YLH    + I
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHI 123

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           +HRD+K+ N+ L    + KV D G++R     ++  +++ + G+  Y+ PE F  +    
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 644 KSDVYSFGVVLFEVLCARTA 663
           KSDV++ G  ++E+   + A
Sbjct: 182 KSDVWALGCCVYEMATLKHA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 20/204 (9%)

Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLS-KIRHRHLVSL 522
           ++G G FG V+   L+   +     A+K+ V      +     E  VLS    H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 523 VGYCEEQSE--MILVYEYMEKGPLKKHLYGPDR--TPLSWKQRLEICIGAARGLHYLHTG 578
             YC  Q++  +  V EY+  G L  H+    +   P +     EI  G    L +LH+ 
Sbjct: 62  --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHS- 114

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
             +GI++RD+K  NILLD +   K+ADFG+ +    L +    T   G+  Y+ PE    
Sbjct: 115 --KGIVYRDLKLDNILLDTDGHIKIADFGMCKEN-MLGDAKTCT-FCGTPDYIAPEILLG 170

Query: 639 QQLTDKSDVYSFGVVLFEVLCART 662
           Q+     D +SFGV+L+E+L  ++
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 20/197 (10%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQ---TEITVLSKIRHRHLVSLVG 524
           IG G FG VY    +R++  VA+K+     +Q   ++Q    E+  L K+RH + +   G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
               +    LV EY         L    + PL   +   +  GA +GL YLH+     +I
Sbjct: 83  CYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMI 137

Query: 585 HRDIKSTNILLDENYVSKVADFG-LSRSGPCLDETHVSTGVKGSFGYLDPEY---FRRQQ 640
           HRD+K+ NILL E  + K+ DFG  S   P       +    G+  ++ PE        Q
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILAMDEGQ 190

Query: 641 LTDKSDVYSFGVVLFEV 657
              K DV+S G+   E+
Sbjct: 191 YDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 43/128 (33%), Positives = 55/128 (42%), Gaps = 17/128 (13%)

Query: 534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR---GLHYLHTGSAEGIIHRDIKS 590
           LV EY+  G     +      P  W          A    G+  LH     GIIHRDIK 
Sbjct: 74  LVMEYLNGGDCASLIKTLGGLPEDW-----AKQYIAEVVLGVEDLH---QRGIIHRDIKP 125

Query: 591 TNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSF 650
            N+L+D+    K+ DFGLSR+G        +    G+  YL PE          SD +S 
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWSL 179

Query: 651 GVVLFEVL 658
           G V+FE L
Sbjct: 180 GCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 59/206 (28%), Positives = 86/206 (41%), Gaps = 36/206 (17%)

Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQ---TEITVLSKIRHRHLVSLVG 524
           +G GG+G V+    +D  + VA+KR        L E +   TE  +L+  +   LV L+ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE-----------ICIGAARGLH 573
             ++   + L  EY+  G          RT L+    L                A   LH
Sbjct: 69  AFQDDEYLYLAMEYVPGGDF--------RTLLNNLGVLSEDHARFYMAEMFE--AVDALH 118

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
            L      G IHRD+K  N L+D +   K+ DFGLS+       + V     GS  Y+ P
Sbjct: 119 EL------GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAP 167

Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLC 659
           E  R +      D +S G +L+E LC
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 16/199 (8%)

Query: 463 FDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQ-TEITVLSKIRHRHLV 520
           F+K   IG G  G VY  + +    +VA+K+ +   +Q   E    EI V+ + +H ++V
Sbjct: 24  FEK---IGQGASGTVYTAIDVATGQEVAIKQ-MNLQQQPKKELIINEILVMRENKHPNIV 79

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
           + +       E+ +V EY+  G L   +     T +   Q   +C    + L +LH   +
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH---S 133

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGL-SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             +IHRDIKS NILL  +   K+ DFG  ++  P  +++  ST V G+  ++ PE   R+
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRK 190

Query: 640 QLTDKSDVYSFGVVLFEVL 658
               K D++S G++  E++
Sbjct: 191 AYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 67/232 (28%), Positives = 102/232 (43%), Gaps = 26/232 (11%)

Query: 468 IIGSGGFGMVYKGVL-RDNTKVAVK---RGVPGSRQGLPEFQTEITVLSK-IRHRHLVSL 522
           +IG G FG V       D    AVK   + +  +R+       E  VL K ++H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
               +   ++  V +++  G L  HL   +R+    + R       A  L YLH+ +   
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAA-EIASALGYLHSIN--- 116

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           I++RD+K  NILLD      + DFGL + G    +T  +T   G+  YL PE  R+Q   
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPYD 174

Query: 643 DKSDVYSFGVVLFEVL-------CARTAV-------DPLLAREQVNLAEWAM 680
           +  D +  G VL+E+L       C   A         PL+ R   +L  W++
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSI 226

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 53/180 (29%), Positives = 85/180 (47%), Gaps = 31/180 (17%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKR--------GVPGSRQGLPEFQTEITVL 511
           + ++K   IG G +G VYK   ++  K VA+K+        G+P      P    EI++L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP------PTALREISLL 54

Query: 512 SKIRHR-HLVSL--VGYCEE---QSEMILVYEYMEKGPLKKHL---YGPDRTPLSWKQRL 562
             +    ++V L  V + EE   +  + LV+EY++   LKK +         PL  K   
Sbjct: 55  QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIK 113

Query: 563 EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSR--SGPCLDETH 619
                  +G+ + H     G++HRD+K  N+L+D +  + K+AD GL R  S P    TH
Sbjct: 114 SFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 28/163 (17%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTK---VAVKR-GVPGSRQGLPEFQT---EITVLSKI 514
            ++K   I  G +G+VY+   RD      VA+K+  +   ++G P   T   EI +L K+
Sbjct: 6   EYEKLNRIEEGTYGVVYRA--RDKKTGEIVALKKLKMEKEKEGFP--ITSLREINILLKL 61

Query: 515 RHRHLVSL----VGYCEEQSEMILVYEYME---KGPLKKHLYGPDRTPLSWKQRLEICIG 567
           +H ++V++    VG      ++ +V EY+E   K  ++       + P    +   + + 
Sbjct: 62  QHPNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETM-----KQPFLQSEVKCLMLQ 114

Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR 610
              G+ +LH      I+HRD+K++N+LL+   + K+ DFGL+R
Sbjct: 115 LLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 63.8 bits (156), Expect = 5e-11
 Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 28/205 (13%)

Query: 469 IGSGGFGMVYK-GVLRDNTKVAVKRGVPGS---RQGLPE-FQTEITVLSKIRHRHLVSLV 523
           +G GGFG V    V   N   A+K  V        G  E   +E  +L +  H  +V L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKC-VKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLS-WKQRLEI-CIGAARGLHYLHTGSAE 581
              +++  + ++ EY   G L   L   DR     +  R  I C+  A    YLH     
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILR--DRGLFDEYTARFYIACVVLA--FEYLH---NR 112

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK-----GSFGYLDPEYF 636
           GII+RD+K  N+LLD N   K+ DFG ++         + +G K     G+  Y+ PE  
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKK--------LKSGQKTWTFCGTPEYVAPEII 164

Query: 637 RRQQLTDKSDVYSFGVVLFEVLCAR 661
             +      D +S G++L+E+L  R
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 19/204 (9%)

Query: 469 IGSGGFGMVYKGVLRD--------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G F  ++KG+ R+         T+V +K      R     F    +++S++ H+HLV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHL-YGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
              G C    E I+V EY++ G L  +L    +   +SWK  LE+    A  LH+L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLED-- 118

Query: 580 AEGIIHRDIKSTNILL--DENYVSKVADFGLSRSGPCLDETHVSTGV-KGSFGYLDPEYF 636
            +G+ H ++ + N+LL  +E+  +    F +  S P +  T +   +      ++ PE  
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPF-IKLSDPGISITVLPKEILLERIPWVPPECI 176

Query: 637 RR-QQLTDKSDVYSFGVVLFEVLC 659
              Q L+  +D +SFG  L+E+  
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 62/197 (31%), Positives = 90/197 (45%), Gaps = 20/197 (10%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQ---TEITVLSKIRHRHLVSLVG 524
           IG G FG VY    +R N  VA+K+     +Q   ++Q    E+  L +I+H + +   G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
               +    LV EY         L    + PL   +   I  GA +GL YLH+ +   +I
Sbjct: 93  CYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 147

Query: 585 HRDIKSTNILLDENYVSKVADFG-LSRSGPCLDETHVSTGVKGSFGYLDPEY---FRRQQ 640
           HRDIK+ NILL E    K+ADFG  S + P       +    G+  ++ PE        Q
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQ 200

Query: 641 LTDKSDVYSFGVVLFEV 657
              K DV+S G+   E+
Sbjct: 201 YDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)

Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           ++G G FG V    L+++ ++     +K+ V      +    TE  +LS  R+   ++ +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 524 GYCEEQSE-MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
             C +  + +  V E++  G L  H+    R   +  +     I +A  L +LH    +G
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--LMFLHD---KG 116

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           II+RD+K  N+LLD     K+ADFG+ + G        ++   G+  Y+ PE  +     
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 643 DKSDVYSFGVVLFEVLC 659
              D ++ GV+L+E+LC
Sbjct: 175 PSVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 63.6 bits (154), Expect = 6e-11
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 25/206 (12%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYC 526
           ++G+G +G VYKG      ++A  + +  +     E + EI +L K   HR++ +  G  
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 527 EEQS------EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            +++      ++ LV E+   G +   +       L  +    IC    RGL +LH    
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--- 129

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF----GYLDPEYF 636
             +IHRDIK  N+LL EN   K+ DFG+S     LD T    G + +F     ++ PE  
Sbjct: 130 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ---LDRT---VGRRNTFIGTPYWMAPEVI 183

Query: 637 RRQQLTD-----KSDVYSFGVVLFEV 657
              +  D     KSD++S G+   E+
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 19/209 (9%)

Query: 462 NFDKNLIIGSGGFGMVY--KGVLRDNT------KVAVKRGVPGSRQGLPEFQTEITVLSK 513
           NF+   ++G+G +G V+  + V   ++      KV  K  +    +     +TE  VL  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 514 IRHR-HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-ARG 571
           IR    LV+L    +  +++ L+ +Y+  G L  HL   +R     +Q ++I  G     
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLA 117

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L +LH     GII+RDIK  NILLD N    + DFGLS+     DE   +    G+  Y+
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCGTIEYM 173

Query: 632 DPEYFRRQQLT-DKS-DVYSFGVVLFEVL 658
            P+  R      DK+ D +S GV+++E+L
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 78/273 (28%), Positives = 111/273 (40%), Gaps = 41/273 (15%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQ---TEITVLSKIRHRHLVSLVG 524
           IG G FG VY       N  VAVK+     +Q   ++Q    E+  L +++H + +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
              ++    LV EY         L    + PL   +   I  GA +GL YLH+     +I
Sbjct: 89  CYLKEHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMI 143

Query: 585 HRDIKSTNILLDENYVSKVADFG-LSRSGPCLDETHVSTGVKGSFGYLDPEY---FRRQQ 640
           HRDIK+ NILL E    K+ADFG  S+S P       +    G+  ++ PE        Q
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQ 196

Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII---DPQLI 697
              K DV+S G+   E           LA  +  L            L HI     P L 
Sbjct: 197 YDGKVDVWSLGITCIE-----------LAERKPPL----FNMNAMSALYHIAQNDSPTLQ 241

Query: 698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
                DS + F    + CL     +RP+  ++L
Sbjct: 242 SNEWTDSFRGF---VDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 12/197 (6%)

Query: 469 IGSGGFGMVYKG--VLRDNTKVAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLVSLVGY 525
           +G G +  VYKG   L DN  VA+K       +G P     E+++L  ++H ++V+L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
              +  + LV+EY++K  LK++L     +      +L       RGL+Y H      ++H
Sbjct: 73  IHTEKSLTLVFEYLDKD-LKQYLDDCGNSINMHNVKL-FLFQLLRGLNYCHR---RKVLH 127

Query: 586 RDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE-YFRRQQLTDK 644
           RD+K  N+L++E    K+ADFGL+R+     +T+ +  V  +  Y  P+        + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQ 185

Query: 645 SDVYSFGVVLFEVLCAR 661
            D++  G + +E+   R
Sbjct: 186 IDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 38/107 (35%), Positives = 61/107 (57%), Gaps = 5/107 (4%)

Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
           ++PL+ +  +      ARG+ +L   ++   IHRD+ + NILL EN V K+ DFGL+R  
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD- 223

Query: 613 PCLDETHVSTG-VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
              D  +V  G  +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 224 IYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 50/158 (31%), Positives = 73/158 (46%), Gaps = 11/158 (6%)

Query: 506 TEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEIC 565
           TE  VL   RH  L +L    +    +  V EY   G L  HL    R  +  ++R    
Sbjct: 44  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARF- 99

Query: 566 IGA--ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
            GA     L YLH+     +++RDIK  N++LD++   K+ DFGL + G   D   + T 
Sbjct: 100 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT- 154

Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
             G+  YL PE           D +  GVV++E++C R
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 68/258 (26%), Positives = 107/258 (41%), Gaps = 73/258 (28%)

Query: 469 IGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQG-LPEFQTEITVLSKI-RHRHLV 520
           +G G FG V +    G+ +  +   VAVK    G+         TE+ +L  I  H ++V
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 521 SLVGYC-EEQSEMILVYEYMEKGPL------KKHLYGPDRT----------PLSWKQRLE 563
           +L+G C +    ++++ EY + G L      K+  + P R               KQRL+
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134

Query: 564 -----------------------------------------IC--IGAARGLHYLHTGSA 580
                                                    I      ARG+ +L   ++
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGSFGYLDPEYFRRQ 639
              IHRD+ + NILL EN V K+ DFGL+R     D  +V  G  +    ++ PE    +
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPESIFDK 250

Query: 640 QLTDKSDVYSFGVVLFEV 657
             T +SDV+SFGV+L+E+
Sbjct: 251 VYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 12/196 (6%)

Query: 468 IIGSGGFGMVYKGVLRDNTKV-AVK---RGVPGSRQGLPEFQTEITVLSK-IRHRHLVSL 522
           +IG G FG V     + + K  AVK   +     ++       E  VL K ++H  LV L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
               +   ++  V +Y+  G L  HL      P    +     I +A G  YLH+     
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS---LN 116

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           II+RD+K  NILLD      + DFGL + G  ++ +  ++   G+  YL PE  R+Q   
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEG--IEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 643 DKSDVYSFGVVLFEVL 658
              D +  G VL+E+L
Sbjct: 175 RTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 14/200 (7%)

Query: 468 IIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           ++G G FG V     K   R      +K+ V  ++  +    TE  VL   RH  L +L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARGLHYLHTGSAE 581
              +    +  V EY   G L  HL   +R     + R     GA     L YLH  S +
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARF---YGAEIVSALDYLH--SEK 115

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            +++RD+K  N++LD++   K+ DFGL + G  + +        G+  YL PE       
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPEVLEDNDY 173

Query: 642 TDKSDVYSFGVVLFEVLCAR 661
               D +  GVV++E++C R
Sbjct: 174 GRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 74/230 (32%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT---------EITVLSKIRHR 517
            IGSG +G+V   +  R   KVA+K+ +P +      F           E+ +L   +H 
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKK-IPHA------FDVPTLAKRTLRELKILRHFKHD 64

Query: 518 HLVSLVG-YCEEQSEMILVY---EYME---------KGPLKKH-----LYGPDRTPLSWK 559
           +++++        ++   VY   + ME           PL +      LY          
Sbjct: 65  NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY---------- 114

Query: 560 QRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET- 618
           Q L       RGL Y+H   +  +IHRD+K +N+L++E+   ++ DFG++R    L  + 
Sbjct: 115 QLL-------RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR---GLSSSP 161

Query: 619 ---------HVSTGVKGSFGYLDPE-YFRRQQLTDKSDVYSFGVVLFEVL 658
                    +V+T       Y  PE      + T   D++S G +  E+L
Sbjct: 162 TEHKYFMTEYVAT-----RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 12/196 (6%)

Query: 468 IIGSGGFGMVYKGVLR-DNTKVAVK---RGVPGSRQGLPEFQTEITVLSK-IRHRHLVSL 522
           +IG G FG V     + D +  AVK   +     ++       E  VL K ++H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
               +   ++  V +Y+  G L  HL   +R  L  + R       A  + YLH+     
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLEPRARF-YAAEVASAIGYLHS---LN 116

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           II+RD+K  NILLD      + DFGL + G  ++    ++   G+  YL PE  R++   
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEG--VEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 643 DKSDVYSFGVVLFEVL 658
              D +  G VL+E+L
Sbjct: 175 RTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 6/105 (5%)

Query: 554 TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP 613
            PL   Q L I      GL YLH   A+ IIHRD+K+ NI +++     + D G ++  P
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-P 207

Query: 614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            +    +  G+ G+     PE   R +   K+D++S G+VLFE+L
Sbjct: 208 VVAPAFL--GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.5 bits (152), Expect = 4e-10
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 28/208 (13%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRHRHLVSLV- 523
           IG G FG+V+     RD  +VA+K+ +P   Q L   +    E+ +L   +H +++S + 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKK-MPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66

Query: 524 ----GYCEEQSEMILVYEYMEKGPLKKHLYGP-----DRTPLSWKQRLEICIGAARGLHY 574
                + +   E+ +V E M+   L K +  P     D   +   Q L       RGL Y
Sbjct: 67  ILQPPHIDPFEEIYVVTELMQSD-LHKIIVSPQPLSSDHVKVFLYQIL-------RGLKY 118

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           LH+    GI+HRDIK  N+L++ N V K+ DFGL+R     +  H++  V   + Y  PE
Sbjct: 119 LHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPE 174

Query: 635 YFR-RQQLTDKSDVYSFGVVLFEVLCAR 661
                +  T   D++S G +  E+L  R
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 14/198 (7%)

Query: 469 IGSGGFGMVYKG--VLRDNTKVAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLVSLVGY 525
           +G G +  V+KG   L +N  VA+K       +G P     E+++L  ++H ++V+L   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI-GAARGLHYLHTGSAEGII 584
                 + LV+EY++K  LK+  Y  D   +     ++I +    RGL Y H      ++
Sbjct: 73  VHTDKSLTLVFEYLDKD-LKQ--YMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVL 126

Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR-RQQLTD 643
           HRD+K  N+L++E    K+ADFGL+R+     +T+ +  V  +  Y  P+      + + 
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184

Query: 644 KSDVYSFGVVLFEVLCAR 661
           + D++  G + FE+   R
Sbjct: 185 QIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 44/143 (30%), Positives = 75/143 (52%), Gaps = 15/143 (10%)

Query: 525 YCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPL---SWKQRLEICIGAARGLHYLHTGS 579
           YC  Q++  +  V E++  G L  H+    R  L   ++     +C     GL +LH+  
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-----GLQFLHS-- 114

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
            +GII+RD+K  N++LD +   K+ADFG+ +      +   ST   G+  Y+ PE  +  
Sbjct: 115 -KGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN-VFGDNRAST-FCGTPDYIAPEILQGL 171

Query: 640 QLTDKSDVYSFGVVLFEVLCART 662
           + T   D +SFGV+L+E+L  ++
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 28/213 (13%)

Query: 469 IGSGGFGMVYKGVL------RDNTKVAVKRGVPGSRQGL-PEFQTEITVLSKIRHRHLVS 521
           +G   FG VYKG L           VA+K     +   L  EF+ E  + S+++H ++V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLS----------WKQRLE------IC 565
           L+G   ++  + +++ Y     L + L    R+P S           K  LE      I 
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVM--RSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK 625
              A G+ +L   S+  ++H+D+ + N+L+ +    K++D GL R     D   +     
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187

Query: 626 GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
               ++ PE     + +  SD++S+GVVL+EV 
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 25/232 (10%)

Query: 444 NGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG----SRQ 499
           N Y ++      LQ    ++D   +IG G FG V     + + KV   + +       R 
Sbjct: 26  NRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRS 85

Query: 500 GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWK 559
               F  E  +++      +V L    ++   + +V EYM  G L   +   D  P  W 
Sbjct: 86  DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWA 144

Query: 560 Q--RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE 617
           +    E+ + A   +H +      G+IHRD+K  N+LLD++   K+ADFG       +DE
Sbjct: 145 KFYTAEVVL-ALDAIHSM------GLIHRDVKPDNMLLDKHGHLKLADFGTCMK---MDE 194

Query: 618 T---HVSTGVKGSFGYLDPEYFRRQ----QLTDKSDVYSFGVVLFEVLCART 662
           T      T V G+  Y+ PE  + Q        + D +S GV LFE+L   T
Sbjct: 195 TGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 6e-10
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)

Query: 463 FDKNLIIGSGGFGMVYKGV-LRDNTKVAVK-RGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           + +  +IG G +G VY+G  +     VA+K   +      + + Q E+ +LS++R     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 521 SLVGY--CEEQ-SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA-----RGL 572
           ++  Y     +   + ++ EY E G +        RT +      E  I          L
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSV--------RTLMKAGPIAEKYISVIIREVLVAL 114

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--STGVKGSFGY 630
            Y+H     G+IHRDIK+ NIL+      K+ DFG++     L++     ST V G+  +
Sbjct: 115 KYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAAL---LNQNSSKRSTFV-GTPYW 167

Query: 631 LDPEYFRRQQLTD-KSDVYSFGVVLFEV 657
           + PE     +  D K+D++S G+ ++E+
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEM 195

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.4 bits (146), Expect = 9e-10
 Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 24/211 (11%)

Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDN---TKVAVKRGVPGSRQGLPEFQTEITVL 511
           D ++   N+ K   IG G  G+V   + R+     +VAVK      +Q       E+ ++
Sbjct: 18  DPRSLLENYIK---IGEGSTGIVC--IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM 72

Query: 512 SKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARG 571
              +H+++V +        E+ ++ E+++ G L   +    +T L+ +Q   +C    + 
Sbjct: 73  RDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQA 129

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG----LSRSGPCLDETHVSTGVKGS 627
           L YLH   ++G+IHRDIKS +ILL  +   K++DFG    +S+  P          + G+
Sbjct: 130 LCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP------KRKSLVGT 180

Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE   R     + D++S G+++ E++
Sbjct: 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.5 bits (146), Expect = 9e-10
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 25/162 (15%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQT--EITVLSKIRHR 517
           ++++K   +G G +  VYKG  + N K VA+K       +G P F    E ++L  ++H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP-FTAIREASLLKGLKHA 63

Query: 518 HLVSLVGYCEEQSEMILVYEY--------MEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
           ++V L      +  + LV+EY        M+K P   H   P+   L   Q L       
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLH---PENVKLFLFQLL------- 113

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           RGL Y+H      I+HRD+K  N+L+ +    K+ADFGL+R+
Sbjct: 114 RGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARA 152

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 28/213 (13%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNT----------KVAVKRGVPGSRQGLPEFQTEITVL 511
           NF+   ++G+G +G V+  ++R  T          KV  K  +    + +   +TE  VL
Sbjct: 1   NFELLKVLGTGAYGKVF--LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58

Query: 512 SKIRHR-HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIG--- 567
             +R    LV+L    + ++++ L+ +Y+  G +  HLY  D      +  +    G   
Sbjct: 59  EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEII 115

Query: 568 -AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
            A   LH L      GI++RDIK  NILLD      + DFGLS+     +E   +    G
Sbjct: 116 LALEHLHKL------GIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCG 168

Query: 627 SFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVL 658
           +  Y+ PE  R +    K+ D +S G+++FE+L
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 17/200 (8%)

Query: 469 IGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           IG G FG VY+   +D  ++     + +    +++ +     E  +L +        +VG
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 525 Y---CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-ARGLHYLHTGSA 580
                +  S++ LV +YM  G L  HL    R     + R +  I      L +LH    
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLHKYD- 116

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
             I++RD+K  NILLD      + DFGLS+    L +   +    G+  YL PE    ++
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 641 -LTDKSDVYSFGVVLFEVLC 659
             T   D +S GV++FE+ C
Sbjct: 173 GYTKHVDFWSLGVLVFEMCC 192

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 41/154 (26%), Positives = 80/154 (51%), Gaps = 1/154 (0%)

Query: 505 QTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEI 564
           ++E+  L+   H  +V      +   +++L+ EY   G L K +    +  L +++  E+
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEY-EV 171

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
            +   + +  L    +  ++HRD+KS NI L    + K+ DFG S+         V++  
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            G+  YL PE + R++ + K+D++S GV+L+E+L
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265

Length = 478

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 18/199 (9%)

Query: 468 IIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +IG G FG V     +        KV  K+ +   ++          +L  ++H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL---EICIGAARGLHYLHTGS 579
               +   ++  V +Y+  G L  HL   +R  L  + R    EI    A  L YLH+ +
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEI----ASALGYLHSLN 116

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              I++RD+K  NILLD      + DFGL +    ++    ++   G+  YL PE   +Q
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCKEN--IEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 640 QLTDKSDVYSFGVVLFEVL 658
                 D +  G VL+E+L
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 59.0 bits (142), Expect = 2e-09
 Identities = 54/193 (27%), Positives = 98/193 (50%), Gaps = 13/193 (6%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQ-TEITVLSKIRHRHLVSLVGYC 526
           IG G  G V+  + +    +VA+K+ +   +Q   E    EI V+ ++++ ++V+ +   
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQ-INLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
               E+ +V EY+  G L   +     T +   Q   +C    + L +LH   A  +IHR
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLH---ANQVIHR 139

Query: 587 DIKSTNILLDENYVSKVADFGL-SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS 645
           DIKS N+LL  +   K+ DFG  ++  P  +++  ST V G+  ++ PE   R+    K 
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 646 DVYSFGVVLFEVL 658
           D++S G++  E++
Sbjct: 197 DIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 5/91 (5%)

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGS 627
           A+G+ +L   ++   IHRD+ + NILL EN V K+ DFGL+R     D  +V  G  +  
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGDARLP 244

Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.3 bits (146), Expect = 3e-09
 Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 13/148 (8%)

Query: 469 IGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           I  G FG VY G  ++N+K+     VK+    ++  + + Q E   L+  +   +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 525 YCEEQSEMILVYEYMEKGPLKK--HLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
             +  + + LV EY+  G +K   H+YG     ++ K   E     A  L YLH     G
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE----VALALDYLHR---HG 124

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSR 610
           IIHRD+K  N+L+      K+ DFGLS+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 11/133 (8%)

Query: 535 VYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTN 592
           V EY+  G L  H+   G  + P +     EI IG    L +LH+   +GII+RD+K  N
Sbjct: 79  VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFFLHS---KGIIYRDLKLDN 131

Query: 593 ILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGV 652
           ++LD     K+ADFG+ +      +T  +    G+  Y+ PE    Q      D ++FGV
Sbjct: 132 VMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189

Query: 653 VLFEVLCARTAVD 665
           +L+E+L  +   D
Sbjct: 190 LLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 35/208 (16%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV--GY 525
           IIG GGFG VY     D  K+   + +   R  + + +T       +  R ++SLV  G 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-----LALNERIMLSLVSTGD 55

Query: 526 C----------EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           C              ++  + + M  G L  HL        S K+          GL ++
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHM 113

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGL----SRSGPCLDETHVSTGVKGSFGYL 631
           H      +++RD+K  NILLDE+   +++D GL    S+  P     H S    G+ GY+
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GTHGYM 162

Query: 632 DPEYFRRQQLTDKS-DVYSFGVVLFEVL 658
            PE  ++    D S D +S G +LF++L
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 59.0 bits (143), Expect = 4e-09
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 49/237 (20%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV------- 520
           +G G  G+V+  V  D + +VAVK+ V    Q +     EI ++ ++ H ++V       
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 521 -------SLVGYCEEQSEMILVYEYM--------EKGPLKKHLYGPDRTPLSWKQRLEIC 565
                    VG   E + + +V EYM        E+GPL +     +   L   Q L   
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSE-----EHARLFMYQLL--- 124

Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSRSGPCLD-----ETH 619
               RGL Y+H+ +   ++HRD+K  N+ ++ E+ V K+ DFGL+R    +D     + +
Sbjct: 125 ----RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR---IVDPHYSHKGY 174

Query: 620 VSTGVKGSFGYLDPE-YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL 675
           +S G+   + Y  P         T   D+++ G +  E+L  +         EQ+ L
Sbjct: 175 LSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 21/152 (13%)

Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +G G +  VYKG  +   + VA+K       +G P F    E ++L  ++H ++V+L   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLHDI 71

Query: 526 CEEQSEMILVYEYMEKGPLKKHL--YG----PDRTPLSWKQRLEICIGAARGLHYLHTGS 579
              +  + LV+EY++   LK+++   G         L   Q L       RGL Y H   
Sbjct: 72  IHTKKTLTLVFEYLDTD-LKQYMDDCGGGLSMHNVRLFLFQLL-------RGLAYCHQ-- 121

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
              ++HRD+K  N+L+ E    K+ADFGL+R+
Sbjct: 122 -RRVLHRDLKPQNLLISERGELKLADFGLARA 152

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 35/91 (38%), Positives = 48/91 (52%), Gaps = 8/91 (8%)

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
           + L+YL       IIHRD+K +NILLD N   K+ DFG+S     L ++   T   G   
Sbjct: 118 KALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ---LVDSIAKTRDAGCRP 172

Query: 630 YLDPEY---FRRQQLTDKSDVYSFGVVLFEV 657
           Y+ PE      R     +SDV+S G+ L+EV
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 35/208 (16%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV--GY 525
           IIG GGFG VY     D  K+   + +   R  +   Q E   L++   R ++SLV  G 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNE---RIMLSLVSTGD 55

Query: 526 C----------EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           C              ++  + + M  G L  HL        S  +          GL ++
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEHM 113

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGL----SRSGPCLDETHVSTGVKGSFGYL 631
           H      +++RD+K  NILLDE+   +++D GL    S+  P     H S    G+ GY+
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GTHGYM 162

Query: 632 DPEYFRRQQLTDKS-DVYSFGVVLFEVL 658
            PE  ++    D S D +S G +LF++L
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 30/237 (12%)

Query: 469 IGSGGFGMVYKG---VLRDNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           IG+G FG V  G         +V VK      +      F  E+    ++ H +++  +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLY-------GPDRTPLSWKQRLEICIGAARGLHYLHT 577
            C E    +LV E+   G LK +L           +  +  +   E+  G    LH    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL-WLHQAD- 120

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--YLDPEY 635
                 IH D+   N  L  +   K+ D+GL+       E +  T    +    +L PE 
Sbjct: 121 -----FIHSDLALRNCQLTADLSVKIGDYGLALEQ--YPEDYYITKDCHAVPLRWLAPEL 173

Query: 636 F--RRQQL-----TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK 685
              R Q L     T KS+++S GV ++E+  A     P L+ EQV L +   +   K
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVREQDIK 229

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.0 bits (143), Expect = 4e-09
 Identities = 77/291 (26%), Positives = 115/291 (39%), Gaps = 33/291 (11%)

Query: 446 YHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKV-AVKRGVPGSRQGLPE- 503
           Y +     T L+    +FD   +IG G FG V     + + +V A+K           + 
Sbjct: 28  YEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS 87

Query: 504 --FQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ- 560
             F  E  +++      +V L    ++   + +V EYM  G L   +   D  P  W + 
Sbjct: 88  AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARF 146

Query: 561 -RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG----LSRSGPCL 615
              E+ + A   +H +      G IHRD+K  N+LLD++   K+ADFG    +  +G   
Sbjct: 147 YTAEVVL-ALDAIHSM------GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG--- 196

Query: 616 DETHVSTGVKGSFGYLDPEYFRRQ----QLTDKSDVYSFGVVLFEVLCARTAVDPLLARE 671
                 T V G+  Y+ PE  + Q        + D +S GV L+E+L   T   P  A  
Sbjct: 197 -MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT---PFYADS 251

Query: 672 QVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVD 722
            V      M    K  L    D   I K   D +  F    E  L   GVD
Sbjct: 252 LVGTYSKIM--DHKNSLTFPDDI-EISKQAKDLICAFLTDREVRLGRNGVD 299

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 58.2 bits (140), Expect = 4e-09
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 11/192 (5%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           IG G  G VY  + +    +VA+K+     +        EI V+ + ++ ++V+ +    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
              E+ +V EY+  G L   +     T +   Q   +C    + L +LH+     +IHRD
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRD 140

Query: 588 IKSTNILLDENYVSKVADFGL-SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
           IKS NILL  +   K+ DFG  ++  P  +++  ST V G+  ++ PE   R+    K D
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197

Query: 647 VYSFGVVLFEVL 658
           ++S G++  E++
Sbjct: 198 IWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 26/201 (12%)

Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +G G +  VYKG+ R N + VA+K     + +G+P F    E ++L  ++H ++V L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHDI 71

Query: 526 CEEQSEMILVYEYMEKGP---LKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
              +  +  V+EYM       + +H  G  P    L   Q L       RGL Y+H    
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYIH---G 121

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           + I+HRD+K  N+L+      K+ADFGL+R+     +T+ S  V  +  Y  P+      
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGA- 178

Query: 641 LTDKS---DVYSFGVVLFEVL 658
            TD S   D++  G +  E+L
Sbjct: 179 -TDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 69/232 (29%), Positives = 102/232 (43%), Gaps = 32/232 (13%)

Query: 446 YHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEF 504
           Y+   +    L   T+ ++    IG G +G VYK    +D +  AVK   P S     E 
Sbjct: 7   YNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEI 65

Query: 505 QTEITVLSKI-RHRHLVSLVG--YCEEQ---SEMILVYEYMEKGPLKKHLYGPDRTPLSW 558
           + E  +L  +  H ++V   G  Y  ++    ++ LV E    G + + + G     L  
Sbjct: 66  EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL----LIC 121

Query: 559 KQRLE------ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
            QRL+      I  GA  GL +LH      IIHRD+K  NILL      K+ DFG+S   
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQ- 177

Query: 613 PCLDETHV--STGVKGSFGYLDPEYFRRQQLTDKS-----DVYSFGVVLFEV 657
             L  T +  +T V   F ++ PE    +Q  D S     DV+S G+   E+
Sbjct: 178 --LTSTRLRRNTSVGTPF-WMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 58.0 bits (140), Expect = 7e-09
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 28/207 (13%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIRHRHLVSLVGY 525
           +GSG +G V   +  R   KVA+K+     +  L       E+ +L  ++H +++ L+  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 526 ------CEEQSEMILVYEYM--EKGPLKKH-LYGPDRTPLSWKQRLEICIGAARGLHYLH 576
                  +   +  LV  +M  + G L KH     DR      Q L       +GL Y+H
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML-------KGLKYIH 135

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY- 635
              A GIIHRD+K  N+ ++E+   K+ DFGL+R           TG   +  Y  PE  
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-----TDSEMTGYVVTRWYRAPEVI 187

Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCART 662
                 T   D++S G ++ E+L  + 
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKP 214

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.4 bits (139), Expect = 7e-09
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 9/99 (9%)

Query: 563 EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST 622
           +I +   + L YLH  S   +IHRD+K +N+L++ N   K+ DFG+  SG  +D     T
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGI--SGYLVDSV-AKT 161

Query: 623 GVKGSFGYLDPEYF---RRQQLTD-KSDVYSFGVVLFEV 657
              G   Y+ PE       Q+  D KSDV+S G+ + E+
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 57/212 (26%), Positives = 106/212 (50%), Gaps = 14/212 (6%)

Query: 469 IGSGGFGMVYKG--VLRDNTKVAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLVSLVGY 525
           +G G +  V+KG   L +N  VA+K       +G P     E+++L  ++H ++V+L   
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI-GAARGLHYLHTGSAEGII 584
              +  + LV+EY++   LK++L   +   L     ++I +    RGL Y H      I+
Sbjct: 72  IHTERCLTLVFEYLDSD-LKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKIL 125

Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE-YFRRQQLTD 643
           HRD+K  N+L++E    K+ADFGL+R+     +T+ +  V  +  Y  P+      + + 
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYST 183

Query: 644 KSDVYSFGVVLFEVLCARTAVDPLLAREQVNL 675
             D++  G +L+E+   R        +E+++L
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 28/208 (13%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNT-------KVAVKRGVPGSRQGLPEFQTEITVLSKI 514
           + ++   +G+G FG V+   +RD         KV     V   +Q       E  VL ++
Sbjct: 2   DLERIKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEV 58

Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR----TPLSWKQRLEICIGAAR 570
            H  ++ L     +Q  + ++ EY+  G L  +L    R    T L +   + +C     
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI-VC----- 112

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
            L YLH+   + I++RD+K  NILLD+    K+ DFG ++     D T     + G+  Y
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTWT---LCGTPEY 164

Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           L PE  + +      D ++ G++++E+L
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 35/210 (16%)

Query: 469 IGSGGFGMVYKGV-LRDNTK-VAVKR-GVPGSRQGLP-EFQTEITVLSKIR---HRHLVS 521
           IG G +G V+K   L++  + VA+KR  V    +G+P     E+ VL  +    H ++V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 522 LVGYC-----EEQSEMILVYE--------YMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
           L   C     + ++++ LV+E        Y++K P       P     + K   ++    
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP------EPGVPTETIK---DMMFQL 119

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
            RGL +LH+     ++HRD+K  NIL+  +   K+ADFGL+R           T V  + 
Sbjct: 120 LRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTL 173

Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            Y  PE   +       D++S G +  E+ 
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 57.3 bits (139), Expect = 8e-09
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 45/211 (21%)

Query: 469 IGSGGFGMVYKG-VLRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIR-HRHLVSL-- 522
           IG G F  V K    +     A+K  +    + L +     EI  L ++  H +++ L  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKC-MKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 523 VGYCEEQSEMILVYEYME-------KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           V +  +   + LV+E M+       KG  +K      R      Q L       + L ++
Sbjct: 66  VLFDRKTGRLALVFELMDMNLYELIKG--RKRPLPEKRVKSYMYQLL-------KSLDHM 116

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
           H     GI HRDIK  NIL+ ++ + K+ADFG  R   S P   E ++ST       Y  
Sbjct: 117 H---RNGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTE-YISTR-----WYRA 166

Query: 633 PEYFRRQQLTD-----KSDVYSFGVVLFEVL 658
           PE      LTD     K D+++ G V FE+L
Sbjct: 167 PECL----LTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 19/198 (9%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQ----TEITVLSKIRHRHLVSLV 523
           I+G G  G VYK       ++   + +P       E Q    +E+ +L K    +++   
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIP--LDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G    ++ + +  E+M+ G L   +Y   + P     R  I +   +GL YL +     I
Sbjct: 66  GAFFVENRISICTEFMDGGSLD--VYR--KIPEHVLGR--IAVAVVKGLTYLWSLK---I 116

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           +HRD+K +N+L++     K+ DFG+S     L  +   T V G+  Y+ PE    +Q   
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQ---LVNSIAKTYV-GTNAYMAPERISGEQYGI 172

Query: 644 KSDVYSFGVVLFEVLCAR 661
            SDV+S G+   E+   R
Sbjct: 173 HSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 36/219 (16%)

Query: 468 IIGSGGFGMVYKGVLRDNT----------KVAVKRGVPGSRQGLPEFQTEITVLSKIRHR 517
           ++G GG+G V++  +R  T          KV  K  +  +++     + E  +L  ++H 
Sbjct: 3   VLGKGGYGKVFQ--VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----YGPDRTP--LSWKQRLEICIGAAR 570
            +V L+   +   ++ L+ EY+  G L  HL     +  D     LS     EI +    
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-----EISLA--- 112

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
            L +LH    +GII+RD+K  NILLD     K+ DFGL +    + E  V+    G+  Y
Sbjct: 113 -LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKES--IHEGTVTHTFCGTIEY 166

Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLA 669
           + PE   R       D +S G +++++L   T   P  A
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDML---TGAPPFTA 202

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 56.7 bits (136), Expect = 1e-08
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 9/191 (4%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           IG G  G VY  + +    +VA+++     +        EI V+ + ++ ++V+ +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
              E+ +V EY+  G L   +     T +   Q   +C    + L +LH+     +IHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           IKS NILL  +   K+ DFG         E    + + G+  ++ PE   R+    K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGF--CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 648 YSFGVVLFEVL 658
           +S G++  E++
Sbjct: 200 WSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 48/217 (22%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT---------EITVLSKIRHRH 518
           +GSG +G V      +   +VAVK+    SR     FQ+         E+ +L  ++H +
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKL---SR----PFQSIIHAKRTYRELRLLKHMKHEN 77

Query: 519 LVSLVGY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICI 566
           ++ L+         EE +++ LV           HL G D   +   Q+L       +  
Sbjct: 78  VIGLLDVFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIY 127

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   
Sbjct: 128 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVA 179

Query: 627 SFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           +  Y  PE        +++ D++S G ++ E+L  RT
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 42/136 (30%), Positives = 66/136 (48%), Gaps = 11/136 (8%)

Query: 532 MILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIK 589
           +  V EY+  G L   +   G  + P +     EI IG    L +LH+   +GII+RD+K
Sbjct: 76  LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFFLHS---KGIIYRDLK 128

Query: 590 STNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYS 649
             N++LD     K+ADFG+ +     D     T   G+  Y+ PE    Q      D ++
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKEN-MWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWA 186

Query: 650 FGVVLFEVLCARTAVD 665
           FGV+L+E+L  +   +
Sbjct: 187 FGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 23/207 (11%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRHR 517
           N F+   ++G G +G+V K   ++  ++   +    S +     +T   E+ +L  ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L      + ++ LV+EY+EK  L+     P+  P   K R  I     + +H+ H 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE-KVRSYI-YQLIKAIHWCHK 118

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG-YLDPEYF 636
                I+HRDIK  N+L+  N V K+ DFG +R+        +S G   ++  Y+   ++
Sbjct: 119 ND---IVHRDIKPENLLISHNDVLKLCDFGFARN--------LSEGSNANYTEYVATRWY 167

Query: 637 RRQQLT------DKSDVYSFGVVLFEV 657
           R  +L          D++S G +L E+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 43/141 (30%), Positives = 67/141 (47%), Gaps = 21/141 (14%)

Query: 532 MILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIK 589
           +  V EY+  G L  H+   G  + P +     EI +G    L +LH     GII+RD+K
Sbjct: 76  LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFFLHR---RGIIYRDLK 128

Query: 590 STNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK-----GSFGYLDPEYFRRQQLTDK 644
             N++LD     K+ADFG+ +        H+  GV      G+  Y+ PE    Q     
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKE-------HMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 645 SDVYSFGVVLFEVLCARTAVD 665
            D +++GV+L+E+L  +   D
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNT-------KVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +FD   ++G G FG V   V+R+         KV +K+ V  +++ +  F+ E  +LS 
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSI 57

Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
                +  L    +++  + LV EY   G L           LS   R E          
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL-----------LSLLNRYEDQFDEDMAQF 106

Query: 574 YL-------HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
           YL       H+    G +HRDIK  N+L+D     K+ADFG S +    ++   S    G
Sbjct: 107 YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVG 165

Query: 627 SFGYLDPEYFRRQQLTDKS------DVYSFGVVLFEVLCART 662
           +  Y+ PE         K       D +S GV+ +E++  R+
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 48/168 (28%), Positives = 67/168 (39%), Gaps = 22/168 (13%)

Query: 496 GSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP 555
           G R G     TE  +L  I H  ++ L G         L+         K  LY      
Sbjct: 125 GQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-----KTDLY----CY 172

Query: 556 LSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS 609
           L+ K+ + IC   A      R + YLH      IIHRDIK+ NI ++      + DFG +
Sbjct: 173 LAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-A 228

Query: 610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
              P     +   G  G+     PE   R       D++S G+VLFE+
Sbjct: 229 ACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 21/210 (10%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE--FQT---EITVLSKIRHRHLVSLV 523
           +G G +G VYK + R        + +   R  L E  F     E+ +L K    ++V   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI---RLELDESKFNQIIMELDILHKAVSPYIVDFY 65

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-EICIGAARGLHYLHTGSAEG 582
           G    +  + +  EYM+ G L K   G   T    +  L  I     +GL +L       
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHN 123

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           IIHRD+K TN+L++ N   K+ DFG+S +   L  +   T + G   Y+ PE  +     
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGN---LVASLAKTNI-GCQSYMAPERIKSGGPN 179

Query: 643 D------KSDVYSFGVVLFEVLCARTAVDP 666
                  +SDV+S G+ + E+   R    P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 39/145 (26%), Positives = 51/145 (35%), Gaps = 13/145 (8%)

Query: 1   NYLINCGSPTNASLYNRFFVPDASSKSVSFSADNSISLKSKTPPQ---DSPSPYDTARVF 57
              INCG P +       +  D      S  AD  +S  + +        P  Y T R  
Sbjct: 2   VLAINCGGPEHTDSDGITYEADTYFTGGS--ADYYVSDTNGSSSIAGTTDPELYQTERYS 59

Query: 58  TSDGSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDF-------STQ 110
            S  SY +    NG + V  HF+        L    F V   G L+L+DF          
Sbjct: 60  PSSFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDVYVQGKLVLKDFDIVAEAGGKG 119

Query: 111 VVVLKEFI-VKVDGDVIEIEFRPVG 134
               KE+I V V    +EI F   G
Sbjct: 120 KTAHKEYIPVTVTDGTLEIHFYWAG 144

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.0 bits (135), Expect = 4e-08
 Identities = 36/112 (32%), Positives = 60/112 (53%), Gaps = 11/112 (9%)

Query: 550 GPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS 609
             D  PL     L      A+G+ +L   +++  IHRD+ + N+LL +  V+K+ DFGL+
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259

Query: 610 RSGPCLDETHVSTGVKGS----FGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
           R     D  +V   VKG+      ++ PE       T +SDV+S+G++L+E+
Sbjct: 260 RD-IMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 28/218 (12%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-TKVAVKRGVPGS---RQGLPEFQTEITVLSKIRH 516
            +F+   +I +G +G VY    ++   + A+K+    +   R  + +   E  +L+   +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKG---PLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
             +VS+    E +  + +V EY+E G    L K++ G     ++     E  +     L 
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLA----LE 115

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG---------- 623
           YLH     GI+HRD+K  N+L+      K+ DFGLS+ G     T++  G          
Sbjct: 116 YLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 624 ---VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
              V G+  Y+ PE   RQ      D ++ G++L+E L
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 5e-08
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 43/214 (20%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEI---------TVLSKIRHRH 518
           +GSG +G V   +  R   KVA+K+    SR     FQ+EI         T+L  ++H +
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKL---SR----PFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 519 LVSLVGYCEEQS------EMILVYEYMEKGPLKK---HLYGPDRTPLSWKQRLEICIGAA 569
           ++ L+             +  LV  YM+   L+K   H    D+      Q L       
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-LQKIMGHPLSEDKVQYLVYQML------- 127

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
            GL Y+H   + GIIHRD+K  N+ ++E+   K+ DFGL+R        +V T       
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179

Query: 630 YLDPEY-FRRQQLTDKSDVYSFGVVLFEVLCART 662
           Y  PE            D++S G ++ E+L  +T
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 19/198 (9%)

Query: 469 IGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           IG G FG V +   RD  ++     +++    SR  +     E TVL+++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEIC--IGAARGLHYLHTGSAEG 582
             +   ++ LV  ++  G L  HL    R  LS + R      + A   LH  +      
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-RARFYTAELLCALENLHKFN------ 113

Query: 583 IIHRDIKSTNILLDENYVSKVA--DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           +I+RD+K  NILLD  Y   +A  DFGL +    + +   +    G+  YL PE      
Sbjct: 114 VIYRDLKPENILLD--YQGHIALCDFGLCKLN--MKDDDKTNTFCGTPEYLAPELLLGHG 169

Query: 641 LTDKSDVYSFGVVLFEVL 658
            T   D ++ GV+L+E+L
Sbjct: 170 YTKAVDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 54.7 bits (131), Expect = 9e-08
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)

Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 137

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 138 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 191

Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 37/209 (17%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           IG G +G+V      + N KVA+K+        +   +T  EI +L  + H +++++   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 526 C-----EEQSEMILVYEYMEKGPLKKHLYGPDRT--PLSWKQRLEICIGAARGLHYLHTG 578
                 E  +++ +VYE M+       L+   R+   LS            RGL Y+H  
Sbjct: 73  MPPPHREAFNDVYIVYELMDT-----DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH-- 125

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYF 636
           SA  ++HRD+K +N+LL+ N   K+ DFGL+R          +T  KG F   Y+   ++
Sbjct: 126 SA-NVLHRDLKPSNLLLNANCDLKICDFGLAR----------TTSEKGDFMTEYVVTRWY 174

Query: 637 RRQQL-------TDKSDVYSFGVVLFEVL 658
           R  +L       T   DV+S G +  E+L
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL 203

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 28/204 (13%)

Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89

Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC--LDETHVSTGVKGSFGYLDPEY 635
               GIIHRD+K +NI++  +   K+ DFGL+R+     +   +V T       Y  PE 
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEV 196

Query: 636 FRRQQLTDKSDVYSFGVVLFEVLC 659
                  +  D++S G ++ E++ 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIK 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 48/213 (22%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT---------EITVLSKIRHRH 518
           +GSG +G V      R   KVAVK+    SR     FQ+         E+ +L  ++H +
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKL---SR----PFQSLIHARRTYRELRLLKHMKHEN 75

Query: 519 LVSLVGY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICI 566
           ++ L+         E  +E+ LV   M          G D   +   Q+L       +  
Sbjct: 76  VIGLLDVFTPATSIENFNEVYLVTNLM----------GADLNNIVKCQKLSDEHVQFLIY 125

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
              RGL Y+H+    GIIHRD+K +N+ ++E+   ++ DFGL+R     DE    TG   
Sbjct: 126 QLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEM---TGYVA 177

Query: 627 SFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVL 658
           +  Y  PE        +++ D++S G ++ E+L
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 20/220 (9%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLR--DNTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRH 516
           NF + L  G+G FG V     +  D   VA+KR        ++ +    +E  +L+ I H
Sbjct: 33  NFIRTL--GTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
              V+L G  +++S + LV E++  G     L    R P         C  AA+ +    
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-----CFYAAQIVLIFE 145

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
              +  I++RD+K  N+LLD++   K+ DFG ++    + +T   T + G+  Y+ PE  
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK----VVDTRTYT-LCGTPEYIAPEIL 200

Query: 637 RRQQLTDKSDVYSFGVVLFEVLCA---RTAVDPLLAREQV 673
                   +D ++ G+ ++E+L       A +PLL  +++
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI 240

Length = 340

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 5/87 (5%)

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L +LH     G+I+RD+K  NILLD     K+ADFG+ + G  +     +T   G+  Y+
Sbjct: 109 LMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPDYI 163

Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            PE  +  +     D ++ GV+++E++
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMM 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 27/224 (12%)

Query: 469 IGSGGFGMVYKGVLRDN---TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           IG+G FG V  G +       +V VK   V  S Q   +F  E      ++H +L+  +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLHYLH 576
            C E +  +LV E+   G LK +L          PD T L   QR+   I  A GL +LH
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL---QRMACEI--ALGLLHLH 117

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
             +    IH D+   N LL  +   K+ D+GLS +    D       +     ++ PE  
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174

Query: 637 RRQQ-------LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV 673
                       T +S+V+S GV ++E+    +     L+ EQV
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 3e-07
 Identities = 61/241 (25%), Positives = 91/241 (37%), Gaps = 54/241 (22%)

Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTKV-AVK---RGVPGSRQGLPEFQTEITVLSKIRHRH 518
           F K  ++G G  G V+   L+   K+ A+K   +     R  +    TE  +L+ + H  
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62

Query: 519 LVSLVGYCEEQSEM--ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR------ 570
           L +L  Y   Q+E    LV +Y   G L + L    R P    + L      AR      
Sbjct: 63  LPTL--YASFQTETYLCLVMDYCPGGELFRLL---QRQP---GKCL--SEEVARFYAAEV 112

Query: 571 --GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
              L YLH     GI++RD+K  NILL E+    ++DF LS+              KGS 
Sbjct: 113 LLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169

Query: 629 G---------------------------YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
                                       Y+ PE           D ++ G++L+E+L   
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Query: 662 T 662
           T
Sbjct: 230 T 230

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 27/222 (12%)

Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG----SRQGLPEFQTEITV 510
           DL+    +++   +IG G FG V     +   KV   + +       R     F  E  +
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ--RLEICIGA 568
           ++      +V L    ++   + +V EYM  G L   +   D  P  W +    E+ + A
Sbjct: 97  MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVL-A 154

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG----LSRSGPCLDETHVSTGV 624
              +H +      G IHRD+K  N+LLD++   K+ADFG    +++ G    +T V    
Sbjct: 155 LDAIHSM------GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV---- 204

Query: 625 KGSFGYLDPEYFRRQ----QLTDKSDVYSFGVVLFEVLCART 662
            G+  Y+ PE  + Q        + D +S GV L+E+L   T
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 52.1 bits (125), Expect = 5e-07
 Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 20/197 (10%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAV-----KRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G+G FG V     +   +        KR +   +Q +     E ++L ++ H  +V+++
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHPFIVNMM 84

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP--LSWKQRLEICIGAARGLHYLHTGSAE 581
              ++++ +  + E++  G L  HL    R P  ++     E+ +       YLH+   +
Sbjct: 85  CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEYLHS---K 137

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            II+RD+K  N+LLD     KV DFG ++  P  D T    G      YL PE  + +  
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFTLCGTP---EYLAPEVIQSKGH 192

Query: 642 TDKSDVYSFGVVLFEVL 658
               D ++ GV+L+E +
Sbjct: 193 GKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 13/95 (13%)

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV-KGS 627
           ARG+ +L   +++  +HRD+ + N+LL +  + K+ DFGL+R     D  H S  V KGS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSNYVSKGS 298

Query: 628 ----FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
                 ++ PE       T  SDV+S+G++L+E+ 
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.6 bits (123), Expect = 7e-07
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 32/219 (14%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG----SRQGLPEFQTEITVLSKIRHR 517
           +F+   +IG G FG V    L++  KV   + +       R     F+ E  VL    ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG-PDRTPLS----WKQRLEICIGAARGL 572
            + +L    ++++ + LV +Y   G L   L    DR P      +   + I I +   L
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL----DETHVSTGVKGSF 628
           HY         +HRDIK  NIL+D N   ++ADF     G CL    D T  S+   G+ 
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADF-----GSCLKLMEDGTVQSSVAVGTP 167

Query: 629 GYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCART 662
            Y+ PE  +     + +   + D +S GV ++E+L   T
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.8 bits (124), Expect = 7e-07
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 11/94 (11%)

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS- 627
           A+G+ +L   +++  IHRD+ + NILL    ++K+ DFGL+R     D  +V   VKG+ 
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN-DSNYV---VKGNA 276

Query: 628 ---FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
                ++ PE       T +SDV+S+G++L+E+ 
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 310

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.5 bits (123), Expect = 1e-06
 Identities = 34/127 (26%), Positives = 61/127 (48%), Gaps = 11/127 (8%)

Query: 536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL 595
           Y        ++     +   LS+   +      A G+ +L   +++  +HRD+ + N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLI 272

Query: 596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGS----FGYLDPEYFRRQQLTDKSDVYSFG 651
            E  + K+ DFGL+R     D  ++S   KGS      ++ PE       T  SDV+SFG
Sbjct: 273 CEGKLVKICDFGLARD-IMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFG 328

Query: 652 VVLFEVL 658
           ++L+E+ 
Sbjct: 329 ILLWEIF 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.1 bits (125), Expect = 1e-06
 Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 44/226 (19%)

Query: 468 IIGSGGFGMVYKGVLRD---NTKVAVKRGVPGSRQGLPE-------FQTEITVLSKIRHR 517
           +IG GG G VY     D   + +VA+K+     R+ L E       F  E  + + + H 
Sbjct: 9   LIGKGGMGEVYLA--YDPVCSRRVALKK----IREDLSENPLLKKRFLREAKIAADLIHP 62

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLK---KHLYGPDRTP------LSWKQRLEICIGA 568
            +V +   C +   +     Y+E   LK   K ++  +          S    L I    
Sbjct: 63  GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS----------------G 612
              + Y+H+   +G++HRD+K  NILL       + D+G +                   
Sbjct: 123 CATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            C     +   + G+  Y+ PE       ++ +D+Y+ GV+L+++L
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 24/201 (11%)

Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   +  VL  N  VAVK+   P   Q        E+ +L  + H++++SL+
Sbjct: 29  IGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 87  NVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHS 141

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+        + T    +  Y  PE   
Sbjct: 142 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVIL 195

Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 196 GMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 61/255 (23%), Positives = 97/255 (38%), Gaps = 68/255 (26%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS----RQGLPEFQTEITVLSKIRH 516
            +F    +IG G FG V     +D  K+   + +  S    +  L   + E  VL++   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEI--CIGAA 569
             +VSL    ++   + L+ E++  G L     K   +  D T      R  +  C+ A 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT------RFYMAECVLAI 114

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS-------------------- 609
             +H L      G IHRDIK  NIL+D     K++DFGLS                    
Sbjct: 115 EAVHKL------GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168

Query: 610 -------RSGPCLDETHVSTGVK------------------GSFGYLDPEYFRRQQLTDK 644
                  R+   +D  +++   K                  G+  Y+ PE F +Q    +
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228

Query: 645 SDVYSFGVVLFEVLC 659
            D +S G ++FE L 
Sbjct: 229 CDWWSLGAIMFECLI 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 60/235 (25%), Positives = 110/235 (46%), Gaps = 50/235 (21%)

Query: 468 IIGSGGFGMVYKGVLRDNT-KVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSLVGY 525
           IIG+G FG+VY+ +  D + KVA+K+ +       P+++  E+ ++  + H +++ L  Y
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDY 127

Query: 526 ----CEEQSEM-ILVYEYMEKGPLKKHLY------GPDRTPLSWKQ--RLEICIGAARGL 572
               C +++E  I +   ME  P   H Y           PL   +    ++C    R L
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC----RAL 183

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
            Y+H+   + I HRD+K  N+L+D N +  K+ DFG +++             + S  Y+
Sbjct: 184 AYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN---------LLAGQRSVSYI 231

Query: 632 DPEYFRRQQL-------TDKSDVYSFGVVLFE------VLCARTAVDPLLAREQV 673
              ++R  +L       T   D++S G ++ E      +   +++VD L+   QV
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286

Length = 440

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 30/149 (20%), Positives = 58/149 (38%), Gaps = 16/149 (10%)

Query: 468 IIGSGGFGMVYKGVLRDNT-KVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS--LVG 524
           ++  G    VY   L        +K     SR+   + + E+ +L  +  + L    ++ 
Sbjct: 5   LLKGGLTNRVYL--LGTKDEDYVLKIN--PSREKGADREREVAILQLLARKGLPVPKVLA 60

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
             E      L+ E++E         G     +S +++ +I    A  L  LH      + 
Sbjct: 61  SGESDGWSYLLMEWIE---------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGP 613
           H D+   NIL+D+  +  + D+  +  GP
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 41/215 (19%)

Query: 469 IGSGGFGMVYKGVLRDNT-------------KVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           +G G    +Y G+L                 KV +K   P  R     F    +++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H+H+V L G C    E I+V E++E GPL   ++      L+   + ++    A  L YL
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPWKFKVAKQLASALSYL 121

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVS-------KVADFG-----LSRSGPCLDETHVSTG 623
                + ++H ++ + NILL    +        K++D G     LSR   C++       
Sbjct: 122 ED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ-ECVER------ 171

Query: 624 VKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEV 657
                 ++ PE     + L+  +D +SFG  L+E+
Sbjct: 172 ----IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 35/289 (12%)

Query: 458 TATNNFDKNLIIGSGG-------FGMVYKGVLRDNT---KVAVKRGVPGSRQGLPEFQTE 507
           T TN +D  L +  GG                 +N    +V +K   P  R     F   
Sbjct: 7   TRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFET 66

Query: 508 ITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPD-RTPLSWKQRLEICI 566
            +++S++ H HL  + G C   SE I+V E++E GPL   L     R P++WK  + +  
Sbjct: 67  ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--ITVAQ 124

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK- 625
             A  L YL   +   ++H ++ + NILL    +++     +  S P +  T +S   + 
Sbjct: 125 QLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERV 181

Query: 626 GSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK 684
               ++ PE       L+  +D +SFG  L E+ C    V PL  R     +E    ++K
Sbjct: 182 ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-CFDGEV-PLKERTP---SEKERFYEK 236

Query: 685 KGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL 733
           K  L    +P         S K+      +CL      RPS   +L +L
Sbjct: 237 KHRLP---EP---------SCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 32/214 (14%)

Query: 469 IGSGGFGMVYKGVLRD--NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL--VG 524
           +G G +G VYK   +D  + +    + + G+   +   + EI +L +++H +++SL  V 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKVF 67

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR--------GLHYLH 576
                 ++ L+++Y E      H+    R   + K+ +++  G  +        G+HYLH
Sbjct: 68  LSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 577 TGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSR-----SGPCLDETHVSTGVKGS 627
              A  ++HRD+K  NIL+     E    K+AD G +R       P  D   V      +
Sbjct: 126 ---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----T 178

Query: 628 FGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVLCA 660
           F Y  PE     +  T   D+++ G +  E+L +
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.6 bits (116), Expect = 8e-06
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 8/93 (8%)

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS---GPCLDETHVSTGVKG 626
            GL Y+H  SA  ++HRD+K  N+L++ +   K+ DFGL+R     P  +   + T    
Sbjct: 116 CGLKYIH--SAN-VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVA 171

Query: 627 SFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVL 658
           +  Y  PE     Q   K+ DV+S G +L E+L
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 47/235 (20%)

Query: 469 IGSGGFGMVYKGVLRDNTKVA--VKRGVPGS----------RQGLPEFQTEITVLSKIRH 516
           IG+G FG V    +  +T VA  V + +  +          +QG P           ++H
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYR--------ILQH 54

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL------YGPDRTPLSWKQRLEICIGAAR 570
            +++  +G C E    +LV+EY E G LK +L          +  L  +   EI  G   
Sbjct: 55  PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH 114

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC-LDETHVSTGVKGSFG 629
            +H  +       +H D+   N  L  +   KV D+G+   GP    E ++ T       
Sbjct: 115 -MHKHN------FLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDKCVP 164

Query: 630 --YLDPEYFRRQQ-------LTDKSDVYSFGVVLFEVL-CARTAVDPLLAREQVN 674
             +L PE              T  S+V++ GV L+E+   A      L  RE +N
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN 219

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.6 bits (116), Expect = 9e-06
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 35/161 (21%)

Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT---------EITVLSKIRH 516
           IGSG  G+V   Y  V      VA+K+    SR     FQ          E+ ++  + H
Sbjct: 24  IGSGAQGIVCAAYDTVT--GQNVAIKKL---SR----PFQNVTHAKRAYRELVLMKLVNH 74

Query: 517 RHLVSLVGY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR 570
           ++++ L+         EE  ++ LV E M+    +      D   +S+     +C     
Sbjct: 75  KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC----- 129

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           G+ +LH   + GIIHRD+K +NI++  +   K+ DFGL+R+
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 48.2 bits (115), Expect = 9e-06
 Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 33/213 (15%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVS--- 521
           +IG G +G+V   +      KVA+K    V            EI +L  +RH  +V    
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 522 --LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWK----QRLEICIGAARGLHYL 575
             L     E  ++ +V+E ME    +      D TP   +    Q L       R L Y+
Sbjct: 67  IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL-------RALKYI 119

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS---TGVKGSFGYLD 632
           HT     + HRD+K  NIL + +   K+ DFGL+R     ++T  +   T    +  Y  
Sbjct: 120 HTA---NVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRA 174

Query: 633 PE----YFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           PE    +F +   T   D++S G +  EVL  +
Sbjct: 175 PELCGSFFSK--YTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 44/166 (26%), Positives = 68/166 (40%), Gaps = 16/166 (9%)

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L  Y   +  + LV ++ E G L  H+      P    +R      AA  +  L  
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRW-----AAEMVVALDA 100

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFG-LSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
              EGI+ RD+   NILLD+    ++  F   S      D   V         Y  PE  
Sbjct: 101 LHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVG 154

Query: 637 RRQQLTDKSDVYSFGVVLFEVLCARTAVDP----LLAREQVNLAEW 678
              + T+  D +S G +LFE+L  +T V+     +     +N+ EW
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEW 200

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 44/226 (19%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV----------AVKRGVPGSRQGLPEFQTEITV 510
           ++F+   +IG G FG V    +++  +V           +KR           F+ E  V
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC------FREERDV 54

Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG-PDRTPLSWKQ----RLEIC 565
           L     R + +L    ++++ + LV +Y   G L   L    DR P    +     + + 
Sbjct: 55  LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLA 114

Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL----DETHVS 621
           I +   L Y         +HRDIK  N+LLD+N   ++ADF     G CL    D T  S
Sbjct: 115 IDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADF-----GSCLRLLADGTVQS 160

Query: 622 TGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCART 662
               G+  Y+ PE  +     + +   + D +S GV ++E+L   T
Sbjct: 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 54/202 (26%), Positives = 81/202 (40%), Gaps = 33/202 (16%)

Query: 470 GSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
                  + K     NT VAVK+      S++ L   Q EI    +++H +++  V    
Sbjct: 11  EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69

Query: 528 EQSEMILVYEYMEKGP----LKKHLYGPDRTPLSWKQRLEICI---GAARGLHYLHTGSA 580
             SE+ +V   M  G     LK H   P+  P      L I          L Y+H+   
Sbjct: 70  VDSELYVVSPLMAYGSCEDLLKTHF--PEGLP-----ELAIAFILKDVLNALDYIHS--- 119

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS-------FGYLDP 633
           +G IHR +K+++ILL  +   KV   GL  S   +        V            +L P
Sbjct: 120 KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 634 EYFRRQQL---TDKSDVYSFGV 652
           E   +Q L    +KSD+YS G+
Sbjct: 178 EVL-QQNLQGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 59/250 (23%), Positives = 98/250 (39%), Gaps = 69/250 (27%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV-AVKRGVPGS---RQGLPEFQTEITVLSKIRH 516
           ++F+   +IG G FG V     +D   + A+K+        ++ +   + E  +L++  +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 517 RHLVSLVGYCEEQSE--MILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEI--CIG 567
             +V L  Y   Q E  + L+ EY+  G +     KK  +  + T      R  I   I 
Sbjct: 61  PWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET------RFYIAETIL 112

Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST----- 622
           A   +H L      G IHRDIK  N+LLD     K++DFGL      L ++H +      
Sbjct: 113 AIDSIHKL------GYIHRDIKPDNLLLDAKGHIKLSDFGLCTG---LKKSHRTEFYRIL 163

Query: 623 ----------------------------------GVKGSFGYLDPEYFRRQQLTDKSDVY 648
                                                G+  Y+ PE F +     + D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223

Query: 649 SFGVVLFEVL 658
           S GV+++E+L
Sbjct: 224 SLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 70/283 (24%), Positives = 117/283 (41%), Gaps = 43/283 (15%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG----SRQGLPEFQTEITVLSKIRH 516
           ++F+   +IG G FG V    ++   ++   + +       R     F+ E  VL     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG-PDRTPLSWKQ----RLEICIGAARG 571
           + + +L    ++++ + LV +Y   G L   L    DR P    +     + + I +   
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL----DETHVSTGVKGS 627
           LHY         +HRDIK  N+LLD N   ++ADF     G CL    D T  S+   G+
Sbjct: 121 LHY---------VHRDIKPDNVLLDMNGHIRLADF-----GSCLKMNQDGTVQSSVAVGT 166

Query: 628 FGYLDPEYFRRQQLTD-------KSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM 680
             Y+ PE    Q + D       + D +S GV ++E+L   T   P  A   V      M
Sbjct: 167 PDYISPEIL--QAMEDGMGKYGPECDWWSLGVCMYEMLYGET---PFYAESLVETYGKIM 221

Query: 681 QWQKKGML-EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVD 722
             +++     HI D     K   D +++   + E+ L   G++
Sbjct: 222 NHEERFQFPSHITDVSEEAK---DLIQRLICSRERRLGQNGIE 261

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 38/111 (34%), Positives = 54/111 (48%), Gaps = 22/111 (19%)

Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS----------RSGP 613
           I  GA RGL+YLH     G IHR+IK+++IL+  + +  ++  GLS          ++  
Sbjct: 106 ILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160

Query: 614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTD---KSDVYSFGVVLFEVLCAR 661
             D    ST V     +L PE   RQ L     KSD+YS G+   E+   R
Sbjct: 161 VYDFPQFSTSV---LPWLSPELL-RQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 469 IGSGGFGMVYKGVLRD--NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL--VG 524
           +G G +G VYK   +D  + K    + + G+   +   + EI +L +++H ++++L  V 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQKVF 67

Query: 525 YCEEQSEMILVYEYMEKG---PLKKHLYG-----PDRTPLSWKQRLEICIGAARGLHYLH 576
                 ++ L+++Y E      +K H        P + P S  + L   I    G+HYLH
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI--LDGIHYLH 125

Query: 577 TGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSR-----SGPCLDETHVSTGVKGS 627
              A  ++HRD+K  NIL+     E    K+AD G +R       P  D   V      +
Sbjct: 126 ---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----T 178

Query: 628 FGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVLCA 660
           F Y  PE     +  T   D+++ G +  E+L +
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 6e-05
 Identities = 33/108 (30%), Positives = 47/108 (43%), Gaps = 15/108 (13%)

Query: 555 PLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL------ 608
           PL   Q   +       + Y+H    EGIIHRDIK+ N+L++      + DFG       
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312

Query: 609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFE 656
           S S P         G+ G+     PE       T   D++S G+V+FE
Sbjct: 313 SWSTP------FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.5 bits (103), Expect = 9e-05
 Identities = 29/106 (27%), Positives = 44/106 (41%), Gaps = 18/106 (16%)

Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             PL+ ++   +C+     L  LH         R  KS NILL  + +       L   G
Sbjct: 11  GRPLNEEEIWAVCLQCLGALRELH---------RQAKSGNILLTWDGL-------LKLDG 54

Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
               +T   +     F    PE  + Q  T+K+D+YS G+ L+E L
Sbjct: 55  SVAFKTPEQSRPDPYFM--APEVIQGQSYTEKADIYSLGITLYEAL 98

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.1 bits (105), Expect = 1e-04
 Identities = 27/96 (28%), Positives = 39/96 (40%), Gaps = 22/96 (22%)

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDEN----YVSKVADFGLSR---SGPCLDETHVSTG 623
            L+ LH      IIH DIK  N+L D      Y   + D+GL +   +  C D T     
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIY---LCDYGLCKIIGTPSCYDGTLD--- 171

Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
                 Y  PE  +        D ++ GV+ +E+L 
Sbjct: 172 ------YFSPEKIKGHNYDVSFDWWAVGVLTYELLT 201

Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.1 bits (101), Expect = 5e-04
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 41/217 (18%)

Query: 471 SGGFGMVYKGVLRDNTKVA-VKRGVPGSRQGLP------------------EFQTEITVL 511
           +G FG ++   LR +T+ A  +RGV  + QG P                  + + EI  L
Sbjct: 158 AGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILAL 217

Query: 512 SKIRHRHLVSL--VGYCEEQSEMIL------VYEYMEKGPLKKHLYGPDRTPLSWKQRLE 563
            ++ H +++ +  +   E  + MI       +Y +M            DR PL  + R  
Sbjct: 218 GRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDR-PLLKQTR-A 271

Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST- 622
           I       + Y+H    + +IHRDIK  NI L+ +    + DFG +      ++   +  
Sbjct: 272 IMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMP---FEKEREAFD 325

Query: 623 -GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            G  G+     PE        + +D++S G++L ++L
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 29/133 (21%), Positives = 48/133 (36%), Gaps = 29/133 (21%)

Query: 181 TILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPDN 240
            +L IN GG E T  +     T+  D                    Y  GG++     D 
Sbjct: 1   VVLAINCGGPEHTDSDGI---TYEAD-------------------TYFTGGSADYYVSDT 38

Query: 241 VYMTAQEMNRDNAM-LGARF---NITWDFPVGSHGNRHLVRLHFCDIV--SPSLNQLYFN 294
              ++     D  +    R+   + ++  P   +GN + V LHF +I      L +  F+
Sbjct: 39  NGSSSIAGTTDPELYQTERYSPSSFSYYIPCLENGN-YTVILHFAEIYFGEDGLGRRVFD 97

Query: 295 VFINDYSAYKDLD 307
           V++      KD D
Sbjct: 98  VYVQGKLVLKDFD 110

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 34/210 (16%)

Query: 469 IGSGGFGMVYKGVL--RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGY 525
           IG G +G V+K VL  ++ +K AVK   P       E + E  +L  +  H ++V   G 
Sbjct: 26  IGKGTYGKVFK-VLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 526 CEEQS-----EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHY 574
             ++      ++ LV E    G +   + G     L   +R+E      I   A  GL +
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGF----LKRGERMEEPIIAYILHEALMGLQH 139

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--STGVKGSFGYLD 632
           LH       IHRD+K  NILL      K+ DFG+S     L  T +  +T V   F ++ 
Sbjct: 140 LHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQ---LTSTRLRRNTSVGTPF-WMA 192

Query: 633 PEYFRRQQLTDKS-----DVYSFGVVLFEV 657
           PE    +Q  D +     DV+S G+   E+
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.3 bits (99), Expect = 8e-04
 Identities = 68/292 (23%), Positives = 112/292 (38%), Gaps = 61/292 (20%)

Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVK--RGVPGSRQGLPEFQTEITVL 511
           D+  +T  F    ++G G FG V +   R   +  AVK  R VP   +   + + EI  +
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTR---DAKIEIQFM 179

Query: 512 SKIRHRH------LVSLVGYCEEQS-EMILVYEYMEKGPLKKHLYGP-------DRTPLS 557
            K+R         L+ +  Y + ++  M +V   M K       YGP          P S
Sbjct: 180 EKVRQADPADRFPLMKIQRYFQNETGHMCIV---MPK-------YGPCLLDWIMKHGPFS 229

Query: 558 WKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD--ENYVSKVADFGLSRS---- 611
            +   +I       L Y HT     ++H D+K  NIL++  +  V  V +  L       
Sbjct: 230 HRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287

Query: 612 -----GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDP 666
                G C DE H  T +  +  Y  PE          +D++S G +++E+   +   D 
Sbjct: 288 RICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347

Query: 667 LLAREQVNL---------AEWAMQ---------WQKKGMLEHIIDPQLIGKI 700
               E ++L         +EWA +         +   G L    DP+ + +I
Sbjct: 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARI 399

Length = 467

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 8e-04
 Identities = 49/242 (20%), Positives = 103/242 (42%), Gaps = 37/242 (15%)

Query: 453 FTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT-----E 507
           + D ++  N ++    IG+G FG V+    +   +    + +  S +GL E +      E
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIE 62

Query: 508 ITVLSKIRHRHLVSLVG--YCEEQSEMILVYEYMEKGPLKKHLYGPDRT--PLSWKQRLE 563
           + V+ +++H+++V  +     +   ++ ++ E+ + G L +++    +    +     ++
Sbjct: 63  VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122

Query: 564 ICIGAARGLHYLHT----GSAEGIIHRDIKSTNILLDENY-----------------VSK 602
           I       L Y H      + E ++HRD+K  NI L                     ++K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182

Query: 603 VADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF--RRQQLTDKSDVYSFGVVLFEVLCA 660
           + DFGLS++       H   G      Y  PE      +   DKSD+++ G +++E+   
Sbjct: 183 IGDFGLSKNIGIESMAHSCVGTPY---YWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 661 RT 662
           +T
Sbjct: 240 KT 241

Length = 1021

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 36/147 (24%), Positives = 53/147 (36%), Gaps = 48/147 (32%)

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGL--------------------------------S 609
           G IHRDIK  NIL+D +   K+ DFGL                                 
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 610 RSGPCLDETH-------------VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFE 656
            +  C D                ++  + G+  Y+ PE   R   T   D +S GV+L+E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240

Query: 657 VLCARTAVDPLLAREQVNLAEWAMQWQ 683
           +L  +    P LA+  +      + WQ
Sbjct: 241 MLVGQP---PFLAQTPLETQMKVINWQ 264

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 71/357 (19%), Positives = 135/357 (37%), Gaps = 62/357 (17%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS----RQGLPEFQTEITVLSKIRH 516
           ++F+   +IG G FG V     +D   +   + +  +    ++ +   + E  +L +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ-RLEICIGAARGLHYL 575
             +V +    +++  + L+ E++  G +   L   D       Q  +   + A   +H L
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS-------RSGPCLDETH--------- 619
                 G IHRDIK  N+LLD     K++DFGL        R+    + TH         
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 620 -----------------VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
                            ++    G+  Y+ PE F +       D +S GV+++E+L    
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML---I 231

Query: 663 AVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL-IGKINLDSLKKFGETAEKCLADYGV 721
              P  +          M W++      +  P++ I +   D + +F   +E  +   GV
Sbjct: 232 GYPPFCSETPQETYRKVMNWKET----LVFPPEVPISEKAKDLILRFCTDSENRIGSNGV 287

Query: 722 DR----PSMGDVLWNLEYALQLQESGSGLPREQRE-DSNTNPPALPTRTIVPQAPSS 773
           +     P    V W       ++E  + +P E +  D  +N    P   I+  A ++
Sbjct: 288 EEIKSHPFFEGVDWG-----HIRERPAAIPIEIKSIDDTSNFDEFPESDILQPAENT 339

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 35/129 (27%), Positives = 47/129 (36%), Gaps = 44/129 (34%)

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGL------------------------------SRS 611
           G IHRDIK  NIL+D +   K+ DFGL                              S  
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 612 GPC----LDETHVSTGVK-------GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
             C    L+        +       G+  Y+ PE   R   T   D +S GV+L+E+L  
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 661 RTAVDPLLA 669
           +    P LA
Sbjct: 241 QP---PFLA 246

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 50/235 (21%), Positives = 92/235 (39%), Gaps = 44/235 (18%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHR 517
           +F+   +IG G FG V     +D   V     +++     ++ +   + E  +L +    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR-TPLSWKQRLEICIGAARGLHYLH 576
            +V +    +++  + L+ E++  G +   L   D  T    +  +   + A   +H L 
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL- 120

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFG----------------LSRSGPC------ 614
                G IHRDIK  N+LLD     K++DFG                L+ S P       
Sbjct: 121 -----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 615 -----------LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
                       +   ++    G+  Y+ PE F +       D +S GV+++E+L
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	803
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN03150	623	hypothetical protein; Provisional	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.77
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
PRK10345	210	hypothetical protein; Provisional	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
smart00090	237	RIO RIO-like kinase.	99.69
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.67
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.54
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.54
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
PLN03150	623	hypothetical protein; Provisional	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.31
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	99.29
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.23
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.21
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.16
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.13
KOG1243	690	consensus Protein kinase [General function predict	99.12
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.09
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.03
KOG3087	229	consensus Serine/threonine protein kinase [General	98.99
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.98
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.88
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.82
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.79
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	98.75
PRK09902	216	hypothetical protein; Provisional	98.58
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.56
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.47
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.46
COG4248	637	Uncharacterized protein with protein kinase and he	98.32
KOG3593	355	consensus Predicted receptor-like serine/threonine	98.31
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.28
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.27
PF01636	239	APH: Phosphotransferase enzyme family This family	98.1
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.07
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.03
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.01
PLN02876	822	acyl-CoA dehydrogenase	97.93
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.88
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.8
PRK10593	297	hypothetical protein; Provisional	97.69
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.69
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.57
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.55
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.5
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.49
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.48
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.38
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.35
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.14
PRK05231	319	homoserine kinase; Provisional	97.0
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.8
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.79
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.77
PLN02236	344	choline kinase	96.63
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.59
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.45
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.43
PLN02756	418	S-methyl-5-thioribose kinase	96.19
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.01
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.74
KOG2270	520	consensus Serine/threonine protein kinase involved	95.3
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.28
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.27
PRK12396	409	5-methylribose kinase; Reviewed	95.24
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.24
COG2334	331	Putative homoserine kinase type II (protein kinase	95.09
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.67

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=100.00  E-value=7.6e-62  Score=527.14  Aligned_cols=326  Identities=33%  Similarity=0.523  Sum_probs=267.4

Q ss_pred             eecCCCcccc-c----CCceeecCCCCCccccccCcccccccCCCCCCCCCCccceeeeecc--ceeEEeee--cCceEE
Q 042150            4 INCGSPTNAS-L----YNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTSD--GSYKLNIK--RNGTHL   74 (803)
Q Consensus         4 I~CG~~~~~~-~----~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~~--~cY~~~~~--~~~~yl   74 (803)
                      ||||++.+.+ +    ++++|++|.+|+++|.++.++...  ........++|+|||+||+|  |||+||+.  +|+|||
T Consensus         1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~--~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yl   78 (347)
T PF12819_consen    1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQP--DSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYL   78 (347)
T ss_pred             CcCCCCCCCcccccCCCCcEEeCCCCcccCCCcccccccc--CCcCCccccccceEEEcCCCCccEEEeeccCCCCceEE
Confidence            8999987766 4    378999999999999988884222  11234578899999999976  99999997  567999


Q ss_pred             EEEeecCCCCCccc----ccccEEEEE--ECcEEEEeccCC-CceEEEEEEEEec-CCeEEEEEeecCCCCcceeeeeEE
Q 042150           75 VRFHFSPFESDNFK----LASAKFGVL--ANGLLLLQDFST-QVVVLKEFIVKVD-GDVIEIEFRPVGDKNFGFVNAIEV  146 (803)
Q Consensus        75 vR~~F~~~~~~~~~----~~~~~F~~~--~~~~~~~~~~~~-~~~~~~e~i~~~~-~~~~~v~~~~~~~~~~~fv~~iE~  146 (803)
                      |||||+|||||+.+    .+++.|||+  +|.|.+|+..+. ..++++|+|+.+. +++|+|||+|++.+.+||||||||
T Consensus        79 iRl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl  158 (347)
T PF12819_consen   79 IRLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIEL  158 (347)
T ss_pred             EEEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEE
Confidence            99999999999875    246889999  777999998762 2579999999998 799999999997788899999999


Q ss_pred             EecCCcccccCCceeecCCCcccccccchHHHHhheeeeecCCcc--cCCCCCeeeeeecCCCcceeecCcccccccCCC
Q 042150          147 FSAPEDFIVDDGARVISGSGSIEEFRNLSSEILETILRINVGGSE--LTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHP  224 (803)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~R~n~Gg~~--~~~~~D~~~r~w~~d~~~~~~~~~~~~~~~s~~  224 (803)
                      |+||+++|.+..              ...+++|++++|+|+||..  +++++|.|||.|.+.    ...+.|.++++..+
T Consensus       159 ~~lp~~ly~~~~--------------~~~s~~L~~~~R~n~G~~~~~iryp~D~~dR~W~~~----~~~~~~~~ist~~~  220 (347)
T PF12819_consen  159 RPLPDSLYPDTD--------------ANSSQALETVYRLNVGGSSSFIRYPDDTYDRIWQPY----SSSPGWSNISTTSN  220 (347)
T ss_pred             EECCccceeccc--------------cCCCceeEEEEeecCCCcccccCCCCCcceeecccc----ccCcccccccccee
Confidence            999999996421              1126899999999999998  999999999999832    22467788877666


Q ss_pred             ccccCCCCCccccchHHHHHHhcccccccccCcccceeEeeeccCCCCeeEEEEEeeeeec--CCCCcEEEEEEEcCeee
Q 042150          225 PNYQKGGASREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVS--PSLNQLYFNVFINDYSA  302 (803)
Q Consensus       225 ~~~~~~~~~~~~~P~~vy~TAr~~~~~~~~~~~~~~lt~~~~~~~~~~~y~v~lhFae~~~--~~~~~R~Fdi~in~~~~  302 (803)
                      ++ .....+.|.||..|||||+++.+++    .+++|+|.+ +++ +..|+|+||||||+.  ...++|+|||||||+.+
T Consensus       221 i~-~~~~~~~~~~P~~V~~TA~~~~~~s----~~~nltw~~-~~~-~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~  293 (347)
T PF12819_consen  221 IN-INSSNNPYDAPSAVYQTARTPSNSS----DPLNLTWSF-VDP-GFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTA  293 (347)
T ss_pred             ee-cccCCccCcChHHHHHhhhcccccc----cceEEEecc-CCC-CccEEEEEEEeecccccCCCCeEEEEEEECCeEc
Confidence            54 2334678999999999999987542    258899999 887 899999999999987  34568999999999999


Q ss_pred             cccCCccccccCCccccEEEEeEEeecCCceeEEEEeccCCCCccccccccccceeeee
Q 042150          303 YKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEIMKM  361 (803)
Q Consensus       303 ~~~~di~~~~~~~~~~~~~~~~~~~~~~~~~~~is~~~s~~s~~~~~~~ilng~ei~~~  361 (803)
                      .+  |+.....+..+.++|++|++.+...+.+.|++++...+..   +|||||+||+++
T Consensus       294 ~~--~~~~~~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~l---ppiLNalEIy~v  347 (347)
T PF12819_consen  294 YS--DVSPPYLGADTVPYYSDYVVNVPDSGFLNISLGPTPDSTL---PPILNALEIYKV  347 (347)
T ss_pred             cC--ccCcccccCcceEeecceEEEecCCCEEEEEEEeCCCCCc---CceeEeeeeEeC
Confidence            97  4443223456778899999999888899999999887733   999999999984

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-55  Score=478.28  Aligned_cols=290  Identities=50%  Similarity=0.829  Sum_probs=257.6

Q ss_pred             ccccChhhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEee
Q 042150          448 RLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE  527 (803)
Q Consensus       448 ~~~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~  527 (803)
                      ...|++.+|..+|++|...++||+|+||.||+|.+.+++.||||++.....+...+|.+|+++|.+++|||||+|+|||.
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~  141 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL  141 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence            45689999999999999999999999999999999999999999876654431556999999999999999999999999


Q ss_pred             ccc-eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeee
Q 042150          528 EQS-EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADF  606 (803)
Q Consensus       528 ~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF  606 (803)
                      +.+ +.+||||||++|+|.++|+.....+++|.+|++||.++|+||+|||+.+...|+|||||++|||||+++++||+||
T Consensus       142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF  221 (361)
T KOG1187|consen  142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF  221 (361)
T ss_pred             cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence            998 5999999999999999998755448999999999999999999999988889999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC
Q 042150          607 GLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG  686 (803)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (803)
                      |+|+..+.. .........||.+|+|||++..+..++|+|||||||+|+||+||+.+.+.........+.+|++....++
T Consensus       222 GLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~  300 (361)
T KOG1187|consen  222 GLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG  300 (361)
T ss_pred             cCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence            999875431 2222211189999999999999999999999999999999999999988665556667999999999999


Q ss_pred             ccccccCcccc-cCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          687 MLEHIIDPQLI-GKINL-DSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       687 ~~~~i~d~~l~-~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      .+.+++|+++. +.+.. ++..++..++.+|++.+|.+||+|.||+++|+.+..
T Consensus       301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99999999997 66664 688899999999999999999999999999965543

>PLN03150 hypothetical protein; Provisional

Probab=100.00  E-value=4.3e-55  Score=510.32  Aligned_cols=323  Identities=20%  Similarity=0.308  Sum_probs=260.7

Q ss_pred             CceeecCCCcccc--cCCceeecCCCCCccccccCcccccccCCCCCCCCCCccceeeeec--c--ceeEEeeecCceEE
Q 042150            1 NYLINCGSPTNAS--LYNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTS--D--GSYKLNIKRNGTHL   74 (803)
Q Consensus         1 ~~~I~CG~~~~~~--~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~--~--~cY~~~~~~~~~yl   74 (803)
                      +|+||||++.+..  .++|+|++|..+.. |.....+.      + ....++|+|||+||.  |  |||+||++++|+||
T Consensus        25 ~~~I~CGs~~~~~~d~~~~~w~~D~~~~~-~~~~~~~~------~-~~~~~~~~t~R~F~~~~g~~~cY~~~~~~~g~yl   96 (623)
T PLN03150         25 TMRISCGARVNVRTAPTNTLWYKDFAYTG-GIPANATR------P-SFIAPPLKTLRYFPLSDGPENCYNINRVPKGHYS   96 (623)
T ss_pred             cEEEeCCCCCCcccCCCCCEEcCCccccc-CccccccC------c-ccccchhhccccCCcccccccceEeeecCCCcEE
Confidence            5899999987764  46899999987753 22222221      1 124577999999995  3  99999999999999


Q ss_pred             EEEeecCCCCCcccccccEEEEEECc--EEEEec-cC-CCceEEEEEEEEecCCeEEEEEeecCCCCcceeeeeEEEecC
Q 042150           75 VRFHFSPFESDNFKLASAKFGVLANG--LLLLQD-FS-TQVVVLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIEVFSAP  150 (803)
Q Consensus        75 vR~~F~~~~~~~~~~~~~~F~~~~~~--~~~~~~-~~-~~~~~~~e~i~~~~~~~~~v~~~~~~~~~~~fv~~iE~~~~~  150 (803)
                      ||+||+|||||+++. +|.|||++++  |.+|.. ++ .+..+++|+|++++++.++|||+|+ ++++||||+|||++||
T Consensus        97 VRl~F~~~~y~~~~~-~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~-~~~~pFIs~iEv~~l~  174 (623)
T PLN03150         97 VRVFFGLVAEPNFDS-EPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHST-GHGDPAILSIEILQVD  174 (623)
T ss_pred             EEEEeecCCcCCCCC-CCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecC-CCCCCceeEEEEEEcC
Confidence            999999999999995 8999999766  888864 33 3567899999999999999999998 6678999999999999


Q ss_pred             CcccccCCceeecCCCcccccccchHHHHhheeeeecCCccc----CCCCCee--eeeecCCCcceeecCcccccccCCC
Q 042150          151 EDFIVDDGARVISGSGSIEEFRNLSSEILETILRINVGGSEL----TPFNDTL--WRTWVPDDEFLVLKSAAKRVATTHP  224 (803)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~R~n~Gg~~~----~~~~D~~--~r~w~~d~~~~~~~~~~~~~~~s~~  224 (803)
                      +++|.... .    .+        .+.+|++++|+|+||.++    +.++|.|  ||.|.+|.+|+  .+.+..+++...
T Consensus       175 ~~~y~~~~-~----~~--------~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~--~~~~~~~st~~~  239 (623)
T PLN03150        175 DKAYNFGP-S----WG--------QGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFG--SGSDQAISTENV  239 (623)
T ss_pred             cccccccc-c----cc--------CceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccC--CCcccccccccc
Confidence            99995220 0    01        145799999999999764    3667777  99999998876  334666766666


Q ss_pred             ccccCCCCCccccchHHHHHHhcccccccccCcccceeEeeeccCCCCeeEEEEEeeeeec--CCCCcEEEEEEEcCeee
Q 042150          225 PNYQKGGASREIGPDNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVS--PSLNQLYFNVFINDYSA  302 (803)
Q Consensus       225 ~~~~~~~~~~~~~P~~vy~TAr~~~~~~~~~~~~~~lt~~~~~~~~~~~y~v~lhFae~~~--~~~~~R~Fdi~in~~~~  302 (803)
                      +++..  .+.+.+|+.||||||++..+      ..+++|.+++++ ++.|+|+|||||++.  ...++|+|||||||+.+
T Consensus       240 I~~~~--~~~~~~P~~VyqTA~~~~~~------~~~lty~~~v~~-~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~  310 (623)
T PLN03150        240 IKKAS--NAPNFYPESLYQSALVSTDT------QPDLSYTMDVDP-NRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTA  310 (623)
T ss_pred             ccccc--CCCccChHHHhhhhccccCC------CCceEEEeecCC-CCCEEEEEEEEeccCccCCCceEEEEEEECCEEe
Confidence            76542  46788999999999998632      256899999988 899999999999974  35689999999999999


Q ss_pred             cccCCccccccCCccccEEEEeEEeecCCceeEEEEeccCCCCccccccccccceeeeeccc
Q 042150          303 YKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKVNAILNGVEIMKMVHL  364 (803)
Q Consensus       303 ~~~~di~~~~~~~~~~~~~~~~~~~~~~~~~~~is~~~s~~s~~~~~~~ilng~ei~~~~~~  364 (803)
                      .+++|+..+ .++...+++++|.+.+++ +.++|+++|...+     +|++||+||+++...
T Consensus       311 ~~~~di~~~-~g~~~~~~~~~~~v~~~~-g~l~isl~p~~~s-----~pilNaiEI~~~~~~  365 (623)
T PLN03150        311 FKDVDIVKM-SGERYTALVLNKTVAVSG-RTLTIVLQPKKGT-----HAIINAIEVFEIITA  365 (623)
T ss_pred             ecccChhhh-cCCcccceEEEeEEeecC-CeEEEEEeeCCCC-----cceeeeeeeeecccc
Confidence            999999887 456678999999888765 8899999996532     699999999998763

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3e-46  Score=403.91  Aligned_cols=256  Identities=36%  Similarity=0.558  Sum_probs=213.3

Q ss_pred             CccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCC--hHHHHHHHHHHHhccCCCeeeEEeEeeccc-eeeEEEEecC
Q 042150          464 DKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG--LPEFQTEITVLSKIRHRHLVSLVGYCEEQS-EMILVYEYME  540 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~lV~Ey~~  540 (803)
                      ...+.||+|+||+||+|.+++...||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. .++||||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            3344699999999999999865559999876543222  569999999999999999999999999887 7999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc-eEeeccCcceEEEccCC-cEEEeeeccccCCCCCCCC
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG-IIHRDIKSTNILLDENY-VSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDLkp~NILl~~~~-~~kl~DFGla~~~~~~~~~  618 (803)
                      +|+|.+++++.....+++..+++|+.|||+||.|||+   .+ ||||||||+|||++.++ ++||+|||+++......  
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--  198 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--  198 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence            9999999977557789999999999999999999999   66 99999999999999997 99999999998633211  


Q ss_pred             ceeccccCCCcccCccccc--cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          619 HVSTGVKGSFGYLDPEYFR--RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      ...+...||+.|||||++.  ...|+.|+||||||++||||+||+.||..... .+  ....            ++....
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~--~~~~------------v~~~~~  263 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ--VASA------------VVVGGL  263 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH--HHHH------------HHhcCC
Confidence            2334478999999999999  66999999999999999999999999986543 11  1111            111122


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                      +..++..+.+.+..++.+||+.+|..||++.+++..|+.+...
T Consensus       264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            2344445778899999999999999999999999999988653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=396.18  Aligned_cols=251  Identities=33%  Similarity=0.454  Sum_probs=215.4

Q ss_pred             cceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCchh
Q 042150          466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLK  545 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~  545 (803)
                      .+.||+|.||.||.|.++...+||+|.++.. ....++|.+|+++|++|+|+|||+|+|+|..++.++||||||++|+|.
T Consensus       211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl  289 (468)
T KOG0197|consen  211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL  289 (468)
T ss_pred             HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence            4479999999999999998889999987665 344578999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceecccc
Q 042150          546 KHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK  625 (803)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  625 (803)
                      ++|....+..+...+.+.++.|||+||+||++   +++|||||.++||||+++..+||+||||||... .+.........
T Consensus       290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~~~~~k  365 (468)
T KOG0197|consen  290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTASEGGK  365 (468)
T ss_pred             HHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccC-CCceeecCCCC
Confidence            99977677889999999999999999999999   999999999999999999999999999999432 34444555666


Q ss_pred             CCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHH
Q 042150          626 GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDS  704 (803)
Q Consensus       626 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  704 (803)
                      -+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+..      ....+.          .+-..+..|
T Consensus       366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~------~~le~G----------yRlp~P~~C  429 (468)
T KOG0197|consen  366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL------ELLERG----------YRLPRPEGC  429 (468)
T ss_pred             CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH------HHHhcc----------CcCCCCCCC
Confidence            7889999999999999999999999999999998 78887655433322      121111          122345567


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          705 LKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       705 ~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      +..+.+|+..||+.+|++|||++.+...|+...
T Consensus       430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            888999999999999999999999988888764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=372.93  Aligned_cols=252  Identities=26%  Similarity=0.354  Sum_probs=207.0

Q ss_pred             CccceEeeeCceEEEEEEECC-CcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccc-eeeEEEEecC
Q 042150          464 DKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS-EMILVYEYME  540 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~lV~Ey~~  540 (803)
                      +....||+|..|+|||++++. ++.+|+|.+... .....++..+|++++++.+||+||.++|.|...+ ...|+||||.
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            344589999999999999874 788899987443 3344578899999999999999999999999988 5999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|+|++++.  ..+.+++..+-+|+.+|++||.|||+  .++||||||||+||||+..|++||||||.++....    ..
T Consensus       162 gGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn----S~  233 (364)
T KOG0581|consen  162 GGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN----SI  233 (364)
T ss_pred             CCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhh----hh
Confidence            999999994  33679999999999999999999995  38999999999999999999999999999986332    24


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      .....||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.+... ......+.         +..|++... ...
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~L---------l~~Iv~~pp-P~l  302 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFEL---------LCAIVDEPP-PRL  302 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHH---------HHHHhcCCC-CCC
Confidence            5567899999999999999999999999999999999999999876411 11111111         112222111 122


Q ss_pred             CH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          701 NL-DSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       701 ~~-~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      +. .++++++.++..||++||.+||++.|++++-.
T Consensus       303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf  337 (364)
T KOG0581|consen  303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF  337 (364)
T ss_pred             CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence            33 47788999999999999999999999998644

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.1e-44  Score=405.06  Aligned_cols=261  Identities=29%  Similarity=0.443  Sum_probs=223.0

Q ss_pred             cCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEeeccceee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      .+....+.||+|.||+||+|...      +...||||.++..... ..++|++|+++|..|+|||||+|+|+|.+++.++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            34445568999999999999853      3467999998877655 7889999999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhccCC--------C----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcE
Q 042150          534 LVYEYMEKGPLKKHLYGP--------D----RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~--------~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~  601 (803)
                      +|+|||.+|+|.+||.-.        .    ..+|+..+.+.||.|||.||+||-+   +.+|||||..+|+||.++..+
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEE
Confidence            999999999999999521        1    2349999999999999999999988   999999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAM  680 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  680 (803)
                      ||+||||+|.....+......+..-+++||+||.+..++||.+||||||||+|||+++ |+.|+......+.+       
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI-------  715 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI-------  715 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH-------
Confidence            9999999998776677666666777899999999999999999999999999999998 88888765444322       


Q ss_pred             HHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      +++..+.        + -..+..++.++.+|+..||+.+|.+||++.||-..|+...+..
T Consensus       716 e~i~~g~--------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  716 ECIRAGQ--------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             HHHHcCC--------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            2223332        2 2456788899999999999999999999999999999876443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-43  Score=384.55  Aligned_cols=250  Identities=26%  Similarity=0.405  Sum_probs=213.6

Q ss_pred             cCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ..|...++||+|||++||+++. ..|+.||+|++...   .....+...+|+++.++|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999997 77999999985542   3444677899999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      |+|++|+|.+++  ++++++++.++..++.||+.||.|||+   ++|+|||||..|+||++++++||+|||||......+
T Consensus        98 ELC~~~sL~el~--Krrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELL--KRRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHH--HhcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999999999  467889999999999999999999999   999999999999999999999999999998754322


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                        ......+||+.|+|||++.....+..+||||+||+||-||.|++||+...-.+...-.       +   ..+.     
T Consensus       173 --Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I-------k---~~~Y-----  235 (592)
T KOG0575|consen  173 --ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI-------K---LNEY-----  235 (592)
T ss_pred             --cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH-------H---hcCc-----
Confidence              3345689999999999999999999999999999999999999999865433321111       0   0111     


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                        .++...+.+..+||.++|+.+|.+|||+++|+.+--
T Consensus       236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F  271 (592)
T KOG0575|consen  236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF  271 (592)
T ss_pred             --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence              123345567899999999999999999999997643

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=364.57  Aligned_cols=202  Identities=31%  Similarity=0.494  Sum_probs=179.5

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .+|...+.||+|+||+||+|+++. +..||||.+...  ..+..+.+..|+.+|+.++|||||.|++++..++.++||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            467777789999999999999764 789999986554  44456678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC------CcEEEeeeccccC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN------YVSKVADFGLSRS  611 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~------~~~kl~DFGla~~  611 (803)
                      ||.+|+|.++|+  .++.+++.....++.|||.||++||+   ++||||||||+||||+..      -.+||+|||+||.
T Consensus        90 yC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   90 YCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             eCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            999999999994  45579999999999999999999999   999999999999999764      5689999999997


Q ss_pred             CCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhh
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAR  670 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~  670 (803)
                      ..   ........+|++-|||||+++.++|+.|+|+||.|++||+|++|+.||+.....
T Consensus       165 L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             CC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            44   344456789999999999999999999999999999999999999999855443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-43  Score=361.80  Aligned_cols=255  Identities=27%  Similarity=0.366  Sum_probs=203.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC-----CC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG-----SR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~  531 (803)
                      ...|...+.||+|+||.|-+|.. ++|+.||||.+...     +.  .......+|+++|++|+|||||++.++++....
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            34567788999999999999995 46999999975432     11  112235799999999999999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC---CcEEEeeecc
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN---YVSKVADFGL  608 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~~kl~DFGl  608 (803)
                      .|||||||++|+|.+.+.  ..+.+.+.....++.|++.|+.|||+   +||+||||||+|||+..+   ..+||+|||+
T Consensus       251 ~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             eEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999993  45667788888999999999999999   999999999999999755   7899999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcC---CCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL---TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK  685 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (803)
                      |+..   .........+||+.|.|||++.++..   ..+.|+||+||+||-+++|.+||.......  .+.    +.+..
T Consensus       326 AK~~---g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~----eQI~~  396 (475)
T KOG0615|consen  326 AKVS---GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK----EQILK  396 (475)
T ss_pred             hhcc---ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH----HHHhc
Confidence            9973   34556677899999999999976533   347899999999999999999997543221  111    11112


Q ss_pred             CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       686 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      +...  +.|    ..-.+...+..++|.+||..||++|||+.|+|++-+
T Consensus       397 G~y~--f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW  439 (475)
T KOG0615|consen  397 GRYA--FGP----LQWDRISEEALDLINWMLVVDPENRPSADEALNHPW  439 (475)
T ss_pred             Cccc--ccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence            2111  111    112356778899999999999999999999998654

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=380.79  Aligned_cols=260  Identities=26%  Similarity=0.416  Sum_probs=216.8

Q ss_pred             CCccceEeeeCceEEEEEEECC----CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ..+.++||.|.||+|++|.++-    ...||||.++... ++...+|+.|+.||.++.||||++|.|+.......+||.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            3456799999999999999864    4579999987764 4456789999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC-
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD-  616 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~-  616 (803)
                      ||++|+|+.+|+... +.+++.++..++++||.||.||-+   +++|||||.++|||++.+..+|++||||+|...... 
T Consensus       711 yMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  711 YMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            999999999997655 459999999999999999999998   999999999999999999999999999999754322 


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                      ......+.+-+.+|.|||.+...++|.+|||||||++|||.++ |.+|+-.....+.+..                ++..
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka----------------Ie~g  850 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA----------------IEQG  850 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH----------------HHhc
Confidence            1122223334689999999999999999999999999999886 8888754433322211                1122


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhcc
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES  742 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  742 (803)
                      .+-..+.+++..|.+|++.||++|-.+||.+.||+..|.+.+.-+.+
T Consensus       851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence            23345678899999999999999999999999999999988754443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-43  Score=348.82  Aligned_cols=257  Identities=25%  Similarity=0.346  Sum_probs=206.9

Q ss_pred             CCCccceEeeeCceEEEEEE-ECCCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEe-Eeeccce-eeEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVG-YCEEQSE-MILVY  536 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g-~~~~~~~-~~lV~  536 (803)
                      +|.+.++||+|.||+|||+. +.+|..+|.|.+.-.  +.+..+++..|+.+|++|+|||||++++ -+.++++ ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            46667789999999999999 567999999975422  3455678999999999999999999999 4555555 89999


Q ss_pred             EecCCCchhhhcc--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-ceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          537 EYMEKGPLKKHLY--GPDRTPLSWKQRLEICIGAARGLHYLHTGSAE-GIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       537 Ey~~~gsL~~~l~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      |||..|+|...+.  +..++.++++.+|+++.|++.||..+|+.... -|+||||||.||+|+.+|.+||+||||++...
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            9999999999983  45667899999999999999999999984322 38999999999999999999999999999754


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                        .........+||+.||+||.+.+.+|+.||||||+||++|||..-++||.+.      ++.+... .+..+...    
T Consensus       180 --s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~-KI~qgd~~----  246 (375)
T KOG0591|consen  180 --SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCK-KIEQGDYP----  246 (375)
T ss_pred             --chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHH-HHHcCCCC----
Confidence              2333455678999999999999999999999999999999999999999754      2221111 11112111    


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                          .......+..+.+||..|+..||..||+.-.+++.+..
T Consensus       247 ----~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  247 ----PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ----CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                11124567889999999999999999997666665554

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=359.78  Aligned_cols=264  Identities=27%  Similarity=0.403  Sum_probs=217.8

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCC-hHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG-LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      ....+.++||+|-||+|.++....+.+||||.+.+..... ..+|.+|+++|.+|+||||++|+|+|..++.+++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            3455667899999999999999888999999988775544 489999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+++.......+.-...++||.|||.||+||.+   .++|||||.++|+|+|.++++||+|||++|.....+..+
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            99999999966544445667788999999999999998   999999999999999999999999999999766666666


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHH--hCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL--CARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ell--tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      .......+++|||+|.+..++++.+||||+||++|||++  |...|+.....+..   .+-..........      ...
T Consensus       695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~------~~~  765 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGR------QVV  765 (807)
T ss_pred             eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCc------cee
Confidence            777778899999999999999999999999999999986  46677754332211   1111111111111      111


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      -..+.-++.++.+++.+|+..+..+||+++++...|++.
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            233456778899999999999999999999999888754

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=350.19  Aligned_cols=242  Identities=25%  Similarity=0.343  Sum_probs=202.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .++|+..++||+|+||+||.++.++ ++.+|+|.+...   ...+.+...+|..+|.+++||+||+++-.|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4678999999999999999999654 888999976543   334567789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      +||+.||.|..+|  .+...+++..+.-++.+|+.||.|||+   .+||||||||+|||||++|+++|+||||++...  
T Consensus       104 ld~~~GGeLf~hL--~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--  176 (357)
T KOG0598|consen  104 LDYLNGGELFYHL--QREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--  176 (357)
T ss_pred             EeccCCccHHHHH--HhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc--
Confidence            9999999999999  456679999999999999999999999   999999999999999999999999999998633  


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                      .........+||+.|||||++.+..|+..+|.||+|++||||++|.+||......+      +.....+. .        
T Consensus       177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~~-k--------  241 (357)
T KOG0598|consen  177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILKG-K--------  241 (357)
T ss_pred             cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhcC-c--------
Confidence            22233445799999999999999999999999999999999999999997653322      21111111 1        


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCC
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRP  724 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RP  724 (803)
                       ....+.-...+.++++.+.|..+|++|-
T Consensus       242 -~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence             0112222456789999999999999995

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-42  Score=363.01  Aligned_cols=250  Identities=29%  Similarity=0.482  Sum_probs=211.1

Q ss_pred             cccChhhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeec
Q 042150          449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE  528 (803)
Q Consensus       449 ~~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~  528 (803)
                      .++||++|..       .+-||.|+.|.||+|+++ ++.||||++....       ..+|+-|++|+||||+.+.|+|..
T Consensus       119 WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  119 WEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             ccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence            4577777754       347999999999999997 6789999854322       357889999999999999999999


Q ss_pred             cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                      ..-+|||||||..|.|...|  +.+..++......+..+||.||+|||.   ++|||||||.-||||..+..+||+|||.
T Consensus       184 sPcyCIiMEfCa~GqL~~VL--ka~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVL--KAGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             CceeEEeeeccccccHHHHH--hccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccc
Confidence            99999999999999999999  556778899999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ++....   .......+||..|||||++++++.++|.|||||||||||||||..|+...+....               +
T Consensus       259 S~e~~~---~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------I  320 (904)
T KOG4721|consen  259 SKELSD---KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------I  320 (904)
T ss_pred             hHhhhh---hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------E
Confidence            986432   2344567899999999999999999999999999999999999999875432211               0


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      -.+-...|.-..+..++..|.-|+++||+..|.+||++++++.+|+.+
T Consensus       321 wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  321 WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            111122233345667888899999999999999999999999999754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=389.26  Aligned_cols=261  Identities=30%  Similarity=0.430  Sum_probs=216.6

Q ss_pred             CCCccceEeeeCceEEEEEEECC--Cc----EEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD--NT----KVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      +......||+|.||.||+|...+  +.    .||||.+... +.+...+|++|..+|++++|||||+++|+|.+....+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            34456689999999999999754  32    4888886655 45667899999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          535 VYEYMEKGPLKKHLYGPD-----RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      ++|||++|+|..+|++.+     ...|+..+++.++.|||+|+.||++   +++|||||.++|+||++...+||+|||||
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchh
Confidence            999999999999997642     4569999999999999999999999   99999999999999999999999999999


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      |.....+............+|||||.+..+.++.|+|||||||+|||++| |..||......+...      .+...++ 
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~ggR-  922 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGGR-  922 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCCc-
Confidence            96544444433333456689999999999999999999999999999998 778886554333221      1222221 


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                             |  ..+..++..+.+|+.+||+.+|++||++..+++++..+.+...
T Consensus       923 -------L--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  923 -------L--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             -------c--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence                   1  3456778889999999999999999999999999888875543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=350.88  Aligned_cols=255  Identities=21%  Similarity=0.286  Sum_probs=211.4

Q ss_pred             HHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccce
Q 042150          457 QTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       457 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~  531 (803)
                      +...++|..++.||+|+|++|++|+.+ .++.+|||++...   .++..+-...|-+.|.+| .||.|++|+-.|++...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            456678999999999999999999954 5899999975432   233345567899999999 79999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      +|+|+||+++|+|.++|.  +-+.|++.....++.+|+.||+|||+   +|||||||||+|||||++|++||+|||.|+.
T Consensus       149 LYFvLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             eEEEEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence            999999999999999994  45779999999999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCCCC---------ce--eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH
Q 042150          612 GPCLDET---------HV--STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM  680 (803)
Q Consensus       612 ~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  680 (803)
                      +......         ..  ....+||..|.+||++..+..+..+|+|+|||+||+|+.|++||....+-   .+.+   
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---liFq---  297 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LIFQ---  297 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HHHH---
Confidence            5432211         11  14478999999999999999999999999999999999999999754221   1111   


Q ss_pred             HHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                               +|++  +.-.+++..++.+.+|+.+.|..||.+|+|..+|-++.
T Consensus       298 ---------kI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  298 ---------KIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ---------HHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                     1111  12244555667889999999999999999999998754

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=349.76  Aligned_cols=259  Identities=26%  Similarity=0.373  Sum_probs=206.3

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccc--eeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS--EMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~--~~~lV~E  537 (803)
                      .++...+.||+|+||.||++...+ |...|||..........+.+.+|+.+|.+++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            346677899999999999999765 8899999865443333677899999999999999999999854444  6899999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-CCcEEEeeeccccCCCC-C
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-NYVSKVADFGLSRSGPC-L  615 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla~~~~~-~  615 (803)
                      |+++|+|.+++.+... .|++..+..+..||++||+|||+   ++|+||||||+||||+. ++.+||+|||+++.... .
T Consensus        97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999966555 79999999999999999999998   99999999999999999 79999999999986442 1


Q ss_pred             CCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ..........||+.|||||++..+ ....++|||||||++.||+||++||....     ....+........        
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~--------  239 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGRED--------  239 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccC--------
Confidence            112233457899999999999854 33359999999999999999999987531     1111111111111        


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                       ....++...+....+++.+|++.+|.+|||+.++|++.....
T Consensus       240 -~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  240 -SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             -CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence             112445556678899999999999999999999998766443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4e-40  Score=361.07  Aligned_cols=262  Identities=26%  Similarity=0.413  Sum_probs=204.9

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhc-cCCCeeeEEeEeecc-
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ-  529 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~-  529 (803)
                      ..++|...++||+|+||.||+|.+.      .+..||||++..... ...+.+.+|+.+|.++ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3467888899999999999999742      246799998764332 2346789999999999 899999999998764 


Q ss_pred             ceeeEEEEecCCCchhhhccCCC---------------------------------------------------------
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPD---------------------------------------------------------  552 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------  552 (803)
                      +.+++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46899999999999999885321                                                         


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCc
Q 042150          553 ---RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG  629 (803)
Q Consensus       553 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  629 (803)
                         ...+++.+++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++...............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               1358889999999999999999999   9999999999999999999999999999976432221122223456788


Q ss_pred             ccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHH
Q 042150          630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKF  708 (803)
Q Consensus       630 y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l  708 (803)
                      |+|||++.+..++.++|||||||+||||++ |+.||......+.     .. .....+..     .    ..+...+..+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~-~~~~~~~~-----~----~~~~~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FC-QRLKDGTR-----M----RAPENATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HH-HHHhcCCC-----C----CCCCCCCHHH
Confidence            999999999999999999999999999997 9999875332111     11 11111111     0    1122345678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          709 GETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       709 ~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      .+++.+||+.+|.+|||+.|+++.|+.+++
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=364.36  Aligned_cols=261  Identities=30%  Similarity=0.449  Sum_probs=210.2

Q ss_pred             cCCCccceEeeeCceEEEEEEECCC-----cEEEEEEcCC---CCCCChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVP---GSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~-----~~vavK~~~~---~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      ++....++||+|.||.||+|.++..     ..||||....   ..+..+.+|++|+++|++++|||||+++|++.....+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            3344457999999999999997542     2389998664   2355678999999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      +||||+|.||+|.++|.+.. ..++..+++.++.++|+||+|||+   ++++||||.++|+|++.++.+||+||||++..
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999995433 269999999999999999999999   99999999999999999999999999999864


Q ss_pred             CCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ..  .........-+..|+|||.+....++.++|||||||++||+++ |..|+.+....+   +..++   ...+     
T Consensus       313 ~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI---~~~~-----  379 (474)
T KOG0194|consen  313 SQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKI---VKNG-----  379 (474)
T ss_pred             cc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHH---HhcC-----
Confidence            31  1111112346789999999999999999999999999999998 788887554321   11111   0111     


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhcc
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES  742 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  742 (803)
                          ..-..+...+..+..+..+|+..+|++||+|.++.+.|+.+......
T Consensus       380 ----~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  380 ----YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ----ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                11122335566778889999999999999999999999988765543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=356.16  Aligned_cols=268  Identities=29%  Similarity=0.484  Sum_probs=215.0

Q ss_pred             ChhhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeecc
Q 042150          452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ  529 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~  529 (803)
                      +.+++....+++.....||+|.||+||+|.|.  ..||||.+...  ..+..+.|++|+..+++-+|.||+-++|||...
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            34555555566667779999999999999986  37999986544  334578899999999999999999999999988


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      .. .||..+|++.+|+.+||..+ ..+...+.+.|+.|||+||.|||.   ++|||||||..||+|.+++++||+||||+
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccce
Confidence            77 99999999999999997644 669999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCceeccccCCCcccCcccccc---CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRR---QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG  686 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (803)
                      .....-..........|...|||||+++.   .+|+..+||||||+|+|||+||..||. ....+++..      +...|
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIif------mVGrG  608 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIF------MVGRG  608 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEE------Eeccc
Confidence            64222222233344567889999999964   589999999999999999999999997 333332210      01111


Q ss_pred             ccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          687 MLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       687 ~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      .    ..+++ ......+.+++.+|+..||..++++||.+.+|+..|+..+.
T Consensus       609 ~----l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  609 Y----LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             c----cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            0    11111 12334677899999999999999999999999999888764

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.3e-40  Score=329.27  Aligned_cols=265  Identities=23%  Similarity=0.310  Sum_probs=206.1

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      +.|+...++|+|+||.|||++.++ |+.||||++.....  ...+-.++|+++|++|+|||||.|+.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            346667789999999999999875 89999999765433  234567899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      ||+.--|.++-+  ....++.+.+.+++.|+++|+.|+|+   ++++||||||+||||+.++.+||||||+|+....  .
T Consensus        82 ~~dhTvL~eLe~--~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--p  154 (396)
T KOG0593|consen   82 YCDHTVLHELER--YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--P  154 (396)
T ss_pred             ecchHHHHHHHh--ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC--C
Confidence            999855555442  33458889999999999999999999   9999999999999999999999999999997542  2


Q ss_pred             CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH--------HH-hhcCc
Q 042150          618 THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM--------QW-QKKGM  687 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~-~~~~~  687 (803)
                      ....+..+.|.-|.|||.+.+ .+|....||||.||++.||++|.+.|.+...-++..+.....        +. .....
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            334456778999999999987 799999999999999999999999887665555443322110        00 01111


Q ss_pred             ccccc-----CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          688 LEHII-----DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       688 ~~~i~-----d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...+.     ++......-+....-+.++++.||+.||.+|++-+|++.+
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            11111     1111111112344578899999999999999999999863

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=347.50  Aligned_cols=263  Identities=22%  Similarity=0.278  Sum_probs=209.2

Q ss_pred             HhcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHH--HHHHHHHHhcc-CCCeeeEEeEeeccc-eee
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEF--QTEITVLSKIR-HRHLVSLVGYCEEQS-EMI  533 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f--~~E~~~l~~l~-HpnIv~l~g~~~~~~-~~~  533 (803)
                      ..++|...++||.|.||.||+|+- ..+..||||+++..-.. .++.  ++|+..|++|+ ||||++|..++.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            346678888999999999999994 45889999987765433 4444  68999999998 999999999998887 999


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +|||||+. +|.+++.++ +..+++..+..|+.||++||+|+|.   +|+.||||||+|||+.....+||+||||||...
T Consensus        87 fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence            99999986 999999765 7889999999999999999999999   999999999999999999999999999999743


Q ss_pred             CCCCCceeccccCCCcccCccccc-cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC------
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG------  686 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------  686 (803)
                      .   ....+..+.|.-|.|||++. ..-|+.+.|+|++|||++|+.+-++.|.+..+.++..-.   .+.....      
T Consensus       162 S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI---c~VLGtP~~~~~~  235 (538)
T KOG0661|consen  162 S---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI---CEVLGTPDKDSWP  235 (538)
T ss_pred             c---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH---HHHhCCCccccch
Confidence            2   23345567889999999875 678999999999999999999999988766555443221   1111111      


Q ss_pred             ---ccccccCccc-------ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          687 ---MLEHIIDPQL-------IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       687 ---~~~~i~d~~l-------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                         .+...+.-++       ....-+.+..++.+++.+||++||.+|||+.|.+++-
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence               1111111111       0111123667889999999999999999999999864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-39  Score=342.37  Aligned_cols=266  Identities=26%  Similarity=0.315  Sum_probs=208.3

Q ss_pred             hcCCCccceEeeeCceEEEEEE-ECCCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeecc--ceeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~l  534 (803)
                      .+.|+...+||+|.||.||+|+ ..+|+.||+|++.-..  ........+||.+|++|.||||++|.+...+.  +.+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3456777799999999999999 5679999999866544  33345668999999999999999999988766  78999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      |+|||++ +|.-++.. ..-.+++.++..++.|++.||+|||+   .+|+|||||.+|||||.+|.+||+|||||+....
T Consensus       196 VFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            9999998 88888843 34579999999999999999999999   9999999999999999999999999999996543


Q ss_pred             CCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH-----HHhhcCcc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM-----QWQKKGML  688 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~~  688 (803)
                       ......+..+-|+-|.|||.+.+ ..|+.+.|+||.||||.||+.|++.+.+..+.++....-...     ..+....+
T Consensus       271 -~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  271 -SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             -CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence             23333566778999999999986 489999999999999999999999998877666654322110     00111111


Q ss_pred             c--cccCc------ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 E--HIIDP------QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~--~i~d~------~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .  .++.+      .+... -........+|+..+|..||.+|.|+.++|+.
T Consensus       350 P~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            1  11111      11100 01224567899999999999999999999864

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.8e-39  Score=342.79  Aligned_cols=249  Identities=23%  Similarity=0.364  Sum_probs=200.9

Q ss_pred             CccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCC---hHHHHHHHHHHHhccCCCeeeEEeEeec----cceeeEEE
Q 042150          464 DKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG---LPEFQTEITVLSKIRHRHLVSLVGYCEE----QSEMILVY  536 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~lV~  536 (803)
                      .....||+|++|.||+|.+ +|+.||||++.......   .+.|.+|+.+|++++||||++++|++.+    ...+++||
T Consensus        23 ~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         23 YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            3345899999999999998 58899999876543333   4678899999999999999999999876    35689999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++..  ...+++...++++.|++.||.|||+  ..+++||||||+|||+++++.+||+|||+++..... 
T Consensus       102 Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-  176 (283)
T PHA02988        102 EYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-  176 (283)
T ss_pred             EeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-
Confidence            99999999999943  4578999999999999999999997  237889999999999999999999999998753221 


Q ss_pred             CCceeccccCCCcccCcccccc--CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                          .....++..|+|||++.+  ..++.++|||||||++|||++|+.||......+.      .......+.       
T Consensus       177 ----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~------~~~i~~~~~-------  239 (283)
T PHA02988        177 ----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI------YDLIINKNN-------  239 (283)
T ss_pred             ----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcCC-------
Confidence                123457889999999976  7899999999999999999999999975432211      111111110       


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                        ....+..++..+.+++.+||+.+|.+|||+.|+++.|+...
T Consensus       240 --~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        240 --SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             --CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence              01122345667899999999999999999999999998764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=350.61  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=209.3

Q ss_pred             cCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      ..|....+||+|..|.||.|.. ..++.||||++........+-..+|+.+|+..+|+|||.++..+...+++++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            3466667899999999999984 558899999987776666677899999999999999999999998889999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+.+   ....+++.++..||.+++.||+|||.   ++|+|||||.+|||++.++.+||+|||++......  ..
T Consensus       353 ~ggsLTDvV---t~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~~  424 (550)
T KOG0578|consen  353 EGGSLTDVV---TKTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--QS  424 (550)
T ss_pred             CCCchhhhh---hcccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccc--cC
Confidence            999999999   44559999999999999999999999   99999999999999999999999999998765432  22


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......||+.|||||+.....|..|.||||||++++||+-|.+||-...+-..    .|...  ..+      -|.+  .
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA----lyLIa--~ng------~P~l--k  490 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIA--TNG------TPKL--K  490 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH----HHHHh--hcC------CCCc--C
Confidence            34567899999999999999999999999999999999999999854222111    11111  111      1111  2


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+...++.|.+++.+||..|+.+||++.|+|++
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            334567889999999999999999999999985

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.5e-39  Score=344.46  Aligned_cols=247  Identities=28%  Similarity=0.408  Sum_probs=210.7

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|...+.||+|.||+||||+-+. .+.||+|.....  .+++.+...+|++++++++||||+.++++|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            467777899999999999999654 778999975443  33456678999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+.+ +|..+|  ...+.++++.+..|+.++..||.|||+   .+|+|||+||+||||+.++.+|+||||+||.+.  ..
T Consensus        82 ~a~g-~L~~il--~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--~~  153 (808)
T KOG0597|consen   82 YAVG-DLFTIL--EQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMS--TN  153 (808)
T ss_pred             hhhh-hHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcc--cC
Confidence            9987 999999  556789999999999999999999999   999999999999999999999999999999754  35


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      ....+.+.||+-|||||...+++|+..+|+||+||+||||++|++||....      +.+.+.....        |+-  
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~--------d~v--  217 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILK--------DPV--  217 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhc--------CCC--
Confidence            566778899999999999999999999999999999999999999986321      1112222111        111  


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       ..+......+..++...|.+||.+|.+..+++.+
T Consensus       218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence             2334667889999999999999999999999875

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=334.20  Aligned_cols=263  Identities=24%  Similarity=0.302  Sum_probs=210.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ...|+....||.|..++||+|+. ..++.||||++... .....+.+.+|+..|+.++||||++++..|..+..+++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            45788888999999999999995 55899999986543 44457889999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      ||.+|++.+.+...-...+++..+..|.+++++||.|||.   +|.||||||+.||||+++|.+||+|||.+-.......
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            9999999999965545569999999999999999999999   9999999999999999999999999998754332222


Q ss_pred             Cc-ee-ccccCCCcccCccccc--cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          618 TH-VS-TGVKGSFGYLDPEYFR--RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       618 ~~-~~-~~~~gt~~y~aPE~~~--~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      .. .. ....||+.|||||+++  -..|+.|+||||||++..||.+|..||....+.+..     ............  -
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tLqn~pp~~~--t  254 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTLQNDPPTLL--T  254 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHhcCCCCCcc--c
Confidence            21 11 4568999999999965  357999999999999999999999999865544321     111111111000  1


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..+..+........+.+++..||+.||.+|||+++++.+
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            111111223345689999999999999999999999863

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.5e-39  Score=354.82  Aligned_cols=259  Identities=24%  Similarity=0.363  Sum_probs=203.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEE------CCCcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL------RDNTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~  531 (803)
                      .++|...+.||+|+||.||+|++      ..+..||||++.... ....+.+.+|+++|..+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45688889999999999999974      235689999876432 23356789999999999 89999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCC-----------------------------------------------------------
Q 042150          532 MILVYEYMEKGPLKKHLYGPD-----------------------------------------------------------  552 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  552 (803)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999998885321                                                           


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          553 --------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       553 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                                    ...+++..+++++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          1257899999999999999999999   89999999999999999999999999999764322221


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......  ....+    ...+..         
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~~~---------  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEGYR---------  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhCcc---------
Confidence            22223345678999999999999999999999999999998 888876432211  11111    111110         


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      ...+...+.++.+|+.+||+.+|.+||++.||++.|+..
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            001112245789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.3e-38  Score=391.77  Aligned_cols=262  Identities=27%  Similarity=0.454  Sum_probs=216.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ...+...++||+|+||.||+|+. .++..||||++.....    ....|++.+++++||||++++|+|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            34577788999999999999997 4688999998654322    123568899999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.++++     .++|.++.+|+.|+|+||+|||..+..+|+||||||+||+++.++..++. ||......     
T Consensus       765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~-----  833 (968)
T PLN00113        765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-----  833 (968)
T ss_pred             CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-----
Confidence            99999999993     38999999999999999999997556899999999999999999988876 66654321     


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                       ......++..|||||++.+..++.++|||||||++|||++|+.|++.... ....+.+|++..........++|+.+..
T Consensus       834 -~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        834 -TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             -cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence             11223678999999999999999999999999999999999999864322 2345667777665555566677776644


Q ss_pred             C--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          699 K--INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       699 ~--~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      .  .+.++..++.+++.+|++.+|++||+|.||++.|+.+.+
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            3  345667788999999999999999999999999998764

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.4e-38  Score=341.74  Aligned_cols=262  Identities=25%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-----------------CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-----------------NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSL  522 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l  522 (803)
                      ++|...+.||+|+||.||++.+++                 +..||+|.+.... .....+|.+|+++|.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467788899999999999998643                 2369999866543 2234679999999999999999999


Q ss_pred             EeEeeccceeeEEEEecCCCchhhhccCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEe
Q 042150          523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPD-----------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH  585 (803)
Q Consensus       523 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  585 (803)
                      ++++.+.+..++||||+++|+|.+++....                 ...++|.++++++.||+.||.|||+   .+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence            999999999999999999999999884321                 1357889999999999999999999   89999


Q ss_pred             eccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh--CCCC
Q 042150          586 RDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC--ARTA  663 (803)
Q Consensus       586 rDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p  663 (803)
                      |||||+|||+++++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999976433222222233456789999999998999999999999999999987  4566


Q ss_pred             CCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          664 VDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       664 ~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      +......+   ....+......... .+     ....+..++..+.+++.+||+.+|.+|||+.+|.+.|+
T Consensus       242 ~~~~~~~~---~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQ---VIENAGEFFRDQGR-QV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHH---HHHHHHHHhhhccc-cc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            65432221   11222221111100 00     01112344567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-38  Score=338.41  Aligned_cols=251  Identities=24%  Similarity=0.331  Sum_probs=202.1

Q ss_pred             CCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          463 FDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      |...+.||+|+||.||++.. .+++.||+|.+....   ......+.+|++++.+++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66778999999999999996 468999999865332   22345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.+++.......+++.+++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....   .
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~  155 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---G  155 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---C
Confidence            999999988865455579999999999999999999999   9999999999999999999999999999876322   1


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .......|+..|+|||++.+..++.++|||||||+||||++|+.||.........  .... ......          ..
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~-~~~~~~----------~~  222 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVD-RRVKED----------QE  222 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHH-HHhhcc----------cc
Confidence            1223456899999999999999999999999999999999999999754321111  0110 000000          01


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWN  732 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  732 (803)
                      .++......+.+|+.+||+.+|.+||+     +++++++
T Consensus       223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            222334567889999999999999997     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=346.51  Aligned_cols=262  Identities=27%  Similarity=0.397  Sum_probs=221.4

Q ss_pred             HHHHhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          456 LQTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       456 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ++....++...++||-|.||.||.|+|+. .-.||||.++.+ ....++|+.|..+|+.++|||+|+|+|+|..+..+||
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI  340 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI  340 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence            33344556677899999999999999975 567999987654 4568999999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      |.|||.+|+|.++|+..++..++--.++.++.||+.||+||..   .++|||||.++|+|+.++..+||+||||++.+..
T Consensus       341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            9999999999999998888889999999999999999999998   9999999999999999999999999999998654


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                       +.........-.+.|.|||.+....++.|+|||+|||+||||.| |-.|+.+.+-.....                ++.
T Consensus       418 -DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~----------------LLE  480 (1157)
T KOG4278|consen  418 -DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG----------------LLE  480 (1157)
T ss_pred             -CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH----------------HHh
Confidence             33333344556889999999999999999999999999999987 667776543222111                112


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ...+-+-+..|++++.+|++.||+++|.+||+++|+-+.+|.+.+
T Consensus       481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            222224456788999999999999999999999999999998764

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.1e-39  Score=337.62  Aligned_cols=250  Identities=36%  Similarity=0.541  Sum_probs=196.6

Q ss_pred             ccceEeeeCceEEEEEEEC-----CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          465 KNLIIGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       465 ~~~~Lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ..+.||.|.||.||+|.+.     .+..|+||.+..... ...++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3468999999999999987     257899999755332 2367899999999999999999999999988889999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.++|.......+++.++++|+.||++||+|||+   .+++|+||+++|||+++++.+||+|||+++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            999999999976656789999999999999999999999   89999999999999999999999999999864222222


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+......+      +.... .++..         
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~~~~~-~~~~~---------  223 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------IIEKL-KQGQR---------  223 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------HHHHH-HTTEE---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc-ccccc---------
Confidence            33344567789999999999999999999999999999999 678876442211      11121 11111         


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      ...+..++..+.+++.+||+.+|.+||++.++++.|
T Consensus       224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            112223456788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-38  Score=352.79  Aligned_cols=261  Identities=23%  Similarity=0.389  Sum_probs=204.6

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccc
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQS  530 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~  530 (803)
                      ..++|...+.||+|+||.||+|+..      ++..||||++.... ....+.+.+|+++++.+ +||||++++++|...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            4457888899999999999998842      23579999875432 22345688999999999 8999999999999999


Q ss_pred             eeeEEEEecCCCchhhhccCCC----------------------------------------------------------
Q 042150          531 EMILVYEYMEKGPLKKHLYGPD----------------------------------------------------------  552 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------  552 (803)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999884311                                                          


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceec
Q 042150          553 ----------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST  622 (803)
Q Consensus       553 ----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  622 (803)
                                ...+++.++++++.||++||+|||+   ++|+||||||+|||+++++.+||+|||+++............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                      1347889999999999999999999   999999999999999999999999999997643222111222


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ...++..|||||++.+..++.++|||||||++|||++ |+.||........  .    ......+.         ....+
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~----~~~~~~~~---------~~~~~  337 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F----YKMVKRGY---------QMSRP  337 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H----HHHHHccc---------CccCC
Confidence            3345678999999999999999999999999999997 9999865432111  1    01111110         00111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      ...+..+.+++.+||+.+|.+||++.+|++.|+++.
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            123467899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.7e-38  Score=340.96  Aligned_cols=242  Identities=24%  Similarity=0.296  Sum_probs=197.4

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      ++||+|+||.||++..+ +++.||+|.+...   .......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999965 5889999986543   2334567889999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceec
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST  622 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  622 (803)
                      +|..++.  ....+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~  153 (328)
T cd05593          81 ELFFHLS--RERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMK  153 (328)
T ss_pred             CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccc
Confidence            9998884  34568999999999999999999999   9999999999999999999999999999875321  111223


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCH
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINL  702 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  702 (803)
                      ...||+.|+|||++.+..++.++|||||||+||||++|+.||......+..      .... ..      +.    .++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~------~~~~-~~------~~----~~p~  216 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELIL-ME------DI----KFPR  216 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH------HHhc-cC------Cc----cCCC
Confidence            457899999999999999999999999999999999999999643322111      1100 00      00    1222


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          703 DSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       703 ~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                      .....+.+++.+||+.+|.+||     ++.+++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            3456788999999999999997     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=343.75  Aligned_cols=252  Identities=28%  Similarity=0.391  Sum_probs=206.8

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC----CC-CChHHHHHHHHHHHhcc-CCCeeeEEeEeeccce
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG----SR-QGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSE  531 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~  531 (803)
                      ....|...+.||+|+||+|++|... ++..||+|.....    .. ...+...+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4567888999999999999999854 5899999964432    11 23455678999999998 9999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC-CcEEEeeecccc
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSR  610 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~kl~DFGla~  610 (803)
                      +++||||+.+|+|.+++..  .+++.+.+...++.|++.|++|||+   ++|+||||||+|||++.+ +++||+|||++.
T Consensus        95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            9999999999999999954  6779999999999999999999999   999999999999999999 999999999998


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccCc-CC-CcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQ-LT-DKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ...  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.....   .+..   . +..+..
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~~---k-i~~~~~  240 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLYR---K-IRKGEF  240 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHHH---H-HhcCCc
Confidence            743  2333455679999999999999877 87 6799999999999999999999863211   1111   1 111110


Q ss_pred             ccccCcccccCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDS-LKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~-~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                                .++... ..++..++.+||..+|.+|+++.+++++-+
T Consensus       241 ----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w  277 (370)
T KOG0583|consen  241 ----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPW  277 (370)
T ss_pred             ----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence                      122222 678899999999999999999999996544

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=356.73  Aligned_cols=263  Identities=21%  Similarity=0.273  Sum_probs=216.3

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEECCC-cEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEe-e----c--
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYC-E----E--  528 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~-~----~--  528 (803)
                      ....+..+.+.|.+|||+.||.|....+ .++|+|++...+++..+...+|+++|++|+ |||||.+++.. .    .  
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3455677788999999999999998765 999999988888888999999999999997 99999999932 1    1  


Q ss_pred             cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                      .-+.+|.||||++|.|-+++..+-...|++.++++|+.|+++|+++||. ...+|||||||-+||||..++..||||||.
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            2468999999999999999965555569999999999999999999998 557799999999999999999999999999


Q ss_pred             ccCCCCCCCCce-------eccccCCCcccCcccc---ccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHH
Q 042150          609 SRSGPCLDETHV-------STGVKGSFGYLDPEYF---RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW  678 (803)
Q Consensus       609 a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  678 (803)
                      +......-....       ......|+.|.|||.+   .+.++++|+|||+|||+||-|+....||+....         
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------  263 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------  263 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence            864221111111       1123578999999987   578999999999999999999999999974311         


Q ss_pred             HHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          679 AMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       679 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                                ..|++....-...+.....|.+||..||+.+|.+||++.+|+..+.++...+
T Consensus       264 ----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  264 ----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                      1234444333333578899999999999999999999999999998887543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.2e-38  Score=342.33  Aligned_cols=245  Identities=21%  Similarity=0.279  Sum_probs=200.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|+.+ +++.||+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56788889999999999999976 4789999986432   2234567899999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.  ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        98 e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         98 EFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             cCCCCChHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            9999999999994  34568899999999999999999999   99999999999999999999999999998753221 


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                          .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.      ... ...+..        
T Consensus       172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~-i~~~~~--------  232 (329)
T PTZ00263        172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI------YEK-ILAGRL--------  232 (329)
T ss_pred             ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH------HHH-HhcCCc--------
Confidence                1235689999999999999999999999999999999999999864322111      011 111111        


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  732 (803)
                        .++......+.+++.+||+.||.+||+     +.+++.+
T Consensus       233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              111223456789999999999999997     6887765

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=317.02  Aligned_cols=236  Identities=25%  Similarity=0.319  Sum_probs=199.7

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .+|+..+.||.|+||+|.+.+.+. |..+|+|++....   .+..+...+|..+|+.+.||++++|.+.|.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            467788899999999999999765 7789999865432   223456788999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|.|..+|+  +.+.+++....-++.||+.||+|||+   .+|++|||||+|||||.+|.+||+|||+|+....  
T Consensus       124 eyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--  196 (355)
T ss_pred             eccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence            9999999999994  45679999999999999999999999   9999999999999999999999999999987432  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                         .....+||+.|+|||.+..+.+..++|.|||||++|||++|.+||.......   +            .+.|+...+
T Consensus       197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---i------------Y~KI~~~~v  258 (355)
T KOG0616|consen  197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---I------------YEKILEGKV  258 (355)
T ss_pred             ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---H------------HHHHHhCcc
Confidence               2556899999999999999999999999999999999999999997554311   1            111222211


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCC
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDR  723 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~R  723 (803)
                        .++.-....+.+|+.+.|+.|-.+|
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence              3445556778999999999999988

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.9e-38  Score=335.34  Aligned_cols=256  Identities=28%  Similarity=0.441  Sum_probs=206.1

Q ss_pred             cCCCccceEeeeCceEEEEEEECCC------cEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDN------TKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~------~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      ++|...+.||+|+||.||+|.....      ..|++|....... ....+|.+|++++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            3577788999999999999986432      5789998654332 23467899999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC
Q 042150          534 LVYEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY  599 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~  599 (803)
                      ++|||+++|+|.+++....              ...+++.+++.++.|++.||.|||+   .+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence            9999999999999985321              1568899999999999999999999   8999999999999999999


Q ss_pred             cEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHH
Q 042150          600 VSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEW  678 (803)
Q Consensus       600 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  678 (803)
                      .+||+|||+++.....+.........+++.|+|||.+.+..++.++|||||||++|||++ |..||......+   +...
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~  238 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM  238 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence            999999999976433222222334456788999999998999999999999999999998 999987543322   1111


Q ss_pred             HHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          679 AMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       679 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                          ...+..         ...+..++.++.+|+.+||+.+|.+||++.||+++|+.
T Consensus       239 ----i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 ----IRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ----HHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                111111         12234556789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-37  Score=338.67  Aligned_cols=242  Identities=22%  Similarity=0.278  Sum_probs=196.8

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      ++||+|+||.||++... ++..||+|.+...   .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999965 5889999986543   2334567789999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceec
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST  622 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  622 (803)
                      +|..++.  ....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~  153 (323)
T cd05595          81 ELFFHLS--RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMK  153 (323)
T ss_pred             cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccc
Confidence            9998883  34568999999999999999999999   8999999999999999999999999999875321  111223


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCH
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINL  702 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  702 (803)
                      ...||+.|+|||++.+..++.++|||||||+||||++|+.||.........      ..... ..      .    .++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~~~~-~~------~----~~p~  216 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------ELILM-EE------I----RFPR  216 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHhc-CC------C----CCCC
Confidence            456899999999999999999999999999999999999998654322111      01000 00      0    1222


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          703 DSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       703 ~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                      .....+.+++.+||+.+|.+||     ++.+++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            3456788999999999999998     88888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1e-37  Score=338.82  Aligned_cols=257  Identities=24%  Similarity=0.372  Sum_probs=202.9

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-Cc----EEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NT----KVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .+|+..+.||+|+||.||+|++.. +.    .||+|.+.... ....++|.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468888999999999999998643 33    48999875433 23456899999999999999999999999765 5679


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      |+||+++|+|.+++... ...+++..++.++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence            99999999999999543 3458899999999999999999999   9999999999999999999999999999986443


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ............+..|+|||.+.+..++.++|||||||++|||++ |+.|++.....+   +...    ...+.      
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~------  228 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGE------  228 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HhCCC------
Confidence            222222223345678999999999999999999999999999997 999986542221   1111    11110      


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                         ....+..+...+.+++.+|++.+|.+||++.+++..|..+..
T Consensus       229 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         229 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence               001112234568899999999999999999999999887753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.4e-38  Score=330.70  Aligned_cols=256  Identities=21%  Similarity=0.361  Sum_probs=203.8

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC----CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR----DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .++|...+.||+|+||.||+|.++    .+..||+|....... .....|.+|+.++.+++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356788889999999999999864    356899998665432 334578999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++... ...+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.+|++|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            99999999999998542 3468999999999999999999998   9999999999999999999999999998765221


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      . .........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+   ..+    ....+..     
T Consensus       160 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~----~~~~~~~-----  226 (266)
T cd05064         160 E-AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK----AVEDGFR-----  226 (266)
T ss_pred             c-chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH----HHHCCCC-----
Confidence            1 1111112345678999999999999999999999999999875 999986543221   111    1111110     


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                          ...+..++..+.+++.+||+.+|.+||++.++++.|...
T Consensus       227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                112234556789999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.9e-38  Score=307.02  Aligned_cols=263  Identities=24%  Similarity=0.325  Sum_probs=205.2

Q ss_pred             CCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCC-C-hHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQ-G-LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|...++||+|.||.||+|+. +.|+.||||++...... + .....+|++.|+.++|+||+.|+++|...+.+.||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            567778999999999999995 56999999987655322 2 34678999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      |+. +|...++. +...++..++..++.++++||+|||+   +.|+||||||.|+||+++|.+||+|||+|+.....+. 
T Consensus        83 m~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-  156 (318)
T KOG0659|consen   83 MPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-  156 (318)
T ss_pred             ccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-
Confidence            986 89888854 45678999999999999999999999   9999999999999999999999999999997554332 


Q ss_pred             ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH------HHhhcCcccc-
Q 042150          619 HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM------QWQKKGMLEH-  690 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~------~~~~~~~~~~-  690 (803)
                       ..+..+-|.-|.|||.+.+ +.|....|+||.|||+.||+-|.+-|.+...-++....-.+.      +|..-..+.+ 
T Consensus       157 -~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  157 -IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             -ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence             2333467889999999876 589999999999999999999998776655444433221110      0000000111 


Q ss_pred             -----ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          691 -----IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       691 -----i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                           .-.+.+..-+ ..+...+.+++.+++..||.+|+++.|++++
T Consensus       236 ~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                 1111111111 2345567999999999999999999999876

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-38  Score=342.33  Aligned_cols=253  Identities=25%  Similarity=0.349  Sum_probs=204.7

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|.... ++.||+|++...   .....+.+.+|++++..++||||+++++++.+.+..+|||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            367888999999999999999764 789999986533   2234567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.  ....+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....  
T Consensus        81 e~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            9999999999994  34568999999999999999999999   9999999999999999999999999999975322  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhh-HHHHHHHHhhcCccccccCcc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN-LAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~i~d~~  695 (803)
                         ......||+.|+|||++.+..++.++|||||||+||||++|+.||......+... +..|.      ..+.   .+.
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~---~~~  221 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK------ETLQ---RPV  221 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc------cccc---CCC
Confidence               2334578999999999999999999999999999999999999997543322211 11110      0000   010


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      . ..........+.+++.+||..+|.+||++.+++++-
T Consensus       222 ~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~  258 (333)
T cd05600         222 Y-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP  258 (333)
T ss_pred             C-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence            0 000123456788999999999999999999998763

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-37  Score=331.28  Aligned_cols=266  Identities=20%  Similarity=0.220  Sum_probs=202.6

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|...+.||+|+||.||+++.+ +++.||+|++...  .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888899999999999999986 4788999986543  23345678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |++++.|..+.  .....+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~~~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  154 (287)
T cd07848          81 YVEKNMLELLE--EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-  154 (287)
T ss_pred             cCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence            99988776554  234568999999999999999999998   999999999999999999999999999997643211 


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHH---------HHHHhhcCcc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW---------AMQWQKKGML  688 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~---------~~~~~~~~~~  688 (803)
                      ........++..|+|||++.+..++.++|||||||++|||++|+.||......+.......         ..........
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            1122335689999999999999999999999999999999999999975433222111100         0000011111


Q ss_pred             ccccCccccc------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EHIIDPQLIG------KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l~~------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .....+....      ......+..+.+++.+||+.+|.+|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            1111111100      0111234678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.5e-37  Score=328.04  Aligned_cols=255  Identities=28%  Similarity=0.398  Sum_probs=206.5

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .+|...+.||+|+||.||+|..++ ++.|++|.... ......++.+|++++++++||||++++++|......++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecC-CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            356777899999999999999754 78899998654 3344678999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.......+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++...... ..
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~-~~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YT  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccce-ee
Confidence            99999999965555679999999999999999999998   899999999999999999999999999987643211 11


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..|+......+      ..... ...         ...
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~-~~~---------~~~  224 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELL-EKG---------YRM  224 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHH-HCC---------CCC
Confidence            1112234668999999999999999999999999999998 888886432221      11111 111         111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      ..+...+..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            22233456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=326.77  Aligned_cols=255  Identities=29%  Similarity=0.457  Sum_probs=207.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .++|...+.||+|++|.||+|...+++.||+|...... ...++|.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688889999999999999998878889999865433 34678999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.......+++.++..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++..... ...
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKED-IYE  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCC-ccc
Confidence            99999999965545578999999999999999999999   89999999999999999999999999998764321 111


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .......+..|+|||.+.+..++.++||||||+++|||++ |+.|+........   ..   . .....         ..
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~---~-~~~~~---------~~  223 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV---LQ---Q-VDQGY---------RM  223 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH---H-HHcCC---------CC
Confidence            1112233468999999999999999999999999999999 9988864322111   11   1 11110         00


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ..+......+.+++.+|++.+|.+||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1122345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.9e-38  Score=341.11  Aligned_cols=242  Identities=22%  Similarity=0.276  Sum_probs=197.4

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      ++||+|+||.||++..+ +++.||+|.+...   .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999965 5889999986543   2233467889999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceec
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST  622 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  622 (803)
                      +|.+++.  ....+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~  153 (323)
T cd05571          81 ELFFHLS--RERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMK  153 (323)
T ss_pred             cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCccc
Confidence            9999984  34578999999999999999999999   9999999999999999999999999999875321  111223


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCH
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINL  702 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  702 (803)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...    ...+.      .    .++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~----~~~~~------~----~~p~  216 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FEL----ILMEE------I----RFPR  216 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---HHH----HHcCC------C----CCCC
Confidence            45689999999999999999999999999999999999999865322111   111    01110      0    1223


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          703 DSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       703 ~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                      .....+.+++.+||+.||.+||     ++.+++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            3456789999999999999999     79998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.2e-38  Score=330.31  Aligned_cols=256  Identities=29%  Similarity=0.453  Sum_probs=212.2

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ...+|...++||+|+||.||+|...++..+++|.+.........++.+|+.+++.++||||+++++++......++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34567888899999999999999988899999997766555677899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++++|.+++.......+++.+++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++......  .
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~  158 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--V  158 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCc--c
Confidence            999999999976666779999999999999999999998   89999999999999999999999999998764321  1


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |+.|+......+.   ....   .. +         ..
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~---~~-~---------~~  222 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQI---TA-G---------YR  222 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHH---Hh-C---------Cc
Confidence            11223446778999999998899999999999999999998 8888865432211   1111   11 0         01


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ...+..++..+.+++.+|++.+|.+|||+.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            11223445678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1e-37  Score=341.00  Aligned_cols=265  Identities=23%  Similarity=0.292  Sum_probs=204.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|+..+.||+|+||.||+++.+ ++..+|+|...... ....+++.+|+++|++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367888899999999999999976 47788999765432 2234679999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++|+|.+++..  ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++....   
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---  156 (331)
T cd06649          84 HMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---  156 (331)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence            9999999999943  4568999999999999999999997  23699999999999999999999999999875322   


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc---Cc-------
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK---GM-------  687 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~-------  687 (803)
                       .......|+..|+|||++.+..++.++|||||||+||||++|+.||......+....   .......   +.       
T Consensus       157 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             -cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hcccccccccCCccccCcc
Confidence             112335689999999999999999999999999999999999999965433221110   0000000   00       


Q ss_pred             ------------------------cccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          688 ------------------------LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       688 ------------------------~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                                              ...+...............++.+++.+||+.||++|||+.|++++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~  304 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI  304 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence                                    000000000000011245678999999999999999999999987653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-38  Score=335.26  Aligned_cols=258  Identities=28%  Similarity=0.406  Sum_probs=214.7

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC---C--cEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD---N--TKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      ..+.....++||+|.||.||+|+..+   |  -.||||..+.+ .....+.|+.|.-+|+++.||||++|+|.|.+ ...
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence            33445566789999999999999643   2  35888987764 44557889999999999999999999999986 478


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      +||||.++.|.|..+|.. +...|+......++.||+.+|+|||+   ..+|||||..+|||+.....+||+||||+|..
T Consensus       466 WivmEL~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             eEEEecccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhc
Confidence            999999999999999954 45568999999999999999999999   99999999999999999999999999999986


Q ss_pred             CCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ....... .+....++.|||||.+.-..++.+||||-|||++||++. |..||.+....+..               .. 
T Consensus       542 ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI---------------~~-  604 (974)
T KOG4257|consen  542 EDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI---------------GH-  604 (974)
T ss_pred             cccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---------------EE-
Confidence            6544333 345667899999999999999999999999999999976 88998765332211               11 


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      +...-+-..++.|++.|..|..+||+.+|.+||.+.++...|..+++
T Consensus       605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            11222235677899999999999999999999999999999988875

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-37  Score=327.64  Aligned_cols=255  Identities=25%  Similarity=0.427  Sum_probs=207.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .++|+..++||+|+||.||+|...++..|++|..... ....+.+.+|+.++++++|+||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            3567888899999999999999888889999986543 234678999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+++.......+++.+++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++...... ..
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YT  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc-ee
Confidence            99999999966556678999999999999999999998   899999999999999999999999999997643211 11


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      ......++..|+|||.+....++.++|||||||++|||++ |+.||.......   .....    ....     ..    
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~-----~~----  223 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSAL----QRGY-----RM----  223 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCC-----CC----
Confidence            1223345678999999998899999999999999999998 999986432211   11111    1110     00    


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ......+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            0111234568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.6e-37  Score=346.40  Aligned_cols=261  Identities=25%  Similarity=0.357  Sum_probs=205.8

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCCC-CChHHHHHHHHHHHhcc-CCCeeeEEeEeeccc
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQS  530 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~  530 (803)
                      ..++|...++||+|+||.||+|+...      +..||||++..... ...+.|.+|+++|+++. ||||++++++|.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            35678888999999999999998532      34699998765433 23467999999999996 999999999999999


Q ss_pred             eeeEEEEecCCCchhhhccCCC----------------------------------------------------------
Q 042150          531 EMILVYEYMEKGPLKKHLYGPD----------------------------------------------------------  552 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------  552 (803)
                      ..+|||||+++|+|.++|+...                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999998874321                                                          


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc
Q 042150          553 ------------------------------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD  596 (803)
Q Consensus       553 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~  596 (803)
                                                          ...+++.++++++.|+++||+|||+   .+|+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence                                                1247889999999999999999999   8999999999999999


Q ss_pred             cCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhH
Q 042150          597 ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNL  675 (803)
Q Consensus       597 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  675 (803)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+||||++ |..|+........  .
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~  349 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F  349 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H
Confidence            999999999999875432222222233456788999999999999999999999999999997 8888864322111  0


Q ss_pred             HHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          676 AEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       676 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                          ......+.         ....+...+..+.+++.+||+.+|.+||++.+|.+.|+.+.
T Consensus       350 ----~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         350 ----YNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ----HHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                01111110         00112344567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.5e-37  Score=324.97  Aligned_cols=251  Identities=30%  Similarity=0.465  Sum_probs=202.0

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ++|...+.||+|+||.||++.++++..+|+|..... ....++|.+|++++++++||||++++++|......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457777899999999999999988888999986533 3345789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|+|.+++.... ..+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++...... ...
T Consensus        83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~  157 (256)
T cd05114          83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTS  157 (256)
T ss_pred             CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eec
Confidence            999999985432 468999999999999999999999   999999999999999999999999999987532211 111


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   .....   . .+.  ....+     
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i---~-~~~--~~~~~-----  223 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMI---S-RGF--RLYRP-----  223 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---H-CCC--CCCCC-----
Confidence            122345678999999998899999999999999999999 898886443211   11111   1 110  01111     


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                        ......+.+++.+|++.+|.+||++.++++.|
T Consensus       224 --~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 --KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              12235689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-38  Score=343.01  Aligned_cols=248  Identities=24%  Similarity=0.314  Sum_probs=207.0

Q ss_pred             CCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      -|+.++.||+|+-|.|-.|++ .+|+.+|||.+...   .........+|+-+|+.+.|||+++|++++++..++|||.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            366677899999999999996 46999999985543   22234567899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++|-|.++|  ..++++++.+..+++.||+.|+.|+|.   .+|+||||||+|+|||..+++||+|||+|-.-   ..
T Consensus        93 yv~gGELFdyl--v~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~  164 (786)
T KOG0588|consen   93 YVPGGELFDYL--VRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLE---VP  164 (786)
T ss_pred             ecCCchhHHHH--HhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecc---cC
Confidence            99999999999  456789999999999999999999999   99999999999999999999999999999752   22


Q ss_pred             CceeccccCCCcccCccccccCcCCC-cceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      .....+-+|++.|.|||++++.+|.- ++||||+|||||.||+|+.||+..      ++.....+ .+.|.         
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLlK-V~~G~---------  228 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLLK-VQRGV---------  228 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHHH-HHcCc---------
Confidence            33345678999999999999999875 799999999999999999999832      12111111 11111         


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                       -+++...+.+.++|+.+|+..||+.|.|++||+++-.
T Consensus       229 -f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  229 -FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             -ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence             1234556778899999999999999999999998754

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-38  Score=335.00  Aligned_cols=246  Identities=22%  Similarity=0.229  Sum_probs=201.1

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      +|...+.||+|+||.||+|..+ +++.||+|++....   ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            5778889999999999999976 58899999864321   2234578899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++|+|.+++.  ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++....   
T Consensus        82 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---  153 (291)
T cd05612          82 YVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---  153 (291)
T ss_pred             CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC---
Confidence            999999999994  34568999999999999999999999   9999999999999999999999999999875321   


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                        ......|++.|+|||++.+..++.++|||||||+||||++|+.||......+.      .... ..+..         
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~------~~~i-~~~~~---------  215 (291)
T cd05612         154 --RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------YEKI-LAGKL---------  215 (291)
T ss_pred             --CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-HhCCc---------
Confidence              11234689999999999999999999999999999999999999875432111      1111 11110         


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWNLE  734 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~L~  734 (803)
                       .++......+.+++.+||+.||.+||+     +.+++++-.
T Consensus       216 -~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  256 (291)
T cd05612         216 -EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW  256 (291)
T ss_pred             -CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence             112223457889999999999999995     888886643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.2e-37  Score=331.66  Aligned_cols=264  Identities=23%  Similarity=0.313  Sum_probs=196.6

Q ss_pred             CCCccceEeeeCceEEEEEEEC--CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhc---cCCCeeeEEeEee-----cc
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR--DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKI---RHRHLVSLVGYCE-----EQ  529 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l---~HpnIv~l~g~~~-----~~  529 (803)
                      +|...+.||+|+||.||+|...  ++..||+|++....  ......+.+|+.+++.+   +||||++++++|.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            6788889999999999999863  36789999765432  22234677788887776   6999999999985     34


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      ..+++||||+. ++|.+++.......+++.+++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            56899999997 589999865555668999999999999999999999   99999999999999999999999999999


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhh-HHHHHH-----HHh
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN-LAEWAM-----QWQ  683 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~-----~~~  683 (803)
                      +.....   .......+++.|+|||.+.+..++.++|||||||++|||++|+.||......+... +.+...     .+.
T Consensus       158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            753321   22334568999999999998999999999999999999999999997543322111 100000     000


Q ss_pred             hcC-ccccccCccc---ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          684 KKG-MLEHIIDPQL---IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       684 ~~~-~~~~i~d~~l---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ... .......+..   ...........+.+++.+||+.+|++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            000 0000010000   000111234567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-39  Score=333.48  Aligned_cols=248  Identities=27%  Similarity=0.364  Sum_probs=207.3

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .|....+||+|.||.||+|... .++.||+|.+... ....+++...|+.+|.+++|+||.+++|.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            3555678999999999999964 4788999986544 4455788999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      .+|++.+.|  .....+.+.++.-|++++..||.|||.   ++.+|||||+.|||+..+|.+||+|||.+-....  ...
T Consensus        94 ~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~--~~~  166 (467)
T KOG0201|consen   94 GGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTN--TVK  166 (467)
T ss_pred             cCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeec--hhh
Confidence            999999999  344555888888899999999999999   9999999999999999999999999999876432  222


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......||+.|||||++....|+.|+||||||++.+||.+|.+|+....+...                .-++.......
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------------lflIpk~~PP~  230 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------------LFLIPKSAPPR  230 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------------EEeccCCCCCc
Confidence            23567899999999999988999999999999999999999999875543221                11122222222


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+..+.+.+.+++..||..+|+.||++.+++++
T Consensus       231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            333566789999999999999999999999874

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-37  Score=325.38  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=205.9

Q ss_pred             cCCCccceEeeeCceEEEEEEECC----CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ++|...+.||+|+||.||+|.++.    ...|+||...... .....+|.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568888999999999999999753    3578999865443 23346799999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++++|.+++... ...+++.++++++.|++.||+|||+   .+|+|+||||+|||+++++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          84 TEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999999998543 3478999999999999999999999   99999999999999999999999999999865422


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ..........++..|+|||.+.+..++.++||||||+++|||++ |..|+......+   +.+..    .....      
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~------  226 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDGYR------  226 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCCC------
Confidence            22222223345678999999999999999999999999999998 998885432211   11111    11100      


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                         ...+...+..+.+++.+|++.+|.+||++.+|+++|+.+
T Consensus       227 ---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 ---LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               011223456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=305.91  Aligned_cols=265  Identities=23%  Similarity=0.329  Sum_probs=213.0

Q ss_pred             HHhcCCCccceEeeeCceEEEEEE-ECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeecc-----ce
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ-----SE  531 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~  531 (803)
                      ...++|.+.+.||+|||+-||.++ +.++..+|+|+......++.+..++|++..++++||||+++++++..+     ..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            345678999999999999999998 567889999998777778888999999999999999999999988543     34


Q ss_pred             eeEEEEecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          532 MILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      .||+++|...|+|.+.+..  .++..+++.+++.|+.+|++||++||+. ..++.||||||.|||+.+.+.++|.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            8999999999999999853  3455799999999999999999999982 245999999999999999999999999998


Q ss_pred             cCCCCCCCCc-------eeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHH
Q 042150          610 RSGPCLDETH-------VSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWA  679 (803)
Q Consensus       610 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  679 (803)
                      ....-.-...       .......|..|.|||.+.   +...++++|||||||+||+|+.|..||+......        
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G--------  248 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG--------  248 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC--------
Confidence            7532211111       012345789999999985   5678999999999999999999999998654321        


Q ss_pred             HHHhhcCccc-cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          680 MQWQKKGMLE-HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       680 ~~~~~~~~~~-~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                            +.+. .+..+.+.-.-....+..+.+++++||+.||.+||++.+++.++....
T Consensus       249 ------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 ------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                  1111 112222222222336788999999999999999999999999887653

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-38  Score=306.06  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=211.8

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .++|+.++.||+|.||.||.|+.+. +-.||+|++...   ..+...++.+|+++-+.|+||||++++++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            4678999999999999999999654 678999986543   234456789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      +||...|.|...|.......+++.....++.|+|.||.|+|.   ++|+||||||+|+|++..+..||+|||.+...+  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            999999999999976677789999999999999999999999   999999999999999999999999999987532  


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                        .......+||..|.+||...+...+.+.|+|++|++.||++.|.+||+.....+.   ....    .   -.++.   
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et---YkrI----~---k~~~~---  240 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET---YKRI----R---KVDLK---  240 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH---HHHH----H---Hcccc---
Confidence              2334557899999999999999999999999999999999999999985542211   1100    0   01122   


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                          ++........++|.+|+..+|.+|.+..|++.+-.
T Consensus       241 ----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  241 ----FPSTISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             ----CCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence                22344567899999999999999999999998755

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.4e-37  Score=330.57  Aligned_cols=259  Identities=27%  Similarity=0.405  Sum_probs=207.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .+|...+.||+|+||.||+|...      ++..+++|..........+.+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            34667789999999999999843      345688888765554445689999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc
Q 042150          535 VYEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV  600 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~  600 (803)
                      ||||+++++|.+++....              ...+++..+++++.||+.||+|||+   .+++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence            999999999999985321              2458999999999999999999998   99999999999999999999


Q ss_pred             EEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHH
Q 042150          601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWA  679 (803)
Q Consensus       601 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  679 (803)
                      +||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+.   .+  
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~--  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IE--  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH--
Confidence            99999999975433222222334456788999999999999999999999999999998 9999864332211   11  


Q ss_pred             HHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          680 MQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       680 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                        ....+...         ......+..+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus       237 --~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 --CITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             --HHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence              11111111         1112245678999999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-38  Score=329.40  Aligned_cols=266  Identities=30%  Similarity=0.405  Sum_probs=202.1

Q ss_pred             cceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHh--ccCCCeeeEEeEeeccc----eeeEEEEec
Q 042150          466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSK--IRHRHLVSLVGYCEEQS----EMILVYEYM  539 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~HpnIv~l~g~~~~~~----~~~lV~Ey~  539 (803)
                      .++||+|.||.||||++. ++.||||++..   +..+.|++|-+|.+.  ++|+||++++++-....    +++||+||.
T Consensus       215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             HHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            447999999999999997 48999999653   445688888888776  48999999999876555    889999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG------SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      ++|+|.++|   ....++|.+..+|+..+++||+|||+.      ..++|+|||||++||||.+|+++.|+|||||....
T Consensus       291 ~kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  291 PKGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             cCCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            999999999   556799999999999999999999974      34679999999999999999999999999998765


Q ss_pred             CCCCCceeccccCCCcccCccccccC-cCC-----CcceehhHHHHHHHHHhCCCCCCc-chhhhhhh----------HH
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQ-QLT-----DKSDVYSFGVVLFEVLCARTAVDP-LLAREQVN----------LA  676 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t-----~ksDV~S~Gvvl~elltG~~p~~~-~~~~~~~~----------l~  676 (803)
                      ...........+||.+|||||++.+. .+.     .+.||||+|.|||||++......+ ..+..+..          +.
T Consensus       368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e  447 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE  447 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence            54444445568999999999999754 222     368999999999999987644421 11111111          11


Q ss_pred             HHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhcc
Q 042150          677 EWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES  742 (803)
Q Consensus       677 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  742 (803)
                      +.......+.....+.|...    ....+..+++.+..||..|++.|-|+.=|-+++.++..+.+.
T Consensus       448 ~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  448 EMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             HHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            11111111111111111111    114467899999999999999999999999988887766543

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.8e-37  Score=328.90  Aligned_cols=255  Identities=28%  Similarity=0.428  Sum_probs=205.2

Q ss_pred             cCCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEeeccceee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      .+|...+.||+|+||.||+|...+      +..||||........ ..++|.+|+++|++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457777899999999999998643      478999987654433 4578999999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcE
Q 042150          534 LVYEYMEKGPLKKHLYGP------------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~  601 (803)
                      +||||+++++|.+++...            ....+++.++..++.|++.||+|||+   .+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence            999999999999998532            23458899999999999999999998   899999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAM  680 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  680 (803)
                      ||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+   ..+.. 
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~-  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI-  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH-
Confidence            9999999875332222222233456788999999999999999999999999999998 999986443222   11111 


Q ss_pred             HHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                         ..+...         ..+...+..+.+++.+||+.+|.+||++.||++.|+
T Consensus       238 ---~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 ---TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               111111         112234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-37  Score=353.18  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=202.9

Q ss_pred             CCccceEeeeCceEEEEEEEC-C-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-D-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      |...+.||+|+||.||+|... + +..||+|............+.+|+.+|+.++||||++++++|...+..+|||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            778889999999999999854 3 57788887654444445678889999999999999999999999999999999999


Q ss_pred             CCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          541 KGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       541 ~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +|+|.++|..  ....++++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            9999988843  234568999999999999999999999   89999999999999999999999999999864322222


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ....... +..    .     
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~~~~~~-~~~----~-----  289 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IMQQVLY-GKY----D-----  289 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCC----C-----
Confidence            22344578999999999999999999999999999999999999986432211      1111111 110    0     


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..+......+.+++.+||+.+|.+||++.+++.+
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            1122344678999999999999999999999763

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=334.82  Aligned_cols=240  Identities=23%  Similarity=0.241  Sum_probs=194.6

Q ss_pred             EeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCch
Q 042150          469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       469 Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      ||+|+||.||++... +++.||+|.+...   .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999976 4788999986532   234456788999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccc
Q 042150          545 KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV  624 (803)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (803)
                      .+++..  ...+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  ........
T Consensus        81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~  153 (312)
T cd05585          81 FHHLQR--EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTF  153 (312)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccc
Confidence            999943  4568999999999999999999999   9999999999999999999999999999875321  11223345


Q ss_pred             cCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHH
Q 042150          625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDS  704 (803)
Q Consensus       625 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  704 (803)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||......      +........ .          ..++...
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~-~----------~~~~~~~  216 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQE-P----------LRFPDGF  216 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcC-C----------CCCCCcC
Confidence            7899999999999999999999999999999999999998643221      111111111 0          0122334


Q ss_pred             HHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 042150          705 LKKFGETAEKCLADYGVDRPS---MGDVLWN  732 (803)
Q Consensus       705 ~~~l~~li~~cl~~~p~~RPs---~~evl~~  732 (803)
                      ...+.+++.+||+.+|.+||+   +.|++.+
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            567889999999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.3e-37  Score=328.26  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=202.5

Q ss_pred             cCCCccceEeeeCceEEEEEEE-----CCCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-----RDNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .+|+..+.||+|+||.||+|.+     ..+..+++|...... .+...+|.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3567778999999999999985     245789999876432 2334678999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC
Q 042150          535 VYEYMEKGPLKKHLYGPD---------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY  599 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~  599 (803)
                      ||||+++++|.+++....               ...+++.+++.++.|++.||.|||+   ++++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence            999999999999984221               2358899999999999999999999   8999999999999999999


Q ss_pred             cEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHH
Q 042150          600 VSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEW  678 (803)
Q Consensus       600 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  678 (803)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||......+   +.+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence            999999999976432222222233445778999999998899999999999999999998 888886432211   1111


Q ss_pred             HHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          679 AMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       679 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      .    .....         ...+......+.+++.+|++.+|.+||++.+|+++|..
T Consensus       239 ~----~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 V----RKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             H----HcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1    11110         01122345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.5e-37  Score=329.94  Aligned_cols=265  Identities=22%  Similarity=0.286  Sum_probs=200.0

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|...++||+|+||.||+|..+ ++..||+|...... ......+.+|++++++++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            45888889999999999999975 57899999865432 23345788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++ +|.+++... ...+++.++..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++.....  .
T Consensus        85 ~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~  157 (288)
T cd07871          85 LDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--T  157 (288)
T ss_pred             CCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--C
Confidence            985 898888432 3457899999999999999999999   99999999999999999999999999998753221  1


Q ss_pred             ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH---------HHhhcCcc
Q 042150          619 HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM---------QWQKKGML  688 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~~  688 (803)
                      .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.........         ........
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            12234567899999999865 568999999999999999999999997554333221110000         00000000


Q ss_pred             ccccCcccccC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EHIIDPQLIGK----INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l~~~----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .....+.....    .......++.+++.+||+.||.+|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            11111111000    011234567899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.4e-37  Score=338.60  Aligned_cols=261  Identities=26%  Similarity=0.410  Sum_probs=203.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhc-cCCCeeeEEeEeec-cc
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKI-RHRHLVSLVGYCEE-QS  530 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~-~~  530 (803)
                      .++|+..++||+|+||.||+|...      .++.||+|++..... ...+.+..|++++.++ +||||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            346888899999999999999742      246899998654322 2345678899999999 89999999998864 45


Q ss_pred             eeeEEEEecCCCchhhhccCCC----------------------------------------------------------
Q 042150          531 EMILVYEYMEKGPLKKHLYGPD----------------------------------------------------------  552 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------  552 (803)
                      .++++|||+++|+|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6889999999999998884321                                                          


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCccc
Q 042150          553 -RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL  631 (803)
Q Consensus       553 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  631 (803)
                       ...++|..+.+++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++...............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             1368999999999999999999998   899999999999999999999999999998643222222222345677899


Q ss_pred             CccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHH
Q 042150          632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGE  710 (803)
Q Consensus       632 aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~  710 (803)
                      |||++.+..++.++|||||||+||||++ |+.||......+.  +    ......+..         ...+.....++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~----~~~~~~~~~---------~~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F----CRRLKEGTR---------MRAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H----HHHHhccCC---------CCCCccCCHHHHH
Confidence            9999999999999999999999999998 9999864322111  1    111111110         0112233467899


Q ss_pred             HHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          711 TAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       711 li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ++.+||+.+|++||++.|++++|+.+++
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.4e-37  Score=330.71  Aligned_cols=261  Identities=26%  Similarity=0.455  Sum_probs=207.5

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeecc
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ  529 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~  529 (803)
                      ...++|+..+.||+|+||.||++....      ...+|+|...... .....++.+|++++.++ +||||++++++|...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            345568888899999999999998642      3578999865432 23345788999999999 799999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccC--------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE
Q 042150          530 SEMILVYEYMEKGPLKKHLYG--------------PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL  595 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~--------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl  595 (803)
                      +..+++|||+++|+|.+++..              .....+++..+++++.|++.||+|||+   .+|+||||||+|||+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence            999999999999999999843              224568999999999999999999998   999999999999999


Q ss_pred             ccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhh
Q 042150          596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVN  674 (803)
Q Consensus       596 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  674 (803)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......+.. 
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-  244 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-  244 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH-
Confidence            9999999999999986443222222223345678999999999999999999999999999998 88887643222111 


Q ss_pred             HHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          675 LAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       675 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                            .....+.         ....+......+.+++.+|+..+|.+|||+.|+++.|+.++
T Consensus       245 ------~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 ------KLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ------HHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                  1111110         01122334567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.9e-37  Score=329.56  Aligned_cols=259  Identities=28%  Similarity=0.415  Sum_probs=207.0

Q ss_pred             cCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .+|...+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||++++++|...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56788889999999999999852      245688998765555556789999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEE
Q 042150          535 VYEYMEKGPLKKHLYGP-----------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKV  603 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl  603 (803)
                      ||||+++++|.+++...           ....+++.+++.++.|++.+|+|||+   .+++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence            99999999999998532           12358999999999999999999998   99999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHH
Q 042150          604 ADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       604 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+   ..+   . 
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~---~-  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE---C-  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H-
Confidence            99999975432222222233445778999999999999999999999999999998 888886443221   111   1 


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ...+...         ..+...+..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       235 i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         235 ITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            1111110         0111234578999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=338.68  Aligned_cols=243  Identities=26%  Similarity=0.357  Sum_probs=207.5

Q ss_pred             HHHhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccce
Q 042150          457 QTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       457 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~  531 (803)
                      ....++|...++||+|+||+|+++.++. ++.+|||.++..   .+.+.+..+.|.+++... +||.|++|+.+|+..++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            3455789999999999999999999865 778999987654   456678889999999888 59999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      +|.||||+.||++..+.   ....+++..+.-++..|+.||+|||+   ++|||||||.+|||||.+|.+||+||||++.
T Consensus       444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence            99999999999955444   55679999999999999999999999   9999999999999999999999999999997


Q ss_pred             CCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ...  ....+.+.+||+.|||||++.+..|+.+.|.|||||+|||||.|..||.+..+++..+                 
T Consensus       518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd-----------------  578 (694)
T KOG0694|consen  518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD-----------------  578 (694)
T ss_pred             cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-----------------
Confidence            442  2335567899999999999999999999999999999999999999998665443321                 


Q ss_pred             cCcccc--cCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 042150          692 IDPQLI--GKINLDSLKKFGETAEKCLADYGVDRPSM  726 (803)
Q Consensus       692 ~d~~l~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~  726 (803)
                        ..+.  ..++...+.+...|+.++|..+|++|--+
T Consensus       579 --sI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  579 --SIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --HHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence              1111  12455667888999999999999999765

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.1e-37  Score=328.28  Aligned_cols=257  Identities=26%  Similarity=0.402  Sum_probs=202.8

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccce
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~  531 (803)
                      .+++|+..+.||+|+||.||+|.++      .+..||+|+..... .....+|.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4577889999999999999999864      24679999864332 2234578999999999999999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEE
Q 042150          532 MILVYEYMEKGPLKKHLYGPD--------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKV  603 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl  603 (803)
                      .++||||+++|+|.+++....        ...+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999985321        2346889999999999999999999   89999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHH
Q 042150          604 ADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       604 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......+.   ..   . 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~~---~-  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---LR---F-  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH---H-
Confidence            99999875432222222222345778999999999999999999999999999999 6788764322211   11   1 


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      .......         ..+...+..+.+++.+|++.+|.+|||+.|+++.|+
T Consensus       234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1111110         112234567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-37  Score=333.54  Aligned_cols=251  Identities=24%  Similarity=0.336  Sum_probs=212.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccce-eeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE-MILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~lV~  536 (803)
                      ++|...+++|+|+||.++..+.+ +++.+++|++...  .....+....|+.++++++|||||.+.+.+.+++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            46778889999999999988865 4678999975433  33445578999999999999999999999998888 99999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      +|++||+|.+.|...++..++++.++.++.|++.|+.|||+   ..|+|||||+.||+++.+..+||+|||+|+......
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            99999999999987777889999999999999999999998   999999999999999999999999999999854322


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                        .......||+.||.||.+.+.+|..|+|||||||++|||++-+++|.......   +..   +     ....     .
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~---k-----i~~~-----~  222 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LIL---K-----INRG-----L  222 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHH---H-----Hhhc-----c
Confidence              24556889999999999999999999999999999999999999997653322   111   1     0111     1


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ....+.....++..++..|++.+|..||++.++|.+
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            234456677899999999999999999999999986

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.7e-37  Score=322.43  Aligned_cols=252  Identities=30%  Similarity=0.433  Sum_probs=202.2

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      .+|...+.||+|+||.||+|..+++..+|+|..... ....++|.+|+.++++++||||++++++|.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            346677899999999999999887778999986543 3345789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|+|.+++... ...+++.+++.++.||+.||+|||+   .+++|+||||+||++++++.+||+|||+++..... ....
T Consensus        83 ~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~-~~~~  157 (256)
T cd05113          83 NGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTS  157 (256)
T ss_pred             CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCC-ceee
Confidence            99999998543 2368999999999999999999998   89999999999999999999999999998753321 1111


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+   .....    ..+...         .
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~~---------~  221 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKV----SQGLRL---------Y  221 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----hcCCCC---------C
Confidence            223345678999999998899999999999999999998 999886443221   11111    111000         0


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      .+......+.+++.+||+.+|.+||++.++++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11123467899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-36  Score=331.24  Aligned_cols=245  Identities=24%  Similarity=0.315  Sum_probs=194.7

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHH---HhccCCCeeeEEeEeeccceeeEE
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVL---SKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l---~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      |...+.||+|+||.||+|... +++.||||.+...   .....+.+.+|++++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            456779999999999999965 5889999986533   233345677777665   456799999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++|+|..++.   ...+++.+++.++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            99999999998883   3569999999999999999999999   99999999999999999999999999998753221


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                        ........|++.|+|||.+.+..++.++|||||||++|||++|+.||......+.      ....... .      . 
T Consensus       155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~~~i~~~-~------~-  218 (324)
T cd05589         155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDSIVND-E------V-  218 (324)
T ss_pred             --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC-C------C-
Confidence              1222345789999999999999999999999999999999999999975432211      1111110 0      0 


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                         .++......+.+++.+||+.+|.+||     ++.+++++
T Consensus       219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence               11223456778999999999999999     46666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.1e-37  Score=329.70  Aligned_cols=256  Identities=20%  Similarity=0.298  Sum_probs=208.7

Q ss_pred             HHHhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          457 QTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       457 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      +...++|+...+||+|+||.||+++-++ |..+|+|++....   ....+..+.|-.+|....+|.||+|+..|++...+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            3356789999999999999999999654 8899999876543   34456788999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ||||||++||++..+|  .+...|++.....++.+++.|++.||+   .|+|||||||+|+|||..|++||+||||+.-.
T Consensus       217 YLiMEylPGGD~mTLL--~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLL--MRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEEecCCccHHHHH--HhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999999999  556789999999999999999999999   99999999999999999999999999998421


Q ss_pred             CC----------------------CCCC------ce-----------------eccccCCCcccCccccccCcCCCccee
Q 042150          613 PC----------------------LDET------HV-----------------STGVKGSFGYLDPEYFRRQQLTDKSDV  647 (803)
Q Consensus       613 ~~----------------------~~~~------~~-----------------~~~~~gt~~y~aPE~~~~~~~t~ksDV  647 (803)
                      ..                      .+..      ..                 ....+|||.|||||++.+..|+..+|.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            10                      0000      00                 112569999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCcchhhhh-hhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCC-
Q 042150          648 YSFGVVLFEVLCARTAVDPLLAREQ-VNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPS-  725 (803)
Q Consensus       648 ~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-  725 (803)
                      |||||||||||.|-+||....+.+. ..+..|...+....              ......+..+||.+||- ||.+|-- 
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            9999999999999999987665443 34555554332211              12233678999999998 9999964 


Q ss_pred             --HHHHHHH
Q 042150          726 --MGDVLWN  732 (803)
Q Consensus       726 --~~evl~~  732 (803)
                        +.||-++
T Consensus       437 ~G~~EIK~H  445 (550)
T KOG0605|consen  437 KGAEEIKKH  445 (550)
T ss_pred             ccHHHHhcC
Confidence              6666543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-37  Score=337.91  Aligned_cols=245  Identities=21%  Similarity=0.261  Sum_probs=199.9

Q ss_pred             cCCCccceEeeeCceEEEEEEECC--CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD--NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ++|...+.||+|+||.||+|.++.  +..||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468888999999999999998654  368999976432   233456788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++|+|.+++.  ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.... 
T Consensus       110 ~Ey~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-  183 (340)
T ss_pred             EeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence            99999999999994  34568999999999999999999999   9999999999999999999999999999975321 


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                          ......||+.|||||++.+..++.++|||||||++|||++|+.||........       ......+..       
T Consensus       184 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~i~~~~~-------  245 (340)
T PTZ00426        184 ----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------YQKILEGII-------  245 (340)
T ss_pred             ----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------HHHHhcCCC-------
Confidence                12245789999999999999999999999999999999999999975432111       011111110       


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                         .++......+.+++.+||+.+|.+|+     ++.+++++
T Consensus       246 ---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 ---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence               11222345678999999999999995     78888765

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.1e-37  Score=337.09  Aligned_cols=264  Identities=23%  Similarity=0.284  Sum_probs=195.9

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeecc-----ceee
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ-----SEMI  533 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~  533 (803)
                      +|...++||+|+||.||+|+.. ++..||||++...  .......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4677889999999999999965 5889999986532  223345788999999999999999999988543     3479


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +||||+. ++|.+++.  ....+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999996 68988883  34569999999999999999999999   899999999999999999999999999997532


Q ss_pred             CCCCC-ceeccccCCCcccCcccccc--CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHH---------HHHH
Q 042150          614 CLDET-HVSTGVKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE---------WAMQ  681 (803)
Q Consensus       614 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~~  681 (803)
                      ..... .......++..|+|||++.+  ..++.++|||||||++|||++|+.||.............         +...
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            21111 11234578999999999875  688999999999999999999999986543222111000         0000


Q ss_pred             HhhcCcccccc---CcccccCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          682 WQKKGMLEHII---DPQLIGKI---NLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       682 ~~~~~~~~~i~---d~~l~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       .......+.+   .+......   -+.....+.+++.+||+.+|.+||++.|++++
T Consensus       235 -i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         235 -VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             -hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence             0000000000   00000000   01223567899999999999999999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.1e-37  Score=326.66  Aligned_cols=256  Identities=28%  Similarity=0.380  Sum_probs=201.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      +++|...+.||+|+||.||+|.+.+      +..|++|...... .....+|.+|+.++++++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4668888899999999999999753      5678888765433 22345799999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC---cEEEe
Q 042150          533 ILVYEYMEKGPLKKHLYGPD-----RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY---VSKVA  604 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~~kl~  604 (803)
                      ++||||+++++|.+++....     ...+++.++++++.||+.||+|||+   .+++||||||+|||++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999985432     2358999999999999999999999   8999999999999998654   69999


Q ss_pred             eeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHh
Q 042150          605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQ  683 (803)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  683 (803)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+..   +   ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~---~~~  235 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---E---FVT  235 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H---HHH
Confidence            9999986422111111112233568999999999999999999999999999997 99988654322211   1   111


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ...          ....+...+..+.+++.+|++.+|++||++.+|+++|+
T Consensus       236 ~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 GGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            110          01122334567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.4e-36  Score=320.04  Aligned_cols=253  Identities=31%  Similarity=0.426  Sum_probs=203.6

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ++|...+.||+|+||.||+|..+++..+|+|....... ..++|.+|+.++++++|+|++++++++.+ ...+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            45777889999999999999988888899998765433 45689999999999999999999998854 56899999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +++|.+++.......+++.+++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++...... ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~~  159 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTA  159 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-ccc
Confidence            9999999966555668999999999999999999999   899999999999999999999999999987533211 111


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   ..+   ......          ...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~---~~~~~~----------~~~  223 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLE---QVERGY----------RMP  223 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHH---HHHcCC----------CCC
Confidence            122345678999999988899999999999999999999 888886432221   111   111100          011


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      .+...+..+.+++.+|+..+|.+|||++++++.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            222345678999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.4e-37  Score=329.34  Aligned_cols=260  Identities=23%  Similarity=0.370  Sum_probs=206.1

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccc
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQS  530 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~  530 (803)
                      ..++|...+.||+|+||.||++...      .+..||||+..... ....+.+.+|+++++++ +||||++++++|...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3456888899999999999999742      24579999865443 23346789999999999 7999999999999999


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..++||||+++|+|.+++.......+++.+++.++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||+++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999999965444558999999999999999999999   899999999999999999999999999997


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      ...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+.  ...    ....+.  
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~----~~~~~~--  261 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYK----LIKEGY--  261 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHH----HHHcCC--
Confidence            6433222112223345778999999999999999999999999999998 9998764322111  111    111110  


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                             ....+......+.+++.+|++.+|++||++.|+++.|+.+
T Consensus       262 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 -------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                   0011112345789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.2e-36  Score=331.22  Aligned_cols=249  Identities=23%  Similarity=0.291  Sum_probs=193.2

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +|...+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+++++.++|+||+++++++...+.+++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3455678999999999999975 588999998654332 23467899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+..      .+.+..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++.....  ..
T Consensus       155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~  223 (353)
T PLN00034        155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MD  223 (353)
T ss_pred             CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccc--cc
Confidence            999987543      35677888999999999999999   99999999999999999999999999998763321  11


Q ss_pred             eeccccCCCcccCcccccc-----CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          620 VSTGVKGSFGYLDPEYFRR-----QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ......||..|+|||.+..     ...+.++|||||||+||||++|+.||......+...+   .......         
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~---------  291 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MCAICMS---------  291 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHHHhcc---------
Confidence            1234578999999998743     2345689999999999999999999873221111111   1000000         


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                       ............+.+++.+||+.+|++||++.|++++-.
T Consensus       292 -~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~  330 (353)
T PLN00034        292 -QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF  330 (353)
T ss_pred             -CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence             001122234567899999999999999999999998643

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-36  Score=324.88  Aligned_cols=268  Identities=24%  Similarity=0.337  Sum_probs=202.0

Q ss_pred             CCccceEeeeCceEEEEEEE-----CCCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeecc--ceeeE
Q 042150          463 FDKNLIIGSGGFGMVYKGVL-----RDNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEMIL  534 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~l  534 (803)
                      |...+.||+|+||+||++..     .++..||+|....... .....|.+|++++++++||||++++++|...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            36778999999999988653     3477899998654432 3456789999999999999999999998653  45899


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++..   ..+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          86 IMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            9999999999999943   459999999999999999999999   8999999999999999999999999999876432


Q ss_pred             CCCCc-eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETH-VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ....+.........+.+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhh
Confidence            21111 11223456679999999988999999999999999999999999754321100 00000000000001111111


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      .......+...+..+.+++.+|++.+|++||+++++++.|+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11111223345678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=322.86  Aligned_cols=260  Identities=25%  Similarity=0.332  Sum_probs=205.1

Q ss_pred             HHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--------------CCChHHHHHHHHHHHhccCCCeee
Q 042150          457 QTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--------------RQGLPEFQTEITVLSKIRHRHLVS  521 (803)
Q Consensus       457 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~f~~E~~~l~~l~HpnIv~  521 (803)
                      .+..++|.....||+|.||.|-+|+.. +++.||+|.+....              ....+...+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            345578999999999999999999954 58999999753221              122457899999999999999999


Q ss_pred             EEeEeecc--ceeeEEEEecCCCchhhhccCCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC
Q 042150          522 LVGYCEEQ--SEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN  598 (803)
Q Consensus       522 l~g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~  598 (803)
                      |+.+..+.  +.+|||+|||..|.+...=   ..++ +++.+.++++.++..||+|||.   ++||||||||+|+||+++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence            99998654  5799999999988776433   3344 9999999999999999999999   999999999999999999


Q ss_pred             CcEEEeeeccccCCCCC---CCCceeccccCCCcccCccccccCc----CCCcceehhHHHHHHHHHhCCCCCCcchhhh
Q 042150          599 YVSKVADFGLSRSGPCL---DETHVSTGVKGSFGYLDPEYFRRQQ----LTDKSDVYSFGVVLFEVLCARTAVDPLLARE  671 (803)
Q Consensus       599 ~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~  671 (803)
                      |++||+|||.+......   +.........||+.|||||...++.    ...+.||||+||+||.|+.|+.||......+
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~  326 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE  326 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence            99999999998754221   1122233478999999999987632    3447899999999999999999986543221


Q ss_pred             hhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          672 QVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       672 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                         +.            ..|+...+.-...+++...+.+||+++|.+||++|.+..+|..+..-..
T Consensus       327 ---l~------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  327 ---LF------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             ---HH------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence               11            1233333333334456778999999999999999999999988776443

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.1e-37  Score=329.86  Aligned_cols=262  Identities=27%  Similarity=0.431  Sum_probs=207.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC--------CcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeecc
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD--------NTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ  529 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~  529 (803)
                      .++|...+.||+|+||.||++....        ...+|+|.+.... .....++.+|++++.++ +||||++++++|...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3568888999999999999998532        3469999876432 33456788999999999 799999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL  595 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl  595 (803)
                      +..++||||+++|+|.+++....              ...+++.++++++.|++.||+|||+   .+++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence            99999999999999999995432              2358999999999999999999998   899999999999999


Q ss_pred             ccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhh
Q 042150          596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVN  674 (803)
Q Consensus       596 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  674 (803)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+   
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---  250 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  250 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence            9999999999999875432221111222334578999999999999999999999999999998 888876432211   


Q ss_pred             HHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          675 LAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       675 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                         ..... ....         ....+......+.+++.+|++.+|.+||+|.+|++.|+.+....
T Consensus       251 ---~~~~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         251 ---LFKLL-KEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             ---HHHHH-HcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence               11111 1111         01122234567889999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.5e-37  Score=333.39  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=197.8

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      ++||+|+||.||++..+ +++.||+|.+...   .....+.+..|..++.++ +||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            37999999999999975 4788999986543   223355688999999998 799999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |+|.+++.  ....+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 g~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~  153 (329)
T cd05588          81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTT  153 (329)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCcc
Confidence            99998884  34579999999999999999999999   9999999999999999999999999999874221  11122


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhh--hhhHHHHHHHHhhcCccccccCcccccC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE--QVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+  .....++..+.......          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence            34578999999999999999999999999999999999999996432111  11222233322222111          1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPS------MGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs------~~evl~~  732 (803)
                      ++......+.+++.+||+.+|.+||+      +.+++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            22234567889999999999999997      6777654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-36  Score=326.27  Aligned_cols=257  Identities=26%  Similarity=0.395  Sum_probs=203.3

Q ss_pred             CCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      +|...+.||+|+||.||+|....      ...+++|....... ...+++.+|+.+++.++||||+++++.|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            36677899999999999998532      35688887654332 234678999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCC----------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcce
Q 042150          535 VYEYMEKGPLKKHLYGP----------------------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTN  592 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~N  592 (803)
                      |+||+.+|+|.+++...                      ....+++..++.++.|++.||+|||+   .+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence            99999999999987431                      12358899999999999999999998   999999999999


Q ss_pred             EEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhh
Q 042150          593 ILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLARE  671 (803)
Q Consensus       593 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~  671 (803)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999875432222112223445778999999998999999999999999999998 998886543222


Q ss_pred             hhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          672 QVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       672 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                         +.+    ......         ....+......+.+++.+|++.+|.+||++.++++.|+.+.
T Consensus       238 ---~~~----~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 ---LFN----LLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             ---HHH----HHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence               111    111110         01112234467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-36  Score=319.25  Aligned_cols=247  Identities=28%  Similarity=0.396  Sum_probs=195.8

Q ss_pred             eEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCchh
Q 042150          468 IIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLK  545 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~  545 (803)
                      .||+|+||.||+|+.. +++.+|+|...... ......|.+|++++++++||||++++++|......++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            6899999999999975 58889999765332 223467999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceecccc
Q 042150          546 KHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK  625 (803)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  625 (803)
                      +++... ...+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++...............
T Consensus        82 ~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          82 TFLRTE-GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            998432 3468999999999999999999998   899999999999999999999999999987533211111111122


Q ss_pred             CCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHH
Q 042150          626 GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDS  704 (803)
Q Consensus       626 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  704 (803)
                      .+..|+|||.+.+..++.++|||||||++|||++ |..|+.........       ......         .....+...
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-------~~~~~~---------~~~~~~~~~  221 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-------EAIEQG---------VRLPCPELC  221 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-------HHHHcC---------CCCCCcccC
Confidence            3567999999999999999999999999999998 88887643222111       001110         011122234


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          705 LKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       705 ~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      +..+.+++.+|++.+|.+||++.++++.|+
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=325.33  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=202.5

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .|+..++||+|+||.||++... +++.||||++....   ......+.+|+.++++++||||+++++++..++.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677789999999999999965 58899999865432   2223567899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++|+|.+++.......+++.++..++.|++.||+|||+   .+++||||||+||++++++.++|+|||+++.....  
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  155 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--  155 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--
Confidence            9999999998865555679999999999999999999999   89999999999999999999999999998763321  


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                       .......|+..|+|||++.+..++.++|||||||++|||++|+.||.........  .. ........          .
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~--~~-~~~~~~~~----------~  221 (285)
T cd05605         156 -ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR--EE-VERRVKED----------Q  221 (285)
T ss_pred             -CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH--HH-HHHHhhhc----------c
Confidence             1122346899999999999999999999999999999999999999754322111  11 11111110          0


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                      ..++......+.+++.+|++.||.+||     ++.+++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            112233456789999999999999999     78888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.9e-37  Score=327.97  Aligned_cols=258  Identities=28%  Similarity=0.425  Sum_probs=203.4

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-Cc--EEEEEEcCCC-CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NT--KVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ++|...++||+|+||.||+|..++ +.  .+++|.+... .....+.|.+|++++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            467888899999999999999754 32  4688876532 223356799999999999 799999999999999999999


Q ss_pred             EEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcE
Q 042150          536 YEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~  601 (803)
                      +||+++|+|.+++....              ...+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence            99999999999985421              1358899999999999999999998   999999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAM  680 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  680 (803)
                      ||+|||++.....   .........+..|+|||.+.+..++.++|||||||++|||++ |+.||......+.      ..
T Consensus       159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~------~~  229 (297)
T cd05089         159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL------YE  229 (297)
T ss_pred             EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HH
Confidence            9999999864211   111111233567999999998899999999999999999997 9999865432211      11


Q ss_pred             HHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      .. ..+         .....+......+.+++.+|++.+|.+||+++++++.|+.+.+..
T Consensus       230 ~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         230 KL-PQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HH-hcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11 111         011112234567899999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9e-37  Score=332.36  Aligned_cols=242  Identities=23%  Similarity=0.315  Sum_probs=195.3

Q ss_pred             ceEeeeCceEEEEEEE----CCCcEEEEEEcCCC----CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          467 LIIGSGGFGMVYKGVL----RDNTKVAVKRGVPG----SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++||+|+||.||++..    ..++.||+|.+...    .......+.+|+++|+.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            4799999999999985    34788999986532    223345678999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.+++.  ....+.+..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  ..
T Consensus        82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~  154 (323)
T cd05584          82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EG  154 (323)
T ss_pred             CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CC
Confidence            99999999984  34568889999999999999999999   9999999999999999999999999999874221  11


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .......|++.|+|||++.+..++.++|||||||+||||++|+.||........      .... ..+.          .
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~~~~-~~~~----------~  217 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------IDKI-LKGK----------L  217 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------HHHH-HcCC----------C
Confidence            122345689999999999999999999999999999999999999975432211      1111 1111          0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                      .++......+.+++.+||+.+|++||     ++.+++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            12223456789999999999999999     78888764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-37  Score=319.20  Aligned_cols=258  Identities=26%  Similarity=0.306  Sum_probs=197.5

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccc-----eeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS-----EMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~l  534 (803)
                      -.|...+++|+|+||.||+|++.. ++.||||+...+.+-    --+|+++|+++.|||||+|+-+|....     .+.|
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            346667799999999999999754 689999986654432    247999999999999999999884332     3468


Q ss_pred             EEEecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC-CcEEEeeeccccC
Q 042150          535 VYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRS  611 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~kl~DFGla~~  611 (803)
                      |||||+. +|.+.++.  ..+..++...+.-+..||++||.|||+   .+|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999987 89988842  235678888888899999999999999   999999999999999955 9999999999987


Q ss_pred             CCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc-
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE-  689 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-  689 (803)
                      ......   ......|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+....++....-   ........+ 
T Consensus       176 L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIi---k~lG~Pt~e~  249 (364)
T KOG0658|consen  176 LVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEII---KVLGTPTRED  249 (364)
T ss_pred             eccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHH---HHhCCCCHHH
Confidence            543222   233456889999999876 589999999999999999999999988755544432211   111111111 


Q ss_pred             ---------cccCccccc-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          690 ---------HIIDPQLIG-----KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       690 ---------~i~d~~l~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                               +...|.+..     .+.....++..+++.++|+.+|.+|.++.|++.+
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                     111122211     1334456788999999999999999999999875

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=319.97  Aligned_cols=250  Identities=31%  Similarity=0.453  Sum_probs=200.9

Q ss_pred             CCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      +|...+.||+|+||.||+|.++++..+|+|..... .....+|.+|++++++++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            46777899999999999999887778999986433 23456799999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      ++|.+++.... ..+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.... ......
T Consensus        84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~-~~~~~~  158 (256)
T cd05059          84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD-DQYTSS  158 (256)
T ss_pred             CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccc-cccccc
Confidence            99999985432 368999999999999999999999   8999999999999999999999999999875321 111111


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+.   ..   . ....     ..    ...
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~---~-~~~~-----~~----~~~  222 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VE---S-VSAG-----YR----LYR  222 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HH---H-HHcC-----Cc----CCC
Confidence            12234568999999999999999999999999999999 7888864432211   11   1 1111     00    111


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       701 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      +...+..+.+++.+|+..+|++|||+.|+++.|
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            223456789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.7e-37  Score=326.69  Aligned_cols=255  Identities=21%  Similarity=0.310  Sum_probs=202.3

Q ss_pred             CCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      +|...+.||+|+||.||+|...+      +..||+|+....... ..+.|.+|+.++.+++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            35566789999999999998642      468999987644332 23568899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc
Q 042150          535 VYEYMEKGPLKKHLYGP--------------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV  600 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~  600 (803)
                      ++||+++++|.+++...              ....+++..++.++.|++.||+|||+   ++++||||||+|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence            99999999999998421              12458899999999999999999998   89999999999999999999


Q ss_pred             EEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHH
Q 042150          601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWA  679 (803)
Q Consensus       601 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  679 (803)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+......+      +.
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------VI  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------HH
Confidence            99999999886433222222233456789999999988899999999999999999998 888876543221      11


Q ss_pred             HHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          680 MQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       680 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      .... ....         ...+..++..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus       237 ~~i~-~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIR-NRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHH-cCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1111 1111         12233456678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.7e-36  Score=319.91  Aligned_cols=254  Identities=30%  Similarity=0.431  Sum_probs=204.3

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ++|...+.||+|+||.||+|.+++...||+|+.... ....++|.+|++++++++||||+++++++.+ ...++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            458888899999999999999877778999986542 3345689999999999999999999998754 56799999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|+|.+++.......+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++....... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~  159 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA  159 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence            9999999965445568999999999999999999999   8999999999999999999999999999875432111 11


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..      .. .....         ...
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~------~~-~~~~~---------~~~  223 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQ-VERGY---------RMP  223 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH------HH-HhcCC---------CCC
Confidence            223446778999999998999999999999999999999 78887644322111      01 01000         001


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      .....+..+.+++.+|++.+|++||++.++++.|+..
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            1234566789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.1e-36  Score=333.08  Aligned_cols=263  Identities=23%  Similarity=0.305  Sum_probs=202.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|+..+.||+|+||.||++..+ ++..+|+|...... ....+.+.+|++++++++||||++++++|.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            467888999999999999999976 47788888755432 2234678999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++|+|.+++..  ...+++..+..++.|++.||.|||+  ..+++||||||+|||+++++.+||+|||++.....   
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---  156 (333)
T cd06650          84 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---  156 (333)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---
Confidence            9999999999943  4568899999999999999999996  24799999999999999999999999999875321   


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc--------
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE--------  689 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--------  689 (803)
                       .......++..|+|||++.+..++.++|||||||++|||++|+.||............   .. ...+...        
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~  231 (333)
T cd06650         157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF---GC-PVEGDPAESETSPRP  231 (333)
T ss_pred             -hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh---cC-cccCCccccccCccc
Confidence             1122346889999999999989999999999999999999999998754322111000   00 0000000        


Q ss_pred             ---------------------cccCcccc---cCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          690 ---------------------HIIDPQLI---GKI-NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       690 ---------------------~i~d~~l~---~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                                           .+.+....   ... ......++.+++.+||+.||.+|||+.|++++-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~  301 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF  301 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence                                 00000000   000 0112456889999999999999999999987644

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.6e-36  Score=323.23  Aligned_cols=257  Identities=25%  Similarity=0.379  Sum_probs=200.5

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCc----EEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNT----KVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .+|+..+.||+|+||.||+|.+. ++.    .+++|...... .....++..|+..++++.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            35677789999999999999964 343    47777754332 2334678888989999999999999999864 45788


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ++||+++|+|.+++... ...+++..++.++.||+.||+|||+   .+++||||||+|||+++++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999999999542 3568999999999999999999998   8999999999999999999999999999976433


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |+.|+........   .++.    ..+..  ...
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~~----~~~~~--~~~  232 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---PDLL----EKGER--LAQ  232 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----HCCCc--CCC
Confidence            222222334557789999999998999999999999999999998 9999865432221   1111    11110  011


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      +       ..+...+.+++.+|+..+|.+|||+.|+++.|..+.+
T Consensus       233 ~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         233 P-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             C-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            1       1123467889999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-36  Score=327.71  Aligned_cols=263  Identities=25%  Similarity=0.434  Sum_probs=208.2

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC--------CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeec
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR--------DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEE  528 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~  528 (803)
                      ...+|...+.||+|+||.||+|+..        ++..|++|...... ....+++.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3456778889999999999999742        23478999865432 34457799999999999 89999999999999


Q ss_pred             cceeeEEEEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEE
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNIL  594 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NIL  594 (803)
                      ....++||||+++|+|.+++....              ...+++.+++.++.||++||+|||+   .+++||||||+|||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence            999999999999999999985421              2458899999999999999999999   89999999999999


Q ss_pred             EccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhh
Q 042150          595 LDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQV  673 (803)
Q Consensus       595 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~  673 (803)
                      +++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......   
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---  246 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---  246 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---
Confidence            99999999999999986543222222233456678999999998899999999999999999998 77777543221   


Q ss_pred             hHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          674 NLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       674 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                         ++.... ..+..         ...+..++..+.+++.+||+.+|.+||++.|+++.|+.+..+.
T Consensus       247 ---~~~~~~-~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         247 ---ELFKLL-KEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             ---HHHHHH-HcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence               111111 11110         0112234567889999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-36  Score=339.66  Aligned_cols=261  Identities=25%  Similarity=0.367  Sum_probs=204.6

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhcc-CCCeeeEEeEeeccc
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQS  530 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~  530 (803)
                      ..++|...++||+|+||.||+|++.      .++.||+|++..... ...+.+.+|+++|.++. ||||++++++|...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3445677789999999999999864      246799999765432 23457899999999997 999999999999999


Q ss_pred             eeeEEEEecCCCchhhhccCCC----------------------------------------------------------
Q 042150          531 EMILVYEYMEKGPLKKHLYGPD----------------------------------------------------------  552 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------  552 (803)
                      ..++||||+++|+|.++++...                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999985321                                                          


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEE
Q 042150          553 --------------------------------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNIL  594 (803)
Q Consensus       553 --------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NIL  594 (803)
                                                            ...+++.++++++.|++.||+|||+   .+++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEE
Confidence                                                  1247888899999999999999998   89999999999999


Q ss_pred             EccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhh
Q 042150          595 LDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQV  673 (803)
Q Consensus       595 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~  673 (803)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+. 
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-  350 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-  350 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence            99999999999999975322111111223456788999999998899999999999999999998 8888754322111 


Q ss_pred             hHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          674 NLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       674 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                           .......+.         ....+......+.+++.+|+..+|.+||+++||++.|+.++
T Consensus       351 -----~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 -----FYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -----HHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                 111111110         01112234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.2e-36  Score=329.32  Aligned_cols=237  Identities=25%  Similarity=0.317  Sum_probs=189.1

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHH-HHHhccCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEIT-VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      ++||+|+||+||+|... +++.||+|.+...   ......++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999975 5889999986532   1223345556655 56778999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |+|.+++.  ....+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~  153 (323)
T cd05575          81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTT  153 (323)
T ss_pred             CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCcc
Confidence            99999884  34578999999999999999999999   9999999999999999999999999999875321  11223


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ....... ..        .  ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~-~~--------~--~~~  216 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILN-KP--------L--RLK  216 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHc-CC--------C--CCC
Confidence            34568999999999999999999999999999999999999987543221      1111111 00        0  112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSMG  727 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~~  727 (803)
                      ......+.+++.+||+.+|.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            23356789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-36  Score=332.47  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=196.1

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      ++||+|+||.||++..+ +++.+|+|.+...   .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            37999999999999975 4788999986543   223345678899998877 799999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |+|..++.  ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 ~~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~  153 (329)
T cd05618          81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTT  153 (329)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCcc
Confidence            99998883  34569999999999999999999999   8999999999999999999999999999875221  11122


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhh--hhhHHHHHHHHhhcCccccccCcccccC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE--QVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.......  ......+..........          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence            34578999999999999999999999999999999999999985321111  11122222222211111          1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPS------MGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs------~~evl~~  732 (803)
                      ++......+.+++.+||+.+|.+||+      +.+++++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            23334567889999999999999998      5677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-36  Score=321.53  Aligned_cols=254  Identities=28%  Similarity=0.400  Sum_probs=197.4

Q ss_pred             CccceEeeeCceEEEEEEECCCc---EEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeecc------cee
Q 042150          464 DKNLIIGSGGFGMVYKGVLRDNT---KVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ------SEM  532 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~  532 (803)
                      ...+.||+|+||.||+|.+.+..   .+|+|.....  .....+.|.+|+++++.++||||++++++|...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            45678999999999999976532   5899976543  233456789999999999999999999987432      246


Q ss_pred             eEEEEecCCCchhhhccC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          533 ILVYEYMEKGPLKKHLYG----PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                      +++|||+++|+|.+++..    .....+++..++.++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence            899999999999988732    223458999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGM  687 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (803)
                      ++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+   +.+    ....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~----~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYD----YLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHcCC
Confidence            986432221111222345678999999999999999999999999999999 788886432211   111    111111


Q ss_pred             cccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          688 LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       688 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      ..         ..+......+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10         11223445689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.2e-36  Score=331.63  Aligned_cols=243  Identities=22%  Similarity=0.278  Sum_probs=196.0

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      +.||+|+||.||++... +++.||+|.+...   .......+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999864 5889999986542   2234567889999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceec
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST  622 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  622 (803)
                      +|..++.  ....+++.++..++.||+.||+|||+  ..+|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~  154 (325)
T cd05594          81 ELFFHLS--RERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMK  154 (325)
T ss_pred             cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccc
Confidence            9999883  34568999999999999999999995  26899999999999999999999999999874221  111223


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCH
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINL  702 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  702 (803)
                      ...||+.|+|||++.+..++.++|||||||+||||++|+.||..........      . .....      .    .++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~------~-i~~~~------~----~~p~  217 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE------L-ILMEE------I----RFPR  217 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH------H-HhcCC------C----CCCC
Confidence            4568999999999999999999999999999999999999996543221111      0 00000      0    1122


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          703 DSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       703 ~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                      .....+.+++.+||+.||.+|+     ++.+++++
T Consensus       218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            3346788999999999999996     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.3e-37  Score=326.14  Aligned_cols=265  Identities=24%  Similarity=0.358  Sum_probs=201.5

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-----CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeec--cceee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE--QSEMI  533 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~  533 (803)
                      ++|...+.||+|+||.||++..+     ++..|++|++........+.|.+|++++++++||||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46777889999999999999853     477899999766555556789999999999999999999998743  34689


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +||||+++|+|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus        84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            999999999999998532 3468999999999999999999999   899999999999999999999999999998643


Q ss_pred             CCCCCce-eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCc-----
Q 042150          614 CLDETHV-STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM-----  687 (803)
Q Consensus       614 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-----  687 (803)
                      ....... .....++..|+|||.+.+..++.++|||||||++|||++|..+.......       +.........     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~  232 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMMGNDKQGQMIV  232 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhcccccccccch
Confidence            3222111 11223445699999999899999999999999999999988765322110       0000000000     


Q ss_pred             --cccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          688 --LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       688 --~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                        +.+.+............+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence              0000000000111233456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-37  Score=338.66  Aligned_cols=254  Identities=23%  Similarity=0.265  Sum_probs=203.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|... +++.||+|++...   .......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888899999999999999976 5889999986532   2244567899999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++..  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            99999999999954  3678999999999999999999999   999999999999999999999999999987543221


Q ss_pred             ---------------------------CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchh
Q 042150          617 ---------------------------ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLA  669 (803)
Q Consensus       617 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  669 (803)
                                                 .........||+.|+|||.+.+..++.++|||||||+||||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                       00122345689999999999999999999999999999999999999975432


Q ss_pred             hhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 042150          670 REQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPS-MGDVLWNL  733 (803)
Q Consensus       670 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~~L  733 (803)
                      ....      ......  ...+.-     .........+.+++.+|+. +|.+||+ +.+++++.
T Consensus       236 ~~~~------~~i~~~--~~~~~~-----p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         236 QETY------NKIINW--KESLRF-----PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             HHHH------HHHhcc--CCcccC-----CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            2110      111100  000000     0111145678899999997 9999999 99998763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-36  Score=320.40  Aligned_cols=255  Identities=27%  Similarity=0.397  Sum_probs=200.3

Q ss_pred             CCccceEeeeCceEEEEEEECC----CcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccce-----
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE-----  531 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~-----  531 (803)
                      |...+.||+|+||.||+|.+..    +..||+|++....  ......+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567789999999999999643    3679999865432  2234678999999999999999999998866554     


Q ss_pred             -eeEEEEecCCCchhhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeee
Q 042150          532 -MILVYEYMEKGPLKKHLYGP----DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADF  606 (803)
Q Consensus       532 -~~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF  606 (803)
                       .++|+||+++|+|..++...    ....+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999888432    23468999999999999999999999   89999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhc
Q 042150          607 GLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKK  685 (803)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  685 (803)
                      |+++................+..|+|||.+.+..++.++|||||||++|||++ |..|+......+   +.++.    ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~----~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL----RH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----Hc
Confidence            99976433222212222335678999999998999999999999999999999 888886433211   11111    11


Q ss_pred             CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       686 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      +..         ...+......+.+++.+|++.+|.+||++.|+++.|+.+
T Consensus       231 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110         011234456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=336.44  Aligned_cols=254  Identities=22%  Similarity=0.288  Sum_probs=197.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||++... +++.||||++...   .....+.+.+|++++++++||||+++++++.+....+|||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36788899999999999999865 5889999986432   2233567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.  ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9999999999984  34568899999999999999999999   999999999999999999999999999986321100


Q ss_pred             CC-----------c----------------------------------eeccccCCCcccCccccccCcCCCcceehhHH
Q 042150          617 ET-----------H----------------------------------VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFG  651 (803)
Q Consensus       617 ~~-----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~G  651 (803)
                      ..           .                                  ......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            00           0                                  00124689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCC---CCHHH
Q 042150          652 VVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDR---PSMGD  728 (803)
Q Consensus       652 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~~e  728 (803)
                      |+||||++|+.||......+..      .......  ..+.-+     ........+.+++.+||. +|.+|   +++.|
T Consensus       236 vil~elltG~~Pf~~~~~~~~~------~~i~~~~--~~~~~p-----~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETY------RKIINWR--ETLYFP-----DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHH------HHHHccC--CccCCC-----CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            9999999999999754332211      0100000  000000     011234568899999997 66665   69999


Q ss_pred             HHHHH
Q 042150          729 VLWNL  733 (803)
Q Consensus       729 vl~~L  733 (803)
                      ++++-
T Consensus       302 ~l~hp  306 (377)
T cd05629         302 IKSHP  306 (377)
T ss_pred             HhcCC
Confidence            98864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-36  Score=324.44  Aligned_cols=255  Identities=27%  Similarity=0.420  Sum_probs=203.0

Q ss_pred             cCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .+|...++||+|+||.||++...      ++..+++|..........++|.+|+++++.++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45667789999999999999742      356788998766555556789999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcE
Q 042150          535 VYEYMEKGPLKKHLYGPDR-------------TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~  601 (803)
                      +|||+++|+|.+++.....             ..+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence            9999999999999854221             358999999999999999999998   999999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAM  680 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  680 (803)
                      ||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+..   .   
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~---  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---E---  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---H---
Confidence            9999999875332221112223345688999999999999999999999999999998 88888643322211   1   


Q ss_pred             HHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      . ...+..         ...+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       236 ~-~~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 C-ITQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             H-HHcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1 111100         0111233467899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.6e-37  Score=350.19  Aligned_cols=258  Identities=24%  Similarity=0.305  Sum_probs=205.6

Q ss_pred             HHHHhcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccc--
Q 042150          456 LQTATNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS--  530 (803)
Q Consensus       456 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~--  530 (803)
                      .....++|...++||+|+||+||+|.. .+++.||||.+...  .......+.+|+.++..++|+||+++...+....  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            344557899999999999999999985 46899999986543  2334567889999999999999999988764332  


Q ss_pred             ------eeeEEEEecCCCchhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEE
Q 042150          531 ------EMILVYEYMEKGPLKKHLYGP--DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSK  602 (803)
Q Consensus       531 ------~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k  602 (803)
                            .+++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEE
Confidence                  368999999999999998532  24578999999999999999999999   9999999999999999999999


Q ss_pred             EeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH
Q 042150          603 VADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       603 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      |+|||+++...............||+.|+|||++.+..++.++|||||||+||||++|+.||......      +.....
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~  257 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKT  257 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH
Confidence            99999997643322222334567999999999999999999999999999999999999999754221      111111


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      . .+..         ...+......+.+++.+||+.+|.+||++.+++++
T Consensus       258 ~-~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 L-AGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             h-cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1 1110         11233445678999999999999999999999875

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.7e-36  Score=337.82  Aligned_cols=254  Identities=22%  Similarity=0.269  Sum_probs=197.0

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .|...+.||+|+||+||+|+.. +++.||+|++...   .....+.+.+|++++++++||||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            4777889999999999999965 4789999986543   22335678999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++|+|.+++..  ...+++..+..++.||+.||+|||+   .+|+||||||+||||+.++++||+|||+++.......
T Consensus        82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            9999999999843  4568899999999999999999999   9999999999999999999999999999753210000


Q ss_pred             ---------------------------------------------CceeccccCCCcccCccccccCcCCCcceehhHHH
Q 042150          618 ---------------------------------------------THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGV  652 (803)
Q Consensus       618 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gv  652 (803)
                                                                   ........||+.|+|||.+.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                         00012346999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHH
Q 042150          653 VLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEK--CLADYGVDRPSMGDVL  730 (803)
Q Consensus       653 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~--cl~~~p~~RPs~~evl  730 (803)
                      ++|||++|+.||......+..      ........       .+..........++.+++.+  |+..++..||++.+++
T Consensus       237 il~elltG~~Pf~~~~~~~~~------~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQ------LKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHH------HHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            999999999999754322211      00000000       00000111234567788877  5566777799999998


Q ss_pred             HHH
Q 042150          731 WNL  733 (803)
Q Consensus       731 ~~L  733 (803)
                      .+-
T Consensus       304 ~hp  306 (381)
T cd05626         304 AHP  306 (381)
T ss_pred             cCc
Confidence            763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.5e-36  Score=327.69  Aligned_cols=246  Identities=22%  Similarity=0.284  Sum_probs=196.7

Q ss_pred             CCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      +|...+.||+|+||.||+|+... ++.||+|.+...   .....+.+..|..++..+ +|++|+++.+++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            47778899999999999999764 678999986543   223345677888888887 5899999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.  ....+++.+++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....  
T Consensus        81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--  153 (323)
T cd05616          81 EYVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--  153 (323)
T ss_pred             cCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC--
Confidence            9999999999884  34568999999999999999999999   8999999999999999999999999999875321  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..   .. ....         
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~~---~i-~~~~---------  217 (323)
T cd05616         154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQ---SI-MEHN---------  217 (323)
T ss_pred             CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---HH---HH-HhCC---------
Confidence            11122345789999999999999999999999999999999999999975432211   11   11 1110         


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSM-----GDVLW  731 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~  731 (803)
                       ..++.....++.+++.+||+.+|.+|++.     .++++
T Consensus       218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence             01222345678999999999999999984     56654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-36  Score=331.83  Aligned_cols=252  Identities=24%  Similarity=0.299  Sum_probs=198.0

Q ss_pred             CCCccceEeeeCceEEEEEEEC----CCcEEEEEEcCCC----CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeecccee
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR----DNTKVAVKRGVPG----SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  532 (803)
                      +|...+.||+|+||.||++...    +++.||+|.....    .....+.+.+|++++.++ +||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4777889999999999998853    5788999986432    223345688999999999 599999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+++|+|.+++.  .+..+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            99999999999999984  34568999999999999999999999   89999999999999999999999999998753


Q ss_pred             CCCCCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      .... ........||+.|+|||.+.+. .++.++|||||||+||||++|+.||........  ..........       
T Consensus       156 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~-------  225 (332)
T cd05614         156 LSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILK-------  225 (332)
T ss_pred             cccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhc-------
Confidence            2211 1122345789999999999865 478899999999999999999999864322111  1111111111       


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                      .++    .++......+.+++.+||+.+|.+||     ++.+++++
T Consensus       226 ~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            111    12223456678999999999999999     67788764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.3e-36  Score=317.19  Aligned_cols=254  Identities=27%  Similarity=0.425  Sum_probs=205.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .++|...++||+|+||.||+|..++++.||+|.+.... ....+|.+|+.++++++||||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            45678888999999999999998889999999865433 34678999999999999999999999874 45689999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.......+++.+++.++.|++.||+|||+   .+++||||||+||++++++.++|+|||+++...... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YT  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-cc
Confidence            99999999866556679999999999999999999998   899999999999999999999999999987543211 11


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.||......+   ...   .. .....         .
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~-~~~~~---------~  222 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQ---NL-ERGYR---------M  222 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHH---HH-HcCCC---------C
Confidence            1223345678999999998899999999999999999999 999986443221   111   11 11100         0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ..+...+..+.+++.+|++.+|++||++++++..|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1112234578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4e-36  Score=324.21  Aligned_cols=264  Identities=22%  Similarity=0.301  Sum_probs=197.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            357888899999999999999976 58899999865432 2234567899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |++ ++|.+++.. ....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....  
T Consensus        84 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--  156 (303)
T cd07869          84 YVH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--  156 (303)
T ss_pred             CCC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--
Confidence            996 578777743 23568899999999999999999999   99999999999999999999999999998753211  


Q ss_pred             CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC---------c
Q 042150          618 THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG---------M  687 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------~  687 (803)
                      ........+++.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+. .........         .
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QLE-RIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHH-HHHHHhCCCChhhccchhh
Confidence            122234567899999999865 4688899999999999999999999975422111 111 110000000         0


Q ss_pred             ccccc--------CcccccCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          688 LEHII--------DPQLIGKIN-LDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       688 ~~~i~--------d~~l~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .....        ...+....+ ......+.+++.+||+.||.+|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            00000        000000000 0123567899999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-36  Score=328.08  Aligned_cols=240  Identities=24%  Similarity=0.324  Sum_probs=191.2

Q ss_pred             eEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          468 IIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      +||+|+||.||+|...+ ++.||+|.+...   .....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            69999999999999754 778999986532   223445667777777755 8999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceec
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST  622 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  622 (803)
                      +|.+++..  ...+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        82 ~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          82 DLMFHIQS--SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99998843  4568999999999999999999999   999999999999999999999999999987532211  2233


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCH
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINL  702 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  702 (803)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.      ...... .          ...++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~-~----------~~~~~~  217 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL------FDSILN-D----------RPHFPR  217 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHc-C----------CCCCCC
Confidence            45789999999999999999999999999999999999999975432211      111111 0          011222


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 042150          703 DSLKKFGETAEKCLADYGVDRPSMG-DVLW  731 (803)
Q Consensus       703 ~~~~~l~~li~~cl~~~p~~RPs~~-evl~  731 (803)
                      .....+.+++.+||+.+|.+||++. ++++
T Consensus       218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            3445678999999999999999875 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.2e-36  Score=326.50  Aligned_cols=241  Identities=23%  Similarity=0.298  Sum_probs=194.0

Q ss_pred             CCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccC-CCeeeEEeEeeccceeeEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRH-RHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~lV~  536 (803)
                      +|...+.||+|+||.||+|..++ ++.||||.+...   .....+.+..|.+++..++| ++|+++.+++...+.+++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            47778899999999999999764 678999986532   23445678899999999976 56888999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.  ....+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05587          81 EYVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-  154 (324)
T ss_pred             cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence            9999999999984  34568999999999999999999999   99999999999999999999999999998742211 


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+..   .   .. ....         
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~---~i-~~~~---------  217 (324)
T cd05587         155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---Q---SI-MEHN---------  217 (324)
T ss_pred             -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---H---HH-HcCC---------
Confidence             11223456899999999999999999999999999999999999999754322111   1   10 1110         


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSM  726 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  726 (803)
                       ..++......+.+++.+||..+|.+|++.
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             11222345678899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=337.28  Aligned_cols=253  Identities=21%  Similarity=0.307  Sum_probs=199.5

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||++... +++.||||++...   .......+.+|+++|..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36888899999999999999975 4889999986532   2233456889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++..  ...+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            99999999999843  4569999999999999999999999   999999999999999999999999999986432111


Q ss_pred             CCc------------------------------------eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhC
Q 042150          617 ETH------------------------------------VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA  660 (803)
Q Consensus       617 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG  660 (803)
                      ...                                    ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            000                                    01124689999999999999999999999999999999999


Q ss_pred             CCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 042150          661 RTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPS---MGDVLWN  732 (803)
Q Consensus       661 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~evl~~  732 (803)
                      +.||......+..   .....+  ..        .+.........+.+.+++.+|+. +|.+|++   +.|++++
T Consensus       236 ~~Pf~~~~~~~~~---~~i~~~--~~--------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         236 YPPFCSDNPQETY---RKIINW--KE--------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCHHHHH---HHHHcC--CC--------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9999754322211   111000  00        00000111234567889999996 9999997   9999875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.7e-36  Score=322.99  Aligned_cols=260  Identities=24%  Similarity=0.356  Sum_probs=206.9

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-----CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeec-cce
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-----NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEE-QSE  531 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~  531 (803)
                      ..++|...++||+|+||.||+|...+     +..|++|++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34678888899999999999999765     6789999865432 2335678999999999999999999998866 567


Q ss_pred             eeEEEEecCCCchhhhccCCCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEee
Q 042150          532 MILVYEYMEKGPLKKHLYGPDR------TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVAD  605 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D  605 (803)
                      .++++||+++|+|.+++.....      ..+++.+++.++.|++.||+|||+   .+++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence            8999999999999999854321      568999999999999999999998   9999999999999999999999999


Q ss_pred             eccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhh
Q 042150          606 FGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQK  684 (803)
Q Consensus       606 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  684 (803)
                      ||+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||......   .+..+..   .
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~---~  234 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK---D  234 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH---c
Confidence            999986433222222233456778999999998999999999999999999999 99998643221   1211111   1


Q ss_pred             cCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          685 KGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       685 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      ....          .....++..+.+++.+|+..+|++|||+.++++.|+.+.
T Consensus       235 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         235 GYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             CCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1000          111223457899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-36  Score=324.61  Aligned_cols=262  Identities=23%  Similarity=0.342  Sum_probs=200.4

Q ss_pred             cCCCccceEeeeCceEEEEEEECC---------------CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD---------------NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVG  524 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g  524 (803)
                      ++|...+.||+|+||.||++...+               ...||+|...... ....+.|.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            568888899999999999987642               1248999865542 223457999999999999999999999


Q ss_pred             EeeccceeeEEEEecCCCchhhhccCCC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEE
Q 042150          525 YCEEQSEMILVYEYMEKGPLKKHLYGPD----------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNIL  594 (803)
Q Consensus       525 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NIL  594 (803)
                      ++...+..++||||+++++|.+++....          ...+++..++.++.|++.||+|||+   .+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence            9999999999999999999999884321          1247899999999999999999999   89999999999999


Q ss_pred             EccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh--CCCCCCcchhhhh
Q 042150          595 LDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC--ARTAVDPLLAREQ  672 (803)
Q Consensus       595 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~~  672 (803)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++  |..||......+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999875432222222223345778999999998999999999999999999998  5566654322211


Q ss_pred             hhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          673 VNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       673 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                        +..........+....       ...+...+..+.+++.+|++.+|.+||++.+|++.|+
T Consensus       242 --~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 --IENTGEFFRNQGRQIY-------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --HHHHHHhhhhcccccc-------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              1111111100010000       1112223467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-36  Score=329.26  Aligned_cols=238  Identities=24%  Similarity=0.290  Sum_probs=192.3

Q ss_pred             ceEeeeCceEEEEEEE----CCCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          467 LIIGSGGFGMVYKGVL----RDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      +.||+|+||.||++..    .+++.+|+|++....  ......+.+|+++|++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4799999999999875    357899999865422  2234567889999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|+|.+++.  ....+++.+++.++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....  ...
T Consensus        82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~  154 (318)
T cd05582          82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK  154 (318)
T ss_pred             CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCc
Confidence            999999983  34568999999999999999999999   99999999999999999999999999998753221  122


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      .....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+..      .... ...          ..+
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~------~~i~-~~~----------~~~  217 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM------TMIL-KAK----------LGM  217 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH------HHHH-cCC----------CCC
Confidence            23457899999999999989999999999999999999999999754322111      1111 110          012


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHH
Q 042150          701 NLDSLKKFGETAEKCLADYGVDRPSMGD  728 (803)
Q Consensus       701 ~~~~~~~l~~li~~cl~~~p~~RPs~~e  728 (803)
                      +......+.+++.+||+.+|.+||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            2234567889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.6e-36  Score=316.65  Aligned_cols=250  Identities=28%  Similarity=0.397  Sum_probs=204.2

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|...+.||+|++|.||+|..+ +++.|++|.....  .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4667789999999999999975 5888999986432  334467899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++++|.+++.......+++.+++.++.|++.||.|||+   .+++|+||||+||++++++.+||+|||+++.....  .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~  155 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--T  155 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc--c
Confidence            999999999966545679999999999999999999998   89999999999999999999999999998754321  1


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .......++..|+|||++.+..++.++|||||||++|||++|+.||.......   ...   . ...+..         .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~-~~~~~~---------~  219 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LIL---K-IIRGVF---------P  219 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHcCCC---------C
Confidence            11233467889999999999999999999999999999999999987543211   111   1 111111         1


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .........+.+++.+|++.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1122345678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-36  Score=316.98  Aligned_cols=246  Identities=26%  Similarity=0.399  Sum_probs=195.3

Q ss_pred             eEeeeCceEEEEEEEC---CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          468 IIGSGGFGMVYKGVLR---DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      .||+|+||.||+|.++   ++..+|+|++.....  ...++|.+|+.+++.+.||||+++++++.. ...++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753   478899998654332  235678999999999999999999999864 5678999999999


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc-ee
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH-VS  621 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~  621 (803)
                      +|.+++.  ....+++..++.++.|++.||+|||+   ++++||||||+||++++++.+||+|||+++......... ..
T Consensus        81 ~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            9999994  33568999999999999999999998   899999999999999999999999999997643222111 11


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      ....++..|+|||.+....++.++|||||||++|||++ |+.||......+   +..   . ...+.         ....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~-i~~~~---------~~~~  219 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQ---M-IESGE---------RMEC  219 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H-HHCCC---------CCCC
Confidence            22334678999999988889999999999999999998 999987543221   111   1 11111         1112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       701 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      +...+..+.+++.+|++.+|++||++.+|.+.|+.
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            23345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.4e-36  Score=325.94  Aligned_cols=259  Identities=30%  Similarity=0.469  Sum_probs=202.8

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-Cc--EEEEEEcCCC-CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NT--KVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ++|...+.||+|+||.||+|.++. +.  .+++|+.... .......|.+|++++.++ +||||+++++++..++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            567888899999999999999753 43  4577765433 233456789999999999 899999999999999999999


Q ss_pred             EEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcE
Q 042150          536 YEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~  601 (803)
                      |||+++|+|.+++....              ...+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence            99999999999985322              2368999999999999999999998   999999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAM  680 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  680 (803)
                      ||+|||+++....   ........++..|+|||.+.+..++.++|||||||+||||++ |..||......+.      ..
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~  234 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YE  234 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH------HH
Confidence            9999999864211   111112234668999999988889999999999999999998 9999864332211      11


Q ss_pred             HHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                      .. ..+         .....+......+.+++.+|++.+|.+||++.++++.|+.+..-..
T Consensus       235 ~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         235 KL-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             HH-hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            11 110         0001112234568899999999999999999999999988765443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.5e-36  Score=320.31  Aligned_cols=248  Identities=22%  Similarity=0.298  Sum_probs=195.6

Q ss_pred             EeeeCceEEEEEEEC-CCcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCch
Q 042150          469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       469 Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      ||+|+||.||++..+ +++.+|+|++....   ......+..|++++++++||||+++.+++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999975 48899999865321   12234566799999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccc
Q 042150          545 KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV  624 (803)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (803)
                      .+++.......+++..++.++.|++.||+|||+   .+++||||||+||++++++.++|+|||++.....   .......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---Cceeecc
Confidence            998866555679999999999999999999999   9999999999999999999999999999875332   1122345


Q ss_pred             cCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHH
Q 042150          625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDS  704 (803)
Q Consensus       625 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  704 (803)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||........  ..+....... .        ... ......
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~-~--------~~~-~~~~~~  222 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLE-D--------EVK-FEHQNF  222 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhc-c--------ccc-cccccC
Confidence            689999999999998999999999999999999999999864322111  1111111110 0        000 001123


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          705 LKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       705 ~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ..++.+++.+||+.+|.+||++.|+++.+.
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            456899999999999999999987765444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.7e-36  Score=329.60  Aligned_cols=236  Identities=22%  Similarity=0.309  Sum_probs=191.4

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      ++||+|+||.||+|..+ +++.||||.+...   .....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999976 4789999986532   234456788899999877 699999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |+|.+++.  ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 g~L~~~i~--~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~  153 (320)
T cd05590          81 GDLMFHIQ--KSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTT  153 (320)
T ss_pred             chHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCcc
Confidence            99999884  34568999999999999999999999   9999999999999999999999999999875321  11223


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ..... .+.   .       ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~-~~~---~-------~~~  216 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAIL-NDE---V-------VYP  216 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHHHh-cCC---C-------CCC
Confidence            345789999999999999999999999999999999999999975432211      11111 110   0       112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSM  726 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~  726 (803)
                      ......+.+++.+||+.||.+||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            2234578899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-36  Score=337.38  Aligned_cols=256  Identities=23%  Similarity=0.248  Sum_probs=201.5

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceee
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      ...++|...++||+|+||.||++..+ +++.||+|.+...   .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34567899999999999999999975 4789999986432   2234456889999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +||||+++|+|.+++..   ..+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+++...
T Consensus       120 lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999999843   358888899999999999999999   999999999999999999999999999987532


Q ss_pred             CCCCCceeccccCCCcccCccccccC----cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQ----QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      .. .........||+.|+|||.+.+.    .++.++|||||||+||||++|+.||........      ........  .
T Consensus       194 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~--~  264 (370)
T cd05596         194 AN-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMDHK--N  264 (370)
T ss_pred             CC-CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------HHHHHcCC--C
Confidence            21 11122345789999999998653    478899999999999999999999975432111      01111100  0


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVD--RPSMGDVLWNL  733 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~L  733 (803)
                      .     +.-......+..+.+++.+||..+|.+  ||++.|++++-
T Consensus       265 ~-----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         265 S-----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             c-----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence            0     000111134567889999999999987  99999998764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-37  Score=316.27  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=209.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ..+|++.+.||+|.||.|-+|+. ..|+.||||.+...   +.++.-...+|+++|+.|+||||++++.+|+..+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45677788999999999999995 67999999976544   344455678999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||..+|.|.+++  ..++.|++.+...+++||..++.|+|.   ++++|||||.+|||||.++++||+||||+..+.  
T Consensus       132 MEYaS~GeLYDYi--Ser~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~--  204 (668)
T KOG0611|consen  132 MEYASGGELYDYI--SERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA--  204 (668)
T ss_pred             EEecCCccHHHHH--HHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc--
Confidence            9999999999999  567789999999999999999999999   999999999999999999999999999997633  


Q ss_pred             CCCceeccccCCCcccCccccccCcCCC-cceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                       ........+|++-|.+||++.+.+|.- ..|-|||||+||-|+.|..||++.+-..   +   +++ +..+...     
T Consensus       205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---l---vrQ-Is~GaYr-----  271 (668)
T KOG0611|consen  205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---L---VRQ-ISRGAYR-----  271 (668)
T ss_pred             -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---H---HHH-hhccccc-----
Confidence             233445689999999999999998864 6999999999999999999998764321   1   112 1222111     


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                            .++.+....-||.+||..+|.+|-|+.+|..+.+
T Consensus       272 ------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  272 ------EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                  1233445678999999999999999999987764

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-36  Score=329.58  Aligned_cols=241  Identities=20%  Similarity=0.290  Sum_probs=194.8

Q ss_pred             eEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          468 IIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      +||+|+||.||+|+.+. ++.||+|.+...   .....+.+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            69999999999999764 789999986543   233456688899999876 7999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceec
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST  622 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  622 (803)
                      +|..++.  ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~  154 (321)
T cd05591          82 DLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTT  154 (321)
T ss_pred             cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccc
Confidence            9998884  34568999999999999999999999   8999999999999999999999999999875321  112223


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCH
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINL  702 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  702 (803)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ...... +.   .       ..+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~~i~~-~~---~-------~~p~  217 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------FESILH-DD---V-------LYPV  217 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------HHHHHc-CC---C-------CCCC
Confidence            45689999999999999999999999999999999999999975432221      111111 10   0       1112


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 042150          703 DSLKKFGETAEKCLADYGVDRP-------SMGDVLWN  732 (803)
Q Consensus       703 ~~~~~l~~li~~cl~~~p~~RP-------s~~evl~~  732 (803)
                      .....+.+++.+||+.+|.+||       ++.+++++
T Consensus       218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            2345788999999999999999       77888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-36  Score=315.41  Aligned_cols=250  Identities=28%  Similarity=0.461  Sum_probs=205.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .++|...+.||+|+||.||+|... ++.|++|....... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            346778889999999999999876 78899998765543 5678999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.......+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++.....    
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~----  155 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----  155 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccc----
Confidence            99999999965555579999999999999999999999   99999999999999999999999999999764211    


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                       ......+..|+|||.+....++.++||||||+++|||++ |+.|+......+   +..    ....+.         ..
T Consensus       156 -~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~----~~~~~~---------~~  218 (256)
T cd05039         156 -QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----HVEKGY---------RM  218 (256)
T ss_pred             -cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHhcCC---------CC
Confidence             112345678999999998899999999999999999997 998886443221   111    111110         01


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ..+...+..+.+++.+||..+|.+||++.++++.|+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            1122345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.7e-36  Score=315.44  Aligned_cols=253  Identities=30%  Similarity=0.437  Sum_probs=202.6

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ++|.....||+|++|.||+|.++.+..+++|..... ....+.|.+|++++++++|||++++++++.. +..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            457777899999999999999887778999986543 2345679999999999999999999998854 56889999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|+|.+++.......+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++...... ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCc-ccc
Confidence            9999999966555668999999999999999999998   899999999999999999999999999987532211 111


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+   ..++.    ..+.         ...
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~---------~~~  223 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV----ERGY---------RMP  223 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCC---------CCC
Confidence            122345678999999998999999999999999999999 888886433221   11111    1110         001


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      .+...+..+.+++.+||+.+|.+||++++|++.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            122345678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.5e-36  Score=334.25  Aligned_cols=254  Identities=21%  Similarity=0.315  Sum_probs=195.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|+..+.||+|+||+||++... +++.||+|.+...   .......+.+|+.++.+++||||+++++.+.+...++|||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36888899999999999999865 4789999986532   1233457889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.  ....+++.++..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            9999999999994  34579999999999999999999999   999999999999999999999999999987532110


Q ss_pred             CC---------------------------------ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCC
Q 042150          617 ET---------------------------------HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTA  663 (803)
Q Consensus       617 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p  663 (803)
                      ..                                 .......||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            00                                 001235799999999999999999999999999999999999999


Q ss_pred             CCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 042150          664 VDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLA--DYGVDRPSMGDVLWN  732 (803)
Q Consensus       664 ~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~--~~p~~RPs~~evl~~  732 (803)
                      |......+..   .   .... .. ..+..+.     .......+.+++.+++.  .++..||+++|++++
T Consensus       236 f~~~~~~~~~---~---~i~~-~~-~~~~~p~-----~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         236 FCSETPQETY---K---KVMN-WK-ETLIFPP-----EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCHHHHH---H---HHHc-Cc-CcccCCC-----cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            9754322211   0   1000 00 0010110     01123456677776443  334457999999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.6e-36  Score=329.32  Aligned_cols=243  Identities=24%  Similarity=0.343  Sum_probs=193.7

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      ++||+|+||.||++... +++.+|+|.+...   .....+.+.+|+.++.++ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            37999999999999975 4788999986543   223355688999999988 699999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |+|..++.  ....+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~  153 (327)
T cd05617          81 GDLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTT  153 (327)
T ss_pred             CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCce
Confidence            99998883  34569999999999999999999999   9999999999999999999999999999874221  11222


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ....||+.|+|||++.+..++.++|||||||+||||++|+.||............++..+.......          .++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence            3457899999999999999999999999999999999999999643322222222232222221111          122


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSM  726 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~  726 (803)
                      ......+.+++.+||+.||.+|+++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            2334567899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=319.91  Aligned_cols=271  Identities=24%  Similarity=0.356  Sum_probs=206.9

Q ss_pred             cChhhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHh--ccCCCeeeEEeEeec
Q 042150          451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSK--IRHRHLVSLVGYCEE  528 (803)
Q Consensus       451 ~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~HpnIv~l~g~~~~  528 (803)
                      .|+.-.+....+....+.||+|.||+||+|.++ |+.||||.+....   .+.+.+|.++.+.  |+|+||+.+++.-..
T Consensus       201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             chhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            456666777888889999999999999999998 7899999976443   3467788888775  599999999998754


Q ss_pred             c----ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCceEeeccCcceEEEccCC
Q 042150          529 Q----SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG-----SAEGIIHRDIKSTNILLDENY  599 (803)
Q Consensus       529 ~----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDLkp~NILl~~~~  599 (803)
                      +    .+++||.+|.++|||.++|   .+..++....++++..+|.||++||..     ..+.|.|||||+.|||+.+++
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL---~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYL---NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHH---hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence            4    3789999999999999999   457899999999999999999999952     457799999999999999999


Q ss_pred             cEEEeeeccccCCCCC-CC-CceeccccCCCcccCccccccC------cCCCcceehhHHHHHHHHHhCC----------
Q 042150          600 VSKVADFGLSRSGPCL-DE-THVSTGVKGSFGYLDPEYFRRQ------QLTDKSDVYSFGVVLFEVLCAR----------  661 (803)
Q Consensus       600 ~~kl~DFGla~~~~~~-~~-~~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltG~----------  661 (803)
                      .+.|+|+|||-..... +. .......+||.+|||||++...      +--..+||||||+||||+....          
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            9999999999654332 11 1122456899999999999643      1223599999999999987532          


Q ss_pred             CCCCcchhhhhhhHHHHHHHHhhcCccccc-cCcccccCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          662 TAVDPLLAREQVNLAEWAMQWQKKGMLEHI-IDPQLIGKI-----NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       662 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i-~d~~l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      .||....+.+.           ..+.+.++ ...+++..+     +.+.+..+.++++.||..+|.-|-|+-.+-+.|.+
T Consensus       434 ~Pyyd~Vp~DP-----------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  434 LPYYDVVPSDP-----------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             CCcccCCCCCC-----------CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence            34432221111           00111111 122222222     35678899999999999999999999999888887


Q ss_pred             HHhh
Q 042150          736 ALQL  739 (803)
Q Consensus       736 ~~~~  739 (803)
                      +.+.
T Consensus       503 l~~~  506 (513)
T KOG2052|consen  503 LSNS  506 (513)
T ss_pred             HhcC
Confidence            7653

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.5e-36  Score=320.50  Aligned_cols=257  Identities=25%  Similarity=0.363  Sum_probs=202.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCc----EEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNT----KVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ++|...++||+|+||+||+|.+. ++.    .||+|....... ...+++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            56778889999999999999853 343    489998654332 2356788999999999999999999999754 5789


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ++||+++|+|.+++... ...+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++....
T Consensus        86 ~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          86 VTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            99999999999998542 3468999999999999999999999   9999999999999999999999999999986432


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |..|++......   +..+..    .+..     
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~-----  229 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----KGER-----  229 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCCc-----
Confidence            222212222345678999999999999999999999999999998 888886543221   111111    1100     


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                          ...+......+.+++.+||+.+|++||++.+++..|+.+..
T Consensus       230 ----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         230 ----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                01122345678899999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.7e-36  Score=318.22  Aligned_cols=257  Identities=28%  Similarity=0.442  Sum_probs=203.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-C---cEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-N---TKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .++|...+.||+|+||.||+|.+.. +   ..+++|...... ....+++.+|++++++++||||+++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3467788899999999999999753 3   368999865442 2335679999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++++|.+++... ...+++.+++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999999998542 3568999999999999999999999   8999999999999999999999999999875432


Q ss_pred             CCCCce-eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          615 LDETHV-STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       615 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ...... ......+..|+|||++.+..++.++|||||||++|||++ |+.|+......+      +.... ....     
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~i-~~~~-----  227 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAI-NDGF-----  227 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHH-hcCC-----
Confidence            211111 111223567999999998899999999999999999997 999986432211      11111 1110     


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                          ...........+.+++.+|++.+|.+||++.+|++.|+++
T Consensus       228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                0111223456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-36  Score=335.30  Aligned_cols=261  Identities=21%  Similarity=0.220  Sum_probs=197.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .++|...+.||+|+||.||++... .++.||+|...      ...+.+|+++|++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999964 57889999632      23578999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +. ++|.+++.  ....+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       165 ~~-~~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~  237 (391)
T PHA03212        165 YK-TDLYCYLA--AKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A  237 (391)
T ss_pred             CC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence            95 68888883  34568999999999999999999999   899999999999999999999999999987522111 1


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh-----hhHHHHHHHHhhc--------
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ-----VNLAEWAMQWQKK--------  685 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-----~~l~~~~~~~~~~--------  685 (803)
                      .......||+.|+|||++.+..++.++|||||||+||||++|+.|+........     ..+...... ...        
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~-~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR-SGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH-hcCChhhcCcc
Confidence            122345799999999999999999999999999999999999987643211000     000000000 000        


Q ss_pred             --Cccccc---------cCcccccCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          686 --GMLEHI---------IDPQLIGKI--NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       686 --~~~~~i---------~d~~l~~~~--~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                        ..+.++         ..+......  ....+..+.+++.+||+.||.+|||+.|++++-.
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~  378 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA  378 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence              000000         000000000  0123567899999999999999999999997543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.1e-36  Score=304.98  Aligned_cols=264  Identities=23%  Similarity=0.283  Sum_probs=203.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCC-h-HHHHHHHHHHHhccCCCeeeEEeEee--ccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQG-L-PEFQTEITVLSKIRHRHLVSLVGYCE--EQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~-~~f~~E~~~l~~l~HpnIv~l~g~~~--~~~~~~lV  535 (803)
                      ++|...+.|++|.||.||+|+.+ +++.||+|+++...... . -.-++|+.+|.+++|||||.+..+..  +-+.+|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45677789999999999999965 58899999976543221 1 24589999999999999999988764  34579999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      ||||++ +|..++... .+++...++..+..|+++|++|||.   ..|+|||||++|+|+...|.+||+||||||.... 
T Consensus       156 Me~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs-  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGS-  229 (419)
T ss_pred             HHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcC-
Confidence            999998 899988543 3679999999999999999999999   9999999999999999999999999999997543 


Q ss_pred             CCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc---Cccccc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK---GMLEHI  691 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~i  691 (803)
                       .....+..+-|+-|.|||.+.+ ..|+...|+||+|||+.||+++++.|.+....++.+..   ......   .....+
T Consensus       230 -p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I---f~llGtPte~iwpg~  305 (419)
T KOG0663|consen  230 -PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI---FKLLGTPSEAIWPGY  305 (419)
T ss_pred             -CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH---HHHhCCCccccCCCc
Confidence             2334566778999999999876 57999999999999999999999988766554443322   111111   000011


Q ss_pred             cC--------------cccccCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          692 ID--------------PQLIGKINLD-SLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       692 ~d--------------~~l~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ..              ..+...+... ....-.+++..+|..||.+|-|+.|.|++=.
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~  363 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY  363 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence            00              1111122211 3356678999999999999999999987643

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.4e-36  Score=323.50  Aligned_cols=260  Identities=25%  Similarity=0.382  Sum_probs=203.9

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccce
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~  531 (803)
                      ..++|...+.||+|+||.||+|..++      +..||+|....... ....++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45678889999999999999997542      45799998653321 223468899999999999999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEE
Q 042150          532 MILVYEYMEKGPLKKHLYGPD--------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKV  603 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl  603 (803)
                      .++||||+++|+|.+++....        ...+++..+++++.|++.||.|||+   ++++||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999995321        2446788899999999999999998   99999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHH
Q 042150          604 ADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       604 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......+      .....
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~~~~~  234 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------VLKFV  234 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH
Confidence            99999875432222222222345678999999999999999999999999999998 777876433221      11111


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      .. +...         ..+......+.+++.+|++.+|.+||++.++++.|+..+
T Consensus       235 ~~-~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 MD-GGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             Hc-CCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11 1000         112233467899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-36  Score=316.29  Aligned_cols=256  Identities=32%  Similarity=0.458  Sum_probs=207.5

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ..++|...+.||+|+||.||+|..+++..++||.+... ....+++.+|+.++++++||||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            34678888999999999999999888888999986543 34467899999999999999999999999998999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++++|.+++.......+++.+++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++..... ..
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~-~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EY  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccch-hh
Confidence            999999999966555679999999999999999999998   89999999999999999999999999998754321 11


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      ........+..|+|||.+.+..++.++|||||||++|||++ |+.||........   .+   .... +         ..
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~---~~~~-~---------~~  222 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LE---QVER-G---------YR  222 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHc-C---------CC
Confidence            11122334568999999999999999999999999999998 9999864332211   11   1111 0         00


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ...+...+..+.+++.+|+..+|.+||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            01112235678999999999999999999999988863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.1e-36  Score=314.96  Aligned_cols=248  Identities=29%  Similarity=0.438  Sum_probs=200.6

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEe-eccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC-EEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~-~~~~~~~lV~Ey~  539 (803)
                      .+|...+.||+|+||.||++... +..+++|.....  ...+.|.+|+.++++++|+|++++++++ .+.+..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46778889999999999999875 778999986432  3356899999999999999999999976 4556789999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.......+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.....    
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~----  155 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  155 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc----
Confidence            99999999966555568999999999999999999998   89999999999999999999999999998753221    


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                       ......+..|+|||++.+..++.++|||||||++|||++ |+.|+.....      .+..... ..+.         ..
T Consensus       156 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~-~~~~---------~~  218 (256)
T cd05082         156 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRV-EKGY---------KM  218 (256)
T ss_pred             -CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-hcCC---------CC
Confidence             122344678999999999999999999999999999997 8888764321      1111111 1110         01


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ......+..+.+++.+|++.+|.+|||+.++++.|+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            1222345678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.1e-36  Score=335.08  Aligned_cols=259  Identities=23%  Similarity=0.243  Sum_probs=200.7

Q ss_pred             hHHHHhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccc
Q 042150          455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS  530 (803)
Q Consensus       455 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~  530 (803)
                      .+....++|...+.||+|+||.||++.... ++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            344456789999999999999999999764 788999976431   2233456889999999999999999999999999


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..++||||+++|+|.+++.   ...+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~---~~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccce
Confidence            9999999999999999993   3358899999999999999999999   999999999999999999999999999997


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccC----cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQ----QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG  686 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (803)
                      ...... ........||+.|+|||++.+.    .++.++|||||||+||||++|+.||........      ........
T Consensus       191 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~~  263 (370)
T cd05621         191 KMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDHK  263 (370)
T ss_pred             ecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC
Confidence            643211 1122345799999999998754    378899999999999999999999975432111      11111100


Q ss_pred             ccccccCcccccCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 042150          687 MLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVD--RPSMGDVLWNL  733 (803)
Q Consensus       687 ~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~L  733 (803)
                      .       .+.-.........+.+++.+|+..++.+  ||++.|++++-
T Consensus       264 ~-------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp  305 (370)
T cd05621         264 N-------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP  305 (370)
T ss_pred             c-------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence            0       0000111233566788999999755543  88999998863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.2e-36  Score=313.51  Aligned_cols=246  Identities=27%  Similarity=0.424  Sum_probs=197.6

Q ss_pred             eEeeeCceEEEEEEECCCcEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCchhh
Q 042150          468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKK  546 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  546 (803)
                      +||+|+||.||+|...++..+|+|........ ....|.+|++++++++||||++++++|...+..++||||+++++|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            68999999999999888899999986554322 23468999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccC
Q 042150          547 HLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG  626 (803)
Q Consensus       547 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  626 (803)
                      ++... ...+++.+++.++.|++.+|.|||+   .+++||||||+||++++++.+||+|||++....... ........+
T Consensus        82 ~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~  156 (250)
T cd05085          82 FLRKK-KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI  156 (250)
T ss_pred             HHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence            98543 3468999999999999999999998   899999999999999999999999999986532111 111112234


Q ss_pred             CCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHH
Q 042150          627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL  705 (803)
Q Consensus       627 t~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~  705 (803)
                      +..|+|||++.+..++.++||||||+++|||++ |..||........   .    .......         ....+...+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~----~~~~~~~---------~~~~~~~~~  220 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---R----EQVEKGY---------RMSCPQKCP  220 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---H----HHHHcCC---------CCCCCCCCC
Confidence            678999999998999999999999999999998 9989864322111   1    1111110         011222345


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          706 KKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       706 ~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ..+.+++.+|++.+|++||++.|+++.|.
T Consensus       221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         221 DDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            67899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3e-36  Score=327.07  Aligned_cols=241  Identities=24%  Similarity=0.327  Sum_probs=192.5

Q ss_pred             ceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      +.||+|+||.||+|...+ ++.||||.+...   .....+.+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            369999999999999764 788999986543   223445677888888765 899999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |+|.+++.  ....+++.++..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....  ....
T Consensus        81 g~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (316)
T cd05619          81 GDLMFHIQ--SCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKT  153 (316)
T ss_pred             CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCce
Confidence            99999984  34568999999999999999999999   99999999999999999999999999998742211  1122


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+.   .+..    ...      .+    .++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~i----~~~------~~----~~~  216 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---FQSI----RMD------NP----CYP  216 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HhC------CC----CCC
Confidence            345689999999999999999999999999999999999999975432211   1111    100      01    111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSMG-DVLW  731 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~~-evl~  731 (803)
                      ......+.+++.+||+.+|.+||++. ++++
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            22345678999999999999999997 5554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.4e-36  Score=314.69  Aligned_cols=248  Identities=24%  Similarity=0.407  Sum_probs=196.0

Q ss_pred             eEeeeCceEEEEEEEC---CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCc
Q 042150          468 IIGSGGFGMVYKGVLR---DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGP  543 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs  543 (803)
                      .||+|+||.||+|.+.   .+..||+|....... ...++|.+|+.++++++||||++++++|.. ...++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999864   355699998765432 234679999999999999999999999864 57899999999999


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc-eec
Q 042150          544 LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH-VST  622 (803)
Q Consensus       544 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~  622 (803)
                      |.+++.. ....+++.++++++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++......... ...
T Consensus        81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            9999853 24568999999999999999999999   899999999999999999999999999987533221111 112


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.      ... ...+.         ....+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~-~~~~~---------~~~~~  220 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV------MSF-IEQGK---------RLDCP  220 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHH-HHCCC---------CCCCC
Confidence            2334678999999998899999999999999999996 9999875432221      111 11111         11223


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      ..+..++.+++.+||+.+|++||++.+|.+.|+..
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            34467888999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.9e-36  Score=322.07  Aligned_cols=263  Identities=26%  Similarity=0.378  Sum_probs=204.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-----------------CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-----------------NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVS  521 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~  521 (803)
                      ..+|...+.||+|+||.||++...+                 +..||+|.+.... ....++|.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3567888899999999999998643                 2458899865443 234567899999999999999999


Q ss_pred             EEeEeeccceeeEEEEecCCCchhhhccCCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcce
Q 042150          522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPD---------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTN  592 (803)
Q Consensus       522 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~N  592 (803)
                      ++++|..+...++||||+++++|.+++....         ...+++..++.++.|++.||+|||+   .+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence            9999999999999999999999999985422         2368999999999999999999998   899999999999


Q ss_pred             EEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh--CCCCCCcchhh
Q 042150          593 ILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC--ARTAVDPLLAR  670 (803)
Q Consensus       593 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~~  670 (803)
                      |+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++  |..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876433222223334556789999999998899999999999999999998  66676533211


Q ss_pred             hhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          671 EQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       671 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      .   ................      ....+...+.++.+++.+|++.+|.+|||+.||++.|+
T Consensus       241 ~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q---VIENAGHFFRDDGRQI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H---HHHHHHhccccccccc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1   1111111111111100      01112233467899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-36  Score=320.09  Aligned_cols=256  Identities=27%  Similarity=0.404  Sum_probs=204.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      .++|...+.||+|+||.||+|..++      +..|++|...... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4567888899999999999998653      3679999865432 23345789999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEe
Q 042150          533 ILVYEYMEKGPLKKHLYGPD--------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA  604 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~  604 (803)
                      ++||||+++|+|.+++....        ...+++..++.++.|++.||.|||+   .+++||||||+|||+++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence            99999999999999985322        2347899999999999999999998   999999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHh
Q 042150          605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQ  683 (803)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  683 (803)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+   ...+.    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~----  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFV----  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHH----
Confidence            9999875433222222233456789999999998899999999999999999998 888886433222   11111    


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ..+..         ...+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 IDGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             hcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11111         0112233567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.1e-36  Score=336.63  Aligned_cols=252  Identities=21%  Similarity=0.240  Sum_probs=197.3

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      +|...+.||+|+||.||+++.. +++.||||.+...   .......+.+|+++|++++||||+++++.+.+++.+++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            5788899999999999999965 4889999986432   22345678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC-
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD-  616 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~-  616 (803)
                      |+++|+|.+++..  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          82 YIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            9999999999943  4568889999999999999999999   999999999999999999999999999974211000 


Q ss_pred             ----------------------------------------CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHH
Q 042150          617 ----------------------------------------ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFE  656 (803)
Q Consensus       617 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~e  656 (803)
                                                              .........||+.|||||++.+..++.++|||||||+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                    0001123468999999999999999999999999999999


Q ss_pred             HHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 042150          657 VLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRP---SMGDVLWN  732 (803)
Q Consensus       657 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP---s~~evl~~  732 (803)
                      |++|+.||......+..      .......       ..+...........+.+++.+|+ .+|.+|+   ++.+++++
T Consensus       237 ll~G~~Pf~~~~~~~~~------~~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAETQ------LKVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHHHH------HHHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999999754332211      0100000       00000111123456778888876 5999999   89999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.7e-36  Score=328.37  Aligned_cols=236  Identities=23%  Similarity=0.276  Sum_probs=187.4

Q ss_pred             eEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHH-HHHhccCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          468 IIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEIT-VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      +||+|+||.||+|+.. +++.||+|.+...   ......++..|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            7999999999999975 4788999986432   1222345556654 578889999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceec
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST  622 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  622 (803)
                      +|..++.  ....+++.++..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~  154 (321)
T cd05603          82 ELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTS  154 (321)
T ss_pred             CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccc
Confidence            9998883  34568899999999999999999998   9999999999999999999999999999875221  112223


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCH
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINL  702 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  702 (803)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.......      ....... ..          ..++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~-~~----------~~~~~  217 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNILH-KP----------LQLPG  217 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHhc-CC----------CCCCC
Confidence            4568999999999999999999999999999999999999997543211      1111111 00          01223


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHH
Q 042150          703 DSLKKFGETAEKCLADYGVDRPSMG  727 (803)
Q Consensus       703 ~~~~~l~~li~~cl~~~p~~RPs~~  727 (803)
                      .....+.+++.+||+.+|.+||+..
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         218 GKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCHHHHHHHHHHccCCHhhcCCCC
Confidence            3456788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.7e-36  Score=336.47  Aligned_cols=252  Identities=21%  Similarity=0.245  Sum_probs=194.8

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .|...++||+|+||.||+|+.. +++.+|+|.+....   ....+.+.+|++++++++||||+++++.+.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            4778889999999999999965 47889999865321   2334578899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC-
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD-  616 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~-  616 (803)
                      |+++|+|.+++..  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            9999999999843  3568899999999999999999999   899999999999999999999999999975321000 


Q ss_pred             --------------------------------------------CCceeccccCCCcccCccccccCcCCCcceehhHHH
Q 042150          617 --------------------------------------------ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGV  652 (803)
Q Consensus       617 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gv  652 (803)
                                                                  .........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                        000012346899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCC---HHHH
Q 042150          653 VLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPS---MGDV  729 (803)
Q Consensus       653 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~ev  729 (803)
                      +||||++|+.||......+..      ......       ...+...........+.+++.+|+ .+|.+|++   +.++
T Consensus       237 il~elltG~~Pf~~~~~~~~~------~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQ------MKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHH------HHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            999999999999754322111      010000       000000111123456677787776 49999987   8887


Q ss_pred             HHH
Q 042150          730 LWN  732 (803)
Q Consensus       730 l~~  732 (803)
                      +++
T Consensus       303 ~~h  305 (382)
T cd05625         303 KAH  305 (382)
T ss_pred             hcC
Confidence            764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-36  Score=315.50  Aligned_cols=252  Identities=23%  Similarity=0.364  Sum_probs=201.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-----CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-----RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ++|...+.||+|++|.||++... +++.+++|......     ....+.+.+|++++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888899999999999999964 58899999754321     1234578899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      |+||+++++|.+++.  ....+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            999999999999984  34568899999999999999999999   9999999999999999999999999999875332


Q ss_pred             CCCCce-eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHV-STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ...... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.........      ......        
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~--------  222 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQ--------  222 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhcc--------
Confidence            111111 12345778999999999999999999999999999999999998643222111      010000        


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       ......+......+.+++.+||..+|.+||++.+++++
T Consensus       223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 -PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             01112233445678999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.7e-36  Score=327.08  Aligned_cols=260  Identities=25%  Similarity=0.418  Sum_probs=204.4

Q ss_pred             cCCCccceEeeeCceEEEEEEECC--------CcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccc
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD--------NTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQS  530 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~  530 (803)
                      .+|...+.||+|+||.||++....        ...||+|...... ....+++.+|+++++++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            457888899999999999997421        2368999765432 23356899999999999 7999999999999999


Q ss_pred             eeeEEEEecCCCchhhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc
Q 042150          531 EMILVYEYMEKGPLKKHLYGP--------------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD  596 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~  596 (803)
                      ..+++|||+++|+|.+++...              ....+++.+++.++.|++.||+|||+   .+++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence            999999999999999998532              12358899999999999999999999   9999999999999999


Q ss_pred             cCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhH
Q 042150          597 ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNL  675 (803)
Q Consensus       597 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  675 (803)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+||||++ |..||......     
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----  243 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-----  243 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence            999999999999876432221112222334568999999999999999999999999999998 78887543221     


Q ss_pred             HHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          676 AEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       676 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                       ++........ .         ...+......+.+++.+|++.+|.+||++.|+++.|+.+...
T Consensus       244 -~~~~~~~~~~-~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         244 -ELFKLLKEGH-R---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             -HHHHHHHcCC-C---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence             1211111111 0         011223456788999999999999999999999999888643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.1e-36  Score=330.96  Aligned_cols=261  Identities=25%  Similarity=0.387  Sum_probs=201.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEE------CCCcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeecc-c
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL------RDNTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ-S  530 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~-~  530 (803)
                      .++|...+.||+|+||.||+|..      .+++.||||++.... ......+.+|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35688889999999999999974      346789999876433 22346788999999999 689999999988654 5


Q ss_pred             eeeEEEEecCCCchhhhccCCC----------------------------------------------------------
Q 042150          531 EMILVYEYMEKGPLKKHLYGPD----------------------------------------------------------  552 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------  552 (803)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999885321                                                          


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceecccc
Q 042150          553 -------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK  625 (803)
Q Consensus       553 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  625 (803)
                             ...+++.++++++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   1247888999999999999999998   999999999999999999999999999987643222211222334


Q ss_pred             CCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHH
Q 042150          626 GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDS  704 (803)
Q Consensus       626 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  704 (803)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..|+........  .    ......+...         ..+...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~~~~~---------~~~~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F----CRRLKEGTRM---------RAPDYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H----HHHHhccCCC---------CCCCCC
Confidence            5678999999999999999999999999999997 8888764322111  0    1111111110         011112


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          705 LKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       705 ~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ...+.+++.+|++.+|.+||++.||+++|+.+.+
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            3568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.9e-36  Score=324.65  Aligned_cols=260  Identities=24%  Similarity=0.433  Sum_probs=204.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC--------CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeecc
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR--------DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ  529 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~  529 (803)
                      ..+|...+.||+|+||.||++...        ....+|+|...... .....++.+|+++++++ +||||++++++|...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356778889999999999999742        24568899865432 23356789999999999 699999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL  595 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl  595 (803)
                      +..++||||+++|+|.+++....              ...+++.++++++.|++.||.|||+   .+++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence            99999999999999999985421              2458999999999999999999998   999999999999999


Q ss_pred             ccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhh
Q 042150          596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVN  674 (803)
Q Consensus       596 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  674 (803)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+.  
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--  245 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL--  245 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            9999999999999986432221111122234567999999999999999999999999999999 8888764332211  


Q ss_pred             HHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          675 LAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       675 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                       .+.    ...+..         ...+..+...+.+++.+|++.+|.+||++.++++.|+.+..
T Consensus       246 -~~~----~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         246 -FKL----LREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             -HHH----HHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence             111    111110         01122345578899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.5e-36  Score=326.66  Aligned_cols=241  Identities=24%  Similarity=0.327  Sum_probs=192.5

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      ++||+|+||.||+|..+ +++.||+|.+...   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999976 4789999986543   123455677888888765 899999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |+|..++.  ....+++.++..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 g~L~~~i~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~  153 (316)
T cd05620          81 GDLMFHIQ--DKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRA  153 (316)
T ss_pred             CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCce
Confidence            99999884  34568999999999999999999999   9999999999999999999999999999874221  11223


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+.   .+   . ....      .+    .++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~~---~-~~~~------~~----~~~  216 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---FE---S-IRVD------TP----HYP  216 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH---H-HHhC------CC----CCC
Confidence            346789999999999999999999999999999999999999975432211   11   1 1100      01    112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSMG-DVLW  731 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~~-evl~  731 (803)
                      .....++.+++.+||+.||.+||++. ++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            22345778999999999999999985 5553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.3e-36  Score=314.83  Aligned_cols=258  Identities=22%  Similarity=0.311  Sum_probs=205.3

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|+.. +++.||||.....   ......+|.+|+++++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46888889999999999999965 5889999975432   2223457899999999999999999999999999999999


Q ss_pred             EecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          537 EYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       537 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||+++|+|.+++..  .....+++..++.++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988842  234568899999999999999999998   9999999999999999999999999999875332


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ..  .......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.....    ....+.... ....     .+
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~-~~~~-----~~  226 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKI-EQCD-----YP  226 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHH-hcCC-----CC
Confidence            11  112234678899999999988899999999999999999999999853221    111111111 1100     11


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      .   .........+.+++.+||..+|.+||++.+|++.|+.+
T Consensus       227 ~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 P---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             C---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            1   11223456789999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7e-36  Score=319.54  Aligned_cols=264  Identities=23%  Similarity=0.311  Sum_probs=195.4

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhc---cCCCeeeEEeEeec-----cc
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKI---RHRHLVSLVGYCEE-----QS  530 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l---~HpnIv~l~g~~~~-----~~  530 (803)
                      +|...+.||+|+||.||+|... +++.||+|.+....  ......+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4677889999999999999976 58889999865432  22234567788877766   69999999998854     34


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..++||||+++ +|.+++.......+++.++..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57999999985 89888865555669999999999999999999999   899999999999999999999999999987


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhh-HHHHHH-----HHhh
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN-LAEWAM-----QWQK  684 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~-----~~~~  684 (803)
                      ....   ........++..|+|||++.+..++.++|||||||++|||++|++||......+... +..+..     .+..
T Consensus       157 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         157 IYSC---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccC---cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            6432   112233567899999999999999999999999999999999999986543222110 100000     0000


Q ss_pred             cCcc-ccccCccc---ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          685 KGML-EHIIDPQL---IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       685 ~~~~-~~i~d~~l---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .... .....+..   .....+.....+.+++.+||+.||.+|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000 00000000   001112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7e-36  Score=316.68  Aligned_cols=248  Identities=31%  Similarity=0.486  Sum_probs=195.2

Q ss_pred             eEeeeCceEEEEEEECC-Cc--EEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          468 IIGSGGFGMVYKGVLRD-NT--KVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      +||+|+||.||+|.+++ +.  .+++|...... ....+.+.+|++++.++ +||||++++++|...+..++||||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            68999999999999764 33  46888765432 33456789999999999 7999999999999999999999999999


Q ss_pred             chhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          543 PLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       543 sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                      +|.+++....              ...+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999985321              2358899999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGM  687 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (803)
                      ++....   .........+..|+|||++....++.++|||||||++|||++ |+.||......+      ..... ....
T Consensus       159 ~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~-~~~~  228 (270)
T cd05047         159 SRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKL-PQGY  228 (270)
T ss_pred             ccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHH-hCCC
Confidence            863211   111112234567999999998899999999999999999997 999986432211      11111 1110


Q ss_pred             cccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          688 LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       688 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                               ....+......+.+++.+|++.+|.+|||+.++++.|+.++
T Consensus       229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                     00111223456889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.2e-36  Score=321.17  Aligned_cols=246  Identities=24%  Similarity=0.329  Sum_probs=195.2

Q ss_pred             EeeeCceEEEEEEEC-CCcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCch
Q 042150          469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       469 Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      ||+|+||+||++... +++.+|+|++....   ....+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999965 57899999865332   22345678899999999999999999999999999999999999999


Q ss_pred             hhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceec
Q 042150          545 KKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST  622 (803)
Q Consensus       545 ~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  622 (803)
                      ..++..  .....+++.+++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence            988743  234569999999999999999999999   999999999999999999999999999987533211  1223


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCH
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINL  702 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  702 (803)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||........  .......         +....  ..++.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~---------~~~~~--~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQR---------ILNDS--VTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHh---------hcccC--CCCcc
Confidence            45689999999999999999999999999999999999999864322111  0111101         01000  01223


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          703 DSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       703 ~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                      ..+..+.+++.+||+.+|.+||     ++++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            4456789999999999999999     67777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.4e-36  Score=316.17  Aligned_cols=254  Identities=24%  Similarity=0.328  Sum_probs=201.3

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .+|...+.||+|+||.||+|+.. +++.||+|+...........+.+|+.++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46888899999999999999964 57889999876554455567889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.  ....+++.++..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||+++.....  ..
T Consensus        89 ~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~  161 (267)
T cd06646          89 GGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IA  161 (267)
T ss_pred             CCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccc--cc
Confidence            9999999984  34568999999999999999999998   89999999999999999999999999998753211  11


Q ss_pred             eeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          620 VSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      ......++..|+|||.+.   ...++.++|||||||++|||++|+.|+......+...      . ...   .....+..
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~-~~~---~~~~~~~~  231 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-MSK---SNFQPPKL  231 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------e-eec---CCCCCCCC
Confidence            122346788999999884   4557889999999999999999999985332211100      0 000   00111111


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      .  .....+..+.+++.+||..+|++||++++++++|
T Consensus       232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1  1123356789999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-37  Score=314.78  Aligned_cols=268  Identities=23%  Similarity=0.287  Sum_probs=206.2

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCC--CCCCChHHHHHHHHHHHhccCCCeeeEEeEeec-----cc
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE-----QS  530 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-----~~  530 (803)
                      ....|...+.||+|+||.|..+... +|+.||+|++..  ...-..++..+|+++|+.++|+||+.+.+.+..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3445555678999999999999965 589999998663  234446778999999999999999999998854     35


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..|+|+|+|+ -+|.+.|  +.++.|+...+.-++.|+++||.|+|+   .+|+||||||+|+|++.+..+||+|||+|+
T Consensus       100 DvYiV~elMe-tDL~~ii--k~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQII--KSQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eeEEehhHHh-hHHHHHH--HcCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccccee
Confidence            6899999995 4899999  344559999999999999999999999   999999999999999999999999999999


Q ss_pred             CCCCCCCCceeccccCCCcccCccccc-cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      ...........+..+.|.-|.|||.+. ...|+.+.||||.||||.||++|++.|.+....++..+......-..+..+.
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            754332333446677899999999875 5789999999999999999999999997766555443322110000011111


Q ss_pred             cccCcc---------------cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          690 HIIDPQ---------------LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       690 ~i~d~~---------------l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      .+-...               +...+ +...+...+|+.+||..||.+|+|++|.+++-
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence            111000               00011 13346778999999999999999999999864

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.6e-36  Score=340.45  Aligned_cols=262  Identities=20%  Similarity=0.252  Sum_probs=194.7

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeecc--------
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--------  529 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--------  529 (803)
                      ...+|...++||+|+||.||+|+.. .++.||||++....    ....+|+.+|+.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3457999999999999999999975 57899999864322    2346799999999999999999876321        


Q ss_pred             ceeeEEEEecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC-cEEEeee
Q 042150          530 SEMILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY-VSKVADF  606 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DF  606 (803)
                      ..+++||||+++ +|.+++..  .....+++..+..++.||+.||+|||+   .+|+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999985 67666632  345679999999999999999999999   9999999999999998654 7999999


Q ss_pred             ccccCCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc
Q 042150          607 GLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK  685 (803)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (803)
                      |+++.....   .......+|+.|+|||++.+ ..++.++|||||||+||||++|++||......+...  ... +....
T Consensus       216 Gla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~--~i~-~~~~~  289 (440)
T PTZ00036        216 GSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV--RII-QVLGT  289 (440)
T ss_pred             ccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHH-HHhCC
Confidence            999864321   12223567999999999865 468999999999999999999999997543322211  110 00000


Q ss_pred             C---------------ccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          686 G---------------MLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       686 ~---------------~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      .               ....+....+...++...+.++.+++.+||..+|.+|||+.|++++-.
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~  353 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF  353 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence            0               000011111111222234567899999999999999999999997644

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.6e-36  Score=316.51  Aligned_cols=258  Identities=22%  Similarity=0.309  Sum_probs=205.6

Q ss_pred             cCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||++.. .++..++||.....   .....++|.+|+.+++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3577778999999999999996 46889999975432   2223467899999999999999999999999999999999


Q ss_pred             EecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          537 EYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       537 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||+++++|.+++..  .....+++..++.++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998842  234568999999999999999999998   9999999999999999999999999999875332


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ..  .......++..|+|||.+.+..++.++||||||+++|||++|..|+......    ...+....      .....+
T Consensus       159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~------~~~~~~  226 (267)
T cd08229         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI------EQCDYP  226 (267)
T ss_pred             CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh------hcCCCC
Confidence            11  1122346888999999999999999999999999999999999998543211    11111110      011111


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      .+   ........+.+++.+|++.+|.+||||.+|++.+++.
T Consensus       227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            11   1123456789999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.2e-36  Score=326.37  Aligned_cols=242  Identities=24%  Similarity=0.302  Sum_probs=195.3

Q ss_pred             ceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      ++||+|+||.||++.... ++.||||.+...   .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            369999999999999764 788999986532   234456778899999888 699999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |+|..++.  ....+++.++..++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (318)
T cd05570          81 GDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTT  153 (318)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcc
Confidence            99999884  34569999999999999999999999   99999999999999999999999999998642211  1122


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||........      ...... ..      .    .++
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~------~~~i~~-~~------~----~~~  216 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL------FQSILE-DE------V----RYP  216 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH------HHHHHc-CC------C----CCC
Confidence            334689999999999999999999999999999999999999975432111      111111 10      0    112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSM-----GDVLWN  732 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~~  732 (803)
                      ......+.+++.+||+.+|.+||++     .+++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            2345678999999999999999999     777754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-35  Score=318.08  Aligned_cols=251  Identities=24%  Similarity=0.329  Sum_probs=199.6

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      |...+.||+|+||+||+|... +++.+|+|.+....   ......+.+|+++|++++|+|++++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            556678999999999999975 58899999865432   22234578899999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++++|.+++.......+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||++......   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---  155 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---  155 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---
Confidence            999999998865555579999999999999999999998   99999999999999999999999999998653221   


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .......|+..|+|||.+.+..++.++|+|||||++|||++|+.||.........  ..+... .....          .
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~~~-~~~~~----------~  222 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVDRR-VLETE----------E  222 (285)
T ss_pred             CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHh-hhccc----------c
Confidence            1123456899999999999999999999999999999999999999754322111  111111 11000          0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWN  732 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  732 (803)
                      .+.......+.+++.+|++.+|.+||+     +.+++.+
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            112233456789999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.3e-36  Score=318.84  Aligned_cols=253  Identities=25%  Similarity=0.326  Sum_probs=201.1

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      |+..++||+|+||.||++... +++.+|||.+....   ....+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566779999999999999965 57899999865432   12234578899999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++++|.+++.......+++.+++.++.|++.||.|||+   .+|+||||||+||++++++.++|+|||++......   
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~---  155 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---  155 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC---
Confidence            999999999865555569999999999999999999998   99999999999999999999999999998753221   


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.........  ... .......          ..
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~-~~~~~~~----------~~  222 (285)
T cd05630         156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEV-ERLVKEV----------QE  222 (285)
T ss_pred             ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHH-Hhhhhhh----------hh
Confidence            1122346899999999999999999999999999999999999999753221100  000 0000000          00


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWNLE  734 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~L~  734 (803)
                      .........+.+++.+||+.+|.+|||     +.|++++-.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~  263 (285)
T cd05630         223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL  263 (285)
T ss_pred             hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence            112223456789999999999999999     889987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1e-35  Score=315.23  Aligned_cols=252  Identities=25%  Similarity=0.325  Sum_probs=191.9

Q ss_pred             eEeeeCceEEEEEEECC---CcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCc
Q 042150          468 IIGSGGFGMVYKGVLRD---NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGP  543 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs  543 (803)
                      .||+|+||.||+|...+   +..+++|+...... .....|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999998654   35789998654432 234578999999999999999999999999999999999999999


Q ss_pred             hhhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          544 LKKHLYGPD---RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       544 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      |.+++....   ....++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999985422   2356778888999999999999999   8999999999999999999999999999875332221122


Q ss_pred             eccccCCCcccCccccccC-------cCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          621 STGVKGSFGYLDPEYFRRQ-------QLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      .....++..|+|||++.+.       .++.++|||||||++|||++ |+.||......+..   .+.    ..+....+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~----~~~~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYT----VREQQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHH----hhcccCCCC
Confidence            2334567889999998642       35789999999999999996 99998654322211   110    011111222


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ++.+.    ......+.+++.+|+ .+|.+|||++||++.|+
T Consensus       232 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22221    123445788999998 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.7e-36  Score=325.81  Aligned_cols=241  Identities=25%  Similarity=0.313  Sum_probs=190.5

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHH-HHHhccCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEIT-VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      ++||+|+||.||+|... +++.+|+|.+...   .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999965 5889999986432   2233445666655 46778999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |+|..++.  ....+++.++..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++....  .....
T Consensus        81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~  153 (325)
T cd05604          81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTT  153 (325)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCc
Confidence            99998884  44578999999999999999999999   9999999999999999999999999999875321  11222


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+.      ....... .+          ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~~~~-~~----------~~~  216 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNILHK-PL----------VLR  216 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHHHcC-Cc----------cCC
Confidence            345789999999999999999999999999999999999999875432211      1111111 00          111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSMGDVLW  731 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~  731 (803)
                      +.....+.+++.+||+.+|.+||++.+.++
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            233456789999999999999998864433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.8e-36  Score=320.11  Aligned_cols=250  Identities=23%  Similarity=0.314  Sum_probs=203.6

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .+|...+.||+|+||.||+|+.. +++.|++|..........+.+.+|+.+++.+.||||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            46788889999999999999964 57899999876655555678999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.   ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......  .
T Consensus       100 ~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~  171 (296)
T cd06654         100 AGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (296)
T ss_pred             CCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence            9999999983   3458999999999999999999999   899999999999999999999999999987532211  1


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......+++.|+|||.+.+..++.++|||||||++|||++|+.||........     +. .....+ .     +.+  .
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~~-~~~~~~-~-----~~~--~  237 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LY-LIATNG-T-----PEL--Q  237 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----HH-HHhcCC-C-----CCC--C
Confidence            12234688899999999988899999999999999999999999864432111     11 111110 0     000  1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+......+.+++.+||..+|.+||++.+++++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            122344678899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.5e-36  Score=332.17  Aligned_cols=262  Identities=26%  Similarity=0.319  Sum_probs=198.9

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccc-----eee
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS-----EMI  533 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~  533 (803)
                      +|+..+.||+|+||.||++... +++.||+|++....  ....+++.+|+++++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4777889999999999999964 68999999865432  223467899999999999999999999998776     789


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +||||+. ++|.+.+.  ....+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999997 57888773  34579999999999999999999999   899999999999999999999999999997533


Q ss_pred             CCCCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHH---------------
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE---------------  677 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------------  677 (803)
                      .. .........++..|+|||.+.+. .++.++|||||||++|||++|+.||.............               
T Consensus       155 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         155 PD-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             cC-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            21 11222334678899999998774 57899999999999999999999997544332211110               


Q ss_pred             -HHHHHhhcCccccccCcccc--cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          678 -WAMQWQKKGMLEHIIDPQLI--GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       678 -~~~~~~~~~~~~~i~d~~l~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                       ............   .+...  ..........+.+++.+||+.||.+|||+.|++++-
T Consensus       234 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         234 EGARAHILRGPHK---PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             HHHHHHHHhCCCC---CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence             000000000000   00000  011122356788999999999999999999998764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-35  Score=312.07  Aligned_cols=249  Identities=34%  Similarity=0.497  Sum_probs=203.2

Q ss_pred             ceEeeeCceEEEEEEECC----CcEEEEEEcCCCCCCC-hHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQG-LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      +.||+|+||.||+|....    +..+++|......... .+.+.+|++++..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            368999999999999754    7789999876554333 67899999999999999999999999999999999999999


Q ss_pred             CchhhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          542 GPLKKHLYGPD-------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       542 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ++|.+++....       ...+++.+++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999995431       3679999999999999999999999   9999999999999999999999999999987543


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ...........++..|+|||.+....++.++|||||||++|||++ |+.|+......+   +   .... ..+.      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~-~~~~------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---V---LEYL-RKGY------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---H---HHHH-HcCC------
Confidence            322223344567889999999998899999999999999999999 588887542211   1   1111 1110      


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                         ....+...+..+.+++.+|+..+|.+||++.|++++|+
T Consensus       225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               01122333567899999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=330.46  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=208.4

Q ss_pred             cceEeeeCceEEEEEEECC--C--cEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          466 NLIIGSGGFGMVYKGVLRD--N--TKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      .++||+|.||.|++|.|..  |  -.||||.+...... ...+|++|+.+|.+|+|||+++|+|+..+ ..+.||+|.++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            3489999999999999864  3  36899998766544 67899999999999999999999999987 78899999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      .|+|.+.|++..+..|-...+..++.|||.||.||.+   +++|||||..+|+||-....+||+||||.+.....+....
T Consensus       194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv  270 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV  270 (1039)
T ss_pred             cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence            9999999987667778889999999999999999998   9999999999999999999999999999997665555444


Q ss_pred             ec-cccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          621 ST-GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       621 ~~-~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .. ...-...|+|||.++...++.+||||+|||+||||++ |..||-+.......                +.+|..-+-
T Consensus       271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----------------~~iD~~erL  334 (1039)
T KOG0199|consen  271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----------------KNIDAGERL  334 (1039)
T ss_pred             ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------HhccccccC
Confidence            33 3445778999999999999999999999999999998 66777654332211                112222222


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      .-+..|++++.++++.||..+|++|||+..+.+.+-
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            345678899999999999999999999999985443

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.3e-36  Score=316.20  Aligned_cols=255  Identities=25%  Similarity=0.402  Sum_probs=201.3

Q ss_pred             CCCccceEeeeCceEEEEEEECC-C---cEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD-N---TKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .|+..+.||+|+||.||+|.+.. +   ..|++|..... ......+|..|+.++++++||||+++.+++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778899999999999999753 2   36999986543 2334568999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++... ...+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        85 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          85 EFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             ecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999998543 3568999999999999999999998   999999999999999999999999999987533211


Q ss_pred             CCceecc-c--cCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          617 ETHVSTG-V--KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       617 ~~~~~~~-~--~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ....... .  ..+..|+|||.+.+..++.++|||||||++|||++ |..||......+   ..++..   ....     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~---~~~~-----  229 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE---QDYR-----  229 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH---cCCc-----
Confidence            1111111 1  12457999999999999999999999999999886 999986443221   112211   0000     


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                           -..+.+.+..+.+++.+|++.+|.+||++.+++..|+.+
T Consensus       230 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 -----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 011223456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.5e-36  Score=319.51  Aligned_cols=256  Identities=29%  Similarity=0.420  Sum_probs=203.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      .++|+..+.||+|+||.||++...      ++..||+|.+.... .....+|.+|+.++++++||||++++++|......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467888899999999999999864      36789999865432 23356799999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcce
Q 042150          533 ILVYEYMEKGPLKKHLYGPD--------------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTN  592 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~N  592 (803)
                      ++||||+++|+|.+++....                    ...+++.+++.++.|++.||+|||+   .+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence            99999999999999985311                    2357899999999999999999998   899999999999


Q ss_pred             EEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhh
Q 042150          593 ILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLARE  671 (803)
Q Consensus       593 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~  671 (803)
                      |++++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..|+......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875332222122223345678999999998999999999999999999997 877875432221


Q ss_pred             hhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          672 QVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       672 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                            +... ...+...         ..+...+..+.+++.+|++.+|.+||++.|+++.|+
T Consensus       241 ------~~~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 ------VIYY-VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             ------HHHH-HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                  1111 1111111         112234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.9e-35  Score=321.84  Aligned_cols=241  Identities=22%  Similarity=0.298  Sum_probs=193.4

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      +|+..+.||+|+||.||+|... +++.||+|.+...   .....+.+..|..++..+. |++|+++.+++...+.+++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999965 5889999986532   2334566888999998885 678888999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.  ....+++.+++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....  
T Consensus        81 Ey~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--  153 (323)
T cd05615          81 EYVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--  153 (323)
T ss_pred             cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC--
Confidence            9999999999983  34569999999999999999999999   9999999999999999999999999999875321  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +.+   ... ...         
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~---~i~-~~~---------  217 (323)
T cd05615         154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQ---SIM-EHN---------  217 (323)
T ss_pred             CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHH-hCC---------
Confidence            1112234568999999999999999999999999999999999999997543221   111   111 110         


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSM  726 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  726 (803)
                       ..++......+.+++.+||+.+|.+|++.
T Consensus       218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence             01222334677899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-35  Score=312.01  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=199.1

Q ss_pred             eEeeeCceEEEEEEECC--C--cEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          468 IIGSGGFGMVYKGVLRD--N--TKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      +||+|++|.||+|.+..  +  ..||+|....... ...++|.+|+.++++++||||+++++.+.. ...++||||+++|
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            68999999999999753  2  3689998766554 456789999999999999999999999988 8899999999999


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc-ee
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH-VS  621 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~  621 (803)
                      +|.+++.......+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++......... ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            99999965433578999999999999999999999   899999999999999999999999999998643322111 11


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+.   ..   .......  ..       ..
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~---~~~~~~~--~~-------~~  222 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LK---KIDKEGE--RL-------ER  222 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHhcCC--cC-------CC
Confidence            23456789999999999999999999999999999998 9999864322211   11   1111100  00       11


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       701 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      +...+..+.+++.+|++.+|.+||++.++++.|.
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            1233567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.5e-35  Score=348.26  Aligned_cols=262  Identities=23%  Similarity=0.310  Sum_probs=204.7

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC---CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR---QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...++||+|+||.||+|... .++.||+|++.....   ...++|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46888899999999999999975 488999998754322   22457999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCC---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeec
Q 042150          537 EYMEKGPLKKHLYGP---------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG  607 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG  607 (803)
                      ||+++|+|.+++...         ....+++..+++++.||++||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988421         12346778899999999999999999   899999999999999999999999999


Q ss_pred             cccCCCCCCC----------------CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhh
Q 042150          608 LSRSGPCLDE----------------THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE  671 (803)
Q Consensus       608 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~  671 (803)
                      +++.......                ........||+.|||||.+.+..++.++|||||||++|||++|+.||......+
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9975411110                001122468999999999999999999999999999999999999986532211


Q ss_pred             hhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHhh
Q 042150          672 QVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRP-SMGDVLWNLEYALQL  739 (803)
Q Consensus       672 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~~~~~  739 (803)
                      ...          .   ..+.++.... ...+.+..+.+++.+|++.+|.+|| +++++++.|+..++.
T Consensus       239 i~~----------~---~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 ISY----------R---DVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhh----------h---hhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            100          0   0011111000 0123446688999999999999996 677788888877654

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.7e-36  Score=324.54  Aligned_cols=240  Identities=23%  Similarity=0.282  Sum_probs=188.9

Q ss_pred             eEeeeCceEEEEEEEC-CCcEEEEEEcCCCC---CCChHHHHHHHH-HHHhccCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          468 IIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS---RQGLPEFQTEIT-VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      .||+|+||.||+++.. +++.||+|.+....   .....++..|.. +++.++||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            6999999999999976 46789999865321   222334555544 567789999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceec
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST  622 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  622 (803)
                      +|.+++..  ...+.+..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        82 ~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~  154 (325)
T cd05602          82 ELFYHLQR--ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTS  154 (325)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcc
Confidence            99999843  4568888899999999999999999   9999999999999999999999999999875321  112233


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCH
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINL  702 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  702 (803)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ...... ..          .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~-~~----------~~~~~  217 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNILN-KP----------LQLKP  217 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------HHHHHh-CC----------cCCCC
Confidence            45689999999999999999999999999999999999999975432211      111111 00          01122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042150          703 DSLKKFGETAEKCLADYGVDRPSMGDVLW  731 (803)
Q Consensus       703 ~~~~~l~~li~~cl~~~p~~RPs~~evl~  731 (803)
                      .....+.+++.+||+.+|.+||++.+.+.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         218 NITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            34567899999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.9e-35  Score=314.99  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=197.7

Q ss_pred             CCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          462 NFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +|+..++||+|+||.||+|+. .+++.||+|...... ....++|.+|++++++++||||++++++|...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            567778999999999999986 457889999865432 233467899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|..+.      .+++..+..++.|++.||.|||+   .+|+|+||||+|||++.++.+||+|||++.....    .
T Consensus        82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~  148 (279)
T cd06619          82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----S  148 (279)
T ss_pred             CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----c
Confidence            999987543      46888999999999999999999   9999999999999999999999999999875321    1


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhh-hHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV-NLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      ......++..|+|||.+.+..++.++|||||||++|||++|+.||......... ....+....... .     .+.+  
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~--  220 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-D-----PPVL--  220 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-C-----CCCC--
Confidence            223357889999999999999999999999999999999999998653322111 111111111100 0     0111  


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                       ........+.+++.+|++.+|.+||++.|++++.
T Consensus       221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence             1112345688999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2e-36  Score=330.69  Aligned_cols=253  Identities=21%  Similarity=0.232  Sum_probs=200.5

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36788899999999999999965 5889999986543   2234567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~-  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN-  155 (330)
T ss_pred             CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCC-
Confidence            999999999999543 3569999999999999999999999   99999999999999999999999999999754321 


Q ss_pred             CCceeccccCCCcccCccccc------cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFR------RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                      .........||+.|+|||++.      ...++.++|||||||++|||++|+.||........      ..........  
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~--  227 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRF--  227 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCc--
Confidence            111223456899999999986      45678999999999999999999999965432211      1111111000  


Q ss_pred             ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       691 i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                           +.-.........+.+++.+|+. +|.+||++.+++++
T Consensus       228 -----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         228 -----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                 0001112345678899999997 99999999999865

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.6e-35  Score=311.14  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=207.0

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|... +++.|++|.....   .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            56888899999999999999976 6889999975432   2233568999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          537 EYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       537 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||+++|+|.+++..  .....+++.+++.++.+++.||.|||+   .+++||||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998843  234568999999999999999999998   9999999999999999999999999999875322


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      .  ........++..|+|||.+.+..++.++|||||||++|||++|+.|+....    ..+.+..... ..+.       
T Consensus       159 ~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~-~~~~-------  224 (267)
T cd08224         159 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKI-EKCD-------  224 (267)
T ss_pred             C--CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhh-hcCC-------
Confidence            1  111223467889999999999999999999999999999999999985332    1111111111 1111       


Q ss_pred             ccccCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          695 QLIGKIN-LDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       695 ~l~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                        ....+ ......+.+++.+|+..+|.+||++.+|++.|+.+
T Consensus       225 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         225 --YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             --CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence              01111 13456789999999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-35  Score=318.28  Aligned_cols=262  Identities=23%  Similarity=0.345  Sum_probs=200.4

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-----------------CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-----------------NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSL  522 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l  522 (803)
                      ++|...+.||+|+||.||++...+                 ...+|+|...... ....++|.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            568888899999999999986432                 3468899865442 2335689999999999999999999


Q ss_pred             EeEeeccceeeEEEEecCCCchhhhccCCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceE
Q 042150          523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPD---------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNI  593 (803)
Q Consensus       523 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NI  593 (803)
                      ++++...+..++||||+++|+|.+++....         ...+++.+++.++.|++.||+|||+   .+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence            999999999999999999999999985422         1347888999999999999999999   8999999999999


Q ss_pred             EEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh--CCCCCCcchhhh
Q 042150          594 LLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC--ARTAVDPLLARE  671 (803)
Q Consensus       594 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~  671 (803)
                      |+++++.++|+|||+++...............++..|++||...++.++.++|||||||++|||++  |..|+......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999875432221111222344678999999888899999999999999999998  667775432222


Q ss_pred             hhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          672 QVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       672 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ...   ........... ....     ..+..++..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       242 ~~~---~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 VIE---NTGEFFRDQGR-QVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHH---HHHHHHhhccc-cccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            111   11111111100 0000     112234467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.8e-36  Score=315.56  Aligned_cols=254  Identities=25%  Similarity=0.351  Sum_probs=200.5

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeecc------
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ------  529 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~------  529 (803)
                      .+++.|...+.||+|+||.||+|... +++.||+|..... .....++..|+.++.++ +||||++++++|...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35667888889999999999999975 4788999986543 34456789999999998 699999999998643      


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      ...++||||+++|+|.+++.......+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            458999999999999999965555679999999999999999999999   89999999999999999999999999998


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhh
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK  684 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  684 (803)
                      +.....  ........|+..|+|||++.     +..++.++|||||||++|||++|+.|+.........     ..  ..
T Consensus       159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~--~~  229 (272)
T cd06637         159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FL--IP  229 (272)
T ss_pred             eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HH--Hh
Confidence            753221  11223456889999999986     346888999999999999999999998643322111     00  00


Q ss_pred             cCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          685 KGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       685 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ......+        .....+..+.+++.+||..+|.+|||+.+++.+
T Consensus       230 ~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         230 RNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             cCCCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            1100111        112234578999999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-35  Score=311.55  Aligned_cols=250  Identities=21%  Similarity=0.320  Sum_probs=202.7

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +|...+.||+|+||.||++... +++.+++|..... .....+.+.+|+.+++.++||||+++++.+..++.+++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677889999999999999965 5788999976432 3344577889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+++.......+++..++.++.|++.||.|||+   ++++|+||||+||++++++.++|+|||+++.....  ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GA  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc--cc
Confidence            99999998865455668999999999999999999999   99999999999999999999999999998753321  11


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......++..|+|||++.+..++.++|+||||+++|+|++|+.||........      .... ..+...         .
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~-~~~~~~---------~  219 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKV-CQGSYK---------P  219 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHH-hcCCCC---------C
Confidence            22345688899999999998999999999999999999999999874322111      1111 111111         1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+......+.+++.+||+.+|.+||++.+++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            122344568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-35  Score=334.11  Aligned_cols=262  Identities=22%  Similarity=0.250  Sum_probs=195.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ...|...+.||+|+||.||++.... ++.||||...      ...+.+|+++|++++||||+++++++..++..+||||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3468888999999999999999764 7889999632      23467899999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +. ++|.+++.. ....++|.+++.|+.|+++||+|||+   .+|+||||||+||||+.++.+||+|||+++........
T Consensus       242 ~~-~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        242 YR-SDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             cC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            95 688888743 23469999999999999999999999   89999999999999999999999999999764322222


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhh-h----hhhHHHHHHHHhhc-Ccccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAR-E----QVNLAEWAMQWQKK-GMLEHII  692 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~----~~~l~~~~~~~~~~-~~~~~i~  692 (803)
                      .......||..|+|||++.+..++.++|||||||+||||++|..++-..... .    ...+.......... .......
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            2223457999999999999999999999999999999999988654321100 0    01111111110000 0000000


Q ss_pred             Cccc------------ccCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          693 DPQL------------IGKIN-------LDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       693 d~~l------------~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..++            .....       ......+.+|+.+||+.||.+|||+.|+|++
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000            00000       0122467899999999999999999999976

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=301.51  Aligned_cols=266  Identities=23%  Similarity=0.320  Sum_probs=221.5

Q ss_pred             ChhhHHHHhcCCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEe
Q 042150          452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVG  524 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g  524 (803)
                      ...+|.....++....++-+|.||+||+|.|.+      .+.|.||.++.. +.-....|+.|..++..+.|||+.++.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            456777777788888899999999999997653      345677765433 4445677899999999999999999999


Q ss_pred             Eeecc-ceeeEEEEecCCCchhhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc
Q 042150          525 YCEEQ-SEMILVYEYMEKGPLKKHLYG------PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE  597 (803)
Q Consensus       525 ~~~~~-~~~~lV~Ey~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~  597 (803)
                      ++.+. ...+.+|.++.-|+|+.+|..      ...+.++..+...++.|++.||+|||.   +++||.||.++|++||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehh
Confidence            98554 567889999999999999962      123568888999999999999999999   99999999999999999


Q ss_pred             CCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHH
Q 042150          598 NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLA  676 (803)
Q Consensus       598 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~  676 (803)
                      ...+||+|=.++|.....+......+...+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+..   
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~---  508 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME---  508 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH---
Confidence            99999999999998887788887778888999999999999999999999999999999997 88898766554432   


Q ss_pred             HHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          677 EWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       677 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                          .+.++|.       ++  .-+.+++.+|..++.-||+..|++||+.+|++.-|.+-
T Consensus       509 ----~ylkdGy-------Rl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  509 ----HYLKDGY-------RL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ----HHHhccc-------ee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                2222221       12  22447888999999999999999999999999888654

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-35  Score=310.98  Aligned_cols=248  Identities=27%  Similarity=0.399  Sum_probs=196.1

Q ss_pred             ceEeeeCceEEEEEEECC----CcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      ++||+|+||.||+|++..    +..+|+|....... ...+++.+|+++++++.||||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            369999999999998533    26899998665433 24567999999999999999999999886 4568999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc-e
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH-V  620 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~  620 (803)
                      |+|.+++..  ...+++..++.++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||+++......... .
T Consensus        80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            999999943  3478999999999999999999998   899999999999999999999999999987543222111 1


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+   +..+...    ...         ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~----~~~---------~~  218 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLES----GER---------LP  218 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHc----CCc---------CC
Confidence            112234568999999999999999999999999999998 999986543221   2222111    100         01


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      .+...+..+.+++.+|+..+|.+||++.++++.|+..
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1223446789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.8e-36  Score=322.49  Aligned_cols=267  Identities=21%  Similarity=0.281  Sum_probs=199.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|...+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            45788889999999999999975 47789999865433 23345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++ +|.+++... ...+++.++..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....  .
T Consensus        86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~  158 (309)
T cd07872          86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--T  158 (309)
T ss_pred             CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCC--c
Confidence            985 888877432 3458899999999999999999999   99999999999999999999999999998753211  1


Q ss_pred             ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH---------HHhhcCcc
Q 042150          619 HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM---------QWQKKGML  688 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~~  688 (803)
                      .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.........         ........
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            12223467899999998865 568899999999999999999999997544332221111000         00000000


Q ss_pred             ccccCccccc----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          689 EHIIDPQLIG----KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       689 ~~i~d~~l~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ...-.+....    .........+.+++.+||+.||.+|||+.|++++-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  288 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY  288 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence            0000000000    011123456789999999999999999999997644

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=325.80  Aligned_cols=246  Identities=26%  Similarity=0.409  Sum_probs=202.5

Q ss_pred             ceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCchh
Q 042150          467 LIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLK  545 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~  545 (803)
                      -+||+|.||+||-|+..+ ...+|||.+.....+..+-+..|+.+.+.|+|.|||+++|.|.+++.+-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            379999999999999665 5578999877777777788999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc-cCCcEEEeeeccccCCCCCCCCceec
Q 042150          546 KHLYGPDRTPL--SWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHVST  622 (803)
Q Consensus       546 ~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~  622 (803)
                      ++|+. .=+++  .+..+--+.+||++||.|||+   +.|||||||-.||||+ -.|.+||+|||.++.......  ...
T Consensus       661 sLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TE  734 (1226)
T KOG4279|consen  661 SLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTE  734 (1226)
T ss_pred             HHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc--ccc
Confidence            99953 23445  667777889999999999999   9999999999999996 688999999999987543322  234


Q ss_pred             cccCCCcccCccccccC--cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          623 GVKGSFGYLDPEYFRRQ--QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      ...||+.|||||++..+  .|..++|||||||++.||.||++||-..... +..       +.+-|.      -+....+
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-qAA-------MFkVGm------yKvHP~i  800 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-QAA-------MFKVGM------YKVHPPI  800 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-hHh-------hhhhcc------eecCCCC
Confidence            56799999999999754  6888999999999999999999998532211 100       011111      1123456


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       701 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +.+...+...+|++|+.++|.+||++.++++.
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            77888899999999999999999999999873

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-36  Score=309.94  Aligned_cols=254  Identities=27%  Similarity=0.307  Sum_probs=208.4

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      +.|+..+.||.|.-|+||++.+++ +...|+|++...   .++...+...|-+||+.+.||.|+.|++.++.+...||||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            345566789999999999999876 588999987654   3445667888999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC--
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC--  614 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~--  614 (803)
                      |||+||+|..+++++..+.+++..+.-++.+++.||+|||-   .|||.|||||+||||.++|++.|+||.|+.....  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            99999999999988888899999999999999999999999   9999999999999999999999999998742110  


Q ss_pred             -------------------------------CCCC---------------------ceeccccCCCcccCccccccCcCC
Q 042150          615 -------------------------------LDET---------------------HVSTGVKGSFGYLDPEYFRRQQLT  642 (803)
Q Consensus       615 -------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~t  642 (803)
                                                     ....                     ......+||-.|+|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           0000                     011235689999999999999999


Q ss_pred             CcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCC
Q 042150          643 DKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVD  722 (803)
Q Consensus       643 ~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~  722 (803)
                      .+.|+|+|||+|||||.|.+||.+....+..               ..++...+.-.-.+..+..+.+||.+.|.+||++
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence            9999999999999999999999866543321               1222222221222356678999999999999999


Q ss_pred             CCC----HHHHHHH
Q 042150          723 RPS----MGDVLWN  732 (803)
Q Consensus       723 RPs----~~evl~~  732 (803)
                      |-.    +.||-++
T Consensus       379 Rlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  379 RLGSKRGAAEIKRH  392 (459)
T ss_pred             hhccccchHHhhcC
Confidence            987    7777653

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.6e-35  Score=313.30  Aligned_cols=256  Identities=27%  Similarity=0.435  Sum_probs=202.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC----CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR----DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .+|+..+.||+|+||.||+|.+.    .+..+|+|.+.... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46778889999999999999864    23478999865432 22346789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++++|.+++... ...+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            9999999999999543 3468999999999999999999998   99999999999999999999999999999864332


Q ss_pred             CCCce-eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          616 DETHV-STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       616 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ..... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||......+   .....    .++.     .
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~-----~  227 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----EEGY-----R  227 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----hCCC-----c
Confidence            21111 112233568999999998899999999999999999886 999986443221   11111    1110     0


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                          .......+..+.+++.+|++.+|.+||+|.++++.|+.+
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                011123456788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-35  Score=308.90  Aligned_cols=247  Identities=30%  Similarity=0.433  Sum_probs=197.9

Q ss_pred             eEeeeCceEEEEEEECCCcEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCchhh
Q 042150          468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKK  546 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  546 (803)
                      +||+|+||.||++...+++.|++|........ ....|.+|++++++++||||+++++++......++||||+++++|.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   81 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT   81 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence            68999999999999877999999986554332 45689999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccC
Q 042150          547 HLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG  626 (803)
Q Consensus       547 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  626 (803)
                      ++... ...+++..++.++.+++.+|+|||+   ++++||||||+|||++.++.+||+|||+++................
T Consensus        82 ~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          82 FLRKK-KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            98543 3468899999999999999999998   8999999999999999999999999999875331111111112234


Q ss_pred             CCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHH
Q 042150          627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL  705 (803)
Q Consensus       627 t~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~  705 (803)
                      +..|+|||.+.+..++.++|||||||++|||++ |..|+........   ...    .....         ....+...+
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~~~----~~~~~---------~~~~~~~~~  221 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---RER----IESGY---------RMPAPQLCP  221 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---HHH----HhcCC---------CCCCCccCC
Confidence            567999999998899999999999999999999 7888754332111   111    11100         011122345


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          706 KKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       706 ~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ..+.+++.+|+..+|.+||++.|+++.|+
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            67899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.5e-35  Score=321.16  Aligned_cols=255  Identities=22%  Similarity=0.235  Sum_probs=196.0

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...++||+|+||.||+++.+. ++.+|+|.+...   .......|.+|+.++..++|+||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            367888999999999999999765 678999986421   2233456889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus        81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~-~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-D  155 (332)
T ss_pred             eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc-C
Confidence            999999999999532 3468999999999999999999999   9999999999999999999999999999875322 1


Q ss_pred             CCceeccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      .........||+.|+|||++.     ...++.++|||||||+||||++|+.||......+.      .........  ..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~--~~  227 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKE--RF  227 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCc--cc
Confidence            112223457899999999986     35688999999999999999999999974422111      111111100  00


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGV--DRPSMGDVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~--~RPs~~evl~~  732 (803)
                      .-+    .........+.+++.+|+..++.  .|+++.|++++
T Consensus       228 ~~p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 QFP----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cCC----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            000    01123356778889998865444  36899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-35  Score=310.36  Aligned_cols=254  Identities=25%  Similarity=0.411  Sum_probs=204.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .++|...+.||+|+||.||++.+.++..+++|..... ....+.|.+|++++++++|+||+++.+++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            3567888899999999999999887888999986543 2345689999999999999999999999887 7789999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+++.......+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++....... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC-cc
Confidence            99999999966555678999999999999999999998   899999999999999999999999999987533211 11


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      ......++..|+|||.+....++.++|+|||||++|||++ |+.||.......   +..+.    ..+..         .
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~~---------~  222 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----ERGYR---------M  222 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hCCCC---------C
Confidence            1222345678999999998899999999999999999999 898886432211   11111    11100         0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1112344678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.6e-36  Score=330.14  Aligned_cols=262  Identities=23%  Similarity=0.230  Sum_probs=202.7

Q ss_pred             hhhHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeec
Q 042150          453 FTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE  528 (803)
Q Consensus       453 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~  528 (803)
                      +.++....++|...+.||+|+||.||++..+ +++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3455556788999999999999999999976 4788999985431   22334568899999999999999999999999


Q ss_pred             cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                      +...++||||+++|+|.+++.   ...++...+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            999999999999999999983   3458888999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccC----cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhh
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ----QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK  684 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  684 (803)
                      ++..... .........||+.|||||++.+.    .++.++|||||||+||||++|+.||........      ......
T Consensus       189 a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~  261 (371)
T cd05622         189 CMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMN  261 (371)
T ss_pred             eeEcCcC-CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHc
Confidence            9754321 11122345799999999998754    378899999999999999999999975432111      111111


Q ss_pred             cCccccccCcccccCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 042150          685 KGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVD--RPSMGDVLWNLE  734 (803)
Q Consensus       685 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~L~  734 (803)
                      ....       +.-.........+.+++.+||..++.+  ||++.+++++..
T Consensus       262 ~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~  306 (371)
T cd05622         262 HKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  306 (371)
T ss_pred             CCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence            1000       000111234567889999999844443  789999988754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-35  Score=312.31  Aligned_cols=238  Identities=23%  Similarity=0.386  Sum_probs=188.6

Q ss_pred             eEeeeCceEEEEEEECC-------------CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          468 IIGSGGFGMVYKGVLRD-------------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .||+|+||.||+|++.+             ...|++|.+..........|.+|+.+++.++||||++++++|......++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            68999999999998542             23588888665555556688999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc-------EEEeeec
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV-------SKVADFG  607 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-------~kl~DFG  607 (803)
                      ||||+++|+|..++.. ....+++..+++++.||++||+|||+   .+|+||||||+|||++.++.       +|++|||
T Consensus        82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          82 VEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            9999999999988853 23568999999999999999999999   99999999999999987664       8999999


Q ss_pred             cccCCCCCCCCceeccccCCCcccCccccc-cCcCCCcceehhHHHHHHHHH-hCCCCCCcchhhhhhhHHHHHHHHhhc
Q 042150          608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVL-CARTAVDPLLAREQVNLAEWAMQWQKK  685 (803)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (803)
                      ++.....      .....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......+..       .... 
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~~-  223 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFYE-  223 (262)
T ss_pred             CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHHh-
Confidence            9865321      12245778899999886 567899999999999999998 577777543221110       0000 


Q ss_pred             CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       686 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      ... .         ........+.+++.+||+.+|.+||++.++++.|
T Consensus       224 ~~~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 GQC-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             cCc-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            000 0         0112235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.9e-35  Score=312.87  Aligned_cols=258  Identities=22%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             hHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceee
Q 042150          455 DLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       455 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      |++.+++++.....||+|+||.||+|... ++..|++|..........+.+.+|+.++++++|+||+++++++..++..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            34456677777789999999999999965 47789999876655556678999999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhccCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-CCcEEEeeecccc
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPL--SWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-NYVSKVADFGLSR  610 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla~  610 (803)
                      +|+||+++++|.+++.... ..+  ++..+..++.||+.||+|||+   .+|+||||||+||+++. ++.+||+|||++.
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            9999999999999995422 334  788899999999999999998   89999999999999986 6799999999987


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccC--cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQ--QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ......  .......++..|+|||.+.+.  .++.++||||||+++|||++|+.|+........   ..+.....     
T Consensus       158 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~-----  227 (268)
T cd06624         158 RLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF-----  227 (268)
T ss_pred             ecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh-----
Confidence            532211  112234578899999998654  378899999999999999999999864321111   11111000     


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                            .....++......+.+++.+||+.+|.+|||+.|++++
T Consensus       228 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 ------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                  00112233445678899999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-35  Score=317.34  Aligned_cols=261  Identities=23%  Similarity=0.383  Sum_probs=201.4

Q ss_pred             CCCccceEeeeCceEEEEEEEC-----CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeecc--ceee
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-----DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEMI  533 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~  533 (803)
                      .|...+.||+|+||.||++.+.     ++..||+|...... ......+.+|++++++++||||+++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            4677789999999999999852     47789999876443 33356799999999999999999999999775  5689


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +||||+++++|.+++... ...+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus        85 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            999999999999998432 3468999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCC-ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhh---------hhhhHHHHHHHHh
Q 042150          614 CLDET-HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAR---------EQVNLAEWAMQWQ  683 (803)
Q Consensus       614 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~~~~~  683 (803)
                      ..... .......++..|+|||.+.+..++.++|||||||++|||++++.|.......         .......+. ...
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  239 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVL  239 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHH
Confidence            22211 1122345677899999999889999999999999999999987664321110         000111111 111


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      ..+.         ........+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       240 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1110         0111223456899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.3e-35  Score=314.09  Aligned_cols=248  Identities=30%  Similarity=0.450  Sum_probs=196.5

Q ss_pred             eEeeeCceEEEEEEECC-------CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          468 IIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .||+|+||.||+|+..+       +..+++|...... .....+|.+|+++++.++||||++++++|......++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            68999999999998653       2578888765432 234678999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC-----cEEEeeeccc
Q 042150          540 EKGPLKKHLYGP-----DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY-----VSKVADFGLS  609 (803)
Q Consensus       540 ~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-----~~kl~DFGla  609 (803)
                      ++++|.+++...     ....+++.+++.++.|++.||+|||+   .+++|+||||+||+++.+.     .+||+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999542     22458899999999999999999998   8999999999999999877     8999999998


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      +...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+   .....    ..+. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~-  230 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----TAGG-  230 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH----hcCC-
Confidence            75432222222223345778999999999999999999999999999998 998886432211   11111    1100 


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                              ....+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                    00112234567899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-35  Score=321.43  Aligned_cols=263  Identities=25%  Similarity=0.324  Sum_probs=201.5

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|+..+.||+|+||.||++... ++..+++|...... .....++.+|++++++++||||++++++|.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888899999999999999965 47778888755432 22345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++++|.+++..  ...+++..+..++.|+++||.|||+  ..+++|+||||+|||++.++.+||+|||++.....    
T Consensus        81 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----  152 (308)
T cd06615          81 MDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----  152 (308)
T ss_pred             cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence            999999999943  3568999999999999999999996  25899999999999999999999999999875321    


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCc-----------
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM-----------  687 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-----------  687 (803)
                      .......++..|+|||.+.+..++.++|||||||++|||++|+.|+.......   ...+.........           
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCC
Confidence            11233567899999999988889999999999999999999999986433211   1111100000000           


Q ss_pred             -------------cccccCcccccCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          688 -------------LEHIIDPQLIGKI-NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       688 -------------~~~i~d~~l~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                                   ...+.... .... .......+.+++.+||+.+|.+||++.+++++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  290 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI  290 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence                         00000000 0000 01134568999999999999999999999987554

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-35  Score=331.18  Aligned_cols=263  Identities=25%  Similarity=0.255  Sum_probs=199.8

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC---CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD---NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ..+|...+.||+|+||.||++...+   +..|++|.....     ..+.+|+++|++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            4578999999999999999997543   578999976432     24578999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      |++. ++|.+++  .....+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus       166 e~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        166 PKYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hhcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9996 5888888  345679999999999999999999999   899999999999999999999999999997643322


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh-hhHHHHHHHHhhcCccccc----
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ-VNLAEWAMQWQKKGMLEHI----  691 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~i----  691 (803)
                      .........||+.|+|||++.+..++.++|||||||+||||++|+.||........ ..+...... .........    
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~-~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC-MQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH-hccCccccCCccc
Confidence            22223346789999999999999999999999999999999999999865332111 111111100 000000000    


Q ss_pred             ---------cCcccccCC-------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          692 ---------IDPQLIGKI-------NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       692 ---------~d~~l~~~~-------~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                               ........+       .......+.+++.+||..+|++|||+.|++.+-.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~  377 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL  377 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence                     000000000       0112356788999999999999999999998743

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.8e-35  Score=316.58  Aligned_cols=252  Identities=21%  Similarity=0.295  Sum_probs=204.7

Q ss_pred             cCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .+|...+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3578888999999999999985 468899999876555555678899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.   ...+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......  .
T Consensus        99 ~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~  170 (296)
T cd06655          99 AGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--S  170 (296)
T ss_pred             CCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccc--c
Confidence            9999999883   3468999999999999999999999   999999999999999999999999999987533211  1


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......++..|+|||.+.+..++.++|||||||++|||++|+.||..........      ..... ....     +  .
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~------~~~~~-~~~~-----~--~  236 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATN-GTPE-----L--Q  236 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhc-CCcc-----c--C
Confidence            1233467889999999999899999999999999999999999987543322111      00000 0000     0  1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      .+......+.+++.+||..+|.+||++.+++++=.
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~  271 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence            12234457889999999999999999999997533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2e-35  Score=315.28  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=199.1

Q ss_pred             CCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      |+..+.||+|+||.||+|.... +..+++|..........+.+.+|+++++.++||||++++++|...+..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            4556689999999999999764 677888887555555567899999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      ++|..++.. ....+++..+..++.|+++||.|||+   .+++||||||+|||++.++.+||+|||+++....  .....
T Consensus        87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~  160 (282)
T cd06643          87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRR  160 (282)
T ss_pred             CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccc--ccccc
Confidence            999988753 23569999999999999999999999   8999999999999999999999999999875321  11222


Q ss_pred             ccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          622 TGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      ....++..|+|||.+.     +..++.++|||||||++|||++|+.|+......+.      ....... .     .+.+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~-~-----~~~~  228 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS-E-----PPTL  228 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhc-C-----CCCC
Confidence            3356889999999984     45678899999999999999999999865432111      0111110 0     0000


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                        ..+......+.+++.+||+.+|.+||++.+++++-
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence              11122346789999999999999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-35  Score=315.29  Aligned_cols=238  Identities=26%  Similarity=0.393  Sum_probs=187.2

Q ss_pred             eEeeeCceEEEEEEECC-------------------------CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeE
Q 042150          468 IIGSGGFGMVYKGVLRD-------------------------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL  522 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l  522 (803)
                      .||+|+||.||+|.+..                         ...|++|.+.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999998521                         13578888655444445678999999999999999999


Q ss_pred             EeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC---
Q 042150          523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY---  599 (803)
Q Consensus       523 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---  599 (803)
                      +++|.+....++||||+++|+|..++.. ....+++..++.++.||++||+|||+   .+|+||||||+|||+++.+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence            9999999999999999999999998853 24568999999999999999999998   8999999999999997644   


Q ss_pred             ----cEEEeeeccccCCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHH-hCCCCCCcchhhhhh
Q 042150          600 ----VSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVL-CARTAVDPLLAREQV  673 (803)
Q Consensus       600 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~~  673 (803)
                          .+|++|||++.....      .....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+......+..
T Consensus       158 ~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             CccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                479999998764221      112356788999998865 56899999999999999995 688888654322211


Q ss_pred             hHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          674 NLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       674 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                         .+..   ...            ..+......+.+++.+||+.+|.+||++.++++.|
T Consensus       232 ---~~~~---~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         232 ---RFYE---KKH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             ---HHHH---hcc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence               1110   000            01111234688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-35  Score=328.99  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=197.1

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|+..+.||+|+||.||++..+ +++.||+|.+...   .......+.+|+.++.+++||||+++++.+.+.+.++|||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            35788889999999999999975 4889999986532   2334567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.  ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            9999999999994  34568999999999999999999999   999999999999999999999999999986432110


Q ss_pred             CC---------------------------------ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCC
Q 042150          617 ET---------------------------------HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTA  663 (803)
Q Consensus       617 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p  663 (803)
                      ..                                 .......||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            00                                 001234689999999999999999999999999999999999999


Q ss_pred             CCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 042150          664 VDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPS---MGDVLWN  732 (803)
Q Consensus       664 ~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~evl~~  732 (803)
                      |.........      .......  ..+.-+     ........+.+++.+|+. +|.+|++   +.+++++
T Consensus       236 f~~~~~~~~~------~~i~~~~--~~~~~p-----~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         236 FCSETPQETY------RKVMNWK--ETLVFP-----PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCHHHHH------HHHHcCC--CceecC-----CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            9754332211      1111000  000000     011234567888888774 9999985   6677654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.2e-35  Score=324.10  Aligned_cols=265  Identities=21%  Similarity=0.256  Sum_probs=198.3

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccc-----
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS-----  530 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----  530 (803)
                      ..++|...+.||+|+||.||++... .+..||+|++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999965 4889999986543  2233567889999999999999999999986443     


Q ss_pred             -eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          531 -EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       531 -~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                       ..++||||+++ +|.+.+.    ..+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             57999999975 5666652    348889999999999999999999   99999999999999999999999999999


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhH--------------
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL--------------  675 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l--------------  675 (803)
                      +....   ........+|..|+|||.+.+..++.++|||||||++|||++|+.||......+....              
T Consensus       171 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         171 RTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            75321   1222345689999999999999999999999999999999999999975432211100              


Q ss_pred             --HHHHHHHhhc-Ccc-----ccccCcccc---cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          676 --AEWAMQWQKK-GML-----EHIIDPQLI---GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       676 --~~~~~~~~~~-~~~-----~~i~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                        ......+... ...     .+.......   ..........+.+++.+||..||.+|||+.|++++-.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  317 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY  317 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence              0000000000 000     000000000   0011122456889999999999999999999998754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-35  Score=317.40  Aligned_cols=255  Identities=22%  Similarity=0.236  Sum_probs=195.3

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCC---CCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVP---GSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+++.. +++.||+|.+..   ......+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36888899999999999999975 488999998643   12334566889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.. ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-  155 (331)
T cd05597          81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-  155 (331)
T ss_pred             ecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-
Confidence            99999999999943 23568999999999999999999999   99999999999999999999999999998653221 


Q ss_pred             CCceeccccCCCcccCcccccc-----CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRR-----QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      .........||+.|+|||++..     ..++.++|||||||++|||++|+.||......+.      ............+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~  229 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQF  229 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCcccC
Confidence            1112223468999999999863     4678899999999999999999999864322111      1111111000000


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccC--CCCCCCHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADY--GVDRPSMGDVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~--p~~RPs~~evl~~  732 (803)
                        +    ......+..+.+++.+|+..+  +..||++.+++++
T Consensus       230 --~----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 --P----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             --C----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence              0    011123456788888877543  3347899999886

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-35  Score=325.07  Aligned_cols=193  Identities=25%  Similarity=0.365  Sum_probs=164.6

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ....+|...+.||+|+||.||+|.... +..||+|.....      ....|+.++++++||||+++++++......++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            344579999999999999999999764 678899973221      2357999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+. ++|.+++.. ....+++.+++.|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....  
T Consensus       137 e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--  209 (357)
T PHA03209        137 PHYS-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--  209 (357)
T ss_pred             EccC-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccccc--
Confidence            9995 588888743 34569999999999999999999999   8999999999999999999999999999874221  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCC
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAV  664 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~  664 (803)
                       ........||..|+|||++.+..++.++|||||||+||||+++..++
T Consensus       210 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 -APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             -CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence             11223456899999999999999999999999999999999866554

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-35  Score=312.99  Aligned_cols=257  Identities=25%  Similarity=0.374  Sum_probs=203.0

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-Cc----EEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NT----KVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .+|...+.||+|+||.||+|.+++ +.    .+++|....... ....++.+|+.++++++||||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            456777899999999999999653 32    588887654432 334678999999999999999999999987 78899


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            99999999999999543 3458999999999999999999999   9999999999999999999999999999986442


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ...........++..|+|||.+....++.++|||||||++|||++ |+.|++.....+      +..... .+..     
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~-~~~~-----  229 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IPDLLE-KGER-----  229 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHh-CCCC-----
Confidence            222222222334678999999988899999999999999999998 999987543221      111111 1100     


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                          ...+..+...+.+++.+||..+|.+||++.++++.|..+..
T Consensus       230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                01112234567899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.6e-35  Score=320.87  Aligned_cols=255  Identities=22%  Similarity=0.223  Sum_probs=196.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...   .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999975 4778999986432   2233456889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD-  155 (331)
T ss_pred             eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-
Confidence            999999999999542 3468999999999999999999999   99999999999999999999999999998753321 


Q ss_pred             CCceeccccCCCcccCcccccc-----CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRR-----QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      .........|++.|+|||++.+     +.++.++|||||||+||||++|+.||......+.      .........  .+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~--~~  227 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEE--RF  227 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCC--cc
Confidence            1112233568999999999875     5688899999999999999999999964332111      111111000  00


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVD--RPSMGDVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~  732 (803)
                         .+ .......+..+.+++.+|+...+.+  |+++++++++
T Consensus       228 ---~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 ---QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ---cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence               00 0001123467888999998865544  4688888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.9e-35  Score=317.52  Aligned_cols=256  Identities=25%  Similarity=0.410  Sum_probs=199.5

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCc----EEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNT----KVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ++|+..+.||+|+||.||+|.+. ++.    .+|+|....... ....++.+|+.++++++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45677789999999999999864 343    478887654332 2234788999999999999999999999754 4679


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ++||+++|+|.+++... ...+++..++.++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence            99999999999998532 3468999999999999999999998   8999999999999999999999999999986432


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |+.|+.......   ..++.    ..+..  .  
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~--~--  230 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLL----EKGER--L--  230 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCCCC--C--
Confidence            222112223445778999999999999999999999999999997 888886432221   11111    11100  0  


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                           ..+..+...+.+++.+|+..+|++||++.++++.|+.+.
T Consensus       231 -----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         231 -----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 011223457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.4e-35  Score=311.13  Aligned_cols=251  Identities=24%  Similarity=0.324  Sum_probs=188.7

Q ss_pred             eEeeeCceEEEEEEECC---CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCc
Q 042150          468 IIGSGGFGMVYKGVLRD---NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGP  543 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs  543 (803)
                      .||+|+||.||+|....   ...+++|...... ......|.+|+++++.++||||+++++.|.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   3468888755432 2234578999999999999999999999999999999999999999


Q ss_pred             hhhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          544 LKKHLYGPD---RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       544 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      |.+++....   ....++...+.++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999995432   2335688889999999999999999   8999999999999999999999999999865322111111


Q ss_pred             eccccCCCcccCccccc-------cCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          621 STGVKGSFGYLDPEYFR-------RQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~-------~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      .....++..|+|||++.       ...++.++|||||||++|||++ |+.|+......+.  +.    ...... ...+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~----~~~~~~-~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LK----QVVREQ-DIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HH----HHhhcc-CccCC
Confidence            22344577899999874       3467889999999999999999 7778764322211  11    111111 11112


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      .+.    .+......+.+++..|+ .+|.+||++++|++.|
T Consensus       232 ~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         232 KPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            222    22234456677888888 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4e-35  Score=307.97  Aligned_cols=251  Identities=33%  Similarity=0.517  Sum_probs=200.9

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      .+|...+.||+|+||.||+|.+.++..+++|..... .....+|.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            356677899999999999999877888999986533 2345689999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +++|.+++... ...+++..++.++.|++.+|+|||+   .+++|+||||+||+++.++.+||+|||+++..... ....
T Consensus        83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD-QYTS  157 (256)
T ss_pred             CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccC-cccc
Confidence            99999998542 3468999999999999999999998   89999999999999999999999999998753221 1111


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....++.+|+|||.+.++.++.++||||||+++|||++ |+.|+......+      ..... .++  .....+.    
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~-~~~--~~~~~~~----  224 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETI-NAG--FRLYKPR----  224 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHH-hCC--CCCCCCC----
Confidence            122335678999999998999999999999999999998 899886433221      11111 111  0111111    


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                         ..+..+.+++.+||+.+|.+||++.+++++|
T Consensus       225 ---~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 ---LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ---CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence               1346789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-35  Score=311.19  Aligned_cols=253  Identities=30%  Similarity=0.465  Sum_probs=199.7

Q ss_pred             CCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCCh--HHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGL--PEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      |+..+.||+|+||+||+++... ++.+|+|..........  ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4567899999999999999865 56899998665433222  23456999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.  ....+++.+++.++.|+++||.+||+   .+++|+||||+||++++++.++|+|||++...  .....
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNE  153 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTS
T ss_pred             cccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--ccccc
Confidence            9999999994  45678999999999999999999999   89999999999999999999999999998743  12223


Q ss_pred             eeccccCCCcccCccccc-cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      ......++..|+|||++. +..++.++||||+|+++|+|++|+.|+......+........   .........       
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~-------  223 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKI---LKRPLPSSS-------  223 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHH---HHTHHHHHT-------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc---ccccccccc-------
Confidence            344567899999999998 889999999999999999999999998755211111111100   000000000       


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .........+.+++.+||+.+|++||++.+++++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000112688999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.7e-35  Score=317.44  Aligned_cols=266  Identities=21%  Similarity=0.287  Sum_probs=199.6

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|...+.||+|+||.||+|..+ +++.||+|...... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            45778889999999999999975 47889999865432 33345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      ++ ++|.+++... ...+++..+..++.|+++||+|||+   .+++|+||||+|||+++++.+||+|||+++.....  .
T Consensus        86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~  158 (301)
T cd07873          86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T  158 (301)
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--C
Confidence            97 5898888543 3468899999999999999999999   99999999999999999999999999998753211  1


Q ss_pred             ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHH---------HHHhhcCcc
Q 042150          619 HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWA---------MQWQKKGML  688 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~  688 (803)
                      .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+........         .........
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            11223456889999998865 45788999999999999999999999754433221110000         000000000


Q ss_pred             ccccCccccc----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          689 EHIIDPQLIG----KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       689 ~~i~d~~l~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      .....+....    .........+.+++.+||+.+|.+|||+.|++++-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~  287 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP  287 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0000011000    11123355788999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3e-35  Score=308.60  Aligned_cols=250  Identities=26%  Similarity=0.374  Sum_probs=203.5

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      ++|...+.||+|+||.||+|...+ +..+++|.......  .+++.+|++++++++||||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            568888899999999999999875 78899998654332  678999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.. ....+++..++.++.|+++||.|||+   .+++|+||+|+||++++++.+||+|||++.......  .
T Consensus        81 ~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~  154 (256)
T cd06612          81 GAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--A  154 (256)
T ss_pred             CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCc--c
Confidence            99999999843 24578999999999999999999998   899999999999999999999999999987643221  1


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...........       ....     ..+.+  .
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~-----~~~~~--~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNK-----PPPTL--S  220 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccC-----CCCCC--C
Confidence            22334578899999999999999999999999999999999999875432221100       0000     00000  1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+......+.+++.+|++.+|.+||++.|++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            122344678999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-35  Score=316.00  Aligned_cols=261  Identities=25%  Similarity=0.381  Sum_probs=202.9

Q ss_pred             CCCccceEeeeCceEEEEEEEC-----CCcEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEeec--cceee
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCEE--QSEMI  533 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~  533 (803)
                      .|...+.||+|+||.||+|.+.     .+..+|||........ ..++|.+|+++++.++||||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4566678999999999999864     3678999987654432 46789999999999999999999999977  55789


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +||||+++++|.+++... ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus        85 lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            999999999999999543 2359999999999999999999998   899999999999999999999999999998644


Q ss_pred             CCCCCc-eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhh---------hHHHHHHHHh
Q 042150          614 CLDETH-VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV---------NLAEWAMQWQ  683 (803)
Q Consensus       614 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~---------~l~~~~~~~~  683 (803)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........         ....+. ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-ELL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-HHH
Confidence            221111 111234566799999999889999999999999999999999887543221100         011111 111


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      ...         .....+..+..++.+++.+|++.+|.+||+|.||+++|+.+
T Consensus       240 ~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         240 KEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111         11111223346789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.3e-35  Score=309.48  Aligned_cols=252  Identities=23%  Similarity=0.407  Sum_probs=200.6

Q ss_pred             CCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCC------CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSR------QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      +|...+.||+|+||.||+|...+++.+|+|.......      ...+.+.+|++++++++|+||++++++|.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            3677889999999999999988889999997653321      1235688999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++++|.+++.  +...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++.....
T Consensus        81 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            99999999999994  33568899999999999999999998   89999999999999999999999999998753211


Q ss_pred             C----CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          616 D----ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       616 ~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      .    .........++..|+|||.+.+..++.++|||||||++|||++|+.||.........  .   ........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~---~~~~~~~~----  226 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--F---YIGAHRGL----  226 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--H---HhhhccCC----
Confidence            1    111122356889999999999999999999999999999999999998643222111  0   00000001    


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       .+    ..+......+.+++.+||+.+|.+||++.+++++
T Consensus       227 -~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         227 -MP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             -CC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             11    1222345677999999999999999999999753

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-35  Score=316.06  Aligned_cols=259  Identities=22%  Similarity=0.321  Sum_probs=205.0

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|+..+.||+|+||+||++... +++.+|+|...... ....+++.+|+++++.++||||+++++++.....+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45677789999999999999965 47889999755432 33457899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++++|.+++..  .+.+++..+..++.+++.+|.|||+  .++++||||||+||++++++.++|+|||++.....    
T Consensus        85 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----  156 (284)
T cd06620          85 MDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----  156 (284)
T ss_pred             CCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----
Confidence            999999998843  4568999999999999999999996  25799999999999999999999999999864321    


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhh-----hhhHHHHHHHHhhcCccccccC
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE-----QVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      .......++..|+|||++.+..++.++|||||||++|||++|+.||......+     ...+.++........      .
T Consensus       157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  230 (284)
T cd06620         157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P  230 (284)
T ss_pred             hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence            11123568999999999988899999999999999999999999997543321     111222222221110      0


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      +.+   .....+..+.+++.+|++.+|.+||++.|++++....
T Consensus       231 ~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         231 PRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             CCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            111   1112456789999999999999999999999875443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.4e-35  Score=316.08  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=203.5

Q ss_pred             cCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .+|...+.||+|+||.||+|.. .+++.||+|..........+.+.+|+.+++.++||||++++++|..+...++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5688888999999999999996 468999999876555555677899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.   ...+++.++..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.......  .
T Consensus        99 ~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~  170 (297)
T cd06656          99 AGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  170 (297)
T ss_pred             CCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--c
Confidence            9999999983   3458999999999999999999999   899999999999999999999999999987532211  1


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...........      ....+      .+.  ..
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~------~~~--~~  236 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG------TPE--LQ  236 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC------CCC--CC
Confidence            12234678899999999999999999999999999999999999864322111100      00000      000  01


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+......+.+++.+||+.+|.+||++.+++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122344667899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.2e-35  Score=310.57  Aligned_cols=256  Identities=25%  Similarity=0.359  Sum_probs=202.1

Q ss_pred             cCCCccceEeeeCceEEEEEEECC----CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ++|...+.||+|+||.||+|...+    ...|++|...... ....+.|.+|+.++++++||||++++++|.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457777899999999999998643    2468889765443 3345679999999999999999999999875 457899


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++|+|.+++... ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          85 MELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            9999999999999542 3458999999999999999999998   99999999999999999999999999998754322


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      . ........++..|+|||.+....++.++|||||||++|||++ |+.||......+..   .+.    ..+.  .+   
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~----~~~~--~~---  227 (270)
T cd05056         161 S-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRI----ENGE--RL---  227 (270)
T ss_pred             c-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH----HcCC--cC---
Confidence            1 111222334568999999988899999999999999999986 99998654332211   111    1110  00   


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                          ..+...+..+.+++.+|+..+|.+|||+.+++..|+.+..
T Consensus       228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                1122345678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.8e-35  Score=314.75  Aligned_cols=248  Identities=28%  Similarity=0.365  Sum_probs=199.9

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      |...+.||+|+||.||+|.+. ++..||+|...... ....+.+.+|++++++++||||+++++++......++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            445568999999999999865 47789999865332 3345678999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +++|.+++.   ...+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.+||+|||+++.....  ...
T Consensus        86 ~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~  157 (277)
T cd06642          86 GGSALDLLK---PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIK  157 (277)
T ss_pred             CCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCc--chh
Confidence            999999883   3568999999999999999999998   89999999999999999999999999998753321  111


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      .....++..|+|||++.+..++.++|||||||++|||++|+.|+.........      . ......     .+    ..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~-~~~~~~-----~~----~~  221 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------F-LIPKNS-----PP----TL  221 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------h-hhhcCC-----CC----CC
Confidence            22345788999999999999999999999999999999999998643221110      0 011110     11    12


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       701 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      .......+.+++.+|++.+|.+||++.+++++-.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF  255 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence            2234567899999999999999999999998643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.8e-35  Score=323.92  Aligned_cols=265  Identities=22%  Similarity=0.271  Sum_probs=198.6

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeecc-----
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ-----  529 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----  529 (803)
                      ...++|...+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999864 47899999865432  22346788999999999999999999988543     


Q ss_pred             -ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          530 -SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       530 -~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                       ...++||||+++ +|.+.+.    ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence             357999999975 6666662    348899999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhH---------HH--
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL---------AE--  677 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l---------~~--  677 (803)
                      ++...   .........+|..|+|||++.+..++.++|||||||++|||++|+.||......+....         .+  
T Consensus       166 ~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         166 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cccCC---CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            97532   12222345689999999999999999999999999999999999999975432211100         00  


Q ss_pred             -----HHHHHhhc-CccccccCcccc--------cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          678 -----WAMQWQKK-GMLEHIIDPQLI--------GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       678 -----~~~~~~~~-~~~~~i~d~~l~--------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                           ....+... .....+..+...        ..........+.+++.+||+.||++|||+.|++++-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp  312 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP  312 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence                 00001000 000000000000        011112345788999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.5e-35  Score=308.34  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=198.8

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC---------ChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ---------GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      |.....||+|++|.||+|... +++.+++|........         ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            566779999999999999864 4788999976543222         125688999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+++++|.+++.  ....+++..+..++.|++.||+|||+   .+++||||+|+||++++++.+||+|||+++..
T Consensus        82 ~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          82 NIFLEYVPGGSVAALLN--NYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             EEEEEecCCCCHHHHHH--hccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            99999999999999994  34568999999999999999999998   89999999999999999999999999998764


Q ss_pred             CCCCCC----ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          613 PCLDET----HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       613 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ......    .......++..|+|||.+.+..++.++|||||||++|||++|+.||.........      ... ..   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~-~~---  226 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI------FKI-GE---  226 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH------HHH-hc---
Confidence            321111    1112245788999999999889999999999999999999999998753221110      000 00   


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        ...+    ..+......+.+++.+||+.+|.+||++.+++++
T Consensus       227 --~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         227 --NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             --cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence              1111    1223345678899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.1e-35  Score=308.99  Aligned_cols=250  Identities=27%  Similarity=0.433  Sum_probs=192.3

Q ss_pred             eEeeeCceEEEEEEECC----CcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEee-ccceeeEEEEecCC
Q 042150          468 IIGSGGFGMVYKGVLRD----NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCE-EQSEMILVYEYMEK  541 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~-~~~~~~lV~Ey~~~  541 (803)
                      +||+|+||.||+|.+.+    ...+|+|+.... .....+.+.+|+.+++.++||||++++++|. .++..++||||+.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            68999999999998642    357899986432 2234568899999999999999999999875 45568999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC--Cc
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE--TH  619 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~--~~  619 (803)
                      |+|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++.......  ..
T Consensus        82 ~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          82 GDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            9999999542 3446888899999999999999998   8999999999999999999999999999875322111  01


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCC-CCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR-TAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      ......++..|+|||.+.+..++.++|||||||++|||++|. .|+.....   ..+...   ......      +    
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~---~~~~~~------~----  221 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVY---LLQGRR------L----  221 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH---HhcCCC------C----
Confidence            112344577899999999899999999999999999999954 55543221   111111   111100      0    


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      ..+...+..+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus       222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            011123457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5e-35  Score=307.21  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=204.2

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|+..+.||+|+||.||.+... +++.+++|.....  .....+++.+|++++++++|+||+++++++.+.+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4777889999999999998854 4788999975433  334467899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++++|.+++.......+++.++..++.|+++||+|||+   .+++|+||||+||++++++.+||+|||+++......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--  155 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--  155 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc--
Confidence            999999999965445678999999999999999999998   899999999999999999999999999987543222  


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .......++..|+|||.+.+..++.++||||||+++|||++|+.|+......+      ...... .+...         
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~~~~~---------  219 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIV-QGNYT---------  219 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-cCCCC---------
Confidence            12234568899999999998889999999999999999999999986533221      111111 11111         


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      .........+.+++.+||+.+|.+||++.++++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11123456788999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.3e-35  Score=304.06  Aligned_cols=263  Identities=24%  Similarity=0.315  Sum_probs=200.6

Q ss_pred             cCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCC-C-hHHHHHHHHHHHhccCCC-eeeEEeEeeccc------
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQ-G-LPEFQTEITVLSKIRHRH-LVSLVGYCEEQS------  530 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~f~~E~~~l~~l~Hpn-Iv~l~g~~~~~~------  530 (803)
                      ..|...++||+|.||+||+|+. .+|+.||+|+....... + -....+|+.+|++|+|+| |+.|.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3455566899999999999995 45889999987655432 2 345789999999999999 999999998776      


Q ss_pred             eeeEEEEecCCCchhhhccCCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDR--TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                      .++||+||++. +|..++.....  ..++...+..++.||++||+|||+   ++|+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence            78999999976 89999854332  357778899999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM  687 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (803)
                      |+....  .....+...+|.-|.|||++.+. .|+...||||+|||+.||++++..|.+..+.++..   ..........
T Consensus       167 Ara~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~---~If~~lGtP~  241 (323)
T KOG0594|consen  167 ARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF---RIFRLLGTPN  241 (323)
T ss_pred             HHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH---HHHHHcCCCC
Confidence            986331  12224556788999999999876 89999999999999999999998887654433221   1111111110


Q ss_pred             ------cccccCcc--c--------ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          688 ------LEHIIDPQ--L--------IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       688 ------~~~i~d~~--l--------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                            +..+.+-.  .        ....-+.......+++.+||+.+|.+|.|+..++.+
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                  00000111  0        000001112478899999999999999999999886

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.7e-35  Score=336.86  Aligned_cols=270  Identities=21%  Similarity=0.284  Sum_probs=197.6

Q ss_pred             hhHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccC------CCeeeEEeEe
Q 042150          454 TDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH------RHLVSLVGYC  526 (803)
Q Consensus       454 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H------pnIv~l~g~~  526 (803)
                      +++...+++|...++||+|+||+||+|... .++.||||++... .....++..|+++++.++|      ++++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            344456788999999999999999999965 4788999986532 2234566778888888765      4588899988


Q ss_pred             ecc-ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC------
Q 042150          527 EEQ-SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY------  599 (803)
Q Consensus       527 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~------  599 (803)
                      ... ...++|||++ +++|.+++.  ....+++.++..|+.||+.||+|||+  ..+|+||||||+|||++.++      
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~--~~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccc
Confidence            654 5789999988 678888884  34579999999999999999999996  14899999999999998765      


Q ss_pred             ----------cEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchh
Q 042150          600 ----------VSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLA  669 (803)
Q Consensus       600 ----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  669 (803)
                                .+||+|||++....     .......||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                      49999999876421     223346789999999999999999999999999999999999999976543


Q ss_pred             hhhhhHHH---------HHHHH--------hh-cCccccccCcccc----c---CCCHHHHHHHHHHHHHccccCCCCCC
Q 042150          670 REQVNLAE---------WAMQW--------QK-KGMLEHIIDPQLI----G---KINLDSLKKFGETAEKCLADYGVDRP  724 (803)
Q Consensus       670 ~~~~~l~~---------~~~~~--------~~-~~~~~~i~d~~l~----~---~~~~~~~~~l~~li~~cl~~~p~~RP  724 (803)
                      .+...+..         |...+        .. .+.+....++...    .   .........+.+|+.+||+.||.+||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            33222111         11100        00 0000000011000    0   00001235678999999999999999


Q ss_pred             CHHHHHHHHH
Q 042150          725 SMGDVLWNLE  734 (803)
Q Consensus       725 s~~evl~~L~  734 (803)
                      |+.|++++-.
T Consensus       431 ta~e~L~Hp~  440 (467)
T PTZ00284        431 NARQMTTHPY  440 (467)
T ss_pred             CHHHHhcCcc
Confidence            9999998644

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-35  Score=312.94  Aligned_cols=239  Identities=24%  Similarity=0.406  Sum_probs=188.8

Q ss_pred             eEeeeCceEEEEEEECC--------CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          468 IIGSGGFGMVYKGVLRD--------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .||+|+||.||+|....        ..++++|..........+.|.+|+.+++.++||||+++++++..+...++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            68999999999998643        2347888765544445678899999999999999999999999989999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc--------EEEeeeccccC
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV--------SKVADFGLSRS  611 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--------~kl~DFGla~~  611 (803)
                      ++|+|.+++... ...+++..+++++.||+.||+|||+   .+|+||||||+|||++.++.        ++++|||++..
T Consensus        82 ~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          82 KFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            999999999543 3368999999999999999999999   99999999999999987765        69999998865


Q ss_pred             CCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCC-CCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCAR-TAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      ...      .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+...........      ....    
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~------~~~~----  221 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF------YEDR----  221 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH------HHcc----
Confidence            321      123457889999999976 45899999999999999999995 55443222111100      0000    


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                              ..++.....++.+++.+||+.+|.+|||++++++.|+
T Consensus       222 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 --------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    0112223356899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.1e-35  Score=308.67  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=195.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-----CCChHHHHHHHHHHHhccCCCeeeEEeEeec--ccee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-----RQGLPEFQTEITVLSKIRHRHLVSLVGYCEE--QSEM  532 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~  532 (803)
                      .+|...+.||+|+||.||+|... .+..|++|+.....     .+....+.+|+.++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888899999999999999975 48899999754322     1224568899999999999999999998865  3578


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++++||+++++|.+++..  ...+++...+.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            899999999999999943  3458999999999999999999998   89999999999999999999999999998753


Q ss_pred             CCCCC-CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          613 PCLDE-THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       613 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ..... ........++..|+|||.+.+..++.++|||||||++|||++|+.||.........      .......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~~~-----  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIATQP-----  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhcCC-----
Confidence            32111 11112345788999999999999999999999999999999999998754221111      1111000     


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..+    .++......+.+++ +||..+|.+||+++||+.+
T Consensus       226 ~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         226 TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            111    22223344566666 7888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.6e-35  Score=311.98  Aligned_cols=262  Identities=23%  Similarity=0.254  Sum_probs=197.2

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|...+.||+|++|.||+|+.. ++..||+|++...  .....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677789999999999999975 5889999986533  223346788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          539 MEKGPLKKHLYGPD-RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       539 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      ++ ++|.+++.... ...+++.++..++.|+++||.|||+   .+++||||||+||++++++.+||+|||+++.....  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  154 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--  154 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence            97 68888875432 3678999999999999999999999   99999999999999999999999999998753211  


Q ss_pred             CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHh--------hcC--
Q 042150          618 THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ--------KKG--  686 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--------~~~--  686 (803)
                      ........+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.........  ........        ...  
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhcchhh
Confidence            112233456889999998865 45788999999999999999999998754322111  00000000        000  


Q ss_pred             -----ccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 -----MLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 -----~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                           .........+ .........++.+++.+||..||.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         233 PDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                 0000000000 00011234677899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.8e-35  Score=309.71  Aligned_cols=255  Identities=27%  Similarity=0.422  Sum_probs=201.1

Q ss_pred             cCCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEeeccceee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      .+|.....||+|+||.||+|+.+.      .+.+++|........ ..++|.+|++++++++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            467788899999999999999642      457889876543333 3568999999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeee
Q 042150          534 LVYEYMEKGPLKKHLYGPD-------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADF  606 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF  606 (803)
                      +||||+++|+|.+++....       ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999995433       1268999999999999999999998   89999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhc
Q 042150          607 GLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKK  685 (803)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  685 (803)
                      |+++.... ..........++..|+|||.+.+...+.++||||||+++|||++ |..||.......      .... ...
T Consensus       162 ~~~~~~~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~~-~~~  233 (275)
T cd05046         162 SLSKDVYN-SEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNR-LQA  233 (275)
T ss_pred             ccccccCc-ccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHHH-HHc
Confidence            99874321 11112223456778999999988889999999999999999998 777875332111      1111 111


Q ss_pred             CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       686 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      +...        .......+..+.+++.+||+.+|.+||++.|++..|.
T Consensus       234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1111        0112234467899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.1e-35  Score=309.10  Aligned_cols=237  Identities=27%  Similarity=0.437  Sum_probs=188.2

Q ss_pred             eEeeeCceEEEEEEECCCc-----------EEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          468 IIGSGGFGMVYKGVLRDNT-----------KVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .||+|+||.||+|.+.+..           .+++|........ ...|.+|+.++++++||||++++++|.. ...++||
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            6899999999999986533           4777765444333 6789999999999999999999999988 7789999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC-------cEEEeeeccc
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY-------VSKVADFGLS  609 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-------~~kl~DFGla  609 (803)
                      ||+++|+|.+++.... ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++       .+||+|||++
T Consensus        80 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          80 EYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999995432 268999999999999999999998   9999999999999999887       7999999998


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccccC--cCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcC
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQ--QLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKG  686 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (803)
                      +....      .....++..|+|||++.+.  .++.++|||||||++|||++ |..|+......+      +...+....
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~~~~~~~~~  223 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KERFYQDQH  223 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------HHHHHhcCC
Confidence            75322      2233466789999999876  78999999999999999999 466665432111      111111110


Q ss_pred             ccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          687 MLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       687 ~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      .            .+......+.+++.+||..+|.+||++.++++.|+
T Consensus       224 ~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         224 R------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             C------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0            01111267889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.7e-35  Score=310.34  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=199.7

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      ++|...+.||+|+||.||+|... +++.||+|............+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            45677778999999999999965 58899999876554455567889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.  ....+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.....  ...
T Consensus        89 ~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~~  161 (267)
T cd06645          89 GGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIA  161 (267)
T ss_pred             CCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccC--ccc
Confidence            9999999984  34568999999999999999999999   8999999999999999999999999999865321  111


Q ss_pred             eeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          620 VSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      ......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+..........      ..... .   ...+..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~~~~~-~---~~~~~~  231 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMTKS-N---FQPPKL  231 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------hhhcc-C---CCCCcc
Confidence            223456889999999874   4568899999999999999999999975432211110      00000 0   001111


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..  .......+.+++.+||+.+|++||++.+++++
T Consensus       232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            10  01233467899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=334.69  Aligned_cols=253  Identities=26%  Similarity=0.393  Sum_probs=212.1

Q ss_pred             CccceEeeeCceEEEEEEE-CCC----cEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          464 DKNLIIGSGGFGMVYKGVL-RDN----TKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ...++||+|+||+||+|.+ .++    .+||+|++... ..+...+|++|+-+|.+|.||||++|+|+|.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3456899999999999996 333    47899986544 4555789999999999999999999999998776 889999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      ||+.|+|.++++. .+..+.-+..+.|+.|||+||.|||.   +.++||||.++|||+.+-..+||.|||+++.....+.
T Consensus       778 ~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  778 LMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             hcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            9999999999965 45678999999999999999999998   9999999999999999999999999999998766555


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      ........-.+.|||-|.+....++.++|||||||.+||++| |..|++....++..++.+       ++         .
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~g---------e  917 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KG---------E  917 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------cc---------c
Confidence            555555666889999999999999999999999999999998 888988765554433322       11         1


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      +-..++-+...+.-++.+||..|+..||+++++...+....
T Consensus       918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            11334567778899999999999999999999988776543

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6e-35  Score=313.25  Aligned_cols=252  Identities=25%  Similarity=0.329  Sum_probs=200.8

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +.|+..+.||+|+||.||+|.... +..+++|..........+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            457778899999999999999764 7889999876655555678999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|..++... ...+++..++.++.|++.+|+|||+   .+++||||||+||+++.++.+||+|||++.....  ...
T Consensus        92 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~~  165 (292)
T cd06644          92 PGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TLQ  165 (292)
T ss_pred             CCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccc--ccc
Confidence            999998887432 3468999999999999999999998   8999999999999999999999999999865221  111


Q ss_pred             eeccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          620 VSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ......++..|+|||.+.     ...++.++|||||||++|||++|+.|+.......      ........ .     .+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~-~-----~~  233 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKS-E-----PP  233 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhcC-C-----Cc
Confidence            223346788999999984     4457889999999999999999999986432211      11111110 0     01


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..  ..+......+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00  1122344578899999999999999999999864

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.1e-35  Score=306.61  Aligned_cols=250  Identities=25%  Similarity=0.371  Sum_probs=201.1

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeec-cceeeEEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE-QSEMILVYE  537 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~lV~E  537 (803)
                      +|...+.||+|++|.||++..+ +++.+++|+....  .....+.+.+|++++++++|||++++.+.+.. ...+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            3677889999999999999965 4778999986433  23345678999999999999999999998764 456899999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|.+++.......+++.+++.++.|++.||++||+   .+++||||||+||+++.++.++|+|||+++.....  
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--  155 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--  155 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc--
Confidence            9999999999965455679999999999999999999999   89999999999999999999999999998754221  


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      ........+++.|+|||.+.+..++.++|||||||+++||++|+.|+.......      ...... .+.+         
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~-~~~~---------  219 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRII-EGKL---------  219 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHH-hcCC---------
Confidence            112234567889999999999999999999999999999999999986433211      111111 1111         


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...+......+.+++.+|++.+|.+||++.+++++
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11223455678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=310.36  Aligned_cols=249  Identities=29%  Similarity=0.365  Sum_probs=202.0

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +|...+.||.|++|.||+|... +++.|++|...... ......+.+|++++++++|+||+++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5677789999999999999975 58899999865443 344567899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++..   ..+++..++.++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++......  .
T Consensus        82 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          82 GGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            99999999943   378999999999999999999998   899999999999999999999999999987643221  1


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......++..|+|||.+.+..++.++|||||||++|||++|+.|+........      ... ......     +.+...
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~-~~~~~~-----~~~~~~  221 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFL-IPKNNP-----PSLEGN  221 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHH-hhhcCC-----CCCccc
Confidence            22345678899999999998899999999999999999999999865432111      101 111111     111100


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                         .....+.+++.+||..+|++||++++++++-
T Consensus       222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~  252 (274)
T cd06609         222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLKHK  252 (274)
T ss_pred             ---ccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence               1445688999999999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=305.72  Aligned_cols=254  Identities=29%  Similarity=0.388  Sum_probs=204.6

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      ++|...+.||+|+||.||+|... +++.+++|..........+.+.+|++++++++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            56788889999999999999975 47789999876555556788999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++... ...+++.++..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||++......  ..
T Consensus        83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~  156 (262)
T cd06613          83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA  156 (262)
T ss_pred             CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence            999999988432 3568999999999999999999998   89999999999999999999999999998753221  11


Q ss_pred             eeccccCCCcccCccccccC---cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQ---QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      ......++..|+|||.+.+.   .++.++|||||||++|||++|+.|+...........      ....    ....+.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~------~~~~----~~~~~~~  226 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL------ISKS----NFPPPKL  226 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhc----cCCCccc
Confidence            22335678899999999776   889999999999999999999999865432221110      0000    0001111


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        .........+.+++.+|+..+|.+||++.+|+.+
T Consensus       227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              1123445678999999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.5e-35  Score=307.42  Aligned_cols=247  Identities=31%  Similarity=0.444  Sum_probs=199.0

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ++|...+.||+|+||.||++.. .++.+|+|.....  ...+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4577888999999999999975 5778999986432  2346799999999999999999999998764 4799999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +++|.+++.......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.....     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            9999999966555678999999999999999999998   99999999999999999999999999998753211     


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......+..|+|||.+.+..++.++|||||||++|||++ |+.||......+      .... ...+.         ...
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~-~~~~~---------~~~  217 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKEC-VEKGY---------RME  217 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHH-HhCCC---------CCC
Confidence            112334578999999998899999999999999999998 999886443221      1111 11111         011


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      .....+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            122345678899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.9e-35  Score=309.84  Aligned_cols=249  Identities=26%  Similarity=0.328  Sum_probs=203.1

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .|...+.||+|+||.||+|... ++..||+|..... .....+.+.+|+.+++++.||||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4566678999999999999975 4789999976533 2334567899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+++.   ...+++.++..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++......  ..
T Consensus        85 ~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~  156 (277)
T cd06640          85 GGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QI  156 (277)
T ss_pred             CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCC--cc
Confidence            9999999983   3468999999999999999999998   89999999999999999999999999998754321  11


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......++..|+|||.+.+..++.++|||||||++|||++|+.|+..........      . ..         ......
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~-~~---------~~~~~~  220 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------L-IP---------KNNPPT  220 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------h-hh---------cCCCCC
Confidence            2233457889999999998899999999999999999999999986543221110      0 00         011122


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ........+.+++.+||+.+|.+||++.+++++-.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF  255 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence            33456678899999999999999999999988644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.5e-35  Score=312.32  Aligned_cols=263  Identities=23%  Similarity=0.309  Sum_probs=203.8

Q ss_pred             cChhhHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEee-
Q 042150          451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCE-  527 (803)
Q Consensus       451 ~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~-  527 (803)
                      +.+..+..+.++|...+.||+|+||.||++... +++.+++|..... .....++.+|+.+++++ +||||++++++|. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            345666778889999999999999999999975 4788999975432 22346788999999999 6999999999883 


Q ss_pred             ----ccceeeEEEEecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcE
Q 042150          528 ----EQSEMILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       528 ----~~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~  601 (803)
                          .++..++||||+++++|.+++..  .....+++..+..++.|+++||.|||+   .+++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence                34568999999999999988743  234568999999999999999999998   899999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCcccccc-----CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR-----QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLA  676 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  676 (803)
                      ||+|||+++.....  ........|+..|+|||.+..     ..++.++|||||||++|||++|+.|+.........  .
T Consensus       164 kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~  239 (286)
T cd06638         164 KLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F  239 (286)
T ss_pred             EEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h
Confidence            99999998754321  112233468999999998853     45788999999999999999999998644221110  0


Q ss_pred             HHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          677 EWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       677 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                          .. .........+       +......+.+++.+||+.+|.+||++.|+++++
T Consensus       240 ----~~-~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 ----KI-PRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ----hc-cccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence                00 0000001111       112235688999999999999999999999764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-34  Score=321.53  Aligned_cols=265  Identities=20%  Similarity=0.271  Sum_probs=198.2

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeecc------
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ------  529 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------  529 (803)
                      ..++|...+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3567999999999999999999965 4788999986543  233356788999999999999999999987543      


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      ...++||||+++ +|.+.+.    ..+++.++..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            357999999975 6777662    348899999999999999999999   99999999999999999999999999999


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHH---------HHH-
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLA---------EWA-  679 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~-  679 (803)
                      +...   .........+|..|+|||++.+..++.++|||||||+||||++|+.||......+.....         ++. 
T Consensus       174 ~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         174 RTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             cccC---CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            7532   122223456899999999999999999999999999999999999999754322211100         000 


Q ss_pred             ------HHHhhc-Cccccc----cCcccc----cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          680 ------MQWQKK-GMLEHI----IDPQLI----GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       680 ------~~~~~~-~~~~~i----~d~~l~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                            ...... ......    ..+...    ..........+.+++.+||+.||.+|||+.|++++-.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~  320 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  320 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence                  000000 000000    000000    0111122357889999999999999999999988643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.7e-34  Score=305.68  Aligned_cols=252  Identities=24%  Similarity=0.315  Sum_probs=189.1

Q ss_pred             eEeeeCceEEEEEEECCC---cEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCc
Q 042150          468 IIGSGGFGMVYKGVLRDN---TKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGP  543 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs  543 (803)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999985443   345666654332 2345789999999999999999999999999999999999999999


Q ss_pred             hhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          544 LKKHLYGPD--RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       544 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |.+++....  ...+++..++.++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999995432  2456777888999999999999998   89999999999999999999999999998642211111222


Q ss_pred             ccccCCCcccCcccccc-------CcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          622 TGVKGSFGYLDPEYFRR-------QQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..|+......+      ........ ....+.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~-~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIKD-QQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhh-cccccCC
Confidence            34567889999998743       346789999999999999997 466765432221      11111111 1122333


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      +.+..    .....+.+++..|+ .+|.+||++.+|++.|.
T Consensus       232 ~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            33322    23456788999999 67999999999988763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.4e-35  Score=343.12  Aligned_cols=256  Identities=21%  Similarity=0.336  Sum_probs=197.2

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeec--ccee
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE--QSEM  532 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~  532 (803)
                      ...++|.+.+.||+|+||+||++.... +..+|+|.+...  .......|..|+.+|++|+||||++++++|..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            345689999999999999999999754 677888875433  22335678999999999999999999998854  4568


Q ss_pred             eEEEEecCCCchhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCceEeeccCcceEEEcc---------
Q 042150          533 ILVYEYMEKGPLKKHLYGP--DRTPLSWKQRLEICIGAARGLHYLHTGS----AEGIIHRDIKSTNILLDE---------  597 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivHrDLkp~NILl~~---------  597 (803)
                      +|||||+++|+|.++|...  ....+++..++.|+.||+.||+|||+..    ..+|+||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999998532  2357999999999999999999999732    145999999999999964         


Q ss_pred             --------CCcEEEeeeccccCCCCCCCCceeccccCCCcccCcccccc--CcCCCcceehhHHHHHHHHHhCCCCCCcc
Q 042150          598 --------NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCARTAVDPL  667 (803)
Q Consensus       598 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~  667 (803)
                              ...+||+|||+++....   ........||+.|+|||++.+  ..++.++||||||||||||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    23589999999976322   112234578999999999854  46889999999999999999999999643


Q ss_pred             hhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          668 LAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       668 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ....     ...... ...       +.+   ........+.+||.+||+.+|.+||++.|++.+
T Consensus       247 ~~~~-----qli~~l-k~~-------p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        247 NNFS-----QLISEL-KRG-------PDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CcHH-----HHHHHH-hcC-------CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            2211     111111 111       100   001234678999999999999999999999864

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9e-35  Score=305.21  Aligned_cols=248  Identities=27%  Similarity=0.392  Sum_probs=200.3

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-----CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-----RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      +|...+.||+|+||.||+|... ++..|++|......     .+..+.+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999976 68899999754332     22456789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      +||+++++|.+++..  ...+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            999999999999943  3468999999999999999999998   89999999999999999999999999998753221


Q ss_pred             CCCceeccccCCCcccCccccccCc-CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQ-LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      .   ......++..|++||.+.... ++.++|+|||||++|+|++|+.||........      ..........      
T Consensus       156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~------  220 (258)
T cd06632         156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFKIGRSKEL------  220 (258)
T ss_pred             c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHHHHhcccC------
Confidence            1   223456888999999987766 89999999999999999999999865432111      1111110111      


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                         ..++......+.+++.+||+.+|.+||++.+++.+
T Consensus       221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence               11222345677899999999999999999999863

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.3e-34  Score=307.34  Aligned_cols=265  Identities=22%  Similarity=0.263  Sum_probs=199.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|+....||+|+||.||+|+.+ +++.||+|+.....  ....+.+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            35778889999999999999976 48899999865332  2234568899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|..++.  ....+++.+++.++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            999998888773  33468999999999999999999999   9999999999999999999999999999876432211


Q ss_pred             CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhH-HHHH----HH---Hhh-cCc
Q 042150          618 THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL-AEWA----MQ---WQK-KGM  687 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~----~~---~~~-~~~  687 (803)
                        ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.... ....    ..   ... ...
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence              1223457789999999876 5688999999999999999999999875433221110 0000    00   000 000


Q ss_pred             cccccCcccccCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          688 LEHIIDPQLIGKIN-----LDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       688 ~~~i~d~~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ......+......+     ......+.+++.+||+.+|++||++.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00011111110001     1224678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-34  Score=315.07  Aligned_cols=195  Identities=25%  Similarity=0.342  Sum_probs=158.3

Q ss_pred             cceEeeeCceEEEEEEEC---CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeec--cceeeEEEEecC
Q 042150          466 NLIIGSGGFGMVYKGVLR---DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE--QSEMILVYEYME  540 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~lV~Ey~~  540 (803)
                      ..+||+|+||.||+|+.+   +++.+|+|.....  .....+.+|+++|++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            357999999999999965   3578999986533  223567899999999999999999998854  456899999986


Q ss_pred             CCchhhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE----ccCCcEEEeeeccc
Q 042150          541 KGPLKKHLYGP-------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLS  609 (803)
Q Consensus       541 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~~kl~DFGla  609 (803)
                      + +|.+++...       ....+++..+..++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 787776321       22358999999999999999999999   999999999999999    45678999999999


Q ss_pred             cCCCCCCC-CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCc
Q 042150          610 RSGPCLDE-THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDP  666 (803)
Q Consensus       610 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~  666 (803)
                      +....... ........+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            76432111 112234578999999999876 4689999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.5e-35  Score=304.82  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=201.3

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|...+.||+|+||.||++... +++.+++|.....  .....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4677889999999999999964 5788999986543  233467899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC-CcEEEeeeccccCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~kl~DFGla~~~~~~~~  617 (803)
                      +++++|.+++.......+++..+++++.+++++|.|||+   ++++|+||||+||+++++ +.+||+|||+++.....  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--  155 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK--  155 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence            999999999965555668999999999999999999999   999999999999999854 56899999998764321  


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                       .......++..|+|||.+.+..++.++||||||+++|+|++|+.|+.......      ....... ...         
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~~-~~~---------  218 (256)
T cd08220         156 -SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIMS-GTF---------  218 (256)
T ss_pred             -ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHHh-cCC---------
Confidence             11223467889999999998889999999999999999999999986543211      1111111 110         


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...+......+.+++.+||+.+|.+|||+.|++++
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            11122345678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.8e-35  Score=305.75  Aligned_cols=250  Identities=25%  Similarity=0.364  Sum_probs=202.7

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|...+.||+|+||.+|++... +++.+++|+....  .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4777889999999999999964 5789999986432  233456899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++++|.+++.......+++.+++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--  155 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--  155 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence            999999999865445568999999999999999999998   899999999999999999999999999987533211  


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .......+++.|+|||++.+..++.++|+|||||+++||++|+.|+......+      ....... +..         .
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~-~~~---------~  219 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKIIR-GSY---------P  219 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHhc-CCC---------C
Confidence            11223457889999999999999999999999999999999999986432211      1111111 110         1


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..+......+.+++.+|++.+|.+||++.+|+++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1222345678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1e-34  Score=311.22  Aligned_cols=262  Identities=24%  Similarity=0.312  Sum_probs=204.8

Q ss_pred             cChhhHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeec
Q 042150          451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEE  528 (803)
Q Consensus       451 ~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~  528 (803)
                      +++.++..++++|...+.||+|+||.||++..+ +++.+|+|..... .....++.+|+.++.++ +|||+++++++|..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            455667777899999999999999999999974 5788999986433 22346788999999999 79999999999865


Q ss_pred             c-----ceeeEEEEecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcE
Q 042150          529 Q-----SEMILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       529 ~-----~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~  601 (803)
                      .     +..++||||+++|+|.+++..  .....+++..++.++.|++.||+|||+   .+++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999998843  234568999999999999999999998   899999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCccccccC-----cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ-----QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLA  676 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  676 (803)
                      ||+|||+++......  .......++..|+|||.+...     .++.++|||||||++|||++|+.|+......+.  +.
T Consensus       168 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~  243 (291)
T cd06639         168 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF  243 (291)
T ss_pred             EEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence            999999987533211  112234678899999998643     368899999999999999999999865432211  11


Q ss_pred             HHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          677 EWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       677 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+     .......+.+       +......+.+++.+|++.+|++||++.|++++
T Consensus       244 ~~-----~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 KI-----PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HH-----hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11     1111111111       12334568999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-34  Score=304.00  Aligned_cols=250  Identities=32%  Similarity=0.507  Sum_probs=200.0

Q ss_pred             CccceEeeeCceEEEEEEECC-----CcEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          464 DKNLIIGSGGFGMVYKGVLRD-----NTKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ...+.||+|+||.||++...+     +..||+|........ ..+.+..|++++..++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456789999999999999764     378999987655433 56789999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|.+++.......+++.+++.++.|++.||+|||+   .+++|+||||+||++++++.++|+|||+++.......
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999954333338999999999999999999999   8999999999999999999999999999976443211


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      ... ....++..|+|||.+.+..++.++||||||++++||++ |+.|+......   .+.+   .. ..+..        
T Consensus       159 ~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~---~~-~~~~~--------  222 (258)
T smart00219      159 YKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLE---YL-KKGYR--------  222 (258)
T ss_pred             ccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HH-hcCCC--------
Confidence            111 12346789999999988899999999999999999998 78887643211   1111   11 11110        


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                       .......+..+.+++.+|+..+|.+|||+.|+++.|
T Consensus       223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 -LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             011122456789999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-34  Score=305.67  Aligned_cols=251  Identities=22%  Similarity=0.321  Sum_probs=196.7

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--C---CChHHHHHHHHHHHhccCCCeeeEEeEeecc--cee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--R---QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEM  532 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~  532 (803)
                      ++|...++||+|+||.||+|... ++..|++|......  .   ...+.+.+|++++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888899999999999999975 48899999754321  1   2245788999999999999999999988663  468


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+++++|.+++.  ....+++...++++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            89999999999999984  33458899999999999999999998   89999999999999999999999999998753


Q ss_pred             CCCCCC-ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          613 PCLDET-HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       613 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ...... .......++..|+|||.+.+..++.++|||||||++|||++|+.||.........      ......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~------  224 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQ------  224 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH------HHHhcC------
Confidence            321111 1122345888999999999889999999999999999999999998643221111      010000      


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                         ......+......+.+++.+|+. +|.+||+++|++++
T Consensus       225 ---~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         225 ---PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence               01112334455677889999995 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-34  Score=307.21  Aligned_cols=255  Identities=22%  Similarity=0.373  Sum_probs=198.4

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC---C-------ChHHHHHHHHHHHhccCCCeeeEEeEeeccc
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR---Q-------GLPEFQTEITVLSKIRHRHLVSLVGYCEEQS  530 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~-------~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~  530 (803)
                      +|...+.||+|+||.||+|... +++.+|+|.......   .       ..+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3566779999999999999864 588999997542111   1       1246788999999999999999999999999


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+   .+++||||+|+||++++++.++|+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999999443  578999999999999999999998   899999999999999999999999999987


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccCc--CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQ--LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ...............++..|+|||.+....  ++.++|+||||+++|||++|..|+.......     .. ...... ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~-~~~~~~-~~  229 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AM-FKLGNK-RS  229 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HH-HHhhcc-cc
Confidence            643221112223456789999999987654  8899999999999999999999986332211     11 111110 00


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...+.    ..........+.+++.+|+..+|.+||++.+|+++
T Consensus       230 ~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11111    11222345688999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-34  Score=316.37  Aligned_cols=259  Identities=21%  Similarity=0.248  Sum_probs=194.5

Q ss_pred             cceEeee--CceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          466 NLIIGSG--GFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       466 ~~~Lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ..+||+|  +|++||++..+ +++.||+|++....  ....+.+.+|+++++.++||||++++++|..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4579999  78999999864 58899999865432  2223567789999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC--
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET--  618 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~--  618 (803)
                      +|+|.+++.......+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.++++||+...........  
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            9999999955444568999999999999999999999   99999999999999999999999999865432111110  


Q ss_pred             ---ceeccccCCCcccCcccccc--CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          619 ---HVSTGVKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       619 ---~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                         .......++..|+|||++.+  ..++.++|||||||++|||++|+.||........  .....     .+......+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-----~~~~~~~~~  232 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKL-----NGTVPCLLD  232 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHh-----cCCcccccc
Confidence               01122346778999999975  4689999999999999999999999864322110  00000     000000000


Q ss_pred             -------------------c-----------------ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          694 -------------------P-----------------QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       694 -------------------~-----------------~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                                         .                 .............+.+++.+||+.||.+|||++|++++-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~  309 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  309 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence                               0                 0000112234567899999999999999999999997543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.3e-35  Score=310.36  Aligned_cols=261  Identities=26%  Similarity=0.363  Sum_probs=205.1

Q ss_pred             cChhhHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeec
Q 042150          451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEE  528 (803)
Q Consensus       451 ~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~  528 (803)
                      .++.++....+.|+..+.||+|+||.||+|... +++.+|+|..... .....++..|+.++.++ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            456677777889999999999999999999974 4788999985433 23456788999999998 69999999999843


Q ss_pred             ------cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEE
Q 042150          529 ------QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSK  602 (803)
Q Consensus       529 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k  602 (803)
                            ....+++|||+++|+|.+++.......+++..++.++.|++.||.|||+   .+++|+||||+||++++++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence                  4578999999999999999965555668899999999999999999999   8999999999999999999999


Q ss_pred             EeeeccccCCCCCCCCceeccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHH
Q 042150          603 VADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE  677 (803)
Q Consensus       603 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  677 (803)
                      |+|||+++.....  ........++..|+|||.+.     +..++.++|||||||++|||++|+.||...........  
T Consensus       162 l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--  237 (282)
T cd06636         162 LVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--  237 (282)
T ss_pred             EeeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence            9999998753211  11122356888999999885     35688899999999999999999999864432211110  


Q ss_pred             HHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          678 WAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       678 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                           ....     ..+.   ......+..+.+++.+||+.+|.+||++.|++++
T Consensus       238 -----~~~~-----~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         238 -----IPRN-----PPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -----HhhC-----CCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                 0000     0011   1112345678999999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.7e-35  Score=312.08  Aligned_cols=265  Identities=23%  Similarity=0.329  Sum_probs=199.1

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|...+.||+|+||.||+|..+ +++.||+|+......  ...+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            35777889999999999999986 488999998654322  234678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|.++...  ...+++.+++.++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          81 FVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             cCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            9999999887732  3458999999999999999999999   899999999999999999999999999987533211 


Q ss_pred             CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhh-hHHHHHH-------HHhhcC-c
Q 042150          618 THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV-NLAEWAM-------QWQKKG-M  687 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~-------~~~~~~-~  687 (803)
                       .......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+......+.. .+..+..       ...... .
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence             22233457889999999875 45788999999999999999999888643321111 0000000       000000 0


Q ss_pred             cccccCccccc-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          688 LEHIIDPQLIG-----KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       688 ~~~i~d~~l~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ......+....     .........+.+++.+||+.+|.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00000000000     0112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.1e-34  Score=307.72  Aligned_cols=255  Identities=27%  Similarity=0.391  Sum_probs=197.9

Q ss_pred             CCccceEeeeCceEEEEEEEC----CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccc------
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR----DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS------  530 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------  530 (803)
                      |...+.||+|+||.||+|.+.    .+..||||.+....  ....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456678999999999999864    36789999865442  233567899999999999999999999885432      


Q ss_pred             eeeEEEEecCCCchhhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeee
Q 042150          531 EMILVYEYMEKGPLKKHLYGP----DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADF  606 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF  606 (803)
                      ..++++||+++|+|.+++...    ....+++..+++++.|++.||+|||+   .+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence            247889999999998887422    22358899999999999999999998   89999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhc
Q 042150          607 GLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKK  685 (803)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  685 (803)
                      |+++...............++..|++||.+....++.++|||||||++|||++ |+.|+......   .+..+..   ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI---KG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH---cC
Confidence            99886432221112223345678999999998899999999999999999999 88887644321   1111111   11


Q ss_pred             CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       686 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      ...          ..+......+.+++.+|++.+|.+||++.++++.|+.+
T Consensus       232 ~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110          11123456889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-35  Score=311.49  Aligned_cols=253  Identities=25%  Similarity=0.360  Sum_probs=202.7

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      ++|...+.||+|+||.||++... ++..+++|..........+.|.+|++++++++||||+++++.+..+...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            45777889999999999999975 57899999876555555678999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++... ...+++.++..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++......  ..
T Consensus        85 ~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~  158 (280)
T cd06611          85 DGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ  158 (280)
T ss_pred             CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence            999999998432 3469999999999999999999999   89999999999999999999999999998653221  11


Q ss_pred             eeccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          620 VSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ......++..|+|||.+.     ...++.++|||||||++|||++|+.|+........  +    ..... ...     +
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~-~~~-----~  226 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--L----LKILK-SEP-----P  226 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--H----HHHhc-CCC-----C
Confidence            223356889999999875     34578899999999999999999999875432211  1    11111 100     1


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      .+  ..+......+.+++.+||+.+|.+||++.+++++-
T Consensus       227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  263 (280)
T cd06611         227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP  263 (280)
T ss_pred             Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence            11  11223445788999999999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-35  Score=318.40  Aligned_cols=241  Identities=23%  Similarity=0.268  Sum_probs=187.0

Q ss_pred             EeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhc---cCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKI---RHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       469 Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l---~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      ||+|+||+||+|... +++.||||++...   .......+..|..++..+   .||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999975 4889999986432   122334566677777665   699999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |+|.+++.  ....+++..+..++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~  153 (330)
T cd05586          81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTT  153 (330)
T ss_pred             ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCc
Confidence            99999884  34568999999999999999999999   99999999999999999999999999998753211  1222


Q ss_pred             ccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          622 TGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      ....||..|+|||++.+. .++.++|||||||+||||++|+.||......+.      ... ...+..      .+.   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~------~~~-i~~~~~------~~~---  217 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM------YRN-IAFGKV------RFP---  217 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH------HHH-HHcCCC------CCC---
Confidence            345789999999998754 589999999999999999999999865432111      111 111110      010   


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 042150          701 NLDSLKKFGETAEKCLADYGVDRP----SMGDVLWN  732 (803)
Q Consensus       701 ~~~~~~~l~~li~~cl~~~p~~RP----s~~evl~~  732 (803)
                      .......+.+++.+||+.+|.+||    ++.+++++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            112345678999999999999998    46666553

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.5e-34  Score=306.06  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=199.5

Q ss_pred             CCCccceEeeeCceEEEEEEECC--CcEEEEEEcCCC----------CCCChHHHHHHHHHHHh-ccCCCeeeEEeEeec
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD--NTKVAVKRGVPG----------SRQGLPEFQTEITVLSK-IRHRHLVSLVGYCEE  528 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~f~~E~~~l~~-l~HpnIv~l~g~~~~  528 (803)
                      +|...+.||+|+||.||+|..+.  ++.+|+|.....          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36677899999999999999765  678999975422          12234567889988875 699999999999999


Q ss_pred             cceeeEEEEecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeee
Q 042150          529 QSEMILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADF  606 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF  606 (803)
                      .+..++||||+++++|.+++..  .....+++..+++++.|++.||.|||+  ..+++|+||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999988732  234568999999999999999999995  257999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC
Q 042150          607 GLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG  686 (803)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (803)
                      |++.......   ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......      ...... ..
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~~~~~-~~  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LATKIV-EA  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HHHHHh-hc
Confidence            9987633221   2334568899999999999889999999999999999999999986432211      111111 11


Q ss_pred             ccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          687 MLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       687 ~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ..    .+    .........+.+++.+|++.+|.+||++.|+.++++
T Consensus       229 ~~----~~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VY----EP----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cC----Cc----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            10    01    011123467899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=314.84  Aligned_cols=254  Identities=23%  Similarity=0.279  Sum_probs=210.0

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCC---CChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceee
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSR---QGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~  533 (803)
                      ....|...+.||+|.||.||+++.+. |+.+|+|.+.....   ...+.+.+|+.+|+++. |||||.+.+.++.....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34567777899999999999999776 99999998654433   24568999999999998 999999999999999999


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc----CCcEEEeeeccc
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE----NYVSKVADFGLS  609 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~----~~~~kl~DFGla  609 (803)
                      +|||++.+|.|.+.+...   .+++.+...++.|++.++.|||+   .+|+||||||+|+|+..    ++.+|++|||++
T Consensus       113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            999999999999999554   39999999999999999999999   99999999999999953    347999999999


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      .....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||..........       ....+.. 
T Consensus       187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~-  255 (382)
T KOG0032|consen  187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF-  255 (382)
T ss_pred             eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence            87443   344567899999999999999999999999999999999999999997654332211       1111111 


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                           ......=......+.+++.+|+..||.+|+|+.+++++-+
T Consensus       256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence                 1111222344678899999999999999999999999633

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.1e-35  Score=322.14  Aligned_cols=263  Identities=23%  Similarity=0.251  Sum_probs=204.1

Q ss_pred             CCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-C-----CCeeeEEeEeeccceeeE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-H-----RHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-H-----pnIv~l~g~~~~~~~~~l  534 (803)
                      +|.+.++||+|.||.|-++.. ++++.||||+++.. .....+...|+.+|..|+ |     -|+|+++++|...+++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            788899999999999999995 45899999986543 334566788999999996 4     489999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC--CcEEEeeeccccCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN--YVSKVADFGLSRSG  612 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~--~~~kl~DFGla~~~  612 (803)
                      |+|.++. +|.++|...+...++...+..|+.||+.||.+||+   .+|||+||||+||||.+.  ..+||+|||.|+..
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9998865 99999988777889999999999999999999998   999999999999999643  37999999999863


Q ss_pred             CCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHH--------HHH----
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE--------WAM----  680 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~----  680 (803)
                      ..    ... ....+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+..+.++.....        |..    
T Consensus       342 ~q----~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  342 SQ----RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             CC----cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            22    111 4556789999999999999999999999999999999988887655554432211        000    


Q ss_pred             ---HHhhc--Cccc-----c--------------------ccCcccc----cCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 042150          681 ---QWQKK--GMLE-----H--------------------IIDPQLI----GKINLDSLKKFGETAEKCLADYGVDRPSM  726 (803)
Q Consensus       681 ---~~~~~--~~~~-----~--------------------i~d~~l~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~  726 (803)
                         .....  +...     .                    ..-|.-.    .......-..+.+++++||..||.+|+|.
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence               00111  0000     0                    0000000    00111334678999999999999999999


Q ss_pred             HHHHHHHH
Q 042150          727 GDVLWNLE  734 (803)
Q Consensus       727 ~evl~~L~  734 (803)
                      .+++++-.
T Consensus       497 ~qal~Hpf  504 (586)
T KOG0667|consen  497 AQALNHPF  504 (586)
T ss_pred             HHHhcCcc
Confidence            99998643

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=308.68  Aligned_cols=265  Identities=22%  Similarity=0.276  Sum_probs=201.4

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|+..+.||+|+||.||+|..+ +++.|++|++...  .....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5788889999999999999976 4789999976543  233457899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      ++++.|..++.  ....+++.+++.++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++........ 
T Consensus        82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          82 VERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            99877776653  33558999999999999999999999   8999999999999999999999999999876443221 


Q ss_pred             ceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH---------HHhhcCcc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM---------QWQKKGML  688 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~~  688 (803)
                      .......++..|+|||++.+. .++.++||||||+++|||++|+.|+......+.........         ........
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            122345678899999999888 88999999999999999999999986543222111000000         00000000


Q ss_pred             c-----cccCccc-ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 E-----HIIDPQL-IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~-----~i~d~~l-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .     ...++.. ...++......+.+++.+||..+|.+||++++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0     0000000 001122236778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=313.50  Aligned_cols=253  Identities=23%  Similarity=0.275  Sum_probs=201.6

Q ss_pred             CCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCC---CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSR---QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      +|...+.||+|++|.||++...+ ++.+|+|.......   ...+.+.+|+++++.++||||+++++.+......++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            57788899999999999999764 88999998654322   245678999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+.+++|.+++.......+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            9999999999965555679999999999999999999998   8999999999999999999999999999865322111


Q ss_pred             C---------------------------ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhh
Q 042150          618 T---------------------------HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAR  670 (803)
Q Consensus       618 ~---------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~  670 (803)
                      .                           .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence            0                           0111235788999999999999999999999999999999999998644322


Q ss_pred             hhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 042150          671 EQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPS----MGDVLWN  732 (803)
Q Consensus       671 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs----~~evl~~  732 (803)
                      ..     +. .         +.+....-.........+.+++.+||+.+|.+||+    +.|++.+
T Consensus       239 ~~-----~~-~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         239 ET-----FS-N---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             HH-----HH-H---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            11     10 0         00111100111124678899999999999999999    6666553

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-34  Score=309.02  Aligned_cols=254  Identities=24%  Similarity=0.339  Sum_probs=200.0

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +|+..+.||+|+||.||++..+ .+..||+|.+... .......+.+|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5677789999999999999976 5889999976543 2233567899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          540 EKGPLKKHLYGP-DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       540 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      ++++|..++... ....+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.+||+|||++.....    
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----  155 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA----  155 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC----
Confidence            999999988542 13478999999999999999999996  25899999999999999999999999999875321    


Q ss_pred             ceeccccCCCcccCccccccC------cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQ------QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      .......++..|+|||.+.+.      .++.++|||||||++|||++|+.||.........   .-..         .+.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~---------~~~  223 (286)
T cd06622         156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---AQLS---------AIV  223 (286)
T ss_pred             CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---HHHH---------HHh
Confidence            112234578899999998544      3588999999999999999999998643221111   0000         011


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      +.. ....+......+.+++.+|++.+|.+||++.+++.+-.
T Consensus       224 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~  264 (286)
T cd06622         224 DGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW  264 (286)
T ss_pred             hcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence            100 11223345677899999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-35  Score=321.60  Aligned_cols=261  Identities=24%  Similarity=0.275  Sum_probs=195.4

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeecc-----
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ-----  529 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----  529 (803)
                      ...++|...+.||+|+||.||+|... +++.||||+.....  ....+.+.+|+++|++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34577899999999999999999964 57899999865432  22345678999999999999999999987533     


Q ss_pred             -ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          530 -SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       530 -~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                       ...++++|++ +++|.+++.   ...+++.++..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence             3578999988 678988873   3569999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH-----
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW-----  682 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-----  682 (803)
                      ++....     ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+.  +..+....     
T Consensus       165 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  237 (343)
T cd07878         165 ARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTPSP  237 (343)
T ss_pred             ceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence            976322     1233568999999999876 5789999999999999999999999864322111  11110000     


Q ss_pred             -----hhcCc-------cccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          683 -----QKKGM-------LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       683 -----~~~~~-------~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                           .....       +.......+.. .-....+.+.+++.+||+.||.+|||+.|++++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp  299 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAHP  299 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence                 00000       00000000000 0001224578999999999999999999999763

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-37  Score=302.27  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=208.6

Q ss_pred             CCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      |++..+||+|+||.||+|.++. |..+|+|+...  ..+.++...|+.+|+++..|++|+++|.+.....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            6667789999999999999765 88999998543  44678999999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |++.+.++- ++++|++.++..++...++||+|||.   ..-+|||||+.||||+.+|.+||+|||.+....  +.....
T Consensus       113 GSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAKR  186 (502)
T KOG0574|consen  113 GSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAKR  186 (502)
T ss_pred             CcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhh--hhHHhh
Confidence            999999854 56789999999999999999999999   888999999999999999999999999986532  333344


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ..+.||+.|||||++..-.|+.++||||||+...||.-|++|+....+......            +.  ..|...-..+
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM------------IP--T~PPPTF~KP  252 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM------------IP--TKPPPTFKKP  252 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe------------cc--CCCCCCCCCh
Confidence            567899999999999999999999999999999999999999875533221100            00  0111112234


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...+.++-+++++||-+.|++|-|+-+++++
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            5677899999999999999999999888775

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.5e-34  Score=312.04  Aligned_cols=195  Identities=24%  Similarity=0.344  Sum_probs=158.1

Q ss_pred             cceEeeeCceEEEEEEECC---CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEee--ccceeeEEEEecC
Q 042150          466 NLIIGSGGFGMVYKGVLRD---NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE--EQSEMILVYEYME  540 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~--~~~~~~lV~Ey~~  540 (803)
                      +.+||+|+||.||+|..++   +..||+|.+....  ....+.+|++++++++||||+++++++.  .+...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3579999999999999753   4689999865432  2356889999999999999999999884  3567899999987


Q ss_pred             CCchhhhccC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE----ccCCcEEEeeeccc
Q 042150          541 KGPLKKHLYG-------PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLS  609 (803)
Q Consensus       541 ~gsL~~~l~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~~kl~DFGla  609 (803)
                      + +|.+++..       .....+++..+..++.|++.||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 77766631       123358899999999999999999999   899999999999999    56779999999999


Q ss_pred             cCCCCCCC-CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCc
Q 042150          610 RSGPCLDE-THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDP  666 (803)
Q Consensus       610 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~  666 (803)
                      +....... ........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            76432111 112234567899999999876 4589999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.9e-35  Score=287.49  Aligned_cols=258  Identities=23%  Similarity=0.325  Sum_probs=204.2

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC----CC----hHHHHHHHHHHHhc-cCCCeeeEEeEeec
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR----QG----LPEFQTEITVLSKI-RHRHLVSLVGYCEE  528 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~----~~~f~~E~~~l~~l-~HpnIv~l~g~~~~  528 (803)
                      .-+.|...++||.|..+.|-+...+ ++...|+|++.....    ..    .+.-..|+.+|+++ -||+|+.+.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3456778889999999999988865 477888887543211    11    23456799999998 59999999999999


Q ss_pred             cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                      +..+++|+|.|+.|.|.++|  .....+++++..+|++|+.+|++|||.   .+||||||||+|||+|++.++||+|||+
T Consensus        95 ~sF~FlVFdl~prGELFDyL--ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYL--TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             cchhhhhhhhcccchHHHHh--hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence            99999999999999999999  566789999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCcccccc------CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRR------QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      ++....   .......+||++|+|||.+..      ..|+...|+|++||+||.|+.|.+||-..   .++...    .+
T Consensus       170 a~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQmlML----R~  239 (411)
T KOG0599|consen  170 ACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQMLML----RM  239 (411)
T ss_pred             eeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HHHHHH----HH
Confidence            987443   233456899999999998853      46788899999999999999999998532   222111    11


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      +.+|..+ .-.|     -=.+.+....+||.+||+.||.+|.|+.|+|++-..+.
T Consensus       240 ImeGkyq-F~sp-----eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  240 IMEGKYQ-FRSP-----EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             HHhcccc-cCCc-----chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            1222111 0001     01244567889999999999999999999998755443

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=308.27  Aligned_cols=265  Identities=22%  Similarity=0.305  Sum_probs=196.3

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|...+.||+|++|.||+|..+ +++.||+|....... .....+.+|++++++++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56788889999999999999976 578999998654332 2234578899999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +.+ +|.+++.... ..+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++.....  .
T Consensus        85 ~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~  157 (291)
T cd07844          85 LDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--S  157 (291)
T ss_pred             CCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC--C
Confidence            985 8998885433 368999999999999999999999   89999999999999999999999999998753211  1


Q ss_pred             ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchh-hhhhhHHHHHHHHhhcCccc-------
Q 042150          619 HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLA-REQVNLAEWAMQWQKKGMLE-------  689 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~-------  689 (803)
                      .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+..................       
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            11223346789999999875 5688999999999999999999999864431 11111000000000000000       


Q ss_pred             -------cccCcccccCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          690 -------HIIDPQLIGKI-NLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       690 -------~i~d~~l~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                             ......+.... .......+.+++.+||+.+|.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                   00000000000 01112577899999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-35  Score=313.43  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=204.3

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcC--CCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ....|++.++||+||.+.||++...+.+.+|+|+..  ..+.+...-|.+|+.+|.+|+ |.+|++|++|-..++.+|||
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            345678888999999999999998888889988743  345667788999999999995 99999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||=+ -+|..+|.+.......| .+..+..|++.++.++|+   +||||.||||.|+|+-+ |.+||+|||+|......
T Consensus       439 mE~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  439 MECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             eeccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            99754 48999996655555556 677889999999999999   99999999999999865 68999999999886655


Q ss_pred             CCCceeccccCCCcccCccccccC-----------cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhh
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQ-----------QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK  684 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  684 (803)
                      ...-....++||..||+||.+...           +...++||||+|||||+|+.|++||.....       .|.     
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a-----  580 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA-----  580 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH-----
Confidence            555566778999999999998532           356789999999999999999999874321       121     


Q ss_pred             cCccccccCcccccCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          685 KGMLEHIIDPQLIGKINL-DSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       685 ~~~~~~i~d~~l~~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        .+..|.||.-.-+++. ....++.++++.||+.||.+||+..++|++
T Consensus       581 --Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 --KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             --HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence              2334555533222221 111238999999999999999999999875

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2e-34  Score=307.56  Aligned_cols=262  Identities=22%  Similarity=0.273  Sum_probs=198.1

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|+..+.||+|++|.||+|+.. +++.|+||+.....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4777889999999999999975 58899999865432  22345789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +. ++|.+++.......+++..++.++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+++......  
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--  154 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  154 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence            96 689998866556779999999999999999999998   899999999999999999999999999987532211  


Q ss_pred             ceeccccCCCcccCccccccCc-CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc------------
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQ-LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK------------  685 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------------  685 (803)
                      .......++..|+|||.+.+.. ++.++|||||||++|||+||+.||......+.  +..........            
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHH
Confidence            1122345688999999887644 68899999999999999999999864332211  11111000000            


Q ss_pred             ---CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          686 ---GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       686 ---~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                         ..........+ ..........+.+++.+||+.||.+||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         233 DYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence               00000000000 00011234567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.2e-34  Score=302.66  Aligned_cols=257  Identities=26%  Similarity=0.368  Sum_probs=204.1

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|+..+.||.|+||+||+|... ++..+++|+..... ....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36888899999999999999965 57789999865432 33567899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          539 MEKGPLKKHLYGPD-RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       539 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      +++++|.+++.... ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999995433 2568999999999999999999998   9999999999999999999999999999875433222


Q ss_pred             Cc--eeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          618 TH--VSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       618 ~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ..  ......++..|+|||.+... .++.++|+|||||++|||++|+.|+......+  .....    ....      .+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~----~~~~------~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLT----LQND------PP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHH----hcCC------CC
Confidence            21  22334688999999998876 78999999999999999999999986443221  11111    1110      11


Q ss_pred             ccccCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          695 QLIGKI-NLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       695 ~l~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+.... ....+..+.+++.+|++.+|.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            111111 12345678999999999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.6e-35  Score=312.14  Aligned_cols=245  Identities=22%  Similarity=0.342  Sum_probs=197.4

Q ss_pred             cceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCch
Q 042150          466 NLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      ...||+|+||.||++... ++..||||+.........+.+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            347999999999999965 5789999987555545566789999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccc
Q 042150          545 KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV  624 (803)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (803)
                      .+++.   ...+++.+++.++.||+.||.|||+   .+++||||||+||++++++.+||+|||++......  .......
T Consensus       107 ~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~  178 (292)
T cd06658         107 TDIVT---HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSL  178 (292)
T ss_pred             HHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cccCcee
Confidence            99883   3458999999999999999999999   89999999999999999999999999998653221  1112234


Q ss_pred             cCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHH
Q 042150          625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDS  704 (803)
Q Consensus       625 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  704 (803)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.||..........      . ..     ....+.+..  ....
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~-~~-----~~~~~~~~~--~~~~  244 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR------R-IR-----DNLPPRVKD--SHKV  244 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-HH-----hcCCCcccc--cccc
Confidence            67899999999998899999999999999999999999986433221110      0 00     011111111  1123


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          705 LKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       705 ~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...+.+++.+|+..+|.+|||+.+++++
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            4567899999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.7e-34  Score=306.72  Aligned_cols=262  Identities=24%  Similarity=0.279  Sum_probs=200.7

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|...+.||+|+||.||+|... +++.|++|+.....  ....+.+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677789999999999999975 58899999865443  33356899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      + +++|.+++.... ..+++.+++.++.||++||+|||+   .+++|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 999999985433 569999999999999999999999   8999999999999999999999999999876433221 


Q ss_pred             ceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC-----------
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG-----------  686 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----------  686 (803)
                      .......++..|+|||.+.+. .++.++|||||||++|||++|++++......+.   ..+........           
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCc
Confidence            122345688999999998654 568999999999999999999877754332211   11111100000           


Q ss_pred             -ccccccCccc----ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 -MLEHIIDPQL----IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 -~~~~i~d~~l----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       ....+..+..    ......+....+.+++.+||..+|.+||++++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0000000000    001112334788999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-34  Score=304.63  Aligned_cols=254  Identities=23%  Similarity=0.371  Sum_probs=200.9

Q ss_pred             CCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCC------CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSR------QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      +|+..+.||+|++|.||+|.. .+++.+|+|.+.....      ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            467778999999999999985 4588999998653321      124678999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC-cEEEeeeccccCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY-VSKVADFGLSRSGP  613 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFGla~~~~  613 (803)
                      ||||+++++|.+++.  ....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            999999999999984  34568999999999999999999999   8999999999999998765 69999999987543


Q ss_pred             CCCC--CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          614 CLDE--THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       614 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ....  ........++..|+|||.+.+..++.++||||+|+++|||++|+.|+.........   ........       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~-------  225 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIAS-------  225 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhc-------
Confidence            2211  11122346788999999999889999999999999999999999998643221111   11111100       


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        .......+......+.+++.+|+..+|.+||++.+++++
T Consensus       226 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         226 --ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             --cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence              011123344556788999999999999999999999854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.9e-34  Score=302.32  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=200.8

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeec--cceeeEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE--QSEMILVY  536 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~lV~  536 (803)
                      +|+..+.||.|+||.||++... ++..+++|.+...  .....+.+.+|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4677789999999999999864 5788999986533  22334678899999999999999999998753  45689999


Q ss_pred             EecCCCchhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          537 EYMEKGPLKKHLYGP--DRTPLSWKQRLEICIGAARGLHYLHTGS--AEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ||+++++|.+++...  ....+++.+++.++.|++.||.|||..+  ..+++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998432  2467999999999999999999999321  289999999999999999999999999998864


Q ss_pred             CCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ....  .......++..|+|||.+.+..++.++||||||+++|+|++|+.|+.......   +.+   . ...+.     
T Consensus       161 ~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~-~~~~~-----  226 (265)
T cd08217         161 GHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LAS---K-IKEGK-----  226 (265)
T ss_pred             cCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHH---H-HhcCC-----
Confidence            3221  11233568899999999999899999999999999999999999987543111   111   1 11111     


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                          ....+......+.+++.+|++.+|.+||++.+|+++
T Consensus       227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                112333455788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.3e-34  Score=309.54  Aligned_cols=257  Identities=23%  Similarity=0.292  Sum_probs=200.5

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||++.... ++.|++|.+....   ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            367888899999999999999764 7889999865432   233567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            99999999999943  3568999999999999999999998   899999999999999999999999999987421100


Q ss_pred             C-------------CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHh
Q 042150          617 E-------------THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ  683 (803)
Q Consensus       617 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  683 (803)
                      .             ........++..|+|||.+.+..++.++|+|||||++|||++|+.||......      ++.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~  229 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVI  229 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence            0             00111245788999999999889999999999999999999999998643221      1111111


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      .. .   +..+..    ....+..+.+++.+||+.+|++||+..++.+.|+..
T Consensus       230 ~~-~---~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         230 SD-D---IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             hc-c---cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            10 0   111111    112345679999999999999999976665555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.7e-34  Score=303.87  Aligned_cols=247  Identities=28%  Similarity=0.359  Sum_probs=199.8

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      -|...+.||+|+||.||+|... ++..+|+|...... ....+.|.+|++++++++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3566778999999999999864 57899999854332 233567899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.   ...+++..+..++.|++.+|.|||+   .+++|+||||+||+++.++.++|+|||+++.....  ..
T Consensus        85 ~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~  156 (277)
T cd06641          85 GGGSALDLLE---PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QI  156 (277)
T ss_pred             CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccc--hh
Confidence            9999999983   3468999999999999999999998   99999999999999999999999999998753321  11


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......++..|+|||.+.+..++.++|||||||++|||++|..|+.......      +... .....         ...
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~---------~~~  220 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL-IPKNN---------PPT  220 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH-HhcCC---------CCC
Confidence            1223467889999999998889999999999999999999999986432211      1111 11110         011


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ........+.+++.+|++.+|.+||++.+++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            222345678899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.6e-34  Score=310.91  Aligned_cols=247  Identities=22%  Similarity=0.323  Sum_probs=198.7

Q ss_pred             ccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCc
Q 042150          465 KNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGP  543 (803)
Q Consensus       465 ~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs  543 (803)
                      ....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3447999999999999965 588999998765555556778999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceecc
Q 042150          544 LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG  623 (803)
Q Consensus       544 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  623 (803)
                      |..++.   ...+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.....  ......
T Consensus       105 L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~  176 (297)
T cd06659         105 LTDIVS---QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKS  176 (297)
T ss_pred             HHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--cccccc
Confidence            999873   3568999999999999999999998   89999999999999999999999999998643221  111233


Q ss_pred             ccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHH
Q 042150          624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLD  703 (803)
Q Consensus       624 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~  703 (803)
                      ..++..|+|||.+.+..++.++|||||||++|||++|+.||......+..   .   . ......     +..  .....
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~---~-~~~~~~-----~~~--~~~~~  242 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---K---R-LRDSPP-----PKL--KNAHK  242 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---H-HhccCC-----CCc--cccCC
Confidence            56889999999999889999999999999999999999998643322111   0   1 011000     000  01112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          704 SLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       704 ~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      ....+.+++.+|++.+|.+||++.+++++-
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~  272 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDHP  272 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence            345678999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.3e-34  Score=307.80  Aligned_cols=251  Identities=22%  Similarity=0.285  Sum_probs=203.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .+|...+.||+|+||.||++... ++..|++|..........+.+.+|+.++++++||||+++++.|...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            56788889999999999999864 57889999875544555678899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.   ...+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......  .
T Consensus        99 ~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~  170 (293)
T cd06647          99 AGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  170 (293)
T ss_pred             CCCcHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--c
Confidence            9999999983   3458899999999999999999999   999999999999999999999999999886533221  1


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......+++.|+|||.+.+..++.++|||||||++|||++|+.||..........      ....        .+.....
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~--------~~~~~~~  236 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT--------NGTPELQ  236 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhc--------CCCCCCC
Confidence            2223467889999999998889999999999999999999999986543221110      0000        0000001


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      ........+.+++.+||..+|.+||++.+++.+-
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~  270 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence            1223445788999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-35  Score=321.95  Aligned_cols=244  Identities=25%  Similarity=0.402  Sum_probs=191.6

Q ss_pred             cceEeeeCceEEEEEEECC-CcEEE---EEE-cCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccce--eeEEEEe
Q 042150          466 NLIIGSGGFGMVYKGVLRD-NTKVA---VKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE--MILVYEY  538 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~-~~~va---vK~-~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~--~~lV~Ey  538 (803)
                      ..+||+|.|-+||||.... |..||   ||. ....+....++|..|+.+|+.|+||||++++.++.+...  +-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            3479999999999999653 66665   332 112244456899999999999999999999998876554  7889999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc-cCCcEEEeeeccccCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |..|+|+.|+.  +.+.++.+.+.+||+||++||.|||+. .++|+|||||..||+|+ ..|.+||+|+|||....    
T Consensus       125 ~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r----  197 (632)
T KOG0584|consen  125 FTSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR----  197 (632)
T ss_pred             ccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh----
Confidence            99999999994  445688899999999999999999984 47899999999999997 67899999999998632    


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      ......+.|||.|||||.+. ..|++..||||||++|+||+|+..|+......-++  ...+..-.+...+..+-     
T Consensus       198 ~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI--YKKV~SGiKP~sl~kV~-----  269 (632)
T KOG0584|consen  198 KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI--YKKVTSGIKPAALSKVK-----  269 (632)
T ss_pred             ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH--HHHHHcCCCHHHhhccC-----
Confidence            23344588999999999987 89999999999999999999999998643322211  11111111222222222     


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                             .+++.++|.+||.. ..+|||+.|+|.+
T Consensus       270 -------dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  270 -------DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             -------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                   24678999999999 9999999999974

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=293.96  Aligned_cols=253  Identities=24%  Similarity=0.322  Sum_probs=200.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCC--CCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      +++|+..+.||+|.|+.|++.... .|+.+|+|.+..  -...+.+++.+|+++.+.|+||||++|.....+.+..|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            345666778999999999998754 588888885332  23346788999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc---cCCcEEEeeeccccCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGP  613 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~DFGla~~~~  613 (803)
                      |+|.|++|..-|.  .+...++...-..+.||+++|.|+|.   ++|||||+||.|+||-   ..--+||+|||+|....
T Consensus        90 e~m~G~dl~~eIV--~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIV--AREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999987663  23456777888899999999999999   9999999999999994   34468999999998754


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                         ......+..||++|||||++...+|+..+|||+.||+||-|+.|+.||......   .+.+    .+..+..  -++
T Consensus       165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye----~I~~g~y--d~~  232 (355)
T KOG0033|consen  165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYE----QIKAGAY--DYP  232 (355)
T ss_pred             ---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHH----HHhcccc--CCC
Confidence               333455678999999999999999999999999999999999999999753221   1111    1111111  011


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      +...    ....++..+|+.+||..||.+|.|+.|.|.+-
T Consensus       233 ~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp  268 (355)
T KOG0033|consen  233 SPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALKHP  268 (355)
T ss_pred             Cccc----CcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence            1111    23346778999999999999999999988654

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.2e-34  Score=306.15  Aligned_cols=262  Identities=23%  Similarity=0.281  Sum_probs=197.5

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC-----ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      +|...+.||+|+||.||+|... +++.|++|++......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3667789999999999999975 5889999986544322     234577899999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+ +|+|.+++.... ..+++.+++.++.||++||.|||+   .+++|+||||+||+++.++.+||+|||+++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 899999995432 369999999999999999999999   89999999999999999999999999999764322


Q ss_pred             CCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH--------hhcC
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW--------QKKG  686 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~~  686 (803)
                      .  .......++..|+|||.+.+ ..++.++|||||||++|||++|.+++......+..  .......        ....
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         156 N--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL--GKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             C--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH--HHHHHHcCCCchhhhhhcc
Confidence            1  11223356788999998854 56789999999999999999998777543321111  1100000        0000


Q ss_pred             ccccccCcccccC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 MLEHIIDPQLIGK-----INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 ~~~~i~d~~l~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+...........     ........+.+++.+||+.+|.+|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000000001     112335678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.5e-34  Score=304.98  Aligned_cols=267  Identities=22%  Similarity=0.286  Sum_probs=197.3

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++++|...+.||+|+||.||+|... +++.|++|....... .....+.+|+++++.++|+||+++.+++..+...++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3567888899999999999999864 588999998654432 33346789999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+. ++|.+++... ...+.+.++..++.|++.||.|||+   .+++|+||||+|||++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9996 6777766432 3457889999999999999999999   899999999999999999999999999987532211


Q ss_pred             CCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH----------HHhhc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM----------QWQKK  685 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~----------~~~~~  685 (803)
                        .......++..|+|||.+.+. .++.++|||||||++|||++|+.||+............|..          .....
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         158 --QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             --CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence              112234568899999998754 57889999999999999999999997543321111111100          00000


Q ss_pred             -CccccccCcccccCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          686 -GMLEHIIDPQLIGKI-----NLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       686 -~~~~~i~d~~l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       ....+..........     .......+.+++.+|+..+|.+|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence             000000000000000     00124577899999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.9e-34  Score=299.28  Aligned_cols=253  Identities=26%  Similarity=0.382  Sum_probs=200.2

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|...+.||+|+||.||+|... +++.|++|.......  ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4677789999999999999965 588999998654433  2567899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++++|.+++..  ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            999999999943  3458899999999999999999999   99999999999999999999999999998764322221


Q ss_pred             ce--eccccCCCcccCccccccCc---CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          619 HV--STGVKGSFGYLDPEYFRRQQ---LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       619 ~~--~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ..  .....++..|+|||.+.+..   .+.++||||||+++|||++|+.||........  .   .... ..+.     .
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~---~~~~-~~~~-----~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--I---MFHV-GAGH-----K  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--H---HHHH-hcCC-----C
Confidence            11  11346788999999998766   88999999999999999999999864421111  0   0000 0010     1


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +.+.  ........+.+++.+|++.+|.+||++.+++.+
T Consensus       225 ~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         225 PPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            1110  011225667899999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.7e-34  Score=303.50  Aligned_cols=259  Identities=24%  Similarity=0.285  Sum_probs=201.0

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeec--cceeeEEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEE--QSEMILVYE  537 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~lV~E  537 (803)
                      +|...+.||.|++|.||++... +++.+|+|....... ....++.+|++++++++||||++++++|.+  .+.+++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5777889999999999999975 478899998654322 345679999999999999999999998854  346899999


Q ss_pred             ecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          538 YMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       538 y~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |+++++|.+++..  .....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999988742  234568999999999999999999999   99999999999999999999999999998653211


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchh--hhhhhHHHHHHHHhhcCccccccC
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLA--REQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                          ......++..|+|||.+.+..++.++|||||||++|||++|+.|+.....  .....+..+....    ....+. 
T Consensus       159 ----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~-  229 (287)
T cd06621         159 ----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELK-  229 (287)
T ss_pred             ----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhhc-
Confidence                11234578899999999999999999999999999999999999875422  1111222221110    000110 


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ...  .........+.+++.+|++.+|.+|||+.|++++-.
T Consensus       230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~  268 (287)
T cd06621         230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW  268 (287)
T ss_pred             cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence            000  111234567899999999999999999999998644

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4e-34  Score=305.07  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=193.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHH-HHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITV-LSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~-l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|...+.||+|+||.||+++.+ +++.||+|+..... .....++..|+.+ ++.++||||+++++++...+..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36788889999999999999975 58999999865432 2234456667765 555689999999999999999999999


Q ss_pred             ecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-ceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          538 YMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAE-GIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       538 y~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      |++ |+|.+++..  .....+++..++.++.|++.||+|||+   + +++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 688777743  234578999999999999999999998   6 899999999999999999999999999875321


Q ss_pred             CCCCceeccccCCCcccCcccccc----CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRR----QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                         ........++..|+|||.+.+    ..++.++|+|||||++|||++|+.|+....... ..+.    .... +.   
T Consensus       157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~----~~~~-~~---  224 (283)
T cd06617         157 ---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLK----QVVE-EP---  224 (283)
T ss_pred             ---ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHH----HHHh-cC---
Confidence               112233467889999998864    457889999999999999999999986422110 0111    1111 10   


Q ss_pred             ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       691 i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                        .+.+   .....+..+.+++.+||+.+|.+||++.+++++-
T Consensus       225 --~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  262 (283)
T cd06617         225 --SPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP  262 (283)
T ss_pred             --CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence              0111   0112346789999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.4e-34  Score=297.26  Aligned_cols=252  Identities=25%  Similarity=0.371  Sum_probs=204.9

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeecc--ceeeEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEMILVY  536 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~lV~  536 (803)
                      +|...+.||+|++|.||+|... +++.|++|+......  ...+.+.+|++++++++||||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999976 588999998654432  4567899999999999999999999999888  8899999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++++|.+++..  ...+++.+++.++.|++++|+|||+   .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            99999999999943  3389999999999999999999999   999999999999999999999999999987644322


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      .........++..|+|||.+.+...+.++||||||+++++|++|+.|+.......     ......         .....
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~---------~~~~~  221 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKI---------GSSGE  221 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhc---------cccCC
Confidence            2111334568889999999998889999999999999999999999987543111     111111         11111


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ....+......+.+++.+|++.+|.+||++.+++++
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            122333446788999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.7e-34  Score=298.45  Aligned_cols=253  Identities=24%  Similarity=0.347  Sum_probs=205.4

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|+..+.||+|++|.||+|+... ++.|++|+...... ....++.+|+..+.+++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            357788899999999999999765 89999998665443 4467899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++++|.+++..  ...+++..++.++.|+++||+|||+  ..+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-  155 (264)
T cd06623          81 MDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-  155 (264)
T ss_pred             cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence            999999999943  3678999999999999999999996  27899999999999999999999999999876432111 


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..........+..+..    ....         .
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~---------~  221 (264)
T cd06623         156 -QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPP---------P  221 (264)
T ss_pred             -cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCC---------C
Confidence             1123467889999999999999999999999999999999999987553211111111111    1100         1


Q ss_pred             CCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          699 KINLD-SLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       699 ~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..+.. .+..+.+++.+||+.+|.+||++.+++++
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            11222 45688999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=304.16  Aligned_cols=255  Identities=27%  Similarity=0.345  Sum_probs=200.5

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccc-----
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQS-----  530 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~-----  530 (803)
                      ..+++|...+.||+|++|.||+|..+ +++.+++|...... ...++|.+|+.+++++ .|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35678999999999999999999975 47789999865433 3457899999999999 6999999999996544     


Q ss_pred             -eeeEEEEecCCCchhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeec
Q 042150          531 -EMILVYEYMEKGPLKKHLYGPD--RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG  607 (803)
Q Consensus       531 -~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG  607 (803)
                       ..++||||+++++|.+++....  ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999885433  4678999999999999999999998   899999999999999999999999999


Q ss_pred             cccCCCCCCCCceeccccCCCcccCcccccc-----CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH
Q 042150          608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFRR-----QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      ++.....  .........++..|+|||.+..     ..++.++|||||||+||||++|+.||........  +.    + 
T Consensus       159 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----~-  229 (275)
T cd06608         159 VSAQLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LF----K-  229 (275)
T ss_pred             cceeccc--chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HH----H-
Confidence            9865321  1112233568889999998753     3577899999999999999999999864322111  11    1 


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ........     +  .........+.+++.+||..+|++|||+.+++++
T Consensus       230 ~~~~~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         230 IPRNPPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             hhccCCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11111111     1  1122345678999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=314.77  Aligned_cols=244  Identities=29%  Similarity=0.395  Sum_probs=198.2

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC---ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ---GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      |...+.||.|+||.||-|+.. +.+.||||++.-...+   ..++++.|+..|.+++|||++.+.||+..+...+|||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            555668999999999999954 5788999986544333   357889999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      |-| +-.++|. -.++++.+.++..|+.+.+.||+|||+   ++.||||||+.||||++.|.+||+|||.|....     
T Consensus       108 ClG-SAsDlle-VhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----  177 (948)
T KOG0577|consen  108 CLG-SASDLLE-VHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-----  177 (948)
T ss_pred             Hhc-cHHHHHH-HHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcC-----
Confidence            965 6666662 235679999999999999999999999   999999999999999999999999999986532     


Q ss_pred             ceeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          619 HVSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                       .....+||+.|||||++.   .++|+-|+||||||++..||.-.++|+-.......  +...+   +.+       .|.
T Consensus       178 -PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--LYHIA---QNe-------sPt  244 (948)
T KOG0577|consen  178 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA---QNE-------SPT  244 (948)
T ss_pred             -chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--HHHHH---hcC-------CCC
Confidence             234578999999999874   68999999999999999999999988654322111  11111   111       122


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +.   ..+.+..++.++..||++-|.+|||.++++.+
T Consensus       245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            21   45678889999999999999999999888764

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.3e-34  Score=305.94  Aligned_cols=262  Identities=22%  Similarity=0.273  Sum_probs=195.1

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|...+.||+|+||.||+|+.. +|+.+++|+.....  ......+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            3667789999999999999975 58899999865432  22345688899999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      ++ ++|.+++... ...+++..++.++.||++||.|||+   .+++||||||+||+++.++.+||+|||+++......  
T Consensus        81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--  153 (284)
T cd07839          81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--  153 (284)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence            97 4788777432 3569999999999999999999999   899999999999999999999999999987532211  


Q ss_pred             ceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC------ccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG------MLEHI  691 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~i  691 (803)
                      .......++..|+|||.+.+. .++.++|||||||++|||++|+.|+........ .+ ..........      .+...
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhhhc
Confidence            112234568899999998764 478999999999999999999988643221111 00 0000000000      00000


Q ss_pred             cCcc----cc-----cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          692 IDPQ----LI-----GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       692 ~d~~----l~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+..    ..     ..........+.+++.+||+.+|.+|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            0000    00     01112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.5e-34  Score=304.93  Aligned_cols=245  Identities=22%  Similarity=0.280  Sum_probs=199.7

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||++... +++.+|+|.....   .....+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            35778889999999999999975 4789999986432   2233567899999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+++|+||+|+|||++.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            99999999999843  3678999999999999999999999   99999999999999999999999999998764322 


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                          .....+++.|+|||.+.+...+.++||||||+++|||++|+.||.......   ..    +....+.         
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~---------  214 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IY----EKILEGK---------  214 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHhcCC---------
Confidence                233468899999999988889999999999999999999999986443111   00    0011111         


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                       ..++......+.+++.+||..+|.+||     +++|++++
T Consensus       215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence             011222356788999999999999999     67777654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-34  Score=301.75  Aligned_cols=248  Identities=24%  Similarity=0.367  Sum_probs=198.9

Q ss_pred             CCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC-CCCChHHHHHHHHHHHhcc---CCCeeeEEeEeeccceeeEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIR---HRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .|+..+.||+|+||.||+|.. .+++.+++|.+... .....+++.+|++++++++   |||+++++++|..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            466677899999999999996 45889999986543 3345678899999999997   999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++++|.+++..   ..+++..++.++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            99999999999833   378999999999999999999998   999999999999999999999999999987643222


Q ss_pred             CCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                        .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........      ... ...     ...+.
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~-~~~-----~~~~~  221 (277)
T cd06917         156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MML-IPK-----SKPPR  221 (277)
T ss_pred             --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhc-ccc-----CCCCC
Confidence              22233468889999998865 4578899999999999999999999875432111      100 000     01111


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +..   ......+.+++.+||+.+|.+||++.+++.+
T Consensus       222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            111   1145678899999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.4e-34  Score=299.97  Aligned_cols=250  Identities=24%  Similarity=0.391  Sum_probs=201.0

Q ss_pred             CCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|...+.||+|+||.||+|..+. +..+++|.....  .....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            46778899999999999999764 788999986433  223456788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC-cEEEeeeccccCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY-VSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFGla~~~~~~~~  617 (803)
                      +++++|.+++.......+++..++.++.|+++||.|||+   .+++|+||||+||++++++ .+||+|||.+......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--  155 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--  155 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC--
Confidence            999999999965555568999999999999999999998   8999999999999998875 5699999998754321  


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      ........++..|+|||.+.+..++.++||||||+++|||++|+.|+.....      .++...... +...        
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~--------  220 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYFA--------  220 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccCC--------
Confidence            1122234578899999999888899999999999999999999999864322      122222111 1111        


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       .........+.+++.+|+..+|++|||+.|++++
T Consensus       221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             1122334578999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=9e-34  Score=303.09  Aligned_cols=255  Identities=25%  Similarity=0.340  Sum_probs=205.0

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++.|.....||+|++|.||+|..+ ++..+++|....... ..+.+.+|++++++++|+|++++++++......++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4556777889999999999999986 588899998765443 56789999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|.+++.... ..+++.+++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......  
T Consensus        96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--  169 (286)
T cd06614          96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--  169 (286)
T ss_pred             ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc--
Confidence            999999999995432 379999999999999999999999   99999999999999999999999999987643221  


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      ........++..|++||.+.+..++.++|||||||++|||++|+.|+.........  .    ..... .....      
T Consensus       170 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~----~~~~~-~~~~~------  236 (286)
T cd06614         170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--F----LITTK-GIPPL------  236 (286)
T ss_pred             hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHHhc-CCCCC------
Confidence            11122345788999999999889999999999999999999999998643322111  1    10111 00000      


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                       .........+.+++.+|++.+|.+||++.+++++..
T Consensus       237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  272 (286)
T cd06614         237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF  272 (286)
T ss_pred             -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence             011124567899999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=302.40  Aligned_cols=248  Identities=25%  Similarity=0.326  Sum_probs=204.0

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCC---CCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVP---GSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ..+.|..-++||+||||.||-.+.+ +|+.+|+|++..   ..+++....++|-.+|++++.+.||.|-..++..+.+||
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            4456888899999999999998865 488899986432   345556678899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      |+..|.||+|.-+|++.....+++...+-++.+|+.||++||.   .+||.|||||+|||||+.|+++|+|+|||...+.
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            9999999999999988888889999999999999999999999   9999999999999999999999999999987543


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      .   ......+||.+|||||++.++.|+...|.|||||+||||+.|+.||........   .+-+.+...+       | 
T Consensus       340 g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~eEvdrr~~~-------~-  405 (591)
T KOG0986|consen  340 G---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---REEVDRRTLE-------D-  405 (591)
T ss_pred             C---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---HHHHHHHHhc-------c-
Confidence            2   223344899999999999999999999999999999999999999864322111   1111111111       1 


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCC
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPS  725 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs  725 (803)
                        ..+++...+++...|....|..||.+|--
T Consensus       406 --~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  406 --PEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             --hhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence              12344556677889999999999999864

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-33  Score=302.35  Aligned_cols=248  Identities=22%  Similarity=0.337  Sum_probs=199.2

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      |...+.||+|++|.||++... +++.+++|+.........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            444568999999999999964 5788999986554444556789999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      ++|.+++..   ..+++.++..++.|++.||+|||+   ++++||||+|+||++++++.++|+|||++......  ....
T Consensus       101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~  172 (285)
T cd06648         101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRR  172 (285)
T ss_pred             CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccc
Confidence            999999843   568999999999999999999999   99999999999999999999999999987653221  1122


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ....++..|+|||.+.+..++.++|||||||++|||++|+.|+.......      ...... ...     .+.+.  ..
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~~~~-~~~-----~~~~~--~~  238 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMKRIR-DNL-----PPKLK--NL  238 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHH-hcC-----CCCCc--cc
Confidence            23468899999999998899999999999999999999999986432211      111111 110     01110  01


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ......+.+++.+||+.+|.+||++.+++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            1234578999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.9e-33  Score=293.25  Aligned_cols=250  Identities=28%  Similarity=0.407  Sum_probs=203.6

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      +|...+.||+|++|.||++... +++.+++|+.........+.+.+|++++++++|||++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3667789999999999999976 588899998766554566789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +++|.+++.... ..+++.++..++.|++.+|.|||+   .+++||||+|+||++++++.++|+|||.+........   
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            999999985432 579999999999999999999999   9999999999999999999999999999876433211   


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...........       ...........       
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~-------  219 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-------IATNGPPGLRN-------  219 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-------HHhcCCCCcCc-------
Confidence            2345678899999999988899999999999999999999999875422111110       00011111111       


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       701 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .......+.+++.+|++.+|.+|||+.|++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11124678999999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=316.01  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=202.4

Q ss_pred             CCccceEeeeCceEEEEEEECCCc-EEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRDNT-KVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~~~-~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      |.+...||.|+||.||+|+.++.. ..|.|.+...+....++|+-|++||..+.||+||+|++.+...+.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            445567999999999999987533 4466777777788899999999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |-.+..+... ...|++.++.-+|.|++.+|.|||+   ++|||||||+.|||++-+|.++|+|||.+-...  ......
T Consensus       114 GAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkR  187 (1187)
T KOG0579|consen  114 GAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKR  187 (1187)
T ss_pred             chHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch--hHHhhh
Confidence            9998887543 4569999999999999999999999   999999999999999999999999999975421  222233


Q ss_pred             ccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          622 TGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      ....||+.|||||+.+     ..+|+.++||||||++|.||..+.+|.....+..      ......+.+      .|.|
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR------VllKiaKSe------PPTL  255 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSE------PPTL  255 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH------HHHHHhhcC------CCcc
Confidence            4578999999999874     5799999999999999999999998865332211      111111111      1112


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        --+......+.+++.+||..||..||++++++++
T Consensus       256 --lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  256 --LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             --cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence              1134567789999999999999999999999864

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-34  Score=302.30  Aligned_cols=261  Identities=24%  Similarity=0.278  Sum_probs=197.3

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      |+..+.||+|++|.||+|... ++..|++|+.....  ......+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            456778999999999999965 68999999865432  223467889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      + ++|.+++.......+++..++.++.|+++||+|||+   ++++||||+|+||++++++.++|+|||+++.....  ..
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VR  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cc
Confidence            5 689999855444579999999999999999999998   89999999999999999999999999998753221  11


Q ss_pred             eeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc--------Ccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK--------GMLEH  690 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--------~~~~~  690 (803)
                      ......++..|+|||++.+. .++.++||||||+++|||++|+.||........  +..........        ..+.+
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence            12233568899999988654 578899999999999999999999864432111  11111000000        00000


Q ss_pred             -------ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          691 -------IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       691 -------i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                             ...+.. ..........+.+++.+|++.+|.+||++.|++++
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                   000000 11122334678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1e-33  Score=303.78  Aligned_cols=265  Identities=23%  Similarity=0.265  Sum_probs=197.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeecc--ceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~lV  535 (803)
                      ++|...+.||+|+||.||+|..+ +++.+++|......  ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46777889999999999999976 47889999865432  22234678899999999999999999998777  889999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++ +|.+++... ...+++.+++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++.....
T Consensus        85 ~e~~~~-~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcCc-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999974 898888442 2368999999999999999999999   89999999999999999999999999998764322


Q ss_pred             CCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhH-H---------HHHHH---
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL-A---------EWAMQ---  681 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~---------~~~~~---  681 (803)
                      .  .......++..|+|||.+.+. .++.++|+||||+++|||++|+.||........... .         .|...   
T Consensus       160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         160 L--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             c--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            1  112234568899999998754 468899999999999999999999875432211100 0         01000   


Q ss_pred             -HhhcCccccccCcccccCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          682 -WQKKGMLEHIIDPQLIGKINLD-SLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       682 -~~~~~~~~~i~d~~l~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       ..............+...++.. ..+.+.+++.+||+.+|++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence             0000001111111111122222 35678899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.4e-34  Score=301.55  Aligned_cols=253  Identities=25%  Similarity=0.346  Sum_probs=201.5

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +|+..+.||+|++|.||++..+ +++.+++|++.... ....+++.+|++++++++||||+++++.+...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5677789999999999999976 47889999865543 334567899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.... ..+++..+..++.|++.||+|||+  ..+++|+||||+||++++++.+||+|||++......    
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~----  154 (265)
T cd06605          82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----  154 (265)
T ss_pred             CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence            9999999985432 678999999999999999999996  468999999999999999999999999998653211    


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ....+.........      .+    .
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~------~~----~  223 (265)
T cd06605         155 LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP------PP----R  223 (265)
T ss_pred             HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC------CC----C
Confidence            1112567889999999999999999999999999999999999986442111 11111111111110      00    1


Q ss_pred             CCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          700 INL-DSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       700 ~~~-~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ... .....+.+++.+|+..+|.+||++.+++.+
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            111 145678999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.7e-34  Score=304.33  Aligned_cols=254  Identities=26%  Similarity=0.327  Sum_probs=194.5

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|.....||+|+||.||++... +++.+|+|...... ......+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3445568999999999999965 47899999865432 234567899999999996 99999999999999999999999


Q ss_pred             cCCCchhh---hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          539 MEKGPLKK---HLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       539 ~~~gsL~~---~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      +.. +|.+   .+.......+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||+++.... 
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc-
Confidence            864 4444   3333344679999999999999999999996  24899999999999999999999999999865321 


Q ss_pred             CCCceeccccCCCcccCccccccC---cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQ---QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                        ........++..|+|||.+.+.   .++.++|||||||++|||++|+.||.....     ..+-..+... +     .
T Consensus       161 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~-----~  227 (288)
T cd06616         161 --SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-G-----D  227 (288)
T ss_pred             --CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-C-----C
Confidence              1112234578899999999765   689999999999999999999999864321     1111111110 0     1


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+.+........+..+.+++.+|++.+|.+|||+.+|+++
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1222222223456688999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-34  Score=312.36  Aligned_cols=263  Identities=25%  Similarity=0.322  Sum_probs=196.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeecc-----cee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ-----SEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~  532 (803)
                      .++|...++||+|+||.||+|+.. +++.||+|+..... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467889999999999999999864 58899999875432 23456788999999999999999999987544     357


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++|+||+.+ +|.+++   ....+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~-~l~~~~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMET-DLYKLI---KTQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhccc-CHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            999999975 888777   33569999999999999999999999   89999999999999999999999999998753


Q ss_pred             CCCCC-CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc---Cc
Q 042150          613 PCLDE-THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK---GM  687 (803)
Q Consensus       613 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~  687 (803)
                      ..... ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........   .+.......   +.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~~~~  233 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPSQED  233 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCCHHH
Confidence            32111 111223467899999998754 56899999999999999999999998643322111   011110000   00


Q ss_pred             cccccCccc---------ccC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          688 LEHIIDPQL---------IGK-----INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       688 ~~~i~d~~l---------~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...+.+...         ...     ..+.....+.+++.+||+.+|.+|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000         000     011234668899999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=305.33  Aligned_cols=267  Identities=21%  Similarity=0.243  Sum_probs=196.3

Q ss_pred             CCCccceEeeeCceEEEEEEECC---CcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeecc--ceee
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD---NTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEMI  533 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~  533 (803)
                      .|...+.||+|+||.||+|....   +..||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            36777899999999999999754   7899999876532   34456788999999999999999999999888  7899


Q ss_pred             EEEEecCCCchhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc----CCcEEEeee
Q 042150          534 LVYEYMEKGPLKKHLYG---PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE----NYVSKVADF  606 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~----~~~~kl~DF  606 (803)
                      +||||+++ +|.+++..   .....+++..++.++.|++.||+|||+   .+++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 66666532   122468999999999999999999998   89999999999999999    999999999


Q ss_pred             ccccCCCCCCC-CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhh-------hhhHHH
Q 042150          607 GLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE-------QVNLAE  677 (803)
Q Consensus       607 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-------~~~l~~  677 (803)
                      |+++....... ........++..|+|||.+.+ ..++.++|||||||+||||++|+.||.......       ...+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99876432221 112233467889999998876 468899999999999999999999987443221       001111


Q ss_pred             HHHHHhh-----------cCccccccCcccccCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          678 WAMQWQK-----------KGMLEHIIDPQLIGKIN---------L--DSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       678 ~~~~~~~-----------~~~~~~i~d~~l~~~~~---------~--~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ....+..           ........+......++         .  .....+.+++.+||+.+|++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1110000           00000000000000011         0  234568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.1e-34  Score=299.45  Aligned_cols=247  Identities=26%  Similarity=0.294  Sum_probs=201.4

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      +|...+.||.|+||.||++..+ +++.+++|......   ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4777889999999999999976 48899999865432   2346789999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|.+++..  ...+++.++..++.|+++||.|||+   ++++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            9999999999943  3579999999999999999999998   899999999999999999999999999987643211 


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......    .++.......          ..
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~  218 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------AD  218 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------cc
Confidence              2234567889999999998889999999999999999999999987543321    1111111110          01


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSM--GDVL  730 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~--~evl  730 (803)
                      ...+...+..+.+++.+||+.+|.+||+.  .|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            12233345788999999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=300.65  Aligned_cols=264  Identities=25%  Similarity=0.286  Sum_probs=197.6

Q ss_pred             CCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeecc--ceeeEEEE
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEMILVYE  537 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~lV~E  537 (803)
                      |...+.||+|+||.||+|...+ ++.+++|+.....  ....+.+.+|++++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            4566789999999999999764 7899999876543  33346788999999999999999999999887  88999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++ +|.+++... ...+++.+++.++.|+++||+|||+   .+++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9985 888888443 2578999999999999999999999   8999999999999999999999999999876433221


Q ss_pred             CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCc---c-----
Q 042150          618 THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM---L-----  688 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~-----  688 (803)
                       .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......................   .     
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence             11233456788999998764 4678999999999999999999999875443222111000000000000   0     


Q ss_pred             ------ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 ------EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ------~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                            .......+...+...+...+.+++.+||..+|.+||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                  00000001111111125678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-33  Score=302.50  Aligned_cols=263  Identities=22%  Similarity=0.277  Sum_probs=196.6

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|...+.||+|++|.||+|..+ +++.|++|+.....  ....+.+.+|++++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46788889999999999999975 58899999865432  2334678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-CCcEEEeeeccccCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-NYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla~~~~~~~  616 (803)
                      |++ ++|.+++.......+++..+..++.||+.||+|||+   .+++|+||||+||+++. ++.+||+|||+++..... 
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-  156 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence            996 578888754444457888899999999999999999   89999999999999985 567999999998753221 


Q ss_pred             CCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC---c-----
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG---M-----  687 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~-----  687 (803)
                       ........+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......+...  ... ......   .     
T Consensus       157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~  232 (294)
T PLN00009        157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF--KIF-RILGTPNEETWPGVT  232 (294)
T ss_pred             -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-HHhCCCChhhccccc
Confidence             111233456889999998866 467899999999999999999999986543222111  000 000000   0     


Q ss_pred             -ccccc--Ccc----cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          688 -LEHII--DPQ----LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       688 -~~~i~--d~~----l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       +....  -+.    ......+....++.+++.+|++.+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00000  000    0000112234668899999999999999999999874

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-33  Score=302.70  Aligned_cols=263  Identities=24%  Similarity=0.280  Sum_probs=194.5

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccce-----
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSE-----  531 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~-----  531 (803)
                      ++|+..+.||+|+||.||+|... +++.||+|......  ......+.+|+.++++++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            35788889999999999999975 58899999754432  223467889999999995 6999999999876655     


Q ss_pred             eeEEEEecCCCchhhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-CCcEEEeeec
Q 042150          532 MILVYEYMEKGPLKKHLYGPD---RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-NYVSKVADFG  607 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DFG  607 (803)
                      .++||||+++ +|.+++....   ...+++..++.++.||++||.|||+   .+++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 7888874322   3468999999999999999999999   89999999999999998 8999999999


Q ss_pred             cccCCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC
Q 042150          608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG  686 (803)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (803)
                      +++.....  ........+++.|+|||.+.+ ..++.++||||||+++|||++|..||......+.  +.... ......
T Consensus       157 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~-~~~~~~  231 (295)
T cd07837         157 LGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIF-KLLGTP  231 (295)
T ss_pred             cceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHH-HHhCCC
Confidence            98753221  111223356788999998865 4678999999999999999999999864322111  00000 000000


Q ss_pred             c---ccccc---C----c----ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 M---LEHII---D----P----QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 ~---~~~i~---d----~----~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .   .....   +    +    .......+.....+.+++.+||..+|.+||++.|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0   00000   0    0    00000112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-33  Score=299.66  Aligned_cols=264  Identities=21%  Similarity=0.271  Sum_probs=198.3

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +|+..+.||+|++|.||+|+.. ++..||+|+...... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4777889999999999999975 488999998655433 33567889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          540 EKGPLKKHLYGPD-RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       540 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      ++ +|.+++.... ...+++.+++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.....  .
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--V  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--c
Confidence            85 8888874322 3568999999999999999999998   89999999999999999999999999998753211  1


Q ss_pred             ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhH-HHHH--------HHHhhcCcc
Q 042150          619 HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL-AEWA--------MQWQKKGML  688 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~--------~~~~~~~~~  688 (803)
                      .......++..|++||.+.+ ..++.++|||||||++|||++|+.||......+.... .+..        .........
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            11223456889999998865 4578899999999999999999999875433221110 0000        000000000


Q ss_pred             cc----ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EH----IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~----i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..    ..+.. .....+.....+.+++.+|++.+|.+||++.+++++
T Consensus       235 ~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         235 KPTFPRYPPQD-LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cccccCCChHH-HHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00    00000 011112335678899999999999999999999853

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-33  Score=300.15  Aligned_cols=243  Identities=22%  Similarity=0.279  Sum_probs=187.9

Q ss_pred             eEeeeCceEEEEEEEC-CCcEEEEEEcCCCC---CCChHHHHHHHHHHHh---ccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          468 IIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS---RQGLPEFQTEITVLSK---IRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~---l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      +||+|+||.||++... +++.+|+|......   ......+.+|..++..   .+||||+.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 47899999764332   1222334555544443   469999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|+|.+++.  ....+++..+..++.|++.||+|||+   .+++||||||+|||+++++.++|+|||++......    .
T Consensus        81 ~~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~  151 (279)
T cd05633          81 GGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K  151 (279)
T ss_pred             CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence            999999884  34569999999999999999999999   89999999999999999999999999998653221    1


Q ss_pred             eccccCCCcccCccccc-cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....++..|+|||.+. +..++.++|||||||++|||++|+.||..........+.    ....      ...    ..
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~------~~~----~~  217 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL------TVN----VE  217 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH----HHhh------cCC----cC
Confidence            22346899999999986 456899999999999999999999998644322111111    1000      001    12


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWNL  733 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L  733 (803)
                      .+......+.+++.+||..+|.+||     ++.+++++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence            2334456789999999999999999     599998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.2e-33  Score=303.29  Aligned_cols=267  Identities=22%  Similarity=0.308  Sum_probs=194.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccc-------
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS-------  530 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-------  530 (803)
                      ++|...+.||+|+||.||+|... +++.||||.+....  ......+.+|++++++++||||++++++|....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            46888899999999999999975 58899999865332  222345678999999999999999999986544       


Q ss_pred             -eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          531 -EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       531 -~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                       ..++||||+.+ +|.+.+.. ....+++.+++.++.|++.||+|||+   ++++|+||||+||+++.++.+||+|||++
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence             45999999975 78877743 23468999999999999999999999   89999999999999999999999999998


Q ss_pred             cCCCCCCCC--ceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC
Q 042150          610 RSGPCLDET--HVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG  686 (803)
Q Consensus       610 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (803)
                      .........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+......................
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            754322111  112234578899999988664 47889999999999999999999987544332222111111000000


Q ss_pred             ccccc-----cC----cc-----cccCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 MLEHI-----ID----PQ-----LIGKI-NLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 ~~~~i-----~d----~~-----l~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .....     .+    +.     ..... .......+.+++.+||..+|.+|||+++++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            00000     00    00     00000 00113456799999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.4e-33  Score=301.99  Aligned_cols=248  Identities=29%  Similarity=0.385  Sum_probs=196.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC---ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ---GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ..|...+.||+|+||.||+|... +++.|++|........   ..+++.+|+++++.++||||+++.++|...+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            44777889999999999999975 5889999986533222   2356889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||++ |+|.+++.. ....+++.++..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||+++..... 
T Consensus        95 e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          95 EYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9997 577766632 23468999999999999999999998   89999999999999999999999999998753221 


Q ss_pred             CCceeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          617 ETHVSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                           ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+.........      .......      .
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~~~~~------~  231 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQND------S  231 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHHhcCC------C
Confidence                 2345788999999874   467889999999999999999999998644322110      0100000      0


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      +.   .........+.+++.+||+.+|.+||++.+++.+..
T Consensus       232 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         232 PT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             CC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence            11   112234567899999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.6e-33  Score=301.81  Aligned_cols=265  Identities=24%  Similarity=0.277  Sum_probs=197.3

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccc----
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS----  530 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~----  530 (803)
                      ...++|+..+.||+|+||.||+|..+ +++.|++|++....  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678888999999999999999986 47899999865432  233457789999999999999999999986654    


Q ss_pred             ------eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEe
Q 042150          531 ------EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA  604 (803)
Q Consensus       531 ------~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~  604 (803)
                            .+++|+||+++ +|...+... ...+++.+++.++.|++.||+|||+   .+|+|+||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999986 676666432 4468999999999999999999999   899999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHh
Q 042150          605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ  683 (803)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  683 (803)
                      |||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+..  .. .....
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~--~~-~~~~~  234 (302)
T cd07864         159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL--EL-ISRLC  234 (302)
T ss_pred             cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH--HH-HHHHh
Confidence            9999876432221 11222346778999998864 45788999999999999999999998743322111  11 11110


Q ss_pred             hcC---cccccc--------Cc------ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          684 KKG---MLEHII--------DP------QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       684 ~~~---~~~~i~--------d~------~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...   ....+.        ++      ..... ....+..+.+++.+||+.+|.+||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            000   000000        00      00000 01235678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.2e-33  Score=303.66  Aligned_cols=265  Identities=26%  Similarity=0.295  Sum_probs=196.7

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeecc--ceeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~l  534 (803)
                      .++|+..+.||+|+||.||+|... +++.||+|+......  .....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            356888899999999999999975 488999998653322  2234567899999999999999999998654  56899


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+.+ +|.+++... ...+++.+++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9999975 788887432 3569999999999999999999999   8999999999999999999999999999876432


Q ss_pred             CCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc---Ccc--
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK---GML--  688 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~--  688 (803)
                      ..  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.....   ......   ...  
T Consensus       161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~~  235 (309)
T cd07845         161 PA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI---IQLLGTPNESIWPG  235 (309)
T ss_pred             cc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChhhchh
Confidence            21  11222345788999999865 56889999999999999999999998754332221110   010000   000  


Q ss_pred             -------ccc-cCcccccCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          689 -------EHI-IDPQLIGKIN---LDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       689 -------~~i-~d~~l~~~~~---~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                             ... ..........   ....+.+.+++.+||+.||++|||+.|++++-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~  292 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY  292 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence                   000 0000000000   113567789999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-33  Score=309.94  Aligned_cols=267  Identities=24%  Similarity=0.333  Sum_probs=197.6

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeecc--cee
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ--SEM  532 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~--~~~  532 (803)
                      ..++|...+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567888889999999999999975 5788999986432  223345678899999999 999999999998643  468


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||++ ++|.+++..   ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999997 599988843   278999999999999999999999   89999999999999999999999999999764


Q ss_pred             CCCCCC---ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH--------
Q 042150          613 PCLDET---HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM--------  680 (803)
Q Consensus       613 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------  680 (803)
                      ......   .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.........        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            332211   12233467889999998764 567889999999999999999999986443222111000000        


Q ss_pred             HHhhcCccccccC----ccc--ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          681 QWQKKGMLEHIID----PQL--IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       681 ~~~~~~~~~~i~d----~~l--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..........+++    ...  ...........+.+++.+||+.+|.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000000000110    000  001111245678999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.2e-33  Score=297.82  Aligned_cols=258  Identities=24%  Similarity=0.246  Sum_probs=192.6

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhcc-CCCeeeEEeEeecc--ceeeEEEE
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQ--SEMILVYE  537 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~--~~~~lV~E  537 (803)
                      |...+.||+|+||.||+|... +++.+|+|+..... ........+|+.++.++. ||||+++++++.+.  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456678999999999999965 58899999865432 222334567999999985 99999999999877  88999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |++ |+|.+++... ...+++.+++.++.|++.||+|||+   .+++||||||+||+++. +.+||+|||+++.....  
T Consensus        81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--  152 (282)
T cd07831          81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--  152 (282)
T ss_pred             cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC--
Confidence            997 5888877432 3568999999999999999999999   89999999999999999 99999999999764321  


Q ss_pred             CceeccccCCCcccCccccc-cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHh-----------hc
Q 042150          618 THVSTGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ-----------KK  685 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-----------~~  685 (803)
                       .......++..|+|||.+. +..++.++|||||||++|||++|+.||......+.   ..+.....           ..
T Consensus       153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         153 -PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             -CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcc
Confidence             1112345788999999764 45678899999999999999999999965432221   11111110           00


Q ss_pred             CccccccCccccc----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          686 GMLEHIIDPQLIG----KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       686 ~~~~~i~d~~l~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ........+....    ......+..+.+++.+||+.+|.+||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0000000110000    0112346789999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.3e-33  Score=298.50  Aligned_cols=245  Identities=24%  Similarity=0.334  Sum_probs=193.7

Q ss_pred             EeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCch
Q 042150          469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       469 Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      ||+|+||+||++..+ +++.+++|.....   .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 5889999976432   122345678999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccc
Q 042150          545 KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV  624 (803)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (803)
                      .+++.......+++.+++.++.|++.||.|||+   .+++||||+|+||++++++.+||+|||+++....   .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence            999965555579999999999999999999999   8999999999999999999999999999875322   1122234


Q ss_pred             cCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHH
Q 042150          625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDS  704 (803)
Q Consensus       625 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  704 (803)
                      .++..|+|||.+.+..++.++|||||||++|+|++|+.||.........  .... .    ....      .....+...
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~-~----~~~~------~~~~~~~~~  221 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EELK-R----RTLE------MAVEYPDKF  221 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HHHH-h----cccc------ccccCCccC
Confidence            5788999999998888999999999999999999999998654321110  0000 0    0000      001122234


Q ss_pred             HHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          705 LKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       705 ~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                      ...+.+++.+||+.+|.+||     ++.+++.+
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            56789999999999999999     66667653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.2e-33  Score=295.92  Aligned_cols=243  Identities=22%  Similarity=0.241  Sum_probs=195.1

Q ss_pred             EeeeCceEEEEEEECC-CcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCch
Q 042150          469 IGSGGFGMVYKGVLRD-NTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       469 Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      ||.|++|.||+++... ++.+++|......   ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999764 7899999865332   23346799999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccc
Q 042150          545 KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV  624 (803)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (803)
                      .+++.+  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||+++......   .....
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            999943  3458999999999999999999999   999999999999999999999999999987643221   12234


Q ss_pred             cCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHH
Q 042150          625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDS  704 (803)
Q Consensus       625 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  704 (803)
                      .++..|++||.+.+..++.++|+||||+++|||++|..|+.......    .+......         +......++...
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~~  219 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDIL---------KGNGKLEFPNYI  219 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHh---------ccCCCCCCCccc
Confidence            67889999999988889999999999999999999999987543211    11111111         101111222233


Q ss_pred             HHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042150          705 LKKFGETAEKCLADYGVDRPS-----MGDVLWN  732 (803)
Q Consensus       705 ~~~l~~li~~cl~~~p~~RPs-----~~evl~~  732 (803)
                      ...+.+++.+||+.+|.+||+     +.|++++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            567899999999999999999     6776653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=294.32  Aligned_cols=251  Identities=23%  Similarity=0.315  Sum_probs=197.7

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC-----CCCChHHHHHHHHHHHhccCCCeeeEEeEeecc--cee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG-----SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEM  532 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~  532 (803)
                      .+|...+.||+|+||.||+|... ++..|++|.....     ..+....+.+|++++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888899999999999999965 4889999975322     123345789999999999999999999998654  468


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++|+||+++++|.+++.  ....+++...++++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~--~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLK--AYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            89999999999999984  33458899999999999999999998   89999999999999999999999999999754


Q ss_pred             CCCCC-CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          613 PCLDE-THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       613 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ..... ........++..|+|||.+.+..++.++|||||||++|||++|+.||.........      .+...       
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-------  223 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI------FKIAT-------  223 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH------HHHHc-------
Confidence            32111 11112346889999999999888999999999999999999999998643222111      11110       


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        .......+......+.+++.+|+. +|..||+..+++.+
T Consensus       224 --~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         224 --QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             --CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence              011122344455778999999999 57999999988754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-33  Score=324.16  Aligned_cols=270  Identities=20%  Similarity=0.248  Sum_probs=188.4

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEECC--CcEEEEEE--------------c---CCCCCCChHHHHHHHHHHHhccCCC
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLRD--NTKVAVKR--------------G---VPGSRQGLPEFQTEITVLSKIRHRH  518 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~--~~~vavK~--------------~---~~~~~~~~~~f~~E~~~l~~l~Hpn  518 (803)
                      ...++|...+.||+|+||+||++.++.  +...++|.              .   ..........+.+|+++|++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999987543  11111110              0   0111223456889999999999999


Q ss_pred             eeeEEeEeeccceeeEEEEecCCCchhhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE
Q 042150          519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPD---RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL  595 (803)
Q Consensus       519 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl  595 (803)
                      |+++++++...+..++|+|++. ++|.+++....   .......++..|+.||+.||+|||+   ++|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence            9999999999999999999985 47777764321   1223456778899999999999999   899999999999999


Q ss_pred             ccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCC-CCcchhhhhhh
Q 042150          596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTA-VDPLLAREQVN  674 (803)
Q Consensus       596 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~  674 (803)
                      +.++.+||+|||+++..... .........||..|+|||++.+..++.++|||||||+||||++|..+ +..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            99999999999999764321 11122345789999999999999999999999999999999998754 33221111111


Q ss_pred             HHHHHH-----------------HHhhcCccccccC--cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          675 LAEWAM-----------------QWQKKGMLEHIID--PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       675 l~~~~~-----------------~~~~~~~~~~i~d--~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      +.+...                 .+...........  +.+..  .......+.+++.+||+.||.+|||+.|++++-.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            111110                 0000000000000  00000  0012345778899999999999999999997533

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3e-33  Score=308.50  Aligned_cols=264  Identities=21%  Similarity=0.269  Sum_probs=198.3

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeecc------
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ------  529 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------  529 (803)
                      ..++|...+.||+|+||.||+|... +++.||+|.+...  ......++.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999965 5889999986532  223345788999999999999999999988543      


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      ...++||||+.+ +|.+.+..    .+++.++..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            357999999964 88887732    28899999999999999999999   89999999999999999999999999999


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhh-H--------HHHH-
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN-L--------AEWA-  679 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l--------~~~~-  679 (803)
                      +....   ........++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... +        .++. 
T Consensus       166 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         166 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eeCCC---CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            76322   111233457889999999999999999999999999999999999986443211100 0        0000 


Q ss_pred             ------HHHhhcC------ccccccCcc----cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          680 ------MQWQKKG------MLEHIIDPQ----LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       680 ------~~~~~~~------~~~~i~d~~----l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                            .......      ...++....    ............+.+++.+||+.||++|||+.|++++-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~  312 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP  312 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence                  0000000      000111110    00111123456788999999999999999999999763

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=329.89  Aligned_cols=261  Identities=27%  Similarity=0.437  Sum_probs=208.3

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC--------CcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeec
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD--------NTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEE  528 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~  528 (803)
                      ..++....+.||+|.||.|++|....        ...||||.++... ..+.+.+..|+++|+.+ +||||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            34444555599999999999998541        3579999876543 34578899999999999 69999999999999


Q ss_pred             cceeeEEEEecCCCchhhhccCCC------------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEE
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGPD------------R--TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNIL  594 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NIL  594 (803)
                      ++..++|+||+.+|+|.++|+..+            .  ..++..+++.++.|||.||+||++   .+++||||.++|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEE
Confidence            999999999999999999996543            0  238999999999999999999999   88999999999999


Q ss_pred             EccCCcEEEeeeccccCCCCCCCCceeccc-cCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhh
Q 042150          595 LDENYVSKVADFGLSRSGPCLDETHVSTGV-KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQ  672 (803)
Q Consensus       595 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~  672 (803)
                      +.++..+||+|||+|+.....+........ .....|||||.+....|+.|+|||||||+||||++ |..|+........
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~  530 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE  530 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence            999999999999999965543333222111 14667999999999999999999999999999998 6677764221111


Q ss_pred             hhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          673 VNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       673 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                        +.    ++.++|..         -+.+..+..++.++++.||+.+|++||+..++++.++..+
T Consensus       531 --l~----~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  531 --LL----EFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             --HH----HHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence              11    12333321         1234456778899999999999999999999999999853

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-33  Score=309.37  Aligned_cols=264  Identities=22%  Similarity=0.298  Sum_probs=197.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeecc-----ce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ-----SE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~  531 (803)
                      .++|...+.||+|+||.||+|... +++.||||+....  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            456888899999999999999964 5889999986543  233355778899999999999999999988644     35


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .++||||+. ++|.+++.  ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            799999996 68988884  34569999999999999999999999   8999999999999999999999999999976


Q ss_pred             CCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH--------HH
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM--------QW  682 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~  682 (803)
                      .....  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............-..        ..
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            43221  12233457889999998864 568899999999999999999999986543211111000000        00


Q ss_pred             hhcCcccc-------ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          683 QKKGMLEH-------IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       683 ~~~~~~~~-------i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ........       ..++... .........+.+++.+||+.+|++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00000000       0000000 0112345678999999999999999999999987

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.7e-33  Score=302.31  Aligned_cols=249  Identities=27%  Similarity=0.352  Sum_probs=197.2

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC---CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR---QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      |...+.||+|+||.||+|+.. ++..+|+|++.....   ...+++.+|++++++++|||+++++++|.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667778999999999999965 578999998654322   2345788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +.+ +|.+.+.. ....+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++.....    
T Consensus       107 ~~g-~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----  177 (317)
T cd06635         107 CLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----  177 (317)
T ss_pred             CCC-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence            974 77777643 24568999999999999999999999   8999999999999999999999999999865322    


Q ss_pred             ceeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          619 HVSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                        .....++..|+|||.+.   .+.++.++|||||||++|||++|+.|+........  +.    .....+.        
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~----~~~~~~~--------  241 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY----HIAQNES--------  241 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HH----HHHhccC--------
Confidence              12346788999999973   46789999999999999999999999864322111  11    1111110        


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                       ...........+.+++.+|++.+|.+||++.++++++....
T Consensus       242 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         242 -PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             -CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence             00111234567899999999999999999999998766543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.3e-33  Score=299.81  Aligned_cols=244  Identities=22%  Similarity=0.340  Sum_probs=196.7

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCchh
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLK  545 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~  545 (803)
                      .+||+|+||.||++..+ +++.||+|+...........+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            47999999999999975 58899999875555555677999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceecccc
Q 042150          546 KHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK  625 (803)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  625 (803)
                      +++.   ...+++..+..++.|++.+|+|||+   .+++|+||||+||++++++.++|+|||++......  ........
T Consensus       106 ~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~~~  177 (292)
T cd06657         106 DIVT---HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLV  177 (292)
T ss_pred             HHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccc--cccccccc
Confidence            9873   3458999999999999999999999   89999999999999999999999999998653321  11223356


Q ss_pred             CCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHH
Q 042150          626 GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL  705 (803)
Q Consensus       626 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~  705 (803)
                      ++..|+|||.+.+..++.++|+||||+++|||++|..|+......+...   ....    .     ..+.+..  .....
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~---~~~~----~-----~~~~~~~--~~~~~  243 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRD----N-----LPPKLKN--LHKVS  243 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh----h-----CCcccCC--cccCC
Confidence            7889999999988889999999999999999999999986433221111   0100    0     0011100  11234


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          706 KKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       706 ~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..+.+++.+||..+|.+||++.+++++
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            567899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.4e-33  Score=308.71  Aligned_cols=270  Identities=20%  Similarity=0.264  Sum_probs=200.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeec----ccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEE----QSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~----~~~~  532 (803)
                      ..+|...+.||+|+||.||+|..+ +++.|++|++....  ......+.+|+.+|++++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888889999999999999965 58899999865432  2345678899999999999999999998753    3568


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+. |+|.+++.  ....+++..+..++.||+.||+|||+   .+++||||||+||++++++.+||+|||+++..
T Consensus        84 ~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999996 68999884  34559999999999999999999999   89999999999999999999999999998753


Q ss_pred             CCCCCC--ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHH--------HHH
Q 042150          613 PCLDET--HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW--------AMQ  681 (803)
Q Consensus       613 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~  681 (803)
                      ......  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............        ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            221111  11223468889999999865 5689999999999999999999999965432221110000        000


Q ss_pred             HhhcCccccccCc-ccc-----cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          682 WQKKGMLEHIIDP-QLI-----GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       682 ~~~~~~~~~i~d~-~l~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ......+.+..+. ...     .......+..+.+++.+||+.+|.+||++.+++.+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~  297 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL  297 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence            0000000000000 000     00112345778999999999999999999999986543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=297.18  Aligned_cols=247  Identities=21%  Similarity=0.307  Sum_probs=204.6

Q ss_pred             cCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .-|+..+.||+|.|..|-+|++ -.|.+||||++....-  .....+..|++.|+.++|||||+|+.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            3466667899999999999984 3699999998655432  234568899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE-ccCCcEEEeeeccccCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL-DENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl-~~~~~~kl~DFGla~~~~~~~  616 (803)
                      .=.+|+|.++|.+.. ..+.+....+++.||..++.|+|+   ..+|||||||+||.+ .+-|-+||.|||++.....  
T Consensus        98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P--  171 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP--  171 (864)
T ss_pred             ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC--
Confidence            999999999996543 458899999999999999999999   999999999999877 5678999999999876433  


Q ss_pred             CCceeccccCCCcccCccccccCcCCC-cceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                       .......+|++.|-|||++.+..|+. +.||||||||||.|+||+.||+.....+.               +..|+|=+
T Consensus       172 -G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCK  235 (864)
T KOG4717|consen  172 -GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCK  235 (864)
T ss_pred             -cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhccc
Confidence             23345678999999999999998875 68999999999999999999975433332               22233322


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLW  731 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  731 (803)
                      .  ..+.....+.++||.+||..||.+|.+.++|+.
T Consensus       236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            2  345667788999999999999999999999865

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=311.52  Aligned_cols=269  Identities=26%  Similarity=0.379  Sum_probs=203.7

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccc------eeeE
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS------EMIL  534 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~l  534 (803)
                      +.....||+|+||.||+|+.+ .|+.||||.+... .....+...+|+++|++|+|||||++++.-++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            334558999999999999954 5999999986654 3445677899999999999999999999875544      5689


Q ss_pred             EEEecCCCchhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc--cCC--cEEEeeeccc
Q 042150          535 VYEYMEKGPLKKHLYGPD-RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD--ENY--VSKVADFGLS  609 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~--~~kl~DFGla  609 (803)
                      |||||.+|+|+..|.... ...|++.+.+.+..+++.||.|||+   ++|+||||||.||++-  ++|  ..||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999996643 4569999999999999999999998   9999999999999993  333  4699999999


Q ss_pred             cCCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      |...   .........||..|++||.+.+ +.|+...|.|||||++||.+||..||.+........-..|.....+....
T Consensus       172 rel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  172 RELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            9744   3346677899999999999985 88999999999999999999999999877654332222232222222111


Q ss_pred             ccccCccccc------------CCCHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHHH
Q 042150          689 EHIIDPQLIG------------KINLDSLKKFGETAEKCLADYGVDRP--SMGDVLWNLEYAL  737 (803)
Q Consensus       689 ~~i~d~~l~~------------~~~~~~~~~l~~li~~cl~~~p~~RP--s~~evl~~L~~~~  737 (803)
                      .-...+...+            .........+...+..+|..+|++|.  ...+....+..++
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence            1111222211            11233445666778888888999998  5555555555444

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=298.15  Aligned_cols=260  Identities=23%  Similarity=0.284  Sum_probs=198.9

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC--ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ--GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      |...+.||+|++|.||++... +++.+++|+.......  ....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            455678999999999999975 5888999986544322  3567889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++ +|.+++... ...+++.+++.++.|+++||.|||+   .+++|+||||+||++++++.+||+|||.+.......  .
T Consensus        81 ~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~  153 (283)
T cd05118          81 DT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R  153 (283)
T ss_pred             CC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence            75 888887442 2579999999999999999999999   999999999999999999999999999987643321  1


Q ss_pred             eeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc---CccccccC--
Q 042150          620 VSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK---GMLEHIID--  693 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~i~d--  693 (803)
                      ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+.....   ......   .....+.+  
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI---FRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCchHhcccchhhh
Confidence            22234578889999998876 7899999999999999999999998654332211110   000000   00000000  


Q ss_pred             -------cc----cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          694 -------PQ----LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       694 -------~~----l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                             +.    ...........++.+++.+||+.+|.+||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                   00    0011123456789999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-33  Score=296.42  Aligned_cols=261  Identities=23%  Similarity=0.258  Sum_probs=195.2

Q ss_pred             CCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCC--CChHHHHHHHHHHHhc---cCCCeeeEEeEeeccce-----
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSR--QGLPEFQTEITVLSKI---RHRHLVSLVGYCEEQSE-----  531 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l---~HpnIv~l~g~~~~~~~-----  531 (803)
                      |+..+.||+|+||.||+|+.+. ++.+|+|+......  .....+.+|+.++.++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            4567799999999999999865 88999998653322  2234567788877766   59999999999987776     


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .+++|||+.+ +|.+++.......+++.+++.++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999974 89888855444569999999999999999999999   8999999999999999999999999999876


Q ss_pred             CCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc--
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE--  689 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--  689 (803)
                      ....   .......++..|+|||.+.+..++.++|||||||++|||++|+.|+......+.  +..+...........  
T Consensus       157 ~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         157 YSFE---MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             ccCC---cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcC
Confidence            4221   111233578899999999999999999999999999999999998864332221  111111110000000  


Q ss_pred             -------cccCcccc---cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          690 -------HIIDPQLI---GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       690 -------~i~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                             ........   ..........+.+++.+||+.+|.+||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                   00000000   11112345678899999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6e-33  Score=290.83  Aligned_cols=250  Identities=26%  Similarity=0.401  Sum_probs=204.0

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|...+.||+|+||.||++... ++..+++|+......  ...+++.+|++++++++|||++++.+.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4677789999999999999975 588999998665433  4566789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          539 MEKGPLKKHLYGPD--RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       539 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      +++++|.+++....  ...+++.+++.++.+++.||.|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999995432  4679999999999999999999999   899999999999999999999999999987643221


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                        .......+++.|+|||.+.+..++.++||||||+++++|++|+.|+......+      ....... ..         
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~~---------  219 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKILK-GQ---------  219 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHhc-CC---------
Confidence              12233467889999999999999999999999999999999999986443211      1111111 11         


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ....+......+.+++.+||..+|.+||++.+++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111222345678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-33  Score=290.04  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=201.1

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|...+.||+|++|.||++... +++.+++|.......  ...+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            3667789999999999999875 478899998665543  3567899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++++|.+++..  ...+++..+..++.|++.+|.|||+   .+++||||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (254)
T cd06627          81 AENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-  154 (254)
T ss_pred             CCCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence            999999999843  3679999999999999999999998   8999999999999999999999999999876432221 


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                       ......++..|+|||.+.+...+.++||||||+++|+|++|+.|+........    .|..  . ...         ..
T Consensus       155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~~--~-~~~---------~~  217 (254)
T cd06627         155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFRI--V-QDD---------HP  217 (254)
T ss_pred             -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHH--h-ccC---------CC
Confidence             12334678899999999888889999999999999999999999864332111    1110  0 000         01


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLW  731 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  731 (803)
                      ..+......+.+++.+||..+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            122233567889999999999999999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.5e-33  Score=292.69  Aligned_cols=250  Identities=20%  Similarity=0.219  Sum_probs=192.1

Q ss_pred             hhHHHHhcCCCccceE--eeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeecc
Q 042150          454 TDLQTATNNFDKNLII--GSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ  529 (803)
Q Consensus       454 ~~l~~~~~~f~~~~~L--g~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~  529 (803)
                      .+.....++|...+.+  |+|+||.||++..+ ++..+++|.........     .|+.....+ +||||+++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444555666766665  99999999999965 47788888754332111     123333323 699999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC-cEEEeeecc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY-VSKVADFGL  608 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFGl  608 (803)
                      +..++||||+++++|.+++..  ...+++.+++.++.|+++||.|||+   .+++||||||+||+++.++ .++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            999999999999999999943  3479999999999999999999999   8999999999999999988 999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ++....      .....++..|+|||++.+..++.++|||||||++|||++|+.||..... +......+........  
T Consensus       157 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~--  227 (267)
T PHA03390        157 CKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQQKKL--  227 (267)
T ss_pred             ceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhhcccC--
Confidence            875321      1224578899999999999999999999999999999999999974322 2222233322211000  


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPS-MGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~~  732 (803)
                                .........+.+++.+||+.+|.+||+ +++++++
T Consensus       228 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        228 ----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             ----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                      111234567899999999999999996 6888753

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.9e-33  Score=302.51  Aligned_cols=263  Identities=23%  Similarity=0.275  Sum_probs=194.2

Q ss_pred             eEeee--CceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          468 IIGSG--GFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       468 ~Lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      .||+|  +||+||++... .++.||+|.......  ...+.+.+|+.+++.++||||++++++|..++..++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            45666  99999999974 689999998654322  23467889999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc---
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH---  619 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~---  619 (803)
                      +|.+++.......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+|++||+.+..........   
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            99999865444568999999999999999999998   899999999999999999999999998653211111000   


Q ss_pred             --eeccccCCCcccCccccccC--cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHH--------------
Q 042150          620 --VSTGVKGSFGYLDPEYFRRQ--QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQ--------------  681 (803)
Q Consensus       620 --~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------------  681 (803)
                        ......++..|+|||++.+.  .++.++|||||||++|||++|+.||.........  ......              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccchh
Confidence              00112345679999999763  5789999999999999999999998754322111  000000              


Q ss_pred             ---------Hh---------hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          682 ---------WQ---------KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       682 ---------~~---------~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                               ..         .......+.+..+...........+.+++.+||+.+|.+|||+.|++++-..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~  311 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF  311 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence                     00         0000001111111122233456788999999999999999999999976543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-33  Score=295.38  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=196.4

Q ss_pred             CCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCC-CChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEEec
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      |...+.||+|++|.||+|+..+ ++.|++|+...... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            4566789999999999999864 78899998654322 22234567999999998 999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                       +|+|.+++.......+++.+++.++.|++.+|.|||+   .+++|+||+|+||++++++.++|+|||+++.....   .
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---P  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCC---C
Confidence             7899998865444578999999999999999999999   89999999999999999999999999998753321   1


Q ss_pred             eeccccCCCcccCccccc-cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhH----------HHHHHHHhhcCcc
Q 042150          620 VSTGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL----------AEWAMQWQKKGML  688 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l----------~~~~~~~~~~~~~  688 (803)
                      ......++..|+|||.+. ...++.++|+||||+++|||++|+.|+......+....          ..|..........
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            122345788999999875 45688999999999999999999998864432221100          0111111000011


Q ss_pred             ccccCccc---ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EHIIDPQL---IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...+....   ...........+.+++.+|++.+|.+||++.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            10000000   000111124678999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.8e-33  Score=299.10  Aligned_cols=254  Identities=24%  Similarity=0.330  Sum_probs=194.4

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC-CCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|...+.||+|+||.||+|..+. ++.||||...... .....++..|+.++.++. ||||++++++|.+....++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567778899999999999999875 8899999865432 223456777888777775 9999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+.+ +|.+++... ...+++..+..++.|+++||+|||+  .++|+||||+|+||++++++.+||+|||++.....   
T Consensus        95 ~~~~-~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~---  167 (296)
T cd06618          95 LMST-CLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---  167 (296)
T ss_pred             ccCc-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccC---
Confidence            9854 676666332 3479999999999999999999996  25899999999999999999999999999875322   


Q ss_pred             CceeccccCCCcccCccccccCc----CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQ----LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ........++..|+|||.+.+..    ++.++||||||+++|||++|+.||........     ........ ....+  
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~-~~~~~--  239 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-----VLTKILQE-EPPSL--  239 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-----HHHHHhcC-CCCCC--
Confidence            11122345788999999987553    88899999999999999999999864321111     11111111 00000  


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                           ........++.+++.+||+.+|.+||++.+++++..
T Consensus       240 -----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         240 -----PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence                 001123467899999999999999999999987644

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.2e-33  Score=292.22  Aligned_cols=248  Identities=26%  Similarity=0.357  Sum_probs=202.4

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|+..+.||+|+||.||++..+ +++.+++|.....  ......++.+|++++++++||||+++.+++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            3667789999999999999865 5788999986543  233456788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          539 MEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       539 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      +++++|.+++..  .....+++..++.++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999843  223568999999999999999999998   89999999999999999999999999999764332 


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                         ......++..|++||.+.+..++.++|+||||+++|||++|+.|+......+.   ..   . ...+.         
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~---~-~~~~~---------  217 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RY---K-VQRGK---------  217 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---H-HhcCC---------
Confidence               22234578899999999999999999999999999999999999875432211   11   1 11111         


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...........+.+++.+|++.+|.+||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            112223455678999999999999999999999865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-33  Score=305.87  Aligned_cols=260  Identities=24%  Similarity=0.322  Sum_probs=192.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeecc------c
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ------S  530 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~  530 (803)
                      .++|.....||+|+||.||+|+.. +++.||||++...  .......+.+|+.++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368888899999999999999964 5889999986543  223345688999999999999999999998654      3


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..++|+||+.. +|..++    ...+++..+..++.|+++||+|||+   .+++||||||+|||++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            46999999964 677665    2358999999999999999999999   899999999999999999999999999987


Q ss_pred             CCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHH--------HH
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWA--------MQ  681 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~  681 (803)
                      ....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...............        .+
T Consensus       166 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         166 HADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            6322     1123456888999999876 56889999999999999999999999754322211100000        00


Q ss_pred             HhhcCccccccC--ccc-ccCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          682 WQKKGMLEHIID--PQL-IGKI---NLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       682 ~~~~~~~~~i~d--~~l-~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ............  +.. ....   .+.....+.+++.+||+.+|.+||++.+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000000  000 0000   01234567899999999999999999999875

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.1e-33  Score=294.47  Aligned_cols=246  Identities=24%  Similarity=0.294  Sum_probs=194.6

Q ss_pred             EeeeCceEEEEEEECC-CcEEEEEEcCCCCC---CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCch
Q 042150          469 IGSGGFGMVYKGVLRD-NTKVAVKRGVPGSR---QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       469 Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      ||+|+||.||+++... ++.+++|.......   ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999875 88999998654432   3456789999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC------C
Q 042150          545 KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE------T  618 (803)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~------~  618 (803)
                      .+++..  ...+++..++.++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||++........      .
T Consensus        81 ~~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLEN--VGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            999943  2378999999999999999999998   9999999999999999999999999999875332211      1


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .......++..|+|||.+.+...+.++||||||+++|||++|+.||......+.      ...... +...    .    
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~----~----  220 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQNILN-GKIE----W----  220 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhc-CCcC----C----
Confidence            122335678899999999888899999999999999999999999865432211      111111 1100    0    


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      .........+.+++.+|++.+|.+||++..+.+.|+
T Consensus       221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            000112567899999999999999999955544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-32  Score=293.62  Aligned_cols=242  Identities=22%  Similarity=0.266  Sum_probs=186.9

Q ss_pred             eEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC---CChHHHHHHHHHH---HhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          468 IIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR---QGLPEFQTEITVL---SKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l---~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      +||+|+||.||++... +++.||+|.......   .....+..|..++   +...||||+.+.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 478999997654321   1122344554443   44579999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|+|.+++.  ....+++.++..++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++.....    .
T Consensus        81 g~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~  151 (278)
T cd05606          81 GGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K  151 (278)
T ss_pred             CCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----C
Confidence            999999884  34579999999999999999999999   89999999999999999999999999998753221    1


Q ss_pred             eccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....|+..|+|||.+.++ .++.++|||||||++|||++|+.||............    .....      ..+    .
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~------~~~----~  217 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLT------MAV----E  217 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhhc------cCC----C
Confidence            2234689999999998754 6899999999999999999999998754222111110    00000      011    1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                      .+......+.+++.+|+..+|.+||     ++.+++++
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            1222356789999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-32  Score=296.13  Aligned_cols=256  Identities=16%  Similarity=0.174  Sum_probs=182.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCC----cEEEEEEcCCCCCCChH-----------HHHHHHHHHHhccCCCeeeEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDN----TKVAVKRGVPGSRQGLP-----------EFQTEITVLSKIRHRHLVSLVG  524 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~-----------~f~~E~~~l~~l~HpnIv~l~g  524 (803)
                      .++|...++||+|+||.||+|...++    ..+++|...........           ....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            35788899999999999999997653    45566653222221111           1223334455678999999999


Q ss_pred             Eeeccc----eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc
Q 042150          525 YCEEQS----EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV  600 (803)
Q Consensus       525 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~  600 (803)
                      ++....    ..++++|++.. ++.+.+.  .....++..+..++.|+++||+|||+   .+|+||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK--RIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHH--hhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence            775443    34677777643 5655552  22346788899999999999999999   89999999999999999999


Q ss_pred             EEEeeeccccCCCCCCCC-----ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh-hh
Q 042150          601 SKVADFGLSRSGPCLDET-----HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ-VN  674 (803)
Q Consensus       601 ~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~  674 (803)
                      ++|+|||+++........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||........ ..
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            999999999754221111     111234689999999999999999999999999999999999999975522111 11


Q ss_pred             --HHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          675 --LAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       675 --l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                        ..++....         ..+.+.   ....++.+.+++..|++.+|.+||++.++++.|
T Consensus       245 ~~~~~~~~~~---------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        245 AAKCDFIKRL---------HEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HhHHHHHHHh---------hhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence              01111111         111110   112346789999999999999999999998865

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-33  Score=303.76  Aligned_cols=263  Identities=25%  Similarity=0.318  Sum_probs=200.9

Q ss_pred             CCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccc-----eee
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS-----EMI  533 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~  533 (803)
                      +|...+.||+|++|.||+|+... ++.+++|++....  ....+.+.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            46778899999999999999754 8899999866543  334568999999999999999999999997765     789


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +||||+++ +|.+++..  ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.++|+|||++....
T Consensus        81 lv~e~~~~-~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMET-DLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhh-hHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            99999984 89888843  3479999999999999999999999   899999999999999999999999999987643


Q ss_pred             CCCC-CceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhh-------
Q 042150          614 CLDE-THVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK-------  684 (803)
Q Consensus       614 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-------  684 (803)
                      .... ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....   ......       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~  231 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEEDL  231 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChhHh
Confidence            3211 0112334578899999999887 899999999999999999999999875543221111   000000       


Q ss_pred             ----cCccccccC------cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          685 ----KGMLEHIID------PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       685 ----~~~~~~i~d------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                          .......+.      +.-...........+.+++.+||+.+|.+||++.+++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  290 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP  290 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence                000000000      0000011122456789999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-34  Score=283.74  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=205.1

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ..++|+..++||+|.||+|-+++-+ .++.+|+|.++..   .+.+...-+.|-++|+..+||.+..|...|+..+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3467888899999999999999865 4888999986654   23344556789999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||..||.|.-+|  ++...+++....-+..+|..||.|||+   .+||.||||.+|.|||.+|++||+||||++..- 
T Consensus       246 VMeyanGGeLf~HL--srer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHL--SRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-  319 (516)
T ss_pred             EEEEccCceEeeeh--hhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc-
Confidence            99999999999888  455678888888899999999999999   999999999999999999999999999998632 


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                       .........+||+.|+|||++....|..+.|.|.+||+||||+||+.||...+......+.          .+.++   
T Consensus       320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI----------l~ed~---  385 (516)
T KOG0690|consen  320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI----------LMEDL---  385 (516)
T ss_pred             -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH----------Hhhhc---
Confidence             3334456789999999999999999999999999999999999999999765433322221          01111   


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWN  732 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  732 (803)
                          .++....++...|+...|..||.+|-.     +.||.++
T Consensus       386 ----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  386 ----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                234445567788999999999999952     5555543

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=335.10  Aligned_cols=256  Identities=27%  Similarity=0.346  Sum_probs=204.1

Q ss_pred             HHHHhcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcC--CCCCCChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          456 LQTATNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGV--PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       456 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      +...+-++..+..||.|.||.||-|.. ++|...|+|...  .......+...+|+.++..|+|||+|+++|+-.+++..
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            444556678888999999999999994 568888999643  22345567788999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      +|.||||++|+|.+.+  ..+...++.....+..|++.|+.|||+   +|||||||||.||+|+.+|.+|++|||.|...
T Consensus      1310 ~IFMEyC~~GsLa~ll--~~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLL--EHGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHHhccCcHHHHH--HhcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEe
Confidence            9999999999999999  334445666666778899999999999   99999999999999999999999999999864


Q ss_pred             CCCCCC--ceeccccCCCcccCccccccC---cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH-hhcC
Q 042150          613 PCLDET--HVSTGVKGSFGYLDPEYFRRQ---QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW-QKKG  686 (803)
Q Consensus       613 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-~~~~  686 (803)
                      ....++  .......||+.|||||++.+.   .-..++||||+|||++||+||++||...+.       +|+..+ ..-+
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAG 1457 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhcc
Confidence            432111  122356899999999999754   345579999999999999999999975432       243322 1111


Q ss_pred             ccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 MLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 ~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .         ..+++.....+-.+++.+||+.||.+|.++.|++++
T Consensus      1458 h---------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 H---------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             C---------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            1         124455577788999999999999999999887754

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.1e-33  Score=300.86  Aligned_cols=262  Identities=22%  Similarity=0.213  Sum_probs=193.4

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCch
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      +.+|.|+++.|+++.. +++.||||+....  .....+.+.+|++++++++||||+++++++.+.+..+++|||+++|+|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3445555555555544 5889999986543  344567899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC-----Cc
Q 042150          545 KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-----TH  619 (803)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~-----~~  619 (803)
                      .+++.......+++..+..++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||.+........     ..
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            999965545568999999999999999999999   8999999999999999999999999998864322111     11


Q ss_pred             eeccccCCCcccCcccccc--CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH----hh-------cC
Q 042150          620 VSTGVKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW----QK-------KG  686 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~----~~-------~~  686 (803)
                      ......++..|+|||.+..  ..++.++|||||||++|||++|+.||........  +.+.....    ..       ..
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcC
Confidence            1223456788999999875  4588999999999999999999999975432211  11100000    00       00


Q ss_pred             cccc----ccCccc----ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          687 MLEH----IIDPQL----IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       687 ~~~~----i~d~~l----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ....    ..++..    ...........+.+++.+||..+|++|||+.+++++-.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~  297 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF  297 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence            0000    000100    01112234567889999999999999999999998644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-34  Score=279.36  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=194.4

Q ss_pred             CccceEeeeCceEEEEEEECC-CcEEEEEEcCCC-CCCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEEecC
Q 042150          464 DKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      +....||.|..|.|+++..+. |..+|||.+... +.++.++.+..++++.+.+ .|.||+.+|||..+...++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            334579999999999999764 889999987655 4445667778888877765 8999999999999999999999985


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      - .+..+|. .-.+++++.-+-++...+.+||.||.+  .++|+|||+||+|||+|+.|++||||||++...   -.+..
T Consensus       175 ~-C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrl---vdSkA  247 (391)
T KOG0983|consen  175 T-CAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRL---VDSKA  247 (391)
T ss_pred             H-HHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccccccee---ecccc
Confidence            3 4444442 335668888888999999999999987  589999999999999999999999999998653   23344


Q ss_pred             eccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          621 STGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      .+...|.+.|||||.+.   ...|+.++||||||+.|+||.||+.||.....+-.. +.    ....++      -|.|.
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-lt----kvln~e------PP~L~  316 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-LT----KVLNEE------PPLLP  316 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-HH----HHHhcC------CCCCC
Confidence            55678999999999985   457899999999999999999999999764321111 11    111111      12232


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +.  ...++.+++++..||..|+.+||...+++++
T Consensus       317 ~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  317 GH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             cc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            21  1267789999999999999999999999875

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.4e-32  Score=300.03  Aligned_cols=266  Identities=23%  Similarity=0.288  Sum_probs=199.1

Q ss_pred             hHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeec-cc
Q 042150          455 DLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE-QS  530 (803)
Q Consensus       455 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~  530 (803)
                      ++...+++|...+.||+|+||.||++... +++.||+|++...  .....+.+.+|++++++++||||+++.++|.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            34456788999999999999999999865 6889999976432  22335678899999999999999999998865 56


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..++|+||+ +++|.+++.   ...+++..+..++.|+++||.|||+   .+++||||||+||++++++.+||+|||+++
T Consensus        84 ~~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            789999998 468988883   3458888899999999999999999   899999999999999999999999999987


Q ss_pred             CCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhh-H--------HHHHH
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN-L--------AEWAM  680 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l--------~~~~~  680 (803)
                      ....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +        .+|..
T Consensus       157 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         157 IQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            5321     1123456889999998865 678999999999999999999999986543221110 1        11111


Q ss_pred             HHhhcCccccccCcccccCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          681 QWQKKGMLEHIIDPQLIGKIN-----LDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..........+.........+     ......+.+++.+||+.+|++||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            110000000000000001111     1234678999999999999999999999765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=289.80  Aligned_cols=241  Identities=22%  Similarity=0.244  Sum_probs=186.3

Q ss_pred             ceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC---CCChHHHHHHHHHHH-hccCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS---RQGLPEFQTEITVLS-KIRHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~-~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      +.||+|+||.||+|... +++.||+|......   ......+..|..++. ..+|||++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            36899999999999975 47899999865332   122234455555443 45899999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      ++|.+++.  ....+++..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||+++....      .
T Consensus        82 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~  150 (260)
T cd05611          82 GDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N  150 (260)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence            99999994  33568999999999999999999999   8999999999999999999999999999875321      2


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ....++..|+|||.+.+..++.++||||||+++|||++|..|+........      .... ......      ......
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~~~~~~------~~~~~~  217 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------FDNI-LSRRIN------WPEEVK  217 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHH-HhcccC------CCCccc
Confidence            234578899999999888899999999999999999999999865432211      1111 000000      001111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSMGDVLW  731 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~  731 (803)
                      ......+.+++.+||+.+|.+||++.++.+
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            234567899999999999999997754433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-33  Score=304.29  Aligned_cols=269  Identities=21%  Similarity=0.274  Sum_probs=200.1

Q ss_pred             ChhhHHHHhcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeec
Q 042150          452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEE  528 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~  528 (803)
                      ...++...+++|...+.||+|+||.||+|.. .+++.||+|+.....  ....+.+.+|++++++++||||+++.+++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3456777889999999999999999999985 468899999865432  2234678899999999999999999998854


Q ss_pred             c------ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEE
Q 042150          529 Q------SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSK  602 (803)
Q Consensus       529 ~------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~k  602 (803)
                      .      ...+++++++ +++|.+++.   ...+++..+..++.|+++||+|||+   .+++||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEE
Confidence            3      3467888876 779988873   3458999999999999999999999   9999999999999999999999


Q ss_pred             EeeeccccCCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHH-HH--
Q 042150          603 VADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLA-EW--  678 (803)
Q Consensus       603 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~--  678 (803)
                      |+|||+++....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ ..  
T Consensus       161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999875321     1223467889999999866 57889999999999999999999998643322111100 00  


Q ss_pred             -----HHHHhhcCc-------cccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          679 -----AMQWQKKGM-------LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       679 -----~~~~~~~~~-------~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                           .........       +..+...... .........+.+++.+||+.+|.+||++.+++.+-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence                 000000000       0000000000 00011245678999999999999999999998764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.8e-32  Score=300.11  Aligned_cols=259  Identities=21%  Similarity=0.215  Sum_probs=193.5

Q ss_pred             cceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCC--------------hHHHHHHHHHHHhccCCCeeeEEeEeeccc
Q 042150          466 NLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQG--------------LPEFQTEITVLSKIRHRHLVSLVGYCEEQS  530 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~  530 (803)
                      .+.||+|+||.||+|... +++.||||.........              ...+.+|++++++++||||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            467999999999999965 58899999865432211              125789999999999999999999999999


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..++||||+. |+|.+++.  ....+++.....++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~~  167 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLAR  167 (335)
T ss_pred             cEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCcccee
Confidence            9999999997 58999883  34568999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCCC------------CCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHH
Q 042150          611 SGPCLD------------ETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE  677 (803)
Q Consensus       611 ~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  677 (803)
                      ......            .........++..|+|||.+.+. .++.++|||||||++|||++|+.|+......+..   .
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~  244 (335)
T PTZ00024        168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL---G  244 (335)
T ss_pred             ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence            533100            01111223467889999998764 4788999999999999999999998754432211   1


Q ss_pred             HHHHHhhcCcc---cc------------ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          678 WAMQWQKKGML---EH------------IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       678 ~~~~~~~~~~~---~~------------i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ...........   ..            ...+... .........+.+++.+||+.+|++||+++|++.+..
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            11111110000   00            0000000 011123467889999999999999999999997544

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.7e-33  Score=293.84  Aligned_cols=250  Identities=23%  Similarity=0.314  Sum_probs=200.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ++|...+.||+|+||.||+|... +++.|++|.....   .....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36778889999999999999975 5889999986542   2233467889999999998 99999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++++|.+++..  ...+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            999999999999943  3479999999999999999999998   99999999999999999999999999998754322


Q ss_pred             CCC------------------ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHH
Q 042150          616 DET------------------HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE  677 (803)
Q Consensus       616 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  677 (803)
                      ...                  .......++..|+|||.+.+..++.++||||||++++||++|+.|+........  . .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~-~  232 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--F-Q  232 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--H-H
Confidence            210                  112234578899999999888899999999999999999999999875431110  0 0


Q ss_pred             HHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 042150          678 WAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSM----GDVLWN  732 (803)
Q Consensus       678 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~----~evl~~  732 (803)
                         ....           ....++....+.+.+++.+||+.+|.+||++    .+++++
T Consensus       233 ---~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         233 ---KILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ---HHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence               0000           0111222335678999999999999999999    777653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.1e-32  Score=291.86  Aligned_cols=252  Identities=23%  Similarity=0.270  Sum_probs=194.9

Q ss_pred             CCCccceEeeeCceEEEEEEE----CCCcEEEEEEcCCCC----CCChHHHHHHHHHHHhc-cCCCeeeEEeEeecccee
Q 042150          462 NFDKNLIIGSGGFGMVYKGVL----RDNTKVAVKRGVPGS----RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  532 (803)
                      +|...+.||+|+||.||++..    .++..||+|++....    ....+.+.+|++++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            366778999999999999986    357889999865422    22346788999999999 599999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+++++|.+++..  ...+++..+..++.|+++||.|||+   .+++||||||+|||+++++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            999999999999999843  4568899999999999999999999   99999999999999999999999999998753


Q ss_pred             CCCCCCceeccccCCCcccCcccccc--CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                      .... ........++..|+|||.+.+  ..++.++||||||+++|+|++|+.|+.....  .....++........    
T Consensus       156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~----  228 (290)
T cd05613         156 HEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSE----  228 (290)
T ss_pred             cccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhhccC----
Confidence            2211 111223457889999999875  3577899999999999999999999863211  111112211111110    


Q ss_pred             ccCcccccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       691 i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                             ..++......+.+++.+|++.+|.+||     ++.+++.+
T Consensus       229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                   112223456778999999999999997     66666653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.9e-32  Score=291.76  Aligned_cols=256  Identities=24%  Similarity=0.274  Sum_probs=197.8

Q ss_pred             CCCccceEeeeCceEEEEEEEC----CCcEEEEEEcCCCC----CCChHHHHHHHHHHHhc-cCCCeeeEEeEeecccee
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR----DNTKVAVKRGVPGS----RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  532 (803)
                      +|...+.||+|++|.||++...    +++.||||......    ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3667789999999999999853    46789999765321    22345788999999999 599999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+++|+|.+++..  ...+++..+..++.|++++|.|||+   .+++||||||+||+++.++.++|+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            999999999999999843  3568999999999999999999998   99999999999999999999999999998753


Q ss_pred             CCCCCCceeccccCCCcccCccccccCc--CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQ--LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                      .... ........++..|+|||.+.+..  .+.++||||||+++|||++|..|+......  ....+........     
T Consensus       156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~-----  227 (288)
T cd05583         156 LAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKS-----  227 (288)
T ss_pred             cccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHcc-----
Confidence            3221 11122345788999999987655  788999999999999999999998532111  1111111111110     


Q ss_pred             ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       691 i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                        .+    ..+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus       228 --~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         228 --KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             --CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence              01    11222345678999999999999999988887666543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.3e-32  Score=295.57  Aligned_cols=249  Identities=27%  Similarity=0.347  Sum_probs=195.3

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .|...+.||+|+||.||+|+.. ++..+++|.....   .....+++.+|+++++.++|+|++++.+++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666678999999999999975 4778999986432   22234578899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+. |+|.+.+.. ....+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....   
T Consensus        96 ~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---  167 (308)
T cd06634          96 YCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (308)
T ss_pred             ccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence            997 578777643 23468999999999999999999998   8999999999999999999999999999875321   


Q ss_pred             CceeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          618 THVSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                         .....++..|+|||.+.   ...++.++|||||||++|||++|+.|+......+.      ........ .     +
T Consensus       168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~-~-----~  232 (308)
T cd06634         168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE-S-----P  232 (308)
T ss_pred             ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHHHhhcC-C-----C
Confidence               12345788999999974   45688899999999999999999999764322111      11111110 0     1


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      .   .........+.+++.+||+.+|.+||++.+++.+....
T Consensus       233 ~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~  271 (308)
T cd06634         233 A---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (308)
T ss_pred             C---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence            0   11123456688999999999999999999999775533

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.5e-32  Score=296.86  Aligned_cols=268  Identities=24%  Similarity=0.274  Sum_probs=194.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeecc-------
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ-------  529 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-------  529 (803)
                      .++|...+.||+|+||.||+|..+ +++.+++|+......  .....+.+|++++++++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467888999999999999999975 478999998654322  2234678999999999999999999987443       


Q ss_pred             -ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          530 -SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       530 -~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                       ..+++||||+.+ +|...+.. ....+++.++..++.|+++||+|||+   .+++|+||||+||++++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence             346999999975 67666643 24569999999999999999999999   8999999999999999999999999999


Q ss_pred             ccCCCCCCCC---------ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHH
Q 042150          609 SRSGPCLDET---------HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW  678 (803)
Q Consensus       609 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  678 (803)
                      ++........         .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            8753321111         11123456788999998765 4588999999999999999999999875433222111100


Q ss_pred             HHH------HhhcCccccccCcccccCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          679 AMQ------WQKKGMLEHIIDPQLIGKIN-------LDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       679 ~~~------~~~~~~~~~i~d~~l~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...      +.....+....+.......+       ....+.+.+++.+||+.+|.+|||+.|++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            000      00000001100000000000       1123578899999999999999999999754

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.9e-32  Score=294.51  Aligned_cols=244  Identities=27%  Similarity=0.391  Sum_probs=192.5

Q ss_pred             CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC---CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR---QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      |...+.||+|+||.||+|+.. +++.|++|++.....   ...+++.+|++++++++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555667999999999999964 578899998654322   2235688999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +. |+|.+++.. ....+++.+++.++.|++.+|.|||+   .+++|+||+|+||+++.++.+||+|||++.....    
T Consensus       103 ~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            96 577777643 24568999999999999999999998   8999999999999999999999999999864221    


Q ss_pred             ceeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          619 HVSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                        .....++..|+|||++.   ...++.++|||||||++|||++|..|+.........      ...... ..     +.
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~-~~-----~~  239 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN-DS-----PT  239 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhc-CC-----CC
Confidence              22346788999999984   467888999999999999999999998644321111      111111 00     00


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                         .........+.+++.+||+.+|.+||++.+++.+
T Consensus       240 ---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 ---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1112233568899999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9.9e-33  Score=303.02  Aligned_cols=265  Identities=22%  Similarity=0.315  Sum_probs=194.1

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeecc----------
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ----------  529 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~----------  529 (803)
                      .+|...+.||+|+||.||+|... +++.|++|+.........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57888899999999999999975 4889999987665556667899999999999999999999776543          


Q ss_pred             ----ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc-cCCcEEEe
Q 042150          530 ----SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVA  604 (803)
Q Consensus       530 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~  604 (803)
                          ...++||||++ ++|.+++.   ...+++..++.++.||+.||.|||+   .+++||||||+||+++ +++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence                35789999997 58988883   3468999999999999999999998   8999999999999997 56678999


Q ss_pred             eeccccCCCCCCC-CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH
Q 042150          605 DFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       605 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      |||+++....... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||......+...........
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999875322111 111123357889999998754 56888999999999999999999999754332221110000000


Q ss_pred             hhc----C---cccc-cc----Cc-ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          683 QKK----G---MLEH-II----DP-QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       683 ~~~----~---~~~~-i~----d~-~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...    .   .... ..    .+ ............++.+++.+||..+|.+|||+.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            000    0   0000 00    00 00000011234578899999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-32  Score=300.06  Aligned_cols=248  Identities=25%  Similarity=0.314  Sum_probs=204.7

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .-...|.....||+|.|++|.+|+.. .+..||+|......  ....+.+.+|+++|..|+|||||+++.+......+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34567888889999999999999964 58999999755432  2233568999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+.+|.+.++|.+  ...+.+.+...++.|+..+++|||+   +.|||||||++||||+.++++||+|||++...  
T Consensus       133 V~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~--  205 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFF--  205 (596)
T ss_pred             EEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceee--
Confidence            9999999999999944  4446668888999999999999999   99999999999999999999999999999763  


Q ss_pred             CCCCceeccccCCCcccCccccccCcCC-CcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLT-DKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                       +........+|++.|.|||++.+.++. +++|+||+|++||-|++|..||++..-                   .++-+
T Consensus       206 -~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------------------k~Lr~  265 (596)
T KOG0586|consen  206 -DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------------------KELRP  265 (596)
T ss_pred             -cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------------------ccccc
Confidence             334445567899999999999987764 589999999999999999999985421                   12222


Q ss_pred             cccccCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          694 PQLIGKIN--LDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~--~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +.+.+.+.  .-...+..++++++|..+|.+|++++++.++
T Consensus       266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            23333322  2234567899999999999999999999764

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-33  Score=280.29  Aligned_cols=263  Identities=22%  Similarity=0.322  Sum_probs=205.4

Q ss_pred             ChhhHHHHhcCCCccceEeeeCceEEEEEE-ECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeecc
Q 042150          452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQ  529 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~  529 (803)
                      +++|+.+.|.+     +||+|+++.|--++ +.++..+|||++.........+..+|++++.+.+ |+||++|+.+|+++
T Consensus        74 ~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            46777777765     89999999999887 6789999999877666666778999999999995 99999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC---cEEEeee
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY---VSKVADF  606 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~~kl~DF  606 (803)
                      ..+|||||.|.||+|..+|+  ++..+++.+..++..+||.||.+||.   +||.||||||+|||..+..   -+|||||
T Consensus       149 ~~FYLVfEKm~GGplLshI~--~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQ--KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             ceEEEEEecccCchHHHHHH--HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecc
Confidence            99999999999999999994  55679999999999999999999999   9999999999999996544   4799999


Q ss_pred             ccccCCCCCCC-----CceeccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhh---
Q 042150          607 GLSRSGPCLDE-----THVSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV---  673 (803)
Q Consensus       607 Gla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~---  673 (803)
                      .|..-......     .-.....+|+..|||||+..     ...|+.+.|.||||||||-||+|.+||.+.-..+..   
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr  303 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR  303 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence            88643211111     11123467889999999863     347888999999999999999999999754332211   


Q ss_pred             -----hHHHHHHHHhhcCccccccCcccccCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          674 -----NLAEWAMQWQKKGMLEHIIDPQLIGKINL----DSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       674 -----~l~~~~~~~~~~~~~~~i~d~~l~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                           .-.+...+-+.++..          +++.    ..+.+..+++...+..++.+|-++.+++++-.
T Consensus       304 Ge~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             CCccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence                 111111111222211          2332    23567788999999999999999999988443

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6e-33  Score=319.64  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=190.1

Q ss_pred             HHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeec------
Q 042150          457 QTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE------  528 (803)
Q Consensus       457 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~------  528 (803)
                      ..-.++|+...+||+||||.|||++.+ ||+.+|||++... +.+......+|+.+|++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345567888889999999999999965 7999999996654 34445678899999999999999998643211      


Q ss_pred             --------------------------------------------------------------------------------
Q 042150          529 --------------------------------------------------------------------------------  528 (803)
Q Consensus       529 --------------------------------------------------------------------------------  528 (803)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------c--------ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 042150          529 -------------------------Q--------SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL  575 (803)
Q Consensus       529 -------------------------~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL  575 (803)
                                               +        ..+||-||||+.-+|++++....... .....++++++|++||.|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence                                     0        12577889998877877774322111 3567899999999999999


Q ss_pred             hcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC----C------------CCCCceeccccCCCcccCccccccC
Q 042150          576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP----C------------LDETHVSTGVKGSFGYLDPEYFRRQ  639 (803)
Q Consensus       576 H~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~  639 (803)
                      |+   ++||||||||.||+||++..+||+|||+|....    .            .......+...||.-|+|||++.+.
T Consensus       714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99   999999999999999999999999999997511    0            0111234567899999999999764


Q ss_pred             ---cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHcc
Q 042150          640 ---QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCL  716 (803)
Q Consensus       640 ---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl  716 (803)
                         +|+.|+|+||+||||+||+   .||....++  ...    ....+++.+..-      ..+..+..+.-..+|.+++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMER--a~i----L~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEML---YPFGTSMER--ASI----LTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHh---ccCCchHHH--HHH----HHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence               5999999999999999998   455433221  111    111223332221      1223334455578999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 042150          717 ADYGVDRPSMGDVLW  731 (803)
Q Consensus       717 ~~~p~~RPs~~evl~  731 (803)
                      +.||.+|||+.|+|.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999875

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3e-32  Score=298.04  Aligned_cols=264  Identities=23%  Similarity=0.259  Sum_probs=191.8

Q ss_pred             CCCccceEeeeCceEEEEEEECC---CcEEEEEEcCCC--CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeecc----ce
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD---NTKVAVKRGVPG--SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ----SE  531 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~----~~  531 (803)
                      +|...+.||+|+||.||++....   +..||+|+....  .....+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            36677899999999999999653   678999986542  222356788999999999 599999999976432    45


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .++++||+. ++|.+++.  ....+++.+++.++.||+.||.|||+   .+++||||||+|||+++++.+||+|||+++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788899886 58988883  44568999999999999999999999   9999999999999999999999999999975


Q ss_pred             CCCCCCC--ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhH---------HHHH
Q 042150          612 GPCLDET--HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL---------AEWA  679 (803)
Q Consensus       612 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l---------~~~~  679 (803)
                      .......  .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........         .++.
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            3321111  11223468899999998765 5789999999999999999999999865432211100         0000


Q ss_pred             HHHhhcCc------cccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          680 MQWQKKGM------LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       680 ~~~~~~~~------~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ........      ....-...+ ..........+.+++.+||+.+|.+|||+.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000      000000000 00111224678899999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.98  E-value=3.1e-32  Score=286.81  Aligned_cols=249  Identities=26%  Similarity=0.350  Sum_probs=193.8

Q ss_pred             CCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC-----CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG-----SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      +|...+.||+|+||.||++.... +..+++|.....     ......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            36777899999999999998654 334445543321     222344677899999999999999999999999999999


Q ss_pred             EEecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          536 YEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      |||+++++|.+++..  .....+++.+++.++.|++.||.|||+   .+++|+||||+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988843  334679999999999999999999998   99999999999999975 569999999987543


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ..  ........++..|+|||.+.+..++.++|+||||+++|+|++|+.|+......      ....... .+.     .
T Consensus       157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~-~~~-----~  222 (260)
T cd08222         157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIV-EGP-----T  222 (260)
T ss_pred             CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHH-cCC-----C
Confidence            21  11222345788999999998888999999999999999999999998643211      1111111 111     1


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                          ...+......+.+++.+|+..+|++||++.|++++
T Consensus       223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         223 ----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ----CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                11233455688999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=2.6e-32  Score=299.78  Aligned_cols=263  Identities=23%  Similarity=0.314  Sum_probs=196.6

Q ss_pred             HHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccc---
Q 042150          457 QTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS---  530 (803)
Q Consensus       457 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~---  530 (803)
                      ....++|...+.||+|+||.||++... ++..||||+.....  ......+.+|+++|++++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            335677999999999999999999854 58899999864322  223456889999999999999999999986543   


Q ss_pred             ---eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeec
Q 042150          531 ---EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG  607 (803)
Q Consensus       531 ---~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG  607 (803)
                         ..++||||+ +++|.+++.   ...+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence               458999999 678988873   3568999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhh-H--------HH
Q 042150          608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN-L--------AE  677 (803)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l--------~~  677 (803)
                      +++....     ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.......... .        .+
T Consensus       164 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         164 LARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             ccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            9875322     1223457889999999876 468899999999999999999999987443211100 0        01


Q ss_pred             HHHHHhhcC------ccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          678 WAMQWQKKG------MLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       678 ~~~~~~~~~------~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +........      .+.......+ ..........+.+++.+|++.+|.+|||+.+++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            110000000      0000000000 01112334568899999999999999999999864

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=4.8e-32  Score=288.58  Aligned_cols=262  Identities=25%  Similarity=0.297  Sum_probs=197.1

Q ss_pred             CCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      |.....||+|++|.||+|+... ++.+++|......  ....+.+..|+.++++++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            4455689999999999999764 8899999866542  333567889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      + ++|.+++.... ..+++.+++.++.|++.||.|||+   .+++||||+|+||++++++.+||+|||+++.......  
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            8 58999995432 469999999999999999999999   8999999999999999999999999999876432111  


Q ss_pred             eeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhh-HHHH-------HHHHhh-----c
Q 042150          620 VSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN-LAEW-------AMQWQK-----K  685 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~-------~~~~~~-----~  685 (803)
                      ......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+... +...       .+....     .
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            22234457789999998766 88999999999999999999999986543221110 0000       000000     0


Q ss_pred             CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       686 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ........... ...-+.....+.+++.+||+.+|.+||++.+++.+
T Consensus       234 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         234 PTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            00000000000 00011225678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.9e-32  Score=300.85  Aligned_cols=261  Identities=23%  Similarity=0.294  Sum_probs=196.2

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccce---
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE---  531 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~---  531 (803)
                      ...++|.....||+|++|.||+|+.. +++.||+|++...  .....+.+.+|+.++++++||||+++.+++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34677889999999999999999975 4788999986542  22234567889999999999999999998765554   


Q ss_pred             ---eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          532 ---MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       532 ---~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                         .++|+||+ +++|.+++.   ...+++.+++.++.|+++||+|||+   .+|+||||||+||++++++.+||+|||+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence               89999998 569999883   3569999999999999999999999   8999999999999999999999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhh-HH--------HH
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN-LA--------EW  678 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~--------~~  678 (803)
                      +......     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+... +.        .+
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            8753221     233467889999999865 467899999999999999999999986443221110 00        00


Q ss_pred             HHHHhhcCccccccC-------cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          679 AMQWQKKGMLEHIID-------PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       679 ~~~~~~~~~~~~i~d-------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...... ......+.       +.... ........+.+++.+||+.+|.+|||+.+|+++
T Consensus       240 ~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         240 LQKISS-ESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             Hhhccc-hhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            000000 00000000       00000 001225678999999999999999999999865

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-31  Score=279.64  Aligned_cols=236  Identities=26%  Similarity=0.301  Sum_probs=191.4

Q ss_pred             EeeeCceEEEEEEEC-CCcEEEEEEcCCCCC---CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCch
Q 042150          469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR---QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       469 Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      ||+|+||.||++... +++.+++|.......   .....+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999976 488999998654322   2456789999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccc
Q 042150          545 KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV  624 (803)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (803)
                      .+++..  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  153 (250)
T cd05123          81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF  153 (250)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence            999943  3468999999999999999999999   999999999999999999999999999987633211  123345


Q ss_pred             cCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHH
Q 042150          625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDS  704 (803)
Q Consensus       625 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  704 (803)
                      .++..|++||.+.+...+.++|+||||+++|||++|+.||.......   ...   .... .          ...++...
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~---~~~~-~----------~~~~~~~~  216 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYE---KILK-D----------PLRFPEFL  216 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHhc-C----------CCCCCCCC
Confidence            67889999999998889999999999999999999999986443211   111   1110 0          01122223


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHH
Q 042150          705 LKKFGETAEKCLADYGVDRPSMGD  728 (803)
Q Consensus       705 ~~~l~~li~~cl~~~p~~RPs~~e  728 (803)
                      ...+.+++.+||..+|.+||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            567899999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=272.55  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=199.9

Q ss_pred             HhcCCCcc-ceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeec----cce
Q 042150          459 ATNNFDKN-LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEE----QSE  531 (803)
Q Consensus       459 ~~~~f~~~-~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~----~~~  531 (803)
                      .+++|.+. ++||-|--|.|-....+ +++++|+|.+...     ....+|+++.-.. .|||||.++++++.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45556554 57999999999998865 4888999986432     3467889886666 69999999998754    456


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc---cCCcEEEeeecc
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGL  608 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~DFGl  608 (803)
                      +++|||+|+||.|...+..+....+++.++-.|+.||+.|+.|||+   .+|.||||||+|+|..   .+-.+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence            7899999999999999988788889999999999999999999999   9999999999999996   455799999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      |+...   ........+-|+.|.|||++..++|+...|+||+||++|-|+||-+||.......   +        ..+.-
T Consensus       211 AK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---i--------spgMk  276 (400)
T KOG0604|consen  211 AKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---I--------SPGMK  276 (400)
T ss_pred             ccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---C--------ChhHH
Confidence            98732   2333455678999999999999999999999999999999999999997543211   1        11111


Q ss_pred             ccccCcccccCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          689 EHIIDPQLIGKINL----DSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       689 ~~i~d~~l~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ..|.....  .++.    ..++...++|+.+|..+|.+|-|+.+++.+-+
T Consensus       277 ~rI~~gqy--~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw  324 (400)
T KOG0604|consen  277 RRIRTGQY--EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW  324 (400)
T ss_pred             hHhhccCc--cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence            11211111  2222    34677889999999999999999999987644

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=5.2e-31  Score=312.20  Aligned_cols=145  Identities=30%  Similarity=0.375  Sum_probs=129.3

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC---CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR---QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...++||+|+||.||+|... +++.||||++.....   .....+..|+.++..++||||+++++++......+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56888899999999999999976 588999998654322   22467889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ||+.+++|.+++..  ...+++..++.|+.||+.||+|||.   .+|+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999943  3468899999999999999999998   899999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=7e-32  Score=269.37  Aligned_cols=271  Identities=21%  Similarity=0.227  Sum_probs=197.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-----CcEEEEEEcCCCCCC--ChHHHHHHHHHHHhccCCCeeeEEeEeec-cce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-----NTKVAVKRGVPGSRQ--GLPEFQTEITVLSKIRHRHLVSLVGYCEE-QSE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~  531 (803)
                      ...|+....||+|.||.||+|+-++     ...+|+|+++.....  ......+|+.+++.++||||+.|..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3568888899999999999997432     236899987654322  23567899999999999999999998876 788


Q ss_pred             eeEEEEecCCCchhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC----CcEEEe
Q 042150          532 MILVYEYMEKGPLKKHLYG---PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN----YVSKVA  604 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~----~~~kl~  604 (803)
                      .+|++||.++ +|.+.|+.   .....++...+..|+.||+.|+.|||+   +=|+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence            9999999998 88888842   234578999999999999999999999   889999999999999877    899999


Q ss_pred             eeccccCCCCCCCC-ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhh------hhhHH
Q 042150          605 DFGLSRSGPCLDET-HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE------QVNLA  676 (803)
Q Consensus       605 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~------~~~l~  676 (803)
                      |||++|.....-.. .....++-|.-|.|||.+.+ ..||.+.|||+.|||+.||++-.+.|......-      +.+..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999875432222 23345677999999999886 579999999999999999999887775432211      01111


Q ss_pred             HHHHHHhhcCc---------ccc-----------ccCcc-cccCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          677 EWAMQWQKKGM---------LEH-----------IIDPQ-LIGKIN--LDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       677 ~~~~~~~~~~~---------~~~-----------i~d~~-l~~~~~--~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      +...+......         +.+           ..|.. +..-+.  ..-.+...+|+.++|..||.+|.|+.+.+++.
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            11111111000         000           00100 000000  00112367899999999999999999998865


Q ss_pred             H
Q 042150          734 E  734 (803)
Q Consensus       734 ~  734 (803)
                      -
T Consensus       339 y  339 (438)
T KOG0666|consen  339 Y  339 (438)
T ss_pred             c
Confidence            3

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-33  Score=276.31  Aligned_cols=250  Identities=25%  Similarity=0.297  Sum_probs=195.3

Q ss_pred             cceEeeeCceEEEEEEECC-CcEEEEEEcCCCCC-CChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          466 NLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSR-QGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      ...||.|.||+|+|-.++. |+..|||++..... .+.++++.|.+...+- +.||||+++|.+-.++..++.||.|.- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            3479999999999998764 89999999765543 5677899999876665 799999999999999999999999964 


Q ss_pred             chhhh---ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          543 PLKKH---LYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       543 sL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      +|+.+   ++...+..+++.-+-.|.....+||.||..  ..+|+|||+||+||||+..|.+||||||++...   ..+.
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL---v~Si  222 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL---VDSI  222 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhH---HHHH
Confidence            55443   344456678888888888899999999986  578999999999999999999999999998652   3344


Q ss_pred             eeccccCCCcccCccccc--cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          620 VSTGVKGSFGYLDPEYFR--RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      ..+...|...|||||.+.  +..|+-+|||||||++|+|+.||+.|+.....     +.+-..+... +.     .|.+.
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~-gd-----pp~l~  291 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI-GD-----PPILL  291 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc-CC-----CCeec
Confidence            456678999999999995  34589999999999999999999999864322     1111111111 11     12222


Q ss_pred             cCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          698 GKI-NLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       698 ~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ... ..+....+..++.-||.+|..+||...++..+
T Consensus       292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            221 24567789999999999999999999998764

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2.5e-31  Score=276.20  Aligned_cols=220  Identities=21%  Similarity=0.176  Sum_probs=176.0

Q ss_pred             eCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCchhhhccC
Q 042150          472 GGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG  550 (803)
Q Consensus       472 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  550 (803)
                      |.||.||++... +++.+|+|++....     .+.+|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999964 57899999865432     344566666667899999999999999999999999999999999843


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcc
Q 042150          551 PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY  630 (803)
Q Consensus       551 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  630 (803)
                        ...+++..+..++.|+++||+|||+   .+++||||||+||+++.++.++++|||++.....     ......++..|
T Consensus        79 --~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y  148 (237)
T cd05576          79 --FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMY  148 (237)
T ss_pred             --hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccc
Confidence              3458999999999999999999998   9999999999999999999999999998765322     11233456789


Q ss_pred             cCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHH
Q 042150          631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGE  710 (803)
Q Consensus       631 ~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~  710 (803)
                      +|||.+.+..++.++||||+|+++|||++|+.|+.......                 .....    ...+......+.+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~~~  207 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTT----LNIPEWVSEEARS  207 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccc----cCCcccCCHHHHH
Confidence            99999988889999999999999999999998764221100                 00000    0122233467889


Q ss_pred             HHHHccccCCCCCCCHH
Q 042150          711 TAEKCLADYGVDRPSMG  727 (803)
Q Consensus       711 li~~cl~~~p~~RPs~~  727 (803)
                      ++.+|++.||.+||++.
T Consensus       208 li~~~l~~dp~~R~~~~  224 (237)
T cd05576         208 LLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHccCCHHHhcCCC
Confidence            99999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.8e-32  Score=277.72  Aligned_cols=240  Identities=24%  Similarity=0.332  Sum_probs=198.2

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC---CCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS---RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .+|....+||+|+||.|.+|.-++ .+.+|||+++.+.   ....+--+.|-++|... +-|.+++|..+|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            468888899999999999998664 5678999766542   23344456788888776 678999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+.+|+|--++  ++-+.+.+....-++.+||-||-+||+   ++|+.||||..|||||.+|++||+|||+++..-. 
T Consensus       429 MEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-  502 (683)
T ss_pred             EEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence            9999999999888  445568888899999999999999999   9999999999999999999999999999986432 


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                       ........+||+.|+|||++..++|..+.|.|||||+||||+.|++||++.++.+..               +.|.+..
T Consensus       503 -~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---------------~aI~ehn  566 (683)
T KOG0696|consen  503 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---------------QAIMEHN  566 (683)
T ss_pred             -CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHHHcc
Confidence             223345689999999999999999999999999999999999999999876544321               1112221


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCC
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRP  724 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RP  724 (803)
                      .  .++...+.+..++....|..+|.+|-
T Consensus       567 v--syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 V--SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             C--cCcccccHHHHHHHHHHhhcCCcccc
Confidence            1  34556677889999999999999995

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-31  Score=294.37  Aligned_cols=260  Identities=25%  Similarity=0.329  Sum_probs=211.3

Q ss_pred             ChhhHHHHhcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEee--
Q 042150          452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCE--  527 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~--  527 (803)
                      .++.+...+.-|.+.+.||.|.+|.||+++. ++++.+|+|++..... ..++...|.++|+.+ .|||++.++|++.  
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3444445566788889999999999999994 5688899998665543 345678899999988 6999999999884  


Q ss_pred             ---ccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEe
Q 042150          528 ---EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA  604 (803)
Q Consensus       528 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~  604 (803)
                         .+++++||||||.+|+..+++.+..+..+.|..+..|+..++.||.+||.   ..++|||||-.|||+++++.+||+
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence               35689999999999999999987778889999999999999999999999   999999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeccccCCCcccCcccccc-----CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHH
Q 042150          605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR-----QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWA  679 (803)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  679 (803)
                      |||++....  ..........||+.|||||++..     ..|+.++|+||||++..||--|.+|+....+....      
T Consensus       166 DFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------  237 (953)
T KOG0587|consen  166 DFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------  237 (953)
T ss_pred             eeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------
Confidence            999987532  22333445689999999999964     35777899999999999999999998654432211      


Q ss_pred             HHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042150          680 MQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLW  731 (803)
Q Consensus       680 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  731 (803)
                              ..-...|...-.-+....+++.++|..||.+|-.+||++.++++
T Consensus       238 --------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 --------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                    01111233322335677899999999999999999999998875

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.7e-32  Score=308.12  Aligned_cols=260  Identities=24%  Similarity=0.252  Sum_probs=209.3

Q ss_pred             ChhhHHHHhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCC---CCCCChHHHHHHHHHHHhccCCCeeeEEeEee
Q 042150          452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVP---GSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE  527 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~  527 (803)
                      ...+++....+|.+.++||+|+||.|...+.+. ++.+|+|++..   ..+....-|..|-.+|..-+.+=|++|.-.|+
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            345677778899999999999999999999765 77889998654   33555678999999999999999999999999


Q ss_pred             ccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeec
Q 042150          528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG  607 (803)
Q Consensus       528 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG  607 (803)
                      +...+|+|||||+||+|..++.+  ...+++..+.-++..|.-||.-||+   .|+|||||||+|||||..|++||+|||
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk--~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSK--FDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhh--cCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccch
Confidence            99999999999999999999933  3379999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCceeccccCCCcccCccccc----c-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH
Q 042150          608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFR----R-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      .+-.+.. +........+|||-|++||++.    + +.|...+|.||+||++|||+.|.+||....-.+     .+    
T Consensus       221 sClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve-----TY----  290 (1317)
T KOG0612|consen  221 SCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE-----TY----  290 (1317)
T ss_pred             hHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH-----HH----
Confidence            8865432 4444566788999999999985    3 678999999999999999999999996432111     11    


Q ss_pred             hhcCccccccCcccccCCC--HHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIGKIN--LDSLKKFGETAEKCLADYGVDRPS---MGDVLWNL  733 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~--~~~~~~l~~li~~cl~~~p~~RPs---~~evl~~L  733 (803)
                            ..|++-.-.-.++  .+.+....+||.+.+ -+|..|-.   +.++-.+.
T Consensus       291 ------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  291 ------GKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             ------HHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCc
Confidence                  1122211111222  345677888998877 47778877   88887653

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=276.78  Aligned_cols=255  Identities=25%  Similarity=0.345  Sum_probs=194.3

Q ss_pred             CCCccceEeeeCceEEEEEE-ECCCcEEEEEEcC--CCCCCC-----hHHHHHHHHHHHhccCCCeeeEEeEee-cccee
Q 042150          462 NFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGV--PGSRQG-----LPEFQTEITVLSKIRHRHLVSLVGYCE-EQSEM  532 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~-~~~~~~vavK~~~--~~~~~~-----~~~f~~E~~~l~~l~HpnIv~l~g~~~-~~~~~  532 (803)
                      +|-..++||+|||+.||+|. +...+-||||...  ...+.+     .+...+|.+|.+.|.||.||++++++. +.+.+
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            45566789999999999998 4557889999732  222222     234678999999999999999999995 55678


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc---cCCcEEEeeeccc
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLS  609 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~DFGla  609 (803)
                      |-|+|||+|.+|+-+|  ...+.+++++...|+.||+.+|.||.+ ...+|||-||||.||||-   ..|.+||.||||+
T Consensus       544 CTVLEYceGNDLDFYL--KQhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYL--KQHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             eeeeeecCCCchhHHH--HhhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            9999999999999999  455679999999999999999999997 457899999999999994   5678999999999


Q ss_pred             cCCCCCCCCc-----eeccccCCCcccCcccccc----CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH
Q 042150          610 RSGPCLDETH-----VSTGVKGSFGYLDPEYFRR----QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM  680 (803)
Q Consensus       610 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  680 (803)
                      +.+......+     ......||.-|++||++.-    .+.+.|.||||.|||+|..+.|+.||........+ +.    
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI-Lq----  695 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI-LQ----  695 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH-Hh----
Confidence            9865433332     2345689999999999853    36788999999999999999999999754332211 11    


Q ss_pred             HHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 042150          681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVL  730 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl  730 (803)
                          +..+-....  ..-...+....+..++|.+||+..-++|....++.
T Consensus       696 ----eNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  696 ----ENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ----hhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                111111100  00111234456778999999999999997765553

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=292.09  Aligned_cols=243  Identities=21%  Similarity=0.276  Sum_probs=196.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      +..|.....+|.|+|+.|-.+... +++..+||++...    ..+-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            556777778999999999998854 4778899986543    23345788777776 69999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE-ccCCcEEEeeeccccCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL-DENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl-~~~~~~kl~DFGla~~~~~~~  616 (803)
                      .+.++-|.+.+...  .... .++..|+.+|+.++.|||+   +|+|||||||+|||+ ++.++++|+|||.++..... 
T Consensus       397 ~l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            99999888877332  2233 7778899999999999999   999999999999999 69999999999999864432 


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                          ....+-|..|.|||++....+++++|+||||++||+||+|+.|+......  ..+    +..+.            
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----~~~i~------------  527 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----HTRIQ------------  527 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----HHhhc------------
Confidence                33456789999999999999999999999999999999999999754333  111    11111            


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      .+.+....+....+|+.+||+.+|.+||+|.++..+=..
T Consensus       528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            223335566788999999999999999999999876443

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2e-32  Score=265.70  Aligned_cols=268  Identities=24%  Similarity=0.355  Sum_probs=197.0

Q ss_pred             CCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC-CCC-hHHHHHHHHHHHhccCCCeeeEEeEeec--------cc
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS-RQG-LPEFQTEITVLSKIRHRHLVSLVGYCEE--------QS  530 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~-~~~f~~E~~~l~~l~HpnIv~l~g~~~~--------~~  530 (803)
                      .|....+||+|.||+||+|+.++ |++||+|+..-.. ..+ -...++|+++|..|+|+|++.++..|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            34555689999999999999654 7888998743322 222 3467899999999999999999998843        23


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      .++||+.+|++ +|..+|.. ....++..++.+++.++..||.|+|.   ..|+|||+|+.|+||+.++.+||+|||+++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            58999999987 88888833 33678999999999999999999999   999999999999999999999999999997


Q ss_pred             CCCCCCCCc--eeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC-
Q 042150          611 SGPCLDETH--VSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG-  686 (803)
Q Consensus       611 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-  686 (803)
                      .....+...  ..++.+-|+-|.+||.+.+ .+++.+.|||.-||||.||+++.+-++......+..+..-..--..++ 
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            643322211  1234556899999999875 689999999999999999999998887665544443322111000000 


Q ss_pred             -------cccccc--CcccccCCC--HHHH------HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          687 -------MLEHII--DPQLIGKIN--LDSL------KKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       687 -------~~~~i~--d~~l~~~~~--~~~~------~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                             .+-+.+  .|-..+.+.  .+..      +...+|+.+++..||.+|+.+++++.+--
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~  317 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF  317 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence                   011111  111111111  1112      36789999999999999999999986543

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=280.66  Aligned_cols=245  Identities=24%  Similarity=0.329  Sum_probs=197.5

Q ss_pred             cceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          466 NLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      .++||+|.||+||-|+++ +|+.||||.+...  ..+....+.+|+.||++++||.||.|.-.|+..+..++|||.+. |
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence            358999999999999964 6999999975432  23344788999999999999999999999999999999999995 5


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc---CCcEEEeeeccccCCCCCCCCc
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---NYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      +..+.|..+..+.|++..-.-++.||+.||.|||.   ++|+|+||||+||||.+   --.+||||||+||..   .+..
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI---gEks  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARII---GEKS  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeec---chhh
Confidence            77777767777889998888899999999999999   99999999999999953   447999999999984   4445


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ....+.||+.|+|||+++++.|...-|+||.|||+|--++|..||+....-.+  ..      +.   ..-+.-+...  
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QI------QN---AaFMyPp~PW--  788 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QI------QN---AAFMYPPNPW--  788 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hh------hc---cccccCCCch--
Confidence            56678999999999999999999999999999999999999999974321111  00      00   0111112222  


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        .+......++|...|+..-++|-|...-+.+
T Consensus       789 --~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  789 --SEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             --hhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence              2445667899999999999999998776643

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=3.5e-30  Score=266.64  Aligned_cols=238  Identities=28%  Similarity=0.326  Sum_probs=192.3

Q ss_pred             CceEEEEEEECC-CcEEEEEEcCCCCCCC-hHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCchhhhccC
Q 042150          473 GFGMVYKGVLRD-NTKVAVKRGVPGSRQG-LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG  550 (803)
Q Consensus       473 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  550 (803)
                      +||.||+|+..+ ++.+++|+........ .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999875 8899999976655544 78999999999999999999999999999999999999999999999843


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcc
Q 042150          551 PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY  630 (803)
Q Consensus       551 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  630 (803)
                      .  ..+++..++.++.+++++|.|||+   .+++|+||+|+||++++++.++|+|||++.......   ......++..|
T Consensus        81 ~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  152 (244)
T smart00220       81 R--GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY  152 (244)
T ss_pred             c--cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence            2  238999999999999999999999   899999999999999999999999999987643221   23345678899


Q ss_pred             cCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHH
Q 042150          631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGE  710 (803)
Q Consensus       631 ~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~  710 (803)
                      ++||.+.+..++.++||||||+++++|++|..|+.......  ...++    ........       ..........+.+
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~----~~~~~~~~-------~~~~~~~~~~~~~  219 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKK----IGKPKPPF-------PPPEWKISPEAKD  219 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHH----HhccCCCC-------ccccccCCHHHHH
Confidence            99999998899999999999999999999999986521111  11111    11111000       0000004467899


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 042150          711 TAEKCLADYGVDRPSMGDVLW  731 (803)
Q Consensus       711 li~~cl~~~p~~RPs~~evl~  731 (803)
                      ++.+|+..+|.+||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=240.75  Aligned_cols=264  Identities=22%  Similarity=0.263  Sum_probs=196.9

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +|+..++||+|.||+||+|+.. .++.||+|+...+.  +..-...++|+.+|+.++|+|||++++....+..+-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4556678999999999999955 47889999865443  23345789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      |.. +|..+... -++.++...+..++.|+++||.++|+   +++.||||||.|.||+.+|++|++|||+++...-  ..
T Consensus        83 cdq-dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgi--pv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PV  155 (292)
T ss_pred             hhH-HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCC--ce
Confidence            965 78877633 35678999999999999999999999   9999999999999999999999999999986321  11


Q ss_pred             ceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcC---ccccccC
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKG---MLEHIID  693 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~i~d  693 (803)
                      .......-|.-|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+.+..++..-.-|..-...++   .+.++-|
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            122334568899999998765 57888999999999999986 555555544444332222221111111   1222333


Q ss_pred             cccccCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          694 PQLIGKIN---------LDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~---------~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      -.....++         +.....=++++.+.+.-+|.+|.++++.+++
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            33322222         1222344678888888899999999888765

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=4.7e-30  Score=289.46  Aligned_cols=261  Identities=23%  Similarity=0.282  Sum_probs=182.5

Q ss_pred             HhcCCCccceEeeeCceEEEEEEE-----------------CCCcEEEEEEcCCCCCCChHHH--------------HHH
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVL-----------------RDNTKVAVKRGVPGSRQGLPEF--------------QTE  507 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~f--------------~~E  507 (803)
                      ..++|...++||+|+||.||+|.+                 ..++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999974                 2356799998765433333333              446


Q ss_pred             HHHHHhccCCCe-----eeEEeEeec--------cceeeEEEEecCCCchhhhccCCC----------------------
Q 042150          508 ITVLSKIRHRHL-----VSLVGYCEE--------QSEMILVYEYMEKGPLKKHLYGPD----------------------  552 (803)
Q Consensus       508 ~~~l~~l~HpnI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~----------------------  552 (803)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++|+|.++|+...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777876554     677888753        356899999999999999986421                      


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccC
Q 042150          553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLD  632 (803)
Q Consensus       553 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  632 (803)
                      ...++|..+..++.|++.+|.|||+   .+|+||||||+|||++.++.+||+|||+++..... .........+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccC-CccCccccCCCcceeC
Confidence            1235678899999999999999998   89999999999999999999999999998753221 1111112334789999


Q ss_pred             ccccccCcC----------------------CCcceehhHHHHHHHHHhCCC-CCCcchhhh------hhhHHHHHHHHh
Q 042150          633 PEYFRRQQL----------------------TDKSDVYSFGVVLFEVLCART-AVDPLLARE------QVNLAEWAMQWQ  683 (803)
Q Consensus       633 PE~~~~~~~----------------------t~ksDV~S~Gvvl~elltG~~-p~~~~~~~~------~~~l~~~~~~~~  683 (803)
                      ||.+.....                      ..+.||||+||+|+||++|.. |+.......      ...+..|...  
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--  456 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--  456 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence            998854321                      234799999999999999875 554221110      1112222211  


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHHH
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYG---VDRPSMGDVLWNL  733 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p---~~RPs~~evl~~L  733 (803)
                      ....    .+-    ..-........+++.+||..+|   .+|+|+.|++++-
T Consensus       457 ~~~~----~~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp  501 (507)
T PLN03224        457 KGQK----YDF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR  501 (507)
T ss_pred             cccC----CCc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence            1000    010    0112234667899999999766   6899999998763

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=7.9e-30  Score=294.90  Aligned_cols=260  Identities=21%  Similarity=0.247  Sum_probs=169.3

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-----CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeE------ee
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-----NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY------CE  527 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~------~~  527 (803)
                      ..++|...+.||+|+||.||+|++.+     +..||+|+......  .+.+..|  .+....+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45688999999999999999999754     58899998643221  1122222  1112222222222211      34


Q ss_pred             ccceeeEEEEecCCCchhhhccCCCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccC
Q 042150          528 EQSEMILVYEYMEKGPLKKHLYGPDR------------------TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIK  589 (803)
Q Consensus       528 ~~~~~~lV~Ey~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk  589 (803)
                      .....+|||||+.+++|.+++.....                  .......+..++.|++.||+|||+   ++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence            56789999999999999998853221                  011233456799999999999999   899999999


Q ss_pred             cceEEEcc-CCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccC----------------------cCCCcce
Q 042150          590 STNILLDE-NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ----------------------QLTDKSD  646 (803)
Q Consensus       590 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksD  646 (803)
                      |+|||+++ ++.+||+|||+++..... .........+++.|||||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 679999999999754321 12223445789999999966322                      2445679


Q ss_pred             ehhHHHHHHHHHhCCCCCCcchhhh-------hhhHHHHHHHHhhcCccccccCcccccCC--CHHHHHHHHHHHHHccc
Q 042150          647 VYSFGVVLFEVLCARTAVDPLLARE-------QVNLAEWAMQWQKKGMLEHIIDPQLIGKI--NLDSLKKFGETAEKCLA  717 (803)
Q Consensus       647 V~S~Gvvl~elltG~~p~~~~~~~~-------~~~l~~~~~~~~~~~~~~~i~d~~l~~~~--~~~~~~~l~~li~~cl~  717 (803)
                      ||||||+||||+++..+.+.....-       ...+..|.......      ..+.+...+  .........+|+.+||+
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence            9999999999999876644221100       11122222111100      000000000  00112345689999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042150          718 DYGVDRPSMGDVLWN  732 (803)
Q Consensus       718 ~~p~~RPs~~evl~~  732 (803)
                      .||.+|||+.|++++
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999986

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.8e-31  Score=269.17  Aligned_cols=265  Identities=20%  Similarity=0.259  Sum_probs=203.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-C-C----CeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-H-R----HLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-H-p----nIv~l~g~~~~~~~~  532 (803)
                      +++|.+...+|+|.||.|-+..... +..||||+++... .-.+..+-|+++|+++. + |    -+|++.+||.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            6789999999999999999988654 6889999865432 33456678999999994 2 3    378888999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc---------------
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---------------  597 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~---------------  597 (803)
                      |||+|.+ |-|+.++|...+-.+++...+..|+.|+++++++||+   .+++|-||||+|||+.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999988 4499999977777889999999999999999999999   99999999999999932               


Q ss_pred             -----CCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh
Q 042150          598 -----NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ  672 (803)
Q Consensus       598 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  672 (803)
                           +..+||+|||.|....   +.  ...++.|..|.|||++.+-.++..+||||+||||.||.+|...|+.....++
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~---e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDH---EH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eccCCCcceEEEecCCcceec---cC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                 3358999999997622   22  2456789999999999999999999999999999999999999886665554


Q ss_pred             hhHHHHHH--------------HHhhcCccc-----------cccCc-ccc---cCCCHHHHHHHHHHHHHccccCCCCC
Q 042150          673 VNLAEWAM--------------QWQKKGMLE-----------HIIDP-QLI---GKINLDSLKKFGETAEKCLADYGVDR  723 (803)
Q Consensus       673 ~~l~~~~~--------------~~~~~~~~~-----------~i~d~-~l~---~~~~~~~~~~l~~li~~cl~~~p~~R  723 (803)
                      ..+-+.+.              ++...+.+.           ...++ ...   -.....+...|.+|+.+||..||.+|
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence            43322211              111111110           00000 000   01123455679999999999999999


Q ss_pred             CCHHHHHHHHH
Q 042150          724 PSMGDVLWNLE  734 (803)
Q Consensus       724 Ps~~evl~~L~  734 (803)
                      +|+.|++++--
T Consensus       398 iTl~EAL~HpF  408 (415)
T KOG0671|consen  398 ITLREALSHPF  408 (415)
T ss_pred             ccHHHHhcCHH
Confidence            99999987643

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=290.80  Aligned_cols=246  Identities=27%  Similarity=0.353  Sum_probs=189.7

Q ss_pred             CCCccceEeeeCceE-EEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEec
Q 042150          462 NFDKNLIIGSGGFGM-VYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      -|...+++|.|+-|+ ||+|..+ ++.||||++....   ..-..+|+..|+.- .|||||++++.-.++..+||..|.|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            466667899999886 7999986 7899999865432   23457999999988 6999999999999999999999999


Q ss_pred             CCCchhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-----CCcEEEeeeccccCC
Q 042150          540 EKGPLKKHLYGP--DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-----NYVSKVADFGLSRSG  612 (803)
Q Consensus       540 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-----~~~~kl~DFGla~~~  612 (803)
                      .. +|.+++...  ......-...+.+..|+++||++||+   .+||||||||.||||+.     ..+++|+|||+++..
T Consensus       586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            75 999999653  11112224557788999999999999   99999999999999975     257899999999976


Q ss_pred             CCCCCC-ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhC-CCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          613 PCLDET-HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA-RTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       613 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                      ...... .......||-+|+|||++....-+.+.||||+||++|+.++| ..||.....++...+.       ....+.+
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-------~~~~L~~  734 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-------GNYTLVH  734 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc-------Cccceee
Confidence            543222 223467899999999999988888899999999999999987 8999865443321110       1111111


Q ss_pred             ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042150          691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLW  731 (803)
Q Consensus       691 i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  731 (803)
                      +.      . ..++  ...+||.+|++.+|..||++.+|+.
T Consensus       735 L~------~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 LE------P-LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ec------c-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            10      0 1112  6789999999999999999999985

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.2e-30  Score=255.74  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=203.1

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCC---CCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceee
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVP---GSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~  533 (803)
                      ..++|+..++||+|+|++|..+.++. .+.+|+|+.+.   ...+.++..+.|-.+..+- +||.+|.|..+|+.+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            34678889999999999999999754 67788886443   2445566778888888877 7999999999999999999


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +|.||+++|+|--++  +++..|+++...-+..+|+.+|.|||+   .||+.||||..|||||..|++||.|+|+++..-
T Consensus       328 fvieyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999998877  455679999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcch-hhhhhhHHHHHHHHhhcCcccccc
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLL-AREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                        .........+||+.|.|||.+++..|....|.|++||+|+||+.|+.||+-.. .....+..++..+.+-+..+.   
T Consensus       403 --~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---  477 (593)
T KOG0695|consen  403 --GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---  477 (593)
T ss_pred             --CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---
Confidence              23334556899999999999999999999999999999999999999997432 222345555655544433221   


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCC
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRP  724 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP  724 (803)
                             ++...+.+...+++..|.+||.+|-
T Consensus       478 -------iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 -------IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -------ccceeehhhHHHHHHhhcCCcHHhc
Confidence                   2223344567889999999999984

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-30  Score=271.47  Aligned_cols=249  Identities=21%  Similarity=0.271  Sum_probs=203.6

Q ss_pred             CccceEeeeCceEEEEEEECCCc-EEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          464 DKNLIIGSGGFGMVYKGVLRDNT-KVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +....||-|+||.|=+...+... .+|+|.++..   .....+....|-++|..++.|.||+|+-.|.+....|++||-|
T Consensus       423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC  502 (732)
T KOG0614|consen  423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC  502 (732)
T ss_pred             hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence            34447999999999988876533 3666654332   3344567889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      -||.|+..|  +.++.++.....-++..+.+|++|||+   ++||.|||||+|.+||.+|-+||.|||+|+...   ...
T Consensus       503 lGGElWTiL--rdRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~g~  574 (732)
T KOG0614|consen  503 LGGELWTIL--RDRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---SGR  574 (732)
T ss_pred             cCchhhhhh--hhcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhc---cCC
Confidence            999999999  456778888888999999999999999   999999999999999999999999999998743   344


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....+||+.|.|||++.++..+.++|.||||+++|||++|++||...++....++.-       ++ +..       -.
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL-------kG-id~-------i~  639 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL-------KG-IDK-------IE  639 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-------hh-hhh-------hh
Confidence            4567899999999999999999999999999999999999999998876655433321       11 111       12


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWNLEY  735 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~L~~  735 (803)
                      ++....+...+++++.+..+|.+|--     +.||-++-+.
T Consensus       640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf  680 (732)
T KOG0614|consen  640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF  680 (732)
T ss_pred             cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence            34455667889999999999999975     6777666543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-29  Score=237.95  Aligned_cols=201  Identities=23%  Similarity=0.347  Sum_probs=165.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC-CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .+.......||+|++|.|=+-++ .+|+..|+|+.... ..+..++.++|+++..+. .+|.+|.++|........++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            33444455799999999988875 45889999986543 445567788899887665 6999999999999999999999


Q ss_pred             EecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          537 EYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       537 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      |.|.- +|..+-.+  ..+..+++.-+=+|+..+.+||.|||+  ...++|||+||+||||+.+|++||||||++...  
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L--  199 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYL--  199 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceee--
Confidence            99965 77665522  346778999999999999999999998  578999999999999999999999999998652  


Q ss_pred             CCCCceeccccCCCcccCccccc----cCcCCCcceehhHHHHHHHHHhCCCCCCc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFR----RQQLTDKSDVYSFGVVLFEVLCARTAVDP  666 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~t~ksDV~S~Gvvl~elltG~~p~~~  666 (803)
                       ..+-..+...|...|||||.+.    ...|+-||||||||+.+.||.+++.|++.
T Consensus       200 -~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  200 -VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             -hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence             2223334467889999999885    34789999999999999999999999874

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3.3e-28  Score=262.09  Aligned_cols=212  Identities=25%  Similarity=0.340  Sum_probs=172.5

Q ss_pred             CCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      -|...+.||-|+||+|.++.- ++...+|.|.+...   .+......+.|-.||..-..+=||+|+-.|++.+.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            366777899999999999884 44667888876543   34445667889999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC-----
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG-----  612 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~-----  612 (803)
                      |++||++-.+|.  +.+.+.+....-++.++.+++++.|.   .|+|||||||+|||||.+|++||.||||+.-.     
T Consensus       710 YIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  710 YIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             ccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccc
Confidence            999999999983  34567888888889999999999999   99999999999999999999999999997311     


Q ss_pred             ----CCCCCC-------------------------------ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHH
Q 042150          613 ----PCLDET-------------------------------HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV  657 (803)
Q Consensus       613 ----~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el  657 (803)
                          ...+..                               ......+||+.|+|||++....++..+|.||.|||||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                000000                               001125699999999999999999999999999999999


Q ss_pred             HhCCCCCCcchhhh-hhhHHHH
Q 042150          658 LCARTAVDPLLARE-QVNLAEW  678 (803)
Q Consensus       658 ltG~~p~~~~~~~~-~~~l~~~  678 (803)
                      +.|+.||-.....+ +..+..|
T Consensus       865 ~~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             hhCCCCccCCCCCcceeeeeeh
Confidence            99999996544333 3333444

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-29  Score=247.34  Aligned_cols=265  Identities=26%  Similarity=0.318  Sum_probs=197.1

Q ss_pred             CCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeecc-----ceeeE
Q 042150          463 FDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ-----SEMIL  534 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~l  534 (803)
                      .+..+.||-|.||.||.... ++|+.|++|++...-  -...+.+.+|+++|..++|.|++..++..+-.     .++|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34556899999999999885 468999999865432  22346789999999999999999998876544     35788


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      +.|.|.. +|.+.|  -..+.++-..+.-+..||++||.|||+   .+|.||||||.|.|++++..+||||||+++....
T Consensus       135 ~TELmQS-DLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  135 LTELMQS-DLHKII--VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHh-hhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence            9999865 888888  455678888888899999999999999   9999999999999999999999999999997443


Q ss_pred             CCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHH--------HHHHhhc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW--------AMQWQKK  685 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~  685 (803)
                       +.....+...-|..|.|||.+++ ..|+.+.||||.|||+.||+..+..|+...+-++..+..-        .+...-+
T Consensus       209 -d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 -RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             -hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence             44445566677899999999987 5799999999999999999988887765444333332111        1111112


Q ss_pred             CccccccCc-----cc---ccCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          686 GMLEHIIDP-----QL---IGKI-NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       686 ~~~~~i~d~-----~l---~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      +.-.+++..     .+   .... +...-.+...+..+++..+|.+|.+..+.+.++-
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            211111111     11   0000 1122234567888999999999999999887653

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=3.7e-27  Score=237.71  Aligned_cols=210  Identities=37%  Similarity=0.568  Sum_probs=181.5

Q ss_pred             EeeeCceEEEEEEECC-CcEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCchhh
Q 042150          469 IGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKK  546 (803)
Q Consensus       469 Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  546 (803)
                      ||+|.+|.||++...+ ++.+++|+....... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999765 889999986654332 35789999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-CCcEEEeeeccccCCCCCCCCceecccc
Q 042150          547 HLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-NYVSKVADFGLSRSGPCLDETHVSTGVK  625 (803)
Q Consensus       547 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~  625 (803)
                      ++.... ..+++..++.++.+++++|++||+   .+++|+||+|.||+++. ++.++|+|||.+........  ......
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV  154 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence            984322 468999999999999999999999   89999999999999999 89999999999875332111  123345


Q ss_pred             CCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHH
Q 042150          626 GSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDS  704 (803)
Q Consensus       626 gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  704 (803)
                      +...|++||.+... ..+.++|+|++|+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            78899999999877 888999999999999998                                               


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          705 LKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       705 ~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       ..+.+++.+|++.+|.+||++.+++..
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             356899999999999999999999865

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-27  Score=249.48  Aligned_cols=133  Identities=26%  Similarity=0.368  Sum_probs=112.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-----C---CCeeeEEeEeec--
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-----H---RHLVSLVGYCEE--  528 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----H---pnIv~l~g~~~~--  528 (803)
                      ..+|...++||.|.|++||++.. .+.+.||+|+.+. ...-.+..+.||++|++++     |   .+||+|+++|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            36788899999999999999985 4577899998543 3344567889999999984     3   369999999954  


Q ss_pred             --cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc
Q 042150          529 --QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD  596 (803)
Q Consensus       529 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~  596 (803)
                        +.+.|||+|++ |.+|..+|....-+.++...+.+|+.||+.||.|||.  ..+|||-||||+||||.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeee
Confidence              45899999998 5589999977777889999999999999999999998  46899999999999993

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=4.5e-28  Score=232.58  Aligned_cols=256  Identities=20%  Similarity=0.310  Sum_probs=194.8

Q ss_pred             hcCCCccceEeeeCceEEEEEE-ECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeecc--ceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQ--SEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~--~~~~lV  535 (803)
                      .++|+..+++|+|.+++||.|. ..++++++||.+++..   .+...+|+.+|..|. ||||+.|++...+.  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            3567778899999999999999 4668899999987654   356789999999997 99999999988654  457899


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc-cCCcEEEeeeccccCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~DFGla~~~~~  614 (803)
                      +||+.+-+...+.     +.|+..++...+.++++||.|+|+   +||+|||+||.|++|| +.-.++|+|+|||.....
T Consensus       114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            9999998877766     557888899999999999999999   9999999999999998 556799999999987544


Q ss_pred             CCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcc-hhhhhh----------hHHHHHHHH
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPL-LAREQV----------NLAEWAMQW  682 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~-~~~~~~----------~l~~~~~~~  682 (803)
                      ..+..   ....+..|.-||.+.. +.|+..-|+|||||+|.+|+..+.||-.. ...++.          .+..+...+
T Consensus       186 ~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  186 GKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             Cceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            33322   2345667889999864 67888999999999999999999997532 222221          111111111


Q ss_pred             hhcCccccccCccccc---C------------CCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIG---K------------INLD-SLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~---~------------~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                          .+.  +||+..+   .            -+.. ..++..+++.+.|..|-++|+|+.|.+.+--.
T Consensus       263 ----~i~--Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  263 ----QID--LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             ----ccC--CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence                111  2332211   0            0111 23678899999999999999999999876443

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.6e-27  Score=229.54  Aligned_cols=245  Identities=20%  Similarity=0.332  Sum_probs=182.1

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEe-EeeccceeeEE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVG-YCEEQSEMILV  535 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g-~~~~~~~~~lV  535 (803)
                      ..+.|.+.+.||+|.||.+-++.++. .+.+++|- .+......++|.+|..---.| .|.||+.-++ .|+..+..+++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKa-vp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKA-VPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeec-cCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            34678889999999999999999876 56777776 344445678999998766556 5999998876 46777888999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc--cCCcEEEeeeccccCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD--ENYVSKVADFGLSRSGP  613 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~~kl~DFGla~~~~  613 (803)
                      +||++.|+|.+-+   ....+.+....+++.|++.|+.|+|+   .++||||||.+||||-  +..++||||||+.+...
T Consensus       101 qE~aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  101 QEFAPRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             eccCccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999999988   33557788889999999999999999   9999999999999993  44589999999987522


Q ss_pred             CCCCCceeccccCCCcccCcccccc-----CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRR-----QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      .     .......+..|.+||....     -...+.+|||.||++++.++||+.||+.. ........+|...  ..+..
T Consensus       175 ~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w--~~rk~  246 (378)
T KOG1345|consen  175 T-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQW--LKRKN  246 (378)
T ss_pred             c-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHH--hcccC
Confidence            1     1122345677999997743     25677899999999999999999999832 2223333333322  12111


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCC
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRP  724 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP  724 (803)
                      .  .-|+.-..    ..+++..+.++-|..++.+|=
T Consensus       247 ~--~~P~~F~~----fs~~a~r~Fkk~lt~~~~drc  276 (378)
T KOG1345|consen  247 P--ALPKKFNP----FSEKALRLFKKSLTPRFKDRC  276 (378)
T ss_pred             c--cCchhhcc----cCHHHHHHHHHhcCCcccccc
Confidence            1  11222122    235567778888999999993

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=6.4e-26  Score=232.32  Aligned_cols=199  Identities=33%  Similarity=0.452  Sum_probs=171.0

Q ss_pred             CCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      |...+.||+|++|.||++...+ ++.+++|........ ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4556789999999999999875 889999987655444 57789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +++|.+++..... .+++..+..++.+++.+|.+||+   .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~  155 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-AL  155 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cc
Confidence            9999999843222 18999999999999999999999   8999999999999999999999999999876433210 12


Q ss_pred             eccccCCCcccCcccc-ccCcCCCcceehhHHHHHHHHHhCCCCCCc
Q 042150          621 STGVKGSFGYLDPEYF-RRQQLTDKSDVYSFGVVLFEVLCARTAVDP  666 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~elltG~~p~~~  666 (803)
                      .....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2334577889999998 777888899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=3.6e-27  Score=237.59  Aligned_cols=260  Identities=22%  Similarity=0.250  Sum_probs=190.1

Q ss_pred             cCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeecc------ce
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ------SE  531 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~  531 (803)
                      .+|.....+|.|.- .|-.+.. -.+++||+|+....  .....++..+|..++..++|+|+++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            34555556777776 4544442 23789999975432  344456788999999999999999999998533      45


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .|+|||||.. +|.+.++    -.++.+.+..|..|+++|+.|||+   .+|+||||||+||++..+..+||.|||+|+.
T Consensus        96 ~y~v~e~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHHhhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcc
Confidence            7999999965 8988884    457778899999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhH----------------
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL----------------  675 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l----------------  675 (803)
                      .   +.....+....|..|.|||++.+..+.+.+||||.||++.||++|+..|.+.+.-++...                
T Consensus       168 e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  168 E---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             c---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            2   222345667788999999999988899999999999999999999987764432222111                


Q ss_pred             HHHHHHHhhc------Ccccccc-Cccccc--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          676 AEWAMQWQKK------GMLEHII-DPQLIG--KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       676 ~~~~~~~~~~------~~~~~i~-d~~l~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..-++.+...      -...+.+ |.....  +.+.-....+++++.+||..+|++|-+++++|++
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            1111111110      0000111 111111  1111234467899999999999999999999876

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-26  Score=247.78  Aligned_cols=196  Identities=22%  Similarity=0.392  Sum_probs=163.9

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC--------CCChHHHHHHHHHHHhcc---CCCeeeEEeEeec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS--------RQGLPEFQTEITVLSKIR---HRHLVSLVGYCEE  528 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~  528 (803)
                      .+|...+.||+|+||.|+.++++. ...|+||.+....        ....-..-.|+.||..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            357778899999999999999875 5678888644321        011112446999999997   9999999999999


Q ss_pred             cceeeEEEEec-CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeec
Q 042150          529 QSEMILVYEYM-EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG  607 (803)
Q Consensus       529 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG  607 (803)
                      ++.+||+||-. ++-+|.++|  .....+++.+..-|+.||+.|+++||+   ++|||||||-+||.++.+|.+||+|||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I--E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI--EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh--hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence            99999999977 455888988  456679999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCceeccccCCCcccCccccccCcCCCc-ceehhHHHHHHHHHhCCCCCC
Q 042150          608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDK-SDVYSFGVVLFEVLCARTAVD  665 (803)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~S~Gvvl~elltG~~p~~  665 (803)
                      .+-...    .......+||..|.|||++.+.+|--| -|||++|++||.++....||.
T Consensus       716 saa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            986522    223345789999999999999888765 799999999999988777764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-26  Score=251.97  Aligned_cols=253  Identities=25%  Similarity=0.354  Sum_probs=200.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ..+|...+.+|.|.+|.|||++.. .++..|+|.++........-...|+-+++..+||||+.++|-+.....+++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            356777889999999999999964 5888999987766666667778899999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      |.+|+|++.-+  ...++++.++-..++...+||.|||+   ++=+|||||-.|||+++.+.+|++|||.+-...  ...
T Consensus        94 cgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqit--ati  166 (829)
T KOG0576|consen   94 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQIT--ATI  166 (829)
T ss_pred             cCCCcccceee--ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhh--hhh
Confidence            99999999874  45789999999999999999999999   888999999999999999999999999975422  112


Q ss_pred             ceeccccCCCcccCcccc---ccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          619 HVSTGVKGSFGYLDPEYF---RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                      .......||+.|||||+.   +.+.|..++|||+.|+...|+---++|.....+....       .++.+    ..++|.
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-------~LmTk----S~~qpp  235 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-------FLMTK----SGFQPP  235 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-------HHhhc----cCCCCC
Confidence            223457899999999987   4578999999999999999987666664322221111       11111    112221


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLW  731 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  731 (803)
                      -..+ .....+.|-++++.|+-.+|.+||++..+++
T Consensus       236 ~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 TLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1111 1234567889999999999999999987765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=2.5e-26  Score=243.17  Aligned_cols=265  Identities=20%  Similarity=0.224  Sum_probs=197.2

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhcc------CCCeeeEEeEeeccce
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIR------HRHLVSLVGYCEEQSE  531 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~------HpnIv~l~g~~~~~~~  531 (803)
                      ....|.+....|+|-|++|.+|.... |..||||++.... --.+.=+.|+++|++|+      --|.++|+-.|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            45678888889999999999998654 7899999865432 22344578999999996      3589999999999999


Q ss_pred             eeEEEEecCCCchhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC-CcEEEeeeccc
Q 042150          532 MILVYEYMEKGPLKKHLYGP-DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLS  609 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~kl~DFGla  609 (803)
                      +|||+|-+. -+|.+.|.+- ....|....+..++.|+.-||..|..   .+|+|.||||.|||+++. ..+||||||.|
T Consensus       509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCccc
Confidence            999999774 4899998432 23458888999999999999999998   999999999999999865 46899999998


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHH-----HHHHhh
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW-----AMQWQK  684 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~-----~~~~~~  684 (803)
                      .....    ...+...-+..|.|||++.+.+|+...|+||.||+||||.||+..|.+........+..-     ...++.
T Consensus       585 ~~~~e----neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  585 SFASE----NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             ccccc----ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            65322    112233446689999999999999999999999999999999998876543332222110     001111


Q ss_pred             cCcc-ccc--------------------------cCc------cccc-----CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 042150          685 KGML-EHI--------------------------IDP------QLIG-----KINLDSLKKFGETAEKCLADYGVDRPSM  726 (803)
Q Consensus       685 ~~~~-~~i--------------------------~d~------~l~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~  726 (803)
                      ++.. .+-                          +.|      .|.+     .-.......|.+|+.+||..||++|-|.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence            1100 000                          111      0011     1123456788999999999999999999


Q ss_pred             HHHHHH
Q 042150          727 GDVLWN  732 (803)
Q Consensus       727 ~evl~~  732 (803)
                      .+.|++
T Consensus       741 nqAL~H  746 (752)
T KOG0670|consen  741 NQALKH  746 (752)
T ss_pred             HHHhcC
Confidence            999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=1.7e-25  Score=271.65  Aligned_cols=197  Identities=20%  Similarity=0.270  Sum_probs=139.6

Q ss_pred             hccC-CCeeeEEeEe-------eccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceE
Q 042150          513 KIRH-RHLVSLVGYC-------EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII  584 (803)
Q Consensus       513 ~l~H-pnIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  584 (803)
                      .++| +||.+++++|       .+...+++++||+ +++|.++|... ...+++.+++.++.||++||+|||+   ++|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS---QGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence            4556 6888888887       2334577888987 55999999542 4569999999999999999999999   9999


Q ss_pred             eeccCcceEEEccC-------------------CcEEEeeeccccCCCCCCC--------------CceeccccCCCccc
Q 042150          585 HRDIKSTNILLDEN-------------------YVSKVADFGLSRSGPCLDE--------------THVSTGVKGSFGYL  631 (803)
Q Consensus       585 HrDLkp~NILl~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~  631 (803)
                      ||||||+||||+..                   +.+||+|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999654                   4455666666543111000              00011235788899


Q ss_pred             CccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHH
Q 042150          632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGET  711 (803)
Q Consensus       632 aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l  711 (803)
                      |||++.+..++.++|||||||+||||++|..|+....    .....+...         ...+..     .........+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~---------~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR---------VLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh---------hcChhh-----hhcCHHHHHH
Confidence            9999999999999999999999999999988754211    011111000         111111     1122345688


Q ss_pred             HHHccccCCCCCCCHHHHHHH
Q 042150          712 AEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       712 i~~cl~~~p~~RPs~~evl~~  732 (803)
                      +.+||+.+|.+||+|.|++++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhc
Confidence            899999999999999999863

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=1.5e-24  Score=226.77  Aligned_cols=267  Identities=24%  Similarity=0.298  Sum_probs=196.0

Q ss_pred             hHHHHhcCCCccceEeeeCceEEEEEEEC----CCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeecc
Q 042150          455 DLQTATNNFDKNLIIGSGGFGMVYKGVLR----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQ  529 (803)
Q Consensus       455 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~  529 (803)
                      ++....+.|...++||+|.|+.||++.+.    ..+.||+|.+...+.  -....+|+++|..+. +.||+++.+++..+
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            34556677889999999999999999954    367899998765443  356899999999994 99999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc-cCCcEEEeeecc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGL  608 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~DFGl  608 (803)
                      +..++|+||+++....+++.     .++..++..++..+..||.++|.   .|||||||||+|+|.+ ..+.-.|+||||
T Consensus       108 d~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             CeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechh
Confidence            99999999999999988883     36788999999999999999999   9999999999999997 566789999999


Q ss_pred             ccCC-----------------CC-CCC----------------C--------ceeccccCCCcccCcccccc-CcCCCcc
Q 042150          609 SRSG-----------------PC-LDE----------------T--------HVSTGVKGSFGYLDPEYFRR-QQLTDKS  645 (803)
Q Consensus       609 a~~~-----------------~~-~~~----------------~--------~~~~~~~gt~~y~aPE~~~~-~~~t~ks  645 (803)
                      |...                 .. ...                .        ...-...||++|.|||++.. ...+.+.
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            8510                 00 000                0        00112469999999999864 5678899


Q ss_pred             eehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHH--------HHH-hhcCc--ccc------c---------cC-ccccc
Q 042150          646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWA--------MQW-QKKGM--LEH------I---------ID-PQLIG  698 (803)
Q Consensus       646 DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~-~~~~~--~~~------i---------~d-~~l~~  698 (803)
                      ||||.|||++.+++++.||-..... ...+.+.+        ++. .-.+.  +.+      +         ++ ..+..
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             ceeeccceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            9999999999999999998432211 11111111        000 00011  000      0         00 00000


Q ss_pred             ---------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          699 ---------KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       699 ---------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                               .........+.+++.+|+..||.+|.|+++.|++
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                     0111123478899999999999999999999874

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=8.3e-24  Score=208.95  Aligned_cols=168  Identities=21%  Similarity=0.221  Sum_probs=126.0

Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |+|.+++.. .+..++|.+++.|+.|+++||+|||+   .+      ||+|||++.++.+|+  ||+++....       
T Consensus         1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------   61 (176)
T smart00750        1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTP-------   61 (176)
T ss_pred             CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecc-------
Confidence            689999853 24569999999999999999999998   44      999999999999999  999876322       


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ....|++.|||||++.+..++.++|||||||++|||++|+.|+........ .+..+.......       ++.. ....
T Consensus        62 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~-------~~~~-~~~~  132 (176)
T smart00750       62 EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPAD-------DPRD-RSNL  132 (176)
T ss_pred             ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhccC-------Cccc-cccH
Confidence            112578999999999999999999999999999999999999864322111 111111111100       0000 0111


Q ss_pred             HHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          702 LDSLK--KFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       702 ~~~~~--~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      .....  .+.+++.+||+.+|.+||++.|+++++....
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            12222  6899999999999999999999999987664

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.5e-24  Score=211.50  Aligned_cols=243  Identities=20%  Similarity=0.321  Sum_probs=192.2

Q ss_pred             eEeeeCceEEEEEEECCCcEEEEEEcC--CCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCchh
Q 042150          468 IIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLK  545 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~  545 (803)
                      +|.+...|+.|+|+++.+ .+++|.+.  .......++|..|.-.|+.+.||||++++|.|.....+.++..||+.|+|.
T Consensus       197 kl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly  275 (448)
T KOG0195|consen  197 KLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY  275 (448)
T ss_pred             hhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence            688899999999999854 45555432  222333468999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEe--eeccccCCCCCCCCceecc
Q 042150          546 KHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA--DFGLSRSGPCLDETHVSTG  623 (803)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~  623 (803)
                      ..|++...-.++..+..+++.++|+||+|||+. ..-|.--.|.+..++||++.+++|+  |--++         .+..+
T Consensus       276 nvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs---------fqe~g  345 (448)
T KOG0195|consen  276 NVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS---------FQEVG  345 (448)
T ss_pred             HHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee---------eeccc
Confidence            999888777888999999999999999999983 2334555799999999999999884  32221         11223


Q ss_pred             ccCCCcccCccccccCcCC---CcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          624 VKGSFGYLDPEYFRRQQLT---DKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       624 ~~gt~~y~aPE~~~~~~~t---~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      ..-.+.||+||.++.++-+   .++|+|||+++||||.|...||....+.+..      .         ++.-..++..+
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------m---------kialeglrv~i  410 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------M---------KIALEGLRVHI  410 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------h---------hhhhccccccC
Confidence            3457899999999876544   3689999999999999999999754433321      1         11122344566


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       701 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      ++.....+.+++.-|+..||.+||.+..|+-.||..
T Consensus       411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            778888999999999999999999999999888865

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.5e-22  Score=219.45  Aligned_cols=170  Identities=22%  Similarity=0.204  Sum_probs=130.2

Q ss_pred             hHHHHhcCCCccceEeeeCceEEEEEEEC--CCcEEEEEEcCCCC-----CCChHHHHHHHHHHHhccCCCeeeEEeEee
Q 042150          455 DLQTATNNFDKNLIIGSGGFGMVYKGVLR--DNTKVAVKRGVPGS-----RQGLPEFQTEITVLSKIRHRHLVSLVGYCE  527 (803)
Q Consensus       455 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~  527 (803)
                      .......+|...+.||+|+||+||+|.++  +++.||||+.....     ....+.|.+|+++|++++|+|+++.+..+ 
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            34456678999999999999999999875  47778999854321     11245689999999999999998543322 


Q ss_pred             ccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeecc-CcceEEEccCCcEEEeee
Q 042150          528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI-KSTNILLDENYVSKVADF  606 (803)
Q Consensus       528 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL-kp~NILl~~~~~~kl~DF  606 (803)
                        +..+|||||+++++|....  .. .      ...++.+++++|.|||+   ++|+|||| ||+|||++.++.+||+||
T Consensus        91 --~~~~LVmE~~~G~~L~~~~--~~-~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHLAR--PH-G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             --CCcEEEEEccCCCCHHHhC--cc-c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence              4579999999999997321  11 1      14678899999999999   99999999 999999999999999999


Q ss_pred             ccccCCCCCCCCce------eccccCCCcccCccccccC
Q 042150          607 GLSRSGPCLDETHV------STGVKGSFGYLDPEYFRRQ  639 (803)
Q Consensus       607 Gla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  639 (803)
                      |+|+..........      .....++..|+|||.+...
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99986433221111      1356788899999998643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=4.5e-21  Score=208.27  Aligned_cols=263  Identities=21%  Similarity=0.217  Sum_probs=195.8

Q ss_pred             CCCccceEeeeCceEEEEEEECCC--cEEEEEEcCCCCCCChHHHHHHHHHHHhccC----CCeeeEEeEe-eccceeeE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRDN--TKVAVKRGVPGSRQGLPEFQTEITVLSKIRH----RHLVSLVGYC-EEQSEMIL  534 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H----pnIv~l~g~~-~~~~~~~l  534 (803)
                      +|...+.||+|+||.||++.....  ..+|+|............+..|..++..+.+    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            788999999999999999997653  4788887554333322368889999999873    6889999888 57778899


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC-----CcEEEeeeccc
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-----YVSKVADFGLS  609 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-----~~~kl~DFGla  609 (803)
                      ||+.+ +.+|.++........++..+.++|+.|++.+|++||+   .|++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99976 6699998754446789999999999999999999999   999999999999999754     46899999999


Q ss_pred             cCCC--CCCCC---ce---eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHH
Q 042150          610 RSGP--CLDET---HV---STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQ  681 (803)
Q Consensus       610 ~~~~--~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  681 (803)
                      +...  .....   ..   .....||..|+++....+.+.+.+.|+||++.++.|++.|..||.........  .. ...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~--~~-~~~  251 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK--SK-FEK  251 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH--HH-HHH
Confidence            8322  11111   11   22355999999999999999999999999999999999999998654322111  00 001


Q ss_pred             HhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          682 WQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       682 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      ....    .....     .....+..+.++...+-..+..++|....+...|+......
T Consensus       252 ~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  252 DPRK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             Hhhh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            0010    11111     11122344556666666689999999999999988776543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=4.6e-20  Score=198.78  Aligned_cols=260  Identities=29%  Similarity=0.386  Sum_probs=195.9

Q ss_pred             CCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCC---ChHHHHHHHHHHHhccCC-CeeeEEeEeeccceeeEEEEe
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ---GLPEFQTEITVLSKIRHR-HLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~Hp-nIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      |.....||.|+||.||++...  ..+++|.+......   ....|.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556678999999999999977  77888876654333   367899999999999988 799999999777778999999


Q ss_pred             cCCCchhhhccCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC-cEEEeeeccccCCCCCC
Q 042150          539 MEKGPLKKHLYGPDR-TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY-VSKVADFGLSRSGPCLD  616 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFGla~~~~~~~  616 (803)
                      +.+++|.+++..... ..+.......++.|++.++.|+|+   .+++|||+||+||+++... .++++|||+++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977733221 268899999999999999999999   8899999999999999988 79999999987533322


Q ss_pred             CCc----eeccccCCCcccCcccccc---CcCCCcceehhHHHHHHHHHhCCCCCCcchhh-hhhhHHHHHHHHhhcCcc
Q 042150          617 ETH----VSTGVKGSFGYLDPEYFRR---QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAR-EQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       617 ~~~----~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~  688 (803)
                      ...    ......++..|++||.+.+   .......|+||+|++++++++|..|+...... ...........    ...
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE----LPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh----cCC
Confidence            221    2456789999999999987   68888999999999999999999996544321 00111111111    000


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      . .................+.+++.+|+..+|..|.++.+....
T Consensus       233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0 000000000002223567899999999999999999887765

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=3.4e-21  Score=186.89  Aligned_cols=261  Identities=19%  Similarity=0.203  Sum_probs=196.6

Q ss_pred             hcCCCccceEeeeCceEEEEEE-ECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccC-CCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH-RHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||.+|.|. ..+|..||+|.....  ....++..|..+...|+| ..|..+..+..+...-.|||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4678899999999999999999 567999999985433  334578889999999975 778888888899999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc---CCcEEEeeeccccCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---NYVSKVADFGLSRSGPC  614 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~kl~DFGla~~~~~  614 (803)
                      .+ +-+|.++..-. ...++.++++.++-|++.-++|+|.   ++++||||||+|+|+.-   ...+.++|||||+....
T Consensus        92 LL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             cc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            87 56888877322 3458899999999999999999999   99999999999999963   34678999999987544


Q ss_pred             CCCCc-----eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          615 LDETH-----VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       615 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      .....     ......||.+|.+--...+.+.+.+.|+-|+|.+|..+..|..||++..........+...+    ..+.
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E----kK~s  242 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE----KKMS  242 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH----hhcC
Confidence            33221     23456799999999888888889999999999999999999999987654433222111111    1110


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                           ..........+.++.-.+.-|-..--++-|...-+.+..+.+
T Consensus       243 -----~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  243 -----TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             -----CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence                 011111223345667777888888888889876666555443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=9.8e-22  Score=226.84  Aligned_cols=254  Identities=21%  Similarity=0.246  Sum_probs=186.6

Q ss_pred             ccceEeeeCceEEEEEEEC-CCcEEEEEEcC----CCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          465 KNLIIGSGGFGMVYKGVLR-DNTKVAVKRGV----PGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       465 ~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~----~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ...++|.|.+|.|+..... ..+..+.|...    ...  .+....+..|+.+-..++|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4568999999977776633 23333333221    111  1111125567778888899999888888877777666799


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++ +|..++  .....++..++..++.|+..|+.|||+   .||.|||||++|++++.++.+||+|||.+.......+
T Consensus       402 ~~~~-Dlf~~~--~~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  402 YCPY-DLFSLV--MSNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             cccH-HHHHHH--hcccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            9999 999998  333578889999999999999999999   9999999999999999999999999999875443333


Q ss_pred             C--ceeccccCCCcccCccccccCcCCCc-ceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          618 T--HVSTGVKGSFGYLDPEYFRRQQLTDK-SDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       618 ~--~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      .  .......|+..|+|||.+.+.+|++. .||||.|+++..|++|+.||......+....     .....+....... 
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----~~~~~~~~~~~~~-  549 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----TNNYSDQRNIFEG-  549 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-----hhccccccccccC-
Confidence            3  56677899999999999999999986 8999999999999999999865433332210     0000000000000 


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        ...+....+.+-+.++.++|+.+|.+|-|+.+|++.
T Consensus       550 --~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  550 --PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             --hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence              001122345567889999999999999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=5.5e-20  Score=186.30  Aligned_cols=261  Identities=18%  Similarity=0.227  Sum_probs=192.2

Q ss_pred             cCCCccceEeeeCceEEEEEE-ECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      -.|.++++||+|.||.++.|+ +-+++.||||.....  ....++..|.+..+.|. .++|...+-+-.++..-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            468899999999999999999 556899999974433  34467889999999884 79999999888888889999998


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-----CCcEEEeeeccccCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-----NYVSKVADFGLSRSGP  613 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-----~~~~kl~DFGla~~~~  613 (803)
                      + |-+|.++..-. +..++.++++.++.|++.-++|+|+   +.+|.|||||+|+||..     ...+.|+|||+|+...
T Consensus       106 L-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  106 L-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             h-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            7 55888776322 4569999999999999999999999   99999999999999964     3368899999998754


Q ss_pred             CCCCC-----ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          614 CLDET-----HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       614 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      .....     .......||.+||+--...+.+.+.+.|+-|+|-++.+.|.|..||++........-      +.+-+..
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k------YeKIGe~  254 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK------YEKIGET  254 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH------HHHhccc
Confidence            33222     123456799999999999999999999999999999999999999986543221111      1111110


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      .....   ........+.++..-+.-.-..+-.+-|..+-+...+..++
T Consensus       255 Kr~T~---i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl  300 (449)
T KOG1165|consen  255 KRSTP---IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL  300 (449)
T ss_pred             cccCC---HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            00000   00111122344444444444557777888776666555554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=4.9e-21  Score=219.33  Aligned_cols=250  Identities=22%  Similarity=0.208  Sum_probs=185.5

Q ss_pred             CCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCC-CCChHHHHHHHHHHH--hccCCCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS-RQGLPEFQTEITVLS--KIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~--~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++...+.||++.|=+|.+|+.++|. |+||++.... .-..+.|.++++-++  .++|||.+++.-+-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5677778999999999999988776 8889865443 455666666555444  44899999998887777788999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC-C-
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL-D-  616 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~-~-  616 (803)
                      +.+ +|.+.|  ..+..+...+..-|+.|+++||..+|.   .+|+|||||.+||||+.-.-+.|+||..-|..... + 
T Consensus       103 vkh-nLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  103 VKH-NLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             Hhh-hhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            976 899998  566778888889999999999999999   99999999999999999999999999876542111 1 


Q ss_pred             ---CCceeccccCCCcccCcccccc----------Cc-CCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHH
Q 042150          617 ---ETHVSTGVKGSFGYLDPEYFRR----------QQ-LTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQ  681 (803)
Q Consensus       617 ---~~~~~~~~~gt~~y~aPE~~~~----------~~-~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~  681 (803)
                         .......-..-.+|+|||.+..          .. .+++.||||+||++.||++ |+++|+..+      +..+...
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr~~  250 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYRSG  250 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHhcc
Confidence               1111222334468999998743          12 7789999999999999988 577776432      1111000


Q ss_pred             --HhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          682 --WQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       682 --~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                        ...+-.+++|-|+            .+++++..|++.||.+|-++++.|+.-+..
T Consensus       251 ~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  251 NADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             CccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence              0000011122222            568999999999999999999999985443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=6e-20  Score=183.20  Aligned_cols=137  Identities=17%  Similarity=0.167  Sum_probs=107.1

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCCCCC--C-------hHHH-----------------HHHHHHHHhccCCCee
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ--G-------LPEF-----------------QTEITVLSKIRHRHLV  520 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~f-----------------~~E~~~l~~l~HpnIv  520 (803)
                      ..||+|+||.||+|...+|+.||||........  .       ...|                 ..|++.|.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            479999999999999888999999986543211  1       1122                 3499999999887764


Q ss_pred             eEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCceEeeccCcceEEEccCC
Q 042150          521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL-HTGSAEGIIHRDIKSTNILLDENY  599 (803)
Q Consensus       521 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDLkp~NILl~~~~  599 (803)
                      ....+..  ...+|||||+++++|...+.  ....+++.+...++.|++.+|.+| |+   .+|+||||||+|||++ ++
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CC
Confidence            3332222  22389999999987765532  235689999999999999999999 67   8999999999999998 47


Q ss_pred             cEEEeeeccccC
Q 042150          600 VSKVADFGLSRS  611 (803)
Q Consensus       600 ~~kl~DFGla~~  611 (803)
                      .++|+|||+|..
T Consensus       155 ~v~LiDFG~a~~  166 (190)
T cd05147         155 KLYIIDVSQSVE  166 (190)
T ss_pred             cEEEEEcccccc
Confidence            899999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=5.5e-20  Score=185.63  Aligned_cols=172  Identities=16%  Similarity=0.156  Sum_probs=133.1

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChH---H------HHHHHHHHHhccCCCeeeEEeEeec
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP---E------FQTEITVLSKIRHRHLVSLVGYCEE  528 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------f~~E~~~l~~l~HpnIv~l~g~~~~  528 (803)
                      ...++|...++||.|+||.||+... ++..+|+|.+.+.......   .      |.+|++.+.+++||+|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3567899999999999999999655 5778999987654333222   2      6899999999999999999888543


Q ss_pred             c--------ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc
Q 042150          529 Q--------SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV  600 (803)
Q Consensus       529 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~  600 (803)
                      .        +..+|||||++|.+|.++.      .++.    ....+++.+|..||.   .+++|||+||+||++++++ 
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-
Confidence            2        3578999999999998874      1222    245689999999999   9999999999999999988 


Q ss_pred             EEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHH
Q 042150          601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL  658 (803)
Q Consensus       601 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ell  658 (803)
                      ++|+|||..+....   ....           ..+.....+..++|+|+||+.+.-+.
T Consensus       173 i~liDfg~~~~~~e---~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQ---RKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccc---hhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999998765321   0000           01344556778999999999987654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1e-19  Score=200.64  Aligned_cols=217  Identities=25%  Similarity=0.366  Sum_probs=162.5

Q ss_pred             HHhccCCCeeeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCc
Q 042150          511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS  590 (803)
Q Consensus       511 l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp  590 (803)
                      |+.+.|.|+.+++|.|.++...++|.+||..|+|.+.+.. ....++|.-...++++|++||+|||. + .-..|+.|++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~-s-~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHN-S-PIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhc-C-cceeeeeecc
Confidence            4578999999999999999999999999999999999965 45679999999999999999999998 2 2239999999


Q ss_pred             ceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccC-------cCCCcceehhHHHHHHHHHhCCCC
Q 042150          591 TNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ-------QLTDKSDVYSFGVVLFEVLCARTA  663 (803)
Q Consensus       591 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvvl~elltG~~p  663 (803)
                      +|+++|..+.+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998764321111122223345679999998753       256789999999999999999999


Q ss_pred             CCcchhhhh-hhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          664 VDPLLAREQ-VNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       664 ~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      |........ ..+..++..     .....+-|.+....  +....+..++.+||..+|.+||++++|-..++.+.
T Consensus       158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             cccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            975332222 112222111     11112222221111  33447899999999999999999999987776654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=1.9e-18  Score=172.93  Aligned_cols=140  Identities=18%  Similarity=0.175  Sum_probs=109.6

Q ss_pred             cceEeeeCceEEEEEEECCCcEEEEEEcCCCCCC---------------------C-----hHHHHHHHHHHHhccCCCe
Q 042150          466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ---------------------G-----LPEFQTEITVLSKIRHRHL  519 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~f~~E~~~l~~l~HpnI  519 (803)
                      ...||+|+||.||+|...+|+.||||........                     .     ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3579999999999999878999999986654211                     0     1124678999999999987


Q ss_pred             eeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC
Q 042150          520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY  599 (803)
Q Consensus       520 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~  599 (803)
                      .....+...  ..+|||||++++++.....  ....++..+..+++.|++.+|.+||+  ..+|+||||||+|||++ ++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~  154 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CC
Confidence            544433322  2489999999886544321  23457888999999999999999996  36999999999999999 88


Q ss_pred             cEEEeeeccccCC
Q 042150          600 VSKVADFGLSRSG  612 (803)
Q Consensus       600 ~~kl~DFGla~~~  612 (803)
                      .++|+|||+++..
T Consensus       155 ~~~liDFG~a~~~  167 (190)
T cd05145         155 KPYIIDVSQAVEL  167 (190)
T ss_pred             CEEEEEcccceec
Confidence            9999999998763

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1.4e-18  Score=204.14  Aligned_cols=202  Identities=22%  Similarity=0.239  Sum_probs=165.7

Q ss_pred             hhhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc---CCCeeeEEeEeecc
Q 042150          453 FTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR---HRHLVSLVGYCEEQ  529 (803)
Q Consensus       453 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~  529 (803)
                      ..+++.....|.+.+.||+|+||.||+|...+++.||+|.-++.+..   +|.--.+++.+|+   -+-|..+..+..-.
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            44556667778899999999999999999888999999997776654   3333445555665   23344444445566


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc-------cCCcEE
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-------ENYVSK  602 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~-------~~~~~k  602 (803)
                      +.-+||+||.+.|+|.+++.  ..+.++|.-++.++.|+++.++.||.   .+|||+||||+|.||.       +...++
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             CcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceE
Confidence            77899999999999999994  66779999999999999999999999   9999999999999993       344689


Q ss_pred             EeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCC
Q 042150          603 VADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART  662 (803)
Q Consensus       603 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~  662 (803)
                      |+|||.+-.+............++|-.+-.+|...+++++...|.|.|+.+++-||.|+.
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999999876554444445566788999999999999999999999999999999999984

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=3e-18  Score=169.26  Aligned_cols=184  Identities=18%  Similarity=0.112  Sum_probs=135.9

Q ss_pred             CccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCC----hHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEEe
Q 042150          464 DKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG----LPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .....|++|+||+||.+.- ++.+++.+.+.......    ...|.+|+++|++|. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3456899999999997655 56777777654433211    125789999999995 5889999886    346999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeecc-CcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI-KSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL-kp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      +.+.+|.+.+.   .      ....++.|++++|.++|+   .||+|||| ||.|||++.++.++|+|||++........
T Consensus        80 I~G~~L~~~~~---~------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         80 LAGAAMYQRPP---R------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             ecCccHHhhhh---h------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            99998876441   1      124577899999999999   99999999 79999999999999999999985332211


Q ss_pred             C----ce-------eccccCCCcccCcccccc--CcCCCcceehhHHHHHHHHHhCCCCC
Q 042150          618 T----HV-------STGVKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCARTAV  664 (803)
Q Consensus       618 ~----~~-------~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~  664 (803)
                      .    ..       ......++.|++|+...-  ..--.+.+.++-|+-+|.++|++.+.
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            0    00       111235778888875432  22224679999999999999999774

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=4.3e-18  Score=176.98  Aligned_cols=231  Identities=21%  Similarity=0.288  Sum_probs=148.1

Q ss_pred             CCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccC----------CCeeeEEeEe--
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRH----------RHLVSLVGYC--  526 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H----------pnIv~l~g~~--  526 (803)
                      +..+..||.|+++.||.++..+ ++++|||.....   .....+++++|.-....+.+          -.++--++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            4456789999999999999865 899999974332   23346677777766555322          1222222211  


Q ss_pred             -------ecc---c-----eeeEEEEecCCCchhhhcc---C--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEee
Q 042150          527 -------EEQ---S-----EMILVYEYMEKGPLKKHLY---G--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR  586 (803)
Q Consensus       527 -------~~~---~-----~~~lV~Ey~~~gsL~~~l~---~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  586 (803)
                             ...   .     ..+++|+-+. ++|.+++.   .  .....+....++.+..|+.+.+++||+   .|++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence                   111   1     2377888774 58877752   1  112234455667788999999999999   999999


Q ss_pred             ccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCcccccc--------CcCCCcceehhHHHHHHHHH
Q 042150          587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR--------QQLTDKSDVYSFGVVLFEVL  658 (803)
Q Consensus       587 DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvvl~ell  658 (803)
                      ||||+|++++.+|.++|+||+......    ..... ...+..|.+||....        -.++.+.|.|++|+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g----~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAG----TRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETT----EEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecC----ceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999998765421    11111 344578999997643        35788999999999999999


Q ss_pred             hCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCC
Q 042150          659 CARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDR  723 (803)
Q Consensus       659 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~R  723 (803)
                      ||+.|++.........                   ..+ ..+. +.+..+..||..+|+.+|.+|
T Consensus       245 C~~lPf~~~~~~~~~~-------------------~~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPE-------------------WDF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSG-------------------GGG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCcccccc-------------------ccc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999998553322110                   011 2233 677889999999999999987

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=99.75  E-value=8.4e-19  Score=171.51  Aligned_cols=141  Identities=20%  Similarity=0.286  Sum_probs=85.2

Q ss_pred             eeeeecCCcccCCCCCeeeeeecCCCcceeecCcccccccCC---CccccCCCCCccccchHHHHHHhcccccccccCcc
Q 042150          182 ILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTH---PPNYQKGGASREIGPDNVYMTAQEMNRDNAMLGAR  258 (803)
Q Consensus       182 ~~R~n~Gg~~~~~~~D~~~r~w~~d~~~~~~~~~~~~~~~s~---~~~~~~~~~~~~~~P~~vy~TAr~~~~~~~~~~~~  258 (803)
                      ++|+||||+..   .|.....|.+|..+....  + ....+.   .........-....+..||||+|.+..        
T Consensus         2 ~~~IN~Gg~~~---~~~~g~~w~~D~~~~~g~--~-~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--------   67 (174)
T PF11721_consen    2 VLRINAGGPAY---TDSSGIVWEADQYYTGGS--W-GYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--------   67 (174)
T ss_dssp             EEEEEETSSSE---EETTTEEE-SSSSSTTSS--------------SSTTS--TTS-HHHHHTTT-----SS--------
T ss_pred             EEEEECCCCcc---cCCCCCEEcCCCCCCCCC--c-ccccccccccccccccccccCCCchhhhHhhcCCCC--------
Confidence            68999999998   444566678888754222  2 110000   000000001112456789999999751        


Q ss_pred             cceeEeeeccCCCCeeEEEEEeeeeecCC------CCcEEEEEEEcCeeecccCCccccccCCccccEEEEe-EEeecCC
Q 042150          259 FNITWDFPVGSHGNRHLVRLHFCDIVSPS------LNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDF-VADSDDA  331 (803)
Q Consensus       259 ~~lt~~~~~~~~~~~y~v~lhFae~~~~~------~~~R~Fdi~in~~~~~~~~di~~~~~~~~~~~~~~~~-~~~~~~~  331 (803)
                       +|+|.+|+.+ +|.|.|+|||||+.+..      .|+|+|||+|||++++++|||..+ +++..+++++.| .+.+ .+
T Consensus        68 -~f~Y~ip~~~-~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~-~G~~~~~~~~~~~~v~v-~d  143 (174)
T PF11721_consen   68 -SFSYDIPVVP-NGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAE-AGGFNKAAVRRFFNVTV-TD  143 (174)
T ss_dssp             -SEEEEEE--S--EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHH-HSSSS---EEEEEEEEE-ET
T ss_pred             -ceEEEEecCC-CcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHH-cCCCceEEEEEEEEEEE-eC
Confidence             3899999777 79999999999998877      899999999999999999999998 566666788777 6666 55


Q ss_pred             ceeEEEEec
Q 042150          332 GVVRVSVGP  340 (803)
Q Consensus       332 ~~~~is~~~  340 (803)
                      |.|.|.|.+
T Consensus       144 g~L~i~f~~  152 (174)
T PF11721_consen  144 GTLNIQFVW  152 (174)
T ss_dssp             TEEETTEEE
T ss_pred             CcEEEEEEe
Confidence            788888864

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=4.1e-19  Score=195.32  Aligned_cols=224  Identities=21%  Similarity=0.217  Sum_probs=175.3

Q ss_pred             EeeeCceEEEEEE----ECCCcEEEEEEcCCCCC--CChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEEecCC
Q 042150          469 IGSGGFGMVYKGV----LRDNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       469 Lg~G~fg~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      +|+|.||.|++..    .+.+..+|.|.+.....  ........|..++..++ ||.++++...++.+..++++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6899999998754    23366677776443321  11124566888888886 99999999999999999999999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCcee
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS  621 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  621 (803)
                      |.|...+  .....+.+.........++-+++++|+   .+++|||+|++||+++.+|++++.|||+++..-..      
T Consensus        82 g~lft~l--~~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------  150 (612)
T KOG0603|consen   82 GDLFTRL--SKEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------  150 (612)
T ss_pred             chhhhcc--ccCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhh------
Confidence            9999888  445556777777788899999999999   99999999999999999999999999999863221      


Q ss_pred             ccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ...+||..|||||++.  ....++|.||||++++||++|..||...    .      .....+           ..-.++
T Consensus       151 ~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----~------~~~Il~-----------~~~~~p  207 (612)
T KOG0603|consen  151 KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----T------MKRILK-----------AELEMP  207 (612)
T ss_pred             hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----H------HHHHhh-----------hccCCc
Confidence            1128899999999998  5678899999999999999999998751    1      111111           111345


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCH
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSM  726 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~  726 (803)
                      .+....+..++..++..+|.+|--.
T Consensus       208 ~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  208 RELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            5667778889999999999999654

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=1.4e-17  Score=167.68  Aligned_cols=136  Identities=15%  Similarity=0.169  Sum_probs=105.8

Q ss_pred             CccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-----cCCCeeeEEeEeeccc---e-eeE
Q 042150          464 DKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-----RHRHLVSLVGYCEEQS---E-MIL  534 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-----~HpnIv~l~g~~~~~~---~-~~l  534 (803)
                      ....+||+|+||.||.  +.+....+||+.........+++.+|+.+++.+     .||||++++|+++++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4456899999999996  433333468876655444567899999999999     5799999999998763   3 347


Q ss_pred             EEEe--cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCceEeeccCcceEEEcc----CCcEEEeeec
Q 042150          535 VYEY--MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGL-HYLHTGSAEGIIHRDIKSTNILLDE----NYVSKVADFG  607 (803)
Q Consensus       535 V~Ey--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDLkp~NILl~~----~~~~kl~DFG  607 (803)
                      |+||  +++|+|.+++.+   ..+++.  ..++.+++.++ +|||+   ++|+||||||+|||++.    +..++|+||+
T Consensus        83 I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            8999  668999999933   235555  35678888887 99999   99999999999999974    3479999955


Q ss_pred             cc
Q 042150          608 LS  609 (803)
Q Consensus       608 la  609 (803)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            43

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=1.2e-16  Score=162.69  Aligned_cols=134  Identities=26%  Similarity=0.403  Sum_probs=112.9

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCC--------hHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG--------LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      +.||+|++|.||+|.. .+..+++|+........        ...+.+|++++..++|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4789999999999987 56788999755432211        23578899999999999998888787777888999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      +++++|.+++...     .+ ++..++.+++.+|.+||+   .+++|+|++|+|||++ ++.++|+|||+++.
T Consensus        81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998321     22 888999999999999999   9999999999999999 78999999998764

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.7e-16  Score=163.76  Aligned_cols=146  Identities=18%  Similarity=0.159  Sum_probs=112.8

Q ss_pred             HHHHhcCCCccceEeeeCceEEEEEE--ECCCcEEEEEEcCCCCCC------------------------ChHHHHHHHH
Q 042150          456 LQTATNNFDKNLIIGSGGFGMVYKGV--LRDNTKVAVKRGVPGSRQ------------------------GLPEFQTEIT  509 (803)
Q Consensus       456 l~~~~~~f~~~~~Lg~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~f~~E~~  509 (803)
                      +..-...|...+.||+|+||.||+|.  ..+|+.||+|........                        ....+.+|++
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            33333457788899999999999998  567999999986543210                        0123568999


Q ss_pred             HHHhccCC--CeeeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc-eEee
Q 042150          510 VLSKIRHR--HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG-IIHR  586 (803)
Q Consensus       510 ~l~~l~Hp--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHr  586 (803)
                      ++.++.+.  .+.+.+++    ...+|||||+++++|...+.  ....+...+...++.|++.+|.+||+   .+ ++||
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~  173 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHG  173 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeC
Confidence            99999753  34455543    23589999999988876652  23345666778999999999999999   88 9999


Q ss_pred             ccCcceEEEccCCcEEEeeeccccC
Q 042150          587 DIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       587 DLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      ||||+||+++ ++.++|+|||++..
T Consensus       174 Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      174 DLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             CCChhhEEEE-CCCEEEEEChhhhc
Confidence            9999999999 88999999999874

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=1.8e-16  Score=164.21  Aligned_cols=194  Identities=19%  Similarity=0.227  Sum_probs=135.1

Q ss_pred             cCCCeeeEEeEeec---------------------------cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHH
Q 042150          515 RHRHLVSLVGYCEE---------------------------QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIG  567 (803)
Q Consensus       515 ~HpnIv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  567 (803)
                      +|||||++.++|.+                           ...+||||.-.+. +|++++..   ...+.....-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~---~~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT---RHRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc---CCCchHHHHHHHHH
Confidence            59999999887633                           2347899987765 89999943   23455566678899


Q ss_pred             HHHHHHHHhcCCCCceEeeccCcceEEE--ccCC--cEEEeeeccccCCCC----CCCCceeccccCCCcccCccccccC
Q 042150          568 AARGLHYLHTGSAEGIIHRDIKSTNILL--DENY--VSKVADFGLSRSGPC----LDETHVSTGVKGSFGYLDPEYFRRQ  639 (803)
Q Consensus       568 ia~gL~yLH~~~~~~ivHrDLkp~NILl--~~~~--~~kl~DFGla~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~  639 (803)
                      +++|+.|||.   ++|.|||||++||||  |+|.  .+.|+|||++-....    ...........|...-||||+....
T Consensus       350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            9999999999   999999999999999  3444  467899998743111    1112222335578889999987532


Q ss_pred             c------CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHH
Q 042150          640 Q------LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAE  713 (803)
Q Consensus       640 ~------~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~  713 (803)
                      +      --.|+|.|+.|.+.||+++...||.... +-..+...+     ++         ......+..+++.+++++.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Y-----qe---------~qLPalp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTY-----QE---------SQLPALPSRVPPVARQLVF  491 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhh-----hh---------hhCCCCcccCChHHHHHHH
Confidence            2      2358999999999999999999986521 111111111     01         1112334455677899999


Q ss_pred             HccccCCCCCCCHHHHH
Q 042150          714 KCLADYGVDRPSMGDVL  730 (803)
Q Consensus       714 ~cl~~~p~~RPs~~evl  730 (803)
                      ..|+.||++|++..-.-
T Consensus       492 ~lL~r~pskRvsp~iAA  508 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAA  508 (598)
T ss_pred             HHhcCCccccCCccHHH
Confidence            99999999999864433

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.67  E-value=2.7e-16  Score=158.65  Aligned_cols=130  Identities=28%  Similarity=0.415  Sum_probs=106.1

Q ss_pred             eEeeeCceEEEEEEECCCcEEEEEEcCCCCCC--------ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ--------GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +||+|+||.||+|.+ ++..+++|........        ...++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            479999999999985 4678999985543211        1256778999999999887665555566666779999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      ++++|.+++...  ..       .++.+++.+|.+||+   .+++|+|++|+||+++ ++.++++|||+++.
T Consensus        80 ~g~~l~~~~~~~--~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG--ND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc--HH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999987321  10       789999999999999   9999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.67  E-value=3e-16  Score=158.24  Aligned_cols=143  Identities=21%  Similarity=0.173  Sum_probs=112.3

Q ss_pred             hhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCC----------------------CChHHHHHHHHHH
Q 042150          454 TDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSR----------------------QGLPEFQTEITVL  511 (803)
Q Consensus       454 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~f~~E~~~l  511 (803)
                      .++......|...+.||+|+||.||++..++|+.||||+......                      .....+..|+.++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            344455555777889999999999999988899999997443210                      0112367889999


Q ss_pred             HhccCC--CeeeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccC
Q 042150          512 SKIRHR--HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIK  589 (803)
Q Consensus       512 ~~l~Hp--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk  589 (803)
                      .++.|+  .++..++.    ...++||||+++++|......        .....++.+++.++.++|+   .+++|||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~  152 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLS  152 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCC
Confidence            999887  44455443    345899999999998776520        3456788999999999999   999999999


Q ss_pred             cceEEEccCCcEEEeeeccccC
Q 042150          590 STNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       590 p~NILl~~~~~~kl~DFGla~~  611 (803)
                      |+||++++++.++|+|||++..
T Consensus       153 p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             cccEEEcCCCcEEEEECCcccc
Confidence            9999999999999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=2.2e-16  Score=183.22  Aligned_cols=138  Identities=25%  Similarity=0.325  Sum_probs=112.8

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCC-CC-------CChHHHHHHHHHHHhccCCCeeeEEeEeeccc
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG-SR-------QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS  530 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~-~~-------~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~  530 (803)
                      ....|...++||+|+||.||+|.+.+.. +++|+.... ..       ...+.+.+|++++.+++|++++....++....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3344566789999999999999876544 444432211 11       11346889999999999999998888887777


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..++||||+++++|.+++.          ....++.+++++|.+||+   .+++||||||+|||+ +++.++|+|||+++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            8899999999999999883          457899999999999999   999999999999999 67899999999987


Q ss_pred             C
Q 042150          611 S  611 (803)
Q Consensus       611 ~  611 (803)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            5

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.65  E-value=2.3e-17  Score=178.41  Aligned_cols=174  Identities=28%  Similarity=0.414  Sum_probs=129.1

Q ss_pred             eeeEEEEecCCCchhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          531 EMILVYEYMEKGPLKKHLYG-PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      .+++.|++|...+|.++|.+ ......++...+.++.|++.|+.|      ++.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            57899999999999999964 334567889999999999999999      57899999999999999999999999997


Q ss_pred             cCCCCCC----CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhh
Q 042150          610 RSGPCLD----ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQK  684 (803)
Q Consensus       610 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  684 (803)
                      .......    .....+...||..||+||.+.++.|+.|+||||||++|+||+. -...++...          +....+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhhh
Confidence            6543322    1223456789999999999999999999999999999999996 333222110          000111


Q ss_pred             cCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 042150          685 KGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDV  729 (803)
Q Consensus       685 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev  729 (803)
                      .+    +++|....+.     +.=..++.+++...|.+||++.++
T Consensus       474 ~g----~ip~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  474 DG----IIPPEFLQDY-----PEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             cC----CCChHHhhcC-----cHHHHHHHHhcCCCcccCchHHHH
Confidence            11    1222222222     123478999999999999954443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=4.9e-16  Score=178.93  Aligned_cols=209  Identities=23%  Similarity=0.306  Sum_probs=144.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ..+|+.+++|..|++|.||..+++. .+.+|.|..+...      ..+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee------------------
Confidence            4578889999999999999998765 5567775422110      0000  22222334333                  


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                         |+-...+..  -++++...        +.+++|||+   .+|+|||+||+|.+|+.-|++|+.|||+++.+......
T Consensus       136 ---gDc~tllk~--~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ---GDCATLLKN--IGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ---chhhhhccc--CCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence               444444422  22333222        678999999   99999999999999999999999999998753221111


Q ss_pred             -------------ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc
Q 042150          619 -------------HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK  685 (803)
Q Consensus       619 -------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (803)
                                   .....++||+.|.|||++..+.|....|+|++|+|+||.+-|+.||.....++....      .+.+
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~------visd  273 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ------VISD  273 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh------hhhh
Confidence                         012346899999999999999999999999999999999999999987655443211      1110


Q ss_pred             CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCC
Q 042150          686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRP  724 (803)
Q Consensus       686 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP  724 (803)
                              .....+-+.....++++++.+.|+.+|..|-
T Consensus       274 --------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  274 --------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             --------hccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                    0111122334456789999999999999994

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.59  E-value=1.7e-14  Score=137.75  Aligned_cols=134  Identities=19%  Similarity=0.203  Sum_probs=114.7

Q ss_pred             cceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccC--CCeeeEEeEeeccceeeEEEEecCCCc
Q 042150          466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH--RHLVSLVGYCEEQSEMILVYEYMEKGP  543 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gs  543 (803)
                      .+.||+|.++.||++...+ ..+++|.......  ...+.+|+.++..++|  .+++++++++...+..+++|||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4579999999999999865 7889998654433  5679999999999976  599999999988889999999999877


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          544 LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       544 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      +..+         +......++.+++++|++||.....+++|+||+|+||++++.+.++++|||+++.
T Consensus        80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            7654         5567788999999999999985556899999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.54  E-value=5.1e-14  Score=145.68  Aligned_cols=135  Identities=19%  Similarity=0.194  Sum_probs=104.8

Q ss_pred             cceEe-eeCceEEEEEEECCCcEEEEEEcCCCC-------------CCChHHHHHHHHHHHhccCCCe--eeEEeEeecc
Q 042150          466 NLIIG-SGGFGMVYKGVLRDNTKVAVKRGVPGS-------------RQGLPEFQTEITVLSKIRHRHL--VSLVGYCEEQ  529 (803)
Q Consensus       466 ~~~Lg-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~f~~E~~~l~~l~HpnI--v~l~g~~~~~  529 (803)
                      ..+|| .||.|+||+.... +..++||+.....             ......+.+|++++.+|+|++|  +..++++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35788 8999999998875 6778888653211             1223568899999999998875  6777765433


Q ss_pred             c----eeeEEEEecCC-CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEe
Q 042150          530 S----EMILVYEYMEK-GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA  604 (803)
Q Consensus       530 ~----~~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~  604 (803)
                      .    ..++|||++++ .+|.+++..   ..++..    .+.+++.+|.+||+   .||+||||||.|||++.++.++|+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEE
Confidence            2    23599999997 689888832   345443    35689999999999   999999999999999998899999


Q ss_pred             eeccccC
Q 042150          605 DFGLSRS  611 (803)
Q Consensus       605 DFGla~~  611 (803)
                      |||.++.
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998865

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.54  E-value=3.2e-14  Score=141.96  Aligned_cols=136  Identities=20%  Similarity=0.196  Sum_probs=97.5

Q ss_pred             cceEeeeCceEEEEEEECCCcEEEEEEcCCCCCC--ChHH----------------------HHHHHHHHHhccCC--Ce
Q 042150          466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ--GLPE----------------------FQTEITVLSKIRHR--HL  519 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------f~~E~~~l~~l~Hp--nI  519 (803)
                      .+.||+|+||.||+|...+++.||||+.......  ....                      ...|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3579999999999999888999999975543211  1111                      13566666666543  24


Q ss_pred             eeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC
Q 042150          520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY  599 (803)
Q Consensus       520 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~  599 (803)
                      .+.+++    ...++||||++++.+........  ... .+...++.+++.++.++|.  .++|+|+||||+||+++ ++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh--hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence            444443    24589999999965432211100  011 6678899999999999996  37899999999999999 89


Q ss_pred             cEEEeeeccccC
Q 042150          600 VSKVADFGLSRS  611 (803)
Q Consensus       600 ~~kl~DFGla~~  611 (803)
                      .++|+|||++..
T Consensus       152 ~~~liDfg~a~~  163 (187)
T cd05119         152 KVYIIDVPQAVE  163 (187)
T ss_pred             cEEEEECccccc
Confidence            999999999865

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=1.7e-14  Score=166.98  Aligned_cols=255  Identities=24%  Similarity=0.283  Sum_probs=184.9

Q ss_pred             CCCccceEeeeCceEEEEEEECC--CcEEEEEEcCCCC--CCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD--NTKVAVKRGVPGS--RQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .|...+.||+|.|+.|-......  ...+++|......  .........|..+-..+. |+|++.+++...+....+++.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            35555679999999998877533  3455666533322  222233345777777776 999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCceEeeccCcceEEEccCC-cEEEeeeccccCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH-TGSAEGIIHRDIKSTNILLDENY-VSKVADFGLSRSGPC  614 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFGla~~~~~  614 (803)
                      +|..++++.+.+........+....-.++.|+..++.|+| .   .++.||||||+|.+++..+ ..+++|||+|.....
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            9999999998884333324566677788999999999999 6   8999999999999999999 999999999986554


Q ss_pred             -CCCCceeccccC-CCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          615 -LDETHVSTGVKG-SFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       615 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                       ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++....... ....|....   +.    
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~~----  249 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---GR----  249 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---cc----
Confidence             333344445677 9999999999874 445679999999999999999999875543331 111111110   00    


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLW  731 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  731 (803)
                      ......    ........+++.+++..+|..|.+.+++..
T Consensus       250 ~~~~~~----~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 FTQLPW----NSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccCcc----ccCChhhhhcccccccCCchhccccccccc
Confidence            001111    122345577888999999999999888764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=4.1e-13  Score=150.87  Aligned_cols=138  Identities=22%  Similarity=0.284  Sum_probs=99.3

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCCh----------------------------------------HHHHH
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGL----------------------------------------PEFQT  506 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~f~~  506 (803)
                      +.||.|++|.||+|++++|+.||||+..+......                                        -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            57999999999999999999999998665421110                                        03556


Q ss_pred             HHHHHHhcc-----CCCeeeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 042150          507 EITVLSKIR-----HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR-GLHYLHTGSA  580 (803)
Q Consensus       507 E~~~l~~l~-----HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~~  580 (803)
                      |.+.+.+++     ++++.-..-+....+..+|||||++|++|.+....... ..   .+.+++..+++ .+..+|.   
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~---  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLR---  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHh---
Confidence            666666663     34332222222334567999999999999887632111 12   24456666666 4678887   


Q ss_pred             CceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          581 EGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       581 ~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .|++|+|+||.||++++++.++|+|||++..
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~  306 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGR  306 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence            9999999999999999999999999999865

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=99.42  E-value=1e-12  Score=154.43  Aligned_cols=148  Identities=24%  Similarity=0.312  Sum_probs=109.9

Q ss_pred             ceeecCCCccc--c-cC------CceeecCCCCCccccccCcc--ccccc--CCCCCCCCCCccceeeeecc---ceeEE
Q 042150            2 YLINCGSPTNA--S-LY------NRFFVPDASSKSVSFSADNS--ISLKS--KTPPQDSPSPYDTARVFTSD---GSYKL   65 (803)
Q Consensus         2 ~~I~CG~~~~~--~-~~------~~~~~~D~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~~t~R~f~~~---~cY~~   65 (803)
                      |+||||+....  . +.      ||.|.+|..|... ....++  ..+.+  .++...+...|+|||.+...   .+|.|
T Consensus       194 ~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~-~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~  272 (623)
T PLN03150        194 KRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSG-SDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTM  272 (623)
T ss_pred             EEEEecCcccccccCCCCCcccCccccCcCcccCCC-cccccccccccccccCCCccChHHHhhhhccccCCCCceEEEe
Confidence            78999985432  1 21      7899999887532 121221  12221  11122244589999999863   89999


Q ss_pred             eeecCceEEEEEeecCCCCCcccccccEEEEEECcEEEEeccCC-------CceEEEEEEEEecCCeEEEEEeecCCCCc
Q 042150           66 NIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFST-------QVVVLKEFIVKVDGDVIEIEFRPVGDKNF  138 (803)
Q Consensus        66 ~~~~~~~ylvR~~F~~~~~~~~~~~~~~F~~~~~~~~~~~~~~~-------~~~~~~e~i~~~~~~~~~v~~~~~~~~~~  138 (803)
                      ++.++++|+||+||+.............|||++||...++.++.       ..++++++.+.+.++.++|+|+|.+ +..
T Consensus       273 ~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~g~l~isl~p~~-~s~  351 (623)
T PLN03150        273 DVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKK-GTH  351 (623)
T ss_pred             ecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecCCeEEEEEeeCC-CCc
Confidence            99899999999999999764444446899999999999888764       2578889999988889999999984 556


Q ss_pred             ceeeeeEEEecCC
Q 042150          139 GFVNAIEVFSAPE  151 (803)
Q Consensus       139 ~fv~~iE~~~~~~  151 (803)
                      |+||||||+.+-.
T Consensus       352 pilNaiEI~~~~~  364 (623)
T PLN03150        352 AIINAIEVFEIIT  364 (623)
T ss_pred             ceeeeeeeeeccc
Confidence            9999999999966

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=1.7e-12  Score=132.29  Aligned_cols=204  Identities=22%  Similarity=0.339  Sum_probs=139.6

Q ss_pred             HHHHhccCCCeeeEEeEeecc-----ceeeEEEEecCCCchhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 042150          509 TVLSKIRHRHLVSLVGYCEEQ-----SEMILVYEYMEKGPLKKHLYGP--DRTPLSWKQRLEICIGAARGLHYLHTGSAE  581 (803)
Q Consensus       509 ~~l~~l~HpnIv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  581 (803)
                      .-|-++-|-|||++..|+.+.     ....++.|||+.|+|..+|++.  ....+..+...+++.||..||.|||+ +.+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            345556799999999988543     3578899999999999999643  34567788888999999999999998 668


Q ss_pred             ceEeeccCcceEEEccCCcEEEeeeccccCCCCC--CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh
Q 042150          582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL--DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC  659 (803)
Q Consensus       582 ~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt  659 (803)
                      .|+|+++..+-|++..++-+||+--.-.......  ..........+-++|.+||.=...+.+..+|||+||++.+||--
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            9999999999999999998887532111100000  00011123346789999998777788889999999999999987


Q ss_pred             CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          660 ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       660 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +..--....  ......+-...     .+..+-++.            -+.++.+|++..|..||+|++++.+
T Consensus       278 lEiq~tnse--S~~~~ee~ia~-----~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  278 LEIQSTNSE--SKVEVEENIAN-----VIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             heeccCCCc--ceeehhhhhhh-----heeeccCcc------------ccCcCcccccCCCCCCcchhhhhcC
Confidence            764311110  00000000000     000000111            1456789999999999999998764

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=99.29  E-value=6e-12  Score=123.21  Aligned_cols=143  Identities=26%  Similarity=0.309  Sum_probs=87.4

Q ss_pred             ceeecCCCcccccCCceeecCCCCCccccccCcc-------cccccCCCCCCCCCCccceeeeeccceeEEeeecCceEE
Q 042150            2 YLINCGSPTNASLYNRFFVPDASSKSVSFSADNS-------ISLKSKTPPQDSPSPYDTARVFTSDGSYKLNIKRNGTHL   74 (803)
Q Consensus         2 ~~I~CG~~~~~~~~~~~~~~D~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~t~R~f~~~~cY~~~~~~~~~yl   74 (803)
                      |+||||++..+...+..|.+|..|..++..-..+       ............+.+|+|.|.=|..+.|.||+.+.|.|.
T Consensus         3 ~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~ip~~~~G~Y~   82 (174)
T PF11721_consen    3 LRINAGGPAYTDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPSSFSYDIPVVPNGTYT   82 (174)
T ss_dssp             EEEEETSSSEEETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SSSEEEEEE--S-EEEE
T ss_pred             EEEECCCCcccCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCCceEEEEecCCCcEEE
Confidence            6899999877666688999999987544410000       011111112335579999999777799999977999999


Q ss_pred             EEEeecCCCCCc----ccccccEEEEEECcEEEEeccCCC------c-eEEEEE-EEEecCCeEEEEEeecC--------
Q 042150           75 VRFHFSPFESDN----FKLASAKFGVLANGLLLLQDFSTQ------V-VVLKEF-IVKVDGDVIEIEFRPVG--------  134 (803)
Q Consensus        75 vR~~F~~~~~~~----~~~~~~~F~~~~~~~~~~~~~~~~------~-~~~~e~-i~~~~~~~~~v~~~~~~--------  134 (803)
                      |||||....+..    .....-.|||++||-.++.+||..      . +.++++ -+.+.++.|.|+|...+        
T Consensus        83 V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~~~~i~~  162 (174)
T PF11721_consen   83 VRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKGTLCIPF  162 (174)
T ss_dssp             EEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--SEEEEEE
T ss_pred             EEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCCcEEeec
Confidence            999998877754    223357999999999999999872      2 567777 55678899999998421        


Q ss_pred             --CCCcceeeee
Q 042150          135 --DKNFGFVNAI  144 (803)
Q Consensus       135 --~~~~~fv~~i  144 (803)
                        ....|.||||
T Consensus       163 ~~~~~~p~IsaI  174 (174)
T PF11721_consen  163 IGSYGNPLISAI  174 (174)
T ss_dssp             ESSSSSSSEEEE
T ss_pred             cccCCCcEEeeC
Confidence              2234777776

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.23  E-value=4.9e-11  Score=116.81  Aligned_cols=130  Identities=19%  Similarity=0.123  Sum_probs=96.0

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCee-eEEeEeeccceeeEEEEecCCCchh
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV-SLVGYCEEQSEMILVYEYMEKGPLK  545 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv-~l~g~~~~~~~~~lV~Ey~~~gsL~  545 (803)
                      +.|+.|.++.||++... +..+++|....... ....+.+|+.+++.+.+.+++ +++.+..  ...++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence            46889999999999876 67899998544322 234578899999999765554 4444433  3357999999998876


Q ss_pred             hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          546 KHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS--AEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      ...       .   ....+..+++++|+.||...  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            431       1   11345678999999999832  23469999999999999 66899999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.21  E-value=3.1e-11  Score=137.29  Aligned_cols=142  Identities=20%  Similarity=0.196  Sum_probs=92.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCC------------------------------h-------
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQG------------------------------L-------  501 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~------------------------------~-------  501 (803)
                      -..|+. +.||+|++|.||+|++++ |+.||||+..+...+.                              .       
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 689999999999999988 9999999876542110                              0       


Q ss_pred             ---HHHHHHHHHHHhcc----CCCeeeEEeEe-eccceeeEEEEecCCCchhhhccCCCCC----CCCHHHHHHHHHHHH
Q 042150          502 ---PEFQTEITVLSKIR----HRHLVSLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRT----PLSWKQRLEICIGAA  569 (803)
Q Consensus       502 ---~~f~~E~~~l~~l~----HpnIv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~----~l~~~~~~~i~~~ia  569 (803)
                         -+|.+|+..+.+++    +.+.+.+-.++ .-....+|||||++|+.|.+.-.-...+    .+....+..++.|  
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--  275 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--  275 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence               12455555555553    33333322222 2245678999999999997742111111    1222222222233  


Q ss_pred             HHHHHHhcCCCCceEeeccCcceEEEccCC----cEEEeeeccccCC
Q 042150          570 RGLHYLHTGSAEGIIHRDIKSTNILLDENY----VSKVADFGLSRSG  612 (803)
Q Consensus       570 ~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~~kl~DFGla~~~  612 (803)
                           ++.   .|++|+|+||.||+++.++    .++++|||++...
T Consensus       276 -----if~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        276 -----VFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             -----HHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence                 333   8899999999999999888    9999999998654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=3.8e-11  Score=133.11  Aligned_cols=248  Identities=21%  Similarity=0.166  Sum_probs=176.1

Q ss_pred             CCCccceEee--eCceEEEEEEE---CCCcEEEEEEcCCCCC--CChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceee
Q 042150          462 NFDKNLIIGS--GGFGMVYKGVL---RDNTKVAVKRGVPGSR--QGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       462 ~f~~~~~Lg~--G~fg~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~  533 (803)
                      .|.....+|.  |.+|.+|.+..   .++..+|+|+-...-.  +....=.+|+...+++ .|+|.++....+...+.++
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3556668999  99999999987   3477889987333222  2233335677777777 4999999888899999999


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCceEeeccCcceEEEccC-CcEEEeeecc
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR----GLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGL  608 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~kl~DFGl  608 (803)
                      +-+|++. .+|.++.+.. ...++...++.+..+...    ||.++|+   ..++|-|+||.||++.++ ...+++|||+
T Consensus       195 iqtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence            9999886 6888877542 233666777777777777    9999999   999999999999999998 8899999999


Q ss_pred             ccCCCCCCCCc---eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc
Q 042150          609 SRSGPCLDETH---VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK  685 (803)
Q Consensus       609 a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (803)
                      ...........   ......+...|++||... .-++.++|+|++|.+..|..++..........      .|..     
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~-----  337 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQ-----  337 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccc-----
Confidence            87544332111   122335778899999875 46788999999999999999887654322100      1110     


Q ss_pred             CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042150          686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLW  731 (803)
Q Consensus       686 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  731 (803)
                        ++...   +..++......++...+..+++.+|..|++.+.+..
T Consensus       338 --~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 --LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence              00000   111222222345666899999999999998877754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.13  E-value=7.6e-10  Score=113.29  Aligned_cols=142  Identities=22%  Similarity=0.321  Sum_probs=112.4

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccC--CCeeeEEeEeeccc---eeeEEEEecC
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRH--RHLVSLVGYCEEQS---EMILVYEYME  540 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~~~~---~~~lV~Ey~~  540 (803)
                      +.|+.|..+.||++...+|+.+++|....... ....++..|.++++.+++  .++.+++.++....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999987778899998544322 245678999999999975  44677888876643   5689999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS-----------------------------------------  579 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----------------------------------------  579 (803)
                      +.++.+.+..   ..++..++..++.++++.|..||+..                                         
T Consensus        84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9988876621   45778888889999999999998521                                         


Q ss_pred             ------------CCceEeeccCcceEEEcc--CCcEEEeeeccccC
Q 042150          580 ------------AEGIIHRDIKSTNILLDE--NYVSKVADFGLSRS  611 (803)
Q Consensus       580 ------------~~~ivHrDLkp~NILl~~--~~~~kl~DFGla~~  611 (803)
                                  ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        245799999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.12  E-value=8.9e-10  Score=123.29  Aligned_cols=166  Identities=17%  Similarity=0.208  Sum_probs=122.5

Q ss_pred             ECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHH
Q 042150          482 LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQR  561 (803)
Q Consensus       482 ~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~  561 (803)
                      ..++.+|.|...+...........+-++.|+.++||||++++...+.++.+|||+|-+.  .|..++..     +.....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v  106 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEV  106 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHH
Confidence            34577787776554444334456777889999999999999999999999999999874  46666622     234555


Q ss_pred             HHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcC
Q 042150          562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL  641 (803)
Q Consensus       562 ~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  641 (803)
                      .-.+.||+.||.|||+  ..+++|++|.-.-|++++.|..||++|.++........  .......-..|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            5677899999999986  37899999999999999999999999998765332221  111112223466676554322 


Q ss_pred             CCcceehhHHHHHHHHHhC
Q 042150          642 TDKSDVYSFGVVLFEVLCA  660 (803)
Q Consensus       642 t~ksDV~S~Gvvl~elltG  660 (803)
                       -..|.|-|||+++|++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             346999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.09  E-value=9.3e-10  Score=109.09  Aligned_cols=134  Identities=16%  Similarity=0.137  Sum_probs=97.1

Q ss_pred             ceEeeeCceEEEEEEECC-------CcEEEEEEcCCC-------------C-C--------CChHHH----HHHHHHHHh
Q 042150          467 LIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPG-------------S-R--------QGLPEF----QTEITVLSK  513 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~-------------~-~--------~~~~~f----~~E~~~l~~  513 (803)
                      ..||.|--+.||.|.-.+       +..+|||..+..             . +        ...+.+    .+|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       478999953211             0 0        011223    389999999


Q ss_pred             cc--CCCeeeEEeEeeccceeeEEEEecCCCchhh-hccCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCceEeeccC
Q 042150          514 IR--HRHLVSLVGYCEEQSEMILVYEYMEKGPLKK-HLYGPDRTPLSWKQRLEICIGAARGLHYL-HTGSAEGIIHRDIK  589 (803)
Q Consensus       514 l~--HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDLk  589 (803)
                      +.  .-++...+++    ..-+|||||+.++.+.. .+   ....++..+...+..+++.+|..| |.   .+++|+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence            95  3566677764    45689999997754422 22   122345566778889999999999 77   899999999


Q ss_pred             cceEEEccCCcEEEeeeccccC
Q 042150          590 STNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       590 p~NILl~~~~~~kl~DFGla~~  611 (803)
                      +.|||++ ++.+.|+|||.+-.
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~  173 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCcee
Confidence            9999997 46799999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.03  E-value=2.2e-10  Score=127.12  Aligned_cols=249  Identities=18%  Similarity=0.190  Sum_probs=176.7

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC--CCcEEEEEEcCCCCCCChHHH--HHHHHHHHhc-cCCCeeeEEeEeecccee
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR--DNTKVAVKRGVPGSRQGLPEF--QTEITVLSKI-RHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~f--~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  532 (803)
                      ..+.+|.....||.|.|+.|++...+  ++..+++|...........+.  ..|+.+...+ .|.+++.....+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567888889999999999987743  577889997655543333332  4566666666 588888887777777777


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC-CcEEEeeeccccC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRS  611 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~kl~DFGla~~  611 (803)
                      ++=-||++++++...+  .-...++...++++..|++.++.++|+   +.++|+|+||+||++..+ +..++.|||+...
T Consensus       342 ~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             cCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccc
Confidence            8899999999887666  234557788899999999999999998   999999999999999875 8889999998763


Q ss_pred             CCCCCCCceeccccCCCccc--CccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          612 GPCLDETHVSTGVKGSFGYL--DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      ....     .....+.-+++  +++......+..+.|++|||.-+.|.++|...-....        +|.  .+..+.+ 
T Consensus       417 ~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~--~i~~~~~-  480 (524)
T KOG0601|consen  417 LAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL--TIRSGDT-  480 (524)
T ss_pred             ccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce--eeecccc-
Confidence            1110     11112233444  5555667788999999999999999998875432111        110  0011110 


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                          +.    .+ .....+..+.+.++..++..||.+.++..+.+..
T Consensus       481 ----p~----~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  481 ----PN----LP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ----cC----CC-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                11    11 1225677888999999999999998887665544

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.99  E-value=4.5e-09  Score=99.92  Aligned_cols=143  Identities=20%  Similarity=0.202  Sum_probs=104.8

Q ss_pred             ccceEeeeCceEEEEEEECCCcEEEEEE-cCCCCCC-------ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          465 KNLIIGSGGFGMVYKGVLRDNTKVAVKR-GVPGSRQ-------GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       465 ~~~~Lg~G~fg~Vy~~~~~~~~~vavK~-~~~~~~~-------~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ...+|-+|+-+.|+++.+. |+...||. +....+.       ...+..+|+++|.+++--.|.--.-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            3458899999999999886 56666664 3222221       2346788999999997555554445566666678999


Q ss_pred             EecCC-CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC---cEEEeeeccccC
Q 042150          537 EYMEK-GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY---VSKVADFGLSRS  611 (803)
Q Consensus       537 Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~~kl~DFGla~~  611 (803)
                      ||+++ -++.+++...............++..|-+.+.-||.   .+|+|+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 477888754333333333447888899999999999   9999999999999996554   458999999754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.98  E-value=4.2e-09  Score=100.78  Aligned_cols=130  Identities=26%  Similarity=0.378  Sum_probs=100.5

Q ss_pred             eEeeeCceEEEEEEECCCcEEEEEEcCCC-CCC-C------hHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPG-SRQ-G------LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~-~------~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .+++|+-+.+|.+.+. |.++++|.-.++ .+. .      .....+|+++|.+++--.|..-+-+..+.....|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999775 445677753222 111 1      235678999999997666665566677777888999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      ++-.|.+.+...         ...++..+-.-+.-||.   .+|+|+||.++||++..+. +.++||||+..
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888332         35677778888888999   9999999999999998765 99999999875

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.88  E-value=4.9e-08  Score=106.09  Aligned_cols=168  Identities=14%  Similarity=0.181  Sum_probs=126.2

Q ss_pred             ceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEee----ccceeeEEEEecCC-Cchhhh
Q 042150          474 FGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE----EQSEMILVYEYMEK-GPLKKH  547 (803)
Q Consensus       474 fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~~  547 (803)
                      -.+.||+.. -||..+++|++.....+.......-++.++++.|+|+|++..++.    .+..++|||+|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            357889884 478999999973333333334456688999999999999998875    34568999999986 567665


Q ss_pred             ccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          548 LYGP-------------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       548 l~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      -...             .+...++..+|.++.|+..||.++|+   .|+.-+-|.+++||++.+.+++|+.+|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            5321             23457889999999999999999999   8888899999999999999999988887654221


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTA  663 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p  663 (803)
                      ..              .  |-+..   -.+-|.=-||.+++.|.||...
T Consensus       446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            11              0  11211   1256888999999999999653

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.82  E-value=4.2e-08  Score=102.81  Aligned_cols=141  Identities=13%  Similarity=0.073  Sum_probs=101.8

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCCCC-----------CChHHHHHHHHHHHhccCC--CeeeEEeEeec-----
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSR-----------QGLPEFQTEITVLSKIRHR--HLVSLVGYCEE-----  528 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~f~~E~~~l~~l~Hp--nIv~l~g~~~~-----  528 (803)
                      +.+-+-.-..|.+..+ +|+.+.||+......           .....+.+|.+.+.+|...  ..++++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3555555556777766 467899997543221           1112488999999998533  33445556543     


Q ss_pred             cceeeEEEEecCCC-chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-------CCc
Q 042150          529 QSEMILVYEYMEKG-PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-------NYV  600 (803)
Q Consensus       529 ~~~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-------~~~  600 (803)
                      ...-+||+|++++- +|.+++........+...+..++.+++..+.-||.   .||+|+||+++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCce
Confidence            23568999999986 78888742223445667778999999999999999   99999999999999975       468


Q ss_pred             EEEeeeccccC
Q 042150          601 SKVADFGLSRS  611 (803)
Q Consensus       601 ~kl~DFGla~~  611 (803)
                      +.|+||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.80  E-value=3.3e-08  Score=97.74  Aligned_cols=124  Identities=27%  Similarity=0.335  Sum_probs=81.6

Q ss_pred             EEEEEEECCCcEEEEEEcCCCC--------------C-------CC-----hHHHHHHHHHHHhccCC--CeeeEEeEee
Q 042150          476 MVYKGVLRDNTKVAVKRGVPGS--------------R-------QG-----LPEFQTEITVLSKIRHR--HLVSLVGYCE  527 (803)
Q Consensus       476 ~Vy~~~~~~~~~vavK~~~~~~--------------~-------~~-----~~~f~~E~~~l~~l~Hp--nIv~l~g~~~  527 (803)
                      .||.|...++..+|||......              +       ..     .....+|.+.|.++..-  ++.+++++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999899999999633210              1       00     12467899999999755  566666542 


Q ss_pred             ccceeeEEEEecC--CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCceEeeccCcceEEEccCCcEEEe
Q 042150          528 EQSEMILVYEYME--KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY-LHTGSAEGIIHRDIKSTNILLDENYVSKVA  604 (803)
Q Consensus       528 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivHrDLkp~NILl~~~~~~kl~  604 (803)
                         .-+|||||++  +..+..+..    ..++..+...++.+++..+.. +|.   .+|+|+||.+.|||++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~----~~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKD----VDLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHH----CGGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHh----ccccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEE
Confidence               3479999998  545544331    112244566777888886665 467   899999999999999988 99999


Q ss_pred             eeccccC
Q 042150          605 DFGLSRS  611 (803)
Q Consensus       605 DFGla~~  611 (803)
                      |||.+..
T Consensus       149 Df~qav~  155 (188)
T PF01163_consen  149 DFGQAVD  155 (188)
T ss_dssp             -GTTEEE
T ss_pred             ecCccee
Confidence            9998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.79  E-value=1.5e-09  Score=126.34  Aligned_cols=247  Identities=19%  Similarity=0.213  Sum_probs=162.7

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEc---CCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRG---VPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~---~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      +.|...+-+-+|.++.++.+.-.. +...+.|..   ........+....+-.++-..+||-++...--+......+|++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            445555567788888888665221 211122211   1111122223333444443445677766655556677889999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC-
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL-  615 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~-  615 (803)
                      +|..+++|...|+...  ..+..-....+..+...++|||.   ..+.|+|++|.|+|+..++..++.|||+....... 
T Consensus       884 ~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             HHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccccc
Confidence            9999999999996533  34444455566778889999998   66899999999999999999999999843211100 


Q ss_pred             ---C-------------------------CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcc
Q 042150          616 ---D-------------------------ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL  667 (803)
Q Consensus       616 ---~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~  667 (803)
                         +                         .........+|+.|.+||.+.+......+|.|++|++++|.++|.+||+..
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence               0                         001122356899999999999999999999999999999999999999865


Q ss_pred             hhhhhhhHHHHHHHHhhcCccccccCccc-ccCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 042150          668 LAREQVNLAEWAMQWQKKGMLEHIIDPQL-IGKINLDSLKKFGETAEKCLADYGVDRPSMG  727 (803)
Q Consensus       668 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  727 (803)
                      ......               +.+....+ ....+........+++.+.+..+|.+|-.|.
T Consensus      1039 tpq~~f---------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIF---------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             chhhhh---------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            443221               00110000 1112234456678888999999999996654

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=98.75  E-value=3.8e-08  Score=107.44  Aligned_cols=146  Identities=21%  Similarity=0.351  Sum_probs=96.3

Q ss_pred             ceeecCCCc--ccccC---CceeecCC---CCCccccccCcccccccCCCCCCCCCCccceeeeecc-----ceeEEeee
Q 042150            2 YLINCGSPT--NASLY---NRFFVPDA---SSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTSD-----GSYKLNIK   68 (803)
Q Consensus         2 ~~I~CG~~~--~~~~~---~~~~~~D~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~~-----~cY~~~~~   68 (803)
                      |++|||+..  -...+   ||.|.+..   ..........+. .....+....+...|+|||.-...     ..|.| +.
T Consensus       181 ~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~-~~~~~~~~~~P~~V~~TA~~~~~~s~~~nltw~~-~~  258 (347)
T PF12819_consen  181 YRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNIN-INSSNNPYDAPSAVYQTARTPSNSSDPLNLTWSF-VD  258 (347)
T ss_pred             EeecCCCcccccCCCCCcceeeccccccCccccccccceeee-cccCCccCcChHHHHHhhhcccccccceEEEecc-CC
Confidence            689999875  22222   68999631   111111111111 011111223355578899988765     45777 77


Q ss_pred             cCceEEEEEeecCCCCCcccccccEEEEEECcEEEEeccCC------CceEEEEEEEEec-CCeEEEEEeecCCCC-cce
Q 042150           69 RNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFST------QVVVLKEFIVKVD-GDVIEIEFRPVGDKN-FGF  140 (803)
Q Consensus        69 ~~~~ylvR~~F~~~~~~~~~~~~~~F~~~~~~~~~~~~~~~------~~~~~~e~i~~~~-~~~~~v~~~~~~~~~-~~f  140 (803)
                      ++..|+||+||+....-..+.....|||++|+......++.      ..+++..+++.++ ++.+.|+|+|+..+. -|+
T Consensus       259 ~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~lppi  338 (347)
T PF12819_consen  259 PGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPDSGFLNISLGPTPDSTLPPI  338 (347)
T ss_pred             CCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecCCCEEEEEEEeCCCCCcCce
Confidence            88899999999999985444435899999999887754433      2345678888887 468999999997543 588


Q ss_pred             eeeeEEEec
Q 042150          141 VNAIEVFSA  149 (803)
Q Consensus       141 v~~iE~~~~  149 (803)
                      +||+||+.|
T Consensus       339 LNalEIy~v  347 (347)
T PF12819_consen  339 LNALEIYKV  347 (347)
T ss_pred             eEeeeeEeC
Confidence            899999875

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>PRK09902 hypothetical protein; Provisional

Probab=98.58  E-value=8.5e-07  Score=88.23  Aligned_cols=138  Identities=19%  Similarity=0.148  Sum_probs=104.6

Q ss_pred             EeeeCceEEEEEEECCCcEEEEEEcCCC------CCCChHHHHHHHHHHHhccC--CCeeeEEeEee-c----cceeeEE
Q 042150          469 IGSGGFGMVYKGVLRDNTKVAVKRGVPG------SRQGLPEFQTEITVLSKIRH--RHLVSLVGYCE-E----QSEMILV  535 (803)
Q Consensus       469 Lg~G~fg~Vy~~~~~~~~~vavK~~~~~------~~~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~-~----~~~~~lV  535 (803)
                      -|+||-+.|++-.+++ ..+-+|+....      .......|.+|+..|.+|..  -.+.+.+ ++. .    .-.-+||
T Consensus        26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            4778999999977764 46889974411      13456789999999999953  3355555 332 2    1246899


Q ss_pred             EEecCC-CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc--EEEeeeccccC
Q 042150          536 YEYMEK-GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV--SKVADFGLSRS  611 (803)
Q Consensus       536 ~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--~kl~DFGla~~  611 (803)
                      +|-+.+ -+|.+++......+.+..++..++.++++.+.-||+   .++.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998764 578888844444456778888999999999999999   99999999999999986666  99999987664

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.57  E-value=3e-07  Score=93.35  Aligned_cols=134  Identities=23%  Similarity=0.213  Sum_probs=94.4

Q ss_pred             CCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCC----------------------CChHHHHHHHHHHHhccCC--C
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSR----------------------QGLPEFQTEITVLSKIRHR--H  518 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~f~~E~~~l~~l~Hp--n  518 (803)
                      ...+..||-|--+.||.|....|.+++||.-.....                      -......+|.+.|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            445678999999999999999999999995221100                      0122467899999999644  6


Q ss_pred             eeeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC
Q 042150          519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN  598 (803)
Q Consensus       519 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~  598 (803)
                      +.+.+++    +.-.+||||+++-.|...-       ++.+..-.|+..|++-+.-+-.   .|+||+|+.+-||+++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~d  238 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecC
Confidence            6666654    4457999999986555432       1223333444444444444444   899999999999999999


Q ss_pred             CcEEEeeecccc
Q 042150          599 YVSKVADFGLSR  610 (803)
Q Consensus       599 ~~~kl~DFGla~  610 (803)
                      |.+.++||--+.
T Consensus       239 g~~~vIDwPQ~v  250 (304)
T COG0478         239 GDIVVIDWPQAV  250 (304)
T ss_pred             CCEEEEeCcccc
Confidence            999999996543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.56  E-value=1.9e-07  Score=105.82  Aligned_cols=144  Identities=23%  Similarity=0.315  Sum_probs=96.1

Q ss_pred             CCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChH---------------------------------------
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP---------------------------------------  502 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------------------------------  502 (803)
                      .|+. .-|+.++-|.||+|++++|+.||||+..++-+...+                                       
T Consensus       127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E  205 (517)
T COG0661         127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE  205 (517)
T ss_pred             HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence            3443 468999999999999999999999986654322111                                       


Q ss_pred             -HHHHHHHHHHhcc-----CCCeeeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 042150          503 -EFQTEITVLSKIR-----HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH  576 (803)
Q Consensus       503 -~f~~E~~~l~~l~-----HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH  576 (803)
                       ++.+|...+.+++     .+++.--.=|.+-.+...|+|||++|-.+.+...-.. ..++.+.+.....++.  +..+-
T Consensus       206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~  282 (517)
T COG0661         206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLL  282 (517)
T ss_pred             hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHH
Confidence             2555666666653     3433222223344567799999999988888742222 3345444333333322  22222


Q ss_pred             cCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       577 ~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      .   .|++|.|.+|.||+++.++++.+.|||+....
T Consensus       283 ~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         283 R---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             h---cCccccCCCccceEEecCCcEEEEcCcceecC
Confidence            2   68999999999999999999999999997653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.47  E-value=8.5e-07  Score=89.82  Aligned_cols=107  Identities=26%  Similarity=0.262  Sum_probs=84.9

Q ss_pred             ChHHHHHHHHHHHhcc--CCCeeeEEeEeeccc----eeeEEEEecCCC-chhhhccCCCCCCCCHHHHHHHHHHHHHHH
Q 042150          500 GLPEFQTEITVLSKIR--HRHLVSLVGYCEEQS----EMILVYEYMEKG-PLKKHLYGPDRTPLSWKQRLEICIGAARGL  572 (803)
Q Consensus       500 ~~~~f~~E~~~l~~l~--HpnIv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL  572 (803)
                      ....+.+|...+..|.  .-..++.+++.....    ..+||+|++++. +|.+++...  ..++......++.++++.+
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~--~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW--EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh--cccchhhHHHHHHHHHHHH
Confidence            3457889999988885  344556677665532    458999999874 799988432  2256677889999999999


Q ss_pred             HHHhcCCCCceEeeccCcceEEEccCC---cEEEeeeccccC
Q 042150          573 HYLHTGSAEGIIHRDIKSTNILLDENY---VSKVADFGLSRS  611 (803)
Q Consensus       573 ~yLH~~~~~~ivHrDLkp~NILl~~~~---~~kl~DFGla~~  611 (803)
                      .-||.   .||+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999   9999999999999999877   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.46  E-value=5.6e-08  Score=109.54  Aligned_cols=152  Identities=20%  Similarity=0.269  Sum_probs=102.8

Q ss_pred             HHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC-----CCCc--eeccccCCCcccCccccc
Q 042150          565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL-----DETH--VSTGVKGSFGYLDPEYFR  637 (803)
Q Consensus       565 ~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~-----~~~~--~~~~~~gt~~y~aPE~~~  637 (803)
                      +.+++.||.|+|.  ..++||++|.|++|.++.++..||+.|+.+......     ....  ...-......|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3445699999997  578999999999999999999999999987543221     1111  011123456899999999


Q ss_pred             cCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHcc
Q 042150          638 RQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCL  716 (803)
Q Consensus       638 ~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl  716 (803)
                      +...+.++|+||+||++|-+.. |+.-+.........   .          .....+..-...+..+.+.++.+=+.+++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~---~----------~~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY---S----------FSRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchh---h----------hhhcccccccccccccCcHHHHHHHHHHh
Confidence            9899999999999999999984 44333221100000   0          00000111111223455678888899999


Q ss_pred             ccCCCCCCCHHHHHH
Q 042150          717 ADYGVDRPSMGDVLW  731 (803)
Q Consensus       717 ~~~p~~RPs~~evl~  731 (803)
                      ..++.-||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998877653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.32  E-value=7.6e-06  Score=87.20  Aligned_cols=257  Identities=14%  Similarity=0.145  Sum_probs=153.5

Q ss_pred             ccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEe------eccce-eeEEE
Q 042150          465 KNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYC------EEQSE-MILVY  536 (803)
Q Consensus       465 ~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~------~~~~~-~~lV~  536 (803)
                      .++-||+|+-+.+|----- +..|| |+.........   ...+..|... .||-+-.-+.+=      -+++. .-+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQVA-KIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh-hchhh-eeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            3457999999999843211 22333 33221111111   1223334443 466443312221      12222 56777


Q ss_pred             EecCCCc-hhhhcc----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          537 EYMEKGP-LKKHLY----GPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       537 Ey~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      ..+++.- +..++.    .+......|.-.++.++.+|.+.+-||.   .|.+-+|+.++|+|+.+++.+.|.|=..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence            7776542 233321    1233458899999999999999999999   8999999999999999999999987433222


Q ss_pred             CCCCCCCceeccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhC-CCCCCcchhhhh--hhHH-HHHHHH
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCA-RTAVDPLLAREQ--VNLA-EWAMQW  682 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~--~~l~-~~~~~~  682 (803)
                      .   ..........|...|.+||...     +..-+...|.|.|||++++|+.| +.||.+......  ..+. +.+   
T Consensus       167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia---  240 (637)
T COG4248         167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA---  240 (637)
T ss_pred             c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh---
Confidence            1   1222233457889999999754     44667789999999999999887 899875432111  0111 000   


Q ss_pred             hhcCccccccCccc-----ccCCCH-HHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHHH
Q 042150          683 QKKGMLEHIIDPQL-----IGKINL-DSLKKFGETAEKCLADY--GVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       683 ~~~~~~~~i~d~~l-----~~~~~~-~~~~~l~~li~~cl~~~--p~~RPs~~evl~~L~~~~  737 (803)
                        .+.....-+...     ...++- -.++.+..+..+|+...  +.-|||++-.+..|..+.
T Consensus       241 --~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         241 --HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             --cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence              000000001000     012222 23467888899999764  568999998888776654

>KOG3593 consensus Predicted receptor-like serine/threonine kinase [Signal transduction mechanisms]

Probab=98.31  E-value=4.6e-07  Score=90.73  Aligned_cols=129  Identities=16%  Similarity=0.136  Sum_probs=91.2

Q ss_pred             HhheeeeecCCcccCCCCCeeeeeecCCCcceeecCcccccccCCCccccCCCCCccccchHHHHHHhcccccccccCcc
Q 042150          179 LETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPDNVYMTAQEMNRDNAMLGAR  258 (803)
Q Consensus       179 l~~~~R~n~Gg~~~~~~~D~~~r~w~~d~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~P~~vy~TAr~~~~~~~~~~~~  258 (803)
                      ...++.+||||....+-|.--++   .|  -+.+.+-+++.+.--.+.     .....-...+|||+|....     .  
T Consensus        58 ~svI~aVncGgdaavd~ygI~f~---aD--~~~~VGrasd~G~~l~i~-----~raeeed~ily~ter~nee-----t--  120 (355)
T KOG3593|consen   58 SSVIPAVNCGGDAAVDNYGIRFA---AD--PLEGVGRASDYGMVLGIG-----CRAEEEDIILYQTERYNEE-----T--  120 (355)
T ss_pred             hhhhheeccCChhhhcccceEee---cc--ccccccccCCccceeecc-----ccCChhhhhhhhhcccchh-----h--
Confidence            44788999999998766665322   11  122222222222111111     0112335669999999862     2  


Q ss_pred             cceeEeeeccCCCCeeEEEEEeeeeecCCCCcEEEEEEEc-CeeecccCCcccccc-CCccccEEEEeEEe
Q 042150          259 FNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFIN-DYSAYKDLDLSSITF-HSLASPVYMDFVAD  327 (803)
Q Consensus       259 ~~lt~~~~~~~~~~~y~v~lhFae~~~~~~~~R~Fdi~in-~~~~~~~~di~~~~~-~~~~~~~~~~~~~~  327 (803)
                        |.|+.|... .|.|-+.|.|||++|...+..+|||-+| +..+.+++||....+ .+.++..+..+...
T Consensus       121 --Fgyd~pik~-dgdyalvlkfaevyF~~~q~kvfdvrln~sh~vVk~ldi~~~vg~rg~AhDe~i~~~i~  188 (355)
T KOG3593|consen  121 --FGYDVPIKE-DGDYALVLKFAEVYFKTCQHKVFDVRLNCSHCVVKALDIFDQVGDRGKAHDEIIPCLIG  188 (355)
T ss_pred             --hcccccccC-CCceehhhhHHHHHHHhhhhhheeeeeccceeEEeccchhhhcCCCcccccceEEEEEc
Confidence              779999998 8999999999999999999999999999 999999999988865 57788877776543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.28  E-value=2.4e-06  Score=96.50  Aligned_cols=138  Identities=20%  Similarity=0.217  Sum_probs=93.3

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCCh-------------------------------------HHHHHHHH
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGL-------------------------------------PEFQTEIT  509 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~~f~~E~~  509 (803)
                      +-||..+.|.||+|++++|+.||||+..+.-+...                                     -+|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            36999999999999999999999997555432210                                     03667776


Q ss_pred             HHHhc----cCCC------eeeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 042150          510 VLSKI----RHRH------LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS  579 (803)
Q Consensus       510 ~l~~l----~Hpn------Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~  579 (803)
                      -..++    +|-+      |.+++  ..-.....|+||||+|..+.+.-.- ....++...+..-+.++..-+-+.    
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~~qIf~----  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYLEQIFK----  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHHHHHHh----
Confidence            65555    3444      22222  2334578999999999877665421 223355555554444433222222    


Q ss_pred             CCceEeeccCcceEEEcc----CCcEEEeeeccccCC
Q 042150          580 AEGIIHRDIKSTNILLDE----NYVSKVADFGLSRSG  612 (803)
Q Consensus       580 ~~~ivHrDLkp~NILl~~----~~~~kl~DFGla~~~  612 (803)
                       .|++|+|-+|.||+++.    ++.+.+-|||+....
T Consensus       320 -~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  320 -TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             -cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence             67999999999999984    678999999998653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.27  E-value=1.5e-05  Score=81.94  Aligned_cols=139  Identities=16%  Similarity=0.173  Sum_probs=85.6

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCC--eeeEEeEeeccceeeEEEEecCCCc-
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH--LVSLVGYCEEQSEMILVYEYMEKGP-  543 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~g~~~~~~~~~lV~Ey~~~gs-  543 (803)
                      ..||+|..+.||+.   .+..+++|......  ...+..+|.++++.+..-.  +.+.++++...+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            37899999999984   24467788754422  3456789999999986433  4667888877778889999999863 


Q ss_pred             hhhhc---------------------cCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhc-CCCCceEeeccC
Q 042150          544 LKKHL---------------------YGPDRTPLSWKQRLE-ICI----------GAAR-GLHYLHT-GSAEGIIHRDIK  589 (803)
Q Consensus       544 L~~~l---------------------~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~-~~~~~ivHrDLk  589 (803)
                      +...+                     |.............. +..          .+.. ...+|.. .....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            21111                     111001111111000 000          0000 1122221 123457899999


Q ss_pred             cceEEEccCCcEEEeeeccccC
Q 042150          590 STNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       590 p~NILl~~~~~~kl~DFGla~~  611 (803)
                      |.||++++++ +.|+||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999888 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.10  E-value=2.8e-05  Score=79.89  Aligned_cols=141  Identities=19%  Similarity=0.193  Sum_probs=84.2

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCC--CeeeEEeEeec---cceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHR--HLVSLVGYCEE---QSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hp--nIv~l~g~~~~---~~~~~lV~Ey~~~  541 (803)
                      +.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  -+.+++.++..   ....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            478999999999999887 68999985433  3456788999999988533  35566665532   3346899999999


Q ss_pred             Cchhh----------------hc---cCC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc-
Q 042150          542 GPLKK----------------HL---YGP--DRTPLSWKQ---------RLEI------------CIGAAR-GLHYLHT-  577 (803)
Q Consensus       542 gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~-  577 (803)
                      ..+..                .+   +..  ....+.+..         ....            ...+.+ .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87777                11   111  111111111         0000            011222 2333332 


Q ss_pred             ---CCCCceEeeccCcceEEEc-cCCcEEEeeecccc
Q 042150          578 ---GSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSR  610 (803)
Q Consensus       578 ---~~~~~ivHrDLkp~NILl~-~~~~~kl~DFGla~  610 (803)
                         .....++|+|+.+.|||++ +++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               2346799999999999999 66666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.07  E-value=4.4e-05  Score=76.37  Aligned_cols=138  Identities=20%  Similarity=0.178  Sum_probs=89.0

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHH---------HHHHHHHHhccC---CCeeeEEeEe
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF---------QTEITVLSKIRH---RHLVSLVGYC  526 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f---------~~E~~~l~~l~H---pnIv~l~g~~  526 (803)
                      ..++|...+++-......|.+-..+ ++.+++|..........+.|         .+++..+.+++.   -....++.++
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            4566777777777666666655544 68889997655433322222         234444444432   2222222222


Q ss_pred             -----eccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcE
Q 042150          527 -----EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       527 -----~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~  601 (803)
                           .-....+|+|||++|..|.+...      ++.    .+...+.+.|.-||+   .|++|+|++|+|+++++++ +
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-E
Confidence                 22345679999999988876541      222    244567788999999   9999999999999998654 8


Q ss_pred             EEeeeccccC
Q 042150          602 KVADFGLSRS  611 (803)
Q Consensus       602 kl~DFGla~~  611 (803)
                      +++||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.03  E-value=5.5e-05  Score=78.81  Aligned_cols=139  Identities=18%  Similarity=0.173  Sum_probs=85.0

Q ss_pred             EeeeCc-eEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEEecCCCchhh
Q 042150          469 IGSGGF-GMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYEYMEKGPLKK  546 (803)
Q Consensus       469 Lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  546 (803)
                      |-.|.. ..||+.... +..++||......   ..+..+|++++..+. +--+.++++++...+..++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            334444 788998765 4678888754332   345778999998884 4446677777776667899999999977764


Q ss_pred             hc-------------------cCCC--CCCCC--HHHHHHHHH--------------------HHHHHHHHHhc----CC
Q 042150          547 HL-------------------YGPD--RTPLS--WKQRLEICI--------------------GAARGLHYLHT----GS  579 (803)
Q Consensus       547 ~l-------------------~~~~--~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~~  579 (803)
                      ..                   |...  ..++.  ....+....                    .+...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   1111  00111  001110000                    01111122211    12


Q ss_pred             CCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       580 ~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      ...++|+|+.|.|||++++....|+||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            35689999999999999988889999997754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.01  E-value=5.3e-05  Score=76.55  Aligned_cols=150  Identities=17%  Similarity=0.196  Sum_probs=97.2

Q ss_pred             ChhhHHHHhcCCCccce---EeeeCceEEEEEEECCCcEEEEEEcCCCCCC-------------------Ch-----HHH
Q 042150          452 PFTDLQTATNNFDKNLI---IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-------------------GL-----PEF  504 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~~~---Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~-----~~f  504 (803)
                      +++.|....+.......   |.+|--+.||+|.-.++..+|||+.......                   ..     ...
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            44555555555555444   5567778899999888999999975432111                   11     123


Q ss_pred             HHHHHHHHhcc--CCCeeeEEeEeeccceeeEEEEecCCCc-hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 042150          505 QTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYEYMEKGP-LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE  581 (803)
Q Consensus       505 ~~E~~~l~~l~--HpnIv~l~g~~~~~~~~~lV~Ey~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  581 (803)
                      .+|..-|.++.  +-.+.+-+++..    -.|||||+...- -.-.|   ....+...+...+..++++.+.-|-.  ..
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~--~a  186 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYK--EA  186 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHH--hc
Confidence            56777777774  444555555443    379999996531 11112   11223333566667777777776654  37


Q ss_pred             ceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          582 GIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       582 ~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      ++||+||..-|||+. ++.+.|+|||-|..
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECccccc
Confidence            899999999999999 88999999997654

>PLN02876 acyl-CoA dehydrogenase

Probab=97.93  E-value=0.00014  Score=88.95  Aligned_cols=79  Identities=16%  Similarity=0.304  Sum_probs=58.5

Q ss_pred             cceEeeeCceEEEEEEECCC---cEEEEEEcCCCC-CCChHHHHHHHHHHHhcc-CCCe--eeEEeEeecc---ceeeEE
Q 042150          466 NLIIGSGGFGMVYKGVLRDN---TKVAVKRGVPGS-RQGLPEFQTEITVLSKIR-HRHL--VSLVGYCEEQ---SEMILV  535 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-HpnI--v~l~g~~~~~---~~~~lV  535 (803)
                      ...|+.|.+..+|+....++   ..+++|+..... ......+.+|.++|+.+. |.++  .+++++|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45688999999999877654   467777754332 223457899999999995 6665  7888888764   467899


Q ss_pred             EEecCCCch
Q 042150          536 YEYMEKGPL  544 (803)
Q Consensus       536 ~Ey~~~gsL  544 (803)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.92  E-value=4.9e-05  Score=75.51  Aligned_cols=102  Identities=21%  Similarity=0.256  Sum_probs=81.9

Q ss_pred             HHHHHHHHhccC-CCeeeEEeEeeccceeeEEEEecCCCchhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc
Q 042150          505 QTEITVLSKIRH-RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG-PDRTPLSWKQRLEICIGAARGLHYLHTGSAEG  582 (803)
Q Consensus       505 ~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  582 (803)
                      .+|.-+|+.+++ +++++++|+|-.    ++|.||...+++...-.. ..-..-+|..+.+|+.++++.+++|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888999976 699999999943    679999988766432100 11124689999999999999999999866566


Q ss_pred             eEeeccCcceEEEccCCcEEEeeecccc
Q 042150          583 IIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       583 ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      +...|++++|+-+++++++|++|.....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcc
Confidence            7789999999999999999999998654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.88  E-value=2e-06  Score=95.97  Aligned_cols=182  Identities=16%  Similarity=0.092  Sum_probs=130.4

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCC-eeeEEeEeeccceeeEEEEecCCC-ch
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH-LVSLVGYCEEQSEMILVYEYMEKG-PL  544 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~lV~Ey~~~g-sL  544 (803)
                      +-+++|+++.++|.+--..+...++.....     ....-++++|.+++||| .+..++-++.+....++++++..+ +-
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence            357889999999987433333344543222     34466899999999999 777777777778889999999877 22


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccc
Q 042150          545 KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV  624 (803)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (803)
                      .... ......+...+...+++.-+++|++||+   ..=+|+|    ||+..+ ...|..||+........   ......
T Consensus       323 ~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~---~~~~t~  390 (829)
T KOG0576|consen  323 ALEM-TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT---MKPRTA  390 (829)
T ss_pred             cccC-ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCcc---cccccC
Confidence            2221 1112234445566777888899999998   3347888    777765 67899999988654322   234456


Q ss_pred             cCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCC
Q 042150          625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVD  665 (803)
Q Consensus       625 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~  665 (803)
                      .+++.++|||+.....+..+.|+|+.|+-..+|--|-+|-.
T Consensus       391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            78999999999999999999999999987777776766543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.80  E-value=0.00029  Score=70.30  Aligned_cols=129  Identities=20%  Similarity=0.286  Sum_probs=91.3

Q ss_pred             ccceEeeeCceEEEEEEECCCcEEEEEEcCCCC----------------CCChHHHHHHHHHHHhcc------CCCeeeE
Q 042150          465 KNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS----------------RQGLPEFQTEITVLSKIR------HRHLVSL  522 (803)
Q Consensus       465 ~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~f~~E~~~l~~l~------HpnIv~l  522 (803)
                      ....||+|+.-.||.  +.+....+||+.....                ....+++.+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            345899999999995  5566677888765544                223466777877666665      8899999


Q ss_pred             EeEeeccceeeEEEEecCC--C----chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc
Q 042150          523 VGYCEEQSEMILVYEYMEK--G----PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD  596 (803)
Q Consensus       523 ~g~~~~~~~~~lV~Ey~~~--g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~  596 (803)
                      +|+.+.+..+-+|+|.+..  |    +|.+++   ....++. +..+.+.+   -..||-+   ..|+.+||+|.||++.
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l---~~~~~~~-~~~~~L~~---f~~~l~~---~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL---KEGGLTE-ELRQALDE---FKRYLLD---HHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHH---HcCCccH-HHHHHHHH---HHHHHHH---cCCeecCCCcccEEEE
Confidence            9999999999999998754  2    467777   2334554 44444443   3456655   7799999999999995


Q ss_pred             cC--C--cEEEee
Q 042150          597 EN--Y--VSKVAD  605 (803)
Q Consensus       597 ~~--~--~~kl~D  605 (803)
                      ..  +  .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            32  2  466676

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.69  E-value=0.00057  Score=73.31  Aligned_cols=78  Identities=10%  Similarity=0.026  Sum_probs=57.4

Q ss_pred             CccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccC---CCeeeEEeEeecc---ceeeEEEE
Q 042150          464 DKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH---RHLVSLVGYCEEQ---SEMILVYE  537 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H---pnIv~l~g~~~~~---~~~~lV~E  537 (803)
                      ...+.||.|..+.||+....++ .+++|....  ......|..|.+.|+.|.-   -.+.+++++|...   +..+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3445799999999999876555 466676322  1123578999999999852   4688889888543   66899999


Q ss_pred             ecCCCch
Q 042150          538 YMEKGPL  544 (803)
Q Consensus       538 y~~~gsL  544 (803)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.69  E-value=0.00041  Score=71.78  Aligned_cols=139  Identities=20%  Similarity=0.227  Sum_probs=77.1

Q ss_pred             ceEeeeCce-EEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCC---CeeeEEeEeecc---ceeeEEEEec
Q 042150          467 LIIGSGGFG-MVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHR---HLVSLVGYCEEQ---SEMILVYEYM  539 (803)
Q Consensus       467 ~~Lg~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hp---nIv~l~g~~~~~---~~~~lV~Ey~  539 (803)
                      +.|+.|+.. .||+.    +..+++|....  .....++.+|.++|..+...   -+.+.++.+...   ...+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            356766666 58874    23567776332  22345789999999888532   344445544332   2348899999


Q ss_pred             CCCchhhhc------------------cCCCCC--C------------C-CHHHHH--HHH-------HHHHHH-HH-HH
Q 042150          540 EKGPLKKHL------------------YGPDRT--P------------L-SWKQRL--EIC-------IGAARG-LH-YL  575 (803)
Q Consensus       540 ~~gsL~~~l------------------~~~~~~--~------------l-~~~~~~--~i~-------~~ia~g-L~-yL  575 (803)
                      +|.++.+..                  |.-...  .            + .|....  .+.       .+.... ++ ++
T Consensus        77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  156 (235)
T cd05155          77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL  156 (235)
T ss_pred             cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence            997764321                  110000  0            0 011110  000       011111 11 11


Q ss_pred             hc--CCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          576 HT--GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       576 H~--~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      +.  .....++|+|+.+.|||++++...-|+||+.+..
T Consensus       157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            11  1235589999999999998776677999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.57  E-value=0.00068  Score=70.05  Aligned_cols=140  Identities=17%  Similarity=0.155  Sum_probs=81.6

Q ss_pred             ceEeeeCceEEEEEEECC--CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCe-eeEEeEeeccceeeEEEEecCCCc
Q 042150          467 LIIGSGGFGMVYKGVLRD--NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL-VSLVGYCEEQSEMILVYEYMEKGP  543 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gs  543 (803)
                      +.|..|-...+|+....+  +..+++|....... ...+-.+|+.++..+...++ +++++.+. .   .+||||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence            357778888999988664  67888887543322 22234578999998854333 34444333 2   37999999876


Q ss_pred             hhhh-----------------ccCCCC---------CCCC-HHHHHHHHH----------------------HHH---HH
Q 042150          544 LKKH-----------------LYGPDR---------TPLS-WKQRLEICI----------------------GAA---RG  571 (803)
Q Consensus       544 L~~~-----------------l~~~~~---------~~l~-~~~~~~i~~----------------------~ia---~g  571 (803)
                      +...                 +|....         .... |..+..+..                      .+.   ..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321                 011110         1111 222212111                      111   11


Q ss_pred             HH-HHhc-CCCCceEeeccCcceEEEcc-CCcEEEeeeccccC
Q 042150          572 LH-YLHT-GSAEGIIHRDIKSTNILLDE-NYVSKVADFGLSRS  611 (803)
Q Consensus       572 L~-yLH~-~~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla~~  611 (803)
                      |. .+.. .....++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            11 1111 12357999999999999997 57899999987754

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.55  E-value=0.00043  Score=66.34  Aligned_cols=129  Identities=22%  Similarity=0.231  Sum_probs=86.5

Q ss_pred             ccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCch
Q 042150          465 KNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       465 ~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      ..+.|++|.+|.||+|.+.+ ..+|+|.-..++  ....+..|+++|..++-.++.+=+-.+.   .-++.|||+.|-.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~L   99 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWRG-GEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhcccccEEEEeeccC-ceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcch
Confidence            34579999999999999874 578888755443  3467899999999998766654332222   22345999998888


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccC-cceEEEccCCcEEEeeeccccC
Q 042150          545 KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIK-STNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk-p~NILl~~~~~~kl~DFGla~~  611 (803)
                      .+.-...     +-+.++    .+++.---|..   .||-|+.|. |..++|-.+..+.|+||.-|..
T Consensus       100 ~~~~~~~-----~rk~l~----~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIGG-----DRKHLL----RVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcc-----cHHHHH----HHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            7765221     223333    33344333443   788888886 5555555555999999998763

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.50  E-value=0.00018  Score=86.10  Aligned_cols=197  Identities=19%  Similarity=0.193  Sum_probs=136.3

Q ss_pred             HHHHHHHHHHhccCCCeeeEEeEeecccee----eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 042150          503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEM----ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG  578 (803)
Q Consensus       503 ~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  578 (803)
                      ...-|++.+.++.|+|++.+++|-.+....    .+..|++..-++...+  ..-..++....+.+..++.+||.|+|+ 
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHHHHH-
Confidence            345577788888999999999987654332    3445788777887777  344567888888999999999999998 


Q ss_pred             CCCceEeeccCcc---eEEEccCCcEEEe--eeccccCCCCCCCCceeccccCCCcccCccccccCcCCCc--ceehhHH
Q 042150          579 SAEGIIHRDIKST---NILLDENYVSKVA--DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDK--SDVYSFG  651 (803)
Q Consensus       579 ~~~~ivHrDLkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k--sDV~S~G  651 (803)
                        ....|.-|..+   +...+..+...++  ||+.++.......   ......+..+.++|......+..+  .|+|.+|
T Consensus       305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             --hccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHH
Confidence              55555555555   5555666777777  8988876443222   223345567888888876655554  7999999


Q ss_pred             HHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042150          652 VVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLW  731 (803)
Q Consensus       652 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~  731 (803)
                      ..+..+..|..+-.....                  ...+++.        .....+.+...+|+..++++|++..+++.
T Consensus       380 ll~~~~~~~~~i~~~~~~------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAV------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             HHHhhhhhcCcccccccc------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhh
Confidence            999999988755321110                  0011110        11114567788999999999999999987


Q ss_pred             HH
Q 042150          732 NL  733 (803)
Q Consensus       732 ~L  733 (803)
                      +.
T Consensus       434 ~~  435 (1351)
T KOG1035|consen  434 HP  435 (1351)
T ss_pred             ch
Confidence            64

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.49  E-value=0.00065  Score=71.30  Aligned_cols=137  Identities=16%  Similarity=0.151  Sum_probs=79.4

Q ss_pred             EeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCe-eeEEeEeeccceeeEEEEecCCCchhhh
Q 042150          469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL-VSLVGYCEEQSEMILVYEYMEKGPLKKH  547 (803)
Q Consensus       469 Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~~  547 (803)
                      +..|-...+|+.. .++..+++|..........-+..+|.++++.+....+ .++++.+.    -.+||||++|..+...
T Consensus         4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            4567778899877 3466788887443322221246789999999864333 34444442    3689999998765421


Q ss_pred             -----------------ccCCC--CCCCCHHHH-HHHHHHH---------HHHHHHHhc-----CCCCceEeeccCcceE
Q 042150          548 -----------------LYGPD--RTPLSWKQR-LEICIGA---------ARGLHYLHT-----GSAEGIIHRDIKSTNI  593 (803)
Q Consensus       548 -----------------l~~~~--~~~l~~~~~-~~i~~~i---------a~gL~yLH~-----~~~~~ivHrDLkp~NI  593 (803)
                                       ||...  ..+++.... .....++         ...+..+-.     .....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             12111  112222221 1111111         111221211     1134689999999999


Q ss_pred             EEccCCcEEEeeeccccC
Q 042150          594 LLDENYVSKVADFGLSRS  611 (803)
Q Consensus       594 Ll~~~~~~kl~DFGla~~  611 (803)
                      ++++++ +.|+||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.48  E-value=0.0014  Score=72.63  Aligned_cols=75  Identities=20%  Similarity=0.221  Sum_probs=54.6

Q ss_pred             ceEeeeCceEEEEEEECCC-cEEEEEEcCCCC-------CCChHHHHHHHHHHHhcc---CCCeeeEEeEeeccceeeEE
Q 042150          467 LIIGSGGFGMVYKGVLRDN-TKVAVKRGVPGS-------RQGLPEFQTEITVLSKIR---HRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~-------~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~lV  535 (803)
                      +.||.|.+..||+....+| +.++||.-.+..       ....+.+..|.+.|..+.   -.++++++.+..  ...++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence            3689999999999998877 589999743221       234567888999888873   245666776643  557899


Q ss_pred             EEecCCCc
Q 042150          536 YEYMEKGP  543 (803)
Q Consensus       536 ~Ey~~~gs  543 (803)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.38  E-value=0.0018  Score=64.28  Aligned_cols=125  Identities=25%  Similarity=0.329  Sum_probs=88.9

Q ss_pred             cCCCccceEeeeCc-eEEEEEEECCCcEEEEEEcCC---CC---------C---------CChHHHHHHHHHHHhcc---
Q 042150          461 NNFDKNLIIGSGGF-GMVYKGVLRDNTKVAVKRGVP---GS---------R---------QGLPEFQTEITVLSKIR---  515 (803)
Q Consensus       461 ~~f~~~~~Lg~G~f-g~Vy~~~~~~~~~vavK~~~~---~~---------~---------~~~~~f~~E~~~l~~l~---  515 (803)
                      .+++..+.||.|.- |.||++.+. |+.+|+|....   ..         .         .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888889999999 999999986 67999998211   00         0         11235888999888885   


Q ss_pred             CCCe--eeEEeEeecc------------------ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 042150          516 HRHL--VSLVGYCEEQ------------------SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL  575 (803)
Q Consensus       516 HpnI--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL  575 (803)
                      +.++  |+.+||..-.                  ....||.||++...           .+..    +-+.+|.+-|..+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~  180 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL  180 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence            4566  8999987211                  01356777765432           2222    3345666778889


Q ss_pred             hcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       576 H~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      |.   .+|+-+|+|+.|..     .-||+|||.+
T Consensus       181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HH---CCeeeccCcccccc-----CCEEEecccC
Confidence            98   99999999999986     5589999853

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.35  E-value=0.0012  Score=70.94  Aligned_cols=142  Identities=19%  Similarity=0.168  Sum_probs=85.9

Q ss_pred             cceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCC--eeeEEeEe------eccceeeEEEE
Q 042150          466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH--LVSLVGYC------EEQSEMILVYE  537 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~g~~------~~~~~~~lV~E  537 (803)
                      .+.|..|....+|+....+ ..+++|....   ....+...|++++..+.+.+  +.+++...      ...+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            3457777778999887654 4688887543   23456778888888885432  44544321      22345689999


Q ss_pred             ecCCCchhh----h----------ccCC----C-----CCCCCHHHHHH----------HHHHHHHHHHHHhc----CCC
Q 042150          538 YMEKGPLKK----H----------LYGP----D-----RTPLSWKQRLE----------ICIGAARGLHYLHT----GSA  580 (803)
Q Consensus       538 y~~~gsL~~----~----------l~~~----~-----~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~  580 (803)
                      |++|..+..    .          +|..    .     .....|.....          ....+...+.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532    0          0110    0     01122222110          11112333444442    234


Q ss_pred             CceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          581 EGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       581 ~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .+++|+|+.|.|||++++..+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            5799999999999999987789999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.14  E-value=0.0031  Score=67.92  Aligned_cols=139  Identities=24%  Similarity=0.260  Sum_probs=83.3

Q ss_pred             eEeeeCceEEEEEEECC-------CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCe-eeEEeEeeccceeeEEEEec
Q 042150          468 IIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL-VSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .|..|-...+|+....+       ++.+++|...... ....+..+|.+++..+...++ .++++++..    .+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            45667777899887655       4788888854432 233456789888888853333 345555542    3589999


Q ss_pred             CCCchhhh-----------------ccCCCCC-------CC--CHHHHHH--------------------------HHHH
Q 042150          540 EKGPLKKH-----------------LYGPDRT-------PL--SWKQRLE--------------------------ICIG  567 (803)
Q Consensus       540 ~~gsL~~~-----------------l~~~~~~-------~l--~~~~~~~--------------------------i~~~  567 (803)
                      +|..+...                 +|.....       ..  -|..+..                          +...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            98766431                 1111110       00  0111111                          1112


Q ss_pred             HHHHHHHHhc------CCCCceEeeccCcceEEEccC----CcEEEeeeccccC
Q 042150          568 AARGLHYLHT------GSAEGIIHRDIKSTNILLDEN----YVSKVADFGLSRS  611 (803)
Q Consensus       568 ia~gL~yLH~------~~~~~ivHrDLkp~NILl~~~----~~~kl~DFGla~~  611 (803)
                      +..-+..|..      .....++|+|+.+.|||++++    +.++++||..|..
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            2223334431      245679999999999999975    8899999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.00  E-value=0.0083  Score=65.14  Aligned_cols=155  Identities=15%  Similarity=0.147  Sum_probs=84.5

Q ss_pred             hhhHHHHhcCCCc-----cceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCC--eeeEEe-
Q 042150          453 FTDLQTATNNFDK-----NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH--LVSLVG-  524 (803)
Q Consensus       453 ~~~l~~~~~~f~~-----~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~g-  524 (803)
                      ..++......|..     .+.|+.|....+|+....+| .+++|+..   ....+....|+.++..|...+  +.+.+. 
T Consensus         9 ~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~---~~~~~~l~~~~~~l~~L~~~glpvP~~i~~   84 (319)
T PRK05231          9 DDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE---RLTAEDLPFFLGLMQHLAARGVPVPAPVAR   84 (319)
T ss_pred             HHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec---cCChHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence            3444444444543     23466777789999876655 67888754   122344455666666663222  333332 


Q ss_pred             -----EeeccceeeEEEEecCCCchhh-----------h---ccCCC---------CCCCCH-HHHHHH-----------
Q 042150          525 -----YCEEQSEMILVYEYMEKGPLKK-----------H---LYGPD---------RTPLSW-KQRLEI-----------  564 (803)
Q Consensus       525 -----~~~~~~~~~lV~Ey~~~gsL~~-----------~---l~~~~---------~~~l~~-~~~~~i-----------  564 (803)
                           +....+..++++||++|..+..           .   +|...         ...+.| .+...-           
T Consensus        85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (319)
T PRK05231         85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA  164 (319)
T ss_pred             CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence                 1223456789999999875421           1   11100         011112 221111           


Q ss_pred             -HHH-HHHHHHHHhc----CCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          565 -CIG-AARGLHYLHT----GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       565 -~~~-ia~gL~yLH~----~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                       ..+ +...++.+..    ....++||+|+++.|||++.+...-|+||+.+..
T Consensus       165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             111 1112233321    1346899999999999999776668999998754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.80  E-value=0.026  Score=60.98  Aligned_cols=155  Identities=15%  Similarity=0.170  Sum_probs=88.6

Q ss_pred             hhHHHHhcCCCc-----cceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCC--eeeEEeEe
Q 042150          454 TDLQTATNNFDK-----NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH--LVSLVGYC  526 (803)
Q Consensus       454 ~~l~~~~~~f~~-----~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~g~~  526 (803)
                      ++|......|..     .+.++.|.-..+|+....++ .+++|.....  ...++...|++++..|....  +.+++...
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~   86 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSR   86 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence            444444444543     34566777789998876555 5777864332  12345667778887774322  44444422


Q ss_pred             ------eccceeeEEEEecCCCchhhh--------------ccCCCC-------C---CCCHHHHHH------------H
Q 042150          527 ------EEQSEMILVYEYMEKGPLKKH--------------LYGPDR-------T---PLSWKQRLE------------I  564 (803)
Q Consensus       527 ------~~~~~~~lV~Ey~~~gsL~~~--------------l~~~~~-------~---~l~~~~~~~------------i  564 (803)
                            ...+..++++||++|..+...              +|....       .   .-.|.....            .
T Consensus        87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~  166 (307)
T TIGR00938        87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM  166 (307)
T ss_pred             CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence                  224567899999998654211              111000       0   011221110            0


Q ss_pred             HHHHHHHHHHHhc----CCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          565 CIGAARGLHYLHT----GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       565 ~~~ia~gL~yLH~----~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      ...+.+.++++..    ....+++|+|+++.||++++++...|+||+.+..
T Consensus       167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            1123344555532    2347899999999999999888778999998653

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.79  E-value=0.015  Score=62.21  Aligned_cols=131  Identities=18%  Similarity=0.217  Sum_probs=80.4

Q ss_pred             eEEEEEEECCCcEEEEEEcC-CCCCCChHHHHHHHHHHHhccC--CCeeeEEeEeeccc--eeeEEEEecCCCchhhhcc
Q 042150          475 GMVYKGVLRDNTKVAVKRGV-PGSRQGLPEFQTEITVLSKIRH--RHLVSLVGYCEEQS--EMILVYEYMEKGPLKKHLY  549 (803)
Q Consensus       475 g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~l~  549 (803)
                      -.+|..... ++++++.+-. ........+..+|.++|+.+.-  -=+...+++|.++.  ..+.||+|+++..+...+.
T Consensus        39 n~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~  117 (321)
T COG3173          39 NDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP  117 (321)
T ss_pred             cceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence            344444333 6677777211 1223334566778888887742  23455677887766  6799999999865443331


Q ss_pred             CCCCCCCCHHHHHHHH-HHHHHHHHHHhc--------------------------------------------------C
Q 042150          550 GPDRTPLSWKQRLEIC-IGAARGLHYLHT--------------------------------------------------G  578 (803)
Q Consensus       550 ~~~~~~l~~~~~~~i~-~~ia~gL~yLH~--------------------------------------------------~  578 (803)
                      ...   ..    .+++ ..+++.|.-||+                                                  .
T Consensus       118 ~~~---~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~  190 (321)
T COG3173         118 PES---LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN  190 (321)
T ss_pred             ccc---ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence            100   00    1111 244444444443                                                  1


Q ss_pred             -----CCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          579 -----SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       579 -----~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                           ....++|+|+++.|++++.+..+-|.||+++....
T Consensus       191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence                 12469999999999999998889999999987643

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.77  E-value=0.0015  Score=68.36  Aligned_cols=132  Identities=17%  Similarity=0.146  Sum_probs=89.9

Q ss_pred             CCccceEeeeCceEEEEEEECCCcEEEEEEcCCC---------CC------C--C-----hHHHHHHHHHHHhcc-CC-C
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG---------SR------Q--G-----LPEFQTEITVLSKIR-HR-H  518 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~---------~~------~--~-----~~~f~~E~~~l~~l~-Hp-n  518 (803)
                      +..++.||-|--+.||.+...+|++.++|.....         .+      .  .     .-...+|...|+.|. |- -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            6678899999999999999999999998842110         00      0  0     113567888888885 32 2


Q ss_pred             eeeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC
Q 042150          519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN  598 (803)
Q Consensus       519 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~  598 (803)
                      +.+.+++    +..++|||++.+-.|.+.-+-     .+...   +...+..-+.-|..   +|+||+|..-=||+++++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~---ly~~lm~~Iv~la~---~GlIHgDFNEFNimv~dd  238 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPT---LYDDLMGLIVRLAN---HGLIHGDFNEFNIMVKDD  238 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeec-----CChHH---HHHHHHHHHHHHHH---cCceecccchheeEEecC
Confidence            3444444    345899999998877664421     12222   22223333334444   899999999999999999


Q ss_pred             CcEEEeeeccc
Q 042150          599 YVSKVADFGLS  609 (803)
Q Consensus       599 ~~~kl~DFGla  609 (803)
                      +.++++||--+
T Consensus       239 ~~i~vIDFPQm  249 (465)
T KOG2268|consen  239 DKIVVIDFPQM  249 (465)
T ss_pred             CCEEEeechHh
Confidence            99999999654

>PLN02236 choline kinase

Probab=96.63  E-value=0.016  Score=63.59  Aligned_cols=139  Identities=18%  Similarity=0.206  Sum_probs=81.9

Q ss_pred             eEeeeCceEEEEEEECC-----CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCee-eEEeEeeccceeeEEEEecCC
Q 042150          468 IIGSGGFGMVYKGVLRD-----NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV-SLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv-~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      .|-.|-.-.+|+..+.+     ++.+++|.........++ -.+|..++..+..-++. ++++.+..+    .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            45457778899887543     357888875544333333 37899999988644443 455655332    58999987


Q ss_pred             Cchhhh-----------------ccCCC----CCCCCHHHHHHHHHHH-----------------HHHHHHH----hc-C
Q 042150          542 GPLKKH-----------------LYGPD----RTPLSWKQRLEICIGA-----------------ARGLHYL----HT-G  578 (803)
Q Consensus       542 gsL~~~-----------------l~~~~----~~~l~~~~~~~i~~~i-----------------a~gL~yL----H~-~  578 (803)
                      .+|...                 +|...    ....-|.++.++..++                 ..-+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            766421                 12211    0112233333332211                 1111122    21 2


Q ss_pred             CCCceEeeccCcceEEEcc-CCcEEEeeeccccC
Q 042150          579 SAEGIIHRDIKSTNILLDE-NYVSKVADFGLSRS  611 (803)
Q Consensus       579 ~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla~~  611 (803)
                      ....++|+|+++.|||+++ ++.++|+||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2357899999999999986 57899999998754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.59  E-value=0.012  Score=62.40  Aligned_cols=75  Identities=19%  Similarity=0.273  Sum_probs=48.8

Q ss_pred             CccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc---CCCeeeEEeEeeccceeeEEEEecC
Q 042150          464 DKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR---HRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ...+.|+.|....+|+.. .+++.+.||...   ......|..|.+-|+.|.   --.+.+.+++....+..+|||||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            334568889999999876 668899999854   233457899999999883   3457788888877777899999998


Q ss_pred             CC
Q 042150          541 KG  542 (803)
Q Consensus       541 ~g  542 (803)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            77

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.45  E-value=0.031  Score=59.21  Aligned_cols=31  Identities=23%  Similarity=0.451  Sum_probs=25.9

Q ss_pred             CceEeeccCcceEEEccCCc-EEEeeeccccC
Q 042150          581 EGIIHRDIKSTNILLDENYV-SKVADFGLSRS  611 (803)
Q Consensus       581 ~~ivHrDLkp~NILl~~~~~-~kl~DFGla~~  611 (803)
                      ..++|+|+++.|||+++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997554 56999998865

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.43  E-value=0.03  Score=60.88  Aligned_cols=80  Identities=20%  Similarity=0.236  Sum_probs=51.1

Q ss_pred             eEeeeCceEEEEEEECCC-cEEEEEEcCC-------CCCCChHHHHHHHHHHHhcc--CCCeeeEEeEeeccceeeEEEE
Q 042150          468 IIGSGGFGMVYKGVLRDN-TKVAVKRGVP-------GSRQGLPEFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~f~~E~~~l~~l~--HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .||.|....||++...++ +.|+||.-.+       ...-..++..-|.+.|+...  -|..++-+-+ .+.....+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FDTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-EccccceehHh
Confidence            478999999999998754 5899996221       22444566777888887763  3544443322 33445568999


Q ss_pred             ecCCC-chhhhc
Q 042150          538 YMEKG-PLKKHL  548 (803)
Q Consensus       538 y~~~g-sL~~~l  548 (803)
                      +++.. .|++.|
T Consensus        81 dL~~~~ilR~~L   92 (370)
T TIGR01767        81 DLSHHKIARKGL   92 (370)
T ss_pred             hCccchHHHHHH
Confidence            98653 343433

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.19  E-value=0.068  Score=59.14  Aligned_cols=73  Identities=19%  Similarity=0.254  Sum_probs=50.6

Q ss_pred             cceEeeeCceEEEEEEECCCcEEEEEEcCCCCC-------CChHHHHHHHHHHHhcc---CCCeeeEEeEeeccceeeEE
Q 042150          466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSR-------QGLPEFQTEITVLSKIR---HRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .+.||.|....||+.... +..++||+-.+..+       ....+-..|.+.|+.+.   ..++.+++.+|.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            346899999999997764 55799997442111       23445556677776663   247888898887  346788


Q ss_pred             EEecCC
Q 042150          536 YEYMEK  541 (803)
Q Consensus       536 ~Ey~~~  541 (803)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.01  E-value=0.00072  Score=82.73  Aligned_cols=159  Identities=14%  Similarity=0.013  Sum_probs=111.4

Q ss_pred             HHHHHHHHHhccCCCeeeEEeEe--eccceeeEEEEecCCCchhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcC-
Q 042150          504 FQTEITVLSKIRHRHLVSLVGYC--EEQSEMILVYEYMEKGPLKKHLYGP--DRTPLSWKQRLEICIGAARGLHYLHTG-  578 (803)
Q Consensus       504 f~~E~~~l~~l~HpnIv~l~g~~--~~~~~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-  578 (803)
                      ...|...++...|+++.....-.  .+..+.+.+++|+..|.+.+.|-+.  +...+...-+.....+......-+|+. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            34455555667898877655443  2344678899999999999988432  233344444443334434444444442 


Q ss_pred             -CCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHH
Q 042150          579 -SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV  657 (803)
Q Consensus       579 -~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el  657 (803)
                       ...-.+|++||+-|.+|..+..+|++++|+.+...  ..........+++.|+.|+....-+++.++|+|..|+.+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence             23447899999999999999999999999998311  112223345678889999999888999999999999999998


Q ss_pred             HhCCCCC
Q 042150          658 LCARTAV  664 (803)
Q Consensus       658 ltG~~p~  664 (803)
                      --|..++
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8777654

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.74  E-value=0.03  Score=56.74  Aligned_cols=121  Identities=20%  Similarity=0.252  Sum_probs=60.1

Q ss_pred             CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCe-eeEEeEeeccceeeEEEEecCCCchhhh-c--------------
Q 042150          485 NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL-VSLVGYCEEQSEMILVYEYMEKGPLKKH-L--------------  548 (803)
Q Consensus       485 ~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~~-l--------------  548 (803)
                      .+.|+|+..... ....-+-..|..+++.+..-++ .++++++.++    +|+||+++..|..- +              
T Consensus         2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence            457788875444 3445567889999999865444 4455555433    57799977654321 1              


Q ss_pred             --cCC-----CCCCCCHHHHHHH----------------------HHHHHHHHHHHhc-----CCCCceEeeccCcceEE
Q 042150          549 --YGP-----DRTPLSWKQRLEI----------------------CIGAARGLHYLHT-----GSAEGIIHRDIKSTNIL  594 (803)
Q Consensus       549 --~~~-----~~~~l~~~~~~~i----------------------~~~ia~gL~yLH~-----~~~~~ivHrDLkp~NIL  594 (803)
                        |..     ....--|..+.++                      ...+.+-+..+.+     .....++|.||.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              110     0111112222222                      0111111222111     12246889999999999


Q ss_pred             E-ccCCcEEEeeecccc
Q 042150          595 L-DENYVSKVADFGLSR  610 (803)
Q Consensus       595 l-~~~~~~kl~DFGla~  610 (803)
                      + +.++.++|+||..|.
T Consensus       157 ~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             ETSSSSCEEE--GTT-E
T ss_pred             eccCCCeEEEecHHHHh
Confidence            9 889999999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.30  E-value=0.1  Score=56.04  Aligned_cols=139  Identities=19%  Similarity=0.188  Sum_probs=92.2

Q ss_pred             ccceEeeeCceEEEEEEECCCcEEEEEEcCCC-----C--------------------CCC-hHHHHHHHHHHHhccCCC
Q 042150          465 KNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG-----S--------------------RQG-LPEFQTEITVLSKIRHRH  518 (803)
Q Consensus       465 ~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~-----~--------------------~~~-~~~f~~E~~~l~~l~Hpn  518 (803)
                      +...|..|--+.||.+.-.+|..+|||+.+..     .                    +.- .-....|++-|.+|+.-.
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            34578899999999999999999999963211     0                    000 113456888888886544


Q ss_pred             eeeEEeEeeccceeeEEEEecCCCch-hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc
Q 042150          519 LVSLVGYCEEQSEMILVYEYMEKGPL-KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE  597 (803)
Q Consensus       519 Iv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~  597 (803)
                      |...--...  ..-.|||+|+..... .-.|   ....++...+..+-.|++.-|.-|.+  ..++||.||.--|+|+-+
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyhd  300 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYHD  300 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEEC
Confidence            331111111  123789999953221 1112   33457777777777888888888876  367999999999999865


Q ss_pred             CCcEEEeeeccccC
Q 042150          598 NYVSKVADFGLSRS  611 (803)
Q Consensus       598 ~~~~kl~DFGla~~  611 (803)
                       |.+.|+|.+-+..
T Consensus       301 -G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 -GKLYIIDVSQSVE  313 (520)
T ss_pred             -CEEEEEEcccccc
Confidence             5889999886643

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.28  E-value=0.12  Score=56.43  Aligned_cols=139  Identities=16%  Similarity=0.236  Sum_probs=79.1

Q ss_pred             eEeeeCceEEEEEEECC----CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCee-eEEeEeeccceeeEEEEecCCC
Q 042150          468 IIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV-SLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv-~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      .|..|-...+|+....+    +..|++|..-.... ..-+-.+|..+++.+..-++- ++++++. .+   +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            34446677788876543    23788887544333 223346899999998655553 4566553 22   589999776


Q ss_pred             chhhh-----------------ccCCC---CC-CCCHHHHHHHHHHH----------------------HHHHH----HH
Q 042150          543 PLKKH-----------------LYGPD---RT-PLSWKQRLEICIGA----------------------ARGLH----YL  575 (803)
Q Consensus       543 sL~~~-----------------l~~~~---~~-~l~~~~~~~i~~~i----------------------a~gL~----yL  575 (803)
                      .|...                 +|...   .. +--|..+.++..++                      ..-+.    .+
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            55321                 12111   01 11233332222221                      11111    11


Q ss_pred             hc-CCCCceEeeccCcceEEEcc-CCcEEEeeeccccC
Q 042150          576 HT-GSAEGIIHRDIKSTNILLDE-NYVSKVADFGLSRS  611 (803)
Q Consensus       576 H~-~~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla~~  611 (803)
                      .. ....-++|.|+.+.|||+++ ++.++++||..|..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11 12235799999999999974 57899999998754

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.27  E-value=0.21  Score=53.89  Aligned_cols=31  Identities=32%  Similarity=0.432  Sum_probs=26.4

Q ss_pred             CCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       580 ~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      ..+++|+|+++.||+++. +.+.|+||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            367999999999999987 5788999997643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.24  E-value=0.083  Score=58.16  Aligned_cols=73  Identities=21%  Similarity=0.186  Sum_probs=49.7

Q ss_pred             ceEeeeCceEEEEEEECC-CcEEEEEEcC------CCCCCChHHHHHHHHHHHhcc--CCCeee-EEeEeeccceeeEEE
Q 042150          467 LIIGSGGFGMVYKGVLRD-NTKVAVKRGV------PGSRQGLPEFQTEITVLSKIR--HRHLVS-LVGYCEEQSEMILVY  536 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~------~~~~~~~~~f~~E~~~l~~l~--HpnIv~-l~g~~~~~~~~~lV~  536 (803)
                      +.||.|...-||++.... ++.|+||.-.      ....-..++..-|.+.|+.+.  -|..++ ++.+  +.....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence            368999999999999753 5689999622      223445677788888888773  454444 4433  334557889


Q ss_pred             EecCC
Q 042150          537 EYMEK  541 (803)
Q Consensus       537 Ey~~~  541 (803)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            98854

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.24  E-value=0.16  Score=54.79  Aligned_cols=32  Identities=16%  Similarity=0.227  Sum_probs=28.8

Q ss_pred             CCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       580 ~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      ..+++|+|+.+.|||+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            46799999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.09  E-value=0.25  Score=53.56  Aligned_cols=136  Identities=21%  Similarity=0.238  Sum_probs=80.2

Q ss_pred             CceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc---CCCeee---EEeE----eeccceeeEEEEecCCC
Q 042150          473 GFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR---HRHLVS---LVGY----CEEQSEMILVYEYMEKG  542 (803)
Q Consensus       473 ~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---HpnIv~---l~g~----~~~~~~~~lV~Ey~~~g  542 (803)
                      .-..+|+....+|+. ++|.....  ....+...|+..|..|.   .+=.++   +=|-    .......+-+++|++|.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            456788888777666 88875554  44566777888888773   222222   2221    11123678899999998


Q ss_pred             chhh-hc--------------c----CC---C---CCCCCHHH-------------HHHHHHHHHHHHHHHhc----CCC
Q 042150          543 PLKK-HL--------------Y----GP---D---RTPLSWKQ-------------RLEICIGAARGLHYLHT----GSA  580 (803)
Q Consensus       543 sL~~-~l--------------~----~~---~---~~~l~~~~-------------~~~i~~~ia~gL~yLH~----~~~  580 (803)
                      .+.. ..              |    +-   .   .....|..             ......++...+..+.+    ...
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            7773 11              0    00   0   11234431             01122333334444433    122


Q ss_pred             Cc---eEeeccCcceEEEccCCc-EEEeeeccccC
Q 042150          581 EG---IIHRDIKSTNILLDENYV-SKVADFGLSRS  611 (803)
Q Consensus       581 ~~---ivHrDLkp~NILl~~~~~-~kl~DFGla~~  611 (803)
                      ..   +||+|+.|.||+++.+.. +.++||+-+..
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            23   999999999999998875 89999997754

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.67  E-value=0.17  Score=50.99  Aligned_cols=73  Identities=21%  Similarity=0.330  Sum_probs=50.6

Q ss_pred             EeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc---CCCeeeEEeEeeccceeeEEEEecCCCchh
Q 042150          469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR---HRHLVSLVGYCEEQSEMILVYEYMEKGPLK  545 (803)
Q Consensus       469 Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~  545 (803)
                      +.-|..-..|... .+..++.||+-   .......|..|+.-|..|.   --++.+.+.+-.....-||||||++-|.+.
T Consensus        24 v~gG~inea~~v~-dg~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          24 VSGGDINEAWRLR-DGTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             cCCccccceeEee-cCCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            3334434444332 33568889972   2334567888988777774   456888888889999999999999987665

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	803
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-105
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-104
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-48
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-37
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-28
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-28
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-27
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-27
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-26
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-26
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-26
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-26
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-26
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-24
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-24
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-24
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-24
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-24
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-24
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-24
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-24
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-24
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-24
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-23
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-23
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-22
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-22
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-22
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-22
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-22
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-22
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-22
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-21
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-21
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-21
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-21
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-21
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-21
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-21
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-21
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-21
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-21
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-21
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-21
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-21
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-21
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-21
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-21
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-21
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-21
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-21
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-21
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-21
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-21
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-20
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-20
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-20
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-20
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-20
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-20
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-20
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-20
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-20
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-20
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-20
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-20
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-20
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-20
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-20
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-20
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-20
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-20
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-20
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-20
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-20
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-20
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-19
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-19
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-19
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-19
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-19
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-18
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-18
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-18
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-18
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		9e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-15
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-15
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-15
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-15
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-15
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-15
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-15
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-15
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-15
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-15
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-11
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-05
3soa_A	444	Full-Length Human Camkii Length = 444		4e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-05

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  378 bits (970), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 189/299 (63%), Positives = 228/299 (76%), Gaps = 5/299 (1%)
Query: 446 YHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQ 505
           +   ++P  DL+ ATNNFD   +IG G FG VYKGVLRD  KVA+KR  P S QG+ EF+
Sbjct: 24  FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 506 TEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPD--RTPLSWKQRLE 563
           TEI  LS  RH HLVSL+G+C+E++EMIL+Y+YME G LK+HLYG D     +SW+QRLE
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
           ICIGAARGLHYLHT     IIHRD+KS NILLDEN+V K+ DFG+S+ G  LD+TH+   
Sbjct: 144 ICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV 200
Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ 683
           VKG+ GY+DPEYF + +LT+KSDVYSFGVVLFEVLCAR+A+   L RE VNLAEWA++  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES 742
             G LE I+DP L  KI  +SL+KFG+TA KCLA    DRPSMGDVLW LEYAL+LQES
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  375 bits (963), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 188/299 (62%), Positives = 227/299 (75%), Gaps = 5/299 (1%)
Query: 446 YHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQ 505
           +   ++P  DL+ ATNNFD   +IG G FG VYKGVLRD  KVA+KR  P S QG+ EF+
Sbjct: 24  FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 506 TEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPD--RTPLSWKQRLE 563
           TEI  LS  RH HLVSL+G+C+E++EMIL+Y+YME G LK+HLYG D     +SW+QRLE
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
           ICIGAARGLHYLHT     IIHRD+KS NILLDEN+V K+ DFG+S+ G  L +TH+   
Sbjct: 144 ICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV 200
Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ 683
           VKG+ GY+DPEYF + +LT+KSDVYSFGVVLFEVLCAR+A+   L RE VNLAEWA++  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES 742
             G LE I+DP L  KI  +SL+KFG+TA KCLA    DRPSMGDVLW LEYAL+LQES
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  190 bits (482), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 112/292 (38%), Positives = 165/292 (56%), Gaps = 10/292 (3%)
Query: 450 KIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP-EFQTEI 508
           +    +LQ A++NF    I+G GGFG VYKG L D T VAVKR      QG   +FQTE+
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICI 566
            ++S   HR+L+ L G+C   +E +LVY YM  G +   L      + PL W +R  I +
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
           G+ARGL YLH      IIHRD+K+ NILLDE + + V DFGL++     D  HV   V+G
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXXAVRG 205
Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAR----EQVNLAEWAMQW 682
           + G++ PEY    + ++K+DV+ +GV+L E++  + A D  LAR    + V L +W    
Sbjct: 206 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD--LARLANDDDVMLLDWVKGL 263
Query: 683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
            K+  LE ++D  L G    + +++  + A  C     ++RP M +V+  LE
Sbjct: 264 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  187 bits (474), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 111/292 (38%), Positives = 163/292 (55%), Gaps = 10/292 (3%)
Query: 450 KIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP-EFQTEI 508
           +    +LQ A++NF    I+G GGFG VYKG L D   VAVKR      QG   +FQTE+
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICI 566
            ++S   HR+L+ L G+C   +E +LVY YM  G +   L      + PL W +R  I +
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
           G+ARGL YLH      IIHRD+K+ NILLDE + + V DFGL++     D  HV   V+G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXXAVRG 197
Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAR----EQVNLAEWAMQW 682
             G++ PEY    + ++K+DV+ +GV+L E++  + A D  LAR    + V L +W    
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD--LARLANDDDVMLLDWVKGL 255
Query: 683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
            K+  LE ++D  L G    + +++  + A  C     ++RP M +V+  LE
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  165 bits (417), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 109/289 (37%), Positives = 162/289 (56%), Gaps = 20/289 (6%)
Query: 453 FTDLQTATNNFDKNLI------IGSGGFGMVYKGVLRDNTKVAVKRGVP----GSRQGLP 502
           F +L+  TNNFD+  I      +G GGFG+VYKG + +NT VAVK+        + +   
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQR 561
           +F  EI V++K +H +LV L+G+  +  ++ LVY YM  G L   L   D TP LSW  R
Sbjct: 76  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS 621
            +I  GAA G+++LH       IHRDIKS NILLDE + +K++DFGL+R+     +T + 
Sbjct: 136 CKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMX 192
Query: 622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE-QVNLAEWAM 680
           + + G+  Y+ PE   R ++T KSD+YSFGVVL E++    AVD    RE Q+ L     
Sbjct: 193 SRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE--HREPQLLLDIKEE 249
Query: 681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDV 729
              ++  +E  ID ++    +  S++     A +CL +    RP +  V
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  164 bits (416), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 109/289 (37%), Positives = 161/289 (55%), Gaps = 20/289 (6%)
Query: 453 FTDLQTATNNFDKNLI------IGSGGFGMVYKGVLRDNTKVAVKRGVP----GSRQGLP 502
           F +L+  TNNFD+  I      +G GGFG+VYKG + +NT VAVK+        + +   
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQR 561
           +F  EI V++K +H +LV L+G+  +  ++ LVY YM  G L   L   D TP LSW  R
Sbjct: 76  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS 621
            +I  GAA G+++LH       IHRDIKS NILLDE + +K++DFGL+R+     +T + 
Sbjct: 136 CKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMX 192
Query: 622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE-QVNLAEWAM 680
             + G+  Y+ PE   R ++T KSD+YSFGVVL E++    AVD    RE Q+ L     
Sbjct: 193 XRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE--HREPQLLLDIKEE 249
Query: 681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDV 729
              ++  +E  ID ++    +  S++     A +CL +    RP +  V
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  162 bits (410), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 108/289 (37%), Positives = 160/289 (55%), Gaps = 20/289 (6%)
Query: 453 FTDLQTATNNFDKNLI------IGSGGFGMVYKGVLRDNTKVAVKRGVP----GSRQGLP 502
           F +L+  TNNFD+  I      +G GGFG+VYKG + +NT VAVK+        + +   
Sbjct: 11  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 69
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQR 561
           +F  EI V++K +H +LV L+G+  +  ++ LVY YM  G L   L   D TP LSW  R
Sbjct: 70  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 129
Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS 621
            +I  GAA G+++LH       IHRDIKS NILLDE + +K++DFGL+R+     +  + 
Sbjct: 130 CKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMX 186
Query: 622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE-QVNLAEWAM 680
             + G+  Y+ PE   R ++T KSD+YSFGVVL E++    AVD    RE Q+ L     
Sbjct: 187 XRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE--HREPQLLLDIKEE 243
Query: 681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDV 729
              ++  +E  ID ++    +  S++     A +CL +    RP +  V
Sbjct: 244 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 291

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  155 bits (391), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 93/224 (41%), Positives = 130/224 (58%), Gaps = 16/224 (7%)
Query: 453 FTDLQTATNNFDKNLI------IGSGGFGMVYKGVLRDNTKVAVKRGVP----GSRQGLP 502
           F +L+  TNNFD+  I       G GGFG+VYKG + +NT VAVK+        + +   
Sbjct: 8   FYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 66
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQR 561
           +F  EI V +K +H +LV L+G+  +  ++ LVY Y   G L   L   D TP LSW  R
Sbjct: 67  QFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXR 126
Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS 621
            +I  GAA G+++LH       IHRDIKS NILLDE + +K++DFGL+R+     +    
Sbjct: 127 CKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXX 183
Query: 622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
           + + G+  Y  PE   R ++T KSD+YSFGVVL E++    AVD
Sbjct: 184 SRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  122 bits (306), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           + ++ +V ++ E   L  HL+  + T    K+ ++I    ARG+ YLH   A+ IIHRD+
Sbjct: 91  KPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDL 146
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +     +  R+Q+      ++   +G L     P L  K+  +  
Sbjct: 207 DVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSL----SPDL-SKVRSNCP 255
Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           K+      +CL     +RPS   +L  +E
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  122 bits (306), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 78
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           + ++ +V ++ E   L  HL+  + T    K+ ++I    ARG+ YLH   A+ IIHRD+
Sbjct: 79  KPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDL 134
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 135 KSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 194
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +     +  R+Q+      ++   +G L     P L  K+  +  
Sbjct: 195 DVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSL----SPDL-SKVRSNCP 243
Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           K+      +CL     +RPS   +L  +E
Sbjct: 244 KRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 134/269 (49%), Gaps = 19/269 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
             ++ +V ++ E   L  HL+  + T    K+ ++I    ARG+ YLH   A+ IIHRD+
Sbjct: 92  -PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDL 146
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +     +  R+Q+      ++   +G L     P L  K+  +  
Sbjct: 207 DVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSL----SPDL-SKVRSNCP 255
Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           K+      +CL     +RPS   +L  +E
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  119 bits (299), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 74/191 (38%), Positives = 108/191 (56%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG+V+ G   +  KVA+K    G+     +F  E  V+ K+ H  LV L G C E
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q+ + LV+E+ME G L  +L    R   + +  L +C+    G+ YL   S   +IHRD+
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIHRDL 129
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+ EN V KV+DFG++R    LD+ +  STG K    +  PE F   + + KSDV
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 648 YSFGVVLFEVL 658
           +SFGV+++EV 
Sbjct: 188 WSFGVLMWEVF 198

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 74/191 (38%), Positives = 107/191 (56%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG+V+ G   +  KVA+K    GS     +F  E  V+ K+ H  LV L G C E
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q+ + LV+E+ME G L  +L    R   + +  L +C+    G+ YL       +IHRD+
Sbjct: 94  QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 149
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+ EN V KV+DFG++R    LD+ +  STG K    +  PE F   + + KSDV
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 207
Query: 648 YSFGVVLFEVL 658
           +SFGV+++EV 
Sbjct: 208 WSFGVLMWEVF 218

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 73/191 (38%), Positives = 107/191 (56%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG+V+ G   +  KVA+K    G+     +F  E  V+ K+ H  LV L G C E
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q+ + LV+E+ME G L  +L    R   + +  L +C+    G+ YL       +IHRD+
Sbjct: 77  QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 132
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+ EN V KV+DFG++R    LD+ +  STG K    +  PE F   + + KSDV
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 190
Query: 648 YSFGVVLFEVL 658
           +SFGV+++EV 
Sbjct: 191 WSFGVLMWEVF 201

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 73/191 (38%), Positives = 107/191 (56%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG+V+ G   +  KVA+K    G+     +F  E  V+ K+ H  LV L G C E
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q+ + LV+E+ME G L  +L    R   + +  L +C+    G+ YL       +IHRD+
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 129
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+ EN V KV+DFG++R    LD+ +  STG K    +  PE F   + + KSDV
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 648 YSFGVVLFEVL 658
           +SFGV+++EV 
Sbjct: 188 WSFGVLMWEVF 198

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 73/191 (38%), Positives = 107/191 (56%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG+V+ G   +  KVA+K    G+     +F  E  V+ K+ H  LV L G C E
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q+ + LV+E+ME G L  +L    R   + +  L +C+    G+ YL       +IHRD+
Sbjct: 72  QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 127
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+ EN V KV+DFG++R    LD+ +  STG K    +  PE F   + + KSDV
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 648 YSFGVVLFEVL 658
           +SFGV+++EV 
Sbjct: 186 WSFGVLMWEVF 196

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  116 bits (290), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 73/191 (38%), Positives = 106/191 (55%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG+V+ G   +  KVA+K    G+     +F  E  V+ K+ H  LV L G C E
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q+ + LV E+ME G L  +L    R   + +  L +C+    G+ YL       +IHRD+
Sbjct: 75  QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 130
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+ EN V KV+DFG++R    LD+ +  STG K    +  PE F   + + KSDV
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 648 YSFGVVLFEVL 658
           +SFGV+++EV 
Sbjct: 189 WSFGVLMWEVF 199

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 131/269 (48%), Gaps = 19/269 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 76
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           + ++ +V ++ E   L  HL+  + T     + ++I    A+G+ YLH   A+ IIHRD+
Sbjct: 77  KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 132
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 133 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 192
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +     +  R+Q+           +G L     P L  K+  +  
Sbjct: 193 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------GRGYL----SPDL-SKVRSNCP 241
Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           K       +CL     +RP    +L ++E
Sbjct: 242 KAMKRLMAECLKKKRDERPLFPQILASIE 270

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 131/269 (48%), Gaps = 19/269 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 94
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           + ++ +V ++ E   L  HL+  + T     + ++I    A+G+ YLH   A+ IIHRD+
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 150
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 151 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 210
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +     +  R+Q+           +G L     P L  K+  +  
Sbjct: 211 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------GRGYLS----PDL-SKVRSNCP 259
Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           K       +CL     +RP    +L ++E
Sbjct: 260 KAMKRLMAECLKKKRDERPLFPQILASIE 288

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 131/269 (48%), Gaps = 19/269 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           + ++ +V ++ E   L  HL+  + T     + ++I    A+G+ YLH   A+ IIHRD+
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 130
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +     +  R+Q+           +G L     P L  K+  +  
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------GRGYL----SPDL-SKVRSNCP 239
Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           K       +CL     +RP    +L ++E
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 131/269 (48%), Gaps = 19/269 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 79
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           + ++ +V ++ E   L  HL+  + T     + ++I    A+G+ YLH   A+ IIHRD+
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 135
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +     +  R+Q+           +G L     P L  K+  +  
Sbjct: 196 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------GRGYLS----PDL-SKVRSNCP 244
Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           K       +CL     +RP    +L ++E
Sbjct: 245 KAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 111/208 (53%), Gaps = 8/208 (3%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 102
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           + ++ +V ++ E   L  HL+  + T     + ++I    A+G+ YLH   A+ IIHRD+
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 158
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 218
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQV 673
           DVY+FG+VL+E++  +     +  R+Q+
Sbjct: 219 DVYAFGIVLYELMTGQLPYSNINNRDQI 246

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 131/269 (48%), Gaps = 19/269 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 79
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           + ++ +V ++ E   L  HL+  + T     + ++I    A+G+ YLH   A+ IIHRD+
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 135
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +     +  R+Q+           +G L     P L  K+  +  
Sbjct: 196 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------GRGYLS----PDL-SKVRSNCP 244
Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           K       +CL     +RP    +L ++E
Sbjct: 245 KAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 131/269 (48%), Gaps = 19/269 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           + ++ +V ++ E   L  HL+  + T     + ++I    A+G+ YLH   A+ IIHRD+
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 130
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +     +  R+Q+           +G L     P L  K+  +  
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------GRGYL----SPDL-SKVRSNCP 239
Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           K       +CL     +RP    +L ++E
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 131/269 (48%), Gaps = 19/269 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 102
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           + ++ +V ++ E   L  HL+  + T     + ++I    A+G+ YLH   A+ IIHRD+
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 158
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 218
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +     +  R+Q+           +G L     P L  K+  +  
Sbjct: 219 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------GRGYLS----PDL-SKVRSNCP 267
Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           K       +CL     +RP    +L ++E
Sbjct: 268 KAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 131/269 (48%), Gaps = 19/269 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 101
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           + ++ +V ++ E   L  HL+  + T     + ++I    A+G+ YLH   A+ IIHRD+
Sbjct: 102 KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 157
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 158 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 217
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +     +  R+Q+           +G L     P L  K+  +  
Sbjct: 218 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------GRGYLS----PDL-SKVRSNCP 266
Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           K       +CL     +RP    +L ++E
Sbjct: 267 KAMKRLMAECLKKKRDERPLFPQILASIE 295

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 16/213 (7%)
Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDN---TKVAVKRGVPGSRQGLPEFQ 505
           + IP+ DL            IG+G FG V++     +    K+ +++     R    EF 
Sbjct: 32  MDIPWCDLNIKEK-------IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVN--EFL 82
Query: 506 TEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPD-RTPLSWKQRLEI 564
            E+ ++ ++RH ++V  +G   +   + +V EY+ +G L + L+    R  L  ++RL +
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               A+G++YLH  +   I+HRD+KS N+L+D+ Y  KV DFGLSR          S   
Sbjct: 143 AYDVAKGMNYLHNRNPP-IVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ASXFLXSKXA 199
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
            G+  ++ PE  R +   +KSDVYSFGV+L+E+
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 19/269 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
             ++ +V ++ E   L  HL+  + T     + ++I    A+G+ YLH   A+ IIHRD+
Sbjct: 76  -PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 130
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +     +  R+Q+           +G L     P L  K+  +  
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------GRGYL----SPDL-SKVRSNCP 239
Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           K       +CL     +RP    +L ++E
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 109/208 (52%), Gaps = 8/208 (3%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V + + V  + +    F+ E+ VL K RH +++  +GY  +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
            + + +V ++ E   L KHL+  + T     Q ++I    A+G+ YLH   A+ IIHRD+
Sbjct: 104 DN-LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDM 158
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E    K+ DFGL+        +       GS  ++ PE  R Q     + +S
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS 218
Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQV 673
           DVYS+G+VL+E++        +  R+Q+
Sbjct: 219 DVYSYGIVLYELMTGELPYSHINNRDQI 246

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 116/214 (54%), Gaps = 18/214 (8%)
Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDN---TKVAVKRGVPGSRQGLPEFQ 505
           + IP+ DL            IG+G FG V++     +    K+ +++     R    EF 
Sbjct: 32  MDIPWCDLNIKEK-------IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVN--EFL 82
Query: 506 TEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPD-RTPLSWKQRLEI 564
            E+ ++ ++RH ++V  +G   +   + +V EY+ +G L + L+    R  L  ++RL +
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST-G 623
               A+G++YLH  +   I+HR++KS N+L+D+ Y  KV DFGLSR       T +S+  
Sbjct: 143 AYDVAKGMNYLHNRNPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFLSSKS 198
Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
             G+  ++ PE  R +   +KSDVYSFGV+L+E+
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 28/207 (13%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVG 524
           IIG GGFG VY+   + D   V   R  P     Q +   + E  + + ++H ++++L G
Sbjct: 14  IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYG---PDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
            C ++  + LV E+   GPL + L G   P    ++W  ++      ARG++YLH  +  
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHDEAIV 127
Query: 582 GIIHRDIKSTNILLDE--------NYVSKVADFGLSRSGPCLDETHVSTGVK--GSFGYL 631
            IIHRD+KS+NIL+ +        N + K+ DFGL+R      E H +T +   G++ ++
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKMSAAGAYAWM 181
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            PE  R    +  SDV+S+GV+L+E+L
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELL 208

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 122/233 (52%), Gaps = 27/233 (11%)
Query: 450 KIPFTDLQT-ATNNFDKNLIIGSGGFGMVYKG-VLRDNTKVAVKRGVPGSRQG------- 500
           + P + L T A N  +    IG GGFG+V+KG +++D + VA+K  + G  +G       
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRT-PLSWK 559
             EFQ E+ ++S + H ++V L G       M++  E++  G L   L   D+  P+ W 
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLL--DKAHPIKWS 122
Query: 560 QRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNIL---LDEN--YVSKVADFGLSRSGPC 614
            +L + +  A G+ Y+   +   I+HRD++S NI    LDEN    +KVADFGLS+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-- 179
Query: 615 LDETHVSTGVKGSFGYLDPEYF--RRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
               H  +G+ G+F ++ PE      +  T+K+D YSF ++L+ +L      D
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 121/233 (51%), Gaps = 27/233 (11%)
Query: 450 KIPFTDLQT-ATNNFDKNLIIGSGGFGMVYKG-VLRDNTKVAVKRGVPGSRQG------- 500
           + P + L T A N  +    IG GGFG+V+KG +++D + VA+K  + G  +G       
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRT-PLSWK 559
             EFQ E+ ++S + H ++V L G       M++  E++  G L   L   D+  P+ W 
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLL--DKAHPIKWS 122
Query: 560 QRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNIL---LDEN--YVSKVADFGLSRSGPC 614
            +L + +  A G+ Y+   +   I+HRD++S NI    LDEN    +KVADFG S+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-- 179
Query: 615 LDETHVSTGVKGSFGYLDPEYF--RRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
               H  +G+ G+F ++ PE      +  T+K+D YSF ++L+ +L      D
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 121/233 (51%), Gaps = 27/233 (11%)
Query: 450 KIPFTDLQT-ATNNFDKNLIIGSGGFGMVYKG-VLRDNTKVAVKRGVPGSRQG------- 500
           + P + L T A N  +    IG GGFG+V+KG +++D + VA+K  + G  +G       
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRT-PLSWK 559
             EFQ E+ ++S + H ++V L G       M++  E++  G L   L   D+  P+ W 
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLL--DKAHPIKWS 122
Query: 560 QRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNIL---LDEN--YVSKVADFGLSRSGPC 614
            +L + +  A G+ Y+   +   I+HRD++S NI    LDEN    +KVADF LS+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-- 179
Query: 615 LDETHVSTGVKGSFGYLDPEYF--RRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
               H  +G+ G+F ++ PE      +  T+K+D YSF ++L+ +L      D
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 469 IGSGGFGMVYKGVL------RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG V+          +D   VAVK     S     +F  E  +L+ ++H H+V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHL--YGPDR---------TPLSWKQRLEICIGAARG 571
            G C E   +I+V+EYM+ G L K L  +GPD          T L+  Q L I    A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           + YL   +++  +HRD+ + N L+ EN + K+ DFG+SR     D   V         ++
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            PE    ++ T +SDV+S GVVL+E+ 
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIF 224

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 108/200 (54%), Gaps = 12/200 (6%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           ++G G FG+V K   R    VA+K+    S +    F  E+  LS++ H ++V L G C 
Sbjct: 16  VVGRGAFGVVCKAKWRAK-DVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGAC- 71
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPL-SWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
             + + LV EY E G L   L+G +  P  +    +  C+  ++G+ YLH+   + +IHR
Sbjct: 72  -LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 587 DIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS 645
           D+K  N+LL     V K+ DFG +    C  +TH+ T  KGS  ++ PE F     ++K 
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM-TNNKGSAAWMAPEVFEGSNYSEKC 185
Query: 646 DVYSFGVVLFEVLCARTAVD 665
           DV+S+G++L+EV+  R   D
Sbjct: 186 DVFSWGIILWEVITRRKPFD 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 108/200 (54%), Gaps = 12/200 (6%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           ++G G FG+V K   R    VA+K+    S +    F  E+  LS++ H ++V L G C 
Sbjct: 15  VVGRGAFGVVCKAKWRAK-DVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGAC- 70
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPL-SWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
             + + LV EY E G L   L+G +  P  +    +  C+  ++G+ YLH+   + +IHR
Sbjct: 71  -LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 587 DIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS 645
           D+K  N+LL     V K+ DFG +    C  +TH+ T  KGS  ++ PE F     ++K 
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM-TNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 646 DVYSFGVVLFEVLCARTAVD 665
           DV+S+G++L+EV+  R   D
Sbjct: 185 DVFSWGIILWEVITRRKPFD 204

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 468 IIGSGGFGMVYKGVLRDNT-----KVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVS 521
           +IG+G FG VYKG+L+ ++      VA+K    G + +   +F  E  ++ +  H +++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L G   +   M+++ EYME G L K L   D    S  Q + +  G A G+ YL   +  
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLDPEYFRR 638
             +HRD+ + NIL++ N V KV+DFGLSR     P  + T+ ++G K    +  PE    
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--EATYTTSGGKIPIRWTAPEAISY 224
Query: 639 QQLTDKSDVYSFGVVLFEVL 658
           ++ T  SDV+SFG+V++EV+
Sbjct: 225 RKFTSASDVWSFGIVMWEVM 244

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 12/201 (5%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ +L   +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---A 150
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRS--GPCLDETHVSTGVKGSFGYLDPEYFR 637
           ++  +HRD+ + N +LDE +  KVADFGL+R       D  H  TG K    ++  E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            Q+ T KSDV+SFGV+L+E++
Sbjct: 211 TQKFTTKSDVWSFGVLLWELM 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 12/201 (5%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ +L   +
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---A 148
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRS--GPCLDETHVSTGVKGSFGYLDPEYFR 637
           ++  +HRD+ + N +LDE +  KVADFGL+R       D  H  TG K    ++  E  +
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            Q+ T KSDV+SFGV+L+E++
Sbjct: 209 TQKFTTKSDVWSFGVLLWELM 229

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 12/201 (5%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ +L   +
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---A 151
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRS--GPCLDETHVSTGVKGSFGYLDPEYFR 637
           ++  +HRD+ + N +LDE +  KVADFGL+R       D  H  TG K    ++  E  +
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            Q+ T KSDV+SFGV+L+E++
Sbjct: 212 TQKFTTKSDVWSFGVLLWELM 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 12/201 (5%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ +L   +
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---A 151
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRS--GPCLDETHVSTGVKGSFGYLDPEYFR 637
           ++  +HRD+ + N +LDE +  KVADFGL+R       D  H  TG K    ++  E  +
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            Q+ T KSDV+SFGV+L+E++
Sbjct: 212 TQKFTTKSDVWSFGVLLWELM 232

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 12/201 (5%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ +L   +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---A 209
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRS--GPCLDETHVSTGVKGSFGYLDPEYFR 637
           ++  +HRD+ + N +LDE +  KVADFGL+R       D  H  TG K    ++  E  +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            Q+ T KSDV+SFGV+L+E++
Sbjct: 270 TQKFTTKSDVWSFGVLLWELM 290

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 12/201 (5%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ +L   +
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---A 155
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRS--GPCLDETHVSTGVKGSFGYLDPEYFR 637
           ++  +HRD+ + N +LDE +  KVADFGL+R       D  H  TG K    ++  E  +
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            Q+ T KSDV+SFGV+L+E++
Sbjct: 216 TQKFTTKSDVWSFGVLLWELM 236

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 74  EEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 129
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 189 WSFGILLTEL 198

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 12/201 (5%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ +L   +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---A 150
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRS--GPCLDETHVSTGVKGSFGYLDPEYFR 637
           ++  +HRD+ + N +LDE +  KVADFGL+R       D  H  TG K    ++  E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            Q+ T KSDV+SFGV+L+E++
Sbjct: 211 TQKFTTKSDVWSFGVLLWELM 231

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 305
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 365 WSFGILLTEL 374

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 305
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 365 WSFGILLTEL 374

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/190 (37%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ KIRH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 84  EEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 139
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 199 WSFGILLTEL 208

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/211 (35%), Positives = 107/211 (50%), Gaps = 9/211 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 333 EEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 388
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 648 YSFGVVLFEVLC-ARTAVDPLLAREQVNLAE 677
           +SFG++L E+    R     ++ RE ++  E
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 77  EEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 132
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 192 WSFGILLTEL 201

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 469 IGSGGFGMVYKGVL------RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG V+          +D   VAVK     S     +FQ E  +L+ ++H+H+V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRT-----------PLSWKQRLEICIGAA 569
            G C E   +++V+EYM  G L + L  +GPD             PL   Q L +    A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
            G+ YL   +    +HRD+ + N L+ +  V K+ DFG+SR     D   V         
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           ++ PE    ++ T +SDV+SFGVVL+E+ 
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIF 231

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 84  EEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 139
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED-NEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 199 WSFGILLTEL 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 81  EEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHRD 136
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIED-NEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 196 WSFGILLTEL 205

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 81  EEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHRD 136
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 196 WSFGILLTEL 205

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 469 IGSGGFGMVYKGVL------RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG V+          +D   VAVK     S     +FQ E  +L+ ++H+H+V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRT-----------PLSWKQRLEICIGAA 569
            G C E   +++V+EYM  G L + L  +GPD             PL   Q L +    A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
            G+ YL   +    +HRD+ + N L+ +  V K+ DFG+SR     D   V         
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           ++ PE    ++ T +SDV+SFGVVL+E+ 
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIF 225

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 469 IGSGGFGMVYKGVL------RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG V+          +D   VAVK     S     +FQ E  +L+ ++H+H+V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRT-----------PLSWKQRLEICIGAA 569
            G C E   +++V+EYM  G L + L  +GPD             PL   Q L +    A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
            G+ YL   +    +HRD+ + N L+ +  V K+ DFG+SR     D   V         
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           ++ PE    ++ T +SDV+SFGVVL+E+ 
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIF 254

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 84  EEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 139
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 199 WSFGILLTEL 208

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 250 EEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 305
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 365 WSFGILLTEL 374

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 84  EEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 139
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 199 WSFGILLTEL 208

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 73  EEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 128
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 188 WSFGILLTEL 197

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 75  EEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 130
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 190 WSFGILLTEL 199

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 84  EEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 139
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 199 WSFGILLTEL 208

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 84  EEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 139
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 199 WSFGILLTEL 208

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 104/201 (51%), Gaps = 12/201 (5%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ YL   +
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---A 149
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRS--GPCLDETHVSTGVKGSFGYLDPEYFR 637
           ++  +HRD+ + N +LDE +  KVADFGL+R          H  TG K    ++  E  +
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            Q+ T KSDV+SFGV+L+E++
Sbjct: 210 TQKFTTKSDVWSFGVLLWELM 230

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 84  EEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 139
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 199 WSFGILLTEL 208

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 469 IGSGGFGMVYKGVL------RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG V+          +D   VAVK     +     +FQ E  +L+ ++H H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHL--YGPD------------RTPLSWKQRLEICIGA 568
            G C +   +I+V+EYM+ G L K L  +GPD            +  L   Q L I    
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           A G+ YL   +++  +HRD+ + N L+  N + K+ DFG+SR     D   V        
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            ++ PE    ++ T +SDV+SFGV+L+E+ 
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ YL   +
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---A 168
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE----THVSTGVKGSFGYLDPEY 635
           ++  +HRD+ + N +LDE +  KVADFGL+R     D+     H  TG K    ++  E 
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
            + Q+ T KSDV+SFGV+L+E++
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELM 249

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G FG VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  +S    L +    +  + YL     +  IHRD+
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDL 135
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTG---DTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 193 VWAFGVLLWEI 203

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ YL   +
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---A 169
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE----THVSTGVKGSFGYLDPEY 635
           ++  +HRD+ + N +LDE +  KVADFGL+R     D+     H  TG K    ++  E 
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
            + Q+ T KSDV+SFGV+L+E++
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELM 250

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/190 (36%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 84  EEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 139
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           + + NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 648 YSFGVVLFEV 657
           +SFG++L E+
Sbjct: 199 WSFGILLTEL 208

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ YL   +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---A 150
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE----THVSTGVKGSFGYLDPEY 635
           ++  +HRD+ + N +LDE +  KVADFGL+R     D+     H  TG K    ++  E 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
            + Q+ T KSDV+SFGV+L+E++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELM 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ YL   +
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---A 142
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE----THVSTGVKGSFGYLDPEY 635
           ++  +HRD+ + N +LDE +  KVADFGL+R     D+     H  TG K    ++  E 
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
            + Q+ T KSDV+SFGV+L+E++
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELM 223

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ YL   +
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---A 149
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE----THVSTGVKGSFGYLDPEY 635
           ++  +HRD+ + N +LDE +  KVADFGL+R     D+     H  TG K    ++  E 
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
            + Q+ T KSDV+SFGV+L+E++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELM 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ YL   +
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---A 147
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE----THVSTGVKGSFGYLDPEY 635
           ++  +HRD+ + N +LDE +  KVADFGL+R     D+     H  TG K    ++  E 
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
            + Q+ T KSDV+SFGV+L+E++
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELM 228

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 74/211 (35%), Positives = 106/211 (50%), Gaps = 9/211 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG V+ G     T+VA+K   PG+    PE F  E  V+ K+RH  LV L     
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+   +    +HRD
Sbjct: 251 EEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 306
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL R     +E     G K    +  PE     + T KSDV
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 648 YSFGVVLFEVLC-ARTAVDPLLAREQVNLAE 677
           +SFG++L E+    R     ++ RE ++  E
Sbjct: 366 WSFGILLTELTTKGRVPYPGMVNREVLDQVE 396

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ YL   +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---A 150
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE----THVSTGVKGSFGYLDPEY 635
           ++  +HRD+ + N +LDE +  KVADFGL+R     D+     H  TG K    ++  E 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
            + Q+ T KSDV+SFGV+L+E++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ YL   +
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---A 148
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE----THVSTGVKGSFGYLDPEY 635
           ++  +HRD+ + N +LDE +  KVADFGL+R     D+     H  TG K    ++  E 
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
            + Q+ T KSDV+SFGV+L+E++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELM 229

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 76/225 (33%), Positives = 113/225 (50%), Gaps = 16/225 (7%)
Query: 435 GTVNA-SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRG 493
           G+ NA S    GY   +I   DL      F K L  G+G FG+V  G  R    VA+K  
Sbjct: 4   GSKNAPSTAGLGYGSWEIDPKDL-----TFLKEL--GTGQFGVVKYGKWRGQYDVAIKMI 56
Query: 494 VPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR 553
             GS     EF  E  V+  + H  LV L G C +Q  + ++ EYM  G L  +L    R
Sbjct: 57  KEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMR 114
Query: 554 TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP 613
                +Q LE+C      + YL +   +  +HRD+ + N L+++  V KV+DFGLSR   
Sbjct: 115 HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-- 169
Query: 614 CLDETHVST-GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
            LD+ + S+ G K    +  PE     + + KSD+++FGV+++E+
Sbjct: 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLV 520
           N +IG G FG VY G L DN    +   V    +      + +F TE  ++    H +++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           SL+G C   +   ++V  YM+ G L+  +      P + K  +   +  A+G+ YL   +
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---A 145
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE----THVSTGVKGSFGYLDPEY 635
           ++  +HRD+ + N +LDE +  KVADFGL+R     D+     H  TG K    ++  E 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
            + Q+ T KSDV+SFGV+L+E++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELM 226

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG+V  G  R    VA+K    GS     EF  E  V+  + H  LV L G C +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q  + ++ EYM  G L  +L    R     +Q LE+C      + YL +   +  +HRD+
Sbjct: 75  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 130
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+++  V KV+DFGLSR    LD+ + S+ G K    +  PE     + + KSD+
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 188
Query: 648 YSFGVVLFEV 657
           ++FGV+++E+
Sbjct: 189 WAFGVLMWEI 198

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG+V  G  R    VA+K    GS     EF  E  V+  + H  LV L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q  + ++ EYM  G L  +L    R     +Q LE+C      + YL +   +  +HRD+
Sbjct: 71  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 126
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+++  V KV+DFGLSR    LD+ + S+ G K    +  PE     + + KSD+
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 648 YSFGVVLFEV 657
           ++FGV+++E+
Sbjct: 185 WAFGVLMWEI 194

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 110/224 (49%), Gaps = 14/224 (6%)
Query: 435 GTVNA-SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRG 493
           G+ NA S    GY   +I   DL      F K L  G+G FG+V  G  R    VA+K  
Sbjct: 4   GSKNAPSTAGLGYGSWEIDPKDL-----TFLKEL--GTGQFGVVKYGKWRGQYDVAIKMI 56
Query: 494 VPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR 553
             GS     EF  E  V+  + H  LV L G C +Q  + ++ EYM  G L  +L    R
Sbjct: 57  KEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMR 114
Query: 554 TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP 613
                +Q LE+C      + YL +   +  +HRD+ + N L+++  V KV+DFGLSR   
Sbjct: 115 HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-V 170
Query: 614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
             DE   S G K    +  PE     + + KSD+++FGV+++E+
Sbjct: 171 LDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG+V  G  R    VA+K    GS     EF  E  V+  + H  LV L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q  + ++ EYM  G L  +L    R     +Q LE+C      + YL +   +  +HRD+
Sbjct: 76  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 131
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+++  V KV+DFGLSR    LD+ + S+ G K    +  PE     + + KSD+
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 648 YSFGVVLFEV 657
           ++FGV+++E+
Sbjct: 190 WAFGVLMWEI 199

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  +S    L +    +  + YL     +  IHRD+
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDL 135
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTG---DTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 193 VWAFGVLLWEI 203

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG+V  G  R    VA+K    GS     EF  E  V+  + H  LV L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q  + ++ EYM  G L  +L    R     +Q LE+C      + YL +   +  +HRD+
Sbjct: 76  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 131
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+++  V KV+DFGLSR    LD+ + S+ G K    +  PE     + + KSD+
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 648 YSFGVVLFEV 657
           ++FGV+++E+
Sbjct: 190 WAFGVLMWEI 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG+V  G  R    VA+K    GS     EF  E  V+  + H  LV L G C +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           Q  + ++ EYM  G L  +L    R     +Q LE+C      + YL +   +  +HRD+
Sbjct: 82  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 137
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQLTDKSDV 647
            + N L+++  V KV+DFGLSR    LD+ + S+ G K    +  PE     + + KSD+
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 195
Query: 648 YSFGVVLFEV 657
           ++FGV+++E+
Sbjct: 196 WAFGVLMWEI 205

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y  +R P   +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  +S    L +    +  + YL     +  IHRD+
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDL 137
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 441 PGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG 500
           P    Y + ++  TD+            +G G +G VY+GV +  +     + +      
Sbjct: 5   PSSPNYDKWEMERTDITMKHK-------LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ 560
           + EF  E  V+ +I+H +LV L+G C  +    ++ E+M  G L  +L   +R  +S   
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 117
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDET 618
            L +    +  + YL     +  IHRD+ + N L+ EN++ KVADFGLSR  +G   D  
Sbjct: 118 LLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTY 171
Query: 619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
               G K    +  PE     + + KSDV++FGV+L+E+
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y  +R P   +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  +S    L +    +  + YL     +  IHRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDL 137
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 101/190 (53%), Gaps = 12/190 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY-CE 527
           IG G FG V  G  R N KVAVK     +      F  E +V++++RH +LV L+G   E
Sbjct: 29  IGKGEFGDVMLGDYRGN-KVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L  +L    R+ L     L+  +     + YL        +HRD
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           + + N+L+ E+ V+KV+DFGL++      +T      K    +  PE  R ++ + KSDV
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREKKFSTKSDV 197
Query: 648 YSFGVVLFEV 657
           +SFG++L+E+
Sbjct: 198 WSFGILLWEI 207

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 101/190 (53%), Gaps = 12/190 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY-CE 527
           IG G FG V  G  R N KVAVK     +      F  E +V++++RH +LV L+G   E
Sbjct: 14  IGKGEFGDVMLGDYRGN-KVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L  +L    R+ L     L+  +     + YL        +HRD
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 127
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           + + N+L+ E+ V+KV+DFGL++      +T      K    +  PE  R ++ + KSDV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREKKFSTKSDV 182
Query: 648 YSFGVVLFEV 657
           +SFG++L+E+
Sbjct: 183 WSFGILLWEI 192

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  +S    L +    +  + YL     +  IHRD+
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDL 137
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 118/230 (51%), Gaps = 24/230 (10%)
Query: 431 KMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLI--IGSGGFGMVYKGVLRDNTKV 488
           K+ EGTV A   Q+ ++R          A N  +  L+  IG G FG V  G  R N KV
Sbjct: 171 KVMEGTVAA---QDEFYRSGW-------ALNMKELKLLQTIGKGEFGDVMLGDYRGN-KV 219
Query: 489 AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY-CEEQSEMILVYEYMEKGPLKKH 547
           AVK     +      F  E +V++++RH +LV L+G   EE+  + +V EYM KG L  +
Sbjct: 220 AVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 277
Query: 548 LYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG 607
           L    R+ L     L+  +     + YL        +HRD+ + N+L+ E+ V+KV+DFG
Sbjct: 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFG 334
Query: 608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
           L++      +T      K    +  PE  R ++ + KSDV+SFG++L+E+
Sbjct: 335 LTKEASSTQDTG-----KLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  +S    L +    +  + YL     +  IHRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 137
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 441 PGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG 500
           P    Y + ++  TD+            +G G +G VY+GV +  +     + +      
Sbjct: 5   PSSPNYDKWEMERTDITMKHK-------LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ 560
           + EF  E  V+ +I+H +LV L+G C  +    ++ E+M  G L  +L   +R  ++   
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDET 618
            L +    +  + YL     +  IHRD+ + N L+ EN++ KVADFGLSR  +G   D  
Sbjct: 118 LLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTX 171
Query: 619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
               G K    +  PE     + + KSDV++FGV+L+E+
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  +S    L +    +  + YL     +  IHRD+
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDL 135
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTG---DTFTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 193 VWAFGVLLWEI 203

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  ++    L +    +  + YL     +  IHRD+
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDL 138
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTG---DTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 196 VWAFGVLLWEI 206

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/193 (34%), Positives = 101/193 (52%), Gaps = 12/193 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +GSG FG+V  G  +    VAVK    GS     EF  E   + K+ H  LV   G C +
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 529 QSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
           +  + +V EY+  G L  +L  +G    P    Q LE+C     G+ +L    +   IHR
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEP---SQLLEMCYDVCEGMAFL---ESHQFIHR 128
Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQLTDKS 645
           D+ + N L+D +   KV+DFG++R    LD+ +VS+ G K    +  PE F   + + KS
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 646 DVYSFGVVLFEVL 658
           DV++FG++++EV 
Sbjct: 187 DVWAFGILMWEVF 199

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 441 PGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG 500
           P    Y + ++  TD+            +G G +G VY+GV +  +     + +      
Sbjct: 5   PSSPNYDKWEMERTDITMKHK-------LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ 560
           + EF  E  V+ +I+H +LV L+G C  +    ++ E+M  G L  +L   +R  ++   
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDET 618
            L +    +  + YL     +  IHRD+ + N L+ EN++ KVADFGLSR  +G   D  
Sbjct: 118 LLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTY 171
Query: 619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
               G K    +  PE     + + KSDV++FGV+L+E+
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 441 PGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG 500
           P    Y + ++  TD+            +G G +G VY+GV +  +     + +      
Sbjct: 5   PSSPNYDKWEMERTDITMKHK-------LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ 560
           + EF  E  V+ +I+H +LV L+G C  +    ++ E+M  G L  +L   +R  ++   
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDET 618
            L +    +  + YL     +  IHRD+ + N L+ EN++ KVADFGLSR  +G   D  
Sbjct: 118 LLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTY 171
Query: 619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
               G K    +  PE     + + KSDV++FGV+L+E+
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y  +R P   +++K  +  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y  +R P   +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 18/225 (8%)
Query: 435 GTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV 494
           G ++ SP    Y + ++  TD+            +G G +G VY+GV +  +     + +
Sbjct: 1   GAMDPSPN---YDKWEMERTDITMKHK-------LGGGQYGEVYEGVWKKYSLTVAVKTL 50
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRT 554
                 + EF  E  V+ +I+H +LV L+G C  +    ++ E+M  G L  +L   +R 
Sbjct: 51  KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 110
Query: 555 PLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SG 612
            ++    L +    +  + YL     +  IHRD+ + N L+ EN++ KVADFGLSR  +G
Sbjct: 111 EVNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
              D      G K    +  PE     + + KSDV++FGV+L+E+
Sbjct: 168 ---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  ++    L +    +  + YL     +  IHRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 137
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 96/191 (50%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    +V EYM  G L  +L   +R  ++    L +    +  + YL     +  IHRD+
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL---EKKNFIHRDL 156
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN+V KVADFGLSR  +G   D      G K    +  PE       + KSD
Sbjct: 157 AARNCLVGENHVVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNTFSIKSD 213
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 214 VWAFGVLLWEI 224

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 441 PGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG 500
           P    Y + ++  TD+            +G G +G VY+GV +  +     + +      
Sbjct: 5   PSSPNYDKWEMERTDITMKHK-------LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ 560
           + EF  E  V+ +I+H +LV L+G C  +    ++ E+M  G L  +L   +R  ++   
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDET 618
            L +    +  + YL     +  IHRD+ + N L+ EN++ KVADFGLSR  +G   D  
Sbjct: 118 LLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTY 171
Query: 619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
               G K    +  PE     + + KSDV++FGV+L+E+
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  ++    L +    +  + YL     +  IHRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 137
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y  +R P   +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  ++    L +    +  + YL     +  IHRD+
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 150
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 151 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 207
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 208 VWAFGVLLWEI 218

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  ++    L +    +  + YL     +  IHRD+
Sbjct: 82  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDL 138
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 196 VWAFGVLLWEI 206

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  ++    L +    +  + YL     +  IHRD+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDL 139
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 197 VWAFGVLLWEI 207

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 99/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    NTKVA+K   PG+    PE F  E  ++ K++H  LV L     
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMS--PESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L   L   +   L     +++    A G+ Y+   +    IHRD
Sbjct: 75  EEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 130
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           ++S NIL+    + K+ADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIED-NEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 190 WSFGILLTELV 200

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  ++    L +    +  + YL     +  IHRD+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDL 139
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 197 VWAFGVLLWEI 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 12/211 (5%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG V+ G   ++TKVAVK   PG+   +  F  E  ++  ++H  LV L      
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +  + ++ EYM KG L   L   +   +   + ++     A G+ Y+     +  IHRD+
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 136
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVY 648
           ++ N+L+ E+ + K+ADFGL+R     +E     G K    +  PE       T KSDV+
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 649 SFGVVLFEVLC-------ARTAVDPLLAREQ 672
           SFG++L+E++         RT  D + A  Q
Sbjct: 196 SFGILLYEIVTYGKIPYPGRTNADVMTALSQ 226

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  ++    L +    +  + YL     +  IHRD+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 139
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 197 VWAFGVLLWEI 207

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 99/190 (52%), Gaps = 12/190 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY-CE 527
           IG G FG V  G  R N KVAVK     +      F  E +V++++RH +LV L+G   E
Sbjct: 20  IGKGEFGDVMLGDYRGN-KVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+  + +V EYM KG L  +L    R+ L     L+  +     + YL        +HRD
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 133
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           + + N+L+ E+ V+KV+DFGL++      +T      K    +  PE  R    + KSDV
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREAAFSTKSDV 188
Query: 648 YSFGVVLFEV 657
           +SFG++L+E+
Sbjct: 189 WSFGILLWEI 198

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y  +R P   +++K  +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y  +R P   +++K  +  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 245

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  +S    L +    +  + YL     +  IHR++
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNL 344
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 402 VWAFGVLLWEI 412

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 112/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           ++ L+G C +   + ++ EY  KG L+++L           Y  +R P   +++K  +  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y  +R P   +++K  +  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 242

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y  +R P   +++K  +  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 240

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y  +R P   +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V ++ADFGL+R    +D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V EYME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 163
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGLSR     P  +  + + G K    +  
Sbjct: 164 ---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTS 218
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 75
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V EYME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 134
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGLSR     P  +  + + G K    +  
Sbjct: 135 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTS 189
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 33  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 92
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V EYME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 151
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGLSR     P  +  + + G K    +  
Sbjct: 152 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTS 206
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 207 PEAIAYRKFTSASDVWSYGIVLWEVM 232

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDN----TKVAVKR-GVPGSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D     TKVAVK      + + L +  +E+ ++  I +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           + P   P   LS K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ E+ V K+ADFGL+R    +D    +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDN----TKVAVKR-GVPGSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D     TKVAVK      + + L +  +E+ ++  I +H++
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y P   P   LS K  +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ E+ V K+ADFGL+R    +D    +T  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDN----TKVAVKR-GVPGSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D     TKVAVK      + + L +  +E+ ++  I +H++
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y P   P   LS K  +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ E+ V K+ADFGL+R    +D    +T  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 235

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V EYME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 163
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGLSR     P  +  + + G K    +  
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTS 218
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDN----TKVAVKR-GVPGSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D     TKVAVK      + + L +  +E+ ++  I +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y P   P   LS K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ E+ V K+ADFGL+R    +D    +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDN----TKVAVKR-GVPGSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D     TKVAVK      + + L +  +E+ ++  I +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y P   P   LS K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ E+ V K+ADFGL+R    +D    +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDN----TKVAVKR-GVPGSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D     TKVAVK      + + L +  +E+ ++  I +H++
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y P   P   LS K  +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ E+ V K+ADFGL+R    +D    +T  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 238

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDN----TKVAVKR-GVPGSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D     TKVAVK      + + L +  +E+ ++  I +H++
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y P   P   LS K  +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ E+ V K+ADFGL+R    +D    +T  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V EYME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 163
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGLSR     P  +  + + G K    +  
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTS 218
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V EYME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 163
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGLSR     P  +  + + G K    +  
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTS 218
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDN----TKVAVKR-GVPGSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D     TKVAVK      + + L +  +E+ ++  I +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y P   P   LS K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ E+ V K+ADFGL+R    +D    +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 43  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 102
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V EYME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 161
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGLSR     P  +  + + G K    +  
Sbjct: 162 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTS 216
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 217 PEAIAYRKFTSASDVWSYGIVLWEVM 242

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V EYME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 163
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGLSR     P  +  + + G K    +  
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTS 218
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDN----TKVAVKR-GVPGSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D     TKVAVK      + + L +  +E+ ++  I +H++
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L           Y P   P   LS K  +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ E+ V K+ADFGL+R    +D    +T  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 112/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++  Y  KG L+++L           Y  +R P   +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V EYME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 163
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGL+R     P  +  + + G K    +  
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDP--EAAYTTRGGKIPIRWTS 218
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G G +G VY+GV +  +     + +      + EF  E  V+ +I+H +LV L+G C  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +    ++ E+M  G L  +L   +R  ++    L +    +  + YL     +  IHR++
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRNL 383
Query: 589 KSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
            + N L+ EN++ KVADFGLSR  +G   D      G K    +  PE     + + KSD
Sbjct: 384 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 440
Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 441 VWAFGVLLWEI 451

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 112/214 (52%), Gaps = 27/214 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V      G+ +D  K AV   V       + + L +  +E+ ++  I +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------YGPDRTP---LSWKQRLEI 564
           +++L+G C +   + ++  Y  KG L+++L           Y  +R P   +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 79  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 194 WSFGILLTEIV 204

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 80  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 135
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 195 WSFGILLTEIV 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 81  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 136
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 195
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 196 WSFGILLTEIV 206

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 26/224 (11%)
Query: 469 IGSGGFGMVY----KGVLRDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY    KGV++D   T+VA+K      S +   EF  E +V+ +    H+V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    +++ E M +G LK +L          P   P S  + +++    A G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYL 631
           YL+   A   +HRD+ + N ++ E++  K+ DFG++R     +  +   G KG     ++
Sbjct: 146 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 200
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
            PE  +    T  SDV+SFGVVL+E+  A  A  P   L+ EQV
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGLSNEQV 242

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 88  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 143
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 202
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 203 WSFGILLTEIV 213

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 26/224 (11%)
Query: 469 IGSGGFGMVY----KGVLRDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY    KGV++D   T+VA+K      S +   EF  E +V+ +    H+V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    +++ E M +G LK +L          P   P S  + +++    A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--YL 631
           YL+   A   +HRD+ + N ++ E++  K+ DFG++R     +  +   G KG     ++
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 207
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
            PE  +    T  SDV+SFGVVL+E+  A  A  P   L+ EQV
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGLSNEQV 249

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V EYME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 163
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGL R     P  +  + + G K    +  
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP--EAAYTTRGGKIPIRWTS 218
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 79  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 194 WSFGILLTEIV 204

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 79  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 194 WSFGILLTEIV 204

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 26/224 (11%)
Query: 469 IGSGGFGMVY----KGVLRDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY    KGV++D   T+VA+K      S +   EF  E +V+ +    H+V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    +++ E M +G LK +L          P   P S  + +++    A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--YL 631
           YL+   A   +HRD+ + N ++ E++  K+ DFG++R     +  +   G KG     ++
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 207
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
            PE  +    T  SDV+SFGVVL+E+  A  A  P   L+ EQV
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGLSNEQV 249

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 26/224 (11%)
Query: 469 IGSGGFGMVY----KGVLRDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY    KGV++D   T+VA+K      S +   EF  E +V+ +    H+V 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    +++ E M +G LK +L          P   P S  + +++    A G+ 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYL 631
           YL+   A   +HRD+ + N ++ E++  K+ DFG++R     +  +   G KG     ++
Sbjct: 143 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 197
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
            PE  +    T  SDV+SFGVVL+E+  A  A  P   L+ EQV
Sbjct: 198 SPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGLSNEQV 239

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 100/190 (52%), Gaps = 5/190 (2%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG V+ G   ++TKVAVK   PG+   +  F  E  ++  ++H  LV L     +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +  + ++ E+M KG L   L   +   +   + ++     A G+ Y+     +  IHRD+
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 135
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVY 648
           ++ N+L+ E+ + K+ADFGL+R     +E     G K    +  PE       T KS+V+
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 649 SFGVVLFEVL 658
           SFG++L+E++
Sbjct: 195 SFGILLYEIV 204

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 26/224 (11%)
Query: 469 IGSGGFGMVY----KGVLRDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY    KGV++D   T+VA+K      S +   EF  E +V+ +    H+V 
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    +++ E M +G LK +L          P   P S  + +++    A G+ 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYL 631
           YL+   A   +HRD+ + N ++ E++  K+ DFG++R     +  +   G KG     ++
Sbjct: 144 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 198
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
            PE  +    T  SDV+SFGVVL+E+  A  A  P   L+ EQV
Sbjct: 199 SPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGLSNEQV 240

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 128/266 (48%), Gaps = 27/266 (10%)
Query: 428 SHSKMSEGTVNASPGQNGYHRLKIPFTD-LQTATNNFDKNLIIGSGGFGMVY----KGVL 482
           ++S++  G + AS     +    +   D  + A      +  +G G FGMVY    KGV+
Sbjct: 13  NNSRLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVV 72
Query: 483 RDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM 539
           +D   T+VA+K      S +   EF  E +V+ +    H+V L+G   +    +++ E M
Sbjct: 73  KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 132
Query: 540 EKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKST 591
            +G LK +L          P   P S  + +++    A G+ YL+   A   +HRD+ + 
Sbjct: 133 TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAAR 189
Query: 592 NILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQLTDKSDVYS 649
           N ++ E++  K+ DFG++R     +  +   G KG     ++ PE  +    T  SDV+S
Sbjct: 190 NCMVAEDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 247
Query: 650 FGVVLFEVLCARTAVDPL--LAREQV 673
           FGVVL+E+  A  A  P   L+ EQV
Sbjct: 248 FGVVLWEI--ATLAEQPYQGLSNEQV 271

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 85  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 140
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 200 WSFGILLTEIV 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 87  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 142
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 201
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 202 WSFGILLTEIV 212

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 84  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 139
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 199 WSFGILLTEIV 209

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 85  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 140
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 200 WSFGILLTEIV 210

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 26/224 (11%)
Query: 469 IGSGGFGMVY----KGVLRDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY    KGV++D   T+VA+K      S +   EF  E +V+ +    H+V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    +++ E M +G LK +L          P   P S  + +++    A G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYL 631
           YL+   A   +HRD+ + N ++ E++  K+ DFG++R     +  +   G KG     ++
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 201
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
            PE  +    T  SDV+SFGVVL+E+  A  A  P   L+ EQV
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGLSNEQV 243

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 26/224 (11%)
Query: 469 IGSGGFGMVY----KGVLRDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY    KGV++D   T+VA+K      S +   EF  E +V+ +    H+V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    +++ E M +G LK +L          P   P S  + +++    A G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYL 631
           YL+   A   +HRD+ + N ++ E++  K+ DFG++R     +  +   G KG     ++
Sbjct: 146 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 200
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
            PE  +    T  SDV+SFGVVL+E+  A  A  P   L+ EQV
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGLSNEQV 242

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 26/224 (11%)
Query: 469 IGSGGFGMVY----KGVLRDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY    KGV++D   T+VA+K      S +   EF  E +V+ +    H+V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    +++ E M +G LK +L          P   P S  + +++    A G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYL 631
           YL+   A   +HRD+ + N ++ E++  K+ DFG++R     +  +   G KG     ++
Sbjct: 140 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 194
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
            PE  +    T  SDV+SFGVVL+E+  A  A  P   L+ EQV
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGLSNEQV 236

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 112/227 (49%), Gaps = 32/227 (14%)
Query: 469 IGSGGFGMVY----KGVLRDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY    KGV++D   T+VA+K      S +   EF  E +V+ +    H+V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    +++ E M +G LK +L          P   P S  + +++    A G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG---- 629
           YL+   A   +HRD+ + N ++ E++  K+ DFG++R     D        KG  G    
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIXETDXXRKGGKGLLPV 198
Query: 630 -YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
            ++ PE  +    T  SDV+SFGVVL+E+  A  A  P   L+ EQV
Sbjct: 199 RWMSPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGLSNEQV 243

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 74  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 129
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 189 WSFGILLTEIV 199

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY+G  RD       T+VAVK      S +   EF  E +V+      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    ++V E M  G LK +L          P R P + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--YL 631
           YL+   A+  +HRD+ + N ++  ++  K+ DFG++R     +  +   G KG     ++
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD--IYETAYYRKGGKGLLPVRWM 199
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV 673
            PE  +    T  SD++SFGVVL+E+          L+ EQV
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 241

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 112/227 (49%), Gaps = 32/227 (14%)
Query: 469 IGSGGFGMVY----KGVLRDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY    KGV++D   T+VA+K      S +   EF  E +V+ +    H+V 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    +++ E M +G LK +L          P   P S  + +++    A G+ 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG---- 629
           YL+   A   +HRD+ + N ++ E++  K+ DFG++R     D        KG  G    
Sbjct: 138 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIXETDXXRKGGKGLLPV 189
Query: 630 -YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
            ++ PE  +    T  SDV+SFGVVL+E+  A  A  P   L+ EQV
Sbjct: 190 RWMSPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGLSNEQV 234

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 89  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 144
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 203
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 204 WSFGILLTEIV 214

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 75
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V E ME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 134
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGLSR     P  +  + + G K    +  
Sbjct: 135 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTS 189
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY+G  RD       T+VAVK      S +   EF  E +V+      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    ++V E M  G LK +L          P R P + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--YL 631
           YL+   A+  +HRD+ + N ++  ++  K+ DFG++R     +  +   G KG     ++
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 199
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV 673
            PE  +    T  SD++SFGVVL+E+          L+ EQV
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 241

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V E ME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 163
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGLSR     P  +  + + G K    +  
Sbjct: 164 ---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTS 218
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY+G  RD       T+VAVK      S +   EF  E +V+      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    ++V E M  G LK +L          P R P + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG---- 629
           YL+   A+  +HRD+ + N ++  ++  K+ DFG++R     D        KG  G    
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIXETDXXRKGGKGLLPV 196
Query: 630 -YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV 673
            ++ PE  +    T  SD++SFGVVL+E+          L+ EQV
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 241

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIRHRHLVSL 522
           IIGSG  G V  G LR   +  V   +   + G  E     F +E +++ +  H +++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
            G        ++V EYME G L   L   D    +  Q + +  G   G+ YL   S  G
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
            +HRD+ + N+L+D N V KV+DFGLSR     P  D  + +TG K    +  PE    +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP--DAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 640 QLTDKSDVYSFGVVLFEVLC 659
             +  SDV+SFGVV++EVL 
Sbjct: 230 TFSSASDVWSFGVVMWEVLA 249

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY+G  RD       T+VAVK      S +   EF  E +V+      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    ++V E M  G LK +L          P R P + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG---- 629
           YL+   A+  +HRD+ + N ++  ++  K+ DFG++R     D        KG  G    
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIXETDXXRKGGKGLLPV 196
Query: 630 -YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV 673
            ++ PE  +    T  SD++SFGVVL+E+          L+ EQV
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 241

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY+G  RD       T+VAVK      S +   EF  E +V+      H+V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    ++V E M  G LK +L          P R P + ++ +++    A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG---- 629
           YL+   A+  +HRD+ + N ++  ++  K+ DFG++R     D        KG  G    
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIXETDXXRKGGKGLLPV 193
Query: 630 -YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV 673
            ++ PE  +    T  SD++SFGVVL+E+          L+ EQV
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 238

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY+G  RD       T+VAVK      S +   EF  E +V+      H+V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    ++V E M  G LK +L          P R P + ++ +++    A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYL 631
           YL+   A+  +HRD+ + N ++  ++  K+ DFG++R     +  +   G KG     ++
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 198
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV 673
            PE  +    T  SD++SFGVVL+E+          L+ EQV
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 240

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 453 FTDLQTATNNFDKNL---------IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE 503
           + D   A + F K L         +IG+G FG V  G L+   K  V   +   + G  E
Sbjct: 26  YEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTE 85
Query: 504 -----FQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSW 558
                F  E +++ +  H ++V L G       +++V E+ME G L   L   D    + 
Sbjct: 86  KQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHD-GQFTV 144
Query: 559 KQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCL 615
            Q + +  G A G+ YL   +  G +HRD+ + NIL++ N V KV+DFGLSR     P  
Sbjct: 145 IQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDP-- 199
Query: 616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +  + +TG K    +  PE  + ++ T  SDV+S+G+V++EV+
Sbjct: 200 EAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 242

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 14/206 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIR 515
            N   + ++G+G FG V  G L+  +K  +   +   + G  E     F  E +++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H +++ L G   +   +++V E ME G L   L   D    +  Q + +  G A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL 163
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLD 632
              S  G +HRD+ + NIL++ N V KV+DFGLSR     P  +  + + G K    +  
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTS 218
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVL 658
           PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 112/224 (50%), Gaps = 26/224 (11%)
Query: 469 IGSGGFGMVY----KGVLRDN--TKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY    KGV++D   T+VA+K      S +   EF  E +V+ +    H+V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    +++ E M +G LK +L          P   P S  + +++    A G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYL 631
           YL+   A   +HRD+ + N  + E++  K+ DFG++R     +  +   G KG     ++
Sbjct: 140 YLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 194
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL--LAREQV 673
            PE  +    T  SDV+SFGVVL+E+  A  A  P   L+ EQV
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEI--ATLAEQPYQGLSNEQV 236

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G FG V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHR+
Sbjct: 75  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRN 130
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 190 WSFGILLTEIV 200

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIRHRHLVSL 522
           IIGSG  G V  G LR   +  V   +   + G  E     F +E +++ +  H +++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
            G        ++V EYME G L   L   D    +  Q + +  G   G+ YL   S  G
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
            +HRD+ + N+L+D N V KV+DFGLSR     P  D    +TG K    +  PE    +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP--DAAXTTTGGKIPIRWTAPEAIAFR 229
Query: 640 QLTDKSDVYSFGVVLFEVLC 659
             +  SDV+SFGVV++EVL 
Sbjct: 230 TFSSASDVWSFGVVMWEVLA 249

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 106/215 (49%), Gaps = 35/215 (16%)
Query: 468 IIGSGGFGMVYKGVLRDN---TKVAVKRGVP-GSRQGLPEFQTEITVLSKIRHR-HLVSL 522
           +IG G FG V K  ++ +      A+KR     S+    +F  E+ VL K+ H  ++++L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 523 VGYCEEQSEMILVYEYMEKGPL-----KKHLYGPD---------RTPLSWKQRLEICIGA 568
           +G CE +  + L  EY   G L     K  +   D          + LS +Q L      
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           ARG+ YL   S +  IHRD+ + NIL+ ENYV+K+ADFGLSR             VK + 
Sbjct: 142 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 190
Query: 629 GYLDPEYFRRQQL-----TDKSDVYSFGVVLFEVL 658
           G L   +   + L     T  SDV+S+GV+L+E++
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY+G  RD       T+VAVK      S +   EF  E +V+      H+V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    ++V E M  G LK +L          P R P + ++ +++    A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG--SFGYL 631
           YL+   A+  +HR++ + N ++  ++  K+ DFG++R     +  +   G KG     ++
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 200
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV 673
            PE  +    T  SD++SFGVVL+E+          L+ EQV
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 242

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FGMVY+G  RD       T+VAVK      S +   EF  E +V+      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLH 573
           L+G   +    ++V E M  G LK +L          P R P + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG--SFGYL 631
           YL+   A+  +HR++ + N ++  ++  K+ DFG++R     +  +   G KG     ++
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 199
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV 673
            PE  +    T  SD++SFGVVL+E+          L+ EQV
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 241

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 108/215 (50%), Gaps = 35/215 (16%)
Query: 468 IIGSGGFGMVYKGVLRDN---TKVAVKRGVP-GSRQGLPEFQTEITVLSKIRHR-HLVSL 522
           +IG G FG V K  ++ +      A+KR     S+    +F  E+ VL K+ H  ++++L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 523 VGYCEEQSEMILVYEYMEKGPL-----KKHLYGPD---------RTPLSWKQRLEICIGA 568
           +G CE +  + L  EY   G L     K  +   D          + LS +Q L      
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           ARG+ YL   S +  IHRD+ + NIL+ ENYV+K+ADFGLSR      E +    VK + 
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVY----VKKTM 200
Query: 629 GYLDPEYFRRQQL-----TDKSDVYSFGVVLFEVL 658
           G L   +   + L     T  SDV+S+GV+L+E++
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 97/191 (50%), Gaps = 8/191 (4%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYCE 527
           +G+G  G V+ G    +TKVAVK    GS    P+ F  E  ++ +++H+ LV L     
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            Q  + ++ EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 79  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     + T    G K    +  PE       T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 194 WSFGILLTEIV 204

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLP-----EFQTEITVLSKIRHRHLVSL 522
           IG G FG V+ G LR DNT VAVK      R+ LP     +F  E  +L +  H ++V L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
           +G C ++  + +V E ++ G     L   +   L  K  L++   AA G+ YL +     
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKCC-- 234
Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG--VKGSFGYLDPEYFRRQQ 640
            IHRD+ + N L+ E  V K++DFG+SR     D  + ++G   +    +  PE     +
Sbjct: 235 -IHRDLAARNCLVTEKNVLKISDFGMSREEA--DGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN 674
            + +SDV+SFG++L+E      +  P L+ +Q  
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTR 325

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 112/226 (49%), Gaps = 23/226 (10%)
Query: 452 PFT--DLQTATNNFDKNL---------IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG 500
           PFT  D   A   F K +         +IG+G FG V  G L+   K  +   +   + G
Sbjct: 13  PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 72
Query: 501 LPE-----FQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP 555
             E     F +E +++ +  H +++ L G   + + ++++ E+ME G L   L   D   
Sbjct: 73  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ- 131
Query: 556 LSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGP 613
            +  Q + +  G A G+ YL   +    +HRD+ + NIL++ N V KV+DFGLSR     
Sbjct: 132 FTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188
Query: 614 CLDETHVST-GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             D T+ S  G K    +  PE  + ++ T  SDV+S+G+V++EV+
Sbjct: 189 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 95/190 (50%), Gaps = 6/190 (3%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG V+      +TKVAVK   PGS   +  F  E  V+  ++H  LV L     +
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +  + ++ E+M KG L   L   + +     + ++     A G+ ++        IHRD+
Sbjct: 82  EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDL 137
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVY 648
           ++ NIL+  + V K+ADFGL+R     +E     G K    +  PE       T KSDV+
Sbjct: 138 RAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 197 SFGILLMEIV 206

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 108/215 (50%), Gaps = 35/215 (16%)
Query: 468 IIGSGGFGMVYKGVLRDN---TKVAVKRGVP-GSRQGLPEFQTEITVLSKIRHR-HLVSL 522
           +IG G FG V K  ++ +      A+KR     S+    +F  E+ VL K+ H  ++++L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 523 VGYCEEQSEMILVYEYMEKGPL-----KKHLYGPD---------RTPLSWKQRLEICIGA 568
           +G CE +  + L  EY   G L     K  +   D          + LS +Q L      
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           ARG+ YL   S +  IHR++ + NIL+ ENYV+K+ADFGLSR      E +    VK + 
Sbjct: 149 ARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRG----QEVY----VKKTM 197
Query: 629 GYLDPEYFRRQQL-----TDKSDVYSFGVVLFEVL 658
           G L   +   + L     T  SDV+S+GV+L+E++
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLP-----EFQTEITVLSKIRHRHLVSL 522
           IG G FG V+ G LR DNT VAVK      R+ LP     +F  E  +L +  H ++V L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
           +G C ++  + +V E ++ G     L   +   L  K  L++   AA G+ YL +     
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKCC-- 234
Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG--VKGSFGYLDPEYFRRQQ 640
            IHRD+ + N L+ E  V K++DFG+SR     D    ++G   +    +  PE     +
Sbjct: 235 -IHRDLAARNCLVTEKNVLKISDFGMSREEA--DGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN 674
            + +SDV+SFG++L+E      +  P L+ +Q  
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTR 325

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 461 NNFDKNLIIGSGGFGMVYK----GVL--RDNTKVAVKR-GVPGSRQGLPEFQTEITVLSK 513
           NN +    IG G FG V++    G+L     T VAVK      S     +FQ E  ++++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG----------------------P 551
             + ++V L+G C     M L++EYM  G L + L                        P
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 552 DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
              PLS  ++L I    A G+ YL   S    +HRD+ + N L+ EN V K+ADFGLSR+
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
               D             ++ PE     + T +SDV+++GVVL+E+ 
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 95/190 (50%), Gaps = 6/190 (3%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG V+      +TKVAVK   PGS   +  F  E  V+  ++H  LV L     +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +  + ++ E+M KG L   L   + +     + ++     A G+ ++        IHRD+
Sbjct: 255 EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDL 310
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVY 648
           ++ NIL+  + V K+ADFGL+R     +E     G K    +  PE       T KSDV+
Sbjct: 311 RAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 370 SFGILLMEIV 379

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 23/223 (10%)
Query: 453 FTDLQTATNNFDKNL---------IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE 503
           + D   A + F K +         +IG+G FG V  G L+   K  +   +   + G  E
Sbjct: 5   YEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTE 64
Query: 504 -----FQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSW 558
                F  E +++ +  H +++ L G   +   +++V EYME G L   L   D    + 
Sbjct: 65  KQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQ-FTV 123
Query: 559 KQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCL 615
            Q + +  G + G+ YL   S  G +HRD+ + NIL++ N V KV+DFGLSR     P  
Sbjct: 124 IQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP-- 178
Query: 616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +  + + G K    +  PE    ++ T  SDV+S+G+V++EV+
Sbjct: 179 EAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVV 221

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 93/190 (48%), Gaps = 16/190 (8%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           +G+G FG V+      +TKVAVK   PGS   +  F  E  V+  ++H  LV L     +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
           +  + ++ E+M KG L   L   + +     + ++     A G+ ++        IHRD+
Sbjct: 249 EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDL 304
Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVY 648
           ++ NIL+  + V K+ADFGL+R            G K    +  PE       T KSDV+
Sbjct: 305 RAANILVSASLVCKIADFGLAR-----------VGAKFPIKWTAPEAINFGSFTIKSDVW 353
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 354 SFGILLMEIV 363

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 468 IIGSGGFGMVYKGVLRDNTK----VAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +IG+G FG V +G L+   K    VA+K  +G    RQ   EF +E +++ +  H +++ 
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR-EFLSEASIMGQFEHPNIIR 79
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L G       ++++ E+ME G L   L   D    +  Q + +  G A G+ YL   S  
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-FTVIQLVGMLRGIASGMRYLAEMS-- 136
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVST-GVKGSFGYLDPEYFRR 638
             +HRD+ + NIL++ N V KV+DFGLSR       D T+ S+ G K    +  PE    
Sbjct: 137 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 639 QQLTDKSDVYSFGVVLFEVL 658
           ++ T  SD +S+G+V++EV+
Sbjct: 196 RKFTSASDAWSYGIVMWEVM 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 468 IIGSGGFGMVYKGVLRDNTK----VAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +IG+G FG V +G L+   K    VA+K  +G    RQ   EF +E +++ +  H +++ 
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR-EFLSEASIMGQFEHPNIIR 81
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L G       ++++ E+ME G L   L   D    +  Q + +  G A G+ YL   S  
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-FTVIQLVGMLRGIASGMRYLAEMS-- 138
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVST-GVKGSFGYLDPEYFRR 638
             +HRD+ + NIL++ N V KV+DFGLSR       D T  S+ G K    +  PE    
Sbjct: 139 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 639 QQLTDKSDVYSFGVVLFEVL 658
           ++ T  SD +S+G+V++EV+
Sbjct: 198 RKFTSASDAWSYGIVMWEVM 217

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 452 PFT--DLQTATNNFDKNL---------IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG 500
           PFT  D   A   F K +         +IG G FG V  G L+   K  +   +   + G
Sbjct: 9   PFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG 68
Query: 501 LPE-----FQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP 555
             +     F +E +++ +  H +++ L G   +   ++++ EYME G L   L   D   
Sbjct: 69  YTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR- 127
Query: 556 LSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SG 612
            +  Q + +  G   G+ YL   SA   +HRD+ + NIL++ N V KV+DFG+SR     
Sbjct: 128 FTVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           P  +  + + G K    +  PE    ++ T  SDV+S+G+V++EV+
Sbjct: 185 P--EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 228

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIRHRHLVSL 522
           +IG+G FG V  G L+   K  +   +   + G  E     F +E +++ +  H +++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
            G   + + ++++ E+ME G L   L   D    +  Q + +  G A G+ YL   +   
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVST-GVKGSFGYLDPEYFRRQ 639
            +HR + + NIL++ N V KV+DFGLSR       D T+ S  G K    +  PE  + +
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 640 QLTDKSDVYSFGVVLFEVL 658
           + T  SDV+S+G+V++EV+
Sbjct: 190 KFTSASDVWSYGIVMWEVM 208

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 469 IGSGGFGMVYKG---VLRDNTKVAVKRGVPGSRQG---LPEFQTEITVLSKIRHRHLVSL 522
           +G GG   VY     +L  N KVA+K      R+    L  F+ E+   S++ H+++VS+
Sbjct: 19  LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
           +   EE     LV EY+E   L +  Y     PLS    +        G+ + H      
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSE--YIESHGPLSVDTAINFTNQILDGIKHAHDMR--- 131
Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--STGVKGSFGYLDPEYFRRQQ 640
           I+HRDIK  NIL+D N   K+ DFG++++   L ET +  +  V G+  Y  PE  + + 
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKA---LSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 641 LTDKSDVYSFGVVLFEVLCAR 661
             + +D+YS G+VL+E+L   
Sbjct: 189 TDECTDIYSIGIVLYEMLVGE 209

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTK---VAVKRGVPGSRQG-LPEFQTEITVLSKIRHRHLVSLVG 524
           +G G FG V +GV R   K   VA+K    G+ +    E   E  ++ ++ + ++V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGP-DRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
            C+ ++ ++LV E    GPL K L G  +  P+S     E+    + G+ YL     +  
Sbjct: 78  VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEE---KNF 131
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV-KGSFGYLDPEYFRRQQLT 642
           +HRD+ + N+LL   + +K++DFGLS++    D  + +    K    +  PE    ++ +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 643 DKSDVYSFGVVLFEVL 658
            +SDV+S+GV ++E L
Sbjct: 192 SRSDVWSYGVTMWEAL 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIRHRHLVSL 522
           +IG G FG V  G L+   K  +   +   + G  +     F +E +++ +  H +++ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
            G   +   ++++ EYME G L   L   D    +  Q + +  G   G+ YL   S   
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKND-GRFTVIQLVGMLRGIGSGMKYLSDMS--- 136
Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
            +HRD+ + NIL++ N V KV+DFG+SR     P  +  + + G K    +  PE    +
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDP--EAAYTTRGGKIPIRWTAPEAIAYR 194
Query: 640 QLTDKSDVYSFGVVLFEVL 658
           + T  SDV+S+G+V++EV+
Sbjct: 195 KFTSASDVWSYGIVMWEVM 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIRHRHLVSL 522
           +IG G FG V  G L+   K  +   +   + G  +     F +E +++ +  H +++ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
            G   +   ++++ EYME G L   L   D    +  Q + +  G   G+ YL   S   
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVGMLRGIGSGMKYLSDMS--- 130
Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
            +HRD+ + NIL++ N V KV+DFG+SR     P  +  + + G K    +  PE    +
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDP--EAAYTTRGGKIPIRWTAPEAIAYR 188
Query: 640 QLTDKSDVYSFGVVLFEVL 658
           + T  SDV+S+G+V++EV+
Sbjct: 189 KFTSASDVWSYGIVMWEVM 207

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 96/194 (49%), Gaps = 20/194 (10%)
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYGPD 552
           P  R G   ++ EI +L  + H H++   G CE+Q E  + LV EY+  G L+ +L    
Sbjct: 57  PQHRSG---WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---P 110
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
           R  +   Q L        G+ YLH   A+  IHR++ + N+LLD + + K+ DFGL+++ 
Sbjct: 111 RHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167
Query: 613 PCLDETHVSTGVK----GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL--CARTAVDP 666
           P   E H    V+        +  PE  +  +    SDV+SFGV L+E+L  C  +   P
Sbjct: 168 P---EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 224
Query: 667 LLAREQVNLAEWAM 680
               E + +A+  M
Sbjct: 225 TKFLELIGIAQGQM 238

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAV-KRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
           ++G G FG   K   R+  +V V K  +    +    F  E+ V+  + H +++  +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
            +   +  + EY++ G L+  +   D +   W QR+      A G+ YLH+ +   IIHR
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMN---IIHR 132
Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK--------------GSFGYLD 632
           D+ S N L+ EN    VADFGL+R    +DE     G++              G+  ++ 
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARL--MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDP 666
           PE    +   +K DV+SFG+VL E++  R   DP
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEII-GRVNADP 223

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 468 IIGSGGFGMVYKGVLR---DNTKVAVKRGVPGSRQGLP---EFQTEITVLSKIRHRHLVS 521
           ++GSG FG VYKG+     +  K+ V   +     G     EF  E  +++ + H HLV 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+G C   + + LV + M  G L ++++   +  +  +  L  C+  A+G+ YL      
Sbjct: 82  LLGVCLSPT-IQLVTQLMPHGCLLEYVHE-HKDNIGSQLLLNWCVQIAKGMMYL---EER 136
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            ++HRD+ + N+L+      K+ DFGL+R     ++ + + G K    ++  E    ++ 
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 642 TDKSDVYSFGVVLFEVL 658
           T +SDV+S+GV ++E++
Sbjct: 197 THQSDVWSYGVTIWELM 213

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE-------FQTEITVL 511
           ++ ++   I+G GG   V+    LRD+  VAVK      R  L         F+ E    
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV----LRADLARDPSFYLRFRREAQNA 66
Query: 512 SKIRHRHLVSLVGYCEEQSEM----ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIG 567
           + + H  +V++    E ++       +V EY++   L+  ++     P++ K+ +E+   
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIAD 124
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR----SGPCLDETHVSTG 623
           A + L++ H     GIIHRD+K  NIL+      KV DFG++R    SG  + +T     
Sbjct: 125 ACQALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT---AA 178
Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           V G+  YL PE  R   +  +SDVYS G VL+EVL
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPG-----SRQGLPEFQTEITVLSKIRHRHLVSL 522
           +IG G FG+VY G   D  +  ++  +         Q +  F  E  ++  + H ++++L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 523 VGYCEEQSEMI-LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           +G       +  ++  YM  G L + +  P R P + K  +   +  ARG+ YL   + +
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP-TVKDLISFGLQVARGMEYL---AEQ 143
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG----VKGSFGYLDPEYFR 637
             +HRD+ + N +LDE++  KVADFGL+R    LD  + S       +    +   E  +
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
             + T KSDV+SFGV+L+E+L
Sbjct: 202 TYRFTTKSDVWSFGVLLWELL 222

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 96/194 (49%), Gaps = 20/194 (10%)
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYGPD 552
           P  R G   ++ EI +L  + H H++   G CE+Q E  + LV EY+  G L+ +L    
Sbjct: 57  PQHRSG---WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---P 110
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
           R  +   Q L        G+ YLH+   +  IHR++ + N+LLD + + K+ DFGL+++ 
Sbjct: 111 RHSIGLAQLLLFAQQICEGMAYLHS---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167
Query: 613 PCLDETHVSTGVK----GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL--CARTAVDP 666
           P   E H    V+        +  PE  +  +    SDV+SFGV L+E+L  C  +   P
Sbjct: 168 P---EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 224
Query: 667 LLAREQVNLAEWAM 680
               E + +A+  M
Sbjct: 225 TKFLELIGIAQGQM 238

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 468 IIGSGGFGMVYKGVLR---DNTKVAVKRGVPGSRQGLP---EFQTEITVLSKIRHRHLVS 521
           ++GSG FG VYKG+     +  K+ V   +     G     EF  E  +++ + H HLV 
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+G C   + + LV + M  G L ++++   +  +  +  L  C+  A+G+ YL      
Sbjct: 105 LLGVCLSPT-IQLVTQLMPHGCLLEYVHE-HKDNIGSQLLLNWCVQIAKGMMYL---EER 159
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            ++HRD+ + N+L+      K+ DFGL+R     ++ + + G K    ++  E    ++ 
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 642 TDKSDVYSFGVVLFEVL 658
           T +SDV+S+GV ++E++
Sbjct: 220 THQSDVWSYGVTIWELM 236

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 10/203 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTK---VAVKRGVPGSRQG-LPEFQTEITVLSKIRH 516
           N    ++ +G G FG V +GV R   K   VA+K    G+ +    E   E  ++ ++ +
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395
Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
            ++V L+G C+ ++ ++LV E    GPL K L G  R  +      E+    + G+ YL 
Sbjct: 396 PYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLE 453
Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV-KGSFGYLDPEY 635
               +  +HR++ + N+LL   + +K++DFGLS++    D  + +    K    +  PE 
Sbjct: 454 E---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 636 FRRQQLTDKSDVYSFGVVLFEVL 658
              ++ + +SDV+S+GV ++E L
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEAL 533

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 95/194 (48%), Gaps = 20/194 (10%)
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEMILVYEYMEKGPLKKHLYGPD 552
           P  R G   ++ EI +L  + H H++   G CE+   + + LV EY+  G L+ +L    
Sbjct: 74  PQHRSG---WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---P 127
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
           R  +   Q L        G+ YLH   A+  IHRD+ + N+LLD + + K+ DFGL+++ 
Sbjct: 128 RHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184
Query: 613 PCLDETHVSTGVK----GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL--CARTAVDP 666
           P   E H    V+        +  PE  +  +    SDV+SFGV L+E+L  C  +   P
Sbjct: 185 P---EGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241
Query: 667 LLAREQVNLAEWAM 680
               E + +A+  M
Sbjct: 242 TKFLELIGIAQGQM 255

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/177 (34%), Positives = 90/177 (50%), Gaps = 19/177 (10%)
Query: 489 AVKRGV-PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE--MILVYEYMEKGPLK 545
           A+K G  P  R G   +Q EI +L  + H H+V   G CE+Q E  + LV EY+  G L+
Sbjct: 45  ALKEGCGPQLRSG---WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLR 101
Query: 546 KHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVAD 605
            +L    R  +   Q L        G+ YLH   A+  IHR + + N+LLD + + K+ D
Sbjct: 102 DYL---PRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGD 155
Query: 606 FGLSRSGPCLDETHVSTGVK----GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           FGL+++ P   E H    V+        +  PE  +  +    SDV+SFGV L+E+L
Sbjct: 156 FGLAKAVP---EGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/177 (34%), Positives = 90/177 (50%), Gaps = 19/177 (10%)
Query: 489 AVKRGV-PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE--MILVYEYMEKGPLK 545
           A+K G  P  R G   +Q EI +L  + H H+V   G CE+Q E  + LV EY+  G L+
Sbjct: 44  ALKEGCGPQLRSG---WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLR 100
Query: 546 KHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVAD 605
            +L    R  +   Q L        G+ YLH   A+  IHR + + N+LLD + + K+ D
Sbjct: 101 DYL---PRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGD 154
Query: 606 FGLSRSGPCLDETHVSTGVK----GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           FGL+++ P   E H    V+        +  PE  +  +    SDV+SFGV L+E+L
Sbjct: 155 FGLAKAVP---EGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE-------FQTEITVL 511
           ++ ++   I+G GG   V+    LRD+  VAVK      R  L         F+ E    
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV----LRADLARDPSFYLRFRREAQNA 66
Query: 512 SKIRHRHLVSLVGYCEEQSEM----ILVYEYMEKGPLKK--HLYGPDRTPLSWKQRLEIC 565
           + + H  +V++    E ++       +V EY++   L+   H  GP    ++ K+ +E+ 
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVI 122
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR----SGPCLDETHVS 621
             A + L++ H     GIIHRD+K  NI++      KV DFG++R    SG  + +T   
Sbjct: 123 ADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT--- 176
Query: 622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
             V G+  YL PE  R   +  +SDVYS G VL+EVL 
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE-------FQTEITVL 511
           ++ ++   I+G GG   V+    LRD+  VAVK      R  L         F+ E    
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV----LRADLARDPSFYLRFRREAQNA 66
Query: 512 SKIRHRHLVSLVGYCEEQSEM----ILVYEYMEKGPLKK--HLYGPDRTPLSWKQRLEIC 565
           + + H  +V++    E ++       +V EY++   L+   H  GP    ++ K+ +E+ 
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVI 122
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR----SGPCLDETHVS 621
             A + L++ H     GIIHRD+K  NI++      KV DFG++R    SG  + +T   
Sbjct: 123 ADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT--- 176
Query: 622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
             V G+  YL PE  R   +  +SDVYS G VL+EVL 
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 469 IGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V KG  +         V + +          E   E  V+ ++ + ++V ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G CE +S M LV E  E GPL K+L       +  K  +E+    + G+ YL   +    
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---F 128
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL   + +K++DFGLS++    DE +      G +   +  PE     + 
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 642 TDKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 188 SSKSDVWSFGVLMWEAF 204

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 469 IGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V KG  +         V + +          E   E  V+ ++ + ++V ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G CE +S M LV E  E GPL K+L       +  K  +E+    + G+ YL   +    
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---F 148
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL   + +K++DFGLS++    DE +      G +   +  PE     + 
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 642 TDKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 208 SSKSDVWSFGVLMWEAF 224

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 469 IGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V KG  +         V + +          E   E  V+ ++ + ++V ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G CE +S M LV E  E GPL K+L       +  K  +E+    + G+ YL   +    
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---F 148
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL   + +K++DFGLS++    DE +      G +   +  PE     + 
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 642 TDKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 208 SSKSDVWSFGVLMWEAF 224

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 469 IGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V KG  +         V + +          E   E  V+ ++ + ++V ++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G CE +S M LV E  E GPL K+L       +  K  +E+    + G+ YL   +    
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---F 126
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL   + +K++DFGLS++    DE +      G +   +  PE     + 
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECINYYKF 185
Query: 642 TDKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 186 SSKSDVWSFGVLMWEAF 202

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 469 IGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V KG  +         V + +          E   E  V+ ++ + ++V ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G CE +S M LV E  E GPL K+L       +  K  +E+    + G+ YL   +    
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---F 132
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL   + +K++DFGLS++    DE +      G +   +  PE     + 
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECINYYKF 191
Query: 642 TDKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 192 SSKSDVWSFGVLMWEAF 208

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 469 IGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V KG  +         V + +          E   E  V+ ++ + ++V ++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G CE +S M LV E  E GPL K+L       +  K  +E+    + G+ YL   +    
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---F 146
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL   + +K++DFGLS++    DE +      G +   +  PE     + 
Sbjct: 147 VHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECINYYKF 205
Query: 642 TDKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 206 SSKSDVWSFGVLMWEAF 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 469 IGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V KG  +         V + +          E   E  V+ ++ + ++V ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G CE +S M LV E  E GPL K+L       +  K  +E+    + G+ YL   +    
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---F 138
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL   + +K++DFGLS++    DE +      G +   +  PE     + 
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 642 TDKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 198 SSKSDVWSFGVLMWEAF 214

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 468 IIGSGGFGMVYKGVL---RDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRHRHLVS 521
           ++GSG FG V+KGV     ++ K+ V   V   + G   FQ     +  +  + H H+V 
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+G C   S + LV +Y+  G L  H+    R  L  +  L   +  A+G++YL      
Sbjct: 98  LLGLCP-GSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYL---EEH 152
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
           G++HR++ + N+LL      +VADFG++   P  D+  + +  K    ++  E     + 
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 642 TDKSDVYSFGVVLFEVL 658
           T +SDV+S+GV ++E++
Sbjct: 213 THQSDVWSYGVTVWELM 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 468 IIGSGGFGMVYKGVL---RDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRHRHLVS 521
           ++GSG FG V+KGV     ++ K+ V   V   + G   FQ     +  +  + H H+V 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+G C   S + LV +Y+  G L  H+    R  L  +  L   +  A+G++YL      
Sbjct: 80  LLGLCP-GSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYL---EEH 134
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
           G++HR++ + N+LL      +VADFG++   P  D+  + +  K    ++  E     + 
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 642 TDKSDVYSFGVVLFEVL 658
           T +SDV+S+GV ++E++
Sbjct: 195 THQSDVWSYGVTVWELM 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 138
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 198
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 199 FSVASDVWSFGVVLYELF 216

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 137
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 197
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 198 FSVASDVWSFGVVLYELF 215

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 469 IGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V KG  +         V + +          E   E  V+ ++ + ++V ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G CE +S M LV E  E GPL K+L       +  K  +E+    + G+ YL   +    
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---F 132
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL   + +K++DFGLS++    DE        G +   +  PE     + 
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENXYKAQTHGKWPVKWYAPECINYYKF 191
Query: 642 TDKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 192 SSKSDVWSFGVLMWEAF 208

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 469 IGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V KG  +         V + +          E   E  V+ ++ + ++V ++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G CE +S M LV E  E GPL K+L       +  K  +E+    + G+ YL   +    
Sbjct: 437 GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---F 490
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL   + +K++DFGLS++    DE +      G +   +  PE     + 
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECINYYKF 549
Query: 642 TDKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 550 SSKSDVWSFGVLMWEAF 566

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 132
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 192
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 193 FSVASDVWSFGVVLYELF 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 164
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 224
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 225 FSVASDVWSFGVVLYELF 242

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 140
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 200
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 201 FSVASDVWSFGVVLYELF 218

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 469 IGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V KG  +         V + +          E   E  V+ ++ + ++V ++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G CE +S M LV E  E GPL K+L       +  K  +E+    + G+ YL   +    
Sbjct: 438 GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---F 491
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL   + +K++DFGLS++    DE +      G +   +  PE     + 
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECINYYKF 550
Query: 642 TDKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 551 SSKSDVWSFGVLMWEAF 567

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 139
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 199
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 200 FSVASDVWSFGVVLYELF 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 136
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 197 FSVASDVWSFGVVLYELF 214

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 133
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 194 FSVASDVWSFGVVLYELF 211

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 42/298 (14%)
Query: 463 FDKNLII-----GSGGFGMVYKGVLRDNTKVAVKRGVP------GSRQGLPEFQTEITVL 511
            D+NL+I     G G FG V +G L+     ++K  V        S++ + EF +E   +
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 512 SKIRHRHLVSLVGYCEEQSEM-----ILVYEYMEKGPLKKHLY------GPDRTPLSWKQ 560
               H +++ L+G C E S       +++  +M+ G L  +L       GP   PL  + 
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL--QT 148
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV 620
            L+  +  A G+ YL   S    +HRD+ + N +L ++    VADFGLS+     D    
Sbjct: 149 LLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205
Query: 621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM 680
               K    ++  E    +  T KSDV++FGV ++E+  A   + P    +   + ++ +
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI--ATRGMTPYPGVQNHEMYDYLL 263
Query: 681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ 738
              +      +  P+       D L +  E    C     +DRP+   +   LE  L+
Sbjct: 264 HGHR------LKQPE-------DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 131
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 191
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 192 FSVASDVWSFGVVLYELF 209

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 133
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 194 FSVASDVWSFGVVLYELF 211

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 13/220 (5%)
Query: 468 IIGSGGFGMVYKG-VLRDNTKVAVKRGVPGS--RQGLPE-FQTEITVLSKIRHRHLVSLV 523
           ++G G F  VY+   +    +VA+K     +  + G+ +  Q E+ +  +++H  ++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
            Y E+ + + LV E    G + ++L    + P S  +          G+ YLH+    GI
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITGMLYLHS---HGI 133
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           +HRD+  +N+LL  N   K+ADFGL+       E H +  + G+  Y+ PE   R     
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGL 191
Query: 644 KSDVYSFGVVLFEVLCARTAVDPLLAREQVN---LAEWAM 680
           +SDV+S G + + +L  R   D    +  +N   LA++ M
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM 231

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 151
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 212 FSVASDVWSFGVVLYELF 229

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 133
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 194 FSVASDVWSFGVVLYELF 211

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 151
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 212 FSVASDVWSFGVVLYELF 229

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q    +FD    +G G FG VY    R +      KV  K  +   + G+  + + E+ +
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQL--EKAGVEHQLRREVEI 65
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    R     +QR    I   A
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD---EQRTATYITELA 122
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL  N   K+ADFG S   P    +   T + G+  
Sbjct: 123 NALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRTTLCGTLD 175
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           YL PE    +   +K D++S GV+ +E L
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFL 204

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L       +   + L+      +G+ YL T   +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER-IDHIKLLQYTSQICKGMEYLGT---K 136
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 197 FSVASDVWSFGVVLYELF 214

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ E++  G L+++L    +  +   + L+      +G+ YL T   +
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 136
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL++  P   E   V    +    +  PE     +
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 197 FSVASDVWSFGVVLYELF 214

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 472 GGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS- 530
           G FG V+K  L  N  VAVK      +Q   + + E+  L  ++H +++  +G  +  + 
Sbjct: 35  GRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 531 ---EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT-------GSA 580
              ++ L+  + EKG L   L       +SW +   I    ARGL YLH        G  
Sbjct: 93  VDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHK 149
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLS---RSGPCLDETHVSTGVKGSFGYLDPEY-- 635
             I HRDIKS N+LL  N  + +ADFGL+    +G    +TH   G  G+  Y+ PE   
Sbjct: 150 PAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH---GQVGTRRYMAPEVLE 206
Query: 636 ----FRRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
               F+R     + D+Y+ G+VL+E+    TA D
Sbjct: 207 GAINFQRDAFL-RIDMYAMGLVLWELASRCTAAD 239

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE-------FQTEITVL 511
           ++ ++   I+G GG   V+    LR +  VAVK      R  L         F+ E    
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV----LRADLARDPSFYLRFRREAQNA 66
Query: 512 SKIRHRHLVSLVGYCEEQSEM----ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIG 567
           + + H  +V++    E ++       +V EY++   L+  ++     P++ K+ +E+   
Sbjct: 67  AALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIAD 124
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR----SGPCLDETHVSTG 623
           A + L++ H     GIIHRD+K  NI++      KV DFG++R    SG  + +T     
Sbjct: 125 ACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT---AA 178
Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           V G+  YL PE  R   +  +SDVYS G VL+EVL
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 110/241 (45%), Gaps = 51/241 (21%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRG----VPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G+GGFG V + + +D   +VA+K+      P +R+    +  EI ++ K+ H ++VS  
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRE---RWCLEIQIMKKLNHPNVVSAR 78
Query: 524 GYCEEQSEM------ILVYEYMEKGPLKKHL----------YGPDRTPLSWKQRLEICIG 567
              +   ++      +L  EY E G L+K+L           GP RT LS          
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS---------D 129
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGV 624
            +  L YLH      IIHRD+K  NI+L    +  + K+ D G ++    LD+  + T  
Sbjct: 130 ISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEF 183
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK 684
            G+  YL PE   +++ T   D +SFG + FE +   T   P L   Q       +QW  
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECI---TGFRPFLPNWQ------PVQWHG 234
Query: 685 K 685
           K
Sbjct: 235 K 235

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG   M     L+DNT   VAVK+    + + L +F+ EI +L  ++H ++V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 524 GYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           G C    +  + L+ EY+  G L+ +L    +  +   + L+      +G+ YL T   +
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT---K 134
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH-VSTGVKGSFGYLDPEYFRRQQ 640
             IHR++ + NIL++     K+ DFGL++  P   E + V    +    +  PE     +
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 194
Query: 641 LTDKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 195 FSVASDVWSFGVVLYELF 212

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 110/241 (45%), Gaps = 51/241 (21%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRG----VPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G+GGFG V + + +D   +VA+K+      P +R+    +  EI ++ K+ H ++VS  
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRE---RWCLEIQIMKKLNHPNVVSAR 79
Query: 524 GYCEEQSEM------ILVYEYMEKGPLKKHL----------YGPDRTPLSWKQRLEICIG 567
              +   ++      +L  EY E G L+K+L           GP RT LS          
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS---------D 130
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGV 624
            +  L YLH      IIHRD+K  NI+L    +  + K+ D G ++    LD+  + T  
Sbjct: 131 ISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEF 184
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK 684
            G+  YL PE   +++ T   D +SFG + FE +   T   P L   Q       +QW  
Sbjct: 185 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECI---TGFRPFLPNWQ------PVQWHG 235
Query: 685 K 685
           K
Sbjct: 236 K 236

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 12/217 (5%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKIRHRHLVS 521
           ++GSG FG VYKG+ + D   V +   +   R+        E   E  V++ +   ++  
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+G C   S + LV + M  G L  H+   +R  L  +  L  C+  A+G+ YL      
Sbjct: 84  LLGICL-TSTVQLVTQLMPYGCLLDHVR-ENRGRLGSQDLLNWCMQIAKGMSYLEDVR-- 139
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            ++HRD+ + N+L+      K+ DFGL+R     +  + + G K    ++  E   R++ 
Sbjct: 140 -LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 642 TDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAE 677
           T +SDV+S+GV ++E++       D + ARE  +L E
Sbjct: 199 THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 235

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE-------FQTEITVL 511
           ++ ++   I+G GG   V+    LR +  VAVK      R  L         F+ E    
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV----LRADLARDPSFYLRFRREAQNA 66
Query: 512 SKIRHRHLVSLVGYCEEQSEM----ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIG 567
           + + H  +V++    E ++       +V EY++   L+  ++     P++ K+ +E+   
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIAD 124
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR----SGPCLDETHVSTG 623
           A + L++ H     GIIHRD+K  NI++      KV DFG++R    SG  + +T     
Sbjct: 125 ACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT---AA 178
Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           V G+  YL PE  R   +  +SDVYS G VL+EVL
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 66
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY  +G + K L    +     +QR    I   A
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD---EQRTATYITELA 123
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 124 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLD 176
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 46/232 (19%)
Query: 465 KNLIIGS----GGFGMVYKGV---LRDN---TKVAVKR-GVPGSRQGLPEFQTEITVLSK 513
           KNL++G     G FG V K     L+     T VAVK      S   L +  +E  VL +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLY----------------------GP 551
           + H H++ L G C +   ++L+ EY + G L+  L                        P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 552 DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           D   L+    +      ++G+ YL   S   ++HRD+ + NIL+ E    K++DFGLSR 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD-----KSDVYSFGVVLFEVL 658
               D     + VK S G +  ++   + L D     +SDV+SFGV+L+E++
Sbjct: 199 ----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV--------AVKRGVPGSRQGLPEFQTEITVLS 512
           N F +  ++G GGFG V    +R   K+           +   G    L E Q    +L 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ----ILE 239
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL----EICIGA 568
           K+  R +VSL    E +  + LV   M  G LK H+Y   +      + +    EIC G 
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG- 298
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
              L  LH    E I++RD+K  NILLD++   +++D GL+   P   E     G  G+ 
Sbjct: 299 ---LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTV 349
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
           GY+ PE  + ++ T   D ++ G +L+E++  ++
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP-----EFQTEITVLSKIRHRHLV 520
           N I+G G FG VY+GV  ++    +   V   ++        +F +E  ++  + H H+V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 521 SLVGYCEEQSEMIL--VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            L+G  EE+   I+  +Y Y E G    H    ++  L     +   +   + + YL + 
Sbjct: 73  KLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLESI 128
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV-KGSFGYLDPEYFR 637
           +    +HRDI   NIL+      K+ DFGLSR     DE +    V +    ++ PE   
Sbjct: 129 NC---VHRDIAVRNILVASPECVKLGDFGLSRYIE--DEDYYKASVTRLPIKWMSPESIN 183
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            ++ T  SDV+ F V ++E+L
Sbjct: 184 FRRFTTASDVWMFAVCMWEIL 204

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE-------FQTEITVL 511
           ++ ++   I+G GG   V+    LR +  VAVK      R  L         F+ E    
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV----LRADLARDPSFYLRFRREAQNA 83
Query: 512 SKIRHRHLVSLVGYCEEQSEM----ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIG 567
           + + H  +V++    E ++       +V EY++   L+  ++     P++ K+ +E+   
Sbjct: 84  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIAD 141
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR----SGPCLDETHVSTG 623
           A + L++ H     GIIHRD+K  NI++      KV DFG++R    SG  + +T     
Sbjct: 142 ACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT---AA 195
Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           V G+  YL PE  R   +  +SDVYS G VL+EVL
Sbjct: 196 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 230

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP-----EFQTEITVLSKIRHRHLV 520
           N I+G G FG VY+GV  ++    +   V   ++        +F +E  ++  + H H+V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 521 SLVGYCEEQSEMIL--VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            L+G  EE+   I+  +Y Y E G    H    ++  L     +   +   + + YL + 
Sbjct: 89  KLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLESI 144
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV-KGSFGYLDPEYFR 637
           +    +HRDI   NIL+      K+ DFGLSR     DE +    V +    ++ PE   
Sbjct: 145 NC---VHRDIAVRNILVASPECVKLGDFGLSRYIE--DEDYYKASVTRLPIKWMSPESIN 199
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            ++ T  SDV+ F V ++E+L
Sbjct: 200 FRRFTTASDVWMFAVCMWEIL 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP-----EFQTEITVLSKIRHRHLV 520
           N I+G G FG VY+GV  ++    +   V   ++        +F +E  ++  + H H+V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 521 SLVGYCEEQSEMIL--VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            L+G  EE+   I+  +Y Y E G    H    ++  L     +   +   + + YL + 
Sbjct: 77  KLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV-KGSFGYLDPEYFR 637
           +    +HRDI   NIL+      K+ DFGLSR     DE +    V +    ++ PE   
Sbjct: 133 NC---VHRDIAVRNILVASPECVKLGDFGLSRYIE--DEDYYKASVTRLPIKWMSPESIN 187
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            ++ T  SDV+ F V ++E+L
Sbjct: 188 FRRFTTASDVWMFAVCMWEIL 208

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           ++G GGFG V+   ++   K+     + +     R+G      E  +L+K+  R +VSL 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARGLHYLHTGSAE 581
              E ++++ LV   M  G ++ H+Y  D     +++   I   A    GL +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQ 640
            II+RD+K  N+LLD++   +++D GL+     L      T G  G+ G++ PE    ++
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVE---LKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAR 670
                D ++ GV L+E++ AR    P  AR
Sbjct: 366 YDFSVDYFALGVTLYEMIAARG---PFRAR 392

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 37/244 (15%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN--------TKVAVKRGVPGSRQGLPEF-QTEITVL 511
             +D   +IG G   +V + V R           +V  +R  P   + + E  + E  +L
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 512 SKIR-HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR 570
            ++  H H+++L+   E  S M LV++ M KG L  +L   ++  LS K+   I      
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL--TEKVALSEKETRSIMRSLLE 211
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK----- 625
            + +LH   A  I+HRD+K  NILLD+N   +++DFG S         H+  G K     
Sbjct: 212 AVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFS--------CHLEPGEKLRELC 260
Query: 626 GSFGYLDPEYFRRQQ------LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWA 679
           G+ GYL PE  +            + D+++ GV+LF +L       P   R Q+ +    
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP---PFWHRRQILMLRMI 317
Query: 680 MQWQ 683
           M+ Q
Sbjct: 318 MEGQ 321

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV--------AVKRGVPGSRQGLPEFQTEITVLS 512
           N F +  ++G GGFG V    +R   K+           +   G    L E Q    +L 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ----ILE 239
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL----EICIGA 568
           K+  R +VSL    E +  + LV   M  G LK H+Y   +      + +    EIC G 
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG- 298
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
              L  LH    E I++RD+K  NILLD++   +++D GL+   P   E     G  G+ 
Sbjct: 299 ---LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTV 349
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
           GY+ PE  + ++ T   D ++ G +L+E++  ++
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q    +FD    +G G FG VY    R +      KV  K  +   + G+  + + E+ +
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQL--EKAGVEHQLRREVEI 65
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    R     +QR    I   A
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD---EQRTATYITELA 122
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL  N   K+ADFG S   P    +     + G+  
Sbjct: 123 NALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRDTLCGTLD 175
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
           YL PE    +   +K D++S GV+ +E L  
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           ++G GGFG V+   ++   K+     + +     R+G      E  +L+K+  R +VSL 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARGLHYLHTGSAE 581
              E ++++ LV   M  G ++ H+Y  D     +++   I   A    GL +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQ 640
            II+RD+K  N+LLD++   +++D GL+     L      T G  G+ G++ PE    ++
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVE---LKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAR 670
                D ++ GV L+E++ AR    P  AR
Sbjct: 366 YDFSVDYFALGVTLYEMIAARG---PFRAR 392

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           ++G GGFG V+   ++   K+     + +     R+G      E  +L+K+  R +VSL 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARGLHYLHTGSAE 581
              E ++++ LV   M  G ++ H+Y  D     +++   I   A    GL +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQ 640
            II+RD+K  N+LLD++   +++D GL+     L      T G  G+ G++ PE    ++
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVE---LKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAR 670
                D ++ GV L+E++ AR    P  AR
Sbjct: 366 YDFSVDYFALGVTLYEMIAARG---PFRAR 392

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 468 IIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           ++G GGFG V+   ++   K+     + +     R+G      E  +L+K+  R +VSL 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARGLHYLHTGSAE 581
              E ++++ LV   M  G ++ H+Y  D     +++   I   A    GL +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST-GVKGSFGYLDPEYFRRQQ 640
            II+RD+K  N+LLD++   +++D GL+     L      T G  G+ G++ PE    ++
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVE---LKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAR 670
                D ++ GV L+E++ AR    P  AR
Sbjct: 366 YDFSVDYFALGVTLYEMIAARG---PFRAR 392

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 66
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY  +G + K L    +     +QR    I   A
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD---EQRTATYITELA 123
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +     + G+  
Sbjct: 124 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLXGTLD 176
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 46/232 (19%)
Query: 465 KNLIIGS----GGFGMVYKGV---LRDN---TKVAVKR-GVPGSRQGLPEFQTEITVLSK 513
           KNL++G     G FG V K     L+     T VAVK      S   L +  +E  VL +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLY----------------------GP 551
           + H H++ L G C +   ++L+ EY + G L+  L                        P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 552 DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           D   L+    +      ++G+ YL   +   ++HRD+ + NIL+ E    K++DFGLSR 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD-----KSDVYSFGVVLFEVL 658
               D     + VK S G +  ++   + L D     +SDV+SFGV+L+E++
Sbjct: 199 ----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 19/202 (9%)
Query: 469 IGSGGFGMVYKGVLR-----DNT--KVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLV 520
           +G G FG V   + R     DNT  +VAVK   P S    + + + EI +L  + H ++V
Sbjct: 29  LGEGHFGKV--ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 521 SLVGYCEEQ--SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
              G C E   + + L+ E++  G LK++L   ++  ++ KQ+L+  +   +G+ YL  G
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--G 143
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS--FGYLDPEYF 636
           S +  +HRD+ + N+L++  +  K+ DFGL+++     E       + S  F Y  PE  
Sbjct: 144 SRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECL 201
Query: 637 RRQQLTDKSDVYSFGVVLFEVL 658
            + +    SDV+SFGV L E+L
Sbjct: 202 MQSKFYIASDVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 19/202 (9%)
Query: 469 IGSGGFGMVYKGVLR-----DNT--KVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLV 520
           +G G FG V   + R     DNT  +VAVK   P S    + + + EI +L  + H ++V
Sbjct: 17  LGEGHFGKV--ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 521 SLVGYCEEQ--SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
              G C E   + + L+ E++  G LK++L   ++  ++ KQ+L+  +   +G+ YL  G
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--G 131
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS--FGYLDPEYF 636
           S +  +HRD+ + N+L++  +  K+ DFGL+++     E       + S  F Y  PE  
Sbjct: 132 SRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECL 189
Query: 637 RRQQLTDKSDVYSFGVVLFEVL 658
            + +    SDV+SFGV L E+L
Sbjct: 190 MQSKFYIASDVWSFGVTLHELL 211

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS---RQGLP-EFQTEITVLSKIRH 516
           ++FD    +G G FG VY    + N  +   + +  S   ++G+  + + EI + S +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
            +++ +  Y  ++  + L+ E+  +G L K L    R     ++        A  LHY H
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCH 132
Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
                 +IHRDIK  N+L+      K+ADFG S   P L    +     G+  YL PE  
Sbjct: 133 E---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMI 185
Query: 637 RRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
             +   +K D++  GV+ +E L      D
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 62
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 119
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    T +S    G+  
Sbjct: 120 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLD 172
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 111/226 (49%), Gaps = 20/226 (8%)
Query: 450 KIPFTD-LQTATNNFDKNLIIGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLP 502
           ++P+ +  +   NN      +G+G FG V +    G+ +++   KVAVK     +     
Sbjct: 26  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 85
Query: 503 E-FQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKGPL--------KKHLYGPD 552
           E   +E+ ++S + +H ++V+L+G C     ++++ EY   G L        +  L   D
Sbjct: 86  EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKED 145
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             PL  +  L      A+G+ +L   +++  IHRD+ + N+LL   +V+K+ DFGL+R  
Sbjct: 146 GRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 202
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
                  V    +    ++ PE       T +SDV+S+G++L+E+ 
Sbjct: 203 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 248

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 13/220 (5%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKR--GVPGS 497
           SP Q+G   ++    D +      +K   IG G FG V+KG+     KV   +   +  +
Sbjct: 4   SPVQSGLPGMQNLKADPEELFTKLEK---IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA 60
Query: 498 RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLS 557
              + + Q EITVLS+    ++    G   + +++ ++ EY+  G     L   +  PL 
Sbjct: 61  EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLD 117
Query: 558 WKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE 617
             Q   I     +GL YLH+   E  IHRDIK+ N+LL E+   K+ADFG+  +G   D 
Sbjct: 118 ETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGV--AGQLTDT 172
Query: 618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
                   G+  ++ PE  ++     K+D++S G+   E+
Sbjct: 173 QIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 212

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 111/226 (49%), Gaps = 20/226 (8%)
Query: 450 KIPFTD-LQTATNNFDKNLIIGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLP 502
           ++P+ +  +   NN      +G+G FG V +    G+ +++   KVAVK     +     
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 93
Query: 503 E-FQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKGPL--------KKHLYGPD 552
           E   +E+ ++S + +H ++V+L+G C     ++++ EY   G L        +  L   D
Sbjct: 94  EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKED 153
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             PL  +  L      A+G+ +L   +++  IHRD+ + N+LL   +V+K+ DFGL+R  
Sbjct: 154 GRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 210
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
                  V    +    ++ PE       T +SDV+S+G++L+E+ 
Sbjct: 211 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 256

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 46/232 (19%)
Query: 465 KNLIIGS----GGFGMVYKGV---LRDN---TKVAVKR-GVPGSRQGLPEFQTEITVLSK 513
           KNL++G     G FG V K     L+     T VAVK      S   L +  +E  VL +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLY----------------------GP 551
           + H H++ L G C +   ++L+ EY + G L+  L                        P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 552 DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           D   L+    +      ++G+ YL   +   ++HRD+ + NIL+ E    K++DFGLSR 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD-----KSDVYSFGVVLFEVL 658
               D     + VK S G +  ++   + L D     +SDV+SFGV+L+E++
Sbjct: 199 ----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 469 IGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           +G+G FG V+    R N +      +K+ +    + +     E  +LS + H  ++ + G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDR--TPLSWKQRLEICIGAARGLHYLHTGSAEG 582
             ++  ++ ++ +Y+E G L   L    R   P++     E+C+     L YLH   ++ 
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA----LEYLH---SKD 126
Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           II+RD+K  NILLD+N   K+ DFG ++  P      V+  + G+  Y+ PE    +   
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYXLCGTPDYIAPEVVSTKPYN 181
Query: 643 DKSDVYSFGVVLFEVLCART 662
              D +SFG++++E+L   T
Sbjct: 182 KSIDWWSFGILIYEMLAGYT 201

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTKVAVKR--GVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           F K   IG G FG V+KG+     KV   +   +  +   + + Q EITVLS+    ++ 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
              G   + +++ ++ EY+  G     L   +  PL   Q   I     +GL YLH+   
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHS--- 142
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           E  IHRDIK+ N+LL E+   K+ADFG+  +G   D         G+  ++ PE  ++  
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 200
Query: 641 LTDKSDVYSFGVVLFEV 657
              K+D++S G+   E+
Sbjct: 201 YDSKADIWSLGITAIEL 217

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 112/232 (48%), Gaps = 26/232 (11%)
Query: 450 KIPFTD-LQTATNNFDKNLIIGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLP 502
           ++P+ +  +   NN      +G+G FG V +    G+ +++   KVAVK     +     
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 93
Query: 503 E-FQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----------Y 549
           E   +E+ ++S + +H ++V+L+G C     ++++ EY   G L   L           Y
Sbjct: 94  EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSY 153
Query: 550 GPDRTP---LSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADF 606
            P   P   LS +  L      A+G+ +L   +++  IHRD+ + N+LL   +V+K+ DF
Sbjct: 154 NPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDF 210
Query: 607 GLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           GL+R         V    +    ++ PE       T +SDV+S+G++L+E+ 
Sbjct: 211 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 262

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 87
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 88  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 144
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 145 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLD 197
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTKVAVKR--GVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           F K   IG G FG V+KG+     KV   +   +  +   + + Q EITVLS+    ++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
              G   + +++ ++ EY+  G     L   +  PL   Q   I     +GL YLH+   
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHS--- 122
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           E  IHRDIK+ N+LL E+   K+ADFG+  +G   D         G+  ++ PE  ++  
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 180
Query: 641 LTDKSDVYSFGVVLFEV 657
              K+D++S G+   E+
Sbjct: 181 YDSKADIWSLGITAIEL 197

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTKVAVKR--GVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           F K   IG G FG V+KG+     KV   +   +  +   + + Q EITVLS+    ++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
              G   + +++ ++ EY+  G     L   +  PL   Q   I     +GL YLH+   
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHS--- 122
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           E  IHRDIK+ N+LL E+   K+ADFG+  +G   D         G+  ++ PE  ++  
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 180
Query: 641 LTDKSDVYSFGVVLFEV 657
              K+D++S G+   E+
Sbjct: 181 YDSKADIWSLGITAIEL 197

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS---RQGLP-EFQTEITVLSKIRH 516
           ++FD    +G G FG VY    + N  +   + +  S   ++G+  + + EI + S +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
            +++ +  Y  ++  + L+ E+  +G L K L    R     ++        A  LHY H
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCH 131
Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
                 +IHRDIK  N+L+      K+ADFG S   P L    +     G+  YL PE  
Sbjct: 132 E---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMI 184
Query: 637 RRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
             +   +K D++  GV+ +E L      D
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 61
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 118
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    T +     G+  
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTLD 171
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 61
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 118
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLD 171
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 62
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 119
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 120 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLD 172
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 78
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 79  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 135
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 136 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLD 188
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 189 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 66
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 123
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 124 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLD 176
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 61
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 118
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLD 171
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKI-R 515
            +FD   +IG G +  V    L+   ++     VK+ +    + +   QTE  V  +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H  LV L    + +S +  V EY+  G L  H+    + P    +     I  A  L+YL
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYL 126
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H     GII+RD+K  N+LLD     K+ D+G+ + G  L     ++   G+  Y+ PE 
Sbjct: 127 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXFCGTPNYIAPEI 181
Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
            R +      D ++ GV++FE++  R+  D
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    +++      KV  K  +   + G+  + + E+ +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQL--EKAGVEHQLRREVEI 61
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 118
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +     + G+  
Sbjct: 119 NALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLD 171
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKI-R 515
            +FD   +IG G +  V    L+   ++     VK+ +    + +   QTE  V  +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H  LV L    + +S +  V EY+  G L  H+    + P    +     I  A  L+YL
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYL 169
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H     GII+RD+K  N+LLD     K+ D+G+ + G  L     ++   G+  Y+ PE 
Sbjct: 170 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEI 224
Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
            R +      D ++ GV++FE++  R+  D
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKI-R 515
            +FD   +IG G +  V    L+   ++     VK+ +    + +   QTE  V  +   
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H  LV L    + +S +  V EY+  G L  H+    + P    +     I  A  L+YL
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYL 137
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H     GII+RD+K  N+LLD     K+ D+G+ + G  L     ++   G+  Y+ PE 
Sbjct: 138 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXFCGTPNYIAPEI 192
Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
            R +      D ++ GV++FE++  R+  D
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 66
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 123
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 124 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLD 176
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 64
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 121
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLD 174
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKI-R 515
            +FD   +IG G +  V    L+   ++     VK+ +    + +   QTE  V  +   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H  LV L    + +S +  V EY+  G L  H+    + P    +     I  A  L+YL
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYL 122
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H     GII+RD+K  N+LLD     K+ D+G+ + G  L     ++   G+  Y+ PE 
Sbjct: 123 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXFCGTPNYIAPEI 177
Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
            R +      D ++ GV++FE++  R+  D
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 61
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 118
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    T +     G+  
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTLD 171
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 61
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 118
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLD 171
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 469 IGSGGFGMVYKGVLRDNTK---------VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL 519
           IG G FG   K +L  +T+         + + R     R+   E + E+ VL+ ++H ++
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKERE---ESRREVAVLANMKHPNI 85
Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           V      EE   + +V +Y E G L K +           Q L+  +     L ++H   
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD-- 143
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET-HVSTGVKGSFGYLDPEYFRR 638
              I+HRDIKS NI L ++   ++ DFG++R    L+ T  ++    G+  YL PE    
Sbjct: 144 -RKILHRDIKSQNIFLTKDGTVQLGDFGIAR---VLNSTVELARACIGTPYYLSPEICEN 199
Query: 639 QQLTDKSDVYSFGVVLFEVLCARTAVD 665
           +   +KSD+++ G VL+E+   + A +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 60
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 61  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 117
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 118 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLD 170
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 171 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 65
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 122
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 123 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLD 175
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 66
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 123
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 124 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLD 176
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 76  DNPHVCRLLGICL-TSTVQLIMQLMPFGXLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 134 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELM 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 110/230 (47%), Gaps = 20/230 (8%)
Query: 435 GTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRG 493
           G++  +P Q     LK            F K  ++GSG FG VYKG+ + +  KV +   
Sbjct: 1   GSMGEAPNQALLRILK---------ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA 51
Query: 494 VPGSRQGL-----PEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL 548
           +   R+        E   E  V++ + + H+  L+G C   S + L+ + M  G L  ++
Sbjct: 52  IKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYV 110
Query: 549 YGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL 608
               +  +  +  L  C+  A+G++YL       ++HRD+ + N+L+      K+ DFGL
Sbjct: 111 R-EHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGL 166
Query: 609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           ++     ++ + + G K    ++  E    +  T +SDV+S+GV ++E++
Sbjct: 167 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 64
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 121
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLD 174
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 79  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 137 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELM 217

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    +        KV  K  +   + G+  + + E+ +
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQL--EKAGVEHQLRREVEI 58
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 59  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 115
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  
Sbjct: 116 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLD 168
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 76  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 134 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELM 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 110/230 (47%), Gaps = 20/230 (8%)
Query: 435 GTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRG 493
           G++  +P Q     LK            F K  ++GSG FG VYKG+ + +  KV +   
Sbjct: 1   GSMGEAPNQALLRILK---------ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA 51
Query: 494 VPGSRQGL-----PEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL 548
           +   R+        E   E  V++ + + H+  L+G C   S + L+ + M  G L  ++
Sbjct: 52  IKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV 110
Query: 549 YGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL 608
               +  +  +  L  C+  A+G++YL       ++HRD+ + N+L+      K+ DFGL
Sbjct: 111 R-EHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGL 166
Query: 609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           ++     ++ + + G K    ++  E    +  T +SDV+S+GV ++E++
Sbjct: 167 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 7/195 (3%)
Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           FD    +G G +G VYK + ++  ++   + VP     L E   EI+++ +    H+V  
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
            G   + +++ +V EY   G +   +   ++T L+  +   I     +GL YLH      
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHFMRK-- 146
Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
            IHRDIK+ NILL+    +K+ADFG+  +G   D       V G+  ++ PE  +     
Sbjct: 147 -IHRDIKAGNILLNTEGHAKLADFGV--AGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 643 DKSDVYSFGVVLFEV 657
             +D++S G+   E+
Sbjct: 204 CVADIWSLGITAIEM 218

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 64
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 121
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +     + G+  
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLD 174
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGXLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 81  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 139 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 195
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 196 SILHRIYTHQSDVWSYGVTVWELM 219

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQ 505
           P    Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + +
Sbjct: 2   PLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLR 59
Query: 506 TEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEIC 565
            E+ + S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATY 116
Query: 566 IGA-ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
           I   A  L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +     +
Sbjct: 117 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDDL 169
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
            G+  YL PE    +   +K D++S GV+ +E L  +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 69  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELM 207

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 78  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 61
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 118
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +     + G+  
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLD 171
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 85  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 143 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 199
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 200 SILHRIYTHQSDVWSYGVTVWELM 223

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 82  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 78  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELM 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 100 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 158 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 214
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 215 SILHRIYTHQSDVWSYGVTVWELM 238

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLPE-FQTEITVLSK 513
           NN      +G+G FG V +    G+ +++   KVAVK     +     E   +E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 514 I-RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR------------TPLSWKQ 560
           + +H ++V+L+G C     ++++ EY   G L   L    R            + LS + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV 620
            L      A+G+ +L   +++  IHRD+ + N+LL   +V+K+ DFGL+R         V
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
               +    ++ PE       T +SDV+S+G++L+E+ 
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 18/222 (8%)
Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV-----PGSRQGLPEFQTEITV 510
           ++   ++F+K   +G+G  G+V+K   + +  V  ++ +     P  R    +   E+ V
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN---QIIRELQV 57
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-EICIGAA 569
           L +    ++V   G      E+ +  E+M+ G L + L    R P   +Q L ++ I   
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVI 114
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
           +GL YL       I+HRD+K +NIL++     K+ DFG+  SG  +D   ++    G+  
Sbjct: 115 KGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDS--MANSFVGTRS 168
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE 671
           Y+ PE  +    + +SD++S G+ L E+   R  + P  A+E
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 87
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 88  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 144
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +     + G+  
Sbjct: 145 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDDLCGTLD 197
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 113/239 (47%), Gaps = 33/239 (13%)
Query: 450 KIPFTD-LQTATNNFDKNLIIGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLP 502
           ++P+ +  +   NN      +G+G FG V +    G+ +++   KVAVK     +     
Sbjct: 19  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 78
Query: 503 E-FQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKGPL-------KKHLYGP-- 551
           E   +E+ ++S + +H ++V+L+G C     ++++ EY   G L        + + GP  
Sbjct: 79  EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSL 138
Query: 552 ------------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY 599
                       D  PL  +  L      A+G+ +L   +++  IHRD+ + N+LL   +
Sbjct: 139 APGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGH 195
Query: 600 VSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           V+K+ DFGL+R         V    +    ++ PE       T +SDV+S+G++L+E+ 
Sbjct: 196 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 254

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 18/222 (8%)
Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV-----PGSRQGLPEFQTEITV 510
           ++   ++F+K   +G+G  G+V+K   + +  V  ++ +     P  R    +   E+ V
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN---QIIRELQV 57
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-EICIGAA 569
           L +    ++V   G      E+ +  E+M+ G L + L    R P   +Q L ++ I   
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVI 114
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
           +GL YL       I+HRD+K +NIL++     K+ DFG+  SG  +D   ++    G+  
Sbjct: 115 KGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDS--MANSFVGTRS 168
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE 671
           Y+ PE  +    + +SD++S G+ L E+   R  + P  A+E
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 18/217 (8%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV-----PGSRQGLPEFQTEITVLSKIR 515
           ++F+K   +G+G  G+V+K   + +  V  ++ +     P  R    +   E+ VL +  
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN---QIIRELQVLHECN 124
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-EICIGAARGLHY 574
             ++V   G      E+ +  E+M+ G L + L    R P   +Q L ++ I   +GL Y
Sbjct: 125 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVIKGLTY 181
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       I+HRD+K +NIL++     K+ DFG+  SG  +D   ++    G+  Y+ PE
Sbjct: 182 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDS--MANSFVGTRSYMSPE 235
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE 671
             +    + +SD++S G+ L E+   R  + P  A+E
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 272

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 109 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNY 166
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 167 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 224 SILHRIYTHQSDVWSYGVTVWELM 247

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 18/222 (8%)
Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV-----PGSRQGLPEFQTEITV 510
           ++   ++F+K   +G+G  G+V+K   + +  V  ++ +     P  R    +   E+ V
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN---QIIRELQV 57
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-EICIGAA 569
           L +    ++V   G      E+ +  E+M+ G L + L    R P   +Q L ++ I   
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVI 114
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
           +GL YL       I+HRD+K +NIL++     K+ DFG+  SG  +D   ++    G+  
Sbjct: 115 KGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDS--MANSFVGTRS 168
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE 671
           Y+ PE  +    + +SD++S G+ L E+   R  + P  A+E
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 14/211 (6%)
Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKR-GVPGSRQGLPEFQT-EITVLSK 513
            Q     + K   +G G +G+VYK        VA+KR  +    +G+P     EI++L +
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
           + H ++VSL+     +  + LV+E+MEK  LKK L   ++T L   Q         RG+ 
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL-DENKTGLQDSQIKIYLYQLLRGVA 133
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG--PCLDETHVSTGVKGSFGYL 631
           + H      I+HRD+K  N+L++ +   K+ADFGL+R+   P    TH       +  Y 
Sbjct: 134 HCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYR 186
Query: 632 DPEYFR-RQQLTDKSDVYSFGVVLFEVLCAR 661
            P+     ++ +   D++S G +  E++  +
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 63
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 64  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 120
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+A+FG S   P    +   T + G+  
Sbjct: 121 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLCGTLD 173
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 18/219 (8%)
Query: 452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTE 507
           P   ++    +F+ + ++G G FG V+    +   +     A+K+ V      +     E
Sbjct: 9   PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 68
Query: 508 ITVLS-KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
             VLS    H  L  +    + +  +  V EY+  G L  H+    +  LS         
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATF 123
Query: 567 GAAR---GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
            AA    GL +LH+   +GI++RD+K  NILLD++   K+ADFG+ +     D    +  
Sbjct: 124 YAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNE 178
Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
             G+  Y+ PE    Q+     D +SFGV+L+E+L  ++
Sbjct: 179 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 217

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 63
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 64  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 120
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P      +     G+  
Sbjct: 121 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLD 173
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSLVG 524
           IG G +GMV   Y  V  +  +VA+K+  P   Q   +    EI +L + RH +++ +  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL---EICI---GAARGLHYLHTG 578
                +      E M+   L  HL G D   L   Q L    IC       RGL Y+H+ 
Sbjct: 109 IIRAPT-----IEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFR 637
           +   ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE   
Sbjct: 164 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCAR 661
             +   KS D++S G +L E+L  R
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 14/211 (6%)
Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKR-GVPGSRQGLPEFQT-EITVLSK 513
            Q     + K   +G G +G+VYK        VA+KR  +    +G+P     EI++L +
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
           + H ++VSL+     +  + LV+E+MEK  LKK L   ++T L   Q         RG+ 
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL-DENKTGLQDSQIKIYLYQLLRGVA 133
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG--PCLDETHVSTGVKGSFGYL 631
           + H      I+HRD+K  N+L++ +   K+ADFGL+R+   P    TH       +  Y 
Sbjct: 134 HCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYR 186
Query: 632 DPEYFR-RQQLTDKSDVYSFGVVLFEVLCAR 661
            P+     ++ +   D++S G +  E++  +
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 64
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 121
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+A+FG S   P    +   T + G+  
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLCGTLD 174
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 18/222 (8%)
Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV-----PGSRQGLPEFQTEITV 510
           ++   ++F+K   +G+G  G+V+K   + +  V  ++ +     P  R    +   E+ V
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN---QIIRELQV 57
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-EICIGAA 569
           L +    ++V   G      E+ +  E+M+ G L + L    R P   +Q L ++ I   
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVI 114
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
           +GL YL       I+HRD+K +NIL++     K+ DFG+  SG  +D   ++    G+  
Sbjct: 115 KGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDS--MANSFVGTRS 168
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE 671
           Y+ PE  +    + +SD++S G+ L E+   R  + P  A+E
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 18/222 (8%)
Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV-----PGSRQGLPEFQTEITV 510
           ++   ++F+K   +G+G  G+V+K   + +  V  ++ +     P  R    +   E+ V
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN---QIIRELQV 57
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-EICIGAA 569
           L +    ++V   G      E+ +  E+M+ G L + L    R P   +Q L ++ I   
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVI 114
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
           +GL YL       I+HRD+K +NIL++     K+ DFG+  SG  +D   ++    G+  
Sbjct: 115 KGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDS--MANSFVGTRS 168
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE 671
           Y+ PE  +    + +SD++S G+ L E+   R  + P  A+E
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A G++Y
Sbjct: 72  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAEGMNY 129
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 130 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 186
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 187 SILHRIYTHQSDVWSYGVTVWELM 210

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 38/226 (16%)
Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +F +  +IGSGGFG V+K   R + K  V R V  + +   + + E+  L+K+ H ++V 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNE---KAEREVKALAKLDHVNIVH 69
Query: 522 LVG------YCEEQSE-----------------------MILVYEYMEKGPLKKHLYGPD 552
             G      Y  E S+                       + +  E+ +KG L++ +    
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
              L     LE+     +G+ Y+H   ++ +IHRD+K +NI L +    K+ DFGL  S 
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS- 185
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             L      T  KG+  Y+ PE    Q    + D+Y+ G++L E+L
Sbjct: 186 --LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 62
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 119
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P    +     + G+  
Sbjct: 120 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDTLCGTLD 172
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 61
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 118
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P      +     G+  
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLD 171
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 463 FDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           F K   IG G FG V+KG+  R    VA+K   +  +   + + Q EITVLS+    ++ 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
              G   + S++ ++ EY+  G     L      P    Q   +     +GL YLH+   
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS--- 138
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           E  IHRDIK+ N+LL E    K+ADFG+  +G   D         G+  ++ PE  ++  
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 196
Query: 641 LTDKSDVYSFGVVLFEV 657
              K+D++S G+   E+
Sbjct: 197 YDSKADIWSLGITAIEL 213

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLP-EFQTEITV 510
           Q A  +F+    +G G FG VY    + +      KV  K  +   + G+  + + E+ +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEI 64
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-A 569
            S +RH +++ L GY  + + + L+ EY   G + + L    +     +QR    I   A
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELA 121
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L Y H+   + +IHRDIK  N+LL      K+ADFG S   P      +     G+  
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLD 174
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           YL PE    +   +K D++S GV+ +E L  +
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 15/213 (7%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITV 510
           D +   N+FD   ++G G FG V     K   R      +++ V  ++  +    TE  V
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 63
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-- 568
           L   RH  L +L    +    +  V EY   G L  HL   +R     + R     GA  
Sbjct: 64  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF---YGAEI 119
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
              L YLH+     +++RDIK  N++LD++   K+ DFGL + G  + +        G+ 
Sbjct: 120 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTP 174
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
            YL PE           D +  GVV++E++C R
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV-PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG VYK   ++ + +A  + +   S + L ++  EI +L+   H ++V L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            ++ + ++ E+   G +   +   +R PL+  Q   +C      L+YLH      IIHRD
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNK---IIHRD 160
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD---- 643
           +K+ NIL   +   K+ADFG+S       +   S    G+  ++ PE    +   D    
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYD 218
Query: 644 -KSDVYSFGVVLFEV 657
            K+DV+S G+ L E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV-PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG VYK   ++ + +A  + +   S + L ++  EI +L+   H ++V L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            ++ + ++ E+   G +   +   +R PL+  Q   +C      L+YLH      IIHRD
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNK---IIHRD 160
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD---- 643
           +K+ NIL   +   K+ADFG+S       +   S    G+  ++ PE    +   D    
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS--FIGTPYWMAPEVVMCETSKDRPYD 218
Query: 644 -KSDVYSFGVVLFEV 657
            K+DV+S G+ L E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQTEITVLSK 513
           D ++  +NF K   IG G  G+V    +R + K VAVK+     +Q       E+ ++  
Sbjct: 17  DPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 73
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
            +H ++V +        E+ +V E++E G L   +     T ++ +Q   +C+   + L 
Sbjct: 74  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALS 130
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
            LH   A+G+IHRDIKS +ILL  +   K++DFG         E      + G+  ++ P
Sbjct: 131 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKXLVGTPYWMAP 185
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVL 658
           E   R     + D++S G+++ E++
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMV 210

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQTEITVLSK 513
           D ++  +NF K   IG G  G+V    +R + K VAVK+     +Q       E+ ++  
Sbjct: 28  DPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 84
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
            +H ++V +        E+ +V E++E G L   +     T ++ +Q   +C+   + L 
Sbjct: 85  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALS 141
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
            LH   A+G+IHRDIKS +ILL  +   K++DFG         E      + G+  ++ P
Sbjct: 142 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKXLVGTPYWMAP 196
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVL 658
           E   R     + D++S G+++ E++
Sbjct: 197 ELISRLPYGPEVDIWSLGIMVIEMV 221

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQTEITVLSK 513
           D ++  +NF K   IG G  G+V    +R + K VAVK+     +Q       E+ ++  
Sbjct: 26  DPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 82
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
            +H ++V +        E+ +V E++E G L   +     T ++ +Q   +C+   + L 
Sbjct: 83  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALS 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
            LH   A+G+IHRDIKS +ILL  +   K++DFG         E      + G+  ++ P
Sbjct: 140 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKXLVGTPYWMAP 194
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVL 658
           E   R     + D++S G+++ E++
Sbjct: 195 ELISRLPYGPEVDIWSLGIMVIEMV 219

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 460 TNNFDKNLI----IGSGGFGMVYKGVLRDNTKVAVKRGV---PGSRQGLPEFQTEITVLS 512
           T N  K  I    +GSG F  V+    R   K+   + +   P  R      + EI VL 
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVLK 61
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIG 567
           KI+H ++V+L    E  +   LV + +  G L     ++ +Y      L  +Q L     
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS---- 117
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGV 624
               + YLH     GI+HRD+K  N+L    +EN    + DFGLS+    +++  + +  
Sbjct: 118 ---AVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTA 167
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            G+ GY+ PE   ++  +   D +S GV+ + +LC
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 18/217 (8%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV-----PGSRQGLPEFQTEITVLSKIR 515
           ++F+K   +G+G  G+V+K   + +  V  ++ +     P  R    +   E+ VL +  
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN---QIIRELQVLHECN 89
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-EICIGAARGLHY 574
             ++V   G      E+ +  E+M+ G L + L    R P   +Q L ++ I   +GL Y
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVIKGLTY 146
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       I+HRD+K +NIL++     K+ DFG+  SG  +D   ++    G+  Y+ PE
Sbjct: 147 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDS--MANSFVGTRSYMSPE 200
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE 671
             +    + +SD++S G+ L E+   R  + P  A+E
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQTEITVLSK 513
           D ++  +NF K   IG G  G+V    +R + K VAVK+     +Q       E+ ++  
Sbjct: 21  DPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 77
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
            +H ++V +        E+ +V E++E G L   +     T ++ +Q   +C+   + L 
Sbjct: 78  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALS 134
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
            LH   A+G+IHRDIKS +ILL  +   K++DFG         E      + G+  ++ P
Sbjct: 135 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKXLVGTPYWMAP 189
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVL 658
           E   R     + D++S G+++ E++
Sbjct: 190 ELISRLPYGPEVDIWSLGIMVIEMV 214

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK+ H+++V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKLNHQNIV 97
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D    S   KG      
Sbjct: 158 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLP 209
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++ SG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 82  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK+ H+++V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKLNHQNIV 111
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D    S   KG      
Sbjct: 172 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLP 223
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 38/229 (16%)
Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTK------VAVK----RGVPGSRQGLPEFQTEITVL 511
           N +   ++GSG FG V        +K      VAVK    +     R+ L    +E+ ++
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL---MSELKMM 102
Query: 512 SKI-RHRHLVSLVGYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLE- 563
           +++  H ++V+L+G C     + L++EY   G L      K+  +  D      ++RLE 
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 564 ------------ICIG--AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS 609
                       +C     A+G+ +L   S    +HRD+ + N+L+    V K+ DFGL+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           R         V    +    ++ PE       T KSDV+S+G++L+E+ 
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 79  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFG ++     ++ + + G K    ++  E
Sbjct: 137 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELM 217

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFG ++     ++ + + G K    ++  E
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELM 215

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 18/219 (8%)
Query: 452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTE 507
           P   ++    +F  + ++G G FG V+    +   +     A+K+ V      +     E
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 508 ITVLS-KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
             VLS    H  L  +    + +  +  V EY+  G L  H+    +  LS         
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATF 122
Query: 567 GAAR---GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
            AA    GL +LH+   +GI++RD+K  NILLD++   K+ADFG+ +     D    +  
Sbjct: 123 YAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNX 177
Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
             G+  Y+ PE    Q+     D +SFGV+L+E+L  ++
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRH 518
            +F+    +G GGFG+V++   + D+   A+KR  +P       +   E+  L+K+ H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 519 LVSLV-GYCEEQSEMIL------VYEYME-----KGPLKKHLYGPDRTPLSWKQR---LE 563
           +V     + E+ +   L      VY Y++     K  LK  + G  R  +  ++R   L 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEERERSVCLH 122
Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--- 620
           I +  A  + +LH+   +G++HRD+K +NI    + V KV DFGL  +    +E      
Sbjct: 123 IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 621 -------STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
                   TG  G+  Y+ PE       + K D++S G++LFE+L
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQTEITVLSK 513
           D ++  +NF K   IG G  G+V    +R + K VAVK+     +Q       E+ ++  
Sbjct: 148 DPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 204
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
            +H ++V +        E+ +V E++E G L   +     T ++ +Q   +C+   + L 
Sbjct: 205 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALS 261
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
            LH   A+G+IHRDIKS +ILL  +   K++DFG         E      + G+  ++ P
Sbjct: 262 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAP 316
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVL 658
           E   R     + D++S G+++ E++
Sbjct: 317 ELISRLPYGPEVDIWSLGIMVIEMV 341

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVP-GSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG VYK   ++   +A  + +   S + L ++  EI +L+   H ++V L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
              ++ ++ E+   G +   +   DR  L+  Q   +C      L++LH+   + IIHRD
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHS---KRIIHRD 134
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD---- 643
           +K+ N+L+      ++ADFG+S     L          G+  ++ PE    + + D    
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 192
Query: 644 -KSDVYSFGVVLFEV 657
            K+D++S G+ L E+
Sbjct: 193 YKADIWSLGITLIEM 207

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQTEITVLSK 513
           D ++  +NF K   IG G  G+V    +R + K VAVK+     +Q       E+ ++  
Sbjct: 71  DPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 127
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
            +H ++V +        E+ +V E++E G L   +     T ++ +Q   +C+   + L 
Sbjct: 128 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALS 184
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
            LH   A+G+IHRDIKS +ILL  +   K++DFG         E      + G+  ++ P
Sbjct: 185 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAP 239
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVL 658
           E   R     + D++S G+++ E++
Sbjct: 240 ELISRLPYGPEVDIWSLGIMVIEMV 264

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFG ++     ++ + + G K    ++  E
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK  H+++V
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D    S   KG      
Sbjct: 157 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLP 208
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 12/195 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV-PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG VYK   ++ + +A  + +   S + L ++  EI +L+   H ++V L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            ++ + ++ E+   G +   +   +R PL+  Q   +C      L+YLH      IIHRD
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNK---IIHRD 160
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD---- 643
           +K+ NIL   +   K+ADFG+S                G+  ++ PE    +   D    
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNT--RXIQRRDXFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 644 -KSDVYSFGVVLFEV 657
            K+DV+S G+ L E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLPE-FQTEITVLSK 513
           NN      +G+G FG V +    G+ +++   KVAVK     +     E   +E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 514 I-RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR------------TPLSWKQ 560
           + +H ++V+L+G C     ++++ EY   G L   L    R            +  S + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV 620
            L      A+G+ +L   +++  IHRD+ + N+LL   +V+K+ DFGL+R         V
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
               +    ++ PE       T +SDV+S+G++L+E+ 
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++ SG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 82  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVP-GSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG VYK   ++   +A  + +   S + L ++  EI +L+   H ++V L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
              ++ ++ E+   G +   +   DR  L+  Q   +C      L++LH+   + IIHRD
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHS---KRIIHRD 142
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD---- 643
           +K+ N+L+      ++ADFG+S     L          G+  ++ PE    + + D    
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 200
Query: 644 -KSDVYSFGVVLFEV 657
            K+D++S G+ L E+
Sbjct: 201 YKADIWSLGITLIEM 215

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++ SG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK  H+++V
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D    S   KG      
Sbjct: 157 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLP 208
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK  H+++V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNIV 111
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D    S   KG      
Sbjct: 172 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLP 223
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFG ++     ++ + + G K    ++  E
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELM 215

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK  H+++V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D    S   KG      
Sbjct: 158 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLP 209
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 457 QTATNNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLS 512
           +   N+FD   ++G G FG V     K   R      +++ V  ++  +    TE  VL 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--AR 570
             RH  L +L    +    +  V EY   G L  HL   +R     + R     GA    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF---YGAEIVS 116
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
            L YLH+     +++RDIK  N++LD++   K+ DFGL + G  + +        G+  Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEY 171
Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 457 QTATNNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLS 512
           +   N+FD   ++G G FG V     K   R      +++ V  ++  +    TE  VL 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--AR 570
             RH  L +L    +    +  V EY   G L  HL   +R     + R     GA    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF---YGAEIVS 116
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
            L YLH+     +++RDIK  N++LD++   K+ DFGL + G  + +        G+  Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEY 171
Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 457 QTATNNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLS 512
           +   N+FD   ++G G FG V     K   R      +++ V  ++  +    TE  VL 
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--AR 570
             RH  L +L    +    +  V EY   G L  HL   +R     + R     GA    
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF---YGAEIVS 119
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
            L YLH+     +++RDIK  N++LD++   K+ DFGL + G  + +        G+  Y
Sbjct: 120 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEY 174
Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           L PE           D +  GVV++E++C R
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 457 QTATNNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLS 512
           +   N+FD   ++G G FG V     K   R      +++ V  ++  +    TE  VL 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--AR 570
             RH  L +L    +    +  V EY   G L  HL   +R     + R     GA    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF---YGAEIVS 116
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
            L YLH+     +++RDIK  N++LD++   K+ DFGL + G  + +        G+  Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEY 171
Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 82  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFG ++     ++ + + G K    ++  E
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL-----PEFQTEITVLSKI 514
             F K  ++GSG FG VYKG+ + +  KV +   +   R+        E   E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            + H+  L+G C   S + L+ + M  G L  ++    +  +  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       ++HRD+ + N+L+      K+ DFG ++     ++ + + G K    ++  E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +  T +SDV+S+GV ++E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 457 QTATNNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLS 512
           +   N+FD   ++G G FG V     K   R      +++ V  ++  +    TE  VL 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--AR 570
             RH  L +L    +    +  V EY   G L  HL   +R     + R     GA    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF---YGAEIVS 116
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
            L YLH+     +++RDIK  N++LD++   K+ DFGL + G  + +        G+  Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEY 171
Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK  H+++V
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNIV 88
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D    S   KG      
Sbjct: 149 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLP 200
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 201 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 231

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK  H+++V
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNIV 113
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D    S   KG      
Sbjct: 174 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLP 225
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 226 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 256

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV-----PGSRQGLPEFQTEITVLSKIR 515
           ++F+K   +G+G  G+V+K   + +  V  ++ +     P  R    +   E+ VL +  
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN---QIIRELQVLHECN 65
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-EICIGAARGLHY 574
             ++V   G      E+ +  E+M+ G L + L    R P   +Q L ++ I   +GL Y
Sbjct: 66  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVIKGLTY 122
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       I+HRD+K +NIL++     K+ DFG+  SG  +DE  ++    G+  Y+ PE
Sbjct: 123 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDE--MANEFVGTRSYMSPE 176
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL 667
             +    + +SD++S G+ L E+   R    P+
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 457 QTATNNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLS 512
           +   N+FD   ++G G FG V     K   R      +++ V  ++  +    TE  VL 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--AR 570
             RH  L +L    +    +  V EY   G L  HL   +R     + R     GA    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF---YGAEIVS 116
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
            L YLH+     +++RDIK  N++LD++   K+ DFGL + G  + +        G+  Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEY 171
Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK  H+++V
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNIV 103
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D    S   KG      
Sbjct: 164 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLP 215
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 216 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 246

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 16/216 (7%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV-----PGSRQGLPEFQTEITVLSKIR 515
           ++F++   +G+G  G+V K   R +  +  ++ +     P  R    +   E+ VL +  
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRN---QIIRELQVLHECN 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
             ++V   G      E+ +  E+M+ G L + L    R P     ++ I +   RGL YL
Sbjct: 73  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYL 130
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
                  I+HRD+K +NIL++     K+ DFG+  SG  +D   ++    G+  Y+ PE 
Sbjct: 131 R--EKHQIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDS--MANSFVGTRSYMAPER 184
Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE 671
            +    + +SD++S G+ L E+   R  + P  A+E
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKE 220

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK  H+++V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVYSEQDELDFLMEALIISKFNHQNIV 111
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D    S   KG      
Sbjct: 172 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLP 223
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK  H+++V
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNIV 123
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D    S   KG      
Sbjct: 184 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLP 235
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 236 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 266

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSK--IRHRHLVSLVGY 525
           I   G FG V+K  L  N  VAVK      +Q    +Q+E  + S   ++H +L+  +  
Sbjct: 22  IKARGRFGCVWKAQLM-NDFVAVKIFPLQDKQS---WQSEREIFSTPGMKHENLLQFIAA 77
Query: 526 CEEQS----EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT---- 577
            +  S    E+ L+  + +KG L  +L G     ++W +   +    +RGL YLH     
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLKG---NIITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 578 ----GSAEGIIHRDIKSTNILLDENYVSKVADFGLS---RSGPCLDETHVSTGVKGSFGY 630
               G    I HRD KS N+LL  +  + +ADFGL+     G    +TH   G  G+  Y
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTH---GQVGTRRY 191
Query: 631 LDPEY------FRRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
           + PE       F+R     + D+Y+ G+VL+E++    A D
Sbjct: 192 MAPEVLEGAINFQRDAFL-RIDMYAMGLVLWELVSRCKAAD 231

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 12/192 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTK--VAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IG G FG VYKG+  ++TK  VA+K   +  +   + + Q EITVLS+    ++    G 
Sbjct: 27  IGKGSFGEVYKGI-DNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
             + +++ ++ EY+  G     L  P   PL       I     +GL YLH+   E  IH
Sbjct: 86  YLKSTKLWIIMEYLGGGS-ALDLLKPG--PLEETYIATILREILKGLDYLHS---ERKIH 139
Query: 586 RDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS 645
           RDIK+ N+LL E    K+ADFG+  +G   D         G+  ++ PE  ++     K+
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKA 197
Query: 646 DVYSFGVVLFEV 657
           D++S G+   E+
Sbjct: 198 DIWSLGITAIEL 209

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +F +  +IGSGGFG V+K   R + K  V + V  + +   + + E+  L+K+ H ++V 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKLDHVNIVH 68
Query: 522 LVG------YCEEQSE----------MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEIC 565
             G      Y  E S           + +  E+ +KG L++ +       L     LE+ 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK 625
               +G+ Y+H   ++ +I+RD+K +NI L +    K+ DFGL  S   L         K
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRXRSK 182
Query: 626 GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           G+  Y+ PE    Q    + D+Y+ G++L E+L
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQT 506
           + +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + 
Sbjct: 1   MAVPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK 54
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           EI +   + H ++V   G+  E +   L  EY   G L   +      P    QR    +
Sbjct: 55  EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
            A  G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G
Sbjct: 115 MA--GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 169
Query: 627 SFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
           +  Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQT 506
           + +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + 
Sbjct: 1   MAVPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK 54
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           EI +   + H ++V   G+  E +   L  EY   G L   +      P    QR    +
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
            A  G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G
Sbjct: 115 MA--GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 627 SFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
           +  Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 14/220 (6%)
Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQT 506
           + +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + 
Sbjct: 1   MAVPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK 54
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           EI + + + H ++V   G+  E +   L  EY   G L   +      P    QR    +
Sbjct: 55  EICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
            A  G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G
Sbjct: 115 MA--GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 627 SFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
           +  Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 14/218 (6%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEI 508
           +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + EI
Sbjct: 2   VPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 55
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +      P    QR    + A
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 116 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
            Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 15/226 (6%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLS 512
           +   +NF+   ++G G FG V    +++   +     +K+ V      +    TE  +LS
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 513 KIR-HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARG 571
             R H  L  L    +    +  V E++  G L  H+    R   +  +     I +A  
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA-- 136
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L +LH    +GII+RD+K  N+LLD     K+ADFG+ + G C   T  +    G+  Y+
Sbjct: 137 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYI 191
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
            PE  +        D ++ GV+L+E+LC      P  A  + +L E
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHA---PFEAENEDDLFE 234

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIR-HRHLVSLVG 524
           +G G +G+V+K + R   +V   + +  + Q   + Q    EI +L+++  H ++V+L+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 525 Y--CEEQSEMILVYEYME---KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
               +   ++ LV++YME      ++ ++  P        Q +++       + YLH+G 
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKV-------IKYLHSG- 128
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL-------------------DETHV 620
             G++HRD+K +NILL+     KVADFGLSRS   +                   D+  +
Sbjct: 129 --GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 621 STGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVLCAR 661
            T    +  Y  PE      + T   D++S G +L E+LC +
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 14/218 (6%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEI 508
           +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + EI
Sbjct: 2   VPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 55
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +      P    QR    + A
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 116 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
            Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 14/218 (6%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEI 508
           +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + EI
Sbjct: 2   VPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 55
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +      P    QR    + A
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 116 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
            Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 14/218 (6%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEI 508
           +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + EI
Sbjct: 2   VPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 55
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +      P    QR    + A
Sbjct: 56  XINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 116 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
            Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 15/217 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF--QTEITVLSKIRHRHLVSLVGYC 526
           +GSG FG+V++ V +   +V V + +  +   L ++  + EI++++++ H  L++L    
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
           E++ EM+L+ E++  G L   +   D   +S  + +     A  GL ++H  S   I+H 
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHS---IVHL 173
Query: 587 DIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDK 644
           DIK  NI+ +    S  K+ DFGL+     L+   +      +  +  PE   R+ +   
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDREPVGFY 230
Query: 645 SDVYSFGV---VLFEVLCARTAVDPLLAREQVNLAEW 678
           +D+++ GV   VL   L      D L   + V   +W
Sbjct: 231 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 461 NNFDKNLIIGSGGFGMVY--KGVLRDNT-----KVAVKRGVPGSRQGLPEFQTEITVLSK 513
           ++F+   ++G G FG V+  + V R ++        +K+     R  +   + E  +L+ 
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRV-RTKMERDILAD 86
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA-ARGL 572
           + H  +V L    + + ++ L+ +++  G L   L    +  +  ++ ++  +   A GL
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALGL 143
Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLD 632
            +LH+    GII+RD+K  NILLDE    K+ DFGLS+    +D    +    G+  Y+ 
Sbjct: 144 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--AIDHEKKAYSFCGTVEYMA 198
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
           PE   RQ  +  +D +S+GV++FE+L  
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 14/218 (6%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEI 508
           +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + EI
Sbjct: 2   VPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 55
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +      P    QR    + A
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 116 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
            Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 469 IGSGGFGMVYKGVLRDNT--KVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG V K      T  KVA+K   + V          + EI+ L  +RH H++ L 
Sbjct: 21  LGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 79
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
              + + E+I+V EY          Y   R  +S ++           + Y H      I
Sbjct: 80  DVIKSKDEIIMVIEYAGNELFD---YIVQRDKMSEQEARRFFQQIISAVEYCHR---HKI 133
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           +HRD+K  N+LLDE+   K+ADFGLS      D   + T   GS  Y  PE    +    
Sbjct: 134 VHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEVISGKLYAG 190
Query: 644 -KSDVYSFGVVLFEVLCARTAVD 665
            + DV+S GV+L+ +LC R   D
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQT 506
           + +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + 
Sbjct: 1   MAVPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK 54
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           EI +   + H ++V   G+  E +   L  EY   G L   +      P    QR    +
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
            A  G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G
Sbjct: 115 MA--GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 627 SFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
           +  Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQT 506
           + +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + 
Sbjct: 1   MAVPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK 54
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           EI +   + H ++V   G+  E +   L  EY   G L   +      P    QR    +
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
            A  G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G
Sbjct: 115 MA--GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 627 SFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
           +  Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 469 IGSGGFGMVYKGVLRDNT--KVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG V K      T  KVA+K   + V          + EI+ L  +RH H++ L 
Sbjct: 22  LGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 80
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
              + + E+I+V EY          Y   R  +S ++           + Y H      I
Sbjct: 81  DVIKSKDEIIMVIEYAGNELFD---YIVQRDKMSEQEARRFFQQIISAVEYCHR---HKI 134
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           +HRD+K  N+LLDE+   K+ADFGLS      D   + T   GS  Y  PE    +    
Sbjct: 135 VHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEVISGKLYAG 191
Query: 644 -KSDVYSFGVVLFEVLCARTAVD 665
            + DV+S GV+L+ +LC R   D
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPFD 214

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQT 506
           + +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + 
Sbjct: 1   MAVPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK 54
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           EI +   + H ++V   G+  E +   L  EY   G L   +      P    QR    +
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
            A  G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G
Sbjct: 115 MA--GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 627 SFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
           +  Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQT 506
           + +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + 
Sbjct: 1   MAVPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK 54
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           EI +   + H ++V   G+  E +   L  EY   G L   +      P    QR    +
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
            A  G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G
Sbjct: 115 MA--GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 627 SFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
           +  Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQT 506
           + +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + 
Sbjct: 1   MAVPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK 54
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           EI +   + H ++V   G+  E +   L  EY   G L   +      P    QR    +
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
            A  G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G
Sbjct: 115 MA--GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 627 SFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
           +  Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 104/253 (41%), Gaps = 30/253 (11%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITV 510
           D +   N F+   ++G G FG V     K   R      +K+ V  ++  +    TE  V
Sbjct: 4   DPRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 63
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEIC 565
           L   RH  L +L    +    +  V EY   G L  HL     +  DR      +     
Sbjct: 64  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE----- 118
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK 625
                 L YLH  S + +++RD+K  N++LD++   K+ DFGL + G  + +        
Sbjct: 119 --IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKXFC 172
Query: 626 GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK 685
           G+  YL PE           D +  GVV++E++C R    P   ++   L E        
Sbjct: 173 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL---PFYNQDHEKLFELI------ 223
Query: 686 GMLEHIIDPQLIG 698
            ++E I  P+ +G
Sbjct: 224 -LMEEIRFPRTLG 235

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD---NTKVAVKRGVPGSRQGLPE-----FQT 506
           D+++    ++K   +G G F  VYK   RD   N  VA+K+   G R    +        
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           EI +L ++ H +++ L+     +S + LV+++ME     + +   +   L+        +
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYML 119
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
              +GL YLH      I+HRD+K  N+LLDEN V K+ADFGL++S    +  +    V  
Sbjct: 120 MTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVT- 175
Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
                   ++R  +L   + +Y  GV ++ V C
Sbjct: 176 -------RWYRAPELLFGARMYGVGVDMWAVGC 201

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK  H+++V
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D        KG      
Sbjct: 198 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLP 249
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 469 IGSGGFGMVYKGVLRDNT--KVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG V K      T  KVA+K   + V          + EI+ L  +RH H++ L 
Sbjct: 12  LGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 70
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
              + + E+I+V EY          Y   R  +S ++           + Y H      I
Sbjct: 71  DVIKSKDEIIMVIEYAGNELFD---YIVQRDKMSEQEARRFFQQIISAVEYCHR---HKI 124
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           +HRD+K  N+LLDE+   K+ADFGLS      D   + T   GS  Y  PE    +    
Sbjct: 125 VHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEVISGKLYAG 181
Query: 644 -KSDVYSFGVVLFEVLCARTAVD 665
            + DV+S GV+L+ +LC R   D
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPFD 204

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK  H+++V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG+++     D    S   KG      
Sbjct: 158 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ-----DIYRASYYRKGGCAMLP 209
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 469 IGSGGFGMVYKGVLRDNT--KVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G FG V K      T  KVA+K   + V          + EI+ L  +RH H++ L 
Sbjct: 16  LGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 74
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
              + + E+I+V EY          Y   R  +S ++           + Y H      I
Sbjct: 75  DVIKSKDEIIMVIEYAGNELFD---YIVQRDKMSEQEARRFFQQIISAVEYCHR---HKI 128
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           +HRD+K  N+LLDE+   K+ADFGLS      D   + T   GS  Y  PE    +    
Sbjct: 129 VHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEVISGKLYAG 185
Query: 644 -KSDVYSFGVVLFEVLCARTAVD 665
            + DV+S GV+L+ +LC R   D
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 30/211 (14%)
Query: 469 IGSGGFGMVYKGVLR------DNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G FG VY+G +          +VAVK  +P   S Q   +F  E  ++SK  H+++V
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNIV 114
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-----LSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L      P     L+    L +    A G  YL
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG--- 629
                   IHRDI + N LL       V+K+ DFG++R     D        KG      
Sbjct: 175 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLP 226
Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE F     T K+D +SFGV+L+E+ 
Sbjct: 227 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 257

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 14/218 (6%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEI 508
           +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + EI
Sbjct: 2   VPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 55
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +      P    QR    + A
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 116 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
            Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 14/218 (6%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEI 508
           +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + EI
Sbjct: 2   VPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 55
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +      P    QR    + A
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 116 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
            Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 14/218 (6%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEI 508
           +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + EI
Sbjct: 2   VPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 55
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +      P    QR    + A
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 116 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
            Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 14/218 (6%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEI 508
           +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + EI
Sbjct: 2   VPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 55
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +      P    QR    + A
Sbjct: 56  XINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 116 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
            Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 14/218 (6%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEI 508
           +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + EI
Sbjct: 2   VPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 55
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +      P    QR    + A
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 116 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
            Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 14/218 (6%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEI 508
           +PF +      ++D    +G G +G V   V R   +    + V   R    PE  + EI
Sbjct: 2   VPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 55
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +      P    QR    + A
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 116 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
            Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL-- 522
           IG G +GMV   Y  V  +  +VA+K+  P   Q   +    EI +L + RH +++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 523 ---VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTG 578
                  E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFR 637
           +   ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE   
Sbjct: 144 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCAR 661
             +   KS D++S G +L E+L  R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 23/228 (10%)
Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDN----TKVAVK--RGVPGSRQGLP 502
           LK    D+      F    ++G G FG V +  L+       KVAVK  +    +   + 
Sbjct: 11  LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEM------ILVYEYMEKGPLKKHLYG------ 550
           EF  E   + +  H H+  LVG              +++  +M+ G L   L        
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 551 PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR 610
           P   PL    R  + I  A G+ YL   S+   IHRD+ + N +L E+    VADFGLSR
Sbjct: 131 PFNLPLQTLVRFMVDI--ACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
                D        K    +L  E       T  SDV++FGV ++E++
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 20/214 (9%)
Query: 457 QTATNNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLS 512
           +   N F+   ++G G FG V     K   R      +K+ V  ++  +    TE  VL 
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIG 567
             RH  L +L    +    +  V EY   G L  HL     +  DR      +       
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------- 256
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS 627
               L YLH  S + +++RD+K  N++LD++   K+ DFGL + G  + +        G+
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGT 312
Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
             YL PE           D +  GVV++E++C R
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL-- 522
           IG G +GMV   Y  V  +  +VA+K+  P   Q   +    EI +L + RH +++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 523 ---VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTG 578
                  E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFR 637
           +   ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE   
Sbjct: 144 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCAR 661
             +   KS D++S G +L E+L  R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 103/251 (41%), Gaps = 30/251 (11%)
Query: 457 QTATNNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLS 512
           +   N F+   ++G G FG V     K   R      +K+ V  ++  +    TE  VL 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIG 567
             RH  L +L    +    +  V EY   G L  HL     +  DR      +       
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------- 116
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS 627
               L YLH  S + +++RD+K  N++LD++   K+ DFGL + G  + +        G+
Sbjct: 117 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKXFCGT 172
Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM 687
             YL PE           D +  GVV++E++C R    P   ++   L E         +
Sbjct: 173 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL---PFYNQDHEKLFELI-------L 222
Query: 688 LEHIIDPQLIG 698
           +E I  P+ +G
Sbjct: 223 MEEIRFPRTLG 233

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 103/251 (41%), Gaps = 30/251 (11%)
Query: 457 QTATNNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLS 512
           +   N F+   ++G G FG V     K   R      +K+ V  ++  +    TE  VL 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIG 567
             RH  L +L    +    +  V EY   G L  HL     +  DR      +       
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------- 117
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS 627
               L YLH  S + +++RD+K  N++LD++   K+ DFGL + G  + +        G+
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKXFCGT 173
Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM 687
             YL PE           D +  GVV++E++C R    P   ++   L E         +
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL---PFYNQDHEKLFELI-------L 223
Query: 688 LEHIIDPQLIG 698
           +E I  P+ +G
Sbjct: 224 MEEIRFPRTLG 234

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 8/209 (3%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEITVLSKIRHR 517
             ++D    +G G +G V   V R   +    + V   R    PE  + EI +   + H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V   G+  E +   L  EY   G L   +      P    QR    + A  G+ YLH 
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH- 120
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+  Y+ PE  +
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 638 RQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
           R++   +  DV+S G+VL  +L      D
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 20/214 (9%)
Query: 457 QTATNNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLS 512
           +   N F+   ++G G FG V     K   R      +K+ V  ++  +    TE  VL 
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIG 567
             RH  L +L    +    +  V EY   G L  HL     +  DR      +       
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------- 259
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS 627
               L YLH  S + +++RD+K  N++LD++   K+ DFGL + G  + +        G+
Sbjct: 260 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGT 315
Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
             YL PE           D +  GVV++E++C R
Sbjct: 316 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL-- 522
           IG G +GMV   Y  V  +  +VA+K+  P   Q   +    EI +L + RH +++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 523 ---VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTG 578
                  E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFR 637
           +   ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE   
Sbjct: 144 N---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCAR 661
             +   KS D++S G +L E+L  R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL-- 522
           IG G +GMV   Y  V  +  +VA+K+  P   Q   +    EI +L + RH +++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 523 ---VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTG 578
                  E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFR 637
           +   ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE   
Sbjct: 144 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCAR 661
             +   KS D++S G +L E+L  R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF-QTEITVLSKIRHRHLVSLVGYCE 527
           IG G FG V++G  R   +VAVK  +  SR+    F + EI     +RH +++  +    
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 528 EQ----SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH-----TG 578
           +     +++ LV +Y E G L  +L   +R  ++ +  +++ +  A GL +LH     T 
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLS-RSGPCLDETHVSTGVK-GSFGYLDPEYF 636
               I HRD+KS NIL+ +N    +AD GL+ R     D   ++   + G+  Y+ PE  
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 637 ------RRQQLTDKSDVYSFGVVLFEV 657
                 +  +   ++D+Y+ G+V +E+
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL- 522
           +G G FG   +     L DNT   VAVK+          +FQ EI +L  +    +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
            V Y   + E+ LV EY+  G L+  L    R  L   + L       +G+ YL    + 
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL---GSR 130
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--STGVKGSFGYLDPEYFRRQ 639
             +HRD+ + NIL++     K+ADFGL++  P   +  V    G    F Y  PE     
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYA-PESLSDN 189
Query: 640 QLTDKSDVYSFGVVLFEVL 658
             + +SDV+SFGVVL+E+ 
Sbjct: 190 IFSRQSDVWSFGVVLYELF 208

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYC 526
           +I +  FG+      R      +K G   S        +E+ +L  I  H ++V+L+G C
Sbjct: 44  VIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGAC 101
Query: 527 EEQS-EMILVYEYMEKGPLKKHL------YGPDRTP-------LSWKQRLEICIGAARGL 572
            +    ++++ E+ + G L  +L      + P +TP       L+ +  +      A+G+
Sbjct: 102 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGM 161
Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGSFGYL 631
            +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D   V  G  +    ++
Sbjct: 162 EFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX-KDPDXVRKGDARLPLKWM 217
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 218 APETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF-QTEITVLSKIRHRHLVSLVGYCE 527
           IG G FG V++G  R   +VAVK  +  SR+    F + EI     +RH +++  +    
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 68
Query: 528 EQ----SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH-----TG 578
           +     +++ LV +Y E G L  +L   +R  ++ +  +++ +  A GL +LH     T 
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLS-RSGPCLDETHVSTGVK-GSFGYLDPEYF 636
               I HRD+KS NIL+ +N    +AD GL+ R     D   ++   + G+  Y+ PE  
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 637 ------RRQQLTDKSDVYSFGVVLFEV 657
                 +  +   ++D+Y+ G+V +E+
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL---- 522
           IG G +GMV       N  +VA+K+  P   Q   +    EI +L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTGSA 580
                E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ + 
Sbjct: 95  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 148
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE     
Sbjct: 149 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 640 QLTDKS-DVYSFGVVLFEVLCAR 661
           +   KS D++S G +L E+L  R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF-QTEITVLSKIRHRHLVSLVGYCE 527
           IG G FG V++G  R   +VAVK  +  SR+    F + EI     +RH +++  +    
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 93
Query: 528 EQ----SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH-----TG 578
           +     +++ LV +Y E G L  +L   +R  ++ +  +++ +  A GL +LH     T 
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLS-RSGPCLDETHVSTGVK-GSFGYLDPEYF 636
               I HRD+KS NIL+ +N    +AD GL+ R     D   ++   + G+  Y+ PE  
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 210
Query: 637 ------RRQQLTDKSDVYSFGVVLFEV 657
                 +  +   ++D+Y+ G+V +E+
Sbjct: 211 DDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL-- 522
           IG G +GMV   Y  V  +  +VA+K+  P   Q   +    EI +L + RH +++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 523 ---VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTG 578
                  E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFR 637
           +   ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE   
Sbjct: 146 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCAR 661
             +   KS D++S G +L E+L  R
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL-- 522
           IG G +GMV   Y  V  +  +VA+K+  P   Q   +    EI +L + RH +++ +  
Sbjct: 39  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 523 ---VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTG 578
                  E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ 
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 151
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFR 637
           +   ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE   
Sbjct: 152 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCAR 661
             +   KS D++S G +L E+L  R
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL-- 522
           IG G +GMV   Y  V  +  +VA+K+  P   Q   +    EI +L + RH +++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 523 ---VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTG 578
                  E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFR 637
           +   ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE   
Sbjct: 144 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCAR 661
             +   KS D++S G +L E+L  R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF-QTEITVLSKIRHRHLVSLVGYCE 527
           IG G FG V++G  R   +VAVK  +  SR+    F + EI     +RH +++  +    
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 528 EQ----SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH-----TG 578
           +     +++ LV +Y E G L  +L   +R  ++ +  +++ +  A GL +LH     T 
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLS-RSGPCLDETHVSTGVK-GSFGYLDPEYF 636
               I HRD+KS NIL+ +N    +AD GL+ R     D   ++   + G+  Y+ PE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 637 ------RRQQLTDKSDVYSFGVVLFEV 657
                 +  +   ++D+Y+ G+V +E+
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF-QTEITVLSKIRHRHLVSLVGYCE 527
           IG G FG V++G  R   +VAVK  +  SR+    F + EI     +RH +++  +    
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 73
Query: 528 EQ----SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH-----TG 578
           +     +++ LV +Y E G L  +L   +R  ++ +  +++ +  A GL +LH     T 
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLS-RSGPCLDETHVSTGVK-GSFGYLDPEYF 636
               I HRD+KS NIL+ +N    +AD GL+ R     D   ++   + G+  Y+ PE  
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 637 ------RRQQLTDKSDVYSFGVVLFEV 657
                 +  +   ++D+Y+ G+V +E+
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF-QTEITVLSKIRHRHLVSLVGYCE 527
           IG G FG V++G  R   +VAVK  +  SR+    F + EI     +RH +++  +    
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 70
Query: 528 EQ----SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH-----TG 578
           +     +++ LV +Y E G L  +L   +R  ++ +  +++ +  A GL +LH     T 
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLS-RSGPCLDETHVSTGVK-GSFGYLDPEYF 636
               I HRD+KS NIL+ +N    +AD GL+ R     D   ++   + G+  Y+ PE  
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 637 ------RRQQLTDKSDVYSFGVVLFEV 657
                 +  +   ++D+Y+ G+V +E+
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL---- 522
           IG G +GMV       N  +VA+K+  P   Q   +    EI +L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTGSA 580
                E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ + 
Sbjct: 95  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 148
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE     
Sbjct: 149 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 640 QLTDKS-DVYSFGVVLFEVLCAR 661
           +   KS D++S G +L E+L  R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL-- 522
           IG G +GMV   Y  V  +  +VA+K+  P   Q   +    EI +L + RH +++ +  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 523 ---VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTG 578
                  E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ 
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFR 637
           +   ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE   
Sbjct: 164 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCAR 661
             +   KS D++S G +L E+L  R
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPE--FQTEITVLSKIRHRHLV 520
           F+    +G+G F  V     +   K+   + +P       E   + EI VL KI+H ++V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 521 SLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           +L    E  + + LV + +  G L     +K  Y         +Q L+        ++YL
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD-------AVYYL 136
Query: 576 HTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLD 632
           H     GI+HRD+K  N+L    DE     ++DFGLS+     D   V +   G+ GY+ 
Sbjct: 137 HRM---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPGYVA 190
Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           PE   ++  +   D +S GV+ + +LC
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAYILLC 217

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 469 IGSGGFGMVYKGVLR-DNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           +G G FG V  G       KVAVK   R    S   + + + EI  L   RH H++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
                S++ +V EY+  G L  ++    R  L  K+   +      G+ Y H      ++
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHR---HMVV 138
Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR-RQQLTD 643
           HRD+K  N+LLD +  +K+ADFGLS     + +        GS  Y  PE    R     
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSN---MMSDGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 644 KSDVYSFGVVLFEVLCARTAVD 665
           + D++S GV+L+ +LC     D
Sbjct: 196 EVDIWSSGVILYALLCGTLPFD 217

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL---- 522
           IG G +GMV       N  +VA+K+  P   Q   +    EI +L + RH +++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTGSA 580
                E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ + 
Sbjct: 89  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 142
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE     
Sbjct: 143 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 640 QLTDKS-DVYSFGVVLFEVLCAR 661
           +   KS D++S G +L E+L  R
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV-----PGSRQGLPEFQTEITVLSKIR 515
           ++F+K   +G+G  G+V+K   + +  V  ++ +     P  R    +   E+ VL +  
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN---QIIRELQVLHECN 81
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-EICIGAARGLHY 574
             ++V   G      E+ +  E+M+ G L + L    R P   +Q L ++ I   +GL Y
Sbjct: 82  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVIKGLTY 138
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L       I+HRD+K +NIL++     K+ DFG+  SG  +D   ++    G+  Y+ PE
Sbjct: 139 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDS--MANSFVGTRSYMSPE 192
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCARTAV 664
             +    + +SD++S G+ L E+   R  +
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL---- 522
           IG G +GMV       N  +VA+K+  P   Q   +    EI +L + RH +++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTGSA 580
                E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ + 
Sbjct: 89  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 142
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE     
Sbjct: 143 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 640 QLTDKS-DVYSFGVVLFEVLCAR 661
           +   KS D++S G +L E+L  R
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL---- 522
           IG G +GMV       N  +VA+K+  P   Q   +    EI +L + RH +++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTGSA 580
                E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ + 
Sbjct: 96  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 149
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE     
Sbjct: 150 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 207
Query: 640 QLTDKS-DVYSFGVVLFEVLCAR 661
           +   KS D++S G +L E+L  R
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL---- 522
           IG G +GMV       N  +VA+K+  P   Q   +    EI +L + RH +++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTGSA 580
                E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ + 
Sbjct: 97  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 150
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE     
Sbjct: 151 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 208
Query: 640 QLTDKS-DVYSFGVVLFEVLCAR 661
           +   KS D++S G +L E+L  R
Sbjct: 209 KGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL---- 522
           IG G +GMV       N  +VA+K+  P   Q   +    EI +L + RH +++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTGSA 580
                E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ + 
Sbjct: 88  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 141
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE     
Sbjct: 142 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 199
Query: 640 QLTDKS-DVYSFGVVLFEVLCAR 661
           +   KS D++S G +L E+L  R
Sbjct: 200 KGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL---- 522
           IG G +GMV       N  +VA+K+  P   Q   +    EI +L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTGSA 580
                E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ + 
Sbjct: 95  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 148
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE     
Sbjct: 149 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 640 QLTDKS-DVYSFGVVLFEVLCAR 661
           +   KS D++S G +L E+L  R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL- 522
           +G G FG   +     L DNT   VAVK+          +FQ EI +L  +    +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
            V Y   +  + LV EY+  G L+  L    R  L   + L       +G+ YL    + 
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL---GSR 133
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--STGVKGSFGYLDPEYFRRQ 639
             +HRD+ + NIL++     K+ADFGL++  P   + +V    G    F Y  PE     
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA-PESLSDN 192
Query: 640 QLTDKSDVYSFGVVLFEVL 658
             + +SDV+SFGVVL+E+ 
Sbjct: 193 IFSRQSDVWSFGVVLYELF 211

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPE-FQTEIT 509
           D +      +    IG G FG V++G+          VA+K     +   + E F  E  
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
            + +  H H+V L+G   E    I++ E    G L+  L    +  L     +      +
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL-QVRKFSLDLASLILYAYQLS 121
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF- 628
             L YL +   +  +HRDI + N+L+  N   K+ DFGLSR    ++++      KG   
Sbjct: 122 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTXXKASKGKLP 175
Query: 629 -GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           NF K   IG G  G+V     +   K VAVK+     +Q       E+ ++    H ++V
Sbjct: 49  NFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVV 105
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            +        E+ +V E++E G L   +     T ++ +Q   +C+   R L YLH    
Sbjct: 106 DMYSSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHN--- 159
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           +G+IHRDIKS +ILL  +   K++DFG         E      + G+  ++ PE   R  
Sbjct: 160 QGVIHRDIKSDSILLTSDGRIKLSDFGF--CAQVSKEVPKRKXLVGTPYWMAPEVISRLP 217
Query: 641 LTDKSDVYSFGVVLFEVL 658
              + D++S G+++ E++
Sbjct: 218 YGTEVDIWSLGIMVIEMI 235

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 14/218 (6%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-GLPE-FQTEI 508
           +PF +      ++D    +G G  G V   V R   +    + V   R    PE  + EI
Sbjct: 2   VPFVE------DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 55
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +      P    QR    + A
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 116 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVD 665
            Y+ PE  +R++   +  DV+S G+VL  +L      D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL-- 522
           IG G +GMV   Y  V  +  +VA+K+  P   Q   +    EI +L   RH +++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 523 ---VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTG 578
                  E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFR 637
           +   ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE   
Sbjct: 146 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCAR 661
             +   KS D++S G +L E+L  R
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL-- 522
           IG G +GMV   Y  V  +  +VA+K+  P   Q   +    EI +L   RH +++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 523 ---VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTG 578
                  E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFR 637
           +   ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE   
Sbjct: 146 N---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCAR 661
             +   KS D++S G +L E+L  R
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 124/285 (43%), Gaps = 67/285 (23%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG----LP---EFQTEITVLSKIR--HR 517
           ++GSGGFG VY G+ + DN  VA+K  V   R      LP       E+ +L K+     
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 73
Query: 518 HLVSLVGYCEEQSEMILVYEYME-----------KGPLKKHLYGPDRTPLSWKQRLEICI 566
            ++ L+ + E     +L+ E ME           +G L++ L         W+      +
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEEL----ARSFFWQ-----VL 124
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVK 625
            A R  H        G++HRDIK  NIL+D N    K+ DFG   SG  L +T V T   
Sbjct: 125 EAVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFD 174
Query: 626 GSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCARTAV--DPLLAREQV--------- 673
           G+  Y  PE+ R  +   +S  V+S G++L++++C       D  + R QV         
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 234
Query: 674 --NLAEWAM-----------QWQKKGMLEHIIDPQLIGKINLDSL 705
             +L  W +           + Q    ++ ++ PQ   +I+L SL
Sbjct: 235 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 279

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL- 522
           +G G FG   +     L DNT   VAVK+          +FQ EI +L  +    +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
            V Y   +  + LV EY+  G L+  L    R  L   + L       +G+ YL    + 
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL---GSR 146
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--STGVKGSFGYLDPEYFRRQ 639
             +HRD+ + NIL++     K+ADFGL++  P   + +V    G    F Y  PE     
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA-PESLSDN 205
Query: 640 QLTDKSDVYSFGVVLFEVL 658
             + +SDV+SFGVVL+E+ 
Sbjct: 206 IFSRQSDVWSFGVVLYELF 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 469 IGSGGFG---MVYKGVLRDNTK--VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL- 522
           +G G FG   +     L DNT   VAVK+          +FQ EI +L  +    +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
            V Y   +  + LV EY+  G L+  L    R  L   + L       +G+ YL    + 
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL---GSR 134
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--STGVKGSFGYLDPEYFRRQ 639
             +HRD+ + NIL++     K+ADFGL++  P   + +V    G    F Y  PE     
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA-PESLSDN 193
Query: 640 QLTDKSDVYSFGVVLFEVL 658
             + +SDV+SFGVVL+E+ 
Sbjct: 194 IFSRQSDVWSFGVVLYELF 212

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 93/183 (50%), Gaps = 27/183 (14%)
Query: 484 DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGP 543
           +N K+++K           +F+ E+ +++ I++ + ++  G      E+ ++YEYME   
Sbjct: 77  NNDKISIK-------SKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS 129
Query: 544 LKK---HLYGPDRTPLSWK--QRLEICIGAA-RGLHYLHTGSAEGIIHRDIKSTNILLDE 597
           + K   + +  D+    +   Q ++  I +      Y+H  + + I HRD+K +NIL+D+
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDK 187
Query: 598 NYVSKVADFGLSRSGPCLDETHVSTGVKGSFG---YLDPEYFRRQQLTD--KSDVYSFGV 652
           N   K++DFG S       E  V   +KGS G   ++ PE+F  +   +  K D++S G+
Sbjct: 188 NGRVKLSDFGES-------EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240
Query: 653 VLF 655
            L+
Sbjct: 241 CLY 243

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLV 520
           +D   ++G+G F  V     +   K VA+K     + +G     + EI VL KI+H ++V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
           +L    E    + L+ + +  G L   +   ++   + +    +       + YLH    
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHD--- 134
Query: 581 EGIIHRDIKSTNIL---LDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
            GI+HRD+K  N+L   LDE+    ++DFGLS+     D   V +   G+ GY+ PE   
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLA 191
Query: 638 RQQLTDKSDVYSFGVVLFEVLCA 660
           ++  +   D +S GV+ + +LC 
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP--EFQTEITVLSKIRHRHLVSLVGYC 526
           +GSG FG V+    R +    V + +   R  +P  + + EI VL  + H +++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDR--TPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
           E+   M +V E  E G L + +         LS     E+       L Y H+   + ++
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVV 146
Query: 585 HRDIKSTNILLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
           H+D+K  NIL  +       K+ DFGL+           ST   G+  Y+ PE F+R  +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEVFKR-DV 202
Query: 642 TDKSDVYSFGVVLFEVL 658
           T K D++S GVV++ +L
Sbjct: 203 TFKCDIWSAGVVMYFLL 219

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPE-FQTEIT 509
           D +      +    IG G FG V++G+          VA+K     +   + E F  E  
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
            + +  H H+V L+G   E    I++ E    G L+  L    +  L     +      +
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 121
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF- 628
             L YL +   +  +HRDI + N+L+  N   K+ DFGLSR    ++++      KG   
Sbjct: 122 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 175
Query: 629 -GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPE-FQTEIT 509
           D +      +    IG G FG V++G+          VA+K     +   + E F  E  
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL----YGPDRTPLSWKQRLEIC 565
            + +  H H+V L+G   E    I++ E    G L+  L    Y  D   L     +   
Sbjct: 61  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASL-----ILYA 114
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK 625
              +  L YL +   +  +HRDI + N+L+  N   K+ DFGLSR    ++++      K
Sbjct: 115 YQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASK 168
Query: 626 GSF--GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           G     ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 29/223 (13%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +IG G +G VYKG L D   VAVK     +RQ     +  I  +  + H ++   +   E
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFIVGDE 77
Query: 528 E-----QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
                 + E +LV EY   G L K+L         W     +     RGL YLHT    G
Sbjct: 78  RVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 583 ------IIHRDIKSTNILLDENYVSKVADFGLSR--SGPCL----DETHVSTGVKGSFGY 630
                 I HRD+ S N+L+  +    ++DFGLS   +G  L    +E + +    G+  Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 631 LDPEYFR-------RQQLTDKSDVYSFGVVLFEVLCARTAVDP 666
           + PE           +    + D+Y+ G++ +E+    T + P
Sbjct: 195 MAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPE-FQTEIT 509
           D +      +    IG G FG V++G+          VA+K     +   + E F  E  
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
            + +  H H+V L+G   E    I++ E    G L+  L    +  L     +      +
Sbjct: 69  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 126
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF- 628
             L YL +   +  +HRDI + N+L+  N   K+ DFGLSR    ++++      KG   
Sbjct: 127 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 180
Query: 629 -GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPE-FQTEIT 509
           D +      +    IG G FG V++G+          VA+K     +   + E F  E  
Sbjct: 32  DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 91
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
            + +  H H+V L+G   E    I++ E    G L+  L    +  L     +      +
Sbjct: 92  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 149
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF- 628
             L YL +   +  +HRDI + N+L+  N   K+ DFGLSR    ++++      KG   
Sbjct: 150 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 203
Query: 629 -GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 204 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL---- 522
           IG G +GMV       N  +VA+++  P   Q   +    EI +L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTGSA 580
                E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ + 
Sbjct: 95  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 148
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE     
Sbjct: 149 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 640 QLTDKS-DVYSFGVVLFEVLCAR 661
           +   KS D++S G +L E+L  R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 137/321 (42%), Gaps = 69/321 (21%)
Query: 433 SEGTVNASPGQNGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           S   + A+P  N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+
Sbjct: 23  SLAHLRAAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 81
Query: 491 KRGVPGSRQG----LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE---- 537
           K  V   R      LP       E+ +L K+      ++ L+ + E     +L+ E    
Sbjct: 82  KH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 140
Query: 538 -------YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS 590
                    E+G L++ L         W+      + A R  H        G++HRDIK 
Sbjct: 141 VQDLFDFITERGALQEEL----ARSFFWQ-----VLEAVRHCHNC------GVLHRDIKD 185
Query: 591 TNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVY 648
            NIL+D N    K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+
Sbjct: 186 ENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 241
Query: 649 SFGVVLFEVLCARTAV--DPLLAREQV-----------NLAEWAM-----------QWQK 684
           S G++L++++C       D  + R QV           +L  W +           + Q 
Sbjct: 242 SLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 301
Query: 685 KGMLEHIIDPQLIGKINLDSL 705
              ++ ++ PQ   +I+L SL
Sbjct: 302 HPWMQDVLLPQETAEIHLHSL 322

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 132/310 (42%), Gaps = 68/310 (21%)
Query: 444 NGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG- 500
           N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+K  V   R   
Sbjct: 5   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISD 63
Query: 501 ---LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE-----------YMEK 541
              LP       E+ +L K+      ++ L+ + E     +L+ E             E+
Sbjct: 64  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 123
Query: 542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS 601
           G L++ L         W+      + A R  H        G++HRDIK  NIL+D N   
Sbjct: 124 GALQEEL----ARSFFWQ-----VLEAVRHCHNC------GVLHRDIKDENILIDLNRGE 168
Query: 602 -KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLC 659
            K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+S G++L++++C
Sbjct: 169 LKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 224
Query: 660 ARTAV--DPLLAREQV-----------NLAEWAM-----------QWQKKGMLEHIIDPQ 695
                  D  + R QV           +L  W +           + Q    ++ ++ PQ
Sbjct: 225 GDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 284
Query: 696 LIGKINLDSL 705
              +I+L SL
Sbjct: 285 ETAEIHLHSL 294

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 137/321 (42%), Gaps = 69/321 (21%)
Query: 433 SEGTVNASPGQNGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           S   + A+P  N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+
Sbjct: 8   SLAHLRAAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 491 KRGVPGSRQG----LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE---- 537
           K  V   R      LP       E+ +L K+      ++ L+ + E     +L+ E    
Sbjct: 67  KH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 125
Query: 538 -------YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS 590
                    E+G L++ L         W+      + A R  H        G++HRDIK 
Sbjct: 126 VQDLFDFITERGALQEELA----RSFFWQ-----VLEAVRHCHNC------GVLHRDIKD 170
Query: 591 TNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVY 648
            NIL+D N    K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+
Sbjct: 171 ENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 226
Query: 649 SFGVVLFEVLCARTAV--DPLLAREQV-----------NLAEWAM-----------QWQK 684
           S G++L++++C       D  + R QV           +L  W +           + Q 
Sbjct: 227 SLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 286
Query: 685 KGMLEHIIDPQLIGKINLDSL 705
              ++ ++ PQ   +I+L SL
Sbjct: 287 HPWMQDVLLPQETAEIHLHSL 307

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 21/230 (9%)
Query: 444 NGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG----SRQ 499
           N Y ++      LQ    ++D   +IG G FG V     + + KV   + +       R 
Sbjct: 58  NRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRS 117
Query: 500 GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWK 559
               F  E  +++      +V L    ++   + +V EYM  G L   +   D  P  W 
Sbjct: 118 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWA 176
Query: 560 QRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET- 618
           +     +  A  L  +H+    G+IHRD+K  N+LLD++   K+ADFG       +DET 
Sbjct: 177 KFYTAEVVLA--LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMK---MDETG 228
Query: 619 --HVSTGVKGSFGYLDPEYFRRQ----QLTDKSDVYSFGVVLFEVLCART 662
             H  T V G+  Y+ PE  + Q        + D +S GV LFE+L   T
Sbjct: 229 MVHCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 277

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPAFV 184
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            PE    + L  ++D++S GV+ + +L
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILL 211

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLV 520
           +D   ++G+G F  V     +   K VA+K     + +G     + EI VL KI+H ++V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
           +L    E    + L+ + +  G L   +   ++   + +    +       + YLH    
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL-- 135
Query: 581 EGIIHRDIKSTNIL---LDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
            GI+HRD+K  N+L   LDE+    ++DFGLS+     D   V +   G+ GY+ PE   
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLA 191
Query: 638 RQQLTDKSDVYSFGVVLFEVLC 659
           ++  +   D +S GV+ + +LC
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLC 213

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 457 QTATNNFDKNLIIGSGGFGMVY--KGVLRDNT------KVAVKRGVPGSRQGLPEFQTEI 508
           +    NF+   ++G+G +G V+  + +   +T      KV  K  +    +     +TE 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 509 TVLSKIRHR-HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIG 567
            VL  IR    LV+L    + ++++ L+ +Y+  G L  HL   +R     +  ++I +G
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHEVQIYVG 166
Query: 568 A-ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
                L +LH     GII+RDIK  NILLD N    + DFGLS+     DET  +    G
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCG 222
Query: 627 SFGYLDPEYFR-RQQLTDKS-DVYSFGVVLFEVLCA 660
           +  Y+ P+  R      DK+ D +S GV+++E+L  
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLV 520
           +D   ++G+G F  V     +   K VA+K     + +G     + EI VL KI+H ++V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
           +L    E    + L+ + +  G L   +   ++   + +    +       + YLH    
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL-- 135
Query: 581 EGIIHRDIKSTNIL---LDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
            GI+HRD+K  N+L   LDE+    ++DFGLS+     D   V +   G+ GY+ PE   
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLA 191
Query: 638 RQQLTDKSDVYSFGVVLFEVLC 659
           ++  +   D +S GV+ + +LC
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLC 213

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 30/286 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRH 518
           ++++   +IGSG   +V          KVA+KR  +   +  + E   EI  +S+  H +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGP---LKKHLYGPDRTP---LSWKQRLEICIGAARGL 572
           +VS       + E+ LV + +  G    + KH+          L       I      GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS---RSGPCLDETHVSTGVKGSFG 629
            YLH     G IHRD+K+ NILL E+   ++ADFG+S    +G  +    V     G+  
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 630 YLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML 688
           ++ PE   + +  D K+D++SFG+   E+    T   P      + +    +Q     + 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIEL---ATGAAPYHKYPPMKVLMLTLQNDPPSLE 248
Query: 689 EHIIDPQLIGKINLDSLKKFGETAEK----CLADYGVDRPSMGDVL 730
             + D ++        LKK+G++  K    CL      RP+  ++L
Sbjct: 249 TGVQDKEM--------LKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPE-FQTEIT 509
           D +      +    IG G FG V++G+          VA+K     +   + E F  E  
Sbjct: 6   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 65
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
            + +  H H+V L+G   E    I++ E    G L+  L    +  L     +      +
Sbjct: 66  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 123
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF- 628
             L YL +   +  +HRDI + N+L+  N   K+ DFGLSR    ++++      KG   
Sbjct: 124 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 177
Query: 629 -GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 178 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 137/321 (42%), Gaps = 69/321 (21%)
Query: 433 SEGTVNASPGQNGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           S   + A+P  N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+
Sbjct: 23  SLAHLRAAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 81
Query: 491 KRGVPGSRQG----LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE---- 537
           K  V   R      LP       E+ +L K+      ++ L+ + E     +L+ E    
Sbjct: 82  KH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 140
Query: 538 -------YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS 590
                    E+G L++ L         W+      + A R  H        G++HRDIK 
Sbjct: 141 VQDLFDFITERGALQEEL----ARSFFWQ-----VLEAVRHCHNC------GVLHRDIKD 185
Query: 591 TNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVY 648
            NIL+D N    K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+
Sbjct: 186 ENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 241
Query: 649 SFGVVLFEVLCARTAV--DPLLAREQV-----------NLAEWAM-----------QWQK 684
           S G++L++++C       D  + R QV           +L  W +           + Q 
Sbjct: 242 SLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQN 301
Query: 685 KGMLEHIIDPQLIGKINLDSL 705
              ++ ++ PQ   +I+L SL
Sbjct: 302 HPWMQDVLLPQETAEIHLHSL 322

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPE-FQTEIT 509
           D +      +    IG G FG V++G+          VA+K     +   + E F  E  
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
            + +  H H+V L+G   E    I++ E    G L+  L    +  L     +      +
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 121
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF- 628
             L YL +   +  +HRDI + N+L+  N   K+ DFGLSR    ++++      KG   
Sbjct: 122 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 175
Query: 629 -GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 30/286 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRH 518
           ++++   +IGSG   +V          KVA+KR  +   +  + E   EI  +S+  H +
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGP---LKKHLYGPDRTP---LSWKQRLEICIGAARGL 572
           +VS       + E+ LV + +  G    + KH+          L       I      GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS---RSGPCLDETHVSTGVKGSFG 629
            YLH     G IHRD+K+ NILL E+   ++ADFG+S    +G  +    V     G+  
Sbjct: 130 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 630 YLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML 688
           ++ PE   + +  D K+D++SFG+   E+    T   P      + +    +Q     + 
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIEL---ATGAAPYHKYPPMKVLMLTLQNDPPSLE 243
Query: 689 EHIIDPQLIGKINLDSLKKFGETAEK----CLADYGVDRPSMGDVL 730
             + D ++        LKK+G++  K    CL      RP+  ++L
Sbjct: 244 TGVQDKEM--------LKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 129 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 183
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCART 662
             +  +   D++S G +  E++  R 
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTRRA 209

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 85/310 (27%), Positives = 133/310 (42%), Gaps = 68/310 (21%)
Query: 444 NGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG- 500
           N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+K  V   R   
Sbjct: 6   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISD 64
Query: 501 ---LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE-----------YMEK 541
              LP       E+ +L K+      ++ L+ + E     +L+ E             E+
Sbjct: 65  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 124
Query: 542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS 601
           G L++ L         W Q LE    A R  H        G++HRDIK  NIL+D N   
Sbjct: 125 GALQEEL----ARSFFW-QVLE----AVRHCHNC------GVLHRDIKDENILIDLNRGE 169
Query: 602 -KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLC 659
            K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+S G++L++++C
Sbjct: 170 LKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 225
Query: 660 ARTAV--DPLLAREQV-----------NLAEWAM-----------QWQKKGMLEHIIDPQ 695
                  D  + R QV           +L  W +           + Q    ++ ++ PQ
Sbjct: 226 GDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 285
Query: 696 LIGKINLDSL 705
              +I+L SL
Sbjct: 286 ETAEIHLHSL 295

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPE-FQTEIT 509
           D +      +    IG G FG V++G+          VA+K     +   + E F  E  
Sbjct: 7   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 66
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
            + +  H H+V L+G   E    I++ E    G L+  L    +  L     +      +
Sbjct: 67  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 124
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF- 628
             L YL +   +  +HRDI + N+L+  N   K+ DFGLSR    ++++      KG   
Sbjct: 125 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 178
Query: 629 -GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 179 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 69/321 (21%)
Query: 433 SEGTVNASPGQNGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           S   + A+P  N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+
Sbjct: 28  SLAHLRAAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 86
Query: 491 KRGVPGSRQG----LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE---- 537
           K  V   R      LP       E+ +L K+      ++ L+ + E     +L+ E    
Sbjct: 87  KH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 145
Query: 538 -------YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS 590
                    E+G L++ L         W Q LE    A R  H        G++HRDIK 
Sbjct: 146 VQDLFDFITERGALQEELA----RSFFW-QVLE----AVRHCHNC------GVLHRDIKD 190
Query: 591 TNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVY 648
            NIL+D N    K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+
Sbjct: 191 ENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 246
Query: 649 SFGVVLFEVLCARTAV--DPLLAREQV-----------NLAEWAM-----------QWQK 684
           S G++L++++C       D  + R QV           +L  W +           + Q 
Sbjct: 247 SLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQN 306
Query: 685 KGMLEHIIDPQLIGKINLDSL 705
              ++ ++ PQ   +I+L SL
Sbjct: 307 HPWMQDVLLPQETAEIHLHSL 327

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 469 IGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGL--PEFQTEITVLSKIRHRHLVS 521
           +GSG F +V K   +        K   KR +  SR+G+   E + E+ +L +IRH ++++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L    E +++++L+ E +  G L   L   ++  L+  +  +       G+HYLH+   +
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHS---K 134
Query: 582 GIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
            I H D+K  NI LLD+N  +   K+ DFG++      +E      + G+  ++ PE   
Sbjct: 135 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVN 191
Query: 638 RQQLTDKSDVYSFGVVLFEVLCA 660
            + L  ++D++S GV+ + +L  
Sbjct: 192 YEPLGLEADMWSIGVITYILLSG 214

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 463 FDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLV 520
           +D   ++G+G F  V     +   K VA+K     + +G     + EI VL KI+H ++V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
           +L    E    + L+ + +  G L   +   ++   + +    +       + YLH    
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL-- 135
Query: 581 EGIIHRDIKSTNIL---LDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
            GI+HRD+K  N+L   LDE+    ++DFGLS+     D   V +   G+ GY+ PE   
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLA 191
Query: 638 RQQLTDKSDVYSFGVVLFEVLC 659
           ++  +   D +S GV+ + +LC
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLC 213

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 14/215 (6%)
Query: 452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EI 508
           P  D++    NF K   IG G +G+VYK   +   +V   + +      +G+P     EI
Sbjct: 2   PLVDME----NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 57
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
           ++L ++ H ++V L+     ++++ LV+E++ +  LKK +     T +            
Sbjct: 58  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQL 116
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
            +GL + H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  + 
Sbjct: 117 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TL 171
Query: 629 GYLDPEYFR-RQQLTDKSDVYSFGVVLFEVLCART 662
            Y  PE     +  +   D++S G +  E++  R 
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 206

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 132/310 (42%), Gaps = 68/310 (21%)
Query: 444 NGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG- 500
           N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+K  V   R   
Sbjct: 5   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISD 63
Query: 501 ---LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE-----------YMEK 541
              LP       E+ +L K+      ++ L+ + E     +L+ E             E+
Sbjct: 64  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 123
Query: 542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS 601
           G L++ L         W+      + A R  H        G++HRDIK  NIL+D N   
Sbjct: 124 GALQEEL----ARSFFWQ-----VLEAVRHCHNC------GVLHRDIKDENILIDLNRGE 168
Query: 602 -KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLC 659
            K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+S G++L++++C
Sbjct: 169 LKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 224
Query: 660 ARTAV--DPLLAREQV-----------NLAEWAM-----------QWQKKGMLEHIIDPQ 695
                  D  + R QV           +L  W +           + Q    ++ ++ PQ
Sbjct: 225 GDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 284
Query: 696 LIGKINLDSL 705
              +I+L SL
Sbjct: 285 ETAEIHLHSL 294

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 85/310 (27%), Positives = 133/310 (42%), Gaps = 68/310 (21%)
Query: 444 NGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG- 500
           N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+K  V   R   
Sbjct: 25  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISD 83
Query: 501 ---LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE-----------YMEK 541
              LP       E+ +L K+      ++ L+ + E     +L+ E             E+
Sbjct: 84  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 143
Query: 542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS 601
           G L++ L         W Q LE    A R  H        G++HRDIK  NIL+D N   
Sbjct: 144 GALQEELA----RSFFW-QVLE----AVRHCHNC------GVLHRDIKDENILIDLNRGE 188
Query: 602 -KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLC 659
            K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+S G++L++++C
Sbjct: 189 LKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
Query: 660 ARTAV--DPLLAREQV-----------NLAEWAM-----------QWQKKGMLEHIIDPQ 695
                  D  + R QV           +L  W +           + Q    ++ ++ PQ
Sbjct: 245 GDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 304
Query: 696 LIGKINLDSL 705
              +I+L SL
Sbjct: 305 ETAEIHLHSL 314

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 469 IGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLV 520
           +G G FG V +    G+ +  T   VAVK    G+         +E+ +L  I  H ++V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 521 SLVGYCEEQS-EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------------IC-- 565
           +L+G C +    ++++ E+ + G L  +L       + +K+  E            IC  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-V 624
              A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D  +V  G  
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDA 212
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 246

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 469 IGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGL--PEFQTEITVLSKIRHRHLVS 521
           +GSG F +V K   +        K   KR +  SR+G+   E + E+ +L +IRH ++++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L    E +++++L+ E +  G L   L   ++  L+  +  +       G+HYLH+   +
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHS---K 127
Query: 582 GIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
            I H D+K  NI LLD+N  +   K+ DFG++      +E      + G+  ++ PE   
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVN 184
Query: 638 RQQLTDKSDVYSFGVVLFEVLCA 660
            + L  ++D++S GV+ + +L  
Sbjct: 185 YEPLGLEADMWSIGVITYILLSG 207

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 505 QTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEI 564
           + E  +L ++ H  +V L    + + ++ L+ +++  G L   L    +  +  ++ ++ 
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKF 130
Query: 565 CIGA-ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
            +   A  L +LH+    GII+RD+K  NILLDE    K+ DFGLS+    +D    +  
Sbjct: 131 YLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYS 185
Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
             G+  Y+ PE   R+  T  +D +SFGV++FE+L  
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 14/217 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQ---TEITVLSKIRHRHLVSLVGY 525
           IG+G +G   K   + + K+ V + +        E Q   +E+ +L +++H ++V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 526 CEEQSE--MILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
             +++   + +V EY E G L   +     +R  L  +  L +       L   H  S  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 582 G--IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
           G  ++HRD+K  N+ LD     K+ DFGL+R      +T  +    G+  Y+ PE   R 
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQMNRM 191
Query: 640 QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLA 676
              +KSD++S G +L+E LCA   + P  A  Q  LA
Sbjct: 192 SYNEKSDIWSLGCLLYE-LCA--LMPPFTAFSQKELA 225

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 85/310 (27%), Positives = 133/310 (42%), Gaps = 68/310 (21%)
Query: 444 NGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG- 500
           N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+K  V   R   
Sbjct: 6   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISD 64
Query: 501 ---LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE-----------YMEK 541
              LP       E+ +L K+      ++ L+ + E     +L+ E             E+
Sbjct: 65  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 124
Query: 542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS 601
           G L++ L         W Q LE    A R  H        G++HRDIK  NIL+D N   
Sbjct: 125 GALQEEL----ARSFFW-QVLE----AVRHCHNC------GVLHRDIKDENILIDLNRGE 169
Query: 602 -KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLC 659
            K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+S G++L++++C
Sbjct: 170 LKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 225
Query: 660 ARTAV--DPLLAREQV-----------NLAEWAM-----------QWQKKGMLEHIIDPQ 695
                  D  + R QV           +L  W +           + Q    ++ ++ PQ
Sbjct: 226 GDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 285
Query: 696 LIGKINLDSL 705
              +I+L SL
Sbjct: 286 ETAEIHLHSL 295

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL---- 522
           IG G +GMV       N  +VA+K+  P   Q   +    EI +L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL---EICI---GAARGLHYL 575
                E+  ++ +V + ME           D   L   Q L    IC       RGL Y+
Sbjct: 95  RAPTIEQMKDVYIVQDLMET----------DLYKLLKCQHLSNDHICYFLYQILRGLKYI 144
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPE 634
           H+ +   ++HRD+K +N+LL+     K+ DFGL+R + P  D T   T    +  Y  PE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 635 YFRRQQLTDKS-DVYSFGVVLFEVLCAR 661
                +   KS D++S G +L E+L  R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 17/227 (7%)
Query: 458 TATNNFDKNLIIGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIR 515
           ++++ F +   +G+G +  VYKG+ +     VA+K     S +G P     EI+++ +++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI------GAA 569
           H ++V L      ++++ LV+E+M+   LKK  Y   RT  +  + LE+ +         
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDND-LKK--YMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
           +GL + H      I+HRD+K  N+L+++    K+ DFGL+R+      T  S  V  +  
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLW 173
Query: 630 YLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCARTAVDPLLAREQVNL 675
           Y  P+     +    S D++S G +L E++  +         EQ+ L
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL 220

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPE-FQTEIT 509
           D +      +    IG G FG V++G+          VA+K     +   + E F  E  
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
            + +  H H+V L+G   E    I++ E    G L+  L    +  L     +      +
Sbjct: 444 TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL-QVRKFSLDLASLILYAYQLS 501
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF- 628
             L YL +   +  +HRDI + N+L+  N   K+ DFGLSR    ++++      KG   
Sbjct: 502 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 555
Query: 629 -GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 85/310 (27%), Positives = 133/310 (42%), Gaps = 68/310 (21%)
Query: 444 NGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG- 500
           N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+K  V   R   
Sbjct: 6   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISD 64
Query: 501 ---LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE-----------YMEK 541
              LP       E+ +L K+      ++ L+ + E     +L+ E             E+
Sbjct: 65  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 124
Query: 542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS 601
           G L++ L         W Q LE    A R  H        G++HRDIK  NIL+D N   
Sbjct: 125 GALQEEL----ARSFFW-QVLE----AVRHCHNC------GVLHRDIKDENILIDLNRGE 169
Query: 602 -KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLC 659
            K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+S G++L++++C
Sbjct: 170 LKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 225
Query: 660 ARTAV--DPLLAREQV-----------NLAEWAM-----------QWQKKGMLEHIIDPQ 695
                  D  + R QV           +L  W +           + Q    ++ ++ PQ
Sbjct: 226 GDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDVLLPQ 285
Query: 696 LIGKINLDSL 705
              +I+L SL
Sbjct: 286 ETAEIHLHSL 295

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRH 516
           ++N+D    +G G F +V + V +        + +   +    +FQ    E  +  K++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAARG 571
            ++V L    +E+S   LV++ +  G L      +  Y         +Q LE        
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------S 116
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           + Y H+    GI+HR++K  N+LL    +    K+ADFGL+     ++++    G  G+ 
Sbjct: 117 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTP 170
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           GYL PE  ++   +   D+++ GV+L+ +L
Sbjct: 171 GYLSPEVLKKDPYSKPVDIWACGVILYILL 200

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 462 NFDKNLIIGSGGFGMVYKG-VLRDNTKVAVKRGVP---GSRQGLPEFQTEITVLSKIRHR 517
           NF     IG G F  VY+   L D   VA+K+         +   +   EI +L ++ H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPL--------KKHLYGPDRTPLSWKQRLEICIGAA 569
           +++       E +E+ +V E  + G L        K+    P+RT   WK  +++C    
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT--VWKYFVQLC---- 146
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             L ++H+     ++HRDIK  N+ +    V K+ D GL R      +T  +  + G+  
Sbjct: 147 SALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPY 201
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
           Y+ PE         KSD++S G +L+E+
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    + L  ++D++S GV+ + +L 
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRH 516
           ++N+D    +G G F +V + V +        + +   +    +FQ    E  +  K++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAARG 571
            ++V L    +E+S   LV++ +  G L      +  Y         +Q LE        
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------S 117
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           + Y H+    GI+HR++K  N+LL    +    K+ADFGL+     ++++    G  G+ 
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTP 171
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           GYL PE  ++   +   D+++ GV+L+ +L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 94/180 (52%), Gaps = 25/180 (13%)
Query: 446 YHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDN-TKVAVKRGV-PGSRQGLP- 502
           Y  ++ PF D     + ++K   IG G FG V+K   R    KVA+K+ +    ++G P 
Sbjct: 6   YDSVECPFCD---EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 62
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSE--------MILVYEYMEK---GPLKKHLYGP 551
               EI +L  ++H ++V+L+  C  ++         + LV+++ E    G L   L   
Sbjct: 63  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF 122
Query: 552 DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
             + +  K+ +++ +    GL+Y+H      I+HRD+K+ N+L+  + V K+ADFGL+R+
Sbjct: 123 TLSEI--KRVMQMLLN---GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 174

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
            PE    + L  ++D++S GV+ + +L  
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 450 KIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEIT 509
           +I  + L+     F+   ++G+G +G VYKG      ++A  + +  +     E + EI 
Sbjct: 13  EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN 72
Query: 510 VLSKI-RHRHLVSLVGYCEEQS------EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL 562
           +L K   HR++ +  G   +++      ++ LV E+   G +   +       L  +   
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 563 EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST 622
            IC    RGL +LH      +IHRDIK  N+LL EN   K+ DFG+S     LD T    
Sbjct: 133 YICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ---LDRT---V 183
Query: 623 GVKGSF----GYLDPEYFRRQQLTD-----KSDVYSFGVVLFEV 657
           G + +F     ++ PE     +  D     KSD++S G+   E+
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 469 IGSGGFGMVYK----GVLRDNTK--VAVKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLV 520
           +G G FG V +    G+ +  T   VAVK    G+         +E+ +L  I  H ++V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 521 SLVGYCEEQS-EMILVYEYMEKGPLKKHL---------YGPD---RTPLSWKQRLEICIG 567
           +L+G C +    ++++ E+ + G L  +L         Y P+   +  L+ +  +     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKG 626
            A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D   V  G  + 
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARD-IXKDPDXVRKGDARL 212
Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
              ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 129
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 130 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 183
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    + L  ++D++S GV+ + +L 
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLS 211

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 129
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 130 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 183
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    + L  ++D++S GV+ + +L 
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLS 211

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRH 516
           ++N+D    +G G F +V + V +        + +   +    +FQ    E  +  K++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAARG 571
            ++V L    +E+S   LV++ +  G L      +  Y         +Q LE        
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------S 117
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           + Y H+    GI+HR++K  N+LL    +    K+ADFGL+     ++++    G  G+ 
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTP 171
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           GYL PE  ++   +   D+++ GV+L+ +L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    + L  ++D++S GV+ + +L 
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLP-EFQTEITVLSKI 514
           ++F+    +G G FG VY    + +      KV  K  +   ++G+  + + EI + + +
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQI--EKEGVEHQLRREIEIQAHL 80
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            H +++ L  Y  ++  + L+ EY  +G L K L          ++   I    A  L Y
Sbjct: 81  HHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQ--KSCTFDEQRTATIMEELADALMY 138
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
            H    + +IHRDIK  N+LL      K+ADFG S   P L    +     G+  YL PE
Sbjct: 139 CH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC----GTLDYLPPE 191
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVL 658
               +   +K D++  GV+ +E+L
Sbjct: 192 MIEGRMHNEKVDLWCIGVLCYELL 215

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 469 IGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGL--PEFQTEITVLSKIRHRHLVS 521
           +GSG F +V K   +        K   KR +  SR+G+   E + E+ +L +IRH ++++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L    E +++++L+ E +  G L   L   ++  L+  +  +       G+HYLH+   +
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHS---K 148
Query: 582 GIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
            I H D+K  NI LLD+N  +   K+ DFG++      +E      + G+  ++ PE   
Sbjct: 149 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVN 205
Query: 638 RQQLTDKSDVYSFGVVLFEVLCA 660
            + L  ++D++S GV+ + +L  
Sbjct: 206 YEPLGLEADMWSIGVITYILLSG 228

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    + L  ++D++S GV+ + +L 
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 114/252 (45%), Gaps = 45/252 (17%)
Query: 433 SEGTVNASPGQNGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           S   + A+P  N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+
Sbjct: 9   SLAHLRAAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 491 KRGVPGSRQG----LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE---- 537
           K  V   R      LP       E+ +L K+      ++ L+ + E     +L+ E    
Sbjct: 68  KH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 126
Query: 538 -------YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS 590
                    E+G L++ L         W+      + A R  H        G++HRDIK 
Sbjct: 127 VQDLFDFITERGALQEEL----ARSFFWQ-----VLEAVRHCHNC------GVLHRDIKD 171
Query: 591 TNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVY 648
            NIL+D N    K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+
Sbjct: 172 ENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 227
Query: 649 SFGVVLFEVLCA 660
           S G++L++++C 
Sbjct: 228 SLGILLYDMVCG 239

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL-- 522
           IG G +GMV   Y  V +  T+VA+K+  P   Q   +    EI +L + RH +++ +  
Sbjct: 51  IGEGAYGMVSSAYDHVRK--TRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 523 ---VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL---EICI---GAARGLH 573
                  E   ++ +V + ME           D   L   Q+L    IC       RGL 
Sbjct: 109 ILRASTLEAMRDVYIVQDLMET----------DLYKLLKSQQLSNDHICYFLYQILRGLK 158
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLD 632
           Y+H+ +   ++HRD+K +N+L++     K+ DFGL+R + P  D T   T    +  Y  
Sbjct: 159 YIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRA 215
Query: 633 PEYFRRQQLTDKS-DVYSFGVVLFEVLCAR 661
           PE     +   KS D++S G +L E+L  R
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 114/252 (45%), Gaps = 45/252 (17%)
Query: 433 SEGTVNASPGQNGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           S   + A+P  N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+
Sbjct: 8   SLAHLRAAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 491 KRGVPGSRQG----LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE---- 537
           K  V   R      LP       E+ +L K+      ++ L+ + E     +L+ E    
Sbjct: 67  KH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 125
Query: 538 -------YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS 590
                    E+G L++ L         W+      + A R  H        G++HRDIK 
Sbjct: 126 VQDLFDFITERGALQEEL----ARSFFWQ-----VLEAVRHCHNC------GVLHRDIKD 170
Query: 591 TNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVY 648
            NIL+D N    K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+
Sbjct: 171 ENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 226
Query: 649 SFGVVLFEVLCA 660
           S G++L++++C 
Sbjct: 227 SLGILLYDMVCG 238

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 505 QTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEI 564
           + E  +L ++ H  +V L    + + ++ L+ +++  G L   L    +  +  ++ ++ 
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKF 130
Query: 565 CIGA-ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
            +   A  L +LH+    GII+RD+K  NILLDE    K+ DFGLS+    +D    +  
Sbjct: 131 YLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYS 185
Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
             G+  Y+ PE   R+  T  +D +SFGV++FE+L  
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 505 QTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEI 564
           + E  +L ++ H  +V L    + + ++ L+ +++  G L   L    +  +  ++ ++ 
Sbjct: 75  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKF 131
Query: 565 CIGA-ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
            +   A  L +LH+    GII+RD+K  NILLDE    K+ DFGLS+    +D    +  
Sbjct: 132 YLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYS 186
Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
             G+  Y+ PE   R+  T  +D +SFGV++FE+L  
Sbjct: 187 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 115/252 (45%), Gaps = 45/252 (17%)
Query: 433 SEGTVNASPGQNGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           S   + A+P  N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+
Sbjct: 8   SLAHLRAAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 491 KRGVPGSRQG----LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE---- 537
           K  V   R      LP       E+ +L K+      ++ L+ + E     +L+ E    
Sbjct: 67  KH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 125
Query: 538 -------YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS 590
                    E+G L++ L         W Q LE    A R  H        G++HRDIK 
Sbjct: 126 VQDLFDFITERGALQEEL----ARSFFW-QVLE----AVRHCHNC------GVLHRDIKD 170
Query: 591 TNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVY 648
            NIL+D N    K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+
Sbjct: 171 ENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 226
Query: 649 SFGVVLFEVLCA 660
           S G++L++++C 
Sbjct: 227 SLGILLYDMVCG 238

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 114/252 (45%), Gaps = 45/252 (17%)
Query: 433 SEGTVNASPGQNGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           S   + A+P  N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+
Sbjct: 9   SLAHLRAAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 491 KRGVPGSRQG----LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE---- 537
           K  V   R      LP       E+ +L K+      ++ L+ + E     +L+ E    
Sbjct: 68  KH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 126
Query: 538 -------YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS 590
                    E+G L++ L         W+      + A R  H        G++HRDIK 
Sbjct: 127 VQDLFDFITERGALQEEL----ARSFFWQ-----VLEAVRHCHNC------GVLHRDIKD 171
Query: 591 TNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVY 648
            NIL+D N    K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+
Sbjct: 172 ENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 227
Query: 649 SFGVVLFEVLCA 660
           S G++L++++C 
Sbjct: 228 SLGILLYDMVCG 239

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRH 516
           ++N+D    +G G F +V + V +        + +   +    +FQ    E  +  K++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAARG 571
            ++V L    +E+S   LV++ +  G L      +  Y         +Q LE        
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------S 140
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           + Y H+    GI+HR++K  N+LL    +    K+ADFGL+     ++++    G  G+ 
Sbjct: 141 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTP 194
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           GYL PE  ++   +   D+++ GV+L+ +L
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILL 224

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 115/252 (45%), Gaps = 45/252 (17%)
Query: 433 SEGTVNASPGQNGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           S   + A+P  N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+
Sbjct: 8   SLAHLRAAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 491 KRGVPGSRQG----LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE---- 537
           K  V   R      LP       E+ +L K+      ++ L+ + E     +L+ E    
Sbjct: 67  KH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 125
Query: 538 -------YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS 590
                    E+G L++ L         W Q LE    A R  H        G++HRDIK 
Sbjct: 126 VQDLFDFITERGALQEEL----ARSFFW-QVLE----AVRHCHNC------GVLHRDIKD 170
Query: 591 TNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVY 648
            NIL+D N    K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+
Sbjct: 171 ENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 226
Query: 649 SFGVVLFEVLCA 660
           S G++L++++C 
Sbjct: 227 SLGILLYDMVCG 238

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF-QTEITVLSKIRHRHLVSLVGY-- 525
           IG G +G V+ G  R   KVAVK  V  + +    F +TEI     +RH +++  +    
Sbjct: 45  IGKGRYGEVWMGKWRGE-KVAVK--VFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 526 --CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG--SAE 581
                 +++ L+ +Y E G L  +L     T L  K  L++   +  GL +LHT   S +
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 582 G---IIHRDIKSTNILLDENYVSKVADFGLS-RSGPCLDETHVSTGVK-GSFGYLDPEYF 636
           G   I HRD+KS NIL+ +N    +AD GL+ +     +E  +    + G+  Y+ PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 637 RRQ------QLTDKSDVYSFGVVLFEVLCARTAV 664
                    Q    +D+YSFG++L+EV  AR  V
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEV--ARRCV 250

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 115/252 (45%), Gaps = 45/252 (17%)
Query: 433 SEGTVNASPGQNGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           S   + A+P  N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+
Sbjct: 9   SLAHLRAAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 491 KRGVPGSRQG----LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE---- 537
           K  V   R      LP       E+ +L K+      ++ L+ + E     +L+ E    
Sbjct: 68  KH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 126
Query: 538 -------YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS 590
                    E+G L++ L         W Q LE    A R  H        G++HRDIK 
Sbjct: 127 VQDLFDFITERGALQEEL----ARSFFW-QVLE----AVRHCHNC------GVLHRDIKD 171
Query: 591 TNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVY 648
            NIL+D N    K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+
Sbjct: 172 ENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 227
Query: 649 SFGVVLFEVLCA 660
           S G++L++++C 
Sbjct: 228 SLGILLYDMVCG 239

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    + L  ++D++S GV+ + +L 
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 38/229 (16%)
Query: 447 HRLKIPFTDLQTATNNF---DKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSR 498
           HR+    T  Q A N+F    K  I+G G FG V+K       L+   K+   RG+    
Sbjct: 75  HRI---VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 499 QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPD------ 552
               E + EI+V++++ H +L+ L    E +++++LV EY++ G L   +          
Sbjct: 132 ----EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL 187
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLS 609
            T L  KQ   IC G  R +H ++      I+H D+K  NIL    D   + K+ DFGL+
Sbjct: 188 DTILFMKQ---ICEG-IRHMHQMY------ILHLDLKPENILCVNRDAKQI-KIIDFGLA 236
Query: 610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           R     ++  V+ G      +L PE      ++  +D++S GV+ + +L
Sbjct: 237 RRYKPREKLKVNFGTP---EFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 468 IIGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPE--FQTEITVLSKIRHRHLVSLVG 524
           ++G G +GMV K   +D  + VA+K+ +      + +     EI +L ++RH +LV+L+ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
            C+++    LV+E+++   L      P+   L ++   +       G+ + H+     II
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHS---HNII 146
Query: 585 HRDIKSTNILLDENYVSKVADFGLSRS 611
           HRDIK  NIL+ ++ V K+ DFG +R+
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFART 173

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 469 IGSGGFGMVYK----GVLRDNTK--VAVKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLV 520
           +G G FG V +    G+ +  T   VAVK    G+         +E+ +L  I  H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 521 SLVGYCEEQS-EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE--------IC--IGAA 569
           +L+G C +    ++++ E+ + G L  +L       + +K   +        IC     A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGSF 628
           +G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D  +V  G  +   
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPL 210
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 94/180 (52%), Gaps = 25/180 (13%)
Query: 446 YHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDN-TKVAVKRGV-PGSRQGLP- 502
           Y  ++ PF D     + ++K   IG G FG V+K   R    KVA+K+ +    ++G P 
Sbjct: 6   YDSVECPFCD---EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 62
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSE--------MILVYEYMEK---GPLKKHLYGP 551
               EI +L  ++H ++V+L+  C  ++         + LV+++ E    G L   L   
Sbjct: 63  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKF 122
Query: 552 DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
             + +  K+ +++ +    GL+Y+H      I+HRD+K+ N+L+  + V K+ADFGL+R+
Sbjct: 123 TLSEI--KRVMQMLLN---GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 174

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 115/252 (45%), Gaps = 45/252 (17%)
Query: 433 SEGTVNASPGQNGYHRLKI-PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           S   + A+P  N  H  K+ P  + +   + +    ++GSGGFG VY G+ + DN  VA+
Sbjct: 9   SLAHLRAAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 491 KRGVPGSRQG----LP---EFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVYE---- 537
           K  V   R      LP       E+ +L K+      ++ L+ + E     +L+ E    
Sbjct: 68  KH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 126
Query: 538 -------YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS 590
                    E+G L++ L         W Q LE    A R  H        G++HRDIK 
Sbjct: 127 VQDLFDFITERGALQEEL----ARSFFW-QVLE----AVRHCHNC------GVLHRDIKD 171
Query: 591 TNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVY 648
            NIL+D N    K+ DFG   SG  L +T V T   G+  Y  PE+ R  +   +S  V+
Sbjct: 172 ENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 227
Query: 649 SFGVVLFEVLCA 660
           S G++L++++C 
Sbjct: 228 SLGILLYDMVCG 239

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL---- 522
           IG G +GMV       N  +VA+K+  P   Q   +    EI +L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTGSA 580
                E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ + 
Sbjct: 95  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 148
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             ++HRD+K +N+LL+     K+ DFGL+R + P  D T        +  Y  PE     
Sbjct: 149 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 206
Query: 640 QLTDKS-DVYSFGVVLFEVLCAR 661
           +   KS D++S G +L E+L  R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 469 IGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL---- 522
           IG G +GMV       N  +VA+K+  P   Q   +    EI +L + RH +++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAARGLHYLHTGSA 580
                E+  ++ +V + ME       LY   +T  LS            RGL Y+H+ + 
Sbjct: 96  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 149
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             ++HRD+K +N+LL+     K+ DFGL+R + P  D T        +  Y  PE     
Sbjct: 150 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 207
Query: 640 QLTDKS-DVYSFGVVLFEVLCAR 661
           +   KS D++S G +L E+L  R
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
            PE    + L  ++D++S GV+ + +L  
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 129 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 183
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCART 662
             +  +   D++S G +  E++  R 
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTRRA 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 452 PFTDLQTATNNFDKNLI--IGSGGFGMVYKGVLR----DNTKVAVKRGVP---GSRQGLP 502
           P   L       D  L+  +G G FG+V +G           VAVK   P      + + 
Sbjct: 7   PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL----KKHLYGPDRTPLSW 558
           +F  E+  +  + HR+L+ L G       M +V E    G L    +KH        LS 
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS- 124
Query: 559 KQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET 618
                  +  A G+ YL    ++  IHRD+ + N+LL    + K+ DFGL R+ P  D+ 
Sbjct: 125 ----RYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 619 HV-STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +V     K  F +  PE  + +  +  SD + FGV L+E+ 
Sbjct: 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    + L  ++D++S GV+ + +L 
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 10/207 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 121 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 175
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 94/180 (52%), Gaps = 25/180 (13%)
Query: 446 YHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDN-TKVAVKRGV-PGSRQGLP- 502
           Y  ++ PF D     + ++K   IG G FG V+K   R    KVA+K+ +    ++G P 
Sbjct: 5   YDSVECPFCD---EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 61
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSE--------MILVYEYMEK---GPLKKHLYGP 551
               EI +L  ++H ++V+L+  C  ++         + LV+++ E    G L   L   
Sbjct: 62  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF 121
Query: 552 DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
             + +  K+ +++ +    GL+Y+H      I+HRD+K+ N+L+  + V K+ADFGL+R+
Sbjct: 122 TLSEI--KRVMQMLLN---GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 173

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            PE    + L  ++D++S GV+ + +L
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILL 211

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 94/180 (52%), Gaps = 25/180 (13%)
Query: 446 YHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDN-TKVAVKRGV-PGSRQGLP- 502
           Y  ++ PF D     + ++K   IG G FG V+K   R    KVA+K+ +    ++G P 
Sbjct: 6   YDSVECPFCD---EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 62
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSE--------MILVYEYMEK---GPLKKHLYGP 551
               EI +L  ++H ++V+L+  C  ++         + LV+++ E    G L   L   
Sbjct: 63  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF 122
Query: 552 DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
             + +  K+ +++ +    GL+Y+H      I+HRD+K+ N+L+  + V K+ADFGL+R+
Sbjct: 123 TLSEI--KRVMQMLLN---GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 174

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 469 IGSGGFGMVYKGVLR----DNTKVAVKRGVP---GSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FG+V +G           VAVK   P      + + +F  E+  +  + HR+L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 522 LVGYCEEQSEMILVYEYMEKGPL----KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           L G       M +V E    G L    +KH        LS        +  A G+ YL  
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYL-- 131
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYF 636
             ++  IHRD+ + N+LL    + K+ DFGL R+ P  D+ +V     K  F +  PE  
Sbjct: 132 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 637 RRQQLTDKSDVYSFGVVLFEVL 658
           + +  +  SD + FGV L+E+ 
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMF 212

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
            PE    + L  ++D++S GV+ + +L  
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 14/217 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQ---TEITVLSKIRHRHLVSLVGY 525
           IG+G +G   K   + + K+ V + +        E Q   +E+ +L +++H ++V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 526 CEEQSE--MILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
             +++   + +V EY E G L   +     +R  L  +  L +       L   H  S  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 582 G--IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
           G  ++HRD+K  N+ LD     K+ DFGL+R      +T  +    G+  Y+ PE   R 
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSPEQMNRM 191
Query: 640 QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLA 676
              +KSD++S G +L+E LCA   + P  A  Q  LA
Sbjct: 192 SYNEKSDIWSLGCLLYE-LCA--LMPPFTAFSQKELA 225

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    + L  ++D++S GV+ + +L 
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 13/168 (7%)
Query: 493 GVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYG 550
           G    R  + +   EI +L K+ H ++V LV   ++ +E  + +V+E + +GP+   +  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEV 128
Query: 551 PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR 610
           P   PLS  Q         +G+ YLH    + IIHRDIK +N+L+ E+   K+ADFG+S 
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 611 SGPCLDETHVSTGVKGSFGYLDPEYFR--RQQLTDKS-DVYSFGVVLF 655
                D    +T   G+  ++ PE     R+  + K+ DV++ GV L+
Sbjct: 186 EFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 124 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 178
Query: 636 FRR-QQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 206

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 122 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 122 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 122 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 20/197 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQ---TEITVLSKIRHRHLVSLVG 524
           IG G FG VY    +R++  VA+K+     +Q   ++Q    E+  L K+RH + +   G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
               +    LV EY         L    + PL   +   +  GA +GL YLH+     +I
Sbjct: 122 CYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMI 176
Query: 585 HRDIKSTNILLDENYVSKVADFG-LSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ---Q 640
           HRD+K+ NILL E  + K+ DFG  S   P       +    G+  ++ PE        Q
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILAMDEGQ 229
Query: 641 LTDKSDVYSFGVVLFEV 657
              K DV+S G+   E+
Sbjct: 230 YDGKVDVWSLGITCIEL 246

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAV--KRGVPGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V    K  +    +G+P     EI++L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAV--KRGVPGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V    K  +    +G+P     EI++L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 121 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 175
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCART 662
             +  +   D++S G +  E++  R 
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE------FQTEITVLSKIRHRHLVS 521
           +G G FG V      +   KVA+K     SRQ L +       + EI+ L  +RH H++ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFI---SRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L       +++++V EY   G L  ++    R      +R    I  A  + Y H     
Sbjct: 74  LYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCHR---H 127
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            I+HRD+K  N+LLD+N   K+ADFGL  S    D   + T   GS  Y  PE    +  
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGL--SNIMTDGNFLKTSC-GSPNYAAPEVINGKLY 184
Query: 642 TD-KSDVYSFGVVLFEVLCARTAVD 665
              + DV+S G+VL+ +L  R   D
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 636 FRR-QQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 121 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 175
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCART 662
             +  +   D++S G +  E++  R 
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 441 PGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQ 499
           P ++G++R ++  T  +      D    +GSG +G V   V  R   KVA+K+     + 
Sbjct: 6   PARSGFYRQEVTKTAWEVRAVYRDLQ-PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS 64
Query: 500 GL--PEFQTEITVLSKIRHRHLVSLVGY------CEEQSEMILVYEYM--EKGPLKKH-L 548
            L       E+ +L  +RH +++ L+         ++ ++  LV  +M  + G L KH  
Sbjct: 65  ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 124
Query: 549 YGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL 608
            G DR      Q L       +GL Y+H   A GIIHRD+K  N+ ++E+   K+ DFGL
Sbjct: 125 LGEDRIQFLVYQML-------KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 609 SRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVLCART 662
           +R         V T       Y  PE      + T   D++S G ++ E++  +T
Sbjct: 175 ARQADSEMXGXVVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF-QTEITVLSKIRHRHLVSLVGY-- 525
           +G G +G V++G+    + VAVK  +  SR     F +TEI     +RH +++  +    
Sbjct: 16  VGKGRYGEVWRGLWHGES-VAVK--IFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDM 72
Query: 526 --CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH-----TG 578
                 +++ L+  Y E G L   L    R  L     L + + AA GL +LH     T 
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFL---QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGL----SRSGPCLDETHVSTGVK-GSFGYLDP 633
               I HRD KS N+L+  N    +AD GL    S+    LD   +    + G+  Y+ P
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLD---IGNNPRVGTKRYMAP 186
Query: 634 EYFRRQQLTDK------SDVYSFGVVLFEVLCARTAVDPLL 668
           E    Q  TD       +D+++FG+VL+E+   RT V+ ++
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI-ARRTIVNGIV 226

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 469 IGSGGFGMVYKGVLR-DNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           +G G FG V  G  +    KVAVK   R    S   + + + EI  L   RH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
                ++  +V EY+  G L  ++    R      +RL   I +A    + H      ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM-----VV 133
Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR-RQQLTD 643
           HRD+K  N+LLD +  +K+ADFGLS      D   + T   GS  Y  PE    R     
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRLYAGP 190
Query: 644 KSDVYSFGVVLFEVLCARTAVD 665
           + D++S GV+L+ +LC     D
Sbjct: 191 EVDIWSCGVILYALLCGTLPFD 212

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LKK +     T +             +GL + H+
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 123 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 177
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCART 662
             +  +   D++S G +  E++  R 
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 20/197 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQ---TEITVLSKIRHRHLVSLVG 524
           IG G FG VY    +R++  VA+K+     +Q   ++Q    E+  L K+RH + +   G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
               +    LV EY         L    + PL   +   +  GA +GL YLH+     +I
Sbjct: 83  CYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMI 137
Query: 585 HRDIKSTNILLDENYVSKVADFG-LSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ---Q 640
           HRD+K+ NILL E  + K+ DFG  S   P       +    G+  ++ PE        Q
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILAMDEGQ 190
Query: 641 LTDKSDVYSFGVVLFEV 657
              K DV+S G+   E+
Sbjct: 191 YDGKVDVWSLGITCIEL 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 469 IGSGGFGMVYKGVLR----DNTKVAVKRGVP---GSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FG+V +G           VAVK   P      + + +F  E+  +  + HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 522 LVGYCEEQSEMILVYEYMEKGPL----KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           L G       M +V E    G L    +KH        LS        +  A G+ YL  
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYL-- 127
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYF 636
             ++  IHRD+ + N+LL    + K+ DFGL R+ P  D+ +V     K  F +  PE  
Sbjct: 128 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 637 RRQQLTDKSDVYSFGVVLFEVL 658
           + +  +  SD + FGV L+E+ 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMF 208

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 463 FDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEITVLSKIR 515
           +D    +GSG F +V K       L+   K   KR    SR+G+   + + E+++L +I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++++L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI LLD N      K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    + L  ++D++S GV+ + +L 
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 469 IGSGGFGMVYKGVLR-DNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           +G G FG V  G  +    KVAVK   R    S   + + + EI  L   RH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
                ++  +V EY+  G L  ++    R      +RL   I +A    + H      ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM-----VV 133
Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR-RQQLTD 643
           HRD+K  N+LLD +  +K+ADFGLS     + +        GS  Y  PE    R     
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 644 KSDVYSFGVVLFEVLCARTAVD 665
           + D++S GV+L+ +LC     D
Sbjct: 191 EVDIWSCGVILYALLCGTLPFD 212

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 469 IGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLV 520
           +G G FG V +    G+ +  T   VAVK    G+         +E+ +L  I  H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 521 SLVGYCEEQS-EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------------IC-- 565
           +L+G C +    ++++ E+ + G L  +L       + +K   E            IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-V 624
              A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D  +V  G  
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDA 210
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 100/208 (48%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++++  LKK +     T +             +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 636 FRR-QQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 469 IGSGGFGMVYKGVLR----DNTKVAVKRGVP---GSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FG+V +G           VAVK   P      + + +F  E+  +  + HR+L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 522 LVGYCEEQSEMILVYEYMEKGPL----KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           L G       M +V E    G L    +KH        LS        +  A G+ YL  
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYL-- 131
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYF 636
             ++  IHRD+ + N+LL    + K+ DFGL R+ P  D+ +V     K  F +  PE  
Sbjct: 132 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 637 RRQQLTDKSDVYSFGVVLFEVL 658
           + +  +  SD + FGV L+E+ 
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMF 212

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 123/285 (43%), Gaps = 67/285 (23%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG----LP---EFQTEITVLSKIR--HR 517
           ++GSGGFG VY G+ + DN  VA+K  V   R      LP       E+ +L K+     
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 518 HLVSLVGYCEEQSEMILVYE-----------YMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
            ++ L+ + E     +L+ E             E+G L++ L         W+      +
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ-----VL 125
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVK 625
            A R  H        G++HRDIK  NIL+D N    K+ DFG   SG  L +T V T   
Sbjct: 126 EAVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFD 175
Query: 626 GSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCARTAV--DPLLAREQV--------- 673
           G+  Y  PE+ R  +   +S  V+S G++L++++C       D  + R QV         
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 235
Query: 674 --NLAEWAM-----------QWQKKGMLEHIIDPQLIGKINLDSL 705
             +L  W +           + Q    ++ ++ PQ   +I+L SL
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 280

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 123/285 (43%), Gaps = 67/285 (23%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG----LP---EFQTEITVLSKIR--HR 517
           ++GSGGFG VY G+ + DN  VA+K  V   R      LP       E+ +L K+     
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 518 HLVSLVGYCEEQSEMILVYE-----------YMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
            ++ L+ + E     +L+ E             E+G L++ L         W+      +
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ-----VL 125
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVK 625
            A R  H        G++HRDIK  NIL+D N    K+ DFG   SG  L +T V T   
Sbjct: 126 EAVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFD 175
Query: 626 GSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCARTAV--DPLLAREQV--------- 673
           G+  Y  PE+ R  +   +S  V+S G++L++++C       D  + R QV         
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 235
Query: 674 --NLAEWAM-----------QWQKKGMLEHIIDPQLIGKINLDSL 705
             +L  W +           + Q    ++ ++ PQ   +I+L SL
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 280

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 469 IGSGGFGMVYKGVLR----DNTKVAVKRGVP---GSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FG+V +G           VAVK   P      + + +F  E+  +  + HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 522 LVGYCEEQSEMILVYEYMEKGPL----KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           L G       M +V E    G L    +KH        LS        +  A G+ YL  
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYL-- 127
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYF 636
             ++  IHRD+ + N+LL    + K+ DFGL R+ P  D+ +V     K  F +  PE  
Sbjct: 128 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 637 RRQQLTDKSDVYSFGVVLFEVL 658
           + +  +  SD + FGV L+E+ 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMF 208

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 123/285 (43%), Gaps = 67/285 (23%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG----LP---EFQTEITVLSKIR--HR 517
           ++GSGGFG VY G+ + DN  VA+K  V   R      LP       E+ +L K+     
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 73
Query: 518 HLVSLVGYCEEQSEMILVYE-----------YMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
            ++ L+ + E     +L+ E             E+G L++ L         W+      +
Sbjct: 74  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ-----VL 124
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVK 625
            A R  H        G++HRDIK  NIL+D N    K+ DFG   SG  L +T V T   
Sbjct: 125 EAVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFD 174
Query: 626 GSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCARTAV--DPLLAREQV--------- 673
           G+  Y  PE+ R  +   +S  V+S G++L++++C       D  + R QV         
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 234
Query: 674 --NLAEWAM-----------QWQKKGMLEHIIDPQLIGKINLDSL 705
             +L  W +           + Q    ++ ++ PQ   +I+L SL
Sbjct: 235 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 279

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 121/258 (46%), Gaps = 60/258 (23%)
Query: 425 GCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRD 484
           G  S SK++  TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D
Sbjct: 1   GAMSLSKVT--TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCD 48
Query: 485 NTK-VAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQSEMILVY 536
           + + VA+K+ +   R     F+  E+ ++ K+ H ++V L       G  +++  + LV 
Sbjct: 49  SGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 103
Query: 537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKS 590
           +Y+ +      +Y   R     KQ L +           R L Y+H+    GI HRDIK 
Sbjct: 104 DYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKP 155
Query: 591 TNILLD-ENYVSKVADFGLSRSGPCLDETHVSTGVKG--SFGYLDPEYFRRQQL------ 641
            N+LLD +  V K+ DFG ++             V+G  +  Y+   Y+R  +L      
Sbjct: 156 QNLLLDPDTAVLKLCDFGSAKQ-----------LVRGEPNVSYICSRYYRAPELIFGATD 204
Query: 642 -TDKSDVYSFGVVLFEVL 658
            T   DV+S G VL E+L
Sbjct: 205 YTSSIDVWSAGCVLAELL 222

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 123/285 (43%), Gaps = 67/285 (23%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG----LP---EFQTEITVLSKIR--HR 517
           ++GSGGFG VY G+ + DN  VA+K  V   R      LP       E+ +L K+     
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 518 HLVSLVGYCEEQSEMILVYE-----------YMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
            ++ L+ + E     +L+ E             E+G L++ L         W+      +
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ-----VL 125
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVK 625
            A R  H        G++HRDIK  NIL+D N    K+ DFG   SG  L +T V T   
Sbjct: 126 EAVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFD 175
Query: 626 GSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCARTAV--DPLLAREQV--------- 673
           G+  Y  PE+ R  +   +S  V+S G++L++++C       D  + R QV         
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 235
Query: 674 --NLAEWAM-----------QWQKKGMLEHIIDPQLIGKINLDSL 705
             +L  W +           + Q    ++ ++ PQ   +I+L SL
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 280

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 23/221 (10%)
Query: 452 PFTDLQTATNNFDKNLI--IGSGGFGMVYKGVLR----DNTKVAVKRGVP---GSRQGLP 502
           P   L       D  L+  +G G FG+V +G           VAVK   P      + + 
Sbjct: 7   PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL----KKHLYGPDRTPLSW 558
           +F  E+  +  + HR+L+ L G       M +V E    G L    +KH        LS 
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS- 124
Query: 559 KQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET 618
                  +  A G+ YL    ++  IHRD+ + N+LL    + K+ DFGL R+ P  D+ 
Sbjct: 125 ----RYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 619 HV-STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            V     K  F +  PE  + +  +  SD + FGV L+E+ 
Sbjct: 178 XVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 469 IGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLV 520
           +G G FG V +    G+ +  T   VAVK    G+         +E+ +L  I  H ++V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 521 SLVGYCEEQS-EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------------IC-- 565
           +L+G C +    ++++ E+ + G L  +L       + +K   E            IC  
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-V 624
              A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D  +V  G  
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDA 247
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 281

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTK---VAVKR-GVPGSRQGLP-EFQTEITVLSK 513
           AT+ ++    IG G +G VYK   RD      VA+K   VP   +GLP     E+ +L +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 514 IR---HRHLVSLVGYC-----EEQSEMILVYEYMEKGPLKKHLYGPDRTP---LSWKQRL 562
           +    H ++V L+  C     + + ++ LV+E++++  L+ +L   D+ P   L  +   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAETIK 115
Query: 563 EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST 622
           ++     RGL +LH   A  I+HRD+K  NIL+      K+ADFGL+R            
Sbjct: 116 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALA 169
Query: 623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            V  +  Y  PE   +       D++S G +  E+ 
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++    LKK +     T +             +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYC 526
           +I +  FG+      R      +K G   S        +E+ +L  I  H ++V+L+G C
Sbjct: 43  VIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGAC 100
Query: 527 EEQS-EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------------IC--IGAARG 571
            +    ++++ E+ + G L  +L       + +K   E            IC     A+G
Sbjct: 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGSFGY 630
           + +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D   V  G  +    +
Sbjct: 161 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX-KDPDXVRKGDARLPLKW 216
Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 217 MAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH--- 516
            ++F++  ++G G FG V K     +++    + +  + + L    +E+ +L+ + H   
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 517 ----------RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPD---RTPLSWKQRLE 563
                     R+ V  +   +++S + +  EY E G L   ++  +   +    W+   +
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS-GPCLDETHVS- 621
           I       L Y+H+   +GIIHRD+K  NI +DE+   K+ DFGL+++    LD   +  
Sbjct: 125 IL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 622 ----------TGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVL 658
                     T   G+  Y+  E         +K D+YS G++ FE++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 469 IGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLV 520
           +G G FG V +    G+ +  T   VAVK    G+         +E+ +L  I  H ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 521 SLVGYCEEQS-EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------------IC-- 565
           +L+G C +    ++++ E+ + G L  +L       + +K   E            IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-V 624
              A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D  +V  G  
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDA 201
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 469 IGSGGFGMVYK----GVLRDNTK--VAVKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLV 520
           +G G FG V +    G+ +  T   VAVK    G+         +E+ +L  I  H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 521 SLVGYCEEQS-EMILVYEYMEKGPLKKHLYGPD----------RTPLSWKQRLEICIGAA 569
           +L+G C +    ++++ E+ + G L  +L              +  L+ +  +      A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGSF 628
           +G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D  +V  G  +   
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARD-IYKDPDYVRKGDARLPL 210
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++    LKK +     T +             +GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 121 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 43/216 (19%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG----LP---EFQTEITVLSKIR--HR 517
           ++GSGGFG VY G+ + DN  VA+K  V   R      LP       E+ +L K+     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 518 HLVSLVGYCEEQSEMILVYE-----------YMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
            ++ L+ + E     +L+ E             E+G L++ L         W+      +
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ-----VL 120
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVK 625
            A R  H        G++HRDIK  NIL+D N    K+ DFG   SG  L +T V T   
Sbjct: 121 EAVRHCH------NXGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFD 170
Query: 626 GSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCA 660
           G+  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF-QTEIT 509
           +PF   +T          +G G +G V++G  +    VAVK  +  SR     F +TE+ 
Sbjct: 27  LPFLVQRTVARQITLLECVGKGRYGEVWRGSWQ-GENVAVK--IFSSRDEKSWFRETELY 83
Query: 510 VLSKIRHRHLVSLVGY----CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEIC 565
               +RH +++  +          +++ L+  Y E G L  +L     T L     L I 
Sbjct: 84  NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIV 140
Query: 566 IGAARGLHYLH-----TGSAEGIIHRDIKSTNILLDENYVSKVADFGLS-RSGPCLDETH 619
           +  A GL +LH     T     I HRD+KS NIL+ +N    +AD GL+       ++  
Sbjct: 141 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 200
Query: 620 VSTGVK-GSFGYLDPEYFRRQQLTD------KSDVYSFGVVLFEV 657
           V    + G+  Y+ PE        D      + D+++FG+VL+EV
Sbjct: 201 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPE-FQTEIT 509
           D +      +    IG G FG V++G+          VA+K     +   + E F  E  
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
            + +  H H+V L+G   E    I++ E    G L+  L    +  L     +      +
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL-QVRKFSLDLASLILYAYQLS 121
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF- 628
             L YL +   +  +HRDI + N+L+      K+ DFGLSR    ++++      KG   
Sbjct: 122 TALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRY---MEDSTYYKASKGKLP 175
Query: 629 -GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 109/247 (44%), Gaps = 35/247 (14%)
Query: 437 VNASPGQNGY-HRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYK----GVLRDNTK--VA 489
           V   P Q  Y H+ + P   L     +F K L  G+G FG V +    G+++ +    VA
Sbjct: 21  VXIDPTQLPYDHKWEFPRNRL-----SFGKTL--GAGAFGKVVEATAYGLIKSDAAMTVA 73
Query: 490 VKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKH 547
           VK   P +     E   +E+ VLS +  H ++V+L+G C      +++ EY   G L   
Sbjct: 74  VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 133
Query: 548 LYGPDRTPLSWKQRLEICIG----------------AARGLHYLHTGSAEGIIHRDIKST 591
           L     + +  K    I                    A+G+ +L   +++  IHRD+ + 
Sbjct: 134 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAAR 190
Query: 592 NILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFG 651
           NILL    ++K+ DFGL+R         V    +    ++ PE       T +SDV+S+G
Sbjct: 191 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 250
Query: 652 VVLFEVL 658
           + L+E+ 
Sbjct: 251 IFLWELF 257

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 469 IGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLV 520
           +G G FG V +    G+ +  T   VAVK    G+         +E+ +L  I  H ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 521 SLVGYCEEQS-EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------------IC-- 565
           +L+G C +    ++++ E+ + G L  +L       + +K   E            IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-V 624
              A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D  +V  G  
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDA 201
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 123/285 (43%), Gaps = 67/285 (23%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG----LP---EFQTEITVLSKIR--HR 517
           ++GSGGFG VY G+ + DN  VA+K  V   R      LP       E+ +L K+     
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 96
Query: 518 HLVSLVGYCEEQSEMILVYE-----------YMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
            ++ L+ + E     +L+ E             E+G L++ L         W+      +
Sbjct: 97  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ-----VL 147
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVK 625
            A R  H        G++HRDIK  NIL+D N    K+ DFG   SG  L +T V T   
Sbjct: 148 EAVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFD 197
Query: 626 GSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCARTAV--DPLLAREQV--------- 673
           G+  Y  PE+ R  +   +S  V+S G++L++++C       D  + R QV         
Sbjct: 198 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE 257
Query: 674 --NLAEWAM-----------QWQKKGMLEHIIDPQLIGKINLDSL 705
             +L  W +           + Q    ++ ++ PQ   +I+L SL
Sbjct: 258 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 302

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 122/264 (46%), Gaps = 62/264 (23%)
Query: 423 AYGCSSHSKMSEG----TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVY 478
           A+G    S+  +G    TV A+PGQ      ++ +TD +          +IG+G FG+VY
Sbjct: 22  AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVY 71
Query: 479 KGVLRDNTK-VAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQS 530
           +  L D+ + VA+K+ +   R     F+  E+ ++ K+ H ++V L       G  +++ 
Sbjct: 72  QAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126
Query: 531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGII 584
            + LV +Y+ +      +Y   R     KQ L +           R L Y+H+    GI 
Sbjct: 127 YLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GIC 178
Query: 585 HRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHVSTGVKG--SFGYLDPEYFRRQQL 641
           HRDIK  N+LLD +  V K+ DFG ++             V+G  +  Y+   Y+R  +L
Sbjct: 179 HRDIKPQNLLLDPDTAVLKLCDFGSAKQ-----------LVRGEPNVSYICSRYYRAPEL 227
Query: 642 -------TDKSDVYSFGVVLFEVL 658
                  T   DV+S G VL E+L
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 122/264 (46%), Gaps = 62/264 (23%)
Query: 423 AYGCSSHSKMSEG----TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVY 478
           A+G    S+  +G    TV A+PGQ      ++ +TD +          +IG+G FG+VY
Sbjct: 16  AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVY 65
Query: 479 KGVLRDNTK-VAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQS 530
           +  L D+ + VA+K+ +   R     F+  E+ ++ K+ H ++V L       G  +++ 
Sbjct: 66  QAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 120
Query: 531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGII 584
            + LV +Y+ +      +Y   R     KQ L +           R L Y+H+    GI 
Sbjct: 121 YLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GIC 172
Query: 585 HRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHVSTGVKG--SFGYLDPEYFRRQQL 641
           HRDIK  N+LLD +  V K+ DFG ++             V+G  +  Y+   Y+R  +L
Sbjct: 173 HRDIKPQNLLLDPDTAVLKLCDFGSAKQ-----------LVRGEPNVSYICSRYYRAPEL 221
Query: 642 -------TDKSDVYSFGVVLFEVL 658
                  T   DV+S G VL E+L
Sbjct: 222 IFGATDYTSSIDVWSAGCVLAELL 245

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 39/229 (17%)
Query: 454 TDLQTATNNFDKN---LIIGSGGFGMVYKGV-LRDNTKVAVKRGVP--GSRQGLPEFQTE 507
           +DL      +D+N   +++G G +G+VY G  L +  ++A+K  +P   SR   P    E
Sbjct: 12  SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKE-IPERDSRYSQP-LHEE 69
Query: 508 ITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL---YGPDR-----TPLSWK 559
           I +   ++H+++V  +G   E   + +  E +  G L   L   +GP +          K
Sbjct: 70  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129
Query: 560 QRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-NYVSKVADFGLSRS----GPC 614
           Q LE       GL YLH      I+HRDIK  N+L++  + V K++DFG S+      PC
Sbjct: 130 QILE-------GLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 615 LDETHVSTGVKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCAR 661
            +         G+  Y+ PE   +  +     +D++S G  + E+   +
Sbjct: 180 TET------FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTK---VAVKR-GVPGSRQGLP-EFQTEITVLSK 513
           AT+ ++    IG G +G VYK   RD      VA+K   VP   +GLP     E+ +L +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 514 IR---HRHLVSLVGYC-----EEQSEMILVYEYMEKGPLKKHLYGPDRTP---LSWKQRL 562
           +    H ++V L+  C     + + ++ LV+E++++  L+ +L   D+ P   L  +   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAETIK 115
Query: 563 EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST 622
           ++     RGL +LH   A  I+HRD+K  NIL+      K+ADFGL+R            
Sbjct: 116 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALD 169
Query: 623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            V  +  Y  PE   +       D++S G +  E+ 
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 122/264 (46%), Gaps = 62/264 (23%)
Query: 423 AYGCSSHSKMSEG----TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVY 478
           A+G    S+  +G    TV A+PGQ      ++ +TD +          +IG+G FG+VY
Sbjct: 24  AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVY 73
Query: 479 KGVLRDNTK-VAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQS 530
           +  L D+ + VA+K+ +   R     F+  E+ ++ K+ H ++V L       G  +++ 
Sbjct: 74  QAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 128
Query: 531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGII 584
            + LV +Y+ +      +Y   R     KQ L +           R L Y+H+    GI 
Sbjct: 129 YLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GIC 180
Query: 585 HRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHVSTGVKG--SFGYLDPEYFRRQQL 641
           HRDIK  N+LLD +  V K+ DFG ++             V+G  +  Y+   Y+R  +L
Sbjct: 181 HRDIKPQNLLLDPDTAVLKLCDFGSAKQ-----------LVRGEPNVSYICSRYYRAPEL 229
Query: 642 -------TDKSDVYSFGVVLFEVL 658
                  T   DV+S G VL E+L
Sbjct: 230 IFGATDYTSSIDVWSAGCVLAELL 253

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 469 IGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLV 520
           +G G FG V +    G+ +  T   VAVK    G+         +E+ +L  I  H ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 521 SLVGYCEEQS-EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------------IC-- 565
           +L+G C +    ++++ E+ + G L  +L       + +K   E            IC  
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-V 624
              A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D   V  G  
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX-KDPDXVRKGDA 201
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 462 NFDKNLI---IGSGGFGMVYKGVLRDNTKVAVKRGVPGS----RQGLPEFQTEITVLSKI 514
           NFD   I   IG G FG V      D  K+   + +       R  +     E+ ++  +
Sbjct: 13  NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ---RLEICIGAARG 571
            H  LV+L    +++ +M +V + +  G L+ HL    +  + +K+   +L IC      
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFIC-ELVMA 127
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YL     + IIHRD+K  NILLDE+    + DF ++   P   ET ++T + G+  Y+
Sbjct: 128 LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITT-MAGTKPYM 181
Query: 632 DPEYFRRQQLTDKS---DVYSFGVVLFEVLCAR 661
            PE F  ++    S   D +S GV  +E+L  R
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 118/256 (46%), Gaps = 46/256 (17%)
Query: 423 AYGCSSHSKMSEG----TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVY 478
           A+G    S+  +G    TV A+PGQ      ++ +TD +          +IG+G FG+VY
Sbjct: 22  AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVY 71
Query: 479 KGVLRDNTK-VAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQS 530
           +  L D+ + VA+K+ +   R     F+  E+ ++ K+ H ++V L       G  +++ 
Sbjct: 72  QAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126
Query: 531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGII 584
            + LV +Y+ +      +Y   R     KQ L +           R L Y+H+    GI 
Sbjct: 127 YLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GIC 178
Query: 585 HRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLT 642
           HRDIK  N+LLD +  V K+ DFG ++    L     +     S  Y  PE  F     T
Sbjct: 179 HRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYT 235
Query: 643 DKSDVYSFGVVLFEVL 658
              DV+S G VL E+L
Sbjct: 236 SSIDVWSAGCVLAELL 251

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 14/217 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQ---TEITVLSKIRHRHLVSLVGY 525
           IG+G +G   K   + + K+ V + +        E Q   +E+ +L +++H ++V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 526 CEEQSE--MILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
             +++   + +V EY E G L   +     +R  L  +  L +       L   H  S  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 582 G--IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
           G  ++HRD+K  N+ LD     K+ DFGL+R     DE      V G+  Y+ PE   R 
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DEDFAKEFV-GTPYYMSPEQMNRM 191
Query: 640 QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLA 676
              +KSD++S G +L+E LCA   + P  A  Q  LA
Sbjct: 192 SYNEKSDIWSLGCLLYE-LCA--LMPPFTAFSQKELA 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 469 IGSGGFGMVYKGV--LRDNTKVAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSLVGY 525
           +G G +  VYKG   L DN  VA+K       +G P     E+++L  ++H ++V+L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
              +  + LV+EY++K  LK++L            +L       RGL Y H    + ++H
Sbjct: 69  IHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKL-FLFQLLRGLAYCH---RQKVLH 123
Query: 586 RDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR-RQQLTDK 644
           RD+K  N+L++E    K+ADFGL+R+     +T+ +  V  +  Y  P+        + +
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYSTQ 181
Query: 645 SDVYSFGVVLFEVLCAR 661
            D++  G + +E+   R
Sbjct: 182 IDMWGVGCIFYEMATGR 198

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 469 IGSGGFGMVYKGVLR----DNTKVAVKRGVP---GSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FG+V +G           VAVK   P      + + +F  E+  +  + HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 522 LVGYCEEQSEMILVYEYMEKGPL----KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           L G       M +V E    G L    +KH        LS        +  A G+ YL  
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYL-- 127
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYF 636
             ++  IHRD+ + N+LL    + K+ DFGL R+ P  D+  V     K  F +  PE  
Sbjct: 128 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 186
Query: 637 RRQQLTDKSDVYSFGVVLFEVL 658
           + +  +  SD + FGV L+E+ 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMF 208

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 43/216 (19%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG----LP---EFQTEITVLSKIR--HR 517
           ++GSGGFG VY G+ + DN  VA+K  V   R      LP       E+ +L K+     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 518 HLVSLVGYCEEQSEMILVYE-----------YMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
            ++ L+ + E     +L+ E             E+G L++ L         W+      +
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ-----VL 120
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVK 625
            A R  H        G++HRDIK  NIL+D N    K+ DFG   SG  L +T V T   
Sbjct: 121 EAVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFD 170
Query: 626 GSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCA 660
           G+  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYC 526
           +I +  FG+      R      +K G   S        +E+ +L  I  H ++V+L+G C
Sbjct: 43  VIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGAC 100
Query: 527 EEQS-EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------------IC--IGAARG 571
            +    ++++ E+ + G L  +L       + +K   E            IC     A+G
Sbjct: 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGSFGY 630
           + +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D   V  G  +    +
Sbjct: 161 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDXVRKGDARLPLKW 216
Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           + PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 217 MAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 43/216 (19%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG----LP---EFQTEITVLSKIR--HR 517
           ++GSGGFG VY G+ + DN  VA+K  V   R      LP       E+ +L K+     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 518 HLVSLVGYCEEQSEMILVYE-----------YMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
            ++ L+ + E     +L+ E             E+G L++ L         W+      +
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ-----VL 120
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVK 625
            A R  H        G++HRDIK  NIL+D N    K+ DFG   SG  L +T V T   
Sbjct: 121 EAVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFD 170
Query: 626 GSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCA 660
           G+  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 43/216 (19%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG----LP---EFQTEITVLSKIR--HR 517
           ++GSGGFG VY G+ + DN  VA+K  V   R      LP       E+ +L K+     
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 72
Query: 518 HLVSLVGYCEEQSEMILVYE-----------YMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
            ++ L+ + E     +L+ E             E+G L++ L         W+      +
Sbjct: 73  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ-----VL 123
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVK 625
            A R  H        G++HRDIK  NIL+D N    K+ DFG   SG  L +T V T   
Sbjct: 124 EAVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFD 173
Query: 626 GSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCA 660
           G+  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 174 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 122/262 (46%), Gaps = 58/262 (22%)
Query: 423 AYGCSSHSKMSEG----TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVY 478
           A+G    S+  +G    TV A+PGQ      ++ +TD +          +IG+G FG+VY
Sbjct: 26  AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVY 75
Query: 479 KGVLRDNTK-VAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQS 530
           +  L D+ + VA+K+ +   R     F+  E+ ++ K+ H ++V L       G  +++ 
Sbjct: 76  QAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 130
Query: 531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGII 584
            + LV +Y+ +      +Y   R     KQ L +           R L Y+H+    GI 
Sbjct: 131 YLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GIC 182
Query: 585 HRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL-- 641
           HRDIK  N+LLD +  V K+ DFG ++      E +VS        Y+   Y+R  +L  
Sbjct: 183 HRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--------YICSRYYRAPELIF 233
Query: 642 -----TDKSDVYSFGVVLFEVL 658
                T   DV+S G VL E+L
Sbjct: 234 GATDYTSSIDVWSAGCVLAELL 255

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 469 IGSGGFGMVYK----GVLRDNT--KVAVKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLV 520
           +G G FG V +    G+ +  T   VAVK    G+         +E+ +L  I  H ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 521 SLVGYCEEQS-EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------------IC-- 565
           +L+G C +    ++++ E+ + G L  +L       + +K   E            IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-V 624
              A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D   V  G  
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX-KDPDXVRKGDA 201
Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTK---VAVKR-GVPGSRQGLP-EFQTEITVLSK 513
           AT+ ++    IG G +G VYK   RD      VA+K   VP   +GLP     E+ +L +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 514 IR---HRHLVSLVGYC-----EEQSEMILVYEYMEKGPLKKHLYGPDRTP---LSWKQRL 562
           +    H ++V L+  C     + + ++ LV+E++++  L+ +L   D+ P   L  +   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAETIK 115
Query: 563 EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST 622
           ++     RGL +LH   A  I+HRD+K  NIL+      K+ADFGL+R            
Sbjct: 116 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALF 169
Query: 623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            V  +  Y  PE   +       D++S G +  E+ 
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSRQGLPE-FQTEIT 509
           D +      +    IG G FG V++G+          VA+K     +   + E F  E  
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
            + +  H H+V L+G   E    I++ E    G L+  L    +  L     +      +
Sbjct: 444 TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFL-QVRKFSLDLASLILYAYQLS 501
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF- 628
             L YL +   +  +HRDI + N+L+      K+ DFGLSR    ++++      KG   
Sbjct: 502 TALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRY---MEDSTYYKASKGKLP 555
Query: 629 -GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 34/235 (14%)
Query: 451 IPFTDLQTATNNFDKN--------LIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSR 498
           +P  D +  +NN D+         +++G G FG V     KG         +K+ V    
Sbjct: 1   MPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQD 60
Query: 499 QGLPEFQTEITVLSKIRHRHLVSLVGYC-EEQSEMILVYEYMEKGPLKKHL--YGPDRTP 555
             +     E  VL+ +     ++ +  C +    +  V EY+  G L  H+   G  + P
Sbjct: 61  DDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP 120
Query: 556 LSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL 615
            +     EI IG    L +LH     GII+RD+K  N++LD     K+ADFG+ +     
Sbjct: 121 QAVFYAAEISIG----LFFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---- 169
Query: 616 DETHVSTGVK-----GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
              H+  GV      G+  Y+ PE    Q      D +++GV+L+E+L  +   D
Sbjct: 170 ---HMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 122/262 (46%), Gaps = 58/262 (22%)
Query: 423 AYGCSSHSKMSEG----TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVY 478
           A+G    S+  +G    TV A+PGQ      ++ +TD +          +IG+G FG+VY
Sbjct: 67  AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVY 116
Query: 479 KGVLRDNTK-VAVKRGVPGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQS 530
           +  L D+ + VA+K+ +   R     F+  E+ ++ K+ H ++V L       G  +++ 
Sbjct: 117 QAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 171
Query: 531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGII 584
            + LV +Y+ +      +Y   R     KQ L +           R L Y+H+    GI 
Sbjct: 172 YLNLVLDYVPET-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GIC 223
Query: 585 HRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL-- 641
           HRDIK  N+LLD +  V K+ DFG ++      E +VS        Y+   Y+R  +L  
Sbjct: 224 HRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--------YICSRYYRAPELIF 274
Query: 642 -----TDKSDVYSFGVVLFEVL 658
                T   DV+S G VL E+L
Sbjct: 275 GATDYTSSIDVWSAGCVLAELL 296

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 12/212 (5%)
Query: 452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQT 506
           P ++     ++F    +IG G FG V     +        KV  K+ +   ++       
Sbjct: 29  PSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE 88
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
              +L  ++H  LV L    +   ++  V +Y+  G L  HL   +R  L  + R     
Sbjct: 89  RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARF-YAA 146
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
             A  L YLH+ +   I++RD+K  NILLD      + DFGL +    ++    ++   G
Sbjct: 147 EIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN--IEHNSTTSTFCG 201
Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +  YL PE   +Q      D +  G VL+E+L
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 109/247 (44%), Gaps = 35/247 (14%)
Query: 437 VNASPGQNGY-HRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYK----GVLRDNTK--VA 489
           V   P Q  Y H+ + P   L     +F K L  G+G FG V +    G+++ +    VA
Sbjct: 5   VYIDPTQLPYDHKWEFPRNRL-----SFGKTL--GAGAFGKVVEATAYGLIKSDAAMTVA 57
Query: 490 VKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKH 547
           VK   P +     E   +E+ VLS +  H ++V+L+G C      +++ EY   G L   
Sbjct: 58  VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117
Query: 548 LYGPDRTPLSWKQRLEICIG----------------AARGLHYLHTGSAEGIIHRDIKST 591
           L     + +  K    I                    A+G+ +L   +++  IHRD+ + 
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAAR 174
Query: 592 NILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFG 651
           NILL    ++K+ DFGL+R         V    +    ++ PE       T +SDV+S+G
Sbjct: 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 234
Query: 652 VVLFEVL 658
           + L+E+ 
Sbjct: 235 IFLWELF 241

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 33/229 (14%)
Query: 469 IGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL----- 522
           +G GG G+V+  V  D + +VA+K+ V    Q +     EI ++ ++ H ++V +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 523 ---------VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
                    VG   E + + +V EYME   L   L   ++ PL  +          RGL 
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVL---EQGPLLEEHARLFMYQLLRGLK 134
Query: 574 YLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSRSGPCLD-----ETHVSTGVKGS 627
           Y+H+ +   ++HRD+K  N+ ++ E+ V K+ DFGL+R    +D     + H+S G+   
Sbjct: 135 YIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR---IMDPHYSHKGHLSEGLVTK 188
Query: 628 FGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL 675
           + Y  P         T   D+++ G +  E+L  +T        EQ+ L
Sbjct: 189 W-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 109/247 (44%), Gaps = 35/247 (14%)
Query: 437 VNASPGQNGY-HRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYK----GVLRDNTK--VA 489
           V   P Q  Y H+ + P   L     +F K L  G+G FG V +    G+++ +    VA
Sbjct: 23  VYIDPTQLPYDHKWEFPRNRL-----SFGKTL--GAGAFGKVVEATAYGLIKSDAAMTVA 75
Query: 490 VKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKH 547
           VK   P +     E   +E+ VLS +  H ++V+L+G C      +++ EY   G L   
Sbjct: 76  VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 135
Query: 548 LYGPDRTPLSWKQRLEICIG----------------AARGLHYLHTGSAEGIIHRDIKST 591
           L     + +  K    I                    A+G+ +L   +++  IHRD+ + 
Sbjct: 136 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAAR 192
Query: 592 NILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFG 651
           NILL    ++K+ DFGL+R         V    +    ++ PE       T +SDV+S+G
Sbjct: 193 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 252
Query: 652 VVLFEVL 658
           + L+E+ 
Sbjct: 253 IFLWELF 259

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 10/207 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LK  +     T +             +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++ +  LK  +     T +             +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 114/246 (46%), Gaps = 56/246 (22%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 5   TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 54
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKHL 548
               QG      E+ ++ K+ H ++V L       G  +++  + LV +Y+ +      +
Sbjct: 55  ----QGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-----V 105
Query: 549 YGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVS 601
           Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V 
Sbjct: 106 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 162
Query: 602 KVADFGLSRSGPCLDETHVSTGVKG--SFGYLDPEYFRRQQL-------TDKSDVYSFGV 652
           K+ DFG ++             V+G  +  Y+   Y+R  +L       T   DV+S G 
Sbjct: 163 KLCDFGSAKQ-----------LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 211
Query: 653 VLFEVL 658
           VL E+L
Sbjct: 212 VLAELL 217

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKR------GVPGSRQGLPEF--QTEITVLSKIRHRHL 519
           +GSG  G V     R   K VA+K        +  +R+  P    +TEI +L K+ H  +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR-----TPLSWKQRLEICIGAARGLHY 574
           + +  + + +   I V E ME G L   + G  R       L + Q L         + Y
Sbjct: 77  IKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 128
Query: 575 LHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           LH     GIIHRD+K  N+LL   +E+ + K+ DFG S+    L ET +   + G+  YL
Sbjct: 129 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLCGTPTYL 182
Query: 632 DPEYFRR---QQLTDKSDVYSFGVVLFEVL 658
            PE              D +S GV+LF  L
Sbjct: 183 APEVLVSVGTAGYNRAVDCWSLGVILFICL 212

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 35/219 (15%)
Query: 458 TATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR--------GVPGSRQGLPEFQTEI 508
           T+ + + +   +G G +G VYK +    N  VA+KR        GVPG+         E+
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI------REV 84
Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIG 567
           ++L +++HR+++ L         + L++EY E   LKK++   D+ P +S +        
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYM---DKNPDVSMRVIKSFLYQ 140
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILL-----DENYVSKVADFGLSRSG--PCLDETHV 620
              G+++ H+      +HRD+K  N+LL      E  V K+ DFGL+R+   P    TH 
Sbjct: 141 LINGVNFCHSRRC---LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
Query: 621 STGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVL 658
                 +  Y  PE     +  +   D++S   +  E+L
Sbjct: 198 II----TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 114/246 (46%), Gaps = 56/246 (22%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 5   TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 54
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKHL 548
               QG      E+ ++ K+ H ++V L       G  +++  + LV +Y+ +      +
Sbjct: 55  ----QGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-----V 105
Query: 549 YGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVS 601
           Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V 
Sbjct: 106 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 162
Query: 602 KVADFGLSRSGPCLDETHVSTGVKG--SFGYLDPEYFRRQQL-------TDKSDVYSFGV 652
           K+ DFG ++             V+G  +  Y+   Y+R  +L       T   DV+S G 
Sbjct: 163 KLCDFGSAKQ-----------LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 211
Query: 653 VLFEVL 658
           VL E+L
Sbjct: 212 VLAELL 217

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGVLRDNTK-VAV------KRGVPGSRQGLPEF--QTEITVLSKIRHRHL 519
           +GSG  G V     R   K VA+      K  +  +R+  P    +TEI +L K+ H  +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR-----TPLSWKQRLEICIGAARGLHY 574
           + +  + + +   I V E ME G L   + G  R       L + Q L         + Y
Sbjct: 217 IKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 268
Query: 575 LHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           LH     GIIHRD+K  N+LL   +E+ + K+ DFG S+    L ET +   + G+  YL
Sbjct: 269 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLCGTPTYL 322
Query: 632 DPEYFRR---QQLTDKSDVYSFGVVLFEVL 658
            PE              D +S GV+LF  L
Sbjct: 323 APEVLVSVGTAGYNRAVDCWSLGVILFICL 352

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 109/247 (44%), Gaps = 35/247 (14%)
Query: 437 VNASPGQNGY-HRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYK----GVLRDNTK--VA 489
           V   P Q  Y H+ + P   L     +F K L  G+G FG V +    G+++ +    VA
Sbjct: 28  VYIDPTQLPYDHKWEFPRNRL-----SFGKTL--GAGAFGKVVEATAYGLIKSDAAMTVA 80
Query: 490 VKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKH 547
           VK   P +     E   +E+ VLS +  H ++V+L+G C      +++ EY   G L   
Sbjct: 81  VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 140
Query: 548 LYGPDRTPLSWKQRLEICIG----------------AARGLHYLHTGSAEGIIHRDIKST 591
           L     + +  K    I                    A+G+ +L   +++  IHRD+ + 
Sbjct: 141 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAAR 197
Query: 592 NILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFG 651
           NILL    ++K+ DFGL+R         V    +    ++ PE       T +SDV+S+G
Sbjct: 198 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 257
Query: 652 VVLFEVL 658
           + L+E+ 
Sbjct: 258 IFLWELF 264

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKR------GVPGSRQGLPEF--QTEITVLSKIRHRHL 519
           +GSG  G V     R   K VA+K        +  +R+  P    +TEI +L K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR-----TPLSWKQRLEICIGAARGLHY 574
           + +  + + +   I V E ME G L   + G  R       L + Q L         + Y
Sbjct: 78  IKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 129
Query: 575 LHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           LH     GIIHRD+K  N+LL   +E+ + K+ DFG S+    L ET +   + G+  YL
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLCGTPTYL 183
Query: 632 DPEYFRR---QQLTDKSDVYSFGVVLFEVL 658
            PE              D +S GV+LF  L
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICL 213

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKR------GVPGSRQGLPEF--QTEITVLSKIRHRHL 519
           +GSG  G V     R   K VA+K        +  +R+  P    +TEI +L K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR-----TPLSWKQRLEICIGAARGLHY 574
           + +  + + +   I V E ME G L   + G  R       L + Q L         + Y
Sbjct: 78  IKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 129
Query: 575 LHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           LH     GIIHRD+K  N+LL   +E+ + K+ DFG S+    L ET +   + G+  YL
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLCGTPTYL 183
Query: 632 DPEYFRR---QQLTDKSDVYSFGVVLFEVL 658
            PE              D +S GV+LF  L
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICL 213

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGVLRDNTK-VAV------KRGVPGSRQGLPEF--QTEITVLSKIRHRHL 519
           +GSG  G V     R   K VA+      K  +  +R+  P    +TEI +L K+ H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR-----TPLSWKQRLEICIGAARGLHY 574
           + +  + + +   I V E ME G L   + G  R       L + Q L         + Y
Sbjct: 203 IKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 254
Query: 575 LHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           LH     GIIHRD+K  N+LL   +E+ + K+ DFG S+    L ET +   + G+  YL
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLCGTPTYL 308
Query: 632 DPEYFRR---QQLTDKSDVYSFGVVLFEVL 658
            PE              D +S GV+LF  L
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICL 338

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKR------GVPGSRQGLPEF--QTEITVLSKIRHRHL 519
           +GSG  G V     R   K VA+K        +  +R+  P    +TEI +L K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR-----TPLSWKQRLEICIGAARGLHY 574
           + +  + + +   I V E ME G L   + G  R       L + Q L         + Y
Sbjct: 78  IKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 129
Query: 575 LHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           LH     GIIHRD+K  N+LL   +E+ + K+ DFG S+    L ET +   + G+  YL
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLCGTPTYL 183
Query: 632 DPEYFRR---QQLTDKSDVYSFGVVLFEVL 658
            PE              D +S GV+LF  L
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICL 213

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 24/219 (10%)
Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITV 510
           IPF  L+          +IG G FG VY G       + +      +   L  F+ E+  
Sbjct: 30  IPFEQLEIGE-------LIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR 570
             + RH ++V  +G C     + ++   + KG     +    +  L   +  +I     +
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITS-LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVK 141
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK---GS 627
           G+ YLH   A+GI+H+D+KS N+  D   V  + DFGL      L        ++   G 
Sbjct: 142 GMGYLH---AKGILHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 628 FGYLDPEYFR---------RQQLTDKSDVYSFGVVLFEV 657
             +L PE  R         +   +  SDV++ G + +E+
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 109/247 (44%), Gaps = 35/247 (14%)
Query: 437 VNASPGQNGY-HRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYK----GVLRDNTK--VA 489
           V   P Q  Y H+ + P   L     +F K L  G+G FG V +    G+++ +    VA
Sbjct: 28  VYIDPTQLPYDHKWEFPRNRL-----SFGKTL--GAGAFGKVVEATAYGLIKSDAAMTVA 80
Query: 490 VKRGVPGSRQGLPE-FQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKH 547
           VK   P +     E   +E+ VLS +  H ++V+L+G C      +++ EY   G L   
Sbjct: 81  VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 140
Query: 548 LYGPDRTPLSWKQRLEICIG----------------AARGLHYLHTGSAEGIIHRDIKST 591
           L     + +  K    I                    A+G+ +L   +++  IHRD+ + 
Sbjct: 141 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAAR 197
Query: 592 NILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFG 651
           NILL    ++K+ DFGL+R         V    +    ++ PE       T +SDV+S+G
Sbjct: 198 NILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 257
Query: 652 VVLFEVL 658
           + L+E+ 
Sbjct: 258 IFLWELF 264

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKR------GVPGSRQGLPEF--QTEITVLSKIRHRHL 519
           +GSG  G V     R   K VA+K        +  +R+  P    +TEI +L K+ H  +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR-----TPLSWKQRLEICIGAARGLHY 574
           + +  + + +   I V E ME G L   + G  R       L + Q L         + Y
Sbjct: 84  IKIKNFFDAEDYYI-VLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 135
Query: 575 LHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           LH     GIIHRD+K  N+LL   +E+ + K+ DFG S+    L ET +   + G+  YL
Sbjct: 136 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLCGTPTYL 189
Query: 632 DPEYFRR---QQLTDKSDVYSFGVVLFEVL 658
            PE              D +S GV+LF  L
Sbjct: 190 APEVLVSVGTAGYNRAVDCWSLGVILFICL 219

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 107/241 (44%), Gaps = 31/241 (12%)
Query: 432 MSEGTVNASPGQNGY-HRLKIPFTDLQTATNNFDKNLIIGSGGFGMVY----KGVLRDNT 486
           MS  T +A+PG         I  ++    ++ F+    +G G   +VY    KG  +   
Sbjct: 23  MSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYA 82
Query: 487 KVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL-- 544
              +K+ V          +TEI VL ++ H +++ L    E  +E+ LV E +  G L  
Sbjct: 83  LKVLKKTVDKKI-----VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFD 137
Query: 545 ---KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---N 598
              +K  Y       + KQ LE        + YLH     GI+HRD+K  N+L      +
Sbjct: 138 RIVEKGYYSERDAADAVKQILE-------AVAYLHEN---GIVHRDLKPENLLYATPAPD 187
Query: 599 YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
              K+ADFGLS+    ++   +   V G+ GY  PE  R      + D++S G++ + +L
Sbjct: 188 APLKIADFGLSK---IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244
Query: 659 C 659
           C
Sbjct: 245 C 245

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 469 IGSGGFGMVYKGVL-----RDNTKVAVKRGVPGSRQG--LPEFQTEITVLSKIRHRHLVS 521
           +G   FG VYKG L      + T+    + +    +G    EF+ E  + ++++H ++V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLY-----------GPDRT---PLSWKQRLEICIG 567
           L+G   +   + +++ Y   G L + L              DRT    L     + +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS 627
            A G+ YL   S+  ++H+D+ + N+L+ +    K++D GL R     D   +       
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE     + +  SD++S+GVVL+EV 
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 115/247 (46%), Gaps = 58/247 (23%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 18  TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 495 PGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKH 547
              R     F+  E+ ++ K+ H ++V L       G  +++  + LV +Y+ +      
Sbjct: 68  QDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET----- 117
Query: 548 LYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYV 600
           +Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V
Sbjct: 118 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAV 174
Query: 601 SKVADFGLSRSGPCLDETHVSTGVKG--SFGYLDPEYFRRQQL-------TDKSDVYSFG 651
            K+ DFG ++             V+G  +  Y+   Y+R  +L       T   DV+S G
Sbjct: 175 LKLCDFGSAKQ-----------LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 223
Query: 652 VVLFEVL 658
            VL E+L
Sbjct: 224 CVLAELL 230

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 42/239 (17%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 17  TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 495 PGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKH 547
              R     F+  E+ ++ K+ H ++V L       G  +++  + LV +Y+ +      
Sbjct: 67  QDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET----- 116
Query: 548 LYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYV 600
           +Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V
Sbjct: 117 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAV 173
Query: 601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVL 658
            K+ DFG ++    L     +     S  Y  PE  F     T   DV+S G VL E+L
Sbjct: 174 LKLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 469 IGSGGFGMVYKGVL-----RDNTKVAVKRGVPGSRQG--LPEFQTEITVLSKIRHRHLVS 521
           +G   FG VYKG L      + T+    + +    +G    EF+ E  + ++++H ++V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLY-----------GPDRT---PLSWKQRLEICIG 567
           L+G   +   + +++ Y   G L + L              DRT    L     + +   
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS 627
            A G+ YL   S+  ++H+D+ + N+L+ +    K++D GL R     D   +       
Sbjct: 154 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE     + +  SD++S+GVVL+EV 
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 109/238 (45%), Gaps = 40/238 (16%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 5   TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 54
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKHL 548
               QG      E+ ++ K+ H ++V L       G  +++  + LV +Y+        +
Sbjct: 55  ----QGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPAT-----V 105
Query: 549 YGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVS 601
           Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V 
Sbjct: 106 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 162
Query: 602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVL 658
           K+ DFG ++    L     +     S  Y  PE  F     T   DV+S G VL E+L
Sbjct: 163 KLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 42/239 (17%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 24  TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 495 PGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKH 547
              R     F+  E+ ++ K+ H ++V L       G  +++  + LV +Y+ +      
Sbjct: 74  QDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET----- 123
Query: 548 LYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYV 600
           +Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V
Sbjct: 124 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAV 180
Query: 601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVL 658
            K+ DFG ++    L     +     S  Y  PE  F     T   DV+S G VL E+L
Sbjct: 181 LKLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 463 FDKN---LIIGSGGFGMVYKGV-LRDNTKVAVKRGVP--GSRQGLPEFQTEITVLSKIRH 516
           +D+N   +++G G +G+VY G  L +  ++A+K  +P   SR   P    EI +   ++H
Sbjct: 7   YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKE-IPERDSRYSQP-LHEEIALHKHLKH 64
Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL---YGPDR-----TPLSWKQRLEICIGA 568
           +++V  +G   E   + +  E +  G L   L   +GP +          KQ LE     
Sbjct: 65  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE----- 119
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDE-NYVSKVADFGLSRS----GPCLDETHVSTG 623
             GL YLH      I+HRDIK  N+L++  + V K++DFG S+      PC +       
Sbjct: 120 --GLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET------ 168
Query: 624 VKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCAR 661
             G+  Y+ PE   +  +     +D++S G  + E+   +
Sbjct: 169 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 42/239 (17%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 13  TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 495 PGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKH 547
              R     F+  E+ ++ K+ H ++V L       G  +++  + LV +Y+ +      
Sbjct: 63  QDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET----- 112
Query: 548 LYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYV 600
           +Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V
Sbjct: 113 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAV 169
Query: 601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVL 658
            K+ DFG ++    L     +     S  Y  PE  F     T   DV+S G VL E+L
Sbjct: 170 LKLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 42/239 (17%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 17  TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 495 PGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKH 547
              R     F+  E+ ++ K+ H ++V L       G  +++  + LV +Y+ +      
Sbjct: 67  QDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET----- 116
Query: 548 LYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYV 600
           +Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V
Sbjct: 117 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAV 173
Query: 601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVL 658
            K+ DFG ++    L     +     S  Y  PE  F     T   DV+S G VL E+L
Sbjct: 174 LKLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 47/219 (21%)
Query: 468 IIGSGGFGMVYKG-VLRDNTKVAVKRGVPGSR----QGLPEFQT---EITVLSKIR---- 515
           ++G GGFG V+ G  L D  +VA+K  +P +R      L +  T   E+ +L K+     
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKV-IPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 516 HRHLVSLVGYCEEQSEMILVYE-----------YMEKGPLKKHLYGPDRTPLSWKQRLEI 564
           H  ++ L+ + E Q   +LV E             EKGPL +   GP R           
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE---GPSRCFFG------- 146
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSRSGPCL-DETHVST 622
                  + + H+    G++HRDIK  NIL+D     +K+ DFG   SG  L DE +  T
Sbjct: 147 --QVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFG---SGALLHDEPY--T 196
Query: 623 GVKGSFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCA 660
              G+  Y  PE+  R Q     + V+S G++L++++C 
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL 519
           +++D +  +G+G FG+V++   R      A K  +          + EI  +S +RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           V+L    E+ +EM+++YE+M  G L + +   +   +S  + +E      +GL ++H  +
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 580 AEGIIHRDIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               +H D+K  NI+      +  K+ DFGL+     LD         G+  +  PE   
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAE 329
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
            + +   +D++S GV+ + +L
Sbjct: 330 GKPVGYYTDMWSVGVLSYILL 350

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEF 504
           PF   Q   + +D    +GSG F +V K       L    K   KR    SR+G+   E 
Sbjct: 4   PFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 505 QTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEI 564
           + E+++L ++ H ++++L    E +++++L+ E +  G L   L    +  LS ++    
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSF 120
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHV 620
                 G++YLHT   + I H D+K  NI LLD+N      K+ DFGL+       E   
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH------EIED 171
Query: 621 STGVKGSFG---YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
               K  FG   ++ PE    + L  ++D++S GV+ + +L
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 115/247 (46%), Gaps = 58/247 (23%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 5   TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 54
Query: 495 PGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKH 547
              R     F+  E+ ++ K+ H ++V L       G  +++  + LV +Y+ +      
Sbjct: 55  QDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET----- 104
Query: 548 LYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYV 600
           +Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V
Sbjct: 105 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAV 161
Query: 601 SKVADFGLSRSGPCLDETHVSTGVKG--SFGYLDPEYFRRQQL-------TDKSDVYSFG 651
            K+ DFG ++             V+G  +  Y+   Y+R  +L       T   DV+S G
Sbjct: 162 LKLCDFGSAKQ-----------LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 652 VVLFEVL 658
            VL E+L
Sbjct: 211 CVLAELL 217

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++    LK  +     T +             +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF-QTEITVLSKIRHRHLVSLVGY-- 525
           +G G +G V++G  +    VAVK  +  SR     F +TE+     +RH +++  +    
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK--IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 526 --CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH-----TG 578
                 +++ L+  Y E G L  +L     T L     L I +  A GL +LH     T 
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLS-RSGPCLDETHVSTGVK-GSFGYLDPEYF 636
               I HRD+KS NIL+ +N    +AD GL+       ++  V    + G+  Y+ PE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 637 RRQQLTD------KSDVYSFGVVLFEV 657
                 D      + D+++FG+VL+EV
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 10/205 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIRHR 517
            NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V L+     ++++ LV+E++ +  LK  +     T +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQD-LKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
                ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 638 -RQQLTDKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQT-EITVLSKIR 515
           +  NF K   IG G +G+VYK   +   +V   + +      +G+P     EI++L ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H ++V L+     ++++ LV+E++    LK  +     T +             +GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++     K+ADFGL+R+      T+    V  +  Y  PE 
Sbjct: 122 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 636 FR-RQQLTDKSDVYSFGVVLFEVLCART 662
               +  +   D++S G +  E++  R 
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEF 504
           PF   Q   + +D    +GSG F +V K       L    K   KR    SR+G+   E 
Sbjct: 4   PFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 505 QTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEI 564
           + E+++L ++ H ++++L    E +++++L+ E +  G L   L    +  LS ++    
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSF 120
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHV 620
                 G++YLHT   + I H D+K  NI LLD+N      K+ DFGL+       E   
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH------EIED 171
Query: 621 STGVKGSFG---YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
               K  FG   ++ PE    + L  ++D++S GV+ + +L  
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEF 504
           PF   Q   + +D    +GSG F +V K       L    K   KR    SR+G+   E 
Sbjct: 4   PFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 505 QTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEI 564
           + E+++L ++ H ++++L    E +++++L+ E +  G L   L    +  LS ++    
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSF 120
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHV 620
                 G++YLHT   + I H D+K  NI LLD+N      K+ DFGL+       E   
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH------EIED 171
Query: 621 STGVKGSFG---YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
               K  FG   ++ PE    + L  ++D++S GV+ + +L
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 502 PEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQR 561
            E   EI++L  + H +++ L    E++    LV E+ E G L + +   +R        
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECDA 148
Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS----KVADFGLSRSGPCLDE 617
             I      G+ YLH      I+HRDIK  NILL EN  S    K+ DFGLS       +
Sbjct: 149 ANIMKQILSGICYLH---KHNIVHRDIKPENILL-ENKNSLLNIKIVDFGLS---SFFSK 201
Query: 618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
            +      G+  Y+ PE  ++ +  +K DV+S GV+++ +LC 
Sbjct: 202 DYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 104/238 (43%), Gaps = 31/238 (13%)
Query: 435 GTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKV-AVKRG 493
           G+  +S  Q GY  L I     Q   N+ +    +GSG  G V+K   R    V AVK+ 
Sbjct: 1   GSSGSSGKQTGY--LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM 58
Query: 494 VPGSRQGLPEFQTEI-----TVLSKIRHRHLVSLVGYCEEQSEMILVYEYM----EKGPL 544
               R G  E    I      VL      ++V   G     +++ +  E M    EK  L
Sbjct: 59  ---RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--L 113
Query: 545 KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA 604
           KK + GP   P     ++ + I   + L+YL      G+IHRD+K +NILLDE    K+ 
Sbjct: 114 KKRMQGP--IPERILGKMTVAI--VKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLC 167
Query: 605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD-----KSDVYSFGVVLFEV 657
           DFG+  SG  +D+        G   Y+ PE       T      ++DV+S G+ L E+
Sbjct: 168 DFGI--SGRLVDDKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 96/203 (47%), Gaps = 10/203 (4%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL 519
           +++D +  +G+G FG+V++   R      A K  +          + EI  +S +RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           V+L    E+ +EM+++YE+M  G L + +   +   +S  + +E      +GL ++H  +
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 580 AEGIIHRDIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               +H D+K  NI+      +  K+ DFGL+     LD         G+  +  PE   
Sbjct: 170 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAE 223
Query: 638 RQQLTDKSDVYSFGVVLFEVLCA 660
            + +   +D++S GV+ + +L  
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSG 246

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEF-QTEITVLSKIRHRHLVSLVGY-- 525
           +G G +G V++G  +    VAVK  +  SR     F +TE+     +RH +++  +    
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK--IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 526 --CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH-----TG 578
                 +++ L+  Y E G L  +L     T L     L I +  A GL +LH     T 
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLS-RSGPCLDETHVSTGVK-GSFGYLDPEYF 636
               I HRD+KS NIL+ +N    +AD GL+       ++  V    + G+  Y+ PE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 637 RRQQLTD------KSDVYSFGVVLFEV 657
                 D      + D+++FG+VL+EV
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEF 504
           PF   Q   + +D    +GSG F +V K       L    K   KR    SR+G+   E 
Sbjct: 4   PFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 505 QTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEI 564
           + E+++L ++ H ++++L    E +++++L+ E +  G L   L    +  LS ++    
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSF 120
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHV 620
                 G++YLHT   + I H D+K  NI LLD+N      K+ DFGL+       E   
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH------EIED 171
Query: 621 STGVKGSFG---YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
               K  FG   ++ PE    + L  ++D++S GV+ + +L
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEF 504
           PF   Q   + +D    +GSG F +V K       L    K   KR    SR+G+   E 
Sbjct: 4   PFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 505 QTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEI 564
           + E+++L ++ H ++++L    E +++++L+ E +  G L   L    +  LS ++    
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSF 120
Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHV 620
                 G++YLHT   + I H D+K  NI LLD+N      K+ DFGL+       E   
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH------EIED 171
Query: 621 STGVKGSFG---YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
               K  FG   ++ PE    + L  ++D++S GV+ + +L
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 42/239 (17%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 5   TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 54
Query: 495 PGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKH 547
              R     F+  E+ ++ K+ H ++V L       G  +++  + LV +Y+ +      
Sbjct: 55  QDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET----- 104
Query: 548 LYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYV 600
           +Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V
Sbjct: 105 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAV 161
Query: 601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVL 658
            K+ DFG ++    L     +     S  Y  PE  F     T   DV+S G VL E+L
Sbjct: 162 LKLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 42/239 (17%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 5   TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 54
Query: 495 PGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKH 547
              R     F+  E+ ++ K+ H ++V L       G  +++  + LV +Y+ +      
Sbjct: 55  QDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET----- 104
Query: 548 LYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYV 600
           +Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V
Sbjct: 105 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAV 161
Query: 601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVL 658
            K+ DFG ++    L     +     S  Y  PE  F     T   DV+S G VL E+L
Sbjct: 162 LKLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 24/162 (14%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKR--------GVPGSRQGLPEFQTEITVL 511
             ++K   IG G +G V+K   R+  + VA+KR        GVP S         EI +L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLL 55
Query: 512 SKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAA 569
            +++H+++V L        ++ LV+E+ ++  LKK+      D  P   K  L       
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFL---FQLL 111
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           +GL + H+     ++HRD+K  N+L++ N   K+ADFGL+R+
Sbjct: 112 KGLGFCHS---RNVLHRDLKPQNLLINRNGELKLADFGLARA 150

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 42/239 (17%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 9   TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 58
Query: 495 PGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKH 547
              R     F+  E+ ++ K+ H ++V L       G  +++  + LV +Y+ +      
Sbjct: 59  QDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET----- 108
Query: 548 LYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYV 600
           +Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V
Sbjct: 109 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAV 165
Query: 601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVL 658
            K+ DFG ++    L     +     S  Y  PE  F     T   DV+S G VL E+L
Sbjct: 166 LKLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 42/239 (17%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 6   TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 55
Query: 495 PGSRQGLPEFQT-EITVLSKIRHRHLVSL------VGYCEEQSEMILVYEYMEKGPLKKH 547
              R     F+  E+ ++ K+ H ++V L       G  +++  + LV +Y+ +      
Sbjct: 56  QDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET----- 105
Query: 548 LYGPDRTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYV 600
           +Y   R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V
Sbjct: 106 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAV 162
Query: 601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVL 658
            K+ DFG ++    L     +     S  Y  PE  F     T   DV+S G VL E+L
Sbjct: 163 LKLCDFGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP----EFQTEITVLSKIRHRHLVSLVG 524
           +G GGF   ++    D  +V   + VP S    P    +   EI++   + H+H+V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
           + E+   + +V E   +  L +      R  L+  +          G  YLH      +I
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 143
Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDK 644
           HRD+K  N+ L+E+   K+ DFGL+       E   +  + G+  Y+ PE   ++  + +
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSFE 201
Query: 645 SDVYSFGVVLFEVLCAR 661
            DV+S G +++ +L  +
Sbjct: 202 VDVWSIGCIMYTLLVGK 218

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 108/234 (46%), Gaps = 32/234 (13%)
Query: 436 TVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKRGV 494
           TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D+ + VA+K+ +
Sbjct: 5   TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL 54
Query: 495 PGSRQGLPEFQT-EITVLSKIRHRHLVSLVGYCEEQSEMI-LVYEYMEKGPLKKHLYGPD 552
              R     F+  E+ ++ K+ H ++V L  +     E   +VY  +    + + +Y   
Sbjct: 55  QDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVA 109
Query: 553 RTPLSWKQRLEICIGAA------RGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVAD 605
           R     KQ L +           R L Y+H+    GI HRDIK  N+LLD +  V K+ D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD 166
Query: 606 FGLSRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVL 658
           FG ++    L     +     S  Y  PE  F     T   DV+S G VL E+L
Sbjct: 167 FGSAKQ---LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP----EFQTEITVLSKIRHRHLVSLVG 524
           +G GGF   ++    D  +V   + VP S    P    +   EI++   + H+H+V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
           + E+   + +V E   +  L +      R  L+  +          G  YLH      +I
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 139
Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDK 644
           HRD+K  N+ L+E+   K+ DFGL+       E      + G+  Y+ PE   ++  + +
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 645 SDVYSFGVVLFEVLCAR 661
            DV+S G +++ +L  +
Sbjct: 198 VDVWSIGCIMYTLLVGK 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP----EFQTEITVLSKIRHRHLVSLVG 524
           +G GGF   ++    D  +V   + VP S    P    +   EI++   + H+H+V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
           + E+   + +V E   +  L +      R  L+  +          G  YLH      +I
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 139
Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDK 644
           HRD+K  N+ L+E+   K+ DFGL+       E      + G+  Y+ PE   ++  + +
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 645 SDVYSFGVVLFEVLCAR 661
            DV+S G +++ +L  +
Sbjct: 198 VDVWSIGCIMYTLLVGK 214

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 463 FDKNLIIGSGGFGMVY--KGVLRDNT------KVAVKRGVPGSRQGLPEFQTEITVLSKI 514
           F+   ++G GG+G V+  + V   NT      KV  K  +  + +     + E  +L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAA 569
           +H  +V L+   +   ++ L+ EY+  G L     ++ ++  D T   +   + + +G  
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-TACFYLAEISMALG-- 135
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
               +LH    +GII+RD+K  NI+L+     K+ DFGL +    + +  V+    G+  
Sbjct: 136 ----HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGTVTHXFCGTIE 186
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           Y+ PE   R       D +S G +++++L
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDML 215

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 469 IGSGGFGMV--YKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
           +G GGF  V   +G L D    A+KR +   +Q   E Q E  +     H +++ LV YC
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 527 EEQ----SEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
             +     E  L+  + ++G L   +         L+  Q L + +G  RGL  +H   A
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS-----------TGVKGSFG 629
           +G  HRD+K TNILL +     + D G S +  C+   HV               + +  
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLG-SMNQACI---HVEGSRQALTLQDWAAQRCTIS 208
Query: 630 YLDPEYFRRQQ---LTDKSDVYSFGVVLFEVL 658
           Y  PE F  Q    + +++DV+S G VL+ ++
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH--- 516
            ++F++  ++G G FG V K     +++    + +  + + L    +E+ +L+ + H   
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 517 ----------RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPD---RTPLSWKQRLE 563
                     R+ V  +   +++S + +  EY E   L   ++  +   +    W+   +
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS-GPCLDETHVS- 621
           I       L Y+H+   +GIIHRD+K  NI +DE+   K+ DFGL+++    LD   +  
Sbjct: 125 IL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 622 ----------TGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVL 658
                     T   G+  Y+  E         +K D+YS G++ FE++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 463 FDKNLIIGSGGFGMVY--KGVLRDNT------KVAVKRGVPGSRQGLPEFQTEITVLSKI 514
           F+   ++G GG+G V+  + V   NT      KV  K  +  + +     + E  +L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAA 569
           +H  +V L+   +   ++ L+ EY+  G L     ++ ++  D T   +   + + +G  
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-TACFYLAEISMALG-- 135
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
               +LH    +GII+RD+K  NI+L+     K+ DFGL +    + +  V+    G+  
Sbjct: 136 ----HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGTVTHTFCGTIE 186
Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           Y+ PE   R       D +S G +++++L
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDML 215

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 5/107 (4%)
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
           + P++ +  +      ARG+ +L   S+   IHRD+ + NILL EN V K+ DFGL+R  
Sbjct: 193 KEPITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARD- 248
Query: 613 PCLDETHVSTG-VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
              +  +V  G  +    ++ PE    +  + KSDV+S+GV+L+E+ 
Sbjct: 249 IYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIF 295

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP----EFQTEITVLSKIRHRHLVSLVG 524
           +G GGF   ++    D  +V   + VP S    P    +   EI++   + H+H+V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
           + E+   + +V E   +  L +      R  L+  +          G  YLH      +I
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 161
Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDK 644
           HRD+K  N+ L+E+   K+ DFGL+       E      + G+  Y+ PE   ++  + +
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 645 SDVYSFGVVLFEVLCAR 661
            DV+S G +++ +L  +
Sbjct: 220 VDVWSIGCIMYTLLVGK 236

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP----EFQTEITVLSKIRHRHLVSLVG 524
           +G GGF   ++    D  +V   + VP S    P    +   EI++   + H+H+V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
           + E+   + +V E   +  L +      R  L+  +          G  YLH      +I
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 163
Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDK 644
           HRD+K  N+ L+E+   K+ DFGL+       E      + G+  Y+ PE   ++  + +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 645 SDVYSFGVVLFEVLCAR 661
            DV+S G +++ +L  +
Sbjct: 222 VDVWSIGCIMYTLLVGK 238

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 94/192 (48%), Gaps = 11/192 (5%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           IG G  G VY  + +    +VA+++     +        EI V+ + ++ ++V+ +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
              E+ +V EY+  G L   +     T +   Q   +C    + L +LH+     +IHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141
Query: 588 IKSTNILLDENYVSKVADFGL-SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
           IKS NILL  +   K+ DFG  ++  P  +++  ST V G+  ++ PE   R+    K D
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 647 VYSFGVVLFEVL 658
           ++S G++  E++
Sbjct: 199 IWSLGIMAIEMI 210

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKXQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 457 QTATNNFDKNLIIGSGGFGMVYKGV-----LRDNTKVAVKRGVPGSRQGL--PEFQTEIT 509
           Q   + +D    +GSG F +V K       L    K   KR    SR+G+   E + E++
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
           +L ++ H ++++L    E +++++L+ E +  G L   L    +  LS ++         
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQIL 125
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNI-LLDENYVS---KVADFGLSRSGPCLDETHVSTGVK 625
            G++YLHT   + I H D+K  NI LLD+N      K+ DFGL+       E       K
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH------EIEDGVEFK 176
Query: 626 GSFG---YLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             FG   ++ PE    + L  ++D++S GV+ + +L
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP----EFQTEITVLSKIRHRHLVSLVG 524
           +G GGF   ++    D  +V   + VP S    P    +   EI++   + H+H+V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
           + E+   + +V E   +  L +      R  L+  +          G  YLH      +I
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 137
Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDK 644
           HRD+K  N+ L+E+   K+ DFGL+       E      + G+  Y+ PE   ++  + +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 645 SDVYSFGVVLFEVLCAR 661
            DV+S G +++ +L  +
Sbjct: 196 VDVWSIGCIMYTLLVGK 212

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           IGSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 95  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 145 YIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEM---TGYVATRWYRAP 196
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 468 IIGSGGFGMVYKG---VLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           ++G G FG V K    + +    V V        +       E+ +L K+ H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
             E+ S   +V E    G L   +    R   S      I      G+ Y+H      I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMH---KHNIV 143
Query: 585 HRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
           HRD+K  NILL   +++   K+ DFGLS    C  +        G+  Y+ PE   R   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 642 TDKSDVYSFGVVLFEVL 658
            +K DV+S GV+L+ +L
Sbjct: 200 DEKCDVWSAGVILYILL 216

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 448 RLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT 506
           R+ +   D +     F+K   IG G  G VY  + +    +VA+++     +        
Sbjct: 11  RIIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 67
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           EI V+ + ++ ++V+ +       E+ +V EY+  G L   +     T +   Q   +C 
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCR 124
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL-SRSGPCLDETHVSTGVK 625
              + L +LH+     +IHR+IKS NILL  +   K+ DFG  ++  P  +++  ST V 
Sbjct: 125 ECLQALEFLHSNQ---VIHRNIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV- 178
Query: 626 GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           G+  ++ PE   R+    K D++S G++  E++
Sbjct: 179 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 211

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 9/191 (4%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           IG G  G VY  + +    +VA+++     +        EI V+ + ++ ++V+ +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
              E+ +V EY+  G L   +     T +   Q   +C    + L +LH+     +IHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           IKS NILL  +   K+ DFG         E    + + G+  ++ PE   R+    K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGF--CAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 648 YSFGVVLFEVL 658
           +S G++  E++
Sbjct: 200 WSLGIMAIEMI 210

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKXQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVA------VKRGVPGSRQGLPEFQTEIT 509
            Q  ++ + +   +GSG +G V   + +D    A      +K+    +         E+ 
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVA 73
Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
           VL ++ H +++ L  + E++    LV E    G L   +    R   S      I     
Sbjct: 74  VLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL--RQKFSEVDAAVIMKQVL 131
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVK- 625
            G  YLH      I+HRD+K  N+LL+    + + K+ DFGLS         H   G K 
Sbjct: 132 SGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLS--------AHFEVGGKM 180
Query: 626 ----GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
               G+  Y+ PE  R++   +K DV+S GV+L+ +LC 
Sbjct: 181 KERLGTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCG 218

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 9/191 (4%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           IG G  G VY  + +    +VA+++     +        EI V+ + ++ ++V+ +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
              E+ +V EY+  G L   +     T +   Q   +C    + L +LH+     +IHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           IKS NILL  +   K+ DFG         E    + + G+  ++ PE   R+    K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGF--CAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 648 YSFGVVLFEVL 658
           +S G++  E++
Sbjct: 200 WSLGIMAIEMI 210

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 9/191 (4%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           IG G  G VY  + +    +VA+++     +        EI V+ + ++ ++V+ +    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
              E+ +V EY+  G L   +     T +   Q   +C    + L +LH+     +IHRD
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 142
Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           IKS NILL  +   K+ DFG         E    + + G+  ++ PE   R+    K D+
Sbjct: 143 IKSDNILLGMDGSVKLTDFGF--CAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDI 200
Query: 648 YSFGVVLFEVL 658
           +S G++  E++
Sbjct: 201 WSLGIMAIEMI 211

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 469 IGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG +G V   + RD        + + R    S     +   E+ VL  + H +++ L 
Sbjct: 45  LGSGAYGEVL--LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
            + E++    LV E  + G L   +    R   +      I      G+ YLH      I
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEII--HRMKFNEVDAAVIIKQVLSGVTYLHK---HNI 157
Query: 584 IHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           +HRD+K  N+LL+   ++ + K+ DFGLS      +         G+  Y+ PE  R++ 
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKERLGTAYYIAPEVLRKK- 213
Query: 641 LTDKSDVYSFGVVLFEVLCA 660
             +K DV+S GV+LF +L  
Sbjct: 214 YDEKCDVWSIGVILFILLAG 233

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 97  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 147 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEM---TGYVATRWYRAP 198
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 102 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 152 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 203
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP----EFQTEITVLSKIRH 516
             + +   +G GGF   Y+    D  +V   + VP S    P    +  TEI +   + +
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
            H+V   G+ E+   + +V E   +  L +      R  ++  +         +G+ YLH
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
                 +IHRD+K  N+ L+++   K+ DFGL+      D     T + G+  Y+ PE  
Sbjct: 160 NNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKT-LCGTPNYIAPEVL 214
Query: 637 RRQQLTDKSDVYSFGVVLFEVLCAR 661
            ++  + + D++S G +L+ +L  +
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP----EFQTEITVLSKIRH 516
             + +   +G GGF   Y+    D  +V   + VP S    P    +  TEI +   + +
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
            H+V   G+ E+   + +V E   +  L +      R  ++  +         +G+ YLH
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
                 +IHRD+K  N+ L+++   K+ DFGL+       E      + G+  Y+ PE  
Sbjct: 160 NNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVL 214
Query: 637 RRQQLTDKSDVYSFGVVLFEVLCAR 661
            ++  + + D++S G +L+ +L  +
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 97  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 147 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEM---TGYVATRWYRAP 198
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 30/206 (14%)
Query: 469 IGSGGFGMVYKGVLRDNTKVA------VKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +GSG +G V   + +D    A      +K+    +         E+ VL ++ H +++ L
Sbjct: 12  LGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
             + E++    LV E    G L   +    R   S      I      G  YLH      
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIIL--RQKFSEVDAAVIMKQVLSGTTYLH---KHN 124
Query: 583 IIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVK-----GSFGYLDPE 634
           I+HRD+K  N+LL+    + + K+ DFGLS         H   G K     G+  Y+ PE
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLS--------AHFEVGGKMKERLGTAYYIAPE 176
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCA 660
             R++   +K DV+S GV+L+ +LC 
Sbjct: 177 VLRKK-YDEKCDVWSCGVILYILLCG 201

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGXVATRWYRAPEIMLNW 197
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 97  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 147 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEM---TGYVATRWYRAP 198
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP----EFQTEITVLSKIRHRHLVSLVG 524
           +G GGF   Y+    D  +V   + VP S    P    +  TEI +   + + H+V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
           + E+   + +V E   +  L +      R  ++  +         +G+ YLH      +I
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VI 148
Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDK 644
           HRD+K  N+ L+++   K+ DFGL+       E      + G+  Y+ PE   ++  + +
Sbjct: 149 HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKGHSFE 206
Query: 645 SDVYSFGVVLFEVLCAR 661
            D++S G +L+ +L  +
Sbjct: 207 VDIWSLGCILYTLLVGK 223

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP----EFQTEITVLSKIRH 516
             + +   +G GGF   Y+    D  +V   + VP S    P    +  TEI +   + +
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
            H+V   G+ E+   + +V E   +  L +      R  ++  +         +G+ YLH
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
                 +IHRD+K  N+ L+++   K+ DFGL+       E      + G+  Y+ PE  
Sbjct: 160 NNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAPEVL 214
Query: 637 RRQQLTDKSDVYSFGVVLFEVLCAR 661
            ++  + + D++S G +L+ +L  +
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 101 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 150
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 151 YIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEM---TGYVATRWYRAP 202
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 24/154 (15%)
Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKR--------GVPGSRQGLPEFQTEITVLSKIRHRHL 519
           IG G +G V+K   R+  + VA+KR        GVP S         EI +L +++H+++
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHKNI 63
Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           V L        ++ LV+E+ ++  LKK+      D  P   K  L       +GL + H+
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFL---FQLLKGLGFCHS 119
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
                ++HRD+K  N+L++ N   K+A+FGL+R+
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARA 150

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V     ++   K+AVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
               + +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 119 FTPATSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 174
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 175 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 226
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              + + D++S G ++ E+L  RT
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGRT 250

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 197
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 95  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 145 YIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEM---TGYVATRWYRAP 196
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 87  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 143 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 194
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 40/208 (19%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKR-GVPGSRQGLPEFQT-EITVLSKIRHRHLVSLVGYC 526
           IG G +G+VYK         A+K+  +    +G+P     EI++L +++H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR-------------GLH 573
             +  ++LV+E++++                 K+ L++C G                G+ 
Sbjct: 70  HTKKRLVLVFEHLDQ---------------DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG--PCLDETHVSTGVKGSFGYL 631
           Y H      ++HRD+K  N+L++     K+ADFGL+R+   P    TH       +  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYR 167
Query: 632 DPEYFR-RQQLTDKSDVYSFGVVLFEVL 658
            P+     ++ +   D++S G +  E++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 97  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 147 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 198
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 40/208 (19%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKR-GVPGSRQGLPEFQT-EITVLSKIRHRHLVSLVGYC 526
           IG G +G+VYK         A+K+  +    +G+P     EI++L +++H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR-------------GLH 573
             +  ++LV+E++++                 K+ L++C G                G+ 
Sbjct: 70  HTKKRLVLVFEHLDQ---------------DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG--PCLDETHVSTGVKGSFGYL 631
           Y H      ++HRD+K  N+L++     K+ADFGL+R+   P    TH       +  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYR 167
Query: 632 DPEYFR-RQQLTDKSDVYSFGVVLFEVL 658
            P+     ++ +   D++S G +  E++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 26/223 (11%)
Query: 454 TDLQTATNNFDKNLIIGSGGFGMVY--KGVLRDNTKVAVK-----RGVPGSRQGLPEFQT 506
           TD Q    N+     IG G F  V   + VL    +VAVK     +  P S Q L  F+ 
Sbjct: 8   TDEQPHIGNYRLQKTIGKGNFAKVKLARHVL-TGREVAVKIIDKTQLNPTSLQKL--FR- 63
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           E+ ++  + H ++V L    E +  + LV EY   G +  +L    R  +  K+      
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFR 121
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS---GPCLDETHVSTG 623
                + Y H    + I+HRD+K+ N+LLD +   K+ADFG S     G  LD       
Sbjct: 122 QIVSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT------ 172
Query: 624 VKGSFGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVD 665
             GS  Y  PE F+ ++    + DV+S GV+L+ ++      D
Sbjct: 173 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 197
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 95  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 151 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 202
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 86  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 193
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 87  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 143 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 194
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 88  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 143
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 144 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 195
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGRT 219

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 92  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 142 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 193
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKSQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 96  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 146 YIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEM---TGYVATRWYRAP 197
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 197
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 92  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 142 YIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEM---TGYVATRWYRAP 193
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 102 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 152 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 203
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 102 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 152 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 203
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 95  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 151 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 202
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 96  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 146 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 197
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 89  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 144
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 145 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 196
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGRT 220

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 40/208 (19%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKR-GVPGSRQGLPEFQT-EITVLSKIRHRHLVSLVGYC 526
           IG G +G+VYK         A+K+  +    +G+P     EI++L +++H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR-------------GLH 573
             +  ++LV+E++++                 K+ L++C G                G+ 
Sbjct: 70  HTKKRLVLVFEHLDQ---------------DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG--PCLDETHVSTGVKGSFGYL 631
           Y H      ++HRD+K  N+L++     K+ADFGL+R+   P    TH       +  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYR 167
Query: 632 DPEYFR-RQQLTDKSDVYSFGVVLFEVL 658
            P+     ++ +   D++S G +  E++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 197
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 101 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 150
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 151 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 202
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 92  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 142 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 193
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 197
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 92  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 142 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 193
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 96  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 146 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 197
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 463 FDKNLIIGSGGFGMVYKGVLRDN-TKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
            D  + IG G  G+V     + +  +VAVK      +Q       E+ ++   +H ++V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           +        E+ ++ E+++ G L   +    +  L+ +Q   +C    + L YLH   A+
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLH---AQ 160
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
           G+IHRDIKS +ILL  +   K++DFG         +      + G+  ++ PE   R   
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGF--CAQISKDVPKRKXLVGTPYWMAPEVISRSLY 218
Query: 642 TDKSDVYSFGVVLFEVL 658
             + D++S G+++ E++
Sbjct: 219 ATEVDIWSLGIMVIEMV 235

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 100 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 149
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 150 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 201
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 110 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 160 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 211
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 109/238 (45%), Gaps = 25/238 (10%)
Query: 435 GTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMV---YKGVLRDNTKVAVK 491
           G+++ S   N ++ ++I  +   T    +     IGSG  G+V   Y  +L  N  VA+K
Sbjct: 4   GSMSRSKRDNNFYSVEIGDSTF-TVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIK 60
Query: 492 R-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLVGY------CEEQSEMILVYEYMEKGP 543
           +   P   Q        E+ ++  + H++++ L+         EE  ++ +V E M+   
Sbjct: 61  KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL 120
Query: 544 LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKV 603
            +      D   +S+     +C     G+ +LH+    GIIHRD+K +NI++  +   K+
Sbjct: 121 CQVIQMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 172
Query: 604 ADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
            DFGL+R+      + + T    +  Y  PE        +  D++S G ++ E++C +
Sbjct: 173 LDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 109 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 158
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 159 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 210
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 86  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 193
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 96  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 146 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 197
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 113 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 162
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 163 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 214
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 15/207 (7%)
Query: 458 TATNNFDKNLIIGSGGFGMVYKG---VLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI 514
           T    ++   ++G G FG V K    + +    V V        +       E+ +L K+
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            H +++ L    E+ S   +V E    G L   +    R   S      I      G+ Y
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII--KRKRFSEHDAARIIKQVFSGITY 136
Query: 575 LHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           +H      I+HRD+K  NILL   +++   K+ DFGLS    C  +        G+  Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYI 190
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            PE   R    +K DV+S GV+L+ +L
Sbjct: 191 APEVL-RGTYDEKCDVWSAGVILYILL 216

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRHRHLVSL-- 522
           IG+G +G+V     R    +VA+K+ +P +   +   +    E+ +L   +H +++++  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKK-IPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 523 -----VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                V Y E +S + +V + ME      H       PL+ +          RGL Y+H+
Sbjct: 121 ILRPTVPYGEFKS-VYVVLDLMES---DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL---DETHVSTGVKGSFGYLDPE 634
                +IHRD+K +N+L++EN   K+ DFG++R G C    +  +  T    +  Y  PE
Sbjct: 177 AQ---VIHRDLKPSNLLVNENCELKIGDFGMAR-GLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 635 -YFRRQQLTDKSDVYSFGVVLFEVLCAR 661
                 + T   D++S G +  E+L  R
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 112/237 (47%), Gaps = 42/237 (17%)
Query: 437 VNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG 496
           V AS G+ G  R +I +T+ +          +IG+G FG+V++  L ++ +VA+K+ +  
Sbjct: 27  VLASDGKTGEQR-EIAYTNCK----------VIGNGSFGVVFQAKLVESDEVAIKKVLQD 75
Query: 497 SRQGLPEFQT-EITVLSKIRHRHLVSLVGYC----EEQSEMI--LVYEYMEKGPLKKHLY 549
            R     F+  E+ ++  ++H ++V L  +     +++ E+   LV EY+ +      +Y
Sbjct: 76  KR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-----VY 125
Query: 550 GPDRTPLSWKQRLEICI------GAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSK 602
              R     KQ + + +         R L Y+H+    GI HRDIK  N+LLD  + V K
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLK 182
Query: 603 VADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVL 658
           + DFG   S   L     +     S  Y  PE  F     T   D++S G V+ E++
Sbjct: 183 LIDFG---SAKILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRHRHLVSL-- 522
           IG+G +G+V     R    +VA+K+ +P +   +   +    E+ +L   +H +++++  
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKK-IPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 523 -----VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                V Y E +S + +V + ME      H       PL+ +          RGL Y+H+
Sbjct: 122 ILRPTVPYGEFKS-VYVVLDLMES---DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL---DETHVSTGVKGSFGYLDPE 634
                +IHRD+K +N+L++EN   K+ DFG++R G C    +  +  T    +  Y  PE
Sbjct: 178 AQ---VIHRDLKPSNLLVNENCELKIGDFGMAR-GLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 635 -YFRRQQLTDKSDVYSFGVVLFEVLCAR 661
                 + T   D++S G +  E+L  R
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 15/207 (7%)
Query: 458 TATNNFDKNLIIGSGGFGMVYKG---VLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI 514
           T    ++   ++G G FG V K    + +    V V        +       E+ +L K+
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            H +++ L    E+ S   +V E    G L   +    R   S      I      G+ Y
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII--KRKRFSEHDAARIIKQVFSGITY 136
Query: 575 LHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           +H      I+HRD+K  NILL   +++   K+ DFGLS    C  +        G+  Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYI 190
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            PE   R    +K DV+S GV+L+ +L
Sbjct: 191 APEVL-RGTYDEKCDVWSAGVILYILL 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 110 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 160 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 211
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 469 IGSGGFGMVYKGVLRD--------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G F  ++KGV R+         T+V +K      R     F    +++SK+ H+HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
              G C    E ILV E+++ G L  +L   ++  ++   +LE+    A  +H+L   + 
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENT- 133
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGV-KGSFGYLDPEYFRR 638
             +IH ++ + NILL      K  +    + S P +  T +   + +    ++ PE    
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN 191
Query: 639 -QQLTDKSDVYSFGVVLFEV 657
            + L   +D +SFG  L+E+
Sbjct: 192 PKNLNLATDKWSFGTTLWEI 211

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 109 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 158
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  P
Sbjct: 159 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAP 210
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG--PCLDETHVSTGVKGSFGYLDPEY 635
               GIIHRD+K +NI++  +   K+ DFGL+R+     + E  V T       Y  PE 
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-----YRAPEV 196
Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCAR 661
                  +  D++S G ++ E++C +
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 469 IGSGGFGMVYKGVLRD--------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           +G G F  ++KGV R+         T+V +K      R     F    +++SK+ H+HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
              G C    E ILV E+++ G L  +L   ++  ++   +LE+    A  +H+L   + 
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAWAMHFLEENT- 133
Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSR-SGPCLDETHVSTGV-KGSFGYLDPEYFRR 638
             +IH ++ + NILL      K  +    + S P +  T +   + +    ++ PE    
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN 191
Query: 639 -QQLTDKSDVYSFGVVLFEV 657
            + L   +D +SFG  L+E+
Sbjct: 192 PKNLNLATDKWSFGTTLWEI 211

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 15/169 (8%)
Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ 560
           L +   E+ ++  + H ++V L    E +  + LV EY   G +  +L    R  +  K+
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKE 114
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS---GPCLDE 617
                      + Y H    + I+HRD+K+ N+LLD +   K+ADFG S     G  LDE
Sbjct: 115 ARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE 171
Query: 618 THVSTGVKGSFGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVD 665
                   GS  Y  PE F+ ++    + DV+S GV+L+ ++      D
Sbjct: 172 ------FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 26  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 84  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 138
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 139 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 192
Query: 638 RQQLTDKSDVYSFGVVLFEVLCAR 661
                +  D++S G ++ E++C +
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 182
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 183 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 236
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 237 GMGYKENVDIWSVGCIMGEMV 257

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ D+GL+R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLARHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 31/208 (14%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSR--------QGLPEFQTEITVLSKIRHRHL 519
           ++G G +G V K VL  +++   +R V   +         G    + EI +L ++RH+++
Sbjct: 12  LLGEGSYGKV-KEVL--DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 520 VSLVG--YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR------G 571
           + LV   Y EE+ +M +V EY   G +++ L   D  P   ++R  +C           G
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCG-MQEML---DSVP---EKRFPVCQAHGYFCQLIDG 121
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH+   +GI+H+DIK  N+LL      K++  G++ +             +GS  + 
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 632 DPEYFRRQQLTD--KSDVYSFGVVLFEV 657
            PE           K D++S GV L+ +
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNI 206

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 145
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 146 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 199
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 200 GMGYKENVDIWSVGCIMGEMV 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 138
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 139 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 192
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 193 GMGYKENVDIWSVGCIMGEMV 213

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 138
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 139 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 192
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 193 GMGYKENVDIWSVGCIMGEMV 213

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG--PCLDETHVSTGVKGSFGYLDPEY 635
               GIIHRD+K +NI++  +   K+ DFGL+R+     + E  V T       Y  PE 
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-----YRAPEV 196
Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCAR 661
                  +  D++S G ++ E++C +
Sbjct: 197 ILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 145
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 146 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 199
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 200 GMGYKENVDIWSVGCIMGEMV 220

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 182
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 183 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 236
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 237 GMGYKENVDIWSVGCIMGEMV 257

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 137
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 138 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 191
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 30  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 86
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 142
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 86  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE     G   +  Y  PE     
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---AGFVATRWYRAPEIMLNW 193
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 143
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 144 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 197
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 198 GMGYKENVDIWSVGCIMGEMV 218

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE     G   +  Y  PE     
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---AGFVATRWYRAPEIMLNW 197
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE     G   +  Y  PE     
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---AGFVATRWYRAPEIMLNW 197
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 28/237 (11%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTK------VAVKRGVPGSRQGLPEFQ----TEITV 510
            N++   I+G G   +V + + +   K      + V  G   S + + E +     E+ +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 511 LSKIR-HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
           L K+  H +++ L    E  +   LV++ M+KG L  +L   ++  LS K+  +I     
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALL 134
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             +  LH  +   I+HRD+K  NILLD++   K+ DFG S     LD       V G+  
Sbjct: 135 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLRSVCGTPS 188
Query: 630 YLDPEYFRRQQ------LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM 680
           YL PE               + D++S GV+++ +L       P   R+Q+ +    M
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIM 242

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 113 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 162
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE     G   +  Y  P
Sbjct: 163 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---XGYVATRWYRAP 214
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 88
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI----RKIGSFDETCTRFYTAEIVSA 144
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
            PE    +  +  SD+++ G ++++++  
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 100/228 (43%), Gaps = 36/228 (15%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL 519
            ++F++  ++G G FG V K     +++    + +  + + L    +E+ +L+ + H+++
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYV 64
Query: 520 VSLVGY-------------CEEQSEMILVYEYMEKGPLKKHLYGPD---RTPLSWKQRLE 563
           V                   +++S + +  EY E   L   ++  +   +    W+   +
Sbjct: 65  VRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS-GPCLDETHVS- 621
           I       L Y+H+   +GIIHR++K  NI +DE+   K+ DFGL+++    LD   +  
Sbjct: 125 IL----EALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 622 ----------TGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVL 658
                     T   G+  Y+  E         +K D YS G++ FE +
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 33  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 89
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 145
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 146 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 38/212 (17%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLV 523
           +GSG +G V   Y   LR   KVAVK+     +  +   +T  E+ +L  ++H +++ L+
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARG 571
                    E+ SE+ LV   M          G D   +   Q L       +     RG
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM----------GADLNNIVKSQALSDEHVQFLVYQLLRG 143
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L Y+H+    GIIHRD+K +N+ ++E+   ++ DFGL+R     DE    TG   +  Y 
Sbjct: 144 LKYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQA---DEE--MTGYVATRWYR 195
Query: 632 DPEYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
            PE        +++ D++S G ++ E+L  + 
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI 514
           ++    N+F  + IIG GGFG VY     D  K+   + +   R  + + +T       +
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-----LAL 237
Query: 515 RHRHLVSLV--GYC----------EEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQ 560
             R ++SLV  G C              ++  + + M  G L  HL  +G          
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 297
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL----SRSGPCLD 616
             EI +G    L ++H      +++RD+K  NILLDE+   +++D GL    S+  P   
Sbjct: 298 AAEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 347
Query: 617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVL 658
             H S    G+ GY+ PE  ++    D S D +S G +LF++L
Sbjct: 348 --HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI 514
           ++    N+F  + IIG GGFG VY     D  K+   + +   R  + + +T       +
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-----LAL 236
Query: 515 RHRHLVSLV--GYC----------EEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQ 560
             R ++SLV  G C              ++  + + M  G L  HL  +G          
Sbjct: 237 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 296
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL----SRSGPCLD 616
             EI +G    L ++H      +++RD+K  NILLDE+   +++D GL    S+  P   
Sbjct: 297 AAEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 346
Query: 617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVL 658
             H S    G+ GY+ PE  ++    D S D +S G +LF++L
Sbjct: 347 --HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 31/219 (14%)
Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTK---VAVKR-GVPGSRQGLPEFQT----EITV 510
           AT+ ++    IG G +G VYK   RD      VA+K   VP    G          E+ +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 511 LSKIR---HRHLVSLVGYC-----EEQSEMILVYEYMEKGPLKKHLYGPDRTP---LSWK 559
           L ++    H ++V L+  C     + + ++ LV+E++++  L+ +L   D+ P   L  +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAE 120
Query: 560 QRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH 619
              ++     RGL +LH   A  I+HRD+K  NIL+      K+ADFGL+R         
Sbjct: 121 TIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQM 174
Query: 620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             T V  +  Y  PE   +       D++S G +  E+ 
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI 514
           ++    N+F  + IIG GGFG VY     D  K+   + +   R  + + +T       +
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-----LAL 237
Query: 515 RHRHLVSLV--GYC----------EEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQ 560
             R ++SLV  G C              ++  + + M  G L  HL  +G          
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 297
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL----SRSGPCLD 616
             EI +G    L ++H      +++RD+K  NILLDE+   +++D GL    S+  P   
Sbjct: 298 AAEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 347
Query: 617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVL 658
             H S    G+ GY+ PE  ++    D S D +S G +LF++L
Sbjct: 348 --HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI 514
           ++    N+F  + IIG GGFG VY     D  K+   + +   R  + + +T       +
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-----LAL 237
Query: 515 RHRHLVSLV--GYC----------EEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQ 560
             R ++SLV  G C              ++  + + M  G L  HL  +G          
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 297
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL----SRSGPCLD 616
             EI +G    L ++H      +++RD+K  NILLDE+   +++D GL    S+  P   
Sbjct: 298 AAEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 347
Query: 617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVL 658
             H S    G+ GY+ PE  ++    D S D +S G +LF++L
Sbjct: 348 --HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 88
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 144
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVA 229

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 35  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 91
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 92  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 147
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 148 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVA 232

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 88
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 144
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 33  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 89
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 145
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 146 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 110 FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DFGL+R     DE     G   +  Y  P
Sbjct: 160 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---XGXVATRWYRAP 211
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 38/208 (18%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLV 523
           +GSG +G V   Y   LR   KVAVK+     +  +   +T  E+ +L  ++H +++ L+
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARG 571
                    E+ SE+ LV   M          G D   +   Q L       +     RG
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLM----------GADLNNIVKCQALSDEHVQFLVYQLLRG 135
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L Y+H+    GIIHRD+K +N+ ++E+   ++ DFGL+R     DE    TG   +  Y 
Sbjct: 136 LKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQA---DEE--MTGYVATRWYR 187
Query: 632 DPEYFRRQQLTDKS-DVYSFGVVLFEVL 658
            PE        +++ D++S G ++ E+L
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELL 215

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 469 IGSGGFGMVYKGV-LRDNTK-VAVKR-GVPGSRQGLP-EFQTEITVLSKIR---HRHLVS 521
           IG G +G V+K   L++  + VA+KR  V    +G+P     E+ VL  +    H ++V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 522 LVGYC-----EEQSEMILVYEYMEKGPLKKHLYGPDRTP---LSWKQRLEICIGAARGLH 573
           L   C     + ++++ LV+E++++  L  +L   D+ P   +  +   ++     RGL 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           +LH+     ++HRD+K  NIL+  +   K+ADFGL+R           T V  +  Y  P
Sbjct: 135 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAP 188
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVL 658
           E   +       D++S G +  E+ 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 28/237 (11%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTK------VAVKRGVPGSRQGLPEFQ----TEITV 510
            N++   I+G G   +V + + +   K      + V  G   S + + E +     E+ +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 511 LSKIR-HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
           L K+  H +++ L    E  +   LV++ M+KG L  +L   ++  LS K+  +I     
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALL 134
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             +  LH  +   I+HRD+K  NILLD++   K+ DFG S     LD       V G+  
Sbjct: 135 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPS 188
Query: 630 YLDPEYFRRQQ------LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM 680
           YL PE               + D++S GV+++ +L       P   R+Q+ +    M
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIM 242

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 88
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 144
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGS 627
           A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D  +V  G  +  
Sbjct: 201 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLP 256
Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 287

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 30  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 86
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 142
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGS 627
           A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D  +V  G  +  
Sbjct: 210 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLP 265
Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 296

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGS 627
           A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D  +V  G  +  
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLP 258
Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGS 627
           A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R     D  +V  G  +  
Sbjct: 208 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLP 263
Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 294

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 37  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 93
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 94  LDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 149
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 150 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 206
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            PE    +     SD+++ G ++++++
Sbjct: 207 SPELLTEKSACKSSDLWALGCIIYQLV 233

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 28/237 (11%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTK------VAVKRGVPGSRQGLPEFQ----TEITV 510
            N++   I+G G   +V + + +   K      + V  G   S + + E +     E+ +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 511 LSKIR-HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
           L K+  H +++ L    E  +   LV++ M+KG L  +L   ++  LS K+  +I     
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALL 121
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
             +  LH  +   I+HRD+K  NILLD++   K+ DFG S     LD       V G+  
Sbjct: 122 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPS 175
Query: 630 YLDPEYFRRQQ------LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM 680
           YL PE               + D++S GV+++ +L       P   R+Q+ +    M
Sbjct: 176 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIM 229

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 18/219 (8%)
Query: 454 TDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGLPEFQTEITV 510
            D Q    N+     IG G F  V     +    +VAVK       +   L +   E+ +
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRI 66
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR 570
           +  + H ++V L    E +  + LV EY   G +  +L    R  +  K+          
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVS 124
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS---GPCLDETHVSTGVKGS 627
            + Y H    + I+HRD+K+ N+LLD +   K+ADFG S     G  LD         GS
Sbjct: 125 AVQYCHQ---KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT------FCGS 175
Query: 628 FGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVD 665
             Y  PE F+ ++    + DV+S GV+L+ ++      D
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLHYLHTGS 579
                 +    E      L  HL G D   +    +L       +     RGL Y+H+  
Sbjct: 86  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
              IIHRD+K +N+ ++E+   K+ DFGL+R     DE    TG   +  Y  PE     
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM---TGYVATRWYRAPEIMLNW 193
Query: 640 QLTDKS-DVYSFGVVLFEVLCART 662
              +++ D++S G ++ E+L  RT
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 88
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 144
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
            PE    +     SD+++ G ++++++  
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 30  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 86
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 142
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 18/219 (8%)
Query: 454 TDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGLPEFQTEITV 510
            D Q    N+     IG G F  V     +    +VAVK       +   L +   E+ +
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRI 66
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR 570
           +  + H ++V L    E +  + LV EY   G +  +L    R  +  K+          
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVS 124
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS---GPCLDETHVSTGVKGS 627
            + Y H    + I+HRD+K+ N+LLD +   K+ADFG S     G  LD         GS
Sbjct: 125 AVQYCHQ---KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT------FCGS 175
Query: 628 FGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVD 665
             Y  PE F+ ++    + DV+S GV+L+ ++      D
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 88
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 144
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 29  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 85
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 141
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 142 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 18/219 (8%)
Query: 454 TDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGLPEFQTEITV 510
            D Q    N+     IG G F  V     +    +VAVK       +   L +   E+ +
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRI 66
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR 570
           +  + H ++V L    E +  + LV EY   G +  +L    R  +  K+          
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVS 124
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS---GPCLDETHVSTGVKGS 627
            + Y H    + I+HRD+K+ N+LLD +   K+ADFG S     G  LD         G+
Sbjct: 125 AVQYCHQ---KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------AFCGA 175
Query: 628 FGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVD 665
             Y  PE F+ ++    + DV+S GV+L+ ++      D
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 38/208 (18%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLV 523
           +GSG +G V   Y   LR   KVAVK+     +  +   +T  E+ +L  ++H +++ L+
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARG 571
                    E+ SE+ LV   M          G D   +   Q L       +     RG
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM----------GADLNNIVKCQALSDEHVQFLVYQLLRG 143
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L Y+H+    GIIHRD+K +N+ ++E+   ++ DFGL+R     DE    TG   +  Y 
Sbjct: 144 LKYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQA---DEE--MTGYVATRWYR 195
Query: 632 DPEYFRRQQLTDKS-DVYSFGVVLFEVL 658
            PE        +++ D++S G ++ E+L
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 29/202 (14%)
Query: 469 IGSGGFGMVYKGVLRDN-TK--VAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVG 524
           IGSG FG+    ++RD  TK  VAVK    G+   + E  Q EI     +RH ++V    
Sbjct: 28  IGSGNFGVA--RLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKE 83
Query: 525 YCEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
                + + ++ EY   G L + +     +  D     ++Q L        G+ Y H+  
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-------GVSYCHSMQ 136
Query: 580 AEGIIHRDIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
              I HRD+K  N LLD +     K+ DFG S+S     +   + G      Y+ PE   
Sbjct: 137 ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLL 190
Query: 638 RQQLTDK-SDVYSFGVVLFEVL 658
           RQ+   K +DV+S GV L+ +L
Sbjct: 191 RQEYDGKIADVWSCGVTLYVML 212

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 13/107 (12%)
Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH-- 619
           L I I  A  + +LH+   +G++HRD+K +NI    + V KV DFGL  +    +E    
Sbjct: 167 LHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 620 --------VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
                      G  G+  Y+ PE       + K D++S G++LFE+L
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +      G+ +LH+
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 9   EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 65
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 121
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 122 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVA 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 10  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 66
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 122
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 123 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVA 207

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+  FGL+R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLARHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 7   EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 63
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 64  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 119
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 120 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVA 204

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 469 IGSGGFGMVYKGV-LRDNTK-VAVKR-GVPGSRQGLP-EFQTEITVLSKIR---HRHLVS 521
           IG G +G V+K   L++  + VA+KR  V    +G+P     E+ VL  +    H ++V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 522 LVGYC-----EEQSEMILVYEYMEKGPLKKHLYGPDRTP---LSWKQRLEICIGAARGLH 573
           L   C     + ++++ LV+E++++  L  +L   D+ P   +  +   ++     RGL 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           +LH+     ++HRD+K  NIL+  +   K+ADFGL+R           T V  +  Y  P
Sbjct: 135 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAP 188
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVL 658
           E   +       D++S G +  E+ 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 8   EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 64
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 120
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 121 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVA 205

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG----SRQGLPEFQTEITV 510
           DL+    +++   +IG G FG V     +   KV   + +       R     F  E  +
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR 570
           ++      +V L    ++   + +V EYM  G L   +   D  P  W +        A 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWAR-----FYTAE 176
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG----LSRSGPCLDETHVSTGVKG 626
            +  L    + G IHRD+K  N+LLD++   K+ADFG    +++ G    +T V     G
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----G 231
Query: 627 SFGYLDPEYFRRQ----QLTDKSDVYSFGVVLFEVLCART 662
           +  Y+ PE  + Q        + D +S GV L+E+L   T
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 14  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 70
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 71  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 126
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 127 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            PE    +     SD+++ G ++++++
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLV 210

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ DF L+R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLARHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ D GL+R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLARHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTK-VAVKR-GVPGSRQGLP-EFQTEITVL 511
           L  A   ++    IG G +G V+K   L++  + VA+KR  V    +G+P     E+ VL
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 512 SKIR---HRHLVSLVGYC-----EEQSEMILVYEYMEKGPLKKHLYGPDRTP---LSWKQ 560
             +    H ++V L   C     + ++++ LV+E++++  L  +L   D+ P   +  + 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVPTET 121
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV 620
             ++     RGL +LH+     ++HRD+K  NIL+  +   K+ADFGL+R          
Sbjct: 122 IKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMA 175
Query: 621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            T V  +  Y  PE   +       D++S G +  E+ 
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-------NTKVAVKRGVPGSRQGLPEFQTEITVLSK 513
            +F    I+G G F  V   + R+         K+  KR +    + +P    E  V+S+
Sbjct: 29  EDFKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSR 85
Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--ARG 571
           + H   V L    ++  ++     Y + G L K++    R   S+ +       A     
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA 141
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH    +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+
Sbjct: 142 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    +     SD+++ G ++++++ 
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 81/175 (46%), Gaps = 10/175 (5%)
Query: 487 KVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKK 546
           K+  KR +    + +P    E  V+S++ H   V L    ++  ++     Y + G L K
Sbjct: 61  KILEKRHIIKENK-VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 119
Query: 547 HLYGPDRTPLSWKQRLEICIGA--ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA 604
           ++    R   S+ +       A     L YLH    +GIIHRD+K  NILL+E+   ++ 
Sbjct: 120 YI----RKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQIT 172
Query: 605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           DFG ++      +   +    G+  Y+ PE    +     SD+++ G ++++++ 
Sbjct: 173 DFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           E+ ++  + H ++V L    E +  + LV EY   G +  +L    R  +  K+      
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFR 120
Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS---GPCLDETHVSTG 623
                + Y H    + I+HRD+K+ N+LLD +   K+ADFG S     G  LD       
Sbjct: 121 QIVSAVQYCHQ---KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT------ 171
Query: 624 VKGSFGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVD 665
             GS  Y  PE F+ ++    + DV+S GV+L+ ++      D
Sbjct: 172 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 121/271 (44%), Gaps = 55/271 (20%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSR---------QGLPEFQTEITVLSKIRHRHL 519
           +GSG FG V+  V ++  K  V + +   +           L +   EI +LS++ H ++
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYG-PDRTPLSWKQRLEICIGA------ARGL 572
           + ++   E Q    LV   MEK      L+   DR P     RL+  + +         +
Sbjct: 92  IKVLDIFENQGFFQLV---MEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAV 143
Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLD 632
            YL     + IIHRDIK  NI++ E++  K+ DFG   S   L+   +     G+  Y  
Sbjct: 144 GYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG---SAAYLERGKLFYTFCGTIEYCA 197
Query: 633 PEY-----FRRQQLTDKSDVYSFGVVLFEVL------C-----ARTAVDP--LLAREQVN 674
           PE      +R  +L    +++S GV L+ ++      C        A+ P  L+++E ++
Sbjct: 198 PEVLMGNPYRGPEL----EMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMS 253
Query: 675 LAEWAMQ--WQKKGMLEHII-DPQLIGKINL 702
           L    +Q   +++  LE ++ DP +   +NL
Sbjct: 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPVNL 284

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ D GL+R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLARHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 454 TDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK-----RGVPGSRQGLPEFQTE 507
           +D Q    N+     IG G F  V     +    +VA+K     +  P S Q L  F+ E
Sbjct: 5   SDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL--FR-E 61
Query: 508 ITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIG 567
           + ++  + H ++V L    E +  + L+ EY   G +  +L    R  +  K+       
Sbjct: 62  VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQ 119
Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS---GPCLDETHVSTGV 624
               + Y H    + I+HRD+K+ N+LLD +   K+ADFG S     G  LD        
Sbjct: 120 IVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT------F 170
Query: 625 KGSFGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVD 665
            GS  Y  PE F+ ++    + DV+S GV+L+ ++      D
Sbjct: 171 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG----SRQGLPEFQTEITV 510
           DL+    +++   +IG G FG V     +   KV   + +       R     F  E  +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR 570
           ++      +V L    ++   + +V EYM  G L   +   D  P  W +        A 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWAR-----FYTAE 181
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG----LSRSGPCLDETHVSTGVKG 626
            +  L    + G IHRD+K  N+LLD++   K+ADFG    +++ G    +T V     G
Sbjct: 182 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----G 236
Query: 627 SFGYLDPEYFRRQ----QLTDKSDVYSFGVVLFEVLCART 662
           +  Y+ PE  + Q        + D +S GV L+E+L   T
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 276

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 87/197 (44%), Gaps = 13/197 (6%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGL---PEFQTEITVLSKIRHR-HLVSLVG 524
           +G G F +V + + +   +    + +   R+G     E   EI VL   +    +++L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
             E  SE+IL+ EY   G +           +S    + +      G++YLH  +   I+
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IV 153
Query: 585 HRDIKSTNILLDENYV---SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
           H D+K  NILL   Y     K+ DFG+SR    +        + G+  YL PE      +
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLAPEILNYDPI 210
Query: 642 TDKSDVYSFGVVLFEVL 658
           T  +D+++ G++ + +L
Sbjct: 211 TTATDMWNIGIIAYMLL 227

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG----SRQGLPEFQTEITV 510
           DL+    +++   +IG G FG V     +   KV   + +       R     F  E  +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR 570
           ++      +V L    ++   + +V EYM  G L   +   D  P  W +        A 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWAR-----FYTAE 181
Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG----LSRSGPCLDETHVSTGVKG 626
            +  L    + G IHRD+K  N+LLD++   K+ADFG    +++ G    +T V     G
Sbjct: 182 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----G 236
Query: 627 SFGYLDPEYFRRQ----QLTDKSDVYSFGVVLFEVLCART 662
           +  Y+ PE  + Q        + D +S GV L+E+L   T
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 276

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 16/212 (7%)
Query: 461 NNFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH 516
            +F+  +++G G FG V     KG         +K+ V      +     E  VL+    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 517 RHLVSLVGYC-EEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              ++ +  C +    +  V EY+  G L  H+   G  + P +     EI IG    L 
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LF 135
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           +L +   +GII+RD+K  N++LD     K+ADFG+ +    + +   +    G+  Y+ P
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKXFCGTPDYIAP 190
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
           E    Q      D ++FGV+L+E+L  +   +
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +      G+ +LH+
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHS 137
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 138 A---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 191
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  VL  N  VA+K+   P   Q        E+ ++  + H++++SL+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +      G+ +LH+
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   +  VL  N  VAVK+   P   Q        E+ +L  + H++++SL+
Sbjct: 30  IGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 88  NVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHS 142
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+        + T    +  Y  PE   
Sbjct: 143 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPYVVTRYYRAPEVIL 196
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 197 GMGYKENVDIWSVGCIMGELV 217

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 462 NFDKNLIIGSGGFGMVY----KGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHR 517
           +F+  +++G G FG V     KG         +K+ V      +     E  VL+     
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 518 HLVSLVGYC-EEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHY 574
             ++ +  C +    +  V EY+  G L  H+   G  + P +     EI IG    L +
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFF 457
Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L +   +GII+RD+K  N++LD     K+ADFG+ +    + +   +    G+  Y+ PE
Sbjct: 458 LQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKXFCGTPDYIAPE 512
Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCARTAVD 665
               Q      D ++FGV+L+E+L  +   +
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMI 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMI 219

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVSLVGY 525
           +GSG +G V      +   +VAVK+     +  +   +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 ------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGLH 573
                  EE +++ LV           HL G D   +   Q+L       +     RGL 
Sbjct: 90  FTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           Y+H+     IIHRD+K +N+ ++E+   K+ D GL+R     DE    TG   +  Y  P
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLARHTD--DEM---TGYVATRWYRAP 191
Query: 634 EYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           E        +++ D++S G ++ E+L  RT
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 145
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 146 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 199
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 200 GMGYKENVDIWSVGCIMGEMI 220

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 30/206 (14%)
Query: 466 NLIIGSGGFGMVYKGVLRDNT------KVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL 519
           ++ IG G F  VYKG+  + T      ++  ++     RQ    F+ E   L  ++H ++
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNI 87
Query: 520 VSLVGYCEE----QSEMILVYEYMEKGPLKKHL----YGPDRTPLSWKQRLEICIGAARG 571
           V      E     +  ++LV E    G LK +L        +   SW      C    +G
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILKG 141
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGY 630
           L +LHT +   IIHRD+K  NI +     S K+ D GL+     L     +  V G+  +
Sbjct: 142 LQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPEF 196
Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFE 656
             PE +  ++  +  DVY+FG    E
Sbjct: 197 XAPEXY-EEKYDESVDVYAFGXCXLE 221

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   +  VL  N  VAVK+   P   Q        E+ +L  + H++++SL+
Sbjct: 32  IGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ LV E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+  C +   + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-CTN--FMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                   D++S G ++ E++
Sbjct: 199 GMGYAANVDIWSVGCIMGELV 219

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 32/210 (15%)
Query: 468 IIGSGGFGMVYKGVLRDNTK------VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +IG G F +V + + R+  +      V V +          + + E ++   ++H H+V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 522 LVGYCEEQSEMILVYEYMEKGPL---------KKHLYGPDRTPLSWKQRLEICIGAARGL 572
           L+        + +V+E+M+   L            +Y         +Q LE        L
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-------AL 143
Query: 573 HYLHTGSAEGIIHRDIKSTNILL--DENYVS-KVADFGLSRSGPCLDETH-VSTGVKGSF 628
            Y H  +   IIHRD+K  N+LL   EN    K+ DFG++     L E+  V+ G  G+ 
Sbjct: 144 RYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQ---LGESGLVAGGRVGTP 197
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            ++ PE  +R+      DV+  GV+LF +L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILL 227

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPEVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMI 219

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ 560
           L +   E+ ++  + H ++V L    E +  + L+ EY   G +  +L    R  +  K+
Sbjct: 58  LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKE 115
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS---GPCLDE 617
                      + Y H    + I+HRD+K+ N+LLD +   K+ADFG S     G  LD 
Sbjct: 116 ARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD- 171
Query: 618 THVSTGVKGSFGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVD 665
                   G+  Y  PE F+ ++    + DV+S GV+L+ ++      D
Sbjct: 172 -----AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   IG+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EYM  G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    KVADFG ++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   IG+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EYM  G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    KVADFG ++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 15/169 (8%)
Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ 560
           L +   E+ ++  + H ++V L    E +  + LV EY   G +  +L         W +
Sbjct: 50  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-----GWMK 104
Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS---GPCLDE 617
             E      + +  +     + I+HRD+K+ N+LLD +   K+ADFG S     G  LD 
Sbjct: 105 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT 164
Query: 618 THVSTGVKGSFGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVD 665
                   GS  Y  PE F+ ++    + DV+S GV+L+ ++      D
Sbjct: 165 ------FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMI 219

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPE--FQTEITVLSKIRHRHLVSLVGY 525
           IG G +G+V+K   RD  + VA+K+ +      + +     EI +L +++H +LV+L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL--EICIGAARGLHYLHTGSAEGI 583
              +  + LV+EY +   L    +  DR      + L   I     + +++ H  +    
Sbjct: 71  FRRKRRLHLVFEYCDHTVL----HELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC--- 123
Query: 584 IHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPEYFR-RQQ 640
           IHRD+K  NIL+ ++ V K+ DFG +R  +GP    +        +  Y  PE      Q
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGP----SDYYDDEVATRWYRSPELLVGDTQ 179
Query: 641 LTDKSDVYSFGVVLFEVL 658
                DV++ G V  E+L
Sbjct: 180 YGPPVDVWAIGCVFAELL 197

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 20/220 (9%)
Query: 454 TDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGLPEFQTEITV 510
            D Q    N+     IG G F  V     +    +VAVK       +   L +   E+ +
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRI 66
Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAA 569
              + H ++V L    E +  + LV EY   G +  +L    R      + +    + A 
Sbjct: 67  XKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAV 126
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS---GPCLDETHVSTGVKG 626
           +  H       + I+HRD+K+ N+LLD +   K+ADFG S     G  LD         G
Sbjct: 127 QYCH------QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLD------AFCG 174
Query: 627 SFGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVD 665
           +  Y  PE F+ ++    + DV+S GV+L+ ++      D
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 36/233 (15%)
Query: 452 PFT----DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG----SRQGLPE 503
           PFT     ++    +F+   +IG G FG V    L++  KV   + +       R     
Sbjct: 61  PFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC 120
Query: 504 FQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG-----PDRTPLSW 558
           F+ E  VL     + + +L    ++ + + LV +Y   G L   L       P+     +
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY 180
Query: 559 KQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL--- 615
              + I I +   LHY         +HRDIK  NIL+D N   ++ADF     G CL   
Sbjct: 181 LAEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADF-----GSCLKLM 226
Query: 616 -DETHVSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCART 662
            D T  S+   G+  Y+ PE  +     + +   + D +S GV ++E+L   T
Sbjct: 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEI---------TVLSKIRHRH 518
           +GSG +G V   +  R   KVA+K+    SR     FQ+EI          +L  ++H +
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKL---SR----PFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGP-LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++ L+      S +   Y++    P ++  L        S ++   +     +GL Y+H+
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               G++HRD+K  N+ ++E+   K+ DFGL+R           TG   +  Y  PE   
Sbjct: 145 A---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVIL 196
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCART 662
                +++ D++S G ++ E+L  +T
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKT 222

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMI 219

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEI---------TVLSKIRHRH 518
           +GSG +G V   +  R   KVA+K+    SR     FQ+EI          +L  ++H +
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKL---SR----PFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 519 LVSLVGYCEEQSEMILVYEYMEKGP-LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++ L+      S +   Y++    P ++  L        S ++   +     +GL Y+H+
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS 162
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               G++HRD+K  N+ ++E+   K+ DFGL+R           TG   +  Y  PE   
Sbjct: 163 A---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVIL 214
Query: 638 RQQLTDKS-DVYSFGVVLFEVLCART 662
                +++ D++S G ++ E+L  +T
Sbjct: 215 SWMHYNQTVDIWSVGCIMAEMLTGKT 240

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 106/235 (45%), Gaps = 25/235 (10%)
Query: 435 GTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMV---YKGVLRDNTKVAVK 491
           G+++ S   N ++ ++I  +   T    +     IGSG  G+V   Y  +L  N  VA+K
Sbjct: 1   GSMSRSKRDNNFYSVEIGDSTF-TVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIK 57
Query: 492 R-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLVGY------CEEQSEMILVYEYMEKGP 543
           +   P   Q        E+ ++  + H++++ L+         EE  ++ +V E M+   
Sbjct: 58  KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL 117
Query: 544 LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKV 603
            +      D   +S+     +C     G+ +LH+    GIIHRD+K +NI++  +   K+
Sbjct: 118 CQVIQMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 169
Query: 604 ADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            DFGL+R+      + +      +  Y  PE        +  D++S G ++ E++
Sbjct: 170 LDFGLARTA---GTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMI 219

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 121/283 (42%), Gaps = 57/283 (20%)
Query: 423 AYGCSSHSKMSEGTVNASPGQNGYHR-----------LKIPFTDLQTATNNFDKNLIIGS 471
           A     H+  ++ TV+ S  Q G  R           +  P +D Q   + ++   +IG+
Sbjct: 6   AAAAQQHNSGTQHTVSGS-QQEGQQRKQHHSSKPTASMPRPHSDWQIP-DRYEIRHLIGT 63
Query: 472 GGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRHRHLVSLVGYC-- 526
           G +G V +   +   +V   + +    + L + +    EI +L+++ H H+V ++     
Sbjct: 64  GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123
Query: 527 ---EEQSEMILVYEYMEKGPLKKHLYGPDRTP--LSWKQRLEICIGAARGLHYLHTGSAE 581
              E+  E+ +V E  +     K L+   RTP  L+      +      G+ Y+H+    
Sbjct: 124 KDVEKFDELYVVLEIADSD--FKKLF---RTPVYLTELHIKTLLYNLLVGVKYVHSA--- 175
Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRS-------------GPCLDET------HVST 622
           GI+HRD+K  N L++++   KV DFGL+R+              P  D+       H   
Sbjct: 176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKN 235
Query: 623 GVKGSFGYLDPEYFRRQQL-------TDKSDVYSFGVVLFEVL 658
             +   G++   ++R  +L       T+  DV+S G +  E+L
Sbjct: 236 LKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +      G+ +LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLVGIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S GV++ E++
Sbjct: 199 GMGYKENVDIWSVGVIMGEMI 219

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 27/201 (13%)
Query: 469 IGSGGFGMVYKGVLRD---NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSG FG+    ++RD   N  VAVK    G +      + EI     +RH ++V     
Sbjct: 27  IGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIAA-NVKREIINHRSLRHPNIVRFKEV 83
Query: 526 CEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
               + + +V EY   G L + +     +  D     ++Q +        G+ Y H   A
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYCH---A 133
Query: 581 EGIIHRDIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
             + HRD+K  N LLD +     K+ DFG S+S     +   + G      Y+ PE   +
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLK 190
Query: 639 QQLTDK-SDVYSFGVVLFEVL 658
           ++   K +DV+S GV L+ +L
Sbjct: 191 KEYDGKVADVWSCGVTLYVML 211

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +      G+ +LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLVGIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S GV++ E++
Sbjct: 199 GMGYKENVDIWSVGVIMGEMI 219

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 21/221 (9%)
Query: 447 HRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQ 505
           HR  I FTD       ++    IG G + +  + + +  N + AVK      R   P  +
Sbjct: 14  HRNSIQFTD------GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD--PTEE 65
Query: 506 TEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEIC 565
            EI +L   +H ++++L    ++   + +V E M+ G L   +    +   S ++   + 
Sbjct: 66  IEI-LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL--RQKFFSEREASAVL 122
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNIL-LDEN---YVSKVADFGLSRSGPCLDETHVS 621
               + + YLH   A+G++HRD+K +NIL +DE+      ++ DFG ++     +   ++
Sbjct: 123 FTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
                +F  + PE   RQ      D++S GV+L+ +L   T
Sbjct: 180 PCYTANF--VAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 40/235 (17%)
Query: 452 PFTDL----QTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG----SRQGLPE 503
           PFT L    Q    +F+   +IG G FG V    +++  ++   + +       R     
Sbjct: 77  PFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETAC 136
Query: 504 FQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG-----PDRTPLSW 558
           F+ E  VL     + + +L    ++++ + LV +Y   G L   L       P+     +
Sbjct: 137 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY 196
Query: 559 KQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL--- 615
              + + I +   LHY         +HRDIK  N+LLD N   ++ADF     G CL   
Sbjct: 197 IGEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADF-----GSCLKMN 242
Query: 616 -DETHVSTGVKGSFGYLDPEYFRRQQLTD-------KSDVYSFGVVLFEVLCART 662
            D T  S+   G+  Y+ PE    Q + D       + D +S GV ++E+L   T
Sbjct: 243 DDGTVQSSVAVGTPDYISPEIL--QAMEDGMGKYGPECDWWSLGVCMYEMLYGET 295

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 25/200 (12%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCE 527
           +G G F +  K V + + +    + +  S++     Q EIT L     H ++V L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 528 EQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           +Q    LV E +  G L      KKH      T  S+  R    + A   +H +      
Sbjct: 77  DQLHTFLVMELLNGGELFERIKKKKHF---SETEASYIMR--KLVSAVSHMHDV------ 125
Query: 582 GIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
           G++HRD+K  N+L    ++N   K+ DFG +R  P  D   + T    +  Y  PE   +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPC-FTLHYAAPELLNQ 183
Query: 639 QQLTDKSDVYSFGVVLFEVL 658
               +  D++S GV+L+ +L
Sbjct: 184 NGYDESCDLWSLGVILYTML 203

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 40/235 (17%)
Query: 452 PFTDL----QTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG----SRQGLPE 503
           PFT L    Q    +F+   +IG G FG V    +++  ++   + +       R     
Sbjct: 61  PFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETAC 120
Query: 504 FQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG-----PDRTPLSW 558
           F+ E  VL     + + +L    ++++ + LV +Y   G L   L       P+     +
Sbjct: 121 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY 180
Query: 559 KQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL--- 615
              + + I +   LHY         +HRDIK  N+LLD N   ++ADF     G CL   
Sbjct: 181 IGEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADF-----GSCLKMN 226
Query: 616 -DETHVSTGVKGSFGYLDPEYFRRQQLTD-------KSDVYSFGVVLFEVLCART 662
            D T  S+   G+  Y+ PE    Q + D       + D +S GV ++E+L   T
Sbjct: 227 DDGTVQSSVAVGTPDYISPEIL--QAMEDGMGKYGPECDWWSLGVCMYEMLYGET 279

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 27/201 (13%)
Query: 469 IGSGGFGMVYKGVLRD---NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSG FG+    ++RD   N  VAVK    G +      + EI     +RH ++V     
Sbjct: 26  IGSGNFGVA--RLMRDKQSNELVAVKYIERGEKID-ENVKREIINHRSLRHPNIVRFKEV 82
Query: 526 CEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
               + + +V EY   G L + +     +  D     ++Q +        G+ Y H   A
Sbjct: 83  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYCH---A 132
Query: 581 EGIIHRDIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
             + HRD+K  N LLD +     K+ DFG S+S     +   + G      Y+ PE   +
Sbjct: 133 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLK 189
Query: 639 QQLTDK-SDVYSFGVVLFEVL 658
           ++   K +DV+S GV L+ +L
Sbjct: 190 KEYDGKVADVWSCGVTLYVML 210

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 563 EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST 622
           +I +   + L++L       IIHRDIK +NILLD +   K+ DFG+S     L ++   T
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ---LVDSIAKT 183
Query: 623 GVKGSFGYLDPEYF----RRQQLTDKSDVYSFGVVLFEVLCAR 661
              G   Y+ PE       RQ    +SDV+S G+ L+E+   R
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 102/253 (40%), Gaps = 36/253 (14%)
Query: 425 GCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTAT----NNFDKNLIIGSGGFGMVYKG 480
           G ++    S G    + G  G H    P   +Q +T    + +    ++G G FG V   
Sbjct: 9   GGAAGEPRSRGHAAGTSGGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVI-- 66
Query: 481 VLRDN-------TKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI 533
           + +D         KV  KR V   +        E+ +L ++ H +++ L  + E++    
Sbjct: 67  LCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 125
Query: 534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNI 593
           LV E    G L   +    R   S      I      G+ Y+H      I+HRD+K  N+
Sbjct: 126 LVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENL 180
Query: 594 LLDENYVS---KVADFGLSRSGPCLDETHVSTGVK-----GSFGYLDPEYFRRQQLTDKS 645
           LL+        ++ DFGLS        TH     K     G+  Y+ PE        +K 
Sbjct: 181 LLESKSKDANIRIIDFGLS--------THFEASKKMKDKIGTAYYIAPEVL-HGTYDEKC 231
Query: 646 DVYSFGVVLFEVL 658
           DV+S GV+L+ +L
Sbjct: 232 DVWSTGVILYILL 244

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 102/253 (40%), Gaps = 36/253 (14%)
Query: 425 GCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTAT----NNFDKNLIIGSGGFGMVYKG 480
           G ++    S G    + G  G H    P   +Q +T    + +    ++G G FG V   
Sbjct: 10  GGAAGEPRSRGHAAGTSGGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVI-- 67
Query: 481 VLRDN-------TKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI 533
           + +D         KV  KR V   +        E+ +L ++ H +++ L  + E++    
Sbjct: 68  LCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 126
Query: 534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNI 593
           LV E    G L   +    R   S      I      G+ Y+H      I+HRD+K  N+
Sbjct: 127 LVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENL 181
Query: 594 LLDENYVS---KVADFGLSRSGPCLDETHVSTGVK-----GSFGYLDPEYFRRQQLTDKS 645
           LL+        ++ DFGLS        TH     K     G+  Y+ PE        +K 
Sbjct: 182 LLESKSKDANIRIIDFGLS--------THFEASKKMKDKIGTAYYIAPEVL-HGTYDEKC 232
Query: 646 DVYSFGVVLFEVL 658
           DV+S GV+L+ +L
Sbjct: 233 DVWSTGVILYILL 245

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 104/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   IG+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    KVADFG ++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/250 (21%), Positives = 118/250 (47%), Gaps = 25/250 (10%)
Query: 463 FDKNLI---IGSGGFGMVYKGVLRDNTKVAVKR--GVPGSRQGLPEFQTEITVLSKIRHR 517
           ++K +I   +G G FG+V++ V   + K  + +   V G+ Q L   + EI++L+  RHR
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHR 61
Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           +++ L    E   E+++++E++    + + +       L+ ++ +         L +LH+
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 578 GSAEGIIHRDIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
                I H DI+  NI+      S  K+ +FG +R     D   +   +  +  Y  PE 
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEV 174
Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ 695
            +   ++  +D++S G +++ +L   + ++P LA     + E  M        E+  D +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLL---SGINPFLAETNQQIIENIMN------AEYTFDEE 225
Query: 696 LIGKINLDSL 705
              +I+++++
Sbjct: 226 AFKEISIEAM 235

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 100/237 (42%), Gaps = 39/237 (16%)
Query: 437 VNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDN-------TKVA 489
           ++A+PG    H   I F+D       +    ++G G FG V   + +D         KV 
Sbjct: 9   LHATPGMFVQHSTAI-FSD------RYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVI 59
Query: 490 VKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLY 549
            KR V   +        E+ +L ++ H +++ L  + E++    LV E    G L   + 
Sbjct: 60  SKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 118
Query: 550 GPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADF 606
              R   S      I      G+ Y+H      I+HRD+K  N+LL+   ++   ++ DF
Sbjct: 119 S--RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 607 GLSRSGPCLDETHVSTGVK-----GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           GLS        TH     K     G+  Y+ PE        +K DV+S GV+L+ +L
Sbjct: 174 GLS--------THFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILL 221

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 30/150 (20%)
Query: 582 GIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           G++HRDIK  NIL+D N    K+ DFG   SG  L +T V T   G+  Y  PE+ R  +
Sbjct: 177 GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHR 232
Query: 641 LTDKS-DVYSFGVVLFEVLCARTAV--DPLLAREQV-----------NLAEWAM------ 680
              +S  V+S G++L++++C       D  + R QV           +L  W +      
Sbjct: 233 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSD 292
Query: 681 -----QWQKKGMLEHIIDPQLIGKINLDSL 705
                + Q    ++ ++ PQ   +I+L SL
Sbjct: 293 RPTFEEIQNHPWMQDVLLPQETAEIHLHSL 322

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 24/201 (11%)
Query: 469 IGSGGFGMV---YKGVLRDNTKVAVKR-GVPGSRQG-LPEFQTEITVLSKIRHRHLVSLV 523
           IGSG  G+V   Y  +L  N  VA+K+   P   Q        E+ ++  + H++++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 524 GY------CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
                    EE  ++ +V E M+    +      D   +S+     +      G+ +LH+
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLVGIKHLHS 144
Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               GIIHRD+K +NI++  +   K+ DFGL+R+      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
                +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMI 219

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 469 IGSGGFGMVYKGVLRD---NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IG+G FG+    ++RD   N  VAVK    G +      + EI     +RH ++V     
Sbjct: 27  IGAGNFGVAR--LMRDKQANELVAVKYIERGEKID-ENVKREIINHRSLRHPNIVRFKEV 83
Query: 526 CEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
               + + +V EY   G L + +     +  D     ++Q +        G+ Y H   A
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYAH---A 133
Query: 581 EGIIHRDIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
             + HRD+K  N LLD +     K+ADFG S++     +   + G      Y+ PE   +
Sbjct: 134 MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTP---AYIAPEVLLK 190
Query: 639 QQLTDK-SDVYSFGVVLFEVLC 659
           ++   K +DV+S GV L+ +L 
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLV 212

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 83/169 (49%), Gaps = 16/169 (9%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRH 516
           +N++   +IG G +G VY    ++ N  VA+K+ V    + L + +    EIT+L++++ 
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKK-VNRMFEDLIDCKRILREITILNRLKS 86
Query: 517 RHLVSLVGYCEEQS-----EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARG 571
            +++ L      +      E+ +V E +    LKK    P    L+ +    I      G
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTP--IFLTEQHVKTILYNLLLG 143
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV 620
             ++H     GIIHRD+K  N LL+++   K+ DFGL+R+     + H+
Sbjct: 144 EKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHI 189

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 23/201 (11%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRHRHLVSLVGY 525
           +G G F +V + V +  T+    + +   +    + Q    E  +   ++H ++V L   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 526 CEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
             E+    LV++ +  G L      +  Y          Q LE        ++++H    
Sbjct: 99  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILE-------SVNHIHQ--- 148
Query: 581 EGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
             I+HRD+K  N+LL    +    K+ADFGL+       E     G  G+ GYL PE  R
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIE--VQGEQQAWFGFAGTPGYLSPEVLR 206
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
           +       D+++ GV+L+ +L
Sbjct: 207 KDPYGKPVDIWACGVILYILL 227

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHR 517
           +++F    ++G G +G+V     +   ++   + +    + L   +T  EI +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 518 HLVSLVGY-----CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI-GAARG 571
           +++++         E  +E+ ++ E M+       L+    T +     ++  I    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFG 629
           +  LH GS   +IHRD+K +N+L++ N   KV DFGL+R       D +  +    G   
Sbjct: 125 VKVLH-GS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 630 YLDPEYFRRQQLTDKS-------DVYSFGVVLFEVLCAR 661
           Y+   ++R  ++   S       DV+S G +L E+   R
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 109/239 (45%), Gaps = 34/239 (14%)
Query: 435 GTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRG 493
           G+ ++ PG+         F D+   T+      ++G G +  V   V L++  + AVK  
Sbjct: 1   GSTDSLPGK---------FEDMYKLTSE-----LLGEGAYAKVQGAVSLQNGKEYAVKII 46
Query: 494 VPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPD 552
              +         E+  L + + +++++ L+ + E+ +   LV+E ++ G +  H+    
Sbjct: 47  EKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI--QK 104
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-NYVS--KVADF--- 606
           +   + ++   +    A  L +LHT   +GI HRD+K  NIL +    VS  K+ DF   
Sbjct: 105 QKHFNEREASRVVRDVAAALDFLHT---KGIAHRDLKPENILCESPEKVSPVKICDFDLG 161
Query: 607 -GLSRSGPCLDETHVS-TGVKGSFGYLDPE----YFRRQQLTDK-SDVYSFGVVLFEVL 658
            G+  +  C   T    T   GS  Y+ PE    +  +    DK  D++S GVVL+ +L
Sbjct: 162 SGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIML 220

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 23/201 (11%)
Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IG G F +V + V L    + A K       S +   + + E  +   ++H ++V L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 526 CEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
             E+    LV++ +  G L      +  Y         +Q LE    A    H +     
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE----AVLHCHQM----- 122
Query: 581 EGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
            G++HRD+K  N+LL    +    K+ADFGL+       +     G  G+ GYL PE  R
Sbjct: 123 -GVVHRDLKPENLLLASKCKGAAVKLADFGLAIE--VQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 638 RQQLTDKSDVYSFGVVLFEVL 658
           ++      D+++ GV+L+ +L
Sbjct: 180 KEAYGKPVDIWACGVILYILL 200

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRHRHLVSLVG 524
           +IG G +G VY    ++  K    + V    + L + +    EIT+L++++  +++ L  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 525 YCEEQS-----EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
                      E+ +V E  +   LKK    P    L+ +    I      G +++H   
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSD-LKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES- 148
Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG------------- 626
             GIIHRD+K  N LL+++   KV DFGL+R+     +T++   ++              
Sbjct: 149 --GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 627 -------SFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVL 658
                  +  Y  PE    Q+   KS D++S G +  E+L
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG  M+ K     N    K+  K+ V   +Q +     E  +L  + 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 120
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 176
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++       T     + G+  YL P
Sbjct: 177 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT-----LCGTPEYLAP 228
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 269

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHR 517
           +++F    ++G G +G+V     +   ++   + +    + L   +T  EI +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 518 HLVSLVGY-----CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI-GAARG 571
           +++++         E  +E+ ++ E M+       L+    T +     ++  I    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFG 629
           +  LH GS   +IHRD+K +N+L++ N   KV DFGL+R       D +  +    G   
Sbjct: 125 VKVLH-GS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 630 YLDPEYFRRQQLTDKS-------DVYSFGVVLFEVLCAR 661
           ++   ++R  ++   S       DV+S G +L E+   R
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           IG G +    + V +  N + AVK      R   P  + EI +L   +H ++++L    +
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRD--PSEEIEI-LLRYGQHPNIITLKDVYD 91
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           +   + LV E M  G L   +    +   S ++   +     + + YLH   ++G++HRD
Sbjct: 92  DGKHVYLVTELMRGGELLDKIL--RQKFFSEREASFVLHTIGKTVEYLH---SQGVVHRD 146
Query: 588 IKSTNIL-LDEN---YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           +K +NIL +DE+      ++ DFG ++     +   ++     +F  + PE  +RQ   +
Sbjct: 147 LKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF--VAPEVLKRQGYDE 204
Query: 644 KSDVYSFGVVLFEVLCART 662
             D++S G++L+ +L   T
Sbjct: 205 GCDIWSLGILLYTMLAGYT 223

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A E + + E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADEPIQIYE 248

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 25/181 (13%)
Query: 563 EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST 622
           +I +   + L +LH  S   +IHRD+K +N+L++     K+ DFG+  SG  +D     T
Sbjct: 157 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDSV-AKT 211
Query: 623 GVKGSFGYLDPEY----FRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW 678
              G   Y+ PE       ++  + KSD++S G+ + E+   R   D            W
Sbjct: 212 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD-----------SW 260
Query: 679 AMQWQKKGMLEHIIDPQLIGKINLDSLK-KFGETAEKCLADYGVDRPSMGDVLWNLEYAL 737
              +Q+   +     PQL      D    +F +   +CL     +RP+  +++ +  + L
Sbjct: 261 GTPFQQLKQVVEEPSPQLPA----DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 316
Query: 738 Q 738
Sbjct: 317 H 317

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG  M+ K     N    K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLAGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 248

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 86
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 142
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+DE    +V DFG ++          +  + G+  YL P
Sbjct: 143 YLHSLD---LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 194
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 235

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLXGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 248

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 96/237 (40%), Gaps = 39/237 (16%)
Query: 437 VNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDN-------TKVA 489
           ++A+PG    H   I F+D       +    ++G G FG V   + +D         KV 
Sbjct: 9   LHATPGXFVQHSTAI-FSD------RYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVI 59
Query: 490 VKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLY 549
            KR V   +        E+ +L ++ H ++  L  + E++    LV E    G L   + 
Sbjct: 60  SKRQVK-QKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEII 118
Query: 550 GPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS---KVADF 606
              R   S      I      G+ Y H      I+HRD+K  N+LL+        ++ DF
Sbjct: 119 S--RKRFSEVDAARIIRQVLSGITYXHKNK---IVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 607 GLSRSGPCLDETHVSTGVK-----GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           GLS        TH     K     G+  Y+ PE        +K DV+S GV+L+ +L
Sbjct: 174 GLS--------THFEASKKXKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILL 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           IG G +    + V +  N + AVK      R   P  + EI +L   +H ++++L    +
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRD--PSEEIEI-LLRYGQHPNIITLKDVYD 91
Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           +   + LV E M  G L   +    +   S ++   +     + + YLH   ++G++HRD
Sbjct: 92  DGKHVYLVTELMRGGELLDKIL--RQKFFSEREASFVLHTIGKTVEYLH---SQGVVHRD 146
Query: 588 IKSTNIL-LDEN---YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           +K +NIL +DE+      ++ DFG ++     +   ++     +F  + PE  +RQ   +
Sbjct: 147 LKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF--VAPEVLKRQGYDE 204
Query: 644 KSDVYSFGVVLFEVLCART 662
             D++S G++L+ +L   T
Sbjct: 205 GCDIWSLGILLYTMLAGYT 223

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 27/201 (13%)
Query: 469 IGSGGFGMVYKGVLRD---NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSG FG+    ++RD   N  VAVK    G +      + EI     +RH ++V     
Sbjct: 27  IGSGNFGVAR--LMRDKQSNELVAVKYIERGEKID-ENVKREIINHRSLRHPNIVRFKEV 83
Query: 526 CEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
               + + +V EY   G L + +     +  D     ++Q +        G+ Y H   A
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYCH---A 133
Query: 581 EGIIHRDIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
             + HRD+K  N LLD +     K+  FG S+S     +   + G      Y+ PE   +
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLK 190
Query: 639 QQLTDK-SDVYSFGVVLFEVL 658
           ++   K +DV+S GV L+ +L
Sbjct: 191 KEYDGKVADVWSCGVTLYVML 211

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 21/221 (9%)
Query: 447 HRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQ 505
           HR  I FTD       ++    IG G + +  + + +  N + AVK      R   P  +
Sbjct: 14  HRNSIQFTD------GYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRD--PTEE 65
Query: 506 TEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEIC 565
            EI +L   +H ++++L    ++   + +V E  + G L   +    +   S ++   + 
Sbjct: 66  IEI-LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL--RQKFFSEREASAVL 122
Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNIL-LDEN---YVSKVADFGLSRSGPCLDETHVS 621
               + + YLH   A+G++HRD+K +NIL +DE+      ++ DFG ++     +    +
Sbjct: 123 FTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT 179
Query: 622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
                +F  + PE   RQ      D++S GV+L+  L   T
Sbjct: 180 PCYTANF--VAPEVLERQGYDAACDIWSLGVLLYTXLTGYT 218

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 33  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 80
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 81  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 139
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 140 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                T     + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 193 KGRTWT-----LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 244
Query: 673 VNLAE 677
           + + E
Sbjct: 245 IQIYE 249

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 18  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 65
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 66  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 124
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 125 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 177
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                T     + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 178 KGRTWT-----LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 229
Query: 673 VNLAE 677
           + + E
Sbjct: 230 IQIYE 234

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHR 517
           +++F    ++G G +G+V     +   ++   + +    + L   +T  EI +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 518 HLVSLVGY-----CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI-GAARG 571
           +++++         E  +E+ ++ E M+       L+    T +     ++  I    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---------SGPCLDETHVST 622
           +  LH GS   +IHRD+K +N+L++ N   KV DFGL+R         S P   ++ ++ 
Sbjct: 125 VKVLH-GS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 623 GVKGSFGYLDPE-YFRRQQLTDKSDVYSFGVVLFEVLCAR 661
            V   + Y  PE      + +   DV+S G +L E+   R
Sbjct: 182 XVATRW-YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG  M+ K     N    K+  K+ V   +Q +     E  +L  + 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 120
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FE 176
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 177 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 228
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 269

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 20/164 (12%)
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLS 557
           + + E  +   ++H ++V L     E+    L+++ +  G L      +  Y        
Sbjct: 67  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC 126
Query: 558 WKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY---VSKVADFGLSRSGPC 614
            +Q LE    A    H +      G++HRD+K  N+LL         K+ADFGL+     
Sbjct: 127 IQQILE----AVLHCHQM------GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVE- 175
Query: 615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             E     G  G+ GYL PE  R+       D+++ GV+L+ +L
Sbjct: 176 -GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 218

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 248

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 27/201 (13%)
Query: 469 IGSGGFGMVYKGVLRD---NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSG FG+    ++RD   N  VAVK    G +      + EI     +RH ++V     
Sbjct: 27  IGSGNFGVAR--LMRDKQSNELVAVKYIERGEKID-ENVKREIINHRSLRHPNIVRFKEV 83
Query: 526 CEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
               + + +V EY   G L + +     +  D     ++Q +        G+ Y H   A
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYCH---A 133
Query: 581 EGIIHRDIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
             + HRD+K  N LLD +     K+  FG S+S     +   + G      Y+ PE   +
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTP---AYIAPEVLLK 190
Query: 639 QQLTDK-SDVYSFGVVLFEVL 658
           ++   K +DV+S GV L+ +L
Sbjct: 191 KEYDGKVADVWSCGVTLYVML 211

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG  M+ K     N    K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 248

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 20/164 (12%)
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLS 557
           + + E  +   ++H ++V L     E+    LV++ +  G L      +  Y        
Sbjct: 49  KLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC 108
Query: 558 WKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPC 614
            +Q LE        +++ H     GI+HRD+K  N+LL    +    K+ADFGL+     
Sbjct: 109 IQQILE-------SVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIE--V 156
Query: 615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             +     G  G+ GYL PE  R+       D+++ GV+L+ +L
Sbjct: 157 QGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILL 200

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 248

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 248

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 248

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 248

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 100
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 156
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 157 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 249

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 248

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG  M+ K     N    K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDR--TPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL    R   P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 248

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 582 GIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
           GI+HRD+K  N+LL    +    K+ADFGL+       +     G  G+ GYL PE  R+
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIE--VQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 639 QQLTDKSDVYSFGVVLFEVL 658
                  D+++ GV+L+ +L
Sbjct: 181 DPYGKPVDMWACGVILYILL 200

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 94
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FE 150
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 151 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 202
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 243

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRDN-------TKVAVKRGVPGSRQGLPEFQTEITVLS 512
           ++ +    ++G G FG V   + +D         KV  KR V   +        E+ +L 
Sbjct: 31  SDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLK 87
Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGL 572
           ++ H +++ L  + E++    LV E    G L   +    R   S      I      G+
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGI 145
Query: 573 HYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVK---- 625
            Y+H      I+HRD+K  N+LL+   ++   ++ DFGLS        TH     K    
Sbjct: 146 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASKKMKDK 194
Query: 626 -GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            G+  Y+ PE        +K DV+S GV+L+ +L
Sbjct: 195 IGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILL 227

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           SP QN  H             + F++   +G+G FG  M+ K     N    K+  K+ V
Sbjct: 25  SPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV 72
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 73  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 131
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 132 XEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 184
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 185 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 236
Query: 673 VNLAE 677
           + + E
Sbjct: 237 IQIYE 241

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           SP QN  H             + F++   +G+G FG  M+ K     N    K+  K+ V
Sbjct: 25  SPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV 72
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 73  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 131
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 132 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 184
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 185 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 236
Query: 673 VNLAE 677
           + + E
Sbjct: 237 IQIYE 241

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 81/183 (44%), Gaps = 29/183 (15%)
Query: 563 EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET--HV 620
           +I +   + L +LH  S   +IHRD+K +N+L++     K+ DFG+  SG  +D+    +
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDDVAKDI 168
Query: 621 STGVKGSFGYLDPEY----FRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLA 676
             G K    Y+ PE       ++  + KSD++S G+ + E+   R   D           
Sbjct: 169 DAGCK---PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD----------- 214
Query: 677 EWAMQWQKKGMLEHIIDPQLIGKINLDSLK-KFGETAEKCLADYGVDRPSMGDVLWNLEY 735
            W   +Q+   +     PQL      D    +F +   +CL     +RP+  +++ +  +
Sbjct: 215 SWGTPFQQLKQVVEEPSPQLPA----DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270
Query: 736 ALQ 738
            L 
Sbjct: 271 TLH 273

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 33  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 80
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 81  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 139
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 140 XEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 193 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 244
Query: 673 VNLAE 677
           + + E
Sbjct: 245 IQIYE 249

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 139 XEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 139 XEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY   G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+++D+    KV DFG ++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY   G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+++D+    KV DFG ++  
Sbjct: 139 XEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 21/176 (11%)
Query: 507 EITVLSKIRHRHLVSLVGYCEEQS--EMILVYEYMEKGPLKKHLYGPDRT-PLSWKQRLE 563
           E  VL K+ H+++V L    EE +    +L+ E+   G L   L  P     L   + L 
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSRSGPCLDETH 619
           +      G+++L      GI+HR+IK  NI+     D   V K+ DFG +R    L++  
Sbjct: 117 VLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDE 170
Query: 620 VSTGVKGSFGYLDPEYFRRQQLTDKS--------DVYSFGVVLFEVLCARTAVDPL 667
               + G+  YL P+ + R  L            D++S GV  +          P 
Sbjct: 171 QFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           SP QN  H             + F++   +G+G FG  M+ K     N    K+  K+ V
Sbjct: 33  SPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV 80
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 81  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 139
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 140 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 193 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 244
Query: 673 VNLAE 677
           + + E
Sbjct: 245 IQIYE 249

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 17/155 (10%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI---- 514
           T  F +   IGSG FG V+K V R D    A+KR    S++ L     E   L ++    
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR----SKKPLAGSVDEQNALREVYAHA 63
Query: 515 ---RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQR--LEICIGAA 569
              +H H+V       E   M++  EY   G L   +    R    +K+    ++ +   
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA 604
           RGL Y+H+ S   ++H DIK +NI +    +   A
Sbjct: 124 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA 155

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 101/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           SP QN  H             + F++   +G+G FG  M+ K     N    K+  K+ V
Sbjct: 33  SPAQNTAH------------LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV 80
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +   +    LV L    ++ S + +V EY   G +  HL   G  
Sbjct: 81  VKLKQ-IEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRF 139
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    KVADFG ++  
Sbjct: 140 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRV 192
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 193 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 244
Query: 673 VNLAE 677
           + + E
Sbjct: 245 IQIYE 249

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           SP QN  H             + F++   +G+G FG  M+ K     N    K+  K+ V
Sbjct: 33  SPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV 80
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY   G +  HL   G  
Sbjct: 81  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF 139
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+++D+    KV DFG ++  
Sbjct: 140 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV 192
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 193 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 244
Query: 673 VNLAE 677
           + + E
Sbjct: 245 IQIYE 249

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           SP QN  H             + F++   +G+G FG  M+ K     N    K+  K+ V
Sbjct: 33  SPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV 80
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 81  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 139
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 140 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 193 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 244
Query: 673 VNLAE 677
           + + E
Sbjct: 245 IQIYE 249

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 33  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 80
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 81  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 139
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 140 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 193 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 244
Query: 673 VNLAE 677
           + + E
Sbjct: 245 IQIYE 249

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           SP QN  H             + F++   +G+G FG  M+ K     N    K+  K+ V
Sbjct: 33  SPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV 80
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 81  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 139
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 140 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 193 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 244
Query: 673 VNLAE 677
           + + E
Sbjct: 245 IQIYE 249

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 17/155 (10%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI---- 514
           T  F +   IGSG FG V+K V R D    A+KR    S++ L     E   L ++    
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR----SKKPLAGSVDEQNALREVYAHA 63
Query: 515 ---RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQR--LEICIGAA 569
              +H H+V       E   M++  EY   G L   +    R    +K+    ++ +   
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA 604
           RGL Y+H+ S   ++H DIK +NI +    +   A
Sbjct: 124 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA 155

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 17/155 (10%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI---- 514
           T  F +   IGSG FG V+K V R D    A+KR    S++ L     E   L ++    
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR----SKKPLAGSVDEQNALREVYAHA 61
Query: 515 ---RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQR--LEICIGAA 569
              +H H+V       E   M++  EY   G L   +    R    +K+    ++ +   
Sbjct: 62  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA 604
           RGL Y+H+ S   ++H DIK +NI +    +   A
Sbjct: 122 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA 153

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 34/221 (15%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV---PGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSGG   V++ VL +  ++   + V       Q L  ++ EI  L+K++ +H   ++  
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 121
Query: 526 CEEQSEMILVYEYMEKGPL-------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            + +     +Y  ME G +       KK    P      WK  LE           +HT 
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 171
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
              GI+H D+K  N L+ +  + K+ DFG++        + V     G+  Y+ PE  + 
Sbjct: 172 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 639 QQLTDKS-----------DVYSFGVVLFEVLCARTAVDPLL 668
              + ++           DV+S G +L+ +   +T    ++
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 17/155 (10%)
Query: 460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI---- 514
           T  F +   IGSG FG V+K V R D    A+KR    S++ L     E   L ++    
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR----SKKPLAGSVDEQNALREVYAHA 65
Query: 515 ---RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQR--LEICIGAA 569
              +H H+V       E   M++  EY   G L   +    R    +K+    ++ +   
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA 604
           RGL Y+H+ S   ++H DIK +NI +    +   A
Sbjct: 126 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA 157

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              ++ +     E  +L  +    LV L    ++ S + +V EY   G +  HL   G  
Sbjct: 80  VKLKE-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+++D+    KV DFGL++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGLAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 34/223 (15%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV---PGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSGG   V++ VL +  ++   + V       Q L  ++ EI  L+K++ +H   ++  
Sbjct: 36  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 93
Query: 526 CEEQSEMILVYEYMEKGPL-------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            + +     +Y  ME G +       KK    P      WK  LE           +HT 
Sbjct: 94  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 143
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
              GI+H D+K  N L+ +  + K+ DFG++        + V     G+  Y+ PE  + 
Sbjct: 144 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 639 QQLTDKS-----------DVYSFGVVLFEVLCARTAVDPLLAR 670
              + ++           DV+S G +L+ +   +T    ++ +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           SP QN  H             + F++   +G+G FG  M+ K     N    K+  K+ V
Sbjct: 53  SPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV 100
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 101 VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 159
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 160 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 212
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 213 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 264
Query: 673 VNLAE 677
           + + E
Sbjct: 265 IQIYE 269

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 34/221 (15%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV---PGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSGG   V++ VL +  ++   + V       Q L  ++ EI  L+K++ +H   ++  
Sbjct: 20  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 77
Query: 526 CEEQSEMILVYEYMEKGPL-------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            + +     +Y  ME G +       KK    P      WK  LE           +HT 
Sbjct: 78  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 127
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
              GI+H D+K  N L+ +  + K+ DFG++        + V     G+  Y+ PE  + 
Sbjct: 128 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 186
Query: 639 QQLTDKS-----------DVYSFGVVLFEVLCARTAVDPLL 668
              + ++           DV+S G +L+ +   +T    ++
Sbjct: 187 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 227

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 21/176 (11%)
Query: 507 EITVLSKIRHRHLVSLVGYCEEQS--EMILVYEYMEKGPLKKHLYGPDRT-PLSWKQRLE 563
           E  VL K+ H+++V L    EE +    +L+ E+   G L   L  P     L   + L 
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSRSGPCLDETH 619
           +      G+++L      GI+HR+IK  NI+     D   V K+ DFG +R    L++  
Sbjct: 117 VLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDE 170
Query: 620 VSTGVKGSFGYLDPEYFRRQQLTDKS--------DVYSFGVVLFEVLCARTAVDPL 667
               + G+  YL P+ + R  L            D++S GV  +          P 
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 34/221 (15%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV---PGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSGG   V++ VL +  ++   + V       Q L  ++ EI  L+K++ +H   ++  
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 121
Query: 526 CEEQSEMILVYEYMEKGPL-------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            + +     +Y  ME G +       KK    P      WK  LE           +HT 
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 171
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
              GI+H D+K  N L+ +  + K+ DFG++        + V     G+  Y+ PE  + 
Sbjct: 172 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 639 QQLTDKS-----------DVYSFGVVLFEVLCARTAVDPLL 668
              + ++           DV+S G +L+ +   +T    ++
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 34/221 (15%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV---PGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSGG   V++ VL +  ++   + V       Q L  ++ EI  L+K++ +H   ++  
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 121
Query: 526 CEEQSEMILVYEYMEKGPL-------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            + +     +Y  ME G +       KK    P      WK  LE           +HT 
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 171
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
              GI+H D+K  N L+ +  + K+ DFG++        + V     G+  Y+ PE  + 
Sbjct: 172 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 639 QQLTDKS-----------DVYSFGVVLFEVLCARTAVDPLL 668
              + ++           DV+S G +L+ +   +T    ++
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 34/221 (15%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV---PGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSGG   V++ VL +  ++   + V       Q L  ++ EI  L+K++ +H   ++  
Sbjct: 17  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 74
Query: 526 CEEQSEMILVYEYMEKGPL-------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            + +     +Y  ME G +       KK    P      WK  LE           +HT 
Sbjct: 75  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 124
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
              GI+H D+K  N L+ +  + K+ DFG++        + V     G+  Y+ PE  + 
Sbjct: 125 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 639 QQLTDKS-----------DVYSFGVVLFEVLCARTAVDPLL 668
              + ++           DV+S G +L+ +   +T    ++
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 468 IIGSGGFGMVYKGVLRDNTK------VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +IG G F +V + + R+  +      V V +          + + E ++   ++H H+V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 522 LVGYCEEQSEMILVYEYMEKGPL---------KKHLYGPDRTPLSWKQRLEICIGAARGL 572
           L+        + +V+E+M+   L            +Y         +Q LE        L
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-------AL 143
Query: 573 HYLHTGSAEGIIHRDIKSTNILL--DENYVS-KVADFGLSRSGPCLDETH-VSTGVKGSF 628
            Y H  +   IIHRD+K   +LL   EN    K+  FG++     L E+  V+ G  G+ 
Sbjct: 144 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ---LGESGLVAGGRVGTP 197
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            ++ PE  +R+      DV+  GV+LF +L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILL 227

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG  M+ K     N    K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+++D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++E+        P  A + + + E
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 248

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 468 IIGSGGFGMVYKGVLRDNTK------VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +IG G F +V + + R+  +      V V +          + + E ++   ++H H+V 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 522 LVGYCEEQSEMILVYEYMEKGPL---------KKHLYGPDRTPLSWKQRLEICIGAARGL 572
           L+        + +V+E+M+   L            +Y         +Q LE        L
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-------AL 145
Query: 573 HYLHTGSAEGIIHRDIKSTNILL--DENYVS-KVADFGLSRSGPCLDETH-VSTGVKGSF 628
            Y H  +   IIHRD+K   +LL   EN    K+  FG++     L E+  V+ G  G+ 
Sbjct: 146 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ---LGESGLVAGGRVGTP 199
Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            ++ PE  +R+      DV+  GV+LF +L
Sbjct: 200 HFMAPEVVKREPYGKPVDVWGCGVILFILL 229

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
           E    +      D ++ GV+++++        P  A + + + E
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMAA---GYPPFFADQPIQIYE 248

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 34/223 (15%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV---PGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSGG   V++ VL +  ++   + V       Q L  ++ EI  L+K++ +H   ++  
Sbjct: 36  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 93
Query: 526 CEEQSEMILVYEYMEKGPL-------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            + +     +Y  ME G +       KK    P      WK  LE           +HT 
Sbjct: 94  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 143
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
              GI+H D+K  N L+ +  + K+ DFG++          V     G+  Y+ PE  + 
Sbjct: 144 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKD 202
Query: 639 QQLTDKS-----------DVYSFGVVLFEVLCARTAVDPLLAR 670
              + ++           DV+S G +L+ +   +T    ++ +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 34/221 (15%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV---PGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IGSGG   V++ VL +  ++   + V       Q L  ++ EI  L+K++ +H   ++  
Sbjct: 16  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 73
Query: 526 CEEQSEMILVYEYMEKGPL-------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            + +     +Y  ME G +       KK    P      WK  LE           +HT 
Sbjct: 74  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 123
Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
              GI+H D+K  N L+ +  + K+ DFG++        + V     G+  Y+ PE  + 
Sbjct: 124 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 182
Query: 639 QQLTDKS-----------DVYSFGVVLFEVLCARTAVDPLL 668
              + ++           DV+S G +L+ +   +T    ++
Sbjct: 183 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 223

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 96/240 (40%), Gaps = 53/240 (22%)
Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSR------QGLPEFQTEITVLSKIRHRHLVSL 522
           IG G +G+V   +      +   + +  ++      + +   +TE+ ++ K+ H ++  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 523 VGYCEEQSEMILVYEYMEKGPL--KKHLYGPD---------------------------- 552
               E++  + LV E    G L  K +++  D                            
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 553 ----RTPLSWKQRLEICIGAAR----GLHYLHTGSAEGIIHRDIKSTNILLDEN--YVSK 602
               R  L + QR ++     R     LHYLH    +GI HRDIK  N L   N  +  K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 603 VADFGLSRSGPCLD--ETHVSTGVKGSFGYLDPEYFR--RQQLTDKSDVYSFGVVLFEVL 658
           + DFGLS+    L+  E +  T   G+  ++ PE      +    K D +S GV+L  +L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 71/164 (43%), Gaps = 20/164 (12%)
Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLS 557
           + + E  +   ++H ++V L     E+    L+++ +  G L      +  Y        
Sbjct: 56  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC 115
Query: 558 WKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY---VSKVADFGLSRSGPC 614
            +Q LE    A    H +      G++HR++K  N+LL         K+ADFGL+     
Sbjct: 116 IQQILE----AVLHCHQM------GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE- 164
Query: 615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
             E     G  G+ GYL PE  R+       D+++ GV+L+ +L
Sbjct: 165 -GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K     N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K     N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY   G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+++D+    +V DFG ++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K     N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    LV L    ++ S + +V EY+  G +  HL   G  
Sbjct: 80  VKLKQ-IEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+L+D+    +V DFG ++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 101/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 33  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 80
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    L  L    ++ S + +V EY   G +  HL   G  
Sbjct: 81  VKLKQ-IEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF 139
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+++D+    KV DFG ++  
Sbjct: 140 XEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV 192
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 193 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 244
Query: 673 VNLAE 677
           + + E
Sbjct: 245 IQIYE 249

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 32  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 79
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              ++ +     E  +L  +    LV L    ++ S + +V EY   G +  HL   G  
Sbjct: 80  VKLKE-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF 138
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+++D+    +V DFGL++  
Sbjct: 139 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGLAKRV 191
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 192 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 243
Query: 673 VNLAE 677
           + + E
Sbjct: 244 IQIYE 248

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 101/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 33  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 80
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    L  L    ++ S + +V EY   G +  HL   G  
Sbjct: 81  VKLKQ-IEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF 139
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+++D+    KV DFG ++  
Sbjct: 140 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV 192
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 193 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 244
Query: 673 VNLAE 677
           + + E
Sbjct: 245 IQIYE 249

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 101/245 (41%), Gaps = 35/245 (14%)
Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGV 494
           +P QN  H             + F++   +G+G FG  M+ K +   N    K+  K+ V
Sbjct: 33  NPAQNTAH------------LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKV 80
Query: 495 PGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPD 552
              +Q +     E  +L  +    L  L    ++ S + +V EY   G +  HL   G  
Sbjct: 81  VKLKQ-IEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF 139
Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
             P +     +I +       YLH+     +I+RD+K  N+++D+    KV DFG ++  
Sbjct: 140 SEPHARFYAAQIVLT----FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV 192
Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                   +  + G+  YL PE    +      D ++ GV+++E+        P  A + 
Sbjct: 193 KGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQP 244
Query: 673 VNLAE 677
           + + E
Sbjct: 245 IQIYE 249

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 26/140 (18%)
Query: 532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKST 591
           ++++ E ME G L   +        + ++  EI       + +LH+     I HRD+K  
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPE 157
Query: 592 NILL---DENYVSKVADFGLSR-------SGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
           N+L    +++ V K+ DFG ++         PC    +V+  V G      PE +     
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLG------PEKY----- 206
Query: 642 TDKS-DVYSFGVVLFEVLCA 660
            DKS D++S GV+++ +LC 
Sbjct: 207 -DKSCDMWSLGVIMYILLCG 225

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 23/224 (10%)
Query: 461 NNFDKNLIIGSGGFG--MVYKGVLRDN---TKVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG  M+ K     N    K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLH 573
              LV L    ++ S + +V EY+  G +  HL   G    P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH+     +I+RD+K  N+L+D+    +V DFG ++          +  + G+  YL P
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
                +      D ++ GV+++E+        P  A + + + E
Sbjct: 208 AIILSKGYNKAVDWWALGVLIYEMAA---GYPPFFADQPIQIYE 248

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 26/140 (18%)
Query: 532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKST 591
           ++++ E ME G L   +        + ++  EI       + +LH+     I HRD+K  
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPE 138
Query: 592 NILL---DENYVSKVADFGLSR-------SGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
           N+L    +++ V K+ DFG ++         PC    +V+  V G      PE +     
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLG------PEKY----- 187
Query: 642 TDKS-DVYSFGVVLFEVLCA 660
            DKS D++S GV+++ +LC 
Sbjct: 188 -DKSCDMWSLGVIMYILLCG 206

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGY 525
           ++  GGF  VY+   +    + A+KR +    +       E+  + K+  H ++V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 526 C----EE----QSEMILVYEYMEKGPLKKHLYGPD-RTPLSWKQRLEICIGAARGLHYLH 576
                EE    Q+E +L+ E + KG L + L   + R PLS    L+I     R + ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFG------------LSRSGPCLDETHVSTGV 624
                 IIHRD+K  N+LL      K+ DFG             S     L E  ++   
Sbjct: 154 RQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 625 KGSFGYLDPE---YFRRQQLTDKSDVYSFGVVLFEVLCAR 661
                Y  PE    +    + +K D+++ G +L+ +LC R
Sbjct: 213 TPM--YRTPEIIDLYSNFPIGEKQDIWALGCILY-LLCFR 249

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 31/158 (19%)
Query: 518 HLVSLVGYCEE----QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
           H+V +V   E     +  +++V E ++ G L   +        + ++  EI       + 
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 574 YLHTGSAEGIIHRDIKSTNILLDE---NYVSKVADFGLSR--------SGPCLDETHVST 622
           YLH+ +   I HRD+K  N+L      N + K+ DFG ++        + PC    +V+ 
Sbjct: 176 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 623 GVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLC 659
            V G      PE +      DKS D++S GV+++ +LC
Sbjct: 233 EVLG------PEKY------DKSCDMWSLGVIMYILLC 258

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 31/159 (19%)
Query: 518 HLVSLVGYCEE----QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
           H+V +V   E     +  +++V E ++ G L   +        + ++  EI       + 
Sbjct: 86  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 145
Query: 574 YLHTGSAEGIIHRDIKSTNILLDE---NYVSKVADFGLSR--------SGPCLDETHVST 622
           YLH+ +   I HRD+K  N+L      N + K+ DFG ++        + PC    +V+ 
Sbjct: 146 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 202
Query: 623 GVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCA 660
            V G      PE +      DKS D++S GV+++ +LC 
Sbjct: 203 EVLG------PEKY------DKSCDMWSLGVIMYILLCG 229

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 31/159 (19%)
Query: 518 HLVSLVGYCEE----QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
           H+V +V   E     +  +++V E ++ G L   +        + ++  EI       + 
Sbjct: 78  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 137
Query: 574 YLHTGSAEGIIHRDIKSTNILLDE---NYVSKVADFGLSR--------SGPCLDETHVST 622
           YLH+ +   I HRD+K  N+L      N + K+ DFG ++        + PC    +V+ 
Sbjct: 138 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 194
Query: 623 GVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLFEVLCA 660
            V G      PE +      DKS D++S GV+++ +LC 
Sbjct: 195 EVLG------PEKY------DKSCDMWSLGVIMYILLCG 221
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	803
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	0.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-127
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-121
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-79
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-64
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-62
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-60
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-58
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-50
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-46
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-45
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-45
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-45
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-45
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-44
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-43
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-43
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-43
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-43
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-43
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-43
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-43
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-43
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-42
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-42
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-41
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-41
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-41
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-41
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-41
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-40
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-40
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-40
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-40
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-39
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-38
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-38
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-38
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-37
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-37
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-37
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-36
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-36
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-36
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-36
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-36
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-33
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-28
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	3e-28
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	1e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-28
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-25
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-25
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-22
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-19
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-16
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-06
1qzv_F	154	Plant photosystem I: subunit PSAF; photosynthesis,	2e-05

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  562 bits (1450), Expect = 0.0
 Identities = 195/320 (60%), Positives = 238/320 (74%), Gaps = 7/320 (2%)

Query: 427 SSHSKMSEGTVNASPGQN--GYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRD 484
           S +SK +    +A        +   ++P  DL+ ATNNFD   +IG G FG VYKGVLRD
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 485 NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL 544
             KVA+KR  P S QG+ EF+TEI  LS  RH HLVSL+G+C+E++EMIL+Y+YME G L
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122

Query: 545 KKHLYGPDR--TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSK 602
           K+HLYG D     +SW+QRLEICIGAARGLHYLHT +   IIHRD+KS NILLDEN+V K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179

Query: 603 VADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
           + DFG+S+ G  LD+TH+ST VKG+ GY+DPEYF + +LT+KSDVYSFGVVLFEVLCAR+
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

Query: 663 AVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVD 722
           A+   L RE VNLAEWA++    G LE I+DP L  KI  +SL+KFG+TA KCLA    D
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299

Query: 723 RPSMGDVLWNLEYALQLQES 742
           RPSMGDVLW LEYAL+LQES
Sbjct: 300 RPSMGDVLWKLEYALRLQES 319

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  380 bits (979), Expect = e-127
 Identities = 108/295 (36%), Positives = 164/295 (55%), Gaps = 20/295 (6%)

Query: 453 FTDLQTATNNFDKNL------IIGSGGFGMVYKGVLRDNTKVAVKR----GVPGSRQGLP 502
           F +L+  TNNFD+         +G GGFG+VYKG + +NT VAVK+        + +   
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75

Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRT-PLSWKQR 561
           +F  EI V++K +H +LV L+G+  +  ++ LVY YM  G L   L   D T PLSW  R
Sbjct: 76  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135

Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS 621
            +I  GAA G+++LH       IHRDIKS NILLDE + +K++DFGL+R+     +T ++
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192

Query: 622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQ 681
           + + G+  Y+ PE   R ++T KSD+YSFGVVL E++    AVD    RE   L +   +
Sbjct: 193 SRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE--HREPQLLLDIKEE 249

Query: 682 -WQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY 735
              ++  +E  ID ++    +  S++     A +CL +    RP +  V   L+ 
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  366 bits (942), Expect = e-121
 Identities = 111/287 (38%), Positives = 165/287 (57%), Gaps = 6/287 (2%)

Query: 453 FTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLP-EFQTEITVL 511
             +LQ A++NF    I+G GGFG VYKG L D T VAVKR      QG   +FQTE+ ++
Sbjct: 22  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81

Query: 512 SKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAA 569
           S   HR+L+ L G+C   +E +LVY YM  G +   L      + PL W +R  I +G+A
Sbjct: 82  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
           RGL YLH      IIHRD+K+ NILLDE + + V DFGL++      +THV+T V+G+ G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAVRGTIG 200

Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDP--LLAREQVNLAEWAMQWQKKGM 687
           ++ PEY    + ++K+DV+ +GV+L E++  + A D   L   + V L +W     K+  
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260

Query: 688 LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           LE ++D  L G    + +++  + A  C     ++RP M +V+  LE
Sbjct: 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  257 bits (659), Expect = 2e-79
 Identities = 76/316 (24%), Positives = 128/316 (40%), Gaps = 30/316 (9%)

Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEI 508
           + +   +L   +       +   G FG V+K  L  N  VAVK      +Q   + + E+
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEV 69

Query: 509 TVLSKIRHRHLVSLVGYCEE----QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEI 564
             L  ++H +++  +G  +       ++ L+  + EKG L   L       +SW +   I
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHI 126

Query: 565 CIGAARGLHYLHTGSAE-------GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE 617
               ARGL YLH             I HRDIKS N+LL  N  + +ADFGL+        
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 618 THVSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
              + G  G+  Y+ PE        ++    + D+Y+ G+VL+E+    TA D  +    
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 673 VNLAEW-----AMQWQKKGMLEHIIDPQLIGKINLDS-LKKFGETAEKCLADYGVDRPSM 726
           +   E      +++  ++ ++     P L       + +    ET E+C       R S 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 727 GDVLWNLEYALQLQES 742
           G V   +    Q+Q  
Sbjct: 307 GCVGERIT---QMQRL 319

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  216 bits (552), Expect = 2e-64
 Identities = 82/318 (25%), Positives = 136/318 (42%), Gaps = 34/318 (10%)

Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITV 510
           I + +++      ++  ++G G FG+V K   R    VA+K     S      F  E+  
Sbjct: 5   IDYKEIE-----VEE--VVGRGAFGVVCKAKWR-AKDVAIK--QIESESERKAFIVELRQ 54

Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP-LSWKQRLEICIGAA 569
           LS++ H ++V L G C     + LV EY E G L   L+G +  P  +    +  C+  +
Sbjct: 55  LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENY-VSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           +G+ YLH+   + +IHRD+K  N+LL     V K+ DFG +      D     T  KGS 
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSA 167

Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML 688
            ++ PE F     ++K DV+S+G++L+EV+  R   D +          WA+    +   
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHNGTR--- 222

Query: 689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPR 748
                P LI  +     K       +C +     RPSM +++  +   L     G+  P 
Sbjct: 223 -----PPLIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMT-HLMRYFPGADEPL 272

Query: 749 EQREDSNTNPPALPTRTI 766
           +     +  P        
Sbjct: 273 QYPCQHSLPPGEDGRVEP 290

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  215 bits (549), Expect = 7e-64
 Identities = 86/330 (26%), Positives = 141/330 (42%), Gaps = 34/330 (10%)

Query: 427 SSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNT 486
            S   +         G      + IP+ DL            IG+G FG V++      +
Sbjct: 10  MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKE-------KIGAGSFGTVHRAEWH-GS 61

Query: 487 KVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL 544
            VAVK         + + EF  E+ ++ ++RH ++V  +G   +   + +V EY+ +G L
Sbjct: 62  DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121

Query: 545 KKHLYGPD-RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKV 603
            + L+    R  L  ++RL +    A+G++YLH      I+HR++KS N+L+D+ Y  KV
Sbjct: 122 YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKV 180

Query: 604 ADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTA 663
            DFGLSR          S    G+  ++ PE  R +   +KSDVYSFGV+L+E+   +  
Sbjct: 181 CDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ- 237

Query: 664 VDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDR 723
             P      +N A+       K     I           +   +     E C  +    R
Sbjct: 238 --PW---GNLNPAQVVAAVGFKCKRLEIPR---------NLNPQVAAIIEGCWTNEPWKR 283

Query: 724 PSMGDVLWNLEYALQLQESGSGLPREQRED 753
           PS   ++  L   ++     S +P   R D
Sbjct: 284 PSFATIMDLLRPLIK-----SAVPPPNRSD 308

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  211 bits (538), Expect = 5e-62
 Identities = 73/338 (21%), Positives = 123/338 (36%), Gaps = 43/338 (12%)

Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTE- 507
           ++   ++     +N     +IG G +G VYKG L     VAVK     +RQ    F  E 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ---NFINEK 56

Query: 508 -ITVLSKIRHRHLVSLVGYCEE-----QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQR 561
            I  +  + H ++   +   E      + E +LV EY   G L K+L         W   
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSS 113

Query: 562 LEICIGAARGLHYLHTGSAEG------IIHRDIKSTNILLDENYVSKVADFGLSR----- 610
             +     RGL YLHT    G      I HRD+ S N+L+  +    ++DFGLS      
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 611 -SGPCLDETHVSTGVKGSFGYLDPEYFR-------RQQLTDKSDVYSFGVVLFEVLCART 662
                 +E + +    G+  Y+ PE           +    + D+Y+ G++ +E+    T
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 663 AVDPLLAREQVNLAEWAMQWQKKG---MLEHIIDPQLIGKI------NLDSLKKFGETAE 713
            + P  +  +  +A             M   +   +   K       N  +++   ET E
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 714 KCLADYGVDRPSMGDVLWNLE-YALQLQESGSGLPREQ 750
            C       R +       +    +  + + S  P   
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  206 bits (526), Expect = 9e-61
 Identities = 86/289 (29%), Positives = 131/289 (45%), Gaps = 30/289 (10%)

Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG--SRQGLPEFQTEI 508
           IP   +            IGSG FG VYKG       VAVK       + Q L  F+ E+
Sbjct: 21  IPDGQITVGQ-------RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEV 71

Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            VL K RH +++  +GY       I V ++ E   L  HL+  +      K+ ++I    
Sbjct: 72  GVLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASET-KFEMKKLIDIARQT 129

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
           ARG+ YLH   A+ IIHRD+KS NI L E+   K+ DFGL+        +H    + GS 
Sbjct: 130 ARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

Query: 629 GYLDPEYFRRQQL---TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK 685
            ++ PE  R Q     + +SDVY+FG+VL+E++  +     +  R+Q+            
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----------I 235

Query: 686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
            M+        + K+  +  K+      +CL     +RPS   +L  +E
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  204 bits (522), Expect = 6e-60
 Identities = 69/322 (21%), Positives = 115/322 (35%), Gaps = 59/322 (18%)

Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG--SRQGLPEFQTEI 508
           IPF  L+          +IG G FG VY G      +VA++       +   L  F+ E+
Sbjct: 30  IPFEQLEIGE-------LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREV 80

Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
               + RH ++V  +G C     + ++    +   L   +    +  L   +  +I    
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEI 139

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR---SGPCLDETHVSTGVK 625
            +G+ YLH   A+GI+H+D+KS N+  D   V  + DFGL                    
Sbjct: 140 VKGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQN 195

Query: 626 GSFGYLDPEYFRRQQL---------TDKSDVYSFGVVLFEVLCART---AVDPLLAREQV 673
           G   +L PE  R+            +  SDV++ G + +E+                 Q+
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255

Query: 674 NLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL 733
                       GM      P L     +   K+  +    C A    +RP+   ++  L
Sbjct: 256 G----------TGMK-----PNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

Query: 734 EYALQLQESGSGLPREQREDSN 755
           E           LP+  R  S+
Sbjct: 298 E----------KLPKRNRRLSH 309

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  201 bits (514), Expect = 3e-59
 Identities = 57/298 (19%), Positives = 114/298 (38%), Gaps = 52/298 (17%)

Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG--SRQGLPEFQTEI 508
           I F  L   T        +     G ++KG  +    + VK       S +   +F  E 
Sbjct: 7   IDFKQLNFLT-------KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEEC 58

Query: 509 TVLSKIRHRHLVSLVGYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
             L    H +++ ++G C+        L+  +M  G L   L+      +   Q ++  +
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
             ARG+ +LHT     I    + S ++++DE+  ++++   +  S         S G   
Sbjct: 119 DMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMY 170

Query: 627 SFGYLDPEYFRRQQL---TDKSDVYSFGVVLFEVLCARTAVDPLLAREQ----VNLAEWA 679
           +  ++ PE  +++        +D++SF V+L+E          L+ RE     ++  E  
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWE----------LVTREVPFADLSNMEIG 220

Query: 680 MQWQKKGMLEHI---IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           M+   +G+   I   I P +   +            + C+ +    RP    ++  LE
Sbjct: 221 MKVALEGLRPTIPPGISPHVSKLM------------KICMNEDPAKRPKFDMIVPILE 266

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  201 bits (512), Expect = 8e-59
 Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 31/224 (13%)

Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKR-------GVPGSRQGLP 502
           +   +++     ++K   IG GGFG+V+KG L  D + VA+K        G     +   
Sbjct: 16  LADNEIE-----YEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68

Query: 503 EFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL 562
           EFQ E+ ++S + H ++V L G         +V E++  G L   L      P+ W  +L
Sbjct: 69  EFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH-PIKWSVKL 125

Query: 563 EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-----NYVSKVADFGLSRSGPCLDE 617
            + +  A G+ Y+       I+HRD++S NI L          +KVADFGLS+       
Sbjct: 126 RLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QS 179

Query: 618 THVSTGVKGSFGYLDPEYFRRQQL--TDKSDVYSFGVVLFEVLC 659
            H  +G+ G+F ++ PE    ++   T+K+D YSF ++L+ +L 
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  199 bits (509), Expect = 1e-58
 Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 27/226 (11%)

Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG----SRQGLPEF 504
           L+I F +L           IIG GGFG VY+       +VAVK           Q +   
Sbjct: 2   LEIDFAELTLEE-------IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENV 53

Query: 505 QTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEI 564
           + E  + + ++H ++++L G C ++  + LV E+   GPL + L G     +     +  
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNW 110

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE--------NYVSKVADFGLSRSGPCLD 616
            +  ARG++YLH  +   IIHRD+KS+NIL+ +        N + K+ DFGL+R      
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EW 166

Query: 617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
                    G++ ++ PE  R    +  SDV+S+GV+L+E+L    
Sbjct: 167 HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  200 bits (510), Expect = 3e-58
 Identities = 67/297 (22%), Positives = 112/297 (37%), Gaps = 31/297 (10%)

Query: 469 IGSGGFGMVYKGVLRDNTK-VAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG   K   R+  + + +K  +    +    F  E+ V+  + H +++  +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           +   +  + EY++ G L+  +   D     W QR+      A G+ YLH   +  IIHRD
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133

Query: 588 IKSTNILLDENYVSKVADFGLSR------------SGPCLDETHVSTGVKGSFGYLDPEY 635
           + S N L+ EN    VADFGL+R                  +      V G+  ++ PE 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ 695
              +   +K DV+SFG+VL E++    A    L R             +  +  +   P 
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD-----FGLNVRGFLDRYC--PP 246

Query: 696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPREQRE 752
                  +    F     +C       RPS   +   LE           L  +  +
Sbjct: 247 -------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQ 296

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  187 bits (477), Expect = 2e-53
 Identities = 72/297 (24%), Positives = 118/297 (39%), Gaps = 30/297 (10%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
            IG G +G V+ G  R   KVAVK             +TEI     +RH +++  +    
Sbjct: 44  QIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASW-FRETEIYQTVLMRHENILGFIAADI 101

Query: 528 E----QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE-- 581
           +     +++ L+ +Y E G L  +L     T L  K  L++   +  GL +LHT      
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 582 ---GIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPE-- 634
               I HRD+KS NIL+ +N    +AD GL+        +         G+  Y+ PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218

Query: 635 ----YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH 690
                    Q    +D+YSFG++L+EV     +   +   +             + M E 
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278

Query: 691 IID----PQLIGKINLDS-LKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES 742
           +      P    + + D  L++ G+   +C A     R +   V   L    ++ ES
Sbjct: 279 VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA---KMSES 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  180 bits (458), Expect = 3e-51
 Identities = 63/291 (21%), Positives = 110/291 (37%), Gaps = 31/291 (10%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQ--TEITVLSKIRHRHLVSLVGY 525
            +G G +G V++G  +    VAVK     S +    +   TE+     +RH +++  +  
Sbjct: 15  CVGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 526 C----EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
                   +++ L+  Y E G L  +L     T L     L I +  A GL +LH     
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 582 -----GIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPE 634
                 I HRD+KS NIL+ +N    +AD GL+   S         +    G+  Y+ PE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 635 YFRRQQLTD------KSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML 688
                   D      + D+++FG+VL+EV     +   +   +             + M 
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247

Query: 689 EHIID----PQLIGKINLDS-LKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           + +      P +  +   D  L    +  ++C       R +   +   L 
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (455), Expect = 3e-50
 Identities = 61/297 (20%), Positives = 118/297 (39%), Gaps = 30/297 (10%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
            IG G FG V++G  R   +VAVK       +     + EI     +RH +++  +    
Sbjct: 49  SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 106

Query: 528 EQS----EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE-- 581
           + +    ++ LV +Y E G L  +L   +R  ++ +  +++ +  A GL +LH       
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 582 ---GIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDPE-- 634
               I HRD+KS NIL+ +N    +AD GL+                  G+  Y+ PE  
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 635 ----YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH 690
                 +  +   ++D+Y+ G+V +E+    +        +             + M + 
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 283

Query: 691 IID----PQL-IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES 742
           + +    P +     + ++L+   +   +C    G  R +   +   L    QL + 
Sbjct: 284 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS---QLSQQ 337

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  170 bits (432), Expect = 5e-46
 Identities = 69/191 (36%), Positives = 95/191 (49%), Gaps = 6/191 (3%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
            +G G FG V+ G     T+VA+K   PG+      F  E  V+ K+RH  LV L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+   I V EYM KG L   L G     L   Q +++    A G+ Y+        +HRD
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 305

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364

Query: 648 YSFGVVLFEVL 658
           +SFG++L E+ 
Sbjct: 365 WSFGILLTELT 375

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  167 bits (425), Expect = 1e-45
 Identities = 62/194 (31%), Positives = 97/194 (50%), Gaps = 10/194 (5%)

Query: 469 IGSGGFGMVYKGVLR-DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
           IG G FG V+ G LR DNT VAVK            +F  E  +L +  H ++V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
            ++  + +V E ++ G     L   +   L  K  L++   AA G+ YL    ++  IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237

Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY--LDPEYFRRQQLTDK 644
           D+ + N L+ E  V K++DFG+SR     D  + ++G           PE     + + +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREE--ADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

Query: 645 SDVYSFGVVLFEVL 658
           SDV+SFG++L+E  
Sbjct: 296 SDVWSFGILLWETF 309

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  163 bits (416), Expect = 2e-45
 Identities = 62/191 (32%), Positives = 96/191 (50%), Gaps = 6/191 (3%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
            +G+G FG V+ G    +TKVAVK    GS      F  E  ++ +++H+ LV L     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           ++   I + EYME G L   L  P    L+  + L++    A G+ ++        IHRD
Sbjct: 79  QEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRD 134

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ +    K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193

Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 194 WSFGILLTEIV 204

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  168 bits (427), Expect = 2e-45
 Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 6/191 (3%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
            +G+G FG V+      +TKVAVK   PGS   +  F  E  V+  ++H  LV L     
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 253

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           ++   I + E+M KG L   L   + +     + ++     A G+ ++        IHRD
Sbjct: 254 KEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRD 309

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+  + V K+ADFGL+R     +E     G K    +  PE       T KSDV
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368

Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 369 WSFGILLMEIV 379

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  168 bits (428), Expect = 7e-45
 Identities = 69/191 (36%), Positives = 95/191 (49%), Gaps = 6/191 (3%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
            +G G FG V+ G     T+VA+K   PG+      F  E  V+ K+RH  LV L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           E+   I V EYM KG L   L G     L   Q +++    A G+ Y+        +HRD
Sbjct: 333 EEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 388

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           +++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     + T KSDV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447

Query: 648 YSFGVVLFEVL 658
           +SFG++L E+ 
Sbjct: 448 WSFGILLTELT 458

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  161 bits (409), Expect = 1e-44
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 12/192 (6%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
            IG G FG V  G  R   KVAVK     +      F  E +V++++RH +LV L+G   
Sbjct: 28  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 528 EQSEMI-LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
           E+   + +V EYM KG L  +L    R+ L     L+  +     + YL        +HR
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 141

Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
           D+ + N+L+ E+ V+KV+DFGL++     + +      K    +  PE  R ++ + KSD
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196

Query: 647 VYSFGVVLFEVL 658
           V+SFG++L+E+ 
Sbjct: 197 VWSFGILLWEIY 208

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  158 bits (403), Expect = 1e-43
 Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 13/199 (6%)

Query: 468 IIGSGGFGMVYKGVLR----DNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
            +G G FG+V +G           VAVK     V    + + +F  E+  +  + HR+L+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            L G        + V E    G L   L                 +  A G+ YL    +
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYL---ES 139

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRS-GPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
           +  IHRD+ + N+LL    + K+ DFGL R+     D   +    K  F +  PE  + +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199

Query: 640 QLTDKSDVYSFGVVLFEVL 658
             +  SD + FGV L+E+ 
Sbjct: 200 TFSHASDTWMFGVTLWEMF 218

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  164 bits (416), Expect = 1e-43
 Identities = 62/192 (32%), Positives = 100/192 (52%), Gaps = 6/192 (3%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
            +G G +G VY+GV +  +  VAVK     + + + EF  E  V+ +I+H +LV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
             +    ++ E+M  G L  +L   +R  +S    L +    +  + YL     +  IHR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 342

Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
           ++ + N L+ EN++ KVADFGLSR     D      G K    +  PE     + + KSD
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401

Query: 647 VYSFGVVLFEVL 658
           V++FGV+L+E+ 
Sbjct: 402 VWAFGVLLWEIA 413

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  157 bits (399), Expect = 2e-43
 Identities = 71/191 (37%), Positives = 103/191 (53%), Gaps = 6/191 (3%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
            IGSG FG+V+ G   +  KVA+K    G+     +F  E  V+ K+ H  LV L G C 
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           EQ+ + LV E+ME G L  +L        + +  L +C+    G+ YL       +IHRD
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYL---EEACVIHRD 129

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           + + N L+ EN V KV+DFG++R     D+   STG K    +  PE F   + + KSDV
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188

Query: 648 YSFGVVLFEVL 658
           +SFGV+++EV 
Sbjct: 189 WSFGVLMWEVF 199

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  162 bits (412), Expect = 2e-43
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 12/192 (6%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
            IG G FG V  G  R   KVAVK     +      F  E +V++++RH +LV L+G   
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256

Query: 528 EQSEMI-LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
           E+   + +V EYM KG L  +L    R+ L     L+  +     + YL        +HR
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 313

Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
           D+ + N+L+ E+ V+KV+DFGL++     + +      K    +  PE  R ++ + KSD
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368

Query: 647 VYSFGVVLFEVL 658
           V+SFG++L+E+ 
Sbjct: 369 VWSFGILLWEIY 380

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  157 bits (399), Expect = 3e-43
 Identities = 63/193 (32%), Positives = 96/193 (49%), Gaps = 10/193 (5%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGY 525
            +G+G FG+V  G  R    VA+K    GS       EF  E  V+  + H  LV L G 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
           C +Q  + ++ EYM  G L  +L          +Q LE+C      + YL    ++  +H
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 586 RDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS 645
           RD+ + N L+++  V KV+DFGLSR     DE   S G K    +  PE     + + KS
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202

Query: 646 DVYSFGVVLFEVL 658
           D+++FGV+++E+ 
Sbjct: 203 DIWAFGVLMWEIY 215

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  156 bits (398), Expect = 3e-43
 Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 20/198 (10%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
            +GSG FG+V  G  +    VAVK    G  S     EF  E   + K+ H  LV   G 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
           C ++  + +V EY+  G L  +L    +  L   Q LE+C     G+ +L    +   IH
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL---ESHQFIH 127

Query: 586 RDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-----VKGSFGYLDPEYFRRQQ 640
           RD+ + N L+D +   KV+DFG++R    LD+ +VS+      VK    +  PE F   +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFPVK----WSAPEVFHYFK 181

Query: 641 LTDKSDVYSFGVVLFEVL 658
            + KSDV++FG++++EV 
Sbjct: 182 YSSKSDVWAFGILMWEVF 199

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  158 bits (403), Expect = 3e-43
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 11/197 (5%)

Query: 468 IIGSGGFGMVYKGVLRD-----NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVS 521
           ++GSG FG VYKG+           VA+K      S +   E   E  V++ + + H+  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+G C   +  + + + M  G L  ++       +  +  L  C+  A+G++YL      
Sbjct: 82  LLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYL---EDR 136

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E    +  
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 642 TDKSDVYSFGVVLFEVL 658
           T +SDV+S+GV ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  156 bits (396), Expect = 9e-43
 Identities = 63/192 (32%), Positives = 100/192 (52%), Gaps = 6/192 (3%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC 526
            +G G +G VY+GV +  +  VAVK     + + + EF  E  V+ +I+H +LV L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
             +    ++ E+M  G L  +L   +R  +S    L +    +  + YL     +  IHR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 135

Query: 587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSD 646
           D+ + N L+ EN++ KVADFGLSR     D      G K    +  PE     + + KSD
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194

Query: 647 VYSFGVVLFEVL 658
           V++FGV+L+E+ 
Sbjct: 195 VWAFGVLLWEIA 206

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  155 bits (394), Expect = 2e-42
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 15/198 (7%)

Query: 468 IIGSGGFGMVYKGVLRDN----TKVAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLVSL 522
           I+G G FG VY+GV  ++      VAVK            +F +E  ++  + H H+V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
           +G  EE+   I + E    G L  +L     + L     +   +   + + YL    +  
Sbjct: 79  IGIIEEEPTWI-IMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYL---ESIN 133

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQ 640
            +HRDI   NIL+      K+ DFGLSR    +++              ++ PE    ++
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSR---YIEDEDYYKASVTRLPIKWMSPESINFRR 190

Query: 641 LTDKSDVYSFGVVLFEVL 658
            T  SDV+ F V ++E+L
Sbjct: 191 FTTASDVWMFAVCMWEIL 208

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  153 bits (388), Expect = 8e-42
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 15/198 (7%)

Query: 468 IIGSGGFGMVYKGVLRD----NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSL 522
            IG G FG V++G+          VA+K      S     +F  E   + +  H H+V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
           +G   E    I + E    G L+  L     + L     +      +  L YL    ++ 
Sbjct: 82  IGVITENPVWI-IMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYL---ESKR 136

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQQ 640
            +HRDI + N+L+  N   K+ DFGLSR    ++++      KG     ++ PE    ++
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFRR 193

Query: 641 LTDKSDVYSFGVVLFEVL 658
            T  SDV+ FGV ++E+L
Sbjct: 194 FTSASDVWMFGVCMWEIL 211

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  154 bits (390), Expect = 1e-41
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 13/198 (6%)

Query: 468 IIGSGGFGMVYKGVLRD-----NTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           ++GSG FG V+KGV           V +K      G +         +  +  + H H+V
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-FQAVTDHMLAIGSLDHAHIV 78

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            L+G C   S  + V +Y+  G L  H+       L  +  L   +  A+G++YL     
Sbjct: 79  RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYL---EE 133

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
            G++HR++ + N+LL      +VADFG++   P  D+  + +  K    ++  E     +
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193

Query: 641 LTDKSDVYSFGVVLFEVL 658
            T +SDV+S+GV ++E++
Sbjct: 194 YTHQSDVWSYGVTVWELM 211

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  153 bits (389), Expect = 2e-41
 Identities = 75/246 (30%), Positives = 118/246 (47%), Gaps = 29/246 (11%)

Query: 438 NASPGQNGYHRLKIP----------FTDLQTATNNFDKNL---------IIGSGGFGMVY 478
           ++S  +N Y + K+P          + +   A  +F + +         IIGSG  G V 
Sbjct: 7   HSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVC 66

Query: 479 KGVLR----DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI 533
            G LR     +  VA+K    G + +   +F +E +++ +  H +++ L G        +
Sbjct: 67  YGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126

Query: 534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNI 593
           +V EYME G L   L   D    +  Q + +  G   G+ YL   S  G +HRD+ + N+
Sbjct: 127 IVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNV 182

Query: 594 LLDENYVSKVADFGLSRS-GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGV 652
           L+D N V KV+DFGLSR      D  + +TG K    +  PE    +  +  SDV+SFGV
Sbjct: 183 LVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGV 242

Query: 653 VLFEVL 658
           V++EVL
Sbjct: 243 VMWEVL 248

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  153 bits (388), Expect = 2e-41
 Identities = 49/197 (24%), Positives = 96/197 (48%), Gaps = 11/197 (5%)

Query: 468 IIGSGGFGMVYKGVLRD-----NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVS 521
           ++GSG FG VYKG+           VA+K     +  +   E   E  V++ + + H+  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+G C   +  + + + M  G L  ++       +  +  L  C+  A+G++YL      
Sbjct: 82  LLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYL---EDR 136

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E    +  
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 642 TDKSDVYSFGVVLFEVL 658
           T +SDV+S+GV ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  152 bits (385), Expect = 3e-41
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 10/195 (5%)

Query: 469 IGSGGFGMVYKGVLR---DNTKVAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLVSLVG 524
           +G G FG V +GV R       VA+K    G+ +    E   E  ++ ++ + ++V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
            C+ ++ M+ V E    GPL K L G     +      E+    + G+ YL     +  +
Sbjct: 78  VCQAEALML-VMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL---EEKNFV 132

Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDET-HVSTGVKGSFGYLDPEYFRRQQLTD 643
           HRD+ + N+LL   + +K++DFGLS++    D      +  K    +  PE    ++ + 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192

Query: 644 KSDVYSFGVVLFEVL 658
           +SDV+S+GV ++E L
Sbjct: 193 RSDVWSYGVTMWEAL 207

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  159 bits (403), Expect = 5e-41
 Identities = 65/281 (23%), Positives = 108/281 (38%), Gaps = 23/281 (8%)

Query: 390 LCLVALAVLVLFKCRKKKPKPRPADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRL 449
            C +       F  R +K   R   S+              +    +V+ +         
Sbjct: 317 YCRLVNGATQSFIIRPQKEGERALPSIPKLANNE---KQGVRSHTVSVSETDDYAEIIDE 373

Query: 450 KIPFTDLQTATNNFDKNLI-----IGSGGFGMVYKGVLRD----NTKVAVKRGVPG-SRQ 499
           +  +T   T      +  I     IG G FG V++G+          VA+K      S  
Sbjct: 374 EDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS 433

Query: 500 GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWK 559
              +F  E   + +  H H+V L+G   E    I + E    G L+  L    +  L   
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQV-RKFSLDLA 491

Query: 560 QRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH 619
             +      +  L YL    ++  +HRDI + N+L+  N   K+ DFGLSR    ++++ 
Sbjct: 492 SLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDST 545

Query: 620 VSTGVKGSF--GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
                KG     ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  152 bits (386), Expect = 5e-41
 Identities = 67/198 (33%), Positives = 109/198 (55%), Gaps = 11/198 (5%)

Query: 468 IIGSGGFGMVYKGVLRDNT-----KVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVS 521
           +IG+G FG VYKG+L+ ++      VA+K    G + +   +F  E  ++ +  H +++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L G   +   M+++ EYME G L K L   D    S  Q + +  G A G+ YL   +  
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYL---ANM 166

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRS-GPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
             +HRD+ + NIL++ N V KV+DFGLSR      + T+ ++G K    +  PE    ++
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226

Query: 641 LTDKSDVYSFGVVLFEVL 658
            T  SDV+SFG+V++EV+
Sbjct: 227 FTSASDVWSFGIVMWEVM 244

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  151 bits (384), Expect = 1e-40
 Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 33/213 (15%)

Query: 468 IIGSGGFGMVYKGVLRDN---TKVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRHLVSL 522
           +IG G FG V K  ++ +      A+KR     S+    +F  E+ VL K+  H ++++L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHL--------------YGPDRTPLSWKQRLEICIGA 568
           +G CE +  + L  EY   G L   L                   + LS +Q L      
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG----V 624
           ARG+ YL   S +  IHRD+ + NIL+ ENYV+K+ADFGLSR     +     T     V
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTMGRLPV 205

Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
           +    ++  E       T  SDV+S+GV+L+E+
Sbjct: 206 R----WMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  152 bits (387), Expect = 1e-40
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 10/197 (5%)

Query: 468 IIGSGGFGMVYKGVL----RDNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSL 522
           ++G+G FG V  G L    +    VA+K    G + +   +F  E +++ +  H +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
            G   +   +++V EYME G L   L   D    +  Q + +  G A G+ YL   S  G
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDMG 167

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRS-GPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            +HRD+ + NIL++ N V KV+DFGL R      +  + + G K    +  PE    ++ 
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227

Query: 642 TDKSDVYSFGVVLFEVL 658
           T  SDV+S+G+VL+EV+
Sbjct: 228 TSASDVWSYGIVLWEVM 244

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  150 bits (380), Expect = 1e-40
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 468 IIGSGGFGMVYKGVLRD--------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL 519
            +G G F  ++KGV R+         T+V +K      R     F    +++SK+ H+HL
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           V   G C    E ILV E+++ G L  +L   ++  ++   +LE+    A  +H+L    
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFL---E 130

Query: 580 AEGIIHRDIKSTNILLD--------ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
              +IH ++ + NILL              K++D G+S +   L +  +   +     ++
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERIP----WV 184

Query: 632 DPE---YFRRQQLTDKSDVYSFGVVLFEVL 658
            PE     +   L   +D +SFG  L+E+ 
Sbjct: 185 PPECIENPKN--LNLATDKWSFGTTLWEIC 212

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  149 bits (378), Expect = 3e-40
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 12/197 (6%)

Query: 468 IIGSGGFGMVYKGVLRDN---TKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSL 522
            +GSG FG V KG  +       VAVK             E   E  V+ ++ + ++V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
           +G CE +S M+ V E  E GPL K+L       +  K  +E+    + G+ YL       
Sbjct: 84  IGICEAESWML-VMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYL---EESN 137

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRS-GPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            +HRD+ + N+LL   + +K++DFGLS++     +     T  K    +  PE     + 
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 642 TDKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 198 SSKSDVWSFGVLMWEAF 214

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  150 bits (381), Expect = 3e-40
 Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 32/214 (14%)

Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG V+     +         VAVK     S     +FQ E  +L+ ++H+H+V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHL-------------YGPDRTPLSWKQRLEICIGAA 569
            G C E   +++V+EYM  G L + L                   PL   Q L +    A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
            G+ YL   +    +HRD+ + N L+ +  V K+ DFG+SR     D         G   
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----VGGRT 220

Query: 630 YL-----DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            L      PE    ++ T +SDV+SFGVVL+E+ 
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  149 bits (378), Expect = 3e-40
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 18/202 (8%)

Query: 468 IIGSGGFGMVYKGVLRDN----TKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSL 522
           +IG G FG VY G L DN       AVK          + +F TE  ++    H +++SL
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 523 VGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           +G C   +   ++V  YM+ G L+  +        + K  +   +  A+G+ YL   +++
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYL---ASK 147

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL-----DPEYF 636
             +HRD+ + N +LDE +  KVADFGL+R    + +    +    +   L       E  
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 637 RRQQLTDKSDVYSFGVVLFEVL 658
           + Q+ T KSDV+SFGV+L+E++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELM 226

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  149 bits (378), Expect = 3e-40
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 12/199 (6%)

Query: 468 IIGSGGFGMVYKGVLRD----NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSL 522
           +IG G FG+VY G   D      + A+K        Q +  F  E  ++  + H ++++L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 523 VGYCEEQSEMIL-VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           +G       +   +  YM  G L + +  P +   + K  +   +  ARG+ YL   + +
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYL---AEQ 143

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF--GYLDPEYFRRQ 639
             +HRD+ + N +LDE++  KVADFGL+R     +   V           +   E  +  
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203

Query: 640 QLTDKSDVYSFGVVLFEVL 658
           + T KSDV+SFGV+L+E+L
Sbjct: 204 RFTTKSDVWSFGVLLWELL 222

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  147 bits (374), Expect = 1e-39
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 31/214 (14%)

Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           +G G FG V+     +         VAVK     +     +FQ E  +L+ ++H H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHL--------------YGPDRTPLSWKQRLEICIGA 568
            G C +   +I+V+EYM+ G L K L                  +  L   Q L I    
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG----V 624
           A G+ YL   +++  +HRD+ + N L+  N + K+ DFG+SR     D   V       +
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 625 KGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           +    ++ PE    ++ T +SDV+SFGV+L+E+ 
Sbjct: 200 R----WMPPESIMYRKFTTESDVWSFGVILWEIF 229

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  149 bits (378), Expect = 2e-39
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 18/202 (8%)

Query: 468 IIGSGGFGMVYKGVLRDN----TKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSL 522
           +IG G FG VY G L DN       AVK          + +F TE  ++    H +++SL
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 523 VGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           +G C   +   ++V  YM+ G L+  +        + K  +   +  A+G+ +L   +++
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFL---ASK 211

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL-----DPEYF 636
             +HRD+ + N +LDE +  KVADFGL+R    + +    +    +   L       E  
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 637 RRQQLTDKSDVYSFGVVLFEVL 658
           + Q+ T KSDV+SFGV+L+E++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELM 290

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  146 bits (371), Expect = 2e-39
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)

Query: 468 IIGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
            +G G FG V               VAVK+    + + L +F+ EI +L  ++H ++V  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 523 VGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            G C       + L+ EY+  G L+ +L    +  +   + L+      +G+ YL     
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL---GT 132

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGP-CLDETHVSTGVKGSFGYLDPEYFRRQ 639
           +  IHRD+ + NIL++     K+ DFGL++  P   +   V    +    +  PE     
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192

Query: 640 QLTDKSDVYSFGVVLFEVL 658
           + +  SDV+SFGVVL+E+ 
Sbjct: 193 KFSVASDVWSFGVVLYELF 211

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  147 bits (373), Expect = 3e-39
 Identities = 55/199 (27%), Positives = 84/199 (42%), Gaps = 12/199 (6%)

Query: 468 IIGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
            +G G FG V               VAVK+          +FQ EI +L  +    +V  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89

Query: 523 VGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            G         + LV EY+  G L+  L    R  L   + L       +G+ YL    +
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL---GS 145

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET-HVSTGVKGSFGYLDPEYFRRQ 639
              +HRD+ + NIL++     K+ADFGL++  P   +   V    +    +  PE     
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205

Query: 640 QLTDKSDVYSFGVVLFEVL 658
             + +SDV+SFGVVL+E+ 
Sbjct: 206 IFSRQSDVWSFGVVLYELF 224

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  146 bits (371), Expect = 3e-39
 Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 15/227 (6%)

Query: 468 IIGSGGFGMVYKGVL-----RDNTKVAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLVS 521
            +G G FG V              +VAVK   P S      + + EI +L  + H ++V 
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 522 LVGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
             G C E     + L+ E++  G LK++L   ++  ++ KQ+L+  +   +G+ YL    
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYL---G 143

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET-HVSTGVKGSFGYLDPEYFRR 638
           +   +HRD+ + N+L++  +  K+ DFGL+++     E   V         +  PE   +
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203

Query: 639 QQLTDKSDVYSFGVVLFEV--LCARTAVDPLLAREQVNLAEWAMQWQ 683
            +    SDV+SFGV L E+   C   +    L  + +      M   
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  146 bits (371), Expect = 4e-39
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 26/210 (12%)

Query: 468 IIGSGGFGMVYKGVLRD----NTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           I+G G FG V +G L+     + KVAVK  +    S++ + EF +E   +    H +++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 522 LVGYC-----EEQSEMILVYEYMEKGPLKKHL----YGPDRTPLSWKQRLEICIGAARGL 572
           L+G C     +   + +++  +M+ G L  +L           +  +  L+  +  A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG----VKGSF 628
            YL   S    +HRD+ + N +L ++    VADFGLS+     D           VK   
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK--- 214

Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
            ++  E    +  T KSDV++FGV ++E+ 
Sbjct: 215 -WIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  145 bits (369), Expect = 9e-39
 Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 29/212 (13%)

Query: 468 IIGSGGFGMVYKGVLRDN----TKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           ++G G FG V +  L+       KVAVK  +    +   + EF  E   + +  H H+  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 522 LVGYC------EEQSEMILVYEYMEKGPLKKHL----YGPDRTPLSWKQRLEICIGAARG 571
           LVG              +++  +M+ G L   L     G +   L  +  +   +  A G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           + YL   S+   IHRD+ + N +L E+    VADFGLSR              +G    L
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASKL 201

Query: 632 -----DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
                  E       T  SDV++FGV ++E++
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (369), Expect = 1e-38
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)

Query: 468 IIGSGGFGMVYKGVL-----RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
            +G G FG V               VAVK+    + + L +F+ EI +L  ++H ++V  
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 523 VGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            G C       + L+ EY+  G L+ +L    +  +   + L+      +G+ YL     
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL---GT 163

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGP-CLDETHVSTGVKGSFGYLDPEYFRRQ 639
           +  IHRD+ + NIL++     K+ DFGL++  P   +   V    +    +  PE     
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223

Query: 640 QLTDKSDVYSFGVVLFEVL 658
           + +  SDV+SFGVVL+E+ 
Sbjct: 224 KFSVASDVWSFGVVLYELF 242

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  145 bits (368), Expect = 1e-38
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 28/211 (13%)

Query: 468 IIGSGGFGMVYKGVLRD------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLV 520
            +G G FGMVY+GV +        T+VA+K      S +   EF  E +V+ +    H+V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHL--------YGPDRTPLSWKQRLEICIGAARGL 572
            L+G   +    +++ E M +G LK +L          P   P S  + +++    A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL- 631
            YL   +A   +HRD+ + N ++ E++  K+ DFG++R     D        KG  G L 
Sbjct: 152 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLP 203

Query: 632 ----DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
                PE  +    T  SDV+SFGVVL+E+ 
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  150 bits (381), Expect = 2e-38
 Identities = 54/195 (27%), Positives = 97/195 (49%), Gaps = 10/195 (5%)

Query: 469 IGSGGFGMVYKGVLR---DNTKVAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLVSLVG 524
           +G G FG V +GV R       VA+K    G+ +    E   E  ++ ++ + ++V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
            C+ ++ M+ V E    GPL K L G     +      E+    + G+ YL     +  +
Sbjct: 404 VCQAEALML-VMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL---EEKNFV 458

Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDET-HVSTGVKGSFGYLDPEYFRRQQLTD 643
           HR++ + N+LL   + +K++DFGLS++    D      +  K    +  PE    ++ + 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518

Query: 644 KSDVYSFGVVLFEVL 658
           +SDV+S+GV ++E L
Sbjct: 519 RSDVWSYGVTMWEAL 533

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  143 bits (364), Expect = 5e-38
 Identities = 63/210 (30%), Positives = 90/210 (42%), Gaps = 28/210 (13%)

Query: 468 IIGSGGFGMVYKGVLRD------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLV 520
            +G G FG VY+G +          +VAVK      S Q   +F  E  ++SK  H+++V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L          + L+    L +    A G  YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL- 631
                   IHRDI + N LL       V+K+ DFG++R     D    S   KG    L 
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLP 208

Query: 632 ----DPEYFRRQQLTDKSDVYSFGVVLFEV 657
                PE F     T K+D +SFGV+L+E+
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  143 bits (362), Expect = 7e-38
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 40/223 (17%)

Query: 468 IIGSGGFGMVYKGVLRD------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLV 520
            +G G FG V K            T VAVK      S   L +  +E  VL ++ H H++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHL----------------------YGPDRTPLSW 558
            L G C +   ++L+ EY + G L+  L                        PD   L+ 
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 559 KQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET 618
              +      ++G+ YL   +   ++HRD+ + NIL+ E    K++DFGLSR     D  
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206

Query: 619 HVSTG----VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
              +     VK    ++  E       T +SDV+SFGV+L+E+
Sbjct: 207 VKRSQGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  141 bits (357), Expect = 1e-37
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 32/215 (14%)

Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVS 521
           +G   FG VYKG L           VA+K            EF+ E  + ++++H ++V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHL--------------YGPDRTPLSWKQRLEICIG 567
           L+G   +   + +++ Y   G L + L                  ++ L     + +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG---- 623
            A G+ YL   S+  ++H+D+ + N+L+ +    K++D GL R     D   +       
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193

Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 658
           ++    ++ PE     + +  SD++S+GVVL+EV 
Sbjct: 194 IR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  142 bits (360), Expect = 2e-37
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 35/217 (16%)

Query: 469 IGSGGFGMVYKGVLRD--------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V                  VAVK      + + L +  +E+ ++  I +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL--------------YGPDRTPLSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L                     +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG- 623
               ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219

Query: 624 ---VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
              VK    ++ PE    +  T +SDV+SFGV+++E+
Sbjct: 220 RLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  142 bits (359), Expect = 2e-37
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 17/224 (7%)

Query: 468 IIGSGGFGMVYKGVLRD-----NTKVAVKRGVPGSRQGLP-EFQTEITVLSKIRHRHLVS 521
            +G G FG V               VAVK     +       ++ EI +L  + H H++ 
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 522 LVGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
             G CE+     + LV EY+  G L+ +L    R  +   Q L        G+ YLH   
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLH--- 151

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP-CLDETHVSTGVKGSFGYLDPEYFRR 638
           A+  IHRD+ + N+LLD + + K+ DFGL+++ P   +   V         +  PE  + 
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211

Query: 639 QQLTDKSDVYSFGVVLFEV--LCARTAVDPLLAREQVNLAEWAM 680
            +    SDV+SFGV L+E+   C  +   P    E + +A+  M
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  142 bits (360), Expect = 3e-37
 Identities = 62/210 (29%), Positives = 89/210 (42%), Gaps = 28/210 (13%)

Query: 468 IIGSGGFGMVYKGVLRD------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLV 520
            +G G FG VY+G +          +VAVK      S Q   +F  E  ++SK  H+++V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHL-----YGPDRTPLSWKQRLEICIGAARGLHYL 575
             +G   +     ++ E M  G LK  L          + L+    L +    A G  YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL- 631
                   IHRDI + N LL       V+K+ DFG++R     D        KG    L 
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLP 249

Query: 632 ----DPEYFRRQQLTDKSDVYSFGVVLFEV 657
                PE F     T K+D +SFGV+L+E+
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  140 bits (356), Expect = 3e-37
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 35/218 (16%)

Query: 468 IIGSGGFGMVYKGVLRD------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRHL 519
            +G+G FG V +              VAVK   P           +E+ VLS +  H ++
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHL----------------YGPDRTPLSWKQRLE 563
           V+L+G C      +++ EY   G L   L                   D   L  +  L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
                A+G+ +L   +++  IHRD+ + NILL    ++K+ DFGL+R         V   
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 624 ----VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
               VK    ++ PE       T +SDV+S+G+ L+E+
Sbjct: 207 ARLPVK----WMAPESIFNCVYTFESDVWSYGIFLWEL 240

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  138 bits (351), Expect = 8e-37
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 27/216 (12%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL 519
            +F +  +IGSGGFG V+K     D     +KR V  + +   + + E+  L+K+ H ++
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR-VKYNNE---KAEREVKALAKLDHVNI 66

Query: 520 VSLVGYCEEQSEMI----------------LVYEYMEKGPLKKHLYGPDRTPLSWKQRLE 563
           V   G  +                      +  E+ +KG L++ +       L     LE
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
           +     +G+ Y+H+   + +I+RD+K +NI L +    K+ DFGL  S   L      T 
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTR 180

Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            KG+  Y+ PE    Q    + D+Y+ G++L E+L 
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  141 bits (357), Expect = 1e-36
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 35/218 (16%)

Query: 468 IIGSGGFGMVYKGVLRD--------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHR 517
            +G G FG V                  VAVK      + + L +  +E+ ++  I +H+
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--------------YGPDRTPLSWKQRLE 563
           ++++L+G C +   + ++ EY  KG L+++L                     +++K  + 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
                ARG+ YL   +++  IHRD+ + N+L+ EN V K+ADFGL+R    +D    +T 
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264

Query: 624 ----VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
               VK    ++ PE    +  T +SDV+SFGV+++E+
Sbjct: 265 GRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  138 bits (351), Expect = 3e-36
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 31/214 (14%)

Query: 468 IIGSGGFGMVYKGVLRD------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRHL 519
            +G+G FG V +             KVAVK               +E+ ++S + +H ++
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHL------------YGPDRTPLSWKQRLEICIG 567
           V+L+G C     ++++ EY   G L   L            +    +  S +  L     
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG---- 623
            A+G+ +L   +++  IHRD+ + N+LL   +V+K+ DFGL+R         V       
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229

Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
           VK    ++ PE       T +SDV+S+G++L+E+
Sbjct: 230 VK----WMAPESIFDCVYTVQSDVWSYGILLWEI 259

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  138 bits (351), Expect = 3e-36
 Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 42/224 (18%)

Query: 469 IGSGGFGMVYKGVLRD------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVS 521
           IG G FG V++            T VAVK      S     +FQ E  ++++  + ++V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHL----------------------YGPDRTPLSWK 559
           L+G C     M L++EYM  G L + L                        P   PLS  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 560 QRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH 619
           ++L I    A G+ YL   S    +HRD+ + N L+ EN V K+ADFGLSR     +   
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYS 226

Query: 620 VSTGVKGSFGYL-----DPEYFRRQQLTDKSDVYSFGVVLFEVL 658
                      +      PE     + T +SDV+++GVVL+E+ 
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  138 bits (351), Expect = 3e-36
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 40/223 (17%)

Query: 468 IIGSGGFGMVYKGVLRD------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRHL 519
           ++GSG FG V             + +VAVK               +E+ +++++  H ++
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHL---------------------YGPDRTPLSW 558
           V+L+G C     + L++EY   G L  +L                        D   L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 559 KQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET 618
           +  L      A+G+ +L     +  +HRD+ + N+L+    V K+ DFGL+R        
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228

Query: 619 HVSTG----VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
            V       VK    ++ PE       T KSDV+S+G++L+E+
Sbjct: 229 VVRGNARLPVK----WMAPESLFEGIYTIKSDVWSYGILLWEI 267

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  137 bits (348), Expect = 5e-36
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 34/217 (15%)

Query: 468 IIGSGGFGMVYKGVLRD------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRHL 519
            +G G FG V +              VAVK    G +        +E+ +L  I  H ++
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 520 VSLVGYCEEQSE-MILVYEYMEKGPLKKHL--------------YGPDRTPLSWKQRLEI 564
           V+L+G C +    ++++ E+ + G L  +L                  +  L+ +  +  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG- 623
               A+G+ +L   ++   IHRD+ + NILL E  V K+ DFGL+R      +       
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210

Query: 624 ---VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
              +K    ++ PE    +  T +SDV+SFGV+L+E+
Sbjct: 211 RLPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  139 bits (352), Expect = 5e-36
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 37/218 (16%)

Query: 469 IGSGGFGMVYKGVLRD--------NTKVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRH 518
           +G G FG V                TKVAVK      + + L +  +E+ ++  I +H++
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHL--------------YGPDRTPLSWKQRLEI 564
           +++L+G C +   + ++ EY  KG L+++L                     LS K  +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
               ARG+ YL   +++  IHRD+ + N+L+ E+ V K+ADFGL+R     D  H+    
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 248

Query: 625 KGSFGYL-----DPEYFRRQQLTDKSDVYSFGVVLFEV 657
           K + G L      PE    +  T +SDV+SFGV+L+E+
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  135 bits (341), Expect = 9e-35
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 12/208 (5%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKIRH 516
             + +   IG G FG         D  +  +K  +  SR    E +    E+ VL+ ++H
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKE-INISRMSSKEREESRREVAVLANMKH 82

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
            ++V      EE   + +V +Y E G L K +           Q L+  +     L ++H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET-HVSTGVKGSFGYLDPEY 635
                 I+HRDIKS NI L ++   ++ DFG++R    L+ T  ++    G+  YL PE 
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARV---LNSTVELARACIGTPYYLSPEI 196

Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCARTA 663
              +   +KSD+++ G VL+E+   + A
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA 224

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  133 bits (337), Expect = 1e-34
 Identities = 48/210 (22%), Positives = 90/210 (42%), Gaps = 13/210 (6%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR---GVPGSRQGLPEFQTEITVLSKIRH 516
            NF     IG G F  VY+   L D   VA+K+         +   +   EI +L ++ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHY 574
            +++       E +E+ +V E  + G L + +  +   +  +  +   +  +     L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH-VSTGVKGSFGYLDP 633
           +H   +  ++HRDIK  N+ +    V K+ D GL R           +  + G+  Y+ P
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYYMSP 205

Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTA 663
           E         KSD++S G +L+E+   ++ 
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  132 bits (334), Expect = 2e-34
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 14/199 (7%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           +G GG   VY       N KVA+K          + L  F+ E+   S++ H+++VS++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
             EE     LV EY+E   L +++      PLS    +        G+ + H      I+
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAH---DMRIV 133

Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV-STG-VKGSFGYLDPEYFRRQQLT 642
           HRDIK  NIL+D N   K+ DFG++++   L ET +  T  V G+  Y  PE  + +   
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKA---LSETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 643 DKSDVYSFGVVLFEVLCAR 661
           + +D+YS G+VL+E+L   
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  132 bits (333), Expect = 5e-34
 Identities = 57/242 (23%), Positives = 94/242 (38%), Gaps = 25/242 (10%)

Query: 438 NASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPG 496
           ++S  +N Y         +     ++     +G GGF  V     L D    A+KR +  
Sbjct: 10  HSSGRENLYF----QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH 65

Query: 497 SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS----EMILVYEYMEKGPLKKHL--YG 550
            +Q   E Q E  +     H +++ LV YC  +     E  L+  + ++G L   +    
Sbjct: 66  EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK 125

Query: 551 PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR 610
                L+  Q L + +G  RGL  +H    +G  HRD+K TNILL +     + D G   
Sbjct: 126 DKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182

Query: 611 SGPCLDETHVSTGV-------KGSFGYLDPEYF---RRQQLTDKSDVYSFGVVLFEVLCA 660
                 E              + +  Y  PE F       + +++DV+S G VL+  +  
Sbjct: 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA-MMF 241

Query: 661 RT 662
             
Sbjct: 242 GE 243

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  129 bits (326), Expect = 1e-33
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 15/214 (7%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQ---TEITVLSKIRH 516
            +++    IG+G +G   K     D   +  K  +        E Q   +E+ +L +++H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKE-LDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 517 RHLVSLVG-YCEEQSEMI-LVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGL 572
            ++V       +  +  + +V EY E G L   +     +R  L  +  L +       L
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 573 HYLHT--GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET-HVSTGVKGSFG 629
              H        ++HRD+K  N+ LD     K+ DFGL+R    L+     +    G+  
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKTFVGTPY 181

Query: 630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTA 663
           Y+ PE   R    +KSD++S G +L+E+      
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  129 bits (327), Expect = 2e-33
 Identities = 52/236 (22%), Positives = 92/236 (38%), Gaps = 38/236 (16%)

Query: 450 KIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVP---GSRQGLPEFQT 506
            + F  +      +     IGSGG   V++ +       A+K  V       Q L  ++ 
Sbjct: 17  NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY-VNLEEADNQTLDSYRN 75

Query: 507 EITVLSKIRH--RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLS------- 557
           EI  L+K++     ++ L  Y      + +V E      L   L    +  +        
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK--KKKSIDPWERKSY 132

Query: 558 WKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE 617
           WK  LE        +H +H     GI+H D+K  N L+ +  + K+ DFG++        
Sbjct: 133 WKNMLE-------AVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTT 181

Query: 618 THVSTGVKGSFGYLDPE-----------YFRRQQLTDKSDVYSFGVVLFEVLCART 662
           + V     G+  Y+ PE              + +++ KSDV+S G +L+ +   +T
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  129 bits (326), Expect = 3e-33
 Identities = 48/199 (24%), Positives = 82/199 (41%), Gaps = 20/199 (10%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK------RGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G GG G VY+         VA+K         P  R      Q E     +++  H+V 
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRT---RMQREARTAGRLQEPHVVP 98

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           +  + E   ++ +    +    L   L    + PL+  + + I       L   H   A 
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH---AA 153

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV-STG-VKGSFGYLDPEYFRRQ 639
           G  HRD+K  NIL+  +  + + DFG++ +     +  +   G   G+  Y+ PE F   
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASA---TTDEKLTQLGNTVGTLYYMAPERFSES 210

Query: 640 QLTDKSDVYSFGVVLFEVL 658
             T ++D+Y+   VL+E L
Sbjct: 211 HATYRADIYALTCVLYECL 229

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  129 bits (325), Expect = 4e-33
 Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 28/225 (12%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRH 518
            +F+    +G GGFG+V++     D+   A+KR  +P       +   E+  L+K+ H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 519 LVSLVGYCEEQSEMI------------LVYEYMEKGPLKKHL-YGPDRTPLSWKQRLEIC 565
           +V       E++               +  +   K  LK  +              L I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS----------GPCL 615
           +  A  + +LH   ++G++HRD+K +NI    + V KV DFGL  +             +
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
                 TG  G+  Y+ PE       + K D++S G++LFE+L  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  130 bits (328), Expect = 4e-33
 Identities = 75/357 (21%), Positives = 129/357 (36%), Gaps = 69/357 (19%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVP---GSRQGLPEFQTEITVLSKIRH--RHLVSLV 523
           IGSGG   V++ +       A+K  V       Q L  ++ EI  L+K++     ++ L 
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKY-VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLS-------WKQRLEICIGAARGLHYLH 576
            Y      + +V E      L   L    +  +        WK  LE        +H +H
Sbjct: 76  DYEITDQYIYMVMECGN-IDLNSWLK--KKKSIDPWERKSYWKNMLE-------AVHTIH 125

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE-- 634
                GI+H D+K  N L+ +  + K+ DFG++        + V     G+  Y+ PE  
Sbjct: 126 ---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 635 ---------YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK 685
                       + +++ KSDV+S G +L+ +   +T   P          +   Q  K 
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT---P--------FQQIINQISK- 229

Query: 686 GMLEHIID-------PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVL---WNLEY 735
             L  IID       P +  K   D LK        CL      R S+ ++L   +    
Sbjct: 230 --LHAIIDPNHEIEFPDIPEKDLQDVLK-------CCLKRDPKQRISIPELLAHPYVQIQ 280

Query: 736 ALQLQESGSGLPREQREDSNTNPPALPTRTIVPQAPSSHVREKEVDGNASSDLRTSQ 792
              + +   G   E +             +I+  A + +      + + SS  +T +
Sbjct: 281 THPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFE 337

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  128 bits (325), Expect = 4e-33
 Identities = 52/227 (22%), Positives = 97/227 (42%), Gaps = 32/227 (14%)

Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH 518
            ++F++  ++G G FG V K     D+   A+K+ +  + + L    +E+ +L+ + H++
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQY 63

Query: 519 LVSLVGYCEEQSEMI-------------LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEIC 565
           +V       E+   +             +  EY E G L   +   +       +   + 
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLF 122

Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR------------SGP 613
                 L Y+H   ++GIIHRD+K  NI +DE+   K+ DFGL++            S  
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLC 659
               +   T   G+  Y+  E        + K D+YS G++ FE++ 
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  128 bits (323), Expect = 6e-33
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 34/268 (12%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
            IG G F  VYKG+      +VA    +    ++     F+ E  +L  ++H ++V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 525 Y----CEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
                 + +  ++LV E M  G LK +L  +      +  K     C    +GL +LHT 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148

Query: 579 SAEGIIHRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
           +   IIHRD+K  NI +       K+ D GL+        +     V G+  ++ PE + 
Sbjct: 149 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKA-VIGTPEFMAPEMY- 202

Query: 638 RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI 697
            ++  +  DVY+FG+ + E+    T+  P    +         Q  ++        P   
Sbjct: 203 EEKYDESVDVYAFGMCMLEMA---TSEYPYSECQNA------AQIYRRVTSGVK--PASF 251

Query: 698 GKINLDSLKKFGETAEKCLADYGVDRPS 725
            K+ +  +K+     E C+     +R S
Sbjct: 252 DKVAIPEVKEI---IEGCIRQNKDERYS 276

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  128 bits (323), Expect = 1e-32
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 14/202 (6%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           +G GG   V+    LRD+  VAVK     +         F+ E    + + H  +V++  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 525 YCEEQSEMI----LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
             E ++       +V EY++   L+  ++     P++ K+ +E+   A + L++ H    
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSH---Q 134

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG-VKGSFGYLDPEYFRRQ 639
            GIIHRD+K  NI++      KV DFG++R+      +   T  V G+  YL PE  R  
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194

Query: 640 QLTDKSDVYSFGVVLFEVLCAR 661
            +  +SDVYS G VL+EVL   
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGE 216

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  129 bits (327), Expect = 1e-32
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 38/217 (17%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVP---GSRQGLPEFQTEITVLSKIRH--RHLVSLV 523
           IGSGG   V++ +       A+K  V       Q L  ++ EI  L+K++     ++ L 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKY-VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLS-------WKQRLEICIGAARGLHYLH 576
            Y      + +V E      L   L    +  +        WK  LE        +H +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLK--KKKSIDPWERKSYWKNMLE-------AVHTIH 172

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE-- 634
                GI+H D+K  N L+ +  + K+ DFG++        + V     G+  Y+ PE  
Sbjct: 173 ---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 635 ---------YFRRQQLTDKSDVYSFGVVLFEVLCART 662
                       + +++ KSDV+S G +L+ +   +T
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  126 bits (319), Expect = 6e-32
 Identities = 44/219 (20%), Positives = 92/219 (42%), Gaps = 32/219 (14%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVK-----------------RGVPGSRQGLPEFQTEITVL 511
           +  G F  +     +DN   A+K                       +    +F+ E+ ++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 512 SKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA--- 568
           + I++ + ++  G      E+ ++YEYME   + K          ++   + I +     
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 569 ---ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK 625
                   Y+H  + + I HRD+K +NIL+D+N   K++DFG S       +  +    +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKG-SR 211

Query: 626 GSFGYLDPEYFRRQQLTD--KSDVYSFGVVLFEVLCART 662
           G++ ++ PE+F  +   +  K D++S G+ L+ +     
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  124 bits (314), Expect = 1e-31
 Identities = 52/205 (25%), Positives = 79/205 (38%), Gaps = 15/205 (7%)

Query: 462 NFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQ---TEITVLSKI-RH 516
           +F +   +G G +G V+K     D    AVKR      +G  +      E+    K+ +H
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
              V L    EE   + L  E      L++H        L   Q           L +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLH 174

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
           +   +G++H D+K  NI L      K+ DFGL      L         +G   Y+ PE  
Sbjct: 175 S---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVE---LGTAGAGEVQEGDPRYMAPELL 228

Query: 637 RRQQLTDKSDVYSFGVVLFEVLCAR 661
            +      +DV+S G+ + EV C  
Sbjct: 229 -QGSYGTAADVFSLGLTILEVACNM 252

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  124 bits (313), Expect = 2e-31
 Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 29/223 (13%)

Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGLPEFQTEITVL 511
            T+ + +  + I+G G    V++G  +      A+K                   E  VL
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ---MREFEVL 61

Query: 512 SKIRHRHLVSLVGYCEEQS--EMILVYEYMEKGPLKKHLYGPDRT-PLSWKQRLEICIGA 568
            K+ H+++V L    EE +    +L+ E+   G L   L  P     L   + L +    
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSRSGPCLDETHVSTGV 624
             G+++L      GI+HR+IK  NI+     D   V K+ DFG +R    L++      +
Sbjct: 122 VGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSL 175

Query: 625 KGSFGYLDPEYFRRQQLTD--------KSDVYSFGVVLFEVLC 659
            G+  YL P+ + R  L            D++S GV  +    
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (325), Expect = 5e-31
 Identities = 43/201 (21%), Positives = 76/201 (37%), Gaps = 23/201 (11%)

Query: 469 IGSGGFGMVYKGV-LR-DNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGY 525
           I  GG G +Y  +    +   V +K  V             E   L+++ H  +V +  +
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147

Query: 526 CEEQSEMI-----LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            E           +V EY+    LK+         L   + +   +     L YLH   +
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH---S 200

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
            G+++ D+K  NI+L E  + K+ D G       ++       + G+ G+  PE  R   
Sbjct: 201 IGLVYNDLKPENIMLTEEQL-KLIDLGAVSR---INSFGY---LYGTPGFQAPEIVRTGP 253

Query: 641 LTDKSDVYSFGVVLFEVLCAR 661
            T  +D+Y+ G  L  +    
Sbjct: 254 -TVATDIYTVGRTLAALTLDL 273

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  123 bits (311), Expect = 1e-30
 Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 29/223 (13%)

Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGLPEFQTEITVL 511
            T+ + +  + I+G G    V++G  +      A+K                   E  VL
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ---MREFEVL 61

Query: 512 SKIRHRHLVSLVGYCEEQS--EMILVYEYMEKGPLKKHLYGPDRT-PLSWKQRLEICIGA 568
            K+ H+++V L    EE +    +L+ E+   G L   L  P     L   + L +    
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSRSGPCLDETHVSTGV 624
             G+++L      GI+HR+IK  NI+     D   V K+ DFG +R    L++      +
Sbjct: 122 VGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSL 175

Query: 625 KGSFGYLDPEYFRRQQLTD--------KSDVYSFGVVLFEVLC 659
            G+  YL P+ + R  L            D++S GV  +    
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  127 bits (320), Expect = 1e-30
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 24/207 (11%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
            +G+GGFG V + + +D   +VA+K       P +R+       EI ++ K+ H ++VS 
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW---CLEIQIMKKLNHPNVVSA 77

Query: 523 VGYCEEQSEM------ILVYEYMEKGPLKKHLYGPDR-TPLSWKQRLEICIGAARGLHYL 575
               +   ++      +L  EY E G L+K+L   +    L       +    +  L YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 576 HTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLD 632
           H      IIHRD+K  NI+L    +  + K+ D G ++    LD+  + T   G+  YL 
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEFVGTLQYLA 191

Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           PE   +++ T   D +SFG + FE + 
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECIT 218

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  118 bits (297), Expect = 5e-29
 Identities = 36/228 (15%), Positives = 68/228 (29%), Gaps = 23/228 (10%)

Query: 452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNT------KVAVKRGVPGSRQGLPEFQ 505
           P T+ Q  +     + ++G G F  VY+    D        K  +K   P +        
Sbjct: 56  PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115

Query: 506 TEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL---YGPDRTPLSWKQRL 562
             +  L        +        Q+  +LV E    G L   +          +     +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175

Query: 563 EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS-----------KVADFGLSRS 611
              +     +  +H      IIH DIK  N +L   ++             + D G S  
Sbjct: 176 SFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232

Query: 612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
                +  + T    + G+   E    +    + D +     ++ +L 
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  115 bits (290), Expect = 1e-28
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 24/204 (11%)

Query: 465 KNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
             +++G G +G+VY G  L +  ++A+K       +       EI +   ++H+++V  +
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 524 GYCEEQSEMILVYEYMEKGPLK---KHLYGPDRTPLSW-----KQRLEICIGAARGLHYL 575
           G   E   + +  E +  G L    +  +GP +          KQ LE       GL YL
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE-------GLKYL 138

Query: 576 HTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           H      I+HRDIK  N+L++  + V K++DFG S+    ++    +    G+  Y+ PE
Sbjct: 139 H---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE 193

Query: 635 YFRRQQL--TDKSDVYSFGVVLFE 656
              +        +D++S G  + E
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIE 217

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  114 bits (289), Expect = 2e-28
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 27/203 (13%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGY 525
           ++GSG F  V+    R      A+K  +  S        + EI VL KI+H ++V+L   
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKC-IKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 526 CEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
            E  +   LV + +  G L      +      D + +  +Q L         + YLH   
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-IQQVLS-------AVKYLH--- 123

Query: 580 AEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
             GI+HRD+K  N+L    +EN    + DFGLS+    +++  + +   G+ GY+ PE  
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGYVAPEVL 179

Query: 637 RRQQLTDKSDVYSFGVVLFEVLC 659
            ++  +   D +S GV+ + +LC
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLC 202

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  115 bits (290), Expect = 3e-28
 Identities = 48/217 (22%), Positives = 85/217 (39%), Gaps = 25/217 (11%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYC 526
           +  GGF  VY+   +    + A+KR +    +       E+  + K+  H ++V      
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 527 --------EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
                     Q+E +L+ E  +   ++       R PLS    L+I     R + ++H  
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR- 154

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLS---RSGPCLDETHVSTGVK-------GSF 628
               IIHRD+K  N+LL      K+ DFG +      P    +     +         + 
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214

Query: 629 GYLDPE---YFRRQQLTDKSDVYSFGVVLFEVLCART 662
            Y  PE    +    + +K D+++ G +L+  LC R 
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYL-LCFRQ 250

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score =  110 bits (277), Expect = 3e-28
 Identities = 35/190 (18%), Positives = 61/190 (32%), Gaps = 31/190 (16%)

Query: 179 LETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGP 238
            + I  +N GG       D     +  D     +  A+            +         
Sbjct: 4   DKVIWAVNAGGESHV---DVHGIHYRKDPLEGRVGRAS---DYGMKLPILRSNPE----D 53

Query: 239 DNVYMTAQEMNRDNAMLGARFNITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFIN 298
             +Y T +             +  +D P+   G  +++ L F ++      Q  F+V +N
Sbjct: 54  QVLYQTERYNE---------DSFGYDIPIKEEGE-YVLVLKFAEVYFAQSQQKVFDVRVN 103

Query: 299 DYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGPSELSGSLKV--------N 350
            ++  KDLD+     HS A    +         G + V    S  +G L V        N
Sbjct: 104 GHTVVKDLDIFDRVGHSTAHDEIIPISIKK---GKLSVQGEVSTFTGKLSVEFVKGYYDN 160

Query: 351 AILNGVEIMK 360
             +  + IMK
Sbjct: 161 PKVCALFIMK 170

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score =  100 bits (250), Expect = 1e-24
 Identities = 24/169 (14%), Positives = 53/169 (31%), Gaps = 20/169 (11%)

Query: 2   YLINCGSPTNASLYNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTSDG 61
           + +N G  ++  ++   +  D     V  ++D  + L       +    Y T R      
Sbjct: 8   WAVNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSF 67

Query: 62  SYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFS------TQVVVLK 115
            Y + IK  G +++   F+  E    +     F V  NG  +++D              +
Sbjct: 68  GYDIPIKEEGEYVLVLKFA--EVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDE 125

Query: 116 EFIVKVDGDVIEIEFRPV------------GDKNFGFVNAIEVFSAPED 152
              + +    + ++                G  +   V A+ +     D
Sbjct: 126 IIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKGTAD 174

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  113 bits (286), Expect = 4e-28
 Identities = 47/237 (19%), Positives = 84/237 (35%), Gaps = 53/237 (22%)

Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT---EITVLSKI- 514
           T  F +   IGSG FG V+K V   D    A+KR       G  + Q    E+   + + 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 68

Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGL 572
           +H H+V       E   M++  EY   G L   +       +     +  ++ +   RGL
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDEN-------------------YVSKVADFGLSRSGP 613
            Y+H   +  ++H DIK +NI +                       + K+ D G      
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-- 183

Query: 614 CLDETHVSTG---------VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
            +    V  G         ++ ++ +L            K+D+++  + +     A 
Sbjct: 184 -ISSPQVEEGDSRFLANEVLQENYTHL-----------PKADIFALALTVVCAAGAE 228

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  117 bits (294), Expect = 4e-28
 Identities = 45/208 (21%), Positives = 86/208 (41%), Gaps = 18/208 (8%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLV 520
           +F    ++G G  G +    + DN  VAVKR      +       E+ +L +   H +++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVI 81

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
                 +++    +  E      L++++   D       + + +      GL +LH   +
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLH---S 136

Query: 581 EGIIHRDIKSTNILLDE-----NYVSKVADFGLSRS-GPCLDETHVSTGVKGSFGYLDPE 634
             I+HRD+K  NIL+          + ++DFGL +            +GV G+ G++ PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 635 YFRR---QQLTDKSDVYSFGVVLFEVLC 659
                  +  T   D++S G V + V+ 
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  113 bits (284), Expect = 7e-28
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 31/208 (14%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGL--PEFQTEITVLSKIRHRHLVS 521
           +GSG F +V K   +    + A K    R +  SR+G+   E + E+ +L +IRH ++++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 522 LVGYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           L    E +++++L+ E +  G L      K+ L   + T    KQ L+       G+HYL
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQILD-------GVHYL 124

Query: 576 HTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+   + I H D+K  NI+L      N   K+ DFG++     ++  +    + G+  ++
Sbjct: 125 HS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFV 178

Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    + L  ++D++S GV+ + +L 
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLS 206

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  116 bits (292), Expect = 7e-28
 Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 37/228 (16%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHL 519
           N      I+G G  G V          VAVKR              EI +L++   H ++
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR---MLIDFCDIALMEIKLLTESDDHPNV 71

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
           +           + +  E      L      K++   +         + +    A G+ +
Sbjct: 72  IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 575 LHTGSAEGIIHRDIKSTNILLD-------------ENYVSKVADFGLSR---SGPCLDET 618
           LH   +  IIHRD+K  NIL+              EN    ++DFGL +   SG     T
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 619 HVSTGVKGSFGYLDPEYFR-------RQQLTDKSDVYSFGVVLFEVLC 659
           +++    G+ G+  PE          +++LT   D++S G V + +L 
Sbjct: 188 NLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  115 bits (289), Expect = 1e-27
 Identities = 45/201 (22%), Positives = 89/201 (44%), Gaps = 24/201 (11%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSLVGYC 526
           +GSG FG+V++ V +        K  +           + EI++++++ H  L++L    
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117

Query: 527 EEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
           E++ EM+L+ E++  G L      + +           +Q  E       GL ++H    
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------GLKHMH---E 167

Query: 581 EGIIHRDIKSTNILL--DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
             I+H DIK  NI+    +    K+ DFGL+     L+   +      +  +  PE   R
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDR 224

Query: 639 QQLTDKSDVYSFGVVLFEVLC 659
           + +   +D+++ GV+ + +L 
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLS 245

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  113 bits (284), Expect = 1e-27
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 5/148 (3%)

Query: 463 FDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           ++    +G G FG VYK          A K     S + L ++  EI +L+   H ++V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+G      ++ ++ E+   G +   +       L+  Q   +C      L++LH   ++
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH---SK 136

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLS 609
            IIHRD+K+ N+L+      ++ADFG+S
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVS 164

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  114 bits (287), Expect = 1e-27
 Identities = 23/231 (9%), Positives = 50/231 (21%), Gaps = 46/231 (19%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
            +  G   +V+     +     A+K    G   SR  L          +++         
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 524 GYC--------------------------EEQSEMILVYEYMEKGPLKK-----HLYGPD 552
                                           +  +L+        L+            
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187

Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
           R          +     R    L    ++G++H      N+ +  +    + D       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK- 243

Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQ--QLTDKSDVYSFGVVLFEVLCAR 661
                            Y   E+        T   + +  G+ ++ V C  
Sbjct: 244 ----VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  116 bits (292), Expect = 1e-27
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 18/200 (9%)

Query: 468 IIGSGGFGMVYKGVLR-DNTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           ++G G FG V     +    + AVK    R V   +        E+ +L ++ H +++ L
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
             + E++    LV E    G L   +    R   S      I      G+ Y+H      
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMH---KNK 146

Query: 583 IIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
           I+HRD+K  N+LL    ++   ++ DFGLS      + +       G+  Y+ PE     
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDKIGTAYYIAPEVLHG- 202

Query: 640 QLTDKSDVYSFGVVLFEVLC 659
              +K DV+S GV+L+ +L 
Sbjct: 203 TYDEKCDVWSTGVILYILLS 222

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  113 bits (284), Expect = 2e-27
 Identities = 52/241 (21%), Positives = 94/241 (39%), Gaps = 27/241 (11%)

Query: 427 SSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDN 485
           S+  +        + G     +LK    + +   +       +G G FG V++    +  
Sbjct: 24  SAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTG 83

Query: 486 TKVAVKRGVPGSRQGLPEF-QTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL 544
            + AVK+ V      L  F   E+   + +    +V L G   E   + +  E +E G L
Sbjct: 84  FQCAVKK-VR-----LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137

Query: 545 KKHL--YGP---DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY 599
            + +   G    DR      Q LE       GL YLH      I+H D+K+ N+LL  + 
Sbjct: 138 GQLIKQMGCLPEDRALYYLGQALE-------GLEYLH---TRRILHGDVKADNVLLSSDG 187

Query: 600 VS-KVADFGLSR--SGPCLDETHVSTG-VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF 655
               + DFG +       L ++ ++   + G+  ++ PE    +    K D++S   ++ 
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 247

Query: 656 E 656
            
Sbjct: 248 H 248

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  116 bits (292), Expect = 2e-27
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 19/200 (9%)

Query: 468 IIGSGGFGMVYKGVLR-DNTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
            +GSG +G V     +  + + A+K      V  S     +   E+ VL  + H +++ L
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN--SKLLEEVAVLKLLDHPNIMKL 101

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
             + E++    LV E  + G L   +    R   +      I      G+ YLH      
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEII--HRMKFNEVDAAVIIKQVLSGVTYLH---KHN 156

Query: 583 IIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
           I+HRD+K  N+LL   +++ + K+ DFGLS      +         G+  Y+ PE  R+ 
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVLRK- 212

Query: 640 QLTDKSDVYSFGVVLFEVLC 659
           +  +K DV+S GV+LF +L 
Sbjct: 213 KYDEKCDVWSIGVILFILLA 232

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  112 bits (282), Expect = 2e-27
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 31/209 (14%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGL--PEFQTEITVLSKIRHRHLV 520
            +GSG F +V K   +    + A K    R    SR+G+   E + E+++L ++ H +++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 521 SLVGYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
           +L    E +++++L+ E +  G L      K+ L   + T    KQ L+       G++Y
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNY 130

Query: 575 LHTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
           LH    + I H D+K  NI+L          K+ DFGL+     +++      + G+  +
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEF 184

Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           + PE    + L  ++D++S GV+ + +L 
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLS 213

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  111 bits (280), Expect = 3e-27
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 13/197 (6%)

Query: 463 FDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           + +   IG G  G VY  + +    +VA+++     +        EI V+ + ++ ++V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
            +       E+ +V EY+  G L   +     T +   Q   +C    + L +LH   + 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH---SN 135

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--STGVKGSFGYLDPEYFRRQ 639
            +IHRDIKS NILL  +   K+ DFG       +       ST V G+  ++ PE   R+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ---ITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 640 QLTDKSDVYSFGVVLFE 656
               K D++S G++  E
Sbjct: 192 AYGPKVDIWSLGIMAIE 208

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  112 bits (282), Expect = 4e-27
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 31/208 (14%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGL--PEFQTEITVLSKIRHRHLVS 521
           +GSG F +V K   +    + A K    R    SR+G+   + + E+++L +I+H ++++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 522 LVGYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           L    E ++++IL+ E +  G L      K+ L   + T    KQ L        G++YL
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILN-------GVYYL 130

Query: 576 HTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           H+     I H D+K  NI+L          K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184

Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    + L  ++D++S GV+ + +L 
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  111 bits (280), Expect = 4e-27
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 29/208 (13%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSL- 522
           +G G +G V + +      + AVK    + +     G    + EI +L ++RH++++ L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 523 -VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR--------GLH 573
            V Y EE+ +M +V EY   G  +  +   D  P   ++R  +C   A         GL 
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--ML--DSVP---EKRFPVC--QAHGYFCQLIDGLE 123

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YLH   ++GI+H+DIK  N+LL      K++  G++ +             +GS  +  P
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 634 EYFRRQQLTD--KSDVYSFGVVLFEVLC 659
           E           K D++S GV L+ +  
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITT 208

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  111 bits (280), Expect = 5e-27
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 13/200 (6%)

Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH 518
              FD    +G G +G VYK +       VA+K         L E   EI+++ +    H
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSPH 85

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
           +V   G   + +++ +V EY   G +   +       L+  +   I     +GL YLH  
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHF- 143

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--STGVKGSFGYLDPEYF 636
                IHRDIK+ NILL+    +K+ADFG++     L +T    +T + G+  ++ PE  
Sbjct: 144 --MRKIHRDIKAGNILLNTEGHAKLADFGVAGQ---LTDTMAKRNTVI-GTPFWMAPEVI 197

Query: 637 RRQQLTDKSDVYSFGVVLFE 656
           +       +D++S G+   E
Sbjct: 198 QEIGYNCVADIWSLGITAIE 217

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  112 bits (282), Expect = 5e-27
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 31/208 (14%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGL--PEFQTEITVLSKIRHRHLVS 521
           +GSG F +V K   +    + A K    R    SR+G+   E + E+++L ++ H ++++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 522 LVGYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           L    E +++++L+ E +  G L      K+ L   + T    KQ L+       G++YL
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131

Query: 576 HTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           HT   + I H D+K  NI+L          K+ DFGL+     +++      + G+  ++
Sbjct: 132 HT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFV 185

Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    + L  ++D++S GV+ + +L 
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLS 213

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  110 bits (278), Expect = 5e-27
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 30/206 (14%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
            +G G F +V + V +    + A K    + +        + + E  +  K++H ++V L
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF--QKLEREARICRKLQHPNIVRL 70

Query: 523 VGYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
               +E+S   LV++ +  G L      ++     D +    +Q LE        + Y H
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-QQILE-------SIAYCH 122

Query: 577 TGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
              + GI+HR++K  N+LL    +    K+ADFGL+     ++++    G  G+ GYL P
Sbjct: 123 ---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSP 176

Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLC 659
           E  ++   +   D+++ GV+L+ +L 
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLV 202

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  112 bits (282), Expect = 5e-27
 Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 22/206 (10%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGLPE-FQTEITVLSKIRHRHLVS 521
           +IG G F +V + + R+   + AVK         S     E  + E ++   ++H H+V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 522 LVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
           L+        + +V+E+M+   L     K+          S              L Y H
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKR---ADAGFVYSEAVASHYMRQILEALRYCH 147

Query: 577 TGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
                 IIHRD+K   +LL   + +   K+  FG++      +   V+ G  G+  ++ P
Sbjct: 148 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAP 202

Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLC 659
           E  +R+      DV+  GV+LF +L 
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLS 228

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  114 bits (288), Expect = 6e-27
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 26/209 (12%)

Query: 468 IIGSGGFGMVYKGVLR-DNTKVAVK-------------RGVPGSRQGLPEFQTEITVLSK 513
            +GSG +G V     +  +++ A+K                    +   E   EI++L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102

Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
           + H +++ L    E++    LV E+ E G L + +   +R          I      G+ 
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII--NRHKFDECDAANIMKQILSGIC 160

Query: 574 YLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
           YLH      I+HRDIK  NILL   +     K+ DFGLS       + +      G+  Y
Sbjct: 161 YLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTAYY 214

Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           + PE  ++ +  +K DV+S GV+++ +LC
Sbjct: 215 IAPEVLKK-KYNEKCDVWSCGVIMYILLC 242

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  113 bits (284), Expect = 6e-27
 Identities = 59/211 (27%), Positives = 86/211 (40%), Gaps = 34/211 (16%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVK--------RGVPGSRQGLPEFQTEITVLSKIRHRHL 519
           +GSG  G V     R    KVA++         G           +TEI +L K+ H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
           + +  + + +    +V E ME G L                L + Q L         + Y
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-------AVQY 254

Query: 575 LHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           LH     GIIHRD+K  N+LL   +E+ + K+ DFG S+    L ET +   + G+  YL
Sbjct: 255 LHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLCGTPTYL 308

Query: 632 DPE---YFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE              D +S GV+LF  L 
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLS 339

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  111 bits (279), Expect = 7e-27
 Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 13/197 (6%)

Query: 463 FDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
            D  + IG G  G+V          +VAVK      +Q       E+ ++   +H ++V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           +        E+ ++ E+++ G L   +    +  L+ +Q   +C    + L YLH   A+
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLH---AQ 160

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--STGVKGSFGYLDPEYFRRQ 639
           G+IHRDIKS +ILL  +   K++DFG       + +      + V G+  ++ PE   R 
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ---ISKDVPKRKSLV-GTPYWMAPEVISRS 216

Query: 640 QLTDKSDVYSFGVVLFE 656
               + D++S G+++ E
Sbjct: 217 LYATEVDIWSLGIMVIE 233

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  112 bits (281), Expect = 8e-27
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 26/209 (12%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHL 519
              K  I+G G FG V+K        K+A K  +     +   E + EI+V++++ H +L
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKI-IKTRGMKDKEEVKNEISVMNQLDHANL 148

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLH 573
           + L    E +++++LV EY++ G L      + +      T L  KQ  E       G+ 
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------GIR 201

Query: 574 YLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
           ++H      I+H D+K  NIL    D   + K+ DFGL+R               G+  +
Sbjct: 202 HMHQ---MYILHLDLKPENILCVNRDAKQI-KIIDFGLARR---YKPREKLKVNFGTPEF 254

Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           L PE      ++  +D++S GV+ + +L 
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  112 bits (281), Expect = 9e-27
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 30/206 (14%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
            +G G F +V + V +    + A K    + +        + + E  +  K++H ++V L
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF--QKLEREARICRKLQHPNIVRL 93

Query: 523 VGYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
               +E+S   LV++ +  G L      ++     D +    +Q LE        + Y H
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-QQILE-------SIAYCH 145

Query: 577 TGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
              + GI+HR++K  N+LL    +    K+ADFGL+     ++++    G  G+ GYL P
Sbjct: 146 ---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSP 199

Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLC 659
           E  ++   +   D+++ GV+L+ +L 
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLV 225

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  110 bits (276), Expect = 1e-26
 Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 37/215 (17%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVK-----RGVPGSRQGLPE----FQTEITVLSKI-RH 516
           I+G G   +V + + +    + AVK      G   S + + E       E+ +L K+  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAAR 570
            +++ L    E  +   LV++ M+KG L      K  L   +   +  +  LE       
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MRALLE------- 135

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
            +  LH      I+HRD+K  NILLD++   K+ DFG S     LD       V G+  Y
Sbjct: 136 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSY 189

Query: 631 LDPEYFRRQQLTDKS------DVYSFGVVLFEVLC 659
           L PE        +        D++S GV+++ +L 
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (276), Expect = 1e-26
 Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 14/198 (7%)

Query: 463 FDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           F K   IG G FG V+KG+  R    VA+K   +  +   + + Q EITVLS+    ++ 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
              G   + +++ ++ EY+  G     L  P   PL   Q   I     +GL YLH+   
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL-DLLEP--GPLDETQIATILREILKGLDYLHS--- 137

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV--STGVKGSFGYLDPEYFRR 638
           E  IHRDIK+ N+LL E+   K+ADFG++     L +T +  +T V G+  ++ PE  ++
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNTFV-GTPFWMAPEVIKQ 193

Query: 639 QQLTDKSDVYSFGVVLFE 656
                K+D++S G+   E
Sbjct: 194 SAYDSKADIWSLGITAIE 211

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  109 bits (275), Expect = 1e-26
 Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 13/196 (6%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G GGF   ++          A K      +    Q   +   EI++   + H+H+V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVGFH 81

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G+ E+   + +V E   +  L +      R  L+  +          G  YLH      +
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLH---RNRV 136

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           IHRD+K  N+ L+E+   K+ DFGL+       E        G+  Y+ PE   ++  + 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSKKGHSF 194

Query: 644 KSDVYSFGVVLFEVLC 659
           + DV+S G +++ +L 
Sbjct: 195 EVDVWSIGCIMYTLLV 210

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  108 bits (273), Expect = 2e-26
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 23/200 (11%)

Query: 469 IGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSRQGLPEFQT--EITVLSKIRHRHLVS 521
           +G G FG VY    + +      KV  K  +  +     E Q   E+ + S +RH +++ 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQSHLRHPNILR 73

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           L GY  + + + L+ EY   G + + L          +     E+       L Y H   
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA----NALSYCH--- 126

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
           ++ +IHRDIK  N+LL      K+ADFG S   P            G+  YL PE    +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLC--GTLDYLPPEMIEGR 182

Query: 640 QLTDKSDVYSFGVVLFEVLC 659
              +K D++S GV+ +E L 
Sbjct: 183 MHDEKVDLWSLGVLCYEFLV 202

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  109 bits (275), Expect = 2e-26
 Identities = 60/212 (28%), Positives = 86/212 (40%), Gaps = 34/212 (16%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVK--------RGVPGSRQGLPEFQTEITVLSKIRHRH 518
            +GSG  G V     R    KVA+K         G           +TEI +L K+ H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPL-----KKHLYGPDRTPLSWKQRLEICIGAARGLH 573
           ++ +  + + +    +V E ME G L                L + Q L         + 
Sbjct: 77  IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-------AVQ 128

Query: 574 YLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
           YLH     GIIHRD+K  N+LL   +E+ + K+ DFG S+    L ET +   + G+  Y
Sbjct: 129 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLCGTPTY 182

Query: 631 LDPE---YFRRQQLTDKSDVYSFGVVLFEVLC 659
           L PE              D +S GV+LF  L 
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  108 bits (272), Expect = 2e-26
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 30/213 (14%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSR---QGLPE-FQTEITVLSKIR 515
            +F    ++G G F  VY+   +    +VA+K  +        G+ +  Q E+ +  +++
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKM-IDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRT---PLSWKQRLEICIGAARGL 572
           H  ++ L  Y E+ + + LV E    G + ++L    +      +     +I      G+
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI----ITGM 125

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK------G 626
            YLH   + GI+HRD+  +N+LL  N   K+ADFGL+        T +    +      G
Sbjct: 126 LYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA--------TQLKMPHEKHYTLCG 174

Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           +  Y+ PE   R     +SDV+S G + + +L 
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLI 207

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  111 bits (279), Expect = 2e-26
 Identities = 30/254 (11%), Positives = 73/254 (28%), Gaps = 47/254 (18%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIR-------- 515
           ++G        +           V             + + + E+  L  +R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 516 --------------HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL---------YGPD 552
                               ++    ++ +M ++  +     ++ +L         +   
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
              L    RL++ +   R L  LH     G++H  ++  +I+LD+     +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 613 PCLDETHVSTGVKGSFGYLDPEYFRRQQ-----LTDKSDVYSFGVVLFEVLCARTAVDPL 667
                + +  G                Q     +T   D ++ G+ ++ + CA     P 
Sbjct: 262 GASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL---PN 317

Query: 668 LAREQVNLAEWAMQ 681
                +  +EW  +
Sbjct: 318 TDDAALGGSEWIFR 331

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  109 bits (275), Expect = 3e-26
 Identities = 41/200 (20%), Positives = 80/200 (40%), Gaps = 23/200 (11%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG+V++ V          K  V          + EI++L+  RHR+++ L    E
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 528 EQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
              E+++++E++    +                     Q  E        L +LH   + 
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-------ALQFLH---SH 121

Query: 582 GIIHRDIKSTNILL--DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
            I H DI+  NI+     +   K+ +FG +R    L        +  +  Y  PE  +  
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQHD 178

Query: 640 QLTDKSDVYSFGVVLFEVLC 659
            ++  +D++S G +++ +L 
Sbjct: 179 VVSTATDMWSLGTLVYVLLS 198

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  109 bits (275), Expect = 3e-26
 Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 13/196 (6%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G GGF   ++          A K      +    Q   +   EI++   + H+H+V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVGFH 107

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G+ E+   + +V E   +  L +      R  L+  +          G  YLH      +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 162

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
           IHRD+K  N+ L+E+   K+ DFGL+       E        G+  Y+ PE   ++  + 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSKKGHSF 220

Query: 644 KSDVYSFGVVLFEVLC 659
           + DV+S G +++ +L 
Sbjct: 221 EVDVWSIGCIMYTLLV 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (274), Expect = 4e-26
 Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 9/151 (5%)

Query: 463 FDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR---GVPGSRQGLPEFQTEITVLSKIRHRH 518
           F     IG G FG VY    +R++  VA+K+       S +   +   E+  L K+RH +
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
            +   G    +    LV EY         L    + PL   +   +  GA +GL YLH+ 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 172

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLS 609
               +IHRD+K+ NILL E  + K+ DFG +
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  109 bits (274), Expect = 5e-26
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 10/211 (4%)

Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKR-GVPGSRQGLPEFQT 506
           L       +   ++F+K   +G+G  G+V+K   +     +A K   +        +   
Sbjct: 21  LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80

Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           E+ VL +    ++V   G      E+ +  E+M+ G L + L    R P     +  + I
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--VSI 138

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
              +GL YL       I+HRD+K +NIL++     K+ DFG+S     L ++  ++ V G
Sbjct: 139 AVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANSFV-G 192

Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV 657
           +  Y+ PE  +    + +SD++S G+ L E+
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  107 bits (270), Expect = 5e-26
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 35/206 (16%)

Query: 469 IGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSL 522
           +G G FG VY    + N      KV  K  +   ++G+    + EI + S +RH +++ +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
             Y  ++  + L+ E+  +G L K L  +G      S     E+    A  LHY H    
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----ADALHYCH---E 132

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGP-------CLDETHVSTGVKGSFGYLDP 633
             +IHRDIK  N+L+      K+ADFG S   P       C           G+  YL P
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-----------GTLDYLPP 181

Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLC 659
           E    +   +K D++  GV+ +E L 
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLV 207

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  109 bits (274), Expect = 5e-26
 Identities = 70/278 (25%), Positives = 113/278 (40%), Gaps = 36/278 (12%)

Query: 404 RKKKPKPRPADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNF 463
           R+   +    D      L A     +    +GT N      G       +   +     +
Sbjct: 37  RRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKY 96

Query: 464 DKNLIIGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGLPE----FQTEITVLSKI 514
           D   +IG G   +V + V R    + AVK         S + L E     + E  +L ++
Sbjct: 97  DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156

Query: 515 R-HRHLVSLVGYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIG 567
             H H+++L+   E  S M LV++ M KG L      K  L   +   +  +  LE    
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-MRSLLE---- 211

Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGS 627
               + +LH   A  I+HRD+K  NILLD+N   +++DFG S     L+       + G+
Sbjct: 212 ---AVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGT 262

Query: 628 FGYLDPEYFRRQQLTD------KSDVYSFGVVLFEVLC 659
            GYL PE  +            + D+++ GV+LF +L 
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  110 bits (278), Expect = 8e-26
 Identities = 56/200 (28%), Positives = 85/200 (42%), Gaps = 19/200 (9%)

Query: 468 IIGSGGFGMVYKGVLR-DNTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           ++G G FG V K   R    + AVK           +       E+ +L K+ H +++ L
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMKL 86

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
               E+ S   +V E    G L   +    R   S      I      G+ Y+H      
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMH---KHN 141

Query: 583 IIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
           I+HRD+K  NILL   +++   K+ DFGLS    C  +        G+  Y+ PE  R  
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEVLRG- 197

Query: 640 QLTDKSDVYSFGVVLFEVLC 659
              +K DV+S GV+L+ +L 
Sbjct: 198 TYDEKCDVWSAGVILYILLS 217

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  108 bits (272), Expect = 9e-26
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 24/201 (11%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
            +G G   +VY+   +   K    + +          +TEI VL ++ H +++ L    E
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118

Query: 528 EQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
             +E+ LV E +  G L      K +    D      KQ LE        + YLH     
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-VKQILE-------AVAYLH---EN 167

Query: 582 GIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
           GI+HRD+K  N+L      +   K+ADFGLS+    ++   +   V G+ GY  PE  R 
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRG 224

Query: 639 QQLTDKSDVYSFGVVLFEVLC 659
                + D++S G++ + +LC
Sbjct: 225 CAYGPEVDMWSVGIITYILLC 245

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  110 bits (276), Expect = 9e-26
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 31/207 (14%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVK-----RGVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
            +G G F +V + V      + A       +      Q L   + E  +   ++H ++V 
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL---EREARICRLLKHPNIVR 74

Query: 522 LVGYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           L     E+    L+++ +  G L      +++    D +    +Q LE        + + 
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI-QQILE-------AVLHC 126

Query: 576 HTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLD 632
           H     G++HR++K  N+LL    +    K+ADFGL+       E     G  G+ GYL 
Sbjct: 127 HQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGYLS 181

Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           PE  R+       D+++ GV+L+ +L 
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLV 208

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (279), Expect = 1e-25
 Identities = 57/265 (21%), Positives = 102/265 (38%), Gaps = 30/265 (11%)

Query: 405 KKKPKPRPADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFD 464
           +K+ +    D  G         SS+       +                 D       +D
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDH------YD 160

Query: 465 KNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
            +  +G+G FG+V++   R      A K  +          + EI  +S +RH  LV+L 
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220

Query: 524 GYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
              E+ +EM+++YE+M  G L      + +    D      +Q  +       GL ++H 
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK-------GLCHMHE 273

Query: 578 GSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
                 +H D+K  NI+      N + K+ DFGL+     LD         G+  +  PE
Sbjct: 274 ---NNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTAH---LDPKQSVKVTTGTAEFAAPE 326

Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLC 659
               + +   +D++S GV+ + +L 
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLS 351

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  106 bits (266), Expect = 2e-25
 Identities = 55/206 (26%), Positives = 83/206 (40%), Gaps = 31/206 (15%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
           ++G G FG V K   R    + AVK                   E+ +L K+ H +++ L
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT--STILREVELLKKLDHPNIMKL 86

Query: 523 VGYCEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
               E+ S   +V E    G L      +K          S      I      G+ Y+H
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKR--------FSEHDAARIIKQVFSGITYMH 138

Query: 577 TGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
                 I+HRD+K  NILL   +++   K+ DFGLS       +        G+  Y+ P
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAP 192

Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLC 659
           E  R     +K DV+S GV+L+ +L 
Sbjct: 193 EVLRG-TYDEKCDVWSAGVILYILLS 217

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  107 bits (268), Expect = 2e-25
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 12/168 (7%)

Query: 450 KIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEI 508
           +I  + L+     F+   ++G+G +G VYKG  ++     A+K  +  +     E + EI
Sbjct: 13  EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIKQEI 71

Query: 509 TVLSKI-RHRHLVSLVG------YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQR 561
            +L K   HR++ +  G            ++ LV E+   G +   +       L  +  
Sbjct: 72  NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 131

Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS 609
             IC    RGL +LH      +IHRDIK  N+LL EN   K+ DFG+S
Sbjct: 132 AYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  108 bits (270), Expect = 2e-25
 Identities = 35/260 (13%), Positives = 76/260 (29%), Gaps = 58/260 (22%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVK--------------------------RGV--PGSR 498
           ++G        +           V                           RG+      
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 499 QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM-EKGPLKKHL-----YGPD 552
           +    F     ++   + + ++ +     +   +   + Y   +  L+        +   
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 553 RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG 612
              L    RL++ +   R L  LH     G++H  ++  +I+LD+     +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 613 PCLDETHVSTGVKGSFGYLDPEYF-----------RRQQLTDKSDVYSFGVVLFEVLCAR 661
                         S G+  PE             RR  +T   D ++ G+V++ + CA 
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 662 TAVDPLLAREQVNLAEWAMQ 681
               P+     +  +EW  +
Sbjct: 311 L---PITKDAALGGSEWIFR 327

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  107 bits (268), Expect = 2e-25
 Identities = 55/272 (20%), Positives = 96/272 (35%), Gaps = 56/272 (20%)

Query: 438 NASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVK----- 491
           + S G+   +       +L      +     IG G +G+V   +        A+K     
Sbjct: 6   HHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62

Query: 492 RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPL------K 545
           +    + + +   +TE+ ++ K+ H ++  L    E++  + LV E    G L       
Sbjct: 63  KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122

Query: 546 KHLYGPDRTPLSWKQRLEICIG-------------------------AAR-------GLH 573
                        K ++  C                            +         LH
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182

Query: 574 YLHTGSAEGIIHRDIKSTNILL--DENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFG 629
           YLH    +GI HRDIK  N L   ++++  K+ DFGLS+        E +  T   G+  
Sbjct: 183 YLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239

Query: 630 YLDPEYFR--RQQLTDKSDVYSFGVVLFEVLC 659
           ++ PE      +    K D +S GV+L  +L 
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  106 bits (266), Expect = 3e-25
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR-GVPGSRQGLPEFQTEITVLSKIRHRH 518
           ++++   +IGSG   +V          KVA+KR  +   +  + E   EI  +S+  H +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE------ICIGAARGL 572
           +VS       + E+ LV + +  G +   +             L+      I      GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST--GVKGSF-G 629
            YLH     G IHRD+K+ NILL E+   ++ADFG+S     L      T   V+ +F G
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA---FLATGGDITRNKVRKTFVG 188

Query: 630 ---YLDPEYFRRQQLTD-KSDVYSFGVVLFE 656
              ++ PE   + +  D K+D++SFG+   E
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  104 bits (262), Expect = 5e-25
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 20/201 (9%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V+    R    +  +K           +   + + EI VL  + H +++ + 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME---QIEAEIEVLKSLDHPNIIKIF 86

Query: 524 GYCEEQSEMILVYEYMEKGPL--KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
              E+   M +V E  E G L  +          LS     E+       L Y H   ++
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQ 143

Query: 582 GIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
            ++H+D+K  NIL      +   K+ DFGL+           ST   G+  Y+ PE F+R
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEVFKR 200

Query: 639 QQLTDKSDVYSFGVVLFEVLC 659
             +T K D++S GVV++ +L 
Sbjct: 201 -DVTFKCDIWSAGVVMYFLLT 220

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  105 bits (263), Expect = 6e-25
 Identities = 62/236 (26%), Positives = 96/236 (40%), Gaps = 62/236 (26%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK---------------RGVPGSRQGLPEFQT------ 506
           IG G +G+V       DNT  A+K               R  P   +  P          
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 507 -----EITVLSKIRHRHLVSL--VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWK 559
                EI +L K+ H ++V L  V     +  + +V+E + +GP+   +  P   PLS  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSED 137

Query: 560 QRLEICIGAAR--------GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS-- 609
           Q        AR        G+ YLH    + IIHRDIK +N+L+ E+   K+ADFG+S  
Sbjct: 138 Q--------ARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 610 -RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT---DKSDVYSFGVVLFEVLCAR 661
            +    L    V     G+  ++ PE     +        DV++ GV L+  +  +
Sbjct: 187 FKGSDALLSNTV-----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  103 bits (259), Expect = 1e-24
 Identities = 44/203 (21%), Positives = 79/203 (38%), Gaps = 27/203 (13%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGY 525
            IG G +G V   V +    + A K+ +P    + +  F+ EI ++  + H +++ L   
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKK-IPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 526 CEEQSEMILVYEYMEKGPL------KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
            E+ +++ LV E    G L      K+                 I       + Y H   
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVHKRV--------FRESDAARIMKDVLSAVAYCH--- 123

Query: 580 AEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
              + HRD+K  N L      +   K+ DFGL+          +     G+  Y+ P+  
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL 180

Query: 637 RRQQLTDKSDVYSFGVVLFEVLC 659
                  + D +S GV+++ +LC
Sbjct: 181 EG-LYGPECDEWSAGVMMYVLLC 202

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  103 bits (259), Expect = 3e-24
 Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 17/231 (7%)

Query: 435 GTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR- 492
           G+  +S  Q GY  L I     Q   N+ +    +GSG  G V+K    +    +AVK+ 
Sbjct: 1   GSSGSSGKQTGY--LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM 58

Query: 493 GVPGSRQGLPEFQTEITVLSK-IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGP 551
              G+++       ++ V+ K     ++V   G     +++ +  E M     K      
Sbjct: 59  RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ 118

Query: 552 DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
              P     +  + +   + L+YL      G+IHRD+K +NILLDE    K+ DFG+S  
Sbjct: 119 GPIPERILGK--MTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISG- 173

Query: 612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD-----KSDVYSFGVVLFEV 657
              L +        G   Y+ PE       T      ++DV+S G+ L E+
Sbjct: 174 --RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  103 bits (259), Expect = 3e-24
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 35/209 (16%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVK-----RGVPGSRQGLPEFQTEITVLSKIRHR-HLVS 521
           +G G F +V + + +    + A K     R     R    E   EI VL   +    +++
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA---EILHEIAVLELAKSCPRVIN 93

Query: 522 LVGYCEEQSEMILVYEYMEKGPL--------KKHLYGPDRTPLSWKQRLEICIGAARGLH 573
           L    E  SE+IL+ EY   G +         + +   D   L  KQ LE       G++
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-IKQILE-------GVY 145

Query: 574 YLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
           YLH      I+H D+K  NILL         K+ DFG+SR    +        + G+  Y
Sbjct: 146 YLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEY 199

Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           L PE      +T  +D+++ G++ + +L 
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLT 228

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  104 bits (261), Expect = 3e-24
 Identities = 40/213 (18%), Positives = 74/213 (34%), Gaps = 23/213 (10%)

Query: 460 TNNFDKNLIIGSG--GFGMVYKGV-LRDNTKVAVKRGVP---GSRQGLPEFQTEITVLSK 513
              ++   +IG G      V           V V+R +     S + +   Q E+ V   
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRR-INLEACSNEMVTFLQGELHVSKL 82

Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
             H ++V         +E+ +V  +M  G  K  +       ++      I  G  + L 
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLD- 632
           Y+H     G +HR +K+++IL+  +    ++    +     +        V   F     
Sbjct: 143 YIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNL---SMISHGQRQRVVHDFPKYSV 196

Query: 633 -------PEYFRRQQL--TDKSDVYSFGVVLFE 656
                  PE  ++       KSD+YS G+   E
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  102 bits (255), Expect = 8e-24
 Identities = 59/263 (22%), Positives = 104/263 (39%), Gaps = 57/263 (21%)

Query: 427 SSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDN 485
              S +     + +P  + +     P  + +   + +    ++GSGGFG VY G+ + DN
Sbjct: 9   HHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDN 68

Query: 486 TKVAVKR------GVPGSRQGLPEFQTEITVLSKIRHR--HLVSLVGYCEEQSEMILVYE 537
             VA+K          G          E+ +L K+      ++ L+ + E     +L+ E
Sbjct: 69  LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128

Query: 538 Y-----------MEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR--------GLHYLHTG 578
                        E+G L++ L                    AR         + + H  
Sbjct: 129 RPEPVQDLFDFITERGALQEEL--------------------ARSFFWQVLEAVRHCH-- 166

Query: 579 SAEGIIHRDIKSTNILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
              G++HRDIK  NIL+D N    K+ DFG       L +T  +    G+  Y  PE+ R
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVYTDFD-GTRVYSPPEWIR 221

Query: 638 RQQLT-DKSDVYSFGVVLFEVLC 659
             +     + V+S G++L++++C
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVC 244

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  101 bits (254), Expect = 1e-23
 Identities = 40/174 (22%), Positives = 70/174 (40%), Gaps = 14/174 (8%)

Query: 497 SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHL-YGPDRTP 555
           S   +     +I  +     ++ V  +     +  + +  +   K  LK  +        
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 556 LSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS---- 611
                 L I I  A  + +LH   ++G++HRD+K +NI    + V KV DFGL  +    
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217

Query: 612 ------GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
                    +      TG  G+  Y+ PE       + K D++S G++LFE+L 
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  102 bits (255), Expect = 1e-23
 Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 25/234 (10%)

Query: 433 SEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK 491
           S G +  SP Q+                 +      IG G +G V K V       +AVK
Sbjct: 5   SSGKLKISPEQH-----------WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVK 53

Query: 492 R-GVPGSRQGLPEFQTEITV-LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLK--KH 547
           R       +   +   ++ V +      ++V   G    + +  +  E M     K  K+
Sbjct: 54  RIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKY 113

Query: 548 LYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG 607
           +Y      +  +   +I +   + L++L       IIHRDIK +NILLD +   K+ DFG
Sbjct: 114 VYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171

Query: 608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD----KSDVYSFGVVLFEV 657
           +S     L ++   T   G   Y+ PE             +SDV+S G+ L+E+
Sbjct: 172 ISG---QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  102 bits (255), Expect = 1e-23
 Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 39/212 (18%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK--------RGVPGSRQGLPEFQTEITVLSKIRHRHL 519
           +GSG FG V+  V    N +V VK                 L +   EI +LS++ H ++
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR--------G 571
           + ++   E Q    LV E    G     L+      +    RL+     A          
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG---LDLF--AF--IDRHPRLDE--PLASYIFRQLVSA 142

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS---RSGPCLDETHVSTGVKGSF 628
           + YL     + IIHRDIK  NI++ E++  K+ DFG +     G     T       G+ 
Sbjct: 143 VGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY-TFC-----GTI 193

Query: 629 GYLDPEYFRRQQLT-DKSDVYSFGVVLFEVLC 659
            Y  PE          + +++S GV L+ ++ 
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =   99 bits (250), Expect = 2e-23
 Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           +G G FG V  G       KVAVK   R    S   + + + EI  L   RH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR--------GLHYLH 576
                ++  +V EY+  G L  ++            R+E     AR         + Y H
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI--------CKHGRVEE--MEARRLFQQILSAVDYCH 128

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLS---RSGPCLDETHVSTGVKGSFGYLDP 633
                 ++HRD+K  N+LLD +  +K+ADFGLS     G  L  +       GS  Y  P
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC------GSPNYAAP 179

Query: 634 EYFRRQQLT-DKSDVYSFGVVLFEVLC 659
           E    +     + D++S GV+L+ +LC
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLC 206

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 30/205 (14%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G +G V   V       VAVK    +      + +   + EI +   + H ++V   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI---KKEICINKMLNHENVVKFY 71

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR--------GLHYL 575
           G+  E +   L  EY   G L   +             +      A+        G+ YL
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI--------EPDIGMPE--PDAQRFFHQLMAGVVYL 121

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+  Y+ PE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 636 FRRQQLT-DKSDVYSFGVVLFEVLC 659
            +R++   +  DV+S G+VL  +L 
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA 203

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 99.3 bits (248), Expect = 8e-23
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 30/204 (14%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSR---QGLPEFQTEITVLSKIRHRHLVSLVG 524
           IG G F  V     +    +VA+K  +  ++     L +   E+ ++  + H ++V L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKI-IDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR--------GLHYLH 576
             E +  + L+ EY   G +  +L    R  +  K+        AR         + Y H
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKE--------ARSKFRQIVSAVQYCH 131

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
               + I+HRD+K+ N+LLD +   K+ADFG S          +     G+  Y  PE F
Sbjct: 132 ---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAPPYAAPELF 185

Query: 637 RRQQLT-DKSDVYSFGVVLFEVLC 659
           + ++    + DV+S GV+L+ ++ 
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVS 209

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (255), Expect = 9e-23
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 23/213 (10%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV-AVK---RGVPGSRQGLPEFQTEITVLSKIRH 516
           + F    ++G GGFG V+   ++   K+ A K   +     R+G      E  +L+K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 517 RHLVSLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL------EICIGAA 569
           R +VSL  Y  E ++++ LV   M  G ++ H+Y  D     +++        +I  G  
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             L +LH      II+RD+K  N+LLD++  V +++D GL+       +T       G+ 
Sbjct: 302 --LEHLH---QRNIIYRDLKPENVLLDDDGNV-RISDLGLAVELK-AGQTKTKGYA-GTP 353

Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           G++ PE    ++     D ++ GV L+E++ AR
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 98.9 bits (247), Expect = 9e-23
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 30/205 (14%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK----RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +G G +G V   V       VAVK    +      + +   + EI +   + H ++V   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI---KKEICINKMLNHENVVKFY 71

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR--------GLHYL 575
           G+  E +   L  EY   G L   +             +      A+        G+ YL
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI--------EPDIGMPE--PDAQRFFHQLMAGVVYL 121

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+  Y+ PE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 636 FRRQQLT-DKSDVYSFGVVLFEVLC 659
            +R++   +  DV+S G+VL  +L 
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA 203

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 15/197 (7%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGY 525
            +G G F +  K V +  N   AVK     S++     Q EIT L     H ++V L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
             +Q    LV E +  G L + +    +   S  +   I       + ++H     G++H
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIK--KKKHFSETEASYIMRKLVSAVSHMHD---VGVVH 129

Query: 586 RDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           RD+K  N+L    ++N   K+ DFG +R  P   +         +  Y  PE   +    
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKTPCFTLHYAAPELLNQNGYD 187

Query: 643 DKSDVYSFGVVLFEVLC 659
           +  D++S GV+L+ +L 
Sbjct: 188 ESCDLWSLGVILYTMLS 204

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)

Query: 432 MSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           M    +   P   G         D +     +    ++G GGFG V+ G  L D  +VA+
Sbjct: 2   MLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAI 61

Query: 491 KR------GVPGSRQGLPEFQTEITVLSKIR----HRHLVSLVGYCEEQSEMILVYEYME 540
           K                     E+ +L K+     H  ++ L+ + E Q   +LV E   
Sbjct: 62  KVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPL 121

Query: 541 KGPLKKHLYGPDRTPLSWKQRL-EICIGAAR--------GLHYLHTGSAEGIIHRDIKST 591
                + L+  D   ++ K  L E   G +R         + + H+    G++HRDIK  
Sbjct: 122 PA---QDLF--DY--ITEKGPLGE---GPSRCFFGQVVAAIQHCHS---RGVVHRDIKDE 168

Query: 592 NILLDENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT-DKSDVYS 649
           NIL+D      K+ DFG       L +   +    G+  Y  PE+  R Q     + V+S
Sbjct: 169 NILIDLRRGCAKLIDFGSGAL---LHDEPYTDFD-GTRVYSPPEWISRHQYHALPATVWS 224

Query: 650 FGVVLFEVLC 659
            G++L++++C
Sbjct: 225 LGILLYDMVC 234

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 41/167 (24%), Positives = 80/167 (47%), Gaps = 24/167 (14%)

Query: 458 TATNNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKR-------GVPGS--RQGLPEFQTE 507
           ++++ F +   +G+G +  VYKG+ +     VA+K        G P +  R        E
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR--------E 53

Query: 508 ITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME---KGPLKKHLYGPDRTPLSWKQRLEI 564
           I+++ +++H ++V L      ++++ LV+E+M+   K  +     G     L        
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
                +GL + H      I+HRD+K  N+L+++    K+ DFGL+R+
Sbjct: 114 QWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA 157

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 44/212 (20%), Positives = 88/212 (41%), Gaps = 17/212 (8%)

Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKR-GVPGSRQGLPEFQTEITV-LS 512
           ++   ++ +  + +G G +G+V K         +AVKR     + Q       ++ + + 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 513 KIRHRHLVSLVGYCEEQSEMILVYEYMEKGP---LKKHLYGPDRTPLSWKQRLEICIGAA 569
            +     V+  G    + ++ +  E M+       K+ +      P     +  I +   
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK--IAVSIV 119

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
           + L +LH  S   +IHRD+K +N+L++     K+ DFG+S     L +        G   
Sbjct: 120 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCKP 174

Query: 630 YLDPEYFRRQQLTD----KSDVYSFGVVLFEV 657
           Y+ PE    +        KSD++S G+ + E+
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 99.9 bits (249), Expect = 3e-22
 Identities = 62/207 (29%), Positives = 91/207 (43%), Gaps = 35/207 (16%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           +G G FG V  G       KVAVK   R    S   + + + EI  L   RH H++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR--------GLHYLH 576
                S++ +V EY+  G L  ++            RL+     +R        G+ Y H
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYI--------CKNGRLDE--KESRRLFQQILSGVDYCH 133

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLS---RSGPCLDETHVSTGVKGSFGYLDP 633
                 ++HRD+K  N+LLD +  +K+ADFGLS     G  L  T       GS  Y  P
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-RTSC-----GSPNYAAP 184

Query: 634 EYFRRQQLT-DKSDVYSFGVVLFEVLC 659
           E    +     + D++S GV+L+ +LC
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLC 211

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.9 bits (242), Expect = 4e-22
 Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 23/165 (13%)

Query: 457 QTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKR--------GVPGS--RQGLPEFQT 506
           Q     + K   +G G +G+VYK        VA+KR        G+P +  R        
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-------- 68

Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           EI++L ++ H ++VSL+     +  + LV+E+MEK  LKK L    +T L   Q      
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDEN-KTGLQDSQIKIYLY 126

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
              RG+ + H      I+HRD+K  N+L++ +   K+ADFGL+R+
Sbjct: 127 QLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARA 168

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  100 bits (250), Expect = 4e-22
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 22/211 (10%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV-AVK---RGVPGSRQGLPEFQTEITVLSKIRH 516
           N F +  ++G GGFG V    +R   K+ A K   +     R+G      E  +L K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 517 RHLVSLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL----EICIGAARG 571
           R +VSL  Y  E +  + LV   M  G LK H+Y   +      + +    EIC G    
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG---- 298

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
           L  LH    E I++RD+K  NILLD++ ++ +++D GL+   P         G  G+ GY
Sbjct: 299 LEDLHR---ERIVYRDLKPENILLDDHGHI-RISDLGLAVHVPEGQTIK---GRVGTVGY 351

Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR 661
           + PE  + ++ T   D ++ G +L+E++  +
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 96.1 bits (240), Expect = 5e-22
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 23/162 (14%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR--------GVPGS--RQGLPEFQTEIT 509
            NF K   IG G +G+VYK         VA+K+        GVP +  R        EI+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR--------EIS 54

Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
           +L ++ H ++V L+     ++++ LV+E++ +  LKK +     T +             
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLL 113

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           +GL + H   +  ++HRD+K  N+L++     K+ADFGL+R+
Sbjct: 114 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA 152

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 94.9 bits (237), Expect = 1e-21
 Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 27/163 (16%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTK--VAVKR--------GVPGS--RQGLPEFQTEI 508
             +     IG G +G+VYK   ++N     A+K+        G+P +  R        EI
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA--QNNYGETFALKKIRLEKEDEGIPSTTIR--------EI 51

Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
           ++L +++H ++V L      +  ++LV+E++++  LKK L       L         +  
Sbjct: 52  SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVC-EGGLESVTAKSFLLQL 109

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
             G+ Y H      ++HRD+K  N+L++     K+ADFGL+R+
Sbjct: 110 LNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARA 149

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 94.9 bits (237), Expect = 2e-21
 Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 39/182 (21%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKR--------GVPGS--RQGLPEFQTEIT 509
             ++K   IG G +G+V+K   RD    VA+K+         +     R        EI 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR--------EIR 54

Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL------E 563
           +L +++H +LV+L+     +  + LV+EY +   +   L   DR      + L      +
Sbjct: 55  MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHEL---DRYQRGVPEHLVKSITWQ 110

Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETH-V 620
                 + +++ H       IHRD+K  NIL+ ++ V K+ DFG +R  +GP       V
Sbjct: 111 TL----QAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163

Query: 621 ST 622
           +T
Sbjct: 164 AT 165

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 47/198 (23%), Positives = 94/198 (47%), Gaps = 17/198 (8%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSK-IRHRHLVSLVGY 525
            IG G + +  + + +  N + AVK  +  S++   +   EI +L +  +H ++++L   
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVKI-IDKSKR---DPTEEIEILLRYGQHPNIITLKDV 84

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
            ++   + +V E M+ G L   +    +   S ++   +     + + YLH   A+G++H
Sbjct: 85  YDDGKYVYVVTELMKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLH---AQGVVH 139

Query: 586 RDIKSTNILL---DENYVS-KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
           RD+K +NIL      N  S ++ DFG ++      E  +      +  ++ PE   RQ  
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLLMTPCYTANFVAPEVLERQGY 197

Query: 642 TDKSDVYSFGVVLFEVLC 659
               D++S GV+L+ +L 
Sbjct: 198 DAACDIWSLGVLLYTMLT 215

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 95.3 bits (238), Expect = 3e-21
 Identities = 50/165 (30%), Positives = 85/165 (51%), Gaps = 15/165 (9%)

Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR----GVPGSRQGLPEFQT--- 506
           D+++    ++K   +G G F  VYK      N  VA+K+        ++ G+   +T   
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALR 61

Query: 507 EITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
           EI +L ++ H +++ L+     +S + LV+++ME   L+  +       L+        +
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDN-SLVLTPSHIKAYML 119

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
              +GL YLH      I+HRD+K  N+LLDEN V K+ADFGL++S
Sbjct: 120 MTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 95.9 bits (239), Expect = 3e-21
 Identities = 62/254 (24%), Positives = 110/254 (43%), Gaps = 38/254 (14%)

Query: 425 GCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTA---TNNFDKNLIIGSGGFGMVYKGV 481
           G  + S      V  +P  +    +K+  +D +T       +    +IG+G FG+V++  
Sbjct: 1   GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60

Query: 482 LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL------VGYCEEQSEMILV 535
           L ++ +VA+K+ +   R        E+ ++  ++H ++V L       G  +++  + LV
Sbjct: 61  LVESDEVAIKKVLQDKRFKN----RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116

Query: 536 YEYMEKGPLKKHL--YGPDRTPLSWK-------QRLEICIGAARGLHYLHTGSAEGIIHR 586
            EY+ +  + +    Y   +  +          Q L       R L Y+H+    GI HR
Sbjct: 117 LEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL-------RSLAYIHS---IGICHR 165

Query: 587 DIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE-YFRRQQLTDK 644
           DIK  N+LLD    V K+ DFG ++    L     +     S  Y  PE  F     T  
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKI---LIAGEPNVSYICSRYYRAPELIFGATNYTTN 222

Query: 645 SDVYSFGVVLFEVL 658
            D++S G V+ E++
Sbjct: 223 IDIWSTGCVMAELM 236

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 94.7 bits (236), Expect = 4e-21
 Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 36/209 (17%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           +G G FG V      +   KVA+K   R +          + EI+ L  +RH H++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR--------GLHYLH 576
                +++++V EY   G L  ++          K+R+       R         + Y H
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYI--------VEKKRMTE--DEGRRFFQQIICAIEYCH 125

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLS---RSGPCLDETHVSTGVKGSFGYLDP 633
                 I+HRD+K  N+LLD+N   K+ADFGLS     G  L  +       GS  Y  P
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC------GSPNYAAP 176

Query: 634 EYFRRQQLT-DKSDVYSFGVVLFEVLCAR 661
           E    +     + DV+S G+VL+ +L  R
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 94.8 bits (236), Expect = 5e-21
 Identities = 60/295 (20%), Positives = 117/295 (39%), Gaps = 56/295 (18%)

Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSR 498
           S   N ++ ++I  +        +     IGSG  G+V           VA+K+      
Sbjct: 5   SKRDNNFYSVEIGDSTFTV-LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK------ 57

Query: 499 QGLPE-FQT---------EITVLSKIRHRHLVSLV------GYCEEQSEMILVYEYMEKG 542
             L   FQ          E+ ++  + H++++ L+         EE  ++ +V E M+  
Sbjct: 58  --LSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA- 114

Query: 543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSK 602
               +L    +  L  ++   +      G+ +LH+    GIIHRD+K +NI++  +   K
Sbjct: 115 ----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 167

Query: 603 VADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
           + DFGL+R+      + + T    +  Y  PE        +  D++S G ++ E++    
Sbjct: 168 ILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG- 223

Query: 663 AVDPLL-AREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCL 716
               L    + ++      QW K      +I+   +G    + +KK   T    +
Sbjct: 224 ---VLFPGTDHID------QWNK------VIE--QLGTPCPEFMKKLQPTVRTYV 261

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.8 bits (234), Expect = 5e-21
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 39/182 (21%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKR--------GVPGS--RQGLPEFQTEIT 509
             ++   ++G G +GMV K   +D    VA+K+         V     R        EI 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR--------EIK 76

Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL------E 563
           +L ++RH +LV+L+  C+++    LV+E+++   +   L   +  P     ++      +
Sbjct: 77  LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDL---ELFPNGLDYQVVQKYLFQ 132

Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETH-V 620
           I      G+ + H   +  IIHRDIK  NIL+ ++ V K+ DFG +R  + P       V
Sbjct: 133 II----NGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV 185

Query: 621 ST 622
           +T
Sbjct: 186 AT 187

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 93.5 bits (233), Expect = 7e-21
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 32/201 (15%)

Query: 427 SSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDN 485
           + H     GT+ A     G   + +      T+ + + +   +G G +G VYK +    N
Sbjct: 2   AHHHHHHMGTLEAQTQGPG--SMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTN 59

Query: 486 TKVAVKR--------GVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV 535
             VA+KR        GVPG+  R        E+++L +++HR+++ L         + L+
Sbjct: 60  ETVAIKRIRLEHEEEGVPGTAIR--------EVSLLKELQHRNIIELKSVIHHNHRLHLI 111

Query: 536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL 595
           +EY E   LKK++       +S +           G+++ H+      +HRD+K  N+LL
Sbjct: 112 FEYAEND-LKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLL 165

Query: 596 DENYVS-----KVADFGLSRS 611
             +  S     K+ DFGL+R+
Sbjct: 166 SVSDASETPVLKIGDFGLARA 186

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 96.5 bits (240), Expect = 8e-21
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 23/213 (10%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV-AVK---RGVPGSRQGLPEFQTEITVLSKI-- 514
           N+F  + IIG GGFG VY     D  K+ A+K   +     +QG      E  +LS +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 515 -RHRHLVSLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ--RLEICIGAAR 570
                +V +  Y      ++  + + M  G L  HL        +  +    EI +G   
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG--- 304

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
            L ++H      +++RD+K  NILLDE+   +++D GL+       + H      G+ GY
Sbjct: 305 -LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH---ASVGTHGY 356

Query: 631 LDPEYFRRQQLTDKS-DVYSFGVVLFEVLCART 662
           + PE  ++    D S D +S G +LF++L   +
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 94.0 bits (234), Expect = 9e-21
 Identities = 57/208 (27%), Positives = 83/208 (39%), Gaps = 35/208 (16%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
           IGSG FG+            VAVK   RG           Q EI     +RH ++V    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFKE 83

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR--------GLHYLH 576
                + + ++ EY   G L + +            R       AR        G+ Y H
Sbjct: 84  VILTPTHLAIIMEYASGGELYERI--------CNAGRFSE--DEARFFFQQLLSGVSYCH 133

Query: 577 TGSAEGIIHRDIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
              +  I HRD+K  N LLD +     K+ DFG S+S   +  +   + V G+  Y+ PE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTV-GTPAYIAPE 187

Query: 635 YFRRQQLT-DKSDVYSFGVVLFEVLCAR 661
              RQ+     +DV+S GV L+ +L   
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 22/208 (10%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPE-FQTEITVLSKIR-HRHLVSLVG 524
           ++G G    V   +    + + AVK  +      +      E+ +L + + HR+++ L+ 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKI-IEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
           + EE+    LV+E M  G +  H++   R   +  +   +    A  L +LH    +GI 
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASVVVQDVASALDFLHN---KGIA 133

Query: 585 HRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVK-----GSFGYLDPEYF 636
           HRD+K  NIL    ++    K+ DF L        +    +  +     GS  Y+ PE  
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193

Query: 637 RRQQLTDKS-----DVYSFGVVLFEVLC 659
                         D++S GV+L+ +L 
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLS 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 94.5 bits (235), Expect = 1e-20
 Identities = 69/341 (20%), Positives = 137/341 (40%), Gaps = 62/341 (18%)

Query: 395 LAVLVLFKCRKKKPKPRPADSVGWTP-LRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPF 453
           +++  L+ C +     + A   G+   +     + H  MS      S   N ++ +++  
Sbjct: 1   MSLHFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMS-----KSKVDNQFYSVEVGD 55

Query: 454 TDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE-FQT----- 506
           +        +     IGSG  G+V        +  VA+K+        L   FQ      
Sbjct: 56  STFTV-LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK--------LSRPFQNQTHAK 106

Query: 507 ----EITVLSKIRHRHLVSLV------GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPL 556
               E+ ++  + H++++SL+         EE  ++ LV E M+      +L    +  L
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-----NLCQVIQMEL 161

Query: 557 SWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD 616
             ++   +      G+ +LH+    GIIHRD+K +NI++  +   K+ DFGL+R+     
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART---AG 215

Query: 617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLL-AREQVNL 675
            + + T    +  Y  PE        +  D++S G ++ E++  +     L   R+ ++ 
Sbjct: 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYID- 270

Query: 676 AEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCL 716
                QW K      +I+   +G    + +KK   T    +
Sbjct: 271 -----QWNK------VIE--QLGTPCPEFMKKLQPTVRNYV 298

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.8 bits (229), Expect = 1e-20
 Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 24/162 (14%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR--------GVPGS--RQGLPEFQTEIT 509
             ++K   IG G +G V+K      +  VA+KR        GVP S  R        EI 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR--------EIC 53

Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
           +L +++H+++V L        ++ LV+E+ ++  LKK+        L  +          
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSC-NGDLDPEIVKSFLFQLL 111

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           +GL + H   +  ++HRD+K  N+L++ N   K+A+FGL+R+
Sbjct: 112 KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARA 150

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 32/169 (18%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR--------GVP--GSRQGLPEFQTEIT 509
           + ++K   IG G FG V+K    +   KVA+K+        G P    R        EI 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR--------EIK 68

Query: 510 VLSKIRHRHLVSLVGYCEEQSEMI--------LVYEYMEKGPLKKHLYGPDRTPLSWKQR 561
           +L  ++H ++V+L+  C  ++           LV+++ E   L   L        +  + 
Sbjct: 69  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVL-VKFTLSEI 126

Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR 610
             +      GL+Y+H      I+HRD+K+ N+L+  + V K+ADFGL+R
Sbjct: 127 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 172

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 44/201 (21%), Positives = 84/201 (41%), Gaps = 21/201 (10%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGY 525
           ++G G  G V +   R    K A+K          P+ + E+    +     H+V ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALK-----LLYDSPKARQEVDHHWQASGGPHIVCILDV 90

Query: 526 CEEQSEMI----LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
            E          ++ E ME G L   +        + ++  EI       + +LH   + 
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SH 147

Query: 582 GIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
            I HRD+K  N+L    +++ V K+ DFG ++      +  + T    +  Y+ PE    
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPC-YTPYYVAPEVLGP 203

Query: 639 QQLTDKSDVYSFGVVLFEVLC 659
           ++     D++S GV+++ +LC
Sbjct: 204 EKYDKSCDMWSLGVIMYILLC 224

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 23/161 (14%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTK-VAVKR-------GVPGS--RQGLPEFQTEITV 510
             + K   +G G +  VYKG  +     VA+K        G P +  R        E+++
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR--------EVSL 53

Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR 570
           L  ++H ++V+L      +  + LV+EY++K  LK++L       ++            R
Sbjct: 54  LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDC-GNIINMHNVKLFLFQLLR 111

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           GL Y H    + ++HRD+K  N+L++E    K+ADFGL+R+
Sbjct: 112 GLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARA 149

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 93.2 bits (232), Expect = 3e-20
 Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 44/195 (22%)

Query: 435 GTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRG 493
            TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D    VA+K+ 
Sbjct: 38  TTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKV 87

Query: 494 VPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI------LVYEYMEKGPLKKH 547
           +   R        E+ ++ K+ H ++V L  +     E        LV +Y+ +  + + 
Sbjct: 88  LQDKRFKN----RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRV 142

Query: 548 LYGPDRTPLSWKQRLE----------ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE 597
                R     KQ L           +     R L Y+H+    GI HRDIK  N+LLD 
Sbjct: 143 A----RHYSRAKQTLPVIYVKLYMYQLF----RSLAYIHSF---GICHRDIKPQNLLLDP 191

Query: 598 N-YVSKVADFGLSRS 611
           +  V K+ DFG ++ 
Sbjct: 192 DTAVLKLCDFGSAKQ 206

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 50/219 (22%), Positives = 84/219 (38%), Gaps = 34/219 (15%)

Query: 460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH 518
            + F    + G G FG V  G  +     VA+K+ +   R    E Q  +  L+ + H +
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80

Query: 519 LVSL--VGYCEEQSEM-----ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLE-------- 563
           +V L    Y   + +       +V EY+    L +      R     +            
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC----RNYYRRQVAPPPILIKVFL 135

Query: 564 --ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHV 620
             +     R +  LH  S   + HRDIK  N+L++  +   K+ DFG ++    L  +  
Sbjct: 136 FQLI----RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKK---LSPSEP 187

Query: 621 STGVKGSFGYLDPEY-FRRQQLTDKSDVYSFGVVLFEVL 658
           +     S  Y  PE  F  Q  T   D++S G +  E++
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 91.0 bits (226), Expect = 1e-19
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 36/169 (21%)

Query: 465 KNLIIGSGGFGMVYKGVLRDNT---KVAVKR----GVPGSRQGLPEFQTEITVLSKIRHR 517
           +   +G G +G VYK   +D       A+K+    G+  S         EI +L +++H 
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHP 78

Query: 518 HLVSLVGYCEEQSEMI--LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA------ 569
           +++SL       ++    L+++Y E   L   +        S   +  + +         
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEHD-LWHII---KFHRASKANKKPVQLPRGMVKSLL 134

Query: 570 ----RGLHYLHTGSAEGIIHRDIKSTNILLDENYVS----KVADFGLSR 610
                G+HYLH   A  ++HRD+K  NIL+          K+AD G +R
Sbjct: 135 YQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 24/199 (12%), Positives = 53/199 (26%), Gaps = 44/199 (22%)

Query: 469 IGSGGFGMVYKGVLRDNT---KVAVK---RGVPGSRQGLPEFQTEITVLSKIRHRHLVSL 522
            G       ++    D     +VA+             L E  +    LS+I    +  +
Sbjct: 39  HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
           +     ++  ++V E++  G L++       T  S    +      A      H     G
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           +       + + +  +    +A                          +           
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA-------N 180

Query: 643 DKSDVYSFGVVLFEVLCAR 661
            + D+   G  L+ +L  R
Sbjct: 181 PQDDIRGIGASLYALLVNR 199

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 90.4 bits (225), Expect = 1e-19
 Identities = 52/225 (23%), Positives = 84/225 (37%), Gaps = 51/225 (22%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKR--GVPGSRQGLPEFQT---------EITVLSKIRH 516
            I SG +G V  GV  +   VA+KR        + +              EI +L+   H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 517 RHLVSLV-----GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWK-------QRLEI 564
            +++ L             ++ LV E M    L + ++   R  +S +         L  
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQ-RIVISPQHIQYFMYHIL-- 144

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
                 GLH LH   A G++HRD+   NILL +N    + DF L+R           T  
Sbjct: 145 -----LGLHVLH--EA-GVVHRDLHPGNILLADNNDITICDFNLARE---DTADANKT-- 191

Query: 625 KGSFGYLDPEYFR-------RQQLTDKSDVYSFGVVLFEVLCART 662
                Y+   ++R        +  T   D++S G V+ E+   + 
Sbjct: 192 ----HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 91.0 bits (226), Expect = 2e-19
 Identities = 51/249 (20%), Positives = 96/249 (38%), Gaps = 48/249 (19%)

Query: 422 RAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV 481
                 S S+                 +  P +D Q   + ++   +IG+G +G V +  
Sbjct: 15  GTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI-PDRYEIRHLIGTGSYGHVCEAY 73

Query: 482 -LRDNTKVAVKRGVPGSRQGLPEFQT---------EITVLSKIRHRHLVSLV-----GYC 526
              +   VA+K+ +         F+          EI +L+++ H H+V ++        
Sbjct: 74  DKLEKRVVAIKK-ILR------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWK-------QRLEICIGAARGLHYLHTGS 579
           E+  E+ +V E  +    KK    P    L+           L        G+ Y+H+  
Sbjct: 127 EKFDELYVVLEIADSD-FKKLFRTPV--YLTELHIKTLLYNLL-------VGVKYVHSA- 175

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF--- 636
             GI+HRD+K  N L++++   KV DFGL+R+    +  +    +      ++   F   
Sbjct: 176 --GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233

Query: 637 --RRQQLTD 643
              ++QLT 
Sbjct: 234 KNLKRQLTG 242

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 89.4 bits (222), Expect = 4e-19
 Identities = 50/268 (18%), Positives = 98/268 (36%), Gaps = 28/268 (10%)

Query: 405 KKKPKPRPADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFD 464
           + +  P P  +    P       + +          P    + +  +            D
Sbjct: 6   QGQSPPVPFPAPAPPP----QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61

Query: 465 K----NLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRH 518
                + ++G G  G V +   +    K A+K       Q  P+ + E+ +  +  +  H
Sbjct: 62  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPH 116

Query: 519 LVSLVGYCEEQSEMI----LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
           +V +V   E          +V E ++ G L   +        + ++  EI       + Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 575 LHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           LH+     I HRD+K  N+L      N + K+ DFG ++        +  T    +  Y+
Sbjct: 177 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCYTPYYV 230

Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE    ++     D++S GV+++ +LC
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLC 258

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.4 bits (222), Expect = 4e-19
 Identities = 54/225 (24%), Positives = 81/225 (36%), Gaps = 40/225 (17%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV-AVK---RGVPGSRQGLPEFQTEITVLSKIRH 516
           ++F+   +IG G F  V    ++   +V A+K   +     R  +  F+ E  VL     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 517 RHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR---- 570
           R +  L  +   Q E  + LV EY   G L   L            +    I A      
Sbjct: 121 RWITQL--HFAFQDENYLYLVMEYYVGGDLLTLL-----------SKFGERIPAEMARFY 167

Query: 571 ------GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV 624
                  +  +H     G +HRDIK  NILLD     ++ADFG                V
Sbjct: 168 LAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224

Query: 625 KGSFGYLDPEYFRRQQLTDKSDVY-------SFGVVLFEVLCART 662
            G+  YL PE  +       +  Y       + GV  +E+   +T
Sbjct: 225 -GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 87.7 bits (217), Expect = 9e-19
 Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 3/143 (2%)

Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
             R L S+       S   +  + +     ++      +  L+ +  +      A+G+ +
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
           L   ++   IHRD+ + NILL E  V K+ DFGL+R      +       +    ++ PE
Sbjct: 209 L---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265

Query: 635 YFRRQQLTDKSDVYSFGVVLFEV 657
               +  T +SDV+SFGV+L+E+
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEI 288

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.5 bits (162), Expect = 9e-12
 Identities = 33/159 (20%), Positives = 61/159 (38%), Gaps = 18/159 (11%)

Query: 468 IIGSGGFGMVYKGVL------RDNTKVAVKRGVPGSRQG-LPEFQTEITVLSKI-RHRHL 519
            +G G FG V +              VAVK    G+         +E+ +L  I  H ++
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 520 VSLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
           V+L+G C +    ++++ E+ + G L  +L           +R E      +G  +    
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFRQGK 139

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE 617
              G I  D+K     +  +  S  + F   +S   ++E
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 88.3 bits (219), Expect = 1e-18
 Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 42/198 (21%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT---------EITVLSKIRHR 517
           +IG G +G VY          VA+K+ V         F+          EIT+L++++  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKK-VNRM------FEDLIDCKRILREITILNRLKSD 85

Query: 518 HLVSLV-----GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWK-------QRLEIC 565
           +++ L          +  E+ +V E  +   LKK    P    L+ +         L   
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLFKTPI--FLTEEHIKTILYNLL--- 139

Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK 625
                G +++H   + GIIHRD+K  N LL+++   KV DFGL+R+     +T++   ++
Sbjct: 140 ----LGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192

Query: 626 GSFGYLDPEYFRRQQLTD 643
            +          ++QLT 
Sbjct: 193 ENEEPGPHNKNLKKQLTS 210

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 53/248 (21%), Positives = 96/248 (38%), Gaps = 35/248 (14%)

Query: 432 MSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNT----- 486
           M        PG       + P    +    +F    I+G G F  V        +     
Sbjct: 1   MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60

Query: 487 KVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKK 546
           K+  KR +    + +P    E  V+S++ H   V L    ++  ++     Y + G L K
Sbjct: 61  KILEKRHIIKENK-VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 119

Query: 547 HLYGPDRTPLSWKQRL-----------EICIGAARGLHYLHTGSAEGIIHRDIKSTNILL 595
           ++          K              EI       L YLH    +GIIHRD+K  NILL
Sbjct: 120 YIR---------KIGSFDETCTRFYTAEIVSA----LEYLH---GKGIIHRDLKPENILL 163

Query: 596 DEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVL 654
           +E+ ++ ++ DFG ++      +   +    G+  Y+ PE    +     SD+++ G ++
Sbjct: 164 NEDMHI-QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCII 222

Query: 655 FEVLCART 662
           ++++    
Sbjct: 223 YQLVAGLP 230

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 85.8 bits (213), Expect = 6e-18
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 17/210 (8%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV-AVK---RGVPGSRQGLPEFQTEITVLSKIRH 516
           ++F+    IG G FG V      D  K+ A+K   +     R  +     E+ ++  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEIC-IGAARGLHYL 575
             LV+L    +++ +M +V + +  G L+ HL            +L IC +  A  L YL
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-TVKLFICELVMA--LDYL 131

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
                + IIHRD+K  NILLDE+    + DF ++   P   +    T + G+  Y+ PE 
Sbjct: 132 Q---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEM 185

Query: 636 FRRQQLT--DKS-DVYSFGVVLFEVLCART 662
           F  ++      + D +S GV  +E+L  R 
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 84.6 bits (210), Expect = 6e-18
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 52/180 (28%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTK--VAVKR--------GVPGS--RQGLPEFQTEI 508
             ++    IG G +G V+K     N    VA+KR        G+P S  R        E+
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR--------EV 62

Query: 509 TVL---SKIRHRHLVSL-----VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSW-- 558
            VL       H ++V L     V   + ++++ LV+E++++  L  +L   D+ P     
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVP 118

Query: 559 --------KQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR 610
                    Q L       RGL +LH   +  ++HRD+K  NIL+  +   K+ADFGL+R
Sbjct: 119 TETIKDMMFQLL-------RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 39/200 (19%)

Query: 432 MSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAV 490
           M+    + S  +  ++R ++  T  +     +     +GSG +G V      +   +VAV
Sbjct: 1   MAHHHHHHSQERPTFYRQELNKTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 59

Query: 491 KRGVPGSRQGLPEFQT---------EITVLSKIRHRHLVSLV------GYCEEQSEMILV 535
           K+         P FQ+         E+ +L  ++H +++ L+         EE +++ LV
Sbjct: 60  KK------LSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112

Query: 536 YEYMEKGPLKKHLYGPDRTPLSWK----QRLEICIGAARGLHYLHTGSAEGIIHRDIKST 591
              M    L   +     T    +    Q L       RGL Y+H+     IIHRD+K +
Sbjct: 113 THLMGAD-LNNIVKCQKLTDDHVQFLIYQIL-------RGLKYIHSA---DIIHRDLKPS 161

Query: 592 NILLDENYVSKVADFGLSRS 611
           N+ ++E+   K+ DFGL+R 
Sbjct: 162 NLAVNEDCELKILDFGLARH 181

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 85.2 bits (211), Expect = 1e-17
 Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 24/216 (11%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV-AVK---RGVPGSRQGLPEFQTEITVLSKIRH 516
            +F+   +IG G FG V    L++  KV A+K   +     R     F+ E  VL     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 517 RHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLY-GPDRTPLSWKQ--RLEICIGAARG 571
           + + +L  +   Q +  + LV +Y   G L   L    DR P    +    E+ I     
Sbjct: 134 KWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA---- 187

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           +  +H       +HRDIK  NIL+D N   ++ADFG             S  V G+  Y+
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 243

Query: 632 DPEYFRRQQLTDKS-----DVYSFGVVLFEVLCART 662
            PE  +  +          D +S GV ++E+L   T
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 37/228 (16%)

Query: 454 TDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKV-AVK---RGVPGSRQGLPEFQTEIT 509
            DL+    +++   +IG G FG V     +   KV A+K   +     R     F  E  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121

Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL------- 562
           +++      +V L    ++   + +V EYM  G L   +             +       
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS---------NYDVPEKWARF 172

Query: 563 ---EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDET 618
              E+ +     L  +H   + G IHRD+K  N+LLD++ ++ K+ADFG           
Sbjct: 173 YTAEVVLA----LDAIH---SMGFIHRDVKPDNMLLDKSGHL-KLADFGTCMKMNKEGMV 224

Query: 619 HVSTGVKGSFGYLDPEYFRRQQLT---DKS-DVYSFGVVLFEVLCART 662
              T V G+  Y+ PE  + Q       +  D +S GV L+E+L   T
Sbjct: 225 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 42/198 (21%), Positives = 80/198 (40%), Gaps = 58/198 (29%)

Query: 443 QNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGL 501
           + G+++  +  T  +     +     +GSG +G V   +  R   KVA+K+        L
Sbjct: 7   KKGFYKQDVNKTAWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK--------L 57

Query: 502 PE-FQT---------EITVLSKIRHRHLVSLV------GYCEEQSEMILVYEYME----- 540
              FQ+         E+ +L  ++H +++ L+             +  LV  +M+     
Sbjct: 58  SRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQK 117

Query: 541 --KGPLK-KH----LYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNI 593
                   +     +Y          Q L       +GL Y+H+    G++HRD+K  N+
Sbjct: 118 IMGLKFSEEKIQYLVY----------QML-------KGLKYIHSA---GVVHRDLKPGNL 157

Query: 594 LLDENYVSKVADFGLSRS 611
            ++E+   K+ DFGL+R 
Sbjct: 158 AVNEDCELKILDFGLARH 175

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 83.0 bits (206), Expect = 2e-17
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 18/167 (10%)

Query: 459 ATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR-GVPGSRQGLPEF-QT---EITVL- 511
           AT+ ++    IG G +G VYK         VA+K   VP    G      +   E+ +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 512 --SKIRHRHLVSLV-----GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEI 564
                 H ++V L+        + + ++ LV+E++++  L+ +L       L  +   ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDL 125

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
                RGL +LH   A  I+HRD+K  NIL+      K+ADFGL+R 
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI 169

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 82.3 bits (204), Expect = 5e-17
 Identities = 48/228 (21%), Positives = 86/228 (37%), Gaps = 65/228 (28%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT---------EITVLSKIRHR 517
           ++G G +G+V           VA+K+  P        F           EI +L   +H 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHE 69

Query: 518 HLVSLV-----GYCEEQSEMILVYEYME--------KGPLKK-H----LYGPDRTPLSWK 559
           +++++         E  +E+ ++ E M+           L   H    +Y          
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY---------- 119

Query: 560 QRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH 619
           Q L       R +  LH      +IHRD+K +N+L++ N   KV DFGL+R        +
Sbjct: 120 QTL-------RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 620 VSTGVKGSF--GYLDPEYFR-------RQQLTDKSDVYSFGVVLFEVL 658
                + S    ++   ++R         + +   DV+S G +L E+ 
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 82.4 bits (204), Expect = 7e-17
 Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 59/202 (29%)

Query: 440 SPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSR 498
            P ++G++R ++  T  +     +     +GSG +G V   V  R   KVA+K+      
Sbjct: 5   PPARSGFYRQEVTKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK------ 57

Query: 499 QGLPE-FQT---------EITVLSKIRHRHLVSLV------GYCEEQSEMILVYEYME-- 540
             L   FQ+         E+ +L  +RH +++ L+         ++ ++  LV  +M   
Sbjct: 58  --LYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD 115

Query: 541 ------KGPL-KKH----LYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIK 589
                    L +      +Y          Q L       +GL Y+H     GIIHRD+K
Sbjct: 116 LGKLMKHEKLGEDRIQFLVY----------QML-------KGLRYIHAA---GIIHRDLK 155

Query: 590 STNILLDENYVSKVADFGLSRS 611
             N+ ++E+   K+ DFGL+R 
Sbjct: 156 PGNLAVNEDCELKILDFGLARQ 177

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 56/171 (32%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT---------EITVLSKIRHRH 518
           IG G +GMV       +  +VA+K+  P        F+          EI +L + RH +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRHEN 86

Query: 519 LVSLV-----GYCEEQSEMILVYEYME--------KGPLKK-H----LYGPDRTPLSWKQ 560
           ++ +         E+  ++ +V + ME           L   H    LY          Q
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY----------Q 136

Query: 561 RLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
            L       RGL Y+H  SA  ++HRD+K +N+LL+     K+ DFGL+R 
Sbjct: 137 IL-------RGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 81.3 bits (201), Expect = 2e-16
 Identities = 53/194 (27%), Positives = 92/194 (47%), Gaps = 38/194 (19%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE-FQT---------EITVLSKIR- 515
            +G G +G+V+K +  R    VAVK+        + + FQ          EI +L+++  
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKK--------IFDAFQNSTDAQRTFREIMILTELSG 67

Query: 516 HRHLVSL--VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWK----QRLEICIGAA 569
           H ++V+L  V   +   ++ LV++YME   L   +      P+  +    Q +       
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVIRANILEPVHKQYVVYQLI------- 119

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFG 629
           + + YLH+G   G++HRD+K +NILL+     KVADFGLSRS   +     +  +  +  
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 630 YLDPEYFRRQQLTD 643
             + +   +  LTD
Sbjct: 177 TENFDD-DQPILTD 189

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 59/292 (20%), Positives = 112/292 (38%), Gaps = 100/292 (34%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQT---------EITVLSKIRHR 517
            +G GG G+V+  V    + +VA+K+ V                     EI ++ ++ H 
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDHD 68

Query: 518 HLVSL--------------VGYCEEQSEMILVYEYME--------KGPL-KKH----LYG 550
           ++V +              VG   E + + +V EYME        +GPL ++H    +Y 
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY- 127

Query: 551 PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLS 609
                    Q L       RGL Y+H+     ++HRD+K  N+ ++ E+ V K+ DFGL+
Sbjct: 128 ---------QLL-------RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLA 168

Query: 610 RS-GPCLDETHVSTGVKGSFGYLDPEYFR-------RQQLTDKSDVYSFGVVLFEVLCAR 661
           R   P        +        L  +++R           T   D+++ G +  E+L  +
Sbjct: 169 RIMDPHYSHKGHLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

Query: 662 TAVDPLLA-REQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETA 712
                L A   ++              ++ I++   I  ++ +  ++     
Sbjct: 223 ----TLFAGAHELE------------QMQLILE--SIPVVHEEDRQELLSVI 256

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 80.5 bits (199), Expect = 5e-16
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 20/208 (9%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRH 516
           N F+   ++G G FG V     +   +      +K+ V  ++  +    TE  VL   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 517 RHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQRL---EICIGAARG 571
             L +L      Q+   +  V EY   G L  HL          + R    EI       
Sbjct: 208 PFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSA---- 260

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           L YLH  S + +++RD+K  N++LD++   K+ DFGL + G  + +        G+  YL
Sbjct: 261 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYL 316

Query: 632 DPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            PE           D +  GVV++E++C
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMC 344

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 52/243 (21%), Positives = 102/243 (41%), Gaps = 52/243 (21%)

Query: 437 VNASPGQNGYHR---LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR 492
           VN    +  Y       + + +     +++     +G G +  V++ + + +N KV VK 
Sbjct: 14  VNTHRPR-EYWDYESHVVEWGN----QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI 68

Query: 493 GVPGSRQGLPEFQTEITVLSKIR-HRHLVSL--VGYCEEQSEMILVYEYMEKGPLKKHLY 549
             P  ++   + + EI +L  +R   ++++L  +          LV+E++     K+   
Sbjct: 69  LKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY- 124

Query: 550 GPDRTPLSWKQRL----------EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-EN 598
                     Q L          EI     + L Y H  S  GI+HRD+K  N+++D E+
Sbjct: 125 ----------QTLTDYDIRFYMYEIL----KALDYCH--SM-GIMHRDVKPHNVMIDHEH 167

Query: 599 YVSKVADFGLSRSG-PCLDETH-VSTGVKGSFGYLDPEYFRRQQLTDKS-DVYSFGVVLF 655
              ++ D+GL+    P  +    V++       +  PE     Q+ D S D++S G +L 
Sbjct: 168 RKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLA 222

Query: 656 EVL 658
            ++
Sbjct: 223 SMI 225

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 79.7 bits (196), Expect = 2e-15
 Identities = 58/263 (22%), Positives = 96/263 (36%), Gaps = 28/263 (10%)

Query: 410 PRPADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLII 469
           P P +                             N   +        +    +F+  +++
Sbjct: 290 PVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVL 349

Query: 470 GSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVG 524
           G G FG V     +   ++     +K+ V      +     E  VL+   +   L  L  
Sbjct: 350 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL-- 407

Query: 525 YCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQ--RLEICIGAARGLHYLHTGSA 580
           +   Q+   +  V EY+  G L  H+    R           EI IG    L +L    +
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQ---S 460

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF-G---YLDPEYF 636
           +GII+RD+K  N++LD     K+ADFG+ +       T        +F G   Y+ PE  
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT------TKTFCGTPDYIAPEII 514

Query: 637 RRQQLTDKSDVYSFGVVLFEVLC 659
             Q      D ++FGV+L+E+L 
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLA 537

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 48/257 (18%), Positives = 96/257 (37%), Gaps = 76/257 (29%)

Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQT---EITVL 511
           L+T++  +     +G+G FG+V +    +   + A+K+ V      L + +    E+ ++
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK-V------LQDPRYKNRELDIM 54

Query: 512 SKIRHRHLVSL--VGYCEEQSEMI------------------------------------ 533
             + H +++ L    Y     E                                      
Sbjct: 55  KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114

Query: 534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLE----------ICIGAARGLHYLHTGSAEGI 583
           ++ EY+    L K L    ++ +   + +           +     R + ++H+    GI
Sbjct: 115 VIMEYVPD-TLHKVL----KSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GI 162

Query: 584 IHRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE-YFRRQQL 641
            HRDIK  N+L++ ++   K+ DFG ++    L  +  S     S  Y  PE      + 
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKK---LIPSEPSVAYICSRFYRAPELMLGATEY 219

Query: 642 TDKSDVYSFGVVLFEVL 658
           T   D++S G V  E++
Sbjct: 220 TPSIDLWSIGCVFGELI 236

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 29/212 (13%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKIRH 516
           N+FD   ++G G FG V     +   +      +++ V  ++  +    TE  VL   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 517 RHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQ--RLEICIGAARGL 572
             L +L      Q+   +  V EY   G L  HL           +    EI       L
Sbjct: 65  PFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA----L 118

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSF-G- 629
            YLH   +  +++RDIK  N++LD++ ++ K+ DFGL + G     T        +F G 
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGAT------MKTFCGT 168

Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
             YL PE           D +  GVV++E++C
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.5 bits (189), Expect = 5e-15
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 26/211 (12%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKI-R 515
            +FD   +IG G +  V    L+   ++     VK+ +    + +   QTE  V  +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 516 HRHLVSLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ--RLEICIGAARGL 572
           H  LV L   C + +S +  V EY+  G L  H+    + P    +    EI +     L
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----L 123

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF-G-- 629
           +YLH     GII+RD+K  N+LLD     K+ D+G+ + G    +T   T    +F G  
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---T---STFCGTP 174

Query: 630 -YLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            Y+ PE  R +      D ++ GV++FE++ 
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 75.7 bits (187), Expect = 7e-15
 Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 43/221 (19%)

Query: 461 NNFDKNLIIGSGGFGMVY---KGVLRDNT-----KVAVKRGVPGSRQGLPEFQTEITVLS 512
             F+   ++G GG+G V+   K    +       KV  K  +  + +     + E  +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 513 KIRHRHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-------- 562
           +++H  +V L      Q+   + L+ EY+  G L   L          ++ +        
Sbjct: 77  EVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLE---------REGIFMEDTACF 125

Query: 563 ---EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDET 618
              EI +     L +LH    +GII+RD+K  NI+L+   +V K+ DFGL +    + + 
Sbjct: 126 YLAEISMA----LGHLH---QKGIIYRDLKPENIMLNHQGHV-KLTDFGLCKES--IHDG 175

Query: 619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            V+    G+  Y+ PE   R       D +S G +++++L 
Sbjct: 176 TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 75.3 bits (186), Expect = 9e-15
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 51/224 (22%)

Query: 461 NNFDKNLIIGSGGFGMVY---KGVLRDNTKV-AVK---RGVPGSRQGLPEFQTEITVLSK 513
           + F+   ++G G FG V+   K    D  ++ A+K   +     R  +   + E  +L +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDILVE 82

Query: 514 IRHRHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQRL--------- 562
           + H  +V L  +   Q+E  + L+ +++  G L   L          K+ +         
Sbjct: 83  VNHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLS---------KEVMFTEEDVKFY 131

Query: 563 --EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETH 619
             E+ +     L +LH   + GII+RD+K  NILLDE  ++ K+ DFGLS+     ++  
Sbjct: 132 LAELALA----LDHLH---SLGIIYRDLKPENILLDEEGHI-KLTDFGLSKESIDHEKK- 182

Query: 620 VSTGVKGSF-G---YLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
                  SF G   Y+ PE   R+  T  +D +SFGV++FE+L 
Sbjct: 183 -----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 26/211 (12%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKI-R 515
            +FD   +IG G +  V    L+   ++     VK+ +    + +   QTE  V  +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 516 HRHLVSLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ--RLEICIGAARGL 572
           H  LV L   C + +S +  V EY+  G L  H+    + P    +    EI +     L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----L 166

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF-G-- 629
           +YLH     GII+RD+K  N+LLD     K+ D+G+ + G    +T   T    +F G  
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---T---STFCGTP 217

Query: 630 -YLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
            Y+ PE  R +      D ++ GV++FE++ 
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 28/212 (13%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSK-IR 515
            +F  + ++G G FG V+    +   +     A+K+ V      +     E  VLS    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 516 HRHLVSLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQ--RLEICIGAARGL 572
           H  L  +     + +  +  V EY+  G L  H+    +  LS       EI +G    L
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG----L 131

Query: 573 HYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSF-G- 629
            +LH   ++GI++RD+K  NILLD++ ++ K+ADFG+ +     D     T    +F G 
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAK---T---NTFCGT 181

Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
             Y+ PE    Q+     D +SFGV+L+E+L 
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 30/213 (14%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKI-R 515
            +F+  +++G G FG V     +   ++     +K+ V      +     E  VL+   +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 516 HRHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQ--RLEICIGAARG 571
              L  L  +   Q+   +  V EY+  G L  H+    R           EI IG    
Sbjct: 80  PPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG---- 133

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSF-G 629
           L +L    ++GII+RD+K  N++LD   ++ K+ADFG+ +       T   T    +F G
Sbjct: 134 LFFLQ---SKGIIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVT---T---KTFCG 183

Query: 630 ---YLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
              Y+ PE    Q      D ++FGV+L+E+L 
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 26/209 (12%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
           + FD+   +G+G FG V     +++      K+  K+ V   +Q +     E  +L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99

Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
              LV L    ++ S + +V EY+  G +  HL    R      +     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYL 157

Query: 576 HTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSF-G---Y 630
           H   +  +I+RD+K  N+L+D+  Y+ +V DFG ++       T        +  G    
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYI-QVTDFGFAKRVK--GRTW-------TLCGTPEA 204

Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           L PE    +      D ++ GV+++E+  
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 28/212 (13%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV----AVKRGVPGSRQGLPEFQTEITVLSKI-R 515
           +NF+   ++G G FG V    +++   +     +K+ V      +    TE  +LS    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 516 HRHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQ--RLEICIGAARG 571
           H  L  L  +C  Q+   +  V E++  G L  H+    R   +  +    EI       
Sbjct: 83  HPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA---- 136

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF-G- 629
           L +LH    +GII+RD+K  N+LLD     K+ADFG+ + G C   T   T    +F G 
Sbjct: 137 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---T---ATFCGT 187

Query: 630 --YLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
             Y+ PE  +        D ++ GV+L+E+LC
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 42/201 (20%), Positives = 77/201 (38%), Gaps = 41/201 (20%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGY 525
           ++G G  G V +   +    K A+K       Q  P+ + E+ +  +  +  H+V +V  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 79

Query: 526 CEEQSEMI----LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
            E          +V E ++ G L   +        + ++  EI       + YLH   + 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 136

Query: 582 GIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
            I HRD+K  N+L      N + K+ DFG +                        E    
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFA-----------------------KE-TTG 172

Query: 639 QQLTDKSDVYSFGVVLFEVLC 659
           ++     D++S GV+++ +LC
Sbjct: 173 EKYDKSCDMWSLGVIMYILLC 193

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 65/258 (25%), Positives = 106/258 (41%), Gaps = 45/258 (17%)

Query: 427 SSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVY---KGVLR 483
            + +   +G       ++      +     +    NF+   ++G+G +G V+   K    
Sbjct: 20  GTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGH 79

Query: 484 DNT-----KVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH-LVSLVGYCEEQSE--MILV 535
           D       KV  K  +    +     +TE  VL  IR    LV+L  +   Q+E  + L+
Sbjct: 80  DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL--HYAFQTETKLHLI 137

Query: 536 YEYMEKGPLKKHLYGPDRTPLSWKQRL-----------EICIGAARGLHYLHTGSAEGII 584
            +Y+  G L  HL          ++             EI +     L +LH     GII
Sbjct: 138 LDYINGGELFTHLS---------QRERFTEHEVQIYVGEIVLA----LEHLH---KLGII 181

Query: 585 HRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL-T 642
           +RDIK  NILLD N +V  + DFGLS+     +         G+  Y+ P+  R      
Sbjct: 182 YRDIKLENILLDSNGHV-VLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRGGDSGH 239

Query: 643 DKS-DVYSFGVVLFEVLC 659
           DK+ D +S GV+++E+L 
Sbjct: 240 DKAVDWWSLGVLMYELLT 257

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 60/222 (27%), Positives = 91/222 (40%), Gaps = 48/222 (21%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKV-AVK---RGVPGSRQGLPEFQTEITVLSK-IR 515
           ++F    +IG G FG V     +      AVK   +     ++      +E  VL K ++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 516 HRHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQRL----------- 562
           H  LV L  +   Q+   +  V +Y+  G L  HL          ++R            
Sbjct: 98  HPFLVGL--HFSFQTADKLYFVLDYINGGELFYHLQ---------RERCFLEPRARFYAA 146

Query: 563 EICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVS 621
           EI       L YLH   +  I++RD+K  NILLD   ++  + DFGL +     + T   
Sbjct: 147 EIASA----LGYLH---SLNIVYRDLKPENILLDSQGHI-VLTDFGLCKENIEHNST--- 195

Query: 622 TGVKGSF-G---YLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
           T    +F G   YL PE   +Q      D +  G VL+E+L 
Sbjct: 196 T---STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 70.3 bits (173), Expect = 3e-13
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 48/220 (21%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQGLPEFQTEITVLSKIR 515
            +F     +G+G FG V+    R N      KV  K  V   +Q +     E  +LS + 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVT 64

Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRL-----------EI 564
           H  ++ + G  ++  ++ ++ +Y+E G L   L          K +            E+
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---------KSQRFPNPVAKFYAAEV 115

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTG 623
           C+     L YLH   ++ II+RD+K  NILLD+N ++ K+ DFG ++  P  D T+    
Sbjct: 116 CLA----LEYLH---SKDIIYRDLKPENILLDKNGHI-KITDFGFAKYVP--DVTY---- 161

Query: 624 VKGSF-G---YLDPEYFRRQQLTDKSDVYSFGVVLFEVLC 659
              +  G   Y+ PE    +      D +SFG++++E+L 
Sbjct: 162 ---TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 61/299 (20%), Positives = 110/299 (36%), Gaps = 57/299 (19%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGLPEFQTEITVLSKIR--------- 515
            +G G F  V+    + +NT VA+K  RG     +     + EI +L ++          
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDS 82

Query: 516 --HRHLVSLVGY----CEEQSEMILVYEYMEKGPLKKHLYG-----PDRTPLSWKQRLEI 564
               H++ L+ +          +++V+E      L ++L         R  +      +I
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHR-GIPLIYVKQI 136

Query: 565 CIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS------KVADFGLSRSGPCLDET 618
                 GL Y+H     GIIH DIK  N+L++           K+AD G +    C  + 
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190

Query: 619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW 678
           H +  ++    Y  PE          +D++S   ++FE++      +P          + 
Sbjct: 191 HYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD- 248

Query: 679 AMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL 737
                    +  II+  L+G++    L+  G+         G+ R       W LE  L
Sbjct: 249 --------HIAQIIE--LLGELPSYLLRN-GKYTRTFFNSRGLLRNISKLKFWPLEDVL 296

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 67.2 bits (163), Expect = 4e-12
 Identities = 37/208 (17%), Positives = 62/208 (29%), Gaps = 54/208 (25%)

Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVK-------RGVPGSRQGLP- 502
           +PF+     T    +   IG G FG V++ +  D+T VA+K         V GS Q    
Sbjct: 11  VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFE 68

Query: 503 EFQTEITVL---SKIRHRHLVSLVGYCE-------------------------------- 527
           E   EI +    S +         G+                                  
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 528 ----EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
               +  ++ +V E+   G   + +        S      I       L       +   
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQM---RTKLSSLATAKSILHQLTASLAVAEA--SLRF 183

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRS 611
            HRD+   N+LL +  + K+      +S
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKS 211

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 41/209 (19%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVK--RGVPG-SRQGLPEFQTEITVLSKIRHR------ 517
           +IG G FG V K    + +  VA+K  R      RQ       EI +L  +R +      
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTM 159

Query: 518 HLVSLVGYCEEQSEMILV--------YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
           +++ ++     ++ + +         YE ++K   +           S     +      
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQ---------GFSLPLVRKFAHSIL 210

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGS 627
           + L  LH      IIH D+K  NILL +   S  KV DFG S    C +   V T ++  
Sbjct: 211 QCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSR 263

Query: 628 FGYLDPEYFRRQQLTDKSDVYSFGVVLFE 656
           F Y  PE     +     D++S G +L E
Sbjct: 264 F-YRAPEVILGARYGMPIDMWSLGCILAE 291

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 48/204 (23%), Positives = 76/204 (37%), Gaps = 29/204 (14%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVK--RGVPG-SRQGLPEFQTEITVLSKIRHR------ 517
           +IG G FG V K     +   VA+K  +       Q       E+ +L  +         
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMKY 116

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKG---PLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
           ++V L  +   ++ + LV+E +       L+   +      +S     +        L +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLF 172

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLD 632
           L T     IIH D+K  NILL     S  K+ DFG S    C     +   ++  F Y  
Sbjct: 173 LATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRF-YRS 226

Query: 633 PEYFRRQQLTDKSDVYSFGVVLFE 656
           PE           D++S G +L E
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVE 250

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 28/165 (16%), Positives = 55/165 (33%), Gaps = 28/165 (16%)

Query: 469 IGSGGFGMVYKGV---------LRDNTKVAVK---RGVPG-------SRQGLPEFQTEIT 509
                 G++Y+                K ++K   +            R   P    +  
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 510 VLSKIRHRHLVSLVGYCEEQSEM-ILVYEYMEKGP-LKKHLYGPDRTPLSWKQRLEICIG 567
            L       + + +G+   Q +   LV   +  G  L+  L    +  LS +  L++   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 568 AARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKV--ADFGLSR 610
               L +LH       +H ++ + NI +D    S+V  A +G + 
Sbjct: 168 LLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 18/151 (11%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH-RHLVSLVGYC 526
           IG G FG++++G  L +N +VA+K     S    P+ + E      +     + ++  + 
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 527 EEQSEMILVYEYMEKGP-LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
           +E    +LV + +  GP L+  L    R   S K            +  +H    + +++
Sbjct: 76  QEGLHNVLVIDLL--GPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHE---KSLVY 129

Query: 586 RDIKSTNILL------DENYVSKVADFGLSR 610
           RDIK  N L+      + N +  V DFG+ +
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIY-VVDFGMVK 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 37/150 (24%), Positives = 61/150 (40%), Gaps = 16/150 (10%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH-RHLVSLVGYC 526
           IG G FG +  G  L  N  VA+K  +   +   P+   E     ++     +  +  + 
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 527 EEQSEMILVYEYMEKGP-LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
                  +V E +  GP L+      DRT  S K  L I I     + Y+H+   + +I+
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRT-FSLKTVLMIAIQLISRMEYVHS---KNLIY 128

Query: 586 RDIKSTNILLDENYVSK-----VADFGLSR 610
           RD+K  N L+            + DF L++
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 16/149 (10%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH-RHLVSLVGYC 526
           IGSG FG +Y G  +    +VA+K     ++   P+   E  +   ++    + ++    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 527 EEQSEMILVYEYMEKGP-LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
            E    ++V E +  GP L+       R   S K  L +       + Y+H   ++  IH
Sbjct: 75  AEGDYNVMVMELL--GPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIH---SKNFIH 128

Query: 586 RDIKSTNILL----DENYVSKVADFGLSR 610
           RD+K  N L+      N V  + DFGL++
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYII-DFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 36/147 (24%), Positives = 68/147 (46%), Gaps = 12/147 (8%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYC 526
           IGSG FG +Y G  ++ N +VA+K     ++   P+   E  +   ++    + ++  + 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
            E    +LV + +  GP  + L+      LS K  L +       + ++H+   +  +HR
Sbjct: 73  VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 127

Query: 587 DIKSTNILLDENYVSK---VADFGLSR 610
           DIK  N L+     +    + DFGL++
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 52/230 (22%), Positives = 80/230 (34%), Gaps = 65/230 (28%)

Query: 468 IIGSGGFGMVYKGV--LRDNTKVAVK--RGVPG-SRQGLPEFQTEITVLSKIRHR----- 517
            +G G FG V + +   R  ++VA+K  R V           + EI VL KI+ +     
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81

Query: 518 -HLVSLVGYCEEQSEMILVYEYMEKGP-----LKKHLYGPDRTPLSWKQRLEICIGAARG 571
              V +  +      M + +E +  G      LK++ +     P        +       
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELL--GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHA 135

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVS-------------------KVADFGLSRSG 612
           L +LH      + H D+K  NIL   +                      +VADFG +   
Sbjct: 136 LRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--- 189

Query: 613 PCLDETHVSTGVKGSFGYLDPE------YFRRQQLTDKSDVYSFGVVLFE 656
              D  H +T V     Y  PE      +          DV+S G +LFE
Sbjct: 190 -TFDHEHHTTIVATRH-YRPPEVILELGW------AQPCDVWSIGCILFE 231

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 45/210 (21%), Positives = 72/210 (34%), Gaps = 37/210 (17%)

Query: 427 SSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKN--LI--IGSGGFGMVYKGV- 481
             H   S   +         +   +PF + +   +       L   IGSGGFG++Y    
Sbjct: 3   HHHHHSSGVDLGTENL----YFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFP 58

Query: 482 LRDNTKVAVKRGVPGSRQGLPEFQTEITVL---------SKIRHRHLVSLVG-----YC- 526
                K A    V    Q      +E+             K   R  +  +G        
Sbjct: 59  TNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117

Query: 527 ----EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
               + +S   +V E +  G   + + G + T       L++ I     L Y+H      
Sbjct: 118 LTEFKGRSYRFMVMERL--GIDLQKISGQNGT-FKKSTVLQLGIRMLDVLEYIH---ENE 171

Query: 583 IIHRDIKSTNILLDENYVSKV--ADFGLSR 610
            +H DIK+ N+LL      +V  AD+GLS 
Sbjct: 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 31/166 (18%), Positives = 57/166 (34%), Gaps = 30/166 (18%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGV--PGSRQGLPEFQTEITVLSKIRHRHLVSLV--- 523
           IG GGFG +Y   +  +  V                   TE+    +      +      
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 524 --------------GYCEEQSEM--ILVYEYMEKGP-LKKHLYGPDRTPLSWKQRLEICI 566
                         G  ++  +    ++ +    G  L+K      +   S K  L++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKR-FSRKTVLQLSL 159

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKV--ADFGLSR 610
                L Y+H       +H DIK++N+LL+     +V   D+GL+ 
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 54.6 bits (132), Expect = 6e-08
 Identities = 51/234 (21%), Positives = 82/234 (35%), Gaps = 69/234 (29%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVK--RGVPG-SRQGLPEFQTEITVLSKIRHR-----H 518
            +G G FG V     + +    AVK  R +   +R      + E  +L KI++      +
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGP-----LKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
           +V   G       M L++E +  GP     + ++ Y         +     CI   + L+
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPL--GPSLYEIITRNNY----NGFHIEDIKLYCIEILKALN 151

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVS-------------------------KVADFGL 608
           YL       + H D+K  NILLD+ Y                           K+ DFG 
Sbjct: 152 YLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 609 SRSGPCLDETHVSTGVKGSFGYLDPE------YFRRQQLTDKSDVYSFGVVLFE 656
           +         +  + +     Y  PE      +         SD++SFG VL E
Sbjct: 209 A----TFKSDYHGSIINTRQ-YRAPEVILNLGW------DVSSDMWSFGCVLAE 251

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.9 bits (131), Expect = 1e-07
 Identities = 62/517 (11%), Positives = 152/517 (29%), Gaps = 168/517 (32%)

Query: 264 DFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFINDYSAYKDLDLSSITF------HSLA 317
           DF  G H      +  + DI+      ++ + F++++      D+           H + 
Sbjct: 8   DFETGEH------QYQYKDIL-----SVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIM 56

Query: 318 SP-------------------VYMDFVADSDD-------AGVVRVSVGPSELSGSL--KV 349
           S                    +   FV +          + +      PS ++     + 
Sbjct: 57  SKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR 116

Query: 350 NAILNGVEIMKMVHLTVSETGEKNKK--------IWIVV-GSVVGGFVLLCLVALAVLVL 400
           + + N  ++    +++  +   K ++          +++ G  V G     +        
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG--VLGSGKTWVALDV---- 170

Query: 401 FKCRKKKPKPRPADSVGWTPLRAYGCSSHSKMSEGTVNASPGQNGYHRLKIPFTDLQTAT 460
             C   K + +    + W  L+   C+S   + E        Q   +++   +T     +
Sbjct: 171 --CLSYKVQCKMDFKIFWLNLKN--CNSPETVLE------MLQKLLYQIDPNWTSRSDHS 220

Query: 461 NNFDKNLIIGSGGF-----GMVYKG---VLRD--NTKVAVKRGVPGSRQGLPEFQTEITV 510
           +N    +               Y+    VL +  N K                F     +
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA------------WNAFNLSCKI 268

Query: 511 LSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR 570
           L   R + +   +      +   +  ++                 L+  +   +      
Sbjct: 269 LLTTRFKQVTDFLS---AATTTHISLDHHSMT-------------LTPDEVKSLL----- 307

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC-------LDETHVSTG 623
            L YL     +  + R++ +TN       +S +A+    R G         ++   ++T 
Sbjct: 308 -LKYLDCRPQD--LPREVLTTNPRR----LSIIAE--SIRDGLATWDNWKHVNCDKLTTI 358

Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQ-- 681
           ++ S   L+P  +R+               +F+ L    +V P       ++    +   
Sbjct: 359 IESSLNVLEPAEYRK---------------MFDRL----SVFP----PSAHIPTILLSLI 395

Query: 682 WQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLAD 718
           W    +++   D  ++    ++ L K        L +
Sbjct: 396 WFD--VIK--SDVMVV----VNKLHK------YSLVE 418

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.2 bits (119), Expect = 3e-06
 Identities = 87/730 (11%), Positives = 192/730 (26%), Gaps = 251/730 (34%)

Query: 106 DFSTQVVVLKEFIVKVDGDVIEIEFRPVGDKNFGFVNAIE-----VFSAPE-DFIV---- 155
           DF T     +        D++ + F      NF     ++     + S  E D I+    
Sbjct: 8   DFETGEHQYQ------YKDILSV-FEDAFVDNFDC-KDVQDMPKSILSKEEIDHIIMSKD 59

Query: 156 -DDGARVI------SGSGSIEEFRNLSSEILETILRINVGGSELTPFNDTLWRTW----- 203
              G   +           +++F       +E +LRIN        F   L         
Sbjct: 60  AVSGTLRLFWTLLSKQEEMVQKF-------VEEVLRINY------KF---LMSPIKTEQR 103

Query: 204 VPDDEFLVLKSAAKRVATTHPPNYQKGGASR------------EIGPDN---VY-MT--- 244
            P     +      R+   +   + K   SR            E+ P     +  +    
Sbjct: 104 QPSMMTRMYIEQRDRLYNDNQV-FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG 162

Query: 245 ----AQEMNRDNAMLGAR-FNITW-DFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFIN 298
               A ++     +     F I W +       N +        ++   L +L + +  N
Sbjct: 163 KTWVALDVCLSYKVQCKMDFKIFWLNL-----KNCNSPE----TVLEM-LQKLLYQIDPN 212

Query: 299 DYSAYKDLDLSSITFHS--------LASPVY------MDFVADSD-----DAGVVRVSVG 339
             S         +  HS        L S  Y      +  V ++      +    ++ + 
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC-KILL- 270

Query: 340 PSELSGSLKVNAILNGVEI--MKMVHLTVSETGEKNKKIWI-VVGSVVGGF-VLLCLVAL 395
               +   +V   L+      + + H +++ T ++ K + +  +          +     
Sbjct: 271 ---TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP 327

Query: 396 AVLVLFKCRKKKPKPRPADSVGWTPLRAYGCSSHSKMSEGTVNA-SPGQNGYHRLKIPFT 454
             L +     +           W   +   C   + + E ++N   P +      +  F 
Sbjct: 328 RRLSIIAESIRDGLAT------WDNWKHVNCDKLTTIIESSLNVLEPAE-----YRKMFD 376

Query: 455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI 514
            L                        V   +  +             P            
Sbjct: 377 RL-----------------------SVFPPSAHI-------------PT-IL-------- 391

Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
               L  +     +   M++V +  +   ++K            K+           +  
Sbjct: 392 ----LSLIWFDVIKSDVMVVVNKLHKYSLVEKQ----------PKEST-------ISIPS 430

Query: 575 LH-----TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE---THVSTGVKG 626
           ++         E  +HR     +I+  ++Y             P LD+   +H       
Sbjct: 431 IYLELKVKLENEYALHR-----SIV--DHYNIPKTFDSDDLIPPYLDQYFYSH------- 476

Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFE-------------VLCARTAVDPLLAREQV 673
             G+    + +  +  ++  +  F +V  +                A  ++   L     
Sbjct: 477 -IGH----HLKNIEHPERMTL--FRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQ---- 525

Query: 674 NLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL 733
                    Q K    +I D     +  ++++  F    E+ L    +      D+   L
Sbjct: 526 ---------QLKFYKPYICDNDPKYERLVNAILDFLPKIEENL----ICSKYT-DL---L 568

Query: 734 EYALQLQESG 743
             AL  ++  
Sbjct: 569 RIALMAEDEA 578

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 3e-06
 Identities = 51/379 (13%), Positives = 108/379 (28%), Gaps = 110/379 (29%)

Query: 36  ISLKSKTPPQDSPSP-----YDTARVFTSDGSYKLNIKRNGTHLVRFHFSPFESDNFKLA 90
           ++LK+   P+          Y     +TS   +  NIK    H ++            L 
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR-IHSIQAELRRL------LK 239

Query: 91  SAKFGVLANGLLLLQD-----------FSTQVVVLKEFIVKVDG-DVIEIEFRPVGDKNF 138
           S  +    N LL+L +            S ++++   F    D           +   + 
Sbjct: 240 SKPY---ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSM 296

Query: 139 GFV--NAIEVFSAPEDFIVDD----------------GARVISGSGSIEEFRNLSSEILE 180
                    +     D    D                   +  G  + + +++++ + L 
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT 356

Query: 181 TILRINVGGSELTP------------FND----------TLWRTWVPDDEFLVL-----K 213
           TI+  ++  + L P            F             +W   +  D  +V+      
Sbjct: 357 TIIESSL--NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY 414

Query: 214 SAAKRVATTHPPNYQKGGASREIGPDNVYMTAQEMNRDNAMLGAR----FNIT-----WD 264
           S  ++     P           I   ++Y+  +    +   L       +NI       D
Sbjct: 415 SLVEK----QPKEST-------ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDD 463

Query: 265 FPVG-------SHGNRHLVRLHFCDIVSPSLNQLYFNV-FI-----NDYSAYKDLDLSSI 311
                      SH   HL  +   + ++     ++ +  F+     +D +A+        
Sbjct: 464 LIPPYLDQYFYSHIGHHLKNIEHPERMT-LFRMVFLDFRFLEQKIRHDSTAWNASGSILN 522

Query: 312 TFHSLASPVYMDFVADSDD 330
           T   L    Y  ++ D+D 
Sbjct: 523 TLQQLK--FYKPYICDNDP 539

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 48/230 (20%), Positives = 84/230 (36%), Gaps = 65/230 (28%)

Query: 468 IIGSGGFGMVYKGV--LRDNTKVAVK--RGVPG-SRQGLPEFQTEITVLSKIRHR----- 517
            +G G FG V + +        VAVK  + V           ++EI VL  +        
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76

Query: 518 -HLVSLVGYCEEQSEMILVYEYMEKGP-----LKKHLYGPDRTPLSWKQRLEICIGAARG 571
              V ++ + E    + +V+E +  G      +K++ +     P       ++     + 
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELL--GLSTYDFIKENGF----LPFRLDHIRKMAYQICKS 130

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVS-------------------KVADFGLSRSG 612
           +++LH+     + H D+K  NIL  ++  +                   KV DFG +   
Sbjct: 131 VNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--- 184

Query: 613 PCLDETHVSTGVKGSFGYLDPE------YFRRQQLTDKSDVYSFGVVLFE 656
              D+ H ST V     Y  PE      +      +   DV+S G +L E
Sbjct: 185 -TYDDEHHSTLVSTRH-YRAPEVILALGW------SQPCDVWSIGCILIE 226

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 47/259 (18%), Positives = 76/259 (29%), Gaps = 77/259 (29%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGLPEFQTEITVLSKIR--------HR 517
           +G G F  V+    ++    VA+K  +      +       EI +L  +R          
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA---LDEIRLLKSVRNSDPNDPNRE 101

Query: 518 HLVSLVGYCEEQSE----MILVYEYMEKGP-LKKHLYGPDRTPLSWKQRLEICIGAARGL 572
            +V L+   +        + +V+E +  G  L K +   +   L      +I     +GL
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159

Query: 573 HYLHTGSAEGIIHRDIKSTNILL------------------------------------- 595
            YLH  +   IIH DIK  NILL                                     
Sbjct: 160 DYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217

Query: 596 ------------DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD 643
                        E    K+AD G +          + T       Y   E         
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNT 272

Query: 644 KSDVYSFGVVLFEVLCART 662
            +D++S   + FE+     
Sbjct: 273 PADIWSTACMAFELATGDY 291

>1qzv_F Plant photosystem I: subunit PSAF; photosynthesis,plant photosynthetic reaction center, peripheral antenna; HET: CL1 PQN; 4.44A {Pisum sativum} SCOP: i.5.1.1 Length = 154

 Score = 44.6 bits (104), Expect = 2e-05
 Identities = 12/30 (40%), Positives = 14/30 (46%), Gaps = 6/30 (20%)

Query: 540 EKGPLKK-----HLYGPDRTP-LSWKQRLE 563
           EK  LKK      LY  D  P L+ K  +E
Sbjct: 18  EKQALKKLQASLKLYADDSAPALAIKATME 47

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	803
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.61
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.97
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.79
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.54
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.49
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.33
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.29
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.24
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.22
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.91
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.79
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.79
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.68
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.4
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.35
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.28
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.25
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.16
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.13
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.06
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.93
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.67
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.66
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.35
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.32
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.57
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.93
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	89.68
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.56
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	85.7
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.25

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2e-53  Score=459.98  Aligned_cols=260  Identities=28%  Similarity=0.414  Sum_probs=209.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ++|...++||+|+||+||+|+++      +++.||||++........++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45667789999999999999975      378899999876666667889999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcE
Q 042150          535 VYEYMEKGPLKKHLYGPD-------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~  601 (803)
                      |||||++|+|.++|+...             ..+++|.+++.|+.|||+||+|||+   ++|+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence            999999999999996432             2469999999999999999999999   999999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAM  680 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  680 (803)
                      ||+|||+|+.....+.........||+.|||||++.+..++.++|||||||+||||+| |+.||......+.   ...  
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~--  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---IDC--  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HHH--
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HHH--
Confidence            9999999987544344444456789999999999999999999999999999999999 8999975433221   111  


Q ss_pred             HHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                        ...+.         ....+..+++.+.+|+.+||+.||.+||||.||+++|+.+.+.
T Consensus       273 --i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          273 --ITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             --HHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --HHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence              11111         0122344567889999999999999999999999999988754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-53  Score=455.55  Aligned_cols=259  Identities=29%  Similarity=0.414  Sum_probs=214.6

Q ss_pred             cCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ++|...+.||+|+||+||+|++.      ++..||||++........++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46777889999999999999874      367899999876666667889999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEE
Q 042150          535 VYEYMEKGPLKKHLYGP-----------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKV  603 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl  603 (803)
                      |||||++|+|.++|+..           ....++|.+++.|+.|||+||+|||+   ++|+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence            99999999999999542           24579999999999999999999999   99999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHH
Q 042150          604 ADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       604 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      +|||+|+.....+.........||+.|||||++.++.++.++|||||||+||||+| |+.||......+   +...    
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~----  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC----  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH----
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----
Confidence            99999986433233333344578999999999999999999999999999999998 899997543322   1111    


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ...+..         ...+..+++++.+|+.+||+.||.+||||.||++.|+.+.+
T Consensus       243 i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          243 ITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            111111         12234456788999999999999999999999999987764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.5e-53  Score=452.25  Aligned_cols=256  Identities=21%  Similarity=0.329  Sum_probs=211.3

Q ss_pred             CCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      +++..+.||+|+||+||+|.+.      +++.||||++.... ....++|.+|+.+|++++|||||+++|+|.+.+.++|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3455678999999999999973      46789999976543 3446789999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc
Q 042150          535 VYEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV  600 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~  600 (803)
                      |||||++|+|.++|....              ...++|.++++|+.|||+||+|||+   ++||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence            999999999999995432              2469999999999999999999999   99999999999999999999


Q ss_pred             EEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHH
Q 042150          601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWA  679 (803)
Q Consensus       601 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  679 (803)
                      +||+|||+|+.....+.........||+.|||||++.++.++.++|||||||+||||+| |+.||......+   +... 
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~-  259 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEM-  259 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHH-
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence            99999999986443333334455689999999999999999999999999999999998 899997543322   1111 


Q ss_pred             HHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          680 MQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       680 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                         ...+..         ...+..++..+.+|+.+||+.||.+||||.||+++|+..
T Consensus       260 ---i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 ---IRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ---HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ---HHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence               112111         123445667889999999999999999999999999753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.6e-52  Score=441.71  Aligned_cols=260  Identities=30%  Similarity=0.501  Sum_probs=204.7

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .+++...+.||+|+||+||+|++++  .||||.+....  .+..++|.+|+++|++++|||||+++|+|.+ +.++||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3566778899999999999998753  69999865432  3345789999999999999999999999865 56899999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      ||++|+|.++|+.. ...++|.+++.|+.|||+||+|||+   ++||||||||+||||++++.+||+|||+|+.......
T Consensus       112 y~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999999643 3569999999999999999999999   8999999999999999999999999999987543333


Q ss_pred             CceeccccCCCcccCcccccc---CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          618 THVSTGVKGSFGYLDPEYFRR---QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ........||+.|||||++.+   .+|+.++|||||||+||||+||+.||.........      ......+    ...|
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~----~~~p  257 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRG----YASP  257 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTT----CCCC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcC----CCCC
Confidence            344456789999999999964   46899999999999999999999999754322211      1111111    1122


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      .+ ...+..++..+.+|+.+||+.+|.+||||.||++.|+.+.
T Consensus       258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            11 1233456678899999999999999999999999998664

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.2e-51  Score=444.34  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=205.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|...+.||+|+||+||+|+.. +|+.||||++....  ....+.|.+|+++|++|+|||||++++++.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999975 58999999865432  2335679999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      ||++|+|.++|.......+++.+++.|+.||+.||+|||+   ++|+||||||+||||++++.+||+|||+|+....  .
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence            9999999999976566678999999999999999999999   9999999999999999999999999999986321  1


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      .......+||+.|||||++.+..|+.++|||||||+||||+||+.||......+.      ...... +..         
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~-~~~---------  242 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------VLKIIS-GSF---------  242 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHH-TCC---------
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHc-CCC---------
Confidence            1223456799999999999999999999999999999999999999975432221      111111 111         


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ...+...+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~  279 (350)
T 4b9d_A          243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF  279 (350)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence            1122344567899999999999999999999998633

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.6e-51  Score=443.33  Aligned_cols=268  Identities=24%  Similarity=0.355  Sum_probs=218.0

Q ss_pred             hHHHHhcCCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCCC-CChHHHHHHHHHHHhccC-CCeeeEEeEe
Q 042150          455 DLQTATNNFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRH-RHLVSLVGYC  526 (803)
Q Consensus       455 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H-pnIv~l~g~~  526 (803)
                      +++...++|...+.||+|+||+||+|.+..      ++.||||++..... ...++|.+|+++|.+++| ||||+++|+|
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            344556788999999999999999999653      35799998765433 335679999999999965 9999999999


Q ss_pred             ec-cceeeEEEEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcc
Q 042150          527 EE-QSEMILVYEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKST  591 (803)
Q Consensus       527 ~~-~~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~  591 (803)
                      .+ ++.++||||||++|+|.++|+...              ...++|.+++.++.|||+||+|||+   ++||||||||+
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~  214 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAAR  214 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCcc
Confidence            66 457899999999999999995421              3458999999999999999999999   99999999999


Q ss_pred             eEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhh
Q 042150          592 NILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAR  670 (803)
Q Consensus       592 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~  670 (803)
                      ||||++++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||......
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987554444444556789999999999999999999999999999999998 99999754322


Q ss_pred             hhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          671 EQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       671 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      +.      +......+.         ....+..+++++.+++.+||+.||.+|||+.||+++|+.+++..
T Consensus       295 ~~------~~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          295 EE------FCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             HH------HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HH------HHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            11      111112221         11223345667899999999999999999999999999887643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.5e-50  Score=433.40  Aligned_cols=250  Identities=23%  Similarity=0.354  Sum_probs=209.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      ..|+..+.||+|+||+||+|+.+ +|+.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45888899999999999999976 58999999976555566778999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+++.   ...+++.++..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+....  ...
T Consensus       154 ~gg~L~~~l~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~  225 (346)
T 4fih_A          154 EGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVP  225 (346)
T ss_dssp             TTEEHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSC
T ss_pred             CCCcHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCC
Confidence            9999999994   3469999999999999999999999   9999999999999999999999999999986432  222


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+..   ..    +....     .+.+  .
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~----i~~~~-----~~~~--~  291 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KM----IRDNL-----PPRL--K  291 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HH----HHHSS-----CCCC--S
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HH----HHcCC-----CCCC--C
Confidence            344578999999999999999999999999999999999999999754322211   11    11111     1111  1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .....++.+.+|+.+||+.||.+|||+.|++++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            122345678999999999999999999999876

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-49  Score=429.42  Aligned_cols=255  Identities=21%  Similarity=0.210  Sum_probs=207.3

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +.|...++||+|+||.||+|+.+ +|+.||||++.....     +.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45777889999999999999975 489999998754322     247999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC-cEEEeeeccccCCCCCCCC
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY-VSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFGla~~~~~~~~~  618 (803)
                      ++|+|.++|.  ....+++.++..++.||+.||+|||+   ++|+||||||+||||+.++ .+||+|||+|+........
T Consensus       133 ~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          133 EGGSLGQLIK--QMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             TTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             CCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            9999999994  34579999999999999999999999   9999999999999999887 6999999999864322111


Q ss_pred             ---ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          619 ---HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       619 ---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                         ......+||+.|||||++.+..++.++|||||||+||||+||+.||......+..   .   .....        +.
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~---~i~~~--------~~  273 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---L---KIASE--------PP  273 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---H---HHHHS--------CC
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---H---HHHcC--------CC
Confidence               1223467999999999999999999999999999999999999999754322211   1   00111        00


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                      ....++...++.+.+++.+||+.||.+|||+.|++++|..+++.
T Consensus       274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            11123445567889999999999999999999999999888753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.9e-50  Score=423.03  Aligned_cols=245  Identities=25%  Similarity=0.401  Sum_probs=195.8

Q ss_pred             CccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeec----cceeeEEE
Q 042150          464 DKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE----QSEMILVY  536 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~lV~  536 (803)
                      ...++||+|+||+||+|... ++..||+|++...  .....+.|.+|+++|++|+|||||+++++|.+    +..++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            44567999999999999976 4889999986533  22335679999999999999999999999865    35689999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--eEeeccCcceEEEc-cCCcEEEeeeccccCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG--IIHRDIKSTNILLD-ENYVSKVADFGLSRSGP  613 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLkp~NILl~-~~~~~kl~DFGla~~~~  613 (803)
                      |||++|+|.++|.  +...+++.++..++.||+.||+|||+   ++  |+||||||+||||+ .++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999994  34679999999999999999999998   66  99999999999998 47999999999998632


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                          .......+||+.|||||++.+ +|+.++|||||||+||||+||+.||........     .... ...+..    .
T Consensus       184 ----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-----~~~~-i~~~~~----~  248 (290)
T 3fpq_A          184 ----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRR-VTSGVK----P  248 (290)
T ss_dssp             ----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHH-HTTTCC----C
T ss_pred             ----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-----HHHH-HHcCCC----C
Confidence                223345689999999998865 699999999999999999999999964322111     1111 111111    0


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +.    ++...++++.+|+.+||+.||.+|||+.|++++
T Consensus       249 ~~----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          249 AS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11    112234568899999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.1e-50  Score=427.33  Aligned_cols=250  Identities=20%  Similarity=0.269  Sum_probs=210.1

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|+..++||+|+||+||+|+.. +++.||||++...   .....+.+.+|+++|++++|||||++++++++++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999975 5899999986432   3445678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      |||++|+|.++|.  +.+.+++.++..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+......
T Consensus       112 Ey~~gG~L~~~i~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999999994  34579999999999999999999999   999999999999999999999999999998754333


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      ........+||+.|||||++.+..|+.++||||+||+||||++|+.||......+.   .   ... ..+..        
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~---~~i-~~~~~--------  251 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI---F---AKI-IKLEY--------  251 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHH-HHTCC--------
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHH-HcCCC--------
Confidence            33445567899999999999999999999999999999999999999975432211   1   111 11111        


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        .++...++++.+|+.+||+.||.+|||+.|++.+
T Consensus       252 --~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          252 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             --CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence              1223345678999999999999999999987543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.7e-49  Score=435.12  Aligned_cols=250  Identities=23%  Similarity=0.354  Sum_probs=210.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +.|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56888999999999999999976 58999999987666666778999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+++.   ...+++.++..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+....  ...
T Consensus       231 ~gG~L~~~i~---~~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~  302 (423)
T 4fie_A          231 EGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVP  302 (423)
T ss_dssp             TTEEHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCC
T ss_pred             CCCcHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCc
Confidence            9999999994   3469999999999999999999999   9999999999999999999999999999986432  222


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+..   ..    +....     .+.+  .
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~----i~~~~-----~~~~--~  368 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KM----IRDNL-----PPRL--K  368 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HH----HHHSC-----CCCC--S
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HH----HHcCC-----CCCC--c
Confidence            334578999999999999999999999999999999999999999754322211   11    11111     1111  1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .....+..+.+|+.+||+.||.+|||+.|++++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            112345678999999999999999999999876

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.9e-50  Score=430.01  Aligned_cols=267  Identities=23%  Similarity=0.345  Sum_probs=200.0

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHH--HHHHHHHhccCCCeeeEEeEeeccc----eeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQ--TEITVLSKIRHRHLVSLVGYCEEQS----EMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~--~E~~~l~~l~HpnIv~l~g~~~~~~----~~~l  534 (803)
                      ++|...+.||+|+||+||+|+++ |+.||||++...   ..+++.  .|+..+.+++|||||+++|+|.+.+    .++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            34666789999999999999985 889999987533   233444  4555667889999999999997654    5899


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG-----SAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      |||||++|+|.++|+   ...++|.++++++.|+|+||+|||+.     ..++|+||||||+||||++++++||+|||+|
T Consensus        79 V~Ey~~~gsL~~~l~---~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHH---HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecCCCCCcHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999994   34699999999999999999999973     1248999999999999999999999999999


Q ss_pred             cCCCCCCCC--ceeccccCCCcccCccccccC------cCCCcceehhHHHHHHHHHhCCCCCCcchhhh---------h
Q 042150          610 RSGPCLDET--HVSTGVKGSFGYLDPEYFRRQ------QLTDKSDVYSFGVVLFEVLCARTAVDPLLARE---------Q  672 (803)
Q Consensus       610 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~---------~  672 (803)
                      +........  .......||+.|||||++.+.      .++.++|||||||+||||+||+.|+.......         .
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            764322211  122346799999999999754      57789999999999999999988764321110         0


Q ss_pred             hhHHHHHHHHhhcCccccccCcccccC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          673 VNLAEWAMQWQKKGMLEHIIDPQLIGK-INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       673 ~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                      ....... ...    .....+|.+... .+.+.+..+.+|+.+||+.||.+||||.||++.|+.+.+.
T Consensus       236 ~~~~~~~-~~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          236 PSVEEMR-KVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHH-HHH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chHHHHH-HHH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            0111111 111    111222222211 1235677899999999999999999999999999987653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.1e-48  Score=407.34  Aligned_cols=248  Identities=25%  Similarity=0.331  Sum_probs=193.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||+||+|+.. +++.||||++...   .....+.+.+|+++|++++|||||++++++.+.+.++|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999964 5899999986533   2334567999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+ +|+|.+++.  ....+++.++..++.||+.||+|||+   ++|+||||||+||||++++.+||+|||+|+....  
T Consensus        93 Ey~-~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--  164 (275)
T 3hyh_A           93 EYA-GNELFDYIV--QRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--  164 (275)
T ss_dssp             ECC-CEEHHHHHH--HSCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence            999 679999984  34579999999999999999999999   9999999999999999999999999999986332  


Q ss_pred             CCceeccccCCCcccCccccccCcC-CCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                       ........||+.|||||++.+..+ +.++||||+||+||||+||+.||.......      ..... ..+..       
T Consensus       165 -~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~------~~~~i-~~~~~-------  229 (275)
T 3hyh_A          165 -GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV------LFKNI-SNGVY-------  229 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHTCC-------
T ss_pred             -CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HcCCC-------
Confidence             223345689999999999998886 579999999999999999999997542211      11111 11111       


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                         .++...++.+.+++.+||+.||.+|||+.|++++-.
T Consensus       230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw  265 (275)
T 3hyh_A          230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW  265 (275)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence               122234567899999999999999999999998644

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9e-49  Score=417.01  Aligned_cols=248  Identities=23%  Similarity=0.290  Sum_probs=197.5

Q ss_pred             cCCCccceEeeeCceEEEEEEEC----CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR----DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ++|+..+.||+|+||+||+|+..    .++.||||.+....  ......+.+|+++|++++|||||++++++.+++.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56899999999999999999863    36789999865321  2223468899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      |||||++|+|.++|.  +...+++.++..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+....
T Consensus       104 vmEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            999999999999994  34579999999999999999999999   9999999999999999999999999999986332


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                        ........+||+.|||||++.+..++.++|||||||+||||+||+.||......+..      .... .+..      
T Consensus       179 --~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~------~~i~-~~~~------  243 (304)
T 3ubd_A          179 --HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM------TMIL-KAKL------  243 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-HCCC------
T ss_pred             --CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH------HHHH-cCCC------
Confidence              222334568999999999999999999999999999999999999999754332211      1111 1111      


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSM-----GDVLWN  732 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~~  732 (803)
                          .++...++++.+|+.+||+.||.+|||+     +|++++
T Consensus       244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             ----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                1223345678999999999999999984     677654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-46  Score=407.34  Aligned_cols=290  Identities=66%  Similarity=1.106  Sum_probs=255.7

Q ss_pred             cccChhhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeec
Q 042150          449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE  528 (803)
Q Consensus       449 ~~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~  528 (803)
                      ..+++.++...+++|...+.||+|+||.||+|.+++++.||||+.........+.|.+|++++++++||||++++++|.+
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            35667778888999999999999999999999988899999999777666677889999999999999999999999999


Q ss_pred             cceeeEEEEecCCCchhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeee
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGPD--RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADF  606 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF  606 (803)
                      .+..++||||+++|+|.+++....  ...++|.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence            999999999999999999996543  3469999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC
Q 042150          607 GLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG  686 (803)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (803)
                      |+++...............||+.|+|||.+.+..++.++|||||||++|||++|+.||......+......|.......+
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            99976433333333344568999999999999999999999999999999999999998766666667777877777777


Q ss_pred             ccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          687 MLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       687 ~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                      .+..++++.+......+....+.+++.+||+.+|.+|||+.|++++|+.++++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            7888888888888888999999999999999999999999999999999987654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.5e-46  Score=401.33  Aligned_cols=251  Identities=25%  Similarity=0.396  Sum_probs=187.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccc--------
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS--------  530 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~--------  530 (803)
                      ++|+..+.||+|+||+||+|+.+ +++.||||++..... ...+.+.+|+++|++|+|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45888999999999999999975 588999998654332 23467999999999999999999999986544        


Q ss_pred             ----eeeEEEEecCCCchhhhccCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEee
Q 042150          531 ----EMILVYEYMEKGPLKKHLYGPDR-TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVAD  605 (803)
Q Consensus       531 ----~~~lV~Ey~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D  605 (803)
                          .+|||||||++|+|.+++..... ...++..++.|+.||++||+|||+   ++|+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence                37999999999999999964332 345667789999999999999999   9999999999999999999999999


Q ss_pred             eccccCCCCCCCC----------ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhH
Q 042150          606 FGLSRSGPCLDET----------HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL  675 (803)
Q Consensus       606 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l  675 (803)
                      ||+|+........          ...+..+||+.|||||++.+..|+.++|||||||+||||++   ||.....  ....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~~  236 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVRT  236 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHHH
Confidence            9999864332111          11234579999999999999999999999999999999996   6643211  1100


Q ss_pred             HHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          676 AEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       676 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                         ... ......     |.    ......+.+.+++.+||+.||.+|||+.|++++
T Consensus       237 ---~~~-~~~~~~-----p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          237 ---LTD-VRNLKF-----PP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             ---HHH-HHTTCC-----CH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---HHH-HhcCCC-----CC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence               001 111111     00    012234567789999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=401.26  Aligned_cols=263  Identities=21%  Similarity=0.293  Sum_probs=201.5

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeec------cce
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEE------QSE  531 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~------~~~  531 (803)
                      ++|...+.||+|+||+||+|+.. +|+.||||++.....  ...+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57899999999999999999975 589999999754332  224578899999999999999999998753      367


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      +|||||||+ |+|.+++.  ....+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            899999996 68999994  45679999999999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCC--CCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          612 GPCLD--ETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       612 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      .....  ........+||+.|||||++.+. .++.++||||+||+||||++|+.||......+.....   .........
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p~~  284 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTPSP  284 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCCCG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCCCh
Confidence            43211  12233457899999999998875 5689999999999999999999999765433322111   111100000


Q ss_pred             ---ccc-----------cCcccc---cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 ---EHI-----------IDPQLI---GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ---~~i-----------~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                         ..+           +.+...   ....+.....+.+|+.+||..||.+|||+.|++++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               000           000000   00001224578899999999999999999999876

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.6e-44  Score=389.26  Aligned_cols=287  Identities=38%  Similarity=0.665  Sum_probs=247.5

Q ss_pred             cccChhhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEee
Q 042150          449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCE  527 (803)
Q Consensus       449 ~~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~  527 (803)
                      ..+++.++....++|...+.||+|+||.||+|...+++.||||++.... ......|.+|++++++++||||++++++|.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            4678899999999999999999999999999998889999999876543 223447999999999999999999999999


Q ss_pred             ccceeeEEEEecCCCchhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEee
Q 042150          528 EQSEMILVYEYMEKGPLKKHLYGPD--RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVAD  605 (803)
Q Consensus       528 ~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D  605 (803)
                      ..+..++||||+++|+|.+++....  ...+++..++.++.|++.||+|||+.+..+|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            9999999999999999999996543  34599999999999999999999993223999999999999999999999999


Q ss_pred             eccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcch--hhhhhhHHHHHHHHh
Q 042150          606 FGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLL--AREQVNLAEWAMQWQ  683 (803)
Q Consensus       606 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~--~~~~~~l~~~~~~~~  683 (803)
                      ||+++.... ..........||+.|+|||.+.+..++.++|||||||++|||++|+.||+...  ........+|.....
T Consensus       178 fg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          178 FGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CSSCEECCS-SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             CccccccCc-ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            999986432 22233445669999999999999999999999999999999999999997432  223445677777777


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      ....+..+.+..+......+....+.+++.+||+.+|.+|||+.||+++|+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            77788888888888888899999999999999999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.8e-44  Score=390.92  Aligned_cols=199  Identities=23%  Similarity=0.375  Sum_probs=170.3

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC----CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeecccee
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  532 (803)
                      ...+.|+..+.||+|+||+||+|+.+    .++.||+|++...  ....++.+|+++|+.+ +||||+++++++.+.+.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            45678999999999999999999863    3678999987543  3456789999999998 699999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC-CcEEEeeeccccC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRS  611 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~kl~DFGla~~  611 (803)
                      +|||||+++|+|.+++     ..+++.++..++.||+.||+|||+   ++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus        96 ~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           96 VIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999999     248999999999999999999999   999999999999999876 7999999999975


Q ss_pred             CCCCCC--------------------------CceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCC
Q 042150          612 GPCLDE--------------------------THVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAV  664 (803)
Q Consensus       612 ~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~  664 (803)
                      ......                          .......+||+.|||||++.+. .++.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            322110                          0112345799999999999875 5899999999999999999999998


Q ss_pred             Cc
Q 042150          665 DP  666 (803)
Q Consensus       665 ~~  666 (803)
                      ..
T Consensus       248 ~~  249 (361)
T 4f9c_A          248 YK  249 (361)
T ss_dssp             SC
T ss_pred             CC
Confidence            54

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.4e-43  Score=411.62  Aligned_cols=253  Identities=22%  Similarity=0.296  Sum_probs=208.8

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .++|...+.||+|+||.||+|+.+ +|+.||+|.+........+.+.+|+++|+.|+|||||++++++.+.+.++|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            367999999999999999999975 5899999987655544567789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC--CcEEEeeeccccCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN--YVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~--~~~kl~DFGla~~~~~~~  616 (803)
                      |++|+|.++|.. ....+++.++..++.||+.||+|||+   ++|+||||||+|||++.+  +.+||+|||+|+....  
T Consensus       236 ~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--  309 (573)
T 3uto_A          236 MSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--  309 (573)
T ss_dssp             CCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred             cCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence            999999999853 33569999999999999999999999   999999999999999854  8999999999987432  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                       .......+||+.|||||++.+..|+.++|||||||+||||++|+.||......+..      .. +.....  -+.+..
T Consensus       310 -~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~------~~-i~~~~~--~~~~~~  379 (573)
T 3uto_A          310 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL------RN-VKSCDW--NMDDSA  379 (573)
T ss_dssp             -TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HH-HHTTCC--CCCSGG
T ss_pred             -CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------HH-HHhCCC--CCCccc
Confidence             23344568999999999999999999999999999999999999999754332221      11 111100  001111


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                          ....+..+.+|+.+||+.||.+|||+.|++++
T Consensus       380 ----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          380 ----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                12234678899999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.3e-43  Score=405.78  Aligned_cols=251  Identities=22%  Similarity=0.265  Sum_probs=201.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHH---HHHHHhccCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTE---ITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E---~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      .++|...++||+|+||+||+|+.+ +|+.||||++...   .......+.+|   +.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            357999999999999999999976 4899999986432   22333344444   5666777899999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      |||||||+||+|.++|.  ....+++.++..++.||+.||+|||+   ++||||||||+||||+.+|.+||+|||+|+..
T Consensus       268 ylVmEy~~GGdL~~~l~--~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEECCCCSCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999994  34579999999999999999999999   99999999999999999999999999999864


Q ss_pred             CCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ..    ......+||+.|||||++.+ ..|+.++|||||||+||||++|+.||......+...+..   ... ...    
T Consensus       343 ~~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~-~~~----  410 (689)
T 3v5w_A          343 SK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTL-TMA----  410 (689)
T ss_dssp             SS----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHH-HCC----
T ss_pred             CC----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhc-CCC----
Confidence            32    12334689999999999964 579999999999999999999999997543322211111   111 110    


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWNL  733 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~L  733 (803)
                            ..++...++.+.+|+.+||+.||.+|++     +.||+++-
T Consensus       411 ------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp  451 (689)
T 3v5w_A          411 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  451 (689)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred             ------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence                  1123344567899999999999999998     68887653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.6e-42  Score=380.45  Aligned_cols=263  Identities=25%  Similarity=0.435  Sum_probs=214.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC--------CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhc-cCCCeeeEEeEeecc
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR--------DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ  529 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~  529 (803)
                      .++|...+.||+|+||.||+|...        ++..||||++..... ...+++.+|+++|+++ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888899999999999999863        345799998765432 2356799999999999 899999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL  595 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl  595 (803)
                      +.+++||||+++|+|.+++....              ...+++.+++.++.||++||+|||+   ++|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence            99999999999999999995432              2458999999999999999999999   999999999999999


Q ss_pred             ccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhh
Q 042150          596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVN  674 (803)
Q Consensus       596 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  674 (803)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+.. 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence            9999999999999986443332233344567889999999999999999999999999999999 99998754332211 


Q ss_pred             HHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          675 LAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       675 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                        .    ....+.         ....+..+...+.+++.+||+.+|.+||++.|+++.|+.++.+..
T Consensus       316 --~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          316 --K----LLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             --H----HHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             --H----HHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence              1    111111         112233455678999999999999999999999999999887653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.9e-41  Score=361.99  Aligned_cols=281  Identities=37%  Similarity=0.626  Sum_probs=229.2

Q ss_pred             cccChhhHHHHhcCCCcc------ceEeeeCceEEEEEEECCCcEEEEEEcCCCC----CCChHHHHHHHHHHHhccCCC
Q 042150          449 LKIPFTDLQTATNNFDKN------LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS----RQGLPEFQTEITVLSKIRHRH  518 (803)
Q Consensus       449 ~~~~~~~l~~~~~~f~~~------~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~Hpn  518 (803)
                      ..+++.++..++++|...      +.||+|+||.||+|.. +++.||||++....    ....+.|.+|+.++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            457889999999999988      8999999999999986 57899999865432    233567999999999999999


Q ss_pred             eeeEEeEeeccceeeEEEEecCCCchhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc
Q 042150          519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGP-DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE  597 (803)
Q Consensus       519 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~  597 (803)
                      |+++++++.+.+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence            999999999999999999999999999998543 24569999999999999999999999   99999999999999999


Q ss_pred             CCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHH
Q 042150          598 NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE  677 (803)
Q Consensus       598 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  677 (803)
                      ++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||........  +..
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~  245 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLD  245 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHH
Confidence            99999999999976443333333345678999999998865 589999999999999999999999975432221  112


Q ss_pred             HHHHHh-hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          678 WAMQWQ-KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       678 ~~~~~~-~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      +..... ....+...+++.+ ...+......+.+++.+||+.+|.+|||+.+++++|+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            222211 1222333444433 3456677889999999999999999999999999999764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.7e-41  Score=361.99  Aligned_cols=252  Identities=22%  Similarity=0.291  Sum_probs=209.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .++|...+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999995 45889999987666666678899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.+++..   ..+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....  .
T Consensus        99 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  170 (297)
T 3fxz_A           99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--Q  170 (297)
T ss_dssp             CTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred             CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--c
Confidence            999999999943   468999999999999999999999   89999999999999999999999999998754321  1


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........      ....... ..       .
T Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~~~~~~-~~-------~  236 (297)
T 3fxz_A          171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT-PE-------L  236 (297)
T ss_dssp             CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS-CC-------C
T ss_pred             cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCC-CC-------C
Confidence            22344679999999999999999999999999999999999999997543322111      1111110 00       0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      ..+......+.+++.+||+.||.+|||+.|++++-
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  271 (297)
T 3fxz_A          237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ  271 (297)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             CCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence            11233456789999999999999999999998753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.4e-42  Score=367.96  Aligned_cols=259  Identities=25%  Similarity=0.358  Sum_probs=211.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      ++|...++||+|+||+||+|... +++.||+|++........+.|.+|++++++++||||++++++|.+.+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            56788889999999999999975 48899999876655566778999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+++... ...+++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.........
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           90 KGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             TTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            999999999542 4569999999999999999999999   999999999999999999999999999997543221110


Q ss_pred             ------------eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh---hhHHHHHHHHhh
Q 042150          620 ------------VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ---VNLAEWAMQWQK  684 (803)
Q Consensus       620 ------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~---~~l~~~~~~~~~  684 (803)
                                  ......||+.|+|||++.+..++.++|||||||++|||++|..|+........   .......     
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-----  240 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-----  240 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-----
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-----
Confidence                        11145799999999999999999999999999999999999998764322211   1111111     


Q ss_pred             cCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          685 KGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       685 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                                  ....+..++..+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus       241 ------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          241 ------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             ------------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                        01112233456789999999999999999999999999876443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.4e-41  Score=363.13  Aligned_cols=263  Identities=21%  Similarity=0.304  Sum_probs=216.7

Q ss_pred             ccChhhHHHHhcC----------CCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCC
Q 042150          450 KIPFTDLQTATNN----------FDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH  518 (803)
Q Consensus       450 ~~~~~~l~~~~~~----------f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hpn  518 (803)
                      .+++++++.+++.          |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4677888887765          666778999999999999986 68999999987776777888999999999999999


Q ss_pred             eeeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC
Q 042150          519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN  598 (803)
Q Consensus       519 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~  598 (803)
                      |+++++++...+..++||||+++|+|.+++.   ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.+
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999983   3569999999999999999999999   899999999999999999


Q ss_pred             CcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHH
Q 042150          599 YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW  678 (803)
Q Consensus       599 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  678 (803)
                      +.+||+|||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||........   .. 
T Consensus       178 ~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~~-  251 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MK-  251 (321)
T ss_dssp             CCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH-
T ss_pred             CcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH-
Confidence            99999999998754321  1123346799999999999999999999999999999999999999875432211   11 


Q ss_pred             HHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          679 AMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       679 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                        . .....     .+.+  .........+.+++.+||+.+|.+|||+.|++++..
T Consensus       252 --~-~~~~~-----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~  297 (321)
T 2c30_A          252 --R-LRDSP-----PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF  297 (321)
T ss_dssp             --H-HHHSS-----CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             --H-HhcCC-----CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence              1 11111     1111  111233467899999999999999999999987643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.2e-42  Score=374.83  Aligned_cols=269  Identities=28%  Similarity=0.364  Sum_probs=209.5

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccc----eeeE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS----EMIL  534 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~----~~~l  534 (803)
                      ..++|...++||+|+||.||+|++. ++.||||++.... .....+..|+.+|++++||||+++++++....    .+++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3467889999999999999999876 7899999875432 22345667899999999999999999997744    4799


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------ceEeeccCcceEEEccCCcEEEe
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE----------GIIHRDIKSTNILLDENYVSKVA  604 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~ivHrDLkp~NILl~~~~~~kl~  604 (803)
                      ||||+++|+|.+++..   ..+++.+++.++.|+++||+|||+   .          +|+||||||+|||++.++.+||+
T Consensus       100 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            9999999999999943   459999999999999999999998   6          99999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeccccCCCcccCcccccc-----CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhh------
Q 042150          605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR-----QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV------  673 (803)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~------  673 (803)
                      |||+++...............||+.|+|||++.+     ..++.++|||||||++|||++|+.||.........      
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            9999975433232223344679999999999986     46667899999999999999999998754322111      


Q ss_pred             ----hHHHHHHHHhhcCccccccCcccccC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          674 ----NLAEWAMQWQKKGMLEHIIDPQLIGK-INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       674 ----~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                          ....+.......     ...+.+... .....+..+.+++.+||+.||.+|||+.||++.|+.+.+..
T Consensus       254 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHK-----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CSSCCHHHHHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ccCCchhhhhhhhhcc-----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                111111111111     111111111 12345677999999999999999999999999999887543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.2e-41  Score=363.45  Aligned_cols=260  Identities=29%  Similarity=0.463  Sum_probs=204.4

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ...++|...+.||+|+||.||+|.. .++.||||++.....  ...++|.+|+++|++++||||+++++++.+.+..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            3456788899999999999999987 478999998754432  2345789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--eEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          536 YEYMEKGPLKKHLYGPD-RTPLSWKQRLEICIGAARGLHYLHTGSAEG--IIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      |||+++|+|.+++.... ...+++.+++.++.|+++||+|||+   .+  |+||||||+|||++.++.+||+|||+++..
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            99999999999995432 2249999999999999999999999   78  999999999999999999999999999753


Q ss_pred             CCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ..  .........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+...      ......      
T Consensus       190 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~------~~~~~~------  255 (309)
T 3p86_A          190 AS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA------AVGFKC------  255 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHHSC------
T ss_pred             cc--cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcC------
Confidence            22  1122334678999999999999999999999999999999999999997543322111      110000      


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                         .....+......+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       256 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          256 ---KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             ---CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence               0112233445678999999999999999999999999998864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=367.28  Aligned_cols=262  Identities=27%  Similarity=0.426  Sum_probs=210.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC----CCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR----DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .++|...+.||+|+||.||+|.+.    .+..||||++... .....+.|.+|++++++++||||++++++|.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            456888899999999999999984    3556999987654 23335679999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++... ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            99999999999999543 3569999999999999999999999   9999999999999999999999999999986433


Q ss_pred             CCC-CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          615 LDE-THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       615 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..      ... ..+      
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~------~~~-~~~------  270 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI------SSV-EEG------  270 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HHH-HTT------
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH------HHH-HcC------
Confidence            221 122233456788999999999999999999999999999999 99998654332211      111 111      


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                         .....+..++..+.+++.+||+.+|.+|||+.+|++.|+.++....
T Consensus       271 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          271 ---YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             ---CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence               0111233455678999999999999999999999999998875443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.2e-42  Score=375.30  Aligned_cols=270  Identities=24%  Similarity=0.354  Sum_probs=215.6

Q ss_pred             ChhhHHHHhcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhc-cCCCeeeEE
Q 042150          452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKI-RHRHLVSLV  523 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~  523 (803)
                      ...++....++|...+.||+|+||.||+|.+.      +++.||||++..... ...+.|.+|++++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            34555667788999999999999999999842      357899998765432 2346799999999999 799999999


Q ss_pred             eEeeccc-eeeEEEEecCCCchhhhccCCCC-------------------------------------------------
Q 042150          524 GYCEEQS-EMILVYEYMEKGPLKKHLYGPDR-------------------------------------------------  553 (803)
Q Consensus       524 g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------  553 (803)
                      ++|.+.+ ..++||||+++|+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            9997755 48999999999999999965332                                                 


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          554 ---------------TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       554 ---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                                     ..+++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                           228999999999999999999999   89999999999999999999999999999865433333


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..  .    .....+.         .
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~----~~~~~~~---------~  314 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--C----RRLKEGT---------R  314 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--H----HHHHHTC---------C
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--H----HHHHcCC---------C
Confidence            34455678999999999999999999999999999999998 99998754322211  1    1111111         0


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                      ...+......+.+++.+||+.+|.+|||+.|++++|+.+++.
T Consensus       315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            112223446789999999999999999999999999988754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.5e-42  Score=365.99  Aligned_cols=266  Identities=24%  Similarity=0.341  Sum_probs=207.7

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-----CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeecc--cee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~  532 (803)
                      .++|+..+.||+|+||.||+|.+.     +++.||||++........+.|.+|++++++++||||++++++|...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            356888899999999999999852     5789999998766555567899999999999999999999998554  458


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999999999999543 3459999999999999999999999   99999999999999999999999999999864


Q ss_pred             CCCCCC-ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhh---------hHHHHHHHH
Q 042150          613 PCLDET-HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV---------NLAEWAMQW  682 (803)
Q Consensus       613 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~---------~l~~~~~~~  682 (803)
                      ...... .......++..|+|||.+.+..++.++|||||||++|||++|..|+.........         .........
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            322211 1223345777899999999999999999999999999999999988643221100         000011111


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ....         .....+..++..+.+++.+||+.+|.+|||+.|+++.|+.+.+
T Consensus       245 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          245 LKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Hhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            1111         1112233456788999999999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.4e-41  Score=366.25  Aligned_cols=258  Identities=24%  Similarity=0.364  Sum_probs=203.5

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-Cc----EEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NT----KVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ++|...++||+|+||.||+|++.. ++    +||+|.+... .....++|.+|+.++++++||||++++++|.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            568888999999999999999643 33    4688876543 3455678999999999999999999999998754 789


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      |+||+++|+|.+++... ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999999543 3569999999999999999999999   8999999999999999999999999999975433


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ...........+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+.   ....    ..+.      
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~----~~~~------  236 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSIL----EKGE------  236 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH----HTTC------
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---HHHH----HcCC------
Confidence            333333344567889999999999999999999999999999999 9999975433221   1111    1110      


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                         ....+..+...+.+++.+||+.+|.+||++.+++++|+.+...
T Consensus       237 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          237 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence               1112333456789999999999999999999999999988653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.8e-42  Score=378.84  Aligned_cols=259  Identities=27%  Similarity=0.380  Sum_probs=209.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||.||+|.+. +++.||||.+..... ...++|.+|+++|++++||||++++++|...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            456788889999999999999986 688999998764322 223568899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++|+|.+++.. ....+++.+++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          193 LVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            9999999999953 23458999999999999999999999   9999999999999999999999999999975322111


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      ........++..|+|||.+.+..++.++|||||||+||||++ |+.||......+.   .+    ....+.         
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---~~----~~~~~~---------  332 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---RE----FVEKGG---------  332 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---HH----HHHTTC---------
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcCC---------
Confidence            111112235778999999999999999999999999999998 9999875432221   11    111111         


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ....+..++..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            011223345678999999999999999999999999998764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.8e-41  Score=373.55  Aligned_cols=261  Identities=26%  Similarity=0.427  Sum_probs=201.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC----CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR----DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ..+|...+.||+|+||.||+|++.    ++..||||++.... ....++|.+|+.+|++++||||++++++|.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357889999999999999999865    46789999876542 2335679999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++.. ....+++.+++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999954 34569999999999999999999999   8999999999999999999999999999986432


Q ss_pred             CCCC-ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          615 LDET-HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       615 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      .... .......++..|+|||++.+..++.++|||||||+||||++ |+.||......+.   ..   . ...+      
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~---~-i~~~------  266 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IK---A-VDEG------  266 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HH---H-HHTT------
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---H-HHcC------
Confidence            2111 11122345778999999999999999999999999999998 9999865432211   11   1 1111      


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                         .....+..++..+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus       267 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          267 ---YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ---EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ---CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence               111222345567899999999999999999999999999887543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.8e-41  Score=354.29  Aligned_cols=256  Identities=31%  Similarity=0.459  Sum_probs=211.3

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ++|...+.||+|+||.||+|...+++.||+|++... ....+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            568888899999999999999988999999987643 3345789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|+|.+++.. ....+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus        89 ~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~  163 (269)
T 4hcu_A           89 HGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTS  163 (269)
T ss_dssp             TCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC-HHHHS
T ss_pred             CCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccc-ccccc
Confidence            9999999954 33569999999999999999999999   9999999999999999999999999999975322 11112


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.      .... ..+.         ...
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~------~~~~-~~~~---------~~~  227 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDI-STGF---------RLY  227 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHH-HTTC---------CCC
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH------HHHH-hcCc---------cCC
Confidence            234456788999999999999999999999999999999 9999875433221      1111 1110         011


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      .+......+.+++.+||+.+|.+||++.+++++|+.+.+
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            122234678999999999999999999999999998864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=373.07  Aligned_cols=264  Identities=26%  Similarity=0.417  Sum_probs=215.4

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC--------CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeec
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR--------DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEE  528 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~  528 (803)
                      ..++|...+.||+|+||.||+|...        .+..||||++.... ....+++.+|+++++++ +||||++++++|..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3467888899999999999999863        23579999876543 23346789999999999 89999999999999


Q ss_pred             cceeeEEEEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEE
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNIL  594 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NIL  594 (803)
                      .+..++||||+++|+|.+++....              ...+++.+++.++.||+.||+|||+   .+|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence            999999999999999999995432              2469999999999999999999999   89999999999999


Q ss_pred             EccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhh
Q 042150          595 LDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQV  673 (803)
Q Consensus       595 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~  673 (803)
                      +++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+. 
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~-  302 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-  302 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            99999999999999986544333333445567889999999999999999999999999999999 9999875432221 


Q ss_pred             hHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          674 NLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       674 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                           ... ...+.         ....+......+.+++.+||+.+|.+|||+.||+++|+.+.....
T Consensus       303 -----~~~-~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          303 -----FKL-LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             -----HHH-HHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             -----HHH-HHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                 111 11111         111222345678999999999999999999999999999986554

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.7e-41  Score=365.31  Aligned_cols=255  Identities=25%  Similarity=0.320  Sum_probs=203.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|...+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57888999999999999999976 68899999865432 22346689999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.+++.  ....+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        87 ~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           87 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             CCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            99999999994  44569999999999999999999999   99999999999999999999999999999754322222


Q ss_pred             ceeccccCCCcccCccccccCcC-CCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      .......||+.|+|||++.+..+ +.++|||||||+||||++|+.||........ ....|.    ....   ..     
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~----~~~~---~~-----  228 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKT---YL-----  228 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH----TTCT---TS-----
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh----cccc---cC-----
Confidence            23345679999999999987775 7789999999999999999999975432211 111111    1100   00     


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                       .........+.+++.+||+.||.+|||+.|++++-.
T Consensus       229 -~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~  264 (323)
T 3tki_A          229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (323)
T ss_dssp             -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             -CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence             011233466789999999999999999999987644

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.1e-41  Score=365.53  Aligned_cols=248  Identities=22%  Similarity=0.332  Sum_probs=205.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .++|...+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+++|+.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35788899999999999999997 56899999986543  2233567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++..  ...+++.++..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++....  
T Consensus        94 e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--  166 (328)
T 3fe3_A           94 EYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--  166 (328)
T ss_dssp             CCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred             ECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence            99999999999943  3569999999999999999999999   9999999999999999999999999999975332  


Q ss_pred             CCceeccccCCCcccCccccccCcCC-CcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLT-DKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                       ........||+.|+|||.+.+..++ .++|||||||+||||++|+.||......+.      .... ..+..       
T Consensus       167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~i-~~~~~-------  231 (328)
T 3fe3_A          167 -GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL------RERV-LRGKY-------  231 (328)
T ss_dssp             -SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH-HHCCC-------
T ss_pred             -CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH------HHHH-HhCCC-------
Confidence             2223456799999999999988876 789999999999999999999975432221      1111 11110       


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                         ..+...+..+.+++.+||+.||.+|||+.|++++
T Consensus       232 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 ---RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ---CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ---CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               1122345678899999999999999999999876

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.8e-40  Score=359.40  Aligned_cols=265  Identities=17%  Similarity=0.156  Sum_probs=209.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||.||+|.. .+++.||||.+....  ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            35788889999999999999996 468899999865433  234689999999999 89999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc-----EEEeeeccccCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV-----SKVADFGLSRSG  612 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-----~kl~DFGla~~~  612 (803)
                      |+ +++|.+++... ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.     +||+|||+++..
T Consensus        86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            99 99999999543 4579999999999999999999999   89999999999999998887     999999999753


Q ss_pred             CCCCCCc-----eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCc
Q 042150          613 PCLDETH-----VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM  687 (803)
Q Consensus       613 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (803)
                      .......     ......||+.|+|||++.+..++.++|||||||+||||++|+.||.......................
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            3221111     12456799999999999999999999999999999999999999976432222111111111100000


Q ss_pred             cccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          688 LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       688 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                      ..     .+    ....+ .+.+++.+|++.+|.+||++.+|++.|+.+.....
T Consensus       241 ~~-----~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          241 IE-----VL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HH-----HH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HH-----HH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            00     00    01122 78999999999999999999999999998775543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.5e-41  Score=384.10  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=211.7

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ..++|...+.||+|+||.||+|.++++..||||++.... ...++|.+|+++|++++||||+++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            456788889999999999999999888999999976543 45789999999999999999999999987 5678999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.+++.......+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~~  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EY  339 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-HH
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-ce
Confidence            999999999965444568999999999999999999999   89999999999999999999999999999863321 11


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      .......++..|+|||++....++.++|||||||+||||++ |+.||......+..   .   .. ..+.         .
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~---~i-~~~~---------~  403 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R---AL-ERGY---------R  403 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H---HH-HHTC---------C
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---H---HH-HcCC---------C
Confidence            11223456789999999999999999999999999999999 99999754332211   1   11 1110         0


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      ...+..++..+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            1122345567899999999999999999999999998764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4e-41  Score=386.26  Aligned_cols=257  Identities=28%  Similarity=0.410  Sum_probs=214.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ..+|...+.||+|+||.||+|.++. +..||||.+... ....++|.+|+++|++++||||++++++|.+....+|||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4567888899999999999999875 789999997654 34578899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.+++.......+++..++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++.... ...
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-~~~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTY  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT-CCE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccC-Cce
Confidence            999999999976556779999999999999999999999   9999999999999999999999999999986432 122


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      .......++..|+|||.+.+..++.++|||||||+||||++ |+.||......+.   .+..    ..+         ..
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~----~~~---------~~  437 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELL----EKD---------YR  437 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHH----HTT---------CC
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcC---------CC
Confidence            22234456789999999999999999999999999999999 9999875433221   1111    111         11


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      ...+..++..+.+|+.+||+.+|.+|||+.+|++.|+.+.
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            1223345577899999999999999999999999998764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7e-41  Score=362.85  Aligned_cols=269  Identities=25%  Similarity=0.356  Sum_probs=199.3

Q ss_pred             hhHHHHhcCCCccceEeeeCceEEEEEEECCC----cEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEee
Q 042150          454 TDLQTATNNFDKNLIIGSGGFGMVYKGVLRDN----TKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCE  527 (803)
Q Consensus       454 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~  527 (803)
                      +++....++|...+.||+|+||.||+|.....    ..||||.+...  .....++|.+|++++++++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            34444567899999999999999999996543    27999987654  2334678999999999999999999999998


Q ss_pred             cccee------eEEEEecCCCchhhhccC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc
Q 042150          528 EQSEM------ILVYEYMEKGPLKKHLYG----PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE  597 (803)
Q Consensus       528 ~~~~~------~lV~Ey~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~  597 (803)
                      .....      ++||||+++|+|.+++..    .....+++.+++.++.|+++||+|||+   .+|+||||||+|||+++
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~  172 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAE  172 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcC
Confidence            77655      999999999999999843    223369999999999999999999999   89999999999999999


Q ss_pred             CCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHH
Q 042150          598 NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLA  676 (803)
Q Consensus       598 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~  676 (803)
                      ++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+..   
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---  249 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---  249 (323)
T ss_dssp             TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---
T ss_pred             CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---
Confidence            99999999999986443333233334567889999999999999999999999999999999 99998754332211   


Q ss_pred             HHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          677 EWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       677 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                      .   ......          ....+...+..+.+++.+||+.||.+|||+.++++.|+.++.-..
T Consensus       250 ~---~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          250 N---YLIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             H---HHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             H---HHhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            1   111110          011223445678999999999999999999999999999886443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-40  Score=359.33  Aligned_cols=261  Identities=25%  Similarity=0.370  Sum_probs=212.4

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccce
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~  531 (803)
                      ..++|...+.||+|+||.||+|...      +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            3567888899999999999999862      35789999876432 2335678999999999999999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPD----------------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIK  589 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk  589 (803)
                      .++||||+++|+|.+++....                      ...+++.+++.++.||++||+|||+   ++|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence            999999999999999995432                      1348999999999999999999999   999999999


Q ss_pred             cceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcch
Q 042150          590 STNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLL  668 (803)
Q Consensus       590 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~  668 (803)
                      |+|||+++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999976433222222334567889999999999999999999999999999999 999987544


Q ss_pred             hhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          669 AREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       669 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      .....   ..    ...+.         ....+...+..+.+++.+||+.+|.+||++.|++++|+.+..
T Consensus       258 ~~~~~---~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          258 PERLF---NL----LKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GGGHH---HH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHH---HH----hhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            32211   11    11111         011223445678999999999999999999999999998865

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2e-40  Score=354.58  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=206.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC---ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ---GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .++|...+.||+|+||.||+|... +++.||+|.+......   ..+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            356888899999999999999975 5889999986543332   246789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++|+|.+++.  ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~e~~~g~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            99999999999994  33569999999999999999999999   99999999999999999999999999999864321


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                       .........||+.|+|||.+.+..++.++|||||||++|||++|+.||........      ........ .     +.
T Consensus       165 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~-----~~  231 (294)
T 4eqm_A          165 -SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-V-----PN  231 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-C-----CC
T ss_pred             -cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-C-----CC
Confidence             11223345689999999999999999999999999999999999999975432211      11111111 0     11


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHh
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRP-SMGDVLWNLEYALQ  738 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~~~~  738 (803)
                      .........+..+.+++.+||+.+|.+|| ++.++.+.|+.++.
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            11122234456789999999999999998 88999888886653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.7e-40  Score=376.77  Aligned_cols=252  Identities=28%  Similarity=0.434  Sum_probs=208.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccc-eeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS-EMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~lV~Ey  538 (803)
                      .++|...+.||+|+||.||+|.++ ++.||||.+....  ..+.|.+|+++|++++||||++++++|.+.. ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            456788889999999999999986 7799999976543  5678999999999999999999999987655 79999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.+++.......+++..++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++....    
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~----  341 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  341 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc----
Confidence            999999999965555568999999999999999999999   9999999999999999999999999999985321    


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                       ......++..|+|||.+.+..++.++|||||||+||||++ |+.||......+..   .   . ...+.         .
T Consensus       342 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~---~-i~~~~---------~  404 (450)
T 1k9a_A          342 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P---R-VEKGY---------K  404 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---H---H-HHTTC---------C
T ss_pred             -cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---H-HHcCC---------C
Confidence             1122357889999999999999999999999999999998 99998754332211   1   1 11111         1


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ...+..++..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            12233456788999999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-40  Score=364.27  Aligned_cols=264  Identities=23%  Similarity=0.358  Sum_probs=211.2

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCC-CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeecc
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ  529 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~  529 (803)
                      ...++|...+.||+|+||.||+|...      ++..||||.+... .....+.+.+|+.++.++ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            34578889999999999999999962      3568999987644 334467899999999999 899999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeecc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDR---------------------TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI  588 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL  588 (803)
                      +..++||||+++|+|.+++.....                     ..+++.+++.++.||+.||+|||+   .+|+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence            999999999999999999965332                     348999999999999999999999   99999999


Q ss_pred             CcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcc
Q 042150          589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPL  667 (803)
Q Consensus       589 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~  667 (803)
                      ||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||+||||++ |+.||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999976433333333445567889999999999999999999999999999998 99998754


Q ss_pred             hhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          668 LAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       668 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                      .....  ..    .....+         .....+......+.+++.+||+.+|.+|||+.+++++|+.+...
T Consensus       279 ~~~~~--~~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          279 PVDAN--FY----KLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CCSHH--HH----HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CcHHH--HH----HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            32211  11    111111         01112233456789999999999999999999999999987643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=353.14  Aligned_cols=272  Identities=20%  Similarity=0.263  Sum_probs=212.8

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccc--eeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS--EMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~--~~~lV~  536 (803)
                      ++|...++||+|+||.||+|.... ++.||||++.... ....+.+.+|+++|++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            568888999999999999999865 8899999875432 345678899999999999999999999997655  789999


Q ss_pred             EecCCCchhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE----ccCCcEEEeeeccccC
Q 042150          537 EYMEKGPLKKHLYGPD-RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSRS  611 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~~kl~DFGla~~  611 (803)
                      ||+++|+|.+++.... ...+++.+++.++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999996533 2349999999999999999999999   999999999999999    7888899999999976


Q ss_pred             CCCCCCCceeccccCCCcccCccccc--------cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhh-hHHHHHHHH
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFR--------RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV-NLAEWAMQW  682 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~  682 (803)
                      ....   .......||+.|+|||++.        +..++.++|||||||++|||++|+.||......... ....-....
T Consensus       166 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          166 LEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             cCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            4322   2223457899999999986        578999999999999999999999999644322211 111111111


Q ss_pred             hhcCcccccc-----------CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          683 QKKGMLEHII-----------DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       683 ~~~~~~~~i~-----------d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ........+.           +..............+.+++.+||+.||.+|||++|++++......
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            1111111100           0011123456778889999999999999999999999999886653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.2e-40  Score=358.92  Aligned_cols=263  Identities=23%  Similarity=0.367  Sum_probs=213.7

Q ss_pred             HhcCCCccceEeeeCceEEEEEEE------CCCcEEEEEEcCCCCC-CChHHHHHHHHHHHhc-cCCCeeeEEeEeeccc
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVL------RDNTKVAVKRGVPGSR-QGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQS  530 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~  530 (803)
                      ..++|...+.||+|+||.||+|..      .+++.||||.+..... ...+.+.+|+.+++++ +||||++++++|...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346788899999999999999985      2467899998765432 2356799999999999 8999999999999999


Q ss_pred             eeeEEEEecCCCchhhhccCCCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEE
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDR----------------TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNIL  594 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NIL  594 (803)
                      ..++||||+++|+|.+++.....                ..+++.+++.++.|+++||+|||+   .+|+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence            99999999999999999954322                259999999999999999999999   89999999999999


Q ss_pred             EccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhh
Q 042150          595 LDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQV  673 (803)
Q Consensus       595 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~  673 (803)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........ 
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence            99999999999999987544333333344567889999999999999999999999999999999 9999875432211 


Q ss_pred             hHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          674 NLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       674 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                       ...    ......         ....+...+..+.+++.+||+.+|.+|||+.|+++.|+.++..
T Consensus       257 -~~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          257 -FYK----MIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             -HHH----HHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHH----HhccCC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence             111    111110         0111223456789999999999999999999999999988753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.9e-40  Score=349.35  Aligned_cols=256  Identities=28%  Similarity=0.416  Sum_probs=210.7

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .++|...+.||+|+||.||+|..+++..||+|++.... ...+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            45788889999999999999999988899999876443 34578999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++... ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        86 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-QYV  160 (268)
T ss_dssp             TTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT-CEE
T ss_pred             CCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchh-hhh
Confidence            999999999432 3459999999999999999999999   99999999999999999999999999999764321 222


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..      ..... +.  ..       
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~-~~--~~-------  224 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVSQ-GH--RL-------  224 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHT-TC--CC-------
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HHHHc-CC--CC-------
Confidence            2334556778999999999999999999999999999999 99998754332211      11111 10  00       


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      ..+...+..+.+++.+||+.+|.+|||+.|++++|+.+.
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            111223457899999999999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=373.74  Aligned_cols=263  Identities=27%  Similarity=0.344  Sum_probs=210.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      .++|...+.||+|+||.||+|.+.      +++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            356888899999999999999953      3668999997543 233345789999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC---cEEEe
Q 042150          533 ILVYEYMEKGPLKKHLYGP-----DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY---VSKVA  604 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~~kl~  604 (803)
                      ++||||+++|+|.+++...     ....+++.+++.++.||++||+|||+   .+|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999999532     22469999999999999999999999   9999999999999999554   59999


Q ss_pred             eeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHh
Q 042150          605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQ  683 (803)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  683 (803)
                      |||+++...............+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+.   ..   . .
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~---~~---~-i  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LE---F-V  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HH---H-H
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---H-H
Confidence            9999974211112222334567899999999999999999999999999999998 9999875433221   11   1 1


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                      ..+.         ....+..++..+.+++.+||+.+|.+||++.+|+++|+.+.+...
T Consensus       300 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          300 TSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             HcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            1111         011223345678999999999999999999999999999876544

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.4e-40  Score=349.01  Aligned_cols=249  Identities=29%  Similarity=0.503  Sum_probs=196.2

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCC----CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS----RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|... ++.||||......    ....+.+.+|+++++.++||||++++++|.+.+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            56888899999999999999976 7899999865432    234578999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc---eEeeccCcceEEEcc--------CCcEEEee
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG---IIHRDIKSTNILLDE--------NYVSKVAD  605 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~---ivHrDLkp~NILl~~--------~~~~kl~D  605 (803)
                      ||+++++|.+++   ....+++.+++.++.|++.||+|||+   .+   |+||||||+|||++.        ++.+||+|
T Consensus        86 e~~~~~~L~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           86 EFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             ECCTTEEHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EcCCCCCHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999999   34579999999999999999999999   66   999999999999986        77899999


Q ss_pred             eccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc
Q 042150          606 FGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK  685 (803)
Q Consensus       606 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (803)
                      ||+++....    .......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........      ......
T Consensus       160 fg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~  229 (271)
T 3dtc_A          160 FGLAREWHR----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YGVAMN  229 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HHHHTS
T ss_pred             CCccccccc----ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HhhhcC
Confidence            999975332    1222457899999999999999999999999999999999999999754322211      111111


Q ss_pred             CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       686 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                               ......+...+..+.+++.+||+.+|.+|||+.|++++|+.
T Consensus       230 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          230 ---------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                     11112233445678999999999999999999999999874

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.8e-41  Score=362.67  Aligned_cols=258  Identities=25%  Similarity=0.354  Sum_probs=205.0

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-Cc----EEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NT----KVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ++|...++||+|+||.||+|.+.. ++    +|++|.+... .....+.+.+|+.++++++||||++++++|. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            467888899999999999999753 43    3788875433 3444567889999999999999999999986 456899


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++... ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999999999543 3579999999999999999999999   8999999999999999999999999999987544


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..   ..    ...+..     
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~----~~~~~~-----  235 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP---DL----LEKGER-----  235 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH---HH----HHTTCB-----
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH---HH----HHcCCC-----
Confidence            333334455678889999999999999999999999999999999 99999754332211   11    111100     


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                          ...+..+...+.+++.+||+.+|.+||++.+++++|+.+...
T Consensus       236 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          236 ----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ----CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ----CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                011112334578899999999999999999999999988643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.7e-40  Score=360.28  Aligned_cols=249  Identities=23%  Similarity=0.289  Sum_probs=206.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+++.+ +++.||+|.+...   .....+.+.+|+++|+.++||||+++++++...+.+++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57888999999999999999976 5889999986532   3445678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.  ....+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....  
T Consensus        85 E~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--  157 (337)
T 1o6l_A           85 EYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--  157 (337)
T ss_dssp             ECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhccc--
Confidence            9999999999984  34568999999999999999999999   9999999999999999999999999999985322  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||........      ...... +..        
T Consensus       158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~~-~~~--------  222 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILM-EEI--------  222 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH-CCC--------
T ss_pred             CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH------HHHHHc-CCC--------
Confidence            12223456799999999999999999999999999999999999999975432211      111111 110        


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWNL  733 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L  733 (803)
                        .++......+.+++.+||+.+|.+||     ++.|++++-
T Consensus       223 --~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~  262 (337)
T 1o6l_A          223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence              12233456789999999999999999     899998753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4e-40  Score=362.23  Aligned_cols=252  Identities=21%  Similarity=0.295  Sum_probs=205.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC------ChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ------GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      .+.|...+.||+|+||.||++..+ +++.||+|.+......      ..+.+.+|+.+|++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467889999999999999999976 4889999986543221      357899999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC----cEEEeeecc
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY----VSKVADFGL  608 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~~kl~DFGl  608 (803)
                      ++||||+++|+|.+++.  ....+++.++..++.||+.||+|||+   .+|+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           91 VLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            99999999999999994  45679999999999999999999999   9999999999999998777    799999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ++....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+..      ... .....
T Consensus       166 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~------~~i-~~~~~  235 (361)
T 2yab_A          166 AHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANI-TAVSY  235 (361)
T ss_dssp             CEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHH-HTTCC
T ss_pred             ceEcCC---CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-HhcCC
Confidence            976432   12234467999999999999999999999999999999999999999754322211      111 11100


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        -+++...    ...+..+.+++.+||..||.+|||+.|++++
T Consensus       236 --~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          236 --DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             --CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              0011111    1224568899999999999999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.2e-41  Score=379.09  Aligned_cols=256  Identities=30%  Similarity=0.439  Sum_probs=206.7

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .++|...+.||+|+||.||+|.++++..||||.+.... ...++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            45678888999999999999999988899999976543 446789999999999999999999999976 6789999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+++.......+++.+++.++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++..... ...
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~  336 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYT  336 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC-cee
Confidence            99999999954344569999999999999999999999   99999999999999999999999999999864321 112


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      ......++..|+|||.+.+..++.++|||||||+||||++ |+.||......+..      .. ...+.         ..
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~------~~-i~~~~---------~~  400 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQ-VERGY---------RM  400 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------HH-HHTTC---------CC
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH------HH-HHcCC---------CC
Confidence            2234457889999999999999999999999999999999 99998754332211      11 11110         11


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      ..+..++..+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            223345677899999999999999999999999998765

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-40  Score=364.00  Aligned_cols=264  Identities=28%  Similarity=0.413  Sum_probs=212.8

Q ss_pred             HHHHhcCCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeec
Q 042150          456 LQTATNNFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEE  528 (803)
Q Consensus       456 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~  528 (803)
                      +....++|...+.||+|+||.||+|...+      ++.||||.+..... ...+.|.+|+.++++++||||++++++|.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            34456789999999999999999999753      47899999765432 235679999999999999999999999999


Q ss_pred             cceeeEEEEecCCCchhhhccCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEee
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGPD----------------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR  586 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  586 (803)
                      .+..++||||+++|+|.+++....                      ...+++.+++.++.||++||+|||+   ++|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence            999999999999999999985422                      2579999999999999999999999   899999


Q ss_pred             ccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCC
Q 042150          587 DIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVD  665 (803)
Q Consensus       587 DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~  665 (803)
                      ||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999875322222222334567899999999999999999999999999999999 999987


Q ss_pred             cchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          666 PLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       666 ~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      .....+.      .. ....+...         ..+...+..+.+++.+||+.+|.+||++.++++.|+.+.+
T Consensus       279 ~~~~~~~------~~-~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          279 GMAHEEV------IY-YVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TSCHHHH------HH-HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCChHHH------HH-HHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            5432211      11 11111111         1223445678999999999999999999999999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-40  Score=353.03  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=209.4

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ..++|...+.||+|+||.||+|.+.++..||+|++.... ...+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            356788889999999999999999988899999876443 3457899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.+++... ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.... ...
T Consensus       101 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~-~~~  175 (283)
T 3gen_A          101 MANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEY  175 (283)
T ss_dssp             CTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC-HHH
T ss_pred             cCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc-ccc
Confidence            9999999999542 3469999999999999999999999   9999999999999999999999999999975322 111


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..      .. ...+.         .
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~------~~-~~~~~---------~  239 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EH-IAQGL---------R  239 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HH-HHTTC---------C
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH------HH-Hhccc---------C
Confidence            12233456788999999999999999999999999999998 99998754332211      11 11110         0


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ...+......+.+++.+||+.+|.+|||+.+++++|+.+..
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            11122234578899999999999999999999999998864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.8e-40  Score=352.15  Aligned_cols=261  Identities=22%  Similarity=0.319  Sum_probs=202.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHh--ccCCCeeeEEeEeec----cceee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSK--IRHRHLVSLVGYCEE----QSEMI  533 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~HpnIv~l~g~~~~----~~~~~  533 (803)
                      .++|...+.||+|+||.||+|.. +++.||||++..   .....+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46788999999999999999998 588999998643   234667778888777  789999999998754    35689


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCceEeeccCcceEEEccCCcEEEee
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH--------TGSAEGIIHRDIKSTNILLDENYVSKVAD  605 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDLkp~NILl~~~~~~kl~D  605 (803)
                      +||||+++|+|.+++   ....+++.+++.++.|++.||+|||        +   ++|+||||||+|||++.++.+||+|
T Consensus        83 lv~e~~~~g~L~~~l---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           83 LITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEECCCTTCBHHHHH---TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EehhhccCCCHHHHH---hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence            999999999999999   3457999999999999999999999        6   8999999999999999999999999


Q ss_pred             eccccCCCCCCCCc--eeccccCCCcccCccccccC------cCCCcceehhHHHHHHHHHhC----------CCCCCcc
Q 042150          606 FGLSRSGPCLDETH--VSTGVKGSFGYLDPEYFRRQ------QLTDKSDVYSFGVVLFEVLCA----------RTAVDPL  667 (803)
Q Consensus       606 FGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltG----------~~p~~~~  667 (803)
                      ||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          +.||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            99986532211111  12234789999999999876      556799999999999999999          7777543


Q ss_pred             hhhhhhhHHHHHHHHhhcCccccccCccc-ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          668 LAREQVNLAEWAMQWQKKGMLEHIIDPQL-IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       668 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      ..... ..............     .+.+ ...........+.+++.+||+.||.+|||+.||++.|+.+
T Consensus       237 ~~~~~-~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          237 VPNDP-SFEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCSSC-CHHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCc-chhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            22211 11111111111111     1111 1112345678899999999999999999999999999865

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=357.81  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=204.8

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC------CChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR------QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      .+.|...+.||+|+||.||+|... +++.||+|.+.....      ...+.+.+|+.+|++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356888999999999999999976 488999997654322      1367899999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC----cEEEeeecc
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY----VSKVADFGL  608 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~~kl~DFGl  608 (803)
                      ++||||+++|+|.+++.  ....+++.+++.++.||+.||.|||+   .+|+||||||+|||++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            99999999999999994  45679999999999999999999999   9999999999999999877    899999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..      ..... ...
T Consensus       165 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~-~~~  234 (326)
T 2y0a_A          165 AHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANVSA-VNY  234 (326)
T ss_dssp             CEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHHH-TCC
T ss_pred             CeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHh-cCC
Confidence            9764321   2233457999999999999999999999999999999999999999754322211      11100 000


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        ......    ....+..+.+++.+||+.||.+|||+.|++++
T Consensus       235 --~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          235 --EFEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             --CCCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --CcCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              000000    01224568899999999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=364.84  Aligned_cols=256  Identities=22%  Similarity=0.311  Sum_probs=200.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccC--CCeeeEEeEeeccceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRH--RHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~~~~~~~lV  535 (803)
                      .++|...+.||+|+||.||++...+++.||||++....  ....+.|.+|+++|.+++|  |||+++++++......++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45688899999999999999998889999999865432  2334678999999999976  9999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      || +.+|+|.+++..  ...+++.++..++.||+.||+|||+   .+|+||||||+|||++ ++.+||+|||+++.....
T Consensus        88 ~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             Ee-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            99 567899999943  4579999999999999999999999   8999999999999997 578999999999865433


Q ss_pred             CCCceeccccCCCcccCcccccc-----------CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhh
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRR-----------QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK  684 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  684 (803)
                      ..........||+.|+|||++.+           ..++.++|||||||+||||++|+.||.......     ....    
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~----  231 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLH----  231 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHH----
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HHHH----
Confidence            33223345679999999999865           678999999999999999999999996432211     0111    


Q ss_pred             cCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          685 KGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       685 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                           .++++.....++......+.+++.+||+.||.+|||+.|++++....
T Consensus       232 -----~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          232 -----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             -----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             -----HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence                 11122222223333345788999999999999999999999886654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.3e-40  Score=350.74  Aligned_cols=249  Identities=24%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--------------------------CChHHHHHHHHHHHh
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--------------------------QGLPEFQTEITVLSK  513 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~f~~E~~~l~~  513 (803)
                      ++|...+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|+++|++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57888999999999999999975 588999998654321                          124678999999999


Q ss_pred             ccCCCeeeEEeEeec--cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcc
Q 042150          514 IRHRHLVSLVGYCEE--QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKST  591 (803)
Q Consensus       514 l~HpnIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~  591 (803)
                      ++||||+++++++.+  ....++||||+++++|.+++   ....+++.+++.++.||++||+|||+   .+|+||||||+
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~  166 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS  166 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence            999999999999976  56889999999999999876   34579999999999999999999999   89999999999


Q ss_pred             eEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCc---CCCcceehhHHHHHHHHHhCCCCCCcch
Q 042150          592 NILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKSDVYSFGVVLFEVLCARTAVDPLL  668 (803)
Q Consensus       592 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~  668 (803)
                      |||++.++.+||+|||+++....  .........||+.|+|||.+.+..   ++.++|||||||++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            99999999999999999976432  122234567999999999997665   4778999999999999999999997542


Q ss_pred             hhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          669 AREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       669 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...      +.... ......   .     .........+.+++.+||+.||.+|||+.|++++
T Consensus       245 ~~~------~~~~~-~~~~~~---~-----~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          245 IMC------LHSKI-KSQALE---F-----PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HHH------HHHHH-HHCCCC---C-----CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HHH------HHHHH-hcccCC---C-----CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            211      11111 111110   0     0112334678999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.3e-40  Score=359.50  Aligned_cols=264  Identities=25%  Similarity=0.431  Sum_probs=212.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC--------CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeecc
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR--------DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ  529 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~  529 (803)
                      .++|...+.||+|+||.||+|...        ++..||||++.... ....+.+.+|+++++++ +||||++++++|.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467888999999999999999873        46789999876443 23356789999999999 899999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL  595 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl  595 (803)
                      +..++||||+++|+|.+++....              ...+++.+++.++.||++||+|||+   .+|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence            99999999999999999996432              2358999999999999999999999   899999999999999


Q ss_pred             ccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhh
Q 042150          596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVN  674 (803)
Q Consensus       596 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  674 (803)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.  
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  268 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--  268 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH--
Confidence            9999999999999976443222222334567889999999999999999999999999999999 9999875432221  


Q ss_pred             HHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhcc
Q 042150          675 LAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES  742 (803)
Q Consensus       675 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  742 (803)
                          ... ...+..         ...+......+.+++.+||+.+|.+||++.|+++.|+.+......
T Consensus       269 ----~~~-~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          269 ----FKL-LKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             ----HHH-HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             ----HHH-HhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence                111 111110         112233456789999999999999999999999999999876543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.3e-40  Score=354.30  Aligned_cols=263  Identities=23%  Similarity=0.289  Sum_probs=202.7

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||.||+|...+++.||+|++.....  ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            467888999999999999999998899999998754422  224678999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++ +|.+++.. ....+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  .
T Consensus       100 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~  172 (311)
T 3niz_A          100 FMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGI--P  172 (311)
T ss_dssp             CCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTS--C
T ss_pred             CCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCC--C
Confidence            9985 78887754 34569999999999999999999999   9999999999999999999999999999976432  1


Q ss_pred             CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc---c----
Q 042150          618 THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML---E----  689 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~----  689 (803)
                      ........+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+...  . ..........   .    
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~-i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP--K-IFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH--H-HHHHHCCCCTTTSGGGTT
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHHHCCCChHHhhhhhc
Confidence            122334578999999999876 568999999999999999999999997554333211  1 1111111000   0    


Q ss_pred             ---------cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          690 ---------HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       690 ---------~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                               ...+............+++.+++.+||+.||.+|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                     0000000001112234678899999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=348.95  Aligned_cols=256  Identities=28%  Similarity=0.486  Sum_probs=200.7

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ++|...+.||+|+||.||+|... ++.||||++..  ....+.|.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            46778889999999999999986 78899998753  3346789999999999999999999999874  4799999999


Q ss_pred             CCchhhhccCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc-EEEeeeccccCCCCCCCC
Q 042150          541 KGPLKKHLYGPDR-TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV-SKVADFGLSRSGPCLDET  618 (803)
Q Consensus       541 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-~kl~DFGla~~~~~~~~~  618 (803)
                      +|+|.+++..... ..+++.+++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||+++....    
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~----  158 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----  158 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc----
Confidence            9999999965332 35789999999999999999999855578999999999999998876 79999999875321    


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........  ..|.  . ..+..     +    
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~--~-~~~~~-----~----  223 (307)
T 2eva_A          159 -HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA--V-HNGTR-----P----  223 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHH--H-HTTCC-----C----
T ss_pred             -ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHH--H-hcCCC-----C----
Confidence             122346899999999999999999999999999999999999998743221110  1111  1 11111     1    


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      ......+..+.+++.+||+.+|.+|||+.++++.|+.+.+..
T Consensus       224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            111233457889999999999999999999999999886543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.5e-40  Score=353.87  Aligned_cols=262  Identities=28%  Similarity=0.405  Sum_probs=217.5

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ...++|...+.||+|+||.||+|.... +..||+|.+.. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            345678889999999999999999875 78899998754 3345678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++++|.+++.......+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++.... .
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~-~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-D  164 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS-S
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC-C
Confidence            99999999999976666779999999999999999999999   9999999999999999999999999999986442 2


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                      .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||........   .+..    ...         
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~~----~~~---------  228 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELL----EKD---------  228 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHH----HTT---------
T ss_pred             ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----hcc---------
Confidence            2233344567889999999999999999999999999999999 9999875433221   1111    111         


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      .....+...+..+.+++.+||+.+|.+|||+.++++.|+.+.+..
T Consensus       229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            111222344567899999999999999999999999999876543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6e-40  Score=345.51  Aligned_cols=251  Identities=19%  Similarity=0.298  Sum_probs=206.0

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeecc--ceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|+++ ++.||||++....  ....+.|.+|+.++++++||||++++++|.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56888899999999999999986 8899999876543  22346799999999999999999999999877  7889999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--eEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG--IIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||+++|+|.+++.......+++.+++.++.|++.||+|||+   .+  ++||||||+|||++.++.++|+|||++.... 
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            99999999999976555579999999999999999999998   77  9999999999999999999999998865421 


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCC---cceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTD---KSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                            .....+|+.|+|||.+.+..++.   ++|||||||++|||++|+.||......+.      .......+.    
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~----  228 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEGL----  228 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSCC----
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcCC----
Confidence                  22346899999999998766555   79999999999999999999975432221      111111111    


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                           ....+...+..+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus       229 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          229 -----RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                 11223344567899999999999999999999999998764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.1e-40  Score=364.35  Aligned_cols=256  Identities=24%  Similarity=0.352  Sum_probs=203.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .++|...++||+|+||.||+|+.+. ++.||+|++...   .....+.+.+|..+|.++ +||||+++++++.+.+.++|
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            3578899999999999999999764 788999986533   233456788999999887 89999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|..++.  ....+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++....
T Consensus       131 V~E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEcCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            999999999999984  34569999999999999999999999   9999999999999999999999999999985322


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh--hhHHHHHHHHhhcCcccccc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ--VNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~i~  692 (803)
                        .........||+.|+|||++.+..++.++|||||||+||||++|+.||......+.  ....++..+.......    
T Consensus       206 --~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----  279 (396)
T 4dc2_A          206 --PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----  279 (396)
T ss_dssp             --TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----
T ss_pred             --CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----
Confidence              22234456899999999999999999999999999999999999999964321111  1111111111111111    


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSM------GDVLWN  732 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~~  732 (803)
                            .++......+.+++.+||+.||.+||++      .|++++
T Consensus       280 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          280 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             ------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence                  2233445678999999999999999985      566654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.1e-40  Score=347.63  Aligned_cols=258  Identities=27%  Similarity=0.402  Sum_probs=210.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .++|...+.||+|+||.||+|..+++..||||.+... ....+.|.+|++++++++||||+++++++.+ +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            4678888999999999999999988889999987543 3456789999999999999999999999874 4689999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++++|.+++.......+++.+++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYT  165 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEE
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCc-ccc
Confidence            99999999954333469999999999999999999999   99999999999999999999999999999764321 112


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.      ... ...+.         ..
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~-~~~~~---------~~  229 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQN-LERGY---------RM  229 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHH-HHTTC---------CC
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH------HHH-Hhccc---------CC
Confidence            2234456789999999999999999999999999999999 8999875432211      111 11110         01


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                      ..+...+..+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus       230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            11223456789999999999999999999999999988654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-40  Score=354.26  Aligned_cols=256  Identities=16%  Similarity=0.221  Sum_probs=207.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .++|...+.||+|+||.||+|... +++.+|+|.+... ......+.+|+.+|+.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467888999999999999999976 4788999986533 23356788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc--CCcEEEeeeccccCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE--NYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~~kl~DFGla~~~~~~~  616 (803)
                      +++|+|.+++.. ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.  ++.+||+|||+++....  
T Consensus        83 ~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~--  156 (321)
T 1tki_A           83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--  156 (321)
T ss_dssp             CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred             CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence            999999999943 23469999999999999999999999   99999999999999987  78999999999986432  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ....... ...  .++..
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~~-~~~--~~~~~  226 (321)
T 1tki_A          157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNA-EYT--FDEEA  226 (321)
T ss_dssp             -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHT-CCC--CCHHH
T ss_pred             -CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHcC-CCC--CChhh
Confidence             2233446789999999999999999999999999999999999999975432221      1111111 000  00000


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      .    ...+..+.+++.+||..||.+|||+.|++++-...
T Consensus       227 ~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  262 (321)
T 1tki_A          227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             h----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence            0    12346789999999999999999999999876543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=356.99  Aligned_cols=259  Identities=24%  Similarity=0.363  Sum_probs=202.8

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-Cc----EEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NT----KVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      .++|...++||+|+||.||+|.... ++    +|++|.+... .....+.+.+|+.++++++||||++++++|.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            3568889999999999999999643 44    3577776443 4456788999999999999999999999998765 78


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +|+||+.+|+|.+++... ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999999999543 3569999999999999999999999   999999999999999999999999999998644


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+..   ...    ..+.     
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~----~~~~-----  236 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SIL----EKGE-----  236 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHH----HTTC-----
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHH----HcCC-----
Confidence            3333333334567889999999999999999999999999999999 99999765433211   111    1110     


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                          ....+......+.+++.+||+.+|.+||++.|+++.|+.+...
T Consensus       237 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          237 ----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                1112233456789999999999999999999999999988754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3e-40  Score=356.30  Aligned_cols=271  Identities=24%  Similarity=0.359  Sum_probs=215.6

Q ss_pred             ChhhHHHHhcCCCccceEeeeCceEEEEEEE------CCCcEEEEEEcCCCCC-CChHHHHHHHHHHHhc-cCCCeeeEE
Q 042150          452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVL------RDNTKVAVKRGVPGSR-QGLPEFQTEITVLSKI-RHRHLVSLV  523 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~  523 (803)
                      ....+....++|...+.||+|+||.||+|..      .+++.||||.+..... ...+.+.+|++++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3344555678899999999999999999985      2467899998765432 2345789999999999 799999999


Q ss_pred             eEeeccc-eeeEEEEecCCCchhhhccCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeecc
Q 042150          524 GYCEEQS-EMILVYEYMEKGPLKKHLYGPDR--------------TPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI  588 (803)
Q Consensus       524 g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL  588 (803)
                      ++|...+ ..++||||+++|+|.+++.....              ..+++.+++.++.|+++||+|||+   .+|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence            9987654 58999999999999999965332              238999999999999999999999   89999999


Q ss_pred             CcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcc
Q 042150          589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPL  667 (803)
Q Consensus       589 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~  667 (803)
                      ||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999986543333333445667899999999999999999999999999999998 99998654


Q ss_pred             hhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          668 LAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       668 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      .....  +.    .....+..         ...+......+.+++.+||+.+|.+|||+.|++++|+.+++..
T Consensus       255 ~~~~~--~~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          255 KIDEE--FC----RRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCSHH--HH----HHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chhHH--HH----HHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            32211  11    11111110         0112233467899999999999999999999999999887644

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.5e-39  Score=343.41  Aligned_cols=265  Identities=17%  Similarity=0.162  Sum_probs=210.7

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||.||+|.. .+++.||||.+....  ..+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            35688899999999999999996 568999999865432  335688999999999 79999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc-----EEEeeeccccCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV-----SKVADFGLSRSG  612 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~-----~kl~DFGla~~~  612 (803)
                      |+ +++|.+++... ...+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.     +||+|||+++..
T Consensus        87 ~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           87 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99 99999999542 3469999999999999999999998   99999999999999987776     999999999754


Q ss_pred             CCCCCC-----ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCc
Q 042150          613 PCLDET-----HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM  687 (803)
Q Consensus       613 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (803)
                      ......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            322111     123456799999999999999999999999999999999999999976432222111111111111111


Q ss_pred             cccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          688 LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       688 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      ...         .....+..+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus       242 ~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          242 LRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             HHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            111         11123467899999999999999999999999999887543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=361.78  Aligned_cols=250  Identities=22%  Similarity=0.311  Sum_probs=201.7

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceee
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~  533 (803)
                      ..++|...++||+|+||.||+|+.+. ++.||||++...   .....+.+.+|.+++..+ +||||+++++++.+.+.++
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            34689999999999999999999764 889999986532   234566788999999998 6999999999999999999


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      |||||+++|+|.+++..  ...+++.++..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++...
T Consensus       101 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999999943  4569999999999999999999999   999999999999999999999999999998532


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      .  .........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ...... +.      
T Consensus       176 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~-~~------  240 (353)
T 3txo_A          176 C--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAILN-DE------  240 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH-CC------
T ss_pred             c--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH------HHHHHc-CC------
Confidence            2  12233456799999999999999999999999999999999999999975433221      111111 11      


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSM------GDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~~  732 (803)
                          ..++......+.+++.+||+.+|.+||++      .|++++
T Consensus       241 ----~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          241 ----VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                01222345678899999999999999998      777764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.6e-40  Score=347.08  Aligned_cols=259  Identities=23%  Similarity=0.324  Sum_probs=198.8

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC----CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .++|...+.||+|+||.||+|....    +..||+|...... ....+.|.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4678889999999999999999753    4569999865432 223567899999999999999999999985 457899


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++... ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            99999999999999532 3469999999999999999999999   8999999999999999999999999999976432


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      .. ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+.   ....    ..+.      
T Consensus       169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i----~~~~------  234 (281)
T 1mp8_A          169 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI----ENGE------  234 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH----HTTC------
T ss_pred             cc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHH----HcCC------
Confidence            11 112233456789999999999999999999999999999996 9999875433221   1111    1111      


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                         ....+...+..+.+++.+||+.+|.+|||+.|+++.|+.+.+.+
T Consensus       235 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          235 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence               01123344567899999999999999999999999999887543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.6e-39  Score=357.99  Aligned_cols=254  Identities=22%  Similarity=0.306  Sum_probs=205.4

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ..++|...+.||+|+||.||+|..+ +++.||+|.+....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567999999999999999999976 48899999865432  22346789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC---CcEEEeeeccccCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN---YVSKVADFGLSRSG  612 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~~kl~DFGla~~~  612 (803)
                      |||+++|+|.+++.  ....+++.+++.++.||+.||+|||+   .+|+||||||+|||++.+   +.+||+|||+++..
T Consensus       107 ~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          107 FDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             ECCCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999999984  34579999999999999999999999   899999999999999865   45999999999864


Q ss_pred             CCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ...   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +..   . ...+... . 
T Consensus       182 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~---~-i~~~~~~-~-  249 (362)
T 2bdw_A          182 NDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYA---Q-IKAGAYD-Y-  249 (362)
T ss_dssp             TTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHHTCCC-C-
T ss_pred             cCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH---H-HHhCCCC-C-
Confidence            321   22334679999999999999999999999999999999999999997543221   111   1 1111110 0 


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      ..    ......+..+.+++.+||+.||.+||++.|++++-
T Consensus       250 ~~----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  286 (362)
T 2bdw_A          250 PS----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  286 (362)
T ss_dssp             CT----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred             Cc----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            00    00123356789999999999999999999998763

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.1e-39  Score=344.90  Aligned_cols=252  Identities=30%  Similarity=0.550  Sum_probs=203.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCC-------hHHHHHHHHHHHhccCCCeeeEEeEeeccce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQG-------LPEFQTEITVLSKIRHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~  531 (803)
                      .++|...+.||+|+||.||+|... +++.||+|++.......       .+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367888899999999999999975 68899999875443322       267899999999999999999999997655 


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--eEeeccCcceEEEccCCc-----EEEe
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG--IIHRDIKSTNILLDENYV-----SKVA  604 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~-----~kl~  604 (803)
                       ++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+   .+  |+||||||+|||++.++.     +||+
T Consensus        97 -~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             -eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence             699999999999988854 34579999999999999999999999   78  999999999999988776     9999


Q ss_pred             eeccccCCCCCCCCceeccccCCCcccCcccc--ccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH
Q 042150          605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF--RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      |||+++....     ......||+.|+|||.+  ....++.++|||||||++|||++|+.||.........    +....
T Consensus       172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~  242 (287)
T 4f0f_A          172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FINMI  242 (287)
T ss_dssp             CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HHHHH
T ss_pred             CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HHHHH
Confidence            9999975221     23446789999999998  4567889999999999999999999999754322211    11111


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ....         .....+...+..+.+++.+||+.+|.+|||+.|+++.|+.
T Consensus       243 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          243 REEG---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             hccC---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            1111         1112233445678999999999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.5e-40  Score=361.63  Aligned_cols=273  Identities=16%  Similarity=0.189  Sum_probs=205.8

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCCCC-----------ChHHHHHHHHHHHhccCCCeee
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGSRQ-----------GLPEFQTEITVLSKIRHRHLVS  521 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-----------~~~~f~~E~~~l~~l~HpnIv~  521 (803)
                      ..++|...+.||+|+||.||+|.+..      ++.||||.+......           ....+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34678999999999999999999865      378999986543311           0112344555666778999999


Q ss_pred             EEeEeecc----ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc-
Q 042150          522 LVGYCEEQ----SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-  596 (803)
Q Consensus       522 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~-  596 (803)
                      +++++...    ...+|||||+ +++|.+++.. ....+++.+++.|+.||+.||+|||+   .+|+||||||+|||++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEec
Confidence            99998765    4589999999 9999999954 33569999999999999999999999   8999999999999999 


Q ss_pred             -cCCcEEEeeeccccCCCCCCCC-----ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhh
Q 042150          597 -ENYVSKVADFGLSRSGPCLDET-----HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAR  670 (803)
Q Consensus       597 -~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~  670 (803)
                       .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999753321111     1113345999999999999999999999999999999999999999753222


Q ss_pred             hhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhcc
Q 042150          671 EQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES  742 (803)
Q Consensus       671 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  742 (803)
                      ..  ...+..... ...+..++++.+.   ....+..+.+++.+|++.+|.+||++.++++.|+.++.....
T Consensus       268 ~~--~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          268 PK--YVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             HH--HHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HH--HHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            11  111111111 1122233333221   122346789999999999999999999999999998865443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.8e-40  Score=344.64  Aligned_cols=256  Identities=31%  Similarity=0.451  Sum_probs=210.5

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ++|...+.||+|+||.||+|...+++.||+|.+.... ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            5678888999999999999999888999999876543 345789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +++|.+++... ...+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.... .....
T Consensus        87 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~-~~~~~  161 (267)
T 3t9t_A           87 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTS  161 (267)
T ss_dssp             TCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC-HHHHS
T ss_pred             CCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccc-ccccc
Confidence            99999999542 3568999999999999999999999   9999999999999999999999999999875321 11112


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.      .... ..+..         ..
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~i-~~~~~---------~~  225 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDI-STGFR---------LY  225 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHH-HTTCC---------CC
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH------HHHH-hcCCc---------CC
Confidence            233456788999999999999999999999999999999 8999875432211      1111 11100         01


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      .+......+.+++.+||+.+|.+||++.+++++|+.+.+
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            122334678999999999999999999999999998764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=361.31  Aligned_cols=253  Identities=20%  Similarity=0.268  Sum_probs=206.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .++|...+.||+|+||.||+|... +++.||+|.+..........+.+|+++|++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467899999999999999999976 5888999987654444456789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc--CCcEEEeeeccccCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE--NYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~~kl~DFGla~~~~~~~  616 (803)
                      +++|+|.+++.. ....+++.+++.++.||+.||+|||+   .+|+||||||+|||++.  ++.+||+|||+++....  
T Consensus       130 ~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~--  203 (387)
T 1kob_A          130 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--  203 (387)
T ss_dssp             CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred             CCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC--
Confidence            999999999953 23469999999999999999999999   99999999999999974  57899999999986432  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                       ........||+.|+|||++.+..++.++|||||||+||||++|+.||......+..      ..... ...  ..++  
T Consensus       204 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~------~~i~~-~~~--~~~~--  271 (387)
T 1kob_A          204 -DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL------QNVKR-CDW--EFDE--  271 (387)
T ss_dssp             -TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHHH-CCC--CCCS--
T ss_pred             -CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH------HHHHh-CCC--CCCc--
Confidence             12233457899999999999999999999999999999999999999754322111      11111 100  0111  


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        .........+.+++.+||+.||.+|||+.|++++
T Consensus       272 --~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          272 --DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             --STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence              1112345678999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.9e-40  Score=360.21  Aligned_cols=276  Identities=24%  Similarity=0.287  Sum_probs=211.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-----CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEee--cccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-----RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE--EQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~--~~~~~  532 (803)
                      .++|...+.||+|+||.||++.+     .+++.||||++........+.+.+|++++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35788889999999999999985     357899999987665555677999999999999999999999886  45678


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+++++|.+++... ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            9999999999999999432 3459999999999999999999999   99999999999999999999999999999864


Q ss_pred             CCCCCC-ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          613 PCLDET-HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       613 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ...... .......+|..|+|||.+.+..++.++|||||||++|||++|+.|+........... .+.........+.+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLLEL  256 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHHHH
Confidence            332221 122345678889999999999999999999999999999999999864332110000 000000000000011


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      +........+...+..+.+++.+||+.+|.+|||+.|++++|+.+....
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            1111112234455678899999999999999999999999999876433

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.1e-39  Score=347.62  Aligned_cols=262  Identities=20%  Similarity=0.251  Sum_probs=200.8

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|...+.||+|+||.||+|...+++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4688889999999999999999889999999865432  23357889999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++ +|.+++... ...+++.++..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++....  ..
T Consensus        82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PV  154 (288)
T ss_dssp             CSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCc--cc
Confidence            985 898888542 3568999999999999999999999   8999999999999999999999999999875321  11


Q ss_pred             ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCc------ccc-
Q 042150          619 HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM------LEH-  690 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~-  690 (803)
                      .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..  .... .......      ..+ 
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MRIF-RILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHH-HHHCCCCTTTSTTGGGS
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-HHHCCCChhhchhhhcc
Confidence            12234568999999999976 46899999999999999999999999754332221  1111 1111000      000 


Q ss_pred             -ccCccc-------ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          691 -IIDPQL-------IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       691 -i~d~~l-------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       ..++..       ...........+.+++.+||+.||.+|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             001111       011112345678899999999999999999999865

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=359.88  Aligned_cols=249  Identities=24%  Similarity=0.312  Sum_probs=203.8

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||++.... ++.||+|.+...   .....+.+.+|+++|++++||||++++++|.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            568888999999999999999764 788999976432   3445678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+.+|+|.+++.  ....+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++....  
T Consensus        95 e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--  167 (384)
T ss_dssp             CCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred             ecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC--
Confidence            9999999999994  34569999999999999999999999   9999999999999999999999999999986432  


Q ss_pred             CCceeccccCCCcccCcccccc---CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRR---QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                       ........||+.|+|||++.+   ..++.++|||||||+||||++|+.||..........+..   ... ..       
T Consensus       168 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~-~~-------  235 (384)
T 4fr4_A          168 -ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFE-TT-------  235 (384)
T ss_dssp             -TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHH-HC-------
T ss_pred             -CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHh-hc-------
Confidence             223345679999999999964   468999999999999999999999997443222211111   111 10       


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPS-MGDVLW  731 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~  731 (803)
                         ...++......+.+++.+||+.+|.+||+ +.++++
T Consensus       236 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 ---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               01223344567899999999999999998 666654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.8e-39  Score=346.60  Aligned_cols=263  Identities=21%  Similarity=0.281  Sum_probs=200.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|...+.||+|+||+||+|... +++.||||++....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888899999999999999976 48899999865433  2234778999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++ +|.+.+.. ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  .
T Consensus        82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--P  154 (292)
T ss_dssp             CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--C
T ss_pred             cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC--c
Confidence            9986 55555432 34569999999999999999999999   8999999999999999999999999999975432  1


Q ss_pred             CceeccccCCCcccCccccccCc-CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCc------ccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQ-LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM------LEH  690 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~  690 (803)
                      ........+|+.|+|||.+.+.. ++.++|||||||++|||++|..|+........ .+.... .......      ...
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~-~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIF-RLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHH-HHHCCCCTTTCTTGGG
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHH-HHhCCCChhhhhhhcc
Confidence            22233457899999999998765 89999999999999999998888543222111 111111 1111000      000


Q ss_pred             ccC---------cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          691 IID---------PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       691 i~d---------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..+         ..............+.+++.+||+.||.+|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000         000011122345678999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.3e-40  Score=354.79  Aligned_cols=272  Identities=25%  Similarity=0.339  Sum_probs=208.6

Q ss_pred             CCccceEeeeCceEEEEEEEC-----CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeec--cceeeE
Q 042150          463 FDKNLIIGSGGFGMVYKGVLR-----DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEE--QSEMIL  534 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~l  534 (803)
                      |...+.||+|+||.||++.+.     +++.||||++..... ...+.|.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            478889999999999998753     578899998765432 335678999999999999999999999977  467899


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++..   ..+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            9999999999999943   349999999999999999999999   9999999999999999999999999999986443


Q ss_pred             CCCC-ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDET-HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      .... .......++..|+|||.+.+..++.++|||||||++|||++|+.|+........ ....+.........+.+.+.
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHHh
Confidence            2211 123345678889999999999999999999999999999999999864322110 00000000000000111111


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                      .......+...+..+.+++.+||+.+|.+|||+.|+++.|+.+.+...
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            111122334456788999999999999999999999999998875543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.7e-40  Score=382.80  Aligned_cols=256  Identities=30%  Similarity=0.441  Sum_probs=210.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .++|...+.||+|+||.||+|.++++..||||++.... ...++|.+|+++|++++||||++++++|.+ +..+|||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            45678888999999999999999988899999976543 446789999999999999999999999976 6789999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.++|.......+++.+++.|+.||++||+|||+   ++|+||||||+||||++++.+||+|||+++.... ....
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-~~~~  419 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYT  419 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC-HHHH
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC-Ccee
Confidence            99999999954334569999999999999999999999   9999999999999999999999999999986432 1111


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      ......++..|+|||.+.+..++.++|||||||+||||++ |+.||......+.      ... ...+.         ..
T Consensus       420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~------~~~-i~~~~---------~~  483 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQ-VERGY---------RM  483 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH------HHH-HHTTC---------CC
T ss_pred             cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHH-HHcCC---------CC
Confidence            1223456789999999999999999999999999999999 9999875433221      111 11111         01


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      ..+..+...+.+|+.+||+.+|.+|||+.+|++.|+.+.
T Consensus       484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            122345567899999999999999999999999998664

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.3e-40  Score=364.49  Aligned_cols=255  Identities=22%  Similarity=0.312  Sum_probs=200.0

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCC--CCChHHHHHHHHHHHhcc--CCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIR--HRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~--HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .+|...+.||+|+||.||++...+++.||||++....  ....+.+.+|+++|.+++  ||||+++++++...+.++|||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4588899999999999999998889999999865432  233567999999999996  599999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      | +.+++|.+++..  ...+++.+++.++.||+.||+|||+   .+|+||||||+|||++ ++.+||+|||+++......
T Consensus       136 E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          136 E-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             E-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             e-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            9 568899999953  3478999999999999999999999   8999999999999995 5799999999998654322


Q ss_pred             CCceeccccCCCcccCcccccc-----------CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRR-----------QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK  685 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (803)
                      .........||+.|+|||++.+           ..++.++|||||||+||||++|+.||.......     .....    
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~~----  279 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHA----  279 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHH----
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHHH----
Confidence            2223345679999999999865           478899999999999999999999996432111     11111    


Q ss_pred             CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       686 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                           ++++.....++......+.+++.+||+.||.+|||+.|++++....
T Consensus       280 -----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~  325 (390)
T 2zmd_A          280 -----IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  325 (390)
T ss_dssp             -----HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             -----HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence                 1122111122222345788999999999999999999999876543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=356.63  Aligned_cols=246  Identities=24%  Similarity=0.299  Sum_probs=193.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC--ChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ--GLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .++|...++||+|+||+||+|... +++.||||++......  ....+..|+..+.++ +||||++++++|.+++..+||
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999986 6899999986543322  233456666666665 899999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+ +++|.+++... ...++|.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.... 
T Consensus       136 ~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~-  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-  209 (311)
T ss_dssp             EECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             Eecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc-
Confidence            9999 66898888542 3569999999999999999999999   8999999999999999999999999999876322 


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                        ........||+.|+|||++.+ .++.++|||||||++|||++|..++.....        |. . ...+.    ..+.
T Consensus       210 --~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~~-~-~~~~~----~~~~  272 (311)
T 3p1a_A          210 --AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------WQ-Q-LRQGY----LPPE  272 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------HH-H-HTTTC----CCHH
T ss_pred             --CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HH-H-HhccC----CCcc
Confidence              223344568999999999876 799999999999999999999776543211        10 0 11111    1111


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +    .......+.+++.+||+.+|.+|||+.|++++
T Consensus       273 ~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          273 F----TAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             H----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             c----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            1    12234678999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.6e-40  Score=355.61  Aligned_cols=250  Identities=22%  Similarity=0.303  Sum_probs=204.7

Q ss_pred             cCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|.. .+++.||||++...   .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5688889999999999999997 46889999986432   2334567999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+ +|+|.+++..  ...+++.+++.++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||+++....  
T Consensus        89 E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--  160 (336)
T 3h4j_B           89 EYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--  160 (336)
T ss_dssp             CCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT--
T ss_pred             ECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccC--
Confidence            999 6899888843  4569999999999999999999999   8999999999999999999999999999986432  


Q ss_pred             CCceeccccCCCcccCccccccCcC-CCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                       ........||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........               ...+... 
T Consensus       161 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~-  223 (336)
T 3h4j_B          161 -GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSC-  223 (336)
T ss_dssp             -SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSS-
T ss_pred             -CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcC-
Confidence             222334579999999999988876 6899999999999999999999964321110               1111110 


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                       ....+...+..+.+++.+||+.||.+|||+.|++++-...
T Consensus       224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  263 (336)
T 3h4j_B          224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN  263 (336)
T ss_dssp             -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred             -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence             1122334456789999999999999999999999876644

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.8e-40  Score=370.72  Aligned_cols=265  Identities=22%  Similarity=0.242  Sum_probs=210.8

Q ss_pred             ChhhHHHHhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEee
Q 042150          452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCE  527 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~  527 (803)
                      .+.++....++|...++||+|+||+||+|+.+. ++.||+|++...   .....+.+.+|..++..++||||++++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            345566677899999999999999999999875 788999986431   2233445899999999999999999999999


Q ss_pred             ccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeec
Q 042150          528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG  607 (803)
Q Consensus       528 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG  607 (803)
                      +.+.++|||||+++|+|.+++... ...+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchh
Confidence            999999999999999999999542 4569999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCceeccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH
Q 042150          608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      +++.... ..........||+.|+|||++.     ...++.++|||||||+||||++|+.||......+...   .....
T Consensus       221 la~~~~~-~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~  296 (437)
T 4aw2_A          221 SCLKLME-DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---KIMNH  296 (437)
T ss_dssp             TCEECCT-TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHTH
T ss_pred             hhhhccc-CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH---hhhhc
Confidence            9976432 2222334468999999999997     5679999999999999999999999997543322211   01000


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVD--RPSMGDVLWNL  733 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~L  733 (803)
                      ...     +.-|..    .......+.+++.+||..+|.+  ||++.|++++-
T Consensus       297 ~~~-----~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp  340 (437)
T 4aw2_A          297 KER-----FQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP  340 (437)
T ss_dssp             HHH-----CCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred             ccc-----ccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence            000     000111    1123467889999999888888  99999998764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=354.38  Aligned_cols=262  Identities=29%  Similarity=0.457  Sum_probs=204.3

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-----CcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-----NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .+|...++||+|+||.||+|....     +..||||.+..... ....+|.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456667899999999999998653     23599998765432 234578999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++.. ....+++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            9999999999999954 23569999999999999999999999   8999999999999999999999999999976432


Q ss_pred             CCC-CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          615 LDE-THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       615 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ... ........+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+.      ... ...+.     
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------~~~-~~~~~-----  267 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV------MKA-INDGF-----  267 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHH-HHTTC-----
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH------HHH-HHCCC-----
Confidence            211 111223456789999999999999999999999999999999 9999865432211      111 11110     


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhcc
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES  742 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  742 (803)
                          ....+...+..+.+++.+||+.+|.+||++.++++.|+.+......
T Consensus       268 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          268 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             ----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence                0111233456789999999999999999999999999998765543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.9e-40  Score=368.81  Aligned_cols=262  Identities=23%  Similarity=0.235  Sum_probs=208.8

Q ss_pred             hhhHHHHhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeec
Q 042150          453 FTDLQTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE  528 (803)
Q Consensus       453 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~  528 (803)
                      +.++....++|...++||+|+||+||+|+.+. ++.||+|++...   .....+.+.+|+.+++.++||||++++++|.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            34555567889999999999999999999864 789999986431   22334568899999999999999999999999


Q ss_pred             cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                      ...++|||||+++|+|.+++..   ..+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccce
Confidence            9999999999999999999943   458999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCc----CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhh
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ----LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK  684 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  684 (803)
                      ++..... .........||+.|+|||++.+..    ++.++|||||||+||||++|+.||......+..      .....
T Consensus       215 a~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~  287 (410)
T 3v8s_A          215 CMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMN  287 (410)
T ss_dssp             CEECCTT-SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHT
T ss_pred             eEeeccC-CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH------HHHHh
Confidence            9764321 122234568999999999998665    889999999999999999999999754322211      11110


Q ss_pred             cCccccccCcccccCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 042150          685 KGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVD--RPSMGDVLWNLE  734 (803)
Q Consensus       685 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~L~  734 (803)
                      ...  .+.-     ......+..+.+|+.+||..+|.+  ||++.||+++-.
T Consensus       288 ~~~--~~~~-----p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~  332 (410)
T 3v8s_A          288 HKN--SLTF-----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  332 (410)
T ss_dssp             HHH--HCCC-----CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred             ccc--cccC-----CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence            000  0000     011123467899999999999988  999999998644

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.5e-40  Score=358.94  Aligned_cols=265  Identities=24%  Similarity=0.357  Sum_probs=211.8

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEECC-C-----cEEEEEEcCCCCC-CChHHHHHHHHHHHhc-cCCCeeeEEeEeecc
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLRD-N-----TKVAVKRGVPGSR-QGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ  529 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~  529 (803)
                      ...++|...+.||+|+||.||+|.... +     ..||+|.+..... ...+.+.+|+++++++ +||||++++++|.+.
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            345788899999999999999999753 2     4799998765432 2356789999999999 899999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGP------------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE  597 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~  597 (803)
                      +..++||||+++|+|.+++...            ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECC
Confidence            9999999999999999998532            13468999999999999999999999   89999999999999999


Q ss_pred             CCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHH
Q 042150          598 NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLA  676 (803)
Q Consensus       598 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~  676 (803)
                      ++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........  ..
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~  277 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FY  277 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HH
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HH
Confidence            99999999999985433222223344567889999999999999999999999999999998 9999875432221  11


Q ss_pred             HHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          677 EWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       677 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      ..    ...+.         ....+...+..+.+++.+||+.+|.+|||+.|+++.|+.+.+..
T Consensus       278 ~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          278 KL----VKDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HH----HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HH----HhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            11    11110         01112223467899999999999999999999999999876543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.4e-39  Score=346.99  Aligned_cols=263  Identities=24%  Similarity=0.382  Sum_probs=207.3

Q ss_pred             cCCCccceEeeeCceEEEEEEE-----CCCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeecc--cee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-----RDNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ--SEM  532 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~  532 (803)
                      +.|...+.||+|+||.||+|++     .+++.||||++... .....+.+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578888999999999999984     35889999987644 344568899999999999999999999999776  668


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            999999999999999843 23469999999999999999999999   99999999999999999999999999999764


Q ss_pred             CCCCCC-ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhh---------hhhhHHHHHHHH
Q 042150          613 PCLDET-HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAR---------EQVNLAEWAMQW  682 (803)
Q Consensus       613 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~~~~  682 (803)
                      ...... .......+|..|+|||.+.+..++.++|||||||++|||++|+.|+......         ........... 
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  255 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT-  255 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH-
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH-
Confidence            432211 2233456788899999999999999999999999999999999886432211         00111111111 


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      ...+         .....+...+..+.+++.+||+.+|.+|||+.++++.|+.++
T Consensus       256 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          256 LKEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Hhcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1111         111223345577899999999999999999999999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=350.14  Aligned_cols=264  Identities=22%  Similarity=0.271  Sum_probs=202.7

Q ss_pred             HhcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC-----CCCChHHHHHHHHHHHhcc---CCCeeeEEeEeecc
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG-----SRQGLPEFQTEITVLSKIR---HRHLVSLVGYCEEQ  529 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~  529 (803)
                      ..++|...+.||+|+||+||+|+. .+++.||||++...     .......+.+|++++++++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999996 45889999986432     1222457888988888875   99999999999765


Q ss_pred             c-----eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEe
Q 042150          530 S-----EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA  604 (803)
Q Consensus       530 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~  604 (803)
                      .     ..++||||+. |+|.+++.......+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5799999997 599999976666669999999999999999999999   899999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhh
Q 042150          605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK  684 (803)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  684 (803)
                      |||+++....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+...  . ......
T Consensus       163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~-i~~~~~  236 (308)
T 3g33_A          163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG--K-IFDLIG  236 (308)
T ss_dssp             SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH--H-HHHHHC
T ss_pred             eCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHhC
Confidence            9999976432   222345678999999999999999999999999999999999999997654332211  1 111111


Q ss_pred             cCc---ccc-------ccCc---ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          685 KGM---LEH-------IIDP---QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       685 ~~~---~~~-------i~d~---~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...   ...       .+.+   ........+....+.+++.+||+.||.+|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            000   000       0000   00000112344678999999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.6e-39  Score=346.57  Aligned_cols=260  Identities=33%  Similarity=0.551  Sum_probs=196.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||.||+|...  ..||||.+....  ....+.|.+|++++++++||||+++++++. ....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence            467888899999999999999864  359999865443  233467999999999999999999999764 456899999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|.+++.. ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       100 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A          100 WCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             CCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             ecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            9999999999954 34569999999999999999999999   9999999999999999999999999999975433222


Q ss_pred             CceeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          618 THVSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ........||+.|+|||.+.   +..++.++|||||||++|||++|+.||......+.  +.+    ....+...    +
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~----~~~~~~~~----~  245 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIE----MVGRGSLS----P  245 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHH----HHHHTSCC----C
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHH----HhcccccC----c
Confidence            33334567899999999986   66788899999999999999999999975433221  111    11111111    1


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      .+ ......++..+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       246 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          246 DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            11 1122345578899999999999999999999999999764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.1e-40  Score=358.47  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=205.5

Q ss_pred             HHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccce
Q 042150          457 QTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       457 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~  531 (803)
                      ....++|...+.||+|+||.||+|+.+ +++.||+|++...   .....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999986 4889999986542   234567788999999987 89999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      +++||||+++|+|.+++..  ...+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999999943  3569999999999999999999999   9999999999999999999999999999985


Q ss_pred             CCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+..      .... .+.    
T Consensus       168 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~-~~~----  234 (345)
T 1xjd_A          168 NMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------HSIR-MDN----  234 (345)
T ss_dssp             CCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-HCC----
T ss_pred             cccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH------HHHH-hCC----
Confidence            3221  12234567999999999999999999999999999999999999999754322211      1111 110    


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMG-DVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl~~  732 (803)
                        +    .++......+.+++.+||+.+|.+||++. +++++
T Consensus       235 --~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          235 --P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             --C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             --C----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence              1    12223456789999999999999999997 77643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=355.59  Aligned_cols=253  Identities=22%  Similarity=0.285  Sum_probs=191.3

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ...+.|...+.||+|+||.||+|.... ++.||||++....  ..+.+.+|+++|++++||||++++++|.+.+..++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            345779999999999999999999864 7889999875432  3457889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc---CCcEEEeeeccccCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---NYVSKVADFGLSRSGP  613 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~kl~DFGla~~~~  613 (803)
                      ||+++|+|.+++.  ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++...
T Consensus       128 e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          128 ELVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCCSCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999994  34569999999999999999999999   89999999999999975   8899999999998632


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      .   ........||+.|+|||++.+..++.++|||||||+||||++|+.||........  +   .... ......    
T Consensus       203 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~---~~~i-~~~~~~----  269 (349)
T 2w4o_A          203 H---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M---FRRI-LNCEYY----  269 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H---HHHH-HTTCCC----
T ss_pred             c---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H---HHHH-HhCCCc----
Confidence            2   2223345789999999999999999999999999999999999999864432211  1   1111 111100    


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        ............+.+++.+||+.||.+|||+.|++++
T Consensus       270 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 --FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             --CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0111122345678999999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-39  Score=350.31  Aligned_cols=245  Identities=22%  Similarity=0.298  Sum_probs=204.7

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...   .....+.+.+|..+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56888899999999999999976 5889999986432   2345678899999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++..  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  
T Consensus        86 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           86 DYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             CCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence            99999999999943  4569999999999999999999998   9999999999999999999999999999986332  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ...... ...        
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~i~~-~~~--------  220 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILN-AEL--------  220 (318)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH-CCC--------
T ss_pred             ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-CCC--------
Confidence               12345799999999999999999999999999999999999999975432211      111111 110        


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                        .++......+.+++.+||+.+|.+||     ++.|++++
T Consensus       221 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          221 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence              12223456789999999999999999     88998865

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-39  Score=355.26  Aligned_cols=255  Identities=21%  Similarity=0.281  Sum_probs=204.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCC-----CCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVP-----GSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      .+.|...+.||+|+||.||+|... +++.||||.+..     ......+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            456889999999999999999975 588999997532     22335678999999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc---EEEeeecc
Q 042150          534 LVYEYMEKGPLKKHLYGP--DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV---SKVADFGL  608 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---~kl~DFGl  608 (803)
                      +||||+++|+|.+++...  ....+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998887432  23468999999999999999999999   99999999999999986654   99999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ++.....  ........||+.|+|||++.+..++.++|||||||+||||++|+.||......    +.   ... ..+..
T Consensus       180 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~---~~i-~~~~~  249 (351)
T 3c0i_A          180 AIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LF---EGI-IKGKY  249 (351)
T ss_dssp             CEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HH---HHH-HHTCC
T ss_pred             eeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HH---HHH-HcCCC
Confidence            9764321  12233457999999999999999999999999999999999999999753211    11   111 11110


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      .  ..+...    ...+..+.+++.+||+.||.+|||+.|++++-
T Consensus       250 ~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp  288 (351)
T 3c0i_A          250 K--MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNHP  288 (351)
T ss_dssp             C--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             C--CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence            0  011111    12245789999999999999999999999753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.1e-40  Score=361.74  Aligned_cols=274  Identities=21%  Similarity=0.210  Sum_probs=211.1

Q ss_pred             cccChhhHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-----CCCeeeE
Q 042150          449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-----HRHLVSL  522 (803)
Q Consensus       449 ~~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----HpnIv~l  522 (803)
                      ..+++.+.....++|...++||+|+||.||+|... +++.||||++.. .....+.+..|++++++++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            34555565666789999999999999999999974 588999998653 2233466888999999996     9999999


Q ss_pred             EeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-----
Q 042150          523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-----  597 (803)
Q Consensus       523 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-----  597 (803)
                      ++++...+..++||||+ +++|.+++.......+++.+++.++.||+.||+|||+   .+|+||||||+|||++.     
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccc
Confidence            99999999999999999 8999999966555679999999999999999999999   99999999999999975     


Q ss_pred             --------------------CCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHH
Q 042150          598 --------------------NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEV  657 (803)
Q Consensus       598 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el  657 (803)
                                          ++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||+||||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                78999999999975322     12345789999999999999999999999999999999


Q ss_pred             HhCCCCCCcchhhhhhhHHHH---------HHHHhhcCccccccCcccccCCC--------------------HHHHHHH
Q 042150          658 LCARTAVDPLLAREQVNLAEW---------AMQWQKKGMLEHIIDPQLIGKIN--------------------LDSLKKF  708 (803)
Q Consensus       658 ltG~~p~~~~~~~~~~~l~~~---------~~~~~~~~~~~~i~d~~l~~~~~--------------------~~~~~~l  708 (803)
                      ++|+.||......+.......         .................+....+                    ......+
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            999999976543332211111         00000000000000000000000                    0012567


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHH
Q 042150          709 GETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       709 ~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+++.+||+.||.+|||+.|++++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHhcCChhhCCCHHHHhcC
Confidence            899999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=365.75  Aligned_cols=254  Identities=20%  Similarity=0.254  Sum_probs=204.1

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ..++|...+.||+|+||.||++... +++.+|+|.+....  ....+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4567999999999999999999975 58899999865432  22345789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc---cCCcEEEeeeccccCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSG  612 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~DFGla~~~  612 (803)
                      |||+++|+|.+.+..  ...+++.++..++.||+.||+|||+   .+|+||||||+|||++   .++.+||+|||+++..
T Consensus        89 ~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           89 FDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             ECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            999999999999843  4569999999999999999999999   9999999999999998   4678999999999764


Q ss_pred             CCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ...  ........||+.|+|||++.+..++.++|||||||+||||++|+.||......+..      .. ...+... ..
T Consensus       164 ~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~------~~-i~~~~~~-~~  233 (444)
T 3soa_A          164 EGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY------QQ-IKAGAYD-FP  233 (444)
T ss_dssp             CTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HH-HHHTCCC-CC
T ss_pred             cCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH------HH-HHhCCCC-CC
Confidence            322  22234567999999999999999999999999999999999999999654322211      11 1111110 00


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                           .......+..+.+++.+||+.||.+|||+.|++++
T Consensus       234 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          234 -----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                 00112335678999999999999999999999985

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.6e-40  Score=352.97  Aligned_cols=256  Identities=26%  Similarity=0.370  Sum_probs=195.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCC---hHHHHHHHHHHHhccCCCeeeEEeEeeccce----
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQG---LPEFQTEITVLSKIRHRHLVSLVGYCEEQSE----  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~----  531 (803)
                      .++|...+.||+|+||.||+|.. .+++.||||++.......   ...|.+|++++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36788899999999999999997 468899999876543332   3578899999999999999999999876553    


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .++||||+++|+|.+++..  ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             cEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            4999999999999999943  4569999999999999999999999   8999999999999999999999999999975


Q ss_pred             CCCCCCC-ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          612 GPCLDET-HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       612 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                      ....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ........... 
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~-  238 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP-  238 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCC-
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCCC-
Confidence            4322111 122345689999999999999999999999999999999999999975433221      11111111100 


Q ss_pred             ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       691 i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                         +.   ......+..+.+++.+||+.||.+||++.+++++-
T Consensus       239 ---~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~  275 (311)
T 3ork_A          239 ---PS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD  275 (311)
T ss_dssp             ---HH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred             ---cc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHH
Confidence               00   00112346789999999999999999877776543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-39  Score=351.56  Aligned_cols=269  Identities=26%  Similarity=0.389  Sum_probs=204.6

Q ss_pred             cChhhHHHHhcCCCccceEeeeCceEEEEEEECC----CcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEe
Q 042150          451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVG  524 (803)
Q Consensus       451 ~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g  524 (803)
                      ..+.++....++|...+.||+|+||.||+|.+..    +..||+|.+....  ....+.+.+|+.++++++||||+++++
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~  103 (313)
T 3brb_A           24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG  103 (313)
T ss_dssp             CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence            3445556667889999999999999999998642    4579999865442  223467999999999999999999999


Q ss_pred             Eeeccc-----eeeEEEEecCCCchhhhccC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE
Q 042150          525 YCEEQS-----EMILVYEYMEKGPLKKHLYG----PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL  595 (803)
Q Consensus       525 ~~~~~~-----~~~lV~Ey~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl  595 (803)
                      ++.+..     ..++||||+++|+|.+++..    .....+++.+++.++.|+++||.|||+   .+|+||||||+|||+
T Consensus       104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli  180 (313)
T 3brb_A          104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCML  180 (313)
T ss_dssp             EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEE
T ss_pred             EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEE
Confidence            997655     35999999999999999832    234679999999999999999999999   899999999999999


Q ss_pred             ccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhh
Q 042150          596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVN  674 (803)
Q Consensus       596 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  674 (803)
                      +.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||........  
T Consensus       181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--  258 (313)
T 3brb_A          181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--  258 (313)
T ss_dssp             CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred             cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--
Confidence            9999999999999976433222223334567889999999999999999999999999999999 8888865433221  


Q ss_pred             HHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          675 LAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       675 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                       ....    ..+.         ....+...+..+.+++.+||+.+|.+|||+.+++++|+.+.+
T Consensus       259 -~~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          259 -YDYL----LHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             -HHHH----HTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHH----HcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             1111    1110         011223345678999999999999999999999999998864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.6e-39  Score=355.46  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=202.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC---CChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR---QGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ++|...+.||+|+||.||+++.+ +++.||+|++.....   ...+.+.+|..++.++ +||||+++++++.+.+.+++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56888899999999999999986 488999998654322   2345688999999988 899999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++|+|.+++..  ...+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.... 
T Consensus        89 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-  162 (345)
T ss_dssp             ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-
T ss_pred             EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC-
Confidence            999999999999943  3569999999999999999999999   9999999999999999999999999999985322 


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhh--hHHHHHHHHhhcCccccccC
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV--NLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~i~d  693 (803)
                       .........||+.|+|||++.+..++.++|||||||+||||++|+.||.........  ...............     
T Consensus       163 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----  236 (345)
T 3a8x_A          163 -PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----  236 (345)
T ss_dssp             -TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-----
T ss_pred             -CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-----
Confidence             112234567999999999999999999999999999999999999999642211100  011111111111111     


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSM------GDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~~  732 (803)
                           .++......+.+++.+||+.||.+||++      .|++++
T Consensus       237 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          237 -----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             -----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                 1233445678999999999999999995      566654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.1e-39  Score=352.16  Aligned_cols=249  Identities=21%  Similarity=0.298  Sum_probs=195.7

Q ss_pred             hcCCCccceEeeeCceEEEEEEE----CCCcEEEEEEcCCCC----CCChHHHHHHHHHHHhccCCCeeeEEeEeeccce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL----RDNTKVAVKRGVPGS----RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~  531 (803)
                      .++|...+.||+|+||.||+++.    .+++.||+|++....    ......+.+|+++|++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35788899999999999999997    468899999876432    2344568899999999999999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .++||||+++|+|.+++.  ....+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLE--REGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999999999999994  34568999999999999999999999   8999999999999999999999999999875


Q ss_pred             CCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ...  .........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.      ...... ..    
T Consensus       171 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~-~~----  237 (327)
T 3a62_A          171 SIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT------IDKILK-CK----  237 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHH-TC----
T ss_pred             ccc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHh-CC----
Confidence            321  11223345789999999999999999999999999999999999999975432221      111111 10    


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                            ..++......+.+++.+||+.+|.+||     ++.|++++
T Consensus       238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                  012233456789999999999999999     77888775

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.1e-39  Score=359.36  Aligned_cols=257  Identities=22%  Similarity=0.258  Sum_probs=197.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .++|...+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            457888999999999999999986 58899999875433 3346789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc--EEEeeeccccCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV--SKVADFGLSRSGPCLD  616 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--~kl~DFGla~~~~~~~  616 (803)
                      +++|+|.+++..  ...+++.+++.++.|++.||+|||+   ++|+||||||+|||++.++.  +||+|||+++...   
T Consensus        98 ~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~---  169 (361)
T 3uc3_A           98 ASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---  169 (361)
T ss_dssp             CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---
Confidence            999999999843  4569999999999999999999999   99999999999999987765  9999999987422   


Q ss_pred             CCceeccccCCCcccCccccccCcCCCc-ceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDK-SDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                      .........||+.|+|||++.+..++.+ +|||||||++|||++|+.||........  ..........         ..
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~---------~~  238 (361)
T 3uc3_A          170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILS---------VK  238 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHT---------TC
T ss_pred             ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhc---------CC
Confidence            1222334579999999999988888766 8999999999999999999975432221  1111111111         10


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      ............+.+++.+||+.+|.+|||+.|++++-...
T Consensus       239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  279 (361)
T 3uc3_A          239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL  279 (361)
T ss_dssp             CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred             CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence            10011112346788999999999999999999999876543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.3e-40  Score=357.28  Aligned_cols=266  Identities=25%  Similarity=0.381  Sum_probs=212.4

Q ss_pred             hhHHHHhcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEe
Q 042150          454 TDLQTATNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYC  526 (803)
Q Consensus       454 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~  526 (803)
                      .++....++|...+.||+|+||.||+|...      .++.||||.+..... .....|.+|++++++++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344456678999999999999999999865      367899998754322 2345689999999999999999999999


Q ss_pred             eccceeeEEEEecCCCchhhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC
Q 042150          527 EEQSEMILVYEYMEKGPLKKHLYGP--------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN  598 (803)
Q Consensus       527 ~~~~~~~lV~Ey~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~  598 (803)
                      .+.+..++||||+++|+|.+++...        ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCC
Confidence            9999999999999999999998431        12567999999999999999999999   899999999999999999


Q ss_pred             CcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHH
Q 042150          599 YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAE  677 (803)
Q Consensus       599 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~  677 (803)
                      +.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........     
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-----  249 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-----  249 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-----
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH-----
Confidence            9999999999875322111122233456889999999999999999999999999999999 8888865432211     


Q ss_pred             HHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          678 WAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       678 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                       .... ..+..         ...+...+..+.+++.+||+.+|.+|||+.|++++|+....
T Consensus       250 -~~~~-~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          250 -LRFV-MEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -HHHH-HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHHH-HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             1111 11111         11123345678999999999999999999999999987653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.6e-39  Score=342.88  Aligned_cols=251  Identities=24%  Similarity=0.358  Sum_probs=204.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .++|...+.||+|+||.||+|.... +..||+|++...   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4678889999999999999999765 678999986432   223456789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++|+|.+++..  ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..... 
T Consensus        88 ~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  161 (279)
T ss_dssp             ECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence            999999999999843  3568999999999999999999998   9999999999999999999999999999865322 


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                         .......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+..      ... ...         
T Consensus       162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~-~~~---------  222 (279)
T 3fdn_A          162 ---SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------KRI-SRV---------  222 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHH-HHT---------
T ss_pred             ---ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH------HHH-HhC---------
Confidence               2223457899999999999999999999999999999999999999754322211      110 100         


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                       ...++......+.+++.+||+.+|.+|||+.|++++-...
T Consensus       223 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~  262 (279)
T 3fdn_A          223 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  262 (279)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred             -CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence             0112223446788999999999999999999999876543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-39  Score=377.55  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=202.5

Q ss_pred             eEeeeCceEEEEEEEC---CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCCc
Q 042150          468 IIGSGGFGMVYKGVLR---DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGP  543 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs  543 (803)
                      .||+|+||.||+|.+.   ++..||||++.... ....++|.+|+++|++++||||++++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999874   45679999976543 3457889999999999999999999999976 56899999999999


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC-ceec
Q 042150          544 LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET-HVST  622 (803)
Q Consensus       544 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~  622 (803)
                      |.+++.. ....+++.+++.++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++........ ....
T Consensus       422 L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          422 LHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             HHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             HHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            9999954 34569999999999999999999999   89999999999999999999999999999864322211 1122


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCC
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN  701 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  701 (803)
                      ...+++.|+|||++.+..++.++|||||||+||||++ |+.||......+.   ..    ....+.         ....+
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~----~i~~~~---------~~~~p  561 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA----FIEQGK---------RMECP  561 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---HH----HHHTTC---------CCCCC
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HH----HHHcCC---------CCCCC
Confidence            3345789999999999999999999999999999998 9999975433221   11    111111         11223


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          702 LDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       702 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      ..++..+.+|+.+||+.+|.+||++.+|++.|+.+....
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            345678899999999999999999999999999876443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-39  Score=342.68  Aligned_cols=261  Identities=25%  Similarity=0.404  Sum_probs=209.2

Q ss_pred             cCCCccc-eEeeeCceEEEEEEEC---CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNL-IIGSGGFGMVYKGVLR---DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~-~Lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ++|.... .||+|+||.||+|.+.   ++..||||.+.... ....+++.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            3455554 8999999999999864   57789999876543 23456799999999999999999999999 45678999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++++|.+++.. ....+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            999999999999953 34569999999999999999999999   89999999999999999999999999999764322


Q ss_pred             CCC-ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          616 DET-HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       616 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+.   ...    ...+.      
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~----i~~~~------  230 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAF----IEQGK------  230 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHH----HHTTC------
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---HHH----HhcCC------
Confidence            211 11223456889999999998999999999999999999998 9999875433221   111    11111      


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhcc
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES  742 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  742 (803)
                         ....+...+..+.+++.+||+.+|.+||++.+++++|+.+......
T Consensus       231 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          231 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             ---cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence               1122334557889999999999999999999999999998765543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=347.89  Aligned_cols=265  Identities=22%  Similarity=0.262  Sum_probs=200.1

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCC--ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQ--GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|...+.||+|+||.||+|.... ++.||||++......  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            578888999999999999999864 889999986544322  24568899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|.+++.  ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  .
T Consensus        83 ~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~  155 (311)
T 4agu_A           83 YCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--P  155 (311)
T ss_dssp             CCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--c
Confidence            999999999884  34569999999999999999999999   8999999999999999999999999999976332  1


Q ss_pred             CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHH---------HHHhhcCc
Q 042150          618 THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWA---------MQWQKKGM  687 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~  687 (803)
                      ........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......+........         ........
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence            122234578999999999976 67899999999999999999999999765443332211110         00000000


Q ss_pred             cccccCcccccCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          688 LEHIIDPQLIGKI-----NLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       688 ~~~i~d~~l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ......+......     .......+.+++.+||+.||.+|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000000000000     01234568899999999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.3e-39  Score=360.51  Aligned_cols=270  Identities=19%  Similarity=0.214  Sum_probs=203.9

Q ss_pred             hcCCCccceEeee--CceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          460 TNNFDKNLIIGSG--GFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .++|...++||+|  +||.||+|+.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4578889999999  99999999986 58999999865432  2334678889999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++.......+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            9999999999999966555679999999999999999999999   9999999999999999999999999998754211


Q ss_pred             CC-----CCceeccccCCCcccCcccccc--CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhH--HHHHHHHhh-
Q 042150          615 LD-----ETHVSTGVKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNL--AEWAMQWQK-  684 (803)
Q Consensus       615 ~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l--~~~~~~~~~-  684 (803)
                      ..     .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........  ......... 
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            11     0111223478999999999987  6899999999999999999999999975432221100  000000000 


Q ss_pred             ----c-------------Ccccccc---Ccc------cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          685 ----K-------------GMLEHII---DPQ------LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       685 ----~-------------~~~~~i~---d~~------l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                          .             ..+....   .+.      ............+.+|+.+||+.||.+|||+.|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                0             0000000   000      0001122335678999999999999999999999876

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.6e-39  Score=347.88  Aligned_cols=264  Identities=20%  Similarity=0.292  Sum_probs=190.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357888899999999999999965 58899999865443 3345789999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          538 YMEKGPLKKHLYG----PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       538 y~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      |++ |+|.+++..    .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 599888842    223468999999999999999999999   899999999999999999999999999997633


Q ss_pred             CCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC---ccc
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG---MLE  689 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~  689 (803)
                      ..  ........+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...   .........   ...
T Consensus       160 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK---LIFDIMGTPNESLWP  234 (317)
T ss_dssp             SC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCTTTCG
T ss_pred             CC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCChhHhh
Confidence            21  112234578999999999976 468999999999999999999999997654332221   111111000   000


Q ss_pred             cc-----cCccc------------ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          690 HI-----IDPQL------------IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       690 ~i-----~d~~l------------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+     ..+.+            ...........+.+++.+||+.||.+|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            00     00000            000111234578999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-39  Score=348.92  Aligned_cols=275  Identities=24%  Similarity=0.342  Sum_probs=206.5

Q ss_pred             hhhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhc--cCCCeeeEEeEeecc-
Q 042150          453 FTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI--RHRHLVSLVGYCEEQ-  529 (803)
Q Consensus       453 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l--~HpnIv~l~g~~~~~-  529 (803)
                      ...-....++|...+.||+|+||.||+|... ++.||||++...   ....+..|.+++..+  +||||+++++++... 
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            3344455678999999999999999999986 899999986432   334566677776665  899999999999876 


Q ss_pred             ---ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCceEeeccCcceEEEccCCcE
Q 042150          530 ---SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS-----AEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       530 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDLkp~NILl~~~~~~  601 (803)
                         ...++||||+++|+|.+++.   ...+++.+++.++.|++.||+|||+..     ..+|+||||||+|||++.++.+
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHH---HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCCceEEEEeccCCCcHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence               68999999999999999994   346999999999999999999999810     1299999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCc--eeccccCCCcccCccccccCcCCCc------ceehhHHHHHHHHHhC----------CCC
Q 042150          602 KVADFGLSRSGPCLDETH--VSTGVKGSFGYLDPEYFRRQQLTDK------SDVYSFGVVLFEVLCA----------RTA  663 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~k------sDV~S~Gvvl~elltG----------~~p  663 (803)
                      ||+|||+++.........  ......||+.|+|||++.+...+.+      +|||||||++|||++|          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999996533211111  1124578999999999988777665      9999999999999999          555


Q ss_pred             CCcchhhhhhhHHHHHHHHhhcCccccccCcccccC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          664 VDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK-INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       664 ~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      +........ ...... .......    ..+.+... ....++..+.+++.+||+.||.+|||+.|++++|+.+.+.+
T Consensus       262 ~~~~~~~~~-~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          262 YHDLVPSDP-SYEDMR-EIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTTTSCSSC-CHHHHH-HHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             HhhhcCCCC-chhhhH-HHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            543221111 111111 1111111    11111111 12367788999999999999999999999999999887654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.2e-39  Score=345.89  Aligned_cols=250  Identities=26%  Similarity=0.399  Sum_probs=205.7

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeec---------
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE---------  528 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~---------  528 (803)
                      ...+|...+.||+|+||.||+|... +++.||+|++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567889999999999999999986 68999999875432    467899999999999999999998854         


Q ss_pred             -------cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcE
Q 042150          529 -------QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       529 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~  601 (803)
                             ....++||||+++|+|.+++.......+++..++.++.|++.||.|||+   .+|+||||||+|||+++++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence                   4568999999999999999965455679999999999999999999999   899999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQ  681 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  681 (803)
                      ||+|||+++.....   .......+++.|+|||.+.+..++.++||||||+++|||++|..|+....        .+...
T Consensus       162 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~~  230 (284)
T 2a19_B          162 KIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFTD  230 (284)
T ss_dssp             EECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHHH
T ss_pred             EECcchhheecccc---ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHHH
Confidence            99999998764321   12234568999999999999999999999999999999999998753211        11111


Q ss_pred             HhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          682 WQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       682 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                       ...+.+            +......+.+++.+||+.+|.+|||+.|++++|+.....
T Consensus       231 -~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          231 -LRDGII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             -HHTTCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             -hhcccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence             111111            122335678999999999999999999999999987643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.7e-39  Score=339.26  Aligned_cols=254  Identities=19%  Similarity=0.282  Sum_probs=206.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .++|...+.||+|+||.||+|.... +..+|+|++........+.+.+|++++++++||||++++++|.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            4678889999999999999999765 678999987766566788999999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE---ccCCcEEEeeeccccCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~DFGla~~~~~~  615 (803)
                      +++++|.+++..  ...+++.+++.++.|++.||+|||+   .+|+||||||+|||+   +.++.+||+|||+++.... 
T Consensus        88 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~-  161 (277)
T 3f3z_A           88 CTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-  161 (277)
T ss_dssp             CCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT-
T ss_pred             cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC-
Confidence            999999998843  4568999999999999999999999   999999999999999   7889999999999875332 


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                        ........+|+.|+|||.+.+. ++.++||||||+++|||++|+.||......+..      ... ..+...  ....
T Consensus       162 --~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~-~~~~~~--~~~~  229 (277)
T 3f3z_A          162 --GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM------LKI-REGTFT--FPEK  229 (277)
T ss_dssp             --TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH-HHCCCC--CCHH
T ss_pred             --ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH------HHH-HhCCCC--CCch
Confidence              2223345789999999998654 899999999999999999999999754332211      111 111100  0000


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ..    ......+.+++.+||+.+|.+|||+.+++++-..
T Consensus       230 ~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  265 (277)
T 3f3z_A          230 DW----LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF  265 (277)
T ss_dssp             HH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             hh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence            00    0234678999999999999999999999986443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-39  Score=353.85  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=197.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccc-------
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS-------  530 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-------  530 (803)
                      .++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++||||++++++|.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457888999999999999999986 68999999875433 334578999999999999999999999985543       


Q ss_pred             --------------------------------------------------eeeEEEEecCCCchhhhccCCC-CCCCCHH
Q 042150          531 --------------------------------------------------EMILVYEYMEKGPLKKHLYGPD-RTPLSWK  559 (803)
Q Consensus       531 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~-~~~l~~~  559 (803)
                                                                        ..++||||+++|+|.+++.... ....++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              2799999999999999995432 2346677


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC----------ceeccccCCCc
Q 042150          560 QRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET----------HVSTGVKGSFG  629 (803)
Q Consensus       560 ~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~  629 (803)
                      .++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            899999999999999999   99999999999999999999999999999764332111          12234579999


Q ss_pred             ccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHH
Q 042150          630 YLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFG  709 (803)
Q Consensus       630 y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~  709 (803)
                      |+|||.+.+..++.++|||||||++|||++|..|+...     ...   . .........         .......+.+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~---~-~~~~~~~~~---------~~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRI---I-TDVRNLKFP---------LLFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHH---H-HHHHTTCCC---------HHHHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHH---H-HHhhccCCC---------cccccCChhHH
Confidence            99999999999999999999999999999987653211     000   0 001111100         01123446778


Q ss_pred             HHHHHccccCCCCCCCHHHHHHH
Q 042150          710 ETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       710 ~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +++.+||+.||.+|||+.|++++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCCCCcCCCHHHHhhc
Confidence            99999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.8e-39  Score=345.64  Aligned_cols=251  Identities=24%  Similarity=0.364  Sum_probs=202.7

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-C-------cEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-N-------TKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~  531 (803)
                      .++|...+.||+|+||.||+|.... +       ..||+|.+........+.|.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3568888999999999999998653 3       4799998766666667889999999999999999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc--------EEE
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV--------SKV  603 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--------~kl  603 (803)
                      .++||||+++|+|.+++... ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.        +||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999999542 3348999999999999999999999   99999999999999998887        999


Q ss_pred             eeeccccCCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCC-CCcchhhhhhhHHHHHHH
Q 042150          604 ADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTA-VDPLLAREQVNLAEWAMQ  681 (803)
Q Consensus       604 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~  681 (803)
                      +|||+++....      .....++..|+|||.+.+ ..++.++|||||||++|||++|..| +.........      ..
T Consensus       163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~------~~  230 (289)
T 4fvq_A          163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL------QF  230 (289)
T ss_dssp             CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HH
T ss_pred             ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH------HH
Confidence            99999865321      123457889999999987 7799999999999999999996544 4332211111      11


Q ss_pred             HhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          682 WQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       682 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ......            .+......+.+++.+||+.+|.+|||+.|++++|+.+..
T Consensus       231 ~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          231 YEDRHQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHTTCC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hhccCC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            111111            111123457899999999999999999999999997653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.9e-39  Score=354.21  Aligned_cols=250  Identities=22%  Similarity=0.279  Sum_probs=205.2

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceee
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~  533 (803)
                      ..++|...++||+|+||.||+|+.+. ++.||+|++...   .....+.+..|..+|..+ +||||+++++++.+.+.++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34678999999999999999999875 788999986532   234567889999999988 7999999999999999999


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +||||+++|+|.+++..  ...+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        98 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999999943  3569999999999999999999999   999999999999999999999999999998532


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      .  .........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ...... ...     
T Consensus       173 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~-~~~-----  238 (353)
T 2i0e_A          173 W--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIME-HNV-----  238 (353)
T ss_dssp             C--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH-CCC-----
T ss_pred             c--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH------HHHHHh-CCC-----
Confidence            2  12223456799999999999999999999999999999999999999975432211      111111 110     


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  732 (803)
                           .++......+.+++.+||+.+|.+||+     +.+++++
T Consensus       239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 122344567899999999999999995     5777654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.1e-39  Score=357.98  Aligned_cols=271  Identities=21%  Similarity=0.262  Sum_probs=213.3

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccc--eeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS--EMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~--~~~lV~  536 (803)
                      ++|...++||+|+||.||+|.... ++.||||++.... ....+.+.+|+++|++++||||+++++++....  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            568888999999999999999865 8899999875432 345678899999999999999999999997655  789999


Q ss_pred             EecCCCchhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE----ccCCcEEEeeeccccC
Q 042150          537 EYMEKGPLKKHLYGPD-RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL----DENYVSKVADFGLSRS  611 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~~kl~DFGla~~  611 (803)
                      ||+++|+|.+++.... ...+++.+++.++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999995432 2349999999999999999999999   899999999999999    7888899999999976


Q ss_pred             CCCCCCCceeccccCCCcccCcccccc--------CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHh
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRR--------QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ  683 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  683 (803)
                      ...   ........||+.|+|||++.+        ..++.++|||||||++|||++|+.||.........  .+......
T Consensus       166 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~  240 (396)
T 4eut_A          166 LED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII  240 (396)
T ss_dssp             CCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHH
T ss_pred             ccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHh
Confidence            432   222334678999999999865        57788999999999999999999999654322211  11111111


Q ss_pred             hcC---ccccc---c--------CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          684 KKG---MLEHI---I--------DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       684 ~~~---~~~~i---~--------d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                      ...   ....+   .        +..............+.+++.+||+.||++||++.|+++.++.+++.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            111   00000   0        00111234567788899999999999999999999999999988754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.6e-39  Score=343.25  Aligned_cols=259  Identities=24%  Similarity=0.349  Sum_probs=205.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC----CcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .++|...+.||+|+||.||+|.+..    +..||+|...... ....+.|.+|+.++++++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4678888999999999999998643    2359999866542 23356799999999999999999999998754 5689


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++++|.+++.. ....+++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        90 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           90 IMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            9999999999999953 23568999999999999999999999   9999999999999999999999999999986432


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      . .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..   ...    ..+..     
T Consensus       166 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~~----~~~~~-----  232 (281)
T 3cc6_A          166 E-DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GVL----EKGDR-----  232 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HHH----HHTCC-----
T ss_pred             c-cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---HHH----hcCCC-----
Confidence            1 1112234557889999999999999999999999999999998 99998644332211   111    11100     


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                          ...+......+.+++.+||+.+|.+||++.|++++|+.+.+..
T Consensus       233 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          233 ----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                0112233467899999999999999999999999999887654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=359.52  Aligned_cols=250  Identities=23%  Similarity=0.266  Sum_probs=197.4

Q ss_pred             CccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCCC
Q 042150          464 DKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKG  542 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g  542 (803)
                      ...++||+|+||.||+|... +++.||+|++........++|.+|+++|++++||||++++++|.+.+..+|||||+++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            33568999999999999975 58899999876655455678999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE--ccCCcEEEeeeccccCCCCCCCCce
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL--DENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|.+++.. ....+++.+++.++.||++||+|||+   .+|+||||||+|||+  +.++.+||+|||+++.....   ..
T Consensus       172 ~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~---~~  244 (373)
T 2x4f_A          172 ELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EK  244 (373)
T ss_dssp             EEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT---CB
T ss_pred             cHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc---cc
Confidence            99998853 23468999999999999999999999   999999999999999  56789999999999864322   22


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      .....||+.|+|||++.+..++.++|||||||+||||++|+.||......+..      ........  . ..+..    
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~~~~~--~-~~~~~----  311 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL------NNILACRW--D-LEDEE----  311 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTCC--C-SCSGG----
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhccC--C-CChhh----
Confidence            23456899999999999999999999999999999999999999754332211      11111100  0 00000    


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       701 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      .......+.+++.+||+.+|.+|||+.|++++-
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp  344 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALKHP  344 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            112346789999999999999999999999853

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=354.13  Aligned_cols=267  Identities=14%  Similarity=0.181  Sum_probs=207.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC---------CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeee---------
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD---------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVS---------  521 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~---------  521 (803)
                      .++|...+.||+|+||.||+|....         ++.||||.....     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3678899999999999999999764         789999986543     46889999999999999988         


Q ss_pred             ------EEeEeec-cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEE
Q 042150          522 ------LVGYCEE-QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNIL  594 (803)
Q Consensus       522 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NIL  594 (803)
                            +++++.. ....++||||+ +++|.+++.......+++.+++.++.||+.||+|||+   .+|+||||||+|||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence                  5677765 67889999999 9999999965444679999999999999999999999   89999999999999


Q ss_pred             EccCC--cEEEeeeccccCCCCCCCC-----ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcc
Q 042150          595 LDENY--VSKVADFGLSRSGPCLDET-----HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL  667 (803)
Q Consensus       595 l~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~  667 (803)
                      ++.++  .+||+|||+++........     .......||+.|+|||.+.+..++.++|||||||+||||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999764321111     1123357899999999999999999999999999999999999999754


Q ss_pred             hhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          668 LAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       668 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                      ..... .+.........  ....+.+....   ....+..+.+++.+||+.+|.+||++.++++.|+.+.+...
T Consensus       272 ~~~~~-~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          272 LPNTE-DIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             TTCHH-HHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CcCHH-HHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            32211 11111111111  11111111100   01224678999999999999999999999999999876554

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.1e-39  Score=353.82  Aligned_cols=246  Identities=20%  Similarity=0.235  Sum_probs=205.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...   .....+.+.+|+++|+.++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888899999999999999976 5889999986432   2345678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++..  ...+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....  
T Consensus       121 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence            99999999999943  3569999999999999999999999   9999999999999999999999999999986432  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                         ......||+.|+|||++.+..++.++|||||||+||||++|+.||......+.      ..... .+..        
T Consensus       194 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~-~~~~--------  255 (350)
T 1rdq_E          194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YEKIV-SGKV--------  255 (350)
T ss_dssp             ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-HCCC--------
T ss_pred             ---CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH------HHHHH-cCCC--------
Confidence               12345789999999999999999999999999999999999999975432211      11111 1111        


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWNL  733 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~L  733 (803)
                        .++......+.+++.+||+.||.+||+     +.|++++-
T Consensus       256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence              122334567899999999999999998     88887653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4e-39  Score=349.79  Aligned_cols=258  Identities=31%  Similarity=0.477  Sum_probs=206.1

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcE--EEEEEcCCC-CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTK--VAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ++|...+.||+|+||.||+|... ++..  +++|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67888999999999999999965 4554  488876543 334567899999999999 899999999999999999999


Q ss_pred             EEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcE
Q 042150          536 YEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~  601 (803)
                      |||+++|+|.+++....              ...+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence            99999999999996432              3479999999999999999999999   999999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAM  680 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  680 (803)
                      ||+|||+++....   ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+      ...
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE  252 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHH
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HHH
Confidence            9999999874221   112233456889999999999999999999999999999998 999987543221      111


Q ss_pred             HHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      . ...+.         ....+......+.+++.+||+.+|.+|||+.|+++.|+.++...
T Consensus       253 ~-~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          253 K-LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             H-GGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             H-hhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            1 11110         11122334567899999999999999999999999999887543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.2e-39  Score=348.07  Aligned_cols=252  Identities=21%  Similarity=0.297  Sum_probs=205.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC------ChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ------GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      .++|...+.||+|+||.||+|... +++.||+|.+......      ..+++.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            466889999999999999999976 4889999986543221      367899999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC----cEEEeeecc
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY----VSKVADFGL  608 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~~kl~DFGl  608 (803)
                      ++||||+++++|.+++..  ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            999999999999999943  4568999999999999999999999   8999999999999999887    799999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ++....   ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..      .... ....
T Consensus       166 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~i~-~~~~  235 (321)
T 2a2a_A          166 AHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANIT-SVSY  235 (321)
T ss_dssp             CEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHH-TTCC
T ss_pred             ceecCc---cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-hccc
Confidence            976432   12223456899999999999999999999999999999999999999754322211      1111 1000


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        -.++...    ...+..+.+++.+||+.+|.+|||+.|++++
T Consensus       236 --~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 --DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             --CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             --ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0011111    1224568899999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.7e-40  Score=354.95  Aligned_cols=266  Identities=24%  Similarity=0.340  Sum_probs=209.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-----CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccc--ee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-----RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS--EM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~--~~  532 (803)
                      .++|...+.||+|+||.||++.+     .+++.||||++........+.|.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35678888999999999999985     358899999987665556678999999999999999999999986654  78


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+++++|.+++... ...+++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            9999999999999999542 3469999999999999999999999   99999999999999999999999999999764


Q ss_pred             CCCCCCc-eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh---------hhHHHHHHHH
Q 042150          613 PCLDETH-VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ---------VNLAEWAMQW  682 (803)
Q Consensus       613 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~---------~~l~~~~~~~  682 (803)
                      ....... ......++..|+|||.+.+..++.++|||||||++|||++|+.|+......-.         ..........
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            3322111 12234567889999999999999999999999999999999988753321100         0000011111


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ...+         .....+..++..+.+++.+||+.+|.+|||+.|+++.|+.+..
T Consensus       276 ~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          276 LKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcC---------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111         0111233455778999999999999999999999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.2e-39  Score=340.35  Aligned_cols=254  Identities=25%  Similarity=0.329  Sum_probs=204.8

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||.||+|... +++.||||...... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467888999999999999999976 58899999865432 3345788999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|.+++.  ....+++.+++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++.......
T Consensus        86 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ecCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            999999999994  34569999999999999999999999   9999999999999999999999999999875322222


Q ss_pred             CceeccccCCCcccCccccccCcC-CCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      ........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....|.    ....   ..    
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~---~~----  228 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKT---YL----  228 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH----TTCT---TS----
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh----hccc---cc----
Confidence            222334678999999999987765 7789999999999999999999975432211 111111    1100   00    


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        .........+.+++.+||+.+|.+|||+.|++++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence              0112334578899999999999999999999865

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.1e-39  Score=344.56  Aligned_cols=259  Identities=25%  Similarity=0.353  Sum_probs=205.1

Q ss_pred             hcCCCccc-eEeeeCceEEEEEEEC---CCcEEEEEEcCCCCCC--ChHHHHHHHHHHHhccCCCeeeEEeEeeccceee
Q 042150          460 TNNFDKNL-IIGSGGFGMVYKGVLR---DNTKVAVKRGVPGSRQ--GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       460 ~~~f~~~~-~Lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      .++|.... .||+|+||.||+|.+.   .++.||||.+......  ..++|.+|++++++++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 8999999999999653   3678999987654322  256799999999999999999999999 566789


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +||||+++++|.+++..  ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        94 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            99999999999999943  4569999999999999999999999   899999999999999999999999999997643


Q ss_pred             CCCCC-ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          614 CLDET-HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       614 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ..    ....+.    
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~----~~~~~~----  237 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TA----MLEKGE----  237 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH----HHHTTC----
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH----HHHcCC----
Confidence            32221 11223446789999999999999999999999999999999 9999875433221   11    111111    


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                           ....+...+..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus       238 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          238 -----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                 01123344567899999999999999999999999999887543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-39  Score=353.39  Aligned_cols=264  Identities=23%  Similarity=0.244  Sum_probs=203.6

Q ss_pred             hHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC-----CCCChHHHHHHHHHHHhccCCCeeeEEeEeec
Q 042150          455 DLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG-----SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE  528 (803)
Q Consensus       455 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~  528 (803)
                      ++....++|...+.||+|+||.||+|... +++.||+|++...     .....+.+.+|++++++++||||++++++|.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            45667789999999999999999999975 4788999975432     34556789999999999999999999999999


Q ss_pred             cceeeEEEEecCCCchhhhccCC--------------------------------------CCCCCCHHHHHHHHHHHHH
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGP--------------------------------------DRTPLSWKQRLEICIGAAR  570 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~  570 (803)
                      .+..++||||+++|+|.+++...                                      ....+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999988410                                      0112457778899999999


Q ss_pred             HHHHHhcCCCCceEeeccCcceEEEccCC--cEEEeeeccccCCCCCC--CCceeccccCCCcccCcccccc--CcCCCc
Q 042150          571 GLHYLHTGSAEGIIHRDIKSTNILLDENY--VSKVADFGLSRSGPCLD--ETHVSTGVKGSFGYLDPEYFRR--QQLTDK  644 (803)
Q Consensus       571 gL~yLH~~~~~~ivHrDLkp~NILl~~~~--~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~t~k  644 (803)
                      ||+|||+   .+|+||||||+|||++.++  .+||+|||+++......  .........||+.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            9999999   8999999999999998766  89999999997532211  1112345678999999999975  688999


Q ss_pred             ceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCC
Q 042150          645 SDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRP  724 (803)
Q Consensus       645 sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP  724 (803)
                      +|||||||+||||++|+.||......+..      ........  ....+     ........+.+++.+||+.+|.+||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTI------SQVLNKKL--CFENP-----NYNVLSPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCC--CTTSG-----GGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHH------HHHHhccc--ccCCc-----ccccCCHHHHHHHHHHcCCChhHCC
Confidence            99999999999999999999754332211      11111110  00001     0112356789999999999999999


Q ss_pred             CHHHHHHHHH
Q 042150          725 SMGDVLWNLE  734 (803)
Q Consensus       725 s~~evl~~L~  734 (803)
                      ++.|++++-.
T Consensus       324 s~~~~l~hp~  333 (345)
T 3hko_A          324 DAMRALQHPW  333 (345)
T ss_dssp             CHHHHHHSHH
T ss_pred             CHHHHhcChh
Confidence            9999998644

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.9e-39  Score=370.49  Aligned_cols=255  Identities=25%  Similarity=0.352  Sum_probs=209.5

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ..++|...++||+|+||.||+|..+ +++.||+|++...   .......+.+|+++|++++||||+++++++.+.+.+++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3466888999999999999999986 5899999986432   23456778999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++.......+++.+++.++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+++....
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            9999999999999976555669999999999999999999999   8999999999999999999999999999986432


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                         ........||+.|+|||++.+..++.++|||||||+||||++|+.||........  ..... ......        
T Consensus       339 ---~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~-~~i~~~--------  404 (576)
T 2acx_A          339 ---GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVE-RLVKEV--------  404 (576)
T ss_dssp             ---TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHH-HHHHHC--------
T ss_pred             ---CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHH-HHhhcc--------
Confidence               1223345899999999999999999999999999999999999999975432111  11111 111110        


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                        ...++...+..+.+|+.+||+.||.+||     ++.|++++
T Consensus       405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence              0112233456789999999999999999     78888875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.2e-39  Score=343.30  Aligned_cols=252  Identities=29%  Similarity=0.425  Sum_probs=200.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeecc-ceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ-SEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~lV~Ey  538 (803)
                      .++|...+.||+|+||.||+|... ++.||||.....  ...+.|.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467888999999999999999875 789999987543  3567899999999999999999999997544 578999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.+++.......+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.....   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            999999999954333348999999999999999999999   89999999999999999999999999998753221   


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                        .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ..   . ...+         ..
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~---~-~~~~---------~~  232 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP---R-VEKG---------YK  232 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HH---H-HTTT---------CC
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---H-HhcC---------CC
Confidence              123357889999999999999999999999999999998 9999875432221   11   1 1111         01


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      ...+...+..+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            12233445678999999999999999999999999998764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.3e-39  Score=349.93  Aligned_cols=267  Identities=25%  Similarity=0.383  Sum_probs=198.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHH--HhccCCCeeeEEeEee-----cccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVL--SKIRHRHLVSLVGYCE-----EQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l--~~l~HpnIv~l~g~~~-----~~~~~  532 (803)
                      .++|...+.||+|+||.||+|+. +++.||||++...   ....+..|.+++  ..++||||+++++.+.     .....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            35788889999999999999987 5789999986532   244566665554  4579999999998553     33467


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------ceEeeccCcceEEEccCCcEEE
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE---------GIIHRDIKSTNILLDENYVSKV  603 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~---------~ivHrDLkp~NILl~~~~~~kl  603 (803)
                      ++||||+++|+|.+++..   ...++..++.++.||++||+|||+   .         +|+||||||+|||++.++.+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence            899999999999999933   345899999999999999999998   6         9999999999999999999999


Q ss_pred             eeeccccCCCCCC------CCceeccccCCCcccCcccccc-------CcCCCcceehhHHHHHHHHHhCCCCCCcchhh
Q 042150          604 ADFGLSRSGPCLD------ETHVSTGVKGSFGYLDPEYFRR-------QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAR  670 (803)
Q Consensus       604 ~DFGla~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~  670 (803)
                      +|||+++......      .........||+.|+|||++.+       ..++.++|||||||+||||++|+.|+......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            9999997543211      1112234569999999999976       46778999999999999999998776432211


Q ss_pred             hhh------------hHHHHHHHHhhcCccccccCcccccC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          671 EQV------------NLAEWAMQWQKKGMLEHIIDPQLIGK--INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       671 ~~~------------~l~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      ...            ...++. .......    ..+.+...  .....++.+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQ-VLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHH-HHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHH-hhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            100            011111 1111111    11111111  1234677899999999999999999999999999998


Q ss_pred             Hhhhc
Q 042150          737 LQLQE  741 (803)
Q Consensus       737 ~~~~~  741 (803)
                      +....
T Consensus       317 l~~~~  321 (336)
T 3g2f_A          317 MMIWE  321 (336)
T ss_dssp             HHCCC
T ss_pred             HHHHH
Confidence            85543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.3e-39  Score=351.50  Aligned_cols=251  Identities=23%  Similarity=0.296  Sum_probs=179.8

Q ss_pred             cceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEEecCCCc
Q 042150          466 NLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYEYMEKGP  543 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~~gs  543 (803)
                      .+.||+|+||.||+|... +++.||||++..   .....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            468999999999999986 488999998643   23567889999999997 9999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC---cEEEeeeccccCCCCCCCCce
Q 042150          544 LKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY---VSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       544 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~  620 (803)
                      |.+++..  ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++   .+||+|||+++.....  ...
T Consensus        93 L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~  165 (325)
T 3kn6_A           93 LFERIKK--KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQP  165 (325)
T ss_dssp             HHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCc
Confidence            9999943  4679999999999999999999999   9999999999999997665   8999999999753321  222


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.....................+...      .....
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~  239 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEA  239 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHH
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCccc
Confidence            334568999999999999999999999999999999999999997543221111111111111111110      00000


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       701 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ....+..+.+++.+||+.||.+|||+.|++++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            01235678999999999999999999999765

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-38  Score=346.59  Aligned_cols=262  Identities=21%  Similarity=0.247  Sum_probs=208.4

Q ss_pred             ChhhHHHHhcCCCcc-ceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhc-cCCCeeeEEeEe
Q 042150          452 PFTDLQTATNNFDKN-LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKI-RHRHLVSLVGYC  526 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~-~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~  526 (803)
                      .+.......+.|... +.||+|+||.||+|... +++.||+|++...  .......+.+|+.++.++ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            345556667777776 88999999999999976 4889999986543  233467899999999999 479999999999


Q ss_pred             eccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc---CCcEEE
Q 042150          527 EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---NYVSKV  603 (803)
Q Consensus       527 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~kl  603 (803)
                      .+.+..++||||+++|+|.+++.......+++.+++.++.|++.||+|||+   .+|+||||||+|||++.   ++.+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEE
Confidence            999999999999999999999966656789999999999999999999999   89999999999999987   789999


Q ss_pred             eeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHh
Q 042150          604 ADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ  683 (803)
Q Consensus       604 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  683 (803)
                      +|||+++....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+...      .. 
T Consensus       176 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~i-  245 (327)
T 3lm5_A          176 VDFGMSRKIGH---ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL------NI-  245 (327)
T ss_dssp             CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH-
T ss_pred             eeCccccccCC---ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH------HH-
Confidence            99999976432   222234578999999999999999999999999999999999999997543322110      00 


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ....      ..............+.+++.+||+.+|.+|||+.|++++
T Consensus       246 ~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          246 SQVN------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHTC------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             Hhcc------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            0000      001111122345678999999999999999999999865

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.5e-38  Score=354.91  Aligned_cols=255  Identities=19%  Similarity=0.291  Sum_probs=194.7

Q ss_pred             cCCCcc-ceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeec----cceee
Q 042150          461 NNFDKN-LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEE----QSEMI  533 (803)
Q Consensus       461 ~~f~~~-~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~----~~~~~  533 (803)
                      ++|... ++||+|+||+||++... +++.||||++..     ...+.+|++++.++ +||||+++++++..    ...++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            455555 68999999999999976 488999998642     35688999988554 89999999998865    66789


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc---CCcEEEeeecccc
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---NYVSKVADFGLSR  610 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~kl~DFGla~  610 (803)
                      |||||+++|+|.+++.......+++.+++.|+.||+.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            99999999999999976555679999999999999999999999   99999999999999997   7899999999998


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhh-hHHHHHHHHhhcCccc
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV-NLAEWAMQWQKKGMLE  689 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~  689 (803)
                      ....   ........||+.|+|||++.+..++.++|||||||+||||++|+.||......... ......    ..+...
T Consensus       213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~~  285 (400)
T 1nxk_A          213 ETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYE  285 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCCC
T ss_pred             ccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCccc
Confidence            6332   22234567899999999999999999999999999999999999999754322110 011111    111100


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                            +...........+.+|+.+||+.||.+|||+.|++++-...
T Consensus       286 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  326 (400)
T 1nxk_A          286 ------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  326 (400)
T ss_dssp             ------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence                  00001123456789999999999999999999999876543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=350.23  Aligned_cols=257  Identities=16%  Similarity=0.172  Sum_probs=209.0

Q ss_pred             HHHHhcCCCccceEeeeCceEEEEEE------ECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc---CCCeeeEEeEe
Q 042150          456 LQTATNNFDKNLIIGSGGFGMVYKGV------LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR---HRHLVSLVGYC  526 (803)
Q Consensus       456 l~~~~~~f~~~~~Lg~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~  526 (803)
                      +....++|...++||+|+||.||+|.      ...++.||||++...   ...++..|++++..++   |+||+++++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            33456778999999999999999994      446889999997543   4568889999988886   99999999999


Q ss_pred             eccceeeEEEEecCCCchhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc------
Q 042150          527 EEQSEMILVYEYMEKGPLKKHLYG---PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE------  597 (803)
Q Consensus       527 ~~~~~~~lV~Ey~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~------  597 (803)
                      ...+..+|||||+++|+|.+++..   .....+++.+++.|+.||++||+|||+   .+|+||||||+||||+.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcc
Confidence            999999999999999999999953   235679999999999999999999999   89999999999999998      


Q ss_pred             -----CCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh
Q 042150          598 -----NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ  672 (803)
Q Consensus       598 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  672 (803)
                           ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+||||++|+.||........
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence                 899999999999753323334445567899999999999999999999999999999999999999854322110


Q ss_pred             hhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHHHhh
Q 042150          673 VNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDR-PSMGDVLWNLEYALQL  739 (803)
Q Consensus       673 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~R-Ps~~evl~~L~~~~~~  739 (803)
                                    .    ....+...   .....+.+++.+|++.+|.+| |++.++.+.|+..++.
T Consensus       294 --------------~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          294 --------------K----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             --------------E----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --------------e----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                          0    11111111   124567789999999999999 6788888888877643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=354.38  Aligned_cols=260  Identities=21%  Similarity=0.311  Sum_probs=191.0

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEe--------ec
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYC--------EE  528 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~--------~~  528 (803)
                      ...+|...++||+|+||.||+|... +++.||||++........+.+.+|+.++.++. ||||+++++++        ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            4467899999999999999999975 58899999876555555678899999999996 99999999998        34


Q ss_pred             cceeeEEEEecCCCchhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--eEeeccCcceEEEccCCcEEEee
Q 042150          529 QSEMILVYEYMEKGPLKKHLYG-PDRTPLSWKQRLEICIGAARGLHYLHTGSAEG--IIHRDIKSTNILLDENYVSKVAD  605 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLkp~NILl~~~~~~kl~D  605 (803)
                      ....++||||+. |+|.+++.. .....+++.+++.++.||+.||+|||+   .+  |+||||||+|||++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence            456899999996 799888843 234569999999999999999999998   77  99999999999999999999999


Q ss_pred             eccccCCCCCCCCc----------eeccccCCCcccCcccc---ccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh
Q 042150          606 FGLSRSGPCLDETH----------VSTGVKGSFGYLDPEYF---RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ  672 (803)
Q Consensus       606 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  672 (803)
                      ||+++.........          ......+|+.|+|||++   .+..++.++|||||||++|||++|+.||....... 
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-  260 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-  260 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence            99998643321111          11134589999999998   56788999999999999999999999986432111 


Q ss_pred             hhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          673 VNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       673 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                                        +................+.+++.+||+.+|.+||++.|++++|+.+.....
T Consensus       261 ------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          261 ------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             -----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                              000000011111223457899999999999999999999999998876443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=362.56  Aligned_cols=264  Identities=22%  Similarity=0.253  Sum_probs=207.8

Q ss_pred             ChhhHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEee
Q 042150          452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCE  527 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~  527 (803)
                      .+.++....++|...++||+|+||.||+++.+ +++.||+|++...   .....+.+.+|..++.+++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34555666788999999999999999999985 5899999986432   1223446889999999999999999999999


Q ss_pred             ccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeec
Q 042150          528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG  607 (803)
Q Consensus       528 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG  607 (803)
                      +.+.++|||||+++|+|.+++... ...+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeech
Confidence            999999999999999999999532 2469999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCceeccccCCCcccCccccc-------cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH
Q 042150          608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFR-------RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM  680 (803)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  680 (803)
                      +++.... ..........||+.|+|||++.       ...++.++|||||||+||||++|+.||......+...  . ..
T Consensus       208 la~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~--~-i~  283 (412)
T 2vd5_A          208 SCLKLRA-DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG--K-IV  283 (412)
T ss_dssp             TCEECCT-TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--H-HH
T ss_pred             hheeccC-CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH--H-HH
Confidence            9976432 1222233468999999999997       4678999999999999999999999997543322111  0 00


Q ss_pred             HHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHH
Q 042150          681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDR---PSMGDVLWNL  733 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~~evl~~L  733 (803)
                      .....     +.-+.    .....+..+.+++.+||. +|.+|   |+++|++++-
T Consensus       284 ~~~~~-----~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          284 HYKEH-----LSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             THHHH-----CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             hcccC-----cCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence            00000     00011    112345678999999999 99998   6899997653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-38  Score=348.19  Aligned_cols=273  Identities=23%  Similarity=0.366  Sum_probs=212.6

Q ss_pred             cChhhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHh--ccCCCeeeEEeEeec
Q 042150          451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSK--IRHRHLVSLVGYCEE  528 (803)
Q Consensus       451 ~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~HpnIv~l~g~~~~  528 (803)
                      .++..-....++|...+.||+|+||.||+|... ++.||||.+..   .....+.+|.+++..  ++||||+++++++..
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            445555667788999999999999999999985 88999998643   235678899999988  689999999999987


Q ss_pred             cc----eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCceEeeccCcceEEEc
Q 042150          529 QS----EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH--------TGSAEGIIHRDIKSTNILLD  596 (803)
Q Consensus       529 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDLkp~NILl~  596 (803)
                      ..    ..++||||+++|+|.+++..   ..+++.+++.++.|++.||+|||        +   .+|+||||||+|||++
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVK  181 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEEC
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEEC
Confidence            76    78999999999999999943   46999999999999999999999        6   8999999999999999


Q ss_pred             cCCcEEEeeeccccCCCCCCCCc--eeccccCCCcccCccccccC------cCCCcceehhHHHHHHHHHhC--------
Q 042150          597 ENYVSKVADFGLSRSGPCLDETH--VSTGVKGSFGYLDPEYFRRQ------QLTDKSDVYSFGVVLFEVLCA--------  660 (803)
Q Consensus       597 ~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltG--------  660 (803)
                      .++.+||+|||+++.........  ......||+.|+|||.+.+.      .++.++|||||||+||||++|        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            99999999999987533221111  12345789999999999765      344689999999999999999        


Q ss_pred             --CCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          661 --RTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK-INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       661 --~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                        +.||....... .....+.......     ...+.+... ...+....+.+++.+||+.+|.+|||+.||+++|+.+.
T Consensus       262 ~~~~p~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          262 DYQLPYYDLVPSD-PSVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             CCCCTTTTTSCSS-CCHHHHHHHHTTS-----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccCccccCcCc-ccHHHHHHHHHHH-----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence              66765332111 1122222221111     111111111 12466788999999999999999999999999999886


Q ss_pred             hh
Q 042150          738 QL  739 (803)
Q Consensus       738 ~~  739 (803)
                      +.
T Consensus       336 ~~  337 (342)
T 1b6c_B          336 QQ  337 (342)
T ss_dssp             HT
T ss_pred             HH
Confidence            53

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-39  Score=357.74  Aligned_cols=258  Identities=27%  Similarity=0.420  Sum_probs=195.4

Q ss_pred             CCCccceEeeeCceEEEEEEECC--C--cEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeec-cceeeEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD--N--TKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEE-QSEMILV  535 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~lV  535 (803)
                      .|...++||+|+||.||+|.+.+  +  ..||||.+.... ....++|.+|+.++++++||||++++++|.+ .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            46667899999999999999642  2  358899865432 2345789999999999999999999998754 5678999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++|+|.+++.. ....+++.+++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       170 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            999999999999954 34568999999999999999999999   89999999999999999999999999999854322


Q ss_pred             CC--CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          616 DE--THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       616 ~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ..  ........+|+.|+|||.+.+..++.++|||||||+||||++ |..||......+   .....    ..+..    
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~----~~~~~----  314 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGRR----  314 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH----HTTCC----
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH----HcCCC----
Confidence            11  112234567889999999999999999999999999999999 667775432221   11111    11110    


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                           ...+..++..+.+++.+||+.+|.+||++.|+++.|+.+...
T Consensus       315 -----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          315 -----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                 011223456789999999999999999999999999988753

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-39  Score=342.13  Aligned_cols=259  Identities=24%  Similarity=0.361  Sum_probs=203.8

Q ss_pred             CCCccceEeeeCceEEEEEEECC-C---cEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeecccee-eEE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRD-N---TKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM-ILV  535 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~-~lV  535 (803)
                      .|...++||+|+||.||+|.+.+ +   ..+|+|....... ...+.|.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45566899999999999998643 2   3699998654332 3356789999999999999999999999766655 999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+.+|+|.+++.. ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            999999999999954 34568999999999999999999999   89999999999999999999999999999754321


Q ss_pred             C--CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCC-CcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          616 D--ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAV-DPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       616 ~--~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~-~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      .  .........++..|+|||.+.+..++.++|||||||++|||++|..|+ ......   .+....    ..+.     
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~~~----~~~~-----  245 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTHFL----AQGR-----  245 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHHHH----HTTC-----
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHHHh----hcCC-----
Confidence            1  111223456788999999999999999999999999999999966554 322221   111111    1110     


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                          ....+...+..+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus       246 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          246 ----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                01112234467899999999999999999999999999887543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.7e-39  Score=339.55  Aligned_cols=255  Identities=22%  Similarity=0.294  Sum_probs=205.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .++|...+.||+|+||.||+|.... ++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4678889999999999999999764 8899999865432  233467889999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc---EEEeeeccccCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV---SKVADFGLSRSGP  613 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---~kl~DFGla~~~~  613 (803)
                      ||+++++|.+.+.  ....+++.+++.++.|++.||.|||+   .+|+||||||+|||++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999998884  34569999999999999999999999   89999999999999986655   9999999997533


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      .   ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.........      .. ...+... .. 
T Consensus       160 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~-~~~~~~~-~~-  227 (284)
T 3kk8_A          160 D---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY------AQ-IKAGAYD-YP-  227 (284)
T ss_dssp             S---SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH-HHHTCCC-CC-
T ss_pred             c---CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH------HH-HHhcccc-CC-
Confidence            2   22233467899999999999999999999999999999999999999654322211      11 1111110 00 


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                          ..........+.+++.+||+.+|.+|||+.|++++-..
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (284)
T 3kk8_A          228 ----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI  265 (284)
T ss_dssp             ----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred             ----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence                01112334678899999999999999999999986543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.1e-38  Score=334.95  Aligned_cols=267  Identities=19%  Similarity=0.237  Sum_probs=208.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEe-eccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC-EEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~-~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||.||+|+. .+++.||||++....  ..+++.+|+.+++.++|+++++.+.++ .+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46788999999999999999997 568999999865443  235799999999999988877666665 66678899999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE---ccCCcEEEeeeccccCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~DFGla~~~~~  614 (803)
                      |+ +++|.+++.. ....+++.+++.++.|++.||+|||+   ++|+||||||+|||+   ++++.+||+|||+++....
T Consensus        86 ~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           86 LL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            99 8999999953 23569999999999999999999999   999999999999999   5889999999999975433


Q ss_pred             CCCC-----ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          615 LDET-----HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       615 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      ....     .......||+.|+|||.+.+..++.++|||||||+||||++|+.||.........................
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence            2211     11234678999999999999999999999999999999999999997543222211111111111000000


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhcc
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES  742 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  742 (803)
                           .    .....+..+.+++.+||+.+|.+||++.++++.|+.+......
T Consensus       241 -----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          241 -----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             -----H----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             -----H----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence                 0    0112346789999999999999999999999999988765543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.5e-39  Score=363.00  Aligned_cols=249  Identities=25%  Similarity=0.317  Sum_probs=205.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|... +|+.||||++...   .....+.+.+|+.+|+.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888899999999999999976 6899999986432   2334568999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.  ....+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  
T Consensus        96 E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~--  168 (476)
T 2y94_A           96 EYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--  168 (476)
T ss_dssp             ECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT--
T ss_pred             eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccc--
Confidence            9999999999994  45679999999999999999999999   9999999999999999999999999999986432  


Q ss_pred             CCceeccccCCCcccCccccccCcC-CCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                       ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......   +   ... ...+..       
T Consensus       169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~---~~~-i~~~~~-------  233 (476)
T 2y94_A          169 -GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---L---FKK-ICDGIF-------  233 (476)
T ss_dssp             -TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---H---HHH-HHTTCC-------
T ss_pred             -cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---H---HHH-HhcCCc-------
Confidence             122334579999999999988766 679999999999999999999997543221   1   111 111110       


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                         ..+......+.+++.+||+.||.+|||+.|++++-.
T Consensus       234 ---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~  269 (476)
T 2y94_A          234 ---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW  269 (476)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             ---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence               112223457899999999999999999999998543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.1e-38  Score=336.12  Aligned_cols=267  Identities=19%  Similarity=0.241  Sum_probs=205.1

Q ss_pred             HhcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEe-eccceeeEEE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYC-EEQSEMILVY  536 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~-~~~~~~~lV~  536 (803)
                      ..++|...+.||+|+||.||+|.. .+++.||||......  ..+++.+|+++++.++|++++..++.+ .+....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999997 568899999754332  224688999999999988877777665 6677889999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE---ccCCcEEEeeeccccCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGP  613 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~DFGla~~~~  613 (803)
                      ||+ +++|.+++... ...+++.+++.++.|++.||+|||+   .+|+||||||+|||+   ++++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999 99999998532 3469999999999999999999999   999999999999999   789999999999997543


Q ss_pred             CCCCC-----ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          614 CLDET-----HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       614 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            22211     1223467899999999999999999999999999999999999999754332222221111111100000


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                      .         ......+..+.+++.+||+.+|.+|||+.++++.|+.+.+...
T Consensus       240 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          240 E---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             H---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             h---------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            0         0011224578999999999999999999999999999876554

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.1e-39  Score=366.13  Aligned_cols=251  Identities=22%  Similarity=0.281  Sum_probs=196.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .++|...++||+|+||.||+|... +++.||||++...   .......+.+|+++|+.++||||++++++|...+.++||
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467889999999999999999975 5889999986532   334456788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++|+|.+++.  ....+++.++..++.||+.||+|||+  ..+|+||||||+||||+.++.+||+|||+++.... 
T Consensus       227 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-  301 (446)
T 4ejn_A          227 MEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-  301 (446)
T ss_dssp             ECCCSSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC-
Confidence            99999999999984  34579999999999999999999995  26899999999999999999999999999985322 


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                       .........||+.|+|||++.+..++.++|||||||+||||++|+.||.........      ...... ..       
T Consensus       302 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~~~-~~-------  366 (446)
T 4ejn_A          302 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELILME-EI-------  366 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHC-CC-------
T ss_pred             -CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH------HHHHhC-CC-------
Confidence             222234567999999999999999999999999999999999999999754322211      111111 00       


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWNL  733 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L  733 (803)
                         .++......+.+++.+||+.||.+||     ++.|++++-
T Consensus       367 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp  406 (446)
T 4ejn_A          367 ---RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR  406 (446)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             ---CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence               12223456789999999999999999     999998753

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.3e-39  Score=351.65  Aligned_cols=263  Identities=27%  Similarity=0.358  Sum_probs=206.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEE------CCCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL------RDNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      .++|...+.||+|+||.||+|.+      .++..||||.+... ......++.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46788999999999999999984      24678999997543 223456789999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc---CCcEEEe
Q 042150          533 ILVYEYMEKGPLKKHLYGPD-----RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---NYVSKVA  604 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~kl~  604 (803)
                      ++||||+++|+|.+++....     ...+++.+++.++.|++.||.|||+   .+|+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999995432     2458999999999999999999999   89999999999999984   4569999


Q ss_pred             eeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHh
Q 042150          605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQ  683 (803)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  683 (803)
                      |||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+   +.+.    .
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~----~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEF----V  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHH----H
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHH----H
Confidence            9999864222122222334567899999999999999999999999999999998 999987543221   1111    1


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                      ..+..         ...+......+.+++.+||+.+|.+||++.+++++|+.+.+...
T Consensus       259 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          259 TSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             hcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence            11110         11222345678999999999999999999999999998876543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.3e-38  Score=340.90  Aligned_cols=259  Identities=27%  Similarity=0.430  Sum_probs=201.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC----CcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEe-eccceee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYC-EEQSEMI  533 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~-~~~~~~~  533 (803)
                      ..+|...++||+|+||.||+|.+.+    ...+|+|.+..... ...+.+.+|+.++++++||||++++++| ..++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3457788899999999999999643    23588888654332 3356789999999999999999999986 4556789


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       104 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccc
Confidence            99999999999999954 34568999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCC--CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          614 CLDE--THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       614 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                      ....  ........+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+......+   .....    ..+.   
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~----~~~~---  249 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGR---  249 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHH----HTTC---
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHH----hcCC---
Confidence            2211  122334567889999999999999999999999999999999 555554332211   11111    1110   


Q ss_pred             ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       691 i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                            ....+...+..+.+++.+||+.+|.+|||+.|+++.|+.+..
T Consensus       250 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          250 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                  001122234578999999999999999999999999998875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-38  Score=343.62  Aligned_cols=260  Identities=20%  Similarity=0.285  Sum_probs=200.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC---ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ---GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .++|...+.||+|+||.||+|... +++.||+|.+......   ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            467999999999999999999976 5889999986544222   246789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++++|.+++..  ...+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       113 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          113 MRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999999943  3569999999999999999999999   89999999999999999999999999998764321


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                       .........+++.|+|||.+.+..++.++||||||+++|||++|+.||.......   +    ........    ..+ 
T Consensus       188 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~----~~~~~~~~----~~~-  254 (309)
T 2h34_A          188 -KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---M----GAHINQAI----PRP-  254 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---H----HHHHHSCC----CCG-
T ss_pred             -ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---H----HHHhccCC----CCc-
Confidence             1122234568999999999999999999999999999999999999997543221   1    11111110    000 


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHhh
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRP-SMGDVLWNLEYALQL  739 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~~~~~  739 (803)
                        .......+..+.+++.+||+.+|.+|| +++++++.|+.++..
T Consensus       255 --~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          255 --STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             --GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             --cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence              112233445788999999999999999 999999999977643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=352.13  Aligned_cols=244  Identities=23%  Similarity=0.300  Sum_probs=202.4

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--------CChHHHHHHHHHHHhccCCCeeeEEeEeecc
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--------QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ  529 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~  529 (803)
                      ..++|...+.||+|+||.||+|... +++.||||++.....        ...+.+.+|+++|++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4567999999999999999999964 588999998654321        1345688899999999999999999999999


Q ss_pred             ceeeEEEEecCCC-chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          530 SEMILVYEYMEKG-PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       530 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                      +..++||||+.+| +|.+++.  ....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999999777 9999994  34569999999999999999999999   8999999999999999999999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcC-CCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM  687 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (803)
                      ++....   ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......                
T Consensus       177 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------  237 (335)
T 3dls_A          177 AAYLER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV----------------  237 (335)
T ss_dssp             CEECCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------------
T ss_pred             ceECCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------------
Confidence            976432   122234578999999999988877 788999999999999999999986432110                


Q ss_pred             cccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          688 LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       688 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                       ....      ..+......+.+++.+||+.+|.+|||+.+++++-
T Consensus       238 -~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          238 -EAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             -TTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             -hhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence             0000      11112345789999999999999999999998864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5e-38  Score=357.76  Aligned_cols=265  Identities=20%  Similarity=0.228  Sum_probs=207.8

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccC-CCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH-RHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...++||+|+||.||+|.. .+++.||||+......  .+++.+|+++++.++| +++..+..++.+....+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            36788899999999999999997 4588999997554332  3468899999999976 566666677788888999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE---ccCCcEEEeeeccccCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~DFGla~~~~~  614 (803)
                      |+ +++|.+++... ...+++.+++.|+.||+.||+|||+   ++|+||||||+||||   +.++.+||+|||+++....
T Consensus        84 ~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99 89999999532 3569999999999999999999999   999999999999999   6899999999999976433


Q ss_pred             CCCC-----ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          615 LDET-----HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       615 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      ....     .......||+.|+|||.+.+..++.++|||||||+||||++|+.||.......................+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            2211     11235679999999999999999999999999999999999999997644322222222111111111111


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      .+.         ..++.++.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus       239 ~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          239 ALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            110         122457899999999999999999999999999887543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3e-38  Score=338.97  Aligned_cols=255  Identities=22%  Similarity=0.280  Sum_probs=202.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC----CCCChHHHHHHHHHHHhccCCCeeeEEeEe--ecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG----SRQGLPEFQTEITVLSKIRHRHLVSLVGYC--EEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~--~~~~~~  532 (803)
                      .++|...+.||+|+||.||++... +++.||+|.+...    .....+.+.+|++++++++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            467999999999999999999974 5789999986532    134457899999999999999999999998  455688


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||++++ |.+++.......+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999976 7777755456679999999999999999999999   89999999999999999999999999999764


Q ss_pred             CCCCCCceeccccCCCcccCccccccCc--CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQ--LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                      .............|++.|+|||.+.+..  .+.++|||||||++|||++|+.||......+.      ... ...+..  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~-i~~~~~--  230 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL------FEN-IGKGSY--  230 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHH-HHHCCC--
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH------HHH-HhcCCC--
Confidence            4333333344567899999999997643  47799999999999999999999975432211      111 111110  


Q ss_pred             ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       691 i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                              ..+......+.+++.+||+.||.+|||+.|++++-..
T Consensus       231 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  267 (305)
T 2wtk_C          231 --------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF  267 (305)
T ss_dssp             --------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred             --------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence                    1122345678899999999999999999999987543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-38  Score=339.13  Aligned_cols=252  Identities=25%  Similarity=0.316  Sum_probs=198.7

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||.||++... ++..+|+|+.... .....+.+.+|++++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            356888999999999999999975 4889999986543 34456889999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE---ccCCcEEEeeeccccCC
Q 042150          538 YMEKGPLKKHLYGP--DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSG  612 (803)
Q Consensus       538 y~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~DFGla~~~  612 (803)
                      |+++|+|.+++...  ....+++..++.++.|+++||+|||+   .+|+||||||+|||+   +.++.+||+|||+++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988432  24679999999999999999999999   999999999999999   45678999999999763


Q ss_pred             CCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ..   ........+|+.|+|||.+. ..++.++|||||||++|||++|+.||......+..      .......      
T Consensus       178 ~~---~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~------  241 (285)
T 3is5_A          178 KS---DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ------QKATYKE------  241 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCC------
T ss_pred             CC---cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH------hhhccCC------
Confidence            32   22234457899999999886 57899999999999999999999999754322211      1111100      


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       +.... ......+.+.+++.+||+.||.+|||+.|++++
T Consensus       242 -~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          242 -PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             -CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             -ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00000 001124567899999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9.6e-39  Score=339.03  Aligned_cols=252  Identities=21%  Similarity=0.307  Sum_probs=201.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC------CChHHHHHHHHHHHhccCCCeeeEEeEeeccceee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR------QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      ++|...+.||+|+||.||+|... +++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56888899999999999999986 588999997543321      23678999999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC----cEEEeeeccc
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY----VSKVADFGLS  609 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~~kl~DFGla  609 (803)
                      +||||+++++|.+++.  ....+++.+++.++.|++.||.|||+   .+++||||||+||+++.++    .+||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLA--EKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            9999999999999994  34569999999999999999999999   8999999999999998877    8999999998


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      +....   ........+++.|+|||.+.+..++.++||||||+++|||++|+.||......+..      ... ..... 
T Consensus       160 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~-~~~~~-  228 (283)
T 3bhy_A          160 HKIEA---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL------TNI-SAVNY-  228 (283)
T ss_dssp             EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHH-HTTCC-
T ss_pred             eeccC---CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH------HHh-Hhccc-
Confidence            75332   11223456899999999999999999999999999999999999998754322211      111 11000 


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                       -..+..    ....+..+.+++.+||+.+|.+||++.|++++-
T Consensus       229 -~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  267 (283)
T 3bhy_A          229 -DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS  267 (283)
T ss_dssp             -CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred             -CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence             001111    012245688999999999999999999999853

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.2e-39  Score=350.01  Aligned_cols=249  Identities=27%  Similarity=0.374  Sum_probs=201.5

Q ss_pred             cCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCC---ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQ---GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      +.|...+.||+|+||.||+|.. .+++.||||++......   ..++|.+|+++|++++||||++++++|...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999996 46889999987544322   2357899999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+. |+|.+++.. ....+++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++....  
T Consensus       134 e~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             ECCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             ecCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            9997 688877742 24569999999999999999999999   8999999999999999999999999999976332  


Q ss_pred             CCceeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          617 ETHVSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                          .....||+.|+|||++.   +..++.++|||||||+||||++|+.||........      ........      .
T Consensus       207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~------~  270 (348)
T 1u5q_A          207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE------S  270 (348)
T ss_dssp             ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC------C
T ss_pred             ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC------C
Confidence                22457899999999984   57899999999999999999999999865432211      11111111      0


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      +.+   ........+.+++.+||+.+|.+|||+.+++++...
T Consensus       271 ~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~  309 (348)
T 1u5q_A          271 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  309 (348)
T ss_dssp             CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred             CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence            111   112334568899999999999999999999986543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2e-38  Score=337.03  Aligned_cols=249  Identities=24%  Similarity=0.335  Sum_probs=205.6

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|... +++.||+|.....   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888899999999999999976 4778999986432   2334578999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++..  ...+++.+++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....  
T Consensus        94 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~--  166 (284)
T 2vgo_A           94 EFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--  166 (284)
T ss_dssp             CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred             EeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence            99999999999843  3468999999999999999999998   9999999999999999999999999999865322  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                        .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.      ...... .      +.  
T Consensus       167 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~-~------~~--  229 (284)
T 2vgo_A          167 --LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HRRIVN-V------DL--  229 (284)
T ss_dssp             --SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHT-T------CC--
T ss_pred             --cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HHHHhc-c------cc--
Confidence              122345789999999999999999999999999999999999999975432221      111111 0      01  


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                        .++......+.+++.+||+.+|.+||++.+++++-..
T Consensus       230 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~  266 (284)
T 2vgo_A          230 --KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV  266 (284)
T ss_dssp             --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred             --CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence              1223345678999999999999999999999986443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.4e-39  Score=349.38  Aligned_cols=256  Identities=21%  Similarity=0.298  Sum_probs=203.0

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ..++|...+.||+|+||.||++..+ +++.||||.+.....    .+.+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3567899999999999999999976 488999998754432    346788899888 7999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC----CcEEEeeeccccCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN----YVSKVADFGLSRSG  612 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~----~~~kl~DFGla~~~  612 (803)
                      ||+++|+|.+++..  ...+++.++..++.||+.||+|||+   .+|+||||||+|||+.++    +.+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999999943  4569999999999999999999999   999999999999999533    35999999999754


Q ss_pred             CCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ...  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........   +.... ...+...   
T Consensus       171 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~~~~-i~~~~~~---  241 (342)
T 2qr7_A          171 RAE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---EILAR-IGSGKFS---  241 (342)
T ss_dssp             BCT--TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---HHHHH-HHHCCCC---
T ss_pred             cCC--CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---HHHHH-HccCCcc---
Confidence            321  12233467899999999999888999999999999999999999999753221111   11111 1111111   


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                         +........+..+.+++.+||+.||.+||++.|++++-..
T Consensus       242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence               1111122345678999999999999999999999987554

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.6e-39  Score=351.49  Aligned_cols=265  Identities=18%  Similarity=0.176  Sum_probs=197.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC----CCcEEEEEEcCCCCCC-----------ChHHHHHHHHHHHhccCCCeeeEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR----DNTKVAVKRGVPGSRQ-----------GLPEFQTEITVLSKIRHRHLVSLVG  524 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~f~~E~~~l~~l~HpnIv~l~g  524 (803)
                      .++|...+.||+|+||.||+|...    .+..+|+|+.......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357888999999999999999986    4678999986544321           1234678888999999999999999


Q ss_pred             Eeec----cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC-
Q 042150          525 YCEE----QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY-  599 (803)
Q Consensus       525 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-  599 (803)
                      ++..    ....++||||+ +++|.+++..  ...+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence            9977    77899999999 9999999943  3379999999999999999999999   8999999999999999887 


Q ss_pred             -cEEEeeeccccCCCCCCC-----CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhh
Q 042150          600 -VSKVADFGLSRSGPCLDE-----THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV  673 (803)
Q Consensus       600 -~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  673 (803)
                       .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             999999999975322111     11123457899999999999999999999999999999999999999643221111


Q ss_pred             hHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          674 NLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       674 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                       ........ ... +...+....   .....+..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       270 -~~~~~~~~-~~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          270 -VQTAKTNL-LDE-LPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             -HHHHHHHH-HHT-TTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             -HHHHHHhh-ccc-ccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence             11111111 000 000000000   0113345789999999999999999999999998854

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7.4e-39  Score=377.22  Aligned_cols=249  Identities=27%  Similarity=0.382  Sum_probs=199.2

Q ss_pred             ceEeeeCceEEEEEEEC---CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLR---DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      +.||+|+||.||+|.+.   .++.||||++.....  ...++|.+|+++|++++||||++++++|.. +..+|||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999763   357899998765432  335789999999999999999999999965 458899999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC-Cce
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE-THV  620 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~  620 (803)
                      |+|.+++.  ....+++.+++.|+.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+++....... ...
T Consensus       454 g~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            99999994  34569999999999999999999999   9999999999999999999999999999976432221 122


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+..       .....+.         ...
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~~---------~~~  592 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGE---------RMG  592 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTC---------CCC
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC---------CCC
Confidence            233456889999999999999999999999999999998 99999755432211       1111111         112


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      .+..++..+.+|+.+||+.+|.+||++.+|++.|+...
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            23345678899999999999999999999999998764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=337.47  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=183.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|... +++.||||.+...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            56888999999999999999974 6889999986432   2334578999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++++|.+++.. ....+++.+++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        91 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           91 EMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             ECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             ecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            99999999999954 23569999999999999999999999   899999999999999999999999999987543211


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                        .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.........               ..+.....
T Consensus       167 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~  229 (278)
T 3cok_A          167 --EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLADY  229 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC
T ss_pred             --CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhccc
Confidence              1122356899999999999999999999999999999999999998754321110               01110000


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        ..+......+.+++.+||+.||.+|||+.+++++
T Consensus       230 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          230 --EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             --CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence              1222345678899999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=349.26  Aligned_cols=262  Identities=24%  Similarity=0.311  Sum_probs=204.8

Q ss_pred             HhcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEee----ccceee
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE----EQSEMI  533 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~----~~~~~~  533 (803)
                      ..++|...+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            356799999999999999999997 568999999876555555678999999999999999999999986    345789


Q ss_pred             EEEEecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          534 LVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      +||||+++|+|.+++..  .....+++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999998843  235679999999999999999999999   8999999999999999999999999999865


Q ss_pred             CCCCCCCc-------eeccccCCCcccCccccccCc---CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHH
Q 042150          612 GPCLDETH-------VSTGVKGSFGYLDPEYFRRQQ---LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQ  681 (803)
Q Consensus       612 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  681 (803)
                      ........       ......||+.|+|||.+.+..   ++.++|||||||++|||++|+.||......... .....  
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~--  260 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAV--  260 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHH--
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHh--
Confidence            22110000       012245799999999987543   789999999999999999999998643221111 11100  


Q ss_pred             HhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          682 WQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       682 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                        ..         .............+.+++.+||+.+|.+||++.+++++|+.+.
T Consensus       261 --~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          261 --QN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             --HC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             --hc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence              00         0001112234567899999999999999999999999998664

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.6e-38  Score=339.53  Aligned_cols=252  Identities=21%  Similarity=0.330  Sum_probs=205.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .++|...+.||+|+||.||++.... ++.+|+|......   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            3568888999999999999999864 7889999864432   22356788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++++|.+++.  ....+++.+++.++.|+++||+|||+   .+++||||||+|||++.++.+||+|||+++.....
T Consensus        94 ~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           94 LELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EECCTTCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            99999999999883  33569999999999999999999999   89999999999999999999999999999764321


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                      .  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.      ..... ....       
T Consensus       169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~-~~~~-------  232 (294)
T 2rku_A          169 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIK-KNEY-------  232 (294)
T ss_dssp             T--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH-TTCC-------
T ss_pred             c--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHh-hccC-------
Confidence            1  122345689999999999999999999999999999999999999975432221      11111 1100       


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                         ..+......+.+++.+||+.+|.+|||+.|++++-..
T Consensus       233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~  269 (294)
T 2rku_A          233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF  269 (294)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence               1122334578899999999999999999999986543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.8e-38  Score=338.08  Aligned_cols=253  Identities=27%  Similarity=0.354  Sum_probs=208.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .+.|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356888899999999999999975 58899999865443 4456889999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|.+++.   ...+++.+++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       101 ~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--  172 (303)
T 3a7i_A          101 YLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--  172 (303)
T ss_dssp             CCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--
T ss_pred             eCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcc--
Confidence            999999999993   3579999999999999999999999   89999999999999999999999999998753321  


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      ........|++.|+|||.+.+..++.++||||||+++|||++|+.|+.........   .   . .....     .+.  
T Consensus       173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~-~~~~~-----~~~--  238 (303)
T 3a7i_A          173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---F---L-IPKNN-----PPT--  238 (303)
T ss_dssp             BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H---H-HHHSC-----CCC--
T ss_pred             ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---H---H-hhcCC-----CCC--
Confidence            11223457899999999999999999999999999999999999998754322111   1   1 11111     111  


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                        ........+.+++.+||+.+|.+|||+.|++++....
T Consensus       239 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          239 --LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             --CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             --CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence              1223345689999999999999999999999876543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.7e-39  Score=349.08  Aligned_cols=261  Identities=22%  Similarity=0.278  Sum_probs=197.9

Q ss_pred             cCCCc-cceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDK-NLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~-~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      +.|.. .++||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            45665 367999999999999954 5889999997766666678899999999995 79999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc---EEEeeeccccCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV---SKVADFGLSRSGPC  614 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---~kl~DFGla~~~~~  614 (803)
                      |+++|+|.+++..  ...+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.   +||+|||+++....
T Consensus        92 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           92 KMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             cCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999943  3568999999999999999999999   89999999999999988776   99999999875332


Q ss_pred             CCC-----CceeccccCCCcccCcccccc-----CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhh--------hHH
Q 042150          615 LDE-----THVSTGVKGSFGYLDPEYFRR-----QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV--------NLA  676 (803)
Q Consensus       615 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~--------~l~  676 (803)
                      ...     ........||+.|+|||.+.+     ..++.++|||||||++|||++|+.||......+..        ...
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            111     111223468999999999875     56899999999999999999999999754321100        000


Q ss_pred             HHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          677 EWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       677 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .........+... . .....    ......+.+++.+||+.||.+|||+.|++++
T Consensus       247 ~~~~~~i~~~~~~-~-~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          247 NMLFESIQEGKYE-F-PDKDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHCCCC-C-CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHhccCcc-c-Cchhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0001111111100 0 00000    1234578999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.1e-38  Score=341.32  Aligned_cols=262  Identities=20%  Similarity=0.280  Sum_probs=199.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC---CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR---QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .+|...+.||+|+||.||+|... +++.||||++.....   ...+++.+|+.++++++||||+++++++.+.+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            56888999999999999999974 688999998764322   23467899999999999999999999999999999999


Q ss_pred             EecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          537 EYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       537 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||+++|+|.+++..  .....+++.+++.++.|+++||.|||+   .+++||||||+|||++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999843  235669999999999999999999999   8999999999999999999999999999875332


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      .  ........++..|+|||.+.+..++.++||||||+++|||++|+.||......    ........ .......    
T Consensus       189 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~~~~----  257 (310)
T 2wqm_A          189 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-EQCDYPP----  257 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHH-HTTCSCC----
T ss_pred             C--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHh-hcccCCC----
Confidence            1  11223456899999999999999999999999999999999999998643211    11111111 1111110    


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                          .........+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       258 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          258 ----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             ----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence                111233467899999999999999999999999999886544

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.8e-38  Score=336.41  Aligned_cols=252  Identities=21%  Similarity=0.342  Sum_probs=199.6

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      +|....+||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4555669999999999999974 578999998776666667889999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-CCcEEEeeeccccCCCCCCCC
Q 042150          541 KGPLKKHLYGP-DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-NYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       541 ~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|.+++... ....+++..+..++.|++.||+|||+   .+++||||||+|||++. ++.+||+|||+++.....  .
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~  177 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--N  177 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCC--C
Confidence            99999999543 23457789999999999999999999   89999999999999987 899999999998754321  1


Q ss_pred             ceeccccCCCcccCccccccCc--CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQ--LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      .......|++.|+|||.+.+..  ++.++||||||+++|||++|+.||......... .  +.....  .     ..   
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~--~~~~~~--~-----~~---  244 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-M--FKVGMF--K-----VH---  244 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-H--HHHHHH--C-----CC---
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-H--Hhhccc--c-----cc---
Confidence            1223457899999999997654  889999999999999999999998643221111 0  000000  0     01   


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       ...+......+.+++.+||+.+|.+||++.+++++
T Consensus       245 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          245 -PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             -CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             -ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             12233445678999999999999999999999865

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-38  Score=342.03  Aligned_cols=253  Identities=24%  Similarity=0.322  Sum_probs=204.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .++|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            467888999999999999999976 5889999987655444556799999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE---ccCCcEEEeeeccccCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~DFGla~~~~~~  615 (803)
                      +++++|.+++..  ...+++.+++.++.|++.||.|||+   .+|+||||||+|||+   +.++.+||+|||+++.... 
T Consensus        88 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-  161 (304)
T 2jam_A           88 VSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-  161 (304)
T ss_dssp             CCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred             CCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence            999999999843  3568999999999999999999999   899999999999999   7889999999999875321 


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                         .......|++.|+|||.+.+..++.++|||||||++|||++|+.||........      ... ...+...      
T Consensus       162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~-i~~~~~~------  225 (304)
T 2jam_A          162 ---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL------FEK-IKEGYYE------  225 (304)
T ss_dssp             ---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH-HHHCCCC------
T ss_pred             ---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------HHH-HHcCCCC------
Confidence               122335689999999999999999999999999999999999999875432211      111 1111110      


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      .........+..+.+++.+||+.||.+|||+.|++++-.
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (304)
T 2jam_A          226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW  264 (304)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence            011112234567899999999999999999999998644

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-39  Score=349.26  Aligned_cols=264  Identities=22%  Similarity=0.312  Sum_probs=196.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|...+.||+|+||.||+|... +++.||||++...... ....+.+|+++|++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888899999999999999986 5889999986543322 223456899999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      ++ |+|.+++... ...+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  ..
T Consensus        82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PT  154 (324)
T ss_dssp             CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC--Cc
Confidence            98 5898888542 3469999999999999999999999   9999999999999999999999999999975332  12


Q ss_pred             ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc---CccccccC-
Q 042150          619 HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK---GMLEHIID-  693 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~i~d-  693 (803)
                      .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....   .......   ........ 
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGGGC
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHhchhhhcc
Confidence            22234568999999999876 6789999999999999999999999976543332211   1111110   00000000 


Q ss_pred             --------ccccc----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          694 --------PQLIG----KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       694 --------~~l~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                              +....    .........+.+++.+||+.||.+|||+.|++++-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  284 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF  284 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence                    00000    001123467889999999999999999999987643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.1e-39  Score=359.40  Aligned_cols=265  Identities=25%  Similarity=0.353  Sum_probs=192.0

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccc--e
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQS--E  531 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~--~  531 (803)
                      ...++|...+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.+|.++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34578999999999999999999975 58899999865432  233456889999999997 999999999996543  6


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      +++|||||+ |+|.+++..   ..+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            899999998 589998843   469999999999999999999999   9999999999999999999999999999975


Q ss_pred             CCCCC-------------------CCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhh
Q 042150          612 GPCLD-------------------ETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE  671 (803)
Q Consensus       612 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~  671 (803)
                      .....                   .........||+.|+|||++.+ ..++.++|||||||+||||++|+.||......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            32210                   1112234579999999999976 679999999999999999999999997654333


Q ss_pred             hhhHHHHHHHHhhcCc---ccccc------------------Cccccc------------CCCHHHHHHHHHHHHHcccc
Q 042150          672 QVNLAEWAMQWQKKGM---LEHII------------------DPQLIG------------KINLDSLKKFGETAEKCLAD  718 (803)
Q Consensus       672 ~~~l~~~~~~~~~~~~---~~~i~------------------d~~l~~------------~~~~~~~~~l~~li~~cl~~  718 (803)
                      .....   ........   +..+.                  ......            .........+.+|+.+||+.
T Consensus       239 ~~~~i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          239 QLERI---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHH---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHH---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            22111   00000000   00000                  000000            00012345789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042150          719 YGVDRPSMGDVLWN  732 (803)
Q Consensus       719 ~p~~RPs~~evl~~  732 (803)
                      ||.+|||+.|++++
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999876

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9e-39  Score=347.48  Aligned_cols=265  Identities=22%  Similarity=0.250  Sum_probs=193.7

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ...++|...+.||+|+||.||+|... +++.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34567999999999999999999965 588999998754432  234568899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE-----ccCCcEEEeeeccc
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL-----DENYVSKVADFGLS  609 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl-----~~~~~~kl~DFGla  609 (803)
                      ||||+++ +|.+++..  ...+++.+++.++.||+.||+|||+   .+|+||||||+|||+     ++++.+||+|||++
T Consensus       111 v~e~~~~-~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEECCSE-EHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEecCCC-CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9999984 99999843  4469999999999999999999999   899999999999999     45566999999999


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhh--cC
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK--KG  686 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~  686 (803)
                      +....  .........+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+..  .........  ..
T Consensus       185 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~  260 (329)
T 3gbz_A          185 RAFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FKIFEVLGLPDDT  260 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCTT
T ss_pred             cccCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HHHHHHhCCCchh
Confidence            75321  11223345679999999999874 5899999999999999999999999754432221  111111000  00


Q ss_pred             ccc-------------cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 MLE-------------HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 ~~~-------------~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...             ......+...........+.+++.+||+.||.+|||+.|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            000             0000000000111134678899999999999999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.3e-39  Score=355.47  Aligned_cols=247  Identities=24%  Similarity=0.289  Sum_probs=192.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC---CCChHHHHHHHHH-HHhccCCCeeeEEeEeeccceeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS---RQGLPEFQTEITV-LSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~f~~E~~~-l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .++|...++||+|+||.||+|+.+. ++.||+|++....   ......+.+|..+ ++.++||||+++++++.+.+.+++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            3678999999999999999999864 7889999865432   2334566777776 567899999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++..  ...+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       117 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            9999999999999943  4568999999999999999999999   9999999999999999999999999999975221


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                        .........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ...... ...      
T Consensus       192 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~-~~~------  256 (373)
T 2r5t_A          192 --HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNILN-KPL------  256 (373)
T ss_dssp             --CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH------HHHHHH-SCC------
T ss_pred             --CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHh-ccc------
Confidence              12223456799999999999999999999999999999999999999975432221      111111 110      


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVL  730 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl  730 (803)
                          .++......+.+++.+||+.||.+||++.+.+
T Consensus       257 ----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          257 ----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             ----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                12223456789999999999999999985433

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-38  Score=345.06  Aligned_cols=268  Identities=24%  Similarity=0.267  Sum_probs=199.3

Q ss_pred             HHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-----CChHHHHHHHHHHHhccCCCeeeEEeEeeccc
Q 042150          457 QTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-----QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS  530 (803)
Q Consensus       457 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~  530 (803)
                      ....++|...+.||+|+||.||+|... +++.||||++.....     ...+.+.+|++++++++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344578999999999999999999975 488999998654322     12357889999999999999999999999999


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..++||||+++ +|.+++.. ....+++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             ceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            99999999986 88888843 34568999999999999999999999   999999999999999999999999999998


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      .....  ........+|+.|+|||.+.+. .++.++|||||||++|||++|..||......+.  +...... .......
T Consensus       161 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~-~~~~~~~  235 (346)
T 1ua2_A          161 SFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFET-LGTPTEE  235 (346)
T ss_dssp             TTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHH-HCCCCTT
T ss_pred             eccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHH-cCCCChh
Confidence            64321  2223446789999999999754 588999999999999999999999875433222  1111111 1100000


Q ss_pred             ---c---ccCc---ccccCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          690 ---H---IIDP---QLIGKIN-----LDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       690 ---~---i~d~---~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                         .   ..+.   ......+     ......+.+++.+||+.||.+|||+.|++++-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~  294 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  294 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence               0   0000   0000011     223467899999999999999999999987643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-38  Score=350.94  Aligned_cols=272  Identities=22%  Similarity=0.268  Sum_probs=203.0

Q ss_pred             ccChhhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCC-----------hHHHHHHHHHHHhccCCC
Q 042150          450 KIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG-----------LPEFQTEITVLSKIRHRH  518 (803)
Q Consensus       450 ~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~f~~E~~~l~~l~Hpn  518 (803)
                      +....++....++|...+.||+|+||.||+|...+++.||||++.......           .+.+.+|++++++++|||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            345678889999999999999999999999998889999999865432211           267999999999999999


Q ss_pred             eeeEEeEeec-----cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceE
Q 042150          519 LVSLVGYCEE-----QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNI  593 (803)
Q Consensus       519 Iv~l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NI  593 (803)
                      |+++++++..     ....++||||++ |+|.+++.. ....+++.+++.++.||+.||+|||+   .+|+||||||+||
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNI  165 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGE
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHE
Confidence            9999999843     346899999998 588888854 34569999999999999999999999   8999999999999


Q ss_pred             EEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh
Q 042150          594 LLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ  672 (803)
Q Consensus       594 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  672 (803)
                      |++.++.+||+|||+++....   ........+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  242 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ  242 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             EEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999999975322   222334578999999999876 7799999999999999999999999976433222


Q ss_pred             hhHHHHHHHHhhcCcc-----------ccccCccc-------ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          673 VNLAEWAMQWQKKGML-----------EHIIDPQL-------IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       673 ~~l~~~~~~~~~~~~~-----------~~i~d~~l-------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...   ..........           .......+       ...........+.+++.+||+.||.+|||+.|++++
T Consensus       243 ~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          243 LNK---IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHH---HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHH---HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            110   0000000000           00000000       001112234678999999999999999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.5e-39  Score=348.85  Aligned_cols=266  Identities=23%  Similarity=0.331  Sum_probs=202.1

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCC--ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQ--GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|...+.||+|+||.||+|.... ++.||||++......  ..+.+.+|++++++++||||++++++|.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            578889999999999999999865 889999986544322  24567899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|.+++.  ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       105 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  177 (331)
T 4aaa_A          105 FVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--  177 (331)
T ss_dssp             CCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             cCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence            999999998873  34569999999999999999999999   89999999999999999999999999999753321  


Q ss_pred             CceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHH---------HHHHHhhcCc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE---------WAMQWQKKGM  687 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~~~~~~~~  687 (803)
                      ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......+......         +...+.....
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence            1223345689999999999875 78999999999999999999999997654332211100         0000011111


Q ss_pred             cccccCcccccCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          688 LEHIIDPQLIGKI-----NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       688 ~~~i~d~~l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      ......+.+....     .+..+..+.+++.+||+.||.+|||+.|++++-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  308 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD  308 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            1111111111111     123456789999999999999999999999754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.5e-38  Score=357.40  Aligned_cols=254  Identities=24%  Similarity=0.332  Sum_probs=191.9

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC--------CCCChHHHHHHHHHHHhccCCCeeeEEeEeec
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG--------SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE  528 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~--------~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~  528 (803)
                      ...++|...+.||+|+||.||+|.... ++.||||.+...        .......+.+|+++|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            346789999999999999999999754 789999985432        11223458899999999999999999999865


Q ss_pred             cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC---CcEEEee
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN---YVSKVAD  605 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~~kl~D  605 (803)
                       +..++||||+++|+|.+++.  ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.+   +.+||+|
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             -CceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEee
Confidence             45799999999999999984  45679999999999999999999999   899999999999999654   4599999


Q ss_pred             eccccCCCCCCCCceeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH
Q 042150          606 FGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       606 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      ||+++...   .........||+.|+|||++.   ...++.++|||||||+||||++|+.||.......  .+...    
T Consensus       286 FG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~----  356 (419)
T 3i6u_A          286 FGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ----  356 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH----
T ss_pred             cccceecC---CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH----
Confidence            99998643   222334567999999999985   3678889999999999999999999997532211  11111    


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...+....  .+...    ......+.+++.+||+.+|.+|||+.|++++
T Consensus       357 i~~~~~~~--~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          357 ITSGKYNF--IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHTTCCCC--CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCCCCC--Cchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            11111100  00000    1234678999999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-38  Score=339.63  Aligned_cols=247  Identities=25%  Similarity=0.396  Sum_probs=196.0

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeec----cceeeE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE----QSEMIL  534 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~l  534 (803)
                      .|...+.||+|+||.||+|... ++..||+|.+...  .....+.+.+|+.++++++||||+++++++..    ...+++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3666778999999999999975 4778999986533  23345678999999999999999999998865    456899


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--eEeeccCcceEEEc-cCCcEEEeeeccccC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG--IIHRDIKSTNILLD-ENYVSKVADFGLSRS  611 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLkp~NILl~-~~~~~kl~DFGla~~  611 (803)
                      ||||+++|+|.+++.  ....+++..++.++.|++.||.|||+   .+  |+||||||+|||++ +++.+||+|||++..
T Consensus       107 v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          107 VTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEecCCCCHHHHHH--HccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            999999999999994  33568999999999999999999998   77  99999999999997 889999999999975


Q ss_pred             CCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ...    .......||+.|+|||.+. +.++.++|||||||++|||++|+.||........     ..... ..+...  
T Consensus       182 ~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~-~~~~~~--  248 (290)
T 1t4h_A          182 KRA----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRV-TSGVKP--  248 (290)
T ss_dssp             CCT----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHH-TTTCCC--
T ss_pred             ccc----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHHHH-hccCCc--
Confidence            322    2233457899999999886 4599999999999999999999999965332221     11111 111111  


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        .    ..+......+.+++.+||+.+|.+|||+.|++++
T Consensus       249 --~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          249 --A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --c----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence              1    1111223568999999999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.5e-38  Score=359.76  Aligned_cols=263  Identities=21%  Similarity=0.270  Sum_probs=196.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeecc------c
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ------S  530 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~  530 (803)
                      .++|...+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+|+.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467899999999999999999975 4889999987543  223356788999999999999999999999654      4


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..+|||||+++ +|.+.+.    ..+++.++..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            57999999986 4666662    248999999999999999999999   899999999999999999999999999998


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHH---------H---
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE---------W---  678 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~---  678 (803)
                      ....   ........||+.|+|||++.+..++.++|||||||+||||++|+.||......++.....         +   
T Consensus       213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          213 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            6332   223345678999999999999999999999999999999999999997654332211100         0   


Q ss_pred             ----HHHHhhcC-c-----cccccCcccccCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          679 ----AMQWQKKG-M-----LEHIIDPQLIGKI---NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       679 ----~~~~~~~~-~-----~~~i~d~~l~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                          ...+.... .     ....+...+....   .......+.+|+.+||+.||.+|||+.|++++-
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence                00000000 0     0000000000000   112256789999999999999999999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.1e-38  Score=345.40  Aligned_cols=251  Identities=21%  Similarity=0.325  Sum_probs=205.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .++|...+.||+|+||.||++...+ ++.+|+|......   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4678889999999999999999865 7789999864332   22356789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++++|.+++.  ....+++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~~~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            99999999999884  33569999999999999999999999   89999999999999999999999999999764321


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                      .  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+.      ...... ...       
T Consensus       195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~-~~~-------  258 (335)
T 2owb_A          195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKK-NEY-------  258 (335)
T ss_dssp             T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH-TCC-------
T ss_pred             c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHhc-CCC-------
Confidence            1  123345789999999999999999999999999999999999999975432221      111111 100       


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                         ..+......+.+++.+||+.||.+||++.|++++-.
T Consensus       259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~  294 (335)
T 2owb_A          259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF  294 (335)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence               112233456789999999999999999999998644

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.1e-38  Score=345.32  Aligned_cols=268  Identities=23%  Similarity=0.308  Sum_probs=200.6

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeec--------c
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEE--------Q  529 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--------~  529 (803)
                      ++|...+.||+|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            57888999999999999999984 68899999865432  2335678999999999999999999999976        4


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      +..++||||+++ +|.+.+.. ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            568999999985 77777643 23469999999999999999999999   99999999999999999999999999999


Q ss_pred             cCCCCCC--CCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC
Q 042150          610 RSGPCLD--ETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG  686 (803)
Q Consensus       610 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (803)
                      +......  .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......................
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            7543211  1122344678999999999876 568999999999999999999999998654333221111100000000


Q ss_pred             ccccccCcccc-------c-CCCH-H------HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          687 MLEHIIDPQLI-------G-KINL-D------SLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       687 ~~~~i~d~~l~-------~-~~~~-~------~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      .....-.....       . .... .      ..+.+.+|+.+||+.||.+|||+.|++++-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  313 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  313 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence            00000000000       0 0000 0      134588999999999999999999998763

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.6e-39  Score=354.22  Aligned_cols=268  Identities=22%  Similarity=0.292  Sum_probs=204.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            356888899999999999999986 58899999865542 2234678999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-ceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE-GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      |+++|+|.+++..  ...+++..+..++.|++.||+|||+   . +|+||||||+|||++.++.+||+|||+++...   
T Consensus       112 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~---  183 (360)
T 3eqc_A          112 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---  183 (360)
T ss_dssp             CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH---
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc---
Confidence            9999999999943  3468999999999999999999997   5 89999999999999999999999999986421   


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHH-----------------
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWA-----------------  679 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-----------------  679 (803)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+........                 
T Consensus       184 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          184 -DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             -HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             -cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence             11223457899999999999999999999999999999999999999754332211110000                 


Q ss_pred             ------HHHhhcCccccc----cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          680 ------MQWQKKGMLEHI----IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       680 ------~~~~~~~~~~~i----~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                            ..........+.    ................+.+++.+||+.||.+|||+.|++++-...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  329 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  329 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence                  000000000000    000000011122355789999999999999999999999865543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.8e-38  Score=362.20  Aligned_cols=254  Identities=23%  Similarity=0.323  Sum_probs=206.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...++||+|+||.||+|+.+ +++.||+|++...   .....+.+.+|+++|++++||||+++++++.....+++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888889999999999999986 5899999986432   2345678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          537 EYMEKGPLKKHLYGPD--RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||+++|+|.+++....  ...+++..++.++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999986533  4579999999999999999999999   9999999999999999999999999999986432


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ..  .......||+.|+|||++.+..++.++|||||||+||||++|+.||.......  ...+....... ..       
T Consensus       342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~-~~-------  409 (543)
T 3c4z_A          342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLE-QA-------  409 (543)
T ss_dssp             TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHH-CC-------
T ss_pred             CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhh-cc-------
Confidence            11  12234589999999999999999999999999999999999999997542211  11111111111 10       


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSM-----GDVLWN  732 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~~  732 (803)
                         ..++...+..+.+++.+||+.+|.+||++     .+++++
T Consensus       410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ---cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence               11233445678999999999999999975     666653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-37  Score=343.53  Aligned_cols=257  Identities=25%  Similarity=0.326  Sum_probs=205.1

Q ss_pred             hHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCC--------hHHHHHHHHHHHhc-cCCCeeeEEe
Q 042150          455 DLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQG--------LPEFQTEITVLSKI-RHRHLVSLVG  524 (803)
Q Consensus       455 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~f~~E~~~l~~l-~HpnIv~l~g  524 (803)
                      ......++|...+.||+|+||.||+|.+. +|+.||||++.......        .+.+.+|+.++.++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34455678999999999999999999986 68999999865543221        34678999999999 7999999999


Q ss_pred             EeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEe
Q 042150          525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA  604 (803)
Q Consensus       525 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~  604 (803)
                      ++......++||||+++++|.+++.  ....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLT--EKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEE
Confidence            9999999999999999999999994  34569999999999999999999999   899999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeccccCCCcccCcccccc------CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHH
Q 042150          605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR------QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW  678 (803)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  678 (803)
                      |||++......   .......||+.|+|||++.+      ..++.++|||||||+||||++|+.||........   ...
T Consensus       243 DfG~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~  316 (365)
T 2y7j_A          243 DFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM---LRM  316 (365)
T ss_dssp             CCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH
T ss_pred             ecCcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH---HHH
Confidence            99998764321   22334678999999999863      3688999999999999999999999965332111   111


Q ss_pred             HHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          679 AMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       679 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                          ...+... ...+ ..    ......+.+++.+||+.+|.+|||+.|++++
T Consensus       317 ----i~~~~~~-~~~~-~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          317 ----IMEGQYQ-FSSP-EW----DDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             ----HHHTCCC-CCHH-HH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----HHhCCCC-CCCc-cc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                1111100 0000 00    1123568999999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-38  Score=337.50  Aligned_cols=246  Identities=22%  Similarity=0.290  Sum_probs=199.1

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ..++|...+.||+|+||.||+|... +++.||+|++....  .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467899999999999999999986 68999999866432  23356788999999999 89999999999999999999


Q ss_pred             EEEecCCCchhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc---------------
Q 042150          535 VYEYMEKGPLKKHLYGPD--RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---------------  597 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~---------------  597 (803)
                      ||||+++|+|.+++....  ...+++.+++.++.||+.||+|||+   ++|+||||||+|||++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999995321  2569999999999999999999999   99999999999999984               


Q ss_pred             ----CCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhh
Q 042150          598 ----NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ  672 (803)
Q Consensus       598 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  672 (803)
                          ...+||+|||+++....      .....||+.|+|||.+.+. .++.++|||||||++|||++|.+++......  
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--  237 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--  237 (289)
T ss_dssp             ----CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH--
T ss_pred             ccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH--
Confidence                44799999999876332      1223589999999999765 6668999999999999999999775432110  


Q ss_pred             hhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          673 VNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       673 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                         .     ....+..         ...+......+.+++.+||+.||.+|||+.|++++
T Consensus       238 ---~-----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          238 ---H-----EIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             ---H-----HHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ---H-----HHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence               0     0111111         11222345678999999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=343.75  Aligned_cols=261  Identities=25%  Similarity=0.341  Sum_probs=202.6

Q ss_pred             ChhhHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeec-
Q 042150          452 PFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEE-  528 (803)
Q Consensus       452 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~-  528 (803)
                      .+.++....++|...+.||+|+||.||+|... +++.||||.+... ....+.+.+|+.+++++ +||||+++++++.. 
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            34455556788999999999999999999974 5889999986543 33457899999999999 79999999999976 


Q ss_pred             -----cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEE
Q 042150          529 -----QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKV  603 (803)
Q Consensus       529 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl  603 (803)
                           .+..++||||+++|+|.+++.......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEE
Confidence                 4678999999999999999965555679999999999999999999999   89999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHH
Q 042150          604 ADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW  678 (803)
Q Consensus       604 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  678 (803)
                      +|||++......  ........|++.|+|||.+.     +..++.++|||||||++|||++|+.||..........    
T Consensus       171 ~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----  244 (326)
T 2x7f_A          171 VDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----  244 (326)
T ss_dssp             CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----
T ss_pred             eeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH----
Confidence            999998753321  11223456899999999987     5678999999999999999999999986543222110    


Q ss_pred             HHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          679 AMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       679 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                        .. ........        ........+.+++.+||+.+|.+||++.+++++-
T Consensus       245 --~~-~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp  288 (326)
T 2x7f_A          245 --LI-PRNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP  288 (326)
T ss_dssp             --HH-HHSCCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred             --Hh-hcCccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence              11 11111111        1122346789999999999999999999998753

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.5e-38  Score=333.43  Aligned_cols=249  Identities=24%  Similarity=0.305  Sum_probs=196.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|... +++.||||.+...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            56888899999999999999986 6889999986432   2345678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++++|.+++..  ...+++.+++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++..... 
T Consensus        91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-  164 (276)
T 2h6d_A           91 EYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  164 (276)
T ss_dssp             ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             eccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence            99999999999943  3468999999999999999999999   99999999999999999999999999999764321 


Q ss_pred             CCceeccccCCCcccCccccccCcC-CCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                        .......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||........      ... ...+..       
T Consensus       165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~~~~~-------  228 (276)
T 2h6d_A          165 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL------FKK-IRGGVF-------  228 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH-HHHCCC-------
T ss_pred             --cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HHH-hhcCcc-------
Confidence              12234568999999999987765 5799999999999999999999875432211      111 111110       


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                         ..+......+.+++.+||+.+|.+|||+.|++++-.
T Consensus       229 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~  264 (276)
T 2h6d_A          229 ---YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW  264 (276)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             ---cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence               112223456889999999999999999999998644

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.2e-39  Score=339.72  Aligned_cols=254  Identities=24%  Similarity=0.371  Sum_probs=202.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEee--ccceeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCE--EQSEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~--~~~~~~l  534 (803)
                      .++|...+.||+|+||.||++... +++.||+|.+....  ....+.+.+|++++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357888899999999999999976 58899999865432  233567899999999999999999999874  4668999


Q ss_pred             EEEecCCCchhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc-----eEeeccCcceEEEccCCcEEEeeec
Q 042150          535 VYEYMEKGPLKKHLYGP--DRTPLSWKQRLEICIGAARGLHYLHTGSAEG-----IIHRDIKSTNILLDENYVSKVADFG  607 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDLkp~NILl~~~~~~kl~DFG  607 (803)
                      ||||+++|+|.+++...  ....+++.+++.++.|++.||+|||+   .+     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999532  34569999999999999999999999   77     9999999999999999999999999


Q ss_pred             cccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCc
Q 042150          608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM  687 (803)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (803)
                      +++....  .........++..|+|||.+.+..++.++||||||+++|||++|+.||......+   +..    ....+.
T Consensus       162 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----~i~~~~  232 (279)
T 2w5a_A          162 LARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAG----KIREGK  232 (279)
T ss_dssp             HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHTC
T ss_pred             hheeecc--ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHH----HHhhcc
Confidence            9875322  1112233568999999999999999999999999999999999999987543221   111    111111


Q ss_pred             cccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          688 LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       688 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ..         ..+......+.+++.+||+.+|.+||++.|+++++.
T Consensus       233 ~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          233 FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             cc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            11         122234567899999999999999999999998755

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-38  Score=350.84  Aligned_cols=256  Identities=25%  Similarity=0.287  Sum_probs=203.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEE----CCCcEEEEEEcCCC----CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccc
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL----RDNTKVAVKRGVPG----SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQS  530 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~  530 (803)
                      .++|...+.||+|+||.||++..    .+++.||||++...    .....+.+.+|+++|.++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36788999999999999999997    36889999986532    223456778899999999 6999999999999999


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..+|||||+++|+|.+++..  ...+++.+++.++.||++||.|||+   .+|+||||||+||||+.++.+||+|||+++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999999943  3569999999999999999999999   899999999999999999999999999997


Q ss_pred             CCCCCCCCceeccccCCCcccCcccccc--CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      .... ..........||+.|+|||++.+  ..++.++|||||||+||||++|+.||........  ...........   
T Consensus       208 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~---  281 (355)
T 1vzo_A          208 EFVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS---  281 (355)
T ss_dssp             ECCG-GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC---
T ss_pred             eccc-CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc---
Confidence            5322 11222334579999999999985  4578999999999999999999999964322111  11111111111   


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWNLE  734 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L~  734 (803)
                              ...++......+.+++.+||+.||.+||     ++.|++++..
T Consensus       282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence                    0122334456788999999999999999     9999988654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-38  Score=350.24  Aligned_cols=262  Identities=19%  Similarity=0.234  Sum_probs=196.9

Q ss_pred             HHHhcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeec-------
Q 042150          457 QTATNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE-------  528 (803)
Q Consensus       457 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-------  528 (803)
                      ....++|...+.||+|+||.||+|.. .+++.||||++......    ..+|+++|+.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999997 45899999987544322    3479999999999999999999843       


Q ss_pred             -------------------------------cceeeEEEEecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHH
Q 042150          529 -------------------------------QSEMILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYL  575 (803)
Q Consensus       529 -------------------------------~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yL  575 (803)
                                                     ...+++||||++ |+|.+.+..  .....+++..+..++.||++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999998 587777632  3456799999999999999999999


Q ss_pred             hcCCCCceEeeccCcceEEEc-cCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccC-cCCCcceehhHHHH
Q 042150          576 HTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVV  653 (803)
Q Consensus       576 H~~~~~~ivHrDLkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvv  653 (803)
                      |+   .+|+||||||+|||++ .++.+||+|||+++.....   .......+|..|+|||.+.+. .++.++|||||||+
T Consensus       158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            98   9999999999999998 6899999999999864321   223345689999999998764 59999999999999


Q ss_pred             HHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc----------Cccccc-----cCcccccCCCHHHHHHHHHHHHHcccc
Q 042150          654 LFEVLCARTAVDPLLAREQVNLAEWAMQWQKK----------GMLEHI-----IDPQLIGKINLDSLKKFGETAEKCLAD  718 (803)
Q Consensus       654 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------~~~~~i-----~d~~l~~~~~~~~~~~l~~li~~cl~~  718 (803)
                      +|||++|+.||......+..  ..... ....          ....+.     ........++...+..+.+++.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~~~~--~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQL--VRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHH--HHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChHHHH--HHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            99999999999765433321  11111 0000          000011     011111112333456789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042150          719 YGVDRPSMGDVLWN  732 (803)
Q Consensus       719 ~p~~RPs~~evl~~  732 (803)
                      +|.+|||+.|++++
T Consensus       309 dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          309 EPDLRINPYEAMAH  322 (383)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             ChhhCCCHHHHhcC
Confidence            99999999999974

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.2e-39  Score=359.17  Aligned_cols=242  Identities=16%  Similarity=0.180  Sum_probs=189.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCC---CCCChHHHHHHHH---HHHhccCCCeeeEE-------eE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPG---SRQGLPEFQTEIT---VLSKIRHRHLVSLV-------GY  525 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~---~l~~l~HpnIv~l~-------g~  525 (803)
                      .++|...+.||+|+||.||+|+. .+++.||||++...   .....+.|.+|++   +|++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788889999999999999995 56899999987532   3344578999994   55556899999998       55


Q ss_pred             eeccc-----------------eeeEEEEecCCCchhhhccCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCce
Q 042150          526 CEEQS-----------------EMILVYEYMEKGPLKKHLYGP-----DRTPLSWKQRLEICIGAARGLHYLHTGSAEGI  583 (803)
Q Consensus       526 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  583 (803)
                      +...+                 ..+|||||+ +|+|.+++...     ....+++..++.|+.||++||+|||+   .+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            55443                 278999999 68999999532     12234568899999999999999999   899


Q ss_pred             EeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccC-----------cCCCcceehhHHH
Q 042150          584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ-----------QLTDKSDVYSFGV  652 (803)
Q Consensus       584 vHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gv  652 (803)
                      +||||||+||||+.++.+||+|||+++...     .......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            999999999999999999999999998522     12334567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          653 VLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       653 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +||||++|+.||........               ...+...      ....+..+.+++.+||+.||.+|||+.|++++
T Consensus       302 il~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHHSSCCC------CC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHHCCCCCcccccccc---------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            99999999999864322111               1111110      11234678999999999999999999999974

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-38  Score=348.06  Aligned_cols=257  Identities=24%  Similarity=0.313  Sum_probs=195.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccc------
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS------  530 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------  530 (803)
                      .++|...+.||+|+||.||+|... +++.||||++.....  ...+.+.+|+++|++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467888999999999999999975 589999998754322  22467889999999999999999999997653      


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..++||||+ +++|.+++..   ..+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            469999999 7899999843   569999999999999999999999   999999999999999999999999999998


Q ss_pred             CCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC---
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG---  686 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---  686 (803)
                      ....     ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+.....   .......   
T Consensus       177 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~~~~~  248 (367)
T 1cm8_A          177 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI---MKVTGTPPAE  248 (367)
T ss_dssp             ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCHH
T ss_pred             cccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCCHH
Confidence            6322     1234578999999999887 78999999999999999999999999765433221110   0000000   


Q ss_pred             ---------------ccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 ---------------MLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 ---------------~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                                     .+.......+ ..........+.+++.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          249 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                           0000000001 11122345678999999999999999999999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-37  Score=336.40  Aligned_cols=257  Identities=19%  Similarity=0.225  Sum_probs=199.4

Q ss_pred             cCCCccceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeec--cceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEE--QSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~--~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|.. .+++.||||.+..   ...+.+.+|++++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            6788899999999999999996 4588999998753   34678999999999997 9999999999987  66789999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC-cEEEeeeccccCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY-VSKVADFGLSRSGPCL  615 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFGla~~~~~~  615 (803)
                      ||+++++|.+++.     .+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus       113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            9999999999982     48999999999999999999999   9999999999999999766 8999999999754322


Q ss_pred             CCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH--------HHhhcC
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM--------QWQKKG  686 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~  686 (803)
                         .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+.....        ......
T Consensus       185 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          185 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHT
T ss_pred             ---CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHHh
Confidence               22334578999999999977 6799999999999999999999999853321111 0110000        000000


Q ss_pred             cc------ccc--------cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 ML------EHI--------IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 ~~------~~i--------~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..      .++        ................+.+++.+||+.||.+|||++|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00      000        00001111122245788999999999999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.3e-38  Score=349.18  Aligned_cols=263  Identities=22%  Similarity=0.225  Sum_probs=202.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc--------CCCeeeEEeEee---
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR--------HRHLVSLVGYCE---  527 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~--------HpnIv~l~g~~~---  527 (803)
                      .++|...++||+|+||.||+|+.. +++.||||++... ....+.+.+|+++|++++        ||||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            467999999999999999999965 5789999987532 233567899999999996        788999999987   


Q ss_pred             -ccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-ceEeeccCcceEEEccCC------
Q 042150          528 -EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE-GIIHRDIKSTNILLDENY------  599 (803)
Q Consensus       528 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLkp~NILl~~~~------  599 (803)
                       .....+|||||+ +++|.+.+.......+++.+++.++.||+.||+|||+   + +|+||||||+||||+.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence             567899999999 5566666654455679999999999999999999999   7 999999999999998775      


Q ss_pred             -------------------------------------------cEEEeeeccccCCCCCCCCceeccccCCCcccCcccc
Q 042150          600 -------------------------------------------VSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF  636 (803)
Q Consensus       600 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~  636 (803)
                                                                 .+||+|||+++....     ......||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhh
Confidence                                                       799999999975321     12345789999999999


Q ss_pred             ccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhh---hHHHHHHHHhhc--------C-----------ccccccCc
Q 042150          637 RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQV---NLAEWAMQWQKK--------G-----------MLEHIIDP  694 (803)
Q Consensus       637 ~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~---~l~~~~~~~~~~--------~-----------~~~~i~d~  694 (803)
                      .+..++.++|||||||+||||++|+.||......+..   ............        +           ....+.+.
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            9999999999999999999999999999754322211   011111111000        0           00000000


Q ss_pred             cc---------ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          695 QL---------IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       695 ~l---------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..         ....+......+.+|+.+||+.||.+|||+.|++++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            00         012356677889999999999999999999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.4e-38  Score=339.26  Aligned_cols=264  Identities=23%  Similarity=0.289  Sum_probs=204.3

Q ss_pred             HhcCCCccceEeeeCceEEEEEEE--CCCcEEEEEEcCCC--CCCChHHHHHHHHHHHhc---cCCCeeeEEeEee----
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVL--RDNTKVAVKRGVPG--SRQGLPEFQTEITVLSKI---RHRHLVSLVGYCE----  527 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~--~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l---~HpnIv~l~g~~~----  527 (803)
                      +.++|...+.||+|+||.||+|..  .+++.||+|++...  .......+.+|+.+++.+   +||||++++++|.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999998  35789999976432  222344677888888777   7999999999987    


Q ss_pred             -ccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeee
Q 042150          528 -EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADF  606 (803)
Q Consensus       528 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DF  606 (803)
                       .....++||||++ |+|.+++.......+++.+++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence             5678899999998 699999966555669999999999999999999999   89999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC
Q 042150          607 GLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG  686 (803)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (803)
                      |+++...   .........++..|+|||.+.+..++.++|||||||++|||++|+.||......+..  .. ........
T Consensus       165 g~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~-i~~~~~~~  238 (326)
T 1blx_A          165 GLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GK-ILDVIGLP  238 (326)
T ss_dssp             CSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCC
T ss_pred             ccccccc---CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH-HHHHcCCC
Confidence            9997632   122234467899999999999999999999999999999999999999765432221  11 11111000


Q ss_pred             ---cc-cc------cc---CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 ---ML-EH------II---DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 ---~~-~~------i~---d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                         .. ..      ..   .......+.......+.+++.+||+.+|.+|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence               00 00      00   0000111223345678999999999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.1e-38  Score=356.80  Aligned_cols=195  Identities=26%  Similarity=0.420  Sum_probs=153.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeec-----cce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEE-----QSE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-----~~~  531 (803)
                      .++|...++||+|+||.||+|+.. +++.||||++.....  ...+.+.+|+++|++++||||++++++|..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367899999999999999999975 588999998754322  234678999999999999999999999943     357


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      +++||||+. |+|.+++.  ....+++..+..++.||++||+|||+   .+|+||||||+||||+.++.+||+|||+++.
T Consensus       132 ~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeccc-cchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            899999985 68999984  34569999999999999999999999   8999999999999999999999999999986


Q ss_pred             CCCCCCC-------------------------ceeccccCCCcccCcccc-ccCcCCCcceehhHHHHHHHHHhC
Q 042150          612 GPCLDET-------------------------HVSTGVKGSFGYLDPEYF-RRQQLTDKSDVYSFGVVLFEVLCA  660 (803)
Q Consensus       612 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~elltG  660 (803)
                      .......                         .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            4321110                         122345789999999986 567799999999999999999993

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-38  Score=339.31  Aligned_cols=258  Identities=25%  Similarity=0.359  Sum_probs=197.8

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC--Cc--EEEEEEcCCCC---CCChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD--NT--KVAVKRGVPGS---RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~--~~--~vavK~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      .++|...+.||+|+||.||+|.+..  ++  .||||.+....   ....+++.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3578888999999999999998642  33  68999865432   233578999999999999999999999998765 8


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+++|+|.+++... ...+++.+++.++.|+++||.|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            8999999999999999532 3468999999999999999999999   89999999999999999999999999999764


Q ss_pred             CCCCCCc-eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          613 PCLDETH-VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       613 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+      ..........   
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~---  242 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGE---  242 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCC---
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHHHHccCC---
Confidence            3322211 2233457889999999999999999999999999999999 999987543221      1111111110   


Q ss_pred             ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       691 i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                            ....+...+..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus       243 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          243 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence                  01112334567899999999999999999999999998775

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.6e-38  Score=340.52  Aligned_cols=265  Identities=23%  Similarity=0.306  Sum_probs=187.4

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ...++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578899999999999999999854 58899999865432 34456789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          536 YEYMEKGPLKKHLYG------PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      |||+++++|.+++..      .....+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999842      234569999999999999999999999   89999999999999999999999999998


Q ss_pred             cCCCCCCC---CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhc
Q 042150          610 RSGPCLDE---THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK  685 (803)
Q Consensus       610 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (803)
                      +.......   ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..........      .....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~  242 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTLQN  242 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHTS
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------HHhcc
Confidence            65332111   112234568999999999876 578999999999999999999999997543322110      01111


Q ss_pred             CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       686 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       .....................+.+++.+||+.||.+||++.|++++
T Consensus       243 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          243 -DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             -SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             1111100000011112334578899999999999999999999874

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.3e-38  Score=350.05  Aligned_cols=260  Identities=21%  Similarity=0.257  Sum_probs=195.4

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccc------eeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS------EMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~l  534 (803)
                      .+|...++||+|+||.||+|+...+..+|+|++......    ..+|+++|+.++||||++++++|...+      .+++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            468888999999999999999988778999986543322    237999999999999999999995443      3789


Q ss_pred             EEEecCCCchhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc-cCCcEEEeeeccccCC
Q 042150          535 VYEYMEKGPLKKHLY-GPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSRSG  612 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~DFGla~~~  612 (803)
                      ||||++++.+..... ......+++..+..++.||++||+|||+   .+|+||||||+|||++ .++.+||+|||+++..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            999998754443321 1235679999999999999999999999   9999999999999999 8999999999999764


Q ss_pred             CCCCCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH---------
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW---------  682 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~---------  682 (803)
                      ...   .......+|+.|+|||.+.+. .++.++|||||||+||||++|+.||......+..  .......         
T Consensus       193 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l--~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          193 IAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL--VEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHH
T ss_pred             cCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHHHH
Confidence            321   122345789999999998764 5999999999999999999999999765433221  1111100         


Q ss_pred             -hhc----CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          683 -QKK----GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       683 -~~~----~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       ...    .....+....+...+.......+.+++.+||+.||.+|||+.|++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence             000    00001100011111222345688999999999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-37  Score=339.24  Aligned_cols=263  Identities=19%  Similarity=0.245  Sum_probs=205.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEE-C-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCC------eeeEEeEeeccce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVL-R-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH------LVSLVGYCEEQSE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hpn------Iv~l~g~~~~~~~  531 (803)
                      .++|...+.||+|+||.||+|.. . +++.||||++... ....+.+.+|+++++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35788899999999999999997 3 5789999986532 233567899999999998765      9999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc--------------
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE--------------  597 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~--------------  597 (803)
                      .++||||+ +++|.+++.......+++.+++.++.|+++||+|||+   ++|+||||||+|||++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 8899999966555679999999999999999999999   89999999999999987              


Q ss_pred             -----CCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh
Q 042150          598 -----NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ  672 (803)
Q Consensus       598 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  672 (803)
                           ++.+||+|||+++....     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                 66899999999975322     12345789999999999999999999999999999999999999976543332


Q ss_pred             hhHHHHHHH-----HhhcCccccc---------------------cCcc-cccCCCHHHHHHHHHHHHHccccCCCCCCC
Q 042150          673 VNLAEWAMQ-----WQKKGMLEHI---------------------IDPQ-LIGKINLDSLKKFGETAEKCLADYGVDRPS  725 (803)
Q Consensus       673 ~~l~~~~~~-----~~~~~~~~~i---------------------~d~~-l~~~~~~~~~~~l~~li~~cl~~~p~~RPs  725 (803)
                      .........     ..........                     ..+. -...........+.+++.+||+.||.+|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            211111000     0000000000                     0000 001123456788999999999999999999


Q ss_pred             HHHHHHH
Q 042150          726 MGDVLWN  732 (803)
Q Consensus       726 ~~evl~~  732 (803)
                      +.|++++
T Consensus       323 ~~ell~h  329 (339)
T 1z57_A          323 LREALKH  329 (339)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.3e-38  Score=360.61  Aligned_cols=254  Identities=23%  Similarity=0.313  Sum_probs=206.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      .++|...++||+|+||.||+|... +++.||||++...   .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457888999999999999999976 5889999986433   234567899999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE---ccCCcEEEeeeccccCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSG  612 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl---~~~~~~kl~DFGla~~~  612 (803)
                      |||+.+|+|.+++..  ...+++.+++.++.||+.||+|||+   .+|+||||||+|||+   +.++.+||+|||+++..
T Consensus       105 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             ECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            999999999999843  4569999999999999999999999   899999999999999   56789999999999753


Q ss_pred             CCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ..   ........||+.|+|||++.+ .++.++|||||||++|||++|+.||......+..   .   . ...+.... .
T Consensus       180 ~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~---~-i~~~~~~~-~  247 (484)
T 3nyv_A          180 EA---SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL---K---K-VEKGKYTF-E  247 (484)
T ss_dssp             CC---CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---H-HHHCCCCC-C
T ss_pred             cc---ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH---H---H-HHcCCCCC-C
Confidence            32   122334579999999999876 6999999999999999999999999754332211   1   1 11111100 0


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      .+     .....+..+.+++.+||+.+|.+|||+.|++++-..
T Consensus       248 ~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~  285 (484)
T 3nyv_A          248 LP-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI  285 (484)
T ss_dssp             SG-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred             Cc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence            00     012335678999999999999999999999987553

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.4e-38  Score=354.55  Aligned_cols=200  Identities=22%  Similarity=0.233  Sum_probs=173.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhc------cCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKI------RHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l------~HpnIv~l~g~~~~~~~~  532 (803)
                      ..+|...++||+|+||.||+|.... ++.||||++... ....+.+.+|+++++.+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            4568889999999999999999764 889999987542 22345788899998887      467999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc--EEEeeecccc
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV--SKVADFGLSR  610 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~--~kl~DFGla~  610 (803)
                      ++||||+. ++|.+++.......+++..++.++.||+.||+|||+   .+|+||||||+||||+.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 699999866555679999999999999999999999   89999999999999999887  9999999997


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchh
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLA  669 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  669 (803)
                      ....     ......||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus       251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          251 YEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             ETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            5321     12345789999999999999999999999999999999999999976543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.4e-38  Score=339.19  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=200.4

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ..++|...+.||+|+||.||+|.... ++.||+|..........+.+.+|++++++++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            34678889999999999999999864 88999999877767778899999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|.+++.. ....+++.+++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++....  ..
T Consensus        97 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--~~  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--KT  170 (302)
T ss_dssp             CCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH--HH
T ss_pred             eCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccc--cc
Confidence            9999999998843 23569999999999999999999999   899999999999999999999999999875311  00


Q ss_pred             CceeccccCCCcccCcccc-----ccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          618 THVSTGVKGSFGYLDPEYF-----RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~-----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ........|+..|+|||.+     .+..++.++|||||||++|||++|+.|+........      ........ .... 
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~-~~~~-  242 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSD-PPTL-  242 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC-CCCC-
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhccC-Cccc-
Confidence            1112234689999999998     467889999999999999999999999875432211      11111111 1110 


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                            ..+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus       243 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          243 ------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                  1122345678999999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.2e-38  Score=359.08  Aligned_cols=253  Identities=24%  Similarity=0.330  Sum_probs=199.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .+.|...+.||+|+||.||+|... ++..||+|++...  .......+.+|+.+|+.++||||++++++|.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456889999999999999999976 5789999986543  2344678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc---CCcEEEeeeccccCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---NYVSKVADFGLSRSGP  613 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~kl~DFGla~~~~  613 (803)
                      ||+++|+|.+++.  ....+++.++..++.||+.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++...
T Consensus       116 e~~~~g~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          116 ECYKGGELFDEII--HRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             ECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             ecCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            9999999999884  34569999999999999999999999   99999999999999976   4559999999997633


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      .   ........||+.|+|||++. ..++.++|||||||++|||++|+.||......+..      ... ..+...  .+
T Consensus       191 ~---~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i-~~~~~~--~~  257 (494)
T 3lij_A          191 N---QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL------RKV-EKGKYT--FD  257 (494)
T ss_dssp             T---TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH-HHTCCC--CC
T ss_pred             C---CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-HhCCCC--CC
Confidence            2   22234467999999999986 56999999999999999999999999754332211      111 111110  00


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ....    ...+..+.+++.+||+.+|.+|||+.|++++-.
T Consensus       258 ~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~  294 (494)
T 3lij_A          258 SPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW  294 (494)
T ss_dssp             SGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             chhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence            0001    123457889999999999999999999998643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.4e-38  Score=341.40  Aligned_cols=261  Identities=21%  Similarity=0.302  Sum_probs=201.2

Q ss_pred             hhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCC--CCChHHHHHHHHHHHhcc--CCCeeeEEeEeecc
Q 042150          454 TDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIR--HRHLVSLVGYCEEQ  529 (803)
Q Consensus       454 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~--HpnIv~l~g~~~~~  529 (803)
                      ..+....++|...+.||+|+||.||++...+++.||||.+....  ....+.+.+|++++.+++  ||||+++++++...
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            34444567899999999999999999998889999999865432  234567899999999997  59999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      +..++||| +.+++|.+++..  ...+++.+++.++.|+++||.|||+   .+|+||||||+|||+++ +.+||+|||++
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~  173 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIA  173 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred             CEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccc
Confidence            99999999 667899999943  4578999999999999999999999   89999999999999964 89999999999


Q ss_pred             cCCCCCCCCceeccccCCCcccCcccccc-----------CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHH
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRR-----------QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEW  678 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  678 (803)
                      +...............|++.|+|||.+.+           ..++.++|||||||++|||++|+.||.......     ..
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~  248 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SK  248 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HH
Confidence            86433222222334578999999999875           478889999999999999999999986432211     11


Q ss_pred             HHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          679 AMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       679 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ....         .++.....++......+.+++.+||+.+|.+||++.|++++-..
T Consensus       249 ~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~  296 (313)
T 3cek_A          249 LHAI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  296 (313)
T ss_dssp             HHHH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HHHH---------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence            1111         11111112222234678999999999999999999999987554

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=334.75  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=201.7

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ..++|...+.||+|+||.||+|.... ++.||+|.+...  ...+++.+|+.++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            45678899999999999999999864 889999987543  345789999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++++|.+++.. ....+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++....  .
T Consensus       105 ~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--~  178 (314)
T 3com_A          105 YCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--T  178 (314)
T ss_dssp             CCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBT--T
T ss_pred             cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhh--h
Confidence            9999999999842 24569999999999999999999999   9999999999999999999999999999875332  1


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      ........+++.|+|||.+.+..++.++||||||+++|||++|+.||.........      .. .........      
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~~~~~------  245 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FM-IPTNPPPTF------  245 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HH-HHHSCCCCC------
T ss_pred             ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HH-HhcCCCccc------
Confidence            12223457899999999999999999999999999999999999998754322211      01 111110000      


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                       ..+......+.+++.+||+.+|.+|||+.+++++-.
T Consensus       246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~  281 (314)
T 3com_A          246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF  281 (314)
T ss_dssp             -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence             112223467899999999999999999999987543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.8e-38  Score=357.75  Aligned_cols=254  Identities=24%  Similarity=0.300  Sum_probs=203.5

Q ss_pred             HhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ..++|...++||+|+||.||+|... +++.||||++...  .......+.+|+++|++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999976 5889999986432  234567899999999999999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc---cCCcEEEeeeccccCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSG  612 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~DFGla~~~  612 (803)
                      |||+++|+|.+.+..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++   .++.+||+|||+++..
T Consensus       100 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            999999999998843  3569999999999999999999999   9999999999999995   5667999999999753


Q ss_pred             CCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      ..   ........||+.|+|||++.+ .++.++|||||||++|||++|+.||......+..      .. ...+...  .
T Consensus       175 ~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~-i~~~~~~--~  241 (486)
T 3mwu_A          175 QQ---NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL------KR-VETGKYA--F  241 (486)
T ss_dssp             CC---C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH-HHHTCCC--S
T ss_pred             CC---CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhCCCC--C
Confidence            32   222344579999999999875 5999999999999999999999999754332211      11 1111110  0


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      +.    ......+..+.+++.+||+.+|.+|||+.|++++-.
T Consensus       242 ~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~  279 (486)
T 3mwu_A          242 DL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (486)
T ss_dssp             CS----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred             CC----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence            00    001233467899999999999999999999998754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-37  Score=333.24  Aligned_cols=252  Identities=23%  Similarity=0.264  Sum_probs=202.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC---------CChHHHHHHHHHHHhcc-CCCeeeEEeEeec
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR---------QGLPEFQTEITVLSKIR-HRHLVSLVGYCEE  528 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~  528 (803)
                      .++|...+.||+|+||.||+|... +++.||||.+.....         ...+.+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            467888999999999999999986 588999998654321         11356889999999995 9999999999999


Q ss_pred             cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecc
Q 042150          529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGL  608 (803)
Q Consensus       529 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGl  608 (803)
                      .+..++||||+++++|.+++..  ...+++.+++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999943  4569999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccc------cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFR------RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      ++....   ........+++.|+|||.+.      ...++.++||||||+++|||++|+.||........      ....
T Consensus       171 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~  241 (298)
T 1phk_A          171 SCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------LRMI  241 (298)
T ss_dssp             CEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH
T ss_pred             hhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH------HHHH
Confidence            876432   12233457899999999985      45788999999999999999999999865432211      1111


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       ..+...      .........+..+.+++.+||+.+|.+|||+.|++++
T Consensus       242 -~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          242 -MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             -HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -hcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence             111110      0001112345678999999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-37  Score=342.85  Aligned_cols=271  Identities=19%  Similarity=0.210  Sum_probs=194.3

Q ss_pred             hhHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccce-
Q 042150          454 TDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE-  531 (803)
Q Consensus       454 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~-  531 (803)
                      .......++|...+.||+|+||.||+|... +++.||||++... ......+.+|++.+..++||||++++++|...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            456677889999999999999999999985 5889999986543 3334577889999999999999999999965433 


Q ss_pred             ------eeEEEEecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCceEeeccCcceEEEcc-CCc
Q 042150          532 ------MILVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLH--TGSAEGIIHRDIKSTNILLDE-NYV  600 (803)
Q Consensus       532 ------~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDLkp~NILl~~-~~~  600 (803)
                            .++||||++++ |...+..  .....+++..+..++.|++.||.|||  +   .+|+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCc
Confidence                  78999999874 4433321  34567899999999999999999999  6   99999999999999996 899


Q ss_pred             EEEeeeccccCCCCCCCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHH
Q 042150          601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWA  679 (803)
Q Consensus       601 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  679 (803)
                      +||+|||+++....   ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.........  ....
T Consensus       171 ~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~  245 (360)
T 3e3p_A          171 LKLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIV  245 (360)
T ss_dssp             EEECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH
T ss_pred             EEEeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHH
Confidence            99999999986432   2223345789999999998654 4899999999999999999999999765433221  1111


Q ss_pred             HH-----------HhhcCccccccC------cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          680 MQ-----------WQKKGMLEHIID------PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       680 ~~-----------~~~~~~~~~i~d------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      ..           ...........+      ..............+.+|+.+||+.||.+|||+.|++++-.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  317 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY  317 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence            10           000000000000      00011122235678999999999999999999999987633

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.9e-37  Score=342.76  Aligned_cols=265  Identities=21%  Similarity=0.257  Sum_probs=194.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccc------
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS------  530 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------  530 (803)
                      .++|...+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367889999999999999999975 58899999865432  223457889999999999999999999997654      


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..++||||+++ +|.+.+.    ..+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            78999999975 7888873    348999999999999999999999   899999999999999999999999999997


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHH---------H----
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLA---------E----  677 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~----  677 (803)
                      ....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.....         +    
T Consensus       176 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          176 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             cccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            6321   22233457899999999999999999999999999999999999999764332211000         0    


Q ss_pred             ---HHHHHhhcC-c-----cccccCcccccC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          678 ---WAMQWQKKG-M-----LEHIIDPQLIGK---INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       678 ---~~~~~~~~~-~-----~~~i~d~~l~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                         ......... .     ....+.......   ........+.+++.+||+.||.+|||+.|++++-..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  322 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  322 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence               000000000 0     000000000000   012236788999999999999999999999987553

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.6e-38  Score=354.87  Aligned_cols=199  Identities=27%  Similarity=0.384  Sum_probs=165.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeecc-----ce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ-----SE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~  531 (803)
                      .++|...+.||+|+||.||+|.... ++.||||++.....  ...+.+.+|+++|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            4679999999999999999999754 78899998764322  2346789999999999999999999999766     57


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .++||||+. |+|.+++.  ....+++..+..++.||++||.|||+   .+|+||||||+||||+.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999987 59999994  34569999999999999999999999   8999999999999999999999999999986


Q ss_pred             CCCCCCC--------------------ceeccccCCCcccCcccc-ccCcCCCcceehhHHHHHHHHHhCCCCC
Q 042150          612 GPCLDET--------------------HVSTGVKGSFGYLDPEYF-RRQQLTDKSDVYSFGVVLFEVLCARTAV  664 (803)
Q Consensus       612 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~elltG~~p~  664 (803)
                      .......                    .......||+.|+|||++ ....++.++|||||||+||||++|..|+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            4322111                    123456789999999986 5667999999999999999999865443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.3e-37  Score=335.17  Aligned_cols=253  Identities=25%  Similarity=0.327  Sum_probs=196.8

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC--------CCChHHHHHHHHHHHhccCCCeeeEEeEeecc
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS--------RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ  529 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~  529 (803)
                      ..++|...+.||+|+||.||+|.... ++.||||.+....        ......+.+|+++|++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            45679999999999999999999754 7899999865332        12234588999999999999999999999765


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc---EEEeee
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV---SKVADF  606 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---~kl~DF  606 (803)
                      . .++||||+++|+|.+++.  ....+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.   +||+||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             c-eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            5 899999999999999984  45679999999999999999999999   99999999999999987654   999999


Q ss_pred             ccccCCCCCCCCceeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHh
Q 042150          607 GLSRSGPCLDETHVSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ  683 (803)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  683 (803)
                      |+++...   .........||+.|+|||++.   ...++.++|||||||++|||++|+.||.......  .+....    
T Consensus       162 g~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----  232 (322)
T 2ycf_A          162 GHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----  232 (322)
T ss_dssp             TTCEECC---CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----
T ss_pred             ccceecc---cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----
Confidence            9997632   122223456899999999974   5678999999999999999999999997543221  111111    


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..+...  ..+...    ......+.+++.+||+.||.+||++.+++++
T Consensus       233 ~~~~~~--~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          233 TSGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhCccc--cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            111100  001110    1234678999999999999999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.8e-38  Score=351.58  Aligned_cols=261  Identities=23%  Similarity=0.242  Sum_probs=195.3

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeecc------ceee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ------SEMI  533 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~  533 (803)
                      .+|...++||+|+||.||+|++. +++.||||++.....    .+.+|+++|++++||||++++++|...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            45888889999999999999986 489999998754322    234799999999999999999988432      2367


Q ss_pred             EEEEecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC-CcEEEeeecccc
Q 042150          534 LVYEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-YVSKVADFGLSR  610 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-~~~kl~DFGla~  610 (803)
                      +||||+++ +|.+.+..  .....+++..++.++.||++||+|||+   .+|+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999986 56555521  235679999999999999999999999   999999999999999954 678999999998


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHh------
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ------  683 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~------  683 (803)
                      .....   .......+|+.|+|||++.+. .++.++|||||||+||||++|+.||......+..  .+......      
T Consensus       206 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          206 QLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPTREQ  280 (420)
T ss_dssp             ECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCHHH
T ss_pred             hcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHH
Confidence            64321   122345789999999998764 7999999999999999999999999765433221  11111100      


Q ss_pred             ---hcCccccccCcccc-----cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          684 ---KKGMLEHIIDPQLI-----GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       684 ---~~~~~~~i~d~~l~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                         ......+...+.+.     ..+.......+.+|+.+||+.||.+||++.|++++-.
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~  339 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  339 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence               00011111111111     0122234567899999999999999999999997643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7e-38  Score=342.83  Aligned_cols=260  Identities=21%  Similarity=0.299  Sum_probs=204.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCC-----------------hHHHHHHHHHHHhccCCCeeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG-----------------LPEFQTEITVLSKIRHRHLVSL  522 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~f~~E~~~l~~l~HpnIv~l  522 (803)
                      .++|...+.||+|+||.||+|.. +++.||||.+.......                 .+.|.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46788999999999999999999 89999999854321111                 1789999999999999999999


Q ss_pred             EeEeeccceeeEEEEecCCCchhhh------ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc
Q 042150          523 VGYCEEQSEMILVYEYMEKGPLKKH------LYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD  596 (803)
Q Consensus       523 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~  596 (803)
                      ++++.+.+..++||||+++|+|.++      +.......+++.+++.++.|++.||+|||+  ..+++||||||+|||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD  186 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence            9999999999999999999999999      644446789999999999999999999996  37899999999999999


Q ss_pred             cCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccC-cCCC-cceehhHHHHHHHHHhCCCCCCcchhhhhhh
Q 042150          597 ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ-QLTD-KSDVYSFGVVLFEVLCARTAVDPLLAREQVN  674 (803)
Q Consensus       597 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~  674 (803)
                      .++.+||+|||+++....    .......++..|+|||.+.+. .++. ++|||||||++|||++|+.||.......  .
T Consensus       187 ~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~  260 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--E  260 (348)
T ss_dssp             TTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--H
T ss_pred             CCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H
Confidence            999999999999976322    134456789999999999877 6666 9999999999999999999997543311  1


Q ss_pred             HHHHHHHHhhcCcccccc------Ccc---cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          675 LAEWAMQWQKKGMLEHII------DPQ---LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       675 l~~~~~~~~~~~~~~~i~------d~~---l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +.   .. ...+......      .+.   ............+.+++.+||+.+|.+|||+.|++++
T Consensus       261 ~~---~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          261 LF---NN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HH---HH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HH---HH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11   11 1111110000      000   0000113345678999999999999999999999874

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.4e-37  Score=356.16  Aligned_cols=255  Identities=24%  Similarity=0.319  Sum_probs=202.5

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCC-------------CCChHHHHHHHHHHHhccCCCeeeEEe
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGS-------------RQGLPEFQTEITVLSKIRHRHLVSLVG  524 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~-------------~~~~~~f~~E~~~l~~l~HpnIv~l~g  524 (803)
                      ..++|...+.||+|+||+||+|.... ++.||+|.+....             ....+.+.+|+.+|++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            45789999999999999999999764 7899999865332             134578999999999999999999999


Q ss_pred             EeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC---cE
Q 042150          525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY---VS  601 (803)
Q Consensus       525 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~---~~  601 (803)
                      +|.+....++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++   .+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence            99999999999999999999998843  4569999999999999999999999   8999999999999998775   69


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQ  681 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  681 (803)
                      ||+|||+++....   ........||+.|+|||++. ..++.++|||||||++|+|++|+.||......+..      ..
T Consensus       189 kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~  258 (504)
T 3q5i_A          189 KIVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII------KK  258 (504)
T ss_dssp             EECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH
T ss_pred             EEEECCCCEEcCC---CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH
Confidence            9999999976432   22234467999999999987 56999999999999999999999999754332211      11


Q ss_pred             HhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          682 WQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       682 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                       ...+...  .+....    ...+..+.+++.+||+.+|.+|||+.|++++-..
T Consensus       259 -i~~~~~~--~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  305 (504)
T 3q5i_A          259 -VEKGKYY--FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI  305 (504)
T ss_dssp             -HHHCCCC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             -HHcCCCC--CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence             1111110  000000    1234678999999999999999999999986543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.1e-38  Score=335.28  Aligned_cols=256  Identities=20%  Similarity=0.265  Sum_probs=188.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-CCh-HHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-QGL-PEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~-~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .++|...+.||+|+||.||+|... +++.||+|++..... ... +.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467888999999999999999974 688999998754422 112 23445555678889999999999999999999999


Q ss_pred             EecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-ceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          537 EYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGSAE-GIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       537 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      ||++ |+|.+++..  .....+++..++.++.|++.||+|||+   . +|+||||||+|||++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9998 488777632  235679999999999999999999998   7 99999999999999999999999999997633


Q ss_pred             CCCCCceeccccCCCcccCcccc----ccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYF----RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      .   ........||+.|+|||.+    .+..++.++|||||||++|||++|+.||........ .+    ........ .
T Consensus       162 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~~~~~-~  232 (290)
T 3fme_A          162 D---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QL----KQVVEEPS-P  232 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HH----HHHHHSCC-C
T ss_pred             c---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HH----HHHhccCC-C
Confidence            2   2222334689999999996    566889999999999999999999999974322111 11    11111110 0


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                              ..........+.+++.+||+.+|.+|||+.|++++-...
T Consensus       233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~  271 (290)
T 3fme_A          233 --------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT  271 (290)
T ss_dssp             --------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             --------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence                    011123456789999999999999999999999865433

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.9e-38  Score=349.43  Aligned_cols=254  Identities=10%  Similarity=0.026  Sum_probs=182.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC---CChHHHHHHHHHHHhc--cCCCeeeEE-------eEee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR---QGLPEFQTEITVLSKI--RHRHLVSLV-------GYCE  527 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l--~HpnIv~l~-------g~~~  527 (803)
                      .+|...+.||+|+||.||+|... +++.||||++.....   ...+.+.+|+.+++.|  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45788889999999999999975 688999998765433   2345677886655555  599988755       3443


Q ss_pred             cc-----------------ceeeEEEEecCCCchhhhccCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCceE
Q 042150          528 EQ-----------------SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQR------LEICIGAARGLHYLHTGSAEGII  584 (803)
Q Consensus       528 ~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iv  584 (803)
                      ..                 ...+|||||++ |+|.+++... ...+.+..+      +.++.||++||+|||+   ++|+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv  216 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLV  216 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence            22                 34899999999 8999999542 223466666      7888999999999999   9999


Q ss_pred             eeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCcccccc--CcCCCcceehhHHHHHHHHHhCCC
Q 042150          585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCART  662 (803)
Q Consensus       585 HrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~  662 (803)
                      ||||||+|||++.++.+||+|||+++....     ......+|+.|+|||++.+  ..++.++|||||||+||||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999986321     1224556799999999987  789999999999999999999999


Q ss_pred             CCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          663 AVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       663 p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ||..........        ......................+..+.+++.+||+.||.+|||+.|++++
T Consensus       292 Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          292 PFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             STTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            997553221100        00000001111111111112446788999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.5e-38  Score=340.40  Aligned_cols=265  Identities=23%  Similarity=0.317  Sum_probs=195.6

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEee------------
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE------------  527 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~------------  527 (803)
                      ++|...+.||+|+||.||+|.... ++.||+|++........+++.+|++++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            578888999999999999999875 8999999876655555678999999999999999999999873            


Q ss_pred             --ccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc-cCCcEEEe
Q 042150          528 --EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVA  604 (803)
Q Consensus       528 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl~  604 (803)
                        +....++||||++ |+|.+++.   ...+++.+++.++.|+++||+|||+   .+|+||||||+|||++ +++.+||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             ccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence              4467899999998 69999993   3569999999999999999999999   9999999999999997 67799999


Q ss_pred             eeccccCCCCCCC-CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH
Q 042150          605 DFGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       605 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      |||+++....... ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....  .....
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~--~~~~~  241 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL--ILESI  241 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHHHS
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhc
Confidence            9999986432111 112233457899999998865 7889999999999999999999999976543222111  00000


Q ss_pred             h--h-------cCccccccCcccc------cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          683 Q--K-------KGMLEHIIDPQLI------GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       683 ~--~-------~~~~~~i~d~~l~------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      .  .       ...+.........      ..........+.+++.+||+.||.+|||+.|++++-.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY  308 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence            0  0       0000000000000      0011223567899999999999999999999998644

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.3e-38  Score=371.23  Aligned_cols=250  Identities=22%  Similarity=0.268  Sum_probs=206.1

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCC---CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceee
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG---SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~  533 (803)
                      ..++|...++||+|+||.||+|..+. ++.||||++...   .....+.+..|..+|..+ +||||+++++++.+.+.++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            45679999999999999999999764 788999986532   334567789999999988 7999999999999999999


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      |||||+++|+|.+++..  ...+++.+++.++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++...
T Consensus       419 lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999999943  3569999999999999999999999   999999999999999999999999999998532


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ..  ........||+.|+|||++.+..++.++|||||||+||||++|+.||......+.      ..... ..       
T Consensus       494 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~------~~~i~-~~-------  557 (674)
T 3pfq_A          494 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIM-EH-------  557 (674)
T ss_dssp             CT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-SS-------
T ss_pred             cC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH------HHHHH-hC-------
Confidence            21  2233456899999999999999999999999999999999999999975433221      11111 11       


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSM-----GDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~~  732 (803)
                       .  ..++......+.+|+.+||+.||.+||++     .||+++
T Consensus       558 -~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          558 -N--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             -C--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             -C--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence             1  12233456778999999999999999997     666653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.6e-38  Score=346.99  Aligned_cols=259  Identities=24%  Similarity=0.320  Sum_probs=184.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeecc------c
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ------S  530 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~  530 (803)
                      .++|...+.||+|+||.||+|... +++.||||++.....  ...+.+.+|+++|+.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            467899999999999999999964 588999999754322  2346788999999999999999999998654      5


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ..++|+||+ +++|.+++.   ...+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            679999999 689999883   3569999999999999999999999   999999999999999999999999999997


Q ss_pred             CCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC---
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG---  686 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---  686 (803)
                      ....     ......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....   ........   
T Consensus       181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~p~~~  252 (367)
T 2fst_X          181 HTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAE  252 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHH
T ss_pred             cccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCHH
Confidence            6321     1234578999999999877 7899999999999999999999999976543322211   11110000   


Q ss_pred             ccccccCc-------ccc--cCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          687 MLEHIIDP-------QLI--GKIN-----LDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       687 ~~~~i~d~-------~l~--~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      .+..+...       .+.  ...+     ......+.+|+.+||+.||.+|||+.|++++-
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp  313 (367)
T 2fst_X          253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  313 (367)
T ss_dssp             HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence            00000000       000  0000     12245688999999999999999999998763

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.1e-37  Score=343.95  Aligned_cols=264  Identities=23%  Similarity=0.291  Sum_probs=200.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeecc-----cee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ-----SEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~  532 (803)
                      .++|...+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++|.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457889999999999999999975 578899998764332 2246789999999999999999999999654     468


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+. |+|.+++.   ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       106 ~iv~e~~~-~~L~~~l~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCS-EEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEcccC-cCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            99999998 59999883   3469999999999999999999999   99999999999999999999999999999764


Q ss_pred             CCCCC-CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc--
Q 042150          613 PCLDE-THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML--  688 (803)
Q Consensus       613 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--  688 (803)
                      ..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.....   .........  
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~  255 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQED  255 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCHHH
Confidence            32111 111234578999999998754 55899999999999999999999999755433322111   000000000  


Q ss_pred             -cc------------ccCccc--ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          689 -EH------------IIDPQL--IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       689 -~~------------i~d~~l--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                       ..            ...+..  ...........+.+++.+||+.||.+|||+.|++++-
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence             00            000000  0000122346789999999999999999999998763

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-37  Score=366.36  Aligned_cols=261  Identities=23%  Similarity=0.325  Sum_probs=206.6

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEECC----CcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      ...++|...+.||+|+||.||+|.+..    +..||+|+...... ...+.|.+|+.+|++++||||+++++++.+ +..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence            345678889999999999999999743    45799998654332 234679999999999999999999999854 568


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+++|+|.+++.. ....+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       466 ~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            999999999999999953 23469999999999999999999999   89999999999999999999999999999864


Q ss_pred             CCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      .... ........+|+.|+|||.+.+..++.++|||||||+||||++ |+.||......+.   ....    ..+.    
T Consensus       542 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~i----~~~~----  609 (656)
T 2j0j_A          542 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI----ENGE----  609 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH----HHTC----
T ss_pred             CCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH----HcCC----
Confidence            3221 122233456789999999999999999999999999999997 9999875433221   1111    1111    


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                           ....+..++..+.+++.+||+.+|.+|||+.++++.|+.+++.+
T Consensus       610 -----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          610 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                 01123344567899999999999999999999999999887543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=340.80  Aligned_cols=264  Identities=23%  Similarity=0.363  Sum_probs=202.6

Q ss_pred             hhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccce
Q 042150          454 TDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       454 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~  531 (803)
                      .+.....++|...+.||+|+||.||+|..++  .+|+|.+...  .....+.|.+|+.++++++||||+++++++.+...
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            3444456788899999999999999999864  5899986543  23345678899999999999999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+   .+++||||||+|||++ ++.+||+|||+++.
T Consensus       104 ~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             eEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            9999999999999999954 23469999999999999999999999   8999999999999998 67999999999875


Q ss_pred             CCCCC---CCceeccccCCCcccCcccccc---------CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHH
Q 042150          612 GPCLD---ETHVSTGVKGSFGYLDPEYFRR---------QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWA  679 (803)
Q Consensus       612 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  679 (803)
                      .....   .........|++.|+|||.+.+         ..++.++|||||||++|||++|+.||........      .
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~  252 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------I  252 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH------H
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H
Confidence            32111   1112233468999999999864         4578899999999999999999999975432221      1


Q ss_pred             HHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          680 MQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       680 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                      .. ...+......        .......+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus       253 ~~-~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          253 WQ-MGTGMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HH-HHTTCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             HH-hccCCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            11 1111111111        112234678999999999999999999999999877543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.7e-37  Score=340.29  Aligned_cols=263  Identities=21%  Similarity=0.243  Sum_probs=200.3

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-----------CCCeeeEEeEeec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-----------HRHLVSLVGYCEE  528 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----------HpnIv~l~g~~~~  528 (803)
                      ++|...+.||+|+||.||+|... +++.||||.+... ....+.+.+|++++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            57888999999999999999974 5889999986532 223467889999999886           8999999999976


Q ss_pred             cc----eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-ceEeeccCcceEEEc------c
Q 042150          529 QS----EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE-GIIHRDIKSTNILLD------E  597 (803)
Q Consensus       529 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLkp~NILl~------~  597 (803)
                      .+    ..++||||+ +++|.+++.......+++..++.++.||+.||+|||+   + +|+||||||+|||++      .
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence            54    789999999 8899999966556679999999999999999999999   7 999999999999994      3


Q ss_pred             CCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh----h
Q 042150          598 NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ----V  673 (803)
Q Consensus       598 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~----~  673 (803)
                      .+.+||+|||+++....     ......+|+.|+|||++.+..++.++|||||||+||||++|+.||........    .
T Consensus       174 ~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            44899999999975322     12345789999999999999999999999999999999999999975432111    1


Q ss_pred             hHHHHHHHH-----------------hhc-CccccccCcc---------cccCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 042150          674 NLAEWAMQW-----------------QKK-GMLEHIIDPQ---------LIGKINLDSLKKFGETAEKCLADYGVDRPSM  726 (803)
Q Consensus       674 ~l~~~~~~~-----------------~~~-~~~~~i~d~~---------l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  726 (803)
                      .+.......                 ... +....+....         -...++......+.+|+.+||+.||.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            111111000                 000 0000000000         0113456778899999999999999999999


Q ss_pred             HHHHHHH
Q 042150          727 GDVLWNL  733 (803)
Q Consensus       727 ~evl~~L  733 (803)
                      .|++++-
T Consensus       329 ~ell~hp  335 (373)
T 1q8y_A          329 GGLVNHP  335 (373)
T ss_dssp             HHHHTCG
T ss_pred             HHHhhCh
Confidence            9998753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-36  Score=336.17  Aligned_cols=204  Identities=25%  Similarity=0.255  Sum_probs=173.0

Q ss_pred             HHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CC-----CeeeEEeEeeccc
Q 042150          458 TATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HR-----HLVSLVGYCEEQS  530 (803)
Q Consensus       458 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-Hp-----nIv~l~g~~~~~~  530 (803)
                      ...++|...+.||+|+||.||+|... +++.||||++... ....+++..|+++++.++ |+     +|+++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34578999999999999999999976 5788999987532 223467788999998885 55     4999999999999


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc--cCCcEEEeeecc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD--ENYVSKVADFGL  608 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~~kl~DFGl  608 (803)
                      ..+|||||++ |+|.+++.......+++..+..++.|++.||.|||+ ...+|+||||||+|||++  .++.+||+|||+
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            9999999996 599999966555679999999999999999999995 237899999999999994  578899999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchh
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLA  669 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  669 (803)
                      ++....     ......+|+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus       208 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          208 SCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             CEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            976422     12345789999999999999999999999999999999999999986543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.5e-37  Score=340.67  Aligned_cols=258  Identities=21%  Similarity=0.302  Sum_probs=197.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC--ChHHHHHHHHHHHhccCCCeeeEEeEeecccee----
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ--GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM----  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~----  532 (803)
                      .++|...+.||+|+||.||+|... +++.||||++......  ..+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467889999999999999999975 5889999987654322  246788999999999999999999999877655    


Q ss_pred             --eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          533 --ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       533 --~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                        ++||||+. ++|.+++    ...+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999998 5888887    2349999999999999999999999   899999999999999999999999999997


Q ss_pred             CCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC---
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG---  686 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---  686 (803)
                      ....     ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....  .. ......   
T Consensus       193 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--i~-~~~~~~~~~  264 (371)
T 4exu_A          193 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ--IL-KVTGVPGTE  264 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HH-HHHCCCCHH
T ss_pred             cccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HH-HHhCCCcHH
Confidence            5321     2234578999999999987 7899999999999999999999999975433222111  00 000000   


Q ss_pred             ccccc-----------cCccccc---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          687 MLEHI-----------IDPQLIG---KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       687 ~~~~i-----------~d~~l~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      ....+           +......   .........+.+++.+||+.||.+|||+.|++++-
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  325 (371)
T 4exu_A          265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  325 (371)
T ss_dssp             HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence            00000           0000000   00112356789999999999999999999998763

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.1e-37  Score=335.80  Aligned_cols=257  Identities=21%  Similarity=0.296  Sum_probs=197.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC--ChHHHHHHHHHHHhccCCCeeeEEeEeeccce-----
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ--GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE-----  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~-----  531 (803)
                      .++|...+.||+|+||.||+|... +++.||||++......  ..+.+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            356888899999999999999975 5899999987554322  24678899999999999999999999977654     


Q ss_pred             -eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          532 -MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       532 -~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                       .++||||+. ++|.+++.    ..+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence             499999998 58988872    349999999999999999999999   899999999999999999999999999997


Q ss_pred             CCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC---
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG---  686 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---  686 (803)
                      ....     ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+...  ... ......   
T Consensus       175 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~i~-~~~~~~~~~  246 (353)
T 3coi_A          175 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QIL-KVTGVPGTE  246 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH--HHH-HHHCBCCHH
T ss_pred             CCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-HHhCCCCHH
Confidence            5321     1234578999999999876 788999999999999999999999997543322111  100 000000   


Q ss_pred             ---------------ccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          687 ---------------MLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       687 ---------------~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                                     .+.....+.+ ..........+.+++.+||+.||.+|||+.|++++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  307 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  307 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence                           0000000000 112234467889999999999999999999998753

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=333.64  Aligned_cols=246  Identities=24%  Similarity=0.367  Sum_probs=191.5

Q ss_pred             hHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC------CChHHHHHHHHHHHhc----cCCCeeeEE
Q 042150          455 DLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR------QGLPEFQTEITVLSKI----RHRHLVSLV  523 (803)
Q Consensus       455 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l----~HpnIv~l~  523 (803)
                      +.....++|...+.||+|+||.||+|... +++.||||++.....      .....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            34455678999999999999999999864 588999998754432      1234467899999998    899999999


Q ss_pred             eEeeccceeeEEEEe-cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc-cCCcE
Q 042150          524 GYCEEQSEMILVYEY-MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVS  601 (803)
Q Consensus       524 g~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~  601 (803)
                      +++...+..++|||| +.+++|.+++..  ...+++.+++.++.||++||+|||+   .+|+||||||+|||++ .++.+
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeE
Confidence            999999999999999 789999999943  4569999999999999999999999   8999999999999999 89999


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCC-CcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT-DKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAM  680 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  680 (803)
                      ||+|||+++....    .......|+..|+|||++.+..+. .++|||||||++|||++|+.||......          
T Consensus       180 kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------  245 (312)
T 2iwi_A          180 KLIDFGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI----------  245 (312)
T ss_dssp             EECCCSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----------
T ss_pred             EEEEcchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH----------
Confidence            9999999876432    122345689999999999877665 4899999999999999999998643210          


Q ss_pred             HHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        .. ..          ..++......+.+++.+||+.+|.+|||+.|++++
T Consensus       246 --~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 --LE-AE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --HH-TC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --hh-hc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00 00          01222345678999999999999999999999875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.8e-37  Score=333.69  Aligned_cols=256  Identities=18%  Similarity=0.268  Sum_probs=176.6

Q ss_pred             HhcCCCcc-ceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHH-HHHHhccCCCeeeEEeEeec----cce
Q 042150          459 ATNNFDKN-LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEI-TVLSKIRHRHLVSLVGYCEE----QSE  531 (803)
Q Consensus       459 ~~~~f~~~-~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~-~~l~~l~HpnIv~l~g~~~~----~~~  531 (803)
                      ..++|... ++||+|+||.||+|... +++.||||++...     ....+|+ ..++.++||||+++++++..    ...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            34678874 46999999999999986 5899999986432     2333344 34566789999999999866    456


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc---CCcEEEeeecc
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---NYVSKVADFGL  608 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~kl~DFGl  608 (803)
                      .++||||+++|+|.+++.......+++.+++.++.|++.||.|||+   .+|+||||||+|||++.   ++.+||+|||+
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            8999999999999999976666689999999999999999999999   89999999999999976   45599999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ++....    .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...........   ......... 
T Consensus       178 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~-  249 (336)
T 3fhr_A          178 AKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLGQ-  249 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ceeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhccc-
Confidence            975321    122345689999999999999999999999999999999999999865432211000   000000000 


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                           ..............+.+++.+||+.+|.+|||+.|++++-..
T Consensus       250 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  291 (336)
T 3fhr_A          250 -----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI  291 (336)
T ss_dssp             ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             -----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence                 000011112345678999999999999999999999987553

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.9e-37  Score=334.83  Aligned_cols=263  Identities=20%  Similarity=0.240  Sum_probs=202.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-C-cEEEEEEcCCCCCCChHHHHHHHHHHHhccCCC------eeeEEeEeeccce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-N-TKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH------LVSLVGYCEEQSE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hpn------Iv~l~g~~~~~~~  531 (803)
                      .++|...+.||+|+||.||+|.... + +.||+|.+... ....+.+.+|++++++++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            4678999999999999999999753 3 68999987532 233567889999999998776      9999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE----------------
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL----------------  595 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl----------------  595 (803)
                      .++||||+ +++|.+++.......+++.+++.++.||+.||+|||+   .+|+||||||+|||+                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 5677777755555679999999999999999999999   899999999999999                


Q ss_pred             ---ccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhh
Q 042150          596 ---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ  672 (803)
Q Consensus       596 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  672 (803)
                         +.++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||+||||++|+.||......+.
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence               6788999999999975322     12345789999999999999999999999999999999999999976543332


Q ss_pred             hhHHHHHHH-----HhhcCccccc-cC--------------------c-ccccCCCHHHHHHHHHHHHHccccCCCCCCC
Q 042150          673 VNLAEWAMQ-----WQKKGMLEHI-ID--------------------P-QLIGKINLDSLKKFGETAEKCLADYGVDRPS  725 (803)
Q Consensus       673 ~~l~~~~~~-----~~~~~~~~~i-~d--------------------~-~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs  725 (803)
                      .........     +......... ..                    + .............+.+++.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            211111000     0000000000 00                    0 0000122345668999999999999999999


Q ss_pred             HHHHHHH
Q 042150          726 MGDVLWN  732 (803)
Q Consensus       726 ~~evl~~  732 (803)
                      +.|++++
T Consensus       328 ~~e~l~h  334 (355)
T 2eu9_A          328 LAEALLH  334 (355)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.6e-37  Score=328.78  Aligned_cols=253  Identities=23%  Similarity=0.377  Sum_probs=193.3

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeec----------
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE----------  528 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~----------  528 (803)
                      .++|...+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            467888999999999999999975 688999998643 22345678999999999999999999998854          


Q ss_pred             ---cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEee
Q 042150          529 ---QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVAD  605 (803)
Q Consensus       529 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D  605 (803)
                         ....++||||+++|+|.+++.. ....+++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence               4678999999999999999953 23467889999999999999999999   8999999999999999999999999


Q ss_pred             eccccCCCCCCC------------CceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhh
Q 042150          606 FGLSRSGPCLDE------------THVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ  672 (803)
Q Consensus       606 FGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  672 (803)
                      ||+++.......            ........|++.|+|||.+.+. .++.++|||||||++|||++   |+......  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--  234 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--  234 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--
Confidence            999976432110            1122345689999999999764 78999999999999999998   44322111  


Q ss_pred             hhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          673 VNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       673 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .   +..... ...      ...+...++......+.+++.+||+.||.+|||+.+++++
T Consensus       235 ~---~~~~~~-~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          235 V---NILKKL-RSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             H---HHHHHH-HST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             H---HHHHhc-ccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            1   111111 111      1111223344455678999999999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=345.33  Aligned_cols=265  Identities=21%  Similarity=0.241  Sum_probs=182.2

Q ss_pred             CCc-cceEeeeCceEEEEEEEC---CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEee--ccceeeEEE
Q 042150          463 FDK-NLIIGSGGFGMVYKGVLR---DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE--EQSEMILVY  536 (803)
Q Consensus       463 f~~-~~~Lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~--~~~~~~lV~  536 (803)
                      |.. +++||+|+||.||+|..+   +++.||||++...  .....+.+|+++|++++||||+++++++.  .....+|||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            544 458999999999999976   4788999987543  23457899999999999999999999994  467899999


Q ss_pred             EecCCCchhhhccC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE----ccCCcEEEee
Q 042150          537 EYMEKGPLKKHLYG-------PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL----DENYVSKVAD  605 (803)
Q Consensus       537 Ey~~~gsL~~~l~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl----~~~~~~kl~D  605 (803)
                      ||+.+ +|.+++..       .....+++..++.++.||+.||+|||+   .+|+||||||+||||    +.++.+||+|
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99975 78777731       123359999999999999999999999   999999999999999    7788999999


Q ss_pred             eccccCCCCCCC-CceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhh-------hhhHH
Q 042150          606 FGLSRSGPCLDE-THVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE-------QVNLA  676 (803)
Q Consensus       606 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-------~~~l~  676 (803)
                      ||+++....... ........||+.|+|||++.+ ..++.++|||||||+||||++|+.||.......       ...+.
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            999986432111 122334678999999999987 458999999999999999999999996433210       00111


Q ss_pred             HHHHHHhhcCc---cccc------------cCcccccC---------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          677 EWAMQWQKKGM---LEHI------------IDPQLIGK---------INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       677 ~~~~~~~~~~~---~~~i------------~d~~l~~~---------~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ... .......   ...+            +.......         ........+.+|+.+||+.||.+|||+.|++++
T Consensus       256 ~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          256 RIF-NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHH-HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHH-HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            111 1000000   0000            00000000         000113567899999999999999999999987


Q ss_pred             HH
Q 042150          733 LE  734 (803)
Q Consensus       733 L~  734 (803)
                      -.
T Consensus       335 p~  336 (405)
T 3rgf_A          335 PY  336 (405)
T ss_dssp             GG
T ss_pred             hh
Confidence            44

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.7e-37  Score=338.82  Aligned_cols=264  Identities=22%  Similarity=0.278  Sum_probs=199.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeecc-----cee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ-----SEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~  532 (803)
                      .++|...+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467888999999999999999976 588999998754322 2345788999999999999999999988654     678


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ++||||+. |+|.+++..   ..+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            99999997 589998843   569999999999999999999999   89999999999999999999999999999754


Q ss_pred             CCCCCCc--------eeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHh
Q 042150          613 PCLDETH--------VSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ  683 (803)
Q Consensus       613 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  683 (803)
                      .......        ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........   .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~  239 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL---IFGII  239 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHH
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHHHh
Confidence            3211110        1223468999999998764 7889999999999999999999999976543322111   01100


Q ss_pred             hcCc----cccccCcc-------c-------ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          684 KKGM----LEHIIDPQ-------L-------IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       684 ~~~~----~~~i~d~~-------l-------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                      ....    ...+..+.       +       ...........+.+++.+||+.||.+|||+.|++++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP  307 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence            0000    00000000       0       0000123456788999999999999999999998753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.7e-37  Score=325.37  Aligned_cols=255  Identities=24%  Similarity=0.294  Sum_probs=203.3

Q ss_pred             HHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceee
Q 042150          457 QTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       457 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      ....++|...+.||+|+||.||+|... +++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            344578999999999999999999986 5889999986433  3445778999999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC---CcEEEeeecccc
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN---YVSKVADFGLSR  610 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~---~~~kl~DFGla~  610 (803)
                      +||||+++++|.+++..  ...+++.+++.++.|++.||.|||+   .+++||||||+||+++.+   +.+||+|||+++
T Consensus        98 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           98 IVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999999998843  3468999999999999999999999   899999999999999754   479999999987


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                      .....   .......+++.|+|||.+.+ .++.++||||||+++|||++|+.||......+.      ... ...+....
T Consensus       173 ~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~  241 (287)
T 2wei_A          173 CFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LKR-VETGKYAF  241 (287)
T ss_dssp             TBCCC---SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH-HHHCCCCC
T ss_pred             eecCC---CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHcCCCCC
Confidence            63321   11223457889999999875 489999999999999999999999875432211      111 11111100


Q ss_pred             ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       691 i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                        +...    ....+..+.+++.+||+.+|.+|||+.|++++-
T Consensus       242 --~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp  278 (287)
T 2wei_A          242 --DLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (287)
T ss_dssp             --CSGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred             --Cchh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence              0000    012345789999999999999999999999853

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=8.2e-37  Score=331.53  Aligned_cols=258  Identities=24%  Similarity=0.272  Sum_probs=181.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-CChHHHHHHHH-HHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-QGLPEFQTEIT-VLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .++|...+.||+|+||.||+|... +++.||||++..... ....++..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367888889999999999999985 588999998754422 23345666666 677789999999999999999999999


Q ss_pred             EecCCCchhhhcc---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-ceEeeccCcceEEEccCCcEEEeeeccccCC
Q 042150          537 EYMEKGPLKKHLY---GPDRTPLSWKQRLEICIGAARGLHYLHTGSAE-GIIHRDIKSTNILLDENYVSKVADFGLSRSG  612 (803)
Q Consensus       537 Ey~~~gsL~~~l~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLkp~NILl~~~~~~kl~DFGla~~~  612 (803)
                      ||+++ +|.+++.   ......+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 7777763   2235679999999999999999999998   7 9999999999999999999999999999764


Q ss_pred             CCCCCCceeccccCCCcccCcccc----ccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYF----RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ..   ........||+.|+|||.+    .+..++.++|||||||++|||++|+.||........     ..    .  ..
T Consensus       177 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~----~--~~  242 (327)
T 3aln_A          177 VD---SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL----T--QV  242 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--CC
T ss_pred             cc---ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH----H--HH
Confidence            32   1122334689999999998    567789999999999999999999999874321100     00    0  00


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      .....+.+...........+.+++.+||+.+|.+||++.+++++-..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~  289 (327)
T 3aln_A          243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI  289 (327)
T ss_dssp             CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred             hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence            00001111111222345678999999999999999999999885443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.3e-36  Score=343.06  Aligned_cols=252  Identities=20%  Similarity=0.231  Sum_probs=188.3

Q ss_pred             CCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEEecC
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      .|...++||+|+||+||.+...+|+.||||++...   ..+.+.+|+++|.++ +||||+++++++.+.+..+|||||+.
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            34556789999999998776777999999986532   245788999999987 89999999999999999999999996


Q ss_pred             CCchhhhccCCCCC-----CCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccC-------------CcEE
Q 042150          541 KGPLKKHLYGPDRT-----PLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDEN-------------YVSK  602 (803)
Q Consensus       541 ~gsL~~~l~~~~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~-------------~~~k  602 (803)
                       |+|.+++......     ..++..++.++.||+.||+|||+   .+|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999543321     12444668899999999999999   999999999999999754             4899


Q ss_pred             EeeeccccCCCCCCCC--ceeccccCCCcccCcccccc-------CcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhh
Q 042150          603 VADFGLSRSGPCLDET--HVSTGVKGSFGYLDPEYFRR-------QQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQ  672 (803)
Q Consensus       603 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~  672 (803)
                      |+|||+++........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||........
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~  248 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES  248 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence            9999999864332111  11234579999999999975       678999999999999999999 9999865432221


Q ss_pred             hhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          673 VNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       673 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                          ....   .....     +.+...........+.+++.+||+.||.+|||+.|++++
T Consensus       249 ----~i~~---~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          249 ----NIIR---GIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             ----HHHH---TCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----HHhc---CCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence                1110   00000     111112244667889999999999999999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.2e-37  Score=335.23  Aligned_cols=246  Identities=24%  Similarity=0.376  Sum_probs=199.3

Q ss_pred             hHHHHhcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC------CChHHHHHHHHHHHhcc--CCCeeeEEeE
Q 042150          455 DLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR------QGLPEFQTEITVLSKIR--HRHLVSLVGY  525 (803)
Q Consensus       455 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~--HpnIv~l~g~  525 (803)
                      +.....++|...+.||+|+||.||+|... +++.||||.+.....      ...+.+.+|+.++++++  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            34445678999999999999999999964 588999998654322      12356788999999996  5999999999


Q ss_pred             eeccceeeEEEEecCC-CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc-cCCcEEE
Q 042150          526 CEEQSEMILVYEYMEK-GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKV  603 (803)
Q Consensus       526 ~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~-~~~~~kl  603 (803)
                      +...+..++|||++.+ ++|.+++..  ...+++..++.++.||++||+|||+   .+|+||||||+|||++ +++.+||
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEE
Confidence            9999999999999976 899999843  4568999999999999999999999   9999999999999999 7899999


Q ss_pred             eeeccccCCCCCCCCceeccccCCCcccCccccccCcC-CCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHH
Q 042150          604 ADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQW  682 (803)
Q Consensus       604 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (803)
                      +|||+++....    .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......            
T Consensus       192 ~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------------  255 (320)
T 3a99_A          192 IDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------  255 (320)
T ss_dssp             CCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------
T ss_pred             eeCcccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh------------
Confidence            99999976432    12234568999999999987766 67899999999999999999998643210            


Q ss_pred             hhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          683 QKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       683 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .. ...          ..+......+.+++.+||+.+|.+|||+.|++++
T Consensus       256 ~~-~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          256 IR-GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             HH-CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hc-ccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00 000          0112234578899999999999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=324.89  Aligned_cols=253  Identities=23%  Similarity=0.294  Sum_probs=179.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC-C-hHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ-G-LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      .++|...+.||+|+||.||+|... +++.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467888899999999999999986 5889999987544221 1 223445556778889999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-ceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE-GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      ||+ ++.+..+. ......+++..++.++.|+++||.|||+   . +++||||||+|||++.++.+||+|||+++.... 
T Consensus       104 e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-  177 (318)
T 2dyl_A          104 ELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-  177 (318)
T ss_dssp             CCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC-
Confidence            999 44444444 2234679999999999999999999997   6 899999999999999999999999999875322 


Q ss_pred             CCCceeccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                        ........+++.|+|||.+.     ...++.++|||||||++|||++|+.||.......     +......... .  
T Consensus       178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-~--  247 (318)
T 2dyl_A          178 --DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQEE-P--  247 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHHSC-C--
T ss_pred             --CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhccC-C--
Confidence              12223456899999999994     5678899999999999999999999987532211     1111111111 0  


Q ss_pred             ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042150          691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNL  733 (803)
Q Consensus       691 i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L  733 (803)
                         +.+.  ........+.+++.+||+.+|.+||++.+++++-
T Consensus       248 ---~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (318)
T 2dyl_A          248 ---PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS  285 (318)
T ss_dssp             ---CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             ---CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence               0000  0112346788999999999999999999999753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.5e-36  Score=337.30  Aligned_cols=252  Identities=23%  Similarity=0.289  Sum_probs=189.4

Q ss_pred             HhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEEE
Q 042150          459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       459 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ...+|...++||+|+||+|+.....+++.||||++....   ...+.+|+++|+++ +||||+++++++.+....+||||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            345688889999999999765556678999999875432   33467899999999 79999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-----CCcEEEeeeccccCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-----NYVSKVADFGLSRSG  612 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-----~~~~kl~DFGla~~~  612 (803)
                      |+. |+|.+++.... ..+.+.+++.++.||++||+|||+   .+|+||||||+|||++.     ...+||+|||+++..
T Consensus        99 ~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           99 LCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            997 59999996433 345566778999999999999999   99999999999999943     336889999999864


Q ss_pred             CCCCC-CceeccccCCCcccCccccc---cCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCc
Q 042150          613 PCLDE-THVSTGVKGSFGYLDPEYFR---RQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGM  687 (803)
Q Consensus       613 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (803)
                      ..... ........||+.|+|||++.   ...++.++|||||||++|||++ |+.||........       ........
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~~~~  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLGACS  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTTCCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhccCC
Confidence            32211 12234467999999999997   4677889999999999999999 8988854322111       01111111


Q ss_pred             cccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          688 LEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       688 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .. .      ..........+.+++.+||+.||.+|||+.|++++
T Consensus       247 ~~-~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          247 LD-C------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             CT-T------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cc-c------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            00 0      01123445668899999999999999999999953

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-35  Score=314.57  Aligned_cols=231  Identities=14%  Similarity=0.109  Sum_probs=184.2

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCC---hHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQG---LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||.||+|.... ++.||||.+.......   .+.|.+|+.++.+++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            568888999999999999999865 8999999976554332   367999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++++|.+++..   . ....++++|+.|++.||+|||+   ++|+||||||+|||++.++.+||+++|         
T Consensus       111 e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            99999999999932   2 3556789999999999999999   999999999999999999999998543         


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC-cc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID-PQ  695 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d-~~  695 (803)
                                   |++       +++.++|||||||+||||++|+.||......+....           ....+.. +.
T Consensus       175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----------~~~~~~~~~~  223 (286)
T 3uqc_A          175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------AERDTAGQPI  223 (286)
T ss_dssp             -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------CCBCTTSCBC
T ss_pred             -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------HHHHhccCCC
Confidence                         333       368899999999999999999999975432211000           0000000 00


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                      .........+..+.+++.+||+.||.+| |+.|+++.|+.+...
T Consensus       224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            0001122345678999999999999999 999999999988643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-35  Score=351.63  Aligned_cols=240  Identities=20%  Similarity=0.309  Sum_probs=192.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC--CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccce-----
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR--DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE-----  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~-----  531 (803)
                      .++|...+.||+|+||.||+|.+.  +++.||||++.... ....+.|.+|+++|++++||||++++++|...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999985  58899999875432 2334578999999999999999999999987665     


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .+|||||+++++|.+++..    .+++.+++.++.||++||.|||+   ++|+||||||+|||++.+ .+||+|||+++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            7999999999999988732    69999999999999999999999   999999999999999986 899999999976


Q ss_pred             CCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ....      ....||+.|+|||++.+.. +.++|||||||+||||++|..|+.......                   +
T Consensus       231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~  284 (681)
T 2pzi_A          231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------L  284 (681)
T ss_dssp             TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------C
T ss_pred             cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------c
Confidence            4321      3457899999999987654 889999999999999999988875321110                   0


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPS-MGDVLWNLEYAL  737 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~~L~~~~  737 (803)
                      ..    ..........+.+++.+||+.||.+||+ ++++.+.|...+
T Consensus       285 ~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          285 PE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             CT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            00    0001123467889999999999999995 556666666554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.8e-36  Score=347.65  Aligned_cols=268  Identities=24%  Similarity=0.312  Sum_probs=203.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeec------ccee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE------QSEM  532 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~------~~~~  532 (803)
                      ++|...+.||+|+||.||+|... +++.||||++... .....+.|.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            67999999999999999999974 5889999986543 22335678999999999999999999999865      6778


Q ss_pred             eEEEEecCCCchhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCc---EEEeeecc
Q 042150          533 ILVYEYMEKGPLKKHLYGPD-RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYV---SKVADFGL  608 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~---~kl~DFGl  608 (803)
                      ++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999996532 3469999999999999999999999   99999999999999986664   99999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ++....   ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     .|..........
T Consensus       171 a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~~  242 (676)
T 3qa8_A          171 AKELDQ---GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSNE  242 (676)
T ss_dssp             CCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC-----
T ss_pred             cccccc---ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccch
Confidence            986432   222344678999999999999999999999999999999999999997532211     111110000000


Q ss_pred             ccccCc------------ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHH-----HHHHHHHHhh
Q 042150          689 EHIIDP------------QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDV-----LWNLEYALQL  739 (803)
Q Consensus       689 ~~i~d~------------~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev-----l~~L~~~~~~  739 (803)
                      ......            .............+.+++.+||..||.+|||+.|+     .+.++.++..
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence            000000            01122345577889999999999999999999884     4566666543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-35  Score=330.98  Aligned_cols=242  Identities=15%  Similarity=0.167  Sum_probs=181.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC---CCChHHHHHHHHHHHhccC-CCeee-------------
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS---RQGLPEFQTEITVLSKIRH-RHLVS-------------  521 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H-pnIv~-------------  521 (803)
                      ...|...++||+|+||.||+|... +++.||||++....   ....+.|.+|+.+++.++| +|...             
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777789999999999999964 58999999866332   2346789999999999977 22111             


Q ss_pred             --------EEeEeec-----cceeeEEEEecCCCchhhhcc-----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCce
Q 042150          522 --------LVGYCEE-----QSEMILVYEYMEKGPLKKHLY-----GPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI  583 (803)
Q Consensus       522 --------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  583 (803)
                              +..++..     ....+++|+++ +++|.+++.     ......+++..++.++.||++||+|||+   ++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence                    1111111     12356777765 579998883     3345568899999999999999999999   999


Q ss_pred             EeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCcccc----------ccCcCCCcceehhHHHH
Q 042150          584 IHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF----------RRQQLTDKSDVYSFGVV  653 (803)
Q Consensus       584 vHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDV~S~Gvv  653 (803)
                      +||||||+||||+.++.+||+|||+++....     ......| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            9999999999999999999999999875321     1344567 999999999          66678899999999999


Q ss_pred             HHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          654 LFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       654 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ||||++|+.||......+.               ...++..      ....+..+.+++.+||+.+|.+||++.+++++
T Consensus       307 l~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHCCCCCCCcchhhh---------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            9999999999975432211               1111110      01224678999999999999999999888753

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.2e-34  Score=306.26  Aligned_cols=230  Identities=20%  Similarity=0.325  Sum_probs=181.9

Q ss_pred             cCCCcc-ceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHH-HhccCCCeeeEEeEeec----cceee
Q 042150          461 NNFDKN-LIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVL-SKIRHRHLVSLVGYCEE----QSEMI  533 (803)
Q Consensus       461 ~~f~~~-~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l-~~l~HpnIv~l~g~~~~----~~~~~  533 (803)
                      ++|... ++||+|+||.||++... +++.||+|++..     ...+.+|++++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456665 68999999999999974 588999998642     35788999998 55589999999999876    67899


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc---CCcEEEeeecccc
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---NYVSKVADFGLSR  610 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~kl~DFGla~  610 (803)
                      +||||+++|+|.+++.......+++.+++.++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            99999999999999976555679999999999999999999999   99999999999999998   7899999999986


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                      ...                        +..++.++|||||||++|||++|+.||........           .......
T Consensus       169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~  213 (299)
T 3m2w_A          169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTR  213 (299)
T ss_dssp             ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred             ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHH
Confidence            421                        24567899999999999999999999964422110           0000011


Q ss_pred             ccCcccccCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          691 IIDPQLIGKIN----LDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       691 i~d~~l~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      +.....  ..+    ......+.+++.+||+.||.+|||+.|++++-..
T Consensus       214 ~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~  260 (299)
T 3m2w_A          214 IRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  260 (299)
T ss_dssp             SCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             Hhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence            111000  111    1235678999999999999999999999987553

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.9e-35  Score=318.28  Aligned_cols=244  Identities=19%  Similarity=0.155  Sum_probs=184.7

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCC--------CCChHHHHHHHHHHHhcc---------CCCeeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGS--------RQGLPEFQTEITVLSKIR---------HRHLVSL  522 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~f~~E~~~l~~l~---------HpnIv~l  522 (803)
                      .++|...+.||+|+||+||+|+. +++.||||++....        ....+.+.+|+++|++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45688889999999999999998 67999999865432        233478999999999986         7777766


Q ss_pred             EeEe-----------------ec-------------cceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHH
Q 042150          523 VGYC-----------------EE-------------QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGL  572 (803)
Q Consensus       523 ~g~~-----------------~~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL  572 (803)
                      .+.+                 .+             .+..+|||||+++|++.+.+.   +..+++.+++.++.||+.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHHHH
Confidence            6653                 22             678999999999998777773   25689999999999999999


Q ss_pred             HHHh-cCCCCceEeeccCcceEEEccCC--------------------cEEEeeeccccCCCCCCCCceeccccCCCccc
Q 042150          573 HYLH-TGSAEGIIHRDIKSTNILLDENY--------------------VSKVADFGLSRSGPCLDETHVSTGVKGSFGYL  631 (803)
Q Consensus       573 ~yLH-~~~~~~ivHrDLkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  631 (803)
                      +||| +   .+|+||||||+||||+.++                    .+||+|||+|+....       ....||+.|+
T Consensus       175 ~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~  244 (336)
T 2vuw_A          175 AVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSM  244 (336)
T ss_dssp             HHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTT
T ss_pred             HHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeeccc
Confidence            9999 8   9999999999999999887                    999999999986321       1347899999


Q ss_pred             CccccccCcCCCcceehhHHHH-HHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHH
Q 042150          632 DPEYFRRQQLTDKSDVYSFGVV-LFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGE  710 (803)
Q Consensus       632 aPE~~~~~~~t~ksDV~S~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~  710 (803)
                      |||++.+.. +.++|||||+++ .+++++|..||.....     .............    ..............+.+.+
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-----~~~~~~~~~~~~~----~~~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW-----LHYLTDKMLKQMT----FKTKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH-----HHHHHHHHHHTCC----CSSCCCSHHHHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh-----hhHHHHhhhhhhc----cCcccchhhhhhcCHHHHH
Confidence            999998776 889999998777 7788889988742110     0000011111100    0111111122456788999


Q ss_pred             HHHHccccCCCCCCCHHHHH-HH
Q 042150          711 TAEKCLADYGVDRPSMGDVL-WN  732 (803)
Q Consensus       711 li~~cl~~~p~~RPs~~evl-~~  732 (803)
                      |+.+||+.+     |+.|++ ++
T Consensus       315 li~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHhccC-----CHHHHHhcC
Confidence            999999865     999988 54

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=3.8e-29  Score=290.27  Aligned_cols=184  Identities=18%  Similarity=0.106  Sum_probs=128.2

Q ss_pred             EeeeCceEEEEEE-ECCCcEEEEEEcCCCCC----------CChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEEE
Q 042150          469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSR----------QGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       469 Lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~----------~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++.|+.|.+..++ .-.|+.++||.+.....          ...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4555565555444 22478899998654321          1235799999999999 7999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||++|++|.++|.  ...+++..   +|+.||+.||+|||+   +|||||||||+||||++++.+||+|||+|+....  
T Consensus       322 Eyv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--  391 (569)
T 4azs_A          322 EKLPGRLLSDMLA--AGEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--  391 (569)
T ss_dssp             ECCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             ecCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCC--
Confidence            9999999999994  34566654   588999999999999   9999999999999999999999999999986432  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCC
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTA  663 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p  663 (803)
                      ........+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus       392 ~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            1223345679999999999975 467789999999999888766543

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=99.93  E-value=2.2e-26  Score=224.66  Aligned_cols=154  Identities=18%  Similarity=0.141  Sum_probs=120.5

Q ss_pred             hheeeeecCCcccCCCCCeeeeeecCCCcceeecCcccccccCCCccccCCCCCccccchHHHHHHhcccccccccCccc
Q 042150          180 ETILRINVGGSELTPFNDTLWRTWVPDDEFLVLKSAAKRVATTHPPNYQKGGASREIGPDNVYMTAQEMNRDNAMLGARF  259 (803)
Q Consensus       180 ~~~~R~n~Gg~~~~~~~D~~~r~w~~d~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~P~~vy~TAr~~~~~~~~~~~~~  259 (803)
                      ++++|+||||+..+   |..||.|.+|..+.... .....  .....+    .....+|..||||||.++.         
T Consensus         5 ~~~~~INcGg~~~~---d~~gr~w~~D~~~~~~g-~~~~~--~~~~~~----~~~~~~~~~lY~TaR~~~~---------   65 (174)
T 2jwp_A            5 KVIWAVNAGGESHV---DVHGIHYRKDPLEGRVG-RASDY--GMKLPI----LRSNPEDQVLYQTERYNED---------   65 (174)
T ss_dssp             HEEEEEEETSSSEE---ETTTEEECSSCSSTTCC-CCCCC--CTTSCC----SSSCHHHHHTTTCCCCCCS---------
T ss_pred             cEEEEEECCCCCcc---CCCCCEEcCCcCcccCC-ccccc--ccceEe----cccCCCCchhhhhhccCCC---------
Confidence            68999999999876   55789999998654211 11111  111111    1124678999999999862         


Q ss_pred             ceeEeeeccCCCCeeEEEEEeeeeecCCCCcEEEEEEEcCeeecccCCccccccCCccccEEEEeEEee-----------
Q 042150          260 NITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADS-----------  328 (803)
Q Consensus       260 ~lt~~~~~~~~~~~y~v~lhFae~~~~~~~~R~Fdi~in~~~~~~~~di~~~~~~~~~~~~~~~~~~~~-----------  328 (803)
                      +|+|.+|+++ +|.|+|||||||+.+.+.++|+|||||||+.++++|||..+ +++ +.+++++|.+.+           
T Consensus        66 ~~tY~f~v~~-~G~Y~VrLhF~ei~~~~~~~rvFdV~ing~~~l~~fdi~~~-ag~-~~~~~~~~~~~v~~~~l~i~~~~  142 (174)
T 2jwp_A           66 SFGYDIPIKE-EGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDR-VGH-STAHDEIIPISIKKGKLSVQGEV  142 (174)
T ss_dssp             CEEEEEECCS-CEEEEEEEEEECCSCCCSSSSCEEEEETTEEEEEEECHHHH-HSS-SSCEEEEEEEEEETTEEEETTEE
T ss_pred             CeEEEEEeCC-CeEEEEEEEEeccccCCCCCeEeEEEECCEEeecCcCHHHh-hCC-CeeEEEEEEEEEecCceeeeeee
Confidence            4999999998 89999999999999888999999999999999999999988 444 789999997764           


Q ss_pred             -cCCceeEEEEeccCCCCccccccccccceeee
Q 042150          329 -DDAGVVRVSVGPSELSGSLKVNAILNGVEIMK  360 (803)
Q Consensus       329 -~~~~~~~is~~~s~~s~~~~~~~ilng~ei~~  360 (803)
                       ...|.|+|+|.|..     ..+|++||+||++
T Consensus       143 ~~~~g~L~I~f~p~~-----~~~a~inaIEI~~  170 (174)
T 2jwp_A          143 STFTGKLSVEFVKGY-----YDNPKVCALFIMK  170 (174)
T ss_dssp             EECCSEEEEEEECSS-----SCSSSEEEEEEES
T ss_pred             cccCCeEEEEEeccC-----CCCcEEEEEEEEe
Confidence             35678999999752     2389999999997

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=8.9e-26  Score=260.55  Aligned_cols=185  Identities=16%  Similarity=0.196  Sum_probs=144.8

Q ss_pred             CccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCC--------hHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          464 DKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQG--------LPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ...++||+|+||.||+|.. .++.+++|+........        .++|.+|+++|++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999954 46788888754432211        24589999999999999999777777777888999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++++|.+++..          ++.++.|+++||+|||+   ++|+||||||+|||+++  .+||+|||+++.....
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999999999943          56899999999999999   99999999999999999  9999999999874321


Q ss_pred             CCCc-----eeccccCCCcccCcccccc--CcCCCcceehhHHHHHHHHHhCCCCC
Q 042150          616 DETH-----VSTGVKGSFGYLDPEYFRR--QQLTDKSDVYSFGVVLFEVLCARTAV  664 (803)
Q Consensus       616 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~  664 (803)
                      ....     ......||+.|||||++..  ..|+.++|+||..+-.++.+.++.++
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1111     1235679999999999986  67888999999999999988877654

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=99.87  E-value=3.2e-22  Score=195.11  Aligned_cols=148  Identities=16%  Similarity=0.189  Sum_probs=113.4

Q ss_pred             CceeecCCCcccccCCceeecCCCCCccccccCcccccccCCCCCCCCCCccceeeeeccceeEEeeecCceEEEEEeec
Q 042150            1 NYLINCGSPTNASLYNRFFVPDASSKSVSFSADNSISLKSKTPPQDSPSPYDTARVFTSDGSYKLNIKRNGTHLVRFHFS   80 (803)
Q Consensus         1 ~~~I~CG~~~~~~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~~~cY~~~~~~~~~ylvR~~F~   80 (803)
                      .|+||||++..+...+|+|.+|..|...|.................++.+|+|+|+||...||.||+.++|+|+|||||+
T Consensus         7 ~~~INcGg~~~~d~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrLhF~   86 (174)
T 2jwp_A            7 IWAVNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFA   86 (174)
T ss_dssp             EEEEEETSSSEEETTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCSCEEEEEECCSCEEEEEEEEEE
T ss_pred             EEEEECCCCCccCCCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCCCeEEEEEeCCCeEEEEEEEEe
Confidence            48999999876555689999998875333222111111111111234568999999999999999998899999999999


Q ss_pred             CCCCCcccccccEEEEEECcEEEEeccCCC------ceEEEEEEEEe-------------cCCeEEEEEeecCCCCccee
Q 042150           81 PFESDNFKLASAKFGVLANGLLLLQDFSTQ------VVVLKEFIVKV-------------DGDVIEIEFRPVGDKNFGFV  141 (803)
Q Consensus        81 ~~~~~~~~~~~~~F~~~~~~~~~~~~~~~~------~~~~~e~i~~~-------------~~~~~~v~~~~~~~~~~~fv  141 (803)
                      +..+.+  .+...|||++||.+++++||..      .++.+|+.+.+             .++.|.|+|.|. ....|||
T Consensus        87 ei~~~~--~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~-~~~~a~i  163 (174)
T 2jwp_A           87 EVYFAQ--SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKG-YYDNPKV  163 (174)
T ss_dssp             CCSCCC--SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECS-SSCSSSE
T ss_pred             ccccCC--CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEecc-CCCCcEE
Confidence            999864  4579999999999999999862      37888888874             567899999985 4667999


Q ss_pred             eeeEEEecCC
Q 042150          142 NAIEVFSAPE  151 (803)
Q Consensus       142 ~~iE~~~~~~  151 (803)
                      |||||++.+-
T Consensus       164 naIEI~~~~~  173 (174)
T 2jwp_A          164 CALFIMKGTA  173 (174)
T ss_dssp             EEEEEESSCC
T ss_pred             EEEEEEeCcc
Confidence            9999998753

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=1.6e-22  Score=213.96  Aligned_cols=153  Identities=16%  Similarity=0.120  Sum_probs=122.1

Q ss_pred             hhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCC------------------ChHHHHHHHHHHHhcc
Q 042150          454 TDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ------------------GLPEFQTEITVLSKIR  515 (803)
Q Consensus       454 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~f~~E~~~l~~l~  515 (803)
                      ..+......|...+.||+|+||.||+|...+++.||||........                  ....+.+|+++|++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            3444555567777999999999999999977999999987533211                  2356899999999999


Q ss_pred             CCCeeeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE
Q 042150          516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL  595 (803)
Q Consensus       516 HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl  595 (803)
                        | +++.+++. .+..++||||+++|+|.+ +..        .+...++.|+++||.|||+   .+|+||||||+|||+
T Consensus       163 --~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl  226 (282)
T 1zar_A          163 --G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLV  226 (282)
T ss_dssp             --T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEE
T ss_pred             --C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEE
Confidence              4 56666543 356799999999999998 511        2355799999999999999   999999999999999


Q ss_pred             ccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCcccccc
Q 042150          596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR  638 (803)
Q Consensus       596 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  638 (803)
                      + ++.+||+|||+++.               +..++|||++.+
T Consensus       227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             E-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             E-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            9 99999999999863               345789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=2e-18  Score=180.28  Aligned_cols=135  Identities=16%  Similarity=0.118  Sum_probs=105.8

Q ss_pred             CCccceEeeeCceEEEEEEE-CCCcE--EEEEEcCCCCCCC------------------------hHHHHHHHHHHHhcc
Q 042150          463 FDKNLIIGSGGFGMVYKGVL-RDNTK--VAVKRGVPGSRQG------------------------LPEFQTEITVLSKIR  515 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~~------------------------~~~f~~E~~~l~~l~  515 (803)
                      |...+.||+|+||.||+|.. .+|+.  ||||.........                        ...+.+|+++|.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998 67888  9999754321110                        136889999999999


Q ss_pred             CCCe--eeEEeEeeccceeeEEEEecCC-C----chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCceEeec
Q 042150          516 HRHL--VSLVGYCEEQSEMILVYEYMEK-G----PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH-TGSAEGIIHRD  587 (803)
Q Consensus       516 HpnI--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrD  587 (803)
                      |+++  +.++++    ...+|||||+.+ |    +|.++...     .++.++..++.|++.+|.||| +   .+|+|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~---~givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE---AELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence            8864  344432    357899999942 4    56665421     235678899999999999999 8   8999999


Q ss_pred             cCcceEEEccCCcEEEeeeccccC
Q 042150          588 IKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       588 Lkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      |||+|||+++  .++|+|||+|..
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEE
T ss_pred             CCHHHEEEcC--cEEEEECccccc
Confidence            9999999998  999999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.61  E-value=5.6e-16  Score=168.43  Aligned_cols=136  Identities=14%  Similarity=0.138  Sum_probs=97.9

Q ss_pred             CCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCC--------------CChHHH--------HHHHHHHHhccCCCe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSR--------------QGLPEF--------QTEITVLSKIRHRHL  519 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~f--------~~E~~~l~~l~HpnI  519 (803)
                      -|.+...||+|+||.||+|...+|+.||||.......              ......        .+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4888999999999999999998999999997543210              011122        345555555544433


Q ss_pred             eeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC
Q 042150          520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY  599 (803)
Q Consensus       520 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~  599 (803)
                      ....-+..  ...+|||||+++++|.++..        ..+...++.|++.+|.+||+   .+||||||||.|||+++++
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence            21111111  22379999999999877652        12345788999999999999   8999999999999998776


Q ss_pred             ----------cEEEeeecccc
Q 042150          600 ----------VSKVADFGLSR  610 (803)
Q Consensus       600 ----------~~kl~DFGla~  610 (803)
                                .+.|+||+-+.
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCE
T ss_pred             CcccccccccceEEEEeCCcc
Confidence                      38999998654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.26  E-value=1.8e-11  Score=127.42  Aligned_cols=147  Identities=14%  Similarity=0.071  Sum_probs=114.9

Q ss_pred             HHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeE
Q 042150          456 LQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       456 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~l  534 (803)
                      +......|.....++.|+.+.||+.... ++.+++|...........++.+|+++|+.+. |..+.++++++...+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3444566877778888899999998754 6789999865422223346899999999994 7788899999998889999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG------------------------------------  578 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------  578 (803)
                      ||||++|.+|.+.+.       +..+...++.+++++|..||+.                                    
T Consensus        88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999999987641       1223457888999999999981                                    


Q ss_pred             --------------------CCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          579 --------------------SAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       579 --------------------~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                                          ....++|+|+++.|||++++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                11458999999999999876667799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=1.2e-10  Score=120.73  Aligned_cols=128  Identities=20%  Similarity=0.150  Sum_probs=98.0

Q ss_pred             eeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCC--eeeEEeEeeccceeeEEEEecCCCchhhh
Q 042150          470 GSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH--LVSLVGYCEEQSEMILVYEYMEKGPLKKH  547 (803)
Q Consensus       470 g~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~  547 (803)
                      +.|..+.||+....+|..+++|.....   ....+.+|+++++.+.+.+  +.++++++..++..++||||+++.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            355569999998777788999985543   2356889999999996545  456888888888899999999998884  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------------
Q 042150          548 LYGPDRTPLSWKQRLEICIGAARGLHYLHTGS------------------------------------------------  579 (803)
Q Consensus       548 l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------  579 (803)
                      ..  .   .+   ...++.++++.|..||+..                                                
T Consensus       104 ~~--~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A          104 SS--H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             TS--C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             cC--c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence            31  1   11   2367788888888888732                                                


Q ss_pred             -------CCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          580 -------AEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       580 -------~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                             ...++|+|++|.|||++++..++|+||+.+.
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                   1239999999999999887667799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.97  E-value=2.1e-09  Score=117.29  Aligned_cols=142  Identities=16%  Similarity=0.197  Sum_probs=107.6

Q ss_pred             ccceEeeeCceEEEEEEECCCcEEEEEEcC--CCC-CCChHHHHHHHHHHHhcc--CCCeeeEEeEeecc---ceeeEEE
Q 042150          465 KNLIIGSGGFGMVYKGVLRDNTKVAVKRGV--PGS-RQGLPEFQTEITVLSKIR--HRHLVSLVGYCEEQ---SEMILVY  536 (803)
Q Consensus       465 ~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~f~~E~~~l~~l~--HpnIv~l~g~~~~~---~~~~lV~  536 (803)
                      ..+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|..+++.|.  +..+++++++|.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            34578999999999988664 578888754  322 123456889999999996  56688899998776   4589999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS-------------------------------------  579 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------  579 (803)
                      ||+++..+.+..    ...++..++..++.++++.|..||+..                                     
T Consensus       121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            999998875432    234778889999999999999999721                                     


Q ss_pred             ------------------CCceEeeccCcceEEEccCCc--EEEeeeccccC
Q 042150          580 ------------------AEGIIHRDIKSTNILLDENYV--SKVADFGLSRS  611 (803)
Q Consensus       580 ------------------~~~ivHrDLkp~NILl~~~~~--~kl~DFGla~~  611 (803)
                                        ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              257999999999999987653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.79  E-value=1.7e-09  Score=115.11  Aligned_cols=183  Identities=19%  Similarity=0.202  Sum_probs=121.5

Q ss_pred             cceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCC--eeeEEeEeeccc---eeeEEEEec
Q 042150          466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRH--LVSLVGYCEEQS---EMILVYEYM  539 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-Hpn--Iv~l~g~~~~~~---~~~lV~Ey~  539 (803)
                      .+.++.|....||+..    ..+++|.....  .....+.+|.++|+.+. +..  +.+.+..+...+   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3468999999999853    56888874322  23467899999999883 332  445555554433   348999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS----------------------------------------  579 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  579 (803)
                      +|.+|.+...    ..++..++..++.++++.|..||+..                                        
T Consensus        99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            9988875431    34677778888888888888888511                                        


Q ss_pred             ---------------CCceEeeccCcceEEEcc--CCcEEEeeeccccCCCCCCCCceeccccCCCcc---cCcccccc-
Q 042150          580 ---------------AEGIIHRDIKSTNILLDE--NYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY---LDPEYFRR-  638 (803)
Q Consensus       580 ---------------~~~ivHrDLkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-  638 (803)
                                     ...++|+|+++.||++++  +..+.|+||+.+........      .......   ..|+.... 
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHHHH
Confidence                           135899999999999998  55688999998764321100      0000011   12222110 


Q ss_pred             ----C---------cCCCcceehhHHHHHHHHHhCCCCC
Q 042150          639 ----Q---------QLTDKSDVYSFGVVLFEVLCARTAV  664 (803)
Q Consensus       639 ----~---------~~t~ksDV~S~Gvvl~elltG~~p~  664 (803)
                          +         ......+.|+++.++|++.+|+.++
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                0         1112358999999999999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.33  E-value=2.8e-06  Score=90.20  Aligned_cols=136  Identities=17%  Similarity=0.140  Sum_probs=95.0

Q ss_pred             cceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCC---CeeeEEeEee-ccceeeEEEEecCC
Q 042150          466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHR---HLVSLVGYCE-EQSEMILVYEYMEK  541 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hp---nIv~l~g~~~-~~~~~~lV~Ey~~~  541 (803)
                      ...++.|....||+.    +..+++|...  .......+.+|.++|+.+.+.   .+.+.+.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            346888888999987    5678888732  122346789999999999642   3566677764 45567899999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG-------------------------------------------  578 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------  578 (803)
                      .+|.+...    ..++..+...++.++++.|..||+.                                           
T Consensus        98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            88876321    1234455555666666666666542                                           


Q ss_pred             --------------CCCceEeeccCcceEEEcc---CCc-EEEeeeccccC
Q 042150          579 --------------SAEGIIHRDIKSTNILLDE---NYV-SKVADFGLSRS  611 (803)
Q Consensus       579 --------------~~~~ivHrDLkp~NILl~~---~~~-~kl~DFGla~~  611 (803)
                                    ....++|+|+++.|||++.   ++. ..|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          2235799999999999987   344 58999997754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.29  E-value=3e-06  Score=91.99  Aligned_cols=80  Identities=8%  Similarity=-0.030  Sum_probs=57.1

Q ss_pred             ceE-eeeCceEEEEEEEC-------CCcEEEEEEcCCCC---CCChHHHHHHHHHHHhcc-C--CCeeeEEeEeecc---
Q 042150          467 LII-GSGGFGMVYKGVLR-------DNTKVAVKRGVPGS---RQGLPEFQTEITVLSKIR-H--RHLVSLVGYCEEQ---  529 (803)
Q Consensus       467 ~~L-g~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~-H--pnIv~l~g~~~~~---  529 (803)
                      +.| +.|....+|+....       ++..+++|......   ......+.+|+.+|+.|. +  -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78888999988764       25678888754322   111246789999999884 3  3577788888665   


Q ss_pred             ceeeEEEEecCCCchhh
Q 042150          530 SEMILVYEYMEKGPLKK  546 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~  546 (803)
                      +..++||||+++..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.22  E-value=4.3e-06  Score=86.82  Aligned_cols=134  Identities=16%  Similarity=0.139  Sum_probs=96.5

Q ss_pred             eEeeeCce-EEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEEecCCCch
Q 042150          468 IIGSGGFG-MVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       468 ~Lg~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      .+..|..| .||+.... ++..+++|+....   ...++.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556655 68987654 4567899974432   2457889999999884 43477889999988999999999999887


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 042150          545 KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS---------------------------------------------  579 (803)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------  579 (803)
                      .+....      ...+...++.++++.|.-||...                                             
T Consensus       108 ~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          108 FQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            765411      12233456666677777777410                                             


Q ss_pred             ----------CCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          580 ----------AEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       580 ----------~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                                ...++|+|+++.|||+++++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      1237999999999999988777899999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.91  E-value=3.5e-05  Score=84.82  Aligned_cols=75  Identities=16%  Similarity=0.187  Sum_probs=50.2

Q ss_pred             cceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-------CChHHHHHHHHHHHhccC--CC-eeeEEeEeeccceeeE
Q 042150          466 NLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-------QGLPEFQTEITVLSKIRH--RH-LVSLVGYCEEQSEMIL  534 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~f~~E~~~l~~l~H--pn-Iv~l~g~~~~~~~~~l  534 (803)
                      .+.||.|.++.||++... +++.++||...+..+       ...+.+..|.++|+.+..  |. +.+++.+.  ....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            347899999999999754 467899997543221       234567889999988842  43 44555543  345689


Q ss_pred             EEEecCCC
Q 042150          535 VYEYMEKG  542 (803)
Q Consensus       535 V~Ey~~~g  542 (803)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.79  E-value=0.0001  Score=78.96  Aligned_cols=140  Identities=18%  Similarity=0.191  Sum_probs=81.6

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccC--CCeeeEEe------EeeccceeeEEEEe
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH--RHLVSLVG------YCEEQSEMILVYEY  538 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H--pnIv~l~g------~~~~~~~~~lV~Ey  538 (803)
                      ..|+.|..+.||+....++ .+++|+...    ...++..|..++..|..  -.+.+++.      +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3455577899999887655 588888654    23455567777776642  12334443      11345678999999


Q ss_pred             cCCCchh--------------hhccC----C--C-C-----CCCCHHHHH------------------------------
Q 042150          539 MEKGPLK--------------KHLYG----P--D-R-----TPLSWKQRL------------------------------  562 (803)
Q Consensus       539 ~~~gsL~--------------~~l~~----~--~-~-----~~l~~~~~~------------------------------  562 (803)
                      ++|..+.              ..+|.    .  . .     ..-.|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              01111    0  0 0     012333211                              


Q ss_pred             -HHHHHHHHHHHHHhc----------CCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          563 -EICIGAARGLHYLHT----------GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       563 -~i~~~ia~gL~yLH~----------~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                       .+...+.+++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             111123345666653          1247899999999999998888999999997643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.79  E-value=0.00021  Score=74.86  Aligned_cols=79  Identities=18%  Similarity=0.138  Sum_probs=58.5

Q ss_pred             CCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-C--CCeeeEEeEeeccceeeEEEEe
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-H--RHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-H--pnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .......+|.|..+.||+..+.+|+.++||+...........|..|.+.|+.|. .  --+.+.+++.    .-++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            344456799999999999999999999999865554444567899999999884 2  1244555543    34789999


Q ss_pred             cCCCch
Q 042150          539 MEKGPL  544 (803)
Q Consensus       539 ~~~gsL  544 (803)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.68  E-value=0.0002  Score=75.83  Aligned_cols=138  Identities=17%  Similarity=0.137  Sum_probs=92.4

Q ss_pred             ccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc---CCCeeeEEeEeeccceeeEEEEecCC
Q 042150          465 KNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR---HRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       465 ~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      ..+.|+.|....+|+... ++..+++|.....   ....|..|.+.|+.|.   ...+++.++++...+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            345789999999999875 4678889975432   3567899999999984   35688889998888889999999998


Q ss_pred             Cchhh-----------hccCCCC-C-------------------CCCHHHHH---HHH--H--------------HHHHH
Q 042150          542 GPLKK-----------HLYGPDR-T-------------------PLSWKQRL---EIC--I--------------GAARG  571 (803)
Q Consensus       542 gsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~--~--------------~ia~g  571 (803)
                      ..+..           .||.... .                   .-+|.+..   ++.  .              .++.-
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            76521           1121111 0                   12454332   111  1              11111


Q ss_pred             -HHHHhc-CCCCceEeeccCcceEEEccCCcEEEeeec
Q 042150          572 -LHYLHT-GSAEGIIHRDIKSTNILLDENYVSKVADFG  607 (803)
Q Consensus       572 -L~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFG  607 (803)
                       ...|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             223421 2347899999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.40  E-value=0.00053  Score=75.96  Aligned_cols=79  Identities=15%  Similarity=0.215  Sum_probs=48.2

Q ss_pred             CCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccc-cCCCcccCccccccC---cCCCcceehhHHHHHH
Q 042150          580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGV-KGSFGYLDPEYFRRQ---QLTDKSDVYSFGVVLF  655 (803)
Q Consensus       580 ~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~  655 (803)
                      ...++|+|+++.|||++.++ ++|+||+.+......-.  ..... .-...|++|+.....   .-....++......+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            37899999999999998876 99999998765221000  00000 012345666554311   1112345667888888


Q ss_pred             HHHhCC
Q 042150          656 EVLCAR  661 (803)
Q Consensus       656 elltG~  661 (803)
                      +.++++
T Consensus       308 ~~y~~~  313 (420)
T 2pyw_A          308 NLFNKR  313 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            887764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.35  E-value=0.001  Score=70.61  Aligned_cols=157  Identities=13%  Similarity=0.110  Sum_probs=88.9

Q ss_pred             cChhhHHHHhcCCCcc-----ceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCC--eeeEE
Q 042150          451 IPFTDLQTATNNFDKN-----LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH--LVSLV  523 (803)
Q Consensus       451 ~~~~~l~~~~~~f~~~-----~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~  523 (803)
                      ++.+++......|...     +.|+.|....+|+....++ .+++|.....  ...+++..|+.++..|...+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            3445666666666542     3466688899999887665 6788875542  12346677888888875322  23333


Q ss_pred             eE------eeccceeeEEEEecCCCchhh--------------hccC--CC--CC---C---CCHHHHHHH---------
Q 042150          524 GY------CEEQSEMILVYEYMEKGPLKK--------------HLYG--PD--RT---P---LSWKQRLEI---------  564 (803)
Q Consensus       524 g~------~~~~~~~~lV~Ey~~~gsL~~--------------~l~~--~~--~~---~---l~~~~~~~i---------  564 (803)
                      ..      ....+..+++|+|++|..+..              .+|.  ..  ..   .   ..|...+.-         
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            22      122356789999999865421              0111  00  00   0   123321110         


Q ss_pred             ---HHHHHHHHHHHhc----CCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          565 ---CIGAARGLHYLHT----GSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       565 ---~~~ia~gL~yLH~----~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                         ...+.+.++.|+.    .....++|+|+++.|||++++..+.|+||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               0113344555542    124679999999999999987666899998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.28  E-value=0.00089  Score=74.32  Aligned_cols=72  Identities=22%  Similarity=0.271  Sum_probs=50.8

Q ss_pred             ceEeeeCceEEEEEEECC--------CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCe-eeEEeEeeccceeeEEEE
Q 042150          467 LIIGSGGFGMVYKGVLRD--------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL-VSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~E  537 (803)
                      +.|+.|....+|+....+        +..+++|+....  ...+.+.+|..+++.|...++ .++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            467888889999998753        478889985321  222567789999998853333 567776653    28999


Q ss_pred             ecCCCch
Q 042150          538 YMEKGPL  544 (803)
Q Consensus       538 y~~~gsL  544 (803)
                      |+++.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9987554

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.25  E-value=0.0014  Score=71.20  Aligned_cols=138  Identities=20%  Similarity=0.210  Sum_probs=84.2

Q ss_pred             eEeeeCceEEEEEEECC--------CcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEEe
Q 042150          468 IIGSGGFGMVYKGVLRD--------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       468 ~Lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .|..|-...+|+....+        ++.+++|+.-. .......+.+|.++++.|. +.-..++++++.++    +||||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~  131 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY  131 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence            56678888899987642        46888988422 2345677889999999885 33346677776542    89999


Q ss_pred             cCCCchhhh-----------------ccCCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHHh-
Q 042150          539 MEKGPLKKH-----------------LYGPD---RTPLS--WKQRLEICIGAAR-------------------GLHYLH-  576 (803)
Q Consensus       539 ~~~gsL~~~-----------------l~~~~---~~~l~--~~~~~~i~~~ia~-------------------gL~yLH-  576 (803)
                      +++.+|...                 ||...   .....  |.++.++..++..                   .+..|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            998665421                 11111   11122  4455555443321                   223332 


Q ss_pred             ---c-CCCCceEeeccCcceEEEccC----CcEEEeeecccc
Q 042150          577 ---T-GSAEGIIHRDIKSTNILLDEN----YVSKVADFGLSR  610 (803)
Q Consensus       577 ---~-~~~~~ivHrDLkp~NILl~~~----~~~kl~DFGla~  610 (803)
                         . .....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               1 234579999999999999876    789999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.16  E-value=0.0024  Score=71.29  Aligned_cols=73  Identities=14%  Similarity=0.145  Sum_probs=48.2

Q ss_pred             ceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCe-eeEEeEeeccceeeEEEEecCCCch
Q 042150          467 LIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL-VSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      +.|+.|-...+|+....+ +..+++|+....... .-+-.+|..++..|...++ .++++++..    .+||||+++.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            467888889999998765 478888875433222 2223689999999864444 567777732    259999998655

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.13  E-value=0.002  Score=68.67  Aligned_cols=139  Identities=11%  Similarity=0.049  Sum_probs=72.8

Q ss_pred             eEeeeCceE-EEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccC--CCeeeEEeEeeccceeeEEEEecCCCch
Q 042150          468 IIGSGGFGM-VYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH--RHLVSLVGYCEEQSEMILVYEYMEKGPL  544 (803)
Q Consensus       468 ~Lg~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gsL  544 (803)
                      .|+.|.... +|+....++..+++|.......   .++..|+.++..+..  -.+.+++.++.+.+  +++||++.+..+
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l   99 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF   99 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence            455555444 6666544466777776433221   334567777777742  23556777654444  689999977655


Q ss_pred             hhhc---------------------cCCCC---CCCCHHHHH-------H-------------HHHHHHHHHHHHh---c
Q 042150          545 KKHL---------------------YGPDR---TPLSWKQRL-------E-------------ICIGAARGLHYLH---T  577 (803)
Q Consensus       545 ~~~l---------------------~~~~~---~~l~~~~~~-------~-------------i~~~ia~gL~yLH---~  577 (803)
                      .+.+                     |....   ..++.....       .             ....+...+..|.   .
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~  179 (333)
T 3csv_A          100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL  179 (333)
T ss_dssp             HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence            4322                     11110   111111100       0             0001111222221   1


Q ss_pred             CCCCceEeeccCcceEEEccC----CcEEEeeeccccC
Q 042150          578 GSAEGIIHRDIKSTNILLDEN----YVSKVADFGLSRS  611 (803)
Q Consensus       578 ~~~~~ivHrDLkp~NILl~~~----~~~kl~DFGla~~  611 (803)
                      .....++|+|+.+.|||++.+    ..+.|+||+.+..
T Consensus       180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            224689999999999999874    6899999998765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.06  E-value=0.0019  Score=67.93  Aligned_cols=137  Identities=13%  Similarity=0.085  Sum_probs=76.2

Q ss_pred             cceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCe-eeEEeEeeccceeeEEEEec-CCCc
Q 042150          466 NLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL-VSLVGYCEEQSEMILVYEYM-EKGP  543 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~-~~gs  543 (803)
                      .+.|+.|....+|+.     ..+++|........ ..+..+|..+++.+...++ .++++++.+  .-++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence            567889999999998     56888875443222 2234678888888753233 466665433  347899999 6544


Q ss_pred             hhh------------------hccCCCC---CCCCH-HHHHHHHHH--------------HHHHH----HHHh-cCCCCc
Q 042150          544 LKK------------------HLYGPDR---TPLSW-KQRLEICIG--------------AARGL----HYLH-TGSAEG  582 (803)
Q Consensus       544 L~~------------------~l~~~~~---~~l~~-~~~~~i~~~--------------ia~gL----~yLH-~~~~~~  582 (803)
                      |..                  .+|....   ..... ..+..+...              +.+.+    ..|. ......
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            431                  0111110   00111 111111000              11111    1111 123356


Q ss_pred             eEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          583 IIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       583 ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      ++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5666789999987754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.93  E-value=0.0089  Score=63.36  Aligned_cols=141  Identities=14%  Similarity=0.100  Sum_probs=83.2

Q ss_pred             ceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCC--eeeEEeE-----eeccceeeEEEEec
Q 042150          467 LIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH--LVSLVGY-----CEEQSEMILVYEYM  539 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~g~-----~~~~~~~~lV~Ey~  539 (803)
                      ..|+ |....||+....+|+.+++|...+. ......+..|..++..+....  +++++..     ....+..++||||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3466 8888999887767778999986533 224567788999988885222  3444443     12244567899999


Q ss_pred             CCCchhh-----------h---ccC----C---CCCCCCHHHH----------------------HHHHHHHHHHHHHHh
Q 042150          540 EKGPLKK-----------H---LYG----P---DRTPLSWKQR----------------------LEICIGAARGLHYLH  576 (803)
Q Consensus       540 ~~gsL~~-----------~---l~~----~---~~~~l~~~~~----------------------~~i~~~ia~gL~yLH  576 (803)
                      ++..+..           .   +|.    .   ....+++...                      ...+..++..+.-+.
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8865421           0   110    0   0112222211                      011112222222221


Q ss_pred             c-CCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          577 T-GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       577 ~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      . .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1 1246789999999999999 4 899999987654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.67  E-value=0.0029  Score=62.11  Aligned_cols=101  Identities=15%  Similarity=0.142  Sum_probs=65.5

Q ss_pred             chhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCceec
Q 042150          543 PLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVST  622 (803)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  622 (803)
                      +|.+.|.. .+.+++++++|.++.|.++.|.-+-... .. ..+=+.|..|+|..+|.+.+.+ +.+.            
T Consensus        34 SL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc------------
Confidence            67887732 4678999999999999999988762100 11 1334457999999999988764 2111            


Q ss_pred             cccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCC
Q 042150          623 GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART  662 (803)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~  662 (803)
                        .....+.+||... ...+.+.=|||+|++||.-+--..
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence              1122456888763 455778899999999999875443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.66  E-value=0.0035  Score=67.92  Aligned_cols=73  Identities=18%  Similarity=0.112  Sum_probs=44.5

Q ss_pred             ceEeeeCceEEEEEEECC---------CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCC-eeeEEeEeeccceeeEEE
Q 042150          467 LIIGSGGFGMVYKGVLRD---------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH-LVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~lV~  536 (803)
                      ..|+.|....+|+....+         +..+++|....... ...+...|.++++.+...+ ..++++.+.    -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence            357778888999988754         26788887543221 1123468888888885334 346665542    26899


Q ss_pred             EecCCCch
Q 042150          537 EYMEKGPL  544 (803)
Q Consensus       537 Ey~~~gsL  544 (803)
                      ||+++..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.35  E-value=0.013  Score=62.56  Aligned_cols=66  Identities=6%  Similarity=0.113  Sum_probs=42.9

Q ss_pred             eCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccC---CCeeeEEeE------eeccceeeEEEEecCCC
Q 042150          472 GGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH---RHLVSLVGY------CEEQSEMILVYEYMEKG  542 (803)
Q Consensus       472 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H---pnIv~l~g~------~~~~~~~~lV~Ey~~~g  542 (803)
                      |....||+....++ .+++|+......      ..|+.++..|..   |++++.+..      +...+..++||+|++|.
T Consensus        34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            33678999887767 889997544321      356667766632   224455432      23356789999999987


Q ss_pred             ch
Q 042150          543 PL  544 (803)
Q Consensus       543 sL  544 (803)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            66

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.57  E-value=0.075  Score=58.42  Aligned_cols=138  Identities=15%  Similarity=0.174  Sum_probs=84.2

Q ss_pred             ceEeeeCceEEEEEEECC--------CcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEE
Q 042150          467 LIIGSGGFGMVYKGVLRD--------NTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      +.|..|-...+|+....+        +..+++|+..... ...-+-.+|..+++.+. +.-..++++.+.    -++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            357778888999988763        5788888854332 22234468999998885 333455565443    268999


Q ss_pred             ecCCCchhhh-----------------ccC--------C---CCCCCCHHHHHHHHHHH-------------------HH
Q 042150          538 YMEKGPLKKH-----------------LYG--------P---DRTPLSWKQRLEICIGA-------------------AR  570 (803)
Q Consensus       538 y~~~gsL~~~-----------------l~~--------~---~~~~l~~~~~~~i~~~i-------------------a~  570 (803)
                      |+++.+|..-                 ||.        .   ...+.-|.++.++..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            9998764210                 011        0   11122244444433222                   12


Q ss_pred             HHHHHhc---------------------CCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          571 GLHYLHT---------------------GSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       571 gL~yLH~---------------------~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      .+..|.+                     .....++|+|+.+.||+ +.++.+.|+||..+.
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence            2333321                     12356899999999999 888899999998875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.93  E-value=0.64  Score=50.60  Aligned_cols=30  Identities=33%  Similarity=0.367  Sum_probs=25.1

Q ss_pred             ceEeeccCcceEEE------ccCCcEEEeeeccccC
Q 042150          582 GIIHRDIKSTNILL------DENYVSKVADFGLSRS  611 (803)
Q Consensus       582 ~ivHrDLkp~NILl------~~~~~~kl~DFGla~~  611 (803)
                      .++|+|+.+.|||+      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4567799999988753

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=89.68  E-value=0.022  Score=40.38  Aligned_cols=28  Identities=29%  Similarity=0.534  Sum_probs=13.0

Q ss_pred             EEehhhHHHHHHHHhheeeeEEEeeccc
Q 042150          379 VVGSVVGGFVLLCLVALAVLVLFKCRKK  406 (803)
Q Consensus       379 iigvvvg~~vll~ll~l~~~~~~~~rrk  406 (803)
                      |++.+++++++++++++++++++|+|++
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            4444555454444444444444444443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.56  E-value=0.02  Score=40.41  Aligned_cols=28  Identities=25%  Similarity=0.567  Sum_probs=13.0

Q ss_pred             EEehhhHHHHHHHHhheeeeEEEeeccc
Q 042150          379 VVGSVVGGFVLLCLVALAVLVLFKCRKK  406 (803)
Q Consensus       379 iigvvvg~~vll~ll~l~~~~~~~~rrk  406 (803)
                      |++.++|++++++++++++++++|+|++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~   39 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSI   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence            4445555454444444444444444433

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=85.70  E-value=0.022  Score=40.13  Aligned_cols=28  Identities=25%  Similarity=0.490  Sum_probs=12.5

Q ss_pred             EEEehhhHHHHHHHHhheeeeEEEeeccc
Q 042150          378 IVVGSVVGGFVLLCLVALAVLVLFKCRKK  406 (803)
Q Consensus       378 iiigvvvg~~vll~ll~l~~~~~~~~rrk  406 (803)
                      .+++.++|.+ +++++++++++++|+|++
T Consensus        13 ~Ia~~vVGvl-l~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           13 SIISAVVGIL-LVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHHHHHHHCS
T ss_pred             chHHHHHHHH-HHHHHHHHHHhheehhhh
Confidence            4556666633 333333333333344433

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.25  E-value=3.1  Score=40.60  Aligned_cols=116  Identities=8%  Similarity=0.117  Sum_probs=78.7

Q ss_pred             cCCCeeeEEeEeeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEE
Q 042150          515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNIL  594 (803)
Q Consensus       515 ~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NIL  594 (803)
                      .||++++. ..-.+.+.+.+.|+.-+++.=...+     ..++..++++++..|+....+++.     -+|--|+|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence            58888876 4556666666666654432222223     457788999999999887766654     478889999999


Q ss_pred             EccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCC
Q 042150          595 LDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVD  665 (803)
Q Consensus       595 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~  665 (803)
                      ++.++.+++.-.|+....                   +|..     .++..=.-.+=|++..+++++..|+
T Consensus       112 f~~~~~p~i~~RGik~~l-------------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVV-------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTTB-------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccCC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999988864331                   2221     1111122356788889999988775

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	803
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-70
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-65
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-60
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-57
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-50
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-50
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-20

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 3e-70
 Identities = 81/283 (28%), Positives = 131/283 (46%), Gaps = 25/283 (8%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IGSG FG VYKG    +  V +      + Q L  F+ E+ VL K RH +++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75

Query: 529 QSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDI 588
             ++ +V ++ E   L  HL+    T     + ++I    A+G+ YLH    + IIHRD+
Sbjct: 76  P-QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDL 130

Query: 589 KSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ---LTDKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190

Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           DVY+FG+VL+E++  +           +N  +  +    +G L        + K+  +  
Sbjct: 191 DVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYL-----SPDLSKVRSNCP 239

Query: 706 KKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESGSGLPR 748
           K       +CL     +RP    +L ++E    L  S   LP+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIE---LLARS---LPK 276

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 9e-65
 Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 21/274 (7%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
                   +G+G FG V+ G    +TKVAVK  +         F  E  ++ +++H+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            L     ++  + ++ EYME G L   L  P    L+  + L++    A G+ ++     
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
              IHRD+++ NIL+ +    K+ADFGL+R     +E     G K    +  PE      
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGT 186

Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI 700
            T KSDV+SFG++L E++       P +   +V      +Q  ++G    ++ P      
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERG--YRMVRPDNC--- 235

Query: 701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
             + L +       C  +   DRP+   +   LE
Sbjct: 236 -PEELYQL---MRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 3e-63
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 24/283 (8%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
           +       IGSG FG+V+ G   +  KVA+K  +        +F  E  V+ K+ H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            L G C EQ+ + LV+E+ME G L  +     R   + +  L +C+    G+ YL     
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
             +IHRD+ + N L+ EN V KV+DFG++R     D+   STG K    +  PE F   +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI 700
            + KSDV+SFGV+++EV           +  +V      ++    G    +  P+L    
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKPRLAS-- 228

Query: 701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQESG 743
               + +       C  +   DRP+   +L  L    ++ ESG
Sbjct: 229 --THVYQI---MNHCWKERPEDRPAFSRLLRQLA---EIAESG 263

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 3e-61
 Identities = 73/274 (26%), Positives = 117/274 (42%), Gaps = 21/274 (7%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
            +      +G+G FG+V  G  R    VA+K  +        EF  E  V+  + H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            L G C +Q  + ++ EYM  G L  +L    R     +Q LE+C      + YL +   
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES--- 118

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
           +  +HRD+ + N L+++  V KV+DFGLSR     DE   S G K    +  PE     +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI 700
            + KSD+++FGV+++E+        P         AE   Q  +      +  P L    
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKM--PYERFTNSETAEHIAQGLR------LYRPHLAS-- 227

Query: 701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
             + +         C  +   +RP+   +L N+ 
Sbjct: 228 --EKVYTI---MYSCWHEKADERPTFKILLSNIL 256

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  205 bits (523), Expect = 5e-61
 Identities = 74/279 (26%), Positives = 121/279 (43%), Gaps = 21/279 (7%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL 519
            +      +G G +G VY+GV +  +  VAVK  +      + EF  E  V+ +I+H +L
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKHPNL 75

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           V L+G C  +    ++ E+M  G L  +L   +R  +S    L +    +  + YL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
            +  IHRD+ + N L+ EN++ KVADFGLSR     D      G K    +  PE     
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 191

Query: 640 QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK 699
           + + KSDV++FGV+L+E+     +  P +   Q               +  +++     +
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEKDYRME 236

Query: 700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ 738
                 +K  E    C      DRPS  ++    E   Q
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  205 bits (523), Expect = 7e-61
 Identities = 75/310 (24%), Positives = 129/310 (41%), Gaps = 38/310 (12%)

Query: 452 PFT--DLQTATNNFDKNL---------IIGSGGFGMVYKGVLRDNTK----VAVKRGVPG 496
           PFT  D   A   F K +         +IG+G FG V  G L+   K    VA+K    G
Sbjct: 6   PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65

Query: 497 -SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTP 555
            + +   +F +E +++ +  H +++ L G   + + ++++ E+ME G L       +   
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQ 124

Query: 556 LSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL 615
            +  Q + +  G A G+ YL        +HRD+ + NIL++ N V KV+DFGLSR     
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 616 DETHVST---GVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ 672
                 T   G K    +  PE  + ++ T  SDV+S+G+V++EV+       P      
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTN 239

Query: 673 VNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN 732
            ++                I+        +D      +    C       RP  G ++  
Sbjct: 240 QDVINA-------------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 733 LEYALQLQES 742
           L+  ++   S
Sbjct: 287 LDKMIRNPNS 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 4e-60
 Identities = 59/281 (20%), Positives = 116/281 (41%), Gaps = 10/281 (3%)

Query: 456 LQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPE-FQTEITVLSK 513
           ++   ++F+K   +G+G  G+V+K   +     +A K      +  +      E+ VL +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
               ++V   G      E+ +  E+M+ G L + L       +  +   ++ I   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 118

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           YL       I+HRD+K +NIL++     K+ DFG+S     L ++  ++ V G+  Y+ P
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANSFV-GTRSYMSP 172

Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID 693
           E  +    + +SD++S G+ L E+   R  + P  A+E   +    ++            
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
           P           +      E          P +   +++LE
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 273

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 4e-60
 Identities = 67/296 (22%), Positives = 127/296 (42%), Gaps = 28/296 (9%)

Query: 469 IGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE 528
           IG G FG V++G  R   +VAVK       +     + EI     +RH +++  +    +
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADNK 68

Query: 529 Q----SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH-----TGS 579
                +++ LV +Y E G L  +L   +R  ++ +  +++ +  A GL +LH     T  
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET--HVSTGVKGSFGYLDPEYFR 637
              I HRD+KS NIL+ +N    +AD GL+       +T         G+  Y+ PE   
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185

Query: 638 RQ------QLTDKSDVYSFGVVLFEVLCAR----TAVDPLLAREQVNLAEWAMQWQKKGM 687
                   +   ++D+Y+ G+V +E+           D  L    +  ++ +++  +K +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245

Query: 688 LEHIIDPQLIGKI-NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES 742
            E  + P +  +  + ++L+   +   +C    G  R +   +   L   L  QE 
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS-QLSQQEG 300

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 1e-58
 Identities = 73/274 (26%), Positives = 114/274 (41%), Gaps = 21/274 (7%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
            +    + +G G FG V+ G     T+VA+K  +         F  E  V+ K+RH  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 521 SLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
            L     E+  + +V EYM KG L   L G     L   Q +++    A G+ Y+     
Sbjct: 76  QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 581 EGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQ 640
              +HRD+++ NIL+ EN V KVADFGL+R     +E     G K    +  PE     +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190

Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI 700
            T KSDV+SFG++L E+        P +   +V                  ++       
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---------------LDQVERGYRMPC 235

Query: 701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
             +  +   +   +C      +RP+   +   LE
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 1e-58
 Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 27/276 (9%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV 520
                   IG G FG V  G  R   KVAVK     +      F  E +V++++RH +LV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLV 63

Query: 521 SLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
            L+G   EE+  + +V EYM KG L  +L    R+ L     L+  +     + YL    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120

Query: 580 AEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
               +HRD+ + N+L+ E+ V+KV+DFGL++     + +      K    +  PE  R +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK 175

Query: 640 QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK 699
           + + KSDV+SFG++L+E+        P +  + V      +   +KG      D      
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPD------ 223

Query: 700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY 735
                     E  + C       RPS   +   LE+
Sbjct: 224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-58
 Identities = 67/286 (23%), Positives = 118/286 (41%), Gaps = 26/286 (9%)

Query: 455 DLQTATNNFD-KNLIIGSGGFGMVYKGVLRDNTK---VAVKRGVPGSRQG-LPEFQTEIT 509
            L    +N    ++ +G G FG V +GV R   K   VA+K    G+ +    E   E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 510 VLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAA 569
           ++ ++ + ++V L+G C+ +  ++LV E    GPL K L G  R  +      E+    +
Sbjct: 62  IMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVS 119

Query: 570 RGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS-GPCLDETHVSTGVKGSF 628
            G+ YL     +  +HRD+ + N+LL   + +K++DFGLS++ G         +  K   
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML 688
            +  PE    ++ + +SDV+S+GV ++E L       P    +   +  +  Q ++    
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQGKRMECP 234

Query: 689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
                           L         C      DRP    V   + 
Sbjct: 235 PEC----------PPELYAL---MSDCWIYKWEDRPDFLTVEQRMR 267

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 6e-58
 Identities = 77/289 (26%), Positives = 131/289 (45%), Gaps = 26/289 (8%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNT-----KVAVKRGVPGSRQG-LPEFQTEITVLSKI 514
           +   +  +IG+G FG VYKG+L+ ++      VA+K    G  +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 515 RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHY 574
            H +++ L G   +   M+++ EYME G L K L   D    S  Q + +  G A G+ Y
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKY 125

Query: 575 LHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS-GPCLDETHVSTGVKGSFGYLDP 633
           L        +HRD+ + NIL++ N V KV+DFGLSR      + T+ ++G K    +  P
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID 693
           E    ++ T  SDV+SFG+V++EV+         L+  +V                  I+
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKAIN 227

Query: 694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES 742
                   +D      +   +C       RP   D++  L+  ++  +S
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (502), Expect = 6e-58
 Identities = 77/315 (24%), Positives = 126/315 (40%), Gaps = 47/315 (14%)

Query: 453 FTDLQTATNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSRQGLP-EFQ 505
              L+   NN +    IG G FG V++            T VAVK     +   +  +FQ
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 506 TEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG--------------- 550
            E  ++++  + ++V L+G C     M L++EYM  G L + L                 
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 551 -------PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKV 603
                  P   PLS  ++L I    A G+ YL        +HRD+ + N L+ EN V K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181

Query: 604 ADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTA 663
           ADFGLSR+    D             ++ PE     + T +SDV+++GVVL+E+      
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 664 VDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDR 723
               +A E+V              + ++ D  ++     +   +       C +    DR
Sbjct: 242 PYYGMAHEEV--------------IYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADR 286

Query: 724 PSMGDVLWNLEYALQ 738
           PS   +   L+   +
Sbjct: 287 PSFCSIHRILQRMCE 301

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 2e-57
 Identities = 76/285 (26%), Positives = 133/285 (46%), Gaps = 29/285 (10%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLRDNTK----VAVKRGVPGSRQG-LPEFQTEITVLSKIRH 516
           +F++  +IG G FG VY G L DN       AVK     +  G + +F TE  ++    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 517 RHLVSLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
            +++SL+G C   +   ++V  YM+ G L ++    +    + K  +   +  A+G+ +L
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFL 146

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR--SGPCLDETHVSTGVKGSFGYLDP 633
            +   +  +HRD+ + N +LDE +  KVADFGL+R       D  H  TG K    ++  
Sbjct: 147 AS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 634 EYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID 693
           E  + Q+ T KSDV+SFGV+L+E++       P       ++  + +Q ++      ++ 
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRR------LLQ 255

Query: 694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ 738
           P+       D L +      KC       RPS  +++  +     
Sbjct: 256 PEYC----PDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIFS 293

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-56
 Identities = 64/299 (21%), Positives = 114/299 (38%), Gaps = 43/299 (14%)

Query: 468 IIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSRQG-LPEFQTEITVLSKI-RHRHL 519
            +G+G FG V +              VAVK   P +         +E+ VLS +  H ++
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYG----------------PDRTPLSWKQRLE 563
           V+L+G C      +++ EY   G L   L                   D   L  +  L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
                A+G+ +L +   +  IHRD+ + NILL    ++K+ DFGL+R         V   
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ 683
            +    ++ PE       T +SDV+S+G+ L+E+    ++  P +  +            
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----------- 255

Query: 684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES 742
                  +I           +  +  +  + C     + RP+   ++  +E   Q+ ES
Sbjct: 256 ---KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISES 309

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 9e-56
 Identities = 66/272 (24%), Positives = 110/272 (40%), Gaps = 27/272 (9%)

Query: 469 IGSGGFGMVYKGVLRD---NTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLV 523
           +GSG FG V KG  +       VAVK  +          E   E  V+ ++ + ++V ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 524 GYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGI 583
           G CE +S  +LV E  E GPL K+L       +  K  +E+    + G+ YL        
Sbjct: 75  GICEAES-WMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEE---SNF 128

Query: 584 IHRDIKSTNILLDENYVSKVADFGLSRS-GPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
           +HRD+ + N+LL   + +K++DFGLS++     +     T  K    +  PE     + +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188

Query: 643 DKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINL 702
            KSDV+SFGV+++E         P    +   +     + ++ G                
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAMLEKGERMGCPAGC----------P 236

Query: 703 DSLKKFGETAEKCLADYGVDRPSMGDVLWNLE 734
             +         C      +RP    V   L 
Sbjct: 237 REMYDL---MNLCWTYDVENRPGFAAVELRLR 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-55
 Identities = 61/271 (22%), Positives = 110/271 (40%), Gaps = 30/271 (11%)

Query: 468 IIGSGGFGMVYKGVLRD-NTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVG 524
            IG G F  VYKG+  +   +VA    +    ++     F+ E  +L  ++H ++V    
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 525 YCEEQSE----MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSA 580
             E   +    ++LV E M  G LK +L       +  K     C    +GL +LHT + 
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRT- 132

Query: 581 EGIIHRDIKSTNILL-DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQ 639
             IIHRD+K  NI +       K+ D GL+     L     +  V G+  ++ PE +  +
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMYE-E 187

Query: 640 QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK 699
           +  +  DVY+FG+ + E+  +                 ++       +   +        
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYP--------------YSECQNAAQIYRRVTSGVKPAS 233

Query: 700 INLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
            +  ++ +  E  E C+     +R S+ D+L
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 8e-55
 Identities = 62/303 (20%), Positives = 114/303 (37%), Gaps = 46/303 (15%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTK------VAVKRGVPGSRQG-LPEFQTEITVLSK 513
            N +   ++GSG FG V        +K      VAVK     +         +E+ ++++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 514 I-RHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGP--------------------- 551
           +  H ++V+L+G C     + L++EY   G L  +L                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 552 DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS 611
           D   L+++  L      A+G+ +L     +  +HRD+ + N+L+    V K+ DFGL+R 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLARE 671
                   V    +    ++ PE       T KSDV+S+G++L+E+        P +  +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 672 QVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLW 731
                              +I           + ++     + C A     RPS  ++  
Sbjct: 274 AN--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319

Query: 732 NLE 734
            L 
Sbjct: 320 FLG 322

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-54
 Identities = 79/301 (26%), Positives = 130/301 (43%), Gaps = 40/301 (13%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDN---TKVAVKR-GVPGSRQGLPEFQTEITVLSKI-R 515
           N+     +IG G FG V K  ++ +      A+KR     S+    +F  E+ VL K+  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYG--------------PDRTPLSWKQR 561
           H ++++L+G CE +  + L  EY   G L   L                   + LS +Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVS 621
           L      ARG+ YL     +  IHRD+ + NIL+ ENYV+K+ADFGLSR      +    
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183

Query: 622 TGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQ 681
           T  +    ++  E       T  SDV+S+GV+L+E++              +  AE   +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK 238

Query: 682 WQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE 741
             +   LE            L+   +  +   +C  +   +RPS   +L +L   L+ ++
Sbjct: 239 LPQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288

Query: 742 S 742
           +
Sbjct: 289 T 289

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 8e-54
 Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 26/268 (9%)

Query: 469 IGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +G G FG VYK   ++ +   A K     S + L ++  EI +L+   H ++V L+    
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
            ++ + ++ E+   G +   +   +R PL+  Q   +C      L+YLH      IIHRD
Sbjct: 80  YENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH---DNKIIHRD 135

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTD---- 643
           +K+ NIL   +   K+ADFG+S                G+  ++ PE    +   D    
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193

Query: 644 -KSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINL 702
            K+DV+S G+ L E+        P      + +    +    K     +  P        
Sbjct: 194 YKADVWSLGITLIEMAEIEP---PHHELNPMRV----LLKIAKSEPPTLAQPSRWS---- 242

Query: 703 DSLKKFGETAEKCLADYGVDRPSMGDVL 730
            + K F    +KCL      R +   +L
Sbjct: 243 SNFKDF---LKKCLEKNVDARWTTSQLL 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-53
 Identities = 62/278 (22%), Positives = 112/278 (40%), Gaps = 27/278 (9%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRH 518
           +++    IG+G +G   K   + D   +  K    GS          +E+ +L +++H +
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 519 LVSLVGYCEEQSE--MILVYEYMEKGPLKKHL--YGPDRTPLSWKQRLEICIGAARGLHY 574
           +V       +++   + +V EY E G L   +     +R  L  +  L +       L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 575 LH--TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLD 632
            H  +     ++HRD+K  N+ LD     K+ DFGL+R      +T  +    G+  Y+ 
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMS 182

Query: 633 PEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII 692
           PE   R    +KSD++S G +L+E+        P  A  Q  LA    + + + +     
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIREGKFRRIPYRYS 239

Query: 693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
                     D L +      + L      RPS+ ++L
Sbjct: 240 ----------DELNEI---ITRMLNLKDYHRPSVEEIL 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (471), Expect = 2e-53
 Identities = 67/269 (24%), Positives = 106/269 (39%), Gaps = 33/269 (12%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQG---LPEFQTEITVLSKIRHRHLVSLVG 524
           IG G FG VY    +R++  VA+K+     +Q      +   E+  L K+RH + +   G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 525 YCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGII 584
               +    LV EY              + PL   +   +  GA +GL YLH   +  +I
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLH---SHNMI 137

Query: 585 HRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR---RQQL 641
           HRD+K+ NILL E  + K+ DFG +           +    G+  ++ PE        Q 
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWMAPEVILAMDEGQY 191

Query: 642 TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKIN 701
             K DV+S G+   E+   +    PL     ++      Q +          P L     
Sbjct: 192 DGKVDVWSLGITCIELAERKP---PLFNMNAMSALYHIAQNE---------SPALQSGHW 239

Query: 702 LDSLKKFGETAEKCLADYGVDRPSMGDVL 730
            +  + F    + CL     DRP+   +L
Sbjct: 240 SEYFRNF---VDSCLQKIPQDRPTSEVLL 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 6e-53
 Identities = 68/286 (23%), Positives = 112/286 (39%), Gaps = 34/286 (11%)

Query: 451 IPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPE-FQTEI 508
           +PF +      ++D    +G G +G V   V R     VAVK          PE  + EI
Sbjct: 1   VPFVE------DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI 54

Query: 509 TVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGA 568
            +   + H ++V   G+  E +   L  EY   G L   +       +            
Sbjct: 55  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQL 112

Query: 569 ARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSF 628
             G+ YLH     GI HRDIK  N+LLDE    K++DFGL+      +   +   + G+ 
Sbjct: 113 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169

Query: 629 GYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM 687
            Y+ PE  +R++   +  DV+S G+VL  +L      D     +  +  +    W++K  
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD-----QPSDSCQEYSDWKEKKT 224

Query: 688 LEHI---IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
             +    ID   +  +             K L +    R ++ D+ 
Sbjct: 225 YLNPWKKIDSAPLALL------------HKILVENPSARITIPDIK 258

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 8e-53
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 30/274 (10%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRH 516
            +F+    +G G FG VY    +     +A+K   +          + + E+ + S +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
            +++ L GY  + + + L+ EY   G + + L     +    ++        A  L Y H
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCH 123

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
           +   + +IHRDIK  N+LL      K+ADFG S   P    +   T + G+  YL PE  
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMI 176

Query: 637 RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL 696
             +   +K D++S GV+ +E L  +   +          A    +  K+        P  
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE----------ANTYQETYKRISRVEFTFPDF 226

Query: 697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
           +     +  +       + L      RP + +VL
Sbjct: 227 VT----EGARDL---ISRLLKHNPSQRPMLREVL 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 2e-52
 Identities = 59/282 (20%), Positives = 110/282 (39%), Gaps = 26/282 (9%)

Query: 463 FDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPG-SRQGLPEFQTEITVLSKIRH 516
           F K  ++GSG FG VYKG+           VA+K      S +   E   E  V++ + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
            H+  L+G C   S + L+ + M  G L  ++          +  L  C+  A+G++YL 
Sbjct: 71  PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE 128

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
                 ++HRD+ + N+L+      K+ DFGL++     ++ + + G K    ++  E  
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 637 RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL 696
             +  T +SDV+S+GV ++E++                             +  I++   
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMT---------------FGSKPYDGIPASEISSILEKGE 230

Query: 697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ 738
                            KC       RP   +++       +
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 8e-52
 Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 26/280 (9%)

Query: 468 IIGSGGFGMVYKGVLRDN----TKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHRHLVSL 522
            IG G FG V++G+          VA+K     +   + E F  E   + +  H H+V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 523 VGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG 582
           +G   E   + ++ E    G L+  L       L     +      +  L YL +   + 
Sbjct: 74  IGVITEN-PVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLES---KR 128

Query: 583 IIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLT 642
            +HRDI + N+L+  N   K+ DFGLSR        + ++  K    ++ PE    ++ T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFT 187

Query: 643 DKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINL 702
             SDV+ FGV ++E+L     V P    +  ++       ++  M  +            
Sbjct: 188 SASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRIENGERLPMPPNC----------P 235

Query: 703 DSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQES 742
            +L        KC A     RP   ++   L   L+ +++
Sbjct: 236 PTLYSL---MTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-50
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 23/263 (8%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           IG G  G VY  + +    +VA+++     +        EI V+ + ++ ++V+ +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
              E+ +V EY+  G L   +     T +   Q   +C    + L +LH   +  +IHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRD 141

Query: 588 IKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 647
           IKS NILL  +   K+ DFG         E    + + G+  ++ PE   R+    K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 648 YSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKK 707
           +S G++  E++       P L     N           G  E     +L         + 
Sbjct: 200 WSLGIMAIEMIEGEP---PYLNE---NPLRALYLIATNGTPELQNPEKL-----SAIFRD 248

Query: 708 FGETAEKCLADYGVDRPSMGDVL 730
           F     +CL      R S  ++L
Sbjct: 249 F---LNRCLDMDVEKRGSAKELL 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-50
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 30/280 (10%)

Query: 469 IGSGGFGMVYKGVLRDNTK----VAVKR---GVPGSRQGLPEFQTEITVLSKIRHRHLVS 521
           +G G FG+V +G     +     VAVK     V    + + +F  E+  +  + HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L G       M +V E    G L   L    +            +  A G+ YL    ++
Sbjct: 76  LYGVVLTP-PMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLE---SK 130

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV-STGVKGSFGYLDPEYFRRQQ 640
             IHRD+ + N+LL    + K+ DFGL R+ P  D+ +V     K  F +  PE  + + 
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190

Query: 641 LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI 700
            +  SD + FGV L+E+          L   Q+              L  I         
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKIDKEGERLPR 236

Query: 701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ 740
             D  +       +C A    DRP+   +    ++ L+ Q
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVAL---RDFLLEAQ 273

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 5e-50
 Identities = 72/293 (24%), Positives = 127/293 (43%), Gaps = 33/293 (11%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKR-GVPGSRQGLPEFQTEITVLSK 513
                +  +G G FGMVY+GV +        T+VA+K      S +   EF  E +V+ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLY--------GPDRTPLSWKQRLEIC 565
               H+V L+G   +    +++ E M +G LK +L          P   P S  + +++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 566 IGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVK 625
              A G+ YL+   A   +HRD+ + N ++ E++  K+ DFG++R     D         
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 626 GSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKK 685
               ++ PE  +    T  SDV+SFGVVL+E+          L+ EQV            
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------------ 244

Query: 686 GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ 738
             L  +++  L+ K + +      E    C       RPS  +++ +++  ++
Sbjct: 245 --LRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  175 bits (444), Expect = 3e-49
 Identities = 58/273 (21%), Positives = 109/273 (39%), Gaps = 23/273 (8%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL 519
           +++D +  +G+G FG+V++          A K  +          + EI  +S +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 520 VSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS 579
           V+L    E+ +EM+++YE+M  G L + +   +   +S  + +E      +GL ++H   
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHE-- 142

Query: 580 AEGIIHRDIKSTNILL--DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
               +H D+K  NI+     +   K+ DFGL+     LD         G+  +  PE   
Sbjct: 143 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAE 198

Query: 638 RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI 697
            + +   +D++S GV+ + +L   +   P                         +D    
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLS---PFGGENDDETLRNVKSCDWN------MDDSAF 249

Query: 698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
             I+ +  K F     K L      R ++   L
Sbjct: 250 SGIS-EDGKDF---IRKLLLADPNTRMTIHQAL 278

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 6e-49
 Identities = 69/296 (23%), Positives = 126/296 (42%), Gaps = 42/296 (14%)

Query: 468 IIGSGGFGMVYKGVLR--------DNTKVAVKR-GVPGSRQGLPEFQTEITVLSKI-RHR 517
            +G G FG V                TKVAVK      + + L +  +E+ ++  I +H+
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLY--------------GPDRTPLSWKQRLE 563
           ++++L+G C +   + ++ EY  KG L+++L                     LS K  + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 564 ICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTG 623
                ARG+ YL    ++  IHRD+ + N+L+ E+ V K+ADFGL+R    +D    +T 
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 624 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ 683
            +    ++ PE    +  T +SDV+SFGV+L+E+     +  P +  E+           
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------- 245

Query: 684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL 739
               L  ++          +   +       C       RP+   ++ +L+  + L
Sbjct: 246 ----LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 3e-48
 Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 9/205 (4%)

Query: 462 NFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRHR 517
           +F    I+G G F  V     L  + + A+K   +        +P    E  V+S++ H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
             V L    ++  ++     Y + G L K++                       L YLH 
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLH- 125

Query: 578 GSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
              +GIIHRD+K  NILL+E+   ++ DFG ++      +   +    G+  Y+ PE   
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 638 RQQLTDKSDVYSFGVVLFEVLCART 662
            +     SD+++ G ++++++    
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLP 208

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-47
 Identities = 67/301 (22%), Positives = 119/301 (39%), Gaps = 40/301 (13%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSRQG-LPEFQTEITVLSK 513
           +       +G G FG V +              VAVK    G+         +E+ +L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 514 IRHRH-LVSLVGYC-EEQSEMILVYEYMEKGPLKKHLYGPD--------------RTPLS 557
           I H   +V+L+G C +    ++++ E+ + G L  +L                  +  L+
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 558 WKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE 617
            +  +      A+G+ +L +      IHRD+ + NILL E  V K+ DFGL+R      +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAE 677
                  +    ++ PE    +  T +SDV+SFGV+L+E+     +  P      V + E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-----GVKIDE 244

Query: 678 WAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL 737
              +  K+G      D          +  +  +T   C       RP+  +++ +L   L
Sbjct: 245 EFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

Query: 738 Q 738
           Q
Sbjct: 296 Q 296

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  167 bits (424), Expect = 2e-46
 Identities = 61/323 (18%), Positives = 123/323 (38%), Gaps = 32/323 (9%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           +GSG FG+V++ V          K             + EI++++++ H  L++L    E
Sbjct: 37  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96

Query: 528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRD 587
           ++ EM+L+ E++  G L   +   D   +S  + +     A  GL ++H      I+H D
Sbjct: 97  DKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 588 IKSTNILLDENYVS--KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS 645
           IK  NI+ +    S  K+ DFGL+     L+   +      +  +  PE   R+ +   +
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209

Query: 646 DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSL 705
           D+++ GV+ + +L   +   P    + +   +   +   +       D      ++    
Sbjct: 210 DMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKRCDWE------FDEDAFSSVS-PEA 259

Query: 706 KKFGETAEKCLADYGVDRPSMGDVL---------WNLEYALQLQESGSGLPREQREDSNT 756
           K F    +  L      R ++ D L          NL   +          + + + ++ 
Sbjct: 260 KDF---IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADW 316

Query: 757 NPPALPTRTIVPQAPSSHVREKE 779
             P      I   +     R +E
Sbjct: 317 PAPQPAIGRIANFSSLRKHRPQE 339

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-45
 Identities = 54/274 (19%), Positives = 111/274 (40%), Gaps = 27/274 (9%)

Query: 463 FDKNLI---IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRH 518
           ++K +I   +G G FG+V++ V          K  V          + EI++L+  RHR+
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRN 62

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
           ++ L    E   E+++++E++    + + +       L+ ++ +         L +LH  
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLH-- 119

Query: 579 SAEGIIHRDIKSTNILLD--ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
            +  I H DI+  NI+     +   K+ +FG +R    L        +  +  Y  PE  
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVH 175

Query: 637 RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL 696
           +   ++  +D++S G +++ +L       P LA     + E  M        E+  D + 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGIN---PFLAETNQQIIENIMNA------EYTFDEEA 226

Query: 697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
             +I+      F    ++ L      R +  + L
Sbjct: 227 FKEIS-IEAMDF---VDRLLVKERKSRMTASEAL 256

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  160 bits (406), Expect = 6e-45
 Identities = 71/285 (24%), Positives = 123/285 (43%), Gaps = 28/285 (9%)

Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR---GVPGSRQGLPEFQTEITVLSKIR 515
           ++ ++   I+G GG   V+    LR +  VAVK     +         F+ E    + + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 516 HRHLVSLVGYCEEQSE----MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARG 571
           H  +V++    E ++       +V EY++   L+  ++     P++ K+ +E+   A + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQA 123

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS-GPCLDETHVSTGVKGSFGY 630
           L++ H     GIIHRD+K  NI++      KV DFG++R+     +    +  V G+  Y
Sbjct: 124 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 631 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH 690
           L PE  R   +  +SDVYS G VL+EVL       P      V++A   ++       E 
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVAYQHVR-------ED 230

Query: 691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRP-SMGDVLWNLE 734
            I P    +     L        K LA    +R  +  ++  +L 
Sbjct: 231 PIPPSARHEGLSADLDAV---VLKALAKNPENRYQTAAEMRADLV 272

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  160 bits (406), Expect = 7e-45
 Identities = 64/286 (22%), Positives = 112/286 (39%), Gaps = 38/286 (13%)

Query: 462 NFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKR---------GVPGSRQGLPEFQTEITVL 511
           N++   I+G G   +V + +      + AVK               ++       E+ +L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 512 SKIR-HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAAR 570
            K+  H +++ L    E  +   LV++ M+KG L  +L   ++  LS K+  +I      
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLE 121

Query: 571 GLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGY 630
            +  LH      I+HRD+K  NILLD++   K+ DFG S     LD       V G+  Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSY 175

Query: 631 LDPEYFR------RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK 684
           L PE               + D++S GV+++ +L       P   R+Q+ +    M    
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSGNY 232

Query: 685 KGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
           +               + D++K       + L      R +  + L
Sbjct: 233 Q------FGSPEWDDYS-DTVKDL---VSRFLVVQPQKRYTAEEAL 268

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (400), Expect = 9e-44
 Identities = 65/276 (23%), Positives = 113/276 (40%), Gaps = 26/276 (9%)

Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHR 517
            + +D   ++G+G F  V      R    VA+K     + +G     + EI VL KI+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 518 HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHT 577
           ++V+L    E    + L+ + +  G L   +   ++   + +    +       + YLH 
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHD 125

Query: 578 GSAEGIIHRDIKSTNILL---DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPE 634
               GI+HRD+K  N+L    DE+    ++DFGLS+     D   V +   G+ GY+ PE
Sbjct: 126 ---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPE 179

Query: 635 YFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP 694
              ++  +   D +S GV+ + +LC      P        L E  ++ + +       D 
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILKAEYE------FDS 230

Query: 695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
                I+ DS K F       +      R +    L
Sbjct: 231 PYWDDIS-DSAKDF---IRHLMEKDPEKRFTCEQAL 262

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 6e-42
 Identities = 65/294 (22%), Positives = 108/294 (36%), Gaps = 29/294 (9%)

Query: 459 ATNNFDKNLIIGSGGFGMVYKGVLRDNTK--VAVK--RGVPGSRQGLPEFQTEITVLSKI 514
           A   ++    IG G +G V+K     N    VA+K  R   G          E+ VL  +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 515 ---RHRHLVSLVGYC-----EEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICI 566
               H ++V L   C     + ++++ LV+E++++     +L       +  +   ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMF 123

Query: 567 GAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKG 626
              RGL +LH+     ++HRD+K  NIL+  +   K+ADFGL+R           T V  
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVV 177

Query: 627 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC------ARTAVDPLLAREQVNLAEWAM 680
           +  Y  PE   +       D++S G +  E+          + VD L     V       
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETA----EKCLADYGVDRPSMGDVL 730
            W +   L          +     +    E       KCL      R S    L
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-41
 Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 15/228 (6%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVK---RGVPGSRQGLPEFQTEITVLSK-IR 515
            +F  + ++G G FG V+    +  N   A+K   + V      +     E  VLS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 516 HRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYL 575
           H  L  +    + +  +  V EY+  G L  H+           +          GL +L
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFL 119

Query: 576 HTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEY 635
           H+   +GI++RD+K  NILLD++   K+ADFG+ +     D         G+  Y+ PE 
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEI 174

Query: 636 FRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ 683
              Q+     D +SFGV+L+E+L  ++   P   +++  L        
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELFHSIRMDN 219

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  153 bits (388), Expect = 2e-41
 Identities = 53/231 (22%), Positives = 94/231 (40%), Gaps = 17/231 (7%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVK---RGVPGSRQGLPEFQTE---ITVLSK 513
           N+F  + IIG GGFG VY     D     A+K   +     +QG      E   ++++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 514 IRHRHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
                +V +        ++  + + M  G L  HL        S             GL 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLE 121

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
           ++H      +++RD+K  NILLDE+   +++D GL+    C           G+ GY+ P
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAP 174

Query: 634 EYFRRQQLTD-KSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ 683
           E  ++    D  +D +S G +LF++L   +       +++  +    +   
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (379), Expect = 1e-40
 Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 14/205 (6%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRH 516
            +F     +G+G FG V+    R +    A+K   + +    + +     E  +LS + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
             ++ + G  ++  ++ ++ +Y+E G L   L    R P    +     +     L YLH
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV--CLALEYLH 121

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
           +   + II+RD+K  NILLD+N   K+ DFG ++  P +  T       G+  Y+ PE  
Sbjct: 122 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVV 173

Query: 637 RRQQLTDKSDVYSFGVVLFEVLCAR 661
             +      D +SFG++++E+L   
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGY 198

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-40
 Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 25/281 (8%)

Query: 468 IIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPE-----FQTEITVLSKIRHRHLVS 521
            +G G F  VYK   +  N  VA+K+   G R    +        EI +L ++ H +++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L+     +S + LV+++ME       +   +   L+        +   +GL YLH     
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 582 GIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL 641
            I+HRD+K  N+LLDEN V K+ADFGL++S          T    +  Y  PE     ++
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 642 TD-KSDVYSFGVVLFEVLC------ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP 694
                D+++ G +L E+L         + +D L    +        QW     L   +  
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 695 QLIGKINLDSL-KKFGETA----EKCLADYGVDRPSMGDVL 730
           +    I L  +    G+      +         R +    L
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-40
 Identities = 73/322 (22%), Positives = 123/322 (38%), Gaps = 42/322 (13%)

Query: 430 SKMSEGTVNASPGQNGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLRD-NTKV 488
           SK++  TV A+PGQ      ++ +TD +          +IG+G FG+VY+  L D    V
Sbjct: 1   SKVT--TVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELV 48

Query: 489 AVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSE------MILVYEYMEKG 542
           A+K+      Q       E+ ++ K+ H ++V L  +     E      + LV +Y+ + 
Sbjct: 49  AIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET 104

Query: 543 PLKKHL-YGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYV 600
             +    Y   +  L             R L Y+H   + GI HRDIK  N+LLD +  V
Sbjct: 105 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAV 161

Query: 601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA 660
            K+ DFG ++    +      + +   +       F     T   DV+S G VL E+L  
Sbjct: 162 LKLCDFGSAKQ--LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

Query: 661 R------TAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAE- 713
           +      + VD L+   +V       Q ++            I       + +     E 
Sbjct: 220 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA 279

Query: 714 -----KCLADYGVDRPSMGDVL 730
                + L      R +  +  
Sbjct: 280 IALCSRLLEYTPTARLTPLEAC 301

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-40
 Identities = 58/284 (20%), Positives = 110/284 (38%), Gaps = 20/284 (7%)

Query: 462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRH 518
           NF K   IG G +G+VYK   +     VA+K  R    +         EI++L ++ H +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
           +V L+     ++++ LV+E++ +  LKK +     T +             +GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
            +  ++HRD+K  N+L++     K+ADFGL+R+         +  V   +          
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGC 177

Query: 639 QQLTDKSDVYSFGVVLFEVLCAR------TAVDPLLAREQVNLAEWAMQWQKKGMLEHII 692
           +  +   D++S G +  E++  R      + +D L    +       + W     +    
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 693 D--PQLIGKINLDSLKKFGETA----EKCLADYGVDRPSMGDVL 730
              P+   +     +    E       + L      R S    L
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  148 bits (373), Expect = 3e-40
 Identities = 46/290 (15%), Positives = 94/290 (32%), Gaps = 28/290 (9%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHR-H 518
            ++     IG G FG++++G  L +N +VA+K      R   P+ + E      +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTG 62

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
           + ++  + +E    +LV + +  GP  + L        S K            +  +H  
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-- 118

Query: 579 SAEGIIHRDIKSTNILLDENYVS-----KVADFGLSR-----SGPCLDETHVSTGVKGSF 628
             + +++RDIK  N L+            V DFG+ +                  + G+ 
Sbjct: 119 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 629 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML 688
            Y+       ++ + + D+ + G V    L        L A             QK   +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---------NKQKYERI 228

Query: 689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ 738
                   + ++     ++F +             P    +       L+
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (373), Expect = 4e-40
 Identities = 45/280 (16%), Positives = 95/280 (33%), Gaps = 26/280 (9%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCE 527
           IGSG FG +Y G  +    +VA+K     ++   P+   E  +   ++    +  + +C 
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 72

Query: 528 EQSEM-ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHR 586
            + +  ++V E +         +       S K  L +       + Y+H   ++  IHR
Sbjct: 73  AEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 127

Query: 587 DIKSTNIL---LDENYVSKVADFGLSR-----SGPCLDETHVSTGVKGSFGYLDPEYFRR 638
           D+K  N L     +  +  + DFGL++               +  + G+  Y        
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187

Query: 639 QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG 698
            + + + D+ S G VL            L A  +        ++++    +     +++ 
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR------QKYERISEKKMSTPIEVLC 241

Query: 699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ 738
           K        +      C +    D+P    +         
Sbjct: 242 KGYPSEFATY---LNFCRSLRFDDKPDYSYLRQLFRNLFH 278

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 6e-40
 Identities = 53/272 (19%), Positives = 105/272 (38%), Gaps = 29/272 (10%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGY 525
           ++G G  G V +    R   K A+K       Q  P+ + E+ +  +  +  H+V +V  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 526 CE----EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
            E     +  +++V E ++ G L   +        + ++  EI       + YLH   + 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 582 GIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
            I HRD+K  N+L      N + K+ DFG ++        +  T    +  Y+ PE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGP 187

Query: 639 QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG 698
           ++     D++S GV+++ +LC      P  +   + ++       + G  E    P    
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEF---PNPEW 241

Query: 699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
               + +K         L      R ++ + +
Sbjct: 242 SEVSEEVKML---IRNLLKTEPTQRMTITEFM 270

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 1e-39
 Identities = 66/293 (22%), Positives = 106/293 (36%), Gaps = 28/293 (9%)

Query: 460 TNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPE-FQTEITVLSKIRHR 517
              +     IG G +GMV       +  +VA+K+  P   Q   +    EI +L + RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 518 HLVSLVGYCE----EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
           +++ +         EQ + + +  ++    L K L       LS            RGL 
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLK 123

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS-GPCLDETHVSTGVKGSFGYLD 632
           Y+H+     ++HRD+K +N+LL+     K+ DFGL+R   P  D T   T    +  Y  
Sbjct: 124 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180

Query: 633 PEYFRRQQLTDKS-DVYSFGVVLFEVLCARTAVDPLLAREQVNL----------AEWAMQ 681
           PE     +   KS D++S G +L E+L  R         +Q+N            +    
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240

Query: 682 WQKKGMLEHIIDPQLIGKINLDSLKKFGETA----EKCLADYGVDRPSMGDVL 730
              K     +  P                 A    +K L      R  +   L
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 3e-39
 Identities = 61/273 (22%), Positives = 118/273 (43%), Gaps = 32/273 (11%)

Query: 469 IGSGGFGMVYKGV-LRDNTKVAVK----RGVPGSRQGLP--EFQTEITVLSKIRHRHLVS 521
           +GSG F +V K        + A K    R    SR+G+   + + E+++L +I+H ++++
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 522 LVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAE 581
           L    E ++++IL+ E +  G L   L   ++  L+ ++  E       G++YLH+    
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHS---L 132

Query: 582 GIIHRDIKSTNILLDENYVS----KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
            I H D+K  NI+L +  V     K+ DFGL+     +D  +    + G+  ++ PE   
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAPEIVN 189

Query: 638 RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI 697
            + L  ++D++S GV+ + +L       P L   +            +       + +  
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVSAVNYE------FEDEYF 240

Query: 698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
              +    K F     + L      R ++ D L
Sbjct: 241 SNTS-ALAKDF---IRRLLVKDPKKRMTIQDSL 269

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  144 bits (364), Expect = 4e-39
 Identities = 52/284 (18%), Positives = 101/284 (35%), Gaps = 20/284 (7%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRH 518
             +     IG G +G+VYK         A+K  R              EI++L +++H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
           +V L      +  ++LV+E++++   K          L         +    G+ Y H  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH-- 117

Query: 579 SAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRR 638
               ++HRD+K  N+L++     K+ADFGL+R+   +     +  +   +          
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 639 QQLTDKSDVYSFGVVLFEVLCAR------TAVDPLLAREQVNLAEWAMQWQKKGMLEHII 692
           ++ +   D++S G +  E++         +  D L+   ++     +  W     L    
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 693 D--PQLIGKINLDSLKKFGETA----EKCLADYGVDRPSMGDVL 730
                         LK   E+      K L      R +    L
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-38
 Identities = 65/274 (23%), Positives = 109/274 (39%), Gaps = 42/274 (15%)

Query: 468 IIGSGGFGMVYKGV-LRDNTKVAVKR------GVPGSRQGLPEFQTEITVLSKIRHRH-- 518
           ++GSGGFG VY G+ + DN  VA+K          G          E+ +L K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 519 LVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG 578
           ++ L+ + E     +L+ E  E           +R  L  +            + + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHN- 128

Query: 579 SAEGIIHRDIKSTNILLDEN-YVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFR 637
              G++HRDIK  NIL+D N    K+ DFG       L +  V T   G+  Y  PE+ R
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDGTRVYSPPEWIR 182

Query: 638 RQQLTDKS-DVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL 696
             +   +S  V+S G++L++++C      P    E++   +   + +     +H+I    
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDI---PFEHDEEIIRGQVFFRQRVSSECQHLI---- 235

Query: 697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVL 730
                             CLA    DRP+  ++ 
Sbjct: 236 ----------------RWCLALRPSDRPTFEEIQ 253

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-37
 Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 11/206 (5%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRH 516
           N+FD   ++G G FG V            A+K   + V  ++  +    TE  VL   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
             L +L    +    +  V EY   G L  HL        + ++           L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLH 122

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
           +     +++RDIK  N++LD++   K+ DFGL + G     T       G+  YL PE  
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVL 177

Query: 637 RRQQLTDKSDVYSFGVVLFEVLCART 662
                    D +  GVV++E++C R 
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 7e-37
 Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 22/278 (7%)

Query: 469 IGSGGFGMVYKGVLR-DNTKVAVK--RGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGY 525
           IG G +G V+K   R  +  VA+K  R              EI +L +++H+++V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH 585
                ++ LV+E+ ++       +      L  +          +GL + H+     ++H
Sbjct: 70  LHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLH 124

Query: 586 RDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKS 645
           RD+K  N+L++ N   K+A+FGL+R+   +     S  V   +       F  +  +   
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 646 DVYSFGVVLFEVLC-------ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG 698
           D++S G +  E+              D L    ++       QW     L       +  
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 699 KIN--LDSLKKFGETA----EKCLADYGVDRPSMGDVL 730
                ++ + K   T     +  L    V R S  + L
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (348), Expect = 3e-36
 Identities = 48/227 (21%), Positives = 88/227 (38%), Gaps = 17/227 (7%)

Query: 461 NNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK---RGVPGSRQGLPEFQTEITVLSKIRH 516
           + FD+   +G+G FG V            A+K   +      + +     E  +L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 517 RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLH 576
             LV L    ++ S + +V EY+  G +  HL        S                YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 577 TGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYF 636
              +  +I+RD+K  N+L+D+    +V DFG ++       T     + G+   L PE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEII 210

Query: 637 RRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ 683
             +      D ++ GV+++E+        P  A + + + E  +  +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVSGK 254

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-36
 Identities = 65/311 (20%), Positives = 123/311 (39%), Gaps = 37/311 (11%)

Query: 449 LKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQG--LPEFQ 505
           ++ PF D     + ++K   IG G FG V+K   R    KVA+K+ +  + +        
Sbjct: 1   VECPFCD---EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 57

Query: 506 TEITVLSKIRHRHLVSLVGYCEEQSE--------MILVYEYMEKGPLKKHLYGPDRTPLS 557
            EI +L  ++H ++V+L+  C  ++         + LV+++ E                +
Sbjct: 58  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFT 115

Query: 558 WKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE 617
             +   +      GL+Y+H      I+HRD+K+ N+L+  + V K+ADFGL+R+      
Sbjct: 116 LSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 172

Query: 618 THVS--TGVKGSFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN 674
           +  +  T    +  Y  PE    ++      D++  G ++ E+      +     + Q+ 
Sbjct: 173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232

Query: 675 LAEWAMQWQKKGMLEHIIDPQLIGKINL---------DSLKKFGETAE------KCLADY 719
           L           +  ++ + +L  K+ L         D LK +           K L   
Sbjct: 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292

Query: 720 GVDRPSMGDVL 730
              R    D L
Sbjct: 293 PAQRIDSDDAL 303

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 3e-34
 Identities = 64/309 (20%), Positives = 116/309 (37%), Gaps = 35/309 (11%)

Query: 445 GYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGL 501
           G++R ++  T  +     +     +GSG +G V   V  R   KVA+K       S    
Sbjct: 3   GFYRQEVTKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61

Query: 502 PEFQTEITVLSKIRHRHLVSLVGYCEEQS------EMILVYEYMEKGPLKKHLYGPDRTP 555
                E+ +L  +RH +++ L+             +  LV  +M     K          
Sbjct: 62  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM----KHEK 117

Query: 556 LSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL 615
           L   +   +     +GL Y+H   A GIIHRD+K  N+ ++E+   K+ DFGL+R     
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--- 171

Query: 616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART--------AVDPL 667
            ++ ++  V   +           + T   D++S G ++ E++  +T             
Sbjct: 172 -DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230

Query: 668 LAREQVNLAEWAMQWQKKGMLEHIID--PQLIGKINLDSLKKFGETA----EKCLADYGV 721
           + +         +Q  +    ++ +   P+L  K     L      A    EK L     
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290

Query: 722 DRPSMGDVL 730
            R + G+ L
Sbjct: 291 QRVTAGEAL 299

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  124 bits (311), Expect = 1e-31
 Identities = 55/312 (17%), Positives = 120/312 (38%), Gaps = 45/312 (14%)

Query: 446 YHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLPEF 504
           Y    + + +     +++     +G G +  V++ + + +N KV VK   P  ++   + 
Sbjct: 24  YESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KI 76

Query: 505 QTEITVLSKIR-HRHLVSLVGYCEEQSE--MILVYEYMEKGPLKKHLYGPDRTPLSWKQR 561
           + EI +L  +R   ++++L    ++       LV+E++     K+         L+    
Sbjct: 77  KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDI 131

Query: 562 LEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFGLSRSGPCLDETHV 620
                   + L Y H+    GI+HRD+K  N+++D E+   ++ D+GL+           
Sbjct: 132 RFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQE 185

Query: 621 STGVKGSFGYLDPEYFRRQQLTD-KSDVYSFGVVLFEVLCAR-------TAVDPLLAREQ 672
                 S  +  PE     Q+ D   D++S G +L  ++  +          D L+   +
Sbjct: 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245

Query: 673 VNLAEWAMQWQKKGMLEHIID-PQLIGKINLDSLKKFGETA-------------EKCLAD 718
           V   E    +  K  +E       ++G+ +    ++F  +              +K L  
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305

Query: 719 YGVDRPSMGDVL 730
               R +  + +
Sbjct: 306 DHQSRLTAREAM 317

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-30
 Identities = 48/228 (21%), Positives = 98/228 (42%), Gaps = 21/228 (9%)

Query: 444 NGYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQG 500
           N ++ +++      T    +     IGSG  G+V        +  VA+K       ++  
Sbjct: 1   NQFYSVEV-GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 59

Query: 501 LPEFQTEITVLSKIRHRHLVSLVGYC------EEQSEMILVYEYMEKGPLKKHLYGPDRT 554
                 E+ ++  + H++++SL+         EE  ++ LV E M+    +       + 
Sbjct: 60  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-----QM 114

Query: 555 PLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC 614
            L  ++   +      G+ +LH   + GIIHRD+K +NI++  +   K+ DFGL+R+   
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-- 169

Query: 615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
              + + T    +  Y  PE        +  D++S G ++ E++  + 
Sbjct: 170 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 7e-30
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 17/213 (7%)

Query: 461 NNFDKNLIIGSGGFGMVYKGVL----RDNTKVAVK----RGVPGSRQGLPEFQTEITVLS 512
            NF+   ++G+G +G V+              A+K      +    +     +TE  VL 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 513 KIRHR-HLVSLVGYCEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARG 571
            IR    LV+L    + ++++ L+ +Y+  G L  HL   +R          + I     
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138

Query: 572 LHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYL 631
           +  L      GII+RDIK  NILLD N    + DFGLS+     DET  +    G+  Y+
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYM 197

Query: 632 DPEYFRRQQ--LTDKSDVYSFGVVLFEVLCART 662
            P+  R          D +S GV+++E+L   +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 3e-28
 Identities = 44/223 (19%), Positives = 85/223 (38%), Gaps = 13/223 (5%)

Query: 445 GYHRLKIPFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVK--RGVPGSRQGL 501
            ++R ++    +      +     +GSG +G V      +   +VAVK       S    
Sbjct: 3   TFYRQEL-NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 502 PEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY--MEKGPLKKHLYGPDRTPLSWK 559
                E+ +L  ++H +++ L+        +    +   +                L+  
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121

Query: 560 QRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH 619
               +     RGL Y+H   +  IIHRD+K +N+ ++E+   K+ DFGL+R        +
Sbjct: 122 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178

Query: 620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART 662
           V+T     +                 D++S G ++ E+L  RT
Sbjct: 179 VAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (277), Expect = 5e-27
 Identities = 46/257 (17%), Positives = 89/257 (34%), Gaps = 26/257 (10%)

Query: 446 YHRLKI--PFTDLQTATNNFDKNLIIGSGGFGMVYKGV-LRDNTKVAVKRGVPGSRQGLP 502
           YH      P+ D       +     +G G F  V+    + +NT VA+K  V G +    
Sbjct: 1   YHPAFKGEPYKD-----ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTE 54

Query: 503 EFQTEITVLSKIRH-----------RHLVSLVGYCEEQSEMILVYEYMEKGPLKKHLY-- 549
             + EI +L ++              H++ L+ +   +    +    + +   +  L   
Sbjct: 55  AAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI 114

Query: 550 -GPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD-ENYVSKVADFG 607
              +   +      +I      GL Y+H     GIIH DIK  N+L++  +    +    
Sbjct: 115 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIK 172

Query: 608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPL 667
           ++  G         T    +  Y  PE          +D++S   ++FE++      +P 
Sbjct: 173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232

Query: 668 LAREQVNLAEWAMQWQK 684
                    +   Q  +
Sbjct: 233 EGHSYTKDDDHIAQIIE 249

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.4 bits (213), Expect = 5e-20
 Identities = 35/202 (17%), Positives = 60/202 (29%), Gaps = 44/202 (21%)

Query: 468 IIGSGGFGMVYKGVLRDNTKVAVKRGVPGSR----------QGLPEFQTEITVLSKIRHR 517
           ++G G    V+        +  VK    G             G   F       ++   R
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 518 HLVSLVGYCE----EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLH 573
            L  L G             ++ E ++   L +            +   E+       + 
Sbjct: 67  ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVA 117

Query: 574 YLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDP 633
             +     GI+H D+   N+L+ E  +  + DF  S          V  G +G    L+ 
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQS----------VEVGEEGWREILER 163

Query: 634 ------EYFRRQQLTDKSDVYS 649
                  YF R   T + D+ S
Sbjct: 164 DVRNIITYFSRTYRT-EKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	803
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.46
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.93
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.43
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.76
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.5
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.35
d2o14a1	146	Hypothetical protein YxiM {Bacillus subtilis [TaxI	96.15
d2o14a1	146	Hypothetical protein YxiM {Bacillus subtilis [TaxI	95.19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=424.72  Aligned_cols=261  Identities=31%  Similarity=0.521  Sum_probs=205.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|...+.||+|+||+||+|+++  ..||||++...  ..+..+.|.+|+++|++++|||||+++|++.+ +.++||||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            457888899999999999999865  36999987543  34456789999999999999999999999865 56899999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++|+|.+++... ...+++.+++.|+.|||+||+|||+   ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus        84 y~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          84 WCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            99999999999643 3569999999999999999999999   8999999999999999999999999999987544333


Q ss_pred             CceeccccCCCcccCcccccc---CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          618 THVSTGVKGSFGYLDPEYFRR---QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ........||+.|||||++.+   ..++.++|||||||+||||+||+.||.........      ......+.    ..|
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~~~~~----~~p  229 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRGY----LSP  229 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHHTS----CCC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCC----CCC
Confidence            344456789999999999864   35899999999999999999999999754332221      11111111    111


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      .+ ...+..+++.+.+|+.+||+.+|.+|||+.||+++|+.+.+
T Consensus       230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            11 12333456788999999999999999999999999997764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=419.41  Aligned_cols=256  Identities=31%  Similarity=0.447  Sum_probs=202.1

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ++|...+.||+|+||+||+|.+.+++.||||++.. .....++|.+|++++++++||||++++|+|.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            46777889999999999999999889999999764 34456889999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|+|.+++.. ....++|..++.++.|||+||+|||+   ++|+||||||+||||++++.+||+|||+++...... ...
T Consensus        84 ~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  158 (263)
T ss_dssp             TCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCC-cee
Confidence            9999999854 34568999999999999999999999   999999999999999999999999999998643322 222


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhC-CCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA-RTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....||+.|||||++.+..++.++|||||||+||||+|+ ++|+......+   +.+.+    ..+.  .       ..
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i----~~~~--~-------~~  222 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDI----STGF--R-------LY  222 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHH----HHTC--C-------CC
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HhcC--C-------CC
Confidence            3345789999999999999999999999999999999995 55544322111   11111    1110  0       11


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      .+..+++++.+++.+||+.||.+||||+||+++|+++.+
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            122345678999999999999999999999999998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.1e-50  Score=424.93  Aligned_cols=257  Identities=25%  Similarity=0.417  Sum_probs=199.2

Q ss_pred             CCccceEeeeCceEEEEEEECC-C---cEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          463 FDKNLIIGSGGFGMVYKGVLRD-N---TKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       463 f~~~~~Lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      |+..++||+|+||+||+|.++. +   ..||||++... .....++|.+|+++|++++|||||+++|+|.+.+.+++|||
T Consensus        28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E  107 (299)
T d1jpaa_          28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE  107 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            4456789999999999999753 2   35888886543 33345689999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      ||++|+|.+++.. ....++|.+++.++.|||+||+|||+   ++|+||||||+||||+.++++||+|||+++.......
T Consensus       108 y~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         108 FMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             CCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             ecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            9999999998854 34569999999999999999999999   9999999999999999999999999999986433221


Q ss_pred             Cc---eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          618 TH---VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       618 ~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ..   ......+|+.|||||.+.++.++.++|||||||+||||+| |+.||......+   +...+    ..+       
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i----~~~-------  249 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAI----EQD-------  249 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH----HTT-------
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC-------
Confidence            11   1223457899999999999999999999999999999998 899987543322   11111    111       


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                        .....+.+++..+.+|+.+||+.+|.+||||.||++.|+.+++-
T Consensus       250 --~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         250 --YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence              01122344567889999999999999999999999999988753

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-50  Score=420.15  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=210.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .++|...+.||+|+||+||+|.+++++.||||++... ....++|.+|+++|++++|||||+++|+|.+ +..+|||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            4578888899999999999999998899999987643 4456789999999999999999999998865 5679999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+++.......++|.++++|+.|||+||+|||+   ++|+||||||+||||++++.+||+|||+|+.... ....
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~-~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS-SCEE
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC-Cccc
Confidence            99999998865555579999999999999999999999   9999999999999999999999999999986442 2223


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......||+.|||||++.++.++.++|||||||+||||+||..|+.......  .+..   . ...+.         ...
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~---~-i~~~~---------~~~  230 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQ---N-LERGY---------RMV  230 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH---H-HHTTC---------CCC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHH---H-HHhcC---------CCC
Confidence            3345678999999999999999999999999999999999665543222111  1111   1 11110         111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      .+...+..+.+|+.+||+.+|.+||||+||++.|+...
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            22344567899999999999999999999999998654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.8e-50  Score=424.13  Aligned_cols=258  Identities=29%  Similarity=0.419  Sum_probs=215.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-CcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-NTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .++|...+.||+|+||+||+|+++. ++.||||++... ....++|.+|+++|++++|||||+++|+|.+++..+|||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            4568888899999999999999864 889999987543 44578899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.+++.......+++..++.|+.|||+||+|||+   ++|+||||||+||||++++.+||+|||+|+.... +..
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~-~~~  170 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTY  170 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS-SSS
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCC-CCc
Confidence            999999999976667789999999999999999999999   8999999999999999999999999999986443 233


Q ss_pred             ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      .......|++.|||||++.+..++.++|||||||+||||++|..|+........  +.+    ....+         ...
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~----~i~~~---------~~~  235 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE----LLEKD---------YRM  235 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH----HHHTT---------CCC
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHH----HHhcC---------CCC
Confidence            334456689999999999999999999999999999999997776543222111  111    11111         111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      ..+...+..+.+|+.+||+.||.+||||+||++.|+.+.
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            233345677899999999999999999999999988764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=416.28  Aligned_cols=253  Identities=25%  Similarity=0.320  Sum_probs=204.1

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|+..+.||+|+||+||+|+.+ +++.||||++.... ....++|.+|+++|++++||||+++++++.+++..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            46888999999999999999975 58999999865432 33446799999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +++|+|.++|.  ....+++.++..++.||++||+|||+   ++|+||||||+|||+++++.+||+|||+|+........
T Consensus        85 ~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          85 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999999994  45679999999999999999999999   99999999999999999999999999999864433333


Q ss_pred             ceeccccCCCcccCccccccCcC-CCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      .......||+.|||||++.+..+ +.++|||||||+||||++|+.||......... ...    ......         .
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~----~~~~~~---------~  225 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD----WKEKKT---------Y  225 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHH----HHTTCT---------T
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHH----HhcCCC---------C
Confidence            33456789999999999988876 56899999999999999999999654322111 111    111100         0


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .......+..+.+|+.+||+.||.+|||++|++++
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            01112334677899999999999999999999764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-49  Score=408.73  Aligned_cols=246  Identities=24%  Similarity=0.376  Sum_probs=206.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|...+.||+|+||+||+|+.+ +++.||+|++...   .....+.+.+|+++|++++||||+++++++.+++..+|||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888999999999999999986 5889999986422   3345678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.  ....+++.++..++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+|+....  
T Consensus        86 Ey~~~g~L~~~l~--~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--  158 (263)
T d2j4za1          86 EYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--  158 (263)
T ss_dssp             ECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--
T ss_pred             eecCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC--
Confidence            9999999999994  34569999999999999999999999   9999999999999999999999999999986432  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                        .......||+.|||||++.+..++.++|||||||+||||++|+.||......+..      .. .....         
T Consensus       159 --~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~-i~~~~---------  220 (263)
T d2j4za1         159 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------KR-ISRVE---------  220 (263)
T ss_dssp             --CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HH-HHTTC---------
T ss_pred             --CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH------HH-HHcCC---------
Confidence              1233467999999999999999999999999999999999999999754322211      11 11111         


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                       ..++...++.+.+++.+||+.||.+|||++|++++
T Consensus       221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence             11223345678999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=404.14  Aligned_cols=253  Identities=28%  Similarity=0.412  Sum_probs=212.2

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ++|+..++||+|+||+||+|++++++.||||++... ....++|++|+.++++++||||++++|+|.+++.+++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            578888999999999999999998899999987643 4456889999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|+|.+++.. ....+++..+++++.|+|+||+|||+   .+|+||||||+|||+++++.+||+|||+++..... ....
T Consensus        83 ~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~  157 (258)
T d1k2pa_          83 NGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS  157 (258)
T ss_dssp             TEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred             CCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCC-Ccee
Confidence            9999999754 34568999999999999999999999   99999999999999999999999999999864432 2223


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+..      .. ...+.         ...
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~------~~-i~~~~---------~~~  221 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EH-IAQGL---------RLY  221 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HH-HHTTC---------CCC
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH------HH-HHhCC---------CCC
Confidence            344678999999999999999999999999999999998 89998755432211      11 11111         011


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      .+...+..+.+++.+||+.+|.+|||+.+++++|..
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            223344678999999999999999999999999853

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=412.56  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=209.0

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      ++|...+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++||||+++++++.+.+.++|||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            46899999999999999999964 58999999876555566788999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+++.   ...+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+....  ...
T Consensus       100 ~gg~L~~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~  171 (293)
T d1yhwa1         100 AGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQS  171 (293)
T ss_dssp             TTCBHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTC
T ss_pred             CCCcHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccc
Confidence            9999999884   3469999999999999999999999   9999999999999999999999999999986432  222


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      ......||+.|||||++.+..++.++|||||||+||||++|+.||......+..      ........      +.+  .
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~~~~~~~------~~~--~  237 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGT------PEL--Q  237 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHHCS------CCC--S
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH------HHHHhCCC------CCC--C
Confidence            334567999999999999999999999999999999999999999754332211      11111111      000  1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .+...+..+.+++.+||+.||.+|||+.|++++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            223445678999999999999999999999865

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=420.76  Aligned_cols=258  Identities=23%  Similarity=0.370  Sum_probs=208.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC-C-----cEEEEEEcCCC-CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD-N-----TKVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~  531 (803)
                      .++|...++||+|+||+||+|++.. +     ..||||++... .......|.+|+.+|.++ +|||||+++++|.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3578888999999999999999753 2     36899986543 344567899999999998 89999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCc
Q 042150          532 MILVYEYMEKGPLKKHLYGPD---------------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKS  590 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp  590 (803)
                      ++|||||+++|+|.++|+...                     ...+++.+++.++.||++||+|||+   ++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence            999999999999999996532                     1358999999999999999999999   9999999999


Q ss_pred             ceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchh
Q 042150          591 TNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLA  669 (803)
Q Consensus       591 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~  669 (803)
                      +|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999986544344444456678999999999999999999999999999999997 8999875432


Q ss_pred             hhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042150          670 REQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEY  735 (803)
Q Consensus       670 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~  735 (803)
                      ...  +..    ....+         .....+..+++.+.+|+.+||+.+|.+|||++||+++|..
T Consensus       273 ~~~--~~~----~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         273 DAN--FYK----LIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             SHH--HHH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHH--HHH----HHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            221  111    11111         1112333456788999999999999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=411.68  Aligned_cols=262  Identities=29%  Similarity=0.450  Sum_probs=203.8

Q ss_pred             cCCCccceEeeeCceEEEEEEECCC-----cEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDN-----TKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      ..|...++||+|+||.||+|.++..     ..||||++..... ....+|.+|+++|++++|||||+++|+|.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            3577788999999999999997642     4699998754432 334579999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+.+|+|.+++.. ....++|.+++.++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+++....
T Consensus        87 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            9999999999988743 34569999999999999999999999   9999999999999999999999999999986433


Q ss_pred             CCC-CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDE-THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ... ........||+.|||||++.++.++.++|||||||+||||++|..|+.......  .+..   . ...+       
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~~---~-i~~~-------  229 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMK---A-INDG-------  229 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH---H-HHTT-------
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHHH---H-Hhcc-------
Confidence            222 222334568999999999999999999999999999999999766654322111  1111   1 1111       


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhhc
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQE  741 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~  741 (803)
                        .....+..++..+.+|+.+||+.+|.+||||.||++.|+.+.+.++
T Consensus       230 --~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~  275 (283)
T d1mqba_         230 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  275 (283)
T ss_dssp             --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             --CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence              1122334456778999999999999999999999999998876543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=407.68  Aligned_cols=248  Identities=27%  Similarity=0.390  Sum_probs=198.9

Q ss_pred             ceEeeeCceEEEEEEECC---CcEEEEEEcCCCCCC--ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecCC
Q 042150          467 LIIGSGGFGMVYKGVLRD---NTKVAVKRGVPGSRQ--GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYMEK  541 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~  541 (803)
                      ++||+|+||+||+|.+++   ++.||||++......  ..++|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998753   467999987543322  34679999999999999999999999965 457899999999


Q ss_pred             CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC-ce
Q 042150          542 GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET-HV  620 (803)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~  620 (803)
                      |+|.+++.  ....+++.+++.++.|||+||+|||+   ++|+||||||+||||+.++.+||+|||+++........ ..
T Consensus        92 g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            99999994  34569999999999999999999999   89999999999999999999999999999864432222 22


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGK  699 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  699 (803)
                      .....||+.|||||.+.+..++.++|||||||+||||+| |+.||......+   +..    ....+.         ...
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~----~i~~~~---------~~~  230 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTA----MLEKGE---------RMG  230 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH----HHHTTC---------CCC
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHH----HHHcCC---------CCC
Confidence            234578999999999999999999999999999999998 899997543222   111    111111         112


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          700 INLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       700 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                      .+..++..+.+|+.+||+.||.+|||+++|++.|+..
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            2334567889999999999999999999999888765

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-48  Score=407.70  Aligned_cols=257  Identities=25%  Similarity=0.414  Sum_probs=207.4

Q ss_pred             cCCCccc-eEeeeCceEEEEEEEC---CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNL-IIGSGGFGMVYKGVLR---DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~-~Lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ++|.... +||+|+||+||+|.++   ++..||||++..... ...++|.+|+++|++++|||||+++|+|.. +.++||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            3455555 4999999999999864   355799998765432 335789999999999999999999999975 468999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++|+|.+++.. .+..+++.++++++.|||+||+|||+   ++|+||||||+||||+.++.+||+|||+++.....
T Consensus        87 mE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            999999999998843 34579999999999999999999999   99999999999999999999999999999864432


Q ss_pred             CCC-ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          616 DET-HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       616 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ... .......||+.|||||++.++.++.++|||||||+||||+| |+.||......+   +.    .....+..     
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~----~~i~~~~~-----  230 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKR-----  230 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTTCC-----
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCC-----
Confidence            222 22234568999999999999999999999999999999998 899997543222   11    11122211     


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                          ...+..++.++.+|+.+||+.+|.+|||+.+|++.|+....
T Consensus       231 ----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         231 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                12334456788999999999999999999999999987653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-48  Score=408.87  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=207.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      +.|+..+.||+|+||+||+|+.. +++.||||++........+.|.+|+++|++++|||||++++++.+.+.++|||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            35788889999999999999975 58899999977666667788999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.+++.. ....+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+....  ...
T Consensus        92 ~~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~  165 (288)
T d2jfla1          92 AGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQ  165 (288)
T ss_dssp             TTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHH
T ss_pred             CCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCC--Ccc
Confidence            99999998743 23569999999999999999999999   9999999999999999999999999999875221  111


Q ss_pred             eeccccCCCcccCccccc-----cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          620 VSTGVKGSFGYLDPEYFR-----RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                      ......||+.|||||++.     +..++.++|||||||+||||++|+.||......+..      ..... +....+   
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~i~~-~~~~~~---  235 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LKIAK-SEPPTL---  235 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHH-SCCCCC---
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HHHHc-CCCCCC---
Confidence            233567999999999984     567899999999999999999999999754332211      11111 111111   


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                          ..+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus       236 ----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         236 ----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             ----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ----CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                1123445678999999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=407.36  Aligned_cols=256  Identities=29%  Similarity=0.422  Sum_probs=205.0

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEecC
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYME  540 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~  540 (803)
                      ++|...+.||+|+||+||+|++++++.||||++.. .....++|.+|+.+|++++|||||+++|+|.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECc-ccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            57888999999999999999999888999999754 44556889999999999999999999999965 56899999999


Q ss_pred             CCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCce
Q 042150          541 KGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETHV  620 (803)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  620 (803)
                      +|+|..++.......++|.+++.++.|||.||+|||+   ++|+||||||+||||++++++||+|||+++.... .....
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~-~~~~~  170 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTA  170 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccC-CCcee
Confidence            9999999865555679999999999999999999999   8999999999999999999999999999986432 22223


Q ss_pred             eccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccccCC
Q 042150          621 STGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKI  700 (803)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  700 (803)
                      .....||+.|+|||++.++.++.++|||||||+||||++|..|+........  +..++    ..+.         ....
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i----~~~~---------~~~~  235 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQV----ERGY---------RMPC  235 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH----HTTC---------CCCC
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHH----HhcC---------CCCC
Confidence            3446789999999999999999999999999999999997666543221111  11111    1111         1123


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          701 NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       701 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      +..+++++.+++.+||+.+|++||+|.+|++.|+...
T Consensus       236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            3445567899999999999999999999999888654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=408.24  Aligned_cols=254  Identities=25%  Similarity=0.384  Sum_probs=194.1

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeec--cceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEE--QSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~lV  535 (803)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||.+....  ....+.|.+|+++|++++|||||++++++.+  .+.++||
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            56888999999999999999975 58899999865443  2234678999999999999999999999864  4568999


Q ss_pred             EEecCCCchhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          536 YEYMEKGPLKKHLYG--PDRTPLSWKQRLEICIGAARGLHYLHTGS--AEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      |||+++|+|.+++..  ..+..+++.+++.++.||+.||+|||+..  ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999843  23567999999999999999999999821  23499999999999999999999999999986


Q ss_pred             CCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ...  .........||+.|||||++.+..++.++|||||||+||||++|+.||......+   +.    .....+...  
T Consensus       164 ~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~----~~i~~~~~~--  232 (269)
T d2java1         164 LNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA----GKIREGKFR--  232 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH----HHHHHTCCC--
T ss_pred             ccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HH----HHHHcCCCC--
Confidence            432  2223345689999999999999999999999999999999999999997543322   11    111111111  


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                             ..+...++++.+|+.+||+.||.+|||+.|++++
T Consensus       233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                   1223345678999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-48  Score=403.91  Aligned_cols=245  Identities=25%  Similarity=0.407  Sum_probs=195.0

Q ss_pred             CccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeec----cceeeEEE
Q 042150          464 DKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE----QSEMILVY  536 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~lV~  536 (803)
                      +..++||+|+||+||+|+.. +++.||+|++...  .....+.|.+|+++|++++|||||++++++.+    ...++|||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            44557999999999999976 4789999986543  23345679999999999999999999999864    45689999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--eEeeccCcceEEEc-cCCcEEEeeeccccCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEG--IIHRDIKSTNILLD-ENYVSKVADFGLSRSGP  613 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLkp~NILl~-~~~~~kl~DFGla~~~~  613 (803)
                      ||+++|+|.+++.  +...+++.+++.++.||++||+|||+   ++  |+||||||+||||+ +++.+||+|||+|+...
T Consensus        92 E~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHh--ccccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999994  34579999999999999999999998   66  99999999999996 57899999999998632


Q ss_pred             CCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                          ........||+.|||||++.+ +++.++|||||||+||||++|+.||........  +   ... ...+..    .
T Consensus       167 ----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~---~~~-i~~~~~----~  231 (270)
T d1t4ha_         167 ----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I---YRR-VTSGVK----P  231 (270)
T ss_dssp             ----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H---HHH-HTTTCC----C
T ss_pred             ----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--H---HHH-HHcCCC----C
Confidence                222345689999999999865 699999999999999999999999964322211  1   111 111111    1


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +.    ++....+++.+++.+||+.||++|||+.|++++
T Consensus       232 ~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         232 AS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cc----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            11    112234568899999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=405.24  Aligned_cols=252  Identities=20%  Similarity=0.259  Sum_probs=205.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|+..+.||+|+||+||+|+.. +++.||||++...   .....+.+.+|+++|++++||||+++++++.+.+.++|||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46889999999999999999975 5889999986432   3445678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|.+++.  ..+.+++.++..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+......
T Consensus        88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            9999999999884  34579999999999999999999999   999999999999999999999999999998654333


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                      .........||+.|||||++.+..++.++|||||||+||||++|+.||......+.   .   .. ......        
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~---~~-i~~~~~--------  227 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---F---QK-IIKLEY--------  227 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HH-HHTTCC--------
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH---H---HH-HHcCCC--------
Confidence            33344456899999999999999999999999999999999999999975432211   1   11 111110        


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                        .++...++.+.+|+.+||+.||.+|||++|+++...
T Consensus       228 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~  263 (288)
T d1uu3a_         228 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP  263 (288)
T ss_dssp             --CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred             --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence              122334567899999999999999999999876533

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-48  Score=415.58  Aligned_cols=265  Identities=22%  Similarity=0.301  Sum_probs=204.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .++|+..+.||+|+||+||+|+.. +++.||+|++..... ...+++.+|+++|++++|||||+++++|.+.+.++||||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467999999999999999999975 588999998755433 335679999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+++|+|.+++.+  ...+++.++..++.|++.||+|||+  .++|+||||||+||||++++.+||+|||+|+...    
T Consensus        85 y~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~----  156 (322)
T d1s9ja_          85 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----  156 (322)
T ss_dssp             CCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred             cCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccC----
Confidence            9999999999943  4569999999999999999999996  1489999999999999999999999999997522    


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHH---------------H
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQ---------------W  682 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~---------------~  682 (803)
                      ........||+.|||||++.+.+++.++|||||||+||||++|+.||......+..........               .
T Consensus       157 ~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence            1222346899999999999999999999999999999999999999975432211100000000               0


Q ss_pred             hhc--------Ccccc----ccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          683 QKK--------GMLEH----IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       683 ~~~--------~~~~~----i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...        ....+    +.............+.++.+++.+||+.||.+|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            000        00000    000000000011124578899999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=397.89  Aligned_cols=250  Identities=29%  Similarity=0.432  Sum_probs=200.0

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeec-cceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE-QSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~lV~Ey~  539 (803)
                      ++|+..+.||+|+||.||+|.++ |+.||||++..  ....++|.+|+++|++++||||++++|+|.+ .+.+++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            45677889999999999999986 78899999754  3456789999999999999999999999855 46789999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      ++|+|.++|.......++|..+++|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....     
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----  155 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----  155 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC-----
Confidence            99999999965444569999999999999999999999   9999999999999999999999999999986322     


Q ss_pred             eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccccc
Q 042150          620 VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIG  698 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  698 (803)
                      ......++..|+|||++.++.++.++|||||||++|||+| |+.|+......   .+..++    ..+         ...
T Consensus       156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~---------~~~  219 (262)
T d1byga_         156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKG---------YKM  219 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTT---------CCC
T ss_pred             CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcC---------CCC
Confidence            2233467899999999999999999999999999999998 67777643222   222221    111         112


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          699 KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       699 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      .++...++++.+|+.+||+.||.+||||.+++++|+.+.
T Consensus       220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            233445578899999999999999999999999998775

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-47  Score=407.26  Aligned_cols=264  Identities=28%  Similarity=0.397  Sum_probs=212.6

Q ss_pred             hHHHHhcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCCC-ChHHHHHHHHHHHhccCCCeeeEEeEee
Q 042150          455 DLQTATNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSRQ-GLPEFQTEITVLSKIRHRHLVSLVGYCE  527 (803)
Q Consensus       455 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~  527 (803)
                      +++...++|+..+.||+|+||+||+|+++      +++.||||++...... ..++|.+|+++|++++||||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999974      3578999997654332 3467999999999999999999999999


Q ss_pred             ccceeeEEEEecCCCchhhhccCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEe
Q 042150          528 EQSEMILVYEYMEKGPLKKHLYGPD----------------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIH  585 (803)
Q Consensus       528 ~~~~~~lV~Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  585 (803)
                      ..+..++||||+++|+|.++++...                      ...+++.+++.|+.|++.||+|||+   ++|+|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEe
Confidence            9999999999999999999985321                      2358999999999999999999999   99999


Q ss_pred             eccCcceEEEccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCC-CCC
Q 042150          586 RDIKSTNILLDENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR-TAV  664 (803)
Q Consensus       586 rDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~  664 (803)
                      |||||+||||+.++.+||+|||+|+...............+++.|+|||.+.+..++.++|||||||+||||++|. +|+
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999997543333333344567899999999999999999999999999999999996 566


Q ss_pred             CcchhhhhhhHHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042150          665 DPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYAL  737 (803)
Q Consensus       665 ~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~  737 (803)
                      ......+.   ..   . ..++...         ..+..++.++.+|+.+||+.+|.+||||.||++.|+++.
T Consensus       244 ~~~~~~e~---~~---~-v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAHEEV---IY---Y-VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCHHHH---HH---H-HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCHHHH---HH---H-HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            54432221   11   1 1222111         223344567899999999999999999999999999764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-47  Score=405.01  Aligned_cols=252  Identities=22%  Similarity=0.309  Sum_probs=191.9

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      .+.|...+.||+|+||+||+|+.+ +++.||||++.... ....+.+.+|+++|++++||||+++++++.+++.++||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            466899999999999999999976 58899999865432 2334568899999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc---cCCcEEEeeeccccCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~DFGla~~~~~  614 (803)
                      |+++|+|.++|.  ....+++.++..++.||+.||+|||+   ++|+||||||+|||+.   +++.+||+|||+|+... 
T Consensus        88 ~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~-  161 (307)
T d1a06a_          88 LVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-  161 (307)
T ss_dssp             CCCSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             ccCCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc-
Confidence            999999999994  35679999999999999999999999   9999999999999994   57899999999998632 


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCc
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDP  694 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  694 (803)
                        .........||+.|||||++.+..++.++|||||||+||||++|+.||......+.   ..   .. ....      .
T Consensus       162 --~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~---~i-~~~~------~  226 (307)
T d1a06a_         162 --PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---FE---QI-LKAE------Y  226 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---HH-HTTC------C
T ss_pred             --CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH---HH---HH-hccC------C
Confidence              22233456799999999999999999999999999999999999999975432221   11   11 1111      0


Q ss_pred             ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          695 QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..........++.+.+++.+||+.||.+|||+.|++++
T Consensus       227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11111223445678999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-47  Score=406.17  Aligned_cols=257  Identities=24%  Similarity=0.377  Sum_probs=204.7

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-Cc----EEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NT----KVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .+|+..++||+|+||+||+|.+.. |+    +||+|++... ..+..++|.+|+++|++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            358889999999999999999753 33    6899987543 445678899999999999999999999999875 5678


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ++||+.+|+|.+++.. ....+++.++++++.|||+||+|||+   ++|+||||||+||||+.++.+||+|||+|+....
T Consensus        88 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            8999999999988854 35679999999999999999999999   8999999999999999999999999999987544


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      ...........||+.|||||.+.++.++.++|||||||+||||+| |+.||......+   +...+    ..+.      
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i----~~~~------  230 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKGE------  230 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHH----HHTC------
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCC------
Confidence            344434445678999999999999999999999999999999998 788887543322   11111    1111      


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                         ....+..++..+.+|+.+||+.+|.+|||+.||+++|+.+..
T Consensus       231 ---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         231 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence               112233455678999999999999999999999999987754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.8e-47  Score=409.15  Aligned_cols=253  Identities=21%  Similarity=0.289  Sum_probs=208.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .++|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+.++|||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999975 5899999997665555567899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc--cCCcEEEeeeccccCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD--ENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~~kl~DFGla~~~~~~~  616 (803)
                      |++|+|.+++.. ....+++.++..++.||+.||+|||+   ++|+||||||+|||++  .++.+||+|||+|+....  
T Consensus       105 ~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--  178 (350)
T d1koaa2         105 MSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--  178 (350)
T ss_dssp             CCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--
T ss_pred             CCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc--
Confidence            999999999854 33569999999999999999999999   9999999999999995  467899999999986432  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                       ........||+.|||||++.+..++.++|||||||++|||++|+.||......+..      ..... ...      ..
T Consensus       179 -~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~-~~~------~~  244 (350)
T d1koaa2         179 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL------RNVKS-CDW------NM  244 (350)
T ss_dssp             -TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH-TCC------CS
T ss_pred             -ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH------HHHHh-CCC------CC
Confidence             23334567999999999999999999999999999999999999999754322211      11111 100      00


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ........++.+.+++.+||+.||.+|||++|++++
T Consensus       245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            011112334678999999999999999999999876

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.8e-47  Score=404.03  Aligned_cols=246  Identities=26%  Similarity=0.359  Sum_probs=201.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC---ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ---GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ..|+..+.||+|+||.||+|+.. +++.||||++......   ..++|.+|+++|++++|||||++++++.+.+..+|||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            34888899999999999999975 5889999986544332   2457899999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      |||++|+|..++.  .+..+++.+++.++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+....  
T Consensus        95 E~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             ECCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence            9999999987663  34679999999999999999999999   9999999999999999999999999999986322  


Q ss_pred             CCceeccccCCCcccCcccccc---CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRR---QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                          .....||+.|||||++.+   ..++.++|||||||+||||++|+.||......+..      ..... +..     
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------~~i~~-~~~-----  231 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-NES-----  231 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-SCC-----
T ss_pred             ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHh-CCC-----
Confidence                234579999999999864   46899999999999999999999998654322211      11111 111     


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +.+   .+...++.+.+++.+||+.||.+|||++|++++
T Consensus       232 ~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            111   122335678999999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=394.63  Aligned_cols=259  Identities=23%  Similarity=0.332  Sum_probs=200.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC----CcEEEEEEcCCCCC-CChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeE
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD----NTKVAVKRGVPGSR-QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMIL  534 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  534 (803)
                      .++|+..+.||+|+||.||+|++..    +..||||.+..... ...+.|.+|+++|++++||||++++|+|.+ +.+++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            3578888999999999999999753    34688888654332 234679999999999999999999999964 67899


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      ||||+++|+|.+++.. ....+++.+++.++.||++||+|||+   ++|+||||||+|||+++++.+||+|||+|+....
T Consensus        85 v~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            9999999999998743 34569999999999999999999999   9999999999999999999999999999986433


Q ss_pred             CCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccccC
Q 042150          615 LDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIID  693 (803)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  693 (803)
                      . .........||+.|+|||.+.+..++.++|||||||+||||++ |+.|+......+   +...+    ..+..     
T Consensus       161 ~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i----~~~~~-----  227 (273)
T d1mp8a_         161 S-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGER-----  227 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCC-----
T ss_pred             C-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCCC-----
Confidence            2 2223345678999999999999999999999999999999998 888887543322   11111    11110     


Q ss_pred             cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          694 PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                          ...+..++..+.+|+.+||+.||.+|||+.||+++|+.+++-+
T Consensus       228 ----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         228 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                1223445678899999999999999999999999999887543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=397.18  Aligned_cols=252  Identities=21%  Similarity=0.290  Sum_probs=205.2

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC------CCChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS------RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      .+.|+..+.||+|+||+||+|+.+ +|+.||||++....      ....+.|.+|+++|++++|||||++++++.+.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357899999999999999999975 58999999864321      22357899999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC----cEEEeeecc
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY----VSKVADFGL  608 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~----~~kl~DFGl  608 (803)
                      +||||||++|+|.+++.  ....+++.+++.++.|++.||+|||+   ++|+||||||+|||++.++    .+||+|||+
T Consensus        89 ~iv~E~~~gg~L~~~i~--~~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          89 ILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCccccchhc--cccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence            99999999999999994  34579999999999999999999999   9999999999999998776    599999999


Q ss_pred             ccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          609 SRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      |+....   ........||+.|+|||++.+..++.++|||||||+||||++|+.||......+..      ... .....
T Consensus       164 a~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------~~i-~~~~~  233 (293)
T d1jksa_         164 AHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANV-SAVNY  233 (293)
T ss_dssp             CEECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH-HTTCC
T ss_pred             hhhcCC---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH------HHH-HhcCC
Confidence            976432   22334567899999999999999999999999999999999999999754332211      111 11100


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                            ..........+..+.+++.+||+.||.+|||++|++++
T Consensus       234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  00000111234678899999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.1e-46  Score=405.45  Aligned_cols=252  Identities=20%  Similarity=0.265  Sum_probs=208.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++.++||||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46889999999999999999975 58999999876554444567889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc--cCCcEEEeeeccccCCCCCCC
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD--ENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~--~~~~~kl~DFGla~~~~~~~~  617 (803)
                      ++|+|.+++.. ....+++.+++.|+.||+.||+|||+   ++|+||||||+||||+  .++.+||+|||+|+....   
T Consensus       109 ~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~---  181 (352)
T d1koba_         109 SGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---  181 (352)
T ss_dssp             CCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---
T ss_pred             CCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCC---
Confidence            99999988743 34569999999999999999999999   9999999999999998  678999999999986432   


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      ........||+.|||||++.+..++.++|||||||+||||+||+.||......+..      ... ....      ....
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i-~~~~------~~~~  248 (352)
T d1koba_         182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL------QNV-KRCD------WEFD  248 (352)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHH-HHCC------CCCC
T ss_pred             CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-HhCC------CCCC
Confidence            23344567899999999999999999999999999999999999999754332211      111 1111      1111


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .......+..+.+|+.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11223345678999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=399.99  Aligned_cols=262  Identities=24%  Similarity=0.364  Sum_probs=201.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC------CcEEEEEEcCCCC-CCChHHHHHHHHHHHhc-cCCCeeeEEeEeecc-c
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD------NTKVAVKRGVPGS-RQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ-S  530 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~-~  530 (803)
                      .++|...+.||+|+||.||+|.+..      ++.||||++.... ....+.+.+|..++.++ +|+||+.+++++.+. .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            4678889999999999999999642      4689999875433 23356788898888887 689999999998654 5


Q ss_pred             eeeEEEEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD  596 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~  596 (803)
                      .+++|||||++|+|.++|+...              ...+++.+++.++.||++||+|||+   ++|+||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence            6899999999999999985321              3458999999999999999999999   9999999999999999


Q ss_pred             cCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCC-CCCCcchhhhhhhH
Q 042150          597 ENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR-TAVDPLLAREQVNL  675 (803)
Q Consensus       597 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l  675 (803)
                      +++.+||+|||+|+...............||+.|||||.+.++.++.++|||||||++|||+||. .||......+.   
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---  245 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---  245 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            99999999999998654444444445678999999999999999999999999999999999975 56654322211   


Q ss_pred             HHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          676 AEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       676 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                         .......+..         ...+...++++.+++.+||+.||.+|||+.||+++|+.+++.
T Consensus       246 ---~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         246 ---FCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             ---HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence               1111122111         122333456789999999999999999999999999988753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-46  Score=396.42  Aligned_cols=256  Identities=30%  Similarity=0.474  Sum_probs=205.0

Q ss_pred             cCCCccceEeeeCceEEEEEEECC-Cc--EEEEEEcCCC-CCCChHHHHHHHHHHHhc-cCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD-NT--KVAVKRGVPG-SRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ++|+..++||+|+||+||+|++++ +.  .||||++... .....++|.+|+++|+++ +|||||+++|+|.+++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            577888899999999999999754 43  4778876433 344567899999999999 799999999999999999999


Q ss_pred             EEecCCCchhhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcE
Q 042150          536 YEYMEKGPLKKHLYGP--------------DRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVS  601 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~  601 (803)
                      |||+++|+|.++|+..              ....+++.++++++.|||+||.|||+   ++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence            9999999999999643              24679999999999999999999999   999999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCC-CCCcchhhhhhhHHHHHH
Q 042150          602 KVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCART-AVDPLLAREQVNLAEWAM  680 (803)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~  680 (803)
                      ||+|||+++....   ........||..|+|||.+.++.++.++|||||||++|||++|.. |+......+   +.   .
T Consensus       167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~---~  237 (309)
T d1fvra_         167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY---E  237 (309)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---H
T ss_pred             EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HH---H
Confidence            9999999986322   122234568999999999999999999999999999999999765 564332211   11   1


Q ss_pred             HHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          681 QWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       681 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      . ..++.         ....+...++.+.+|+.+||+.||++||||.||+++|+.+.+
T Consensus       238 ~-i~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         238 K-LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             H-GGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H-HHhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1 11111         112233456788999999999999999999999999998875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-46  Score=397.40  Aligned_cols=261  Identities=23%  Similarity=0.371  Sum_probs=212.4

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCCC-CChHHHHHHHHHHHhc-cCCCeeeEEeEeeccce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGSR-QGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQSE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~  531 (803)
                      .++|...++||+|+||.||+|++.      .++.||||++..... ....+|.+|+.+++++ +|||||+++|+|.+...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            467888899999999999999863      356899999765433 2345789999999999 69999999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE
Q 042150          532 MILVYEYMEKGPLKKHLYGPD----------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL  595 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl  595 (803)
                      .+|||||+++|+|.++++...                ...+++.++++++.||++||+|||+   ++++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence            999999999999999985322                2369999999999999999999999   999999999999999


Q ss_pred             ccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhC-CCCCCcchhhhhhh
Q 042150          596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA-RTAVDPLLAREQVN  674 (803)
Q Consensus       596 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~  674 (803)
                      +.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||+||||+|+ .+|+......+.  
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            99999999999999976554444555667899999999999999999999999999999999995 555543322111  


Q ss_pred             HHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          675 LAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       675 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                      +...+    ..+         .....+...+..+.+|+.+||+.||.+||||.||+++|+..+.
T Consensus       257 ~~~~i----~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         257 FYKMI----KEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HHHHH----HHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHH----hcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            11111    111         1112223345678999999999999999999999999997753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-46  Score=395.76  Aligned_cols=261  Identities=27%  Similarity=0.432  Sum_probs=209.0

Q ss_pred             hcCCCccceEeeeCceEEEEEEECC--------CcEEEEEEcCCCCC-CChHHHHHHHHHHHhc-cCCCeeeEEeEeecc
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLRD--------NTKVAVKRGVPGSR-QGLPEFQTEITVLSKI-RHRHLVSLVGYCEEQ  529 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~  529 (803)
                      .++|...+.||+|+||.||+|+...        +..||||++..... ....++.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3567888899999999999998632        24799998765433 3357889999999998 799999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEE
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPD--------------RTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILL  595 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl  595 (803)
                      +..++||||+++|+|.++|....              ...+++.++++++.|||.||+|||+   ++|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence            99999999999999999996432              2468999999999999999999999   999999999999999


Q ss_pred             ccCCcEEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhh
Q 042150          596 DENYVSKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVN  674 (803)
Q Consensus       596 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  674 (803)
                      +.++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||+||||++ |+.||.......   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence            9999999999999986544444444455778999999999999999999999999999999998 688876443221   


Q ss_pred             HHHHHHHHhhcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 042150          675 LAEWAMQWQKKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQL  739 (803)
Q Consensus       675 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~  739 (803)
                      +.    .....+.         ....+...++.+.+|+.+||+.+|.+|||+.||++.|+.++.+
T Consensus       246 ~~----~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         246 LF----KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HH----HHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH----HHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            11    1111111         1122333456789999999999999999999999999988654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-45  Score=393.11  Aligned_cols=254  Identities=28%  Similarity=0.454  Sum_probs=202.8

Q ss_pred             cceEeeeCceEEEEEEECCC----cEEEEEEcCCC-CCCChHHHHHHHHHHHhccCCCeeeEEeEeec-cceeeEEEEec
Q 042150          466 NLIIGSGGFGMVYKGVLRDN----TKVAVKRGVPG-SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE-QSEMILVYEYM  539 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~lV~Ey~  539 (803)
                      .++||+|+||+||+|++.++    ..||||++... .....++|.+|+++|++++||||++++|+|.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999997542    35899987543 33345789999999999999999999999865 56899999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC--
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE--  617 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~--  617 (803)
                      ++|+|.+++.. ....+++.++++++.|+|+||.|||+   .+|+||||||+||||++++.+||+|||+++.......  
T Consensus       112 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            99999999854 34568899999999999999999999   9999999999999999999999999999986443221  


Q ss_pred             CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQLI  697 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  697 (803)
                      ........||..|+|||.+.+..++.++||||||++||||+||+.|+.......  .+..++    ..+.  ..      
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i----~~g~--~~------  253 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL----LQGR--RL------  253 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTC--CC------
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HcCC--CC------
Confidence            222334678999999999999999999999999999999999888875432111  111111    1111  01      


Q ss_pred             cCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          698 GKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       698 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                       ..+..++..+.+|+.+||+.||.+||+|.||+++|+.+.+
T Consensus       254 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         254 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             1223345678999999999999999999999999998865

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=392.96  Aligned_cols=256  Identities=25%  Similarity=0.368  Sum_probs=197.4

Q ss_pred             cCCCccceEeeeCceEEEEEEECC--C--cEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRD--N--TKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      ++|+..+.||+|+||+||+|+++.  +  ..||||++...   ..+..++|.+|+++|++++||||++++|+|.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            568888899999999999998643  2  36899986543   22335689999999999999999999999976 4678


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      +||||+++|+|.+++.. ....+++..++.++.|||+||.|||+   ++|+||||||+||||+.++.+||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            99999999999988753 33569999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCCCc-eeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHh-CCCCCCcchhhhhhhHHHHHHHHhhcCccccc
Q 042150          614 CLDETH-VSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLC-ARTAVDPLLAREQVNLAEWAMQWQKKGMLEHI  691 (803)
Q Consensus       614 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  691 (803)
                      ...... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||......+.   ..   .....+     
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~~---~i~~~~-----  231 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LH---KIDKEG-----  231 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH---HHHTSC-----
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---HH---HHHhCC-----
Confidence            332222 2234567889999999999999999999999999999998 8999875433221   11   111111     


Q ss_pred             cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042150          692 IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYA  736 (803)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~  736 (803)
                          .....+...+..+.+|+.+||+.||.+|||+.||++.|+++
T Consensus       232 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                11122234456789999999999999999999999988865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=395.89  Aligned_cols=248  Identities=23%  Similarity=0.283  Sum_probs=207.4

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|+..+.||+|+||.||+|+.+ +++.||||++...   .....+.+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57899999999999999999975 5899999986532   3445778999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      |||++|+|.+++.  ....+++.++..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+..... 
T Consensus        85 ey~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-  158 (337)
T d1o6la_          85 EYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             ECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             eccCCCchhhhhh--cccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence            9999999999984  34568999999999999999999999   99999999999999999999999999999864321 


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                       .......+||+.|||||++.+..++.++|||||||+||||++|+.||......+.   .   .. ...+..        
T Consensus       159 -~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~---~~-i~~~~~--------  222 (337)
T d1o6la_         159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---F---EL-ILMEEI--------  222 (337)
T ss_dssp             -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HH-HHHCCC--------
T ss_pred             -CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH---H---HH-HhcCCC--------
Confidence             2233456899999999999999999999999999999999999999976433221   1   11 111111        


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  732 (803)
                        .++...++++.+|+.+||+.||.+||+     +.|++++
T Consensus       223 --~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence              123334567899999999999999995     7888764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.2e-45  Score=391.99  Aligned_cols=245  Identities=22%  Similarity=0.289  Sum_probs=205.6

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||++...   .....+.+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46888999999999999999975 5899999986432   3445678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+++|+|..++.  ....+++..+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+....  
T Consensus        84 E~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--  156 (316)
T d1fota_          84 DYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  156 (316)
T ss_dssp             CCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             eecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence            9999999999883  45568899999999999999999999   9999999999999999999999999999986432  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                         ......||+.|||||++.+..++.++|||||||+||||++|+.||......+.      ...... +.         
T Consensus       157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~-~~---------  217 (316)
T d1fota_         157 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILN-AE---------  217 (316)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH-CC---------
T ss_pred             ---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------HHHHHc-CC---------
Confidence               22346899999999999999999999999999999999999999975432221      111111 11         


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                       ..++...++.+.+++.+||+.||.+||     |+++++++
T Consensus       218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence             012233456789999999999999996     89999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.6e-45  Score=383.84  Aligned_cols=260  Identities=25%  Similarity=0.325  Sum_probs=201.8

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC---ChHHHHHHHHHHHhccCCCeeeEEeEeeccc----e
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ---GLPEFQTEITVLSKIRHRHLVSLVGYCEEQS----E  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~----~  531 (803)
                      .++|...+.||+|+||.||+|+.. +++.||||++......   ..+.|.+|+++|++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            356889999999999999999974 6899999997654332   2457899999999999999999999987643    4


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .||||||+++|+|.+++.  ....+++.+++.++.||++||+|||+   ++|+||||||+|||++.++..+|+|||+++.
T Consensus        86 ~~lvmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhc--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence            799999999999999883  34579999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCC-CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          612 GPCLD-ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       612 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                      ..... .........||+.|||||++.+..++.++|||||||+||||+||+.||......+.      ..........  
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~--  232 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPI--  232 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCC--
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCC--
Confidence            32221 22233456799999999999999999999999999999999999999975432221      1111121111  


Q ss_pred             ccCcccccCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 042150          691 IIDPQLIGKINLDSLKKFGETAEKCLADYGVDRP-SMGDVLWNLEYAL  737 (803)
Q Consensus       691 i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~~~  737 (803)
                           .........++.+.+++.+||+.||.+|| |++++++.|..+.
T Consensus       233 -----~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 -----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             -----CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -----CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                 11111223456789999999999999999 8999998887653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-45  Score=391.38  Aligned_cols=260  Identities=25%  Similarity=0.386  Sum_probs=210.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC------CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeecccee
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR------DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~  532 (803)
                      .++|...+.||+|+||+||+|.+.      +++.||||++.... .+....|.+|++++++++||||++++|+|......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467788889999999999999864      25789999876432 23345689999999999999999999999999999


Q ss_pred             eEEEEecCCCchhhhccC--------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEe
Q 042150          533 ILVYEYMEKGPLKKHLYG--------PDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVA  604 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~  604 (803)
                      ++||||+++|+|.+++..        .....+++..+++++.|+|+||.|||+   ++|+||||||+||||++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence            999999999999998843        223458999999999999999999999   899999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCC-CCCCcchhhhhhhHHHHHHHHh
Q 042150          605 DFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR-TAVDPLLAREQVNLAEWAMQWQ  683 (803)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~  683 (803)
                      |||+|+...............+|+.|+|||.+.+..++.++|||||||+||||+||+ +|+......      ++.....
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~~~~~i~  249 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVM  249 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHHHHHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH
Confidence            999998643333333344457899999999999999999999999999999999985 666543222      1211111


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQ  738 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~  738 (803)
                       ++..         ...+..++..+.+++.+||+.+|.+||||.+|+++|+..++
T Consensus       250 -~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         250 -EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -hCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             1111         11223345678999999999999999999999999987643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.6e-45  Score=380.88  Aligned_cols=251  Identities=23%  Similarity=0.279  Sum_probs=204.3

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC--C-------hHHHHHHHHHHHhcc-CCCeeeEEeEeecc
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ--G-------LPEFQTEITVLSKIR-HRHLVSLVGYCEEQ  529 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~-------~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~  529 (803)
                      ++|+..+.||+|+||+||+|+.. +++.||||++......  .       .+.+.+|+.+|++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57888999999999999999974 5889999986543221  1       235889999999997 99999999999999


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      +..+|||||+++|+|.++|.  ....+++.++..++.||++||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEcCCCchHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence            99999999999999999994  34579999999999999999999999   99999999999999999999999999999


Q ss_pred             cCCCCCCCCceeccccCCCcccCcccccc------CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHh
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRR------QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQ  683 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  683 (803)
                      +....   ........||+.|+|||.+.+      ..++.++||||+||+||||++|+.||.........       ...
T Consensus       158 ~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-------~~i  227 (277)
T d1phka_         158 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------RMI  227 (277)
T ss_dssp             EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHH
T ss_pred             eEccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-------HHH
Confidence            86432   223345679999999999863      45788999999999999999999999755332211       111


Q ss_pred             hcCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          684 KKGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       684 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..+...      .........++++.+++.+||+.+|.+|||+.||+++
T Consensus       228 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            111110      1111122455788999999999999999999999765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-46  Score=394.61  Aligned_cols=268  Identities=22%  Similarity=0.325  Sum_probs=200.2

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHH--HHHhccCCCeeeEEeEeeccc----eeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEIT--VLSKIRHRHLVSLVGYCEEQS----EMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~--~l~~l~HpnIv~l~g~~~~~~----~~~l  534 (803)
                      ++|...+.||+|+||.||+|+++ |+.||||++...   ..+++..|.+  .+.+++||||++++|+|.+.+    .+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            34566778999999999999974 789999987532   2344545544  556789999999999997654    6899


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTG-----SAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      |||||++|+|.++|+.   ..++|.++++++.|+|.||+|||+.     ..++|+||||||+||||+.++.+||+|||++
T Consensus        79 v~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999943   4699999999999999999999973     2369999999999999999999999999999


Q ss_pred             cCCCCCCCC--ceeccccCCCcccCccccccC------cCCCcceehhHHHHHHHHHhCCCCCCcchhhhh---------
Q 042150          610 RSGPCLDET--HVSTGVKGSFGYLDPEYFRRQ------QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQ---------  672 (803)
Q Consensus       610 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~---------  672 (803)
                      +........  .......||+.|||||++.+.      .++.++|||||||+||||+||..|+........         
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            764322221  123456799999999998754      367789999999999999999987643221110         


Q ss_pred             hhHHHHHHHHhhcCccccccCcccccCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          673 VNLAEWAMQWQKKGMLEHIIDPQLIGKI-NLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       673 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      ..... .......    ....|.+.... ..+....+.+|+.+||+.||.+|||+.||++.|+++.+-+
T Consensus       236 ~~~~~-~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         236 PSVEE-MRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CCHHH-HHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chHHH-HHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            11111 1111111    11222222221 2356677999999999999999999999999999876543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=382.44  Aligned_cols=257  Identities=24%  Similarity=0.240  Sum_probs=196.4

Q ss_pred             cceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCC-----ChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEec
Q 042150          466 NLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQ-----GLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEYM  539 (803)
Q Consensus       466 ~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~  539 (803)
                      .++||+|+||+||+|+.+ +|+.||||++......     ..+.+.+|+++|++++|||||++++++.+++..+|||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999975 5899999986543221     2357899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCCc
Q 042150          540 EKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDETH  619 (803)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  619 (803)
                      .++++..++  .....+++.++..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+.....  ..
T Consensus        83 ~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~  155 (299)
T d1ua2a_          83 ETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NR  155 (299)
T ss_dssp             SEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CC
T ss_pred             cchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCC--cc
Confidence            998877766  345679999999999999999999999   99999999999999999999999999999864322  22


Q ss_pred             eeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc------
Q 042150          620 VSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII------  692 (803)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~------  692 (803)
                      ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||......+....   ..............      
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~---i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR---IFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTTTSSSTTSST
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH---HHHhcCCCChhhccchhccc
Confidence            2334578999999999865 4679999999999999999999999975543332111   11111100000000      


Q ss_pred             Ccc---cccCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          693 DPQ---LIGKIN-----LDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       693 d~~---l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...   .....+     ....+.+.+|+.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            000   000011     1234678999999999999999999999865

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=389.15  Aligned_cols=250  Identities=20%  Similarity=0.285  Sum_probs=199.2

Q ss_pred             cCCCcc-ceEeeeCceEEEEEEE-CCCcEEEEEEcCCCCCCChHHHHHHHHHHHhc-cCCCeeeEEeEeec----cceee
Q 042150          461 NNFDKN-LIIGSGGFGMVYKGVL-RDNTKVAVKRGVPGSRQGLPEFQTEITVLSKI-RHRHLVSLVGYCEE----QSEMI  533 (803)
Q Consensus       461 ~~f~~~-~~Lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~----~~~~~  533 (803)
                      ++|.+. ++||+|+||.||+|+. .+++.||||++..     ...+.+|++++.++ +|||||++++++.+    ...+|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            578765 4699999999999997 4589999998642     35788999987665 89999999999865    46789


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc---CCcEEEeeecccc
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE---NYVSKVADFGLSR  610 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~---~~~~kl~DFGla~  610 (803)
                      ||||||++|+|.++|.......+++.++..|+.||+.||+|||+   ++|+||||||+|||+++   ++.+||+|||+|+
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence            99999999999999976555679999999999999999999999   99999999999999975   5679999999998


Q ss_pred             CCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccc
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEH  690 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (803)
                      ....   ........||+.|||||++.+..++.++|||||||+||||+||+.||.........   .....        .
T Consensus       163 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~--------~  228 (335)
T d2ozaa1         163 ETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKT--------R  228 (335)
T ss_dssp             ECCC---CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------C
T ss_pred             eccC---CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHH--------H
Confidence            6432   22234567999999999999999999999999999999999999999654322111   00000        1


Q ss_pred             ccCccc--ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          691 IIDPQL--IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       691 i~d~~l--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +.....  ........++++.+|+.+||+.||.+|||+.|++++
T Consensus       229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            111111  001112345788999999999999999999999886

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-44  Score=391.18  Aligned_cols=245  Identities=20%  Similarity=0.239  Sum_probs=205.3

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  536 (803)
                      ++|+..+.||+|+||.||+|+.+ +|+.||||++...   .....+.+.+|+++|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47899999999999999999975 5899999986422   3345678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~  616 (803)
                      ||+.+|+|.+++.  ....+++.++..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+....  
T Consensus       121 e~~~~g~l~~~l~--~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             ECCTTCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             ccccccchhhhHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence            9999999999984  34569999999999999999999999   9999999999999999999999999999986432  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                         ......||+.|||||++.+..++.++|||||||+||||++|+.||........      ... ...+..        
T Consensus       194 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~-i~~~~~--------  255 (350)
T d1rdqe_         194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YEK-IVSGKV--------  255 (350)
T ss_dssp             ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH-HHHCCC--------
T ss_pred             ---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH------HHH-HhcCCC--------
Confidence               12346799999999999999999999999999999999999999975432211      111 111110        


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRP-----SMGDVLWN  732 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~  732 (803)
                        ..+...++.+.+++.+||+.||.+|+     |++|++++
T Consensus       256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence              12233456789999999999999994     89999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.8e-44  Score=393.57  Aligned_cols=249  Identities=22%  Similarity=0.276  Sum_probs=199.0

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHH---HHHHHhccCCCeeeEEeEeeccceee
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTE---ITVLSKIRHRHLVSLVGYCEEQSEMI  533 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E---~~~l~~l~HpnIv~l~g~~~~~~~~~  533 (803)
                      ++|+..++||+|+||.||+|+.. +|+.||||++...   .......+.+|   +.+++.++|||||++++++.+.+.++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57889999999999999999976 5899999986421   12333445555   66667778999999999999999999


Q ss_pred             EEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCC
Q 042150          534 LVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGP  613 (803)
Q Consensus       534 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~  613 (803)
                      |||||+++|+|.++|.  ....+++.++..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+...
T Consensus        84 ivmE~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHH--hcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            9999999999999994  34568999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcccccc
Q 042150          614 CLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHII  692 (803)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  692 (803)
                      .    .......||+.|||||++.+ ..++.++|||||||+||||++|+.||......+...+.    ......      
T Consensus       159 ~----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~~------  224 (364)
T d1omwa3         159 K----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTM------  224 (364)
T ss_dssp             S----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSSC------
T ss_pred             C----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcccC------
Confidence            2    12334679999999999974 56899999999999999999999999754332221111    100000      


Q ss_pred             CcccccCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042150          693 DPQLIGKINLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWN  732 (803)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  732 (803)
                          ....+...++.+.+|+.+||+.||.+|||     ++|++++
T Consensus       225 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         225 ----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                01122234567899999999999999999     6888764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=388.28  Aligned_cols=247  Identities=24%  Similarity=0.330  Sum_probs=204.0

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC---CCCChHHHHHHHHHHH-hccCCCeeeEEeEeeccceeeEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG---SRQGLPEFQTEITVLS-KIRHRHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~-~l~HpnIv~l~g~~~~~~~~~lV  535 (803)
                      ++|...+.||+|+||+||+|+.. +++.||||++...   .....+.+..|..++. .++||||+++++++.+++.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46888999999999999999975 5899999986532   2445677888888776 57999999999999999999999


Q ss_pred             EEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCC
Q 042150          536 YEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       536 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~  615 (803)
                      |||+++|+|.+++.  ....+++.++..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            99999999999994  34568999999999999999999999   99999999999999999999999999999864322


Q ss_pred             CCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCcc
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQ  695 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  695 (803)
                        ........||+.|+|||++.+..++.++|||||||+||||++|+.||.........       .....+      .+ 
T Consensus       157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------~~i~~~------~~-  220 (320)
T d1xjda_         157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------HSIRMD------NP-  220 (320)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHC------CC-
T ss_pred             --cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHHcC------CC-
Confidence              22334567999999999999999999999999999999999999999754332211       111111      11 


Q ss_pred             cccCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 042150          696 LIGKINLDSLKKFGETAEKCLADYGVDRPSMG-DVLW  731 (803)
Q Consensus       696 l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl~  731 (803)
                         .++...+..+.+|+.+||+.||.+||++. |+++
T Consensus       221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               12233456789999999999999999995 7765

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-44  Score=382.99  Aligned_cols=254  Identities=17%  Similarity=0.226  Sum_probs=205.1

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      .++|...+.||+|+||+||+|+.. +++.||||.+.... .....+.+|+++|++++||||+++++++.+.+.+||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            357888999999999999999976 58899999875432 2345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc--CCcEEEeeeccccCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE--NYVSKVADFGLSRSGPCLD  616 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~--~~~~kl~DFGla~~~~~~~  616 (803)
                      |++|+|.+++.. ....+++.++..++.||+.||+|||+   ++|+||||||+|||++.  ...+||+|||+++....  
T Consensus        83 ~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--  156 (321)
T d1tkia_          83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--  156 (321)
T ss_dssp             CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred             CCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence            999999999943 23469999999999999999999999   99999999999999984  45899999999986432  


Q ss_pred             CCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccccccCccc
Q 042150          617 ETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLEHIIDPQL  696 (803)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  696 (803)
                       ........+|+.|+|||.+.+..++.++|||||||+||||++|+.||......+.      ...... +..  .++...
T Consensus       157 -~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~------~~~i~~-~~~--~~~~~~  226 (321)
T d1tkia_         157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMN-AEY--TFDEEA  226 (321)
T ss_dssp             -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH-TCC--CCCHHH
T ss_pred             -CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-CCC--CCChhh
Confidence             2233446789999999999999999999999999999999999999975433221      111111 100  000000


Q ss_pred             ccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042150          697 IGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLE  734 (803)
Q Consensus       697 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~  734 (803)
                      .    ...+.++.+++.+||..||.+|||+.|++++-.
T Consensus       227 ~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~  260 (321)
T d1tkia_         227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             c----cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            0    123456889999999999999999999998643

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-43  Score=375.33  Aligned_cols=262  Identities=19%  Similarity=0.221  Sum_probs=202.5

Q ss_pred             cCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|...+.||+|+||+||+|+.++++.||||++...  .....+.|.+|+.+|++++||||+++++++...+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            578888999999999999999999999999986543  234467899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDET  618 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~~  618 (803)
                      +.++.+..+.  .....+++.++..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||++.....  ..
T Consensus        82 ~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~  154 (286)
T d1ob3a_          82 LDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PV  154 (286)
T ss_dssp             CSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceeccc--Cc
Confidence            9987777776  345679999999999999999999999   9999999999999999999999999999975322  11


Q ss_pred             ceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCc------cccc
Q 042150          619 HVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGM------LEHI  691 (803)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~i  691 (803)
                      .......+++.|+|||.+.+ ..++.++|||||||+||||++|+.||......+.....  . .......      ....
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i--~-~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI--F-RILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--H-HHHCCCCTTTSTTGGGS
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH--H-HhhCCCChhhccchhhh
Confidence            22334468999999999875 46789999999999999999999999754433221111  0 1000000      0000


Q ss_pred             ---------cCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          692 ---------IDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       692 ---------~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                               ..+...........+.+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     00100111122345678999999999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=376.02  Aligned_cols=264  Identities=22%  Similarity=0.276  Sum_probs=200.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|+..+.||+|+||+||+|+.. +++.||||++....  ....+.+.+|+++|++++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            47888999999999999999974 58999999875432  3346789999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      |+.++ +.+++.......+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+....  .
T Consensus        82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~  155 (298)
T d1gz8a_          82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--P  155 (298)
T ss_dssp             CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--C
T ss_pred             ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC--C
Confidence            99764 4445544456679999999999999999999999   9999999999999999999999999999975332  2


Q ss_pred             CceeccccCCCcccCccccccCc-CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhh--cCcccccc-C
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQ-LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQK--KGMLEHII-D  693 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~i~-d  693 (803)
                      ........||+.|+|||.+.... ++.++|||||||++|||++|+.||......+...  ........  +....... .
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--RIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGGGS
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH--HHHHhcCCCchhhccccccc
Confidence            22334457999999999887655 5789999999999999999999997543322211  11111000  00000000 0


Q ss_pred             cccccC-----------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          694 PQLIGK-----------INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       694 ~~l~~~-----------~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      +.....           ......+.+.+++.+||+.||.+|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000000           011234678899999999999999999999876

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-44  Score=376.22  Aligned_cols=240  Identities=25%  Similarity=0.391  Sum_probs=195.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC------CChHHHHHHHHHHHhcc--CCCeeeEEeEeeccce
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR------QGLPEFQTEITVLSKIR--HRHLVSLVGYCEEQSE  531 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~--HpnIv~l~g~~~~~~~  531 (803)
                      ++|...++||+|+||+||+|+.. +++.||||++.....      ....++.+|+.+|++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57888999999999999999975 589999998643211      12345779999999996  8999999999999999


Q ss_pred             eeEEEEecCC-CchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-CCcEEEeeeccc
Q 042150          532 MILVYEYMEK-GPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-NYVSKVADFGLS  609 (803)
Q Consensus       532 ~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-~~~~kl~DFGla  609 (803)
                      .++||||+.+ +++.+++.  ....+++.++..++.||++||+|||+   ++|+||||||+|||++. ++.+||+|||+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 57777773  34579999999999999999999999   99999999999999985 579999999999


Q ss_pred             cCCCCCCCCceeccccCCCcccCccccccCcC-CCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          610 RSGPCLDETHVSTGVKGSFGYLDPEYFRRQQL-TDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      +....    .......||+.|||||++.+..+ +.++|||||||+||||++|+.||.....     .       . .+..
T Consensus       159 ~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i-------~-~~~~  221 (273)
T d1xwsa_         159 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------I-RGQV  221 (273)
T ss_dssp             EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------H-HCCC
T ss_pred             eeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H-------h-hccc
Confidence            76322    22345679999999999987776 5678999999999999999999974321     0       0 0000


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                                .++...+.++.+++.+||+.||.+|||++|++++
T Consensus       222 ----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 ----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                      1122234678999999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-43  Score=373.91  Aligned_cols=263  Identities=23%  Similarity=0.272  Sum_probs=200.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-C-CcEEEEEEcCCC--CCCChHHHHHHHHHHHhc---cCCCeeeEEeEee-----
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-D-NTKVAVKRGVPG--SRQGLPEFQTEITVLSKI---RHRHLVSLVGYCE-----  527 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l---~HpnIv~l~g~~~-----  527 (803)
                      .++|+..+.||+|+||+||+|+.. + ++.||||++...  .......+.+|+.+|+.|   +||||++++++|.     
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 4 567999986432  223344677888887776   7999999999985     


Q ss_pred             ccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeec
Q 042150          528 EQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFG  607 (803)
Q Consensus       528 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFG  607 (803)
                      ....++++|||+.++++..... .....+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence            3457899999999887654442 345678999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC-
Q 042150          608 LSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG-  686 (803)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-  686 (803)
                      +++...   .........||+.|||||++.+.+++.++||||+||+||||++|+.||......+.....   ....... 
T Consensus       162 ~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~  235 (305)
T d1blxa_         162 LARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI---LDVIGLPG  235 (305)
T ss_dssp             SCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCC
T ss_pred             hhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhhCCCc
Confidence            987632   233345678999999999999999999999999999999999999999765433322111   1110000 


Q ss_pred             --c------ccc-cc---CcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 --M------LEH-II---DPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 --~------~~~-i~---d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                        .      ... ..   .......+.....+.+.+|+.+||+.||.+|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              0      000 00   0000111222345678899999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=365.50  Aligned_cols=267  Identities=22%  Similarity=0.287  Sum_probs=198.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCC--CCCChHHHHHHHHHHHhccCCCeeeEEeEeec--------c
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPG--SRQGLPEFQTEITVLSKIRHRHLVSLVGYCEE--------Q  529 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--------~  529 (803)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++...  .....+++.+|+++|++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67889999999999999999975 6899999986433  33446789999999999999999999998854        3


Q ss_pred             ceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccc
Q 042150          530 SEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLS  609 (803)
Q Consensus       530 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla  609 (803)
                      +..++||||++++.+....  .....++..++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence            4689999999988777655  445678999999999999999999999   99999999999999999999999999999


Q ss_pred             cCCCCCCCC--ceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC
Q 042150          610 RSGPCLDET--HVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG  686 (803)
Q Consensus       610 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (803)
                      +........  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+...............
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            754322211  122345799999999998765 68999999999999999999999997544333222111110000000


Q ss_pred             ccccccCcccc-------c-CCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 MLEHIIDPQLI-------G-KINL-------DSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 ~~~~i~d~~l~-------~-~~~~-------~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...........       . ....       ...+.+.+|+.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00000000000       0 0000       113456789999999999999999999876

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=370.38  Aligned_cols=261  Identities=23%  Similarity=0.243  Sum_probs=194.9

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeEEeEeecc------ceeeE
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQ------SEMIL  534 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~l  534 (803)
                      +|...++||+|+||+||+|+.. +++.||||++.....    .+.+|+++|++++||||++++++|...      ..++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5777889999999999999985 589999998754432    234799999999999999999998432      34789


Q ss_pred             EEEecCCCchhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC-cEEEeeeccccCC
Q 042150          535 VYEYMEKGPLKKHLY-GPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY-VSKVADFGLSRSG  612 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFGla~~~  612 (803)
                      ||||++++.+..+.. ......+++.++..++.||+.||+|||+   ++|+||||||+||||+.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998765444332 1345679999999999999999999998   9999999999999999765 8999999999764


Q ss_pred             CCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHH---------HHHHHH
Q 042150          613 PCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLA---------EWAMQW  682 (803)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~~~~  682 (803)
                      ..   ........||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+.....         ++....
T Consensus       174 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            32   222334578999999998765 57899999999999999999999999755433322111         011111


Q ss_pred             hh---cCccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          683 QK---KGMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       683 ~~---~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..   .....................+.+.+|+.+||..||.+|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00   000111111111111223345678999999999999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-40  Score=354.49  Aligned_cols=263  Identities=18%  Similarity=0.203  Sum_probs=198.2

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCeeeE-EeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLVSL-VGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l-~g~~~~~~~~~lV~Ey  538 (803)
                      ++|+..+.||+|+||.||+|+.. +++.||||......  ..+++..|++++++++|+|++.. .++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            46888999999999999999974 58899999865433  23468899999999987765555 4555777888999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEc---cCCcEEEeeeccccCCCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLD---ENYVSKVADFGLSRSGPCL  615 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~---~~~~~kl~DFGla~~~~~~  615 (803)
                      +.+ +|.+.+.. ....+++.+++.++.|++.||+|||+   ++|+||||||+|||++   .+..+||+|||+|+.....
T Consensus        85 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          85 LGP-SLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CCC-BHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             cCC-chhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            954 55555532 34569999999999999999999999   9999999999999985   4567999999999864332


Q ss_pred             CCC-----ceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHH-HHHHHHhhcCccc
Q 042150          616 DET-----HVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLA-EWAMQWQKKGMLE  689 (803)
Q Consensus       616 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~~~~~~~~~~~  689 (803)
                      ...     .......||+.|||||.+.+..++.++|||||||++|||++|+.||............ .+...... ... 
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~-  237 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI-  237 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCH-
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CCh-
Confidence            211     1234567999999999999999999999999999999999999999754433222111 11111000 000 


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                          +.    .....++++.+++.+|++.+|.+||++.++.+.|+.+....
T Consensus       238 ----~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         238 ----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ----HH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----hH----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                00    11123467899999999999999999999999888876433

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=367.30  Aligned_cols=260  Identities=23%  Similarity=0.313  Sum_probs=193.6

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeeccc------
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS------  530 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------  530 (803)
                      .++|...+.||+|+||+||+|... +|+.||||++.....  ...+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467889999999999999999975 589999999764322  22457899999999999999999999997654      


Q ss_pred             eeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          531 EMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       531 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      .+++||||+ +.+|..++   ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+
T Consensus        97 ~~~lv~e~~-~~~l~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLM---KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHH---HhccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence            579999999 55777776   33569999999999999999999999   999999999999999999999999999998


Q ss_pred             CCCCCCCCceeccccCCCcccCcccccc-CcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHH-----Hhh
Q 042150          611 SGPCLDETHVSTGVKGSFGYLDPEYFRR-QQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQ-----WQK  684 (803)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~~~  684 (803)
                      ....     ..+...||+.|+|||.+.+ ..++.++||||+||+||||++|+.||.................     ...
T Consensus       170 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         170 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            6332     2345678999999999876 4678999999999999999999999976543322211110000     000


Q ss_pred             c----------CccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          685 K----------GMLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       685 ~----------~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      .          ..+.+.....+ ........+.+.+|+.+||..||.+|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0          00000000000 11112334567899999999999999999999876

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3e-40  Score=350.16  Aligned_cols=264  Identities=17%  Similarity=0.168  Sum_probs=207.1

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhccC-CCeeeEEeEeeccceeeEEEEe
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH-RHLVSLVGYCEEQSEMILVYEY  538 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~lV~Ey  538 (803)
                      ++|...+.||+|+||+||+|+.. +++.||||......  ..+.+.+|+++++.++| +|++.+++++.+....++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57889999999999999999975 58899999864432  23467889999999965 9999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEcc-----CCcEEEeeeccccCCC
Q 042150          539 MEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDE-----NYVSKVADFGLSRSGP  613 (803)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~-----~~~~kl~DFGla~~~~  613 (803)
                      + +++|.+++.. ....+++.++..++.|++.||+|||+   ++|+||||||+|||++.     ++.+||+|||+|+...
T Consensus        83 ~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          83 L-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             c-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            9 6799988853 34569999999999999999999999   99999999999999974     5789999999997543


Q ss_pred             CCCC-----CceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc
Q 042150          614 CLDE-----THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML  688 (803)
Q Consensus       614 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (803)
                      ....     ........||+.|||||++.+..++.++|||||||++|||++|+.||........................
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            2111     11233467999999999999999999999999999999999999999754333222211111111111111


Q ss_pred             ccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhh
Q 042150          689 EHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQ  740 (803)
Q Consensus       689 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~  740 (803)
                      .+     +    ....++++.+++..|++.+|.+||+++.+.+.|+.+.+..
T Consensus       238 ~~-----l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         238 RE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HH-----h----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            11     1    1123457889999999999999999999999888876533

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=353.48  Aligned_cols=263  Identities=20%  Similarity=0.254  Sum_probs=203.3

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeeccceeeEEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      ++|+..+.||+|+||+||+|+.. +++.||||++....  ....+.+.+|+.+|++++||||++++++|.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47888999999999999999975 58899999865432  2336789999999999999999999999999999999999


Q ss_pred             ecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCCCCC
Q 042150          538 YMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPCLDE  617 (803)
Q Consensus       538 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~~~~  617 (803)
                      ++.+++|..++.  ..+.+++.++..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++.....  
T Consensus        82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--  154 (292)
T d1unla_          82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--  154 (292)
T ss_dssp             CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--
T ss_pred             eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC--
Confidence            999999988874  45678999999999999999999999   99999999999999999999999999999864322  


Q ss_pred             CceeccccCCCcccCccccccCc-CCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC---c---ccc
Q 042150          618 THVSTGVKGSFGYLDPEYFRRQQ-LTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG---M---LEH  690 (803)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~---~~~  690 (803)
                      ........++..|+|||.+.... ++.++|||||||++|||++|+.|+........  ...-........   .   ...
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred             CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhh
Confidence            22233446788999999987654 68999999999999999999999753322111  111111111100   0   000


Q ss_pred             ccC---------cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          691 IID---------PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       691 i~d---------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ..+         ..-.........+.+.+|+.+||+.||.+|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000         000111223345678899999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.5e-40  Score=356.97  Aligned_cols=258  Identities=17%  Similarity=0.217  Sum_probs=197.1

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeec--cceeeEEE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEE--QSEMILVY  536 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~--~~~~~lV~  536 (803)
                      ++|...++||+|+||+||+|+.. +++.||||++..   ...+++.+|+++|++++ ||||+++++++..  ...+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999974 589999998753   34578999999999995 9999999999864  45689999


Q ss_pred             EecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC-cEEEeeeccccCCCCC
Q 042150          537 EYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY-VSKVADFGLSRSGPCL  615 (803)
Q Consensus       537 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~-~~kl~DFGla~~~~~~  615 (803)
                      ||+.+++|..+.     +.+++.++..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+|+.... 
T Consensus       112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~-  182 (328)
T d3bqca1         112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-  182 (328)
T ss_dssp             ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred             eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC-
Confidence            999999998765     359999999999999999999999   9999999999999998654 699999999986432 


Q ss_pred             CCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhh-----------HHHHHHHHh
Q 042150          616 DETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN-----------LAEWAMQWQ  683 (803)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-----------l~~~~~~~~  683 (803)
                        ........+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..........           ...|.....
T Consensus       183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence              2223456789999999998765 57999999999999999999999986433211110           011111100


Q ss_pred             hcC--ccccccC--------cccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          684 KKG--MLEHIID--------PQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       684 ~~~--~~~~i~d--------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                      ...  .......        ............+++.+|+.+||..||.+|||++|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000  0000000        000111112345678999999999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-41  Score=367.75  Aligned_cols=266  Identities=23%  Similarity=0.275  Sum_probs=194.8

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC-CCChHHHHHHHHHHHhccCCCeeeEEeEeeccc----eeeE
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS-RQGLPEFQTEITVLSKIRHRHLVSLVGYCEEQS----EMIL  534 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~----~~~l  534 (803)
                      .+|...+.||+|+||+||+|+.. +++.||||++.... ....+.+++|+++|++++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            46888899999999999999964 68999999875433 223567899999999999999999999996543    2345


Q ss_pred             EEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccCCCC
Q 042150          535 VYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRSGPC  614 (803)
Q Consensus       535 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~~~~  614 (803)
                      +++|+.+|+|.+++.   ...+++.++..++.|++.||+|||+   ++|+||||||+||||+.++.+||+|||+++....
T Consensus        88 l~~~~~~g~L~~~l~---~~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          88 LVTHLMGADLYKLLK---TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEECCCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEeecCCchhhhhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            556777999999994   3469999999999999999999999   9999999999999999999999999999975332


Q ss_pred             CCC-CceeccccCCCcccCccccc-cCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCcc----
Q 042150          615 LDE-THVSTGVKGSFGYLDPEYFR-RQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGML----  688 (803)
Q Consensus       615 ~~~-~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----  688 (803)
                      ... ........||+.|+|||.+. +..++.++||||+||++|||++|+.||......+.................    
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            211 11234467899999999985 456788999999999999999999999765433222111110000000000    


Q ss_pred             -----ccc-cCccccc----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          689 -----EHI-IDPQLIG----KINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       689 -----~~i-~d~~l~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                           ... ..+....    ........++.+++.+||+.||.+|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 000 0000000    0011223568899999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-41  Score=359.54  Aligned_cols=253  Identities=25%  Similarity=0.295  Sum_probs=200.9

Q ss_pred             cCCCccceEeeeCceEEEEEEEC----CCcEEEEEEcCCC----CCCChHHHHHHHHHHHhccC-CCeeeEEeEeeccce
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR----DNTKVAVKRGVPG----SRQGLPEFQTEITVLSKIRH-RHLVSLVGYCEEQSE  531 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~f~~E~~~l~~l~H-pnIv~l~g~~~~~~~  531 (803)
                      ++|+..+.||+|+||+||+|+..    +|+.||||.+...    .....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999862    3789999986432    23446678999999999976 899999999999999


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .++||||+.+|+|.+++.  ....++......++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~--~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHH--hcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            999999999999999984  34467889999999999999999999   9999999999999999999999999999976


Q ss_pred             CCCCCCCceeccccCCCcccCccccccC--cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcCccc
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRRQ--QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKGMLE  689 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (803)
                      ... ..........|++.|+|||.+.+.  .++.++|||||||+||||++|+.||......+..  ..........    
T Consensus       179 ~~~-~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~~~----  251 (322)
T d1vzoa_         179 FVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS----  251 (322)
T ss_dssp             CCG-GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC----
T ss_pred             hcc-cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcccC----
Confidence            432 122223456799999999999754  5788999999999999999999999754332211  1111111110    


Q ss_pred             cccCcccccCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042150          690 HIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPS-----MGDVLWN  732 (803)
Q Consensus       690 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~  732 (803)
                             ...++...+.++.+++.+||+.||.+|||     ++|++++
T Consensus       252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                   01223345678899999999999999994     7888764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-40  Score=358.68  Aligned_cols=261  Identities=21%  Similarity=0.267  Sum_probs=190.5

Q ss_pred             cCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCC--CCChHHHHHHHHHHHhccCCCeeeEEeEeec------cce
Q 042150          461 NNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGS--RQGLPEFQTEITVLSKIRHRHLVSLVGYCEE------QSE  531 (803)
Q Consensus       461 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~------~~~  531 (803)
                      ++|+..++||+|+||+||+|+.. +|+.||||++....  .....++.+|+.+|++++||||++++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57899999999999999999976 58999999875443  2234568999999999999999999999953      468


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      +|+||||+.++.+. .+    ...+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~~-~~----~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VI----QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHH-HH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchHHHH-hh----hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence            89999999775554 44    2358999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHH---------H-H---
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLA---------E-W---  678 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~-~---  678 (803)
                      ..   .........+|+.|+|||++.+..++.++||||+||++|||++|+.||............         + |   
T Consensus       169 ~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         169 AG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             cc---cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            32   223334567899999999999999999999999999999999999999654322211100         0 0   


Q ss_pred             ---HHHHhhcC-cc-----ccccCcccccC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          679 ---AMQWQKKG-ML-----EHIIDPQLIGK---INLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       679 ---~~~~~~~~-~~-----~~i~d~~l~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                         ........ ..     ...........   ........+.+|+.+||..||++|||++|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               00000000 00     00011111111   112356788999999999999999999999876

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-40  Score=356.28  Aligned_cols=258  Identities=21%  Similarity=0.281  Sum_probs=194.5

Q ss_pred             hcCCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCC--CChHHHHHHHHHHHhccCCCeeeEEeEeec-----cce
Q 042150          460 TNNFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSR--QGLPEFQTEITVLSKIRHRHLVSLVGYCEE-----QSE  531 (803)
Q Consensus       460 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-----~~~  531 (803)
                      .++|+..+.||+|+||+||+|+.. +|+.||||++.....  ...+.+.+|+++|++++||||+++++++..     ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            467999999999999999999964 689999999764432  234578899999999999999999999853     334


Q ss_pred             eeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          532 MILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       532 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      .+++++|+.+|+|.+++.   ...+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence            577788889999999993   3469999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCCCCceeccccCCCcccCccccccC-cCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhhHHHHHHHHhhcC----
Q 042150          612 GPCLDETHVSTGVKGSFGYLDPEYFRRQ-QLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVNLAEWAMQWQKKG----  686 (803)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----  686 (803)
                      ..     .......|+..|+|||.+.+. .++.++|||||||++|||++|+.||............   .......    
T Consensus       171 ~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~~~~~~  242 (348)
T d2gfsa1         171 TD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAEL  242 (348)
T ss_dssp             CT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCHHH
T ss_pred             cC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChHH
Confidence            32     223446789999999987665 5688999999999999999999999754332221111   0000000    


Q ss_pred             --------------ccccccCcccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042150          687 --------------MLEHIIDPQLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDVLWN  732 (803)
Q Consensus       687 --------------~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~  732 (803)
                                    .........+.. ........+.+|+.+||..||.+|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         243 LKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HTTCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                          000000000000 001234567899999999999999999999875

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-34  Score=316.67  Aligned_cols=263  Identities=19%  Similarity=0.206  Sum_probs=190.0

Q ss_pred             CCCccceEeeeCceEEEEEEEC-CCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-----------CCCeeeEEeEeecc
Q 042150          462 NFDKNLIIGSGGFGMVYKGVLR-DNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-----------HRHLVSLVGYCEEQ  529 (803)
Q Consensus       462 ~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----------HpnIv~l~g~~~~~  529 (803)
                      +|...++||+|+||+||+|+.. +|+.||||++.... ...+.+.+|+++++.++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            4888999999999999999974 68999999975432 22467789999998875           57899999988543


Q ss_pred             --ceeeEEEEecCCCch-hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCC------c
Q 042150          530 --SEMILVYEYMEKGPL-KKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENY------V  600 (803)
Q Consensus       530 --~~~~lV~Ey~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~------~  600 (803)
                        ...+++|+++..+.. ...........+++..+..++.||+.||+|||+  ..+|+||||||+||||+.++      .
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence              456677776655433 333333456678999999999999999999996  37899999999999998655      4


Q ss_pred             EEEeeeccccCCCCCCCCceeccccCCCcccCccccccCcCCCcceehhHHHHHHHHHhCCCCCCcchhhhhhh----HH
Q 042150          601 SKVADFGLSRSGPCLDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARTAVDPLLAREQVN----LA  676 (803)
Q Consensus       601 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~----l~  676 (803)
                      +||+|||.++....     ......||+.|+|||++.+..++.++||||+||+++||++|+.||..........    +.
T Consensus       171 ~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         171 IKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            89999999875321     2234679999999999999999999999999999999999999987543221111    11


Q ss_pred             HHHHHH-------hhcC-ccccccC---------c----------ccccCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 042150          677 EWAMQW-------QKKG-MLEHIID---------P----------QLIGKINLDSLKKFGETAEKCLADYGVDRPSMGDV  729 (803)
Q Consensus       677 ~~~~~~-------~~~~-~~~~i~d---------~----------~l~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev  729 (803)
                      ......       .... ......+         .          ...........+.+.+|+.+||..||.+|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            111000       0000 0000000         0          00122345677889999999999999999999999


Q ss_pred             HHH
Q 042150          730 LWN  732 (803)
Q Consensus       730 l~~  732 (803)
                      |++
T Consensus       326 L~H  328 (362)
T d1q8ya_         326 VNH  328 (362)
T ss_dssp             HTC
T ss_pred             hcC
Confidence            875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=4.1e-22  Score=195.97  Aligned_cols=163  Identities=16%  Similarity=0.145  Sum_probs=119.6

Q ss_pred             CccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCC-------------C-----hHHHHHHHHHHHhccCCCeeeEEeE
Q 042150          464 DKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQ-------------G-----LPEFQTEITVLSKIRHRHLVSLVGY  525 (803)
Q Consensus       464 ~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------~-----~~~f~~E~~~l~~l~HpnIv~l~g~  525 (803)
                      ..+++||+|+||+||+|+..+|+.||||........             .     ...+.+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            356799999999999999989999999975432110             0     1234568889999999999988866


Q ss_pred             eeccceeeEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceEeeccCcceEEEccCCcEEEee
Q 042150          526 CEEQSEMILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGSAEGIIHRDIKSTNILLDENYVSKVAD  605 (803)
Q Consensus       526 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLkp~NILl~~~~~~kl~D  605 (803)
                      ..    .+++|||+++..+.+         ++.....+++.|++++|+|||+   ++|+||||||+|||++++ .++|+|
T Consensus        83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred             cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence            42    379999998866544         3344567899999999999999   999999999999999865 589999


Q ss_pred             eccccCCCCCCCCceeccccCCCcccCc------cccccCcCCCcceehhHHHHH
Q 042150          606 FGLSRSGPCLDETHVSTGVKGSFGYLDP------EYFRRQQLTDKSDVYSFGVVL  654 (803)
Q Consensus       606 FGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~t~ksDV~S~Gvvl  654 (803)
                      ||+|+.......          ..|...      |. -.+.|..++|+||..--+
T Consensus       146 FG~a~~~~~~~~----------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGW----------REILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTH----------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCc----------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            999875321110          011111      11 136788999999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.46  E-value=3.9e-07  Score=91.78  Aligned_cols=149  Identities=14%  Similarity=0.081  Sum_probs=103.7

Q ss_pred             hhHHHHhcCCCccceEeeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeecccee
Q 042150          454 TDLQTATNNFDKNLIIGSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEM  532 (803)
Q Consensus       454 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~  532 (803)
                      .++...-..|...+..+-++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.++.+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            35666666776655433344568998764 46677888866555555567888999988874 44467788888888899


Q ss_pred             eEEEEecCCCchhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------
Q 042150          533 ILVYEYMEKGPLKKHLYGPDRTPLSWKQRLEICIGAARGLHYLHTGS---------------------------------  579 (803)
Q Consensus       533 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------  579 (803)
                      ++||+++++.++.+....       ......++.++++.|..||+..                                 
T Consensus        86 ~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            999999999888665411       1122334556666666666411                                 


Q ss_pred             -----------------------CCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          580 -----------------------AEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       580 -----------------------~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                                             ...++|+|+.|.|||+++++..-|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                   1247999999999999987777899999764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.93  E-value=2.8e-05  Score=77.30  Aligned_cols=129  Identities=21%  Similarity=0.170  Sum_probs=86.1

Q ss_pred             EeeeCc-eEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccC--CCeeeEEeEeeccceeeEEEEecCCCchh
Q 042150          469 IGSGGF-GMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRH--RHLVSLVGYCEEQSEMILVYEYMEKGPLK  545 (803)
Q Consensus       469 Lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gsL~  545 (803)
                      +..|.. +.||+...+++..+++|.......   .++..|...|+.+..  -.+.++++++.+.+..++||+++++.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            344443 678998887788889997554432   356788888887743  33567788888888899999999987664


Q ss_pred             hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 042150          546 KHLYGPDRTPLSWKQRLEICIGAARGLHYLHT------------------------------------------------  577 (803)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~------------------------------------------------  577 (803)
                      +..       +..   ..++.++++.|.-||+                                                
T Consensus        95 ~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          95 SSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             ccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            421       110   1112233333333332                                                


Q ss_pred             -------CCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          578 -------GSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       578 -------~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                             .....++|+|+.|.|||++++..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                   012348999999999999987777899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.43  E-value=0.00021  Score=75.89  Aligned_cols=75  Identities=16%  Similarity=0.164  Sum_probs=49.2

Q ss_pred             ceEeeeCceEEEEEEECC-CcEEEEEEcCCC-------CCCChHHHHHHHHHHHhcc-C--CCeeeEEeEeeccceeeEE
Q 042150          467 LIIGSGGFGMVYKGVLRD-NTKVAVKRGVPG-------SRQGLPEFQTEITVLSKIR-H--RHLVSLVGYCEEQSEMILV  535 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~f~~E~~~l~~l~-H--pnIv~l~g~~~~~~~~~lV  535 (803)
                      +.||.|....||+....+ ++.++||.-.+.       ......+...|.+.|+.+. +  ..+++++.++  ....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence            368999999999988654 678999963321       1223456677888888773 2  3455666554  3456789


Q ss_pred             EEecCCCc
Q 042150          536 YEYMEKGP  543 (803)
Q Consensus       536 ~Ey~~~gs  543 (803)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.76  E-value=0.0028  Score=64.92  Aligned_cols=135  Identities=16%  Similarity=0.100  Sum_probs=80.3

Q ss_pred             ceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCee--eEEe-----EeeccceeeEEEEecCCCchhh
Q 042150          474 FGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHLV--SLVG-----YCEEQSEMILVYEYMEKGPLKK  546 (803)
Q Consensus       474 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnIv--~l~g-----~~~~~~~~~lV~Ey~~~gsL~~  546 (803)
                      --.||+...++|+.+++|...+. ....+++..|...|..|....+.  ..+.     .....+..+.++++++|..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            35899999999999999986554 34567788999999888533221  1111     2234556788999998754321


Q ss_pred             -----------hc---c----C---CCCCCCCHH----------------------HHHHHHHHHHHHHHHH-hcCCCCc
Q 042150          547 -----------HL---Y----G---PDRTPLSWK----------------------QRLEICIGAARGLHYL-HTGSAEG  582 (803)
Q Consensus       547 -----------~l---~----~---~~~~~l~~~----------------------~~~~i~~~ia~gL~yL-H~~~~~~  582 (803)
                                 .+   |    .   ..+..+++.                      .....+.++...+.-+ .+....+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                       00   0    0   011112211                      1112222233222222 1223467


Q ss_pred             eEeeccCcceEEEccCCcEEEeeeccccC
Q 042150          583 IIHRDIKSTNILLDENYVSKVADFGLSRS  611 (803)
Q Consensus       583 ivHrDLkp~NILl~~~~~~kl~DFGla~~  611 (803)
                      +||+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            9999999999999754  45899997764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.50  E-value=0.0046  Score=65.08  Aligned_cols=72  Identities=18%  Similarity=0.181  Sum_probs=49.9

Q ss_pred             ceEeeeCceEEEEEEECCC--------cEEEEEEcCCCCCCChHHHHHHHHHHHhcc-CCCeeeEEeEeeccceeeEEEE
Q 042150          467 LIIGSGGFGMVYKGVLRDN--------TKVAVKRGVPGSRQGLPEFQTEITVLSKIR-HRHLVSLVGYCEEQSEMILVYE  537 (803)
Q Consensus       467 ~~Lg~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E  537 (803)
                      +.|+.|-.-.+|+....++        ..|+++..- . .....+..+|..+++.+. +.-..+++++|.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4678888899999887643        346665533 2 334556778999999885 4334577787754    58999


Q ss_pred             ecCCCch
Q 042150          538 YMEKGPL  544 (803)
Q Consensus       538 y~~~gsL  544 (803)
                      |+++..|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.35  E-value=0.008  Score=60.88  Aligned_cols=157  Identities=13%  Similarity=0.066  Sum_probs=85.5

Q ss_pred             cChhhHHHHhcCCCccceE-----eeeCceEEEEEEECCCcEEEEEEcCCCCCCChHHHHHHHHHHHhccCCCe--eeEE
Q 042150          451 IPFTDLQTATNNFDKNLII-----GSGGFGMVYKGVLRDNTKVAVKRGVPGSRQGLPEFQTEITVLSKIRHRHL--VSLV  523 (803)
Q Consensus       451 ~~~~~l~~~~~~f~~~~~L-----g~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~HpnI--v~l~  523 (803)
                      ++.+++.....+|..+++.     ..|---+.|+...++| .+++|+.....  ..++...|+++|..|.+.++  ...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            4567888888889876543     3555678899887765 47888754322  23455667777777753322  1111


Q ss_pred             e------EeeccceeeEEEEecCCCchhhhc--------------c----C---CC-CCCC-----------------CH
Q 042150          524 G------YCEEQSEMILVYEYMEKGPLKKHL--------------Y----G---PD-RTPL-----------------SW  558 (803)
Q Consensus       524 g------~~~~~~~~~lV~Ey~~~gsL~~~l--------------~----~---~~-~~~l-----------------~~  558 (803)
                      .      +.........++.++.+......-              +    .   .. ....                 ..
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      112234556667776654331100              0    0   00 0000                 00


Q ss_pred             HHHHHHHHHHHHHHHHHhc-CCCCceEeeccCcceEEEccCCcEEEeeecccc
Q 042150          559 KQRLEICIGAARGLHYLHT-GSAEGIIHRDIKSTNILLDENYVSKVADFGLSR  610 (803)
Q Consensus       559 ~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLkp~NILl~~~~~~kl~DFGla~  610 (803)
                      ......+..+...+.-.+. ....++||+|+.+.||+++.+...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            1111222222222332221 245789999999999999988878899999764

>d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]}

class: All beta proteins
fold: Galactose-binding domain-like
superfamily: Galactose-binding domain-like
family: YxiM N-terminal domain-like
domain: Hypothetical protein YxiM
species: Bacillus subtilis [TaxId: 1423]

Probab=96.15  E-value=0.019  Score=50.70  Aligned_cols=80  Identities=13%  Similarity=0.189  Sum_probs=63.5

Q ss_pred             ceeEEeeecCceEEEEEeecCCCCCcccccccEEEEEECcEEEEeccCCCceEEEEEEEEecCCeEEEEEeecCCCCcce
Q 042150           61 GSYKLNIKRNGTHLVRFHFSPFESDNFKLASAKFGVLANGLLLLQDFSTQVVVLKEFIVKVDGDVIEIEFRPVGDKNFGF  140 (803)
Q Consensus        61 ~cY~~~~~~~~~ylvR~~F~~~~~~~~~~~~~~F~~~~~~~~~~~~~~~~~~~~~e~i~~~~~~~~~v~~~~~~~~~~~f  140 (803)
                      +.|.+++ +.|.|.|+++|-.-         ...++.+.|-..+..+.. ...-+.+.+.+.++.|+|.|....++.+|-
T Consensus        65 ~~f~v~v-PnG~Y~Vtv~~Gd~---------~~~~~~~eg~~~~~~~~g-~~~~~~~~V~VtDG~L~l~ft~~~~G~~~~  133 (146)
T d2o14a1          65 NTFNVDL-PNGLYEVKVTLGNT---------ARASVAAEGVFQVINMTG-DGAEDTFQIPVTDGQLNLLVTEGKAGTAFT  133 (146)
T ss_dssp             CCEEEEC-CSEEEEEEEEESSC---------SEEEEEETTEEEEEEEES-TTCEEEEEEEECSSEEEEEEEESSTTSCCE
T ss_pred             ceEEEEC-CCCeEEEEEEEecC---------CCccEEEeeEEeccccCC-ccEEEEEEEEEECCeEEEEEecCCCCCccE
Confidence            5788888 79999999998751         234677888777766544 234567889999999999998776788999


Q ss_pred             eeeeEEEecCC
Q 042150          141 VNAIEVFSAPE  151 (803)
Q Consensus       141 v~~iE~~~~~~  151 (803)
                      ||+|||-+.++
T Consensus       134 in~l~I~~~~d  144 (146)
T d2o14a1         134 LSALKIKKLSD  144 (146)
T ss_dssp             EEEEEEEEEES
T ss_pred             EEEEEEEeccc
Confidence            99999998765

>d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]}

class: All beta proteins
fold: Galactose-binding domain-like
superfamily: Galactose-binding domain-like
family: YxiM N-terminal domain-like
domain: Hypothetical protein YxiM
species: Bacillus subtilis [TaxId: 1423]

Probab=95.19  E-value=0.029  Score=49.50  Aligned_cols=79  Identities=11%  Similarity=0.081  Sum_probs=56.6

Q ss_pred             eeEeeeccCCCCeeEEEEEeeeeecCCCCcEEEEEEEcCeeecccCCccccccCCccccEEEEeEEeecCCceeEEEEec
Q 042150          261 ITWDFPVGSHGNRHLVRLHFCDIVSPSLNQLYFNVFINDYSAYKDLDLSSITFHSLASPVYMDFVADSDDAGVVRVSVGP  340 (803)
Q Consensus       261 lt~~~~~~~~~~~y~v~lhFae~~~~~~~~R~Fdi~in~~~~~~~~di~~~~~~~~~~~~~~~~~~~~~~~~~~~is~~~  340 (803)
                      ..|.++++  +|.|.|.++|.|.       ...++.+.|......     .    .+....+.|.|.+ .+|.|+|.+..
T Consensus        65 ~~f~v~vP--nG~Y~Vtv~~Gd~-------~~~~~~~eg~~~~~~-----~----~g~~~~~~~~V~V-tDG~L~l~ft~  125 (146)
T d2o14a1          65 NTFNVDLP--NGLYEVKVTLGNT-------ARASVAAEGVFQVIN-----M----TGDGAEDTFQIPV-TDGQLNLLVTE  125 (146)
T ss_dssp             CCEEEECC--SEEEEEEEEESSC-------SEEEEEETTEEEEEE-----E----ESTTCEEEEEEEE-CSSEEEEEEEE
T ss_pred             ceEEEECC--CCeEEEEEEEecC-------CCccEEEeeEEeccc-----c----CCccEEEEEEEEE-ECCeEEEEEec
Confidence            46999998  5999999999995       345788888776542     2    2333456777877 45789998744


Q ss_pred             cCCCCccccccccccceeeeec
Q 042150          341 SELSGSLKVNAILNGVEIMKMV  362 (803)
Q Consensus       341 s~~s~~~~~~~ilng~ei~~~~  362 (803)
                      .....    .+.||++||.+..
T Consensus       126 ~~~G~----~~~in~l~I~~~~  143 (146)
T d2o14a1         126 GKAGT----AFTLSALKIKKLS  143 (146)
T ss_dssp             SSTTS----CCEEEEEEEEEEE
T ss_pred             CCCCC----ccEEEEEEEEecc
Confidence            33211    7899999998864